Citrus Sinensis ID: 003780
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 796 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.861 | 0.656 | 0.393 | 1e-144 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.864 | 0.614 | 0.395 | 1e-130 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.863 | 0.623 | 0.381 | 1e-118 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.846 | 0.611 | 0.367 | 1e-111 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.874 | 0.619 | 0.368 | 1e-110 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.819 | 0.571 | 0.364 | 1e-106 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.830 | 0.582 | 0.339 | 1e-105 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.851 | 0.669 | 0.343 | 1e-103 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.824 | 0.523 | 0.347 | 1e-102 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.829 | 0.528 | 0.345 | 1e-102 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 514 bits (1324), Expect = e-144, Method: Compositional matrix adjust.
Identities = 313/795 (39%), Positives = 444/795 (55%), Gaps = 109/795 (13%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
+++ +N+ E +L GE+ L++LSL N L G IPS +G + L L N
Sbjct: 262 KNVTLLNMFENQLSGEIPP-EIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLN 320
Query: 132 NLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD 191
L GSIPPELG + ++ L + N L G +P S +LT L + L N L GPIP I +
Sbjct: 321 QLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIAN 380
Query: 192 LNNLLILSLDSNKLSGMLHQEL---GKLKNLVALNVGGNKLMGPIPSTL----------- 237
L +L LD+N +G L + GKL+NL + N GP+P +L
Sbjct: 381 STELTVLQLDTNNFTGFLPDTICRGGKLENLT---LDDNHFEGPVPKSLRDCKSLIRVRF 437
Query: 238 ---------------------FRLTN----------------LTYLYLHSNHLNGSIPPE 260
L+N L L +N + G+IPPE
Sbjct: 438 KGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPE 497
Query: 261 IGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDL 320
I NMT + ++D+S N I G +P ++ ++++ L ++ N LSG+IP I L +L+ LDL
Sbjct: 498 IWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDL 557
Query: 321 SNNKLSGPIPPEIG------------------------KCSELRNITLRNNNLSGSIPPE 356
S+N+ S IPP + K S+L+ + L N L G I +
Sbjct: 558 SSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQ 617
Query: 357 I-GLMKLEYLDLSHNKLNGTIPPFLYHRFPL---DLSYNDLEGEIPD--YFRDSPFKVY- 409
L LE LDLSHN L+G IPP L D+S+N+L+G IPD FR++P +
Sbjct: 618 FRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFE 677
Query: 410 GNQGIC-------YFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLA---FIVF 459
GN+ +C CS + + K ++L++ +L +PI +I L++ FI F
Sbjct: 678 GNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYIL---VPIIGAIIILSVCAGIFICF 734
Query: 460 LLNKNEIAKLMTGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQ 519
+I + T G+ SI+++DG++ +++IIKAT +FD KY IGTGG+G VYKA+
Sbjct: 735 RKRTKQIEE-HTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAK 793
Query: 520 LPNGKVVALKKLHRAETEETTFFN-----SFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574
LPN ++A+KKL+ ET +++ N F NE L++I HRN+VKL+GFC H++ F
Sbjct: 794 LPNA-IMAVKKLN--ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTF 850
Query: 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNN 634
L+Y+YM+RGSL L ND EA LDW R+N++K VA+ALSY+HHD P+IVHRDISS N
Sbjct: 851 LVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGN 910
Query: 635 ILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVA 694
ILL EA ++DFGTA+LL DSSN + VAGTYGY+APELAY M VTEKCDVYSFGV+
Sbjct: 911 ILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLT 970
Query: 695 LEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHS 754
LEV+ G HPG+L+S+LSS D + L + D RL P + ++++ + VAL CLHS
Sbjct: 971 LEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE-IKEEVLEILKVALLCLHS 1029
Query: 755 KPKFRPTMQRVCQEF 769
P+ RPTM + F
Sbjct: 1030 DPQARPTMLSISTAF 1044
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 467 bits (1201), Expect = e-130, Method: Compositional matrix adjust.
Identities = 283/716 (39%), Positives = 413/716 (57%), Gaps = 28/716 (3%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
S+I ++L + KL G + +F F LESL LR N+L G+IP V S L L N
Sbjct: 414 ESMINLDLSQNKLTGSVPD-SFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTN 472
Query: 132 NLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD 191
N TG P + R L+ ++L N+L G IP SL LI N G I A G
Sbjct: 473 NFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGI 532
Query: 192 LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSN 251
+L + NK G + K L AL + N + G IP+ ++ +T L L L +N
Sbjct: 533 YPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTN 592
Query: 252 HLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311
+L G +P IGN+T + ++ ++ N + G +P L+ L+ L L +SSN S +IP T
Sbjct: 593 NLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDS 652
Query: 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHN 370
+ L ++LS NK G IP + K ++L + L +N L G IP ++ L L+ LDLSHN
Sbjct: 653 FLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHN 711
Query: 371 KLNGTIPPFLYHRFPL---DLSYNDLEGEIPD---YFRDSPFKVYGNQGIC------YFS 418
L+G IP L D+S N LEG +PD + + + + N G+C
Sbjct: 712 NLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLK 771
Query: 419 ACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFL--LNKNEIAKLMTGPTKS 476
C L P K+ +LV+ +L +PI ++ L++ F + K ++ ++
Sbjct: 772 PCRELKKP--KKNGNLVVWIL---VPILGVLVILSICANTFTYCIRKRKLQNGRNTDPET 826
Query: 477 GDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAET 536
G+ SI++ DG+ ++DII++T +FD + IGTGGY VY+A L + ++A+K+LH
Sbjct: 827 GENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTID 885
Query: 537 EETT---FFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY 593
EE + F NE L++I HRN+VKL+GFC H++ FLIY+YM++GSL L ND
Sbjct: 886 EEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDE 945
Query: 594 EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653
EA L WT R+N++K VA+ALSY+HHD + IVHRDISS NILL++ A ++DFGTA+L
Sbjct: 946 EAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKL 1005
Query: 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP 713
L +DSSN + VAGTYGY+APE AYTM VTEKCDVYSFGV+ LE+++G+HPG+L+SSLSS
Sbjct: 1006 LKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSS- 1064
Query: 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
S + + L + D R+ P + + ++ + +AL CL + P+ RPTM + F
Sbjct: 1065 SPGEALSLRSISDERVLEPRGQN-REKLLKMVEMALLCLQANPESRPTMLSISTTF 1119
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 426 bits (1096), Expect = e-118, Method: Compositional matrix adjust.
Identities = 290/761 (38%), Positives = 403/761 (52%), Gaps = 74/761 (9%)
Query: 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG 135
EI+ E +L G + + F L+ L L N L G IP ++G L+ L LD S N L G
Sbjct: 311 EIDFSENQLTGFIPK-EFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNG 369
Query: 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNL 195
+IP EL L L L L N L G IP + + + +S N L GPIP+ L
Sbjct: 370 TIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTL 429
Query: 196 LILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG 255
++LSL SNKLSG + ++L K+L L +G N+L G +P LF L NLT L LH N L+G
Sbjct: 430 ILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSG 489
Query: 256 SI------------------------PPEIGNMTGILKVDMSMNNIEGTIPLEL------ 285
+I PPEIGN+T I+ ++S N + G IP EL
Sbjct: 490 NISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTI 549
Query: 286 ---------------TRLSQLLYLSI---SSNMLSGQIPITIAGLISLKGLDLSNNKLSG 327
L QL+YL I S N L+G+IP + L L L L N LS
Sbjct: 550 QRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSE 609
Query: 328 PIPPEIGKCSELR-NITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFLYHRFP 385
IP E+GK + L+ ++ + +NNLSG+IP +G L LE L L+ NKL+G IP + +
Sbjct: 610 NIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMS 669
Query: 386 L---DLSYNDLEGEIPD---YFRDSPFKVYGNQGIC--YFSACSTLHTPTASKSKSLV-- 435
L ++S N+L G +PD + R GN G+C S C L + SK L+
Sbjct: 670 LLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLING 729
Query: 436 ---LRVLNIILPITACVIFLTLAFIVFLLNKNEIAKLMTGPTKSGDVFSIWNYDGR-IAF 491
++L I + V +T + + + + E A + DV + + + +
Sbjct: 730 SQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTY 789
Query: 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHV 551
+ ++ AT +F +G G G+VYKA++ G+V+A+KKL+ + E + NSF+ E
Sbjct: 790 QGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEIST 848
Query: 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
L KI HRNIVKLYGFC H+ L+Y+YM +GSL L+ + +LDW R I A
Sbjct: 849 LGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAA 908
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD-SDSSNRTIVAGTYGY 670
L YLHHDC P IVHRDI SNNILL+ + +A V DFG A+L+D S S + + VAG+YGY
Sbjct: 909 EGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGY 968
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP------GELLSSLSSPSSDQKIMLIDV 724
IAPE AYTM VTEKCD+YSFGVV LE++ G+ P G L + S I I++
Sbjct: 969 IAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEM 1028
Query: 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
D+RL D+ + ++ LV +AL C + P RPTM+ V
Sbjct: 1029 FDARLDTN-DKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1038), Expect = e-111, Method: Compositional matrix adjust.
Identities = 285/776 (36%), Positives = 400/776 (51%), Gaps = 102/776 (13%)
Query: 75 IEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLT 134
IEI+ E L GE+ GLE L L N L G+IP ++ L L LD S N LT
Sbjct: 316 IEIDFSENALTGEIP-LELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALT 374
Query: 135 GSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNN 194
G IP LR L +L L N+L+G IP L + L + +S N L G IPS + +N
Sbjct: 375 GPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSN 434
Query: 195 LLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254
++IL+L +N LSG + + K LV L + N L+G PS L + N+T + L N
Sbjct: 435 MIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFR 494
Query: 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314
GSIP E+GN + + ++ ++ N G +P E+ LSQL L+ISSN L+G++P I
Sbjct: 495 GSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKM 554
Query: 315 LKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG----LMKLEY------ 364
L+ LD+ N SG +P E+G +L + L NNNLSG+IP +G L +L+
Sbjct: 555 LQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFN 614
Query: 365 ----------------LDLSHNKLNGTIPPFLYHRFPLDL-------------------- 388
L+LS+NKL G IPP L + L+
Sbjct: 615 GSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLS 674
Query: 389 -------SYNDLEGEIPDYFRDSPFKVYGNQGICYFSACSTLHT----PTASKSKSLVLR 437
SYN L G IP S GN+G+C + T P+ S K +R
Sbjct: 675 SLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMR 734
Query: 438 VLNIILPITACVI----FLTLAFIVFLLNK--------------NEIAKLMTGPTKSGDV 479
II ITA VI + +A IV+L+ + +E++ + P K G
Sbjct: 735 SSKII-AITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-- 791
Query: 480 FSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKL--HRAETE 537
F+D++ AT++FD + +G G G+VYKA LP G +A+KKL +
Sbjct: 792 ---------FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGN 842
Query: 538 ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV 597
NSF+ E L I HRNIVKL+GFC H+ L+Y+YM +GSL L + +
Sbjct: 843 NNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDP--SCN 900
Query: 598 LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD-S 656
LDW+ R I A L+YLHHDC P I HRDI SNNILL+ K EA V DFG A+++D
Sbjct: 901 LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 960
Query: 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP-------GELLSS 709
S + + +AG+YGYIAPE AYTM VTEK D+YS+GVV LE+L G+ P G++++
Sbjct: 961 HSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNW 1020
Query: 710 LSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
+ S + + VLD+RL+ +R+V ++ V +AL C P RP+M++V
Sbjct: 1021 VRS-YIRRDALSSGVLDARLTLEDERIV-SHMLTVLKIALLCTSVSPVARPSMRQV 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-110, Method: Compositional matrix adjust.
Identities = 274/744 (36%), Positives = 399/744 (53%), Gaps = 48/744 (6%)
Query: 62 KLDGVTCN---TARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVG 118
KL G+ N R++ +++L L G + F + L L N L G IP +G
Sbjct: 360 KLTGIIPNELSKLRNLAKLDLSINSLTGPIPP-GFQNLTSMRQLQLFHNSLSGVIPQGLG 418
Query: 119 ALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178
S L +DFS N L+G IPP + NL +LNL N + G IP + + L+ + +
Sbjct: 419 LYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVG 478
Query: 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF 238
N L G P+ + L NL + LD N+ SG L E+G + L L++ N+ +P+ +
Sbjct: 479 NRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEIS 538
Query: 239 RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISS 298
+L+NL + SN L G IP EI N + ++D+S N+ G++P EL L QL L +S
Sbjct: 539 KLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSE 598
Query: 299 NMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELR-NITLRNNNLSGSIPPEI 357
N SG IP TI L L L + N SG IPP++G S L+ + L N+ SG IPPEI
Sbjct: 599 NRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEI 658
Query: 358 G-LMKLEYLDLSHNKLNGTIPPFLYHRFPL---DLSYNDLEGEIP--DYFRDSPFKVY-G 410
G L L YL L++N L+G IP + L + SYN+L G++P F++ + G
Sbjct: 659 GNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLG 718
Query: 411 NQGIC--YFSACSTLHT--PTASKSKSLVLR---VLNIILPITACVIFLTLAFIVFLLNK 463
N+G+C + +C H+ P S K+ R ++ I+ + + L +A +V L +
Sbjct: 719 NKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFL-R 777
Query: 464 NEIAKLMTGPT--------KSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSV 515
N + T P + D++ + R +DI++AT+ F Y +G G G+V
Sbjct: 778 NPVEP--TAPYVHDKEPFFQESDIYFV--PKERFTVKDILEATKGFHDSYIVGRGACGTV 833
Query: 516 YKAQLPNGKVVALKKLHRAETEETTFFNS----FQNEAHVLSKIAHRNIVKLYGFCLHK- 570
YKA +P+GK +A+KKL N+ F+ E L KI HRNIV+LY FC H+
Sbjct: 834 YKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQG 893
Query: 571 -KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRD 629
L+Y+YM RGSL L ++ +DW R I A L+YLHHDC P I+HRD
Sbjct: 894 SNSNLLLYEYMSRGSLGELLHGG-KSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRD 952
Query: 630 ISSNNILLNSKLEAFVADFGTARLLDSD-SSNRTIVAGTYGYIAPELAYTMVVTEKCDVY 688
I SNNIL++ EA V DFG A+++D S + + VAG+YGYIAPE AYTM VTEKCD+Y
Sbjct: 953 IKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIY 1012
Query: 689 SFGVVALEVLMGRHP-------GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDI 741
SFGVV LE+L G+ P G+L + + D + ++LD L+ D +++ +
Sbjct: 1013 SFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLT-SEILDPYLTKVEDDVILNHM 1071
Query: 742 VLVTTVALACLHSKPKFRPTMQRV 765
+ VT +A+ C S P RPTM+ V
Sbjct: 1072 ITVTKIAVLCTKSSPSDRPTMREV 1095
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-106, Method: Compositional matrix adjust.
Identities = 266/729 (36%), Positives = 375/729 (51%), Gaps = 77/729 (10%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
LE + N GSIP+ + S L L N ++G IP ELG+L L + N L
Sbjct: 348 LEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLE 407
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKN 218
G+IP L T L + LSRN L G IPS + L NL L L SN LSG + QE+G +
Sbjct: 408 GSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSS 467
Query: 219 LVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278
LV L +G N++ G IPS + L + +L SN L+G +P EIG+ + + +D+S N++E
Sbjct: 468 LVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLE 527
Query: 279 GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSE 338
G++P ++ LS L L +S+N SG+IP ++ L+SL L LS N SG IP +G CS
Sbjct: 528 GSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSG 587
Query: 339 LRNITLRNNNLSGSIPPEIG--------------------------LMKLEYLDLSHNKL 372
L+ + L +N LSG IP E+G L KL LDLSHN L
Sbjct: 588 LQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNML 647
Query: 373 NGTIPPF--LYHRFPLDLSYNDLEGEIPD--YFRD-SPFKVYGNQGICYFSACSTLHT-- 425
G + P + + L++SYN G +PD FR SP + GN+ +C + S T
Sbjct: 648 EGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYR 707
Query: 426 --------PTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKNEIAKLMTGPTKSG 477
AS+++ L L + +I +I +A I N + G T
Sbjct: 708 KGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKW 767
Query: 478 DV--FSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRA- 534
F N+ + + II+ + ++ IG G G VY+A + NG+V+A+KKL A
Sbjct: 768 QFTPFQKLNF----SVDQIIRCLVEPNV---IGKGCSGVVYRADVDNGEVIAVKKLWPAM 820
Query: 535 -----ETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL 589
+ + +SF E L I H+NIV+ G C ++ L+Y YM GSL L
Sbjct: 821 VNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 880
Query: 590 RNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649
++ LDW +R I+ A L+YLHHDC+P IVHRDI +NNIL+ E ++ADFG
Sbjct: 881 -HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFG 939
Query: 650 TARLLDSDSSNR--TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELL 707
A+L+D R VAG+YGYIAPE Y+M +TEK DVYS+GVV LEVL G+ P +
Sbjct: 940 LAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID-- 997
Query: 708 SSLSSPSSDQKIMLID----------VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPK 757
P+ + I L+D VLDS L + +++ V AL C++S P
Sbjct: 998 -----PTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEA-DEMMQVLGTALLCVNSSPD 1051
Query: 758 FRPTMQRVC 766
RPTM+ V
Sbjct: 1052 ERPTMKDVA 1060
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (986), Expect = e-105, Method: Compositional matrix adjust.
Identities = 264/778 (33%), Positives = 386/778 (49%), Gaps = 117/778 (15%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
LE + L N L G IP ++G + L +D S N +G+IP G+L NL+ L L NN+
Sbjct: 301 LEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNIT 360
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKN 218
G+IPS L TKL+ + N + G IP IG L L I NKL G + EL +N
Sbjct: 361 GSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQN 420
Query: 219 LVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV-------- 270
L AL++ N L G +P+ LF+L NLT L L SN ++G IP EIGN T ++++
Sbjct: 421 LQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRIT 480
Query: 271 ----------------DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314
D+S NN+ G +PLE++ QL L++S+N L G +P++++ L
Sbjct: 481 GEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTK 540
Query: 315 LKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLN 373
L+ LD+S+N L+G IP +G L + L N+ +G IP +G L+ LDLS N ++
Sbjct: 541 LQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNIS 600
Query: 374 GTIPPFLYHRFPLD----LSYNDLEGEIPD------------------------------ 399
GTIP L+ LD LS+N L+G IP+
Sbjct: 601 GTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLEN 660
Query: 400 -------------YFRDSPF-------KVYGNQGIC-------YFSACSTLHTPTASKSK 432
Y DS ++ GN G+C + S S L T S
Sbjct: 661 LVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSH 720
Query: 433 SLVLRVLNIILPITACVIFLTLAFIVFLLNKNEIAKLMTGPTKSGDVFSIWNYDG----R 488
L + + +++ +TA + L + + K I +++G+ W +
Sbjct: 721 RLRIAI-GLLISVTA--VLAVLGVLAVIRAKQMIRD--DNDSETGENLWTWQFTPFQKLN 775
Query: 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLH-------RAETEETTF 541
E ++K + ++ IG G G VYKA++PN +V+A+KKL +T+ +
Sbjct: 776 FTVEHVLKCLVEGNV---IGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGV 832
Query: 542 FNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWT 601
+SF E L I H+NIV+ G C +K L+Y YM GSL L L W
Sbjct: 833 RDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWE 892
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
+R II A L+YLHHDC+P IVHRDI +NNIL+ E ++ DFG A+L+D R
Sbjct: 893 VRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFAR 952
Query: 662 T--IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE--LLSSLSSPSSDQ 717
+ +AG+YGYIAPE Y+M +TEK DVYS+GVV LEVL G+ P + + L +
Sbjct: 953 SSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVK 1012
Query: 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQ-------RVCQE 768
KI I V+D L + V ++++ VAL C++ P+ RPTM+ +CQE
Sbjct: 1013 KIRDIQVIDQGLQARPESEV-EEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEICQE 1069
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (962), Expect = e-103, Method: Compositional matrix adjust.
Identities = 272/791 (34%), Positives = 386/791 (48%), Gaps = 113/791 (14%)
Query: 77 INLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGS 136
+ L L GEL P LE+ L +N G IP + G ++ L+YLD + L+G
Sbjct: 193 LGLSGNNLTGELPSV-LGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGE 251
Query: 137 IPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALS------------------- 177
IP ELG L++LE L L NN G IP + +T L + S
Sbjct: 252 IPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQ 311
Query: 178 -----RNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP 232
RN L G IP AI L L +L L +N LSG L +LGK L L+V N G
Sbjct: 312 LLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGE 371
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292
IPSTL NLT L L +N G IP + +++V M N + G+IP+ +L +L
Sbjct: 372 IPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQ 431
Query: 293 YLSISSNMLSGQIPITIAGLISLK------------------------------------ 316
L ++ N LSG IP I+ +SL
Sbjct: 432 RLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGE 491
Query: 317 ------------GLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMK-LE 363
LDLS+N L+G IP I C +L ++ LRNNNL+G IP +I M L
Sbjct: 492 VPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALA 551
Query: 364 YLDLSHNKLNGTIPPFLYHRFPLDL---SYNDLEGEIP--DYFRD-SPFKVYGNQGIC-- 415
LDLS+N L G +P + L+L SYN L G +P + + +P + GN G+C
Sbjct: 552 VLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGG 611
Query: 416 YFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFL-TLAFIVFLLNKNEIAKLMTGPT 474
CS T+S S R++ L A V+ L L + L K + G
Sbjct: 612 VLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDE 671
Query: 475 KSGDVFSIWNYDG--RIAF--EDIIKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALK 529
+ W R+ F DI+ ++ ++ IG G G VYKA++ + V+A+K
Sbjct: 672 TASKGEWPWRLMAFHRLGFTASDILACIKESNM---IGMGATGIVYKAEMSRSSTVLAVK 728
Query: 530 KLHRAETE-ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCF 588
KL R+ + E F E ++L K+ HRNIV+L GF + K M ++Y++M G+L
Sbjct: 729 KLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDA 788
Query: 589 L--RNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA 646
+ +N +++DW R NI VA+ L+YLHHDC P ++HRDI SNNILL++ L+A +A
Sbjct: 789 IHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIA 848
Query: 647 DFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEL 706
DFG AR++ ++VAG+YGYIAPE YT+ V EK D+YS+GVV LE+L GR P E
Sbjct: 849 DFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLE- 907
Query: 707 LSSLSSPSSDQKIMLID----------VLDSRLSPPVD--RMVMQDIVLVTTVALACLHS 754
P + + +++ L+ L P V R V ++++LV +AL C
Sbjct: 908 ------PEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTK 961
Query: 755 KPKFRPTMQRV 765
PK RP+M+ V
Sbjct: 962 LPKDRPSMRDV 972
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 375 bits (962), Expect = e-102, Method: Compositional matrix adjust.
Identities = 255/733 (34%), Positives = 387/733 (52%), Gaps = 77/733 (10%)
Query: 75 IEINLPEKKLK-GELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNL 133
++ NLP+ + L++ NFS S +FN GSI G+ S L + D + N
Sbjct: 541 LQGNLPDSLINLKNLTRINFS--------SNKFN---GSISPLCGSSSYLSF-DVTENGF 588
Query: 134 TGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLN 193
G IP ELG NL+ L L N G IP + ++++L + +SRN L G IP +G
Sbjct: 589 EGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCK 648
Query: 194 NLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253
L + L++N LSG++ LGKL L L + NK +G +P+ +F LTN+ L+L N L
Sbjct: 649 KLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSL 708
Query: 254 NGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLI 313
NGSIP EIGN+ + +++ N + G +P + +LS+L L +S N L+G+IP+ I L
Sbjct: 709 NGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQ 768
Query: 314 SLK-GLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMK-LEYLDLSHNK 371
L+ LDLS N +G IP I +L ++ L +N L G +P +IG MK L Y
Sbjct: 769 DLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGY------- 821
Query: 372 LNGTIPPFLYHRFPLDLSYNDLEGEIPDYF-RDSPFKVYGNQGICYFSACSTLHTPTASK 430
L+LSYN+LEG++ F R GN G+C S S + +
Sbjct: 822 --------------LNLSYNNLEGKLKKQFSRWQADAFVGNAGLCG-SPLSHCNRAGSKN 866
Query: 431 SKSLVLRVLNIILPIT--ACVIFLTLAFIVFLLNKNEIAKLMTG---------PTKSGDV 479
+SL + + II I+ A + + L I+F +++ K + G + +
Sbjct: 867 QRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPL 926
Query: 480 FSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEET 539
FS I ++DI++AT + ++ IG+GG G VYKA+L NG+ +A+KK+ ++
Sbjct: 927 FSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI--LWKDDL 984
Query: 540 TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK--CMFLIYKYMKRGSLFCFL---RNDYE 594
SF E L I HR++VKL G+C K LIY+YM GS++ +L N +
Sbjct: 985 MSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKK 1044
Query: 595 AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654
VL W R+ I +A + YLH+DC+P IVHRDI S+N+LL+S +EA + DFG A++L
Sbjct: 1045 KEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKIL 1104
Query: 655 ----DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL 710
D+++ + T+ AG+YGYIAPE AY++ TEK DVYS G+V +E++ G+ P E +
Sbjct: 1105 TGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDE 1164
Query: 711 SS-------------PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPK 757
+ P S+ + LID L P + Q V +AL C S P+
Sbjct: 1165 ETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQ----VLEIALQCTKSYPQ 1220
Query: 758 FRPTMQRVCQEFL 770
RP+ ++ + L
Sbjct: 1221 ERPSSRQASEYLL 1233
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 373 bits (958), Expect = e-102, Method: Compositional matrix adjust.
Identities = 255/737 (34%), Positives = 381/737 (51%), Gaps = 77/737 (10%)
Query: 102 LSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAI 161
L L N L GSIPS G L L L N+L G++P L SLRNL +NL N LNG I
Sbjct: 509 LDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTI 568
Query: 162 PSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVA 221
LC + ++ ++ NG IP +G+ NL L L N+L+G + LGK++ L
Sbjct: 569 -HPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSL 627
Query: 222 LNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTI 281
L++ N L G IP L LT++ L++N L+G IPP +G ++ + ++ +S N ++
Sbjct: 628 LDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESL 687
Query: 282 PLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRN 341
P EL ++LL LS+ N L+G IP I L +L L+L N+ SG +P +GK S+L
Sbjct: 688 PTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYE 747
Query: 342 ITLRNNNLSGSIPPEIG--------------------------LMKLEYLDLSHNKLNGT 375
+ L N+L+G IP EIG L KLE LDLSHN+L G
Sbjct: 748 LRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGE 807
Query: 376 IPPFLYHRFP---LDLSYNDLEGEIPDYFRDSPFKVY-GNQGICY--FSACSTLHTPTAS 429
+P + L++S+N+L G++ F P + GN G+C S C+ + + +
Sbjct: 808 VPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVR--SNN 865
Query: 430 KSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKNE---IAKLMTGPTK----------- 475
K + L R + II I+A + ++ L K K+ G T
Sbjct: 866 KQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQAT 925
Query: 476 SGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAE 535
+F I +EDI++AT + ++ IG+GG G VYKA+L NG+ VA+KK+
Sbjct: 926 HKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI--LW 983
Query: 536 TEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK--CMFLIYKYMKRGSLFCFLRNDY 593
++ SF E L +I HR++VKL G+C K LIY+YMK GS++ +L D
Sbjct: 984 KDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDK 1043
Query: 594 EAV-----VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648
+ +LDW R+ I +A + YLHHDC+P IVHRDI S+N+LL+S +EA + DF
Sbjct: 1044 PVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDF 1103
Query: 649 GTARLL----DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPG 704
G A++L D+++ + T A +YGYIAPE AY++ TEK DVYS G+V +E++ G+ P
Sbjct: 1104 GLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPT 1163
Query: 705 E-----------LLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLH 753
+ + + + + LID L P + Q V +AL C
Sbjct: 1164 DSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ----VLEIALQCTK 1219
Query: 754 SKPKFRPTMQRVCQEFL 770
+ P+ RP+ ++ C L
Sbjct: 1220 TSPQERPSSRQACDSLL 1236
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 796 | ||||||
| 359484066 | 843 | PREDICTED: probable LRR receptor-like se | 0.923 | 0.871 | 0.486 | 0.0 | |
| 225465647 | 820 | PREDICTED: probable LRR receptor-like se | 0.894 | 0.868 | 0.482 | 0.0 | |
| 296085303 | 789 | unnamed protein product [Vitis vinifera] | 0.912 | 0.920 | 0.486 | 0.0 | |
| 225452749 | 783 | PREDICTED: probable LRR receptor-like se | 0.917 | 0.932 | 0.498 | 0.0 | |
| 296085307 | 874 | unnamed protein product [Vitis vinifera] | 0.928 | 0.845 | 0.472 | 0.0 | |
| 225452694 | 783 | PREDICTED: probable LRR receptor-like se | 0.939 | 0.955 | 0.487 | 0.0 | |
| 225452751 | 878 | PREDICTED: probable leucine-rich repeat | 0.915 | 0.830 | 0.463 | 0.0 | |
| 359488983 | 758 | PREDICTED: probable LRR receptor-like se | 0.890 | 0.935 | 0.491 | 0.0 | |
| 359488981 | 757 | PREDICTED: probable LRR receptor-like se | 0.886 | 0.932 | 0.487 | 0.0 | |
| 224110024 | 827 | predicted protein [Populus trichocarpa] | 0.963 | 0.927 | 0.471 | 0.0 |
| >gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/804 (48%), Positives = 514/804 (63%), Gaps = 69/804 (8%)
Query: 43 LVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKG-ELSQFNFSCFPGLES 101
L NS+WW +++ +S HC +G+TCNT ++ I K ELS+ FS FP L
Sbjct: 46 LRNSTWWW-YMENTTSHHCTWEGITCNTEGHVVRITYSYIDGKMVELSKLKFSSFPSLLH 104
Query: 102 LSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAI 161
L++ + ++G IP ++G L+KL YL S ++ G +P LG+L LE L+L NNL+G I
Sbjct: 105 LNVSHSSIYGRIPDEIGMLTKLTYLRISECDVHGELPVSLGNLTLLEELDLAYNNLSGVI 164
Query: 162 PSSLCQLTKLITMALSRN-GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLV 220
PSSL L LI + LS N GL G IPS++G L NL L L N+++G + ++G LKNL
Sbjct: 165 PSSLGYLKNLIHLDLSFNYGLSGVIPSSLGYLKNLKYLDLSINEINGSIPYQIGNLKNLT 224
Query: 221 ALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGT 280
L + N L G IPS+L L+NL YL+L+ N +NGSIP EIGN+ ++++ S N++ GT
Sbjct: 225 HLYLVSNSLSGVIPSSLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCFSHNSLIGT 284
Query: 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELR 340
IP L L+ L YL + +N + G IP++ L L L+L +N+++G IPP I L
Sbjct: 285 IPPSLGHLTNLTYLHLFNNQIQGGIPLSFGHLTKLTDLNLCDNQINGSIPPIIWNLKNLI 344
Query: 341 NITLRNNNLSGSIPPEIG------------------------------------------ 358
++ L +NNL+G IP +G
Sbjct: 345 HLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDLSANLIHGK 404
Query: 359 -------LMKLEYLDLSHNKLNGTIPPFLYH---RFPLDLSYNDLEGEIP----DYFRDS 404
L +L YL+LSHNKL+G+IP L + + LDLS+NDLEG IP F
Sbjct: 405 IPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSHNDLEGHIPFELQSKFSQG 464
Query: 405 PFKVYGNQGICYFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKN 464
F N+G+C + K + R++ I L T + F+ L F++ L K
Sbjct: 465 SFD--NNKGLC-----GDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLL-LSRKT 516
Query: 465 EIAKLMTGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGK 524
+ PTK+GD+FS+WNYDG+IA+EDIIKATEDFDIKYCIGTGGYGSVYKAQLP G
Sbjct: 517 RKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGN 576
Query: 525 VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584
VVALKKLH E +E + SFQNE +LSKI HRNIVKL G+CLHK+CMFLIY YM RGS
Sbjct: 577 VVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGS 636
Query: 585 LFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644
L+C L N+ EA+ LDW RVN++K + +A+ Y+HHDC P I+HRDISSNNILL+SKL+AF
Sbjct: 637 LYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAF 696
Query: 645 VADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPG 704
++DFGTARLL DSSN+T++AGTYGYIAPELAYTMVVTEKCDVYSFGVVALE +MG+HPG
Sbjct: 697 LSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPG 756
Query: 705 ELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQR 764
EL + LSS SS Q IML ++LDSRL P D+ V +D+VLV +AL C+HS P+ RPTMQ
Sbjct: 757 ELFTLLSS-SSTQNIMLTNILDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRSRPTMQH 815
Query: 765 VCQEFLTCKIALVNPFEEISIWQL 788
+ + LT + + PF IS+ QL
Sbjct: 816 ILSKLLT-QSPFLGPFNWISLCQL 838
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/804 (48%), Positives = 502/804 (62%), Gaps = 92/804 (11%)
Query: 43 LVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKG-ELSQFNFSCFPGL-- 99
L NS+WW +++ +S HC +G+TCNT ++ I K ELS+ FS FP L
Sbjct: 46 LRNSTWWW-YMENTTSHHCTWEGITCNTEGHVVRITYSYIDGKMVELSKLKFSSFPSLLH 104
Query: 100 ----------------------------------------------ESLSLRFNYLFGSI 113
E L L +N L G I
Sbjct: 105 LYVSHSSIYGRIPDEIGMLTKLTYLRISECDVYGELPVSLGNLTLLEELDLAYNNLSGVI 164
Query: 114 PSQVGALSKLRYLDFSFN-NLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLI 172
PS +G L L +LD SFN L+G IPP LG L+NL+ L+L N +NG+IPS + L L
Sbjct: 165 PSSLGYLKNLIHLDLSFNYGLSGVIPPSLGYLKNLKYLDLSINEINGSIPSQIGNLKNLT 224
Query: 173 TMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP 232
+ L N L G IPS + +L+NL L L+ N+++G + E+G LKNLV L + N L+G
Sbjct: 225 HLYLVSNSLSGVIPSPLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCLSHNSLIGA 284
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292
IPS+L LTNLTYL+L +N + G IP G++T + + + N I G+IP + L L+
Sbjct: 285 IPSSLGHLTNLTYLHLFNNQIQGGIPLSFGHLTNLTDLYLCYNQINGSIPPIIWNLKNLI 344
Query: 293 YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGS 352
+L + N L+G IP ++ LI L ++S N++SG IP IG + L + L +N + G
Sbjct: 345 HLRLDHNNLTGVIPSSLGYLIHLHEFNISGNQISGQIPSSIGNLNNLTRLDLSDNLIHGK 404
Query: 353 IPPEI-GLMKLEYLDLSHNKLNGTIPPFLYH---RFPLDLSYNDLEGEIP----DYFRDS 404
IP ++ L +L YL+LSHNKL+G+IP L + R LDLSYNDLEG IP F
Sbjct: 405 IPSQVQNLKRLVYLNLSHNKLSGSIPTLLIYDHIRPSLDLSYNDLEGHIPFELQSKFSQG 464
Query: 405 PFKVYGNQGICYFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKN 464
F N+G+C H K+ ++ R +
Sbjct: 465 SFD--NNKGLC-GDIKGLPHCKEEYKTTRIITRKIQ----------------------TK 499
Query: 465 EIAKLMTGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGK 524
EI PTK+GD+FS+WNYDG+IA+EDIIKATEDFDIKYCIGTGGYGSVYKAQLP G
Sbjct: 500 EI------PTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGN 553
Query: 525 VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584
VVALKKLH ET+E T+ SFQNE +LSKI HRNIVKL G+CLHK+CMFLIY YM RGS
Sbjct: 554 VVALKKLHGWETDEATYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGS 613
Query: 585 LFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644
L+C L N+ EA+ LDW RVN++K + +A+ Y+HHDC P I+HRDISSNNILL+SKL+AF
Sbjct: 614 LYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAF 673
Query: 645 VADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPG 704
++DFGT+RLL DSSN+T+++GTYGYIAPELAYTMVVTEKCDVYSFGVVALE +MG+HPG
Sbjct: 674 LSDFGTSRLLHPDSSNQTLLSGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPG 733
Query: 705 ELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQR 764
EL + LSS SS Q IML D+LDSRL P D+ V +D+VLV +AL C+HS P+ RPTMQ
Sbjct: 734 ELFTLLSS-SSTQNIMLTDMLDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRSRPTMQH 792
Query: 765 VCQEFLTCKIALVNPFEEISIWQL 788
+ + LT + + PF IS+WQL
Sbjct: 793 ISSKLLT-QSPFLGPFHGISLWQL 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/794 (48%), Positives = 508/794 (63%), Gaps = 68/794 (8%)
Query: 53 IDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKG-ELSQFNFSCFPGLESLSLRFNYLFG 111
+++ +S HC +G+TCNT ++ I K ELS+ FS FP L L++ + ++G
Sbjct: 1 MENTTSHHCTWEGITCNTEGHVVRITYSYIDGKMVELSKLKFSSFPSLLHLNVSHSSIYG 60
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
IP ++G L+KL YL S ++ G +P LG+L LE L+L NNL+G IPSSL L L
Sbjct: 61 RIPDEIGMLTKLTYLRISECDVHGELPVSLGNLTLLEELDLAYNNLSGVIPSSLGYLKNL 120
Query: 172 ITMALSRN-GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230
I + LS N GL G IPS++G L NL L L N+++G + ++G LKNL L + N L
Sbjct: 121 IHLDLSFNYGLSGVIPSSLGYLKNLKYLDLSINEINGSIPYQIGNLKNLTHLYLVSNSLS 180
Query: 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQ 290
G IPS+L L+NL YL+L+ N +NGSIP EIGN+ ++++ S N++ GTIP L L+
Sbjct: 181 GVIPSSLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCFSHNSLIGTIPPSLGHLTN 240
Query: 291 LLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350
L YL + +N + G IP++ L L L+L +N+++G IPP I L ++ L +NNL+
Sbjct: 241 LTYLHLFNNQIQGGIPLSFGHLTKLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLT 300
Query: 351 GSIPPEIG-------------------------------------------------LMK 361
G IP +G L +
Sbjct: 301 GVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKR 360
Query: 362 LEYLDLSHNKLNGTIPPFLYH---RFPLDLSYNDLEGEIP----DYFRDSPFKVYGNQGI 414
L YL+LSHNKL+G+IP L + + LDLS+NDLEG IP F F N+G+
Sbjct: 361 LTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSHNDLEGHIPFELQSKFSQGSFD--NNKGL 418
Query: 415 CYFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKNEIAKLMTGPT 474
C + K + R++ I L T + F+ L F++ L K + PT
Sbjct: 419 C-----GDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLL-LSRKTRKIQTKEIPT 472
Query: 475 KSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRA 534
K+GD+FS+WNYDG+IA+EDIIKATEDFDIKYCIGTGGYGSVYKAQLP G VVALKKLH
Sbjct: 473 KNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGW 532
Query: 535 ETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYE 594
E +E + SFQNE +LSKI HRNIVKL G+CLHK+CMFLIY YM RGSL+C L N+ E
Sbjct: 533 ERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVE 592
Query: 595 AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654
A+ LDW RVN++K + +A+ Y+HHDC P I+HRDISSNNILL+SKL+AF++DFGTARLL
Sbjct: 593 ALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLL 652
Query: 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS 714
DSSN+T++AGTYGYIAPELAYTMVVTEKCDVYSFGVVALE +MG+HPGEL + LSS S
Sbjct: 653 HPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSS-S 711
Query: 715 SDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774
S Q IML ++LDSRL P D+ V +D+VLV +AL C+HS P+ RPTMQ + + LT +
Sbjct: 712 STQNIMLTNILDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRSRPTMQHILSKLLT-QS 770
Query: 775 ALVNPFEEISIWQL 788
+ PF IS+ QL
Sbjct: 771 PFLGPFNWISLCQL 784
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452749|ref|XP_002277477.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1783), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/767 (49%), Positives = 511/767 (66%), Gaps = 37/767 (4%)
Query: 39 EREALVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINL-PEKKLKGELSQFNFSCFP 97
E EAL ++ WW++ +S HC DGV CN A + I L K GELS+ +FS FP
Sbjct: 40 EAEALRSTGWWNS-----TSAHCHWDGVFCNNAGRVTGIALYGSGKELGELSKLDFSSFP 94
Query: 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNL 157
L LSL L GSIP Q+G L++L YL NNLTG +P L +L LEVL+ N L
Sbjct: 95 SLVELSLSDCGLNGSIPHQIGTLTQLTYLSLGLNNLTGELPLSLANLTQLEVLSFYSNRL 154
Query: 158 NGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLK 217
+G+I + ++ L + L N L G IPS+ G+L NL L LD NK+SG + ++GKLK
Sbjct: 155 HGSILPEIGKMKNLTVLDLGNNNLTGVIPSSFGNLTNLTFLYLDGNKISGFIPPQIGKLK 214
Query: 218 NLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNI 277
NL L + N L GPIP + +L NL LYL N L+G IPPEIGNM ++ +++ NN+
Sbjct: 215 NLRFLYLSSNGLHGPIPPEIGKLKNLEVLYLFYNKLHGLIPPEIGNMKKLIFLNLRSNNL 274
Query: 278 EGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337
G IP L+ L L++ N +SG IP I L++L LDLS N++SG IP EI
Sbjct: 275 TGVIPSSFGNLTNLNSLTLRGNQISGFIPPEIGYLLNLSYLDLSENQISGFIPEEIVNLK 334
Query: 338 ELRNITLRNNNLSGSIPPEIGLMK-LEYLDLSHNKLNGTIPPFL---YHRFPLDLSYNDL 393
+L ++ + NN + G IP ++G +K +EY +LSHN L+GTIP + Y +DLS+N L
Sbjct: 335 KLGHLDMSNNLIRGKIPSQLGYLKEVEYFNLSHNNLSGTIPHSISNNYMWTSIDLSHNQL 394
Query: 394 EGEIPDYFRDSPFKVYG-NQGICY----FSACSTLHTPTASKSKSLVLRVLNIILPITAC 448
E + +P + +G ++G+C S C H +++ I++ +
Sbjct: 395 ESQ-----STTPHEAFGHDKGLCGGINGLSHCKKRH------------QIVLIVVISLSA 437
Query: 449 VIFLTLAFIVFLLNKNEIAKLM---TGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKY 505
+ L++ + FL +K +I K T K+GD+FSIW+YDG IA++DII+ATEDFDIKY
Sbjct: 438 TLLLSVTALGFLFHKQKIRKNQLSKTTKAKNGDLFSIWDYDGTIAYDDIIQATEDFDIKY 497
Query: 506 CIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
CIGTGGYGSVY+AQLP+GKVVALKKLH E E+ T+ SF+NE +LS I HRNIVKL+G
Sbjct: 498 CIGTGGYGSVYRAQLPSGKVVALKKLHSWEREDPTYLKSFENEVQMLSTIQHRNIVKLHG 557
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
FCLH +CMFL+YKYM++GSL+C LR++ E V LDW RVN++K +A+ALSY+HHD + I
Sbjct: 558 FCLHNRCMFLVYKYMEKGSLYCMLRDEVEVVELDWIKRVNVVKSIASALSYMHHDYVMPI 617
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRDISSNNILL+SKLEA V+DFGTARLLD SSN+T++ GTYGYIAPELAYTMVVTEKC
Sbjct: 618 IHRDISSNNILLDSKLEACVSDFGTARLLDPYSSNQTLLVGTYGYIAPELAYTMVVTEKC 677
Query: 686 DVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745
DVYSFG+VALE +MG HPGEL++SLSS SS Q L DVLDSRLS P V ++ L+
Sbjct: 678 DVYSFGMVALETMMGMHPGELVTSLSS-SSTQNTTLKDVLDSRLSSPKSTRVANNVALIV 736
Query: 746 TVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLRNQI 792
++AL CLHS P+FRP+MQ V + ++ K + P IS+ QL++++
Sbjct: 737 SLALKCLHSNPRFRPSMQEVSLKLVSTK-SFPQPISAISLLQLKDEV 782
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/848 (47%), Positives = 522/848 (61%), Gaps = 109/848 (12%)
Query: 37 ELEREALVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEIN--------LPEKKLKGEL 88
E E EAL NS+WW +++ +S HC DG+TCN +I+I + + L GEL
Sbjct: 41 EAEAEALRNSTWWW-YMENITSHHCTWDGITCNREGHVIQITYSHYNSPRISDCGLDGEL 99
Query: 89 SQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN----------------- 131
+ L LSL FN + GSIPS++G L L +LD S+N
Sbjct: 100 P-VSLGNLTLLVYLSLNFNRINGSIPSEIGNLKNLIHLDLSYNYYLSGAIPSSLGYLKNL 158
Query: 132 ---------NLTGSIPPELGSLRNLEVLNLKGN-NLNGAIPSSLCQLTKLITMALSRNGL 181
+L G+IP LG L+NL L+L N +L G IPSSL LT L+ ++L+ N +
Sbjct: 159 IHLDLSHCYSLYGAIPSSLGYLKNLIHLDLSHNSDLYGVIPSSLGNLTNLVYLSLNFNRI 218
Query: 182 HGPIPSAIGDLNNLLILSLDSNK-LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRL 240
+G IPS IG+L NL+ L L N LSG + +G LKNL+ L++G N L IPS+L L
Sbjct: 219 NGSIPSEIGNLKNLIHLDLSYNYYLSGAIPSSIGYLKNLIHLDLGSNSLSSVIPSSLGSL 278
Query: 241 TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNM 300
TNL YLYL+ N +NGSIP EIGN+ ++++ +S N + GTIP L L L Y + N
Sbjct: 279 TNLEYLYLNFNRINGSIPSEIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHLIDNQ 338
Query: 301 LSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG--------- 351
+ G IP++ L +L L L N+++G IPP I L ++ L +NNL+G
Sbjct: 339 IQGLIPLSFGNLTNLTHLYLRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIPSLGYLI 398
Query: 352 --------------SIPPEIG-------------------------LMKLEYLDLSHNKL 372
IP +IG L LE L+LSHNKL
Sbjct: 399 HLNVFNIRRNRIRGHIPSKIGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKL 458
Query: 373 NGTIPP---FLYHRFPLDLSYNDLEGEIPDYFR-DSPFKVYG-NQGICY----FSACSTL 423
+G IPP +++ +D S+ND EG IP + P +V+G N+G+C C
Sbjct: 459 SGHIPPLSIYIHKGSSIDFSHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRG 518
Query: 424 HTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKNEIAKLMTGPTKSGDVFSIW 483
H K++++ L+ IL ++ F+ L I+ L K + TK+GD+FS+W
Sbjct: 519 H-------KTILIISLSTILFLS----FVALG-ILLLSRKTRRNQTKATSTKNGDIFSVW 566
Query: 484 NYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFN 543
NYDG+IA+EDII+ATEDFDIKYCIGTGGYGSVYKAQLP G VVALKKLH E +E T+
Sbjct: 567 NYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLK 626
Query: 544 SFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR 603
SFQNE VLSKI HRNI+KL+G+CLHK+CMFLIYKYM+RGSL+C L N+ EA+ LDW R
Sbjct: 627 SFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKR 686
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663
VN+IK + +AL Y+HHD P I+HRD+SSNNILL+ KL+AF++DFGTARLL DSSN+T+
Sbjct: 687 VNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTL 746
Query: 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723
+AGTYGYIAPELAYTM VTEKCDVYSFGVVALE +MGRHP EL + LSS SS Q IML D
Sbjct: 747 LAGTYGYIAPELAYTMAVTEKCDVYSFGVVALETMMGRHPRELFTLLSS-SSAQNIMLTD 805
Query: 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783
+LDSRL P DR V +D+VLV +AL C+HS P+ RPTMQ + + L + + PF I
Sbjct: 806 ILDSRLPSPQDRQVARDVVLVVWLALKCIHSNPRSRPTMQHISSKLL-IQSPFLEPFHGI 864
Query: 784 SIWQLRNQ 791
S+WQL Q
Sbjct: 865 SLWQLNIQ 872
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452694|ref|XP_002276873.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1762), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/786 (48%), Positives = 513/786 (65%), Gaps = 38/786 (4%)
Query: 18 LVGASYFGATTDDICVAAFELEREALVNSSWWSNLIDSN--SSDHCKLDGVTCNTARSII 75
+ A+ ++TD V A E +AL NS WW I S+ +S+HC G+TCN A+ +
Sbjct: 22 MTHAASTHSSTDHSQVVA---EADALRNSGWW---IWSHPATSNHCSWSGITCNEAKHVT 75
Query: 76 EINLPEKKLK---GELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132
EI+L ++ GELS+ N S P L L L L GSI ++G+L+KL +LD S+N
Sbjct: 76 EISLHGYQVLLPLGELSKLNLSSLPSLNFLILSGMGLNGSISDEIGSLTKLTHLDLSYNQ 135
Query: 133 LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDL 192
L G+IP ++ +L L L+L N + G IP + LT+LI + LS N L G IPS+ G L
Sbjct: 136 LNGNIPQQMYTLTELTHLDLSSNQMTGPIPHQIGTLTELIFLHLSGNELTGAIPSSFGRL 195
Query: 193 NNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252
L L L SN+L+G + +G L L+ L++ +L G IPS+L LT LT+L L N
Sbjct: 196 TKLTHLDLSSNQLTGPIPHPIGTLTELIFLHLSWTELTGAIPSSLGHLTKLTHLDLSYNQ 255
Query: 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGL 312
LNGSI ++ +T + +D+S N + G+IP ++ L++L YL +S + L+G +P ++ L
Sbjct: 256 LNGSISHQMYTLTELTHLDLSNNQLSGSIPHQIGTLTELTYLDLSWSELTGAMPSSLGSL 315
Query: 313 ISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNK 371
L L+L N+++G IPPEIG +L ++ L N +SG IP ++ L +LE LDLS+N+
Sbjct: 316 TKLTSLNLCMNQINGSIPPEIGNIKDLVSLDLHRNLISGEIPSKLKKLKRLECLDLSYNR 375
Query: 372 LNGTIPPFLYHRF---PLDLSYND-LEGEIPDYFRDSPFKVYGNQGICYFSACSTLHTPT 427
L+G IPPFL + LDLS+ND LEG P F + + G Q PT
Sbjct: 376 LSGKIPPFLTNNSDWEKLDLSHNDDLEGYTP--FVHNGGEKTGAQ------------VPT 421
Query: 428 ASKSKSLVLRVLNIILPITACVIFLT--LAFIVFLLNKNEIAKLMTGPTKSGDVFSIWNY 485
+ II P+ ++F+T L K ++ K+GD+FSIW+Y
Sbjct: 422 RDTTSQHT-----IITPLLLTLVFVTLILGLACLWWKKRKVQPESMATKKNGDLFSIWDY 476
Query: 486 DGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSF 545
DGRIAFEDII ATEDFDI+YCIG GGYGSVY+AQLP+G VV +KKLHR+E +E T+ SF
Sbjct: 477 DGRIAFEDIISATEDFDIRYCIGVGGYGSVYRAQLPSGNVVVVKKLHRSEIDEPTYLRSF 536
Query: 546 QNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
+NE +L +I HRNIVKL+G+CLH +CMFLI YM+RGSL C L N+ EAV LDW RVN
Sbjct: 537 KNEVQMLEEIRHRNIVKLHGYCLHNRCMFLICMYMERGSLNCMLSNEVEAVELDWVKRVN 596
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
I+K +A+ALSY+HHDC P I+HRDISSNNILL+SKLE FV+DFGTARLLD SSN+T++A
Sbjct: 597 IVKNMAHALSYMHHDCTPPIIHRDISSNNILLDSKLEGFVSDFGTARLLDPSSSNQTLIA 656
Query: 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725
GTYGYIAPE AYTM+VTEKCDVYSFGVVALE ++G+HPGEL++SL S S Q IML DVL
Sbjct: 657 GTYGYIAPEFAYTMIVTEKCDVYSFGVVALETMIGKHPGELITSLLS-SLCQDIMLRDVL 715
Query: 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISI 785
DSRLS P D V +D+V V +AL C+H P+ RPTMQ++ + L +PF IS+
Sbjct: 716 DSRLSLPEDLQVAKDVVFVVLLALKCIHPNPQSRPTMQQISYKLLGNIPFPKSPFYAISL 775
Query: 786 WQLRNQ 791
+L+NQ
Sbjct: 776 HELKNQ 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452751|ref|XP_002277606.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/861 (46%), Positives = 511/861 (59%), Gaps = 132/861 (15%)
Query: 39 EREALVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLK-GELSQFNFSCFP 97
E EAL ++ WW++ +S HC DGV CN A + +I + K GELS+ FS FP
Sbjct: 40 EAEALRSTGWWNS-----TSAHCNWDGVYCNNAGRVTQIAFFDSGKKLGELSKLEFSSFP 94
Query: 98 GLESLSLRFNYLFGSIPSQVGALSKL------------------------RYLDFSFNNL 133
L L L L GSIP Q+G L++L YL N L
Sbjct: 95 SLVELFLSDCGLNGSIPHQIGTLTQLIILYLPLNNLTGELPLSLANLTQLEYLSLHSNRL 154
Query: 134 TGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLN 193
GSIPPE+G ++NL L NNL G IPSS LT L + L N + G IP IG +
Sbjct: 155 HGSIPPEIGKMKNLIYFILHDNNLTGVIPSSFGNLTNLTYLYLGSNQISGFIPPQIGKMK 214
Query: 194 NLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253
NL LSL N L G + E+GKL+NL L + N L IPS+ LTNLTYLYL SN +
Sbjct: 215 NLEFLSLSYNGLHGSIPPEIGKLQNLNYLFLDYNNLTSVIPSSFGNLTNLTYLYLDSNQI 274
Query: 254 NGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLI 313
+G IPP+IG + + +++S N + G IPLE+ +L L L++ N L G IP + L
Sbjct: 275 SGFIPPQIGKIKNLELLELSYNGLHGPIPLEIGKLKNLKILNLGYNNLIGVIPSSFGNLT 334
Query: 314 SLKGLDLSNNKLSGPIPPEIGKC------------------------SELRNITLRNNNL 349
+L L L N++SG IPPEIGK + L ++ LR N +
Sbjct: 335 NLTYLTLGGNQISGFIPPEIGKMKNLIFFNLGYNSLTGVIPSSFGNLTHLTSLILRGNQI 394
Query: 350 SGSIPPEIG-------------------------LMKLEYLDLSHNKLNGTIPPFLYH-- 382
+GSIPPEIG L KL +LD+S+N ++G IP L +
Sbjct: 395 NGSIPPEIGYLLDLLYLDLNTNQISGFIPEEILNLKKLGHLDISNNLISGKIPSELGNLK 454
Query: 383 --------------RFPL----------DLSYNDLEGEIPDYFRDSPFKVYG-NQGIC-- 415
PL DLS+N LEG+ +P + + N+G+C
Sbjct: 455 EAIYFNLSRNNISGTIPLSISNNMWTLFDLSHNQLEGQ-----STAPLEAFDHNKGLCDG 509
Query: 416 --YFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKNEIAKLM--- 470
S C H + SL +L L++A + FL K +I K
Sbjct: 510 IKGLSHCKKRHQIILIIAISLSATLL------------LSVAVLGFLFRKQKIRKNQLPK 557
Query: 471 TGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKK 530
T K+GD+FSIW+YDG IA++DII+ATEDFDIKYCIGTGGYGSVY+AQLP+GKVVALKK
Sbjct: 558 TTKVKNGDLFSIWDYDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKK 617
Query: 531 LHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR 590
LH E ++ T+ SF+NE +LS+I HRNIVKL+GFCLH KCMFL+YKYM++GSL+C LR
Sbjct: 618 LHGWERDDPTYLKSFENEVQMLSRIQHRNIVKLHGFCLHNKCMFLVYKYMEKGSLYCMLR 677
Query: 591 NDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650
++ E V LDW RVN++K +ANALSY+HHD I+HRDISSNNILL+SKLEAFVADFGT
Sbjct: 678 DEVEVVQLDWIKRVNVVKGIANALSYMHHDSTLPIIHRDISSNNILLDSKLEAFVADFGT 737
Query: 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL 710
ARLLD DSSN+T++AGTYGYIAPELAYTMVVTEKCDVYSFG+VALE +MG+HPG+L++SL
Sbjct: 738 ARLLDPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGMVALETIMGKHPGDLVTSL 797
Query: 711 SSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770
S+ SS Q I L DVLDSRLS P V D+ LV ++AL CLH P+FRP+MQ+V L
Sbjct: 798 SA-SSTQNITLKDVLDSRLSSPKGPQVANDVALVVSLALKCLHCNPRFRPSMQQVSWR-L 855
Query: 771 TCKIALVNPFEEISIWQLRNQ 791
+ + P IS+ QL+N+
Sbjct: 856 SASKSFPQPVGAISLLQLKNE 876
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/765 (49%), Positives = 501/765 (65%), Gaps = 56/765 (7%)
Query: 39 EREALVNSSWWSNLIDSNSSDHCKLDGVTCNTARSI--IEINLPEKKLKGELSQFNFSCF 96
E EAL ++ WW++ +S HC DGV CN A + I +N K+L GELS+ FS F
Sbjct: 38 EAEALRSTGWWNS-----TSAHCHWDGVYCNNAGRVTGIALNGSGKEL-GELSKLEFSSF 91
Query: 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNN 156
P L L+L L GSIP ++G+L L VL+L NN
Sbjct: 92 PSLVELNL------------------------CACGLNGSIPHQIGTLTQLTVLSLHDNN 127
Query: 157 LNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKL 216
L G IP SL LT+L+ + L N LHG IP IG + NL+ L L + L G++ G L
Sbjct: 128 LTGEIPLSLANLTQLLYLTLCSNPLHGSIPPEIGKMKNLIFLDLGYSNLIGVIPSSFGNL 187
Query: 217 KNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNN 276
L L + GN++ G IP + ++ NL L L N L+G IPPEIG M + K+++ NN
Sbjct: 188 TTLTTLYLDGNQISGLIPPQIGKMKNLKSLLLSHNGLHGPIPPEIGGMKNLNKLNLGYNN 247
Query: 277 IEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKC 336
+ G IP L+ + LS N +SG IP+ I L++L LDLS N++SG IP EI
Sbjct: 248 LTGVIPSSFGNLTNMNSLSFRGNQISGFIPLEIWYLLNLSYLDLSENQISGFIPEEIVNL 307
Query: 337 SELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFL---YHRFPL-DLSYN 391
+L ++ + NN +SG IP ++G L +++Y +LSHN L+GTIP + Y+++ L DLS N
Sbjct: 308 KKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSNYNKWTLIDLSNN 367
Query: 392 DLEGEIPDYFRDSPFKVYG-NQGICYFSACSTLHTPTASKSKSLVLRVLNIILPITACVI 450
LEG+ +P + +G N+G+C P K + L II+ + +
Sbjct: 368 RLEGQT-----RAPVEAFGHNKGLC----GEIKGRPRCKKRHQITL----IIVVSLSTTL 414
Query: 451 FLTLAFIVFLLNKNEIAK---LMTGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCI 507
L++A + FL +K I K L T K+GD+FSIW+YDG IA++DII+ATEDFDIKYCI
Sbjct: 415 LLSIAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDYDGVIAYQDIIQATEDFDIKYCI 474
Query: 508 GTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFC 567
GTGGYGSVY+AQLP+GKVVALKKLH E + T+ SF+NE +L++I HRNIVKL+GFC
Sbjct: 475 GTGGYGSVYRAQLPSGKVVALKKLHGWERGDPTYLKSFENEVQMLTRIRHRNIVKLHGFC 534
Query: 568 LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVH 627
LHK+CMFL+YKYM++GSL+C LR++ EAV LDW RVN++K +ANALSY+HHDC I+H
Sbjct: 535 LHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIH 594
Query: 628 RDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDV 687
RDISSNNILL+SKLEAFV+DFGTARLLD+DSSNRT++ GTYGYIAPELAYTMVVTEKCD+
Sbjct: 595 RDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLVGTYGYIAPELAYTMVVTEKCDI 654
Query: 688 YSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTV 747
YSFG+VALE +MG HPGE ++SLSS SS Q L DVLDSRLS P V +I L+ ++
Sbjct: 655 YSFGMVALETMMGMHPGEFVTSLSS-SSTQNTTLKDVLDSRLSSPKSTQVANNIALIVSL 713
Query: 748 ALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLRNQI 792
AL CLHS P+FRP+MQ V + ++ + + P IS+ QL++++
Sbjct: 714 ALKCLHSNPQFRPSMQEVSSKLVSTR-SFPQPISTISLLQLKDEV 757
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1744), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/767 (48%), Positives = 496/767 (64%), Gaps = 61/767 (7%)
Query: 39 EREALVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINL-PEKKLKGELSQFNFSCFP 97
E EAL ++ WW++ +S HC DGV CN A + I L K GELS+ FS FP
Sbjct: 38 EAEALRSTGWWNS-----TSAHCHWDGVYCNNAGRVTGIALYGSGKELGELSKLEFSSFP 92
Query: 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNL 157
L L+L S L GSIP ++G+L L VL+L NNL
Sbjct: 93 SLVELNL------------------------SACGLNGSIPHQIGTLTQLTVLSLHDNNL 128
Query: 158 NGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLK 217
G IP SL LT+L+ + L N LHG IP IG + NL+ L L + L G++ G L
Sbjct: 129 TGEIPLSLANLTQLLYLTLCSNPLHGSIPPEIGKMKNLIFLDLGYSNLIGVIPSSFGNLT 188
Query: 218 NLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNI 277
L L + GN++ G IP + ++ NL L L N L+G IPPEIG M + K+++ NN+
Sbjct: 189 TLTTLYLDGNQISGFIPPQIGKMKNLKSLLLSYNGLHGPIPPEIGKMKNLNKLNLGYNNL 248
Query: 278 EGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337
G IP L+ + LS N +SG IP I L++L LDLS N++SG IP E+
Sbjct: 249 TGVIPSSFGNLTNMNSLSFRGNQISGFIPPEIGHLLNLSYLDLSENQISGFIPEEMVNLK 308
Query: 338 ELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFL---YHRFPLDLSYNDL 393
+L ++ + NN +SG IP ++G L +++Y +LSHN L+GTIP + Y +DLS N L
Sbjct: 309 KLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSNYRWTLIDLSNNRL 368
Query: 394 EGEIPDYFRDSPFKVYG-NQGICY----FSACSTLHTPTASKSKSLVLRVLNIILPITAC 448
EG+ +P + +G N+G+C ++ C H T II+ +
Sbjct: 369 EGQ-----ARAPVEAFGHNKGLCGEIKGWARCKKRHQITL------------IIVVSLST 411
Query: 449 VIFLTLAFIVFLLNKNEIAK---LMTGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKY 505
+ L++A + FL +K I K L T K+GD+FSIW++DG IA++DII+ATEDFDIKY
Sbjct: 412 TLLLSVAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDFDGVIAYQDIIQATEDFDIKY 471
Query: 506 CIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
CIGTGGYGSVY+AQLP+GKVVALKKLH E E+ T+ SF+NE +L++I HRNIVKL+G
Sbjct: 472 CIGTGGYGSVYRAQLPSGKVVALKKLHGWEREDPTYLKSFENEVQMLTRIRHRNIVKLHG 531
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
FCLHK+CMFL+YKYM++GSL+C LR++ EAV LDW RVN++K +ANALSY+HHDC I
Sbjct: 532 FCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPI 591
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRDISSNNILL+SKLEAFV+DFGTARLLD+DSSNRT++AGTYGYIAPELAYTMVVTEKC
Sbjct: 592 IHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAPELAYTMVVTEKC 651
Query: 686 DVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745
DVYSFG+VALE +MG HPGE ++SLSS SS Q L DVLDSRLS P V +I L+
Sbjct: 652 DVYSFGMVALETMMGMHPGEFITSLSS-SSTQNTTLKDVLDSRLSSPKSTRVANNIALIV 710
Query: 746 TVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLRNQI 792
++AL CLH P+F P+MQ V + ++ + + P IS+ QL++++
Sbjct: 711 SLALKCLHFNPQFCPSMQEVSSKLVSTR-SFPQPISAISLLQLKDEV 756
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110024|ref|XP_002333161.1| predicted protein [Populus trichocarpa] gi|222835014|gb|EEE73463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/823 (47%), Positives = 526/823 (63%), Gaps = 56/823 (6%)
Query: 1 MVLSFCIARVFVIGATLLVGASYFGATTDDICVAAFELEREALVNSSWWSNLIDSNSSDH 60
+ +SF ++ +FV L+ A DD + A E++ AL+ S WWS SN + H
Sbjct: 14 LSISFFLSCIFVSSTGLV-------AALDDSALLASEVK--ALLESGWWSQY--SNLTSH 62
Query: 61 -CKL-DGVTCNTARSIIEINLPEKKLK--GELSQFNFSCF-------------------- 96
CK G+ CN A SI +I+ P + LK + + NFSCF
Sbjct: 63 RCKYWPGIFCNRAGSITKISPPPEFLKVGNKFGKMNFSCFSNLVRLHLPNHELNGSIPPQ 122
Query: 97 ----PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152
P L L+L N L G +PS +G LS+L LDFS NN SIPPELG+L+NLE+L+
Sbjct: 123 ISILPQLRYLNLSSNNLAGELPSSLGNLSRLVELDFSSNNFINSIPPELGNLKNLEILDA 182
Query: 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE 212
N LNG IP ++ L KL ++ LSRN ++G IP IG+L NL L L SN L G +
Sbjct: 183 SNNRLNGPIPRTMGSLAKLRSLILSRNAINGFIPLEIGNLTNLKDLQLISNILVGSIPST 242
Query: 213 LGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDM 272
+G L +L L++ N + G IP + LTNL +L L SN L GSIP G ++ ++ + +
Sbjct: 243 IGFLSDLTNLDLSYNVINGSIPLQIGNLTNLEHLDLSSNILAGSIPSTFGFLSNLILLHL 302
Query: 273 SMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPE 332
N I G+I LE+ L+ L L + N +SG IPI++ L +L LDLSNN+++G I
Sbjct: 303 FDNQINGSISLEIGNLTNLCRLFLKGNKISGSIPISLGDLRNLAFLDLSNNQINGSIASS 362
Query: 333 IGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYN 391
+ C L + L NNLSG IP ++ L L Y++ +N L+G +P L F + + +
Sbjct: 363 LKNCKYLTYLDLSYNNLSGQIPSQLHNLPSLSYVNFRYNNLSGFVPLQLPQPFDVSFTCD 422
Query: 392 DLEGE---IPDYFRDSPFKVYGNQGIC-YFSACSTLHTPTASKSKSLVLRVLNIILPITA 447
L G+ P+ F+ + F+ GN+ + FS CS++++P + ++ ++ + I LPIT
Sbjct: 423 SLHGQRTNSPEIFQATVFE--GNKDLHPDFSRCSSIYSPPSKDNR--IIHSIKIFLPITT 478
Query: 448 CVIFLTLAFIVFLLNKNEIAKLMTGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCI 507
+ L L++ + + K+GD+FSIWNYDGRIA+EDII ATE+FD++YCI
Sbjct: 479 -ISLCLLCLGCCYLSRCKATQPEATSLKNGDLFSIWNYDGRIAYEDIIAATENFDLRYCI 537
Query: 508 GTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFC 567
G+GGYGSVY+AQLP+GK+VALKKLH E EE F S +NE +L++I HR+IVKLYGFC
Sbjct: 538 GSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSLKNEVELLTQIRHRSIVKLYGFC 597
Query: 568 LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVH 627
LH++CMFL+Y+YM++GSLFC LRND AV L W R +IIK +A+ALSYLHHDC P IVH
Sbjct: 598 LHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVH 657
Query: 628 RDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDV 687
RDISS+N+LLNS+ ++FVADFG ARLLD DSSN T++AGTYGYIAPELAYTM VTEKCDV
Sbjct: 658 RDISSSNVLLNSEFKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMAVTEKCDV 717
Query: 688 YSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTV 747
YSFGVVALE LMGRHPG++LS SS Q I L +VLD RL PP + +V+Q+I + ++
Sbjct: 718 YSFGVVALETLMGRHPGDILS-----SSAQAITLKEVLDPRLPPPTNEIVIQNICTIASL 772
Query: 748 ALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLRN 790
+CLHS PK+RP+M+ V QEFL+ K L EIS +LRN
Sbjct: 773 IFSCLHSNPKYRPSMKFVSQEFLSPKRLLGG--LEISFLELRN 813
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 796 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.864 | 0.658 | 0.404 | 2.8e-130 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.863 | 0.613 | 0.384 | 1.6e-118 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.863 | 0.623 | 0.370 | 6.3e-108 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.869 | 0.627 | 0.373 | 1.2e-104 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.840 | 0.595 | 0.354 | 9.6e-101 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.639 | 0.407 | 0.332 | 7.2e-61 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.865 | 0.680 | 0.345 | 1.1e-96 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.869 | 0.716 | 0.344 | 1.8e-96 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.846 | 0.618 | 0.331 | 3e-94 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.830 | 0.659 | 0.357 | 7.8e-94 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1278 (454.9 bits), Expect = 2.8e-130, P = 2.8e-130
Identities = 291/719 (40%), Positives = 407/719 (56%)
Query: 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132
S+I++ + E KL G + +F LE L LR N L G IP + ++L L NN
Sbjct: 335 SMIDLEISENKLTGPVPD-SFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNN 393
Query: 133 LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDX 192
TG +P + LE L L N+ G +P SL LI + N G I A G
Sbjct: 394 FTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVY 453
Query: 193 XXXXXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252
G L + + LVA + N + G IP ++ +T L+ L L SN
Sbjct: 454 PTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNR 513
Query: 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGL 312
+ G +P I N+ I K+ ++ N + G IP + L+ L YL +SSN S +IP T+ L
Sbjct: 514 ITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNL 573
Query: 313 ISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNK 371
L ++LS N L IP + K S+L+ + L N L G I + L LE LDLSHN
Sbjct: 574 PRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNN 633
Query: 372 LNGTIPPFLYHRFPL---DLSYNDLEGEIPDY--FRDSPFKVY-GNQGICY-------FS 418
L+G IPP L D+S+N+L+G IPD FR++P + GN+ +C
Sbjct: 634 LSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLK 693
Query: 419 ACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLA---FIVFLLNKNEIAKLMTGPTK 475
CS + + K ++L++ +L +PI +I L++ FI F +I + T
Sbjct: 694 PCSITSSKKSHKDRNLIIYIL---VPIIGAIIILSVCAGIFICFRKRTKQIEE-HTDSES 749
Query: 476 SGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAE 535
G+ SI+++DG++ +++IIKAT +FD KY IGTGG+G VYKA+LPN ++A+KKL+ E
Sbjct: 750 GGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLN--E 806
Query: 536 TEETTFFN-----SFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR 590
T +++ N F NE L++I HRN+VKL+GFC H++ FL+Y+YM+RGSL L
Sbjct: 807 TTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLE 866
Query: 591 NDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650
ND EA LDW R+N++K VA+ALSY+HHD P+IVHRDISS NILL EA ++DFGT
Sbjct: 867 NDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGT 926
Query: 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEXXXXX 710
A+LL DSSN + VAGTYGY+APELAY M VTEKCDVYSFGV+ LEV+ G HPG+
Sbjct: 927 AKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTL 986
Query: 711 XXXXXDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
D + L + D RL P + ++++ + VAL CLHS P+ RPTM + F
Sbjct: 987 SSSPPDATLSLKSISDHRLPEPTPE-IKEEVLEILKVALLCLHSDPQARPTMLSISTAF 1044
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1167 (415.9 bits), Expect = 1.6e-118, P = 1.6e-118
Identities = 275/715 (38%), Positives = 399/715 (55%)
Query: 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132
S+I ++L + KL G + +F F LESL LR N+L G+IP V S L L NN
Sbjct: 415 SMINLDLSQNKLTGSVPD-SFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNN 473
Query: 133 LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDX 192
TG P + R L+ ++L N+L G IP SL LI N G I A G
Sbjct: 474 FTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIY 533
Query: 193 XXXXXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252
G + K L AL + N + G IP+ ++ +T L L L +N+
Sbjct: 534 PDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNN 593
Query: 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGL 312
L G +P IGN+T + ++ ++ N + G +P L+ L+ L L +SSN S +IP T
Sbjct: 594 LFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSF 653
Query: 313 ISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNK 371
+ L ++LS NK G IP + K ++L + L +N L G IP ++ L L+ LDLSHN
Sbjct: 654 LKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNN 712
Query: 372 LNGTIPPFLYHRFPL---DLSYNDLEGEIPDY--FRDSPFKVYG-NQGICY------FSA 419
L+G IP L D+S N LEG +PD FR + N G+C
Sbjct: 713 LSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKP 772
Query: 420 CSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFL--LNKNEIAKLMTGPTKSG 477
C L P K+ +LV+ +L +PI ++ L++ F + K ++ ++G
Sbjct: 773 CRELKKP--KKNGNLVVWIL---VPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETG 827
Query: 478 DVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETE 537
+ SI++ DG+ ++DII++T +FD + IGTGGY VY+A L + ++A+K+LH E
Sbjct: 828 ENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDE 886
Query: 538 ETT---FFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYE 594
E + F NE L++I HRN+VKL+GFC H++ FLIY+YM++GSL L ND E
Sbjct: 887 EISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEE 946
Query: 595 AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654
A L WT R+N++K VA+ALSY+HHD + IVHRDISS NILL++ A ++DFGTA+LL
Sbjct: 947 AKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLL 1006
Query: 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEXXXXXXXXX 714
+DSSN + VAGTYGY+APE AYTM VTEKCDVYSFGV+ LE+++G+HPG+
Sbjct: 1007 KTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSP 1066
Query: 715 XDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ + L + D R+ P + + ++ + +AL CL + P+ RPTM + F
Sbjct: 1067 GEA-LSLRSISDERVLEPRGQN-REKLLKMVEMALLCLQANPESRPTMLSISTTF 1119
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 264/713 (37%), Positives = 374/713 (52%)
Query: 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG 135
+++L +L G + Q P L L L N L G IP +G S LD S N+L+G
Sbjct: 359 KLDLSINRLNGTIPQ-ELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSG 417
Query: 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDXXXX 195
IP + L +L+L N L+G IP L L + L N L G +P + +
Sbjct: 418 PIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNL 477
Query: 196 XXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG 255
G + +LGKLKNL L + N G IP + LT + + SN L G
Sbjct: 478 TALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTG 537
Query: 256 SIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISL 315
IP E+G+ I ++D+S N G I EL +L L L +S N L+G+IP + L L
Sbjct: 538 HIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRL 597
Query: 316 KGLDLSNNKLSGPIPPEIGKCSELR-NITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLN 373
L L N LS IP E+GK + L+ ++ + +NNLSG+IP +G L LE L L+ NKL+
Sbjct: 598 MELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLS 657
Query: 374 GTIPPFLYHRFPL---DLSYNDLEGEIPD---YFRDSPFKVYGNQGICYF--SACSTLHT 425
G IP + + L ++S N+L G +PD + R GN G+C S C L
Sbjct: 658 GEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVP 717
Query: 426 PTASKSKSLV-----LRVLNIILPITACVIFLTLAFIVFLLNKNEIAKLMTGPTKSGDVF 480
+ SK L+ ++L I + V +T + + + + E A + DV
Sbjct: 718 HSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVM 777
Query: 481 SIWNYDGR-IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEET 539
+ + + ++ ++ AT +F +G G G+VYKA++ G+V+A+KKL+ + E
Sbjct: 778 DSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGA 836
Query: 540 TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLD 599
+ NSF+ E L KI HRNIVKLYGFC H+ L+Y+YM +GSL L+ + +LD
Sbjct: 837 SSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLD 896
Query: 600 WTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD-SDS 658
W R I A L YLHHDC P IVHRDI SNNILL+ + +A V DFG A+L+D S S
Sbjct: 897 WNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYS 956
Query: 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP------GEXXXXXXX 712
+ + VAG+YGYIAPE AYTM VTEKCD+YSFGVV LE++ G+ P G
Sbjct: 957 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVR 1016
Query: 713 XXXDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
I I++ D+RL D+ + ++ LV +AL C + P RPTM+ V
Sbjct: 1017 RSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 272/728 (37%), Positives = 387/728 (53%)
Query: 66 VTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRY 125
V +T +++ +++L L G + F GL L L N L G+IP ++G S L
Sbjct: 355 VELSTLKNLSKLDLSINALTGPIP-LGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWV 413
Query: 126 LDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI 185
LD S N+L+G IP L N+ +LNL NNL+G IP+ + L+ + L+RN L G
Sbjct: 414 LDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRF 473
Query: 186 PSAIGDXXXXXXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTY 245
PS + G + +E+G L L + N G +P + L+ L
Sbjct: 474 PSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGT 533
Query: 246 LYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI 305
L + SN L G +P EI N + ++DM NN GT+P E+ L QL L +S+N LSG I
Sbjct: 534 LNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTI 593
Query: 306 PITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELR-NITLRNNNLSGSIPPEIG-LMKLE 363
P+ + L L L + N +G IP E+G + L+ + L N L+G IPPE+ L+ LE
Sbjct: 594 PVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLE 653
Query: 364 YLDLSHNKLNGTIPPFLYHRFPL---DLSYNDLEGEIPDYFRDSPFKVYGNQGICY--FS 418
+L L++N L+G IP + L + SYN L G IP S GN+G+C +
Sbjct: 654 FLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGPPLN 713
Query: 419 ACSTLH--TPTASKSKSLVLRVLNIILPITACVI----FLTLAFIVFLLNK--NEIAK-L 469
C P+ S K +R II ITA VI + +A IV+L+ + +A
Sbjct: 714 QCIQTQPFAPSQSTGKPGGMRSSKIIA-ITAAVIGGVSLMLIALIVYLMRRPVRTVASSA 772
Query: 470 MTG-PTK-SGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVA 527
G P++ S D++ +G F+D++ AT++FD + +G G G+VYKA LP G +A
Sbjct: 773 QDGQPSEMSLDIY-FPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLA 830
Query: 528 LKKL---HRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584
+KKL H NSF+ E L I HRNIVKL+GFC H+ L+Y+YM +GS
Sbjct: 831 VKKLASNHEGGNNNNVD-NSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGS 889
Query: 585 LFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644
L L + + LDW+ R I A L+YLHHDC P I HRDI SNNILL+ K EA
Sbjct: 890 LGEILHDP--SCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH 947
Query: 645 VADFGTARLLDSD-SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
V DFG A+++D S + + +AG+YGYIAPE AYTM VTEK D+YS+GVV LE+L G+ P
Sbjct: 948 VGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAP 1007
Query: 704 ------GEXXXXXXXXXXDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPK 757
G + + VLD+RL+ +R+V ++ V +AL C P
Sbjct: 1008 VQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSH-MLTVLKIALLCTSVSPV 1066
Query: 758 FRPTMQRV 765
RP+M++V
Sbjct: 1067 ARPSMRQV 1074
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 981 (350.4 bits), Expect = 9.6e-101, Sum P(2) = 9.6e-101
Identities = 256/722 (35%), Positives = 364/722 (50%)
Query: 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132
S+ ++ L L G + Q + L + N L G IP + S L L+ N
Sbjct: 398 SMRQLQLFHNSLSGVIPQ-GLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNR 456
Query: 133 LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDX 192
+ G+IPP + ++L L + GN L G P+ LC+L L + L +N GP+P IG
Sbjct: 457 IFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTC 516
Query: 193 XXXXXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252
L E+ KL NLV NV N L GPIPS + L L L N
Sbjct: 517 QKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNS 576
Query: 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGL 312
GS+PPE+G++ + + +S N G IP + L+ L L + N+ SG IP + L
Sbjct: 577 FIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLL 636
Query: 313 ISLK-GLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHN 370
SL+ ++LS N SG IPPEIG L ++L NN+LSG IP L L + S+N
Sbjct: 637 SSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYN 696
Query: 371 KLNGTIPPFLYHRFPLDLSYNDLEGEIPDYFRDSPFKVY-GNQGIC--YFSACSTLHT-- 425
L G +P H F++ + GN+G+C + +C H+
Sbjct: 697 NLTGQLP----HT---------------QIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSW 737
Query: 426 PTASKSKSLVLR---VLNIILPITACVIFLTLAFIV-FLLNKNE-IAKLMTGPT---KSG 477
P S K+ R ++ I+ + + L +A +V FL N E A + +
Sbjct: 738 PHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQES 797
Query: 478 DVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKL--HRA- 534
D++ + R +DI++AT+ F Y +G G G+VYKA +P+GK +A+KKL +R
Sbjct: 798 DIYFVPKE--RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREG 855
Query: 535 -ETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMFLIYKYMKRGSLFCFLRN 591
NSF+ E L KI HRNIV+LY FC H+ L+Y+YM RGSL L
Sbjct: 856 NNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHG 915
Query: 592 DYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651
++ +DW R I A L+YLHHDC P I+HRDI SNNIL++ EA V DFG A
Sbjct: 916 G-KSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLA 974
Query: 652 RLLDSD-SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP------- 703
+++D S + + VAG+YGYIAPE AYTM VTEKCD+YSFGVV LE+L G+ P
Sbjct: 975 KVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQG 1034
Query: 704 GEXXXXXXXXXXDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQ 763
G+ D + ++LD L+ D +++ ++ VT +A+ C S P RPTM+
Sbjct: 1035 GDLATWTRNHIRDHSLTS-EILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMR 1093
Query: 764 RV 765
V
Sbjct: 1094 EV 1095
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 7.2e-61, P = 7.2e-61
Identities = 180/541 (33%), Positives = 271/541 (50%)
Query: 77 INLPEKKLKGEL-SQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG 135
++L + +L G + S F F GLE L L N L G++P + +L L ++ S N L G
Sbjct: 509 LDLADNQLSGSIPSSFGF--LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNG 566
Query: 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDXXXX 195
+I P GS L ++ N IP L L + L +N L G IP +G
Sbjct: 567 TIHPLCGSSSYLS-FDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIREL 625
Query: 196 XXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG 255
G + +L K L +++ N L GPIP L +L+ L L L SN
Sbjct: 626 SLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVE 685
Query: 256 SIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISL 315
S+P E+ N T +L + + N++ G+IP E+ L L L++ N SG +P + L L
Sbjct: 686 SLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKL 745
Query: 316 KGLDLSNNKLSGPIPPEIGKCSELRN-ITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLN 373
L LS N L+G IP EIG+ +L++ + L NN +G IP IG L KLE LDLSHN+L
Sbjct: 746 YELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLT 805
Query: 374 GTIPPFLYHRFPL---DLSYNDLEGEIPDYFRDSPFKVY-GNQGICY--FSACSTLHTPT 427
G +P + L ++S+N+L G++ F P + GN G+C S C+ + +
Sbjct: 806 GEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSN- 864
Query: 428 ASKSKSLVLRVLNIILPITA--CVIFLTLAFIVFLLNKNEIAKLM----TGPTKSGD--- 478
+K + L R + II I+A + + L +F +++ K + T T S
Sbjct: 865 -NKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQ 923
Query: 479 -----VFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHR 533
+F I +EDI++AT + ++ IG+GG G VYKA+L NG+ VA+KK+
Sbjct: 924 ATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI-- 981
Query: 534 AETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK--CMFLIYKYMKRGSLFCFLRN 591
++ SF E L +I HR++VKL G+C K LIY+YMK GS++ +L
Sbjct: 982 LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHE 1041
Query: 592 D 592
D
Sbjct: 1042 D 1042
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
Identities = 248/718 (34%), Positives = 370/718 (51%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
+S+ + L E G + + L+ L N L G IP ++ L L+ L+ N
Sbjct: 260 KSLETLLLYENNFTGTIPR-EIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRN 318
Query: 132 NLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD 191
L+GSIPP + SL L+VL L N L+G +PS L + + L + +S N G IPS + +
Sbjct: 319 KLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCN 378
Query: 192 XXXXXXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSN 251
G + L ++LV + + N L G IP +L L L L N
Sbjct: 379 KGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGN 438
Query: 252 HLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311
L+G IP +I + + +D S N I ++P + + L ++ N +SG++P
Sbjct: 439 RLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQD 498
Query: 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMK-LEYLDLSHN 370
SL LDLS+N L+G IP I C +L ++ LRNNNL+G IP +I M L LDLS+N
Sbjct: 499 CPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNN 558
Query: 371 KLNGTIPPFLYHRFPLDL---SYNDLEGEIP--DYFRD-SPFKVYGNQGIC--YFSACST 422
L G +P + L+L SYN L G +P + + +P + GN G+C CS
Sbjct: 559 SLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSK 618
Query: 423 LHTPTASKSKSLVLRVL-NIILPITACVIFLTLAFIVFLLNKNEIAKLMTGPTKSGDVFS 481
T+S S R++ ++ I + + L + L K + G +
Sbjct: 619 FQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEW 678
Query: 482 IWNYDG--RIAF--EDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGK-VVALKKLHR--A 534
W R+ F DI+ ++ ++ IG G G VYKA++ V+A+KKL R A
Sbjct: 679 PWRLMAFHRLGFTASDILACIKESNM---IGMGATGIVYKAEMSRSSTVLAVKKLWRSAA 735
Query: 535 ETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RND 592
+ E+ T F E ++L K+ HRNIV+L GF + K M ++Y++M G+L + +N
Sbjct: 736 DIEDGTT-GDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNA 794
Query: 593 YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652
+++DW R NI VA+ L+YLHHDC P ++HRDI SNNILL++ L+A +ADFG AR
Sbjct: 795 AGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLAR 854
Query: 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEXXXXXXX 712
++ ++VAG+YGYIAPE YT+ V EK D+YS+GVV LE+L GR P E
Sbjct: 855 MMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESV 914
Query: 713 XXXD---QKIMLIDVLDSRLSPPVD--RMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
+ +KI L+ L P V R V ++++LV +AL C PK RP+M+ V
Sbjct: 915 DIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDV 972
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 959 (342.6 bits), Expect = 1.8e-96, P = 1.8e-96
Identities = 252/732 (34%), Positives = 370/732 (50%)
Query: 57 SSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQ 116
SSD C+L G+ R L G + + +C + L + +N + G IP
Sbjct: 208 SSDMCQLTGLWYFDVRG--------NNLTGTIPESIGNC-TSFQILDISYNQITGEIPYN 258
Query: 117 VGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176
+G L ++ L N LTG IP +G ++ L VL+L N L G IP L L+ + L
Sbjct: 259 IGFL-QVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYL 317
Query: 177 SRNGLHGPIPSAIGDXXXXXXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPST 236
N L GPIPS +G+ G + ELGKL+ L LN+ N+L+GPIPS
Sbjct: 318 HGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSN 377
Query: 237 LFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSI 296
+ L +H N L+GSIP N+ + +++S NN +G IP+EL + L L +
Sbjct: 378 ISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDL 437
Query: 297 SSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPE 356
S N SG IP+T+ L L L+LS N LSG +P E G ++ I + N LSG IP E
Sbjct: 438 SGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTE 497
Query: 357 IG-LMKLEYLDLSHNKLNGTIPPFLYHRFPL---DLSYNDLEGEIP---DYFRDSPFKVY 409
+G L L L L++NKL+G IP L + F L ++S+N+L G +P ++ R +P
Sbjct: 498 LGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFV 557
Query: 410 GNQGIC---YFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKNEI 466
GN +C S C L +L+ VL +I + C+IFL + +
Sbjct: 558 GNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLL--CMIFLAV------YKSMQQ 609
Query: 467 AKLMTGPTKSGDVFS---IWNYDGRI-AFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPN 522
K++ G +K + + I + D I F+DI++ TE+ + K+ IG G +VYK L +
Sbjct: 610 KKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKS 669
Query: 523 GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582
+ +A+K+L+ F+ E + I HRNIV L+G+ L L Y YM+
Sbjct: 670 SRPIAIKRLYNQYPHN---LREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMEN 726
Query: 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE 642
GSL+ L + V LDW R+ I A L+YLHHDC P I+HRDI S+NILL+ E
Sbjct: 727 GSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFE 786
Query: 643 AFVADFGTARLLDSDSSNR-TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGR 701
A ++DFG A+ + + ++ T V GT GYI PE A T + EK D+YSFG+V LE+L G+
Sbjct: 787 AHLSDFGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGK 846
Query: 702 HP--GEXXXXXXXXXXDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFR 759
E +++ +D ++ V M + I +AL C P R
Sbjct: 847 KAVDNEANLHQLILSKADDNTVMEAVDPEVT--VTCMDLGHIRKTFQLALLCTKRNPLER 904
Query: 760 PTMQRVCQEFLT 771
PTM V + L+
Sbjct: 905 PTMLEVSRVLLS 916
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
Identities = 247/745 (33%), Positives = 382/745 (51%)
Query: 70 TARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFS 129
T + ++L E L G + + +F P L+ L L N L G+IP ++ +KL +L+
Sbjct: 311 TCPELFLVDLSENLLTGNIPR-SFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEID 369
Query: 130 FNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAI 189
N ++G IPP +G L +L + N L G IP SL Q +L + LS N L G IP+ I
Sbjct: 370 NNQISGEIPPLIGKLTSLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGI 429
Query: 190 GDXXXXXXXXXXXXXXXGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLH 249
+ G + ++G NL L + GN+L G IP+ + L NL ++ +
Sbjct: 430 FEIRNLTKLLLLSNYLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDIS 489
Query: 250 SNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITI 309
N L G+IPPEI T + VD+ N + G +P L + L ++ +S N L+G +P I
Sbjct: 490 ENRLIGNIPPEISGCTSLEFVDLHSNGLTGGLPGTLPK--SLQFIDLSDNSLTGSLPTGI 547
Query: 310 AGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG----------- 358
L L L+L+ N+ SG IP EI C L+ + L +N +G IP E+G
Sbjct: 548 GSLTELTKLNLAKNRFSGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNL 607
Query: 359 ---------------LMKLEYLDLSHNKLNGTIPPF--LYHRFPLDLSYNDLEGEIPD-- 399
L L LD+SHNKL G + L + L++S+N+ GE+P+
Sbjct: 608 SCNHFTGEIPSRFSSLTNLGTLDVSHNKLAGNLNVLADLQNLVSLNISFNEFSGELPNTL 667
Query: 400 YFRDSPFKVY-GNQGICYFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIV 458
+FR P V N+G+ + S + ++ +S V ++I+ + A V+ + +A V
Sbjct: 668 FFRKLPLSVLESNKGL-FIS--TRPENGIQTRHRSAVKVTMSIL--VAASVVLVLMA--V 720
Query: 459 FLLNKNEIAKLMTGPTKSGDVFSIWNYDGR-IAFEDIIKATEDFDIKYCIGTGGYGSVYK 517
+ L K A+ +TG + D + + Y + +DI+K ++ IGTG G VY+
Sbjct: 721 YTLVK---AQRITGKQEELDSWEVTLYQKLDFSIDDIVKNLTSANV---IGTGSSGVVYR 774
Query: 518 AQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577
+P+G+ +A+KK+ EE FNS E + L I HRNI++L G+C ++ L Y
Sbjct: 775 VTIPSGETLAVKKMW--SKEENRAFNS---EINTLGSIRHRNIIRLLGWCSNRNLKLLFY 829
Query: 578 KYMKRGSLFCFLRNDYEAVV-LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNIL 636
Y+ GSL L + DW R +++ VA+AL+YLHHDC+P I+H D+ + N+L
Sbjct: 830 DYLPNGSLSSLLHGAGKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILHGDVKAMNVL 889
Query: 637 LNSKLEAFVADFGTARLL------DSDSS---NRTIVAGTYGYIAPELAYTMVVTEKCDV 687
L S+ E+++ADFG A+++ D DSS NR +AG+YGY+APE A +TEK DV
Sbjct: 890 LGSRFESYLADFGLAKIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASMQHITEKSDV 949
Query: 688 YSFGVVALEVLMGRHP-------GEXXXXXXXXXXDQKIMLIDVLDSRLSPPVDRMVMQD 740
YS+GVV LEVL G+HP G K ++LD RL D +M +
Sbjct: 950 YSYGVVLLEVLTGKHPLDPDLPGGAHLVQWVRDHLAGKKDPREILDPRLRGRADP-IMHE 1008
Query: 741 IVLVTTVALACLHSKPKFRPTMQRV 765
++ V+ C+ +K RP M+ +
Sbjct: 1009 MLQTLAVSFLCVSNKASDRPMMKDI 1033
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 7.8e-94, P = 7.8e-94
Identities = 252/704 (35%), Positives = 356/704 (50%)
Query: 86 GELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR 145
G ++Q L+S+ L N G IP+ L L L+ N L G+IP +G +
Sbjct: 277 GTITQ-ELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMP 335
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDXXXXXXXXXXXXXX 205
LEVL L NN G+IP L + +L+ + LS N L G +P +
Sbjct: 336 ELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFL 395
Query: 206 XGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
G + LGK ++L + +G N L G IP LF L L+ + L N+L G +P G ++
Sbjct: 396 FGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVS 455
Query: 266 GIL-KVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNK 324
G L ++ +S N + G++P + LS + L + N SG IP I L L LD S+N
Sbjct: 456 GDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNL 515
Query: 325 LSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMK-LEYLDLSHNKLNGTIPPFLYHR 383
SG I PEI +C L + L N LSG IP E+ MK L YL+LS N L G+IP +
Sbjct: 516 FSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASM 575
Query: 384 FPL---DLSYNDLEGEIPD-----YFRDSPFKVYGNQGIC--YFSACSTLHTPTASKSKS 433
L D SYN+L G +P YF + F GN +C Y C + K S
Sbjct: 576 QSLTSVDFSYNNLSGLVPSTGQFSYFNYTSF--VGNSHLCGPYLGPCGKGTHQSHVKPLS 633
Query: 434 LVLRVLNIILPITAC-VIFLTLAFIVFLLNKNEIAKLMTGPTKSGDVFSIWNYDGRIAFE 492
++L ++L + C ++F +A I +N K+ + + D +
Sbjct: 634 ATTKLL-LVLGLLFCSMVFAIVAIIKARSLRN------ASEAKAWRLTAFQRLD--FTCD 684
Query: 493 DIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVL 552
D++ + ++ +I IG GG G VYK +P G +VA+K+L + ++ + F E L
Sbjct: 685 DVLDSLKEDNI---IGKGGAGIVYKGTMPKGDLVAVKRL-ATMSHGSSHDHGFNAEIQTL 740
Query: 553 SKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN 612
+I HR+IV+L GFC + + L+Y+YM GSL L + L W R I A
Sbjct: 741 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGHLHWNTRYKIALEAAK 799
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL-DSDSSN-RTIVAGTYGY 670
L YLHHDC P IVHRD+ SNNILL+S EA VADFG A+ L DS +S + +AG+YGY
Sbjct: 800 GLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 859
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP-GEXXXXXX------XXXXDQKIMLID 723
IAPE AYT+ V EK DVYSFGVV LE++ G+ P GE K ++
Sbjct: 860 IAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRSMTDSNKDCVLK 919
Query: 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
V+D RLS + + ++ V VAL C+ + RPTM+ V Q
Sbjct: 920 VIDLRLSS----VPVHEVTHVFYVALLCVEEQAVERPTMREVVQ 959
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00031862001 | SubName- Full=Chromosome undetermined scaffold_60, whole genome shotgun sequence; (722 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 796 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-70 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-59 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-57 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-45 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-26 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 248 bits (634), Expect = 5e-70
Identities = 213/711 (29%), Positives = 319/711 (44%), Gaps = 53/711 (7%)
Query: 79 LPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIP 138
L + KL G + FS L SL L N L G IP V L L L NN TG IP
Sbjct: 267 LYQNKLSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
Query: 139 PELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLIL 198
L SL L+VL L N +G IP +L + L + LS N L G IP + NL L
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385
Query: 199 SLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258
L SN L G + + LG ++L + + N G +PS +L + +L + +N+L G I
Sbjct: 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445
Query: 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGL 318
+M + + ++ N G +P + +L L +S N SG +P + L L L
Sbjct: 446 SRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQL 504
Query: 319 DLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMK-LEYLDLSHNKLNGTIP 377
LS NKLSG IP E+ C +L ++ L +N LSG IP M L LDLS N+L+G IP
Sbjct: 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564
Query: 378 PFLYHRFPL---DLSYNDLEGEIPD---YFRDSPFKVYGNQGICYFSACSTLHTPTASKS 431
L + L ++S+N L G +P + + V GN +C S L P +
Sbjct: 565 KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL--PPCKRV 622
Query: 432 KSLVLRVLNIILPITACVIFLTLAFIVFLLNKNEIAKLMTGPTKSGDVFSIWN---YDGR 488
+ I + A ++ +AF + +L + G W +D +
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG----TWELQFFDSK 678
Query: 489 ----IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNS 544
I DI+ + ++ ++ I G G+ YK + + + K E NS
Sbjct: 679 VSKSITINDILSSLKEENV---ISRGKKGASYKGKSIKNGMQFVVK-------EINDVNS 728
Query: 545 F-QNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR 603
+E + K+ H NIVKL G C +K +LI++Y++ +L LRN L W R
Sbjct: 729 IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERR 782
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663
I +A AL +LH C P++V ++S I+++ K E + LL +D+
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841
Query: 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723
A Y+APE T +TEK D+Y FG++ +E+L G+ P + + S +
Sbjct: 842 SA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYC 895
Query: 724 VLDSRLSPPVDRMVMQD-------IVLVTTVALACLHSKPKFRPTMQRVCQ 767
D L +D + D IV V +AL C + P RP V +
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 9e-59
Identities = 139/387 (35%), Positives = 204/387 (52%), Gaps = 34/387 (8%)
Query: 46 SSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLR 105
S+W ++S+D C G+TCN + ++ I+L K + G++S F P +++++L
Sbjct: 49 SNW------NSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLS 101
Query: 106 FNYLFGSIPSQV-----------------------GALSKLRYLDFSFNNLTGSIPPELG 142
N L G IP + G++ L LD S N L+G IP ++G
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIG 161
Query: 143 SLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDS 202
S +L+VL+L GN L G IP+SL LT L + L+ N L G IP +G + +L + L
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221
Query: 203 NKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIG 262
N LSG + E+G L +L L++ N L GPIPS+L L NL YL+L+ N L+G IPP I
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 263 NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSN 322
++ ++ +D+S N++ G IP + +L L L + SN +G+IP+ + L L+ L L +
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 323 NKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLY 381
NK SG IP +GK + L + L NNL+G IP + L L L N L G IP L
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401
Query: 382 HRFPLD---LSYNDLEGEIPDYFRDSP 405
L L N GE+P F P
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSEFTKLP 428
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 2e-57
Identities = 131/335 (39%), Positives = 176/335 (52%), Gaps = 29/335 (8%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
L+ + L +N L G IP ++G L+ L +LD +NNLTG IP LG+L+NL+ L L N L+
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLI--------------------- 197
G IP S+ L KLI++ LS N L G IP + L NL I
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333
Query: 198 ---LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254
L L SNK SG + + LGK NL L++ N L G IP L NL L L SN L
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314
G IP +G + +V + N+ G +P E T+L + +L IS+N L G+I + S
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453
Query: 315 LKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLN 373
L+ L L+ NK G +P G L N+ L N SG++P ++G L +L L LS NKL+
Sbjct: 454 LQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512
Query: 374 GTIPPFLY---HRFPLDLSYNDLEGEIPDYFRDSP 405
G IP L LDLS+N L G+IP F + P
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMP 547
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 5e-52
Identities = 122/329 (37%), Positives = 166/329 (50%), Gaps = 29/329 (8%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
LE L+L N L G IP ++G + L+++ +NNL+G IP E+G L +L L+L NNL
Sbjct: 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKN 218
G IPSSL L L + L +N L GPIP +I L L+ L L N LSG + + + +L+N
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN 309
Query: 219 LVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278
L L++ N G IP L L L L L SN +G IP +G + +D+S NN+
Sbjct: 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369
Query: 279 GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSE 338
G IP L L L + SN L G+IP ++ SL+ + L +N SG +P E K
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429
Query: 339 LRNITLRNNNLSGSI------------------------PPEIGLMKLEYLDLSHNKLNG 374
+ + + NNNL G I P G +LE LDLS N+ +G
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSG 489
Query: 375 TIPPFLYHRFP----LDLSYNDLEGEIPD 399
+P L L LS N L GEIPD
Sbjct: 490 AVPRKL-GSLSELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 7e-46
Identities = 67/193 (34%), Positives = 104/193 (53%), Gaps = 10/193 (5%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G GG+G+VY A+ GK VA+K + + + ++ E +L K+ H NIVKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
+ ++L+ +Y + GSL L+ + L + I+ + L YLH + I
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 626 VHRDISSNNILLNSK-LEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYTMVVTE 683
+HRD+ NILL+S + +ADFG ++LL SD S + GT Y+APE L +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 684 KCDVYSFGVVALE 696
K D++S GV+ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 82/272 (30%), Positives = 130/272 (47%), Gaps = 21/272 (7%)
Query: 501 FDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
+++ +G+G +G+VYKA+ GK+VA+K L + +E++ + + E +L +++H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
IV+L K ++L+ +Y + G LF +L L I + L YLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHS 116
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYT 678
+ I+HRD+ NILL+ +ADFG A+ L SS+ T GT Y+APE L
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 679 MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738
K DV+S GV+ E+L G+ P S + Q I I L PP++
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP---FSGENILDQLQLIRRI------LGPPLEFDEP 224
Query: 739 QDIVLVTT---VALACLHSKPKFRPTMQRVCQ 767
+ + CL+ P RPT + + Q
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-45
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
++I +G G +G VY A+ GK+VA+K + + + ++ E +L K+ H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANALSY 616
IV+LY + ++L+ +Y + G LF L+ E ++ + +AL Y
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA------RFYLRQILSALEY 112
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
LH IVHRD+ NILL+ +ADFG AR LD T V GT Y+APE+
Sbjct: 113 LHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-GTPEYMAPEVL 168
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ D++S GV+ E+L G+ P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-43
Identities = 101/307 (32%), Positives = 150/307 (48%), Gaps = 24/307 (7%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
+ +I ++L + L GE+ + LE L L N G IP + +L +L+ L N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQ-LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 132 NLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD 191
+G IP LG NL VL+L NNL G IP LC L + L N L G IP ++G
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 192 LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPST--------------- 236
+L + L N SG L E KL + L++ N L G I S
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 237 --------LFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRL 288
F L L L N +G++P ++G+++ ++++ +S N + G IP EL+
Sbjct: 463 KFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522
Query: 289 SQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNN 348
+L+ L +S N LSGQIP + + + L LDLS N+LSG IP +G L + + +N+
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582
Query: 349 LSGSIPP 355
L GS+P
Sbjct: 583 LHGSLPS 589
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 31/273 (11%)
Query: 507 IGTGGYGSVYKAQL----PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +G VYK L +V VA+K L +E+ F EA ++ K+ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHPNIV 64
Query: 562 KLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
KL G C ++ + ++ +YM G L +LR L + ++ +A + YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLES-- 121
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA-GTYGYIAPELAYTMV 680
+HRD+++ N L+ L ++DFG +R L D + ++APE
Sbjct: 122 KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 681 VTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP---VDRM 736
T K DV+SFGV+ E+ +G P + S+ +++ RL P +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGM-------SNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ L C P+ RPT + +
Sbjct: 234 Y--------KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 40/277 (14%)
Query: 507 IGTGGYGSVYKAQL--PNGKV---VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +G VYK +L GK VA+K L +E+ F EA ++ K+ H N+V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHPNVV 64
Query: 562 KLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
KL G C ++ ++++ +YM+ G L +LR L + ++ +A + YL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLES-- 120
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA-GTYGYIAPELAYTMV 680
+HRD+++ N L+ L ++DFG +R L D R ++APE
Sbjct: 121 KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 681 VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL-----DSRLSPP--- 732
T K DV+SFGV+ E+ GE P + +VL RL P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTL---GE------QPYPG--MSNEEVLEYLKNGYRLPQPPNC 228
Query: 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ + L C P+ RPT + +
Sbjct: 229 PPELY--------DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 53/284 (18%)
Query: 507 IGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +G VYK L VA+K L +EE F EA ++ K++H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER--EEFLEEASIMKKLSHPNIV 64
Query: 562 KLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH-HD 620
+L G C + ++++ +YM G L FLR E + L + + +A + YL +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESKN 122
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----APEL 675
VHRD+++ N L+ L ++DFG +R + D R G + APE
Sbjct: 123 F----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLPIKWMAPES 175
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS-----RLS 730
T K DV+SFGV +L E+ + P + +VL+ RL
Sbjct: 176 LKDGKFTSKSDVWSFGV----LLW-----EIFTLGEQPYPG--MSNEEVLELLEDGYRLP 224
Query: 731 PPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P + +M C P+ RPT + ++
Sbjct: 225 RPENCPDELYELMLQ----------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 507 IGTGGYGSVYKAQL---PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
+G G +G VYK +L VA+K L +EE F EA V+ K+ H N+V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNVVR 60
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRN------DYEAVVLDWTMRVNIIKCVANALSY 616
L G C ++ ++L+ +YM+ G L +LR E L ++ +A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI----- 671
L VHRD+++ N L+ L ++DFG +R + D R T G +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK---KTGGKLPIRWM 174
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVL-MGRHP-GELLSSLSSPSSDQKIM--LIDVLDS 727
APE + T K DV+SFGV+ E+ +G P L S+++++ L
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEYLRK--GY 224
Query: 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P D + + L+C P+ RPT + +
Sbjct: 225 RLPKPEY---CPDE--LYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 500 DFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
F+I IG GG+G VYKA GK VA+K + E NE +L K H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN------IIKCVAN 612
NIVK YG L K ++++ ++ GSL + ++ + + K +
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTESQIAYVCKELLK 109
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA-RLLDSDSSNRTIVAGTYGYI 671
L YLH + I+HRDI + NILL S E + DFG + +L D+ + N + GT ++
Sbjct: 110 GLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWM 164
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
APE+ K D++S G+ A+E+ G+ P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 32/266 (12%)
Query: 506 CIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLY 564
+G G +GSVY A G+++A+K + + + + E +LS + H NIV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 565 GFCLHK-KCMFLIY-KYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANALSYLH- 618
G + K I+ +Y+ GSL L+ E V+ +T + + L+YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT------RQILEGLAYLHS 119
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELA 676
+ IVHRDI NIL++S +ADFG A+ L + V GT ++APE+
Sbjct: 120 NG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP-GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735
D++S G +E+ G+ P EL + +++ + LS
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA-- 233
Query: 736 MVMQDIVLVTTVALACLHSKPKFRPT 761
+D + CL PK RPT
Sbjct: 234 ---KDFL------RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 136 bits (342), Expect = 1e-34
Identities = 83/286 (29%), Positives = 126/286 (44%), Gaps = 17/286 (5%)
Query: 500 DFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-R 558
+ I +G G +G VY A+ K+VALK L + ++ F E +L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
NIVKLY F + ++L+ +Y+ GSL L+ L + + I+ + +AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFV-ADFGTARLLDSDSSNRTIVA------GTYGYI 671
I+HRDI NILL+ DFG A+LL S +I A GT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 672 APELAYTMV---VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728
APE+ + + D++S G+ E+L G P E + S+ S KI+L S
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTM-QRVCQEFLTCK 773
SP + + L PK R + + + L
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 78/272 (28%), Positives = 114/272 (41%), Gaps = 32/272 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
D + +G G G VYK + P GK+ ALKK+H EE E L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCES 58
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRV--NIIKCVANALS 615
+VK YG + + ++ +YM GSL D V V I + + L
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSL-----ADLLKKVGKIPEPVLAYIARQILKGLD 113
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
YLH I+HRDI +N+L+NSK E +ADFG +++L++ GT Y++PE
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPER 171
Query: 676 ----AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731
+Y+ D++S G+ LE +G+ P S Q I S
Sbjct: 172 IQGESYSY----AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSL 223
Query: 732 PVDRMV--MQDIVLVTTVALACLHSKPKFRPT 761
P + +D + ACL PK RP+
Sbjct: 224 PAEEFSPEFRDFI------SACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 80/290 (27%), Positives = 124/290 (42%), Gaps = 58/290 (20%)
Query: 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLH-----RAETEETTFFNSFQNEAHVLS 553
++I IG G +G VY + +GK+ LK++ E E+ NE +L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA------LNEVKILK 54
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-------EAVVLDWTMRVNI 606
K+ H NI+K Y K + ++ +Y G L ++ E +LDW V +
Sbjct: 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL 112
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG 666
AL YLH I+HRDI NI L S + DFG +++L S V G
Sbjct: 113 ----CLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 667 TYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIM 720
T Y++PEL Y K D++S G V E+ +HP GE L L+ KI+
Sbjct: 166 TPYYLSPELCQNKPY----NYKSDIWSLGCVLYELCTLKHPFEGENLLELA-----LKIL 216
Query: 721 LIDVLDSRLSPPVDRMV---MQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
PP+ ++++V + L P+ RP++ ++ Q
Sbjct: 217 ------KGQYPPIPSQYSSELRNLV------SSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 76/281 (27%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEE-TTFFNSFQNEAHVLSKIA 556
+D+++ IG G VY A LPN + VA+K++ + E+ T + + E +S+
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
H N+VK Y + ++L+ Y+ GSL +++ Y LD + ++K V L Y
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL----DSDSSNRTIVAGTYGYIA 672
LH + +HRDI + NILL +ADFG + L D R GT ++A
Sbjct: 118 LHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 673 PEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHPGE-------LLSSLSSPSSDQKIM 720
PE+ Y K D++SFG+ A+E+ G P L+ +L + +
Sbjct: 175 PEVMEQVHGY----DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS---L 227
Query: 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
+ S +M+ CL P RPT
Sbjct: 228 ETGADYKKYSKSFRKMISL-----------CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 81/272 (29%), Positives = 133/272 (48%), Gaps = 38/272 (13%)
Query: 500 DFDIKYCIGTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFFNSFQNEAHVLS 553
DF+I IG G +G V+K + + +V A+K K++R E EE +EA VL+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI------DEARVLA 54
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLD---WTMRVNIIKCV 610
K+ I++ Y L K + ++ +Y + G L L+ + + W + I+
Sbjct: 55 KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-- 112
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTY 668
L++LH I+HRDI S N+ L++ + D G A+LL SD++N TIV GT
Sbjct: 113 --GLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIV-GTP 165
Query: 669 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728
Y++PEL EK DV++ GVV E G+HP + +++Q +++ ++
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGV 217
Query: 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRP 760
PPV +M Q + + CL + RP
Sbjct: 218 F-PPVSQMYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 500 DFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++ + IG G +G VYK L G VA+K++ + +E S E +L + H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNLKHP 59
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANALS 615
NIVK G +++I +Y + GSL ++ E++V + + V L+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY------VYQVLQGLA 113
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
YLH ++HRDI + NIL +ADFG A L+ S + V GT ++APE+
Sbjct: 114 YLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV 170
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ D++S G +E+L G P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 71/231 (30%), Positives = 107/231 (46%), Gaps = 35/231 (15%)
Query: 488 RIAFEDIIKATEDFDIKYC----IGTGGYGSVYKA-QLPNGKVVALKKLH-RAETEETTF 541
+ A +DI+ D Y IG G G VYKA GK VA+KK+ R + +E
Sbjct: 5 KAALKDIVSE-GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII 63
Query: 542 FNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWT 601
NE ++ H NIV Y L ++++ +YM GSL ++
Sbjct: 64 -----NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQN 109
Query: 602 -MRVN------IIKCVANALSYLH--HDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652
+R+N + + V L YLH + ++HRDI S+NILL+ +ADFG A
Sbjct: 110 FVRMNEPQIAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAA 164
Query: 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
L + S R V GT ++APE+ K D++S G++ +E+ G P
Sbjct: 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL-Y 564
+G G +G V + + GK+ A+K L + + + E ++LS+I H IVKL Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH-HDCMP 623
F +K ++L+ +Y G LF L E + R + AL YLH
Sbjct: 61 AFQTEEK-LYLVLEYAPGGELFSHLSK--EGRFSEERARF-YAAEIVLALEYLHSLG--- 113
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL----AYTM 679
I++RD+ NILL++ + DFG A+ L S+ S GT Y+APE+ Y
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 680 VVTEKCDVYSFGVVALEVLMGRHP 703
V D +S GV+ E+L G+ P
Sbjct: 173 AV----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 20/247 (8%)
Query: 501 FDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
F++ IG G +G V Q K+ A+K +++ + E + NE +L ++ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 560 IVKL-YGFCLHKKCMFLIYKYMKRGSL-FCFLRNDY--EAVVLDWTMRVNIIKCVANALS 615
+V L Y F + M+L+ + G L + + E V W I + AL
Sbjct: 62 LVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW------ICEIVLALE 114
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
YLH I+HRDI +NILL+ + + DF A + + + T +GT GY+APE+
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTSGTPGYMAPEV 170
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735
+ D +S GV A E L G+ P S DQ I L P
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYR---GHSRTIRDQ-IRAKQETADVLYPATWS 226
Query: 736 MVMQDIV 742
D +
Sbjct: 227 TEAIDAI 233
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 82/278 (29%), Positives = 128/278 (46%), Gaps = 50/278 (17%)
Query: 507 IGTGGYGSVYKA--QLPNGKV--VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
IG G +G V + +LP K VA+K L +++ F EA ++ + H NI++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIR 69
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCM 622
L G + + +I +YM+ GSL FLR + V +++ +A+ + YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYLSEMNY 127
Query: 623 PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG--YIAPE-LAYTM 679
VHRD+++ NIL+NS L V+DFG +R L+ + T G + APE +AY
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR- 183
Query: 680 VVTEKCDVYSFGVVALEVL-MGRHP-GELLSSLSSPSSDQKIMLIDVLDS-----RLSPP 732
T DV+SFG+V EV+ G P ++ S+Q DV+ + RL PP
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDM--------SNQ-----DVIKAVEDGYRLPPP 230
Query: 733 VD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
+D +M D C RPT ++
Sbjct: 231 MDCPSALYQLMLD----------CWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++ + IG G +G V KV A+K L ++T +F EA V++ + H
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQKV-AVKCLKD----DSTAAQAFLAEASVMTTLRHP 60
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC--VANALSY 616
N+V+L G L ++++ +YM +GSL +LR+ AV+ T+ + V + Y
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI---TLAQQLGFALDVCEGMEY 117
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
L + VHRD+++ N+L++ L A V+DFG A+ S + + APE
Sbjct: 118 LEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEAL 171
Query: 677 YTMVVTEKCDVYSFGVVALEVL-MGRHP 703
+ K DV+SFG++ E+ GR P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 79/243 (32%), Positives = 123/243 (50%), Gaps = 26/243 (10%)
Query: 503 IKYCIGTGGYGSVYKAQL-PNGK---VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
I+ IG G +G V + +L GK VA+K L TE+ F +EA ++ + H
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 65
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWTMRVNIIKCVANALSYL 617
NI+ L G + + +I ++M+ G+L FLR ND + V+ V +++ +A + YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL 122
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----A 672
+ VHRD+++ NIL+NS L V+DFG +R L+ D+S+ T + G I A
Sbjct: 123 SE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731
PE T DV+S+G+V EV+ G P S+Q ++ D RL P
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDVINAIEQDYRLPP 232
Query: 732 PVD 734
P+D
Sbjct: 233 PMD 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 73/274 (26%), Positives = 115/274 (41%), Gaps = 39/274 (14%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G G V K P GK++A+K + E E +L K IV YG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA--IQKQILRELDILHKCNSPYIVGFYG 66
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
+ + + +YM GSL L+ + + I V L+YLH I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKH--KI 122
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRD+ +NIL+NS+ + + DFG + L +S +T V GT Y+APE + K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFV-GTSSYMAPERIQGNDYSVKS 180
Query: 686 DVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD------------SRLSPPV 733
D++S G+ +E+ GR P P +D + ++L + SP
Sbjct: 181 DIWSLGLSLIELATGRFP-------YPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD- 232
Query: 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
QD V + CL P+ RP+ + + +
Sbjct: 233 ----FQDFVNL------CLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 507 IGTGGYGSVYKA--QLPNGK--VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
IG G +G V++ ++P K VA+K L TE+ F +EA ++ + +H NI++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIR 70
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
L G K +I +YM+ G+L +LR +D E V +++ +A + YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGMKYLSD-- 125
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG---TYGYIAPELAYT 678
+ VHRD+++ NIL+NS LE V+DFG +R+L+ D +G + APE
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 679 MVVTEKCDVYSFGVVALEVL-MGRHP 703
T DV+SFG+V EV+ G P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 9e-25
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 38/213 (17%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G YG VYKA+ G++VALKK+ R E E+ F + E +L K+ H NIV+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 566 FCLHKKC--MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI--IKCVA----NALSYL 617
K ++++++YM +D ++ ++ IKC L YL
Sbjct: 66 IVTSKGKGSIYMVFEYMD---------HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS----NRTIVAGTYGYIAP 673
H + I+HRDI +NIL+N+ +ADFG AR +S NR I T Y P
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI---TLWYRPP 170
Query: 674 EL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
EL Y + D++S G + E+ +G+
Sbjct: 171 ELLLGATRY----GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
E FDI +G G YGSVYKA G+VVA+K + EE E +L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQ--EIIKEISILKQCDS 57
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR------NDYE-AVVLDWTMRVNIIKCV 610
IVK YG ++++ +Y GS+ ++ + E A +L
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAIL---------YQT 108
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
L YLH + +HRDI + NILLN + +A +ADFG + L + R V GT +
Sbjct: 109 LKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+APE+ + K D++S G+ A+E+ G+ P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 13/202 (6%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E+F ++ +G+G +G V++ N VA+K L + + FQ E L ++ H+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ---DFQKEVQALKRLRHK 62
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+++ L+ C + +++I + M++GSL FLR+ E VL +++ VA ++YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE 121
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD---SSNRTIVAGTYGYIAPEL 675
+ +HRD+++ NIL+ L VADFG ARL+ D SS++ I Y + APE
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEA 175
Query: 676 AYTMVVTEKCDVYSFGVVALEV 697
A + K DV+SFG++ E+
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 84/271 (30%), Positives = 122/271 (45%), Gaps = 35/271 (12%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
E F + CIG G +G VYKA +VVA+K + E E+ Q E LS+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED--IQQEIQFLSQCRS 58
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
I K YG L +++I +Y GS L+ LD T I++ V L YL
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYL 114
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H + +HRDI + NILL+ + + +ADFG + L S S R GT ++APE+
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-LI------DVLDSRLS 730
EK D++S G+ A+E+ G P LS L +++ LI + ++ S
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP---LSDLHP----MRVLFLIPKNNPPSLEGNKFS 224
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
P V CL+ PK RP+
Sbjct: 225 KPFKDFVSL-----------CLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 83/275 (30%), Positives = 132/275 (48%), Gaps = 59/275 (21%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH---RNIVK 562
IG G YG+VY+ +P G+VVALK ++ +T + + Q E +LS++ NI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDV-SDIQREVALLSQLRQSQPPNITK 66
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVANALSYL 617
YG L +++I +Y + GS+ ++ Y +V II+ V AL Y+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV---------IIREVLVALKYI 117
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H ++HRDI + NIL+ + + DFG A LL+ +SS R+ GT ++APE
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE--- 171
Query: 678 TMVVTE------KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731
V+TE K D++S G+ E+ G P S + + +MLI + P
Sbjct: 172 --VITEGKYYDTKADIWSLGITIYEMATGNPP------YSDVDAFRAMMLI----PKSKP 219
Query: 732 PVDRM-------VMQDIVLVTTVALACLHSKPKFR 759
P R+ ++++ V ACL +PK R
Sbjct: 220 P--RLEDNGYSKLLREFV------AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 71/257 (27%), Positives = 125/257 (48%), Gaps = 23/257 (8%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G+G +G V+ + VA+K ++ E F EA V+ K++H +V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYGV 67
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C +K ++++ ++M+ G L +LR + D M +++ + V + YL + S +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERN---SFI 122
Query: 627 HRDISSNNILLNSKLEAFVADFGTAR-LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+++ N L++S V+DFG R +LD + ++ + + PE+ + K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 686 DVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLV 744
DV+SFGV+ EV G+ P E S+ + + +I P + M V
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE------KKSNYEVVEMISRGFRLYRPKLASMT------V 230
Query: 745 TTVALACLHSKPKFRPT 761
V +C H KP+ RPT
Sbjct: 231 YEVMYSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 25/224 (11%)
Query: 494 IIKATEDFDIKYCIGTGGYGSVYKAQ-LPNG---KV-VALKKLHRAETEETTFFNSFQNE 548
I+K TE + +G+G +G+VYK +P G K+ VA+K L + + +E
Sbjct: 3 ILKETE-LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDE 59
Query: 549 AHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAV----VLDWTMRV 604
A+V++ + H ++V+L G CL + LI + M G L ++RN + + +L+W +++
Sbjct: 60 AYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI 118
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664
A +SYL +VHRD+++ N+L+ + + DFG A+LLD D
Sbjct: 119 ------AKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE 169
Query: 665 AGTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGE 705
G ++A E + T K DV+S+GV E++ G P E
Sbjct: 170 GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 54/221 (24%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLH-----RAETEETTFFNSFQNEAHVLS 553
D+++ IG G +G+V K + +GK++ K++ E ++ +E ++L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV------SEVNILR 54
Query: 554 KIAHRNIVKLYGFCLHK--KCMFLIYKYMKRGSLFCFLRNDY-------EAVVLDWTMRV 604
++ H NIV+ Y + + + ++++ +Y + G L ++ E +
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------ 108
Query: 605 NIIKCVANALSYLHH--DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662
I+ + AL H+ D +++HRD+ NI L++ + DFG A++L DSS
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
Query: 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
GT Y++PE M EK D++S G + E+ P
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 82/284 (28%), Positives = 127/284 (44%), Gaps = 54/284 (19%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
ED+++ IG+G YG VYKA+ + G++VA+K + ++ F Q E +L + H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD---FEIIQQEISMLKECRH 59
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSL---FCFLRNDYE----AVVLDWTMRVNIIKCV 610
NIV +G L + ++++ +Y GSL + R A V T++
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK------- 112
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
L+YLH +HRDI NILL + +ADFG + L + + R GT +
Sbjct: 113 --GLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167
Query: 671 IAPELA-------YTMVVTEKCDVYSFGVVALEV------LMGRHPGELLSSLSSPSSDQ 717
+APE+A Y KCD+++ G+ A+E+ + HP L +S S+
Sbjct: 168 MAPEVAAVERKGGY----DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SNFP 222
Query: 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
L D + SP V D + CL PK RPT
Sbjct: 223 PPKLKD--KEKWSP-----VFHDFIKK------CLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 35/215 (16%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G VY A L G+++A+K++ R + + +E VL + H N+VK YG
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFL---RNDYEAVVLDWTMRVNIIKCVANALSYLHHDCM 622
+H++ +++ +Y G+L L R E V+ +T+++ L+YLH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE------GLAYLH---S 117
Query: 623 PSIVHRDISSNNILLNS----KLEAFVADFGTARLLDSDSSNRTIV-------AGTYGYI 671
IVHRDI NI L+ KL DFG A L +N T + AGT Y+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKL----GDFGCAVKL---KNNTTTMGEEVQSLAGTPAYM 170
Query: 672 APELAYTMVVTEK---CDVYSFGVVALEVLMGRHP 703
APE+ D++S G V LE+ G+ P
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 81/279 (29%), Positives = 120/279 (43%), Gaps = 38/279 (13%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G V+K KVVA+K + E E+ Q E VLS+ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L +++I +Y+ GS L E LD T I++ + L YLH +
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KK 122
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRDI + N+LL+ E +ADFG A L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 686 DVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI------DVLDSRLSPPVDRMVMQ 739
D++S G+ A+E+ G P L + K++ + L+ S P+ V
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPM-------KVLFLIPKNNPPTLEGNYSKPLKEFVE- 234
Query: 740 DIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVN 778
ACL+ +P FRPT +E L K +
Sbjct: 235 ----------ACLNKEPSFRPT----AKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 68/262 (25%), Positives = 119/262 (45%), Gaps = 28/262 (10%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G V++ N VA+K L + F EA ++ K+ H +++LY
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA----EAQIMKKLRHPKLIQLYAV 69
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C ++ ++++ + MK GSL +L+ L +++ VA+ ++YL + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQ---NYI 125
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLLDSDSSN-RTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+++ N+L+ VADFG AR++ D R + APE A + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 686 DVYSFGVVALE-VLMGRHPGELLSSLSSPSSDQKIMLIDVLDS--RLSPPVD-RMVMQDI 741
DV+SFG++ E V GR P +++ ++ +D R+ P + DI
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAE---------VLQQVDQGYRMPCPPGCPKELYDI 236
Query: 742 VLVTTVALACLHSKPKFRPTMQ 763
+ L C P RPT +
Sbjct: 237 M------LDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 72/221 (32%), Positives = 112/221 (50%), Gaps = 27/221 (12%)
Query: 500 DFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
D +K+ +G G YG VY+ VA+K L E+T F EA V+ +I H
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 62
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYE---AVVLDWTMRVNIIKCVANAL 614
N+V+L G C + ++I ++M G+L +LR + + AVVL + + +++A+
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 117
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT---YGYI 671
YL + +HRD+++ N L+ VADFG +RL+ D+ T AG +
Sbjct: 118 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWT 172
Query: 672 APE-LAYTMVVTEKCDVYSFGVVALEVL---MGRHPGELLS 708
APE LAY K DV++FGV+ E+ M +PG LS
Sbjct: 173 APESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLS 212
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G GG+G V ++ + ALK + + ET +E +L + H IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLD-WTMRVNIIKCVANALSYLHHDCMPS 624
KK ++++ +Y G L+ LR + + D +T R I CV A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARF-YIACVVLAFEYLHNR---G 113
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEK 684
I++RD+ N+LL+S + DFG A+ L S T GT Y+APE ++ K
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-GTPEYVAPE-----IILNK 167
Query: 685 -----CDVYSFGVVALEVLMGRHP 703
D +S G++ E+L GR P
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 23/261 (8%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G+G +G V+ + VA+K + E F EA V+ K++H N+V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLYGV 67
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C ++ +F++ +YM G L +LR + +W + + C A+ YL + +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVC--EAMEYLESNG---FI 122
Query: 627 HRDISSNNILLNSKLEAFVADFGTAR-LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+++ N L+ V+DFG AR +LD ++ + PE+ + K
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 686 DVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLV 744
DV+SFGV+ EV G+ P E S +S + + +L+P +M
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSAGYRLYRPKLAPTEVYTIMYS---- 236
Query: 745 TTVALACLHSKPKFRPTMQRV 765
C H KP+ RP +++
Sbjct: 237 ------CWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALK----KLHRAETEETTFFNSFQNEAHVLS 553
+DF IG G + +V A+ K A+K + E + + E VL+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV----KYVKIEKEVLT 56
Query: 554 KIA-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN 612
++ H I+KLY ++ ++ + +Y G L ++R LD +
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILL 113
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN------------ 660
AL YLH I+HRD+ NILL+ + + DFGTA++LD +SS
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 661 --------RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
GT Y++PEL + D+++ G + ++L G+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
I G YG V+ A+ + G + A+K + +A+ + E +LS+ +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
KK ++L+ +Y+ G L L N + LD + I + AL YLH + I
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN-VGS--LDEDVARIYIAEIVLALEYLHSN---GI 114
Query: 626 VHRDISSNNILLNS----KLEAFVADFG---------TARLLDSDSSNRTIVAGTYGYIA 672
+HRD+ +NIL++S KL DFG L D + ++ IV GT YIA
Sbjct: 115 IHRDLKPDNILIDSNGHLKL----TDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIA 169
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
PE+ ++ D +S G + E L+G P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 75/260 (28%), Positives = 116/260 (44%), Gaps = 22/260 (8%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G V+K +VVA+K + E E+ Q E VLS+ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L +++I +Y+ GS LR A D ++K + L YLH +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KK 122
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRDI + N+LL+ + + +ADFG A L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 686 DVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745
D++S G+ A+E+ G P+SD M + L + +PP + +
Sbjct: 183 DIWSLGITAIELAKGE----------PPNSDMHPMRVLFLIPKNNPPT--LTGEFSKPFK 230
Query: 746 TVALACLHSKPKFRPTMQRV 765
ACL+ P FRPT + +
Sbjct: 231 EFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 78/260 (30%), Positives = 118/260 (45%), Gaps = 22/260 (8%)
Query: 507 IGTGGYGSVYKAQLPNGK-VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G VYK K VVA+K + E E+ Q E VLS+ I + YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L +++I +Y+ GS L+ L+ T I++ + L YLH +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RK 122
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRDI + N+LL+ + + +ADFG A L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 686 DVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745
D++S G+ A+E+ G P+SD M + L + SPP + Q
Sbjct: 183 DIWSLGITAIELAKGE----------PPNSDLHPMRVLFLIPKNSPPT--LEGQYSKPFK 230
Query: 746 TVALACLHSKPKFRPTMQRV 765
ACL+ P+FRPT + +
Sbjct: 231 EFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 47/280 (16%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVL 552
+ +K +G G +G V+ + + + +VA+K L + + F+ EA +L
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELL 62
Query: 553 SKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDW----------T 601
+ H NIVK YG C ++++YM+ G L FLR + +A L +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 602 MRVNIIKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659
+ I +A+ + YL H VHRD+++ N L+ L + DFG +R D ++
Sbjct: 123 QLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTT 175
Query: 660 NRTIVAGT----YGYIAPE-LAYTMVVTEKCDVYSFGVVALEVL-MGRHPG-ELLSSLSS 712
+ V G ++ PE + Y TE DV+SFGVV E+ G+ P L +
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234
Query: 713 PSSDQKIMLI-------DVLDSRLS----PPVDRMVMQDI 741
Q +L +V D L P R+ ++DI
Sbjct: 235 ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-21
Identities = 59/160 (36%), Positives = 91/160 (56%), Gaps = 2/160 (1%)
Query: 77 INLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGS 136
+++ L+G ++ + P L+ LSL N FG +P G+ +L LD S N +G+
Sbjct: 433 LDISNNNLQGRINSRKWD-MPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGA 490
Query: 137 IPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL 196
+P +LGSL L L L N L+G IP L KL+++ LS N L G IP++ ++ L
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 197 ILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPST 236
L L N+LSG + + LG +++LV +N+ N L G +PST
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 68/243 (27%), Positives = 98/243 (40%), Gaps = 40/243 (16%)
Query: 507 IGTGGYGSVYKAQLPNGK-VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G GSV K +L N + ALK + + E + IVK YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66
Query: 566 FCLHKK-CMFLI-YKYMKRGSLFCFLRNDYEAVVLDWTMRVN------IIKCVANALSYL 617
L + I +Y + GSL + V R+ I + V LSYL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKK-----VKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFG-TARLLDSDSSNRTIVAGTYGYIAPE-- 674
H I+HRDI +NILL K + + DFG + L++S + T GT Y+APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERI 175
Query: 675 --LAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD--SRLS 730
Y++ DV+S G+ LEV R P P + + I++L +
Sbjct: 176 QGKPYSI----TSDVWSLGLTLLEVAQNRFPFP-------PEGEPPLGPIELLSYIVNMP 224
Query: 731 PPV 733
P
Sbjct: 225 NPE 227
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 64/267 (23%), Positives = 127/267 (47%), Gaps = 31/267 (11%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKL---HRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
+GTG + S Y+A+ + G ++A+K++ +E+ + + E +++++ H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY----EAVVLDWTMRVNIIKCVANALSYLH 618
+ G L ++M GS+ L Y EAV++++T + + LSYLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQ------LLRGLSYLH 120
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAF-VADFGTARLLDSDSSN----RTIVAGTYGYIAP 673
+ I+HRD+ N+L++S + +ADFG A L + + + + GT ++AP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733
E+ CDV+S G V +E+ + P + S+ ++ + + +P +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-----AEKHSNHLALIFKIASATTAPSI 232
Query: 734 DRMVMQDIVLVTTVALACLHSKPKFRP 760
+ + V L CL +P+ RP
Sbjct: 233 PEHLSPG---LRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 1e-21
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 506 CIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLY 564
+G G YG VYKA+ G++VALKK+ R + EE ++ E +L ++ H NIVKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA----NALSYLHHD 620
++ ++L+++Y L +L + N+IK + L+Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP------NLIKSIMYQLLRGLAYCHSH 117
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL----- 675
I+HRD+ NIL+N +ADFG AR T T Y APE+
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGR 701
Y+ V D++S G + E++ G+
Sbjct: 175 HYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 66/259 (25%), Positives = 118/259 (45%), Gaps = 23/259 (8%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+GTG +G V + VA+K + E F EA V+ K++H +V+LYG
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLSHEKLVQLYGV 67
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C ++ ++++ +YM G L +LR + + + + K V ++YL +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 627 HRDISSNNILLNSKLEAFVADFGTAR-LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+++ N L++ + V+DFG +R +LD + ++ + PE+ + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 686 DVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLV 744
DV++FGV+ EV +G+ P E ++ + + RL P V
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERF-------NNSETVEKVSQGLRLYRP-----HLASEKV 230
Query: 745 TTVALACLHSKPKFRPTMQ 763
+ +C H K + RPT Q
Sbjct: 231 YAIMYSCWHEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G V+ VA+K L T +F EA ++ K+ H +V+LY
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C ++ ++++ +YM +GSL FL++ E L V++ +A ++YL + +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYI 125
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLLDSD-----SSNRTIVAGTYGYIAPELAYTMVV 681
HRD+++ NIL+ L +ADFG ARL++ D + + T APE A
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRF 181
Query: 682 TEKCDVYSFGVVALEVLM-GRHP 703
T K DV+SFG++ E++ GR P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 46/289 (15%)
Query: 507 IGTGGYGSVYKAQLPN-----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +G V + G+ VA+K L EE + F+ E +L + H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHR-SDFEREIEILRTLDHENIV 69
Query: 562 KLYGFC--LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
K G C + + LI +Y+ GSL +L+ + ++ + + + YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGS 127
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS------SNRTIVAGTYGYIAP 673
+HRD+++ NIL+ S+ ++DFG A++L D Y AP
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY---AP 181
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVL-MGR---HPGELLSSLSSPSSDQKIM--LIDVLDS 727
E T + DV+SFGV E+ G P + + Q I+ L+++L
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 728 --RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P +M+ C ++P+ RP+ +
Sbjct: 242 GERLPRPPSCPDEVYDLMKL----------CWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 503 IKYCIGTGGYGSVY--KAQLPNGK--VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
I+ IG G +G V + +LP + VA+K L TE+ F +EA ++ + H
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWTMRVNIIKCVANALSYL 617
NI+ L G K + ++ +YM+ GSL FLR +D + V+ V +++ +A+ + YL
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYL 122
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG---TYGYIAPE 674
VHRD+++ NIL+NS L V+DFG +R+L+ D G + APE
Sbjct: 123 SD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 675 LAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
T DV+S+G+V EV+ G P
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 497 ATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI 555
T F++ IG G YG VYKA G++VA+K + E EE + E ++L K
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE----EIKEEYNILRKY 59
Query: 556 A-HRNIVKLYGFCLHKKC------MFLIYKYMKRGS---LFCFLRNDYEAVVLDWTMRVN 605
+ H NI YG + K ++L+ + GS L LR + + +W
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI--AY 117
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
I++ L+YLH ++HRDI NILL E + DFG + LDS R
Sbjct: 118 ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 666 GTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
GT ++APE+ + DV+S G+ A+E+ G+ P
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 69/227 (30%), Positives = 99/227 (43%), Gaps = 52/227 (22%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAET-----EETTFFNSFQNEAHVL 552
+DF+ +GTG +G V + +GK ALK L +A+ E NE +L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL-----NEKRIL 55
Query: 553 SKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEA-VVLDWT 601
I H +V LYG ++L+ +Y+ G LF LR Y A VVL
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL--- 112
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
AL YLH IV+RD+ N+LL+S + DFG A+ + R
Sbjct: 113 -----------ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GR 154
Query: 662 T-IVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T + GT Y+APE+ Y V D ++ G++ E+L G P
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 75/271 (27%), Positives = 113/271 (41%), Gaps = 42/271 (15%)
Query: 507 IGTGGYGSVYKAQL--PNGKV--VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
+G G +G V + + GKV VA+K L + + + F EA ++ + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLDHENLIR 60
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEA-----VVLDWTMRVNIIKCVANALSYL 617
LYG L M ++ + GSL LR D + D+ +++ AN + YL
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYL 113
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD------SSNRTIVAGTYGYI 671
+HRD+++ NILL S + + DFG R L + + + + +
Sbjct: 114 E---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWC 167
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730
APE T + DV+ FGV E+ G P LS Q + ID RL
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGERLE 221
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
P QDI V L C P RPT
Sbjct: 222 RPEA--CPQDIY---NVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G YG VYKA+ G++VA+KK+ E + E +L ++ H NI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF-ESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
HK ++L++++M L+ ++ D + + + ++ + + + L++ H I
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIK-DRQRGLPESLIK-SYLYQLLQGLAFCHSH---GI 119
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEK 684
+HRD+ N+L+N++ +ADFG AR S T T Y APEL +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 685 CDVYSFGVVALEVLMGR 701
D++S G + E+L R
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 24/198 (12%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEE----TTFFNSFQNEAHVLSKI---AHR 558
IG G YG+VYKA+ L G+ VALKK+ +EE +T E +L ++ H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL-----REIALLKQLESFEHP 61
Query: 559 NIVKLYGFCL-----HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
NIV+L C + + L+++++ + L +L + + T++ ++++ +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLLRG 119
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAP 673
+ +LH IVHRD+ NIL+ S + +ADFG AR+ + + T V T Y AP
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAP 175
Query: 674 ELAYTMVVTEKCDVYSFG 691
E+ D++S G
Sbjct: 176 EVLLQSSYATPVDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 35/271 (12%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
IG+G +G V+ + VA+K + E F EA V+ K++H +V+LYG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C + + L++++M+ G L +LR + + + + C ++YL ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVC--EGMAYLESSN---VI 122
Query: 627 HRDISSNNILLNSKLEAFVADFGTARL-LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+++ N L+ V+DFG R LD ++ T + +PE+ + K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 686 DVYSFGVVALEVLM-GRHP------GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738
DV+SFGV+ EV G+ P E++ ++++ + RL+ +M
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR--------LYKPRLASQSVYELM 234
Query: 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
Q C +P+ RP+ + +
Sbjct: 235 QH----------CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E ++ +G G +G V+ VA+K L T +F EA V+ K+ H
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHE 61
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V+LY + ++ ++++ +YM +GSL FL+ + L V++ +A+ ++Y+
Sbjct: 62 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE 119
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL-DSDSSNRTIVAGTYGYIAPELAY 677
+ VHRD+ + NIL+ L VADFG ARL+ D++ + R + APE A
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 678 TMVVTEKCDVYSFGVVALEVLM-GRHP 703
T K DV+SFG++ E+ GR P
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 79/288 (27%), Positives = 122/288 (42%), Gaps = 47/288 (16%)
Query: 507 IGTGGYGSVYKAQLPN------GKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
+G+G +G VY+ + G + VA+K L + T++ F EAH++S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN----DYEAVVLDWTMRVNIIKCVANALS 615
IVKL G CL + ++I + M+ G L +LR+ + +L ++I VA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAF-----VADFGTARLLDSDSSNRTIVAGTYG- 669
YL +HRD+++ N L++ K + DFG AR + R G
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 670 -YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVL-- 725
++APE T + DV+SFGV+ E+L +G+ P L++ +VL
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------------QEVLQH 225
Query: 726 ---DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770
RL P I + C P RPT QE L
Sbjct: 226 VTAGGRLQKP--ENCPDKI---YQLMTNCWAQDPSERPTF-DRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 77/279 (27%), Positives = 126/279 (45%), Gaps = 39/279 (13%)
Query: 507 IGTGGYGSVYKA--QLPNGKV--VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
+G G +GSV K + +GK VA+K L + F EA V++++ H IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCM 622
L G C + M L+ + G L +L+ E V D + VA ++YL
Sbjct: 61 LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESK-- 114
Query: 623 PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG-----YIAPELAY 677
VHRD+++ N+LL ++ +A ++DFG +R L + S A T G + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECIN 171
Query: 678 TMVVTEKCDVYSFGVVALEVL-MGRHP-GELLSSLSSPSSDQKIMLIDVLDS--RLSPPV 733
+ K DV+S+GV E G P GE+ +++ +L+S RL P
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--------KGAEVI--AMLESGERLPRP- 220
Query: 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772
+ + + ++ L+C +P+ RPT + F
Sbjct: 221 EECPQE----IYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 60/210 (28%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLH------RAETEETTFFNSFQNEAHVLSKIAHRN 559
IG+G +GSVY +G+++A+K++ ++ + + ++ E +L ++ H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
IV+ G L + + +Y+ GS+ L N+Y A + T+ N ++ + L+YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGA--FEETLVRNFVRQILKGLNYLH- 123
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS------SNRTIVAGTYGYIAP 673
I+HRDI NIL+++K ++DFG ++ L+++S R + G+ ++AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
E+ T K D++S G + +E+L G+HP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G V+ VA+K L T SF EA ++ K+ H +V+LY
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG----TMSPESFLEEAQIMKKLRHDKLVQLYA- 68
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
+ ++ ++++ +YM +GSL FL+ D E L V++ VA ++Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLL-DSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+ S NIL+ L +ADFG ARL+ D++ + R + APE A T K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 686 DVYSFGVVALE-VLMGRHP 703
DV+SFG++ E V GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 31/234 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ----LPNGK--VVALKKLHRAETEETTFFNSFQNEAHVL 552
D +K+ +G G +G V+ A+ LP +VA+K L A +E FQ EA +L
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESAR--QDFQREAELL 61
Query: 553 SKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLD-----------W 600
+ + H++IV+ YG C + + ++++YM+ G L FLR + +A +L
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 601 TMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN 660
+ I +A+ + YL VHRD+++ N L+ L + DFG +R D S++
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTD 176
Query: 661 RTIVAG----TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSS 709
V G ++ PE T + D++SFGVV E+ G+ P LS+
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G YGSVYK P G +A+K++ R E +E+ F N E +L K IV YG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKF-NQIIMELDILHKAVSPYIVDFYG 66
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
+ +++ +YM GSL + + I V L +L + +I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE----------L 675
+HRD+ N+L+N + + DFG + L + + I G Y+APE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAPERIKSGGPNQNP 182
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
YT+ + DV+S G+ LE+ +GR+P
Sbjct: 183 TYTV----QSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G V+KA+ G+ VALKK+ E N E L H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQACQHPYVVKLLD 66
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA----NALSYLHHDC 621
H L+ +YM L LR+ + + +K ++Y+H +
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRD------EERPLPEAQVKSYMRMLLKGVAYMHAN- 118
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR-TIVAGTYGYIAPELAY-TM 679
I+HRD+ N+L+++ +ADFG ARL + + T Y APEL Y
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 680 VVTEKCDVYSFGVVALEVLMGR--HPGE 705
D+++ G + E+L G PGE
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-19
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG+G G+VYK P G++ ALK ++ E T E +L + H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIY--GNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
H + ++ ++M GSL D E + D + + + + ++YLH I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIAD-EQFLAD------VARQILSGIAYLHRR---HI 189
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDS--DSSNRTIVAGTYGYIAPE-----LAYT 678
VHRDI +N+L+NS +ADFG +R+L D N ++ GT Y++PE L +
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHG 247
Query: 679 MVVTEKCDVYSFGVVALEVLMGRHP 703
D++S GV LE +GR P
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 506 CIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQ-----NEAHVLSKI-AHR 558
+G G +GSVY A+ G++VA+KK+ + F S++ E L K+ H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKK-------FYSWEECMNLREVKSLRKLNEHP 58
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
NIVKL ++ +++YM+ G+L+ ++ D + ++ +II + L+++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQLMK-DRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 619 -HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-- 675
H HRD+ N+L++ +ADFG AR + S V T Y APE+
Sbjct: 117 KHGFF----HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV-STRWYRAPEILL 171
Query: 676 ---AYTMVVTEKCDVYSFGVVALEVLMGR 701
+Y+ V D+++ G + E+ R
Sbjct: 172 RSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 38/270 (14%)
Query: 507 IGTGGYGSVYKAQLPNG-KVVALKKL--HRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
+G G +G V+ + K+V +K++ + +E + QNE VL ++H NI++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER---LAAQNECQVLKLLSHPNIIEY 64
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFL---RNDY--EAVVLDWTMRVNIIKCVANALSYLH 618
Y L K + ++ +Y G+L ++ N E +L + +++ L LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---------LLALH 115
Query: 619 HDCMPSIVHRDISSNNILLNS-KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H I+HRD+ + NILL+ K+ + DFG +++L S S T+V GT YI+PEL
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPELCE 174
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM--LIDVLDSRLSPPVDR 735
+K D+++ G V E+ + E + + P+ KIM + R SP + +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE---AANLPALVLKIMSGTFAPISDRYSPDLRQ 231
Query: 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
++ L+ L+ P RP + ++
Sbjct: 232 LI-----------LSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 507 IGTGGYGSVYKAQL--PNGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G VYK +L PN + VA+K L E E F+ EA ++S + H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLK--ENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFL-----RNDYEAVVLDWTMR--------VNII 607
V L G C ++ ++++Y+ G L FL +D A D T++ ++I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 608 KCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
+A + YL HH VHRD+++ N L+ L ++DFG +R + S R
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 666 GTYG--YIAPELAYTMVVTEKCDVYSFGVVALEV 697
++ PE T + D++SFGVV E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKL---HRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
+G G Y VYKA G++VA+KK+ R E ++ F + + E +L ++ H NI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI--IKCVA----NALSY 616
L HK + L++++M D E V+ D ++ + IK L Y
Sbjct: 67 LLDVFGHKSNINLVFEFM---------ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL- 675
LH + I+HRD+ NN+L+ S +ADFG AR S + T T Y APEL
Sbjct: 118 LHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174
Query: 676 ----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
Y + V D++S G + E L+ R P
Sbjct: 175 FGARHYGVGV----DMWSVGCIFAE-LLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 69/268 (25%), Positives = 132/268 (49%), Gaps = 26/268 (9%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G V+ A VA+K + + +F EA+V+ + H +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHA- 68
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
+ K+ +++I ++M +GSL FL++D E ++ +A ++++ + +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 124
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLL-DSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+ + NIL+++ L +ADFG AR++ D++ + R + APE T K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 686 DVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLV 744
DV+SFG++ +E++ GR P +S+P +I L+ P +++
Sbjct: 185 DVWSFGILLMEIVTYGRIP---YPGMSNPE------VIRALERGYRMPRPENCPEELY-- 233
Query: 745 TTVALACLHSKPKFRPT---MQRVCQEF 769
+ + C ++P+ RPT +Q V +F
Sbjct: 234 -NIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 84/304 (27%), Positives = 126/304 (41%), Gaps = 67/304 (22%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G YG V K + G++VA+KK +E +E + E VL ++ H NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK-KTALREVKVLRQLRHENIVNLKE 67
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRN----DYEAVVLDWTMRVNIIKCVANALSYLH-HD 620
K ++L+++Y++R L + +AV I + A++Y H H+
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS-------YIWQLLQAIAYCHSHN 120
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR--TIVAGTYGYIAPEL--- 675
I+HRDI NIL++ + DFG AR L + ++ VA T Y APEL
Sbjct: 121 ----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVG 175
Query: 676 --AYTMVVTEKCDVYSFGVVALEVLMGR--HPGELLSSLSSPSSDQ--KIMLI------- 722
Y V DV++ G + E+L G PG+ S + DQ I
Sbjct: 176 DTNYGKPV----DVWAIGCIMAELLDGEPLFPGD--SDI-----DQLYLIQKCLGPLPPS 224
Query: 723 --DVLDS-------RLSPPVDRMVMQD--IVLVTTVAL----ACLHSKPKFRPTMQRVCQ 767
++ S P ++ V++ AL ACL PK R T C
Sbjct: 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CD 280
Query: 768 EFLT 771
E L
Sbjct: 281 ELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 53/281 (18%)
Query: 507 IGTGGYGSVYKAQ---LPNGKV---VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G VY+ V VA+K L + +E+ + F EA ++SK H+NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE--SDFLMEALIMSKFNHQNI 71
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV--LDWTMRVNIIKC---VANALS 615
V+L G + F++ + M G L FLR + TM+ +++ C VA
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK-DLLFCARDVAKGCK 130
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLE---AFVADFGTARLLDSDS----SNRTIVAGTY 668
YL + +HRDI++ N LL K A +ADFG AR + S R ++
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP--I 185
Query: 669 GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPS-SDQKIMLIDVLD 726
++ PE + T K DV+SFGV+ E+ +G P P ++Q++M
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP--------YPGRTNQEVMEFVTGG 237
Query: 727 SRLSPP------VDRMVMQDIVLVTTVALACLHSKPKFRPT 761
RL PP V R++ C P+ RP
Sbjct: 238 GRLDPPKGCPGPVYRIMTD-----------CWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 57/213 (26%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G V+ N VA+K L T +F EA+++ + H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
++ +++I +YM +GSL FL++D E + ++ +A ++Y+ + +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLL-DSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+ + N+L++ L +ADFG AR++ D++ + R + APE T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 686 DVYSFGVVALEVLM-------GRHPGELLSSLS 711
DV+SFG++ E++ G +++S+L
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G VYKAQ + A K + E F E +LS+ H NIV LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAK--IIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
++ ++++ ++ G+L + + E + + +R + + + AL++LH ++
Sbjct: 71 YFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVI 125
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE--- 683
HRD+ + NILL + +ADFG + S R GT ++APE+ V E
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV----VACETFK 181
Query: 684 ------KCDVYSFGVVALEVLMGRHP 703
K D++S G+ +E+ P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 42/281 (14%)
Query: 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKK-----LHRAETEETTFFNSFQNEAHVLS 553
DF + +G G YGSVYK + L + + ALK+ + + E E+ NE +L+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV------NEIRILA 54
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVL-----DWTMRVNIIK 608
+ H NI+ L + ++ +Y G L + + L W + + +++
Sbjct: 55 SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 609 CVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTY 668
L LH I+HRD+ S NILL + + D G +++L + + I GT
Sbjct: 115 ----GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GTP 165
Query: 669 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIMLIDVLD 726
Y+APE+ + K D++S G + E+ P + L K+
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-----YKVQ------ 214
Query: 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
PP+ + QD+ + L KPK RP ++
Sbjct: 215 RGKYPPIPPIYSQDL---QNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 70/270 (25%), Positives = 130/270 (48%), Gaps = 30/270 (11%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G V+ VA+K L + F EA+++ ++ H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRLYA- 68
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
+ ++ +++I +YM+ GSL FL+ E + L +++ +A ++++ + +
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLL-DSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
HRD+ + NIL++ L +ADFG ARL+ D++ + R + APE T K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 686 DVYSFGVVALE-VLMGR--HPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742
DV+SFG++ E V GR +PG +++P +I L+ P +++
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPG-----MTNPE------VIQNLERGYRMPRPDNCPEELY 233
Query: 743 LVTTVALACLHSKPKFRPT---MQRVCQEF 769
+ C KP+ RPT ++ V ++F
Sbjct: 234 ---ELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 39/274 (14%)
Query: 507 IGTGGYGSVYK---AQLPNGKV---VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G VY+ + G+ VA+K ++ E F NEA V+ + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--ENASMRERIEFLNEASVMKEFNCHHV 71
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR----NDYEAVVLDWTMRVNIIKC---VANA 613
V+L G + ++ + M +G L +LR L I+ +A+
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG--YI 671
++YL VHRD+++ N ++ L + DFG R + R G ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLI---DVLDS 727
APE V T K DV+SFGVV E+ + P + L S+++ + + LD
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL------SNEEVLKFVIDGGHLDL 242
Query: 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
+ P + + C PK RPT
Sbjct: 243 PENCP---------DKLLELMRMCWQYNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 507 IGTGGYGSVYKAQLPNG--KVVALKKLH-------RAETEETTFFNSFQNEAHVLSK-IA 556
+G+G +G VYK + N ++ALK+++ + + E +E ++ + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSL---FCFLRNDYEAVVLD--WTMRVNIIKCVA 611
H NIV+ Y L ++++ ++ L F L+ + + W + V ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
AL YLH + IVHRD++ NNI+L + + DFG A+ S T V GT Y
Sbjct: 125 -ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYS 180
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP--SSDQKIMLIDVLDSRL 729
PE+ EK DV++FG + ++ L P S++ + ++++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT----------LQPPFYSTNMLSLATKIVEAVY 230
Query: 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
P + M +D+ V T +CL + RP + +V
Sbjct: 231 EPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 30/269 (11%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
IG G +G VYK L VA+K + F EA +L + H NIVKL G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C+ K+ ++++ + + GSL FLR + + +++++ A + YL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD--AAAGMEYLESKN---CI 115
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT----YGYIAPELAYTMVVT 682
HRD+++ N L+ ++DFG +R + + T+ G + APE T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 683 EKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDS--RLSPPVDRMVMQ 739
+ DV+S+G++ E +G P +S+ + ++I +S R+ P
Sbjct: 174 SESDVWSYGILLWETFSLGDTP---YPGMSNQQTRERI------ESGYRMPAP-QLCP-- 221
Query: 740 DIVLVTTVALACLHSKPKFRPTMQRVCQE 768
+ + L C P+ RP+ + E
Sbjct: 222 --EEIYRLMLQCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 72/267 (26%), Positives = 120/267 (44%), Gaps = 27/267 (10%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++ + IG G +G V G VA+K + T + +F EA V++++ H
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 59
Query: 559 NIVKLYGFCLHKK-CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+V+L G + +K ++++ +YM +GSL +LR+ +V L + V A+ YL
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 118
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
+ + VHRD+++ N+L++ A V+DFG L SS + + APE
Sbjct: 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALR 172
Query: 678 TMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736
+ K DV+SFG++ E+ GR P + +K +D D PPV
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG--CPPVVYD 230
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQ 763
VM+ C H RP+
Sbjct: 231 VMKQ----------CWHLDAATRPSFL 247
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 76/267 (28%), Positives = 134/267 (50%), Gaps = 33/267 (12%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
IG G +G+V + + G+ VA+K + T + +F E V++K+ H+N+V+L G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLGV 67
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV-LDWTMRVNIIKCVANALSYLHHDCMPSI 625
LH ++++ + M +G+L FLR A+V + ++ ++ VA + YL +
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD--VAEGMEYLESK---KL 121
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARL--LDSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
VHRD+++ NIL++ A V+DFG AR+ + D+S + + APE +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSS 176
Query: 684 KCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742
K DV+S+GV+ EV GR P +S +K R+ PP + V
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-------GYRMEPP-EGCPADVYV 228
Query: 743 LVTTVALACLHSKPKFRPTMQRVCQEF 769
L+T+ C ++PK RP+ ++ ++
Sbjct: 229 LMTS----CWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+D + +GTG +G V+ + + ALK + E NE VL +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
I++L+ ++ ++++ +Y+ G LF +LRN + + + + AL YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYL 117
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT-IVAGTYGYIAPELA 676
H IV+RD+ NILL+ + + DFG A+ L +RT + GT Y+APE+
Sbjct: 118 HSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPEVI 170
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + D ++ G++ E+L+G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 11/207 (5%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E + +G G +G V+ VA+K L T +F EA ++ K+ H
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG----TMMPEAFLQEAQIMKKLRHD 61
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V LY + ++ ++++ ++M +GSL FL+ + + L V++ +A+ ++Y+
Sbjct: 62 KLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL-DSDSSNRTIVAGTYGYIAPELAY 677
+ +HRD+ + NIL+ L +ADFG ARL+ D++ + R + APE A
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 678 TMVVTEKCDVYSFGVVALE-VLMGRHP 703
T K DV+SFG++ E V GR P
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 33/279 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
EDF++ IG+G YG VYKA+ + G++ A+K + E+ F Q E ++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED---FAVVQQEIIMMKDCKH 65
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAV-VLDWTMRVNIIKCVANALSY 616
NIV +G L + +++ ++ GSL ++ Y L + + + L Y
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSL----QDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
LH +HRDI NILL +ADFG + + + + R GT ++APE+A
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 677 YTMVVTEK------CDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM--LIDVLDSR 728
V K CD+++ G+ A+E L+ L P D M L + S
Sbjct: 179 ---AVERKGGYNQLCDIWAVGITAIE----------LAELQPPMFDLHPMRALFLMTKSN 225
Query: 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
PP + M+ L PK RPT +++ Q
Sbjct: 226 FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 71/219 (32%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 499 EDFDIKYCIGTGGYGSVY----KAQLPNGKVVALKKLHRAET--EETTFFNSFQNEAHVL 552
+DFD+K +G G +G V KA G + A+K + ++ +ET F F+ E +L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSF--FEEERDIL 55
Query: 553 SKIAHRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
S I +L Y F K ++L+ +Y G L L N YE D M + +
Sbjct: 56 SISNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLL-NRYEDQ-FDEDMAQFYLAELV 112
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS-NRTIVAGTYGY 670
A+ +H VHRDI N+L++ +ADFG+A L ++ N + GT Y
Sbjct: 113 LAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 671 IAPELAYTMVVTEK------CDVYSFGVVALEVLMGRHP 703
IAPE+ TM K CD +S GV+A E++ GR P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 20/274 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
ED + +G G GSV K + +P G V+A K +H E ++ +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRS 62
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
IV YG L++ + + ++M GSL + + ++ + I V L+YL
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGK--IAVAVVEGLTYL 119
Query: 618 ---HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
H I+HRDI +NIL+NS+ + + DFG + L +S T V GT Y++PE
Sbjct: 120 YNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFV-GTSTYMSPE 172
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734
T K DV+S G+ +E+ +G+ P + D + ++D+L + P
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP-MGILDLLQQIVQEPPP 231
Query: 735 RMVMQDI--VLVTTVALACLHSKPKFRPTMQRVC 766
R+ D L V ACL P RPT Q++C
Sbjct: 232 RLPSSDFPEDLRDFVD-ACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 73/223 (32%), Positives = 110/223 (49%), Gaps = 38/223 (17%)
Query: 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
FDI IG G YG VYKA+ G++VALKK+ R + E+ F + E +L ++ HRN
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 560 IVKLY----------GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR--VNII 607
IV L F K +L+++YM L L E+ ++ ++ + +
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL----ESGLVHFSEDHIKSFM 122
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS----NRTI 663
K + L+Y H + +HRDI +NILLN+K + +ADFG ARL +S+ S N+ I
Sbjct: 123 KQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 664 VAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
T Y PEL Y + DV+S G + E+ +
Sbjct: 180 ---TLWYRPPELLLGEERYGPAI----DVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 29/228 (12%)
Query: 503 IKYCIGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+K +G G +G V+ A+ N +VA+K L A F EA +L+ +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 65
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVV---------LDWTMRVNI 606
H +IVK YG C+ + ++++YMK G L FLR + +AV+ L + ++I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG 666
+ +A + YL VHRD+++ N L+ L + DFG +R D S++ V G
Sbjct: 126 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGG 180
Query: 667 ----TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSS 709
++ PE T + DV+S GVV E+ G+ P LS+
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 501 FDIKYCIGTGGYGSVYKAQLPN---GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
++I+ CIG G YG VYKA+ N GK A+KK + + T S E +L ++ H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 558 RNIVKLYGFCLHK--KCMFLIYKYMKRGSLFCFLRNDYE--AVVLDWTMRVNIIKCVANA 613
N+V L L K ++L++ Y + L+ ++ + V + +M +++ + N
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSD-----SSNRTIV 664
+ YLH + ++HRD+ NIL+ + + D G ARL ++ + +V
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 665 AGTYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVL 698
T Y APEL YT + D+++ G + E+L
Sbjct: 178 --TIWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 32/228 (14%)
Query: 500 DFDIKYCIGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVLS 553
D +K +G G +G V+ A+ N +VA+K L + FQ EA +L+
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLT 62
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVV------------LDW 600
+ H +IVK YG C + ++++YMK G L FLR + +A++ L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 601 TMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN 660
+ ++I +A+ + YL VHRD+++ N L+ + L + DFG +R D S++
Sbjct: 123 SQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTD 177
Query: 661 RTIVAG----TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHP 703
V G ++ PE T + DV+SFGV+ E+ G+ P
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 76/288 (26%), Positives = 133/288 (46%), Gaps = 37/288 (12%)
Query: 494 IIKATEDFDIKYCIGTGGYGSVYKA-QLPNGKVV----ALKKLHRAETEETTFFNSFQNE 548
I+K TE +K +G+G +G+VYK +P G+ V A+K L+ ET F +E
Sbjct: 3 ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANVEFMDE 59
Query: 549 AHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR----NDYEAVVLDWTMRV 604
A +++ + H ++V+L G CL + L+ + M G L ++ N ++L+W +++
Sbjct: 60 ALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI 118
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664
A + YL +VHRD+++ N+L+ S + DFG ARLL+ D
Sbjct: 119 ------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 665 AGTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIML 721
G ++A E + T + DV+S+GV E++ G P + + + P
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------- 221
Query: 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
D+L+ P + D+ +V + C RP + + EF
Sbjct: 222 -DLLEKGERLPQPPICTIDVYMVM---VKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G YG VY+A+ +G++VALKK+ R + E S E +L + H NIV+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 566 FCL--HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI--IKCVA----NALSYL 617
+ H +FL+ +Y C D +++ + + +KC+ L YL
Sbjct: 74 VVVGKHLDSIFLVMEY-------C--EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H + I+HRD+ +N+LL K +ADFG AR + T T Y APEL
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 678 TMVV-TEKCDVYSFGVVALEVLMGR 701
T D+++ G + E+L +
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 35/275 (12%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G V+ +L + VA+K ET F EA +L + +H NIV+L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
C K+ ++++ + ++ G FLR E L + +++ A + YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG-------YIAPE-LAY 677
+HRD+++ N L+ K ++DFG +R + A T G + APE L Y
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 678 TMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736
+E DV+SFG++ E +G P LS+ + + ++ RL P +
Sbjct: 171 GRYSSES-DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------GVRLPCP--EL 220
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771
V + C P RP+ V QE +
Sbjct: 221 CPDA---VYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 74/236 (31%), Positives = 109/236 (46%), Gaps = 69/236 (29%)
Query: 501 FDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQN---------EAH 550
++I +G G YG V+KA +VVALKK+ F++F+N E
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQRTFREIM 58
Query: 551 VLSKIA-HRNIVKLYGFCLHK----KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
L ++ H NIVKL + K K ++L+++YM+ D AV+ R N
Sbjct: 59 FLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYME---------TDLHAVI-----RAN 102
Query: 606 IIKCV---------ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656
I++ V AL Y+H +++HRD+ +NILLNS +ADFG AR L
Sbjct: 103 ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 657 DSSNRTI------VAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
N VA T Y APE+ YT V D++S G + E+L+G+
Sbjct: 160 LEENPENPVLTDYVA-TRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G G+VY A + G+ VA+K+++ + + NE V+ + H NIV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI---INEILVMRENKHPNIVNYLD 83
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA----NALSYLHHDC 621
L ++++ +Y+ GSL VV + M I V AL +LH +
Sbjct: 84 SYLVGDELWVVMEYLAGGSL--------TDVVTETCMDEGQIAAVCRECLQALEFLHSN- 134
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVV 681
++HRDI S+NILL + DFG + + S R+ + GT ++APE+
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 682 TEKCDVYSFGVVALEVLMGRHP 703
K D++S G++A+E++ G P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 501 FDIKYCIGTGGYGSVY--KAQLPNG----KVVALKKLHRAETEETTFFNSFQNEAHVLSK 554
++I IG G +G +Y KA+ + K + L K+ E E + + E +L+K
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS------KKEVILLAK 55
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKY-----------MKRGSLFCFLRNDYEAVVLDWTMR 603
+ H NIV + +F++ +Y +RG LF E +L W ++
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS------EDQILSWFVQ 109
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTARLLDSDSSNRT 662
+++ L ++H I+HRDI S NI L+ + A + DFG AR L+
Sbjct: 110 ISL------GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160
Query: 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE 705
GT Y++PE+ K D++S G V E+ +HP E
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 40/228 (17%)
Query: 502 DIKYC--IGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVLS 553
+I+Y IG G +G V++A+ P +VA+K L + + FQ EA +++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 63
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR------------NDYEAVV---- 597
+ H NIVKL G C K M L+++YM G L FLR + A
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 598 ---LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654
L T ++ I K VA ++YL VHRD+++ N L+ + +ADFG +R +
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 655 DSD-----SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEV 697
S S N I ++ PE + T + DV+++GVV E+
Sbjct: 181 YSADYYKASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 37/279 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
D+++ +G+G YG VYKA+ L G++ A+K + + E F+ Q E ++ + H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKH 65
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV--LDWTMRVNIIKCVANALS 615
NIV +G L ++ +++ +Y GSL D V L + + L+
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSL-----QDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
YLH +HRDI NILL + +ADFG A + + + R GT ++APE+
Sbjct: 121 YLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 676 AYTMVVTEK-------CDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM--LIDVLD 726
A EK CD+++ G+ A+E L+ L P D M L +
Sbjct: 178 A----AVEKNGGYNQLCDIWAVGITAIE----------LAELQPPMFDLHPMRALFLMSK 223
Query: 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
S PP + + L PK RPT +R+
Sbjct: 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-R 558
F++ +G G YG VYK + + G++ A+K + E EE + E ++L K +H R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73
Query: 559 NIVKLYGFCL------HKKCMFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVA 611
NI YG + H ++L+ ++ GS+ ++N A+ DW I + +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREIL 131
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
L++LH ++HRDI N+LL E + DFG + LD R GT ++
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188
Query: 672 APELAYT-----MVVTEKCDVYSFGVVALEVLMGRHP 703
APE+ + D++S G+ A+E+ G P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 75/291 (25%), Positives = 138/291 (47%), Gaps = 43/291 (14%)
Query: 494 IIKATEDFDIKYCIGTGGYGSVYKA-QLPNGK----VVALKKLHRAETEETTFFNSFQNE 548
I+K TE IK +G+G +G+VYK +P G+ VA+K+L A + + +E
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 59
Query: 549 AHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAV----VLDWTMRV 604
A+V++ + + ++ +L G CL LI + M G L ++R + + +L+W +++
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664
A ++YL +VHRD+++ N+L+ + + DFG A+LL +D
Sbjct: 119 ------AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 665 AGTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIML 721
G ++A E + T + DV+S+GV E++ G P + + P+S+ +
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASE----I 220
Query: 722 IDVLDS--RL-SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+L+ RL PP+ + V + + C RP + + EF
Sbjct: 221 SSILEKGERLPQPPI------CTIDVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 75/292 (25%), Positives = 135/292 (46%), Gaps = 41/292 (14%)
Query: 494 IIKATEDFDIKYCIGTGGYGSVYKA-QLPNGK----VVALKKLHRAETEETTFFNSFQNE 548
I+K TE +K +G+G +G+VYK +P+G+ VA+K L + + +E
Sbjct: 3 ILKETELKKVK-VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDE 59
Query: 549 AHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAV----VLDWTMRV 604
A+V++ + + +L G CL L+ + M G L ++R + + + +L+W +++
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI 118
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664
A +SYL +VHRD+++ N+L+ S + DFG ARLLD D +
Sbjct: 119 ------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 169
Query: 665 AGTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIML 721
G ++A E T + DV+S+GV E++ G P + + + P
Sbjct: 170 GGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-------- 221
Query: 722 IDVLDS--RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771
D+L+ RL P + D+ ++ + C + RP + + EF
Sbjct: 222 -DLLEKGERLPQPP--ICTIDVYMIM---VKCWMIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 75/282 (26%), Positives = 137/282 (48%), Gaps = 43/282 (15%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLH-------RAETEETTFFNSFQNEAHVLSKIAHR 558
IG G YG VY A + G+++A+K++ R ++ + + ++E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND---YEAVVLDWTMRVNIIKCVANALS 615
NIV+ GF ++ + + +Y+ GS+ LR E +V +T +V L+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------LEGLA 122
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS--DSSNRTIVAGTYGYIAP 673
YLH I+HRD+ ++N+L+++ ++DFG ++ D D+ + G+ ++AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 674 EL--AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKI-MLIDVLDSRLS 730
E+ +Y+ + K D++S G V LE+ GR P S ++ I + + + R +
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---------SDEEAIAAMFKLGNKRSA 230
Query: 731 PPVDRMVMQDIV-LVTTVAL----ACLHSKPKFRPTMQRVCQ 767
PP+ D+ ++ VAL AC P RPT + + Q
Sbjct: 231 PPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-R 558
F++ +G G YG VYK + + G++ A+K + EE + E ++L K +H R
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63
Query: 559 NIVKLYGFCLHKKC------MFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVA 611
NI YG + K ++L+ ++ GS+ ++N + +W I + +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 121
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
LS+LH ++HRDI N+LL E + DFG + LD R GT ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 672 APELAYT-----MVVTEKCDVYSFGVVALEVLMGRHP 703
APE+ K D++S G+ A+E+ G P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 52/284 (18%)
Query: 507 IGTGGYGSVYKAQL-----PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRN 559
+G G +G V KA+ PN VA+K L TE+ + +E ++ I H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKN 77
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMR-----VNIIKC 609
I+ L G C + ++++ +Y G+L FLR +Y + +++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 610 ---VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG 666
VA + +L +HRD+++ N+L+ +ADFG AR + R G
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 667 --TYGYIAPELAYTMVVTEKCDVYSFGVVALEV--LMGR-HPG----ELLSSLSSPSSDQ 717
++APE + V T + DV+SFGV+ E+ L G +PG EL L
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE----- 249
Query: 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
R+ P + Q+ + + C H P RPT
Sbjct: 250 --------GYRMEKPQN--CTQE---LYHLMRDCWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 62/261 (23%), Positives = 119/261 (45%), Gaps = 20/261 (7%)
Query: 507 IGTGGYGS--VYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLY 564
+G G +G +Y+ + VV K+++ E ++ NE +LS + H NI+ Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAYY 65
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
+ + + +Y G+L+ + + + + M + + + +A+SY+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEK 684
I+HRDI + NI L + DFG +++L S+ S V GT Y++PEL + K
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFK 181
Query: 685 CDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLV 744
D+++ G V E+L + + +++ +++ ++ +P V + I LV
Sbjct: 182 SDIWALGCVLYELLTLKRTFD--------ATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233
Query: 745 TTVALACLHSKPKFRPTMQRV 765
+ L P+ RPT V
Sbjct: 234 H----SLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 79/275 (28%), Positives = 117/275 (42%), Gaps = 49/275 (17%)
Query: 507 IGTGGYGSVYKAQL----PNGKVVALKKLHR-AETEETTFFNSFQNEAHVLSKIAHRNIV 561
IG G +G VY L A+K L+R + EE F E ++ +H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV---EQFLKEGIIMKDFSHPNVL 59
Query: 562 KLYGFCLHKKCMFLI-YKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHH 619
L G CL + L+ YMK G L F+R++ + V D + VA + YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLAS 116
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTAR-LLDSD---SSNRTIVAGTYGYIAPEL 675
VHRD+++ N +L+ VADFG AR + D + N T ++A E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735
T T K DV+SFGV+ EL++ + P D +D D +
Sbjct: 174 LQTQKFTTKSDVWSFGVLLW---------ELMTRGAPPYPD-----VDSFD------ITV 213
Query: 736 MVMQDIVL---------VTTVALACLHSKPKFRPT 761
++Q L + V L+C H KP+ RPT
Sbjct: 214 YLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 506 CIGTGGYGSVYKA-QLPNGKVVALKKLH--RAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
+G G +G VY + G+ +A+K++ E N+ + E +L + H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 563 LYGFCLHKKCMFLIY-KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
YG CL I+ +YM GS+ L+ Y A L T+ + + + YLH +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKA-YGA--LTETVTRKYTRQILEGVEYLHSN- 123
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI---VAGTYGYIAPELAYT 678
IVHRDI NIL +S + DFG ++ L + S+ T V GT +++PE+
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 679 MVVTEKCDVYSFGVVALEVLMGRHP 703
K DV+S G +E+L + P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHV--LSKIAHRNIVKL 563
+G+G +GSVY+ L +G A+K++ A+ +T Q E + LSK+ H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
G + +++ + + GSL L+ Y + + + + L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLK-KYGS--FPEPVIRLYTRQILLGLEYLHDR--- 121
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-----AYT 678
+ VHRDI NIL+++ +ADFG A+ + S ++ Y ++APE+ Y
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVIAQQGGYG 180
Query: 679 MVVTEKCDVYSFGVVALEVLMGRHP 703
+ D++S G LE+ G+ P
Sbjct: 181 LAA----DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 507 IGTGGYGSVYKAQLPNG------KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G V+ A+ +V +K L +T++ + F+ E + K++H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR------NDYEAVVLDWTMRVNIIKCVANAL 614
V+L G C + ++I +Y G L FLR + L +V + +A +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS-----NRTIVAGTYG 669
+L + VHRD+++ N L++S+ E V+ ++ D +S ++
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIP--LR 183
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEV 697
++APE + K DV+SFGV+ EV
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 32/285 (11%)
Query: 501 FDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
F + +G G +GSV +AQL + + VA+K L +A+ ++ F EA + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 557 HRNIVKLYGFCLHKKCM------FLIYKYMKRGSLFCFL---RNDYEAVVLDWTMRVNII 607
H N++KL G L + +I +MK G L FL R E L V +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT 667
+A+ + YL + +HRD+++ N +LN + VADFG ++ + S R A
Sbjct: 120 IDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 668 Y--GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDV 724
++A E V T DV++FGV E++ G+ P + + +I +
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP-------YAGVENSEIYNYLI 229
Query: 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+RL P D ++D+ + C +PK RP+ Q + +
Sbjct: 230 KGNRLKQPPD--CLEDVY---ELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKK--LHRAETEETTFFNSFQNEAHVLSKI 555
D IG G G V A G+ VA+KK L + + E F NE ++
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-----NEVVIMRDY 73
Query: 556 AHRNIVKLYGFCLHKKCMFLIYKYMKRGSL---FCFLRNDYEAVVLDWTMRVNIIKCVAN 612
H NIV++Y L ++++ ++++ G+L R + E + + V
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLAVLK 126
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
ALS+LH ++HRDI S++ILL S ++DFG + + R + GT ++A
Sbjct: 127 ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
PE+ + + D++S G++ +E++ G P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 71/256 (27%), Positives = 107/256 (41%), Gaps = 62/256 (24%)
Query: 500 DFDIKY----CIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK 554
D +Y IG+G YG V A +GK VA+KK+ A T + + E +L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH 60
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN---IIKC-- 609
H NI+ + + + G+ F ++ Y VV+D M + II
Sbjct: 61 FKHDNIIAI-------RDIL-----RPPGADF---KDVY--VVMD-LMESDLHHIIHSDQ 102
Query: 610 -------------VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656
+ L Y+H ++HRD+ +N+L+N E + DFG AR L S
Sbjct: 103 PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159
Query: 657 DSSNRTI-----VAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRH--PGE--- 705
+ VA T Y APEL ++ T D++S G + E+L R PG+
Sbjct: 160 SPTEHKYFMTEYVA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218
Query: 706 -----LLSSLSSPSSD 716
+LS L SPS +
Sbjct: 219 HQLKLILSVLGSPSEE 234
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 69/219 (31%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLH------RAETEETTFFNSFQNEAHV 551
+DF+I IG G +G V ++ N G+V A+K L+ RAET F+ E V
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETA------CFREERDV 54
Query: 552 LSKIAHRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCV 610
L R I L Y F + ++L+ Y G L L + +E + + R + + V
Sbjct: 55 LVNGDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMV 112
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA-GTYG 669
A+ +H VHRDI +N+LL+ +ADFG+ L +D + ++ VA GT
Sbjct: 113 L-AIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 670 YIAPELAYTM-----VVTEKCDVYSFGVVALEVLMGRHP 703
YI+PE+ M +CD +S GV E+L G P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 486 DGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALK--KLHRAETEETTFF 542
D R E+ IK IG G G V A + +G+ VA+K L + + E F
Sbjct: 18 DPRSLLENYIK----------IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF- 66
Query: 543 NSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTM 602
NE ++ H+N+V++Y L + ++++ ++++ G+L + L+
Sbjct: 67 ----NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL----TDIVSQTRLNEEQ 118
Query: 603 RVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662
+ + V AL YLH ++HRDI S++ILL ++DFG + D R
Sbjct: 119 IATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175
Query: 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ GT ++APE+ + D++S G++ +E++ G P
Sbjct: 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G G+V+ A + G+ VA+K+++ + + NE V+ ++ + NIV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI---INEILVMKELKNPNIVNFLD 83
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L +F++ +Y+ GSL + +D + + AL +LH + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSL----TDVVTETCMDEAQIAAVCRECLQALEFLHAN---QV 136
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRDI S+N+LL + DFG + + S R+ + GT ++APE+ K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 686 DVYSFGVVALEVLMGRHP 703
D++S G++A+E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-15
Identities = 40/92 (43%), Positives = 60/92 (65%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
++ L L L G IP+ + L L+ ++ S N++ G+IPP LGS+ +LEVL+L N+ N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIG 190
G+IP SL QLT L + L+ N L G +P+A+G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 70/247 (28%), Positives = 108/247 (43%), Gaps = 27/247 (10%)
Query: 507 IGTGGYGSVYKA-----QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +GSV Q G+VVA+KKL + E F+ E +L + H NIV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH---LRDFEREIEILKSLQHDNIV 68
Query: 562 KLYGFCLH--KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
K G C ++ + L+ +Y+ GSL +L+ E LD + + + YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGS 126
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI---APELA 676
VHRD+++ NIL+ S+ + DFG ++L D + I APE
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 677 YTMVVTEKCDVYSFGVVALEVLM-----GRHPGELLSSLSSPSSDQKIM--LIDVLDS-- 727
+ DV+SFGVV E+ P E + + + Q I+ LI++L +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243
Query: 728 RLSPPVD 734
RL P
Sbjct: 244 RLPAPPG 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKK--LHRAETEETTF-FNSFQNEAHVLSKIAHRNIVKL 563
+G G YG+VY G+++A+K+ L + + Q E +L + H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDY----EAVVLDWTMRVNIIKCVANALSYLHH 619
G CL + + +++ GS+ L N + E V +T K + + ++YLH+
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYT------KQILDGVAYLHN 120
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT------IVAGTYGYIAP 673
+C +VHRDI NN++L + DFG AR L + T + GT ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
E+ K D++S G E+ G+ P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 66/250 (26%), Positives = 120/250 (48%), Gaps = 36/250 (14%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKK--LHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
IG G G V A + +GK+VA+KK L + + E F NE ++ H N+V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82
Query: 564 YGFCLHKKCMFLIYKYMKRGSL---FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
Y L ++++ ++++ G+L R + E + + + ++K ALS LH
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---AVCLAVLK----ALSVLHAQ 135
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMV 680
++HRDI S++ILL ++DFG + + R + GT ++APEL +
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 681 VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL------SPP-- 732
+ D++S G++ +E++ G P + P M+ D L +L SP
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP-----YFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK 247
Query: 733 --VDRMVMQD 740
+DR++++D
Sbjct: 248 GFLDRLLVRD 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 494 IIKATEDFDIKYCIGTGGYGSVYKA-QLPNGKV----VALKKLHRAETEETTFFNSFQNE 548
I+K TE +K +G+G +G+V+K +P G VA+K + +T F +
Sbjct: 3 ILKETELRKLK-LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT--FQEITDH 59
Query: 549 AHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAV----VLDWTMRV 604
+ + H IV+L G C + L+ + GSL +R +++ +L+W +++
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI- 663
A + YL M VHR++++ NILL S +ADFG A LL D
Sbjct: 119 ------AKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169
Query: 664 -VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIML 721
++A E T + DV+S+GV E++ G P + P +K
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK--- 226
Query: 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL+ P ++ D+ +V + C RPT + + EF
Sbjct: 227 ----GERLAQP--QICTIDVYMVM---VKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKA--QLPNGKVVALK-KLHRAETEETTFFNSFQNEAHVLSKI 555
ED + CIG G +G VY+ P + +A+ K + T + F EA+++ +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQF 64
Query: 556 AHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC--VANA 613
H +IVKL G ++++ + G L +L+ + ++ + I+ ++ A
Sbjct: 65 DHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSL----DLASLILYSYQLSTA 119
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR-TIVAGTYGYIA 672
L+YL VHRDI++ N+L++S + DFG +R L+ +S + + ++A
Sbjct: 120 LAYLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLM-GRHP 703
PE T DV+ FGV E+LM G P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNG-KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
EDF+I IG G +G V +L N KV A+K L++ E + F+ E VL +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA--NALS 615
+ I L+ + ++L+ Y G L L + +E + + R + + V +++
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA-RLLDSDSSNRTIVAGTYGYIAPE 674
LH+ VHRDI +NIL++ +ADFG+ +L++ + ++ GT YI+PE
Sbjct: 120 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 675 LAYTMV-----VTEKCDVYSFGVVALEVLMGRHP 703
+ M +CD +S GV E+L G P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 1e-14
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G G+VY A + G+ VA+K+++ + + NE V+ + + NIV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 83
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L ++++ +Y+ GSL + +D + + AL +LH + +
Sbjct: 84 SYLVGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALDFLHSN---QV 136
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRDI S+NILL + DFG + + S R+ + GT ++APE+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 686 DVYSFGVVALEVLMGRHP 703
D++S G++A+E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 70/237 (29%), Positives = 105/237 (44%), Gaps = 38/237 (16%)
Query: 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYK-AQLPNGKVVALKKLH--RAETEETTFFNSF 545
+ E + T+ ++I IG G YG VYK +G + A+K L EE
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE------I 65
Query: 546 QNEAHVLSKIA-HRNIVKLYG-FCLHKKC----MFLIYKYMKRGS--------LFCFLRN 591
+ E ++L + H N+VK YG F K ++L+ + GS L C R
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR- 124
Query: 592 DYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651
LD M I+ L +LH++ I+HRD+ NNILL ++ + DFG +
Sbjct: 125 ------LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175
Query: 652 RLLDSDSSNRTIVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
L S R GT ++APE+ Y +CDV+S G+ A+E+ G P
Sbjct: 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 507 IGTGGYGSVYKAQ-LPNG-KVVALKKLHRAETEETTFFNSFQNEAHVLSKIA---HRNIV 561
IG G YG V+KA+ L NG + VALK++ R +T E S E VL + H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 562 KLYGFCLHKKC-----MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
+L+ C + + L+++++ + L +L E V T++ +++ + L +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDF 125
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
LH +VHRD+ NIL+ S + +ADFG AR+ S T V T Y APE+
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVL 181
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP-----------GELLSSLSSPSSD---QKIMLI 722
D++S G + E+ R P G++L + P + + + L
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240
Query: 723 -DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
S+ + P+++ V L + L CL P R +
Sbjct: 241 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 507 IGTGGYGSVYKAQ------LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G V KA VA+K L E ++ +E ++L ++ H ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK--ENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-----------------------NDYEAVV 597
+KLYG C + LI +Y K GSL FLR D A+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 598 LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657
+ ++ ++ + YL +VHRD+++ N+L+ + ++DFG +R + +
Sbjct: 126 MG--DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 658 SS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
S R+ ++A E + + T + DV+SFGV+ E++ +G +P
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKK--LHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
IG G G V A + GK VA+KK L + + E F NE ++ H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHENVVDM 84
Query: 564 YGFCLHKKCMFLIYKYMKRGSL---FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
Y L ++++ ++++ G+L R + E + T+ +++++ ALSYLH+
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLR----ALSYLHNQ 137
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMV 680
++HRDI S++ILL S ++DFG + + R + GT ++APE+ +
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194
Query: 681 VTEKCDVYSFGVVALEVLMGRHP 703
+ D++S G++ +E++ G P
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 507 IGTGGYGSVYKAQLPNGKV---VALKKLH-----RAETEETTFFNSFQNEAHVLSKIAHR 558
+G G +GSV + QL VA+K + R+E E+ F +EA + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED------FLSEAVCMKEFDHP 60
Query: 559 NIVKLYGFCLHKK------CMFLIYKYMKRGSLFCFL---RNDYEAVVLDWTMRVNIIKC 609
N+++L G CL +I +MK G L FL R L M V +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT--IVAGT 667
+A+ + YL S +HRD+++ N +LN + VADFG ++ + + R I
Sbjct: 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 668 YGYIAPELAYTMVVTEKCDVYSFGVVALEV 697
+IA E V T K DV+SFGV E+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-14
Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 501 FDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
+DI IG GG G VY A P + VALKK+ +E F EA + + + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
IV +Y C ++ Y++ +L L++ ++ L + + V LS H
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHK 121
Query: 620 DCMP-------SIVHRDISSNNILLNSKLEAFVADFGTAR--------LLDSD------- 657
C ++HRD+ +NILL E + D+G A LLD D
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 658 SSNRTI---VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS 714
S+ TI + GT Y+APE + +E D+Y+ GV+ ++L +LS P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML----------TLSFPY 231
Query: 715 SDQKIMLIDVLDSRLSPPVDRMVMQDI-VLVTTVALACLHSKPKFR 759
+K I + P++ ++I ++ +A+ L P R
Sbjct: 232 RRKKGRKI-SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 32/281 (11%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+F I+ IG G + VYKA L +G+VVALKK+ E + E +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVL-----DWTMRVNIIKCVA 611
H N++K + + ++ + G L +++ + L W V +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
+AL ++H I+HRDI N+ + + + D G R S ++ + GT Y+
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS---- 727
+PE + K D++S G + E +++L SP K+ L +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE----------MAALQSPFYGDKMNLYSLCKKIEKC 223
Query: 728 RLSP-PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
P P D + LV+ C++ P+ RP + V Q
Sbjct: 224 DYPPLPADHYSEELRDLVS----RCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI 555
ED + IG G +G V +A + A+K L +E F E VL K+
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND--HRDFAGELEVLCKL 59
Query: 556 AHR-NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-------------EAVVLDWT 601
H NI+ L G C ++ +++ +Y G+L FLR A L
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
+ VA + YL +HRD+++ N+L+ L + +ADFG +R
Sbjct: 120 QLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR------GEE 170
Query: 662 TIVAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVL 698
V T G ++A E V T K DV+SFGV+ E++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G G+VY A + G+ VA+++++ + + NE V+ + + NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 84
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L ++++ +Y+ GSL + +D + + AL +LH + +
Sbjct: 85 SYLVGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRDI S+NILL + DFG + + S R+ + GT ++APE+ K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 686 DVYSFGVVALEVLMGRHP 703
D++S G++A+E++ G P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 37/277 (13%)
Query: 505 YC----IGTGGYGSVYKAQ-LPNGKVVALKKLH--RAETEETTFFNSFQNEAHVLSKIAH 557
YC +G G YG V + +GK +KKL+ A E + + EA +LS++ H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER---KAAEQEAQLLSQLKH 58
Query: 558 RNIVKLYGFCLHKKCM-FLIYKYMKRGSLFCFLRNDY-----EAVVLDWTMRVNIIKCVA 611
NIV + + +++ + + G L+ L+ E V++W +++ A
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------A 112
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
AL YLH I+HRD+ + N+ L V D G AR+L++ + + GT Y+
Sbjct: 113 MALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731
+PEL K DV++ G E+ +H + + D ++ +++ +L P
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKH--------AFNAKDMNSLVYRIIEGKLPP 221
Query: 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
+ L+ T+ L +P+ RP+++ + ++
Sbjct: 222 MPKDYSPELGELIATM----LSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G V+K L + VA+K +E F +EA +L + H NIVKL G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C ++ ++++ + + G FLR + + ++ + A ++YL + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALD--AAAGMAYLE---SKNCI 115
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLLD----SDSSNRTIVAGTYGYIAPELAYTMVVT 682
HRD+++ N L+ ++DFG +R D S S + I + APE +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI---PIKWTAPEALNYGRYS 172
Query: 683 EKCDVYSFGVVALEVL---MGRHPG 704
+ DV+S+G++ E + +PG
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 502 DIKY--CIGTGGYGSVYKAQLPNGKV---VALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
DIK+ IG G +G V KA++ + A+K++ +++ F E VL K+
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLG 65
Query: 557 -HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN-------------DYEAVVLDWTM 602
H NI+ L G C H+ ++L +Y G+L FLR + A L
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 603 RVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662
++ VA + YL +HRD+++ NIL+ A +ADFG +R
Sbjct: 126 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEV 176
Query: 663 IVAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVL 698
V T G ++A E V T DV+S+GV+ E++
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-14
Identities = 72/235 (30%), Positives = 113/235 (48%), Gaps = 16/235 (6%)
Query: 96 FPGLESLSLRFNYLFGSIPSQVGAL-SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154
L SL L N + IP +G L S L+ LD S N + S+P L +L NL+ L+L
Sbjct: 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172
Query: 155 NNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELG 214
N+L+ +P L L+ L + LS N + +P I L+ L L L +N + +L L
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELL-SSLS 229
Query: 215 KLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSM 274
LKNL L + NKL +P ++ L+NL L L +N S +G++T + ++D+S
Sbjct: 230 NLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSG 286
Query: 275 NNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPI 329
N++ L + L + +L + A + L + L+NN LS
Sbjct: 287 NSL-------SNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALK---KLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
+G G +GSV + QL LK K + + + F +EA + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 564 YGFCLHKKCM------FLIYKYMKRGSLFCFL---RNDYEAVVLDWTMRVNIIKCVANAL 614
G C + +I +MK G L FL R L + + +A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT--IVAGTYGYIA 672
YL + + +HRD+++ N +L + VADFG ++ + S R I +IA
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
E V T K DV++FGV E+ G+ P
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 42/206 (20%)
Query: 497 ATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKL--HRAETEETTFFNSFQNEAHVLS 553
D++I +G G +G VYKA Q+ G+VVALKK+ H E+ F + E +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH---NEKDGFPITALREIKILK 62
Query: 554 KIAHRNIVKLYGFCLH--------KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
K+ H N+V L + + ++++ YM L L N V
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP----------SVK 111
Query: 606 I----IKCVANAL----SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657
+ IKC L +YLH + I+HRDI + NIL++++ +ADFG AR D
Sbjct: 112 LTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 658 SSNRTIVAGTYGYIAPELAYT-MVVT 682
N G YT +VVT
Sbjct: 169 PPN-----PKGGGGGGTRKYTNLVVT 189
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 37/212 (17%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G+VY A+ + +VVA+KK+ + + + E L ++ H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 566 FCLHKKCMFLIYKY-----------MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
L + +L+ +Y K+ L+ A + ++ L
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKP-----LQEVEIAAICHGALQ---------GL 128
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
+YLH +HRDI + NILL +ADFG+A L+ +S GT ++APE
Sbjct: 129 AYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPE 181
Query: 675 LAYTM---VVTEKCDVYSFGVVALEVLMGRHP 703
+ M K DV+S G+ +E L R P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
DF++ +GTG +G V A+ G+ A+K L + E + E +L +++H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR------ND----YEA-VVLDWTMRVNII 607
IV + + ++ + +++ G LF LR ND Y A +VL
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL--------- 129
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI-VAG 666
A YLH I++RD+ N+LL++K V DFG A+ + +RT + G
Sbjct: 130 -----AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCG 177
Query: 667 TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T Y+APE+ + + D ++ GV+ E + G P
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 8/199 (4%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL-Y 564
+G GG+G V Q+ GK+ A KKL + ++ NE +L K++ R IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
F K + L+ M G L + N E + + + L +LH
Sbjct: 61 AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---R 115
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEK 684
IV+RD+ N+LL+ ++D G A L AGT GY+APE+ V
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 685 CDVYSFGVVALEVLMGRHP 703
D ++ G E++ GR P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G YG VY A+ L +A+K++ ++ E + S + HRNIV+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV---QPLHEEIALHSYLKHRNIVQYLG 72
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRN------DYEAVVLDWTMRVNIIKCVANALSYLHH 619
+ + + GSL LR+ D E ++ +T K + L YLH
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT------KQILEGLKYLHD 126
Query: 620 DCMPSIVHRDISSNNILLNSKLEAF-VADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT 678
+ IVHRDI +N+L+N+ ++DFGT++ L + GT Y+APE
Sbjct: 127 N---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE---- 179
Query: 679 MVVTEK--------CDVYSFGVVALEVLMGRHP 703
V +K D++S G +E+ G+ P
Sbjct: 180 --VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKV--VALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
EDF+ +GTG +G V A N VA+K+ +++ + + +E +L+ I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
H V LYG + ++L+ +++ G F FLR + N + C A
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF--------PNDVGCFYAAQIV 141
Query: 617 LHHDCMPS--IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
L + + S IV+RD+ N+LL+ + DFG A+++D+ + + GT YIAPE
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT---LCGTPEYIAPE 198
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + + D ++ G+ E+L+G P
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 46/287 (16%)
Query: 507 IGTGGYGSVYKAQ---LPNGKV---VALKKL----HRAETEETTFFNSFQNEAHVLSKIA 556
+G G +G V +A L VA+K L H +E E + +E ++S +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE------ALMSELKIMSHLG 96
Query: 557 -HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALS 615
H NIV L G C + +I +Y G L FLR E+ + + ++ VA ++
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMA 155
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT----YGYI 671
+L + +HRD+++ N+LL + DFG AR + +DS+ +V G ++
Sbjct: 156 FLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN--YVVKGNARLPVKWM 210
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVL---MGRHPGELL-SSLSSPSSDQKIMLIDVLDS 727
APE + V T + DV+S+G++ E+ +PG + S + M
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM------- 263
Query: 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774
P + DI+ C + P RPT +++ Q + ++
Sbjct: 264 -AQPEHAPAEIYDIM------KTCWDADPLKRPTFKQIVQ-LIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 36/82 (43%), Positives = 52/82 (63%)
Query: 133 LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDL 192
L G IP ++ LR+L+ +NL GN++ G IP SL +T L + LS N +G IP ++G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 193 NNLLILSLDSNKLSGMLHQELG 214
+L IL+L+ N LSG + LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQ-NEAHVLSKIAHRNIVKLY 564
+G G YG V K + G++VA+KK E+E+ E +L ++ H N+V L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV--LDWTMRVNIIKCVANALSYLHHDCM 622
KK ++L+++++ L +D E LD + + + + + H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-- 119
Query: 623 PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-----AY 677
+I+HRDI NIL++ + DFG AR L + T T Y APEL Y
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKY 178
Query: 678 TMVVTEKCDVYSFGVVALEVLMG 700
V D+++ G + E+L G
Sbjct: 179 GRAV----DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 31/217 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
++++ I G YG VY+A+ G++VALKKL + E E+ F + E ++L K+ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQH 63
Query: 558 RNIVKL----YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR----VNIIKC 609
NIV + G L K ++++ +Y+ +++ L TM+ + +KC
Sbjct: 64 PNIVTVKEVVVGSNLDK--IYMVMEYV-----------EHDLKSLMETMKQPFLQSEVKC 110
Query: 610 VA----NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
+ + +++LH + I+HRD+ ++N+LLN++ + DFG AR S T +
Sbjct: 111 LMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 666 GTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGR 701
T Y APEL + D++S G + E+L +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 65/254 (25%), Positives = 103/254 (40%), Gaps = 34/254 (13%)
Query: 526 VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585
VA+K L ++ F E +LS+++ NI +L G C + +I +YM+ G L
Sbjct: 49 VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 586 FCFLRNDYEAVV---------LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNIL 636
FL+ + A L ++ + + +A+ + YL + VHRD+++ N L
Sbjct: 107 NQFLQK-HVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCL 162
Query: 637 LNSKLEAFVADFGTARLLDSDSSNRTIVAGT----YGYIAPELAYTMVVTEKCDVYSFGV 692
+ +ADFG +R L S R V G ++A E T K DV++FGV
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYYR--VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 693 VALEVLM--GRHPGELLSSLSSPSSDQKIMLIDVLDSR---LSPPVDRMVMQDIVLVTTV 747
E+L P L+ + D R L P +DI +
Sbjct: 221 TLWEILTLCREQP---YEHLTDQQVIENAGHFFRDDGRQIYLPRP--PNCPKDIY---EL 272
Query: 748 ALACLHSKPKFRPT 761
L C + RPT
Sbjct: 273 MLECWRRDEEDRPT 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 70/255 (27%), Positives = 115/255 (45%), Gaps = 32/255 (12%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA---HRNIVK 562
IG G YG+VYKA+ P+ G VALK + R +T E S E +L ++ H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 563 LYGFCLHKKC-----MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
L C + + L+++++ + L +L + T++ ++++ L +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIK-DLMRQFLRGLDFL 124
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H +C IVHRD+ NIL+ S + +ADFG AR+ + +V T Y APE+
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPEVLL 180
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHP-----------GELLSSLSSPSSDQKIMLIDVLD 726
D++S G + E + R P G++ + P D + +
Sbjct: 181 QSTYATPVDMWSVGCIFAE-MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239
Query: 727 SRLSP----PVDRMV 737
SP PV +V
Sbjct: 240 GAFSPRGPRPVQSVV 254
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 66/300 (22%)
Query: 507 IGTGGYGSVYKAQL-------PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIA-H 557
+G G +G V A+ P V VA+K L TE+ + +E ++ I H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 80
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN----------DYEAVVLDWTMRVNII 607
+NI+ L G C +++I +Y +G+L +LR D V + +++
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 608 KC---VANALSYL-HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663
C VA + YL C +HRD+++ N+L+ +ADFG AR +++ +
Sbjct: 141 SCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 664 VAGTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVLM---GRHPG----ELLSSLSSPS 714
G ++APE + V T + DV+SFGV+ E+ +PG EL L
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-- 254
Query: 715 SDQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
R+ P + M+M+D C H+ P RPT +++ ++
Sbjct: 255 -----------GHRMDKPANCTNELYMMMRD----------CWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 507 IGTGGYGSVYKAQL----PNGKVVALK-----KLHRAETEETTFFNSFQNEAHVLSKIAH 557
IG G +G KA L +GK +K K+ E EE+ + E VLS + H
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES------RKEVAVLSNMKH 58
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-----EAVVLDWTMRVNIIKCVAN 612
NIV+ ++++ Y + G L+ + E +LDW +++ C+A
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI----CLA- 113
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
L ++H I+HRDI S NI L + DFG AR+L+S GT Y++
Sbjct: 114 -LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLS 169
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE 705
PE+ K D+++ G V E+ +H E
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-13
Identities = 41/108 (37%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 317 GLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMK-LEYLDLSHNKLNGT 375
GL L N L G IP +I K L++I L N++ G+IPP +G + LE LDLS+N NG+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 376 IPPFLYHRFP---LDLSYNDLEGEIPDY-----FRDSPFKVYGNQGIC 415
IP L L+L+ N L G +P + F N G+C
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 25/271 (9%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G+VY A+ + +VVA+KK+ + + + E L +I H N ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L + +L+ +Y GS L + L I L+YLH M
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHNM--- 146
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE-- 683
+HRDI + NILL + +ADFG+A + +S GT ++APE+ M +
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQYD 202
Query: 684 -KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742
K DV+S G+ +E+ + P ++++S+ L + + SP + D
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNE-SPTLQSNEWSD-- 251
Query: 743 LVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773
+CL P+ RPT + + + +
Sbjct: 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 507 IGTGGYGSVYKAQLPNGKV---VALKKLHRAETEETTFFNSFQNEAHVLSKIAHR-NIVK 562
IG G +G V KA++ + A+K++ +++ F E VL K+ H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNIIN 60
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-------------EAVVLDWTMRVNIIKC 609
L G C H+ ++L +Y G+L FLR A L ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
VA + YL +HRD+++ NIL+ A +ADFG +R V T G
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMG 171
Query: 670 -----YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
++A E V T DV+S+GV+ E++ +G P
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G VYKAQ V+A K+ ++EE + E +L+ H NIVKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 70
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
++ ++++ ++ G++ + + E + + +RV + K AL+YLH + I+
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRV-VCKQTLEALNYLHEN---KII 125
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE--- 683
HRD+ + NIL + +ADFG + R GT ++APE+ +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 684 --KCDVYSFGVVALEV 697
K DV+S G+ +E+
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLH-RAETEETTF-FNSFQNEAHVLSKIAHRNIVKL 563
+G G +G VY G+ +A+K++ E+ ET+ N+ + E +L + H IV+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 564 YGFCLH---KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
YG CL ++ + + ++M GS+ L++ Y A+ + T + + + +SYLH +
Sbjct: 70 YG-CLRDPMERTLSIFMEHMPGGSIKDQLKS-YGALTENVTRKYT--RQILEGVSYLHSN 125
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS---DSSNRTIVAGTYGYIAPELAY 677
IVHRDI NIL +S + DFG ++ L + + V GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHP 703
K D++S G +E+L + P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 500 DFDIKYCIGTGGYGSVYKAQLPNG-KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+++ +G G +G Q N + A+K++ ++ + EA +L+K+ H
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSRKEAVLLAKMKHP 58
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-----EAVVLDWTMRVNIIKCVANA 613
NIV ++++ +Y G L ++ E +L W +++ C+
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM----CLG-- 112
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAP 673
+ ++H ++HRDI S NI L + + DFG+ARLL S + GT Y+ P
Sbjct: 113 VQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
E+ M K D++S G + E+ +HP
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK 554
EDFD+ IG G +G V QL + +V A+K L + E + + F E ++
Sbjct: 43 EDFDVIKVIGRGAFGEV---QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIM-- 97
Query: 555 IAHRN---IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
AH N IV+L+ K ++++ +YM G L + N Y+ + W R + V
Sbjct: 98 -AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YD-IPEKWA-RFYTAEVVL 153
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA-GTYGY 670
AL +H +HRD+ +N+LL+ +ADFGT +D++ R A GT Y
Sbjct: 154 -ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 671 IAPELAYTMVVT----EKCDVYSFGVVALEVLMGRHP 703
I+PE+ + +CD +S GV E+L+G P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 542 FNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWT 601
FN+ + H L K + N +KLY K LI Y+K G LF L+ + + L
Sbjct: 54 FNAIEPMVHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEA 109
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN-SKLEAFVADFGTARLLDSDSSN 660
II+ + AL+ LH +I+H DI N+L + +K ++ D+G +++ + S
Sbjct: 110 EVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY 166
Query: 661 RTIVAGTYGYIAPELAYTMVVTEKCDVYSF-----GVVALEVLMGRHP 703
GT Y +PE + D SF GV+ E+L G+HP
Sbjct: 167 D----GTLDYFSPE----KIKGHNYD-VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQ-NEAHVLSKIAHRNIVKLY 564
IG G YG V+K + G++VA+KK E+E+ E +L ++ H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV--LDWTMRVNIIKCVANALSYLH-HDC 621
K+ + L+++Y L N+ E + + II A+++ H H+C
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVL-----NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-----A 676
+HRD+ NIL+ + + + DFG AR+L + T T Y APEL
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 677 YTMVVTEKCDVYSFGVVALEVLMG 700
Y V DV++ G V E+L G
Sbjct: 178 YGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-13
Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 22/238 (9%)
Query: 548 EAHVLSKIAHRNIVKLYG-FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI 606
EAH+L I H +I++L G F +K ++ +Y + L+C+L + D + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICDI---LAI 187
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI-VA 665
+ V A+ YLH + I+HRDI + NI +N + + DFG A ++N+ A
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP-SSDQKIMLIDV 724
GT APEL D++S G+V E+ L SD++I LI +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI-I 303
Query: 725 LDSRLSP---PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-----EFLTCKI 774
S P P+D D + + + KP RP + + E+L CK+
Sbjct: 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSS--RKPGSRPLWTNLYELPIDLEYLICKM 359
|
Length = 391 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 45/255 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAE---TEETTFFNSFQNEAHVLSK 554
+DF++ IG G +G V+ + G+V A+K L +++ + E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVR---AERDILAD 57
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
IVKLY ++ ++L+ +YM G L L + + R I + V AL
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETA-RFYIAELVL-AL 114
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA---------------RLLDSDSS 659
+H + +HRDI +NIL+++ +ADFG
Sbjct: 115 DSVHK--L-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 660 NRTI--------------VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE 705
N + GT YIAPE+ +CD +S GV+ E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP-- 229
Query: 706 LLSSLSSPSSDQKIM 720
S + + KI+
Sbjct: 230 -FYSDTLQETYNKII 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G YG VYKA+ G+VVALKK+ R +TE ++ E +L ++ H NIVKL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC----VANALSYLHHDC 621
+ ++L+++++ + L+ +A L + + +IK + L++ H
Sbjct: 67 VIHTENKLYLVFEFLHQD-----LKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCHSH- 119
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYTMV 680
++HRD+ N+L+N++ +ADFG AR T T Y APE L
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 681 VTEKCDVYSFGVVALEVLMGR--HPGE 705
+ D++S G + E++ R PG+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G Y +VYK + NGK+VALK + R + EE T F + + EA +L + H NIV L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
K+ + L+++Y+ + C + + + +++ + + + LSY+H I
Sbjct: 71 IIHTKETLTLVFEYVH--TDLCQYMDKHPGGLHPENVKLFLFQLL-RGLSYIHQR---YI 124
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
+HRD+ N+L++ E +ADFG AR S + T Y P++ C
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 686 -DVYSFGVVALEVLMG 700
D++ G + +E++ G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLH-RAETEETTF-FNSFQNEAHVLSKIAHRNIVKL 563
+G G +G VY + G+ +A K++ E+ ET+ ++ + E +L + H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 564 YGFCLH---KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
YG CL +K + + +YM GS+ L+ Y A+ T + + + +SYLH +
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYT--RQILEGMSYLHSN 125
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD----SDSSNRTIVAGTYGYIAPELA 676
IVHRDI NIL +S + DFG ++ L S + R+ V GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVI 181
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP 703
K DV+S G +E+L + P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 65/233 (27%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKL---HRAETEETTFFNS 544
I F+ ++ ++I IG G YG V+K NG A+K L H + E
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE------- 60
Query: 545 FQNEAHVLSKIA-HRNIVKLYGFCLHKKC-----MFLIYKYMKRGSLFCFLRNDYEAVVL 598
+ E ++L ++ H N+VK YG K ++L+ + GS+ D L
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFL 115
Query: 599 DWTMRVN---IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655
R+ I + AL L H + +HRD+ NNILL ++ + DFG + L
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175
Query: 656 SDSSNRTIVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
S R GT ++APE+ +CDV+S G+ A+E+ G P
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 32/88 (36%), Positives = 51/88 (57%)
Query: 150 LNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGML 209
L L L G IP+ + +L L ++ LS N + G IP ++G + +L +L L N +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 210 HQELGKLKNLVALNVGGNKLMGPIPSTL 237
+ LG+L +L LN+ GN L G +P+ L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNE-AHVLSKIAHRNIVKLY 564
I G +GSVY A+ G A+K L +++ + + E A ++ + + KLY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
K ++L+ +Y+ G ++ + DW I V + LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAK--QYIAEVVLGVEDLHQR---G 117
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEK 684
I+HRDI N+L++ + DFG +R N+ V GT Y+APE + +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFV-GTPDYLAPETILGVGDDKM 173
Query: 685 CDVYSFGVVALEVLMGRHP 703
D +S G V E L G P
Sbjct: 174 SDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNG-KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DF+I IG G +G V ++ + ++ A+K L++ E + F+ E +VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCV--ANALS 615
+ I L+ + ++L+ Y G L L + +E + + R I + V +++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA-GTYGYIAPE 674
LH+ VHRDI +N+LL+ +ADFG+ ++ D + ++ VA GT YI+PE
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 675 LAYTM-----VVTEKCDVYSFGVVALEVLMGRHP 703
+ M +CD +S GV E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 63/258 (24%), Positives = 99/258 (38%), Gaps = 84/258 (32%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQN---------EAHVLSKIA 556
IG+G YG V A G+ VA+KK+ F + E +L +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV----------FDDLIDAKRILREIKLLRHLR 57
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND-YEAVVLDWTMRV---NIIKC--- 609
H NI+ L I + ND Y +V + M +IK
Sbjct: 58 HENIIGL----------LDILRPPSPEDF-----NDVY--IVTEL-METDLHKVIKSPQP 99
Query: 610 ------------VANALSYLHHDCMPS--IVHRDISSNNILLNSKLEAFVADFGTARLLD 655
+ L YLH S ++HRD+ +NIL+NS + + DFG AR +D
Sbjct: 100 LTDDHIQYFLYQILRGLKYLH-----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154
Query: 656 SDSSNRTIVAG---TYGYIAPELAYTMVVTEKC----DVYSFGVVALEVLMGRH--PGE- 705
D + + T Y APEL ++ + + D++S G + E+L + PG
Sbjct: 155 PDEDEKGFLTEYVVTRWYRAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211
Query: 706 -------LLSSLSSPSSD 716
++ L +PS +
Sbjct: 212 YIDQLNLIVEVLGTPSEE 229
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DF+ +G G G V K Q P+G ++A K +H + N E VL +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNS 62
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
IV YG + + ++M GSL L+ EA + + + V L+YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYL 119
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFG-TARLLDSDSSNRTIVAGTYGYIAPELA 676
I+HRD+ +NIL+NS+ E + DFG + +L+DS +++ GT Y++PE
Sbjct: 120 REK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERL 174
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + D++S G+ +E+ +GR+P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G+VY A+ + N +VVA+KK+ + + + E L K+ H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L + +L+ +Y GS L + L + L+YLH M
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHNM--- 136
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE-- 683
+HRD+ + NILL+ + DFG+A ++ + GT ++APE+ M +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQYD 192
Query: 684 -KCDVYSFGVVALEVLMGRHPGELLSSLSS 712
K DV+S G+ +E+ + P ++++S+
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSA 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 31/89 (34%), Positives = 55/89 (61%), Gaps = 2/89 (2%)
Query: 272 MSMNN--IEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPI 329
+ ++N + G IP ++++L L +++S N + G IP ++ + SL+ LDLS N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 330 PPEIGKCSELRNITLRNNNLSGSIPPEIG 358
P +G+ + LR + L N+LSG +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 31/92 (33%), Positives = 55/92 (59%)
Query: 221 ALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGT 280
L + L G IP+ + +L +L + L N + G+IPP +G++T + +D+S N+ G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGL 312
IP L +L+ L L+++ N LSG++P + G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 74/248 (29%), Positives = 109/248 (43%), Gaps = 36/248 (14%)
Query: 119 ALSKLRYLDFSFNNLTGSIPPELGSL-RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALS 177
L+ L LD NN+T IPP +G L NL+ L+L N + ++PS L L L + LS
Sbjct: 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLS 171
Query: 178 RNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTL 237
N L +P + +L+NL L L NK+S L E+ L L L++ N ++ + S+L
Sbjct: 172 FNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL 228
Query: 238 FRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSIS 297
L NL+ L L +N L +P + LS L L +S
Sbjct: 229 SNLKNLSGLELSNNKLE-------------------------DLPESIGNLSNLETLDLS 263
Query: 298 SNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI 357
+N +S I + L +L+ LDLS N LS +P L + N L E+
Sbjct: 264 NNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLELL---LNLLLTLKALEL 318
Query: 358 GLMKLEYL 365
L +
Sbjct: 319 KLNSILLN 326
|
Length = 394 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 38/250 (15%)
Query: 500 DFDIKYCIGTGGYGSVY---KAQLPN-GKVVALKKL------HRAETEETTFFNSFQNEA 549
+F++ +GTG YG V+ K + GK+ A+K L +A+T E T + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-----RTER 55
Query: 550 HVLSKIAHRN-IVKL-YGFCLHKKCMFLIYKYMKRGSLFCFL-RNDY--EAVVLDWTMRV 604
+VL + +V L Y F K + LI Y+ G +F L + D E V ++ +
Sbjct: 56 NVLEHVRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEI 114
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI- 663
+ AL +LH IV+RDI NILL+S+ + DFG ++ S+ RT
Sbjct: 115 IL------ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 664 VAGTYGYIAPELAYTMVVTEKC-DVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722
GT Y+APE+ K D +S G++ E+L G P L ++ S + +L
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL- 224
Query: 723 DVLDSRLSPP 732
+ PP
Sbjct: 225 -----KCDPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G+VY A +VVA+KK+ + + + E L ++ H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
L + +L+ +Y GS L + L I L+YLH M
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHNM--- 142
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE-- 683
+HRDI + NILL + +ADFG+A S SS GT ++APE+ M +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 684 -KCDVYSFGVVALEVLMGRHP 703
K DV+S G+ +E L R P
Sbjct: 199 GKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLH---RAETEETTFFNSFQNEAHVLSK 554
+DF+ +G G G V K P+G ++A K +H + N E VL +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIR-----NQIIRELKVLHE 55
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
IV YG + + ++M GSL L+ +A + + I V L
Sbjct: 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPENILGKISIAVLRGL 112
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
+YL I+HRD+ +NIL+NS+ E + DFG + L DS + V GT Y++PE
Sbjct: 113 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMSPE 168
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T + D++S G+ +E+ +GR+P
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIVKLY 564
+G G YG V K + +P G ++A+K++ RA T + + + + V Y
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RA-TVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRV------NIIKCVANALSYLH 618
G + +++ + M SL F + V D + + I + AL YLH
Sbjct: 67 GALFREGDVWICMEVMDT-SLDKFYKK-----VYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL--- 675
S++HRD+ +N+L+N + + DFG + L DS +TI AG Y+APE
Sbjct: 121 SKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERINP 177
Query: 676 -----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
Y + K DV+S G+ +E+ GR P
Sbjct: 178 ELNQKGYDV----KSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 502 DIKY--CIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
DI+Y +G G G+VYKA L +++A+K + T E +E +L K
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSP 59
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
I+ YG + + + ++M GSL + R E V+ I V L+YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY-RKIPEHVL------GRIAVAVVKGLTYLW 112
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT 678
I+HRD+ +N+L+N++ + + DFG + L +S +T V GT Y+APE
Sbjct: 113 S---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYV-GTNAYMAPERISG 167
Query: 679 MVVTEKCDVYSFGVVALEVLMGRHP 703
DV+S G+ +E+ +GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 507 IGTGGYGSVYKA---QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
+G+G +G+V K + K VA+K L + + + + EA+V+ ++ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
G C + M L+ + + G L FL+ + + T ++ V+ + YL
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNIT---ELVHQVSMGMKYLEET--- 114
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG-----YIAPELAYT 678
+ VHRD+++ N+LL ++ A ++DFG ++ L +D + A T+G + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNY 172
Query: 679 MVVTEKCDVYSFGVVALE 696
+ K DV+SFGV+ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 491 FEDIIK-------ATEDFDIKYCIGTGGYGSV----YKAQLPNGKVVALKKLHRAETEET 539
+E I++ ED+D+ IG G +G V +K+ + KV A+K L + E +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKR 84
Query: 540 TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLD 599
+ F E +++ +V+L+ K ++++ +YM G L + N Y+ V
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YD-VPEK 142
Query: 600 WTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659
W V AL +H ++HRD+ +N+LL+ +ADFGT +D
Sbjct: 143 WAKFYT--AEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197
Query: 660 NRTIVA-GTYGYIAPELAYTM----VVTEKCDVYSFGVVALEVLMGRHP 703
R A GT YI+PE+ + +CD +S GV E+L+G P
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 64/286 (22%), Positives = 117/286 (40%), Gaps = 30/286 (10%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
+G G +G VYKA+ +A K+ ++EE + E +L+ H IVKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNHPYIVKLLGA 77
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA----NALSYLHHDCM 622
++++ ++ G++ D + LD + I+ + AL YLH
Sbjct: 78 FYWDGKLWIMIEFCPGGAV------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM-- 129
Query: 623 PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY--TMV 680
I+HRD+ + N+LL + +ADFG + R GT ++APE+ TM
Sbjct: 130 -KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 681 VTE---KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737
T K D++S G+ +E ++ + P + M + + ++ PP
Sbjct: 189 DTPYDYKADIWSLGITLIE----------MAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238
Query: 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783
+ + L P+ RP+ ++ + + P E+
Sbjct: 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLREL 284
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 500 DFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
DF I +G GGYG V+ A+ + G++VALK++ ++ + E +L+
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 559 NIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+VKL Y F + ++L +Y+ G L N V+ + R + + A+ L
Sbjct: 62 WLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFE-AVDAL 117
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H +HRD+ N L+++ + DFG ++ + + +++ V G+ Y+APE+
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS---VVGSPDYMAPEVLR 171
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHP 703
D +S G + E L G P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL-Y 564
+G GG+G V Q+ GK+ A KKL++ ++ + E +L+K+ R IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRN-DYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
F K + L+ M G L + N D E + + L +LH
Sbjct: 61 AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL----AYTM 679
I++RD+ N+LL++ ++D G A L S AGT G++APEL Y
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 680 VVTEKCDVYSFGVVALEVLMGRHP 703
V D ++ GV E++ R P
Sbjct: 177 SV----DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 66/300 (22%)
Query: 507 IGTGGYGSVYKAQL-------PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIA-H 557
+G G +G V A+ PN VA+K L TE+ + +E ++ I H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 83
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-----------NDYEAVVLDWTMRVNI 606
+NI+ L G C +++I +Y +G+L +LR N + + + ++
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK-DL 142
Query: 607 IKC---VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663
+ C VA + YL +HRD+++ N+L+ +ADFG AR + +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 664 VAGTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVLM---GRHPG----ELLSSLSSPS 714
G ++APE + + T + DV+SFGV+ E+ +PG EL L
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-- 257
Query: 715 SDQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
R+ P + M+M+D C H+ P RPT +++ ++
Sbjct: 258 -----------GHRMDKPSNCTNELYMMMRD----------CWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKL-HRAETEETTF-FNSFQNEAHVLSKIAHRNIVKL 563
+G G +G VY G+ +A+K++ +++ET+ N+ + E +L + H IV+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 564 YGFCLH---KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
YG CL +K + + +YM GS+ L+ Y A+ + T R + + +SYLH +
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKA-YGALTENVTRRYT--RQILQGVSYLHSN 125
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT---IVAGTYGYIAPELAY 677
IVHRDI NIL +S + DFG ++ + + + T V GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHP 703
K DV+S +E+L + P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G YG VYK + G++VA+KK+ R E+EE ++ E +L ++ H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC----VANALSYLHHDC 621
+ + ++LI+++ L L+ +++ M ++K + + + H
Sbjct: 67 VLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-----A 676
++HRD+ N+L+++K +ADFG AR T T Y APE+
Sbjct: 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 677 YTMVVTEKCDVYSFGVVALEV 697
Y+ V D++S G + E+
Sbjct: 179 YSTPV----DIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 75/213 (35%), Positives = 104/213 (48%), Gaps = 8/213 (3%)
Query: 167 QLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL--SGMLHQELGKLKNLVALNV 224
L + L+ N + L+ LL L L S S + L L L +L++
Sbjct: 41 NLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDL 100
Query: 225 GGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV-DMSMNNIEGTIPL 283
N+L I S L LTNLT L L +N++ IPP IG + LK D+S N IE ++P
Sbjct: 101 NLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPS 157
Query: 284 ELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNIT 343
L L L L +S N LS +P ++ L +L LDLS NK+S +PPEI S L +
Sbjct: 158 PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELD 215
Query: 344 LRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTI 376
L NN++ + L L L+LS+NKL
Sbjct: 216 LSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 26/185 (14%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G V+KA+ ++VALKK+ E E+ F + E +L + H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 566 FCLHKKCMFLIYKYMKRGSL-----FC------FLRNDYEAVVLDWTMRVNIIKCVANAL 614
C K + YK GS FC L N V + ++K + N L
Sbjct: 79 ICRTKATPYNRYK----GSFYLVFEFCEHDLAGLLSNKN--VKFTLSEIKKVMKMLLNGL 132
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR---LLDSDSSNR-TIVAGTYGY 670
Y+H + I+HRD+ + NIL+ +ADFG AR L + NR T T Y
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 671 IAPEL 675
PEL
Sbjct: 190 RPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G YG VYKA+ G++VALKK+ R ETE+ ++ E +L ++ H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 566 FCLHKKCMFLIY--------KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+ ++L++ KYM L LD + + + + ++Y
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLT----------GLDPPLIKSYLYQLLQGIAYC 115
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-- 675
H ++HRD+ N+L++ + +ADFG AR T T Y APE+
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 172
Query: 676 ---AYTMVVTEKCDVYSFGVVALEVLMGR 701
Y+ V D++S G + E++ R
Sbjct: 173 GSRQYSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 69/244 (28%), Positives = 102/244 (41%), Gaps = 55/244 (22%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G V+ P +GK VALKK+ N FQN V K R + K+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMP----------NVFQN--LVSCKRVFREL-KMLC 54
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN------------- 612
F H + + ++ + F E V+ M+ ++ K + +
Sbjct: 55 FFKHDNVLSAL-DILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL 109
Query: 613 -----ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS-NRTIVAG 666
L YLH I+HRDI N+L+NS + DFG AR+ + D S + T
Sbjct: 110 YQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 667 TYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIML 721
T Y APE+ YT V D++S G + E+L R +L SP Q ++
Sbjct: 167 TQYYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR----ILFQAQSPIQ-QLDLI 217
Query: 722 IDVL 725
D+L
Sbjct: 218 TDLL 221
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 37/216 (17%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G+V K P+G ++A+K++ R+ +E + V+ IVK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 566 FCLHKK----CMFLI-------YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
+ CM L+ YKY+ + V+ + I AL
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYV----------YEVLKSVIPEEILGKIAVATVKAL 120
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
+YL + I+HRD+ +NILL+ + DFG + L DS +T AG Y+APE
Sbjct: 121 NYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 177
Query: 675 L-------AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
Y + + DV+S G+ EV G+ P
Sbjct: 178 RIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 79/322 (24%), Positives = 136/322 (42%), Gaps = 72/322 (22%)
Query: 507 IGTGGYGSVYKAQL-------PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIA-H 557
+G G +G V A+ PN V VA+K L T++ + +E ++ I H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKH 77
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN------DYE----AVVLDWTMRVNII 607
+NI+ L G C ++++ +Y +G+L +LR DY + + +++
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 608 KC---VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664
C VA + YL +HRD+++ N+L+ +ADFG AR + + +
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 665 AGTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVLM---GRHPG----ELLSSLSSPSS 715
G ++APE + V T + DV+SFGV+ E+ +PG EL L
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE--- 251
Query: 716 DQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF- 769
R+ P + M+M++ C H+ P RPT +++ ++
Sbjct: 252 ----------GHRMDKPANCTHELYMIMRE----------CWHAVPSQRPTFKQLVEDLD 291
Query: 770 --LTCK-----IALVNPFEEIS 784
LT + L PFE+ S
Sbjct: 292 RVLTVTSTDEYLDLSVPFEQYS 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 14/224 (6%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLY 564
IG G Y V +L ++ A+K + + + + Q E HV + + H +V L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFL---RNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
+ +F + +Y+ G L + R E ++ +++ AL+YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER- 115
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVV 681
I++RD+ +N+LL+S+ + D+G + + GT YIAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 682 TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725
D ++ GV+ E++ GR P +++ S +P + + L V+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 507 IGTGGYGSV--YKAQLPN---GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +G V Y N G++VA+K L R ++ T + ++ E ++L + H NIV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIV 69
Query: 562 KLYGFCLHK--KCMFLIYKYMKRGSLFCFL-RNDYEAVVLDWTMRVNIIKCVANALSYLH 618
K G C + K + LI +Y+ GSL +L ++ L+ + + + ++YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLH 124
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL-----------DSDSSNRTIVAGT 667
+HRD+++ N+LL++ + DFG A+ + D DS
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-------- 173
Query: 668 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLM----GRHPGELLSSLSSPSSDQ--KIML 721
+ A E + DV+SFGV E+L + P + + P Q + L
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771
I++L+ + P + Q++ ++ C ++ KFRPT + +
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 67/272 (24%), Positives = 106/272 (38%), Gaps = 78/272 (28%)
Query: 493 DIIKATEDFDIKY----CIGTGGYGSVYKAQLPNGKV-VALKKLHRAETEETTFFNSFQN 547
++ K + +Y +G+G YG V A VA+KKL R FQ+
Sbjct: 5 ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP----------FQS 54
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--------RNDYEAVVLD 599
H +K +R + L K+M ++ L D++ V L
Sbjct: 55 AIH--AKRTYRELRLL--------------KHMDHENVIGLLDVFTPASSLEDFQDVYL- 97
Query: 600 WTMRV-----NIIKC--------------VANALSYLHHDCMPSIVHRDISSNNILLNSK 640
T + NI+KC + L Y+H I+HRD+ +NI +N
Sbjct: 98 VTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNED 154
Query: 641 LEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLM 699
E + DFG AR D + T T Y APE+ M + D++S G + E+L
Sbjct: 155 CELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 700 GR--HPGE--------LLSSLSSPSSD--QKI 719
G+ PG +++ + +P + QKI
Sbjct: 212 GKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 58/250 (23%), Positives = 101/250 (40%), Gaps = 35/250 (14%)
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKK--CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
EA +L + H +++++ + CM L + L+ +L + +D +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLTKRSRPLPIDQAL--I 161
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
I K + L YLH I+HRD+ + NI +N + + D G A+ + +A
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLGLA 217
Query: 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELL----SSLSSPSSDQKIML 721
GT APE+ K D++S G+V E+L +P + S+ L
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPSTPEEYVKSCHSHL 275
Query: 722 IDVLDS-RLSP------PVDRMVMQDIVLVTTVALACLHSKPKFR-PTMQRV----CQEF 769
+ ++ + ++ P P R+V + A L +P R P QRV EF
Sbjct: 276 LKIISTLKVHPEEFPRDPGSRLVRG------FIEYASLERQPYTRYPCFQRVNLPIDGEF 329
Query: 770 LTCKIALVNP 779
L K+ +
Sbjct: 330 LVHKMLTFDA 339
|
Length = 357 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 507 IGTGGYGSVYKAQL----PNGKVVALKKLHRAETEETTFFNSFQNEAH------VLSKIA 556
+G GGYG V++ + GK+ A+K L +A T + ++ AH +L +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-----TIVRNQKDTAHTKAERNILEAVK 58
Query: 557 HRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALS 615
H IV L Y F K ++LI +Y+ G LF L + E + ++ T + + AL
Sbjct: 59 HPFIVDLIYAFQTGGK-LYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISL-ALE 114
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
+LH I++RD+ NILL+++ + DFG + + + GT Y+APE+
Sbjct: 115 HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ D +S G + ++L G P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 19/209 (9%)
Query: 506 CIGTGGYGSVYKAQLPNGKVVALKK--LHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
C + K + P +VA+KK L E+ Q E ++ H NI+
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLL---QQEIITSRQLQHPNILPY 64
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
+ ++++ M GS L+ + L I+K V NAL Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK--- 120
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTAR-LLDSDSSNRTIVAGTYG------YIAPELA 676
+HR + +++ILL+ + ++ + ++ R + +++PE+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 677 YTMV--VTEKCDVYSFGVVALEVLMGRHP 703
+ EK D+YS G+ A E+ G P
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 507 IGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G +G +YK L + ++VA+K L + + FQ EA +++++ H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 562 KLYGFCLHKKCMFLIYKYMKRGSLFCFL-----------RNDYEAVV---LDWTMRVNII 607
L G ++ + ++++Y+ +G L FL +D + V LD ++I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT 667
+A + YL VH+D+++ NIL+ +L ++D G +R + S R
Sbjct: 131 IQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 668 YG--YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
++ PE + D++SFGVV E+ G P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 81/325 (24%), Positives = 137/325 (42%), Gaps = 79/325 (24%)
Query: 507 IGTGGYGSVYKA-------QLPNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIA-H 557
+G G +G V +A P+ V VA+K L T++ +E ++ I H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD--LADLISEMELMKLIGKH 77
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN------DYEAVV-------LDWTMRV 604
+NI+ L G C + +++I +Y +G+L FLR DY + L + V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR-LLDSDSSNRTI 663
+ VA + YL +HRD+++ N+L+ +ADFG AR + D D +T
Sbjct: 138 SCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT- 193
Query: 664 VAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVLM---GRHPG----ELLSSLS 711
+ G ++APE + V T + DV+SFG++ E+ +PG EL L
Sbjct: 194 ---SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250
Query: 712 SPSSDQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVC 766
R+ P + M+M++ C H+ P RPT +++
Sbjct: 251 E-------------GHRMDKPSNCTHELYMLMRE----------CWHAVPTQRPTFKQLV 287
Query: 767 QEF--LTCKIA-----LVNPFEEIS 784
+ + ++ L PFE+ S
Sbjct: 288 EALDKVLAAVSEEYLDLSMPFEQYS 312
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 50/248 (20%)
Query: 499 EDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ IG G YG V A P G VA+KK+ E TF E +L + H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS--PFEHQTFCQRTLREIKILRRFKH 62
Query: 558 RNIVKLY------GFCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNI 606
NI+ + F ++++ + M+ L+ ++ ND+ L +R
Sbjct: 63 ENIIGILDIIRPPSFESFND-VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR--- 117
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR---TI 663
L Y+H +++HRD+ +N+LLN+ + + DFG AR+ D + + T
Sbjct: 118 ------GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 664 VAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR--HPGE--------LLS 708
T Y APE+ YT + D++S G + E+L R PG+ +L
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAI----DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224
Query: 709 SLSSPSSD 716
L +PS +
Sbjct: 225 VLGTPSQE 232
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 13/217 (5%)
Query: 493 DIIKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHV 551
D+ ED+++ IG G +G V + KV A+K L + E + + F E +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
++ +V+L+ + ++++ +YM G L + N Y+ V W R + V
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YD-VPEKWA-RFYTAEVVL 153
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA-GTYGY 670
AL +H +HRD+ +N+LL+ +ADFGT ++ + R A GT Y
Sbjct: 154 -ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 671 IAPELAYTM----VVTEKCDVYSFGVVALEVLMGRHP 703
I+PE+ + +CD +S GV E+L+G P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G YG VYKA+ + +ALKK+ R E E+ ++ E +L ++ H NIV+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC----VANALSYLHHDC 621
+K ++L+++Y+ L+ ++ D+ +IK + ++Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLD-----LKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 622 MPSIVHRDISSNNILLNSKLEAF-VADFGTARLLDSDSSNRTIVAGTYGYIAPEL----- 675
++HRD+ N+L++ + A +ADFG AR T T Y APE+
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGR--HPGE 705
Y+ V D++S G + E++ + PG+
Sbjct: 180 HYSTPV----DIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 41/226 (18%)
Query: 500 DFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKL------HRAETEETTFFNSFQNEA 549
+F++ +GTG YG V+ + GK+ A+K L +A+T E T + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-----RTER 55
Query: 550 HVLSKIAHRN--IVKL-YGFCLHKKCMFLIYKYMKRGSLFCFL--RNDYEAVVLDWTMRV 604
VL + R +V L Y F K + LI Y+ G LF L R + + +RV
Sbjct: 56 QVLEAV-RRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFT----ESEVRV 109
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI- 663
I + V AL +LH I++RDI NILL+S+ + DFG ++ ++ R
Sbjct: 110 YIAEIVL-ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
Query: 664 VAGTYGYIAPEL------AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
GT Y+APE+ + V D +S GV+ E+L G P
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAV----DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 503 IKYCIGTGGYGSVYKA--QLPNGK--VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
I+ +GTG +G + + +LP+ + VA+ L +++ F EA L + H
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHS 66
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
NIV+L G M ++ +YM G+L FLR +V M ++ +A+ + YL
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM--GMLPGLASGMKYLS 124
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG-----YIAP 673
VH+ ++++ +L+NS L ++ F R L D S I G + AP
Sbjct: 125 E---MGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKS-EAIYTTMSGKSPVLWAAP 177
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
E + DV+SFG+V EV+ G P
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 32/85 (37%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 294 LSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSI 353
L + + L G IP I+ L L+ ++LS N + G IPP +G + L + L N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 354 PPEIG-LMKLEYLDLSHNKLNGTIP 377
P +G L L L+L+ N L+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 66/240 (27%), Positives = 95/240 (39%), Gaps = 60/240 (25%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN------------EAHVLS 553
+G G YG V KA GK+VA+KK+ E Q E +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS-NDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYE-AVVLDWTMRVNI--IKCV 610
+I H NI+ L + + L+ M + V+D +R+ +KC+
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM-----------ASDLKKVVDRKIRLTESQVKCI 124
Query: 611 A----NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR------LLDSDSS- 659
N L+ LH +HRD+S NI +NSK +ADFG AR D+ S
Sbjct: 125 LLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 660 -------NRTIVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR--HPGE 705
T T Y APEL Y D++S G + E+L G+ PGE
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKY----HFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 499 EDFDIKYCIGTGGYGSVYK-AQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DF+ +G G G V+K + P+G ++A K +H + N E VL +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNS 62
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
IV YG + + ++M GSL L+ +A + + + V L+YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 119
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFG-TARLLDSDSSNRTIVAGTYGYIAPELA 676
I+HRD+ +NIL+NS+ E + DFG + +L+DS +++ GT Y++PE
Sbjct: 120 REK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERL 174
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + D++S G+ +E+ +GR+P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G Y +VYK + G++VALK++H + EE T + + E ++ ++ H NIV+L+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIR-EISLMKELKHENIVRLHD 65
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
+ + L+++YM L ++ LD + + +++ H + +
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLD---SDSSNRTIVAGTYGYIAPE-LAYTMVV 681
+HRD+ N+L+N + E +ADFG AR + SN + T Y AP+ L +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLGSRTY 178
Query: 682 TEKCDVYSFGVVALEVLMGR 701
+ D++S G + E++ GR
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G Y +VYK NG++VALK + +TEE F + + EA +L + H NIV L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
K+ + +++YM L ++ + + + +R+ + + + L+Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYM-IQHPGGLHPYNVRLFMFQLL-RGLAYIHGQ---HI 124
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE--LAYTMVVTE 683
+HRD+ N+L++ E +ADFG AR S + T Y P+ L T +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 684 KCDVYSFGVVALEVLMGR 701
D++ G + +E+L G+
Sbjct: 185 -LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 30/85 (35%), Positives = 53/85 (62%)
Query: 198 LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI 257
L LD+ L G + ++ KL++L ++N+ GN + G IP +L +T+L L L N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 258 PPEIGNMTGILKVDMSMNNIEGTIP 282
P +G +T + ++++ N++ G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 507 IGTGGYGSV-YKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G+G YG+V G VA+KKL+R E F E +L + H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHENVIGLLD 81
Query: 566 FCLHKKCM------FLIYKYMKR--GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+ +L+ +M G L + + + ++ + L Y+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYI 134
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H I+HRD+ N+ +N E + DFG AR DS+ + + T Y APE+
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV---TRWYRAPEVIL 188
Query: 678 T-MVVTEKCDVYSFGVVALEVLMGR 701
M T+ D++S G + E+L G+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 65/231 (28%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 507 IGTGGYGSVY---KAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
+G G +G V+ K P+ G++ A+K L +A + + + E +L+++ H IVK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 563 L-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
L Y F K ++LI +++ G LF L E + + ++ + + +A AL +LH
Sbjct: 63 LHYAFQTEGK-LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAE-LALALDHLHS-- 116
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVV 681
I++RD+ NILL+ + + DFG ++ GT Y+APE+
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 682 TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732
T+ D +SFGV+ E+L G SL D+K + +L ++L P
Sbjct: 176 TQSADWWSFGVLMFEMLTG--------SLPFQGKDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 507 IGTGGYGSVYKA--QLPNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
+G+G +G V K ++ ++ VA+K L E + + EA ++ ++ + IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLK--NENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
G C + M L+ + G L FL + + + V ++ V+ + YL
Sbjct: 61 IGVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNV--VELMHQVSMGMKYLEGK--- 114
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG-----YIAPELAYT 678
+ VHRD+++ N+LL ++ A ++DFG ++ L +D S A + G + APE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINF 172
Query: 679 MVVTEKCDVYSFGVVALEVL-MGRHP 703
+ + DV+S+G+ E G+ P
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 16/151 (10%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G YG+V+KA+ ++VALK++ R + ++ +S E +L ++ H+NIV+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN----ALSYLHHDC 621
K + L+++Y + L+ +++ + + I+K L++ H
Sbjct: 67 VLHSDKKLTLVFEYCDQD-----LKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTAR 652
+++HRD+ N+L+N E +ADFG AR
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 23/154 (14%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G Y +VYK + G++VALK++ R E EE F + + EA +L + H NIV L+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDW---TMRVNIIKC----VANALSYLH 618
KK + L+++Y+ D +D + ++ ++ + L+Y H
Sbjct: 71 IIHTKKTLTLVFEYLDT---------DL-KQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652
++HRD+ N+L++ + E +ADFG AR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 61/264 (23%), Positives = 117/264 (44%), Gaps = 38/264 (14%)
Query: 510 GGYGSVYKAQLPNGKVVALK---KLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566
G YG ++K + V LK K HR +E SF A ++S+++H+++V YG
Sbjct: 20 GDYGELHKTE------VLLKVLDKSHRNYSE------SFFEAASMMSQLSHKHLVLNYGV 67
Query: 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626
C+ ++ +Y+K GSL +L+ + + + W + V K +A AL +L +
Sbjct: 68 CVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV--AKQLAWALHFLEDK---GLT 122
Query: 627 HRDISSNNILLNSKLEAFVADFGTARLLDSDSS----NRTIVAGTYGYIAPE-LAYTMVV 681
H ++ + N+LL + + + +L D S + I+ ++ PE + +
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNL 182
Query: 682 TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDI 741
+ D +SFG E+ G G+ LS+ S +K+ + R P +
Sbjct: 183 SLAADKWSFGTTLWEIFSG---GDK--PLSALDSQKKLQF---YEDRHQLPAPKWTE--- 231
Query: 742 VLVTTVALACLHSKPKFRPTMQRV 765
+ + C+ +P FRP+ + +
Sbjct: 232 --LANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 6/198 (3%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G GG+G V Q+ GK+ A KKL + ++ + NE +L K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
K + L+ M G L + + EA + V + L LH + I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
V+RD+ NILL+ ++D G A + + + V GT GY+APE+ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSP 182
Query: 686 DVYSFGVVALEVLMGRHP 703
D ++ G + E++ G+ P
Sbjct: 183 DWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 507 IGTGGYGSV----YKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +G V Y + N G+ VA+K L + E +L + H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIV 69
Query: 562 KLYGFCLHK--KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
K G C + LI +++ GSL +L + + L ++ + C + YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC--KGMDYLGS 127
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI---VAGTYGYIAPELA 676
VHRD+++ N+L+ S+ + + DFG + +++D T+ + + APE
Sbjct: 128 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 677 YTMVVTEKCDVYSFGVVALEVL 698
DV+SFGV E+L
Sbjct: 185 IQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLY 564
+G G +G V A+L ++ A+K L + + E VL+ H + +L+
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
K +F + +Y+ G L ++ D + L +LH
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---G 116
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTAR--LLDSDSSNRTIVAGTYGYIAPELAYTMVVT 682
I++RD+ +N+LL+S+ +ADFG + +L +++ GT YIAPE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS--TFCGTPDYIAPEILSYQPYG 174
Query: 683 EKCDVYSFGVVALEVLMGRHPGE 705
D ++ GV+ E+L G+ P E
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 33/209 (15%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G+G YGSV A G+ VA+KKL R E F E +L + H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGLLD 81
Query: 566 FCLHKKCM------FLIYKYMK------RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
+L+ YM+ G + Y ++ +
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY------------LVYQMLCG 129
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAP 673
L Y+H I+HRD+ N+ +N E + DFG AR D++ + + T Y AP
Sbjct: 130 LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAP 183
Query: 674 ELAYT-MVVTEKCDVYSFGVVALEVLMGR 701
E+ M + D++S G + E+L G+
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 501 FDIKYCIGTGGYGSVYKAQLPNGK-VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
F++ +G G YG V K + K +VA+KK +E E + + E +L + N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
IV+L + ++L+++Y+++ L L + V +R I + + A+ + H
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHK 118
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTAR-LLDSDSSNRTIVAGTYGYIAPELAYT 678
+ IVHRDI N+L++ + DFG AR L + ++N T T Y +PEL
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 679 MVVTEKCDVYSFGVVALEVLMGR--HPGE 705
+ D++S G + E+ G+ PGE
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-10
Identities = 32/89 (35%), Positives = 51/89 (57%)
Query: 246 LYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI 305
L L + L G IP +I + + +++S N+I G IP L ++ L L +S N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 306 PITIAGLISLKGLDLSNNKLSGPIPPEIG 334
P ++ L SL+ L+L+ N LSG +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 500 DFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKL------HRAETEETTFFNSFQNEA 549
+F++ +GTG YG V+ + +GK+ A+K L +A+T E T + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-----RTER 55
Query: 550 HVLSKIAHRN-IVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNII 607
VL I +V L Y F K + LI Y+ G LF L + + I
Sbjct: 56 QVLEHIRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEI 114
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI-VAG 666
AL +LH I++RDI NILL+S + DFG ++ D R G
Sbjct: 115 VL---ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168
Query: 667 TYGYIAPELAYTMVV--TEKCDVYSFGVVALEVLMGRHP 703
T Y+AP++ + D +S GV+ E+L G P
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 42/241 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
EDF+ IG G +G V Q + G V A+K L +A+ E + E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+VK++ K ++LI +++ G + L + + + + I + V A+ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVL-AIDSI 117
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFG---------------------------- 649
H +HRDI +N+LL+SK ++DFG
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 650 ---TARLLDSDSSNRTIVA----GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRH 702
+ R ++ NR +A GT YIAPE+ + CD +S GV+ E+L+G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 703 P 703
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-10
Identities = 58/191 (30%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 523 GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLY--GFCLHKKCMFLIYKYM 580
G VA+K L EE F+ E + +++ H NIV L G +F +++Y+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 581 KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS- 639
+L L D L ++ V +AL+ H+ IVHRD+ NI+++
Sbjct: 62 PGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 640 --KLEAFVADFGTARLL----DSDSSNRTI---VAGTYGYIAPELAYTMVVTEKCDVYSF 690
+ A V DFG LL D+D + T V GT Y APE VT D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 691 GVVALEVLMGR 701
G++ LE L G+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 507 IGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G +G VYK L + VA+K L + E F++EA + S++ H NI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFL-----RNDYEAVVLDWTMR--------VNII 607
V L G ++ + +I+ Y L FL +D + D T++ V+I+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 608 KCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
+A + +L HH +VH+D+++ N+L+ KL ++D G R + + + +
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 666 GTYG--YIAPELAYTMVVTEKCDVYSFGVVALEVL 698
+++PE + D++S+GVV EV
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
D + IG+G G VYK + G V+A+K++ R +E + V+ K +H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN--KRILMDLDVVLK-SH 71
Query: 558 R--NIVKLYGFCLHKK----CMFLIY----KYMKRGSLFCFLRNDYEAVVLDWTMRVNII 607
IVK YG+ + CM L+ K +KR ++ +L M V I+
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKR------IQGPIPEDILG-KMTVAIV 124
Query: 608 KCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA-RLLDSDSSNRTIV 664
K AL YL H ++HRD+ +NILL++ + DFG + RL+DS + R+
Sbjct: 125 K----ALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174
Query: 665 AGTYGYIAPELAYTMVVTEK----CDVYSFGVVALEVLMGRHP 703
AG Y+APE K DV+S G+ +E+ G+ P
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLS-KIAHRNIVKLY 564
+G G +G V+ A+L + A+K L + E VLS H + LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
K+ +F + +Y+ G L +++ ++ + T I C L +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC---GLQFLHSK---G 116
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEK 684
IV+RD+ +NILL++ +ADFG + + GT YIAPE+
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 685 CDVYSFGVVALEVLMGRHP 703
D +SFGV+ E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 53/171 (30%), Positives = 81/171 (47%), Gaps = 37/171 (21%)
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD---SDSSNRTIVAGTYGYIAP 673
+HH ++HRDI S NILL S + DFG +++ SD RT GT Y+AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAP 214
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIM------LIDVL 725
E+ ++K D++S GV+ E+L + P GE + +++M D L
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---------NMEEVMHKTLAGRYDPL 265
Query: 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQR-----VCQEFLT 771
+SP MQ+IV A L S PK RP+ + +C+ F++
Sbjct: 266 PPSISPE-----MQEIV------TALLSSDPKRRPSSSKLLNMPICKLFIS 305
|
Length = 496 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 10/200 (5%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IAHRNIVKL- 563
IG G +G V A+ +G A+K L + + N E +VL K + H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
Y F +K ++ + Y+ G LF L+ E L+ R + VA+A+ YLH
Sbjct: 63 YSFQTAEK-LYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAE-VASAIGYLHS---L 115
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
+I++RD+ NILL+S+ + DFG + + GT Y+APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 684 KCDVYSFGVVALEVLMGRHP 703
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G GG+G V Q+ GK+ A K+L + ++ + NE +L K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRN------DYEAVVLDWTMRVNIIKCVANALSYLHH 619
K + L+ M G L + N + E + I C L LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF----YAAEILC---GLEDLHR 120
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM 679
+ + V+RD+ NILL+ ++D G A + S R V GT GY+APE+
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQ 176
Query: 680 VVTEKCDVYSFGVVALEVLMGRHP 703
T D + G + E++ G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 65/253 (25%), Positives = 103/253 (40%), Gaps = 54/253 (21%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
EDF IG G +G V Q GK+ A+K L ++E + + E VL++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+V LY + ++LI +++ G L L Y+ D T R + +CV A+ +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVT-RFYMAECVL-AIEAV 117
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA-------------RLLDSDSS----- 659
H +HRDI +NIL++ ++DFG + +LL S+
Sbjct: 118 HK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 660 -------------------------NRTIVA----GTYGYIAPELAYTMVVTEKCDVYSF 690
NR ++A GT YIAPE+ ++CD +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 691 GVVALEVLMGRHP 703
G + E L+G P
Sbjct: 235 GAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 543 NSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN----------- 591
N F E +LS++ NI++L G C+ + + +I +YM+ G L FL +
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 592 -----DYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA 646
+ + ++ +++ +A+ + YL + VHRD+++ N L+ L +A
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 647 DFGTARLLDSDSSNRTIVAG----TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM 699
DFG +R L + R + G ++A E T DV++FGV E+LM
Sbjct: 181 DFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 10/200 (5%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IAHRNIVKL- 563
IG G +G V A+ +GK A+K L + E +VL K + H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
Y F +K ++ + ++ G LF L+ E + R + +A+AL YLH
Sbjct: 63 YSFQTTEK-LYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAE-IASALGYLHS---I 115
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
+IV+RD+ NILL+S+ + DFG + + S T GT Y+APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 684 KCDVYSFGVVALEVLMGRHP 703
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 545 FQNEAHVLSKIAHRNIVKL--------YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAV 596
+NE L ++ H NI+K+ + + +K F +Y +M + D++
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDR 263
Query: 597 VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656
L R I+K + A+ Y+H ++HRDI NI LN + + DFGTA +
Sbjct: 264 PLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 657 DSSNRTIVAGTYGYI------APELAYTMVVTEKCDVYSFGVVALEVL 698
+ A YG++ +PE+ E D++S G++ L++L
Sbjct: 320 ER-----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 10/200 (5%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IAHRNIVKL- 563
IG G +G V A+ K A+K L + + +E +VL K + H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
+ F K ++ + Y+ G LF L+ E L+ R + +A+AL YLH
Sbjct: 63 FSFQTADK-LYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAE-IASALGYLHS---L 115
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
+IV+RD+ NILL+S+ + DFG + + + GT Y+APE+ +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 684 KCDVYSFGVVALEVLMGRHP 703
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 525 VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584
+VA+K L RA+ +T N F E ++S++ + NI++L G C+ + +I +YM+ G
Sbjct: 46 LVAVKML-RADVTKTAR-NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 585 LFCFL--RNDYEAVV----LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN 638
L FL R + N++ S + + + VHRD+++ N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 639 SKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVV----TEKCDVYSFGVVA 694
+ +ADFG +R L S R + G +A+ ++ T DV++FGV
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 695 LEV--LMGRHPGELLS 708
E+ L P LLS
Sbjct: 222 WEMFTLCKEQPYSLLS 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 507 IGTGGYGSVYKAQLPNGKV-------VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
+G G +G VY+ + G V VA+K ++ A + F NEA V+ + +
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFNCHH 70
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-------NDYEAVVLDWTMRVNIIKCVAN 612
+V+L G + +I + M RG L +LR N+ + + +A+
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG--Y 670
++YL+ + VHRD+++ N ++ + DFG R + R G +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEV 697
++PE V T DV+SFGVV E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G Y +V+K + +VALK++ R E EE + + E +L + H NIV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC----VANALSYLHHDC 621
++C+ L+++Y+ L +L N M ++ +K + LSY H
Sbjct: 71 IIHTERCLTLVFEYLD-SDLKQYLDN------CGNLMSMHNVKIFMFQLLRGLSYCHKR- 122
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYTMV 680
I+HRD+ N+L+N K E +ADFG AR + + T Y P+ L +
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 681 VTEKCDVYSFGVVALEVLMGR 701
+ D++ G + E+ GR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 32/212 (15%)
Query: 507 IGTGGYGSVY-----KA----QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+G G +G+VY KA +L K + + +L+ ET + EA +LSK+ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ------EAQLLSKLDH 61
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-------EAVVLDWTMRVNIIKCV 610
IVK + L + +I +Y + L C L E V +W +++ +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL---- 117
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
+ Y+H I+HRD+ + NI L + L + DFG +RLL T GT Y
Sbjct: 118 --GVHYMHQR---RILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYY 171
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRH 702
++PE K D++S G + E+ H
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 42/231 (18%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G G V+ +L GK+ ALK L + E + E +L+ + H + LY
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
+ + L+ Y G LF L+ + + R + + AL YLH + I
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLH--LL-GI 124
Query: 626 VHRDISSNNILLN-------------------SKLEAFVADFGTARLLDSDSSNRTIVA- 665
V+RD+ NILL+ + G+ R + + T
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 666 ---------GTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
GT YIAPE+ + V D ++ G++ E+L G P
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 48/261 (18%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DF+ IG G +G V Q + G + A+KKL ++E E + E +L++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+VKLY + ++LI +Y+ G + L + + T R I + + A+ +
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEET-RFYIAETIL-AIDSI 117
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFG---------------------------- 649
H +HRDI +N+LL++K ++DFG
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 650 ------TARLLDSDSSNRTIVA----GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM 699
+ R ++ NR +A GT YIAPE+ ++CD +S GV+ E+L+
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 700 GRHPGELLSSLSSPSSDQKIM 720
G P S + + +KI+
Sbjct: 235 GYPP---FCSDNPQETYRKII 252
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 47/207 (22%), Positives = 96/207 (46%), Gaps = 7/207 (3%)
Query: 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+F I+ IG G + VY+A L +G VALKK+ + + E +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN--DYEAVVLDWTMRVNIIKCVANALSY 616
N++K Y + + ++ + G L +++ + ++ + T+ ++ + +AL +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ-LCSALEH 121
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
+H ++HRDI N+ + + + D G R S ++ + GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ K D++S G + E+ + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DF+ IG G +G V Q + G + A+K L +A+ E + E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+VK++ K+ ++LI +++ G + L + + + + I + V A+ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVL-AIDAI 117
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFG---------------------------- 649
H +HRDI +N+LL++K ++DFG
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 650 ---TARLLDSDSSNRTIVA----GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRH 702
+ R ++ NR +A GT YIAPE+ + CD +S GV+ E+L+G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 703 P 703
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 59/278 (21%), Positives = 121/278 (43%), Gaps = 30/278 (10%)
Query: 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+F I+ IG G + VY+A L + K VALKK+ E + E +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR--NDYEAVVLDWTMRVNIIKCVANALSY 616
N++K + + ++ + G L ++ + ++ + T+ ++ + +A+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ-LCSAVEH 121
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
+H ++HRDI N+ + + + D G R S ++ + GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV---LDSRLSPPV 733
+ K D++S G + E +++L SP K+ L + ++ PP+
Sbjct: 179 HENGYNFKSDIWSLGCLLYE----------MAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228
Query: 734 DR----MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
++++V + C++ P RP + V Q
Sbjct: 229 PTEHYSEKLRELVSM------CIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 6/198 (3%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G GG+G V Q+ GK+ A KKL + ++ NE +L K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
K + L+ M G L + N D + + L L + I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQRE---RI 123
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
V+RD+ NILL+ + ++D G A + + R V GT GY+APE+ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFSP 182
Query: 686 DVYSFGVVALEVLMGRHP 703
D + G + E++ G+ P
Sbjct: 183 DWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 64/239 (26%), Positives = 94/239 (39%), Gaps = 72/239 (30%)
Query: 502 DIKY----CIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQN--------- 547
D KY IG G YG V A + VA+KK+ N+F N
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIA----------NAFDNRIDAKRTLR 53
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCM-----------FLIYKYMK-------RGSLFCFL 589
E +L + H N++ + K M +++Y+ M R S L
Sbjct: 54 EIKLLRHLDHENVIAI------KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT--L 105
Query: 590 RNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649
+D+ L +R L Y+H +++HRD+ +N+LLN+ + + DFG
Sbjct: 106 SDDHCQYFLYQLLR---------GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFG 153
Query: 650 TARLLDSDSSNRTIVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
AR T T Y APEL YT + DV+S G + E L+GR P
Sbjct: 154 LARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL-Y 564
+G GG+G V Q+ N GK+ A KKL + ++ + E +L K+ IV L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
F K + L+ M G L + N E L+ ++ + + +LH
Sbjct: 61 AF-ESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEK 684
IV+RD+ N+LL+ + ++D G A L D T AGT GY+APE+ +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 685 CDVYSFGVVALEVLMGRHP 703
D ++ G E++ GR P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IAHRNIVKL- 563
IG G +G V A+ +GK A+K L + + E +VL K + H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
Y F K F++ Y+ G LF L+ E + R + +A+AL YLH
Sbjct: 63 YSFQTADKLYFVL-DYVNGGELFFHLQR--ERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
+I++RD+ NILL+S+ + DFG + S + GT Y+APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 684 KCDVYSFGVVALEVLMGRHP 703
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 10/200 (5%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN--IVKL 563
+G G +G V A+L G+ A+K L + E VL+ +A N + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-LAWENPFLTHL 61
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
Y K+ +F + +++ G L +++ + T I C L +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC---GLQFLHSK--- 115
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
I++RD+ +N++L+ +ADFG + + + GT YIAPE+ + T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 684 KCDVYSFGVVALEVLMGRHP 703
D +SFGV+ E+L+G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 18/177 (10%)
Query: 73 SIIEINLPEKKLKGELSQFNFSC------------FPGLESLSLRFNYLFGSIPSQVGAL 120
+I +I LK L + + S P L++L L FN L +P + L
Sbjct: 127 NITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNL 185
Query: 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180
S L LD S N ++ +PPE+ L LE L+L N++ + SSL L L + LS N
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243
Query: 181 LHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTL 237
L +P +IG+L+NL L L +N++S + LG L NL L++ GN L +P
Sbjct: 244 L-EDLPESIGNLSNLETLDLSNNQISSIS--SLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 507 IGTGGYGSVYKAQLPNGK----VVALKK---LHRAETEETTFFNSFQNEAHVLS-KIAHR 558
+G G +G V A+L + ALKK L + E T E VL+ H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMV------ERRVLALAWEHP 56
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+ L+ K+ +F + +Y+ G L +++ I C L +LH
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIIC---GLQFLH 113
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT 678
I++RD+ +N+LL+ +ADFG + + + GT YIAPE+
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 679 MVVTEKCDVYSFGVVALEVLMGRHP 703
E D +SFGV+ E+L+G+ P
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 7/198 (3%)
Query: 507 IGTGGYGSVYKAQLPNG-KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G V + + + ++ ALK + +A + E VL+++ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
+ ++L+ ++ G LF L+ + D + + AL LH ++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLHK---FNV 114
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKC 685
++RD+ NILL+ + + DFG +L D GT Y+APEL T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 686 DVYSFGVVALEVLMGRHP 703
D ++ GV+ E+L G P
Sbjct: 175 DWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 62/256 (24%), Positives = 112/256 (43%), Gaps = 16/256 (6%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN--IVKL 563
IG G Y V +L N ++ A+K + + + + Q E HV + A N +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQ-ASSNPFLVGL 61
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
+ +FL+ +Y+ G L ++ + I C+A L++LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEI-CIA--LNFLHER--- 115
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
I++RD+ +N+LL++ + D+G + + GT YIAPE+
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 684 KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL 743
D ++ GV+ E++ GR P ++++ +P + + L V+ L P+ R+ V
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIIT--DNPDMNTEDYLFQVI---LEKPI-RIPRFLSVK 229
Query: 744 VTTVALACLHSKPKFR 759
+ V L+ PK R
Sbjct: 230 ASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G+G YGSV A G VA+KKL R FQ+ H +K +R + +L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSR----------PFQSIIH--AKRTYREL-RLLK 71
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKC--------------V 610
H+ + L+ + SL F ND Y L NI+KC +
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
L Y+H I+HRD+ +N+ +N E + DFG AR D + T T Y
Sbjct: 130 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWY 183
Query: 671 IAPELAYT-MVVTEKCDVYSFGVVALEVLMGR 701
APE+ M + D++S G + E+L GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 9/199 (4%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL-Y 564
+G G +G V + +GK A+K L + E+ VL H + L Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
F + F++ +Y+ G LF L E V + R + V+ AL YLH
Sbjct: 63 SFQTKDRLCFVM-EYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVS-ALDYLHSG---K 115
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEK 684
IV+RD+ N++L+ + DFG + +D++ GT Y+APE+
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 685 CDVYSFGVVALEVLMGRHP 703
D + GVV E++ GR P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 78/280 (27%), Positives = 120/280 (42%), Gaps = 52/280 (18%)
Query: 521 PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYM 580
P KVVA K + + + + S E H L+ H IVK + + LI +Y
Sbjct: 92 PKEKVVA-KFVMLNDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147
Query: 581 KRGSLFCFLRN---------DYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDIS 631
G L ++ +YE +L + + + AL +H M +HRD+
Sbjct: 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL--------ALDEVHSRKM---MHRDLK 196
Query: 632 SNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA---GTYGYIAPELAYTMVVTEKCDVY 688
S NI L + DFG ++ SDS + + + GT Y+APEL ++K D++
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQY-SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 689 SFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP---PVDRMVMQDIVLVT 745
S GV+ E+L P PS Q+ ++ VL + P PV M+ +
Sbjct: 256 SLGVILYELLTLHRP------FKGPS--QREIMQQVLYGKYDPFPCPVSS-GMKAL---- 302
Query: 746 TVALACLHSK-PKFRPTMQRVCQ-EFLTCKIALVNPFEEI 783
L L SK P RPT Q++ EFL + N F++I
Sbjct: 303 ---LDPLLSKNPALRPTTQQLLHTEFLK---YVANLFQDI 336
|
Length = 478 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G Y +VYK + +VALK++ R E EE + + E +L + H NIV L+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
+K + L+++Y+ + L +L +D + +++ + + + L+Y H +
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYL-DDCGNSINMHNVKLFLFQLL-RGLNYCHRR---KV 125
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYTMVVTEK 684
+HRD+ N+L+N + E +ADFG AR + + T Y P+ L + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 685 CDVYSFGVVALEVLMGR 701
D++ G + E+ GR
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G VY+ + + ++ A+K L + E E ++L + + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 566 --FCLHKKC-MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH-HDC 621
F ++L+ YM G LF L+ E + + I + V AL +LH +D
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVL-ALEHLHKYD- 116
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-----A 676
IV+RD+ NILL++ + DFG ++ +D+ GT Y+APE+
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP 703
YT V D +S GV+ E+ G P
Sbjct: 174 YTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G Y +V+K + +VALK++ R E EE + + E +L + H NIV L+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
K + L+++Y+ + L ++ +D ++ +++ + + + L+Y H +
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYM-DDCGNIMSMHNVKIFLYQ-ILRGLAYCHRR---KV 125
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYTMVVTEK 684
+HRD+ N+L+N + E +ADFG AR + + T Y P+ L + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 685 CDVYSFGVVALEVLMGR 701
D++ G + E+ GR
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G GG+G V Q+ GK+ A KKL + ++ NE +L K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRN------DYEAVVLDWTMRVNIIKCVANALSYLHH 619
K + L+ M G L + N D E V I C L LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF----YAAEITC---GLEDLHR 120
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM 679
+ IV+RD+ NILL+ ++D G A + + R V GT GY+APE+
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVKNE 176
Query: 680 VVTEKCDVYSFGVVALEVLMGRHP 703
T D + G + E++ G+ P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 548 EAHVLSKIAHRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI 606
E+ VL H + L Y F H + F++ +Y G LF L E V + R
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSR--ERVFTEERARFYG 101
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG 666
+ V+ AL YLH +V+RDI N++L+ + DFG + SD + G
Sbjct: 102 AEIVS-ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157
Query: 667 TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T Y+APE+ D + GVV E++ GR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 32/103 (31%), Positives = 46/103 (44%), Gaps = 6/103 (5%)
Query: 45 NSSWWSNLIDSNSSDHCKLDGVTCNTA---RSIIEINLPEKKLKGELSQFNFSCFPGLES 101
W ID D+ L G N R + INL ++G + + LE
Sbjct: 414 TKGKW--FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP-PSLGSITSLEV 470
Query: 102 LSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSL 144
L L +N GSIP +G L+ LR L+ + N+L+G +P LG
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 27/167 (16%)
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN-- 605
E +L I+HR I+ L I+ Y + S C + Y+ + + R
Sbjct: 136 EIDILKTISHRAIINL------------IHAY-RWKSTVCMVMPKYKCDLFTYVDRSGPL 182
Query: 606 -------IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA-RLLDSD 657
I + + AL+YLH I+HRD+ + NI L+ A + DFG A +L
Sbjct: 183 PLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 658 SSNRTI-VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + +GT +PEL K D++S G+V E+ +
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN---IVK 562
IG GG+G VY + + GK+ A+K L + + NE +LS ++ + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 563 L-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
+ Y F K F I M G L L V + MR + + L ++H+
Sbjct: 62 MSYAFHTPDKLSF-ILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIIL-GLEHMHNR- 116
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYTMV 680
+V+RD+ NILL+ ++D G A D GT+GY+APE L +
Sbjct: 117 --FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVA 172
Query: 681 VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV-LDSRLSP 731
D +S G + ++L G P + D+ + + V L SP
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 20/153 (13%)
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR---NDYEAVVLDWTMRVNIIKCVANALS 615
N+V L+ + + + +FL+ ++ + G L+ + N E V W + + AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
LH + IV RD++ NNILL+ + + F ++ DS + V Y APE+
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE-DSCDGEAVENMY--CAPEV 153
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGR-----HP 703
TE CD +S G + E+L G+ HP
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKL--HRAETEETTFFNSFQNEAHVLSKIA-HRNIVK 562
IG G + V KAQ GK A+K + H E+ Q L +++ H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ----ALRRLSPHPNILR 62
Query: 563 LYGFCLHKK--CMFLIYKYMKRGSLFCFLRNDY----EAVVLDWTMRVNIIKCVANALSY 616
L +K + L+++ M +L+ ++ E V + M ++K +L +
Sbjct: 63 LIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSY-MY-QLLK----SLDH 115
Query: 617 LHHDCMPSIVHRDISSNNILLNS---KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAP 673
+H + I HRDI NIL+ KL ADFG+ R + S T T Y AP
Sbjct: 116 MHRN---GIFHRDIKPENILIKDDILKL----ADFGSCRGIYSKPP-YTEYISTRWYRAP 167
Query: 674 ELAYTM-VVTEKCDVYSFGVVALEVL 698
E T K D+++ G V E+L
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 49/177 (27%)
Query: 610 VANALSYL-HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT- 667
VA + +L +C +HRD+++ N+LL A + DFG AR + +DS+ +V G
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--YVVKGNA 274
Query: 668 ---YGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGR--HPGELLSS-----------L 710
++APE + V T + DV+S+G++ E+ +G+ +PG L++S +
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334
Query: 711 SSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
S P +PP +M+ C + +P RPT ++ Q
Sbjct: 335 SRPD--------------FAPPEIYSIMK----------MCWNLEPTERPTFSQISQ 367
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 8/199 (4%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL-Y 564
+G G +G V + G+ A+K L + E VL H + L Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
F H + F++ +Y G LF L + V + R + V+ AL YLH + +
Sbjct: 63 SFQTHDRLCFVM-EYANGGELFFHLSRE--RVFSEDRARFYGAEIVS-ALDYLHSE--KN 116
Query: 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEK 684
+V+RD+ N++L+ + DFG + D + GT Y+APE+
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 685 CDVYSFGVVALEVLMGRHP 703
D + GVV E++ GR P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVL---SKIAHRNIVK 562
+G G +G V A+ G++ A+K L + + S E + + H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCM 622
L+ + + + +Y G L + D V V CV L YLH +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN-- 120
Query: 623 PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT-IVAGTYGYIAPEL----AY 677
IV+RD+ +N+LL+++ +ADFG + +RT GT ++APE+ +Y
Sbjct: 121 -KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHP 703
T V D + GV+ E+L+G P
Sbjct: 179 TRAV----DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 548 EAHVLSKIAHRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI 606
E+ VL H + L Y F H + F++ +Y G LF L E V + R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSR--ERVFSEDRARFYG 101
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG 666
+ V+ AL YLH +V+RD+ N++L+ + DFG + SD + G
Sbjct: 102 AEIVS-ALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157
Query: 667 TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T Y+APE+ D + GVV E++ GR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG+G G V A G VA+KKL R FQN+ H +K A+R +V L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSR----------PFQNQTH--AKRAYRELVLLK- 75
Query: 566 FCL-HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL-----SYLHH 619
C+ HK + L+ + + SL F ++ Y + L M N+ + + L SYL +
Sbjct: 76 -CVNHKNIISLLNVFTPQKSLEEF-QDVYLVMEL---MDANLCQVIHMELDHERMSYLLY 130
Query: 620 DCM--------PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
+ I+HRD+ +NI++ S + DFG AR ++ V Y Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YR 189
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMG 700
APE+ M E D++S G + E++ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 41/197 (20%)
Query: 525 VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584
+VA+K L R + + N F E ++S++ NI++L C+ + +I +YM+ G
Sbjct: 48 LVAVKML-REDANKNAR-NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 585 LFCFLRN--------DYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNIL 636
L FL + V + ++ + + +A+ + YL + VHRD+++ N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162
Query: 637 LNSKLEAFVADFGTARLLDSDSSNR---------------TIVAGTYGYIAPELAYTMVV 681
+ +ADFG +R L S R +I+ G +
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF------------- 209
Query: 682 TEKCDVYSFGVVALEVL 698
T DV++FGV E+L
Sbjct: 210 TTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
E+F I I G +G VY + N K+ A+K + +A+ + Q E L+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWTMRVNIIKCVANALSY 616
IV LY ++L+ +Y+ G + L Y D M V I VA AL Y
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDY 119
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653
LH I+HRD+ +N+L++++ + DFG +++
Sbjct: 120 LHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 58/242 (23%)
Query: 507 IGTGGYGSV---YKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
+G+G YGSV Y +L + VA+KKL R FQ+ H ++ +R + +L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRP----------FQSLIH--ARRTYREL-RL 67
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR----VNIIKCVA-------- 611
H+ + L+ + S+ ++ V L + NI+KC
Sbjct: 68 LKHMKHENVIGLLDVFTPATSI-----ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122
Query: 612 ------NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
L Y+H I+HRD+ +N+ +N E + DFG AR D + T
Sbjct: 123 LIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYV 176
Query: 666 GTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGR--HPGE--------LLSSLSSPS 714
T Y APE+ M + D++S G + E+L G+ PG ++ + +PS
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 715 SD 716
+
Sbjct: 237 PE 238
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 62/295 (21%), Positives = 117/295 (39%), Gaps = 44/295 (14%)
Query: 492 EDIIKATEDFDIKY------------CIGTGGYGSVYKAQLPNGKVVALKKLHRAETEET 539
++II + DIK I S+YK N K V ++ +
Sbjct: 1 QNIITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHK 59
Query: 540 TFFNSFQNEAHVLSKIAHRNIVKLYGF----CLHKKCMFLIYKYMKRGSLFCFLRNDYEA 595
+ +NE L +I NI+K+YGF + LI +Y RG L L + +
Sbjct: 60 VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD- 118
Query: 596 VVLDWTMRVNIIKCVANALSYLH-HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654
L + ++++ L L+ + P +++++S + L+ + + G ++L
Sbjct: 119 --LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKIL 173
Query: 655 DSDSSNRTIVAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGRHPGELLSSLSS 712
S Y + ++ + T K D+YS GVV E+ G+ P E L++
Sbjct: 174 SSPPFKNV---NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--- 227
Query: 713 PSSDQKI--MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
++I ++I+ +S P + ++ IV AC RP ++ +
Sbjct: 228 ----KEIYDLIINKNNSLKLPLDCPLEIKCIV------EACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 69/294 (23%), Positives = 118/294 (40%), Gaps = 36/294 (12%)
Query: 507 IGTGGYGSVYKA---QLPNGKV---VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G VY+ + G+ VA+K ++ + + F NEA V+ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 71
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-------NDYEAVVLDWTMRVNIIKCVANA 613
V+L G + ++ + M G L +LR N+ + + +A+
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTY--GYI 671
++YL+ VHRD+++ N ++ + DFG R + R G ++
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 672 APELAYTMVVTEKCDVYSFGVVALEV-LMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730
APE V T D++SFGVV E+ + P LS+ + +M LD +
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVMDGGYLDQPDN 245
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEIS 784
P +R+ T + C PK RPT + K L F E+S
Sbjct: 246 CP-ERV--------TDLMRMCWQFNPKMRPTFLEIVNLL---KDDLHPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 501 FDIKYC-IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
F+ + C +G G YG VYKA+ +GK K+ + E T S E +L ++ H N
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 560 IVKLYG-FCLHK-KCMFLIYKYMKRG--SLFCFLR---NDYEAVVLDWTMRVNIIKCVAN 612
++ L F H + ++L++ Y + + F R + + + L +M +++ + +
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 613 ALSYLHHDCMPSIVHRDISSNNILL----NSKLEAFVADFGTARLLDS---DSSNRTIVA 665
+ YLH + ++HRD+ NIL+ + +AD G ARL +S ++ V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 666 GTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVL 698
T+ Y APEL T+ D+++ G + E+L
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 501 FDIKYC-IGTGGYGSVYKAQLPNG---KVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
F+ + C +G G YG VYKA+ +G + ALK++ E T S E +L ++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELK 56
Query: 557 HRNIVKLYG-FCLH-KKCMFLIYKYMKRG--SLFCFLR---NDYEAVVLDWTMRVNIIKC 609
H N++ L F H + ++L++ Y + + F R + + V L M +++
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILL----NSKLEAFVADFGTARLLDS---DSSNRT 662
+ + + YLH + ++HRD+ NIL+ + +AD G ARL +S ++
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 663 IVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVL 698
V T+ Y APEL T+ D+++ G + E+L
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 73/257 (28%), Positives = 108/257 (42%), Gaps = 50/257 (19%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG+G G V A G+ VA+KKL R FQN H +K A+R +V L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSR----------PFQNVTH--AKRAYRELV-LMK 70
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA-----NALSYL--- 617
HK + L+ + + SL F ++ Y + L M N+ + + +SYL
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEF-QDVYLVMEL---MDANLCQVIQMDLDHERMSYLLYQ 126
Query: 618 -----HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
H I+HRD+ +NI++ S + DFG AR + V Y Y A
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRA 185
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGR--HPG--------ELLSSLSSPSSDQKIMLI 722
PE+ M E D++S G + E++ G PG +++ L +PS + M
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS--DEFM-- 241
Query: 723 DVLDSRLSPPVDRMVMQ 739
SRL P V V
Sbjct: 242 ----SRLQPTVRNYVEN 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 49/224 (21%), Positives = 99/224 (44%), Gaps = 14/224 (6%)
Query: 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLY 564
IG G Y V +L ++ A+K + + + + Q E HV + H +V L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFL---RNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
+ +F + +++ G L + R E ++ +++ AL++LH
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNFLHER- 115
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVV 681
I++RD+ +N+LL+++ + D+G + + GT YIAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 682 TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725
D ++ GV+ E++ GR P +++ +P + + L V+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 10/112 (8%)
Query: 526 VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585
V LK L + +F A ++S+++H+++VKLYG C+ + + ++ +Y+K G L
Sbjct: 33 VVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL 87
Query: 586 FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL 637
FL + V L W + V K +A+AL YL +VH ++ NIL+
Sbjct: 88 DVFLHREKNNVSLHWKLDV--AKQLASALHYLEDK---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
+ +AL +LH I++RD+ +N+LL+ + +ADFG + + + GT
Sbjct: 105 ITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD 161
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE 705
YIAPE+ M+ D ++ GV+ E+L G P E
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 63/249 (25%), Positives = 105/249 (42%), Gaps = 51/249 (20%)
Query: 501 FDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA--- 556
+ I+ IG G YG V A G+ VA+KK++ F + +L +I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-------FEHVSDATRILREIKLLR 54
Query: 557 ---HRNIVKLYGFCLHK-----KCMFLIYKYMKRGSLFCFLRND-----YEAVVLDWTMR 603
H +IV++ L K ++++++ M+ ND + L +R
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR-- 661
AL Y+H ++ HRD+ NIL N+ + + DFG AR+ +D+
Sbjct: 115 ---------ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162
Query: 662 -TIVAGTYGYIAPEL--AYTMVVTEKCDVYSFGVVALEVLMGR---------HPGELLSS 709
T T Y APEL ++ T D++S G + EVL G+ H +L++
Sbjct: 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222
Query: 710 -LSSPSSDQ 717
L +PS +
Sbjct: 223 LLGTPSPET 231
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL-LDSDSSNRTIVAGTY 668
+A L +LH I++RD+ +N++L+++ +ADFG + + + RT GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF-CGTP 165
Query: 669 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
YIAPE+ + D ++FGV+ E+L G+ P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
V AL +LH +++RD+ +NILL+++ +ADFG + + T GT
Sbjct: 105 VTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE 705
YIAPE+ + D ++ GV+ E++ G+ P E
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 15/203 (7%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN----IV 561
IG GG+G VY + + GK+ A+K L + + NE +LS ++ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 562 KLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
Y F K F I M G L L V + MR + + L ++H+
Sbjct: 62 MTYAFHTPDKLCF-ILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIIL-GLEHMHNRF 117
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYTMV 680
+V+RD+ NILL+ ++D G A D GT+GY+APE L
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGTA 172
Query: 681 VTEKCDVYSFGVVALEVLMGRHP 703
D +S G + ++L G P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
+A L +LH I++RD+ +N++L+S+ +ADFG + D GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE 705
YIAPE+ + D ++FGV+ E+L G+ P E
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 38/212 (17%)
Query: 507 IGTGGYGSV---YKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
IG+G G V Y A L + VA+KKL R FQN+ H +K A+R +V +
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRP----------FQNQTH--AKRAYRELVLM 77
Query: 564 YGFCL-HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL-----SYL 617
C+ HK + L+ + + SL F + ++ M N+ + + L SYL
Sbjct: 78 K--CVNHKNIIGLLNVFTPQKSLEEF----QDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 618 HHDCM--------PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
+ + I+HRD+ +NI++ S + DFG AR + V Y
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 190
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGR 701
Y APE+ M E D++S G + E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN-IVKLY 564
IG G YG VYKA+ GK+VALKK R E +E + E +L ++ IV+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66
Query: 565 GFCLH-------KKCMFLIYKYMKRGSLFCFLRNDY--EAVVLDWTMRVNIIKCVANALS 615
+ K ++L+++Y+ L F+ ++ L + + + ++
Sbjct: 67 -LDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAF-VADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
+ H ++HRD+ N+L++ + +AD G R + T T Y APE
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 675 L-----AYTMVVTEKCDVYSFGVVALEVLMGR--HPGE 705
+ Y+ V D++S G + E+ + PG+
Sbjct: 182 VLLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKV-VALKKLHRAETEETTFFNSFQN---EAHVLSK 554
EDF+ I G YG+VY + + A+KK+++ + N Q E +L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINK---QNLILRNQIQQVFVERDILTF 57
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
+ +V ++ K+ + ++ +Y++ G L+N A+ +D R+ + V AL
Sbjct: 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVD-MARMYFAETVL-AL 114
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL-------------LDSDSSN- 660
YLH+ IVHRD+ +N+L+ S + DFG +++ ++ D+
Sbjct: 115 EYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 661 -RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
V GT YIAPE+ + D ++ G++ E L+G P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 48/207 (23%), Positives = 86/207 (41%), Gaps = 23/207 (11%)
Query: 507 IGTGGYGSVYKAQLPNGKVVA---LKKLHRAET--EETTFFNSFQNEAHVLSKIAHRNIV 561
IG G +G V + G A +K+L + T E+ F E ++ H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ----EVQPYRELNHPNVL 58
Query: 562 KLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLD-WTMRVNIIKC-VANALSYLHH 619
+ G C+ L+ ++ G L +LR++ V + + C VA+ L +LH
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTA--RLLDSDSSNRTIVAGTYGYIAPELA- 676
+H D++ N L + L + D+G A + + + A ++APEL
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 677 ------YTMVVTEKCDVYSFGVVALEV 697
T+K +++S GV E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 42/238 (17%)
Query: 548 EAHVLSKIAHRNIVKLYGFC--LHKKCMFLIYKYMKRGSLFCFLRN-----DYEAVVLDW 600
E+ +L ++H+NI+ + C + F++Y YM G+L FL+ L
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 601 TMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL---D-- 655
V++ +A +SYLH ++H+DI++ N +++ +L+ + D +R L D
Sbjct: 117 QQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
Query: 656 --SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALE-VLMGRHPGELLSSLSS 712
D+ NR + ++A E + DV+SFGV+ E + +G+ P +
Sbjct: 174 CLGDNENRPV-----KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-- 226
Query: 713 PSSDQKIMLIDVLDSRLSPPV---DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+ L D RL+ P+ D + V C P+ RP+ ++ Q
Sbjct: 227 ---EMAAYLKD--GYRLAQPINCPDELF--------AVMACCWALDPEERPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
++ L +LH I++RD+ +N++L+S+ +ADFG + D GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
YIAPE+ + D +++GV+ E+L G+ P
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 43/146 (29%), Positives = 63/146 (43%), Gaps = 16/146 (10%)
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLL--DSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
+HRD+++ NILL+ + DFG AR + D D + ++APE + V T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 684 KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL 743
+ DV+SFGV+ E+ S +SP KI D R RM D
Sbjct: 261 QSDVWSFGVLLWEIF---------SLGASPYPGVKI---DEEFCRRLKEGTRMRAPDYTT 308
Query: 744 --VTTVALACLHSKPKFRPTMQRVCQ 767
+ L C H +P RPT + +
Sbjct: 309 PEMYQTMLDCWHGEPSQRPTFSELVE 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 40/213 (18%)
Query: 507 IGTGGYGSV---YKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
IG+G G V Y A L + VA+KKL R FQN+ H +K A+R +V +
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP----------FQNQTH--AKRAYRELVLM 70
Query: 564 YGFCL-HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL-----SYL 617
C+ HK + L+ + + SL F ++ Y + L M N+ + + L SYL
Sbjct: 71 K--CVNHKNIISLLNVFTPQKSLEEF-QDVYLVMEL---MDANLCQVIQMELDHERMSYL 124
Query: 618 HHDCM--------PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
+ + I+HRD+ +NI++ S + DFG AR + V Y
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 183
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRH 702
Y APE+ M E D++S G + E M RH
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGE--MVRH 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 16/147 (10%)
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLL--DSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
+HRD+++ NILL+ + DFG AR + D D + ++APE + V T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 684 KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL 743
+ DV+SFGV+ E+ S +SP +I + RL RM +
Sbjct: 255 QSDVWSFGVLLWEI---------FSLGASPYPGVQID--EEFCRRLKEGT-RMRAPEYAT 302
Query: 744 --VTTVALACLHSKPKFRPTMQRVCQE 768
+ ++ L C H+ P+ RPT + +
Sbjct: 303 PEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 31/168 (18%)
Query: 610 VANALSYL-HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT- 667
VA +S+L +C +HRD+++ NILL + DFG AR + +DS+ +V G
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSN--YVVKGNA 276
Query: 668 ---YGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP----SSDQKIM 720
++APE + V T + DV+S+G++ E+ S SSP D K
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLW---------EIFSLGSSPYPGMPVDSKFY 327
Query: 721 -LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+I LSP M DI+ +C + P RPT +++ Q
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDIM------KSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 31/113 (27%), Positives = 59/113 (52%), Gaps = 10/113 (8%)
Query: 526 VALKKLHRAETE-ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584
V LK L + + FF + A ++ +++H++IV LYG C+ ++ ++++ G
Sbjct: 35 VILKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 585 LFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL 637
L F+ + + W + + K +A+ALSYL +VH ++ + NILL
Sbjct: 91 LDLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 16/140 (11%)
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLL--DSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
+HRD+++ NILL+ + DFG AR + D D + ++APE + V T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 684 KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL 743
+ DV+SFGV+ E+ S +SP + + + RL RM +
Sbjct: 256 QSDVWSFGVLLWEI---------FSLGASPYPG--VQINEEFCQRLKDGT-RMRAPENAT 303
Query: 744 --VTTVALACLHSKPKFRPT 761
+ + LAC PK RPT
Sbjct: 304 PEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 20/175 (11%)
Query: 544 SFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR 603
+F A ++S+++H ++ ++G C+ ++ ++++ G L LR + V + W +
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTARLLDSDSS--- 659
V + +A+ALSYL ++VH ++ + NILL L + F +L D S
Sbjct: 122 V--AQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPF--IKLSDPGVSFTA 174
Query: 660 -NRTIVAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEV-------LMGRHPGE 705
+R +IAPE + ++ D +SFG LE+ L R P E
Sbjct: 175 LSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 26/152 (17%), Positives = 55/152 (36%), Gaps = 20/152 (13%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV--KLY 564
+ G VY + V LK E + E +L +A + + K+
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD-----REREVAILQLLARKGLPVPKVL 59
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
+L+ ++++ +L + + +I + +A L+ LH +
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDEVSEEE----------KEDIAEQLAELLAKLHQLPLLV 109
Query: 625 IVHRDISSNNILL-NSKLEAFVADFGTARLLD 655
+ H D+ NIL+ + K+ + D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGII-DWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 27/61 (44%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNN 156
L+SL L N L L L+ LD S NNLT SI PE L +L L+L GNN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 157 L 157
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 26/61 (42%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 122 KLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180
L+ LD S N LT IP L NL+VL+L GNNL P + L L ++ LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 181 L 181
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAP 673
L Y+H +VHRD+ +NIL+N + + DFG AR+ D T T Y AP
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD---PQMTGYVSTRYYRAP 174
Query: 674 ELAYT-MVVTEKCDVYSFGVVALEVLMGR--HPGE 705
E+ T + D++S G + E+L G+ PG+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 53/250 (21%), Positives = 91/250 (36%), Gaps = 68/250 (27%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G +G V ++ + A+K L +A+ + E +L++ + +VKLY
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI---------IKCVANALSY 616
K ++ + Y+ G + L +R+ I I + A+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL------------IRLGIFEEDLARFYIAELTCAIES 116
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFG--------------------------- 649
+H M +HRDI +NIL++ + DFG
Sbjct: 117 VHK--M-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 650 TARLLDSDSSNRTIV----------------AGTYGYIAPELAYTMVVTEKCDVYSFGVV 693
+ + D + GT YIAPE+ T+ CD +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 694 ALEVLMGRHP 703
E+L+G+ P
Sbjct: 234 LYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 38/119 (31%), Positives = 55/119 (46%), Gaps = 18/119 (15%)
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI--VAGTYGY 670
A+ Y+H + I+HRDI + N+L+N + + DFG A S +AGT
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328
Query: 671 IAPE-LA---YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS---DQKIMLI 722
APE LA YT V D++S G+V E + H L S+ D +I+ I
Sbjct: 329 NAPEVLAGDPYTPSV----DIWSAGLVIFEAAV--HTASLFSASRGDERRPYDAQILRI 381
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 9e-05
Identities = 54/251 (21%), Positives = 114/251 (45%), Gaps = 39/251 (15%)
Query: 500 DFDIKYCIGTGGYGSVYKAQLPNG------KVVALKKLHRAETEETTFFNSFQNEAHVLS 553
++++ IG G +G V+ + K ++ + L E + E +V+
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI------EVNVMR 67
Query: 554 KIAHRNIVKLYGFCLHK--KCMFLIYKYMKRGSLFCFLRNDYEAV-VLDWTMRVNIIKCV 610
++ H+NIV+ L+K + ++++ ++ G L ++ Y+ ++ V+I + +
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 611 ANALSYLHH-DCMPS---IVHRDISSNNILLNSKLE-----------------AFVADFG 649
+AL+Y H+ P+ ++HRD+ NI L++ + A + DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 650 TARLLDSDSSNRTIVAGTYGYIAPELAY--TMVVTEKCDVYSFGVVALEVLMGRHPGELL 707
++ + +S + V GT Y +PEL T +K D+++ G + E+ G+ P
Sbjct: 188 LSKNIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246
Query: 708 SSLSSPSSDQK 718
++ S S+ K
Sbjct: 247 NNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 29/62 (46%), Positives = 35/62 (56%), Gaps = 5/62 (8%)
Query: 314 SLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHN 370
+LK LDLSNN+L+ IP L+ + L NNL+ SI PE GL L LDLS N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGN 58
Query: 371 KL 372
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 501 FDI--KYC----IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLS 553
FD+ +Y +G G G V+ A K VA+KK+ + + E ++
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKIIR 57
Query: 554 KIAHRNIVKLY--------------GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLD 599
++ H NIVK+Y G ++++ +YM+ D V+
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME---------TDLANVLEQ 108
Query: 600 WTMRVNIIKCVA----NALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTARLL 654
+ + L Y+H +++HRD+ N+ +N++ L + DFG AR++
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165
Query: 655 DSDSSNR---TIVAGTYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVLMGR 701
D S++ + T Y +P L YT + D+++ G + E+L G+
Sbjct: 166 DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 63/289 (21%), Positives = 99/289 (34%), Gaps = 66/289 (22%)
Query: 126 LDFSFNNLTGS----IPPELGSLRNLEVLNLKGNNLN------GAIPSSLCQLTKLITMA 175
L N L + L +L+ L L N ++ L + L +
Sbjct: 28 LRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELD 87
Query: 176 LSRNGLHGPIPSAIGDL---NNLLILSLDSNKLSGMLHQELGK-LK----NLVALNVGGN 227
LS N L + L ++L L L++N L + L K LK L L +G N
Sbjct: 88 LSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRN 147
Query: 228 KL----MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGI--LKVDMSMNNIEGTI 281
+L + L +L L L +N + + GI L + N
Sbjct: 148 RLEGASCEALAKALRANRDLKELNLANNGIGDA---------GIRALAEGLKAN------ 192
Query: 282 PLELTRLSQLLYLSISSNML----SGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337
L L +++N L + + T+A L SL+ L+L +N L+ +
Sbjct: 193 -------CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASAL 245
Query: 338 ELRNITLRNNNLSGSIPPEIGL-------------MKLEYLDLSHNKLN 373
NI+L +LS + +I L LDL NK
Sbjct: 246 LSPNISLLTLSLSCN---DITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 60/247 (24%), Positives = 109/247 (44%), Gaps = 31/247 (12%)
Query: 507 IGTGGYGSVYKAQLPNG---KVVALKKLH-RAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
IG G +G V ++ +G V +K+L A +E F EA + H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM---KFLEEAQPYRSLQHSNLLQ 59
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRV-NIIKC-VANALSYLHHD 620
G C L+ ++ G L +LR+ +A ++ + C +A L +LH +
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD----SSNRTIVAGTYGYIAPEL- 675
+ +H D++ N LL + L + D+G + + + ++ V +IAPEL
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP--LRWIAPELV 174
Query: 676 ----AYTMVV--TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729
+VV T++ +V+S GV E+ EL S SD++++ V + +L
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELF------ELGSQPYRHLSDEQVLTYTVREQQL 228
Query: 730 SPPVDRM 736
P R+
Sbjct: 229 KLPKPRL 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 610 VANALSYL-HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTY 668
VAN + +L +C VHRD+++ N+L+ + DFG AR + D SN T+
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGSTF 302
Query: 669 ---GYIAPELAYTMVVTEKCDVYSFGVVALEVL 698
++APE + + T DV+SFG++ E+
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 8/61 (13%)
Query: 339 LRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYND 392
L+++ L NN L+ IP GL L+ LDLS N L +I P + P LDLS N+
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 393 L 393
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 11/148 (7%)
Query: 507 IGTGGYGSVYKAQL---PNGKVVALKKLH-RAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
IG G +G V +++ V +K+L A ++E N F + + H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ---NEFLQQGDPYRILQHPNILQ 59
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC-VANALSYLHHDC 621
G C+ L+++Y + G L +L + + + + C +A ++++H
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH- 118
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFG 649
+ +H D++ N L S L V D+G
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYG 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTY---GYIAPELAYTMVVT 682
VHRD+++ N+LL + DFG AR + D SN T+ ++APE + + T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYT 317
Query: 683 EKCDVYSFGVVALEVL-MG--RHPGELLSS 709
DV+S+G++ E+ +G +PG ++ S
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 53/245 (21%), Positives = 91/245 (37%), Gaps = 54/245 (22%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G +G V A ++ + A+K L + + + E +L++ + +VKLY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
K ++ + Y+ G + L V + I + A+ +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---IRMEVFPEVLARFYIAELTLAIESVHK---MGF 122
Query: 626 VHRDISSNNILLNSKLEAFVADFG--------------------------TARLLDSDSS 659
+HRDI +NIL++ + DFG + L D S+
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 660 NRT---------------------IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 698
R + GT YIAPE+ T+ CD +S GV+ E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 699 MGRHP 703
+G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 25/84 (29%), Positives = 30/84 (35%), Gaps = 24/84 (28%)
Query: 242 NLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNML 301
NL L L +N L IP L L L +S N L
Sbjct: 1 NLKSLDLSNNRL-TVIPDGA-----------------------FKGLPNLKVLDLSGNNL 36
Query: 302 SGQIPITIAGLISLKGLDLSNNKL 325
+ P +GL SL+ LDLS N L
Sbjct: 37 TSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.7 bits (86), Expect = 0.001
Identities = 17/36 (47%), Positives = 22/36 (61%), Gaps = 2/36 (5%)
Query: 122 KLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNL 157
L LD S N +T +PP L +L NLE L+L GN +
Sbjct: 2 NLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 514 SVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572
SVY A+ P G +V ++ + E + QNE + H NI+ +
Sbjct: 15 SVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73
Query: 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISS 632
+++I +M GS L+ + + + + NI+ L+YLH + +HR+I +
Sbjct: 74 LWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN---GYIHRNIKA 129
Query: 633 NNILLN----------SKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL------A 676
++IL++ S L + V + A+++ T V +++PEL
Sbjct: 130 SHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYG 186
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP 703
Y + K D+YS G+ A E+ GR P
Sbjct: 187 YNV----KSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 23/103 (22%)
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG------ 666
L Y+H +++HRD+ N+L+N+ E + DFG AR S N AG
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPGENAGFMTEYV 170
Query: 667 -TYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T Y APE+ +YT + DV+S G + E L+GR P
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAI----DVWSVGCILAE-LLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 11/99 (11%)
Query: 507 IGTGGYGSVYKA------QLPNGKVVALKKLH-RAETEETTFFNSFQNEAHVLSKIA-HR 558
+G G +G V +A + N VA+K L A T+E + +E +LS + H+
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER---EALMSELKILSHLGQHK 102
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV 597
NIV L G C H + +I +Y G L FLR E +
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL 141
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 23/58 (39%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 293 YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPE-IGKCSELRNITLRNNNL 349
L +S+N L+ GL +LK LDLS N L+ I PE LR++ L NNL
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.004
Identities = 20/60 (33%), Positives = 25/60 (41%)
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL 205
NL+ L+L N L + L L + LS N L P A L +L L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 52/245 (21%), Positives = 92/245 (37%), Gaps = 54/245 (22%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G +G V A ++ + A+K L + + + E +L++ + +V+LY
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
K ++ + Y+ G + L + + I + A+ +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCAVESVHK---MGF 122
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLL-----------------DS--------DSSN 660
+HRDI +NIL++ + DFG DS D +N
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 661 -------------------RTI---VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 698
R + + GT YIAPE+ T+ CD +S GV+ E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 699 MGRHP 703
+G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 796 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.34 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.28 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.25 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.2 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.43 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-86 Score=812.65 Aligned_cols=720 Identities=32% Similarity=0.493 Sum_probs=425.4
Q ss_pred CCCchHHHhhcHHHHHHhhcCCccccCCCCCCCCCccCCceeeCCCCCeEEEeCCCCCccccccc---------------
Q 003780 26 ATTDDICVAAFELEREALVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQ--------------- 90 (796)
Q Consensus 26 ~~~~~~~~~~~~~~~~~l~~~~w~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~--------------- 90 (796)
...|..++.+++... .+...+...| ..+.+||.|.||+|+..++|+.|+|+++++.|.++.
T Consensus 27 ~~~~~~~l~~~~~~~---~~~~~~~~~w-~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 27 HAEELELLLSFKSSI---NDPLKYLSNW-NSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSN 102 (968)
T ss_pred CHHHHHHHHHHHHhC---CCCcccCCCC-CCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCC
Confidence 345666777765543 2111111111 235689999999999878899998888776554432
Q ss_pred ---------cccCCC----------------------CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCC
Q 003780 91 ---------FNFSCF----------------------PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPP 139 (796)
Q Consensus 91 ---------~~~~~l----------------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~ 139 (796)
..+..+ ++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|.
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence 112122 3333333333444445566677777888888888887777777
Q ss_pred CCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCc
Q 003780 140 ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNL 219 (796)
Q Consensus 140 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 219 (796)
.|+++++|++|+|++|++.+.+|..++++++|+.|+|++|++++.+|..|+++++|++|+|++|++++.+|..++++++|
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 262 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCC
Confidence 77777777777777777776666666666666666666666666556555555555555555555555555444444444
Q ss_pred cccccCCccccccCCCccccc------------------------CccceEEecccccc---------------------
Q 003780 220 VALNVGGNKLMGPIPSTLFRL------------------------TNLTYLYLHSNHLN--------------------- 254 (796)
Q Consensus 220 ~~L~l~~N~l~~~~~~~l~~l------------------------~~L~~L~L~~N~l~--------------------- 254 (796)
++|++++|++++.+|..+.++ ++|+.|++++|.++
T Consensus 263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n 342 (968)
T PLN00113 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342 (968)
T ss_pred CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCC
Confidence 444444444443333333333 33333333333333
Q ss_pred ---ccCCccccCCcccceeecccccccccCccc------------------------cccccccccccccCccc------
Q 003780 255 ---GSIPPEIGNMTGILKVDMSMNNIEGTIPLE------------------------LTRLSQLLYLSISSNML------ 301 (796)
Q Consensus 255 ---~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------------------------l~~l~~L~~L~l~~N~l------ 301 (796)
+.+|..++.+++|+.|+|++|++++.+|.. +..+++|+.|++++|.+
T Consensus 343 ~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~ 422 (968)
T PLN00113 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422 (968)
T ss_pred CCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECCh
Confidence 333333333333334444333333222211 11112222222222222
Q ss_pred -----------------------------------------------------------------cCccccccccccccc
Q 003780 302 -----------------------------------------------------------------SGQIPITIAGLISLK 316 (796)
Q Consensus 302 -----------------------------------------------------------------~~~~~~~~~~l~~L~ 316 (796)
++.+|..+.++++|+
T Consensus 423 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~ 502 (968)
T PLN00113 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELM 502 (968)
T ss_pred hHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccC
Confidence 222222233333444
Q ss_pred eecccccccccCCCcccCCCCCCcEEEeecccccCCCCcccc-ccccceEEecccccCCCCCccccc---cccccccCCC
Q 003780 317 GLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFLYH---RFPLDLSYND 392 (796)
Q Consensus 317 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~L~~L~l~~N~l~~~~p~~~~~---~~~l~l~~N~ 392 (796)
.|+|++|++.+.+|..+..+++|+.|+|++|.+++.+|..+. +++|+.|+|++|+++|.+|..+.+ +..+++++|.
T Consensus 503 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~ 582 (968)
T PLN00113 503 QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582 (968)
T ss_pred EEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc
Confidence 444444444445555555555566666666666666655553 566777777777777767655433 4467777777
Q ss_pred CcccCCCCCCCC---CccccCCccccccCCCCCCCC-CCCCccchhHHHHHHHHhhHHHHHHHHHHhhheeeeecchhhh
Q 003780 393 LEGEIPDYFRDS---PFKVYGNQGICYFSACSTLHT-PTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKNEIAK 468 (796)
Q Consensus 393 l~~~~p~~~~~~---~~~~~~n~~~c~~~~~~~~~~-~~~~~~~~~~~~vl~ii~~v~~~~~~l~l~~~~~~~~~~~~~~ 468 (796)
+.|.+|..-... ...+.||+++|+......... ....+....+. ++++ ++++++++++++++++++++++..+
T Consensus 583 l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (968)
T PLN00113 583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWF-YITC--TLGAFLVLALVAFGFVFIRGRNNLE 659 (968)
T ss_pred ceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeee-ehhH--HHHHHHHHHHHHHHHHHHHhhhccc
Confidence 777777532211 123468899997542111000 00111111111 1111 1111122222222222222222111
Q ss_pred ccCCCCCCCCc-eeeec--cCCcccHHHHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHH
Q 003780 469 LMTGPTKSGDV-FSIWN--YDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNS 544 (796)
Q Consensus 469 ~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~ 544 (796)
........+.. ..... ....++++++ ...|...+.||+|+||.||+|+. .+++.||||++......
T Consensus 660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------- 729 (968)
T PLN00113 660 LKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------- 729 (968)
T ss_pred ccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------
Confidence 11111111110 00000 0112344443 35677888999999999999976 57999999998654322
Q ss_pred HHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 003780 545 FQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624 (796)
Q Consensus 545 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 624 (796)
...|++.+++++|||||+++++|.+++..++||||+++|+|.++++. ++|..+.+++.|+|+||+|||+.+.++
T Consensus 730 ~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~ 803 (968)
T PLN00113 730 PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803 (968)
T ss_pred cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCC
Confidence 23468889999999999999999999999999999999999999963 789999999999999999999776779
Q ss_pred eEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCC
Q 003780 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPG 704 (796)
Q Consensus 625 ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~ 704 (796)
|+||||||+||+++.++.+++. ||.+..... .....+++.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 804 iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~ 878 (968)
T PLN00113 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878 (968)
T ss_pred eecCCCCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 9999999999999999988875 665543321 12235889999999999999999999999999999999999998
Q ss_pred cccccCCCCCchh------hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 705 ELLSSLSSPSSDQ------KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 705 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
+............ .......+++.+.... .....+..++.+++.+|++.||++||+|+||++.|++...
T Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 879 DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CcccCCCCcHHHHHHHhcCccchhheeCccccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 6322111000000 0011122233332221 1233455678899999999999999999999999987754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-50 Score=427.31 Aligned_cols=283 Identities=39% Similarity=0.632 Sum_probs=236.6
Q ss_pred CCcccHHHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEe
Q 003780 486 DGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565 (796)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~ 565 (796)
...++++++..+|++|...+.||+|+||.||+|...+|+.||||++....... .++|.+|++++.+++|||+|+++|
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEE
Confidence 45689999999999999999999999999999999999999999887665432 346999999999999999999999
Q ss_pred EEEecc-eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEE
Q 003780 566 FCLHKK-CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 566 ~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 644 (796)
||.+.+ ..+||||||++|+|.++++..... .++|..|++|+.++|+||+|||+.+.|+||||||||+|||+|+++++|
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 999998 599999999999999999976543 689999999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCCCCCCcccc-ccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCC-------ch
Q 003780 645 VADFGTARLLDSDSSNRTIV-AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS-------SD 716 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~-------~~ 716 (796)
|+|||+|+............ .||.+|+|||+...+..++|+|||||||+++|++||+.|.+......... ..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999997654311222222 79999999999999999999999999999999999999877432111110 11
Q ss_pred hhhHHHHhhcCCCCC-ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 717 QKIMLIDVLDSRLSP-PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
....+.+++|+++.. .... ..++..+..++.+|++.+|++||+|.||++.|+....
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~--~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPD--EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCCh--HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 111456677777652 2221 1566679999999999999999999999999966543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=397.77 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=220.6
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.+|...+.||+|||+.+|+++. ..|+.||+|++.+.........+.+.+|+++.++++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999976 789999999999877666666778999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|+|++++|.+++++.+ .+++.++..+..||+.||.|||+. +|+|||||..|+|++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998554 499999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.....+.+|||.|+|||++....++..+||||+|||+|-|+.|++||+.. .-+..+..+.......+.
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~~Y~~P~---- 239 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLNEYSMPS---- 239 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhcCccccc----
Confidence 77777889999999999999999999999999999999999999999831 223333333333222111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.-..+..++|.++|++||.+|||+++|+.+=.
T Consensus 240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred -ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 11223568999999999999999999998843
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=391.91 Aligned_cols=258 Identities=32% Similarity=0.530 Sum_probs=215.7
Q ss_pred CccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-eeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK-CMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~e~ 579 (796)
....+.+|+|+||+||+|.++....||||++......... .++|.+|+.++.+++|||||+++|+|.++. ..++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3445569999999999999975444999999887766554 679999999999999999999999999988 79999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC-eEEecCCCCCeEecCCC-cEEEeeeccccccCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS-IVHRDISSNNILLNSKL-EAFVADFGTARLLDSD 657 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 657 (796)
|++|+|.+++++. ....+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999875 345699999999999999999999999 7 99999999999999998 9999999999876543
Q ss_pred CCCccccccccCccCccccc--cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSNRTIVAGTYGYIAPELAY--TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
....+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ......+.....++....
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGGLRPPIPK 269 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCCCCCc
Confidence 33444467999999999999 56899999999999999999999999985332 223333443444444332
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
. ....+..++.+||+.||++||++.|++..|+.+..
T Consensus 270 ~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 E---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred c---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1 33347788999999999999999999999986543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=376.89 Aligned_cols=257 Identities=27% Similarity=0.380 Sum_probs=211.5
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-eeeEEEe
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK-CMFLIYK 578 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~e 578 (796)
.+..+.||+|..|+||+++++ +++.+|.|.++.... ....+++.+|++++++.+||+||+++|.|..++ ...++||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~--~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID--PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 445678999999999999765 799999999954443 344689999999999999999999999999999 5999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++|+|++++...+ .+++....+|+.+|++||.|||+ + +||||||||+|||++..|++||||||.++.+...
T Consensus 159 YMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999998653 48999999999999999999996 5 9999999999999999999999999999887644
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... .........+..+.+...+ .....
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~ppP-~lP~~- 305 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEPPP-RLPEG- 305 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCCCC-CCCcc-
Confidence 3445679999999999999999999999999999999999999987421 1111222233334443222 22111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
....+++.++..||++||.+||+++|+++|-.-.+
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 23456899999999999999999999999965443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=380.64 Aligned_cols=259 Identities=25% Similarity=0.322 Sum_probs=210.6
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhH----HHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETT----FFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
..+.|.+.+.+|+|+||.|-+|. .++|+.||||+++........ ....+.+|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34568888999999999999994 668999999999876654422 2234679999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC---CcEEEeee
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK---LEAFVADF 648 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Df 648 (796)
..|+||||++||.|.+.+-.... +.+..-..+++|++.|+.|||++ ||+||||||+|||++.+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999876543 67777788999999999999999 99999999999999876 78999999
Q ss_pred ccccccCCCCCCccccccccCccCccccccCCc---CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYTMVV---TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
|+|+..+ ......+.||||.|.|||++.+..+ ..++|+||+||++|-+++|.+||... .......+.+
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~--------~~~~sl~eQI 394 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE--------YTDPSLKEQI 394 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc--------cCCccHHHHH
Confidence 9999876 4455677899999999999986543 34789999999999999999999732 1122122333
Q ss_pred cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.+...........+-..+..++|.+||..||++|||++|+++|-+
T Consensus 395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 333222222223344456889999999999999999999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=363.22 Aligned_cols=201 Identities=28% Similarity=0.512 Sum_probs=181.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||.|+||+||+|+++ ++..||||.+....... +..+.+..|+++++.++|||||++++++..++..++|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~-k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK-KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH-HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 467888899999999999999765 68999999998876432 3356788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC------CcEEEeeecc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK------LEAFVADFGT 650 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~------~~~kl~Dfg~ 650 (796)
||||.||+|.+++++.+ .+++..+..++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999999765 489999999999999999999999 99999999999999875 4579999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcc
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEL 706 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~ 706 (796)
|+.+.+. ......+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||+.
T Consensus 162 AR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9988743 344567899999999999999999999999999999999999999983
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=361.65 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=211.0
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.++||+|+||.||.++.+ +++.||+|++++....+....+...+|..++.+++||.||+++-.|++++..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999654 6899999999998877766677899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+||+.||.|..++++... +++..+.-++..|+.||.|||+. +||||||||+|||+|.+|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987643 88888888999999999999999 999999999999999999999999999996555
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
........+||+.|||||++.+..|+.++|+||+|+++|||++|..||... ....+...+...+..... ..
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k~~~~p-~~ 248 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGKLPLPP-GY 248 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCcCCCCC-cc
Confidence 555566689999999999999999999999999999999999999999832 223444444444422211 11
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCC
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPT 761 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs 761 (796)
.. .+..+++.+.++.||++|-.
T Consensus 249 ls---~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 249 LS---EEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CC---HHHHHHHHHHhccCHHHhcC
Confidence 11 23668999999999999963
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=349.45 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=211.6
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEe-EEEecc-eeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG-FCLHKK-CMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~-~~~l 575 (796)
.+|++.+.||.|.||+||+++ ..+|..+|.|.++-... +....+....|+.++++++|||||++++ .+.++. ..++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 458888999999999999995 67899999999984443 4445678999999999999999999998 444444 4899
Q ss_pred EEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCC-eEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 576 IYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPS-IVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
|||++..|+|...++..+ ++..+++..+++++.|+++||.++|+..+.+ |+||||||.||+++.+|.+|++|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999987543 4466999999999999999999999943322 78999999999999999999999999999
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC-CCCc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR-LSPP 732 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 732 (796)
+..........+|||.||+||.+.+..|+.||||||+||++|||+.-+.||+..+ -..+...+... .++-
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---------~~~L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---------LLSLCKKIEQGDYPPL 248 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---------HHHHHHHHHcCCCCCC
Confidence 9877666667889999999999999999999999999999999999999998431 12222222222 2211
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
... -....+.++|..|+.+||+.||+...+++.+..
T Consensus 249 p~~---~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 PDE---HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cHH---HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 112 223458889999999999999997666666654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.89 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=206.5
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|+....+|+|+||+||+++.+ +|+.||||++.....+ ....+-..+|++++++++|||+|.++++|......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46778889999999999999876 5999999999876543 333456789999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++..-|.+ +.+... .++...+.++++|+++|+.|+|++ ++|||||||+||+++.++.+|+||||+|+.+..+
T Consensus 81 E~~dhTvL~e-Le~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 81 EYCDHTVLHE-LERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred eecchHHHHH-HHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9999855544 443322 378899999999999999999999 9999999999999999999999999999998877
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC----------CCchhhhHH-HHhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS----------PSSDQKIML-IDVL 725 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~----------~~~~~~~~~-~~~~ 725 (796)
....+.++.|.+|+|||.+.+ .+|...+||||+||++.||++|.+-|...++++. -....+..+ ....
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 777778889999999999887 7899999999999999999999988764433210 000000000 0000
Q ss_pred cC--CCCCc-----cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 DS--RLSPP-----VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 ~~--~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
-. +++.. .++........+.++++.|++.||.+|++-+|++.|
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00 01111 111111112247899999999999999999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=366.74 Aligned_cols=255 Identities=27% Similarity=0.472 Sum_probs=211.2
Q ss_pred CCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
.+...+.||+|.||.||.|.+.....||+|.++..... .+.|.+|+++|++++|++||+++++|..++..+|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 45567889999999999999987789999999876544 24788999999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
|+.|+|.++++.. ....+...+.+.++.|||+|++||+++ ++|||||.++|||++++..+||+|||+|+...++.+
T Consensus 283 m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999873 345688999999999999999999999 999999999999999999999999999996554433
Q ss_pred Ccc-ccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 660 NRT-IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 660 ~~~-~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
... ...-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..+. ...+.+.+.+..+-+.+..
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms---------n~ev~~~le~GyRlp~P~~- 428 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS---------NEEVLELLERGYRLPRPEG- 428 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---------HHHHHHHHhccCcCCCCCC-
Confidence 222 1223567999999999999999999999999999998 777765322 2234444555444333222
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.+..+.+++..||+.+|++|||++.+...++....
T Consensus 429 --CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 --CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 33447889999999999999999999888876643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=355.43 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=213.7
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
...+|.+.+.||+|+|++|++|+ .+.+++||||++.+.-...+.-.+-+..|-.+|.+| .||.|++++..|+++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 45689999999999999999996 457999999999876655544456788899999999 7999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
.|+||+++|+|.+++++.+. +++.....++.+|+.||+|||++ |||||||||+|||+|+||++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999997643 89999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC-------------ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHH
Q 003780 655 DSDSSN-------------RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 655 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (796)
.+.... ....+||..|++||++.....++.+|+|+|||++|+|+.|++||...+. ...+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------yliF 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--------YLIF 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--------HHHH
Confidence 542111 1346799999999999999999999999999999999999999985332 2333
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
..+++-....+. .....+.+|+.+.|..||.+|+|..||-+|..-.
T Consensus 297 qkI~~l~y~fp~-----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 297 QKIQALDYEFPE-----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred HHHHHhcccCCC-----CCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 334333322111 1113467899999999999999997766664433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=343.43 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=213.0
Q ss_pred hcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||.|..++||+|+ .+.++.||||++.-++.... .+.+.+|+..|+.++||||++++..|..+...|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 4689999999999999999996 56789999999998877654 67899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|.||.+|++.++++...... +++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999998765543 89999999999999999999999 999999999999999999999999998776544
Q ss_pred CCCCc----cccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 657 DSSNR----TIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 657 ~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
..... ....||+.|||||++.. ..|+.|+||||||++..||.+|+.||..+.+. .++...+....+
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------kvLl~tLqn~pp 250 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------KVLLLTLQNDPP 250 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------HHHHHHhcCCCC
Confidence 33222 33579999999999543 35889999999999999999999999854431 222222222221
Q ss_pred -----CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 731 -----PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 731 -----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
....+........+.+++..||+.||.+|||+++++++=
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 111111222233688999999999999999999999873
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.68 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=213.5
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
..|.....||+|+.|.||.|. ..+++.||||++........ +-+.+|+.+|+..+|+|||++++.|...+..++||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 457777889999999999995 56799999999987776543 46889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|||++|+|.+.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999987543 89999999999999999999999 9999999999999999999999999999988877
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........|||.|||||+.....|.+|+||||||+++.||+.|.+||-....+ .....+...-.+.... .
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---------rAlyLIa~ng~P~lk~-~ 492 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------RALYLIATNGTPKLKN-P 492 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH---------HHHHHHhhcCCCCcCC-c
Confidence 66666778999999999999999999999999999999999999998643221 1111222222222221 2
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
......+.+++.+||+.||++||++.|+|+|-.
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 223345889999999999999999999999843
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=319.38 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=207.9
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|...+.+|+|.||.||+|+ .++|+.||||+++.....+. ......+|++.++.++||||+.+++.|.+.+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 467888999999999999995 56899999999988765533 2356789999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|||+. +|+..++... ..++...+..++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 81 Efm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred Eeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 99987 8999988643 4588999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh-----------
Q 003780 658 SSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL----------- 725 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 725 (796)
....+..+-|.+|+|||.+.|. .|+..+||||.||++.||+-|.+-|...+++ ++-..+...+
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-----dQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-----DQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-----HHHHHHHHHcCCCCcccCccc
Confidence 6666656789999999988764 6999999999999999999988766543321 1111111111
Q ss_pred -------cC--CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 -------DS--RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 -------~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.- ...+..............+++.+|+..||.+|+++.|++++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 01111111122223346899999999999999999999988
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=352.43 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=215.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....+++ .+.+.+|++++++++|||||.++++|+...+.++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 56888899999999999999766 6899999999887766544 678999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+.| +|..++..... ++++.+..++.++..||.|||+. +|.|||+||+||+++..+.+|+||||+|+.+...
T Consensus 81 e~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 99988 99999987654 99999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
....+...|||-|||||+..+..|+..+|.||+||++|||++|++||.... -...+..+......++
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v~~p----- 220 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPVKPP----- 220 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCCCCc-----
Confidence 776777889999999999999999999999999999999999999997321 1111222222222221
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+..++...+.+||.+|.+-.+++.|-
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 13344588999999999999999999999884
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=343.12 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=205.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc--eeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK--CMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~l 575 (796)
.+|...+.||+|+||+||++... +|+..|||.+....... .+.+.+|+.++++++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 35677889999999999999765 49999999987763322 567899999999999999999999855544 6899
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-CCcEEEeeecccccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-KLEAFVADFGTARLL 654 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~ 654 (796)
.|||+++|+|.+++.+... .+++..+..+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999999998754 499999999999999999999999 9999999999999999 799999999999876
Q ss_pred CCC---CCCccccccccCccCccccccCC-cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSD---SSNRTIVAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
... ........||+.|||||++..+. ...++||||+||++.||+||+.||... ......+..+......
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSL 241 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCC
Confidence 631 12233467999999999998543 335999999999999999999998742 1111122222222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
|..... -.....+++.+|++.||++||||+++++|......
T Consensus 242 P~ip~~---ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 PEIPDS---LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred CCCCcc---cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 222222 22346789999999999999999999999876543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.31 Aligned_cols=239 Identities=25% Similarity=0.364 Sum_probs=208.2
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|+..+.||.|+||.|..++.+ +|..+|+|++.....-..+..+...+|..+++.+.||.++++++.+.+....++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57888999999999999999765 68999999999888777666778899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||.+||-|.+++++.+. +++..+..++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999997654 89999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.-+.||||.|+|||.+....|..++|.|||||++|||+.|..||..... ...+..++......+.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v~fP~---- 262 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKVKFPS---- 262 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcccCCc----
Confidence 4457899999999999999999999999999999999999999984322 3445555555543221
Q ss_pred HHHHHHHHHHHHHcCCCCCCCC
Q 003780 738 MQDIVLVTTVALACLHSKPKFR 759 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~R 759 (796)
-....+.+++...++.|-.+|
T Consensus 263 -~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 -YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -ccCHHHHHHHHHHHhhhhHhh
Confidence 111236689999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=346.40 Aligned_cols=263 Identities=28% Similarity=0.372 Sum_probs=205.6
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 575 (796)
+.|+.++.||+|+||.||+|+ ..+|+.||+|++..+...+. ......+|+.+|++++||||+++.+...+. +..|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 457777889999999999996 56899999999988765443 356788999999999999999999999877 78999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|+|||+. +|.-++... ...+++.++..++.|+++||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999998 787777653 34589999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCC-ccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCchhhh--HH
Q 003780 656 SDSSN-RTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSDQKI--ML 721 (796)
Q Consensus 656 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~~~~--~~ 721 (796)
..... .+..+-|.+|+|||++.|. .|+.++|+||.|||+.||++|++.|.....+ ..+...... .+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 65443 5667789999999998865 6999999999999999999999998754331 001000000 00
Q ss_pred HHhhcCCCCCccchh----hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 722 IDVLDSRLSPPVDRM----VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....-.....+.+. .........+|+..+|..||.+|.|+.+++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000000000111110 11112346789999999999999999999876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=352.55 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=210.1
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhh--HHHHHHHHHHHHHhhcC-CCceeeEEeEEEecce
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEET--TFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKC 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 572 (796)
..+.|.+.+.||+|+||+|+.|. ..+|+.||+|.+........ ...+.+.+|+.++++++ ||||+++++++..+..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45689999999999999999995 45789999997766522211 23456778999999999 9999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEeeeccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTA 651 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a 651 (796)
.++||||+.+|+|.+++.+.. .+.+.++.++++|++.|++|+|++ +|+||||||+||+++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999998743 378899999999999999999999 99999999999999999 99999999999
Q ss_pred cccCCCCCCccccccccCccCccccccCC-cC-cchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYTMV-VT-EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
.............+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.. .......+.....
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIRKGEF 240 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcCCc
Confidence 98743344556688999999999999877 76 68999999999999999999998521 1222222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..+.. .. ..++..++.+|+..||.+|+++.|++.+-+
T Consensus 241 ~~p~~--~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 241 KIPSY--LL--SPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred cCCCC--cC--CHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 21111 10 334778999999999999999999997743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=368.65 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=214.7
Q ss_pred hcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
..+....+.||+|+||.||+|+.. +...||||.++...... ..++|++|++++..++|||||+++|.|.+++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~--~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ--ARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH--HHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 345566778999999999999643 45679999998877553 3579999999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCc-----------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYE-----------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
..++|+|||..|+|.++|....+ +..++..+.+.|+.|||.|++||-++ .+|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999975431 23488899999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCcc--ccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchh
Q 003780 641 LEAFVADFGTARLLDSDSSNRT--IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~ 717 (796)
..|||+|||+++.+-..++... ...-..+|||||.+..++++++||||||||+|||+++ |+.|++. ..+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g--------lSn 711 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG--------LSN 711 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc--------cch
Confidence 9999999999997544333221 2234678999999999999999999999999999997 8899873 344
Q ss_pred hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
++.+..+-...+-+- +...+.++..|+..||+..|++||+++||-..|+....
T Consensus 712 ~EVIe~i~~g~lL~~----Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 712 QEVIECIRAGQLLSC----PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHHcCCcccC----CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 455555544444222 22344568899999999999999999999999977544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=354.85 Aligned_cols=269 Identities=25% Similarity=0.411 Sum_probs=216.4
Q ss_pred ccHHHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEE
Q 003780 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCL 568 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 568 (796)
.+.+++....+++.+.+.||+|.||+||+|++. ..||||+++....... ..+.|++|+.++++-+|.||+-+.|||.
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 344556666677888899999999999999985 3699999998877665 4789999999999999999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
.+.. .||+.+|+|.+|+.++|... ..++....+.|++|||+|+.|||.+ +|||||||..||++.++++|||+||
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 8888 99999999999999999754 3588899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCC--CCCCccccccccCccCcccccc---CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 649 GTARLLDS--DSSNRTIVAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 649 g~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|++..... .........|...|||||++.. .+|++.+||||||+|+|||+||..||.. .. .+..+..
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~-------~dqIifm 604 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QN-------RDQIIFM 604 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CC-------hhheEEE
Confidence 99975322 2222333457889999999874 4689999999999999999999999872 11 1111111
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
+-...+.+...........++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 605 VGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 VGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111212222222223334458899999999999999999999998877655
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.95 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=210.4
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecc-ee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKK-CM 573 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~ 573 (796)
..++|.+.+.||.|+||.||+|+ ...|+.||||+++......++. .=.+|++.+++++ |||||++.+.+.+.+ ..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 45689999999999999999996 4579999999998766553321 2368999999998 999999999999988 99
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++|||||+. +|+++++.+ ...+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 999999976 999999876 45699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCccccccccCccCccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCC---chhhh
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPS---SDQKI 719 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~---~~~~~ 719 (796)
+... ...+.++.|.+|+|||++. .+.|+.+.|||++|||++|+.+-++-|...+..+ .+. .....
T Consensus 160 v~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 160 VRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 7643 3345567899999999765 6789999999999999999999888876543321 000 00001
Q ss_pred HHHHhhcCCCCC----ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 720 MLIDVLDSRLSP----PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 720 ~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.+...+.-+++. ...........+..+++.+|+..||.+|||++|++++-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 122222222221 11222223445688999999999999999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=350.02 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=212.2
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+-|++.+.||.|+.|.|-.|++ .+|+.+|||++.+...-.......+.+|+.+|+-+.||||+++++.++.+.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999964 579999999998874443344567899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|-|++++-+.+. +++.++.+++.||..|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..-. +
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-P 164 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-C
Confidence 99999999999986654 89999999999999999999999 99999999999999999999999999998644 3
Q ss_pred CCCccccccccCccCccccccCCcC-cchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
+.-..+.||+|.|.|||++.|.+|. .++||||+|||||.|+||+.||++.+ -..+...+.... + .+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---------ir~LLlKV~~G~---f-~M 231 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---------IRVLLLKVQRGV---F-EM 231 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---------HHHHHHHHHcCc---c-cC
Confidence 4445667899999999999999887 58999999999999999999998422 112222222221 1 11
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
+..-..+.++|+.+|+..||++|.|++||++|..-
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 22333457899999999999999999999999653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=330.01 Aligned_cols=253 Identities=21% Similarity=0.386 Sum_probs=217.8
Q ss_pred hcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..+|++.+.||+|.||.|-+|. .+.|+.||||.+++++..++...-.+.+|+++|+.++||||+.++++|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3478888999999999999995 578999999999999988877667889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||..+|.|++|+.+.+. +++.+...++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++-.+..
T Consensus 132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999997654 99999999999999999999999 999999999999999999999999999987764
Q ss_pred CCCCccccccccCccCccccccCCcC-cchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
. ....+++|+|.|.+||...+.+|. +.+|-||+||+||.|+.|..||+.. .....+.++-......+..
T Consensus 206 ~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs~GaYrEP~~- 275 (668)
T KOG0611|consen 206 K-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQISRGAYREPET- 275 (668)
T ss_pred c-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhhcccccCCCC-
Confidence 3 445668999999999999998887 6899999999999999999999843 2233333333332222221
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
+.....+|.+||..+|++|-|+.+|..|..-
T Consensus 276 -----PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 276 -----PSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -----CchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 1124578999999999999999999999754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=350.03 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=203.2
Q ss_pred HhcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLH 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 569 (796)
..++|++.+.||+|+||.||+|.. .+++.||+|++....... ..+.+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS--EHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH--HHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 356899999999999999999963 235789999987543322 245789999999999 89999999999876
Q ss_pred cc-eeeEEEeeccCCcHHHHHhhcCc------------------------------------------------------
Q 003780 570 KK-CMFLIYKYMKRGSLFCFLRNDYE------------------------------------------------------ 594 (796)
Q Consensus 570 ~~-~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 594 (796)
++ ..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 58899999999999999875321
Q ss_pred -----ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC--Cccccccc
Q 003780 595 -----AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS--NRTIVAGT 667 (796)
Q Consensus 595 -----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt 667 (796)
...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....... ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 12477888899999999999999999 999999999999999999999999999986543221 12223466
Q ss_pred cCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHH
Q 003780 668 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTT 746 (796)
Q Consensus 668 ~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 746 (796)
+.|+|||++.+..++.++|||||||++|||++ |..||..... .. .....+......... ......+.+
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-------~~-~~~~~~~~~~~~~~~---~~~~~~l~~ 308 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------NE-EFCQRLKDGTRMRAP---ENATPEIYR 308 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-------cH-HHHHHHhcCCCCCCC---CCCCHHHHH
Confidence 78999999998899999999999999999997 9999874221 11 111111111111111 112234789
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 747 VALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 747 li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
++.+||+.||++|||+.|+++.|++..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.24 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=204.3
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe----cceeeEEEee
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH----KKCMFLIYKY 579 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV~e~ 579 (796)
...||+|++|.||+|.. +|+.||||++...........+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 689999999987665554556788999999999999999999999976 3468899999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+++|+|.+++.+.. .+++....+++.+++.||.|||+.. +++||||||+||+++.++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999998653 4889999999999999999999732 78899999999999999999999999998654322
Q ss_pred CccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 660 NRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..................
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~~~~--- 244 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------TKEIYDLIINKNNSLKLP--- 244 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCCCCCCC---
Confidence 22457889999999876 678999999999999999999999997421 112222222222222221
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
......+.+++.+||+.||++|||++|+++.|+..+.
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1223458899999999999999999999999988654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.09 Aligned_cols=246 Identities=28% Similarity=0.470 Sum_probs=203.5
Q ss_pred ccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeecc
Q 003780 502 DIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
...+.||.|+.|.||+|+++ ++.||||+++..+ ..+++-|++++||||+.+.|+|.....++||||||.
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 34578999999999999986 7899999886443 236788999999999999999999999999999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCc
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 661 (796)
.|-|...|+... .+.......|..+||.|+.|||.+ +|||||||.-||||+.+..+||+|||-++....- ..+
T Consensus 196 ~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STk 268 (904)
T KOG4721|consen 196 QGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STK 268 (904)
T ss_pred cccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhh
Confidence 999999998654 377888899999999999999999 9999999999999999999999999999876543 334
Q ss_pred cccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHH
Q 003780 662 TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDI 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
-.++||..|||||++...+.++|+||||||||||||+||..||.+.+.... +..+-...+.-+ .+...+
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--------IwGVGsNsL~Lp---vPstcP 337 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--------IWGVGSNSLHLP---VPSTCP 337 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee--------EEeccCCccccc---CcccCc
Confidence 457899999999999999999999999999999999999999885443211 111111111111 122333
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 742 VLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 742 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
..+.-+++.||+-.|..||++.+++.||.-..++.
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 45777899999999999999999999998765543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=337.73 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=208.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++...||+|+||.||.|+.+ +|..+|+|++++.........+-++.|-.+|...++|.||+++-.|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3578999999999999999999754 699999999999988777777889999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||++||++..+|.+.. .+++..+..++.+++-|++.+|.. |+|||||||+|+|||..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998654 488888999999999999999999 99999999999999999999999999985321
Q ss_pred C----------------------CCCC-----c--------------------cccccccCccCccccccCCcCcchhHH
Q 003780 656 S----------------------DSSN-----R--------------------TIVAGTYGYIAPELAYTMVVTEKCDVY 688 (796)
Q Consensus 656 ~----------------------~~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~DVw 688 (796)
. .... . ...+|||.|+|||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 0 013599999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC--CCCccchhhHHHHHHHHHHHHHcCCCCCCCCC---CHH
Q 003780 689 SFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR--LSPPVDRMVMQDIVLVTTVALACLHSKPKFRP---TMQ 763 (796)
Q Consensus 689 SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ 763 (796)
|+|||+|||+.|.+||.... .......++.-+ +..+...... .+..++|.+|+. ||++|- .++
T Consensus 373 SLG~ImyEmLvGyPPF~s~t--------p~~T~rkI~nwr~~l~fP~~~~~s---~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSET--------PQETYRKIVNWRETLKFPEEVDLS---DEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhhhccCCCcCccc---HHHHHHHHHHhc-CHHHhcCcccHH
Confidence 99999999999999998432 223333333322 2222111111 346789999999 999996 466
Q ss_pred HHHHH
Q 003780 764 RVCQE 768 (796)
Q Consensus 764 evl~~ 768 (796)
||-+|
T Consensus 441 EIK~H 445 (550)
T KOG0605|consen 441 EIKKH 445 (550)
T ss_pred HHhcC
Confidence 66655
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.31 Aligned_cols=251 Identities=30% Similarity=0.459 Sum_probs=214.7
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
..|+..+.||+|.||.||+|. .+.++.||+|++......+. ..++.+|+.++.+++++||.++++.+..+...+++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 457777899999999999995 55799999999987766543 568999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+.+|++.+.++.... +++..+.-|++++..|+.|+|++ +.+|||||+.||++..+|.+|++|||.+..+...
T Consensus 91 ey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999999986542 47777888999999999999999 9999999999999999999999999999988766
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........|||.|||||++.+..|+.|+||||||++++||.+|.+|+....+. .+.-.+.+..+|..+.
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------rvlflIpk~~PP~L~~-- 233 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------RVLFLIPKSAPPRLDG-- 233 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------eEEEeccCCCCCcccc--
Confidence 65556788999999999999889999999999999999999999998755432 1222333444444433
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++..||+.||+.||+++++++|=
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred -ccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 2334488999999999999999999999883
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.27 Aligned_cols=256 Identities=23% Similarity=0.245 Sum_probs=203.1
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|+..+.||+|+||.||+|.. .+|+.||+|.+.............+.+|+.++++++|+||+++++++.+++..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999975 5799999999876554333334567899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988865322 3488999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...... .........+.... ... ..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~-~~~---~~ 226 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKEDQ-EEY---SE 226 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhccc-ccC---Cc
Confidence 223346899999999999999999999999999999999999999743211 11111111111111 111 11
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPT-----MQRVCQEF 769 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 769 (796)
.....+.+++.+||+.||++||+ +++++++-
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 12234778999999999999997 78888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.84 Aligned_cols=263 Identities=23% Similarity=0.306 Sum_probs=209.5
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhh-----------HHHHHHHHHHHHHhhcCCCceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEET-----------TFFNSFQNEAHVLSKIAHRNIVKLY 564 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~l~ 564 (796)
..++|++.+.||+|.||.|-+|+. .+++.||||++.+...... ...+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 457899999999999999999975 4799999999976543221 1235889999999999999999999
Q ss_pred eEEEec--ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc
Q 003780 565 GFCLHK--KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE 642 (796)
Q Consensus 565 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 642 (796)
++..++ +..|||+|||..|.+.+.-. ....++..++++++.++..||+|||.+ +||||||||+|+|++++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 999765 58999999999998754322 222389999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCC-----CCCccccccccCccCccccccCC----cCcchhHHHHHHHHHHHHhCCCCCcccccCCCC
Q 003780 643 AFVADFGTARLLDSD-----SSNRTIVAGTYGYIAPELAYTMV----VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP 713 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~ 713 (796)
+||+|||.+...... ........|||.|+|||...++. .+.+.||||+||+||+|+.|+.||-+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~------- 321 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD------- 321 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-------
Confidence 999999999765222 11122356999999999988733 34578999999999999999999873
Q ss_pred CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
.........++...+..+... +..+.+.++|++||++||++|.+..+|..|........
T Consensus 322 -~~~~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 322 -DFELELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred -chHHHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 223344455555555443322 23345789999999999999999999999987766543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=343.41 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=218.7
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce-eeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC-MFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~l 575 (796)
.++|...+.+|+|+||.++.++++ +++.|++|.+......+.. .+...+|+.++++++|||||.+.+.+.+++. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 357889999999999999999765 6889999999888776654 3478899999999999999999999999998 999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||+|++||++.+.+.+.+ ...++++.+..++.|++.|+.|||+. +|+|||||+.|||++.+..|||+|||+|+.+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999998765 45689999999999999999999988 99999999999999999999999999999998
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.+......+.||+.|+.||.+.+.+|..|+||||+||++|||++-+.+|...+. ...+..+...... +.
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~~~~-Pl-- 226 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRGLYS-PL-- 226 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhccCC-CC--
Confidence 776566778899999999999999999999999999999999999999984322 1222223332222 22
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+.....++..++..|++.+|+.||++.+++.+
T Consensus 227 -p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 -PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22334458899999999999999999999987
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=344.01 Aligned_cols=245 Identities=22% Similarity=0.280 Sum_probs=200.3
Q ss_pred eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCC
Q 003780 505 YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRG 583 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 583 (796)
+.||+|+||.||+++. .+|+.||+|++.............+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999975 478999999998654433333457789999999999999999999999999999999999999
Q ss_pred cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccc
Q 003780 584 SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663 (796)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 663 (796)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 9999987643 478999999999999999999999 9999999999999999999999999999764333333445
Q ss_pred cccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHH
Q 003780 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...............+ ......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~p-----~~~~~~ 221 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFP-----RTLSPE 221 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCCC-----CCCCHH
Confidence 679999999999999999999999999999999999999986321 1112222222221111 112234
Q ss_pred HHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 744 VTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 744 l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
+.+++.+||+.||++|| ++.++++|
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 77899999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=338.92 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=204.4
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|..+ +|+.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999765 68999999997654433334567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997653 378899999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.......+.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~---- 219 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAGKLEFPR---- 219 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCcCCCc----
Confidence 223468999999999998889999999999999999999999987321 11122222222221111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPT-----MQRVCQEF 769 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 769 (796)
.....+.+++.+|++.||.+||+ ++|+++|-
T Consensus 220 -~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 220 -HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred -cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 11234779999999999999995 88888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=306.18 Aligned_cols=254 Identities=30% Similarity=0.405 Sum_probs=216.4
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|.||.||.|+. +++-.||+|++.+..........++.+|+++.+.++||||+++++|+.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46899999999999999999974 57889999999988766666667999999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+||..+|.++..+..... ..+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..|++|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999985433 3478888899999999999999999 99999999999999999999999999986533
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.......+||..|.|||...+..++.++|+|++|++.||++.|..||+.. ...+.+..+...+...+.
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~--------~~~etYkrI~k~~~~~p~--- 243 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ--------SHSETYKRIRKVDLKFPS--- 243 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh--------hhHHHHHHHHHccccCCc---
Confidence 34455678999999999999999999999999999999999999999832 233344444443333221
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......++|.+|+..+|.+|.+..|++.+-.
T Consensus 244 --~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 244 --TISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred --ccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11223678999999999999999999998854
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=345.34 Aligned_cols=265 Identities=25% Similarity=0.403 Sum_probs=211.6
Q ss_pred HHhcCCccceeeecccceeEEEEEcc--CC--cE-EEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP--NG--KV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
-..++....+.||+|+||.||+|+++ ++ .. ||||..+..........++|.+|+++|++++|||||+++|++..+
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 34456666789999999999999754 23 23 899999864433444578999999999999999999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...++|||+|.||+|.+++++.+. .++..++..++.+.|+||+|||++ +++||||.++|+|++.++.+||+|||+
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence 999999999999999999998654 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
++.-..-........-+..|+|||.+..+.+++++|||||||++||+++ |..||.... .......+.....
T Consensus 309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~--------~~~v~~kI~~~~~ 380 (474)
T KOG0194|consen 309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK--------NYEVKAKIVKNGY 380 (474)
T ss_pred ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC--------HHHHHHHHHhcCc
Confidence 8754311111111224578999999999999999999999999999998 888987332 2222333323333
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
+..... ..+..+..++.+|+..||++||+|.++.+.++......
T Consensus 381 r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 381 RMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred cCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 322222 22344778888999999999999999999998765443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.36 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=200.7
Q ss_pred cCCccceeeecccceeEEEEEccC-----------------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCcee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN-----------------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 561 (796)
++|.+.+.||+|+||.||+|..++ +..||+|.+...... ...+.+.+|++++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--HHHHHHHHHHHHHhhcCCCCee
Confidence 578899999999999999997432 346999998765432 2246789999999999999999
Q ss_pred eEEeEEEecceeeEEEeeccCCcHHHHHhhcC----------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003780 562 KLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY----------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625 (796)
Q Consensus 562 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 625 (796)
++++++...+..++||||+++|+|.+++.... ....+++..+.+++.||+.||+|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 99999999999999999999999999986532 113467888999999999999999999 99
Q ss_pred EEecCCCCCeEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh--CC
Q 003780 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GR 701 (796)
Q Consensus 626 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt--g~ 701 (796)
+||||||+||+++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999865432211 122345788999999988889999999999999999987 55
Q ss_pred CCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 702 HPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 702 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.||..... .............................+.+++.+||+.||++|||+.||.+.|++
T Consensus 240 ~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTD-----EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCH-----HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 67653221 111111111111111000000011122357899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.84 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=204.4
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999765 68999999997654433334567899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999997643 378888999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+ .
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~~p--~-- 236 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILAGRLKFP--N-- 236 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhcCCcCCC--C--
Confidence 223569999999999999889999999999999999999999986321 1112222222222111 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPT-----MQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 768 (796)
.....+.+++.+||+.||.+||+ ++++++|
T Consensus 237 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 -WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11224678999999999999996 6777766
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=311.24 Aligned_cols=260 Identities=24% Similarity=0.343 Sum_probs=210.3
Q ss_pred HhcCCccceeeecccceeEEEE-EccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
.++.|++.+.||+|.|+.||++ ..++|+.+|+|.+........ ..+++.+|+.+.+.++||||+++.+.+.+.+..|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3567888899999999999999 456899999999877665544 36789999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~ 652 (796)
|+|+|.|++|..-+-.. ...++..+-..++||+++|.|+|.+ +|||||+||+|+++.. ...+|++|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999987554432 3477888889999999999999999 9999999999999954 3458999999999
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
.+. +........|||+|||||+....+|+..+|||+.||+||-|+.|..||.+. .....+..++.....-+
T Consensus 162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~--------~~~rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--------DQHRLYEQIKAGAYDYP 232 (355)
T ss_pred EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc--------cHHHHHHHHhccccCCC
Confidence 887 445555678999999999999999999999999999999999999998732 22223333332222111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.+......++..+++.+||..||.+|.|+.|.+.|-.-+.
T Consensus 233 -~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 233 -SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 1111122234678999999999999999999998865443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=314.77 Aligned_cols=256 Identities=24% Similarity=0.252 Sum_probs=204.1
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKCMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 575 (796)
+.|+..+.|++|+||.||+|+.+ +++.||+|+++.....+.- .-.-.+|+.++.+.+|||||.+-++... -+..|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF-PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF-PITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC-cchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 45778899999999999999754 7899999999987744322 2245789999999999999999988754 467999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||++. +|.++++... +.+...++..++.|+++|++|||+. .|+|||||++|+|++..|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999988 8999998765 3588899999999999999999999 99999999999999999999999999999998
Q ss_pred CCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH-------hhcC
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID-------VLDS 727 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~ 727 (796)
.+....+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|...... .+-..+.. .+++
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-----dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-----DQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-----HHHHHHHHHhCCCccccCC
Confidence 887777778899999999998865 5999999999999999999999887643321 00000100 0001
Q ss_pred CC-------------------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 728 RL-------------------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 728 ~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.. ...+.... -...-.+++..++..||.+|-|+.|.++|
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~--lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALS--LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccc--cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 00000000 01234578999999999999999999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.27 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=205.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999765 58999999998664433334567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997543 378899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC-Cccchh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS-PPVDRM 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 736 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ..... +.....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~-~~~~~~~~~~~~ 225 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----NETWENLKYW-KETLQRPVYDDP 225 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-----HHHHHHHHhc-cccccCCCCCcc
Confidence 22345699999999999998999999999999999999999999873221 0000011110 11111 111100
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.......+.+++.+|++.+|++||+++|++++-
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 011233577899999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=337.85 Aligned_cols=245 Identities=23% Similarity=0.284 Sum_probs=199.5
Q ss_pred eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCC
Q 003780 505 YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRG 583 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 583 (796)
+.||+|+||.||+++. .+|+.||+|++.............+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999975 478999999998654333333557788999999999999999999999999999999999999
Q ss_pred cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccc
Q 003780 584 SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663 (796)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 663 (796)
+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++............
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9998887543 488999999999999999999999 9999999999999999999999999998764333333344
Q ss_pred cccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHH
Q 003780 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...............+ ......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~~~~~~p-----~~~~~~ 221 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRFP-----RTLSPE 221 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCCCCC-----CCCCHH
Confidence 569999999999999899999999999999999999999986321 1112222222222111 111234
Q ss_pred HHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 744 VTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 744 l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
+.+++.+||+.||++|| ++.+++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 77899999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.18 Aligned_cols=243 Identities=24% Similarity=0.307 Sum_probs=197.7
Q ss_pred eecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcH
Q 003780 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 585 (796)
||+|+||.||+|+.. +++.||+|++.............+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999765 6889999999765433333456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccc
Q 003780 586 FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665 (796)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 665 (796)
.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 99997643 388999999999999999999999 999999999999999999999999999986443333334467
Q ss_pred cccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHH
Q 003780 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745 (796)
Q Consensus 666 gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 745 (796)
||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...............+ ......+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~~~~~-----~~~~~~~~ 221 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEPLRFP-----DGFDRDAK 221 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCCCCC-----CcCCHHHH
Confidence 9999999999999999999999999999999999999987321 1122222222222111 11223477
Q ss_pred HHHHHcCCCCCCCCCC---HHHHHHH
Q 003780 746 TVALACLHSKPKFRPT---MQRVCQE 768 (796)
Q Consensus 746 ~li~~cl~~dP~~RPs---~~evl~~ 768 (796)
+++.+||+.||++||+ +.|++.|
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 8999999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=320.15 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=207.2
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-----c
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-----K 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~ 570 (796)
....|...+.||+|+||.|+.+.. .+|+.||||++........ ..++..+|+++++.++|+||+.+.+.+.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~-~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI-DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH-HHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 455677788999999999999964 5799999999986544432 35678899999999999999999998865 3
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...|+|+|+|+ .+|...++.... ++......+++|+++||.|+|+. +|+||||||+|++++.+...||+|||+
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 57899999994 489999986543 88999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC--CCCccccccccCccCccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCchh
Q 003780 651 ARLLDSD--SSNRTIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSDQ 717 (796)
Q Consensus 651 a~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~~ 717 (796)
|+..... ....+....|.+|+|||.+. ...|+.+.||||.||++.||++|+.-|...+.+ ..++...
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9987642 23345667899999999875 457999999999999999999999888754332 1111111
Q ss_pred hh--------HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 718 KI--------MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 718 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. .+...+......++............+++.+||..||.+|+|++|.++|-
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 00 01111222222222222233344578999999999999999999999984
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.00 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=207.8
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 575 (796)
.++|...++||+|.||+|+.+..+ +++.+|||++++...-.....+..+.|.+++.... ||.+++++.+++.+++.+.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 468999999999999999999765 68899999999988776666788999999998885 9999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||..||++..+.+. ..+++..+.-++..|+.||.|||++ +||+||||.+|||+|.+|++||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999995544432 3489999999999999999999999 99999999999999999999999999998755
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
......++.+|||.|+|||++.+..|+.++|.|||||++|||+.|..||.. ..+++....++......+.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g--------ddEee~FdsI~~d~~~yP~-- 589 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG--------DDEEEVFDSIVNDEVRYPR-- 589 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHhcCCCCCCC--
Confidence 445566778999999999999999999999999999999999999999973 2334444444444332221
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTM 762 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 762 (796)
--..+...++.+++..+|++|--+
T Consensus 590 ---~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 ---FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---cccHHHHHHHHHHhccCcccccCC
Confidence 112346689999999999999755
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=338.02 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=199.5
Q ss_pred eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCC
Q 003780 505 YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRG 583 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 583 (796)
+.||+|+||.||+++. .+|+.||+|++.............+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999975 468999999998654433334567889999999999999999999999999999999999999
Q ss_pred cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccc
Q 003780 584 SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663 (796)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 663 (796)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9998887543 488999999999999999999999 9999999999999999999999999998764333333344
Q ss_pred cccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHH
Q 003780 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ............... . ......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~~~~~~~--p---~~~~~~ 221 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEDIKF--P---RTLSAD 221 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhccCCccC--C---CCCCHH
Confidence 579999999999998899999999999999999999999986321 111111111111111 1 111234
Q ss_pred HHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 744 VTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 744 l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
+.+++.+||+.||++|| ++.|++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 77899999999999997 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=303.25 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=207.5
Q ss_pred hcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----- 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 571 (796)
.++|.+.+.+|+|||+-||.++ ..+++.||+|++......+ .+...+|++..++++||||++++++...+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~---~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED---IEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH---HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4689999999999999999996 5679999999998877443 467899999999999999999999875443
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcc-cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEA-VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
..|++++|...|+|.+.+.+.... ..+++.+.++|+.+|++||++||+. .++.+||||||.||++++.+.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 589999999999999999865433 3689999999999999999999997 34699999999999999999999999999
Q ss_pred ccccCCCCCC---------ccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhh
Q 003780 651 ARLLDSDSSN---------RTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQK 718 (796)
Q Consensus 651 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~ 718 (796)
++...-.-.. .....+|..|+|||.+. +...++++|||||||++|+|+.|..||+..-.. ..+.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSl--- 251 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSL--- 251 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeE---
Confidence 9865322111 12234789999999886 445778999999999999999999999843221 0000
Q ss_pred hHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 719 IMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
...+....+..+... ...+.+.+++++|+++||.+||++.+++..+...
T Consensus 252 --aLAv~n~q~s~P~~~---~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 --ALAVQNAQISIPNSS---RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --EEeeeccccccCCCC---CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111122222222211 1334588999999999999999999999988653
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=337.50 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=199.4
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +++.||+|++...........+.+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 6889999999876544444456788899888877 799999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|..++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 99998887543 488999999999999999999999 999999999999999999999999999976433333334
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH-hhcCCCCCccchhhHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID-VLDSRLSPPVDRMVMQDI 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 741 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||................... ........+ ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-----~~~~ 229 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-----RSLS 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC-----CCCC
Confidence 4679999999999999999999999999999999999999996432221111111111222 222222111 1122
Q ss_pred HHHHHHHHHcCCCCCCCCCC------HHHHHHH
Q 003780 742 VLVTTVALACLHSKPKFRPT------MQRVCQE 768 (796)
Q Consensus 742 ~~l~~li~~cl~~dP~~RPs------~~evl~~ 768 (796)
..+.+++.+||+.||++||+ +.++++|
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 34778999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=339.82 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=204.1
Q ss_pred hcCCccceeeecccceeEEEEEcc--CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP--NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||.||+|..+ ++..||+|++...........+.+.+|+++++.++||||+++++++..++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357999999999999999999754 346899999976544333345678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999998653 388999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+ .
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~p--~ 249 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--------PLLIYQKILEGIIYFP--K 249 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--------HHHHHHHHhcCCCCCC--C
Confidence 32 234569999999999998889999999999999999999999987322 1122222222222111 1
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
.....+.+++.+|++.||++|+ +++|+++|
T Consensus 250 ---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 ---FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1122367899999999999995 89998877
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=342.79 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=203.7
Q ss_pred hcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 570 (796)
.++|++.+.||+|+||.||+|.. .++..||||+++...... ..+.+.+|++++..+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH--HHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45789999999999999999953 246689999997554322 235788999999999 899999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCc--------------------------------------------------------
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYE-------------------------------------------------------- 594 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 594 (796)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999865321
Q ss_pred ----------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 595 ----------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 595 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
...+++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 12478889999999999999999998 99999999999999999999999999998664332
Q ss_pred CC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 659 SN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 659 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .......+..........
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--------DSKFYKMIKEGYRMLSPE 340 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--------hHHHHHHHHhCccCCCCC
Confidence 21 112335667999999999999999999999999999998 8888863211 111222222222211111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
....++.+++.+|++.||++||+++||++.|++
T Consensus 341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 112347899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=337.00 Aligned_cols=253 Identities=21% Similarity=0.346 Sum_probs=200.6
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +++.||+|+++..........+.+..|..++.++ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999754 6899999999876544444456788999999988 699999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 99998887543 489999999999999999999999 999999999999999999999999999875333333334
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhh-HHHHhhcCCCCCccchhhHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKI-MLIDVLDSRLSPPVDRMVMQDI 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
...||+.|+|||++.+..++.++||||+||++|+|++|+.||+.............. ............+ ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-----~~~~ 229 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-----RSLS 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC-----CCCC
Confidence 467999999999999999999999999999999999999999743322211111111 1222222222111 1112
Q ss_pred HHHHHHHHHcCCCCCCCCCC------HHHHHHH
Q 003780 742 VLVTTVALACLHSKPKFRPT------MQRVCQE 768 (796)
Q Consensus 742 ~~l~~li~~cl~~dP~~RPs------~~evl~~ 768 (796)
..+.+++.+|++.||.+||+ ++++++|
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 34778999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.77 Aligned_cols=262 Identities=22% Similarity=0.274 Sum_probs=198.4
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+.+ +++.||+|++....... ....+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 57999999999999999999754 68999999987543221 1346778999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++ +|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 83 EYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred eCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99985 8988886543 2478889999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCchh------hhH
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSDQ------KIM 720 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~~------~~~ 720 (796)
........+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... .+.... ...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 333334568999999998865 568899999999999999999999986322100 000000 000
Q ss_pred HHHhhcCCCCC-ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 721 LIDVLDSRLSP-PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 721 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.... ..............+++.+|++.||.+|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 0000001112347799999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.04 Aligned_cols=267 Identities=30% Similarity=0.488 Sum_probs=217.4
Q ss_pred cCCcccHHHHHHHhcC---------CccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHH
Q 003780 485 YDGRIAFEDIIKATED---------FDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHV 551 (796)
Q Consensus 485 ~~~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~ 551 (796)
+.+..+|||-.++... ..+.++||.|.||.||+|+++ ....||||.++....+.. ..+|..|+.+
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq--rrdFL~EAsI 683 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ--RRDFLSEASI 683 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHH--Hhhhhhhhhh
Confidence 4455666655544433 456789999999999999865 245699999987765543 5789999999
Q ss_pred HhhcCCCceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCC
Q 003780 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDIS 631 (796)
Q Consensus 552 l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk 631 (796)
|.++.||||+++.|+.......+||+|||++|+|+.+|+.+. ..+.+.+..-+.++||.|+.||-+. +.|||||.
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLA 758 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLA 758 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhh
Confidence 999999999999999999999999999999999999998764 3488999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeeeccccccCCCCCCc-ccccc--ccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCccc
Q 003780 632 SNNILLNSKLEAFVADFGTARLLDSDSSNR-TIVAG--TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELL 707 (796)
Q Consensus 632 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~ 707 (796)
++|||++.+...||+|||+++.+.++.... +...| +..|.|||.+.-.+++.++|||||||++||.++ |.+||=++
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 999999999999999999999887655322 22223 468999999999999999999999999999875 88886432
Q ss_pred ccCCCCCchhhhHHHHh-hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 708 SSLSSPSSDQKIMLIDV-LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 708 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.++..+..+ .+-+++++ ++.+..+.+|+..||++|-.+||.+.||+..|..
T Consensus 839 --------SNQdVIkaIe~gyRLPpP-----mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 839 --------SNQDVIKAIEQGYRLPPP-----MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred --------chHHHHHHHHhccCCCCC-----CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 222233222 22334433 3445568899999999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=356.99 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=207.1
Q ss_pred cCCccceeeecccceeEEEEEcc--CCc----EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP--NGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
...+..+.||+|+||.||+|... +|. .||||.+.+..... ...+|.+|..+|+.++|||||+++|.|.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~--~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ--EVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH--HHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 44566788999999999999754 343 48999888765443 35799999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcC----cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 573 MFLIYKYMKRGSLFCFLRNDY----EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
.++++|||++|+|..++++.. +...+...+.+.++.|||+|+.||+++ ++|||||.++|+|++....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999998762 245688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCc-ccc-ccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhh
Q 003780 649 GTARLLDSDSSNR-TIV-AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 649 g~a~~~~~~~~~~-~~~-~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
|+|+.+-...+.. ... .-...|||||.+..+.++.|+|||||||++||++| |..||...+ +.+....++
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--------n~~v~~~~~ 918 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--------NFEVLLDVL 918 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--------hHHHHHHHH
Confidence 9999554333222 111 23468999999999999999999999999999998 778876322 223333222
Q ss_pred -cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 726 -DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 726 -~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
..++.++. +. +..+.+++..||+.+|++||++..+++.+....
T Consensus 919 ~ggRL~~P~--~C---P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 EGGRLDPPS--YC---PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred hCCccCCCC--CC---ChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 23343322 12 234779999999999999999999999876543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.17 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=204.5
Q ss_pred HhcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLH 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 569 (796)
..++|++.+.||+|+||.||+|.. .++..||+|++......+ ..+.+.+|+++++.+ +||||+++++++..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345799999999999999999863 234579999997654332 245788999999999 89999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCc-------------------------------------------------------
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYE------------------------------------------------------- 594 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 594 (796)
.+..++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864311
Q ss_pred ------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC--
Q 003780 595 ------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN-- 660 (796)
Q Consensus 595 ------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 660 (796)
...+++..+.+++.||++||+|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12367888999999999999999999 9999999999999999999999999999865432211
Q ss_pred ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHH
Q 003780 661 RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQ 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ...................
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~~--- 339 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--------NSKFYKMVKRGYQMSRPDF--- 339 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--------cHHHHHHHHcccCccCCCC---
Confidence 112235567999999988899999999999999999997 9999874221 1112222222222111111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 740 DIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 740 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
....+.+++.+||+.||++||++.++++.|++.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=317.01 Aligned_cols=260 Identities=24% Similarity=0.314 Sum_probs=205.1
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCc-eeeEEeEEEecc-----
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN-IVKLYGFCLHKK----- 571 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----- 571 (796)
..|+..+.||+|+||+||+|+. .+|+.||+|++.-....+ .......+|+.++++++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4566677899999999999964 478999999998776542 23456789999999999999 999999998877
Q ss_pred -eeeEEEeeccCCcHHHHHhhcCcc-cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 572 -CMFLIYKYMKRGSLFCFLRNDYEA-VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 572 -~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
..++|+||++. +|..++...... ..++...+..++.|+++||+|||++ +|+||||||+||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 88999999977 899999876532 3467788999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC-
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS- 727 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 727 (796)
+|+...-+....+...+|.+|+|||++.+. .|++..||||+||+++||++++.-|...... .+-..+.+.+..
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-----~ql~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-----DQLFRIFRLLGTP 240 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-----HHHHHHHHHcCCC
Confidence 999877555556667799999999998876 6899999999999999999998888743321 111111111000
Q ss_pred ----------------CCCCc-----cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 728 ----------------RLSPP-----VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 728 ----------------~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..... .............+++.+|++.+|.+|.|++.+++|
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000 000001111347789999999999999999999998
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.97 Aligned_cols=260 Identities=25% Similarity=0.321 Sum_probs=199.0
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ +++.||+|++........ ...+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 468999999999999999999765 689999999875543221 23577899999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||++ ++|.+++.... ..++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99996 57877776542 3478888999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC--------
Q 003780 657 DSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS-------- 727 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 727 (796)
.........+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .............
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI----QDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhCCCChhhccc
Confidence 3333344568999999998765 45788999999999999999999999743211 0000000000000
Q ss_pred -----CCCCc-c----chhhH------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 728 -----RLSPP-V----DRMVM------QDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 728 -----~~~~~-~----~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
...+. . ..... .....+.+++.+|++.||++|||++|+++|-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 00000 0 00000 0112467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=347.56 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=211.0
Q ss_pred hcCCccceeeecccceeEEEEEccCC-cEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeE-EEe-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNG-KVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGF-CLH----- 569 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~-~~~----- 569 (796)
..++++.+.|.+|||+.||.|+...+ ..||+|++.... +...+.+.+|+++|++|+ |||||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d---e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND---EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC---HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34677889999999999999986655 999999987663 344678999999999997 9999999993 321
Q ss_pred -cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 570 -KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 570 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
..+++|.||||++|.|-+++..+.... +++.++++|+.|+++|+++||.. .|+|||||||-+|||++.+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 236889999999999999998765544 99999999999999999999985 778999999999999999999999999
Q ss_pred ccccccCCCCCC-cc--------ccccccCccCcccc---ccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCch
Q 003780 649 GTARLLDSDSSN-RT--------IVAGTYGYIAPELA---YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD 716 (796)
Q Consensus 649 g~a~~~~~~~~~-~~--------~~~gt~~y~aPE~~---~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~ 716 (796)
|.|.-....... .. ...-|+.|+|||++ .+..+++|+|||++||+||.|+....||+....+
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 999754332211 11 12368999999976 4778999999999999999999999999953322
Q ss_pred hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCcccccc
Q 003780 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEIS 784 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~ 784 (796)
.++......+.. ......+.+||..||++||++||++.+|+.++.++... ..+..++.
T Consensus 265 ------aIlng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~-~~~~~~~~ 322 (738)
T KOG1989|consen 265 ------AILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK-PCPIPDIY 322 (738)
T ss_pred ------eEEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC-CCCccccc
Confidence 233333332221 23344588999999999999999999999999776532 23444444
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.72 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=205.1
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+++.+ +|..||+|.+...... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999765 6889999998765322 2346799999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999997643 3788999999999999999999852 699999999999999999999999999976543
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC------C-----C-----------
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS------P-----S----------- 714 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~------~-----~----------- 714 (796)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.||........ . .
T Consensus 157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred c--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2 22334689999999999998999999999999999999999999863211000 0 0
Q ss_pred ---------------chhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 715 ---------------SDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 715 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
........+.+.....+... .......+.+++.+||+.||++|||++|++++..-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000000000000011100 00123358899999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.90 Aligned_cols=263 Identities=20% Similarity=0.282 Sum_probs=211.2
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+.+ +++.||||.+......+......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999754 78999999887654444444567899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 578 KYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886432 223478889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ........+.....++..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~-- 229 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLFSLCQKIEQCDYPPLP-- 229 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-------cHHHHHHHHhcCCCCCCC--
Confidence 33323334588899999999888889999999999999999999999863211 111122222221111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.......+.+++.+||+.+|++||++.+|++.+++.+
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1122345889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=386.12 Aligned_cols=318 Identities=34% Similarity=0.509 Sum_probs=223.6
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEe
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (796)
++..|+++++.+.+.++. .+..+++|++|+|++|.+.+.+|..+.++++|++|+|++|.+++.+|..+.++++|+.|+|
T Consensus 261 ~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 339 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPP-SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339 (968)
T ss_pred CCCEEECcCCeeeccCch-hHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence 455566666666555443 2455556666666666665555555555555666665555555555555555555555555
Q ss_pred cCCCCCCCCchhhhccCccceeeccccccCCC------------------------CCccccCCCCccEEEcccccccCc
Q 003780 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGP------------------------IPSAIGDLNNLLILSLDSNKLSGM 208 (796)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------------------------~p~~~~~l~~L~~L~L~~N~l~~~ 208 (796)
++|++++.+|..++.+++|+.|+|++|++++. +|..+..+++|+.|+|++|++++.
T Consensus 340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~ 419 (968)
T PLN00113 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419 (968)
T ss_pred cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence 55555555555555555555555555555544 444455555555555555555555
Q ss_pred chhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccc
Q 003780 209 LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRL 288 (796)
Q Consensus 209 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 288 (796)
.|..+.++++|+.|++++|.+++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..+.++
T Consensus 420 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l 498 (968)
T PLN00113 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSL 498 (968)
T ss_pred CChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhh
Confidence 55555555566666666666665555555566666666666666666666544 34678888888899999999999999
Q ss_pred cccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEe
Q 003780 289 SQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDL 367 (796)
Q Consensus 289 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l 367 (796)
++|++|+|++|.+.+.+|..+.++++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+ .+..|+.|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 999999999999999999999999999999999999999999999999999999999999999999887 4789999999
Q ss_pred cccccCCCCCcc--ccccccccccCCC
Q 003780 368 SHNKLNGTIPPF--LYHRFPLDLSYND 392 (796)
Q Consensus 368 ~~N~l~~~~p~~--~~~~~~l~l~~N~ 392 (796)
++|+++|.+|.. +.......+.+|.
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~ 605 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNI 605 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCc
Confidence 999999999964 2222334455664
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.62 Aligned_cols=258 Identities=25% Similarity=0.325 Sum_probs=200.7
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+.+ +++.||+|++....... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 36899999999999999999765 68899999997654332 22457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 80 EYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999998776554322 2488899999999999999999999 9999999999999999999999999999876432
Q ss_pred CC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh-----------
Q 003780 658 SS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL----------- 725 (796)
Q Consensus 658 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 725 (796)
.. ......|++.|+|||++.+..++.++||||+||++|||++|+.||...... ..........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-----DQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhhCCCCHHHHHhh
Confidence 22 223356899999999999888999999999999999999999999743210 0000000000
Q ss_pred --cCC---CC-Ccc-c------hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 --DSR---LS-PPV-D------RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 --~~~---~~-~~~-~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+.. .. +.. . .........+.+++.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 00 000 0 0000112358899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=341.05 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=206.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+.. +|+.||+|++...........+.+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999765 79999999998655433334567899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999865 3488999999999999999999998 9999999999999999999999999999866543
Q ss_pred C-----------------------------CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccc
Q 003780 658 S-----------------------------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLS 708 (796)
Q Consensus 658 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~ 708 (796)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 12233568999999999999999999999999999999999999987322
Q ss_pred cCCCCCchhhhHHHHhhc--CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH
Q 003780 709 SLSSPSSDQKIMLIDVLD--SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT-MQRVCQEF 769 (796)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L 769 (796)
.......+.. .....+... .....+.+++.+|++ ||.+||+ ++|++++.
T Consensus 235 --------~~~~~~~i~~~~~~~~~p~~~---~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 --------LQETYNKIINWKESLRFPPDP---PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred --------HHHHHHHHhccCCcccCCCCC---CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 1112222222 111111111 023347789999997 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.83 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=197.2
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +++.||+|++...........+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999765 6899999999765433333345677888888876 699999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 99999887653 388999999999999999999999 999999999999999999999999999876443333344
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+ . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~~--~---~~~~ 221 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEVVYP--T---WLSQ 221 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCCCCC--C---CCCH
Confidence 4679999999999998899999999999999999999999997322 1122222222222111 1 1123
Q ss_pred HHHHHHHHcCCCCCCCCCCH------HHHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTM------QRVCQE 768 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~------~evl~~ 768 (796)
.+.+++.+|++.||++||++ +++++|
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 47789999999999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.88 Aligned_cols=256 Identities=23% Similarity=0.254 Sum_probs=201.2
Q ss_pred eecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcH
Q 003780 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 585 (796)
||+|+||.||+++.+ +|+.||+|++...........+.+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999754 6999999999764433322234566799999999999999999999999999999999999999
Q ss_pred HHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccc
Q 003780 586 FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665 (796)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 665 (796)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 98886543 23488999999999999999999999 99999999999999999999999999998664322 223346
Q ss_pred cccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHH
Q 003780 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745 (796)
Q Consensus 666 gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 745 (796)
|+..|+|||++.+..++.++||||+||++|||++|+.||..... ..................... .....+.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 227 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTLEDEVKFEHQ----NFTEESK 227 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhhccccccccc----cCCHHHH
Confidence 89999999999988899999999999999999999999863221 011111122222222211111 1223478
Q ss_pred HHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 746 TVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 746 ~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
+++.+||+.||++||+++|+++++..+.+.
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 999999999999999998888777766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.75 Aligned_cols=250 Identities=24% Similarity=0.293 Sum_probs=199.0
Q ss_pred eecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcH
Q 003780 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 585 (796)
||+|+||+||++..+ +|+.||+|.+...........+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999754 7899999999765544433456778899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcccc
Q 003780 586 FCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664 (796)
Q Consensus 586 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 664 (796)
.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||.+.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 98875432 234589999999999999999999999 99999999999999999999999999998765443333445
Q ss_pred ccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHH
Q 003780 665 AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLV 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 744 (796)
.|++.|+|||++.+..++.++|||||||++|||++|+.||...... ................ . .......+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~--~---~~~~~~~~ 228 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRILNDSVT--Y---PDKFSPAS 228 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhcccCCC--C---cccCCHHH
Confidence 6899999999999999999999999999999999999998742211 1111111111111111 1 11123347
Q ss_pred HHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 745 TTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 745 ~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
.+++.+|++.||++|| +++++++|
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 7899999999999999 66777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.25 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=197.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+.+ +++.||+|++.............+.+|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999654 68999999997654443344567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997643 488999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCC
Q 003780 658 SS-----------------------------------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRH 702 (796)
Q Consensus 658 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~ 702 (796)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123469999999999999899999999999999999999999
Q ss_pred CCcccccCCCCCchhhhHHHHhhcC--CCCCccchhhHHHHHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Q 003780 703 PGELLSSLSSPSSDQKIMLIDVLDS--RLSPPVDRMVMQDIVLVTTVALACLH--SKPKFRPTMQRVCQE 768 (796)
Q Consensus 703 p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~ 768 (796)
||.... .......+... ....+... .......+++.+|+. .++..||+++|+++|
T Consensus 235 Pf~~~~--------~~~~~~~i~~~~~~~~~p~~~---~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSET--------PQETYKKVMNWKETLIFPPEV---PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCC--------HHHHHHHHHcCcCcccCCCcC---CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 997321 11122222211 11111000 011235566666443 233456999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.85 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=197.0
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHH---hhcCCCceeeEEeEEEecceeeEE
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVL---SKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
|++.+.||+|+||.||+|..+ +|+.||||++...........+.+..|++++ +.++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999754 6899999999765433323345566666554 567899999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|..++++. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999888643 489999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||.... .......+.......+ .
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~~~~p--~- 222 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVNDEVRYP--R- 222 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCC--C-
Confidence 3333445679999999999999899999999999999999999999987321 1112222222221111 1
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
.....+.+++.+||+.||.+|| ++.+++++
T Consensus 223 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 223 --FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1123467899999999999999 56777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.03 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=198.4
Q ss_pred eeeecccceeEEEEEc----cCCcEEEEEEeccccchh-hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 505 YCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETEE-TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
+.||+|+||.||+++. .+++.||+|++....... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 358899999997654321 22234678899999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+++|+|.+++.+.. .+.+..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987643 377888889999999999999999 999999999999999999999999999875443333
Q ss_pred CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHH
Q 003780 660 NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQ 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~~~~~~~-----~ 222 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKGKLNLPP-----Y 222 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCC-----C
Confidence 3334569999999999998889999999999999999999999987321 12222333332221111 1
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 740 DIVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 740 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
....+.+++.+|++.||++|| ++.+++++-
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 123477999999999999999 788888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=336.11 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=198.7
Q ss_pred eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCC
Q 003780 505 YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRG 583 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 583 (796)
+.||+|+||.||++.. .+|+.||+|++.............+..|++++..++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999965 478999999998654433333457788999999999999999999999999999999999999
Q ss_pred cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 584 SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
+|..++.+.. .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9998887543 48899999999999999999997 6 999999999999999999999999999875433333334
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~~~~~~p-----~~~~~ 221 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFP-----RTLSP 221 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhcCCCCCC-----CCCCH
Confidence 4569999999999999899999999999999999999999986321 1111122222211111 11123
Q ss_pred HHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 743 LVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
.+.+++.+|++.||++|+ +++++++|
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 477899999999999996 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=318.64 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=202.0
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
++|++.+.||+|+||.||+++.+++..+|+|.+...... .+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 468888999999999999999888889999988754432 2468889999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 9999999999875432 478999999999999999999999 99999999999999999999999999998654322
Q ss_pred CC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 659 SN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 659 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+... .......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~-~~~~~~~- 224 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRG-FRLYRPK- 224 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCC-CCCCCCC-
Confidence 21 112235568999999988889999999999999999999 899986321 11112222111 1111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+|++.+|++||+++|+++.|
T Consensus 225 --~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 --LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1123478999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=320.40 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=202.6
Q ss_pred cCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||.||+|..+ .+..||+|.++...... ..+.+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 46889999999999999999643 46789999998654332 2457889999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999997643 2488999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 655 DSDSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 655 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
...... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ...... +......+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~-~~~~~~~~ 228 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKA-VEDGFRLP 228 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHH-HHCCCCCC
Confidence 322111 111234678999999999999999999999999999775 9999864221 111111 12211111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.. ......+.+++.+||+.+|++||+++|+.+.|.+.
T Consensus 229 ~~---~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 AP---RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC---CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11 11233578899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=340.29 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=194.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|+..+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|+++++.++|+||+++++++..++..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 34667788999999999999754 7899999998654322 23467899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+.. ...+..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999986432 246677889999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccCccCcccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
........||..|+|||++.. ...+.++|||||||++|||++|+.||..... .. .......... .....
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~-~~~~~~~~~~-~~~~~ 295 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GD-WASLMCAICM-SQPPE 295 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----cc-HHHHHHHHhc-cCCCC
Confidence 333334569999999998743 2345689999999999999999999872211 11 1111111111 11111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. ......+.+++.+||+.||++||+++|+++|-
T Consensus 296 ~~---~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 296 AP---ATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred CC---CccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 11 11223478999999999999999999999984
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.87 Aligned_cols=249 Identities=33% Similarity=0.541 Sum_probs=192.7
Q ss_pred cceeeecccceeEEEEEcc-----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 503 IKYCIGTGGYGSVYKAQLP-----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 503 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.+.||.|.||.||+|.+. .+..|+||.+......+ ..+.+.+|++.+++++||||++++|++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE--EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH--HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc--cceeeeecccccccccccccccccccccccccccccc
Confidence 4678999999999999765 36789999996543322 2578999999999999999999999999888899999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.++++.. ....+++..+.+|+.|||+||+|||+. +++|+||+++||+++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999876 223489999999999999999999999 9999999999999999999999999999876322
Q ss_pred CCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 658 SSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 658 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... .....+...|+|||.+.+..++.++||||||+++|||++ |+.||... ......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~-~~~~~~~~~ 227 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKL-KQGQRLPIP 227 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHH-HTTEETTSB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-cccccceec
Confidence 211 223346778999999998889999999999999999999 67887632 112222222 222221111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
. .....+.+++..||+.||++||++.++++.|
T Consensus 228 ~---~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 D---NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp T---TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c---chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 1223477999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.54 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=202.3
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+.. +|+.||||++.............+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999764 68999999997654333334567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997643 388999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC--------------------------------------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh
Q 003780 658 SS--------------------------------------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM 699 (796)
Q Consensus 658 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt 699 (796)
.. ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012358999999999998899999999999999999999
Q ss_pred CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Q 003780 700 GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT---MQRVCQEF 769 (796)
Q Consensus 700 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L 769 (796)
|+.||..... ......+........... .......+.+++.+|+. +|.+|++ ++|++++-
T Consensus 235 G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 235 GYPPFCSDNP--------QETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCCH--------HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999973221 112222222111111000 00112346788999996 8999997 99998863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=331.25 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=199.6
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC-CceeeEEeEEEecceeeEEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~ 577 (796)
+|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999755 578999999986543333335678889999999976 56889999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999987543 378899999999999999999999 9999999999999999999999999998754333
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........||+.|+|||++.+..++.++||||+||++|||+||+.||.... .......+.......+ .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~~~~~~--~-- 222 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIMEHNVSYP--K-- 222 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCCC--C--
Confidence 333444569999999999999899999999999999999999999987321 1222222222222111 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTM-----QRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 768 (796)
.....+.+++.+|++.||.+||+. +++.++
T Consensus 223 -~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 223 -SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112347789999999999999986 455544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=300.79 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=208.3
Q ss_pred hcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchh-----hHHHHHHHHHHHHHhhcC-CCceeeEEeEEEec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEE-----TTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 570 (796)
-+.|...+.+|.|..++|-++. .++|.++|+|++....... ....+.-.+|+.+++++. ||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 4567778899999999999885 4578999999987543322 223456688999999995 99999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...++|+|.|+.|.|++++... ..++++...+|+.|+.+|++|||.. .||||||||+|||++++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999854 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCcccccc------CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYT------MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
|+.+.+. ......+|||+|+|||.+.. ..|+..+|+|++||++|.++.|..||-.. .+..++..+
T Consensus 170 a~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------kQmlMLR~I 240 (411)
T KOG0599|consen 170 ACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------KQMLMLRMI 240 (411)
T ss_pred eeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------HHHHHHHHH
Confidence 9988754 34556889999999998753 34777899999999999999999998632 222333334
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
+....... .....+......++|.+|++.||.+|.|++|+++|-
T Consensus 241 meGkyqF~-speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 241 MEGKYQFR-SPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HhcccccC-CcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 33333211 111223334577999999999999999999999884
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.02 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=205.6
Q ss_pred cCCccceeeecccceeEEEEEccC------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
++|++.+.||+|+||.||+|.... .+.||+|.+...... .....+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH--HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 468889999999999999997532 267999998755432 234578999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcc-------------cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEA-------------VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
.+++|||+++|+|.+++.+.... ..+++..+..++.|++.||+|||+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 99999999999999999764221 3478889999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCch
Q 003780 640 KLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSD 716 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~ 716 (796)
++.++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-------- 231 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-------- 231 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--------
Confidence 99999999999986543221 1223346788999999988889999999999999999998 999987321
Q ss_pred hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.. .....+........ .......+.+++.+||+.||.+||+++||+++|+.
T Consensus 232 ~~-~~~~~i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 232 NQ-EVIEMIRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH-HHHHHHHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 12222222222221 11223458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.31 Aligned_cols=257 Identities=24% Similarity=0.308 Sum_probs=204.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+++.+ +++.||+|++...........+.+.+|+.+++.++||||+++++++..+...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999754 689999999976443333334567889999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.+++.+. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998753 277888889999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-CccccccccCccCccccccC----CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 656 SDSS-NRTIVAGTYGYIAPELAYTM----VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 656 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+......
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~ 265 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMDHKNS 265 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCCc
Confidence 3322 22345699999999988643 47889999999999999999999987422 11222333322211
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKF--RPTMQRVCQEF 769 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 769 (796)
..... .......+.+++.+|++.+|++ ||+++|+++|-
T Consensus 266 ~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 266 LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 11111 1112235778999999999998 99999998874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.30 Aligned_cols=258 Identities=27% Similarity=0.381 Sum_probs=194.8
Q ss_pred cCCccceeeecccceeEEEEEc-c-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc---CCCceeeEEeEEEe----
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-P-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI---AHRNIVKLYGFCLH---- 569 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---- 569 (796)
++|++.+.||+|+||.||+|+. + +++.||+|++......+.. ...+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 3689999999999999999975 3 4788999998765433221 23456677776665 69999999999852
Q ss_pred -cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 570 -KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 570 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999997 589988875432 3478999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh---
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL--- 725 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 725 (796)
|+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.+..
T Consensus 155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-----~~~~~i~~~~~~~ 228 (290)
T cd07862 155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGLP 228 (290)
T ss_pred cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHHhCCC
Confidence 999876533 2233456899999999998888999999999999999999999998743211 0000000000
Q ss_pred ----------------cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 ----------------DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 ----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..................+.+++.+|++.||++|||+.|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000000001011122346799999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=326.28 Aligned_cols=264 Identities=25% Similarity=0.332 Sum_probs=211.8
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.+...+.+.||+|-||.|..+....+..||||+++....... .++|.+|+++|.+++||||++++|.|..++..++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~--r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA--RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH--HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 345567789999999999999998889999999998876543 479999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|||++|+|.+++.++.... .+...-.+|+.|||.|++||.+. ++||||+.++|+|++.++++||+|||+++-+-..
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999998774322 45566678999999999999998 9999999999999999999999999999965433
Q ss_pred CCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh--CCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 658 SSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 658 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
++. .....-+..|||||.+.-+++++++|||+||+++||+++ ...||....+ ..-.+......+..-....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCccee
Confidence 332 223345678999999999999999999999999999875 6788774322 1111122223332222222
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
...+.-...++.+++.+||..|-++||+++++..+|++.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222223334577999999999999999999999998764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=330.00 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=193.8
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999754 5889999999865433333344556677777654 799999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 99999987643 388899999999999999999999 999999999999999999999999999986543333344
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... .... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~--~~~~---~~~~ 221 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFDSILNDRP--HFPR---WISK 221 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCC--CCCC---CCCH
Confidence 5679999999999999899999999999999999999999987321 1112222221111 1111 1123
Q ss_pred HHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTMQ-RVCQE 768 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~-evl~~ 768 (796)
.+.+++.+||+.||++||++. +++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 467899999999999999875 55553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.96 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=209.7
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
...+|++.+.||+|+||.||+|..++++.+|+|.+....... ...+..|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh---HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 445788999999999999999998889999999987654422 35788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999998643 23478999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.........++..|+|||...+..++.++||||||+++|+|++ |+.||.... ......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~~- 226 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQIT-AGYRMPCP- 226 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHH-hCCcCCCC-
Confidence 3332233346678999999988889999999999999999998 899986322 111222222 22222111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|++.||++|||++++++.|+.
T Consensus 227 --~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 --AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=319.17 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=212.5
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|++|.||+|... +|+.||+|.++.....+....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999765 79999999987654443344568899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 578 KYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
||+++|+|.+++.+.. ....+++..+..++.++++||+|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987532 234578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ......+.+.....++..
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~-- 229 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLYSLCKKIEKCDYPPLP-- 229 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-------cHHHHHhhhhcCCCCCCC--
Confidence 43333445688899999999888899999999999999999999999863211 111111111111111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.......+.+++.+|++.+|++||++.+|++.+++..
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1122345789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.83 Aligned_cols=243 Identities=24% Similarity=0.301 Sum_probs=192.6
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHH-HHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAH-VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||+||+|+.+ +|+.||+|++...........+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999764 79999999997654333222345555554 56789999999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.+++.+.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 99999987643 478889999999999999999999 999999999999999999999999999875433333344
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ................ . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~-~----~~~~ 221 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKPLRLK-P----NISV 221 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCCC-C----CCCH
Confidence 4569999999999999999999999999999999999999987321 1122222222222111 1 1123
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTMQRVC 766 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~evl 766 (796)
.+.+++.+|++.||.+||++.+.+
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCCCH
Confidence 477899999999999999985333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=339.03 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=198.7
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|+..+.||+|+||+||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999964 4689999999976554444445678999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987643 378888899999999999999999 99999999999999999999999999975431100
Q ss_pred -----------------------------------------------CCccccccccCccCccccccCCcCcchhHHHHH
Q 003780 659 -----------------------------------------------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFG 691 (796)
Q Consensus 659 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG 691 (796)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001124699999999999988899999999999
Q ss_pred HHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc--CCCCCccchhhHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHH
Q 003780 692 VVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD--SRLSPPVDRMVMQDIVLVTTVALA--CLHSKPKFRPTMQRVCQ 767 (796)
Q Consensus 692 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~ 767 (796)
|++|||++|+.||..... ......+.. .....+... ....++.+++.+ |+..+|..||+++|+++
T Consensus 236 ~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~~---~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP--------TETQLKVINWENTLHIPPQV---KLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hHHHHHHhCCCCCcCCCH--------HHHHHHHHccccccCCCCCC---CCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999999973221 111111221 111111100 112236677777 55666667999999998
Q ss_pred HH
Q 003780 768 EF 769 (796)
Q Consensus 768 ~L 769 (796)
|-
T Consensus 305 hp 306 (381)
T cd05626 305 HP 306 (381)
T ss_pred Cc
Confidence 74
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=330.92 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=200.6
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999755 6789999999865433333345667788888777 5899999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999887543 378899999999999999999999 9999999999999999999999999999764433
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~~~~~~p~---- 222 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHNVAYPK---- 222 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCC----
Confidence 333445679999999999999999999999999999999999999997321 12222223332222111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTM-----QRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 768 (796)
.....+.+++.+|++.||++|++. .++.++
T Consensus 223 -~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 223 -SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 122347789999999999999985 555544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.91 Aligned_cols=255 Identities=24% Similarity=0.271 Sum_probs=203.5
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|++.+.||+|+||+||++.. .+++.||+|++.............+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999975 4689999999976544333334567889999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886542 23488999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
. .....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+...+..... .. ..
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~-~~---~~ 226 (285)
T cd05605 157 T-IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-----KVKREEVERRVKEDQE-EY---SE 226 (285)
T ss_pred c-cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-----hhHHHHHHHHhhhccc-cc---Cc
Confidence 2 2234689999999999988899999999999999999999999974221 1111112222221111 11 11
Q ss_pred HHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
.....+.+++.+|++.||++|| ++++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1233477999999999999999 88888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.96 Aligned_cols=262 Identities=25% Similarity=0.328 Sum_probs=196.5
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----cee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-----KCM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 573 (796)
+|++.+.||+|+||.||+|.. .+|+.||||++....... .....+.+|++++++++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 588899999999999999975 478999999987543222 2235688999999999999999999988643 247
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+. ++|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99999996 68988887543 388999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC---CccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCchhh
Q 003780 654 LDSDSS---NRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSDQK 718 (796)
Q Consensus 654 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~~~ 718 (796)
...... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 1233568999999999865 578899999999999999999999986422100 0000000
Q ss_pred --------hHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 719 --------IMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 719 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+..................+.+++.+|++.||++|||++|++++-
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 000011111111111110111223477999999999999999999999883
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=317.96 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=205.7
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|++|.||+|...+++.||+|.+...... .+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 4578999999999999999999888889999998754332 357899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999997643 23478889999999999999999998 9999999999999999999999999999876432
Q ss_pred CCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
... .....++..|+|||+..+..++.++|||||||++|+|++ |+.||.... ..... ..+......+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--------~~~~~-~~~~~~~~~~~~~ 227 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--------NSDVM-SALQRGYRMPRME 227 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--------HHHHH-HHHHcCCCCCCCC
Confidence 211 122335678999999988889999999999999999998 999986321 11111 1111111111111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.02 Aligned_cols=257 Identities=24% Similarity=0.316 Sum_probs=202.6
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+++.+ +++.||+|++...........+.+.+|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999765 688999999875443333334567899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999998753 278888999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-CccccccccCccCccccccC----CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 656 SDSS-NRTIVAGTYGYIAPELAYTM----VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 656 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+......
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~ 265 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIMDHKNS 265 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCcc
Confidence 3322 22345699999999998653 37789999999999999999999997322 12222333332211
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKF--RPTMQRVCQEF 769 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 769 (796)
..... .......+.+++..|++.+|.+ ||+++|+++|-
T Consensus 266 ~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 266 LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 11111 0111234668889999866654 89999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=331.60 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=198.3
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +++.||+|++...........+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999765 5889999999765433333345677888888866 799999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 99999887543 378899999999999999999999 999999999999999999999999999876443333344
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~~~~p~-----~~~~ 221 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDDVLYPV-----WLSK 221 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCC-----CCCH
Confidence 4569999999999998899999999999999999999999997322 12222222222221111 1123
Q ss_pred HHHHHHHHcCCCCCCCCC-------CHHHHHHHH
Q 003780 743 LVTTVALACLHSKPKFRP-------TMQRVCQEF 769 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RP-------s~~evl~~L 769 (796)
.+.+++.+|++.||++|| ++++++++-
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 477899999999999999 788887663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=321.99 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=203.6
Q ss_pred HhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
..++|++.+.||+|+||.||+|..+ .++.||+|++...... ....++.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4678999999999999999998643 3577999998654322 2245788999999999999999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCc-------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcE
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYE-------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEA 643 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 643 (796)
...++||||+++|+|.+++++... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 999999999999999999875432 13367888999999999999999998 99999999999999999999
Q ss_pred EEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhH
Q 003780 644 FVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIM 720 (796)
Q Consensus 644 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (796)
+|+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |..||.... ....
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQV 230 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHH
Confidence 99999998765432211 112345778999999998889999999999999999999 688876321 1122
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.............. .....+.+++.+|++.||++|||+.|+++.+++
T Consensus 231 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LRFVMEGGLLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22222222211111 122357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.26 Aligned_cols=257 Identities=24% Similarity=0.326 Sum_probs=216.8
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 574 (796)
..+.|++.+.||.|.||.||+++.+ +|+.+|+|.+.+...........+.+|+++|+++. |||||.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3567888899999999999999766 49999999998877655444568999999999998 999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC----CcEEEeeecc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK----LEAFVADFGT 650 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~ 650 (796)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+. ||+|||+||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999866 289999999999999999999998 99999999999999643 4799999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
+..... .......+||+.|+|||++.+..|+..+||||+||++|.|++|..||.... .......+......
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~--------~~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET--------EFEIFLAILRGDFD 256 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC--------hhHHHHHHHcCCCC
Confidence 998876 555667889999999999999999999999999999999999999998432 22233344444332
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..... .........+++..|+..||.+|+|++++++|.+
T Consensus 257 f~~~~-w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 257 FTSEP-WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCCCC-ccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 21111 1222345778999999999999999999999854
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.19 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=193.5
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +|+.||+|.+...........+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999765 6899999999765432222244567788887754 899999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+++..........
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 99999987643 378899999999999999999999 999999999999999999999999999875433333344
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.... +.... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--------~~~~~~~~~~~~--~~~~~---~~~~ 221 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--------EDELFESIRVDT--PHYPR---WITK 221 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC--CCCCC---CCCH
Confidence 5679999999999999999999999999999999999999987321 111111111111 11111 1123
Q ss_pred HHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTMQ-RVCQE 768 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~-evl~~ 768 (796)
.+.+++.+|++.||++||++. ++.+|
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 467899999999999999984 66544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=340.21 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=199.8
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+++. .+++.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999965 478999999987654433344567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999997543 378888999999999999999999 9999999999999999999999999998633210
Q ss_pred CC-----------------------------------------------CccccccccCccCccccccCCcCcchhHHHH
Q 003780 658 SS-----------------------------------------------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSF 690 (796)
Q Consensus 658 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSl 690 (796)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012458999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHH
Q 003780 691 GVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFR---PTMQRVCQ 767 (796)
Q Consensus 691 Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 767 (796)
||++|||++|+.||..... ......+........... .......+.+++.+|++ +|.+| +++.|+++
T Consensus 235 Gvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS--------HETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred chhhhhhhcCCCCCCCCCH--------HHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 9999999999999973221 111222221111111110 00112347789999998 66665 69999998
Q ss_pred HH
Q 003780 768 EF 769 (796)
Q Consensus 768 ~L 769 (796)
+-
T Consensus 305 hp 306 (377)
T cd05629 305 HP 306 (377)
T ss_pred CC
Confidence 84
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.38 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=206.2
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|++|.||+|...+++.||+|.++..... .+++.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 4678999999999999999998877889999998765432 357889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999997653 23478999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCc-cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSNR-TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.... .....+..|+|||++.+..++.++||||||+++|||++ |+.||.... ... ....+.........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~-~~~~~~~~~~~~~~- 226 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--------NAE-VLQQVDQGYRMPCP- 226 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------HHH-HHHHHHcCCCCCCC-
Confidence 2211 11123457999999998889999999999999999999 999986321 111 11222222211111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|++.+|++||++.++.+.|++
T Consensus 227 --~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 --PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1223458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.05 Aligned_cols=257 Identities=24% Similarity=0.274 Sum_probs=197.0
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..+|++.+.||+|+||.||+|.. .+++.||+|.... +.+.+|++++++++||||+++++++..+...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 35799999999999999999965 5789999996431 3467899999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+|++. ++|..++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 162 ~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99986 68888886543 378999999999999999999999 999999999999999999999999999975432
Q ss_pred CC-CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCC--Cchhh---------------
Q 003780 657 DS-SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP--SSDQK--------------- 718 (796)
Q Consensus 657 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~--~~~~~--------------- 718 (796)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.|+......... .....
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 21 2223356999999999999989999999999999999999999886432211100 00000
Q ss_pred ----hHHHH----hhcCCC-CCc---cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 719 ----IMLID----VLDSRL-SPP---VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 719 ----~~~~~----~~~~~~-~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..... ...... .+. ...........+.+++.+||+.||++|||++|++++-.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 00000 000000 000 00001122346889999999999999999999998743
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.44 Aligned_cols=268 Identities=25% Similarity=0.408 Sum_probs=205.8
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc--CCCceeeEEeEEEecc----e
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI--AHRNIVKLYGFCLHKK----C 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~----~ 572 (796)
...+..+.||+|.||.||||++. ++.||||++.... .+.|.+|.++.+.. +|+||++++++-.... .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 34556778999999999999986 5999999996443 45788888888764 7999999999887655 8
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC------CCCeEEecCCCCCeEecCCCcEEEe
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC------MPSIVHRDISSNNILLNSKLEAFVA 646 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~dlkp~NIll~~~~~~kl~ 646 (796)
++||+||.+.|+|.++|+.+ .++|....+|+..+++||+|||+.. .|+|+|||||++|||+..|++..|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 99999999999999999875 3899999999999999999999863 4689999999999999999999999
Q ss_pred eeccccccCCCCCC--ccccccccCccCccccccCC-cC-----cchhHHHHHHHHHHHHhCCCCCcc--cccCCC----
Q 003780 647 DFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMV-VT-----EKCDVYSFGVVALEVLMGRHPGEL--LSSLSS---- 712 (796)
Q Consensus 647 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~-----~~~DVwSlGv~l~elltg~~p~~~--~~~~~~---- 712 (796)
|||+|..+...... ....+||.+|||||++.+.. .. .+.||||+|.|+|||+++-.-++. ......
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999887654322 12256999999999987643 11 368999999999999986544321 111000
Q ss_pred ---CCchhhhHHHHhhcCCCCCccchhh--HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcccc
Q 003780 713 ---PSSDQKIMLIDVLDSRLSPPVDRMV--MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALV 777 (796)
Q Consensus 713 ---~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 777 (796)
....-..+...++.++.+|...+.. ...+..+.+.+..||+.||+.|-|+.=|.+.+.++.....
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0011122233344444444433321 2445678999999999999999999999999887765543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=318.85 Aligned_cols=262 Identities=19% Similarity=0.283 Sum_probs=210.9
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|++|.||+++. .+++.+|||.+......+....+++.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999974 579999999887655444444568899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 578 KYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999887432 234588999999999999999999999 999999999999999999999999999887654
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........++..|+|||+..+..++.++||||||+++|+|++|..||..... ...............+...
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~-- 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCDYPPLPS-- 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhhhcCCCCCCCc--
Confidence 43333345688999999999888899999999999999999999999863211 0111111111111111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
......+.+++.+|++.||++||||.+|++.+++.
T Consensus 231 -~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 231 -DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 12234588999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.02 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=205.4
Q ss_pred hcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
.++|.+.+.||+|+||.||+|... +++.||+|.+......+ ..+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH--HHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 356888899999999999999753 35789999987654432 2468999999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCc-----------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYE-----------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
..++||||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 99999999999999999976421 24478889999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchh
Q 003780 641 LEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~ 717 (796)
+.++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--------~ 230 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--------N 230 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--------H
Confidence 9999999999976533221 1223346788999999999999999999999999999998 999986321 1
Q ss_pred hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
................. .....+.+++.+||+.||++||++.|+++.|+
T Consensus 231 ~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 EEVIECITQGRLLQRPR----TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11222222222211111 12335789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.38 Aligned_cols=251 Identities=23% Similarity=0.247 Sum_probs=202.1
Q ss_pred CCccceeeecccceeEEEEEcc-C-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-N-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.|.+.+.||+|++|.||+|... + ++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4889999999999999999643 4 67888887754432 22346788999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 578 KYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
||+++|+|.++++.. .....+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999988653 2234578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............+...
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~~~~~~~ 293 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGKYDPFPC 293 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCCc
Confidence 321 1334569999999999999899999999999999999999999986321 122222222222221111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+||+.||++||++++++.+
T Consensus 294 ----~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 294 ----PVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----cCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 122347889999999999999999999765
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.84 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=202.8
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
++|++.+.||+|+||+||+|+..++..+|+|.+...... .+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 468888999999999999998877778999998755432 3468899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999999976432 489999999999999999999999 99999999999999999999999999988654332
Q ss_pred CCc-cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 659 SNR-TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 659 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
... ....++..|+|||+..+..++.++|||||||++|+|++ |+.||.... ........... .......
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~~~- 224 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--------NSETVEKVSQG-LRLYRPH- 224 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHhcC-CCCCCCC-
Confidence 211 12235677999999988889999999999999999998 999986322 11112222221 1111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.....+.+++.+||+.+|++||++.++++.++
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 --LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12345789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=331.17 Aligned_cols=250 Identities=23% Similarity=0.268 Sum_probs=195.6
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHH-HHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAH-VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +++.||+|++.............+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999765 67889999997654332222334444444 56788999999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.+++.... .+.+..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 99999987643 377888888999999999999999 999999999999999999999999999976443333344
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... ................ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~~-----~~~~~ 221 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKPLQLK-----PNITN 221 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCCcCCC-----CCCCH
Confidence 5679999999999999999999999999999999999999987321 1122222222222111 11123
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 743 LVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.+.+++.+|++.||.+||++.+.+.++.+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 4778999999999999999886665555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.38 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=205.4
Q ss_pred HhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLH 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 569 (796)
..++|.+.+.||+|+||.||+|... .+..||||++...... ...+.+.+|+++++++. ||||+++++++.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3568999999999999999999642 2457999999765432 22457899999999996 9999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCc-------------------------------------------------------
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYE------------------------------------------------------- 594 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 594 (796)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998865311
Q ss_pred --------------------------------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeE
Q 003780 595 --------------------------------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNIL 636 (796)
Q Consensus 595 --------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 636 (796)
...+++..+.+++.|+++||+|||+. +|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 12367888899999999999999998 9999999999999
Q ss_pred ecCCCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCC
Q 003780 637 LNSKLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSP 713 (796)
Q Consensus 637 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~ 713 (796)
++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---- 345 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---- 345 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence 99999999999999986543221 1222346788999999998889999999999999999997 9999863211
Q ss_pred CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.......+.......... .....+.+++.+||+.||++||++.+|.+.|++..
T Consensus 346 ----~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 346 ----DSTFYNKIKSGYRMAKPD---HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----hHHHHHHHhcCCCCCCCc---cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111222222111111 12335789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.21 Aligned_cols=249 Identities=24% Similarity=0.286 Sum_probs=196.2
Q ss_pred eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHH-HHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAH-VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+. .+|+.||+|++...........+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999975 478999999997654333233345555655 46778999999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|..++.+.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99998887543 488999999999999999999999 999999999999999999999999999875433333344
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ................. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~~~~~~-----~~~~ 221 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKPLVLRP-----GASL 221 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCCccCCC-----CCCH
Confidence 5679999999999999999999999999999999999999987321 11222222222221111 1223
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 743 LVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+.+++.+|++.+|.+||++.+.++++..+
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 467899999999999999987555555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=328.48 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=198.3
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||+||+|+.+ +++.||+|++...........+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999765 5889999999865433333345677888988887 699999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|..++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 99999887653 389999999999999999999999 999999999999999999999999999875433333334
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.......+ .....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~~~~~~~~-----~~~~~ 221 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSILEDEVRYP-----RWLSK 221 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCCCC-----CcCCH
Confidence 4568999999999999999999999999999999999999987322 1112222222222111 11123
Q ss_pred HHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTM-----QRVCQE 768 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~-----~evl~~ 768 (796)
.+.+++.+||+.||++||++ .+++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 47799999999999999999 888776
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=327.12 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=193.1
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +++.||+|++...........+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999765 5789999999865432222234566778887764 899999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 99999987543 378899999999999999999999 999999999999999999999999999875433223334
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+..... .... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~~--~~~~---~~~~ 221 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRMDNP--CYPR---WLTR 221 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC--CCCc---cCCH
Confidence 4568999999999998899999999999999999999999987321 1111111111111 1111 1123
Q ss_pred HHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTMQ-RVCQE 768 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~-evl~~ 768 (796)
.+.+++.+|++.||++||++. ++.++
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 467899999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.72 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=202.9
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||++..+ +++.+|+|.+...... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 468999999999999999999765 6889999988765322 2245789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999997643 3788899999999999999999742 799999999999999999999999999976533
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC----------CCc-----------
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS----------PSS----------- 715 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~----------~~~----------- 715 (796)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 2 12234689999999999988899999999999999999999999863211000 000
Q ss_pred --------------hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 716 --------------DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 716 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.........+.....+.... .....++.+++.+||+.||++|||++|++++-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS--GVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCC--CCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 00000000000000000000 011234789999999999999999999998843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.33 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=206.9
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|++|.||+|..+ +++.|++|.+....... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4778899999999999999754 68999999987554332 234678999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.++++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999998652 24588999999999999999999998 99999999999999999999999999998765543
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......|++.|+|||+..+..++.++|||||||++|+|++|+.||.... .............. ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~~~--- 223 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRGVFP-PVSQ--- 223 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCC-CCcc---
Confidence 33344568899999999998889999999999999999999999987322 12222222222221 1111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|++.+|++||++.+++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 223357899999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.59 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=202.0
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|+.++++++||||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 35799999999999999999975 578999999987543322 34678899999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+||+++++|.+++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999987543 378999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 657 DSSNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
.........|++.|+|||.+. ...++.++||||+||++|||++|+.||...... ............+..
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~ 230 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMSKSNFQPPK 230 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--------hhheeeecCCCCCCC
Confidence 333233456888999999874 345778999999999999999999998633211 001111111111111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..........+.+++.+||+.+|++||+++++++++
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000111234578999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=329.58 Aligned_cols=240 Identities=25% Similarity=0.331 Sum_probs=190.8
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHH-HHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAH-VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +|+.||+|++...........+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999764 68999999997654333333345555554 67889999999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|..++.+.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 99998887543 378888899999999999999998 999999999999999999999999999875433333334
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+.......+ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~~-----~~~~~ 221 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHKPLQLP-----GGKTV 221 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcCCCCCC-----CCCCH
Confidence 4568999999999998889999999999999999999999987321 1122222222222111 11223
Q ss_pred HHHHHHHHcCCCCCCCCCCHH
Q 003780 743 LVTTVALACLHSKPKFRPTMQ 763 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~ 763 (796)
.+.+++.+|++.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 477899999999999999765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=309.50 Aligned_cols=255 Identities=23% Similarity=0.292 Sum_probs=216.8
Q ss_pred cCCccceeeecccceeEEEEEccC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|+..+.||.|.-|+||.++.++ +..+|+|++.+..........+...|.+||+.++||.+..+++.++.++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778899999999999998764 5899999999888776666778899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC-
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS- 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 656 (796)
|||+||+|..+.+++.. ..+++..+..++..|+-||+|||.. |||.|||||+|||+.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999987644 5589999999999999999999999 999999999999999999999999999754311
Q ss_pred --------------------------------CCCC-----------------------ccccccccCccCccccccCCc
Q 003780 657 --------------------------------DSSN-----------------------RTIVAGTYGYIAPELAYTMVV 681 (796)
Q Consensus 657 --------------------------------~~~~-----------------------~~~~~gt~~y~aPE~~~~~~~ 681 (796)
.... ....+||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0000 011458999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCC
Q 003780 682 TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761 (796)
Q Consensus 682 ~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 761 (796)
+.++|+|+|||++|||+.|.-||.. ......+..++...+..+... .......+||++.|.+||.+|-.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG--------~~~~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKG--------SNNKETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCC--------CCchhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhc
Confidence 9999999999999999999999973 445667777877776654433 33345789999999999999998
Q ss_pred ----HHHHHHH
Q 003780 762 ----MQRVCQE 768 (796)
Q Consensus 762 ----~~evl~~ 768 (796)
+.||-+|
T Consensus 382 ~~rGA~eIK~H 392 (459)
T KOG0610|consen 382 SKRGAAEIKRH 392 (459)
T ss_pred cccchHHhhcC
Confidence 7777666
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=344.14 Aligned_cols=256 Identities=24% Similarity=0.276 Sum_probs=204.9
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK---- 571 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 571 (796)
..++|.+.+.||+|+||+||+|+. .+|+.||||++........ ....+.+|+..+..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA-DKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH-HHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 457999999999999999999964 5799999999976544332 2457889999999999999999988775432
Q ss_pred ----eeeEEEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEe
Q 003780 572 ----CMFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA 646 (796)
Q Consensus 572 ----~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 646 (796)
..++||||+++|+|.++++... ....+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999987542 234588999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCC--CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh
Q 003780 647 DFGTARLLDSDS--SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 647 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMHKT 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHH
Confidence 999998764321 12234569999999999999999999999999999999999999987321 11222222
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.. ......+.+++.+||+.||++||++.+++++
T Consensus 258 ~~~~~~~~~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYDPLP----PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222221111 1122347899999999999999999999876
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=338.09 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=197.2
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|+..+.||+|+||+||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999975 4688999999976544334445678999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987643 378888899999999999999999 99999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCccccccccCccCccccccCCcCcchhHHHHH
Q 003780 659 -----------------------------------------------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFG 691 (796)
Q Consensus 659 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG 691 (796)
.......||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc--CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHH
Q 003780 692 VVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD--SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT---MQRVC 766 (796)
Q Consensus 692 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 766 (796)
|++|||++|+.||..... ......+.. .....+... .......+++.+|+ .+|++|++ +.|++
T Consensus 236 vil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~---~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP--------LETQMKVINWQTSLHIPPQA---KLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHHHhCCCCCCCCCH--------HHHHHHHHccCCCcCCCCcc---cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999999973221 111112221 111111111 11223567777776 49999987 88888
Q ss_pred HH
Q 003780 767 QE 768 (796)
Q Consensus 767 ~~ 768 (796)
+|
T Consensus 304 ~h 305 (382)
T cd05625 304 AH 305 (382)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.00 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=203.7
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+++.+ +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36889999999999999999754 78999999998765433344567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997652 2488999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ccccccccCccCccccc------cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 658 SSN-RTIVAGTYGYIAPELAY------TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 658 ~~~-~~~~~gt~~y~aPE~~~------~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~ 227 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQRF 227 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCCc
Confidence 222 23346899999999986 45677899999999999999999999873211 1122222221111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..... .......+.+++..|++ +|.+||+++++++|
T Consensus 228 ~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 LKFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cCCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01110 01122347789999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.22 Aligned_cols=255 Identities=29% Similarity=0.426 Sum_probs=204.4
Q ss_pred cCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||+||+|..+ +...||+|.+....... ....+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK--QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 57889999999999999999764 24579999887654332 2457889999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++++|.+++..... .+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++|+|||++...
T Consensus 82 iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 82 IITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999976432 588999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 655 DSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 655 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
...... .....++..|+|||...+..++.++||||||+++|+|++ |..||.... ..............+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~ 228 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAVEDGYRLP 228 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHHHHHHcCCCCC
Confidence 522211 112234678999999998889999999999999999998 999985321 111112221111111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.. ......+.+++.+|++.+|++||++.|++++|++.
T Consensus 229 ~~----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 PP----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 12234578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=329.70 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=199.6
Q ss_pred CCccceeeecccceeEEEEEc----cCCcEEEEEEeccccch-hhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEeccee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETE-ETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 573 (796)
+|++.+.||+|+||.||+++. .+++.||+|++...... .....+.+..|+.++++++ ||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999864 35889999999764322 1223456788999999995 99999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 388999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 654 LDSDSS-NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 654 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............. +
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~--~ 228 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRILKCD--P 228 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHHhcCC--C
Confidence 543322 22345699999999998765 4788999999999999999999999633211 11111111111111 1
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
.... .....+.+++.+|++.||++|| ++++++++-
T Consensus 229 ~~~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 229 PFPS---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCCC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 1111 1123467899999999999999 777888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.58 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=204.4
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.+|++.+.||+|++|.||+|..+ .++.||+|.+...... .+++.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH----HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 45888899999999999999754 5889999998754322 357889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999987543 23478999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCc-cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSNR-TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.... .......+..........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~ 228 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYELLEKGYRMERPE 228 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---------HHHHHHHHHCCCCCCCCC
Confidence 2211 11224568999999998899999999999999999998 889976321 111122222222222111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.....+.+++.+|++.||++||++.++++.|+..
T Consensus 229 ---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 ---GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1234588999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=329.38 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=202.9
Q ss_pred hcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 570 (796)
.++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+..|+.++.++ +||||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 457999999999999999999532 3578999999755432 2245778899999999 799999999988754
Q ss_pred -ceeeEEEeeccCCcHHHHHhhcCc-------------------------------------------------------
Q 003780 571 -KCMFLIYKYMKRGSLFCFLRNDYE------------------------------------------------------- 594 (796)
Q Consensus 571 -~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 594 (796)
...++++||+++|+|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999999864321
Q ss_pred ---ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC--ccccccccC
Q 003780 595 ---AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYG 669 (796)
Q Consensus 595 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~ 669 (796)
...+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++.+...... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12578999999999999999999999 9999999999999999999999999999876433221 222345678
Q ss_pred ccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHH
Q 003780 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVA 748 (796)
Q Consensus 670 y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 748 (796)
|+|||++.+..++.++|||||||++|||++ |..||..... .......+.......... .....+.+++
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 309 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--------DEEFCRRLKEGTRMRAPE---YATPEIYSIM 309 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--------cHHHHHHHhccCCCCCCc---cCCHHHHHHH
Confidence 999999999999999999999999999998 9999863211 011112222221111111 1223578999
Q ss_pred HHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 749 LACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 749 ~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+|++.+|++||++.|++++|++.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.77 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=198.9
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|+.+ +++.||+|++...........+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 6889999999876554444456788999999888 599999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|..++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 99998887543 389999999999999999999999 999999999999999999999999999975433333334
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ................+ . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~p--~---~~~~ 228 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIRIP--R---FLSV 228 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCCCC--C---CCCH
Confidence 5679999999999999999999999999999999999999996432211111 11111112222211111 1 1123
Q ss_pred HHHHHHHHcCCCCCCCCCCH------HHHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTM------QRVCQE 768 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~------~evl~~ 768 (796)
.+.+++.+||+.||++||++ .++.+|
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 46789999999999999985 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=338.79 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=197.7
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 689999999999999999975 4689999999976543333334678899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999997643 378888899999999999999999 99999999999999999999999999975321000
Q ss_pred -------------------------------------------CCccccccccCccCccccccCCcCcchhHHHHHHHHH
Q 003780 659 -------------------------------------------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVAL 695 (796)
Q Consensus 659 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ 695 (796)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0011246999999999999999999999999999999
Q ss_pred HHHhCCCCCcccccCCCCCchhhhHHHHhhcC--CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH
Q 003780 696 EVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS--RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRP---TMQRVCQE 768 (796)
Q Consensus 696 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 768 (796)
||++|+.||..... ......+... ....+.. ......+.+++.+|+ .+|.+|+ ++.|+++|
T Consensus 236 ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~---~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTP--------AETQLKVINWETTLHIPSQ---AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCH--------HHHHHHHhccCccccCCCC---CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999974221 1111111111 1111110 011223567777776 5999999 89999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.45 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=193.9
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----ee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK-----CM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~ 573 (796)
.|...+++|.|+||.||+|... +++.||||++..+.... .+|+++|+.++|||||++.-+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 4667899999999999999754 57999999998766432 45899999999999999999886532 34
Q ss_pred eEEEeeccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEeeeccc
Q 003780 574 FLIYKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTA 651 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a 651 (796)
.+|||||+. +|.+.++.. .....++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 589999987 898888742 1223477777888999999999999998 99999999999999987 88999999999
Q ss_pred cccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh-----
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL----- 725 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 725 (796)
+.+.....+ ..+.+|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|...+.. .+-..+.+++
T Consensus 174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-----dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-----DQLVEIIKVLGTPTR 247 (364)
T ss_pred eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-----HHHHHHHHHhCCCCH
Confidence 988766555 445678889999988765 6999999999999999999999888743221 1111111110
Q ss_pred --------------cCCCCCc-cch-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 --------------DSRLSPP-VDR-MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 --------------~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.+.+... ... .......+..+++.++++.+|.+|.++.|++.|
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0111110 000 111223457899999999999999999999987
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.44 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=203.3
Q ss_pred cCCccceeeecccceeEEEEEc-----cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
++|++.+.||+|+||.||+|.. .+++.||+|.+...... .....+.+|++++++++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4688889999999999999963 35688999999754332 2246788999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCc--------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 574 FLIYKYMKRGSLFCFLRNDYE--------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
++||||+++++|.+++..... ...+++.....++.|++.||+|||+. +++||||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 999999999999999864321 23478889999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCch
Q 003780 640 KLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSD 716 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~ 716 (796)
++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-------- 231 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-------- 231 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------
Confidence 99999999999986543221 1222345678999999988889999999999999999998 888986321
Q ss_pred hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.....+.+......... ......+.+++.+|++.||++||++.++.++|+.
T Consensus 232 -~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 -NQEVIEMVRKRQLLPCS---EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11222222222211111 1122347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=330.63 Aligned_cols=240 Identities=25% Similarity=0.324 Sum_probs=194.4
Q ss_pred eeeecccceeEEEEEc----cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeec
Q 003780 505 YCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
+.||+|+||.||+++. .+|+.||+|++........ ....+..|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999864 3689999999976543322 2346778999999999999999999999999999999999
Q ss_pred cCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC
Q 003780 581 KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN 660 (796)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 660 (796)
++|+|.+++.+.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 9999999987543 489999999999999999999999 9999999999999999999999999999865444333
Q ss_pred ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHH
Q 003780 661 RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQD 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... .......+.......+ ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~~~~~p-----~~~ 221 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKAKLGMP-----QFL 221 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcCCCCCC-----CCC
Confidence 344568999999999998888999999999999999999999987321 1222222222222111 111
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHH
Q 003780 741 IVLVTTVALACLHSKPKFRPTMQR 764 (796)
Q Consensus 741 ~~~l~~li~~cl~~dP~~RPs~~e 764 (796)
...+.+++.+||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 234678999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.39 Aligned_cols=245 Identities=20% Similarity=0.306 Sum_probs=197.0
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 577 (796)
+|+..+.||+|+||.||+|+.+ +|+.||+|++...........+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999754 68999999998654333333456778888888886 578889999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987543 388999999999999999999999 9999999999999999999999999998764433
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~~~~~p~---- 222 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--------EDELFQSIMEHNVSYPK---- 222 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCc----
Confidence 333344569999999999998889999999999999999999999987321 12222233322222111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQ 763 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~ 763 (796)
.....+.+++.+|++.+|.+|++..
T Consensus 223 -~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 223 -SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1123467899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=333.24 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=203.9
Q ss_pred HHHHHHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 492 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
.++....++|++.+.||+|+||.||+++.+ +++.||+|++...........+.+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344445689999999999999999999765 6889999998754433333345678899999999999999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
+..++||||+++|+|.+++... .++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999998753 278888899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-CccccccccCccCccccccC----CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 651 ARLLDSDSS-NRTIVAGTYGYIAPELAYTM----VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 651 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~ 260 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIM 260 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 987653322 22345699999999998653 378899999999999999999999973221 11222222
Q ss_pred cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 003780 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKF--RPTMQRVCQEF 769 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 769 (796)
.......... .......+.+++.+|++.+|.+ ||+++|++++.
T Consensus 261 ~~~~~~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 2111111110 0112234678999999854443 78999999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=348.34 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=203.8
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|... +|+.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999754 68999999997654444444567999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCc--------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 578 KYMKRGSLFCFLRNDYE--------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
||+++|+|.+++..... ....++..+.+++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999875311 12356778899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC------------------CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC
Q 003780 650 TARLLDSDS------------------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS 711 (796)
Q Consensus 650 ~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~ 711 (796)
+++...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 998652110 011124689999999999999999999999999999999999999874211
Q ss_pred CCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhhc
Q 003780 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRP-TMQRVCQEFLTC 772 (796)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 772 (796)
........+..... ... .......+.+++.+|++.||++|| +++++.+.|+..
T Consensus 237 -----~ki~~~~~i~~P~~--~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 237 -----RKISYRDVILSPIE--VAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred -----hhhhhhhhccChhh--ccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01111111111000 000 011223477899999999999995 667777777654
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.34 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=207.2
Q ss_pred cCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH---HHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 45888899999999999999632 3567899988655432 23578899999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
.++||||+++++|.+++..... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 9999999999999999975431 23478999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCch
Q 003780 640 KLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSD 716 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~ 716 (796)
++.++|+|||++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------- 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------- 231 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence 99999999999976543221 1223446788999999998899999999999999999999 9999863211
Q ss_pred hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
.. ..+.+......... ......+.+++.+|++.||++||++++|++.|++.....
T Consensus 232 -~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 232 -TE-VIECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred -HH-HHHHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 11 11112222111111 112335789999999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.09 Aligned_cols=256 Identities=24% Similarity=0.409 Sum_probs=201.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCc----EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.+|+..+.||+|+||.||+|.+. +++ .||+|++...... ...+++.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 46899999999999999999753 343 4899998754322 2346788999999999999999999999764 56
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++|+||+++|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 79999999999999998643 2478889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc--cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSSNR--TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||+.... ......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~ 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------SEISSILEKGER 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHhCCCC
Confidence 65432221 11234668999999999999999999999999999998 9999873211 111222222221
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
..... .....+.+++.+|++.+|.+||++.+++.++.....
T Consensus 230 ~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 LPQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11111 122347789999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.60 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=200.7
Q ss_pred CCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
+|++.+.||+|+||.||+|..++++.+|+|.+...... ...+.+|++++++++||||+++++++...+..++|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 57888999999999999998887889999998654332 24678899999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999976432 488999999999999999999999 999999999999999999999999999976543211
Q ss_pred C-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 660 N-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 660 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
. .....++..|+|||...+..++.++||||||+++|+|++ |+.||..... . .....+..........
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~~-- 224 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------S-EVVESVSAGYRLYRPK-- 224 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------H-HHHHHHHcCCcCCCCC--
Confidence 1 111223457999999998889999999999999999999 8999863211 1 1111122222111111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+|++.+|++|||+.|+++.|
T Consensus 225 -~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 -LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1234588999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.16 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=206.0
Q ss_pred cCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
++|.+.+.||+|+||.||++.. .++..+|+|.+...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH---HHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 5688899999999999999964 23566899988754322 24578999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcC----------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDY----------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE 642 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 642 (796)
.++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999999997543 123489999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhh
Q 003780 643 AFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKI 719 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (796)
++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.... ...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--------~~~ 230 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNE 230 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHH
Confidence 99999999986543221 1122335778999999998889999999999999999998 899986321 111
Q ss_pred HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 720 MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
....+....... ... .....+.+++.+|++.||.+|||+.|+.+.|+.....
T Consensus 231 ~~~~i~~~~~~~-~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 VIECITQGRVLQ-RPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHcCCcCC-CCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 222222222111 111 1223488999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.45 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=205.0
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||.||+|..++++.||+|.+...... .+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 34678999999999999999999888999999998765543 347889999999999999999999874 5678999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999876432 3588999999999999999999998 999999999999999999999999999976653
Q ss_pred CCC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .. ....+......+..
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~-~~~~~~~~~~~~~~ 225 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PE-VIQNLERGYRMPRP 225 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HH-HHHHHHcCCCCCCC
Confidence 221 1222345678999999988889999999999999999999 9999863221 11 11112222221111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
. .....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 226 ~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 D---NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 122358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.21 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=199.6
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|++|.||+|..+ +++.||+|++....... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4788899999999999999764 68999999987543322 224578889999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|++ ++|.+++........+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 998 58888887654445689999999999999999999999 99999999999999999999999999998654433
Q ss_pred CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCC------chhhhHH
Q 003780 659 SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPS------SDQKIML 721 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~------~~~~~~~ 721 (796)
.......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||....... ... .......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 333334578899999987654 47889999999999999999999987422100 000 0000000
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....................++.+++.+|++.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000001112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.36 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=204.5
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|++.+.||+|+||+||+++.+ +++.||+|++......... .....+|+.++++++||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 677899999999999999765 5778999999888665433 23445699999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+++++|.+++... ..+++..+..++.|+++||++||+. +|+|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp ETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999833 3489999999999999999999999 999999999999999999999999999976533333
Q ss_pred CccccccccCccCccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 660 NRTIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
......++..|+|||++. +..++.++||||+|+++|+|++|..||.... ...................... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-~~ 227 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRPLPSSSQQ-SR 227 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTHHHHHTTS-HT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhcccccccccccc-cc
Confidence 444566899999999998 8889999999999999999999999987431 1112222222222111111100 01
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112568899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=311.44 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=204.6
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchh--hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEE--TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
++|++.+.||+|++|.||+|.. .+++.||+|.+....... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999975 468999999987554322 2234578899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|+||+++++|.+++.... .+++..+.+++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987643 378888999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCc---cccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 656 SDSSNR---TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 656 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||.... ................
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~~~~ 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--------AMAAIFKIATQPTNPQ 227 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc--------hHHHHHHHhccCCCCC
Confidence 322111 23457889999999999889999999999999999999999986321 1111222222222222
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
... .....+.+++.+|++.+|++||++.|++++.
T Consensus 228 ~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 228 LPS---HVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred CCc---cCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 211 2233477899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.22 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=204.0
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|+||.||+++.+ +++.+|+|.+...... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4788999999999999999754 6899999998654432 234678899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++.... ...++......++.|++.||.|||+. +|+|+||||+||+++.++.++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999999887542 23478899999999999999999999 99999999999999999999999999998765443
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ..............+...
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~---- 222 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVCQGSYKPLPS---- 222 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHhcCCCCCCCc----
Confidence 33344568899999999998889999999999999999999999987321 111122222222211111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+||+.||++||++.|++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=310.58 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=196.8
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRG 583 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 583 (796)
+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999764 7899999988654332 22457899999999999999999999999999999999999999
Q ss_pred cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC--c
Q 003780 584 SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--R 661 (796)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~ 661 (796)
+|.+++.+.. ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+......... .
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999997543 2478999999999999999999999 9999999999999999999999999998765432111 1
Q ss_pred cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHH
Q 003780 662 TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQD 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+.......... ..
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---------~~~~~~~~~~~~~~~~~---~~ 221 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---------QQTREAIEQGVRLPCPE---LC 221 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---------HHHHHHHHcCCCCCCcc---cC
Confidence 11223457999999998889999999999999999998 8888863211 11112222222212111 12
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 741 IVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 741 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
...+.+++.+|++.+|++||++.|+++.|++
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 3357899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.19 Aligned_cols=258 Identities=25% Similarity=0.295 Sum_probs=198.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+++.+ +++.||+|++...........+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999754 68999999997644333333456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997532 2478889999999999999999999 9999999999999999999999999998765443
Q ss_pred CCC-ccccccccCccCcccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 658 SSN-RTIVAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 658 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~ 227 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKEHF 227 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCcc
Confidence 222 223469999999999863 4577899999999999999999999873211 11111222111111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKF--RPTMQRVCQEF 769 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 769 (796)
............+.+++.+|+..++++ ||++++++++-
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 111101112234677888877654443 88999999883
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.61 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=198.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|+..+.||+|+||.||+++.+ +++.||+|++...........+.+..|+.++.+++||||+++++++..++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999754 68999999997654433344567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999997643 388999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCC
Q 003780 658 SS-----------------------------------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRH 702 (796)
Q Consensus 658 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~ 702 (796)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0112469999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Q 003780 703 PGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT---MQRVCQE 768 (796)
Q Consensus 703 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 768 (796)
||..... ......+........... .......+.+++.+|+. ||++|++ +.|+++|
T Consensus 235 Pf~~~~~--------~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETP--------QETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCH--------HHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9973221 112222221111100000 00112236677888764 9999985 6777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.94 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=203.7
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|+||.||+|..+++..+|+|.+...... .+.+.+|+.++++++|||++++++++. ....++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 4578899999999999999998888889999998765443 246889999999999999999999885 45678999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.++++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+..+...
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 80 EYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999976432 3478999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCCc-cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSNR-TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.... ....++..|+|||+..+..++.++||||||+++|+|++ |+.||.... .. .....+......+..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~-~~~~~~~~~~~~~~~- 225 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NR-EVLEQVERGYRMPCP- 225 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HH-HHHHHHHcCCCCCCC-
Confidence 2211 12235668999999988889999999999999999999 888986321 11 111222222221111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|++.+|++|||++++.+.|+.
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 --QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223458899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.84 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=202.6
Q ss_pred HhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
..++|.+.+.||+|++|.||+|... .+..||+|.+....... ....+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ--DESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3467899999999999999999764 35778999886544322 235688999999999999999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCc----ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC---cE
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYE----AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL---EA 643 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~ 643 (796)
+..++||||+++++|.+++++... ...+++..+.+++.||+.||+|||+. +++||||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 999999999999999999976532 13588999999999999999999999 999999999999998764 58
Q ss_pred EEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhH
Q 003780 644 FVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIM 720 (796)
Q Consensus 644 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (796)
||+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||..... . .
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~-~ 229 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------Q-E 229 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------H-H
Confidence 99999999876332211 111223567999999998899999999999999999997 9999873211 1 1
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
....+......... ......+.+++.+|++.+|++||++.+|+++|+.
T Consensus 230 ~~~~~~~~~~~~~~---~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 230 VMEFVTGGGRLDPP---KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 12222222111111 1123457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.19 Aligned_cols=255 Identities=22% Similarity=0.237 Sum_probs=200.7
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|+..+.||+|+||+||+|.. .+++.||+|.+...........+.+.+|++++++++|+||+++.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 366778999999999999965 4789999999976554433334567889999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999988875432 3489999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
......|+..|+|||++.+..++.++||||+||++|||++|+.||..... ..........+.... ... ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~-----~~~~~~~~~~~~~~~-~~~---~~ 226 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-----KVKREEVDRRVLETE-EVY---SA 226 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhhhccc-ccc---Cc
Confidence 22334689999999999888899999999999999999999999873211 000111111111111 011 11
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPT-----MQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 768 (796)
.....+.+++..|++.||++||+ +++++.+
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 12234678999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=306.64 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=215.0
Q ss_pred CccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|.+...+|+|+||.||+|.+ ..|..+|||.+..... .+++..|+.+|.+.+.|++|+++|.|......++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 66788999999999999954 4799999999875542 56899999999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
|-.|+..+.++-+. ..+.+.++..+++..+.||+|||.. .-+|||||+-|||++.+|.+|++|||.|..+.+.-.
T Consensus 110 CGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999999997643 3589999999999999999999998 889999999999999999999999999987765444
Q ss_pred CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHH
Q 003780 660 NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQ 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
....+.|||.|||||++..-.|..++||||+|+...||..|++||.+..+... -++-+..+++.-..+..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------IFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------IFMIPTKPPPTFKKPEE 254 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------eEeccCCCCCCCCChHh
Confidence 45568899999999999999999999999999999999999999986554311 11222233333333334
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 740 DIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 740 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
-..++.+++++||-..|++|-|+-++++|-.-.+.
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 44568899999999999999999999999765544
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=314.23 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=200.1
Q ss_pred cCCccceeeecccceeEEEEEcc-CCc----EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
++|++.+.||+|+||+||+|... +++ .+++|.+..... .....++..|+..+++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 46888899999999999999753 454 477787754322 2234678888889999999999999998864 457
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++++||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 78999999999999997643 2488999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~~~ 229 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---------HEVPDLLEKGER 229 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHHCCCc
Confidence 543322 1223457778999999998899999999999999999998 9999863211 112222222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
...... ....+.+++.+|++.||++|||+.|+++.|.....
T Consensus 230 ~~~~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQPQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111111 12346789999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.36 Aligned_cols=256 Identities=23% Similarity=0.267 Sum_probs=202.5
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|+..+.||+|+||.||++..+ +++.||+|.+...........+.+.+|+.++++++|++++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999654 789999999876554433334567889999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998865432 3488999999999999999999998 99999999999999999999999999987654322
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
......|+..|+|||++.+..++.++||||+||++|+|++|+.||..... ............. ...... .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-----~~~~~~~~~~~~~-~~~~~~---~ 226 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK-----KIKREEVERLVKE-VQEEYS---E 226 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc-----cchHHHHHhhhhh-hhhhcC---c
Confidence 22234689999999999988899999999999999999999999974221 0011111111111 111111 1
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPT-----MQRVCQEF 769 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 769 (796)
.....+.+++.+||+.||++||| ++|+++|-
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 12234778999999999999999 88988763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=310.47 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=203.0
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|+||.||+|+..++..||+|++...... .+.+.+|++++++++||||+++++++. .+..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 3579999999999999999998777778999999754432 246889999999999999999999875 45678999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+... ..+++..+..++.|+++||+|+|+. +++||||||+||+++.++.++|+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999976432 3478999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCCc-cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSNR-TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.... ....++..|+|||+..+..++.++|||||||++|||+| |+.||.... ........ ........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--------~~~~~~~~-~~~~~~~~-- 224 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQV-ERGYRMPC-- 224 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------hHHHHHHH-hcCCCCCC--
Confidence 2221 22346678999999988889999999999999999999 888876321 11111111 11111111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.......+.+++.+|++.||++||+++++++.|+..
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 112334578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=309.90 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=196.7
Q ss_pred eeecccceeEEEEEc---cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 506 CIGTGGYGSVYKAQL---PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
.||+|+||.||+|.+ ++++.+|+|++...... ....+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999954 36789999998755432 234568899999999999999999999885 4567899999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC--
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN-- 660 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 660 (796)
|+|.+++.... .+++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999997543 488999999999999999999998 9999999999999999999999999999876443221
Q ss_pred -ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 661 -RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 661 -~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.....++..|+|||.+....++.++|||||||++|||++ |+.||..... ....+.+..........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~i~~~~~~~~~~--- 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---------NEVTQMIESGERMECPQ--- 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHCCCCCCCCC---
Confidence 112234578999999988888999999999999999998 9999873211 11222222222222111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.....+.+++.+|++.||++||++++|.+.|+..
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1234578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=315.44 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=204.3
Q ss_pred HhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
..++|++.+.||+|+||.||+|..+ .+..||+|.+....... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4678999999999999999999643 25689999887554322 234678899999999999999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCc-------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcE
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYE-------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEA 643 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 643 (796)
...++||||+++|+|.+++.+... ....++..+.+++.|++.||.|||++ +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 23356778899999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhH
Q 003780 644 FVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIM 720 (796)
Q Consensus 644 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (796)
+++|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence 99999999865432211 122235678999999998889999999999999999998 788876321 1112
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
............. ......+.+++.+|++.||++|||+.++++.++...
T Consensus 231 ~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 LKFVMDGGYLDQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 2222222211111 112245889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.81 Aligned_cols=253 Identities=28% Similarity=0.394 Sum_probs=200.6
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++..++..++|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 4788889999999999999965 46899999998755332 2346788999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999987543 488999999999999999999999 9999999999999999999999999998766543
Q ss_pred CCCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 658 SSNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
........|++.|+|||++. ...++.++||||+||++|+|++|+.||..... .............+...
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~ 231 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP--------MRALFLMTKSNFQPPKL 231 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc--------hhhHHhhhccCCCCCcc
Confidence 33334456899999999874 45578899999999999999999999863221 01111111111111110
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.........+.+++.+|++.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0001112347789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.11 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=207.5
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|+..+.||+|+||.||.++. .+++.+++|.+........ ..+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh-HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 488899999999999999964 4689999999876543332 24678899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++.+.. ...+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999998653 23578999999999999999999998 99999999999999999999999999998765444
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||.... ..............+.. .
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~~----~ 223 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQGNYTPVV----S 223 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCCc----c
Confidence 33344568999999999988888999999999999999999999986321 11222222222222221 1
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+|++.+|++||+++|+++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2233477899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=318.23 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=205.5
Q ss_pred HhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLH 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 569 (796)
..++|++.+.||+|+||.||++... ....+|+|.+....... ....+.+|++++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 4467899999999999999999753 24689999987654322 245788999999999 79999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcC-------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeE
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDY-------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNIL 636 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 636 (796)
++..++||||+++|+|.+++++.. ....+++..+++++.|++.||+|||+. +|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999997531 234588999999999999999999998 9999999999999
Q ss_pred ecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCC
Q 003780 637 LNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSP 713 (796)
Q Consensus 637 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~ 713 (796)
++.++.+||+|||.++.+...... .....++..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 240 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 240 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence 999999999999999876543211 112234578999999988889999999999999999997 8898763211
Q ss_pred CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
......+......... ......+.+++.+|++.||++|||++|++++|+..
T Consensus 241 -----~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 -----EELFKLLKEGYRMEKP---QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred -----HHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111222222211111 12233578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.21 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=200.5
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+++.+ +++.||+|.+...........+.+.+|..++..++|+||+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999755 68899999997644333333456888999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997632 2478889999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ccccccccCccCcccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 658 SSN-RTIVAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 658 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+.......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~ 227 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEERF 227 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCCcc
Confidence 222 223569999999998875 467889999999999999999999987321 111222222221111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKF--RPTMQRVCQE 768 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 768 (796)
............+.+++.+|+..++++ |++++++++|
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111111112345778999999876654 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.65 Aligned_cols=257 Identities=25% Similarity=0.303 Sum_probs=199.7
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+++.+ +++.||+|++...........+.+..|+.++..++|++|+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999765 57889999987544333333456888999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976322 478889999999999999999999 9999999999999999999999999998765433
Q ss_pred CCC-ccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 658 SSN-RTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 658 ~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~ 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKERF 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCccc
Confidence 222 23356999999999886 3457889999999999999999999987321 112222222221111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKF--RPTMQRVCQE 768 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 768 (796)
............+.+++.+|+..+|++ |++++|+++|
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111111112334778888988665544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=316.80 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=203.6
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..+|++.+.||+|++|.||+|.. .+++.||+|.+....... .+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 35788999999999999999974 478999999987655432 35688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++++. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999998653 378889999999999999999999 999999999999999999999999999886554
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ............ +... .
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--------~~~~~~~~~~~~-~~~~-~ 238 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGT-PELQ-N 238 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--------HHhHHHHhcCCC-CCCC-C
Confidence 33333345688999999999888889999999999999999999999864221 011111111111 1100 0
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.......+.+++.+|++.||++||++.|++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11222447789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.27 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=199.0
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|.+.+.||+|+||.||+|+.+ +++.||+|++........ ...+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 57899999999999999999754 688999999875543221 245778999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++ +|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99985 8888876543 2478888999999999999999999 9999999999999999999999999999765443
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc----------
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD---------- 726 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 726 (796)
........+++.|+|||.+.+ ..++.++||||+||++|+|+||+.||...... .........+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhh
Confidence 333334467899999998765 45788999999999999999999998643210 00000000000
Q ss_pred --------CCCCCc----cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 727 --------SRLSPP----VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 727 --------~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
...... ..........++.+++.+|++.||++|||++|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000000 00000112234779999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.15 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=203.7
Q ss_pred CCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
+|++.+.||+|+||.||+|... ....+++|.+...... ...+.+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4778899999999999999642 2367899988755433 2246789999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcC---------------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCC
Q 003780 574 FLIYKYMKRGSLFCFLRNDY---------------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISS 632 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp 632 (796)
++|+||+.+|+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 99999999999999986431 113478899999999999999999998 999999999
Q ss_pred CCeEecCCCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCccccc
Q 003780 633 NNILLNSKLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSS 709 (796)
Q Consensus 633 ~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~ 709 (796)
+||++++++.+||+|||+++....... ......++..|+|||...+..++.++||||||+++|||++ |..||....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~- 234 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA- 234 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-
Confidence 999999999999999999986533221 1122345678999999988889999999999999999998 999986321
Q ss_pred CCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 710 LSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
...+.+............ .....+.+++.+|++.+|++||+++|+++.|++..
T Consensus 235 --------~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 --------PERLFNLLKTGYRMERPE---NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --------HHHHHHHHhCCCCCCCCC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 112222333322222111 12235789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=316.12 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=202.4
Q ss_pred cCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
.+|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++..++.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 35777889999999999999753 3578999999755432 224578899999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcC-------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 573 MFLIYKYMKRGSLFCFLRNDY-------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
.++++||+++++|.+++.... ....+++..+.+++.|+++||+|+|+. +|+||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence 999999999999999986321 123478888999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCch
Q 003780 640 KLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSD 716 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~ 716 (796)
++.+||+|||+++........ .....+++.|+|||.+.+..++.++||||+||++|||++ |..||....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------- 231 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------- 231 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------
Confidence 999999999998865432211 122345778999999988889999999999999999998 888876321
Q ss_pred hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.......+......+ .. ......+.+++.+|++.+|++||+++||++.|+.
T Consensus 232 ~~~~~~~i~~~~~~~-~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 232 NQDVIEMIRNRQVLP-CP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHHcCCcCC-CC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 122222222222211 11 1223447899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=316.98 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=203.6
Q ss_pred hcCCccceeeecccceeEEEEEccC-----------------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN-----------------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 560 (796)
.++|++.+.||+|+||.||+|...+ +..||+|.+...... ...+.+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 4578999999999999999986532 356899998766443 235688999999999999999
Q ss_pred eeEEeEEEecceeeEEEeeccCCcHHHHHhhcCc--------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCC
Q 003780 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYE--------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISS 632 (796)
Q Consensus 561 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp 632 (796)
+++++++..++..++|+||+++++|.+++.+... ...+++..+..++.|++.||+|||+. +|+||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 9999999999999999999999999999976531 12588999999999999999999998 999999999
Q ss_pred CCeEecCCCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh--CCCCCcccc
Q 003780 633 NNILLNSKLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GRHPGELLS 708 (796)
Q Consensus 633 ~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt--g~~p~~~~~ 708 (796)
+||+++.++.++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999976543221 1223446778999999988889999999999999999998 667775321
Q ss_pred cCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 709 SLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
. ............................++.+++.+|++.||++|||+.|+++.|++
T Consensus 239 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 D-----QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred h-----HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 000001111100000000000011122458899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.79 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=201.2
Q ss_pred CccceeeecccceeEEEEEccC----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce----
Q 003780 501 FDIKYCIGTGGYGSVYKAQLPN----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC---- 572 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 572 (796)
|.+.+.||+|+||.||+|.... +..||+|+++...... ...+.+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5678899999999999997542 4789999987654332 234678999999999999999999999876554
Q ss_pred --eeEEEeeccCCcHHHHHhhcC---cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEee
Q 003780 573 --MFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVAD 647 (796)
Q Consensus 573 --~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 647 (796)
.++|+||+++|+|..++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 789999999999999986432 224588999999999999999999998 999999999999999999999999
Q ss_pred eccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHh
Q 003780 648 FGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 648 fg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
||.++.+...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ........
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--------~~~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--------NHEIYDYL 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH
Confidence 9999876433221 112235678999999988889999999999999999999 888886322 11122222
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.... .... +......+.+++.+|++.||++||++.|++++|++.
T Consensus 229 ~~~~-~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGN-RLKQ---PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCC-CCCC---CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221 1111 112334588999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.50 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=200.0
Q ss_pred cCCccceeeecccceeEEEEEccC---------------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN---------------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 563 (796)
++|++.+.||+|+||.||+++.++ ...||+|.++..... .....+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK--TARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCcCeE
Confidence 578999999999999999986532 235899998765332 224578999999999999999999
Q ss_pred EeEEEecceeeEEEeeccCCcHHHHHhhcCc---------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCC
Q 003780 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYE---------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNN 634 (796)
Q Consensus 564 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 634 (796)
++++...+..++||||+++++|.+++..... ...+++..+.+++.|+++||+|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999865321 12368889999999999999999999 99999999999
Q ss_pred eEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh--CCCCCcccccC
Q 003780 635 ILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GRHPGELLSSL 710 (796)
Q Consensus 635 Ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt--g~~p~~~~~~~ 710 (796)
|+++.++.+||+|||++......... .....++..|+|||+..+..++.++|||||||++|+|++ |..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 99999999999999999765432211 122335678999999988889999999999999999998 5667663211
Q ss_pred CCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 711 SSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.............................+.+++.+|++.||++||++++|++.|++
T Consensus 239 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 ----EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ----HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 000001111111110000000011122358899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=316.42 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=200.9
Q ss_pred cCCccceeeecccceeEEEEEccC-Cc--EEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN-GK--VVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||.||+|..++ +. .+++|.++..... ...+.+.+|+++++++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH--HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 578899999999999999997653 33 4788887643322 2245789999999999 7999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC
Q 003780 575 LIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL 641 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 641 (796)
+|+||+++|+|.+++++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 99999999999999975421 13478899999999999999999998 999999999999999999
Q ss_pred cEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhH
Q 003780 642 EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIM 720 (796)
Q Consensus 642 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (796)
.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |+.||..... ..
T Consensus 157 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~- 226 (297)
T cd05089 157 ASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AE- 226 (297)
T ss_pred eEEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH-
Confidence 9999999998643211 11111223557999999988889999999999999999997 9999863211 11
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
............... .....+.+++.+|++.+|.+||+++++++.|+....
T Consensus 227 ~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 227 LYEKLPQGYRMEKPR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112222222221111 122347899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.33 Aligned_cols=244 Identities=24% Similarity=0.301 Sum_probs=189.4
Q ss_pred eecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc---CCCceeeEEeEEEecceeeEEEeeccC
Q 003780 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI---AHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
||+|+||+||+|+.+ +++.||+|++.............+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999754 6899999999764433322234555677776655 699999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.+++.+.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.++|+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 99999887543 388999999999999999999999 999999999999999999999999999976433333334
Q ss_pred ccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHH
Q 003780 663 IVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDI 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
...||+.|+|||++.+. .++.++||||+||++|+|++|+.||.... .......+........... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~----~~ 222 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAFGKVRFPKNV----LS 222 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHcCCCCCCCcc----CC
Confidence 56799999999998754 47899999999999999999999986321 1112222222221111111 12
Q ss_pred HHHHHHHHHcCCCCCCCCCC----HHHHHHH
Q 003780 742 VLVTTVALACLHSKPKFRPT----MQRVCQE 768 (796)
Q Consensus 742 ~~l~~li~~cl~~dP~~RPs----~~evl~~ 768 (796)
..+.+++.+||+.||++||+ +.|+++|
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 34678999999999999984 5666554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=327.38 Aligned_cols=263 Identities=23% Similarity=0.254 Sum_probs=197.7
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK---- 571 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 571 (796)
..++|++.+.||+|+||.||++.. .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 457899999999999999999975 468999999997653322 22457789999999999999999999986543
Q ss_pred --eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 572 --CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 572 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
..++||||+++ ++.+.++. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999976 56665543 277888899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCchhh-
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSDQK- 718 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~~~- 718 (796)
+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+... .+.....
T Consensus 169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred CccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 99764332 22233468999999999999999999999999999999999999997432110 0000000
Q ss_pred ---hHHHHhhcCCCCCc---------------cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 719 ---IMLIDVLDSRLSPP---------------VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 719 ---~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.............. ...........+.+++.+||+.||++|||++|+++|-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000110000000 00000011234789999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=313.77 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=200.0
Q ss_pred HHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec---
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK--- 570 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--- 570 (796)
.+++.|++.+.||+|+||.||+|..+ +++.||+|++...... ...+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 35677889999999999999999754 6889999998755322 24678899999998 699999999998753
Q ss_pred ---ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEee
Q 003780 571 ---KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVAD 647 (796)
Q Consensus 571 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 647 (796)
...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 46899999999999999987643 23478999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
||++..............|++.|+|||++. +..++.++||||+||++|||++|+.||..... . ....
T Consensus 155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~---~~~~ 226 (272)
T cd06637 155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----M---RALF 226 (272)
T ss_pred CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----H---HHHH
Confidence 999987654333344466899999999886 34578899999999999999999999863221 1 1111
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
............. .....+.+++.+||+.||.+|||++|++++
T Consensus 227 ~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 227 LIPRNPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHhcCCCCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1111111111111 112347899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.08 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=197.2
Q ss_pred CccceeeecccceeEEEEEccC-Cc--EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------c
Q 003780 501 FDIKYCIGTGGYGSVYKAQLPN-GK--VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------K 571 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 571 (796)
|.+.+.||+|+||.||+|+..+ ++ .||+|.+....... ...+.+..|+++++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3467889999999999997654 32 68999887653322 2256788999999999999999999987532 2
Q ss_pred eeeEEEeeccCCcHHHHHhhcC---cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
..++|+||+++|+|.+++.... ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 4689999999999998874321 223478999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhh
Q 003780 649 GTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 649 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
|+++.+...... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||.... ... ..+.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~-~~~~~ 227 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSE-IYDYL 227 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHH-HHHHH
Confidence 999876433221 122346778999999998889999999999999999999 788886321 111 11112
Q ss_pred cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.......... .....+.+++.+||+.||++|||+.|+++.|++.
T Consensus 228 ~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNRLKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2111111111 1223478999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=326.99 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=205.1
Q ss_pred HhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLH 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 569 (796)
..++|.+.+.||+|+||.||+|+++ .++.||+|++....... ..+.+.+|++++.++. ||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 4457888899999999999999743 35689999997654332 2357889999999997 9999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCc-------------------------------------------------------
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYE------------------------------------------------------- 594 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 594 (796)
++..++|+||+++|+|.+++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999975421
Q ss_pred ----------------------------------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCC
Q 003780 595 ----------------------------------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNN 634 (796)
Q Consensus 595 ----------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 634 (796)
...+++....+++.|++.||+|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 12367778889999999999999998 99999999999
Q ss_pred eEecCCCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCC
Q 003780 635 ILLNSKLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLS 711 (796)
Q Consensus 635 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~ 711 (796)
|++++++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~--- 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP--- 346 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC---
Confidence 9999999999999999986533211 1222346788999999998889999999999999999998 888976321
Q ss_pred CCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
........+.......... .....+.+++.+||+.+|++||+++||++.|+..
T Consensus 347 -----~~~~~~~~~~~~~~~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 347 -----MNEQFYNAIKRGYRMAKPA---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -----chHHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111222222222221111 1234588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.24 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=202.3
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|.+.+.||+|++|.||+|..+++..+|+|.+...... .+.+.+|++++++++|||++++++++. .+..++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 3568899999999999999998877778999988654432 346888999999999999999999885 45678999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.++++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 80 EFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999997643 23478999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
... .....++..|+|||+..+..++.++||||||+++|||++ |+.||.... ...... .+.........
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~-~~~~~~~~~~~- 225 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--------NREVLE-QVERGYRMPCP- 225 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHH-HHHcCCCCCCC-
Confidence 221 122335678999999988889999999999999999999 899986321 111111 12222211111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|+..||++||+++++.+.|++
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 --QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=318.34 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=205.2
Q ss_pred hcCCccceeeecccceeEEEEEcc--------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP--------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+...... ....++..|+++++++ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 467999999999999999999642 2357999999765322 2245788899999999 7999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
..+..++||||+++|+|.+++..... ...+++..+.+++.|++.||+|||+. +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999976432 13478999999999999999999998 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCCCc--cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSSNR--TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~ 712 (796)
+++.++.+||+|||.++......... ....+++.|+|||...+..++.++|||||||++|||++ |+.||....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---- 247 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 247 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----
Confidence 99999999999999997654322111 11224568999999988889999999999999999998 888875211
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
.......+......+.. ......+.+++.+|++.+|++||++.|+++.|++....
T Consensus 248 -----~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 -----VEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -----HHHHHHHHHcCCCCCCC---CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11122222222221111 12233577899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.35 Aligned_cols=255 Identities=29% Similarity=0.427 Sum_probs=205.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++...+..+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 357899999999999999999754 6788999999765433 246889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999999987642 2488999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccC---CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTM---VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
.........++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .............+..
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~ 225 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLISKSNFPPPK 225 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCCCcc
Confidence 33233345688899999998776 788999999999999999999999863221 1111111111111111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..........+.+++.+|++.+|.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11122334568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.72 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=200.2
Q ss_pred HHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
.+++.+.....||+|+||.||+|... +++.||+|.+....... .+.+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY---VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH---HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 35566667789999999999999754 67889999887654332 457899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-CCcEEEeeeccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-KLEAFVADFGTARL 653 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~ 653 (796)
+|+||+++++|.+++.........++..+..++.|+++||+|||+. +|+||||||+||+++. ++.++|+|||.+..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999998643322237888889999999999999998 9999999999999986 67899999999976
Q ss_pred cCCCCCCccccccccCccCccccccCC--cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
............|++.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ..............+
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~ 231 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-------PQAAMFKVGMFKIHP 231 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-------hhhhHhhhhhhccCC
Confidence 644333333345889999999986543 77899999999999999999999863211 000111110001111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
... ......+.+++.+|++.+|++|||+.|++++
T Consensus 232 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 EIP---ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCC---cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 111 1122347789999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.61 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=200.6
Q ss_pred cCCccceeeecccceeEEEEEcc-----------------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCcee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-----------------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 561 (796)
++|++.+.||+|+||.||+++.. ++..||+|++...... ...+.+.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK--NARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcc
Confidence 56899999999999999998532 2456899998755322 2245789999999999999999
Q ss_pred eEEeEEEecceeeEEEeeccCCcHHHHHhhcCc--------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCC
Q 003780 562 KLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYE--------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSN 633 (796)
Q Consensus 562 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~ 633 (796)
++++++..++..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999876431 13477888999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh--CCCCCccccc
Q 003780 634 NILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GRHPGELLSS 709 (796)
Q Consensus 634 NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt--g~~p~~~~~~ 709 (796)
||+++.++.++|+|||+++.+...... .....+++.|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999999865432211 122334678999999888889999999999999999998 7788763221
Q ss_pred CCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 710 LSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
. ............................+.+++.+|++.||++||++.||.+.|++
T Consensus 240 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 E-----QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-----HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 00000111111100000000011122457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.80 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=206.7
Q ss_pred HhcCCccceeeecccceeEEEEEc--------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL--------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFC 567 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 567 (796)
..++|.+.+.||+|+||.||+|+. .++..||+|.+...... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 356788999999999999999963 13457999988754322 2246789999999999 799999999999
Q ss_pred EecceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCC
Q 003780 568 LHKKCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNN 634 (796)
Q Consensus 568 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 634 (796)
......++||||+++|+|.+++.+... ...+++..+..++.||++||+|||+. +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999976421 23478889999999999999999999 99999999999
Q ss_pred eEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCC
Q 003780 635 ILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLS 711 (796)
Q Consensus 635 Ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~ 711 (796)
|+++.++.+||+|||.++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--- 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence 99999999999999999876543222 122335678999999988889999999999999999998 788875321
Q ss_pred CCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
.. .....+......... ......+.+++.+||+.+|++||++.|+++.|++.....
T Consensus 245 -----~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 -----VE-ELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred -----HH-HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11 111222222211111 122345788999999999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.02 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=200.1
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV--ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh--HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 3678889999999999999964 57899999998755322 22457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999996542 267888899999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... ............. .+... .
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~--~ 222 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDED-PPVLP--V 222 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccC-CCCCC--C
Confidence 2233568999999999998889999999999999999999999987432211100 0011111111111 11110 0
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|++.+|++||+++|++++-.-
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 1122347899999999999999999999988543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.17 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=205.1
Q ss_pred hcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 570 (796)
.++|.+.+.||+|+||.||++.. ..+..||+|++...... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 35789999999999999999963 23568999998765432 2245789999999999 799999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
+..++||||+++|+|.+++++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++++|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999975432 2379999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 651 ARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 651 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
++....... ......++..|+|||.+.+..++.++||||+||++|||++ |+.||..... ..........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--------~~~~~~~~~~ 259 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--------DSKFYKLIKE 259 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------hHHHHHHHHc
Confidence 986543321 1122335678999999998889999999999999999998 9999863221 1112222222
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
........ .....+.+++.+|++.+|++||++.|+++.|++.
T Consensus 260 ~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GYRMAQPE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCcCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 22211111 1123588999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.62 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=204.9
Q ss_pred CCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-C-----CceeeEEeEEEecce
Q 003780 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-H-----RNIVKLYGFCLHKKC 572 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~ 572 (796)
+|++.+.||+|+||.|-+|. .++++.||||+++.... +.++...|+.+|..++ | -|+|++++||...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 89999999999999999995 56799999999987654 3567888999999997 4 399999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC--CcEEEeeecc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK--LEAFVADFGT 650 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfg~ 650 (796)
.|||+|.++. +|+++++.+.- ..++...+..++.||+.||..||.. +|||+||||+|||+.+. ..+||+|||.
T Consensus 263 lciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999866 99999997754 3489999999999999999999999 99999999999999754 4799999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC--------------------
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL-------------------- 710 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~-------------------- 710 (796)
|++....-. .+..+..|+|||++.|.+|+.+.||||||||++||++|.+-|...+..
T Consensus 338 Sc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 338 SCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 997654332 456788899999999999999999999999999999997666432210
Q ss_pred --------CC-CC------c----------hhhhHHHHhhcCCCCC-c---cc-hhhHHHHHHHHHHHHHcCCCCCCCCC
Q 003780 711 --------SS-PS------S----------DQKIMLIDVLDSRLSP-P---VD-RMVMQDIVLVTTVALACLHSKPKFRP 760 (796)
Q Consensus 711 --------~~-~~------~----------~~~~~~~~~~~~~~~~-~---~~-~~~~~~~~~l~~li~~cl~~dP~~RP 760 (796)
.. .. . ..........+....+ . .. .....+...+.+++++|++.||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 00 00 0 0000011111111111 1 11 11213455689999999999999999
Q ss_pred CHHHHHHHHhh
Q 003780 761 TMQRVCQEFLT 771 (796)
Q Consensus 761 s~~evl~~L~~ 771 (796)
|+.|.++|-.-
T Consensus 495 tp~qal~Hpfl 505 (586)
T KOG0667|consen 495 TPAQALNHPFL 505 (586)
T ss_pred CHHHHhcCccc
Confidence 99999999643
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.20 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=202.8
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-cceeeEEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-KKCMFLIY 577 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~ 577 (796)
+|++.+.||+|++|.||++..+ +++.||+|++....... ...+.+.+|++++++++|||++++++.+.. +...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4888999999999999999754 57899999987544332 224578899999999999999999998764 44678999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999997642 23478999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........+++.|+|||+..+..++.++||||+|+++|+|++|+.||.... ............... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~-~~--- 223 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIEGKLPP-MP--- 223 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCC-Cc---
Confidence 333344568899999999999889999999999999999999999986321 111112222222211 11
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.+++.+|++.||++||++.+++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1223457899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.25 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=204.1
Q ss_pred hcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
.++|++.+.||+|+||.||+|..+ .+..||+|.+....... ....+.+|+.++..++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 457889999999999999999654 24789999986554322 2357889999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCc-------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEE
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYE-------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 644 (796)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 99999999999999999875432 22468889999999999999999998 999999999999999999999
Q ss_pred EeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHH
Q 003780 645 VADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 721 (796)
|+|||+++.+..... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... .....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------NEEVL 231 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--------HHHHH
Confidence 999999986543321 1223446788999999988889999999999999999998 888986321 11111
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
....... ...... .....+.+++.+|++.+|++|||+.++++.|++
T Consensus 232 ~~~~~~~-~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 KFVIDGG-HLDLPE---NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHhcCC-CCCCCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1122211 111111 123458899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.33 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=204.9
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCc----EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
.++|++.+.||+|+||+||+|.+ .+|+ .||+|++....... ..+.+.+|+.++..++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH--HHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 35788899999999999999974 3454 48999987554332 246788999999999999999999999754 5
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++++||+++|+|.++++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 679999999999999997643 2488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc--cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 653 LLDSDSSNR--TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 653 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
......... ....+++.|+|||...+..++.++|||||||++|||++ |..||+... .......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---------~~~~~~~~~~~~ 228 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---------AREIPDLLEKGE 228 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---------HHHHHHHHHCCC
Confidence 765332211 11234678999999988889999999999999999998 889986321 111222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccc
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFE 781 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 781 (796)
..+... .....+.+++.+|++.||++||++.|+++.+++..... .+|.
T Consensus 229 ~~~~~~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~-~~~~ 276 (279)
T cd05109 229 RLPQPP---ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP-SRFV 276 (279)
T ss_pred cCCCCc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC-cCeE
Confidence 211111 12335778999999999999999999999998775433 3443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.55 Aligned_cols=246 Identities=22% Similarity=0.357 Sum_probs=194.5
Q ss_pred eecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCC
Q 003780 507 IGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRG 583 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 583 (796)
||+|+||.||+|..+ .+..||+|++..... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 899999999999653 456799999876533 223467899999999999999999999885 45788999999999
Q ss_pred cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCc--
Q 003780 584 SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR-- 661 (796)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-- 661 (796)
+|.+++.... ..+++..+.+++.|+++||+|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999987532 3488999999999999999999998 99999999999999999999999999998654332211
Q ss_pred -cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHH
Q 003780 662 -TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQ 739 (796)
Q Consensus 662 -~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
....+++.|+|||.+....++.++|||||||++|||++ |+.||..... ......+.......... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~---~ 222 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---------PEVMSFIEQGKRLDCPA---E 222 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---------HHHHHHHHCCCCCCCCC---C
Confidence 11223568999999988889999999999999999996 9999874221 11222222222222111 2
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 740 DIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 740 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
....+.+++.+||+.||++||++.+|.+.|+..
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 234577899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.42 Aligned_cols=259 Identities=20% Similarity=0.321 Sum_probs=206.3
Q ss_pred hcCCccceeeecccceeEEEEEccC-----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-cc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN-----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-KK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 571 (796)
.++|++.+.||+|+||.||+|...+ +..|++|++...... ...+.+.+|+.++++++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--IQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4678899999999999999998665 788999988754322 234678899999999999999999998876 56
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcc-----cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEe
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEA-----VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA 646 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 646 (796)
..++++||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999765322 4588999999999999999999998 99999999999999999999999
Q ss_pred eeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHH
Q 003780 647 DFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 647 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|||+++.+...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||..... .....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~~ 230 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---------FEMAA 230 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---------HHHHH
Confidence 99999865433221 112335678999999988889999999999999999999 9999873221 11222
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.+.......... .....+.+++.+|++.||++|||+.|+++.|+...
T Consensus 231 ~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 231 YLKDGYRLAQPI---NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHcCCCCCCCC---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 222222211111 12234789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.37 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=205.2
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|+||.+|++.. .+|+.||+|++........ ..+++.+|+.++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 488899999999999999964 4789999999876543322 24678999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999999875432 3478899999999999999999998 99999999999999999999999999998665433
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......|++.|+|||+..+..++.++|||||||++|+|++|+.||... .........+........ .
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~~~~~~~~----~ 223 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--------NMKNLVLKIIRGSYPPVS----S 223 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--------CHHHHHHHHhcCCCCCCc----c
Confidence 3333455888999999998888999999999999999999999998631 112222222222222111 1
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|++.+|++||++.||+++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 223347899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.04 Aligned_cols=250 Identities=29% Similarity=0.437 Sum_probs=204.2
Q ss_pred cCCccceeeecccceeEEEEEccC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|..++ ++.|++|.+..... .+++.+|++++++++||||+++++++..+...++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 578899999999999999998664 89999999865432 468999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999987543 3489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........++..|+|||++.+..++.++||||||+++|+|++|+.||...... ..... .......... ..
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~~-~~~~~~~~~~-~~ 222 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIFM-IPNKPPPTLS-DP 222 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhhh-hccCCCCCCC-ch
Confidence 33334455888999999998888999999999999999999999998732211 11111 1111111111 01
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.+++.+|++.||++|||+.|++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1122357889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.98 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=198.0
Q ss_pred eeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCc
Q 003780 505 YCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gs 584 (796)
+.||+|+||.||+|..++++.+|+|.+....... ....+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE--LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 3689999999999998889999999987654332 23468899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC-ccc
Q 003780 585 LFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN-RTI 663 (796)
Q Consensus 585 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~ 663 (796)
|.+++.... ..+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+|++|||++......... ...
T Consensus 79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999987543 2478999999999999999999998 9999999999999999999999999998754432211 112
Q ss_pred cccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
..+++.|+|||+..+..++.++||||||+++|+|++ |..||..... .... ..+......... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~-~~~~~~~~~~~~---~~~~~ 221 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAR-EQVEKGYRMSCP---QKCPD 221 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHH-HHHHcCCCCCCC---CCCCH
Confidence 234678999999998889999999999999999998 9999863211 1111 111111111111 11234
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 743 LVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.+.+++.+|++.+|++||++.|++++|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 5889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.48 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=200.5
Q ss_pred cCCccceeeecccceeEEEEEc-----cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--c
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--K 571 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~ 571 (796)
.+|++.+.||+|+||.||++.. .+++.||+|++...... ..+.+.+|++++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4788899999999999999964 35889999998765432 246789999999999999999999987543 4
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++|+||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 6889999999999999997543 2478999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc---cccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC-----CC--chhhhHH
Q 003780 652 RLLDSDSSNR---TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS-----PS--SDQKIML 721 (796)
Q Consensus 652 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~-----~~--~~~~~~~ 721 (796)
+......... ....++..|+|||+..+..++.++|||||||++|||++|..|+........ .. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8764332211 111234469999999888899999999999999999998877542211000 00 0000111
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+.+......+.. ......+.+++.+||+.+|++|||+.|+++.|+..
T Consensus 236 ~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAP---PGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1222222111111 11223488999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.28 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=206.3
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||.||+|..++++.||+|.+...... .+++.+|+.++++++||||+++++++......++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 34689999999999999999998888889999998765433 35788999999999999999999999998999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 80 ~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999976432 3488999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... .....++..|+|||.+.+..++.++||||+|+++|+|++ |+.||.... ....... +.........
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~-~~~~~~~~~~ 226 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQ-VERGYRMPRP 226 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-HHcCCCCCCC
Confidence 2111 112224568999999998889999999999999999998 999985321 1112222 2222111111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
. .....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ~---~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 P---NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1 113358899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.58 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=201.6
Q ss_pred cCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
.+|...+.||+|+||.||++.. .++..+|+|.+...... ..+.+.+|+++++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH---HHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 4677789999999999999953 24668999987754432 24578999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCc------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYE------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
.++|+||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 9999999999999999976432 13478899999999999999999998 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchh
Q 003780 641 LEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~ 717 (796)
+.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~ 230 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--------N 230 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC--------H
Confidence 9999999999976543221 1122335678999999998899999999999999999998 899986321 1
Q ss_pred hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
....... .......... .....+.+++.+||+.||++||+++||.+.|+.
T Consensus 231 ~~~~~~~-~~~~~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 231 TEAIECI-TQGRELERPR---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHH-HcCccCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1112112 1111111111 122347799999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.60 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=200.7
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCc--EEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGK--VVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.+...... ...+.+.+|++++.++ +||||+++++++...+..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH--HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 357889999999999999999754 454 4577776543322 2346788999999999 899999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 574 FLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
++|+||+++|+|.+++++... ...+++..+..++.|+++|++|||+. +++||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999999975421 23578999999999999999999998 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhh
Q 003780 641 LEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKI 719 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (796)
+.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... .
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~- 230 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------A- 230 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------H-
Confidence 99999999998643211 11112234667999999988889999999999999999998 9999863221 1
Q ss_pred HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 720 MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
...+.+......... ......+.+++.+|++.+|++||+++++++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 231 ELYEKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHHHHhcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111122222111111 112234789999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.77 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=204.7
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 357888999999999999999875 88999999976654 2467899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999976532 3489999999999999999999999 9999999999999999999999999999876322
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.. ....+..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.........
T Consensus 156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~-- 221 (256)
T cd05039 156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------LKDVVPHVEKGYRMEAP-- 221 (256)
T ss_pred cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---------HHHHHHHHhcCCCCCCc--
Confidence 11 2235667999999988889999999999999999997 999986321 11112222222111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|+..+|++||+++|++++|+.
T Consensus 222 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 -EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1123457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.22 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=200.1
Q ss_pred CccceeeecccceeEEEEE-----ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--cee
Q 003780 501 FDIKYCIGTGGYGSVYKAQ-----LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCM 573 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 573 (796)
|+..+.||+|+||+||++. ..+++.||+|.+...... ...+.+.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3888999999999998864 236889999998765332 2245788999999999999999999998754 467
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 8999999999999999754 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC-----C-CCchhhhHHHHh
Q 003780 654 LDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS-----S-PSSDQKIMLIDV 724 (796)
Q Consensus 654 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~-----~-~~~~~~~~~~~~ 724 (796)
....... .....++..|+|||...+..++.++||||||+++|||+||..|+....... . ..........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 6533221 112235667999999988889999999999999999999999976322100 0 000001111112
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+.....+.. ......+.+++.+|++.+|++|||++++++.|+..
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCP---KNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCC---CCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222211111 11234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=298.77 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=205.2
Q ss_pred HHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhh--cCCCceeeEEeEEEecc--
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK--IAHRNIVKLYGFCLHKK-- 571 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~-- 571 (796)
....+..+.+.||+|.||.||+|+++ |+.||||++..... +.+.+|.++.+. ++|+||+.+++.-..+.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 34567888999999999999999996 89999999975542 356778888775 49999999999876443
Q ss_pred --eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEecCCCCCeEecCCCcEE
Q 003780 572 --CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD-----CMPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 572 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~k 644 (796)
+.+||++|.+.|||+|+|.+. .++....++++..+|.||++||.. ..|.|.|||||+.|||+..++...
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 689999999999999999874 388999999999999999999974 467899999999999999999999
Q ss_pred EeeeccccccCCCCC----CccccccccCccCccccccCCc------CcchhHHHHHHHHHHHHhC----------CCCC
Q 003780 645 VADFGTARLLDSDSS----NRTIVAGTYGYIAPELAYTMVV------TEKCDVYSFGVVALEVLMG----------RHPG 704 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~------~~~~DVwSlGv~l~elltg----------~~p~ 704 (796)
|+|+|+|........ .....+||.+|||||++...-- -..+||||||.|+||+.-. +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999987655422 2344679999999999865421 1368999999999999762 4677
Q ss_pred cccccCCCCCchhhhHHHHhhcCCCCCccc--hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 705 ELLSSLSSPSSDQKIMLIDVLDSRLSPPVD--RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
++.-+. +...+++..-+-..+++|..+ ....+.+..+.++++.||..+|..|-|+-.+-+.|.+..
T Consensus 437 yd~Vp~---DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 437 YDVVPS---DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ccCCCC---CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 643322 122222322233333333322 223456677899999999999999999999988887764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=326.72 Aligned_cols=262 Identities=24% Similarity=0.278 Sum_probs=197.3
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----ee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK-----CM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~ 573 (796)
+|++.+.||+|+||.||++.. .+|+.||+|++....... ...+.+.+|+++++.++||||+++++++..++ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL-VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch-HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478889999999999999975 479999999986543222 22467889999999999999999999998776 78
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++|+||+. ++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999997 47877776432 488999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC-CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCchhhh--
Q 003780 654 LDSDS-SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSDQKI-- 719 (796)
Q Consensus 654 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~~~~-- 719 (796)
..... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||....... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 54322 122334578899999998764 47889999999999999999999997432110 00000000
Q ss_pred --HHHH-hhcCCCCCcc-c---hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 720 --MLID-VLDSRLSPPV-D---RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 720 --~~~~-~~~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.... .......+.. . .........+.+++.+|++.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 0000 0011111100 0 00011133577999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.31 Aligned_cols=267 Identities=24% Similarity=0.379 Sum_probs=207.7
Q ss_pred hcCCccceeeecccceeEEEEEcc--------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP--------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
.++|.+.+.||+|+||.||+|+.. ....+|+|.+...... .....+..|+++++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 457889999999999999999632 3457999988754332 2245788999999999 6999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
..+..++|+||+++|+|.+++..... ...+++..+.+++.|++.||.|||++ +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 99999999999999999999976421 23488899999999999999999998 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCCCc--cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSSNR--TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~ 712 (796)
+++.++.+||+|||.++......... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--- 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--- 242 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence 99999999999999998664322211 11224467999999988889999999999999999999 8888763211
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFE 781 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 781 (796)
. .....+......... ......+.+++.+|++.+|++||++.|+++.|++........|.
T Consensus 243 -----~-~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 302 (314)
T cd05099 243 -----E-ELFKLLREGHRMDKP---SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302 (314)
T ss_pred -----H-HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCce
Confidence 1 111122221111111 11223477899999999999999999999999887655544443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.96 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=203.9
Q ss_pred eeecccceeEEEEEccC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCc
Q 003780 506 CIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gs 584 (796)
++|+|.||+||.|+..+ ...+|||-+...... ..+.+..|+...++++|.|||+++|.+.+++..-+.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 69999999999998664 567899988655433 24578999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec-CCCcEEEeeeccccccCCCCCCccc
Q 003780 585 LFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN-SKLEAFVADFGTARLLDSDSSNRTI 663 (796)
Q Consensus 585 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~ 663 (796)
|.++++.......-.+...-.+.+||++||.|||+. .|||||||-+||+++ ..|.+||+|||-++.+..-+.-...
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 999999877655557888888999999999999999 999999999999996 4688999999999988766555666
Q ss_pred cccccCccCccccccCC--cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHH
Q 003780 664 VAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDI 741 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~--~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
..||..|||||++..++ |..++|||||||++.||.||++||..... .+..++.--+-+. .|+ .+.+-.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs------pqAAMFkVGmyKv-HP~---iPeels 805 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS------PQAAMFKVGMYKV-HPP---IPEELS 805 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC------hhHhhhhhcceec-CCC---CcHHHH
Confidence 78999999999998664 88899999999999999999999974332 1111221111111 122 223334
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 742 VLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 742 ~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.+...+|.+|+.+||.+||+++++++.-
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 5577899999999999999999999874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=332.06 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=190.9
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------ 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 570 (796)
..+|++.+.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 45799999999999999999975 4689999998864321 345799999999999999999987432
Q ss_pred --ceeeEEEeeccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEe
Q 003780 571 --KCMFLIYKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVA 646 (796)
Q Consensus 571 --~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~ 646 (796)
...++||||+++ ++.+++... .....+++..+..++.||++||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 246789999986 676666432 2234588999999999999999999999 999999999999999765 69999
Q ss_pred eeccccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 647 DFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 647 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
|||+|+.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+...+
T Consensus 214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-----~~~~~i~~~~ 287 (440)
T PTZ00036 214 DFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-----DQLVRIIQVL 287 (440)
T ss_pred ccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHh
Confidence 9999987654322 2235689999999988654 6899999999999999999999999743211 0000111100
Q ss_pred c-----------C-----CCCCc----cch-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 726 D-----------S-----RLSPP----VDR-MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 726 ~-----------~-----~~~~~----~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
. + ..+.. ... .+.....++.+++.+||+.||.+|||+.|+++|-
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0 0 00000 000 0001224578999999999999999999999884
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.55 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=203.9
Q ss_pred hcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
.++|++.+.||+|+||.||+|..+ +++.||+|++...... ...+++.+|+.++++++||||+++++++..++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 457889999999999999999753 4788999998755432 22467899999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCc-------------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCC
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYE-------------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISS 632 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp 632 (796)
..++|+||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 99999999999999999974321 13477888999999999999999998 999999999
Q ss_pred CCeEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCccccc
Q 003780 633 NNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSS 709 (796)
Q Consensus 633 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~ 709 (796)
+||+++.++.++|+|||.+..+...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~- 237 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA- 237 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 9999999999999999998765432211 122335667999999988889999999999999999997 888875321
Q ss_pred CCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 710 LSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.........+....+.. ......+.+++.+|++.||++|||+.|+++.|++
T Consensus 238 -------~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 -------HEEVIYYVRDGNVLSCP----DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11222222222221111 1123458899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.17 Aligned_cols=251 Identities=31% Similarity=0.455 Sum_probs=205.8
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||.|++|.||+|... +++.||+|.+...... .....+.+|+++++.++||||+++++++..+...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36888899999999999999754 6899999998765422 22457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999998754 488999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........+++.|+|||++.+..++.++||||||+++|+|+||+.||..... .... ..+.....+.....
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~-~~~~~~~~~~~~~~- 221 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVL-FLIPKNNPPSLEGN- 221 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHH-HHhhhcCCCCCccc-
Confidence 3333445688899999999988899999999999999999999999873221 1111 11112222221111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+|+..||++||++++++++-
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 0233478899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.78 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=199.2
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEE-ecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCL-HKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||++..+ |+.||+|.+..... .+.+.+|+.++++++|+|++++++++. .+...++|+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 47889999999999999999765 78899998864432 357889999999999999999999765 456789999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++++... ..+++..+.+++.|++.||+|||++ +++||||||+||++++++.+|++|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999876432 3478999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.........
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~-- 221 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------LKDVVPRVEKGYKMDAP-- 221 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---------HHHHHHHHhcCCCCCCC--
Confidence 2 22335668999999988889999999999999999997 999986321 11111112222111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|++.+|++|||++++++.|++
T Consensus 222 -~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 -DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.57 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=203.6
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.+|++.+.||.|++|.||+|.. .+++.||+|.+....... .+.+.+|+++++.++|||++++++++...+..++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4689999999999999999964 578999999987554332 357889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.+. .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999988653 378999999999999999999999 9999999999999999999999999998866544
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ............ +... ..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~~~~-~~~~-~~ 238 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNGT-PELQ-NP 238 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCC-cccC-Cc
Confidence 3333345688899999999888899999999999999999999999874221 111111111111 1100 01
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+.+++.+||..||++||++.+++++=
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 11223477899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.38 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=204.7
Q ss_pred ccHHHHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeE
Q 003780 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGF 566 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 566 (796)
+.++++..+.++|++.+.||+|+||.||++.. .+++.+|+|.+...... ...+.+|+.+++++ +||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 45566667889999999999999999999965 46889999987653322 24678899999999 69999999998
Q ss_pred EE-----ecceeeEEEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 567 CL-----HKKCMFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 567 ~~-----~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
+. .++..++||||+++++|.++++... ....+++..+..++.|+++||.|||+. +|+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~ 160 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence 84 3456899999999999999876432 224578889999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCccccccccCccCcccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc
Q 003780 641 LEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS 715 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~ 715 (796)
+.++|+|||++..............|++.|+|||++.. ..++.++||||+||++|||++|+.||......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----- 235 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----- 235 (286)
T ss_pred CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----
Confidence 99999999999876543333334568999999998753 44788999999999999999999998743211
Q ss_pred hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 716 DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
....... ....+.... .......+.+++.+|++.||++||++.|++++.
T Consensus 236 ---~~~~~~~-~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 ---RALFKIP-RNPPPTLHQ-PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---HHHhhcc-ccCCCcccC-CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111111 111111000 011123478899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.88 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=201.1
Q ss_pred hcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 570 (796)
.++|++.+.||+|+||.||+|.. .+++.||||+++..... ...+.+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 45799999999999999999963 35789999999765432 2245788999999999 689999999988654
Q ss_pred -ceeeEEEeeccCCcHHHHHhhcCc-------------------------------------------------------
Q 003780 571 -KCMFLIYKYMKRGSLFCFLRNDYE------------------------------------------------------- 594 (796)
Q Consensus 571 -~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 594 (796)
...++||||+++|+|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999865321
Q ss_pred ---------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC--Cccc
Q 003780 595 ---------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS--NRTI 663 (796)
Q Consensus 595 ---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~ 663 (796)
...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999999 999999999999999999999999999986533221 1122
Q ss_pred cccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .......+........... ...
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~---~~~ 309 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--------DEEFCRRLKEGTRMRAPDY---TTP 309 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc--------cHHHHHHHhccCCCCCCCC---CCH
Confidence 335678999999988889999999999999999997 8899863211 0111122222111111111 123
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 743 LVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.+.+++..|++.||++||++.|++++|+...
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 4778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=325.29 Aligned_cols=262 Identities=21% Similarity=0.243 Sum_probs=197.6
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK----- 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 570 (796)
..++|++.+.||+|+||.||++... .++.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4578999999999999999999654 68999999997654332 2245778899999999999999999988643
Q ss_pred -ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 571 -KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 571 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999976 56666643 278888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC----------CCchh--
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS----------PSSDQ-- 717 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~----------~~~~~-- 717 (796)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99865432 222335689999999999998899999999999999999999999874321000 00000
Q ss_pred --hhHHHHhhcCCC---------------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 718 --KIMLIDVLDSRL---------------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 718 --~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
............ .+............+.+++.+|++.||++|||+.|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000100000 0000000011123578999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.78 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=201.8
Q ss_pred CCccceeeecccceeEEEEEccCCcEEEEEEeccccch---hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETE---ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
+|.+.+.||+|+||.||+|...+|+.+|+|.+...... .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999998888999999988754321 122345789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+||+++++|.+++.+.. .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997643 378899999999999999999998 999999999999999999999999999876532
Q ss_pred CC------CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC-CC
Q 003780 657 DS------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS-RL 729 (796)
Q Consensus 657 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 729 (796)
.. .......|+..|+|||++.+..++.++||||+||++|+|++|+.||..... .......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~ 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--------LAAMFYIGAHRGL 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--------HHHHHHhhhccCC
Confidence 11 111234588899999999988899999999999999999999999863221 1111111111 11
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.+... ......+.+++.+|++.+|++||++.|++++
T Consensus 227 ~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 MPRLP---DSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCC---CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111 1123347789999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.32 Aligned_cols=251 Identities=24% Similarity=0.431 Sum_probs=201.6
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.+|++.+.||+|+||.||++...+++.+|+|.+...... ..++.+|++++++++|||++++++++......++|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 468888999999999999998877889999998755433 2468899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 80 FMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999999987543 2478899999999999999999999 99999999999999999999999999987654322
Q ss_pred CC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 659 SN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 659 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.. .....++.+|+|||+..+..++.++||||||+++|||++ |+.||.... ..... +.+...........
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~-~~~~~~~~~~~~~~ 225 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVV-ETINAGFRLYKPRL 225 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHH-HHHhCCCCCCCCCC
Confidence 11 112235678999999998889999999999999999998 999986321 11111 11111111111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
....+.+++.+|++.+|++||++.|++++|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1234889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.01 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=209.4
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV 576 (796)
...|++.+.||.||.+.||++...+.+.||+|++.....+. .....|.+|+..|.+++ |.+||++++|-..++..|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~-qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN-QTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH-HHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 35688999999999999999999889999999887666544 34678999999999996 99999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||-+- +|..++.+.... ...| .+..++.|++.|+.++|.+ ||||.||||.|+++-. |.+||+|||+|..+..
T Consensus 439 mE~Gd~-DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECGDI-DLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecccc-cHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 998654 899999876432 2334 7788999999999999999 9999999999999876 6899999999998876
Q ss_pred CCCC--ccccccccCccCccccccCC-----------cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 657 DSSN--RTIVAGTYGYIAPELAYTMV-----------VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 657 ~~~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
+... ....+||+.||+||.+.... +++++||||+||+||+|+.|+.||..... ....+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl~a 584 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKLHA 584 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHHHh
Confidence 6443 34567999999999886432 55789999999999999999999984321 2334555
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
+.++.-..++....... +++++++.||..||++||+..|++++-.
T Consensus 585 I~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred hcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 66665544544433222 2889999999999999999999999843
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.96 Aligned_cols=255 Identities=28% Similarity=0.418 Sum_probs=202.6
Q ss_pred cCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||.||+|+.. .+..+|+|.+...... ...+.+.+|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56888999999999999999753 2347999998754432 22467899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++++|.+++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..+
T Consensus 82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999997643 3478999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCc---cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSDSSNR---TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
....... ....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~-~~~~ 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAIE-EGYR 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHHh-CCCc
Confidence 5432211 11123567999999998889999999999999999886 9999863221 11111111 1111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+.. ......+.+++.+|++.+|++||++.++++.|++.
T Consensus 228 ~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 LPAP---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCC---CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111 11233578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.98 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=202.3
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||++..+ +|+.||+|.+...... ...+.+.+|++++++++||||+++++++..++..++|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36888999999999999999765 7899999988754322 22467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++........+++..+..++.|+++||.|||+.+ +|+||||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999876433345899999999999999999999632 8999999999999999999999999998765332
Q ss_pred CCCccccccccCccCccccccCC------cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMV------VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ............... +
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~-~ 228 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVDGDP-P 228 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhhcCC-C
Confidence 222345788999999886543 47899999999999999999999863211 111111111222111 1
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. .......+.+++.+|++.+|++||++++++.+-.
T Consensus 229 ~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 229 TL---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred CC---CcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 11 1123345778999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=311.39 Aligned_cols=258 Identities=24% Similarity=0.283 Sum_probs=213.0
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..+.|..-++||+|+||.||-++.+ +|+.||.|++.+.+...........+|..++.+++.+.||.+--.|+.++..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467888899999999999999754 699999999988777666656678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|+..|.||+|.-++.+... ..+++..+..++.+|+.||++||.. +||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999887754 4589999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
...... ..+||.+|||||++....|+...|.||+||++|||+.|+.||.... .....+.++.+.......
T Consensus 339 ~g~~~~-~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---------eKvk~eEvdrr~~~~~~e 408 (591)
T KOG0986|consen 339 EGKPIR-GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---------EKVKREEVDRRTLEDPEE 408 (591)
T ss_pred CCCccc-cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---------hhhhHHHHHHHHhcchhh
Confidence 544433 3479999999999999999999999999999999999999997332 122222333333222222
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
++.....+...+....|+.||++|- .+++|-+|
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 2233334466788889999999996 55666655
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=308.17 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=213.5
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+-|.+.+.||+|.|++|-.|+ .-.|+.||||++.+.+.++.. ...+.+|++.|+-++|||||+++++.......|+|.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 457778899999999999996 457999999999998876543 457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe-cCCCcEEEeeeccccccCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL-NSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~Dfg~a~~~~~ 656 (796)
|.-++|+|++++.++.. .+.+....+++.||..|+.|+|.. .+|||||||+||.+ ..-|-+|+.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999987654 388999999999999999999999 99999999999876 4568999999999987765
Q ss_pred CCCCccccccccCccCccccccCCcC-cchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
. ......+|+..|-|||.+.+..|+ +++||||+||+||-|++|+.||+..++ .+.+..++|-....+
T Consensus 172 G-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND--------SETLTmImDCKYtvP--- 239 (864)
T KOG4717|consen 172 G-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND--------SETLTMIMDCKYTVP--- 239 (864)
T ss_pred c-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc--------hhhhhhhhcccccCc---
Confidence 3 445567899999999999998888 578999999999999999999984432 334555555554322
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.-...++.++|..||..||++|.+.+||...-+
T Consensus 240 --shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 240 --SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred --hhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 222345889999999999999999999987743
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.28 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=204.4
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..+|++.+.||+|++|.||++.. .+++.||+|.+....... .+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 36799999999999999999975 579999999987654332 35678999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.+. .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999998653 378889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........+++.|+|||...+..++.++|||||||++|+|++|+.||....... ......... .+... .
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--------~~~~~~~~~-~~~~~-~ 237 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG-TPELQ-N 237 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--------heeeeccCC-CCCCC-C
Confidence 4433344568899999999998889999999999999999999999986422110 000001001 11100 0
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.......+.+++.+|++.+|++||++++++++-
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 112223477899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=305.34 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=202.6
Q ss_pred eeeecccceeEEEEEccC----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeec
Q 003780 505 YCIGTGGYGSVYKAQLPN----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
+.||+|+||.||+|.... +..|++|.+....... ..+.+.+|+++++.++|+||+++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 468999999999997653 8899999998766543 3568899999999999999999999999999999999999
Q ss_pred cCCcHHHHHhhcCc------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 581 KRGSLFCFLRNDYE------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 581 ~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
++++|.+++..... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999987521 24589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCC--CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 655 DSDS--SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 655 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
.... .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||.... .......... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~-~~~~ 226 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRK-GYRL 226 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHc-CCCC
Confidence 5432 12233457889999999988889999999999999999999 699987431 1111112211 1111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
... ......+.+++.+|++.+|++||++.|++++|+
T Consensus 227 ~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKP---EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC---ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 112345889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=305.74 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=202.3
Q ss_pred cCCccceeeecccceeEEEEEcc-CC---cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NG---KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|+..+.||+|+||.||+|..+ ++ ..+|+|.+...... ...+.+..|++++++++|||++++.+++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 46888899999999999999764 23 37999988655322 22467889999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999997543 3488999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCCcc---ccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSDSSNRT---IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
........ ....++.|+|||++.+..++.++|||||||++|||++ |+.||.... ... ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~-~~~~i~~~~~ 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHE-VMKAINDGFR 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHH-HHHHHhcCCC
Confidence 43222111 1123457999999988889999999999999999997 999986321 111 1122222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+.. ......+.+++.+|++.+|++||++.+|++.|++.
T Consensus 229 ~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LPAP---MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 11234578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.10 Aligned_cols=194 Identities=27% Similarity=0.426 Sum_probs=159.9
Q ss_pred ceeeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cceeeEEEe
Q 003780 504 KYCIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKCMFLIYK 578 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~e 578 (796)
.+.||+|+||+||+|+.+ +++.||+|.+...... ..+.+|++++++++||||+++++++.. +...++|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999754 5688999998754322 356789999999999999999998854 456889999
Q ss_pred eccCCcHHHHHhhcC------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe----cCCCcEEEeee
Q 003780 579 YMKRGSLFCFLRNDY------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL----NSKLEAFVADF 648 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Df 648 (796)
|+.+ +|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9865 7888775321 123588899999999999999999999 99999999999999 45678999999
Q ss_pred ccccccCCCCC---CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcc
Q 003780 649 GTARLLDSDSS---NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGEL 706 (796)
Q Consensus 649 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~ 706 (796)
|+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 99987653321 1234568999999999876 4588999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=303.84 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=196.1
Q ss_pred eeeecccceeEEEEEcc--C--CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeec
Q 003780 505 YCIGTGGYGSVYKAQLP--N--GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
+.||+|+||.||+|... + +..+|+|.+...... ...+++.+|+++++++.||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 36899999999999643 2 378999999866553 23467899999999999999999999876 45679999999
Q ss_pred cCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC
Q 003780 581 KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN 660 (796)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 660 (796)
++|+|.+++.+.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++........
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999998654 488999999999999999999998 9999999999999999999999999999876443222
Q ss_pred cc---ccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 661 RT---IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 661 ~~---~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.. ...++..|+|||...+..++.++|||||||++|+|++ |+.||..... . .....+......+..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~-- 220 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------A-EVIAMLESGERLPRP-- 220 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------H-HHHHHHHcCCcCCCC--
Confidence 11 1123467999999998899999999999999999998 9999863211 1 111122222111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
......+.+++.+|++.+|++||++.++++.|+..
T Consensus 221 -~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 -EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11223578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=306.44 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=206.3
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||.|+||+||+|... ++..+|+|++....... ..+.+.+|++.++.++|+||+++++.+..++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 46899999999999999999754 68899999987654433 3568999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|++++++|.++++.......+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999998654434589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCC----ccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 658 SSN----RTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 658 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
... .....|+..|+|||++... .++.++|||||||++|+|++|+.||...... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~ 227 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQNDPPSL 227 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCCCCCc
Confidence 222 2334588999999998776 7889999999999999999999998743221 11212222111110
Q ss_pred cchh-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 733 VDRM-VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 733 ~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... .......+.+++.+|++.||++||+++|++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 01223457899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=310.60 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=201.5
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|++.+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|+++++.++||||+++++++..++..++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 56889999999999999999765 5899999998754322 2467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|..++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+......
T Consensus 89 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 89 EFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred ecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999988876532 2488999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 658 SSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
........+++.|+|||++. ...++.++|||||||++|||++|+.||..... ............. .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~-~ 234 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPP-T 234 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCCCc-c
Confidence 33334456888999999884 34567899999999999999999999863221 1111122111111 1
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. ........+.+++.+|++.||++||+++|++++-.
T Consensus 235 ~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 235 LS-QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred CC-CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 01112234778999999999999999999998743
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.48 Aligned_cols=262 Identities=24% Similarity=0.301 Sum_probs=202.1
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||++... ++..+|+|.+...... ...+++.+|++++++++||||+++++++..++..++|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP--AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36889999999999999999754 6888999988754322 23457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++++.. .+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 79 EHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999999997653 3788999999999999999999732 8999999999999999999999999998765332
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCC------C---c-------------
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP------S---S------------- 715 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~------~---~------------- 715 (796)
......|+..|+|||...+..++.++|||||||++|+|++|+.||......... . .
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 123346889999999998888999999999999999999999998532110000 0 0
Q ss_pred -----hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 716 -----DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 716 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.......+.+.....+.... ......+.+++.+|++.||++||+++|++++..-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000000000000000000 0122347899999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.51 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=203.8
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|++++++++|+||+++++++.. ...++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 4568999999999999999999877788899998875432 23578899999999999999999999987 778999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999997643 23478889999999999999999998 999999999999999999999999999976543
Q ss_pred CCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... .....++..|+|||++.+..++.++|||||||++|++++ |+.||..... . .....+......+..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~ 225 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------P-EVIRALERGYRMPRP 225 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------H-HHHHHHhCCCCCCCc
Confidence 2211 122335677999999998889999999999999999999 8999863211 1 111111222111111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=305.38 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=201.4
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchh------hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEE------TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
+|.+...||+|++|.||+|.. .+++.||+|.+....... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999975 468899999887654322 1234578899999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++|+||+++++|.+++.+.. .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997653 378888999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc
Q 003780 653 LLDSDSS------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD 726 (796)
Q Consensus 653 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (796)
....... ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||..... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~ 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQAIFKIGE 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHHHHHHhc
Confidence 7653211 11223578899999999988899999999999999999999999873211 111111111
Q ss_pred CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...+... ......+.+++.+||+.||++||++.|++++
T Consensus 227 -~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 -NASPEIP---SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -cCCCcCC---cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111111 1223457789999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=308.68 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=206.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
..|+..+.||+|+||.||+|..+ +++.||+|.+...... ...+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35777889999999999999764 6889999998754332 22467899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++... .+++..+..++.|++.||+|+|+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999998643 378888999999999999999998 9999999999999999999999999999876544
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....+.. .
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---------~~~~~~~~~~~~~~---~ 222 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---------RVLFLIPKNNPPTL---T 222 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---------hHhhhhhcCCCCCC---c
Confidence 33334456888999999998888999999999999999999999998732211 11111111111111 2
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
......+.+++.+|++.+|++||++++++++-.-.+.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 2334558899999999999999999999998554433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.16 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=205.1
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|+..+.||+|++|.||+|... +++.||+|.+...........+.+..|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999765 58999999998765544344567899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+.+++|.+++.+.. ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987542 24588999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccc
Q 003780 658 SS-----------------------------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLS 708 (796)
Q Consensus 658 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~ 708 (796)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 0112357889999999998889999999999999999999999986322
Q ss_pred cCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH
Q 003780 709 SLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT----MQRVCQE 768 (796)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 768 (796)
................... .....+.+++.+|++.||++||+ ++|++.+
T Consensus 237 --------~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 --------RDETFSNILKKEVTFPGSP---PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred --------hHHHHHHHhcCCccCCCcc---ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1222233333332222111 12345889999999999999999 6666554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=342.94 Aligned_cols=259 Identities=21% Similarity=0.328 Sum_probs=200.4
Q ss_pred HHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cce
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKC 572 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~ 572 (796)
...++|.+.+.||+|+||+||+|... +++.||+|.+....... .....+..|+.++++++|||||++++++.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34578999999999999999999754 57889999887654332 234678999999999999999999998854 457
Q ss_pred eeEEEeeccCCcHHHHHhhcCc-ccccCHHHHHHHHHHHHHHHHHHhhcCC----CCeEEecCCCCCeEecC--------
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYE-AVVLDWTMRVNIIKCVANALSYLHHDCM----PSIVHRDISSNNILLNS-------- 639 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~dlkp~NIll~~-------- 639 (796)
+++||||+++|+|.+++..... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999999976422 2358999999999999999999998521 25999999999999964
Q ss_pred ---------CCcEEEeeeccccccCCCCCCccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccc
Q 003780 640 ---------KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLS 708 (796)
Q Consensus 640 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~ 708 (796)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23489999999987643322 234569999999999854 457899999999999999999999997322
Q ss_pred cCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 709 SLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. ...+...+......+.. .....+.+++..||+.+|++||++.|++++
T Consensus 248 ~--------~~qli~~lk~~p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 N--------FSQLISELKRGPDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred c--------HHHHHHHHhcCCCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 1 11112222221111111 112347899999999999999999999965
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.90 Aligned_cols=262 Identities=21% Similarity=0.236 Sum_probs=197.2
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK----- 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 570 (796)
..++|++.+.||+|+||.||++.. ..++.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 457899999999999999999975 468899999997654322 2245778899999999999999999987543
Q ss_pred -ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 571 -KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 571 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
...++||||+++ +|.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999976 67666643 277888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCchhhh
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSDQKI 719 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~~~~ 719 (796)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+......
T Consensus 172 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 172 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 998654322 2233468999999999999999999999999999999999999997432110 00000000
Q ss_pred ----HHHHhhcCCCC---------------CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 720 ----MLIDVLDSRLS---------------PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 720 ----~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
........+.. +............+.+++.+|++.||++|||+.|+++|-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00000000000 000000001123578999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.00 Aligned_cols=258 Identities=25% Similarity=0.345 Sum_probs=200.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|++|.||+|..+ +|+.||+|++....... ...+.+.+|++++++++|||++++++++..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 46888999999999999999765 68999999987554222 22356789999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++++.|..+..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999998888765432 389999999999999999999998 9999999999999999999999999999876554
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc----------
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD---------- 726 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 726 (796)
........++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ...........
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-----DQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCChHHhhhc
Confidence 333334457889999999875 45788999999999999999999998643211 00000000000
Q ss_pred -------CCCCCccc------hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 -------SRLSPPVD------RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 -------~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
....+... .........+.+++.+|++.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000 0001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.88 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=204.8
Q ss_pred ccHHHHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeE
Q 003780 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGF 566 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 566 (796)
+++.++..+.++|++.+.||+|+||.||++.. .+++.+|+|.+...... ...+.+|+.+++++ +|||+++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 44556666788999999999999999999975 46899999998654322 34677899999998 79999999999
Q ss_pred EEec-----ceeeEEEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 567 CLHK-----KCMFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 567 ~~~~-----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
+... +..++|+||+++|+|.++++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.+
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 8754 35899999999999999886432 223578999999999999999999998 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCccccccccCccCccccccC-----CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc
Q 003780 641 LEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-----VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS 715 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~ 715 (796)
+.+||+|||.+..............|+..|+|||.+... .++.++|||||||++|||++|+.||.....
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------ 238 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------ 238 (291)
T ss_pred CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------
Confidence 999999999998765433333345688999999987543 367899999999999999999999863221
Q ss_pred hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 716 DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.......... ..+.... .......+.+++.+|++.+|++||++.|++++
T Consensus 239 --~~~~~~~~~~-~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 --VKTLFKIPRN-PPPTLLH-PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHHHHHHhcC-CCCCCCc-ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111111 1111100 11122357899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.74 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=199.5
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|++.+.||+|+||.||+|... ++..+++|.+...... ..+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH---HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 677888999999999999765 5788899988654322 245788999999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+++++|..++.+.. ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999998876532 3488999999999999999999999 999999999999999999999999999876543333
Q ss_pred CccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 660 NRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
......+++.|+|||++. +..++.++|||||||++|||++|+.||..... .................
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~ 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPPTLAQ 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcCCCCCCC
Confidence 333456889999999874 34577899999999999999999999874221 11111111111110000
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......+.+++.+||+.||++||++.+++++-.
T Consensus 231 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 231 --PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 1112235789999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.94 Aligned_cols=257 Identities=28% Similarity=0.367 Sum_probs=193.0
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc---CCCceeeEEeEEEe-----c
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI---AHRNIVKLYGFCLH-----K 570 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~ 570 (796)
+|++.+.||+|+||+||+|+.+ +++.||+|.+........ ....+.+|+++++++ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4888999999999999999755 689999999876432221 123455677766655 69999999998864 3
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...++|+||+++ +|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 457899999985 88888875432 3488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc----
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD---- 726 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 726 (796)
++...... ......|+..|+|||++.+..++.++||||+||++|+|++|+.||..... ......+.....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----ADQLGKIFDLIGLPPE 228 (288)
T ss_pred cccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-----HHHHHHHHHHhCCCCh
Confidence 98764322 22334588999999999988899999999999999999999999863211 000001111100
Q ss_pred ---------------CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 ---------------SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 ---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.................+.+++.+|++.||++|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000001111123347799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=306.26 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=189.5
Q ss_pred eeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 506 CIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
.||+|+||.||+|... .+..+|+|.+....... ....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ--EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 5899999999999754 34679999887654332 234788899999999999999999999999999999999999
Q ss_pred CcHHHHHhhcCc--ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC-
Q 003780 583 GSLFCFLRNDYE--AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS- 659 (796)
Q Consensus 583 gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 659 (796)
|+|.++++.... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975432 23456778889999999999999999 999999999999999999999999999975433221
Q ss_pred -CccccccccCccCccccccC-------CcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 660 -NRTIVAGTYGYIAPELAYTM-------VVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~~-------~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||..... .+............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-------EQVLTYTVREQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-------HHHHHHHhhcccCC
Confidence 11234577889999987642 35789999999999999996 9999863211 11111111111111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.............+.+++..|+ .+|++|||++||.+.|.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111101112234677889998 58999999999998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.64 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=198.5
Q ss_pred eeeecccceeEEEEEccC--C--cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeec
Q 003780 505 YCIGTGGYGSVYKAQLPN--G--KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999997543 3 36999999876654 345789999999999999999999999988 8899999999
Q ss_pred cCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC
Q 003780 581 KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN 660 (796)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 660 (796)
++|+|.+++.+... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999987543 4589999999999999999999999 9999999999999999999999999999876542211
Q ss_pred ---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 661 ---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 661 ---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ................
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~--- 222 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGERLER--- 222 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCCcCCC---
Confidence 112346788999999998889999999999999999998 9999863211 1111111111111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......+.+++.+|++.+|++||+++|+++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1122345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.91 Aligned_cols=250 Identities=29% Similarity=0.459 Sum_probs=202.3
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|+..+.||+|+||.||+|.. .+++.||+|.+....... ..+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 466678899999999999965 468899999887554322 24678999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++... .+++..+..++.|+++|+.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999988642 378899999999999999999998 99999999999999999999999999998765433
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......++..|+|||++.+..++.++|||||||++|||++|+.|+...... .....+.....+.. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---------~~~~~~~~~~~~~~---~~ 223 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---------RVLFLIPKNSPPTL---EG 223 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---------hHHhhhhcCCCCCC---Cc
Confidence 3333345888999999999888999999999999999999999998632211 11111111111111 11
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.....+.+++.+|++.+|++||++.+++++-.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 22345789999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=304.23 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=196.6
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccch--hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cceee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETE--ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKCMF 574 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 574 (796)
+|+..+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688899999999999999975 46899999988654321 22234578899999999999999999999875 35788
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+++||+++++|.+++.+.. .+++.....++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 83 l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999997643 378888999999999999999998 9999999999999999999999999999765
Q ss_pred CCCC---CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 655 DSDS---SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 655 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
.... .......++..|+|||++.+..++.++||||+||++|||++|+.||..... .............+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 228 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAAIFKIATQPTNP 228 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHHHHHHhcCCCCC
Confidence 4321 112234588899999999988899999999999999999999999873211 11122222211122
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... .....+..++ +|+..+|++||+++||++|
T Consensus 229 ~~~~---~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 229 QLPS---HISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCch---hcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 2111 1122355566 6888999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.55 Aligned_cols=263 Identities=19% Similarity=0.242 Sum_probs=192.1
Q ss_pred HHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC------CceeeEEeE
Q 003780 494 IIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH------RNIVKLYGF 566 (796)
Q Consensus 494 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~ 566 (796)
+....++|++.+.||+|+||+||+|.. ..++.||||+++.... ..+.+..|+++++.++| +++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 334568899999999999999999975 4688999999964322 12345667777777654 458899998
Q ss_pred EEec-ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCC---
Q 003780 567 CLHK-KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKL--- 641 (796)
Q Consensus 567 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~--- 641 (796)
+..+ +..++|||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 8764 5788999987 668888887543 48899999999999999999997 5 999999999999998765
Q ss_pred -------------cEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccc
Q 003780 642 -------------EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLS 708 (796)
Q Consensus 642 -------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~ 708 (796)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886432 22334679999999999999999999999999999999999999997432
Q ss_pred cCC----------CCCchh-----hhHHHHhhcC--CCCCccch------------hhHHHHHHHHHHHHHcCCCCCCCC
Q 003780 709 SLS----------SPSSDQ-----KIMLIDVLDS--RLSPPVDR------------MVMQDIVLVTTVALACLHSKPKFR 759 (796)
Q Consensus 709 ~~~----------~~~~~~-----~~~~~~~~~~--~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~R 759 (796)
... ...... .......... .+.+.... ...-....+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 110 000000 0000000000 00000000 000112347799999999999999
Q ss_pred CCHHHHHHHHh
Q 003780 760 PTMQRVCQEFL 770 (796)
Q Consensus 760 Ps~~evl~~L~ 770 (796)
||++|+++|-.
T Consensus 430 ~ta~e~L~Hp~ 440 (467)
T PTZ00284 430 LNARQMTTHPY 440 (467)
T ss_pred CCHHHHhcCcc
Confidence 99999999743
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.62 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=203.3
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||++... +++.||+|.+..... ...+.+..|++++++++||||+++++++..+...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE---EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH---HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 356889999999999999999764 689999999865432 2246788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.+.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 81 IEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999987643 2488999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 657 DSSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
.........+++.|+|||++. ...++.++||||||+++|+|++|+.||..... ............ +
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-~ 226 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILKSEP-P 226 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHhcCCC-C
Confidence 333334456899999999874 34467799999999999999999999874221 111112211111 1
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.... .......+.+++.+|++.+|++||++.+++++-.
T Consensus 227 ~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 227 TLDQ-PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred CcCC-cccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 1100 1112234778999999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.66 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=198.4
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+.+ +++.||+|.+........ ...+.+|+.++++++||||+++++++..++..++|+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 57899999999999999999754 688999999875543221 245778999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++ ++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 84 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9997 58988887543 2478889999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC--------
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR-------- 728 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 728 (796)
........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ..........+...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhh
Confidence 333333457889999998765 3478899999999999999999999874221 00000000000000
Q ss_pred --------CC-Ccc-----chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 729 --------LS-PPV-----DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 729 --------~~-~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. +.. ..........+.+++.+|++.||.+|||++|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 000 0000111234778999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=324.71 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=194.7
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..+|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++||||+++++++..++..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999765 58889999532 22456899999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
||++. ++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 239 ~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 239 LPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99995 68888876532 2489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCC--chhhhHHHHhhcC---CC
Q 003780 657 DSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS--SDQKIMLIDVLDS---RL 729 (796)
Q Consensus 657 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~---~~ 729 (796)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..|+.......... ......+...... ..
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 3221 223569999999999999999999999999999999999887643221110000 0000011110000 00
Q ss_pred --------------------CCccchh----hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 730 --------------------SPPVDRM----VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 730 --------------------~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.+..... .......+.+++.+||+.||.+|||+.|++++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 00111247789999999999999999999987
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.85 Aligned_cols=263 Identities=23% Similarity=0.337 Sum_probs=201.9
Q ss_pred CCccceeeecccceeEEEEEc-----cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ce
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KC 572 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~ 572 (796)
.|++.+.||+|+||.||.++. .+++.||+|.+...... ...+.+.+|++++++++||||+++.+++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH--HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 467889999999999999963 35889999998755432 2346799999999999999999999999875 56
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+++++|.+++.+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 889999999999999987543 2478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC------CCCchhhhHHHH
Q 003780 653 LLDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS------SPSSDQKIMLID 723 (796)
Q Consensus 653 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~------~~~~~~~~~~~~ 723 (796)
........ .....++..|+|||+..+..++.++|||||||++|||++++.|+....... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433221 122446778999999988889999999999999999999887643211100 000000011111
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+......+.. ......+.+++.+|++.+|++||+++++++.+++.
T Consensus 238 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRP---PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111111 11234588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=303.80 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=203.8
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cceeeEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKCMFLI 576 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV 576 (796)
+|++.+.||.|+||.||++.. .+++.||+|.+....... ...+.+..|++++++++||||+++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 478889999999999999964 478899999987654332 224678899999999999999999998764 4567899
Q ss_pred EeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 577 YKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLH-----HDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
|||+++++|.+++.+.. ....+++..+..++.|++.||+||| +. +++|+||+|+||+++.++.+|++|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 99999999999987642 2345899999999999999999999 66 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
+..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+.+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---------~~~~~~~~~~~~~ 227 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---------QLQLASKIKEGKF 227 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---------HHHHHHHHhcCCC
Confidence 9877654432344568999999999998889999999999999999999999987321 1112222222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+.. .......+.+++.+|++.+|++||++++|+++
T Consensus 228 ~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRI---PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC---ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 211 11223457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.69 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=203.5
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||++... +|+.||+|++..... ....+.+.+|+++++.++||||+++++++......++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 56888899999999999999754 689999998875432 223468899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.+.. .+++..+..++.+++.||.|||+.+ +++||||||+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999999987643 3789999999999999999999732 8999999999999999999999999998754322
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc---hhhhHHHHhhcCCCCCccc
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS---DQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 734 (796)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........... ............... ...
T Consensus 158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 234 (284)
T cd06620 158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP-RLP 234 (284)
T ss_pred c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC-CCC
Confidence 1 2234689999999999888899999999999999999999999974322100000 001111122211111 110
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.......+.+++.+|++.||++||+++|++++.
T Consensus 235 --~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 235 --SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 011234578999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=315.37 Aligned_cols=260 Identities=24% Similarity=0.380 Sum_probs=204.2
Q ss_pred hcCCccceeeecccceeEEEEEcc--------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP--------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
..+|++.+.||+|+||.||+|+.. .+..||+|.+...... ...+++.+|+++++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 357899999999999999999642 1246899988754322 2246889999999999 7999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcC-------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDY-------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
.++..++|+||+++|+|.+++.+.. ....+++..+..++.|+++||+|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 9999999999999999999997532 123578899999999999999999998 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCCCc--cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSSNR--TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~ 712 (796)
+++.++.+||+|||+++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence 99999999999999998654322111 11224567999999999889999999999999999998 888876321
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.. .....+......... ......+.+++.+|++.+|++||++.|+++.|+....
T Consensus 242 ----~~-~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 ----VE-ELFKLLKEGHRMDKP---ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HH-HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 111222222211111 1122357899999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.68 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=196.1
Q ss_pred HHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec----
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK---- 570 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---- 570 (796)
...++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 4567899999999999999999964 578899999987653322 2245677899999999999999999987543
Q ss_pred --ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 571 --KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 571 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
...++++|++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3568999987 67898877542 388999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCchh
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSDQ 717 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~~ 717 (796)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ......
T Consensus 163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999865432 233468999999999876 568899999999999999999999986422100 000000
Q ss_pred hh-----HHHHhhcC--CCCC-ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 718 KI-----MLIDVLDS--RLSP-PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 718 ~~-----~~~~~~~~--~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. ........ .... ............+.+++.+|++.||++|||+.|+++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00 00000000 0000 00000001122467899999999999999999999883
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.79 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=202.5
Q ss_pred CCccceeeecccceeEEEEEccC--CcEEEEEEeccccc-------hhhHHHHHHHHHHHHHhh-cCCCceeeEEeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLPN--GKVVALKKLHRAET-------EETTFFNSFQNEAHVLSK-IAHRNIVKLYGFCLH 569 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 569 (796)
+|++.+.||+|+||.||+|..+. ++.+|+|.+..... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998654 78899998864321 112234567788888875 789999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEee
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVAD 647 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~D 647 (796)
++..++||||+++++|.+++... .....+++..+++++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 123458889999999999999999996 5 899999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...........
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVEA 228 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhhc
Confidence 99998765433 3334568899999999998889999999999999999999999986321 11112222222
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
...+.... .....+.+++.+|++.||++||++.|+..+++
T Consensus 229 ~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPLPEG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcCCcc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 22221111 12235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.36 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=198.3
Q ss_pred eeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCc
Q 003780 505 YCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS 584 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gs 584 (796)
+.||+|+||.||++...+++.||+|.+...... .....+.+|++++++++||||+++++++......++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999998777999999998766543 234678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC--cc
Q 003780 585 LFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--RT 662 (796)
Q Consensus 585 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~ 662 (796)
|.+++.+... .+++..+..++.+++.|++|||++ +++||||||+||+++.++.++|+|||.+......... ..
T Consensus 79 l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999976432 478889999999999999999999 9999999999999999999999999999765422111 11
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDI 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
...++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+......... ....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---------~~~~~~~~~~~~~~~~---~~~~ 221 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---------QQTRERIESGYRMPAP---QLCP 221 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---------HHHHHHHhcCCCCCCC---ccCC
Confidence 2234567999999988889999999999999999999 7888763211 1111222222111111 1123
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 742 VLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 742 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..+.+++.+|++.+|++||++.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 45889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=314.29 Aligned_cols=262 Identities=19% Similarity=0.275 Sum_probs=194.0
Q ss_pred cceeeecc--cceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 503 IKYCIGTG--GYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 503 ~~~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
+.++||+| +|++||++.. .+|+.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 7889999965 579999999997654332 2245778899999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+++|+|.+++..... ..+++..+.+++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999975432 2378999999999999999999998 999999999999999999999999986543321111
Q ss_pred -------CccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh-----
Q 003780 660 -------NRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL----- 725 (796)
Q Consensus 660 -------~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 725 (796)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.....................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0112346778999999876 45889999999999999999999999743210000000000000000
Q ss_pred --------------cCC---------CCC-----ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 726 --------------DSR---------LSP-----PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 726 --------------~~~---------~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
+.. ..+ ............+.+++.+|++.||++|||++|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 000 000 00000111234588999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.44 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=203.7
Q ss_pred ccHHHHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeE
Q 003780 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGF 566 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 566 (796)
.++.++....+.|++.+.||+|+||.||+|.. .+++.+|+|.+...... ...+..|+.++.++ +||||++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE----EEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH----HHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 34555666778999999999999999999975 46899999988654322 34678899999998 69999999999
Q ss_pred EEe------cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 567 CLH------KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 567 ~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
+.. ....++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||+|+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 853 457899999999999999987543 23477888899999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc
Q 003780 641 LEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS 715 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~ 715 (796)
+.++|+|||++..............|++.|+|||.+. ...++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~------ 231 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP------ 231 (282)
T ss_pred CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH------
Confidence 9999999999876543333333456899999999875 34578899999999999999999999864221
Q ss_pred hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 716 DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
................ .......+.+++.+||+.||.+||++.|++++
T Consensus 232 --~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 232 --MRALFLIPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --HhhhhhHhhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1111111111111111 11123458899999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.96 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=200.7
Q ss_pred cCCccceeeecccceeEEEEEcc-CC---cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NG---KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
.+|++.+.||+|+||.||+|..+ ++ ..||+|.+...... ...+.+..|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35788999999999999999764 23 36999998765322 23468999999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+...
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999987643 3478999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCCcc---ccc--cccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 655 DSDSSNRT---IVA--GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 655 ~~~~~~~~---~~~--gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
........ ... .+..|+|||++.+..++.++||||+||++|||++ |..||..... . .....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~-~~~~~i~~~ 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------Q-DVINAIEQD 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------H-HHHHHHHcC
Confidence 43222111 111 2357999999998899999999999999999886 9999863211 1 111111111
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
...+.. ...+..+.+++.+|++.+|.+||+++++++.|+..
T Consensus 228 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPP---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCc---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 11234578999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.95 Aligned_cols=248 Identities=26% Similarity=0.354 Sum_probs=203.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|++|.||++... +++.||+|++...........+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999754 68999999997665444444567899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999997653 488999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ...............+ .
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~--~-- 219 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKILEGKVRFP--S-- 219 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCccCC--c--
Confidence 233468899999999988888899999999999999999999986322 1112222222221111 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
.....+.+++.+||+.||.+|| +++|++++
T Consensus 220 -~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 220 -FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1123477899999999999998 67777655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.80 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=200.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|..+ +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46888999999999999999765 58999999987654332 23457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.++..... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999988766432 388999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH-------------
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID------------- 723 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------------- 723 (796)
........++..|+|||+..+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-----DQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-----HHHHHHHHHhCCCchhhHHHh
Confidence 333334558889999998875 44778999999999999999999998632210 00000000
Q ss_pred ----hhcCCCCCccc------hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 724 ----VLDSRLSPPVD------RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 724 ----~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.......+... .........+.+++.+|++.+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000 0001123458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.47 Aligned_cols=253 Identities=29% Similarity=0.452 Sum_probs=202.8
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+..|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 578889999999999999975 47899999998766543 3346789999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999997643 378889999999999999999999 99999999999999999999999999998765433
Q ss_pred CCcc----ccccccCccCccccccCC---cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 659 SNRT----IVAGTYGYIAPELAYTMV---VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 659 ~~~~----~~~gt~~y~aPE~~~~~~---~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
.... ...++..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ......... ....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~~~~~~-~~~~~ 225 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQIMFHVG-AGHKP 225 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHHHHHHh-cCCCC
Confidence 2211 245788999999988766 88899999999999999999999873211 111111111 11111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... .......+.+++.+|++.+|++||++.|++.+
T Consensus 226 ~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 226 PIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111 11113346789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.31 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=191.0
Q ss_pred eeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEE-ecceeeEEEee
Q 003780 505 YCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCL-HKKCMFLIYKY 579 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV~e~ 579 (796)
+.||+|+||.||+|... ++..||+|++...... ...+.+.+|+.+++.++||||+++++++. .++..++|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH--HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 36899999999999743 2467999988643322 22467889999999999999999999876 45568899999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+.+|+|.+++.+... ..++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 79 MKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999976432 357778889999999999999998 999999999999999999999999999976543211
Q ss_pred ----CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCC-CCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 660 ----NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGR-HPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 660 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
......+++.|+|||...+..++.++|||||||++|||++|+ .||.... ..... ..+.........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~~ 224 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--------SFDIT-VYLLQGRRLLQP 224 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH-HHHhcCCCCCCC
Confidence 112234677899999998888999999999999999999964 5554211 11111 112111111111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
. .....+.+++.+||+.+|++||++.|+++.+++.
T Consensus 225 ~---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 225 E---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred C---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 1123477999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.16 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=194.0
Q ss_pred eeeecccceeEEEEEccC-Cc--EEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEEeec
Q 003780 505 YCIGTGGYGSVYKAQLPN-GK--VVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
+.||+|+||.||+|..++ +. .+++|.+...... ...+.+.+|++++.++ +||||+++++++...+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 358999999999997653 43 4688888744322 2245788999999999 7999999999999999999999999
Q ss_pred cCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEee
Q 003780 581 KRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVAD 647 (796)
Q Consensus 581 ~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 647 (796)
++|+|.++++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 99999999975421 12478899999999999999999998 999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhc
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLD 726 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (796)
||++...... ........+..|+|||++....++.++|||||||++|||++ |..||..... . .....+.
T Consensus 156 fgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~-~~~~~~~ 225 (270)
T cd05047 156 FGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------A-ELYEKLP 225 (270)
T ss_pred CCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------H-HHHHHHh
Confidence 9998632211 11112234567999999988889999999999999999997 9999863211 1 1111222
Q ss_pred CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.....+... .....+.+++.+|++.+|.+|||+.|+++.|++.
T Consensus 226 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 226 QGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCCCCCCC---cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 221111111 1223477999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.97 Aligned_cols=240 Identities=22% Similarity=0.326 Sum_probs=186.8
Q ss_pred eeeecccceeEEEEEccC-------------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 505 YCIGTGGYGSVYKAQLPN-------------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
+.||+|+||.||+|...+ ...|++|.+..... .....+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999997432 23588888765432 22457888999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc-------EE
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE-------AF 644 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-------~k 644 (796)
..++||||+++|+|..++++.. ..+++..+.+++.||++||+|||+. +|+||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999998887543 2488999999999999999999999 9999999999999987654 89
Q ss_pred EeeeccccccCCCCCCccccccccCccCccccc-cCCcCcchhHHHHHHHHHHHH-hCCCCCcccccCCCCCchhhhHHH
Q 003780 645 VADFGTARLLDSDSSNRTIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+..... .. ..
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~---~~ 219 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL------AE---KE 219 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch------hH---HH
Confidence 9999998754322 2245788899999886 466889999999999999998 58888753211 11 11
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......... ......+.+++.+||+.||++||++.+++++++
T Consensus 220 ~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEGQCMLV-----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhcCccCC-----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1111111110 111234789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.60 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=199.1
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|.....||+|+||.||++.. .+++.||||.+...... ..+.+.+|+.++++++||||+++++.+..++..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH---HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 344456799999999999975 46899999998654322 24578899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 100 FLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 99999999988543 378899999999999999999999 99999999999999999999999999997654433
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......|+..|+|||...+..++.++||||||+++|||++|+.||..... ................. ..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~-----~~ 242 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----LQAMRRIRDNLPPRVKD-----SH 242 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCCCcccc-----cc
Confidence 333445688999999999888899999999999999999999999863211 11111111111111111 11
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|+..||.+|||++|++++
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122347789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.73 Aligned_cols=256 Identities=25% Similarity=0.309 Sum_probs=197.4
Q ss_pred hcCCccceeeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
..+|.+.+.||+|+||.||++... .++.||+|.+.... ...+|++++++++||||+++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 457999999999999999999643 46789999876432 3467999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+|||++. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999986 5888888433 3489999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH---------
Q 003780 655 DSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID--------- 723 (796)
Q Consensus 655 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 723 (796)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...-..+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS--SSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc--HHHHHHHHHHhccCcccc
Confidence 543221 2235699999999999998999999999999999999999999864322100 000000000
Q ss_pred -------------hhcCCCCCccc--hh--hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 724 -------------VLDSRLSPPVD--RM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 724 -------------~~~~~~~~~~~--~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......+... .. .......+.+++.+|++.||++||++.|++.+-.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 00001111000 00 0011234778999999999999999999999843
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.83 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=202.6
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|+..+.||+|++|.||++.. .+++.+|+|.+........ ..+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH-HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 478899999999999999965 4688999999976543332 35688999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 657 (796)
|+++++|.+++.... ...+++..+.+++.++++|++|||++ +++|+||+|+||+++.++ .++++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999997643 23478999999999999999999999 999999999999998654 5799999999876543
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+.... .............+...
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~--- 223 (256)
T cd08220 156 SK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGTFAPISD--- 223 (256)
T ss_pred cc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcCCCCCCC---
Confidence 22 2234588899999999988889999999999999999999999863211 11222222222211111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|++.+|++|||+.|++++
T Consensus 224 -~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 -RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 122347799999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=318.33 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=198.7
Q ss_pred cceeeecccceeEEEEEcc-CCcEEEEEEecccc-chhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce--eeEEEe
Q 003780 503 IKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAE-TEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC--MFLIYK 578 (796)
Q Consensus 503 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~lV~e 578 (796)
...+||+|+|-+||+|... +|-.||=-.++... .......+.|..|+++++.|+||||+++++++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3567999999999999653 56666532222111 1122235789999999999999999999999987654 778999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~ 657 (796)
.+..|+|..|.++.+. .+.....+|++||++||.|||++ .|+|+|||||.+||||+.+ |.|||+|+|+|+.+...
T Consensus 124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999998754 78889999999999999999997 6799999999999999875 89999999999987543
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc-cchh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP-VDRM 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 736 (796)
+...+.|||.|||||+.. ..|++.+||||||+.++||+|+.+||. .......+...+.+.+.|. +..
T Consensus 200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs--------EC~n~AQIYKKV~SGiKP~sl~k- 267 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS--------ECTNPAQIYKKVTSGIKPAALSK- 267 (632)
T ss_pred --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh--------hhCCHHHHHHHHHcCCCHHHhhc-
Confidence 333478999999999876 779999999999999999999999975 2333444444445554433 222
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
-..+++.++|.+|+.. ..+|||+.|++.+-
T Consensus 268 --V~dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 268 --VKDPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred --cCCHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 2245688999999999 99999999999873
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.75 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=206.1
Q ss_pred cCCccceeeecccceeEEEEEcc-----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cc
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KK 571 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~ 571 (796)
++|++.+.||+|+||.||+|... +++.||||.+...... ...+.+.+|++++++++||||+++++++.. +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46778899999999999999743 4789999999866543 235689999999999999999999999987 55
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 78999999999999999986532 489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCC------CchhhhHHH
Q 003780 652 RLLDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP------SSDQKIMLI 722 (796)
Q Consensus 652 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~------~~~~~~~~~ 722 (796)
......... .....++..|+|||...+..++.++||||||+++|||++|+.|+......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 876532211 11123456799999998888999999999999999999999997642211000 000111122
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
+.+......... ......+.+++.+|++.+|++||+|.||+++|+..
T Consensus 237 ~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRP---PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCC---ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 222222221111 11224588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.34 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=203.6
Q ss_pred CccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|+-.+.||.|+||.||-|+ .++.+.||||++.-.......-++++..|+..+++++|||++.+-|+|..+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4445779999999999996 457899999999876655555578999999999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
|-| +-.+++.-.+ .++.+.++..|+.+.++||+|||+. +.||||||+-|||+++.|.||++|||.|..+.+..
T Consensus 108 ClG-SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn- 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN- 180 (948)
T ss_pred Hhc-cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence 975 6666665433 2488889999999999999999999 99999999999999999999999999998776532
Q ss_pred CccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 660 NRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.++|||.|||||++. .+.|+-|+||||+|++..||...++|.-.++. .-.+..+.... +|....
T Consensus 181 ---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--------MSALYHIAQNe-sPtLqs- 247 (948)
T KOG0577|consen 181 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNE-SPTLQS- 247 (948)
T ss_pred ---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--------HHHHHHHHhcC-CCCCCC-
Confidence 367999999999876 57899999999999999999999999542221 11122222111 111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.+-...++.++..||+.-|.+|||.+++++|-.....
T Consensus 248 -~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 248 -NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 1112348899999999999999999999999665543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.69 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=201.6
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccch--hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETE--ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
+|+..+.||+|++|.||+|..+ +++.|++|.+...... .....+.+.+|++++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999765 7999999998654322 123356889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+||+++++|.+++.+.. .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997653 378899999999999999999999 999999999999999999999999999886543
Q ss_pred CCCCccccccccCccCccccccCC-cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ..............+...
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~- 224 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELPPIP- 224 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCCCcC-
Confidence 32 223456888999999987766 8899999999999999999999987322 111111111101111111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.+++.+|++.+|++||++.+++++
T Consensus 225 --~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 225 --DHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1122347789999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.03 Aligned_cols=193 Identities=27% Similarity=0.426 Sum_probs=158.7
Q ss_pred eeeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cceeeEEEee
Q 003780 505 YCIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKCMFLIYKY 579 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~e~ 579 (796)
..||+|+||.||+|+.+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++|+||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 57999999999999754 457899999875432 2357789999999999999999999854 5678999999
Q ss_pred ccCCcHHHHHhhc------CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe----cCCCcEEEeeec
Q 003780 580 MKRGSLFCFLRND------YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL----NSKLEAFVADFG 649 (796)
Q Consensus 580 ~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg 649 (796)
+++ +|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 875 777776532 1223578899999999999999999999 99999999999999 566789999999
Q ss_pred cccccCCCCC---CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcc
Q 003780 650 TARLLDSDSS---NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGEL 706 (796)
Q Consensus 650 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~ 706 (796)
+++....... ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9987654322 1223468999999999876 4578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.25 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=196.7
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|++|.||+|..+ +++.||+|.+........ ...+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57899999999999999999765 689999999876543221 235678999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++ +|.+++.+... .+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99985 89998876432 478999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC--------
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR-------- 728 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 728 (796)
........++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...... ........+.+...
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV----EDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHhcCCCChhhhhhh
Confidence 222223346788999998865 45788999999999999999999998643210 00000000000000
Q ss_pred ----------CC----Cccchh--hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 729 ----------LS----PPVDRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 729 ----------~~----~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.. ...... .......+.+++.+|++.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 000000 00011456789999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.14 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=208.5
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|++|.||+|+.+ +++.|++|++...... ...+.+.+|++++.+++|||++++++++..++..++|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 36888999999999999999765 5999999998766542 23568999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999765 348999999999999999999999 8 999999999999999999999999999987655
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........++..|+|||...+..++.++||||||+++|+|++|+.||..... ............... +.....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~ 226 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPP-PSLPAE 226 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCC-CCCCcc
Confidence 44333345688899999999988899999999999999999999999874332 011112222222221 111110
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|++.+|++||++.|++++
T Consensus 227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 --EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 023458899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.76 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=204.0
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|+..+.||+|++|.||++..+ +++.+|+|++...... ...+++.+|++++++++||||+++++++..+...++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 36778889999999999999765 6899999998766433 23467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
||+++++|.+++.... ..+++..+.+++.|+++|++|+|+ . +++|+||||+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 9999999999998653 347889999999999999999999 7 999999999999999999999999999876543
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.... ...++..|+|||...+..++.++||||+|+++|+|++|+.||...... ............... .+....
T Consensus 154 ~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~- 226 (265)
T cd06605 154 SLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEP-PPRLPS- 226 (265)
T ss_pred HHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCC-CCCCCh-
Confidence 2211 156888999999999889999999999999999999999998743211 011111111122111 111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.+++.+|+..||++|||+.|++.+
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 -GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0123447899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=308.91 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=196.2
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|+||.||+|+.+ +|+.||+|++....... .....+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4788899999999999999764 68999999987543222 223467789999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++ +|.+++.... ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.++|+|||+++......
T Consensus 80 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 80 YCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred cCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 9975 7877776532 2489999999999999999999999 99999999999999999999999999998665433
Q ss_pred CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH--------------
Q 003780 659 SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID-------------- 723 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------- 723 (796)
.......+++.|+|||++.+. .++.++||||+||++|+|+||+.|+...... ......+..
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH----HHHHHHHHHHhCCCChHHhHHhh
Confidence 333334578899999988764 4688999999999999999999996421110 000000000
Q ss_pred -hhcCCCCCccch------hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 724 -VLDSRLSPPVDR------MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 724 -~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..+....+.... ........+.+++.+||+.||.+|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000000 001112357789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.29 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=198.0
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccch--hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--cee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETE--ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 573 (796)
.+|++.+.||+|+||.||+|..+ +|+.||+|.+...... .....+.+.+|+.++++++||||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46889999999999999999754 6899999988643221 122346788999999999999999999998764 467
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++++|.+++.+.. .+++....+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 378888899999999999999999 999999999999999999999999999976
Q ss_pred cCCCC---CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDS---SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~~ 227 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--------AMAAIFKIATQPTN 227 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--------hHHHHHHHhcCCCC
Confidence 54211 11223458889999999988888999999999999999999999986321 11112222211111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+.. +......+.+++.+|+. +|++||+++|++++
T Consensus 228 ~~~---~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 228 PVL---PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCC---chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111 12223457788899985 89999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.79 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=186.2
Q ss_pred eeecccceeEEEEEccC---CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 506 CIGTGGYGSVYKAQLPN---GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
.||+|+||.||+|...+ ...+|+|.+...... .....+.+|++.++.++||||+++++++......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP--DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh--HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999996433 457888887654322 2245788999999999999999999999999999999999999
Q ss_pred CcHHHHHhhcCcc--cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC-
Q 003780 583 GSLFCFLRNDYEA--VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS- 659 (796)
Q Consensus 583 gsL~~~l~~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 659 (796)
|+|.+++...... ...++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 9999999765321 2346778889999999999999999 999999999999999999999999999875432211
Q ss_pred -CccccccccCccCccccc-------cCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCC-C
Q 003780 660 -NRTIVAGTYGYIAPELAY-------TMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSR-L 729 (796)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~-------~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 729 (796)
......+++.|+|||+.. ...++.++|||||||++|||++ |..||.... ............ .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~~~ 228 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--------DEQVLKQVVREQDI 228 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhhccCc
Confidence 112234567899999864 3356789999999999999999 778876321 111111111111 1
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..............+.+++..|+ .||++||+++||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111111122234567888888 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=305.69 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=201.5
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecc---
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKK--- 571 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~--- 571 (796)
.+++|++.+.||+|++|.||+|..+ +++.+++|++...... .+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4678999999999999999999764 6889999998765432 35789999999999 6999999999997644
Q ss_pred ---eeeEEEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEee
Q 003780 572 ---CMFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVAD 647 (796)
Q Consensus 572 ---~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 647 (796)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999987532 234588999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCccCcccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
||.+..............|+..|+|||++.. ..++.++|||||||++|+|++|+.||..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~ 228 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--------MRALF 228 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--------HHHHH
Confidence 9999766543333344568899999998753 3467889999999999999999999863211 11111
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..... ..+.... .......+.+++.+|+..||++|||+.|++++
T Consensus 229 ~~~~~-~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 KIPRN-PPPTLKS-PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred Hhhcc-CCCCCCc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 22111 1111111 11123357899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.55 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=203.0
Q ss_pred cCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+...... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 57888999999999999999754 3567999988654432 234678999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcc------cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEe
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEA------VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA 646 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 646 (796)
.++||||+++|+|.++++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 99999999999999999765422 2589999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCC-CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHh
Q 003780 647 DFGTARLLDSDS-SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 647 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNRL 231 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHHH
Confidence 999987543221 11223346778999999988888999999999999999998 7888863211 1122222
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
........... .....+.+++.+|++.+|++||++.|+++.|.
T Consensus 232 ~~~~~~~~~~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELPVPE---GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 21222111111 12235889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.98 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=212.5
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..+....+.||-|.||.||.|.++ ..-.||||.++.+... ..+|..|+.+|+.++|||+|+++|+|..+..+|||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 445677889999999999999876 4678999999877654 57899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+|||.+|+|.+|+++.. +..++....++++.||+.|++||..+ ++|||||.++|+|+.++..+||+|||+++++..
T Consensus 342 TEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999998764 34577778899999999999999999 999999999999999999999999999999987
Q ss_pred CCCCccc-cccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSSNRTI-VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
+.+.... ..-...|.|||-+.-..++.|+|||+|||+|||+.| |-.||...+ .-.+.+.+.+..+-...
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---------lSqVY~LLEkgyRM~~P 488 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYGLLEKGYRMDGP 488 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---------HHHHHHHHhccccccCC
Confidence 6543211 113567999999988889999999999999999997 556654221 22334444454443322
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
...+..+.+++..||+..|.+||+++|+-+.++....
T Consensus 489 ---eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 489 ---EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ---CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 2334558899999999999999999999999987643
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.47 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=198.5
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
++|++.+.||+|+||.||++.. +++.||+|.+..... .+.+.+|+.++++++|||++++++++..+ ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4688999999999999999975 578899999865432 24788999999999999999999998765 4789999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 999999999997643 23478999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+.........
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~--- 219 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---------KEVKECVEKGYRMEPP--- 219 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---------HHHHHHHhCCCCCCCC---
Confidence 112234567999999988889999999999999999997 9999863211 1112222222222211
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......+.+++.+|++.+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1223457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.40 Aligned_cols=256 Identities=22% Similarity=0.264 Sum_probs=199.8
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||++..+ .++.||+|.+...........+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999754 57899999987664433333567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997643 378899999999999999999998 9999999999999999999999999998642110
Q ss_pred C---------------CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 658 S---------------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 658 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
. .......++..|+|||.+.+..++.++|||||||++|||++|+.||.... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~~ 226 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFG 226 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 0 01112357889999999988889999999999999999999999986321 112222
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
............. ......+.+++.+|++.||++||++.++.+.++
T Consensus 227 ~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 227 QVISDDIEWPEGD--EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHhcccCCCCcc--ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 2222211111110 012234789999999999999998655544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.90 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=203.4
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|+||.||++..+ +|..+|+|.+........ ..+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4788899999999999999765 688999999876533222 24578899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 657 (796)
|+++++|.+++.+... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++ .++++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999976432 3478999999999999999999998 999999999999999886 4699999999876544
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..............+...
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~--- 224 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQGYFAPISP--- 224 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcccCCCCCC---
Confidence 333334568899999999988889999999999999999999999986321 112222222222221111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|++.+|++|||+.|++++
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 -NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 122347899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.36 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=199.5
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccch-------hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETE-------ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
+|...+.||+|+||.||+|.. .+|+.||+|.+...... .....+.+..|+.++++++|||++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999965 46899999988643221 1112456888999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++|+||+++++|.+++.+.. .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997653 488899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC--CccccccccCccCccccccCC--cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 652 RLLDSDSS--NRTIVAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 652 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
+....... ......|+..|+|||.+.... ++.++||||+|+++|+|++|+.||..... .....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~ 227 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--------IAAMFKLGNK 227 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--------HHHHHHhhcc
Confidence 76543211 122345788999999987654 78899999999999999999999863211 1111111111
Q ss_pred CCCCcc-chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 728 RLSPPV-DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 728 ~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...... ..........+.+++.+|++.||++||++++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 11111223458889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=300.98 Aligned_cols=249 Identities=30% Similarity=0.456 Sum_probs=202.5
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
-|+..+.||+|+||.||+|.. .+++.||+|.+...... ...+.+.+|+..+++++||||+++++++..++..++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 477888999999999999965 47899999988654332 234678899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999998643 378999999999999999999998 99999999999999999999999999987665433
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......++..|+|||...+..++.++|||||||++|+|++|..||..... .... ..+.....+... .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~-~~~~~~~~~~~~---~ 223 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVL-FLIPKNNPPTLE---G 223 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHH-HHHhcCCCCCCC---c
Confidence 333345688899999999888889999999999999999999999863211 1111 111111111111 1
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+|++.+|++||++++++++-
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 2234477899999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.68 Aligned_cols=255 Identities=23% Similarity=0.423 Sum_probs=202.3
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchh---hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEE---TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
+|+..+.||+|++|.||++.. .+++.||+|.+....... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999964 578999999987544221 2235688999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEeeecccccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTARLL 654 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~ 654 (796)
|+||+++++|.+++.+.. .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997643 478899999999999999999999 999999999999998776 5899999999776
Q ss_pred CCCCC----CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSDSS----NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
..... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~ 229 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASATTA 229 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhccCCC
Confidence 53311 12234578899999999888899999999999999999999999863221 1111111111111111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+... ......+.+++.+|++.+|++||++.|++++
T Consensus 230 ~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 230 PSIP---EHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCc---hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 2211 1223457889999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.13 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=202.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCc----EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.+|++.+.||+|+||.||+|..+ +|+ .+|+|.+...... .....+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 56888999999999999999754 333 5899988766432 224578899999999999999999999987 788
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++|+||+++|+|.+++.+... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999986433 388999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCcc--ccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSSNRT--IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
......... ...++..|+|||.+....++.++||||||+++||+++ |+.||+.... . .....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~-~~~~~~~~~~~ 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------V-EIPDLLEKGER 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------H-HHHHHHhCCCC
Confidence 653322111 1223567999999988889999999999999999998 9999873211 1 11222222211
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
..... .....+.+++.+||..||.+||++.++++.|++...
T Consensus 230 ~~~~~---~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 LPQPP---ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111 122347789999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=309.24 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=198.7
Q ss_pred ccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeec
Q 003780 502 DIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
+....||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch---HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 33457999999999999754 68999999986543322 356889999999999999999999999999999999999
Q ss_pred cCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC
Q 003780 581 KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN 660 (796)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 660 (796)
++++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 101 ~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 101 QGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred CCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 999999887542 378999999999999999999999 9999999999999999999999999999765544333
Q ss_pred ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHH
Q 003780 661 RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQD 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+.....+.... ....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~-~~~~~~~~~~~~~-~~~~ 243 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAM-KRLRDSPPPKLKN-AHKI 243 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHhccCCCCccc-cCCC
Confidence 3445689999999999988899999999999999999999999863211 1111 1111111111110 1112
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 741 IVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 741 ~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
...+.+++.+|++.+|++||++++++++-
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 23477899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.25 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=200.3
Q ss_pred cCCccceeeecccceeEEEEEccC----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|.+.+.||+|+||.||+|...+ ...||+|........ ...+.+.+|+.++++++||||+++++++.. +..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 468888999999999999997543 346899988755432 224678999999999999999999999875 4578
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.+... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999976432 479999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 655 DSDSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 655 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.||..... ....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~-~~~~~~~ 228 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIGRI-ENGERLP 228 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHH-HcCCcCC
Confidence 443221 122234568999999988889999999999999999996 9999863221 1111111 1111111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.. ......+.+++.+|+..+|++|||+.++++.|+...
T Consensus 229 ~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 229 MP---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 112235889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=332.76 Aligned_cols=254 Identities=25% Similarity=0.427 Sum_probs=198.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe------
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH------ 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------ 569 (796)
...+|+..+.||+||||.||+++.+ ||+.||||++.... . ....+.+.+|+..+++++|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s-~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S-DKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H-HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4567888899999999999999877 89999999998876 2 3346789999999999999999999763210
Q ss_pred --------------------------------------------------------------------------------
Q 003780 570 -------------------------------------------------------------------------------- 569 (796)
Q Consensus 570 -------------------------------------------------------------------------------- 569 (796)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------c--------ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHH
Q 003780 570 -------------------------K--------KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616 (796)
Q Consensus 570 -------------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 616 (796)
+ -..||-||||+...+.++++++.-.. .....++++++|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0 12467799999988888887654211 466788999999999999
Q ss_pred HhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC------------------CCCCCccccccccCccCcccccc
Q 003780 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD------------------SDSSNRTIVAGTYGYIAPELAYT 678 (796)
Q Consensus 617 LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~ 678 (796)
+|++ |||||||||.||+++++..|||+|||+|+... .+....+..+||..|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 01123455679999999999876
Q ss_pred CC---cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCC
Q 003780 679 MV---VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSK 755 (796)
Q Consensus 679 ~~---~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 755 (796)
.. |+.|+|+||+|||++||+. ||.. ..++...+...-+..++.+ .+...+....-.++|.+|++.|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-------sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGT-------SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCc-------hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCC
Confidence 54 9999999999999999995 5541 2333334444444444433 3333344444568999999999
Q ss_pred CCCCCCHHHHHHH
Q 003780 756 PKFRPTMQRVCQE 768 (796)
Q Consensus 756 P~~RPs~~evl~~ 768 (796)
|.+|||+.|++..
T Consensus 859 P~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 859 PSKRPTATELLNS 871 (1351)
T ss_pred CccCCCHHHHhhc
Confidence 9999999999875
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.09 Aligned_cols=258 Identities=26% Similarity=0.330 Sum_probs=200.3
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccch--hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETE--ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
+|++.+.||+|++|.||+|..+ +|+.||+|.+...... .......+..|++++++++||||+++++++..++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999754 6899999999766543 122234677899999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+ +|+|.+++.+.. ..+++..+..++.||++||+|||+. +|+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997643 2589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc---------
Q 003780 657 DSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD--------- 726 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 726 (796)
.........+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... ...........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-----DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-----HHHHHHHHHcCCCchhhhhh
Confidence 4333333456788999998854 45788999999999999999998777632211 00000000000
Q ss_pred ---------CCCCC--ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 ---------SRLSP--PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 ---------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
....+ ............+.+++.+|++.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 0000011123457899999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.94 Aligned_cols=192 Identities=23% Similarity=0.330 Sum_probs=164.3
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
...+|++.+.||+|+||.||+|..+ +++.||+|..... ....|+.++++++||||+++++++...+..++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3457999999999999999999765 5788999974322 23468999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|+|++. ++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||.++...
T Consensus 135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999995 58888886533 3488999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCC
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPG 704 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~ 704 (796)
.. .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22 2223356899999999999999999999999999999999866554
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.99 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=197.6
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|+..+.||.|++|.||+|+.+ +|+.||||++....... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4788999999999999999754 68999999987554322 123578899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+. ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 996 58988887543 24588999999999999999999998 99999999999999999999999999988665433
Q ss_pred CCccccccccCccCccccccCC-cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc-----------
Q 003780 659 SNRTIVAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD----------- 726 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 726 (796)
.......+++.|+|||+..+.. ++.++|||||||++|||+||+.||...... ...........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-----DQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHhCCCChhhhhhhh
Confidence 3333345788999999877644 578999999999999999999998632110 00000000000
Q ss_pred ----------CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 ----------SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.................+.+++.+|++.||++||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000001112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=301.94 Aligned_cols=260 Identities=26% Similarity=0.302 Sum_probs=201.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 575 (796)
++|+..+.||.|++|.||++..+ +++.+|+|.+...... ....++.+|++++++++||||+++++++... +..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 36888899999999999999764 6899999998755432 2346789999999999999999999998653 47899
Q ss_pred EEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 576 IYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
||||+++++|.+++.... ....++...+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999998876432 234478889999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... .....++..|+|||...+..++.++||||+||++|+|++|+.||+..... ................ +...
T Consensus 156 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~ 229 (287)
T cd06621 156 VNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLSYIVNMPN-PELK 229 (287)
T ss_pred cccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHHHHhcCCc-hhhc
Confidence 4322 12345788999999999888999999999999999999999998744221 0111111111111111 1110
Q ss_pred hh---hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 735 RM---VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 735 ~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. .......+.+++.+|++.+|++|||+.|++++-
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 00 011234578999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.30 Aligned_cols=238 Identities=27% Similarity=0.417 Sum_probs=188.2
Q ss_pred eeeecccceeEEEEEccCCc-----------EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 505 YCIGTGGYGSVYKAQLPNGK-----------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
+.||+|+||.||+|..++.. .+++|.+...... ...+.+|+.++++++||||+++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999775432 5777876544322 4578899999999999999999999988 778
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-------cEEEe
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-------EAFVA 646 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-------~~kl~ 646 (796)
++|+||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999999986542 488999999999999999999998 999999999999999887 79999
Q ss_pred eeccccccCCCCCCccccccccCccCccccccC--CcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHH
Q 003780 647 DFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 647 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|||++..... .....++..|+|||++.+. .++.++|||||||++|||++ |..|+..... ........
T Consensus 151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~------~~~~~~~~ 220 (259)
T cd05037 151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS------SEKERFYQ 220 (259)
T ss_pred CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc------hhHHHHHh
Confidence 9999986543 2223467789999998876 78899999999999999999 5777653221 01111111
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.....+.. ....+.+++.+|++.+|.+||++.|+++.|.
T Consensus 221 --~~~~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHRLPMP------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCCCCCC------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111111 1145789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.42 Aligned_cols=239 Identities=22% Similarity=0.334 Sum_probs=185.0
Q ss_pred eeecccceeEEEEEccC-------------------------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCce
Q 003780 506 CIGTGGYGSVYKAQLPN-------------------------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 560 (796)
.||+|+||.||+|.... ...||+|++..... .....+.+|+.++++++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 58999999999996421 23588898865432 224578889999999999999
Q ss_pred eeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 561 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
+++++++..+...++||||+++|+|..++.+.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++..
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999999987532 2478899999999999999999998 99999999999999764
Q ss_pred C-------cEEEeeeccccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHH-hCCCCCcccccCC
Q 003780 641 L-------EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLS 711 (796)
Q Consensus 641 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~ell-tg~~p~~~~~~~~ 711 (796)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 3 3799999988644321 12347788999998865 56789999999999999995 78999863221
Q ss_pred CCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. ...........+. .....+.+++.+||+.+|++||++++++++|.
T Consensus 228 ----~~---~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ----SE---KERFYEKKHRLPE-----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ----HH---HHHHHHhccCCCC-----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 1111111111111 01124778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.81 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=195.7
Q ss_pred eeeecccceeEEEEEccC-------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 505 YCIGTGGYGSVYKAQLPN-------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.||+|+||.||+|+.++ ++.+|+|.+...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 358999999999997542 357999988654322 22457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcC----cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-----cEEEeee
Q 003780 578 KYMKRGSLFCFLRNDY----EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-----EAFVADF 648 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~Df 648 (796)
||+++++|.+++.+.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999997542 223478899999999999999999998 999999999999999887 8999999
Q ss_pred ccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhh
Q 003780 649 GTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 649 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
|+++....... ......++..|+|||++.++.++.++|||||||++|||++ |+.||..... . .....+
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~-~~~~~~ 226 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------Q-EVLQHV 226 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------H-HHHHHH
Confidence 99976543221 1122345678999999999999999999999999999998 9999863211 1 111111
Q ss_pred cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
......... ......+.+++.+||+.+|++||+++++++.|++
T Consensus 227 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 TAGGRLQKP---ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hcCCccCCc---ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 211111111 1123457899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.23 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=199.4
Q ss_pred cCCccceeeecccceeEEEEEcc-CCc----EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
++|+..+.||+|+||.||+|... +|+ .||+|.+...... ....++.+|+.++++++||||+++++++..+ ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 56788899999999999999753 444 5788888654432 2234688999999999999999999999754 46
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 79999999999999987643 2478889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.... .....+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---------~~~~~~~~~~~~~ 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---------TREIPDLLEKGER 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---------HHHHHHHHHCCCC
Confidence 6433221 122335678999999998889999999999999999997 899986321 1111122222211
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
..... .....+.+++.+|+..+|++||+++++++.+++..
T Consensus 230 ~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 LPQPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 12234778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=296.32 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=200.0
Q ss_pred CccceeeecccceeEEEEEccC-----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 501 FDIKYCIGTGGYGSVYKAQLPN-----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
+++.+.||.|+||.||+++..+ +..||+|++....... ..+.+..|++++++++||||+++++++...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 3567889999999999997653 4889999997664432 34688999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
+|||+++++|.+++...... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999999764321 279999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcc-ccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 656 SDSSNRT-IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 656 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
....... ...+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... ............. ...
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~-~~~ 225 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--------NEEVLEYLKKGYR-LPK 225 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcCCC-CCC
Confidence 4322111 1236789999999988889999999999999999998 788876311 1111112211111 111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. .....+.+++.+|++.||++|||+.|+++.|
T Consensus 226 ~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PE---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 1233578899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.24 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=202.5
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|.+.+.||+|+||.||++.. .+++.||+|.+....... .+.+.+|+.++++++||||+++++++...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH---HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 5789999999999999999964 468899999986443322 357889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.+. .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999998753 378889999999999999999999 9999999999999999999999999998766544
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........+++.|+|||......++.++||||||+++|++++|+.||....... ......... .+.... .
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--------~~~~~~~~~-~~~~~~-~ 238 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG-TPELQN-P 238 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--------heeehhcCC-CCCCCC-c
Confidence 433444568889999999988888999999999999999999999997432210 000010011 111110 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.+++.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122347789999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=303.74 Aligned_cols=254 Identities=25% Similarity=0.355 Sum_probs=200.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
...|+..+.||+|+||.||+|... +++.||+|.+...........+.+.+|+++++.++||||+++.+++..++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 346888899999999999999754 6899999998755443333456788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+||++ |++.+.+.... ..+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 47777665432 2488999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 657 DSSNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
. ....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ............ +..
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~~~~-~~~ 234 (307)
T cd06607 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNDS-PTL 234 (307)
T ss_pred C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhcCCC-CCC
Confidence 2 2345788999999874 45678899999999999999999999863221 111111111111 111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
. .......+.+++.+||+.||++||++.+++++..-.
T Consensus 235 ~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 235 S--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred C--chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 1 111223578999999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=298.75 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=197.9
Q ss_pred CccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----- 571 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 571 (796)
|.+.+.||+|+||.||+|..+ +++.||+|++........ ..+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS-DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567789999999999999643 468899999976544332 2567889999999999999999999886542
Q ss_pred -eeeEEEeeccCCcHHHHHhhcC---cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEee
Q 003780 572 -CMFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVAD 647 (796)
Q Consensus 572 -~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 647 (796)
..++++||+++|+|.+++.... ....+++....+++.|++.||+|||+. +|+||||||+||+++.++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 2478899999999998875332 223478889999999999999999998 999999999999999999999999
Q ss_pred eccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHh
Q 003780 648 FGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 648 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
||.++....... ......+++.|++||...+..++.++|||||||++|||++ |+.||..... .......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYL 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHH
Confidence 999986543221 1122335678999999988889999999999999999999 8888763211 1111111
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
....... .. ......+.+++.+|++.+|++||++.|+++.|+..
T Consensus 229 ~~~~~~~-~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNRLK-QP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCcCC-CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111 10 11223588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.82 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=200.3
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|...+.||+|++|.||++.. .+++.+++|++...... ..+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 355567999999999999975 47899999988644322 23568899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 97 FLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999999998762 378899999999999999999999 99999999999999999999999999887654433
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......|++.|+|||...+..++.++|||||||++|+|++|+.||..... ..... .+.....+.... ..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~-~~~~~~~~~~~~-~~ 239 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMK-RIRDNLPPKLKN-LH 239 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHH-HHHhcCCCCCcc-cc
Confidence 333345689999999999888899999999999999999999999863211 11111 111111111111 11
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+|++.+|++||++.+++++-
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 1234588999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=302.97 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=203.6
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|+||.||+|..+ +++.||+|.+...........+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999765 689999999987654443446789999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999765 2488999999999999999999998 99999999999999999999999999988654432
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ........... ...... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~~~~---~ 223 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET-ADVLYP---A 223 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc-ccccCc---c
Confidence 223455888999999998888999999999999999999999998743210 11111122221 111111 1
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTM--QRVCQ 767 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~--~evl~ 767 (796)
.....+.+++.+|++.||.+||++ +|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 122457899999999999999999 55543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.18 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=201.1
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC---CCceeeEEeEEEecceeeE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA---HRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l 575 (796)
.|+..+.||+|+||.||+|.. .+++.||+|.+....... ..+++.+|+.++++++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch--hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 477788999999999999975 578999999987543322 2457888999999987 9999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++++|.+++... .+++.....++.|+++||.|||+. +|+|+||+|+||+++.++.++++|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999998653 488999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
..........|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... .... .......+...
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~-~~~~~~~~~~~ 223 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMM-LIPKSKPPRLE 223 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhh-ccccCCCCCCC
Confidence 544334445688999999988654 4688999999999999999999998743211 1111 11111111111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
. ......+.+++.+|++.||++||++.|++++-.
T Consensus 224 ~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 224 D--NGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred c--ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 1 012345789999999999999999999988643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.58 Aligned_cols=258 Identities=28% Similarity=0.356 Sum_probs=200.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|++|.||+|..+ +++.||+|+++...... ...+.+.+|++++++++||||+++++++..++..++|+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE-DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc-cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36889999999999999999765 58899999887654322 23467899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++++.+..+..+. ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 80 EYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999987777665543 2378999999999999999999999 9999999999999999999999999999876544
Q ss_pred CC-CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh----------
Q 003780 658 SS-NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL---------- 725 (796)
Q Consensus 658 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 725 (796)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----DQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHHhhh
Confidence 32 23345678899999999888 7889999999999999999999998632210 0000000000
Q ss_pred ---cC-----CCCCccch------hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 ---DS-----RLSPPVDR------MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 ---~~-----~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+. ........ ........+.+++.+||+.+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000000 000113458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=302.08 Aligned_cols=260 Identities=24% Similarity=0.262 Sum_probs=196.1
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
++++|.+.+.||+|+||.||+|.. .+|+.||+|++........ ...+.+|+.+++.++|+||+++.+++..++..++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC--cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 356899999999999999999965 4689999999875543221 2356789999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|+||+. +++.+++.... ..+.+..+..++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||+++...
T Consensus 81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 999996 67776665432 2367888889999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc--------
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD-------- 726 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 726 (796)
..........+++.|+|||++.+. .++.++|||||||++|+|++|+.||+..... ............
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV----FEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH----HHHHHHHHHHcCCCChhhhh
Confidence 333333334578899999998753 4788999999999999999999999743210 000000000000
Q ss_pred ----------CCC----CCccch--hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 ----------SRL----SPPVDR--MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 ----------~~~----~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
... ...... ........+.+++.+|++.||.+|||++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000 000000 000113457789999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=290.48 Aligned_cols=253 Identities=25% Similarity=0.308 Sum_probs=208.9
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|+..+++|+|.||.|..++-+ .|+.||+|++++..........--..|-+++...+||.+..+--.++..+..+.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3568999999999999999999754 799999999998876655545556788899999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||..||.|+.++.+.. .+++.....+-..|..||.|||++ +||.||+|.+|.|+|.+|++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999998887643 478887888889999999999999 99999999999999999999999999998655
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.........+|||.|+|||++....|..++|.|.+||++|||++|+.||... .......-++...+..+..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--------dh~kLFeLIl~ed~kFPr~- 390 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--------DHEKLFELILMEDLKFPRT- 390 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--------chhHHHHHHHhhhccCCcc-
Confidence 5555667789999999999999999999999999999999999999999832 2222333333333322211
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
.. .+...++...+..||.+|- .++||.++
T Consensus 391 -ls---~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 391 -LS---PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -CC---HHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11 1245688899999999995 56777666
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=298.01 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=199.5
Q ss_pred eecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcH
Q 003780 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 585 (796)
||.|++|.||+++.. +++.||+|++...........+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999765 5899999999876554444457899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccc
Q 003780 586 FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665 (796)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 665 (796)
.+++.+.. .+++..+..++.|+++||+|+|+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 99998653 378899999999999999999998 99999999999999999999999999998765432 223346
Q ss_pred cccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHH
Q 003780 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745 (796)
Q Consensus 666 gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 745 (796)
+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ...................... ...+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 224 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLEFPNYI---DKAAK 224 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCCCCccc---CHHHH
Confidence 88899999999888899999999999999999999999874321 1122222333211122221111 34588
Q ss_pred HHHHHcCCCCCCCCCC-----HHHHHHH
Q 003780 746 TVALACLHSKPKFRPT-----MQRVCQE 768 (796)
Q Consensus 746 ~li~~cl~~dP~~RPs-----~~evl~~ 768 (796)
+++.+||+.+|++||+ ++|++++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 9999999999999999 6777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.63 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=199.4
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|++|.||+|+.+ +|+.||+|++....... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4788999999999999999865 68999999987654322 13567789999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++ +|.+++........+++..+..++.|+++||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 8888887654445689999999999999999999998 99999999999999999999999999997654432
Q ss_pred CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc-----------
Q 003780 659 SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD----------- 726 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 726 (796)
.......++..|+|||++.+. .++.++||||+||++|+|++|+.||...... .......+...
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-----DQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCChhhHHHHh
Confidence 222334578899999987654 5688999999999999999999998743210 00000000000
Q ss_pred --CCCCCccc--------hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 --SRLSPPVD--------RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 --~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
........ .........+.+++.+|++.||.+||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 0001123457799999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.96 Aligned_cols=240 Identities=22% Similarity=0.434 Sum_probs=187.1
Q ss_pred eeeecccceeEEEEEccC--------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 505 YCIGTGGYGSVYKAQLPN--------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
+.||+|+||.||+|..+. ...||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR---NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH---HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999996532 23488887754332 2345788899999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc--------EEEeee
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE--------AFVADF 648 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~Df 648 (796)
|||+++|+|.++++.... .+++..+.+++.||+.||+|||+. +|+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999999976533 478899999999999999999999 9999999999999987765 589999
Q ss_pred ccccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCC-CCCcccccCCCCCchhhhHHHHhhc
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGR-HPGELLSSLSSPSSDQKIMLIDVLD 726 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (796)
|.+..... .....++..|+|||++.+. .++.++|||||||++|||++|. .|+..... . .......
T Consensus 153 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~-~~~~~~~ 219 (258)
T cd05078 153 GISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------Q-KKLQFYE 219 (258)
T ss_pred ccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------H-HHHHHHH
Confidence 98865432 2234578899999998864 5788999999999999999995 55542111 1 1111112
Q ss_pred CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.....+. .....+.+++.+||+.||++|||++++++.|+
T Consensus 220 ~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 DRHQLPA-----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccccCCC-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111111 11234789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.72 Aligned_cols=248 Identities=25% Similarity=0.269 Sum_probs=194.1
Q ss_pred eecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcH
Q 003780 507 IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585 (796)
Q Consensus 507 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 585 (796)
||+|+||+||++.. .+|+.||+|.+...........+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999964 46899999998765433333345677899999999999999999999999999999999999999
Q ss_pred HHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccc
Q 003780 586 FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665 (796)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 665 (796)
.+++.+... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 999976543 3488999999999999999999999 9999999999999999999999999998765432 2222345
Q ss_pred cccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHH
Q 003780 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745 (796)
Q Consensus 666 gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 745 (796)
++..|+|||+..+..++.++||||+||++|+|++|+.||...... .....+....... .... .......+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-~~~~---~~~~~~~~~ 226 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-----VEKEELKRRTLEM-AVEY---PDKFSPEAK 226 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-----ccHHHHHhccccc-cccC---CccCCHHHH
Confidence 788999999998888999999999999999999999998743221 0111111111111 1111 111233578
Q ss_pred HHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 746 TVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 746 ~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
+++.+||+.||++|| ++.+++++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHhC
Confidence 999999999999999 55555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.73 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=184.8
Q ss_pred eeecccceeEEEEEccCC---cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 506 CIGTGGYGSVYKAQLPNG---KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
.||+|+||.||+|+..++ ..+++|.+...... ...+.+.+|+..++.++||||+++++++......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999975433 34566766544322 2246889999999999999999999999999999999999999
Q ss_pred CcHHHHHhhcCc-ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC--C
Q 003780 583 GSLFCFLRNDYE-AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS--S 659 (796)
Q Consensus 583 gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~ 659 (796)
|+|.+++++... ....++..+..++.||++||+|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999986432 23456777889999999999999998 99999999999999999999999999986432211 1
Q ss_pred CccccccccCccCcccccc-------CCcCcchhHHHHHHHHHHHHhC-CCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 660 NRTIVAGTYGYIAPELAYT-------MVVTEKCDVYSFGVVALEVLMG-RHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwSlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
......++..|+|||+... ..++.++|||||||++|||+++ ..||.... ........+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~~~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKDQQVK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhhcccc
Confidence 1233457889999998743 2356799999999999999974 66765321 111111111111100
Q ss_pred -ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 732 -PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 732 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
............+.+++..|+ .+|++||+++||++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 000001112234677888999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=279.48 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=200.1
Q ss_pred ccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEEee
Q 003780 502 DIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
+....+|.|+.|.||+++.+ .|...|||.+.+....++ .+++...+.++..-+ +|+||+.+|||..+...++.||.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee--~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH--HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 34456999999999999765 689999999988765543 467778888777665 89999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
|.. .++.++++.+. ++++...-++...+..||.||.+++ +|+|||+||+|||+|+.|++|+||||++.++-+ ..
T Consensus 173 Ms~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-Sk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-SK 246 (391)
T ss_pred HHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec-cc
Confidence 864 56666665433 3788888899999999999999886 999999999999999999999999999987754 34
Q ss_pred CccccccccCccCccccccC---CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 660 NRTIVAGTYGYIAPELAYTM---VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
..+..+|.+.|||||.+.-. .|+.++||||||+.++||.||+.||..-. .+...+..+++... +....
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-------tdFe~ltkvln~eP-P~L~~- 317 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-------TDFEVLTKVLNEEP-PLLPG- 317 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-------ccHHHHHHHHhcCC-CCCCc-
Confidence 44556799999999988643 58889999999999999999999987421 22334444444322 22221
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......+++++..||+.|+.+||...++++|-.
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 1123455889999999999999999999998854
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=301.61 Aligned_cols=257 Identities=25% Similarity=0.330 Sum_probs=200.4
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|++|.||+|... +|+.||+|++....... ...+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 4788999999999999999754 78999999987655322 224678999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+ +++|.+++.... ..+++..+..++.||++||+|||+. +++|+||||+||+++.++.++++|||.+.......
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99 999999987643 3489999999999999999999999 99999999999999999999999999998765432
Q ss_pred C-CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC--------
Q 003780 659 S-NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR-------- 728 (796)
Q Consensus 659 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 728 (796)
. ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... .........+...
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-----EQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-----HHHHHHHHHcCCCChHHHhhc
Confidence 1 12334588899999988654 4688999999999999999998877532110 0000000000000
Q ss_pred --------C------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 729 --------L------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 729 --------~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. ..............+.+++.+|++.+|++||+++++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000011223568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=301.35 Aligned_cols=255 Identities=28% Similarity=0.397 Sum_probs=206.5
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
.++.|+..+.||+|++|.||+|..+ +++.|++|++..... ..+.+.+|++++++++|+|++++++++..++..++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4567888899999999999999765 689999999976544 24578899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999998754 3589999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
..........++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .............. ...
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~-~~~ 238 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLITTKGIPP-LKN 238 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCCCC-Ccc
Confidence 433333344578899999999888899999999999999999999999863221 11111111111111 111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......+.+++.+|++.+|.+||++.+++++-.
T Consensus 239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 239 -PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred -hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 1112345789999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=300.32 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=194.8
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHH-HhhcCCCceeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHV-LSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
++|++.+.||+|+||.||+++.+ +|+.||+|++........ ..++..|+.. ++..+||||+++++++..++..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 46889999999999999999764 699999999876543222 2345556664 5667899999999999999999999
Q ss_pred EeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|||++ |+|.+++.... ....+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||.+....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99997 58888776532 2245899999999999999999999853 89999999999999999999999999998654
Q ss_pred CCCCCccccccccCccCcccccc----CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYT----MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
.. .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ............. +
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~ 226 (283)
T cd06617 156 DS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-------PFQQLKQVVEEPS-P 226 (283)
T ss_pred cc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-------CHHHHHHHHhcCC-C
Confidence 32 12233458889999998865 4467899999999999999999999863211 1111222221111 1
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.... ......+.+++.+|+..+|++||++++++++-
T Consensus 227 ~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 227 QLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred CCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1110 01123478999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.91 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=197.5
Q ss_pred CCccceeeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ceee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMF 574 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 574 (796)
+|++.+.||+|++|.||+|..+ +++.||+|.+...........+.+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999764 4799999999875432233345678899999999999999999999988 8899
Q ss_pred EEEeeccCCcHHHHHhhcCc--ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC----CCcEEEeee
Q 003780 575 LIYKYMKRGSLFCFLRNDYE--AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADF 648 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~Df 648 (796)
+||||+++ ++.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 66666653322 23588999999999999999999999 9999999999999999 899999999
Q ss_pred ccccccCCCCC---CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCC-CchhhhH---
Q 003780 649 GTARLLDSDSS---NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP-SSDQKIM--- 720 (796)
Q Consensus 649 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~-~~~~~~~--- 720 (796)
|++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......... .......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 12234578899999987664 5788999999999999999999998743321100 0000000
Q ss_pred HHHhhc---------------------CCCCCccc--hhhH------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 721 LIDVLD---------------------SRLSPPVD--RMVM------QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 721 ~~~~~~---------------------~~~~~~~~--~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+...+. ........ .... .....+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 00000000 0000 123457899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.42 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=210.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
...|.+...||+|.|+.|..|++ .+|..||+|.+.+....... .+.+.+|+++|..++|||||+++.+...+...|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45788899999999999999965 46999999999888766544 34589999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||..+|.+++++.++.. ..+..+..++.|+.+|++|||++ .|||||||++||+++.++++||+|||++.++..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999997754 45578888999999999999999 999999999999999999999999999998874
Q ss_pred CCCCccccccccCccCccccccCCcC-cchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
. ......+|++.|.|||++.+..|. +.+|+||+|+++|-|+.|..||+.-.. ...-...+....+.++.-
T Consensus 208 ~-~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------k~Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 208 G-LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------KELRPRVLRGKYRIPFYM 278 (596)
T ss_pred c-ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------ccccchheeeeeccccee
Confidence 3 334557899999999999988765 689999999999999999999984221 111122233333322211
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..++.+++++++-.+|.+|++++++.++-.
T Consensus 279 -----s~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 279 -----SCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred -----echhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 123568999999999999999999998854
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.87 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=197.5
Q ss_pred CccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|++.+.||.|++|.||+|.. .+|+.||+|++....... ...+.+.+|++++++++|||++++++++..++..++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67788999999999999975 479999999987654322 2235688899999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
++ ++|.+++..... ..+++..+.+++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 95 689998876542 3489999999999999999999998 999999999999999999999999999976543332
Q ss_pred CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH---------------
Q 003780 660 NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID--------------- 723 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--------------- 723 (796)
......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...... ........
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-----DQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhhhhh
Confidence 22333568899999987654 5688999999999999999999998632210 00000000
Q ss_pred ------hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 724 ------VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 724 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
....................+.+++.+|++.||++||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000011112357799999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=302.64 Aligned_cols=256 Identities=24% Similarity=0.303 Sum_probs=198.5
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 575 (796)
++|++.+.||+|+||.||+|..+ +++.+|+|.+....... .....+.+|+.++++++||||+++++++... +..++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 47888999999999999999765 68999999997654332 2234677899999999999999999999877 89999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|+||+++ +|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 84 v~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999985 89888876432 589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc--------
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD-------- 726 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 726 (796)
..........+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...... .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-----DQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchHHHH
Confidence 543333344578899999988754 4688999999999999999999998743210 00000000000
Q ss_pred ------------------CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 ------------------SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 ------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..+....... .....+.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPAL--SLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred Hhhccchhcccccccccchhhhcccccc--CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000 013347789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.30 Aligned_cols=250 Identities=31% Similarity=0.457 Sum_probs=204.0
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|+..+.||+|++|.||++..+ +++.+++|++..... ...+.+.+|++++++++|||++++++++..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4778899999999999999765 789999999977654 224688999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999999987653 3489999999999999999999998 99999999999999999999999999998765443
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ...+.... ..
T Consensus 153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~~~-~~ 221 (253)
T cd05122 153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------MKALFKIAT-NGPPGLRN-PE 221 (253)
T ss_pred c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------HHHHHHHHh-cCCCCcCc-cc
Confidence 2 3345688999999999888889999999999999999999999873211 111111111 11111111 11
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|++.||++|||+.|++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 113357899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.24 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=202.3
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|+..+.||+|+||.||+++. .+++.||+|++...........+.+.+|++++++++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 367788999999999999975 4689999999876544333445678999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+.+ ++.+.+.... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 7777775432 3488999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 659 SNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
....|++.|+|||++. +..++.++|||||||++|||++|+.||.... ..................
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~- 246 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPTLQS- 246 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhccCCCCCC-
Confidence 2345888999999874 4568889999999999999999999986321 111222222222211111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
......+.+++.+|++.+|++||++.+++++........
T Consensus 247 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 247 --NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred --ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 112234789999999999999999999999876655433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=301.34 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=195.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|++|.||+|..+ +|+.||+|.+....... ...+.+.+|++++++++||||+++++++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 47889999999999999999765 68999999986553322 22357888999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-CCcEEEeeeccccccCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-KLEAFVADFGTARLLDS 656 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 656 (796)
||++ +++.+++..... ...++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.....
T Consensus 81 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred eccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9996 478877765432 2357888889999999999999999 9999999999999985 55789999999976543
Q ss_pred CCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc---------
Q 003780 657 DSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD--------- 726 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 726 (796)
.........+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...... ...........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-----DELFKIFRILGTPNEETWPG 230 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChhhccc
Confidence 3222233457889999998765 45788999999999999999999998632210 00000000000
Q ss_pred -----------CCCCCc-cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 -----------SRLSPP-VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 -----------~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...... ...........+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000011123347889999999999999999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=305.80 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=206.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc---CCc--EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP---NGK--VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
..+..+..+.||+|-||.||+|... .|+ .||||..+.+...+. .+.|..|..+|+.++||||++++|.|.+.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3445566678999999999999643 233 488898877655443 56899999999999999999999999754
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++|||.++-|-|.++++.++. .++......++.||..||+|||+. ++|||||..+|||+....-+|++|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 56899999999999999997654 488888899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCccc-cccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 652 RLLDSDSSNRTI-VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 652 ~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
+.+..+...... ..-+..|||||.+.-..++.++|||.|||.+||++. |..||......+. ...+...-
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---------I~~iEnGe 609 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---------IGHIENGE 609 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---------EEEecCCC
Confidence 998877654433 223567999999999999999999999999999875 9999985432211 11111211
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
+.+. +...++.+..+..+||.+||.+||.+.|+...|....
T Consensus 610 RlP~---P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 610 RLPC---PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CCCC---CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 1111 2234445778999999999999999999988886553
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.33 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=203.6
Q ss_pred ccceeeecccceeEEEEE-ccCCc----EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 502 DIKYCIGTGGYGSVYKAQ-LPNGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~-~~~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
...++||+|+||+||+|. .++|+ +||+|++........ ..++..|+-.|.+++|||+++++++|.... ..||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--SIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 346789999999999995 44444 588888876554432 468999999999999999999999998766 7899
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
++||+.|+|.++++.++. .+-.+..+.|..|||+||.|||.+ ++|||||.++|||+.....+||.|||+++....
T Consensus 776 tq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999988654 477888999999999999999999 999999999999999999999999999998877
Q ss_pred CCCCccccc--cccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 657 DSSNRTIVA--GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 657 ~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
+........ -.+.|||=|.+.-..|+.++|||||||++||++| |..|++... ...+.+.+...-+-+.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~---------~~eI~dlle~geRLsq 921 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP---------AEEIPDLLEKGERLSQ 921 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---------HHHhhHHHhccccCCC
Confidence 655443333 3567999999999999999999999999999997 889987432 2233333333322111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
+.-....+..++.+||..|++.||+++++..++.+..
T Consensus 922 ---PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 922 ---PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ---CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 1122334677889999999999999999999987643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=301.75 Aligned_cols=260 Identities=23% Similarity=0.277 Sum_probs=196.1
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecce----
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKC---- 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~---- 572 (796)
++|++.+.||+|+||.||+|... +++.||+|++....... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46889999999999999999754 68999999887654322 22356788999999995 6999999999987665
Q ss_pred -eeEEEeeccCCcHHHHHhhcCc--ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-CCcEEEeee
Q 003780 573 -MFLIYKYMKRGSLFCFLRNDYE--AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-KLEAFVADF 648 (796)
Q Consensus 573 -~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Df 648 (796)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 78888765432 24579999999999999999999999 9999999999999998 889999999
Q ss_pred ccccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
|.+..............+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+...+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~ 230 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-----QQLLHIFKLLGT 230 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHhCC
Confidence 999865433222233457888999998765 45789999999999999999999998632211 000000000000
Q ss_pred -------------------CCCC-ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 728 -------------------RLSP-PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 728 -------------------~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...+ ............+.+++.+|+++||.+||+++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0000001123457889999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=314.36 Aligned_cols=306 Identities=26% Similarity=0.287 Sum_probs=222.9
Q ss_pred CcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccc
Q 003780 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178 (796)
Q Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 178 (796)
|+.|+|.+|.|+.+-.+++..++.|+.||||.|.|+.+.-+.|..=.++++|+|++|+|+..-.+.|..+.+|..|.|++
T Consensus 127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsr 206 (873)
T KOG4194|consen 127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSR 206 (873)
T ss_pred eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeeccc
Confidence 55555555555555555555556666666666666644444555556666666666666666666666666777777777
Q ss_pred cccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCC
Q 003780 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 258 (796)
|+|+...+..|.+|+.|+.|+|..|+|.-.---.|.++++|+.|.|..|.++....+.|..+.++++|+|+.|+++..-.
T Consensus 207 NrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~ 286 (873)
T KOG4194|consen 207 NRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE 286 (873)
T ss_pred CcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc
Confidence 77766666666667777777777777665545566677777777777777776666777778888888888888877667
Q ss_pred ccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCC
Q 003780 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSE 338 (796)
Q Consensus 259 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 338 (796)
.++.+++.|+.|+||+|.|..+.++++.-.++|+.|+|++|+|+...+.+|..+..|++|+|++|.+...-...|..+++
T Consensus 287 g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lss 366 (873)
T KOG4194|consen 287 GWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSS 366 (873)
T ss_pred ccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhh
Confidence 77888888888888888888888888888888888888888888878888888888888888888887766777888888
Q ss_pred CcEEEeecccccCCCCccc----cccccceEEecccccCCCCCc----cccccccccccCCCCcccCCCCCCCCC
Q 003780 339 LRNITLRNNNLSGSIPPEI----GLMKLEYLDLSHNKLNGTIPP----FLYHRFPLDLSYNDLEGEIPDYFRDSP 405 (796)
Q Consensus 339 L~~L~L~~N~l~~~~~~~~----~~~~L~~L~l~~N~l~~~~p~----~~~~~~~l~l~~N~l~~~~p~~~~~~~ 405 (796)
|+.|+|++|.|+..+.+.. ++++|+.|++.+|+|. .||+ .+..+..|||.+|.+-...|+.|....
T Consensus 367 L~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~ 440 (873)
T KOG4194|consen 367 LHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPME 440 (873)
T ss_pred hhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccch
Confidence 8888888888887665542 5788888888888887 5664 234556788888888888888776653
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=291.23 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=206.5
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ceeeEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMFLI 576 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV 576 (796)
+|...+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++||||+++++.+... ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4777899999999999999765 7999999998766543 23356889999999999999999999999988 899999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+||+++++|.+++.+.. .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999998654 589999999999999999999998 999999999999999999999999999987665
Q ss_pred CCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... ......++..|+|||...+...+.++||||||+++|+|++|+.||.... ...............+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCCcCCC
Confidence 432 1334568889999999988889999999999999999999999987432 1111112222111111111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.+++.+|++.||++||++.|++++
T Consensus 227 ---~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 ---EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1223458899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.56 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=205.4
Q ss_pred cCCccceeeecccceeEEEEEccCCcE-EEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|+++..||.|+||.||+|..++... .|.|++.-... .....+.-|++++...+||+||++++.|..++..+++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse---EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE---EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch---hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 346667789999999999998775444 45566643332 23678999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|||.||-.+.++-.-. ..+.+.++..+++|++.||.|||++ +|||||||+.|||++-+|.++++|||.+......
T Consensus 109 EFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 9999999988876543 3489999999999999999999999 9999999999999999999999999998754433
Q ss_pred CCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 658 SSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
......+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|....+. ...+..+..+.. |.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaKSeP-PT 254 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEP-PT 254 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhhcCC-Cc
Confidence 33445678999999999864 56799999999999999999999999663322 122222222222 21
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
.-. +..-...+.+++.+||..||+.||+++++++|-.--..+.
T Consensus 255 Llq-PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 255 LLQ-PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred ccC-cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 111 2222345889999999999999999999999976554433
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.71 Aligned_cols=246 Identities=22% Similarity=0.232 Sum_probs=187.8
Q ss_pred eeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHh---hcCCCceeeEEeEEEecceeeEEEeecc
Q 003780 506 CIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLS---KIAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
.||+|+||.||++... +++.+|+|.+.............+.+|..+++ ..+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999754 68999999987654332221223344444333 3479999999999999999999999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCc
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 661 (796)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++...... ..
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence 999999887543 489999999999999999999999 9999999999999999999999999998755432 22
Q ss_pred cccccccCccCccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHH
Q 003780 662 TIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQD 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
....|++.|+|||... +..++.++||||+||++|+|++|+.||...... ........ ......... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~-~~~~~~~~~---~~~ 222 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK------DKHEIDRM-TLTVNVELP---DSF 222 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc------CHHHHHHH-hhcCCcCCc---ccc
Confidence 2346899999999886 456789999999999999999999998743210 11111111 111111111 112
Q ss_pred HHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 741 IVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 741 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
...+.+++.+|++.||++|| +++|+++|.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 23577899999999999999 599888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.21 Aligned_cols=250 Identities=27% Similarity=0.446 Sum_probs=205.1
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|++|.||++..+ +++.|++|.+....... ...+.+.+|++++++++|||++++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4788899999999999999654 68899999998775432 335689999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++++|.+++.+. ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999998765 3489999999999999999999999 99999999999999999999999999998776544
Q ss_pred CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhH
Q 003780 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVM 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.......++..|+|||...+..++.++||||+|+++|+|++|+.||..... ............ +... .
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-~~~~---~ 221 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--------MAALFRIVQDDH-PPLP---E 221 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhccCC-CCCC---C
Confidence 433445688999999998888888999999999999999999999863221 111111111111 1111 1
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 739 QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 739 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|++.+|++||++.+++.+
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 123347799999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.12 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=201.4
Q ss_pred CccceeeecccceeEEEEEcc--CCc--EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP--NGK--VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
....+.||+|.||+|++|.++ +|+ .||||.+....... ...+|.+|+.+|.+++|||+++++|...+ ....+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344578999999999999765 344 58999998877654 46799999999999999999999999987 677899
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+|.++.|+|.+.|++. ....+.......++.|||.||.||.++ +.|||||..+|+++-..-.+||+|||+++-++.
T Consensus 189 ~ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999983 345578888899999999999999999 999999999999999999999999999998876
Q ss_pred CCCCccc---cccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 657 DSSNRTI---VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 657 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
......+ ..-.+.|+|||.+.-..++.++|||+|||++|||+| |..||-... ...+.+.+|.+-.-+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---------g~qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---------GIQILKNIDAGERLP 335 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---------HHHHHHhccccccCC
Confidence 5433322 123567999999999999999999999999999998 567765221 122333333222211
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. ......+.++++.||..+|.+|||+..+.+.+
T Consensus 336 RP---k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RP---KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CC---CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11 22334588999999999999999999998554
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.25 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=206.8
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||.|++|.||++... +++.||+|++....... ...+.+.+|++++++++|||++++.+.+...+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh-HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4788899999999999999754 68999999997765432 234678899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|+++++|.+++.+.. ....+++..+..++.++++||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999997642 124589999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........|++.|+|||...+..++.++||||+|+++++|++|+.||.... ..............+ ...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~-~~~-- 225 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKGQYPP-IPS-- 225 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcCCCCC-CCC--
Confidence 323334568889999999988889999999999999999999999986322 111222222222211 111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|+..+|++||++.|++++
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 -QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=299.98 Aligned_cols=257 Identities=24% Similarity=0.295 Sum_probs=194.8
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 577 (796)
+|+..+.||+|+||.||++.. .+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 455667899999999999965 46899999998765433 22457889999999996 999999999999999999999
Q ss_pred eeccCCcHHHHH---hhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 578 KYMKRGSLFCFL---RNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 578 e~~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
||+.. ++.++. ... ....+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.++|+|||+++..
T Consensus 83 e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99875 554433 221 2245889999999999999999999742 8999999999999999999999999999765
Q ss_pred CCCCCCccccccccCccCccccccC---CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTM---VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
.... ......|+..|+|||++.+. .++.++||||+||++|+|++|+.||.... ................
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGDPPI 230 (288)
T ss_pred ccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCCCCc
Confidence 4322 12233588899999998766 68899999999999999999999986321 1111112221111111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
............+.+++.+|++.||++|||++||+++-.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 111111123345889999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.91 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=204.6
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|++.+.||+|++|.||++.. .+++.+|+|.+........ ...++.+|++++++++||||+++.+++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH-HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 478889999999999999964 4788999999876554332 24577889999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|+++++|.+++.+.. ....+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+|++|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999987632 224588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
......+++.|+|||...+..++.++|+||+|+++|+|++|+.||..... . ...........+...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~--- 222 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------Q-DLRYKVQRGKYPPIP--- 222 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------H-HHHHHHhcCCCCCCc---
Confidence 22234588899999999998899999999999999999999999873221 1 111112222212111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.+++.+|++.+|++||++.|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1233458899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.23 Aligned_cols=245 Identities=23% Similarity=0.360 Sum_probs=196.7
Q ss_pred ceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 504 KYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
...||+|+||.||++.. .+++.||+|++...... ..+.+.+|+.++++++|||++++++++..++..++||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh---HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 35799999999999976 47899999988543322 245788999999999999999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+...........
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 9999987543 378899999999999999999999 999999999999999999999999999876654333334
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...|++.|+|||...+..++.++||||+|+++|+|++|+.||..... . .....+.......... ......
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~----~~~~~~~~~~~~~~~~-~~~~~~ 244 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----L----KAMKMIRDNLPPKLKN-LHKVSP 244 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHhhCCcccCC-cccCCH
Confidence 45688999999999888889999999999999999999999863211 1 1111111111111111 111223
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.+.+++.+|++.+|.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 47789999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=290.80 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=199.1
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccc--hhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--cee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAET--EETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 573 (796)
.+|++.+.||+|+||.||+|.. .+++.||+|.+..... ......+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999975 4689999998754321 1223356889999999999999999999998764 468
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++|+||+++++|.+++.+.. .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 378888999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSD---SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
.... ........++..|+|||++.+..++.++|||||||++|+|++|+.||.... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--------AMAAIFKIATQPTK 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--------HHHHHHHHHcCCCC
Confidence 5321 111223458899999999988888999999999999999999999987321 11222222222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+.... .....+.+++.+|++ +|.+||++.+++.|
T Consensus 228 ~~~p~---~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 PMLPD---GVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCc---ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 22211 222347889999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=306.60 Aligned_cols=267 Identities=23% Similarity=0.278 Sum_probs=199.6
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-----K 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~ 571 (796)
.++|.+.+.||+|+||+||+|+. .+++.||||.+........ ....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc-hhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 45799999999999999999965 4689999999875432222 235677899999999999999999988654 3
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999996 68888887543 488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCch----
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSD---- 716 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~---- 716 (796)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 876543333334557889999998764 46889999999999999999999998642210 000000
Q ss_pred ----hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--Hhhc
Q 003780 717 ----QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE--FLTC 772 (796)
Q Consensus 717 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 772 (796)
...........................+.+++.+|++.+|++|||++|++++ ++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000000000111111111223457899999999999999999999999 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=335.07 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=205.9
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
.+-+++....||.|.||.||.|. ..+|+..|+|-++-.... ....+.+.+|..++..++|||+|+++|+-.+.+..+|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 45567778899999999999996 557999999988776655 4456789999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
.||||++|+|.+.+.... ..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|.+|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999997653 256666677889999999999999 99999999999999999999999999999876
Q ss_pred CCCCC----ccccccccCccCccccccCC---cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 656 SDSSN----RTIVAGTYGYIAPELAYTMV---VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 656 ~~~~~----~~~~~gt~~y~aPE~~~~~~---~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
.+... .....||+.|||||++.+.. ...++||||+|||+.||+||+.||...+. ..+.++ .+-...
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy-~V~~gh 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMY-HVAAGH 1458 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHh-HHhccC
Confidence 54322 12356999999999998654 44689999999999999999999874322 122222 222222
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.+...+. -..+=.+++..|++.||++|.++.|++++=..
T Consensus 1459 ~Pq~P~~----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1459 KPQIPER----LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred CCCCchh----hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 2222222 12234589999999999999999998887543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.19 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=197.9
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK----- 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 570 (796)
..++|++.+.||+|+||.||+|.. .+|+.||+|.+....... ...+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 457899999999999999999975 479999999986543222 2245677899999999999999999988643
Q ss_pred -ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 571 -KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 571 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999965 888777542 78888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCchhhh
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSDQKI 719 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~~~~ 719 (796)
+++....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||...+.. ..+......
T Consensus 164 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 164 LARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred cceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9987644322 22345788999999999999999999999999999999999998643210 000000000
Q ss_pred ----HHHHhhcCCCC---------------Ccc-chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 720 ----MLIDVLDSRLS---------------PPV-DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 720 ----~~~~~~~~~~~---------------~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
........+.. +.. ..........+.+++.+|++.||++|||+.|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00000110000 000 000011234578999999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.30 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=198.6
Q ss_pred eecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcH
Q 003780 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 585 (796)
||+|+||.||++... +|+.+++|.+...........+.+.+|++++++++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999866 5999999999766554444567889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC------
Q 003780 586 FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS------ 659 (796)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------ 659 (796)
.+++.+.. .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99998654 489999999999999999999999 999999999999999999999999999876443311
Q ss_pred --CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 660 --NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
......++..|+|||...+..++.++||||||+++|+|++|+.||.... ...............+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~-- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILNGKIEWPEDV-- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCcCCCccc--
Confidence 2233457889999999988888999999999999999999999987322 1222222222222211110
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.....+.+++.+|++.+|++|||+.++.+.++
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 -EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01345789999999999999999955555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.30 Aligned_cols=261 Identities=27% Similarity=0.327 Sum_probs=197.7
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ceee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMF 574 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 574 (796)
.++|++.+.||+|+||.||+|..+ +|+.||+|++....... .....+.+|+.++++++|+||+++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 467999999999999999999754 69999999987554322 1123566899999999999999999998765 5689
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++ +|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 7888877542 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC------
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS------ 727 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 727 (796)
...........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChhhc
Confidence 543333333346788999998865 45788999999999999999999998732211 000001110000
Q ss_pred ----------C--CCCc-cc---hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 728 ----------R--LSPP-VD---RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 728 ----------~--~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
. .... .. .........+.+++.+|++.||++|||+.|++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0 0000 00 000011334678999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.07 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=188.0
Q ss_pred eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHH-hhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVL-SKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|.. .+|+.||+|.+.............+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999975 46899999998765433222233445555544 455899999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999997643 378899999999999999999998 999999999999999999999999999875432 22
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHH
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIV 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...+++.|+|||...+..++.++||||+|+++|+|++|..||.... .................. .......
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~-~~~~~~~ 222 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--------PDAVFDNILSRRINWPEE-VKEFCSP 222 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcccCCCCc-ccccCCH
Confidence 3458889999999988888999999999999999999999986321 111122222211111110 0111234
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHH
Q 003780 743 LVTTVALACLHSKPKFRPTMQRVCQ 767 (796)
Q Consensus 743 ~l~~li~~cl~~dP~~RPs~~evl~ 767 (796)
.+.+++.+|++.+|++||++.++.+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHH
Confidence 5789999999999999997754433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.58 Aligned_cols=311 Identities=26% Similarity=0.267 Sum_probs=284.9
Q ss_pred CCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEE
Q 003780 71 ARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150 (796)
Q Consensus 71 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (796)
.++++.|+|.+|.+.. +....++.++.|+.||||.|.|+.+.-..|..-.++++|+|++|.|+....+.|.+|.+|..|
T Consensus 124 sghl~~L~L~~N~I~s-v~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISS-VTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred ccceeEEeeecccccc-ccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence 4688999998887764 455568999999999999999998888889888999999999999999999999999999999
Q ss_pred EecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc
Q 003780 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 151 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 230 (796)
.|+.|+++...+..|.+|++|+.|+|..|+|.-..--.|.+|++|+.|.|..|.++......|-.+.++++|+|..|+++
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 99999999888899999999999999999999666789999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccc
Q 003780 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIA 310 (796)
Q Consensus 231 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 310 (796)
..-.+++.+|++|+.|+|+.|.|..+-++.+.-..+|+.|+||+|+|+...+.+|..+..|+.|+|++|.++......|.
T Consensus 283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~ 362 (873)
T KOG4194|consen 283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV 362 (873)
T ss_pred hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence 88889999999999999999999988889888899999999999999999999999999999999999999988888999
Q ss_pred cccccceecccccccccCCCc---ccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCccccc
Q 003780 311 GLISLKGLDLSNNKLSGPIPP---EIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLYH 382 (796)
Q Consensus 311 ~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~ 382 (796)
++.+|+.|||++|.|+..+.+ .|..+++|+.|.|.+|+|....-..+ ++..|++|||.+|.|...-|..+.+
T Consensus 363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~ 438 (873)
T KOG4194|consen 363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEP 438 (873)
T ss_pred HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccccc
Confidence 999999999999999876654 57889999999999999995444444 7999999999999998766765543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=291.64 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=193.7
Q ss_pred HHHHHHHhcCCccceee--ecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeE
Q 003780 491 FEDIIKATEDFDIKYCI--GTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGF 566 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 566 (796)
..+.....+.|++.+.+ |+|+||.||+++. .+++.+|+|.+....... . |+.....+ +||||++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~--e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------I--EPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------h--hHHHHHHhhcCCCEEEEEEE
Confidence 34555566778887776 9999999999975 468899999987543221 1 22222222 69999999999
Q ss_pred EEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEE
Q 003780 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFV 645 (796)
Q Consensus 567 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl 645 (796)
+..++..++||||+++++|.+++.+.. .+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence 999999999999999999999997653 489999999999999999999999 999999999999999998 9999
Q ss_pred eeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 646 ADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 646 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
+|||.++...... ...++..|+|||++.+..++.++||||+|+++|||++|+.||...... ...........
T Consensus 152 ~dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~ 223 (267)
T PHA03390 152 CDYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE----ELDLESLLKRQ 223 (267)
T ss_pred ecCccceecCCCc----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc----hhhHHHHHHhh
Confidence 9999987654322 235889999999999888999999999999999999999998732211 00011111111
Q ss_pred cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q 003780 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT-MQRVCQE 768 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 768 (796)
..... . .......+.+++.+|++.+|++||+ ++|++++
T Consensus 224 ~~~~~--~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 QKKLP--F---IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cccCC--c---ccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 11111 1 1123345789999999999999996 6998865
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.96 Aligned_cols=265 Identities=25% Similarity=0.295 Sum_probs=199.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe----cce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH----KKC 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~ 572 (796)
.++|++.+.||+|++|.||+|.. .+|+.||+|++....... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 46899999999999999999975 469999999987653322 224567889999999999999999998763 346
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++|+||+. |+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 899999996 58988886543 389999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCC----ccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCc--
Q 003780 653 LLDSDSSN----RTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSS-- 715 (796)
Q Consensus 653 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~-- 715 (796)
........ .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65432211 123468889999998765 458899999999999999999999996432110 0000
Q ss_pred ---hhhhHHHH---hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 716 ---DQKIMLID---VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 716 ---~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
........ ....................+.+++.+|++.+|++||++++++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 00000000 01111111111111223456889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.66 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=203.5
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV 576 (796)
++|.+.+.||+|++|.||+|..+ +|+.||+|++...........+.+..|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999754 79999999997654433333567889999999998 99999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999998653 489999999999999999999998 999999999999999999999999999986544
Q ss_pred CCC--------------------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCch
Q 003780 657 DSS--------------------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD 716 (796)
Q Consensus 657 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~ 716 (796)
... ......++..|+|||...+..++.++||||+|++++++++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------- 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------- 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--------
Confidence 321 1122357889999999988888999999999999999999999987332
Q ss_pred hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Q 003780 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTM----QRVCQE 768 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~ 768 (796)
...............+ ......+.+++.+|++.+|++||++ ++++++
T Consensus 227 ~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 EYLTFQKILKLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHHhcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1122222222111111 1112347799999999999999999 676654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=277.89 Aligned_cols=266 Identities=22% Similarity=0.313 Sum_probs=203.3
Q ss_pred cHHHHHHHhcCCccceeeecccceeEEEE-EccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEE
Q 003780 490 AFEDIIKATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFC 567 (796)
Q Consensus 490 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~ 567 (796)
+|+|+.+.++ +.||+|+|+.|-.+ .+.+|.+||||++.+...- ..+.+.+|++++.+.+ |+||++++++|
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 3677766665 57999999999988 4778999999999877432 3468899999999996 99999999999
Q ss_pred EecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC---cEE
Q 003780 568 LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL---EAF 644 (796)
Q Consensus 568 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~k 644 (796)
+++..+|+|||.|.||+|.++++++.. +++.++.++.++||.||.+||.+ ||.|||+||+|||..... -+|
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence 999999999999999999999987643 89999999999999999999999 999999999999997654 479
Q ss_pred EeeeccccccCCCC-------CCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCccccc--C
Q 003780 645 VADFGTARLLDSDS-------SNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSS--L 710 (796)
Q Consensus 645 l~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~--~ 710 (796)
||||.++..+.... ......+|+..|||||+.. ...|+.+.|.||+|||+|-|+.|..||...-. .
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99999876543211 1123467889999999753 34588899999999999999999999974321 1
Q ss_pred CCCC----chhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 711 SSPS----SDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 711 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.+.. ..-+..+.+.+........+........+..+++...+..||.+|-++.+++.+-
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 1111 1112223333333322111111122223466788899999999999999999853
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.47 Aligned_cols=261 Identities=23% Similarity=0.351 Sum_probs=194.8
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----- 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 571 (796)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46899999999999999999964 4789999999864322 223456788999999999999999999876543
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++|+||+++ ++.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 57999999975 787777543 388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC---ccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCchh
Q 003780 652 RLLDSDSSN---RTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSDQ 717 (796)
Q Consensus 652 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~~ 717 (796)
......... .....|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...... ..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 765432211 123468899999998654 56888999999999999999999998642210 0000000
Q ss_pred hhHH-----HHhh---cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 718 KIML-----IDVL---DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 718 ~~~~-----~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... .... ......+...........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0000 0000000000011123457899999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=294.17 Aligned_cols=256 Identities=26% Similarity=0.363 Sum_probs=200.1
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|++.+.||+|++|.||+|... +++.+++|++....... .....+..|++++++++||||+++++++..+...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 567789999999999999764 78999999987654432 2346788899999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+++ ++.+++.... ..+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 976 8888876542 3489999999999999999999999 999999999999999999999999999987655432
Q ss_pred CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC-----------
Q 003780 660 NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS----------- 727 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 727 (796)
......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... .........+..
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-----DQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCchHhcccchh
Confidence 23334578889999998776 7889999999999999999999998642211 000000000000
Q ss_pred -----------CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 728 -----------RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 728 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
................+.+++.+|+++||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000111111234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=292.73 Aligned_cols=253 Identities=23% Similarity=0.269 Sum_probs=191.7
Q ss_pred CccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEec--ceeeEE
Q 003780 501 FDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHK--KCMFLI 576 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lV 576 (796)
|++.+.||+|+||.||+|.. .+++.||+|+++........ ....+|+.++.++. |||++++++++.++ +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 66788999999999999975 46899999998765332221 23457888898885 99999999999987 899999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.+.....
T Consensus 79 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 79 FELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 999974 7877776532 3489999999999999999999999 9999999999999999 9999999999987643
Q ss_pred CCCCccccccccCccCccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH-----------h
Q 003780 657 DSSNRTIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID-----------V 724 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 724 (796)
... .....++..|+|||+.. +..++.++||||+||++|||++|+.||...+.. .......+ .
T Consensus 152 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 152 KPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-----DQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-----HHHHHHHHHcCCCCHHHHHh
Confidence 322 22345788999999764 455788999999999999999999998643211 00000000 0
Q ss_pred hcCC------CCCc----cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 725 LDSR------LSPP----VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 725 ~~~~------~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... .... ...........+.+++.+|++++|++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 0000 000011224568899999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=292.23 Aligned_cols=256 Identities=27% Similarity=0.337 Sum_probs=196.2
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc---CCCceeeEEeEEEecce----
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI---AHRNIVKLYGFCLHKKC---- 572 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~---- 572 (796)
|++.+.||+|+||.||+|+.+ +++.||+|++......+ .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 667889999999999999876 58999999997654432 2234566788777666 59999999999988776
Q ss_pred -eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 573 -MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 573 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
.+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 79888876432 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh-------
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV------- 724 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 724 (796)
........ .....++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+.+.
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-----DQLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-----HHHHHHHHHcCCCChH
Confidence 87643322 22334788999999999988999999999999999999999998743210 000001000
Q ss_pred ------------hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 725 ------------LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 725 ------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...................+.+++.+||+.||++||+++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00011111111111223457789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=279.66 Aligned_cols=267 Identities=24% Similarity=0.298 Sum_probs=199.0
Q ss_pred hcCCccceeeecccceeEEEEEcc---C--CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-cc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP---N--GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-KK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 571 (796)
...|+....||+|+||.||+|..+ + .+.+|+|+++..+.... .-....+|+..++.++||||+.+..++.+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 357889999999999999999533 2 33799999987755432 23467789999999999999999998877 78
Q ss_pred eeeEEEeeccCCcHHHHHhhc--CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC----CcEEE
Q 003780 572 CMFLIYKYMKRGSLFCFLRND--YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK----LEAFV 645 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl 645 (796)
..++++||.+. +|++.++-+ .....++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 99999999988 888888643 3345789999999999999999999999 89999999999999887 89999
Q ss_pred eeeccccccCCCCC---CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccC----CCCCchh
Q 003780 646 ADFGTARLLDSDSS---NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSL----SSPSSDQ 717 (796)
Q Consensus 646 ~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----~~~~~~~ 717 (796)
+|+|+++.+...-. ....++-|.+|+|||.+.|. .|+.+.|||+.||++.||+|-.+-|.....- ......+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 99999998765422 23446689999999998876 4888999999999999999977665422110 0001111
Q ss_pred hhHHHHhhcCCCC---------Cccchhh--------------------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 718 KIMLIDVLDSRLS---------PPVDRMV--------------------MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 718 ~~~~~~~~~~~~~---------~~~~~~~--------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...+.+++...-. ++..... ......-.+++.++|+.||.+|.|+++.+++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1112111111100 0000000 0001125678999999999999999999998
Q ss_pred H
Q 003780 769 F 769 (796)
Q Consensus 769 L 769 (796)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 5
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=295.61 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=196.4
Q ss_pred hcCCccceeeecccceeEEEEEccC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|++|.||+|..++ ++.||||++........ ...+..|+.++.+.. ||||+++++++......++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH--HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3578889999999999999998764 89999999976543322 345666777676665 9999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+.+ ++.++..... ..+++..+.+++.|+++||+|||+.+ +|+||||+|+||+++.++.+||+|||++..+.
T Consensus 92 v~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 92 CMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EeeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999854 6777665432 25889999999999999999999732 89999999999999999999999999997654
Q ss_pred CCCCCccccccccCccCccccccCC----cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMV----VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.... .........+......
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 238 (296)
T cd06618 167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-------TEFEVLTKILQEEPPS 238 (296)
T ss_pred CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch-------hHHHHHHHHhcCCCCC
Confidence 3222 22234788999999987553 7889999999999999999999986311 1112222222222111
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
... .......+.+++.+|++.||++||++.+++++-.
T Consensus 239 -~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 239 -LPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -CCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 110 0112345789999999999999999999998853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.24 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=196.6
Q ss_pred HHHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-cce
Q 003780 495 IKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-KKC 572 (796)
Q Consensus 495 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~ 572 (796)
..++++|++.+.||+|+||.||+|..+ +++.||+|++....... ...+.+..|++++++++||||+++.+++.. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 346788999999999999999999644 79999999886543222 224577889999999999999999999876 457
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++|+||+ +++|.++++.. .+++.....++.|+++||+|||+. +|+||||+|+||+++.++.++|+|||.+.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 45888887643 367888889999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCch-----
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSD----- 716 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~----- 716 (796)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .....
T Consensus 157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 54322 122357888999998765 568899999999999999999999986322100 00000
Q ss_pred ---hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 717 ---QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 717 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...............+...........+.+++.+|++.+|++||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000001111011123458899999999999999999999988
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=298.55 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=192.4
Q ss_pred eeeecc--cceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeecc
Q 003780 505 YCIGTG--GYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 505 ~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
..||+| +||+||++.. .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 9999999975 479999999987654433 235788999999999999999999999999999999999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCc
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 661 (796)
+|++.+++.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999999886532 2478899999999999999999998 99999999999999999999999998654332211111
Q ss_pred -------cccccccCccCccccccC--CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC----
Q 003780 662 -------TIVAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR---- 728 (796)
Q Consensus 662 -------~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 728 (796)
....++..|+|||++.+. .++.++||||+||++|||++|+.||...... ......+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~ 230 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--------QMLLQKLKGPPYSP 230 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--------HHHHHHhcCCCCCC
Confidence 112345679999998763 4788999999999999999999998743210 0000000000
Q ss_pred ------------------------------------CC-Cc-cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 729 ------------------------------------LS-PP-VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 729 ------------------------------------~~-~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. .. ...........+.+++.+||+.||++|||++|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00 00 00001123446889999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=318.02 Aligned_cols=266 Identities=20% Similarity=0.231 Sum_probs=187.3
Q ss_pred HhcCCccceeeecccceeEEEEEcc--CCcEEEEEEe--------------ccccchhhHHHHHHHHHHHHHhhcCCCce
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP--NGKVVALKKL--------------HRAETEETTFFNSFQNEAHVLSKIAHRNI 560 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~--------------~~~~~~~~~~~~~~~~E~~~l~~l~hpni 560 (796)
..++|++.+.||+|+||+||++..+ .+..++.|.+ .+...........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998643 2222222211 11111112234568899999999999999
Q ss_pred eeEEeEEEecceeeEEEeeccCCcHHHHHhhcCc--ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec
Q 003780 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYE--AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN 638 (796)
Q Consensus 561 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~ 638 (796)
+++++++..++..++|+|++.+ ++.+++..... ...........++.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999864 67776654321 11234566778999999999999999 999999999999999
Q ss_pred CCCcEEEeeeccccccCCCCC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCC-CcccccCCCCCch
Q 003780 639 SKLEAFVADFGTARLLDSDSS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP-GELLSSLSSPSSD 716 (796)
Q Consensus 639 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p-~~~~~~~~~~~~~ 716 (796)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|..+ +...... ...
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~---~~~ 378 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK---PGK 378 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC---HHH
Confidence 999999999999987654322 22335699999999999999999999999999999999998854 3321100 000
Q ss_pred hhhH------------------HHHhhcCCCCC----ccchhh--HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 717 QKIM------------------LIDVLDSRLSP----PVDRMV--MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 717 ~~~~------------------~~~~~~~~~~~----~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
+... ..+.+...... ...... ......+.+++.+||+.||++|||+.|++++-
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 0000 00111000000 000000 00112366788999999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=295.85 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=199.8
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
..|+..+.||+|+||.||+|+.. +++.+|+|.+...........+++.+|+++++.++|||++++.+++..+...++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999754 68899999987543333333567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+. |++.+.+.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 57877775432 2478899999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 658 SSNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
....+++.|+|||.+. ...++.++|||||||++|+|++|+.||.... ..................
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPALQS 236 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHhhcCCCCcCc
Confidence 2345788999999874 3567889999999999999999999976321 111111122221111111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
......+.+++.+||+.+|++||++.+++++.....
T Consensus 237 ---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 237 ---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 122344778999999999999999999999976554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.67 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=193.0
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----- 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 571 (796)
.++|++.+.||+|+||.||+|..+ +++.||+|.+........ ....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 457999999999999999999754 689999999865443221 1235678999999999999999999987654
Q ss_pred ---eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 572 ---CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 572 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
..++||||+.+ ++.+.+.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999975 7887776532 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC----ccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 649 GTARLLDSDSSN----RTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 649 g~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|.+......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~~ 238 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLISQ 238 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHH
Confidence 999866432211 1234577889999987654 368899999999999999999999863221 000000000
Q ss_pred hhcC------------------CCCCccchhhH------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 724 VLDS------------------RLSPPVDRMVM------QDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 724 ~~~~------------------~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... ........... .....+.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 00000000000 012346789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=293.58 Aligned_cols=260 Identities=18% Similarity=0.235 Sum_probs=182.6
Q ss_pred hcCCccceeeecccceeEEEEEccC----CcEEEEEEeccccchhhH---H-----HHHHHHHHHHHhhcCCCceeeEEe
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN----GKVVALKKLHRAETEETT---F-----FNSFQNEAHVLSKIAHRNIVKLYG 565 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~---~-----~~~~~~E~~~l~~l~hpniv~l~~ 565 (796)
.++|.+.+.||+|+||.||+|...+ +..+|+|+.......... . ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999997654 455666654322211000 0 011223344556678999999999
Q ss_pred EEEecc----eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC
Q 003780 566 FCLHKK----CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL 641 (796)
Q Consensus 566 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 641 (796)
++.... ..++++|++.. ++.+.+.... ..++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 876543 34677777644 5655555432 256778899999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccCCCCC-------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCC
Q 003780 642 EAFVADFGTARLLDSDSS-------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS 714 (796)
Q Consensus 642 ~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~ 714 (796)
.++|+|||+|+.+..... ......||+.|+|||+..+..++.++||||+||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643211 1123469999999999999999999999999999999999999997542210000
Q ss_pred chhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 715 SDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..........+..... ... .....+.+++..|++.+|++||++.++.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI-KIK----NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhh-ccC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000111111111100 011 1124477999999999999999999999876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=299.44 Aligned_cols=288 Identities=23% Similarity=0.315 Sum_probs=209.2
Q ss_pred CCccceeeecccceeEEEEEcc-C--CcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec----c
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-N--GKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK----K 571 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~ 571 (796)
+|++.+.||+|+||.||+++.. . +..||+|++...... ....+.+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4788899999999999999754 3 789999998754322 12245678899999999 499999999976433 4
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++++||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 5788888886 58988886543 488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCch
Q 003780 652 RLLDSDSS----NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSD 716 (796)
Q Consensus 652 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~ 716 (796)
........ ......|++.|+|||+..+ ..++.++||||+||++|+|++|+.||....... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86543221 1223458899999998765 468899999999999999999999987432100 00000
Q ss_pred hhh--------HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--h---------hcCcccc
Q 003780 717 QKI--------MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF--L---------TCKIALV 777 (796)
Q Consensus 717 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L--~---------~~~~~~~ 777 (796)
... ........................+.+++.+|++.||++|||+.|++++= . .+...+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~ 312 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFD 312 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccccccccc
Confidence 000 00000000000011111111234588999999999999999999998873 1 1334455
Q ss_pred Cccc-cccHHHHhhhhccC
Q 003780 778 NPFE-EISIWQLRNQINTT 795 (796)
Q Consensus 778 ~~~~-~~~~~~~~~~~~~~ 795 (796)
.+|+ |.+.++.|++++++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~ 331 (332)
T cd07857 313 FSFESEDSMEELRDMIIEE 331 (332)
T ss_pred CCccccccHHHHHHHHhhc
Confidence 5666 77788889999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.55 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=195.4
Q ss_pred CccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|...+.||+|+||.||+|+. .+|+.|++|++...........+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999975 46899999998765444334456788999999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+. |++.+++.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57777776432 3488999999999999999999999 999999999999999999999999999864322
Q ss_pred CccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 660 NRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||..... ..................
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~- 243 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNDSPTLQSN- 243 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcCCCCCCcc-
Confidence 22345888999999974 45678899999999999999999999863221 111111111111111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+|++.+|++||++.+++++-
T Consensus 244 --~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 244 --EWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred --ccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1122477899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=295.31 Aligned_cols=261 Identities=29% Similarity=0.362 Sum_probs=197.1
Q ss_pred HHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc---
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK--- 571 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--- 571 (796)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++....... ....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-FPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-chHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 35678999999999999999999765 689999999976543221 2346778999999999999999999987654
Q ss_pred -------eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEE
Q 003780 572 -------CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 572 -------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 644 (796)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 676666543 23489999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCC-CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 645 VADFGTARLLDSDSS-NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
|+|||.+........ ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELIS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHH
Confidence 999999987654332 1222346778999998764 3578899999999999999999999873221 11111111
Q ss_pred HhhcCCCCC----------------------ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 723 DVLDSRLSP----------------------PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 723 ~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......... ............+.+++.+|++.||.+||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111000000 0000000113458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=292.24 Aligned_cols=256 Identities=28% Similarity=0.368 Sum_probs=196.6
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ceeeEEE
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMFLIY 577 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~ 577 (796)
|++.+.||+|++|.||+|... +++.+|+|++..... .....+.+.+|++++++++|||++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 667889999999999999765 589999999987642 222345788999999999999999999999988 8999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++ +|.+++.+.. ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99985 8888886542 3588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC-------
Q 003780 658 SS-NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR------- 728 (796)
Q Consensus 658 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 728 (796)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+..... .....+.......
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-----EQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchhhccc
Confidence 21 1223456788999997764 45788999999999999999999998743210 0000010000000
Q ss_pred -----------CCCccc----hhhHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 729 -----------LSPPVD----RMVMQ-DIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 729 -----------~~~~~~----~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...... ..... ....+.+++.+|++.+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 00001 13457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=299.84 Aligned_cols=267 Identities=24% Similarity=0.288 Sum_probs=199.5
Q ss_pred HHHHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 003780 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH 569 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 569 (796)
.+++...+++|++.+.||+|+||.||+|.. ++++.||+|++....... ...+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 456667889999999999999999999964 579999999997643322 224567889999999999999999998864
Q ss_pred c------ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcE
Q 003780 570 K------KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEA 643 (796)
Q Consensus 570 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 643 (796)
. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3467888876 77998877643 388999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC----------
Q 003780 644 FVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS---------- 712 (796)
Q Consensus 644 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~---------- 712 (796)
||+|||+++.... ......++..|+|||...+ ..++.++||||+||++|||++|+.||........
T Consensus 160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876432 2223457889999998766 4678899999999999999999999863221000
Q ss_pred CC--------chhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 713 PS--------SDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 713 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. ..........+..................+.+++.+|++.||++||++.+++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00 0000000000111111111110011233578999999999999999999999884
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.12 Aligned_cols=246 Identities=22% Similarity=0.222 Sum_probs=187.8
Q ss_pred eeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHH---HHHhhcCCCceeeEEeEEEecceeeEEEeecc
Q 003780 506 CIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEA---HVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
.||+|+||.||+|... +++.||+|.+.............+..|. +.++...||+|+++.+++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999754 6899999998765433222112233343 34445579999999999999999999999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCc
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 661 (796)
+|+|.+++.+.. .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 999999887543 489999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred cccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHH
Q 003780 662 TIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQD 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...... .......... ........ ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~~~~~---~~ 222 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK------DKHEIDRMTL-TMAVELPD---SF 222 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc------chHHHHHHhh-ccCCCCCC---cC
Confidence 234689999999998754 5889999999999999999999998743211 0111111111 11111111 11
Q ss_pred HHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 741 IVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 741 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
...+.+++.+|+..+|.+|| ++.|++++-
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 23478899999999999999 999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=296.22 Aligned_cols=253 Identities=19% Similarity=0.244 Sum_probs=190.6
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCC
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRG 583 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 583 (796)
.+.+|.|+++.||++.. +++.||+|++....... ...+.+.+|++++++++||||+++++++..++..+++|||+++|
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 33445555555555544 69999999997653322 23568999999999999999999999999999999999999999
Q ss_pred cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC----
Q 003780 584 SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS---- 659 (796)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---- 659 (796)
+|.+++.+... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999986533 3478888999999999999999999 999999999999999999999999998875532211
Q ss_pred ---CccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC------
Q 003780 660 ---NRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR------ 728 (796)
Q Consensus 660 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 728 (796)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--------QMLLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccCccccc
Confidence 1122346778999999865 35788999999999999999999998743211 0000000000
Q ss_pred ----------------------CCC-ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 729 ----------------------LSP-PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 729 ----------------------~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
... ............+.+++.+||+.||++|||++|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000 000011122345788999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.95 Aligned_cols=263 Identities=30% Similarity=0.399 Sum_probs=196.5
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec--ce
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK--KC 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~ 572 (796)
..++|++.+.||+|+||.||+|... +|+.+|+|++........ ....+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4568999999999999999999765 688999999865432222 234677899999999 999999999998654 36
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||++ ++|.+++.+. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 899999997 4898888653 478889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC-----CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCch
Q 003780 653 LLDSDSS-----NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSD 716 (796)
Q Consensus 653 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~ 716 (796)
....... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6543321 1223458899999998754 457889999999999999999999986322110 00000
Q ss_pred hh-----hHHHHhhc---CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 717 QK-----IMLIDVLD---SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 717 ~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.. ......++ .................+.+++.+|++.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 00000010 000000011011123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.06 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=196.3
Q ss_pred CCccceeeecccceeEEEEEc----cCCcEEEEEEeccccchh-hHHHHHHHHHHHHHhhc-CCCceeeEEeEEEeccee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETEE-TTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 573 (796)
+|++.+.||+|+||.||++.. .+|+.||+|++....... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999965 368999999987643322 22245678899999999 599999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++|+||+++++|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987643 378888899999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC-CccccccccCccCccccccC--CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSS-NRTIVAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
...... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ................
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~- 229 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSEP- 229 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccCC-
Confidence 543321 12234588899999998753 467899999999999999999999863211 1111112222222111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
+ .. ......+.+++.+|++.||++|| ++.+++.+
T Consensus 230 ~-~~---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 P-YP---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred C-CC---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1 11 11223477899999999999997 66666554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=275.29 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=201.5
Q ss_pred HhcCCccc-eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEe----
Q 003780 497 ATEDFDIK-YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLH---- 569 (796)
Q Consensus 497 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---- 569 (796)
.+++|++. ++||-|-.|.|-.+.. .+|+.+|+|++.... ..++|++..-.. .|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 45667664 5799999999999854 479999999886442 457788876666 49999999998864
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEe
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVA 646 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~ 646 (796)
.+...+|||.|+||.|++.+++.+. ..+++.++..|+.||+.|+.|||+. +|.||||||+|+|.+. +..+|++
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 4578899999999999999987643 4589999999999999999999999 9999999999999975 4568999
Q ss_pred eeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc
Q 003780 647 DFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD 726 (796)
Q Consensus 647 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (796)
|||+|+.-.. .......+.||.|.|||++....|+...|+||+||++|-|++|.+||+........ ..+...+..
T Consensus 207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais----pgMk~rI~~ 281 (400)
T KOG0604|consen 207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKRRIRT 281 (400)
T ss_pred ccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC----hhHHhHhhc
Confidence 9999986543 23345577899999999999999999999999999999999999999854432111 112222222
Q ss_pred CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.....+ ............++|+.+|..+|.+|.|+.|++.+-.-
T Consensus 282 gqy~FP-~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 282 GQYEFP-EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred cCccCC-ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 222111 11123334457789999999999999999999998653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=305.12 Aligned_cols=201 Identities=31% Similarity=0.451 Sum_probs=175.1
Q ss_pred CccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc------ee
Q 003780 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK------CM 573 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~ 573 (796)
|...+.||+|+||.||+|+ .+.|+.||||.++...... ..+...+|++++++++|||||++++.-+... ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4556789999999999998 4579999999998865432 2467889999999999999999999765433 56
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec--CCCc--EEEeeec
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN--SKLE--AFVADFG 649 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~--~kl~Dfg 649 (796)
.+|||||.+|||+..+.+......+++.+.+.+..+++.||.|||++ +|+||||||.||++- ++|+ -||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 89999999999999999887777899999999999999999999998 999999999999984 3343 5899999
Q ss_pred cccccCCCCCCccccccccCccCccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCccc
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGRHPGELL 707 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~elltg~~p~~~~ 707 (796)
.|+.++++. ......||..|.+||+.. ...|+..+|.|||||++|+.+||..||...
T Consensus 170 ~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 170 AARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 999887654 455678999999999998 588999999999999999999999999854
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.85 Aligned_cols=261 Identities=24% Similarity=0.310 Sum_probs=200.3
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----ee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK-----CM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~ 573 (796)
+|++.+.||.|++|.||+|+.. +++.||+|++...... ....+.+.+|+++++.++||||+++.+++...+ ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5788999999999999999765 5899999998765421 223467899999999999999999999998775 78
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++ +|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||.+..
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 999999984 8888887543 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC---CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCch---
Q 003780 654 LDSDS---SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSD--- 716 (796)
Q Consensus 654 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~--- 716 (796)
..... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||....... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 65443 122334578899999999887 78899999999999999999999986432100 00000
Q ss_pred --hhhHHHHhhc---CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 717 --QKIMLIDVLD---SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 717 --~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
........+. .................+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 000000000111123457899999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.11 Aligned_cols=257 Identities=25% Similarity=0.304 Sum_probs=199.4
Q ss_pred CCccceeeecccceeEEEEEc----cCCcEEEEEEeccccchh-hHHHHHHHHHHHHHhhc-CCCceeeEEeEEEeccee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETEE-TTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 573 (796)
+|++.+.||+|++|.||+++. .+++.||||.+....... ....+.+.+|++++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999863 357889999987543321 22345788999999999 599999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 378889999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCC-ccccccccCccCccccccCC--cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSSN-RTIVAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
....... .....|+..|+|||...+.. .+.++||||||+++|||++|+.||...... ...............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~- 229 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKSKP- 229 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHccCC-
Confidence 5433221 22345888999999987655 678999999999999999999998632211 111111112222111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
+.. ......+.+++.+|++.||++|||+.++.+.++-
T Consensus 230 ~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 PFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111 1122347789999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.07 Aligned_cols=239 Identities=27% Similarity=0.349 Sum_probs=196.0
Q ss_pred eecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcH
Q 003780 507 IGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 585 (796)
||+|+||.||++... +++.+|+|.+...........+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 5899999998876554444456889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccc
Q 003780 586 FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665 (796)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 665 (796)
.+++.... .+++..+..++.|+++|+.|+|+. +++|+||+|+||+++.++.++|+|||.+..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99997653 388999999999999999999998 999999999999999999999999999987654433334456
Q ss_pred cccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHH
Q 003780 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVT 745 (796)
Q Consensus 666 gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 745 (796)
++..|+|||...+...+.++|+||||+++|+|++|+.||.... ...............+ . .....+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~--~---~~~~~l~ 221 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--------RKEIYEKILKDPLRFP--E---FLSPEAR 221 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHhcCCCCCC--C---CCCHHHH
Confidence 8889999999988888899999999999999999999986321 1222222222222111 1 1123477
Q ss_pred HHHHHcCCCCCCCCCCHHH
Q 003780 746 TVALACLHSKPKFRPTMQR 764 (796)
Q Consensus 746 ~li~~cl~~dP~~RPs~~e 764 (796)
+++.+|+..||++||++++
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 8999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=287.44 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=196.8
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchh--hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEE--TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
+|.+.+.||+|+||.||++... .+..+++|.++.....+ .....++..|+.++++++||||+++++++..+...++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999654 34556666655432211 11123567889999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
+||+++++|.+++.+.. ....+++..+..++.|+++|+.|||+. +++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999887532 234589999999999999999999998 9999999999999976 569999999998765
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
..........|++.|+|||...+..++.++||||||+++|+|++|..||.... ............ .+..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~-- 225 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEGP-TPSL-- 225 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcCC-CCCC--
Confidence 44333344568889999999888888899999999999999999999986321 111222222211 1111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.......+.+++.+|++.+|++||++.|++++
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 226 -PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 12223457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.50 Aligned_cols=258 Identities=25% Similarity=0.331 Sum_probs=194.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----- 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 571 (796)
.++|...+.||+|+||.||+|.. .+|+.||+|++......+ .....+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 47899999999999999999975 468999999987643322 22356789999999999999999999987543
Q ss_pred -eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 572 -CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 572 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
..++|+||+.. ++.++.. ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 6766542 2378899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH------
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID------ 723 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 723 (796)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 235 (342)
T cd07879 164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-----DQLTQILKVTGVPG 235 (342)
T ss_pred CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCC
Confidence 8765322 223457889999999876 46888999999999999999999999742210 00000000
Q ss_pred --------------hhcC--CC-CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhhcC
Q 003780 724 --------------VLDS--RL-SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE--FLTCK 773 (796)
Q Consensus 724 --------------~~~~--~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 773 (796)
.... .. ..............+.+++.+|++.||++||+++|++++ ++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 00 000000001122347799999999999999999999977 55443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.24 Aligned_cols=261 Identities=25% Similarity=0.266 Sum_probs=195.6
Q ss_pred hcCCcc-ceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhH-----------HHHHHHHHHHHHhhcCCCceeeEE
Q 003780 498 TEDFDI-KYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETT-----------FFNSFQNEAHVLSKIAHRNIVKLY 564 (796)
Q Consensus 498 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~l~ 564 (796)
.++|.. .+.||+|+||+||+|..+ +++.||+|.+......... ....+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 567999999999999754 6999999998654332200 112477899999999999999999
Q ss_pred eEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEE
Q 003780 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 565 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 644 (796)
+++..++..++||||++ |+|.+++.... .+++.....++.|++.||+|||+. +++||||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 99999999999999997 58988886533 388899999999999999999998 999999999999999999999
Q ss_pred EeeeccccccCCC--------------CCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCccccc
Q 003780 645 VADFGTARLLDSD--------------SSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSS 709 (796)
Q Consensus 645 l~Dfg~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~ 709 (796)
++|||.+...... ........+++.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999765411 1111223467889999998764 468899999999999999999999874321
Q ss_pred CCCCCchhhhHHHHhhcCC--------------------CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 710 LSSPSSDQKIMLIDVLDSR--------------------LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
. .....+....... ...............+.+++.+|++.+|++||+++|++.+-
T Consensus 240 ~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 I-----DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred H-----HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1 0000111100000 00000000111234578999999999999999999999874
Q ss_pred h
Q 003780 770 L 770 (796)
Q Consensus 770 ~ 770 (796)
.
T Consensus 315 ~ 315 (335)
T PTZ00024 315 Y 315 (335)
T ss_pred c
Confidence 3
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.87 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=195.6
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEEe
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 578 (796)
|++.+.||+|++|+||+|... +++.||+|++........ .....+|+..+++++ |||++++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 667889999999999999865 588999999876543221 224457899999999 9999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+ +|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99 789998887653 23489999999999999999999998 99999999999999999999999999998664332
Q ss_pred CCccccccccCccCccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCc---hhhhHHHHh
Q 003780 659 SNRTIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSS---DQKIMLIDV 724 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~---~~~~~~~~~ 724 (796)
. .....++..|+|||++. ...++.++||||||++++||++|+.||....... .... .........
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 P-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred C-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2 22345788999999875 4557889999999999999999999986332100 0000 000000000
Q ss_pred hcCCCC----CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 725 LDSRLS----PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 725 ~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...... .............+.+++.+|++.||++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 00011111123458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.76 Aligned_cols=260 Identities=24% Similarity=0.304 Sum_probs=195.3
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK---- 571 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 571 (796)
..++|++.+.||+|+||.||++. ..+|+.||||++...... ....+.+.+|++++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 46789999999999999999996 457999999998654322 223456889999999999999999999987543
Q ss_pred --eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 572 --CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 572 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 67898887642 388999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC---------CCc-h--
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS---------PSS-D-- 716 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~---------~~~-~-- 716 (796)
++...... .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ ... .
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 164 LARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99865432 223457889999998875 4578899999999999999999999874321000 000 0
Q ss_pred ------hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 717 ------QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 717 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
........+..................+.+++.+|++.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000000001122347799999999999999999999966
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=317.95 Aligned_cols=149 Identities=30% Similarity=0.442 Sum_probs=134.1
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||.||+|... +++.||+|++.............+..|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357999999999999999999765 6899999999866544444456789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
|||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997643 378888999999999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.76 Aligned_cols=259 Identities=27% Similarity=0.346 Sum_probs=192.8
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------ 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 570 (796)
.++|++.+.||+|+||.||+|..+ +++.+|+|++......+. ....+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 468999999999999999999754 689999999865543221 123567899999999999999999987543
Q ss_pred --ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 571 --KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 571 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
...++|+||+.+ ++...+... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999976 676666543 23489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC-----------ccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCch
Q 003780 649 GTARLLDSDSSN-----------RTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD 716 (796)
Q Consensus 649 g~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~ 716 (796)
|+++........ .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~ 234 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----D 234 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----H
Confidence 999765432211 1223467889999987654 5788999999999999999999998642211 0
Q ss_pred hhhHHHHh----------------------hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 717 QKIMLIDV----------------------LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 717 ~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
........ ......+............+.+++.+|++.||++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 00000000000001112357899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.19 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=198.8
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+..|++++++++|||++++++++...+..++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 566788999999999999765 5999999999876422 22245778899999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
++ ++|.+++.+.. ..+++..+..++.|+++||+|||+. +|+||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 98 58999998653 3489999999999999999999999 999999999999999999999999999987654433
Q ss_pred CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCchhhhHHHHh--hc
Q 003780 660 NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSDQKIMLIDV--LD 726 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~~~~~~~~~--~~ 726 (796)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ............. .+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 33334467789999998766 78899999999999999999999986422100 0000000000000 00
Q ss_pred CCCC----CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 SRLS----PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 ~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... .............+.+++.+|++.||++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 00000001113458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=275.44 Aligned_cols=253 Identities=25% Similarity=0.306 Sum_probs=194.3
Q ss_pred ceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhh-cCCCceeeEEeEEEecceeeEEEeecc
Q 003780 504 KYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
...||.|+||+|+|-.+ +.|+..|||++.......+ .+++..|.+...+ -++||||+++|.+..++..++.||.|+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 45699999999999965 5799999999998776332 4678888876544 479999999999999999999999996
Q ss_pred CCcHHHHHhhc--CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 582 RGSLFCFLRND--YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 582 ~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
- |++.+.+.. .+...+++...-.|......||.||.... .|||||+||+|||++..|.+|+||||.+..+.. ..
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-Si 222 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-SI 222 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-HH
Confidence 5 665543322 13345888888899999999999999874 899999999999999999999999999987643 33
Q ss_pred CccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch-h
Q 003780 660 NRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR-M 736 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 736 (796)
..+.-+|...|||||.+.. ..|+-+|||||+|+++||+.||+.|+...+ ...+.+..++....+.-..+ .
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCCCeecCccc
Confidence 4455568889999998863 348889999999999999999999987321 11122222222222211111 1
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.......+..++..|+..|-..||...++.++-
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 223445688999999999999999999988763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=316.47 Aligned_cols=259 Identities=25% Similarity=0.311 Sum_probs=210.2
Q ss_pred HHHHHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 493 DIIKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 493 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
++.-..++|.+.++||+|+||.|..++.+ .++.||.|++.+..........-|..|-.+|..-+.+=|+.++-.|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44445679999999999999999999865 68999999998865544444567899999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..|+|||||+||+|..++.+.. .+++..+..++..|.-||+.+|+. |+|||||||+|||+|..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999998764 488888888999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-ccccccccCccCccccc----c-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 652 RLLDSDSSN-RTIVAGTYGYIAPELAY----T-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 652 ~~~~~~~~~-~~~~~gt~~y~aPE~~~----~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
-.+..++.. ....+|||.|++||++. + +.|+..+|.||+||++|||+.|..||+.. .-...+..++
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------slveTY~KIm 294 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------SLVETYGKIM 294 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------HHHHHHHHHh
Confidence 887755443 44567999999999875 3 56889999999999999999999999842 2233444455
Q ss_pred cC--CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Q 003780 726 DS--RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT---MQRVCQEF 769 (796)
Q Consensus 726 ~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L 769 (796)
+. .+..+. .........++|.+.+. +|+.|-. +.++-.|.
T Consensus 295 ~hk~~l~FP~---~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 295 NHKESLSFPD---ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred chhhhcCCCc---ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 44 222221 11233346677777765 5778876 88887764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.36 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=197.0
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce---
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC--- 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 572 (796)
..++|++.+.||+|++|.||+|+.. +++.||+|++....... ...+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4678999999999999999999764 68899999987543222 224567889999999999999999998876554
Q ss_pred ---eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 573 ---MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 573 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 56999888752 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh----
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV---- 724 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 724 (796)
++...... .....++..|+|||...+ ..++.++||||+||++|+|++|+.||...... .....+.+.
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-----~~~~~i~~~~~~~ 235 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-----DQLKRIMNLVGTP 235 (343)
T ss_pred cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHhcCCC
Confidence 99865432 223457889999998765 36788999999999999999999998632210 000000000
Q ss_pred -------------------hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 725 -------------------LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 725 -------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
+..................+.+++.+|++.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 000000001010111234588999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=297.49 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=216.5
Q ss_pred cHHHHHHHhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 003780 490 AFEDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFC 567 (796)
Q Consensus 490 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 567 (796)
.++.+...++.|++.+.||+|.+|.||+++ .++|+.+|+|+.......+ +++..|..+++.. .|||++.++|++
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEE
Confidence 344444567889999999999999999996 4579999999998877654 4678889999888 599999999999
Q ss_pred Ee-----cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc
Q 003780 568 LH-----KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE 642 (796)
Q Consensus 568 ~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 642 (796)
.. +++.++|||||.+|+.-+++++.. ...+.|..+..|++.+++|+.+||.. .++|||+|-.||+++.++.
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence 64 578999999999999999998876 55699999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCCccccccccCccCccccccC-----CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchh
Q 003780 643 AFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-----VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 717 (796)
+|++|||.+..+........+..|||.|||||++... .|+.++|+||+|++..||--|.+|+.++.+.
T Consensus 162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------- 234 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------- 234 (953)
T ss_pred EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------
Confidence 9999999999887666666677899999999998643 3667899999999999999999998865542
Q ss_pred hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..-+.-++-+++.-..+..-..++.++|..|+..|.++||++.++++|-.
T Consensus 235 ---raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 235 ---RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred ---hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 11111222222222223333446889999999999999999999998743
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=293.75 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=191.6
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------ 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 570 (796)
..+|.+.+.||.|+||.||+|.. .+|+.||+|.+...... ..+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 46899999999999999999965 46899999998665432 245788999999999999999999876543
Q ss_pred --------ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-CC
Q 003780 571 --------KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-KL 641 (796)
Q Consensus 571 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~ 641 (796)
...++|+||++ ++|.+++... .+++..+..++.||++||.|||+. +|+||||||+||+++. ++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 5888887543 378899999999999999999999 9999999999999985 55
Q ss_pred cEEEeeeccccccCCCCC---CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC------
Q 003780 642 EAFVADFGTARLLDSDSS---NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS------ 711 (796)
Q Consensus 642 ~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~------ 711 (796)
.++++|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 789999999976543211 1122357889999997654 557889999999999999999999996432100
Q ss_pred ----CCCchhhhHHH----Hhhc---CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 712 ----SPSSDQKIMLI----DVLD---SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 712 ----~~~~~~~~~~~----~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
........... .... ................++.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000000000 0000 000000000001122357789999999999999999999977
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=277.85 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=202.2
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 576 (796)
.+|....+||+|+||.|..|..+ +.+.||||+++++........+--..|-+++... +-|.+++++.+++.-+..|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46999999999999999999655 5788999999987655433334445677777665 478999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+.||+|.-++++-+. +.+..+..++..||-||-+||++ +|+.||||.+|||++.+|++||+|||+++.--.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999988876543 77778888999999999999999 999999999999999999999999999986554
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
+.......+|||.|+|||.+...+|+..+|.|||||+||||+.|+.||+. ..+.+....+.+.....+..
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--------eDE~elF~aI~ehnvsyPKs-- 572 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--------EDEDELFQAIMEHNVSYPKS-- 572 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHHccCcCccc--
Confidence 55566778999999999999999999999999999999999999999983 34455566666666554332
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCC
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRP 760 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RP 760 (796)
-..+...+.+..+...|.+|-
T Consensus 573 ---lSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 573 ---LSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---ccHHHHHHHHHHhhcCCcccc
Confidence 122356788899999999995
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=287.62 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=200.9
Q ss_pred ceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccC
Q 003780 504 KYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
.++||.|.||+||-|. .++|+.||||++.+.+..... ..++++|+.++++++||.||.+...|+.++..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 5789999999999995 568999999999988776554 47899999999999999999999999999999999999987
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC---CcEEEeeeccccccCCCCC
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK---LEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~ 659 (796)
.=|.-++.... ..+++.....++.||+.||.|||.+ +|+|+||||+|||+... .++||||||+|+.+++. .
T Consensus 648 DMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-s 721 (888)
T KOG4236|consen 648 DMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-S 721 (888)
T ss_pred hHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-h
Confidence 65665665543 4588888888999999999999999 99999999999999654 47999999999988754 4
Q ss_pred CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHH
Q 003780 660 NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQ 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
....+.|||.|+|||++....|...-|+||.||++|--++|..||....+ ..++.....++.+.-+ ..+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQNAaFMyPp~P------W~e 790 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQNAAFMYPPNP------WSE 790 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhccccccCCCc------hhh
Confidence 45567899999999999999999999999999999999999999973221 1111111111111111 122
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 740 DIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 740 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......++|...|+..-++|-|.+.-+.|.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 234467899999999999999998877664
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=308.06 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=207.4
Q ss_pred hcCCccceeeecccceeEEEEEcc----C----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP----N----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
.++..+.+.+|+|.||.|++|... . ...||||.++...... ..+.+..|+++|+.+ +||||+.++|+|.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~--~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSS--EKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcH--HHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 344456669999999999999632 1 4579999998777652 357899999999999 5999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcC-----c------c--cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDY-----E------A--VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
..+..++|+||++.|+|.++++..+ . . ..+...+.+.++.|||.|++||++. ++|||||.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999998765 0 0 2388899999999999999999999 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCCCc-ccccc--ccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSSNR-TIVAG--TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLS 711 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~ 711 (796)
+++++..+||+|||+|+......... ....| ...|||||.+....++.|+|||||||++||++| |..||...
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~---- 525 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI---- 525 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC----
Confidence 99999999999999999765443332 21222 345999999999999999999999999999998 67776531
Q ss_pred CCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.....+.+.+....+.+.+....+ ++.++++.||+.+|++||++.|+.+.+...
T Consensus 526 ----~~~~~l~~~l~~G~r~~~P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 ----PPTEELLEFLKEGNRMEQPEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----CcHHHHHHHHhcCCCCCCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 101122334555444443333333 467899999999999999999999999884
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=265.95 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=212.2
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 575 (796)
.++|...++||+|+|+.|..++++ +.+.||+|++++.-..+.+.++-.+.|..+..+. +||.+|.++.+++.+...+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999764 6889999999987766666566778888888877 59999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|.||++||+|.-++++.. .++++.+..+...|.-||.|||++ ||+.||||.+||++|.+|++|+.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999988887654 388999988999999999999999 99999999999999999999999999998755
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.+....+..+|||.|+|||.+.+..|...+|.|++||+++||+.|+.||+...........+.....-++.+.++.+..-
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 55666778899999999999999999999999999999999999999999766444444444444445555555543321
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCC
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRP 760 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RP 760 (796)
......+++.-+..||.+|.
T Consensus 483 -----svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 483 -----SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----ehhhHHHHHHhhcCCcHHhc
Confidence 12344688899999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-33 Score=279.98 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=200.9
Q ss_pred HhcCCccceeeecccceeEEEE-EccCCcEEEEEEeccccchhh----HHHHHHHHHHHHHhhcCCCceeeEEeEEE-ec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEET----TFFNSFQNEAHVLSKIAHRNIVKLYGFCL-HK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 570 (796)
..++|-..+.||+|+|+.||+| .+...+.||||+-...+.+.. .+.+-..+|..+.+.+.||.||++++|+. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4467888899999999999999 466788999998765554432 23456779999999999999999999996 45
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVAD 647 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~D 647 (796)
+.++-|.||++|.+|+.+++.+. .+++.++..|+.||+.||.||... .|+|||.||||.|||+-. -|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 78899999999999999998664 489999999999999999999986 678999999999999954 47899999
Q ss_pred eccccccCCCCCCc-------cccccccCccCccccccC----CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCch
Q 003780 648 FGTARLLDSDSSNR-------TIVAGTYGYIAPELAYTM----VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD 716 (796)
Q Consensus 648 fg~a~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~----~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~ 716 (796)
||+++.++++.... +..+||++|++||.+.-+ .++.|+||||+||++|+.+.|+.||.... .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq-------s 689 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ-------S 689 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-------h
Confidence 99999998765542 235699999999987633 46779999999999999999999998422 1
Q ss_pred hhhHHHH--hhcCC-CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 717 QKIMLID--VLDSR-LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 717 ~~~~~~~--~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
++..+.. ++... ...+.. .....+...+|.+||++--++|..+.++..+
T Consensus 690 QQdILqeNTIlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 690 QQDILQENTILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred HHHHHhhhchhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 2221111 11111 111111 1112235689999999999999988887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=290.74 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=194.3
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
.++.|.....+|.|+|+.|-.+. ..+++..+||++.+... +-.+|+.++... +||||+++.+.+.++...+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 35678888889999999998885 45789999999987632 234567666665 5999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe-cCCCcEEEeeeccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL-NSKLEAFVADFGTARL 653 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~Dfg~a~~ 653 (796)
+|||.+.++-+.+.+...+. ....+..|+.+|+.|+.|||++ |||||||||+|||+ +..++++|+|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999988777765432 2267778999999999999999 99999999999999 6889999999999987
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
...+ ....+-|..|.|||+.....|++++|+||||++||+|++|+.||..... . ..+ ......+.+
T Consensus 466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-------~-~ei---~~~i~~~~~ 531 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-------G-IEI---HTRIQMPKF 531 (612)
T ss_pred Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-------h-HHH---HHhhcCCcc
Confidence 6654 2234567899999999999999999999999999999999999883221 1 111 112222222
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
..... ....+++.+||+.||.+||+|.++..+-.-
T Consensus 532 s~~vS---~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 SECVS---DEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccccC---HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 22122 236689999999999999999999988655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=272.10 Aligned_cols=220 Identities=21% Similarity=0.221 Sum_probs=174.5
Q ss_pred ccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcHHHH
Q 003780 510 GGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCF 588 (796)
Q Consensus 510 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 588 (796)
|.+|.||+++. .+++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 88999999975 478999999987543 223344455556799999999999999999999999999999999
Q ss_pred HhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcccccccc
Q 003780 589 LRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTY 668 (796)
Q Consensus 589 l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 668 (796)
+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+....... ....++.
T Consensus 76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 146 (237)
T cd05576 76 ISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVEN 146 (237)
T ss_pred HHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCc
Confidence 87643 388999999999999999999998 99999999999999999999999999887654321 2234567
Q ss_pred CccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHH
Q 003780 669 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVA 748 (796)
Q Consensus 669 ~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 748 (796)
.|+|||...+..++.++||||+|+++|||++|+.|+...... .........+. .....+.+++
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~~-------~~~~~~~~li 209 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIPE-------WVSEEARSLL 209 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCcc-------cCCHHHHHHH
Confidence 899999998888899999999999999999999886532110 00000001111 1123477899
Q ss_pred HHcCCCCCCCCCCHH
Q 003780 749 LACLHSKPKFRPTMQ 763 (796)
Q Consensus 749 ~~cl~~dP~~RPs~~ 763 (796)
.+|++.||++||++.
T Consensus 210 ~~~l~~dp~~R~~~~ 224 (237)
T cd05576 210 QQLLQFNPTERLGAG 224 (237)
T ss_pred HHHccCCHHHhcCCC
Confidence 999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=239.83 Aligned_cols=197 Identities=25% Similarity=0.391 Sum_probs=170.2
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
.|...+.||+|.||+||+|+.+ +++.||+|+++.+..++. ......+|+-+++.++|+|||++++....++..-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4556678999999999999755 689999999987765543 34678899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
||.. +|..+..... ..++.+....++.|+++||.++|++ ++.|||+||.|.+++.+|+.|++|||+++.++-+-
T Consensus 82 ~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9975 7877776543 2488889999999999999999999 99999999999999999999999999999877654
Q ss_pred CCccccccccCccCccccccCC-cCcchhHHHHHHHHHHHHhCCCC
Q 003780 659 SNRTIVAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRHP 703 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGv~l~elltg~~p 703 (796)
.-.+...-|.+|.+|.++.+.. |++..|+||-||++.|+.....|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 4444556799999999988765 88899999999999999976655
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=271.83 Aligned_cols=257 Identities=22% Similarity=0.311 Sum_probs=198.5
Q ss_pred HHhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-C-C----ceeeEEeEEE
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-H-R----NIVKLYGFCL 568 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p----niv~l~~~~~ 568 (796)
..+++|.+...+|+|.||.|-++. .+.+..||+|+++... .+.+...-|++++.++. + | -+|.+.+|+.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 347899999999999999999994 4458999999997654 23456778999999994 2 2 4788889999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---------
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS--------- 639 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--------- 639 (796)
..++.++|+|.+ |-|+++++.++.. .+++...+..|+.|+++++++||+. +++|.||||+||++..
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence 999999999988 4489999987643 4588899999999999999999999 9999999999999842
Q ss_pred -----------CCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccc
Q 003780 640 -----------KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLS 708 (796)
Q Consensus 640 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~ 708 (796)
+..++|+|||.|+.-.. .....+.|..|+|||++.+-.++.++||||+||||+|+.||..-|+.-.
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 24578999999986433 3355678999999999999999999999999999999999998877322
Q ss_pred cCCCCCchhhhHHHHhhc------------------CCCC------------------Cc--cchhhHHHHHHHHHHHHH
Q 003780 709 SLSSPSSDQKIMLIDVLD------------------SRLS------------------PP--VDRMVMQDIVLVTTVALA 750 (796)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~------------------~~~~------------------~~--~~~~~~~~~~~l~~li~~ 750 (796)
.. +.-.+...++. .++. +. .-.....+...+.+++.+
T Consensus 314 n~-----EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 314 NL-----EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cH-----HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 10 00000000000 0110 00 000112344569999999
Q ss_pred cCCCCCCCCCCHHHHHHHH
Q 003780 751 CLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 751 cl~~dP~~RPs~~evl~~L 769 (796)
||..||.+|+|+.|+++|-
T Consensus 389 mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHP 407 (415)
T ss_pred HHccCccccccHHHHhcCH
Confidence 9999999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=279.33 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=207.3
Q ss_pred cCCccceeeecccceeEEEEEccCCc-EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGK-VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.+++.+..||-|+||.|=.++.+..+ .+|+|.+++....+....+-+..|-.+|...+.|.||+++..|.+.+..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566677999999999998765433 48999888776666555667889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|-|-||.++..+++.+ .++......++.++.+|++|||++ +||.|||||+|.+++.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999998654 388888889999999999999999 9999999999999999999999999999998765
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.... +.+|||.|.|||.+....++.++|.||+|+++|||++|.+||...++. ..+..++..--...++.
T Consensus 574 ~KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--------ktYn~ILkGid~i~~Pr-- 642 (732)
T KOG0614|consen 574 RKTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--------KTYNLILKGIDKIEFPR-- 642 (732)
T ss_pred Ccee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--------HHHHHHHhhhhhhhccc--
Confidence 5544 478999999999999999999999999999999999999999854332 22222222111111111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhh
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPT-----MQRVCQEFLT 771 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~ 771 (796)
.-.....+++++.+..+|.+|-. +.+|-+|-.-
T Consensus 643 -~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 643 -RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred -ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 11223567889999999999974 7788777543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=259.36 Aligned_cols=264 Identities=24% Similarity=0.333 Sum_probs=193.9
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--------
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-------- 569 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 569 (796)
..|+....||+|.||.||+|+.+ +|+.||+|++......+ .+-....+|++++..++|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45666778999999999999755 57889998776543332 223456789999999999999999998853
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
....|+|+++|+. +|.-++.+.. ..++..++.+++.++..||.|+|.. .|+|||+||.|++++.++.+||+|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 3468999999987 7888887543 3488899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC----CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccC--------------
Q 003780 650 TARLLDSDSS----NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSL-------------- 710 (796)
Q Consensus 650 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~-------------- 710 (796)
+++.+..... ..+...-|.+|++||.+.| ..|+++.|||+-||++.||+||.+-+......
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9976643221 1233456999999998876 46899999999999999999998876632210
Q ss_pred --CCCCchhhhHHHHhhcCC-CCCccchhhHH------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 711 --SSPSSDQKIMLIDVLDSR-LSPPVDRMVMQ------DIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 711 --~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.++.... ..+.+.+... ++....+...+ ......+++..++..||.+|+++++++.|-.
T Consensus 250 kevWP~~d~-lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 250 KEVWPNVDN-LPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred cccCCCccc-chHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 0011000 0111111111 11000000000 0113668999999999999999999998754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=262.80 Aligned_cols=265 Identities=18% Similarity=0.278 Sum_probs=209.8
Q ss_pred HHHHHHHhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEE
Q 003780 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLY 564 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 564 (796)
..++....++++....+-+|.||.||+|.+. +.+.|-+|.++.....- ....+..|.-++..+.|||+.++.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i--Qv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI--QVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH--HHHHHHHHHHHHhcCcCCCcccee
Confidence 3466666778888888999999999999543 34567778777665432 245788888889999999999999
Q ss_pred eEEEec-ceeeEEEeeccCCcHHHHHh-----hcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec
Q 003780 565 GFCLHK-KCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN 638 (796)
Q Consensus 565 ~~~~~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~ 638 (796)
+.+.++ +..++.|.++.-|+|..++. +....+.+...+...++.|++.|++|||++ +|||.||.++|++++
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 998764 56788899999999999998 444456678888899999999999999999 999999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCCc--cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCc
Q 003780 639 SKLEAFVADFGTARLLDSDSSNR--TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSS 715 (796)
Q Consensus 639 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~ 715 (796)
+.-++||+|=.+++.+-+.+++. .....+..||+||.+....|+.++|||||||++|||+| |+.|+...++
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------ 504 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------ 504 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------
Confidence 99999999999999876554432 12234568999999999999999999999999999997 8899874432
Q ss_pred hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 716 DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+....+....+-.. +...+.++..++.-||..+|++||+++|+..-|.+.
T Consensus 505 ---fEm~~ylkdGyRlaQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 505 ---FEMEHYLKDGYRLAQ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ---HHHHHHHhccceecC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 223333333332211 122334588899999999999999999999988664
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=283.87 Aligned_cols=268 Identities=17% Similarity=0.211 Sum_probs=182.8
Q ss_pred HhcCCccceeeecccceeEEEEEc-----------------cCCcEEEEEEeccccchhhH-----------HHHHHHHH
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-----------------PNGKVVALKKLHRAETEETT-----------FFNSFQNE 548 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~-----------~~~~~~~E 548 (796)
..++|++.++||+|+||+||+|.. .+++.||||++......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999953 24578999998754322110 01223457
Q ss_pred HHHHhhcCCCce-----eeEEeEEEe--------cceeeEEEeeccCCcHHHHHhhcCc---------------------
Q 003780 549 AHVLSKIAHRNI-----VKLYGFCLH--------KKCMFLIYKYMKRGSLFCFLRNDYE--------------------- 594 (796)
Q Consensus 549 ~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------- 594 (796)
+.++.+++|.++ ++++++|.. ++..++||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876554 677887753 3568999999999999999874311
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC-ccccccccCccCc
Q 003780 595 AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN-RTIVAGTYGYIAP 673 (796)
Q Consensus 595 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aP 673 (796)
...+++..+..++.|+++||+|+|+. +|+||||||+||+++.++.+||+|||++..+...... .....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12346778889999999999999999 9999999999999999999999999999765432211 1122357899999
Q ss_pred cccccCC--------------------c--CcchhHHHHHHHHHHHHhCCC-CCcccccCCCCCch--hhhH-HHHhhcC
Q 003780 674 ELAYTMV--------------------V--TEKCDVYSFGVVALEVLMGRH-PGELLSSLSSPSSD--QKIM-LIDVLDS 727 (796)
Q Consensus 674 E~~~~~~--------------------~--~~~~DVwSlGv~l~elltg~~-p~~~~~~~~~~~~~--~~~~-~~~~~~~ 727 (796)
|.+.... + ..+.||||+||++|+|++|.. |+............ .... .......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875322 1 124699999999999999985 66532211110000 0000 0001111
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCC---CCCCCHHHHHHHHh
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKP---KFRPTMQRVCQEFL 770 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~L~ 770 (796)
...... .........+++.+|+..+| .+|+|++|+++|-.
T Consensus 460 ~~~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 460 KYDFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred CCCccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 111111 11122346789999999766 68999999998843
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=261.51 Aligned_cols=240 Identities=29% Similarity=0.412 Sum_probs=194.0
Q ss_pred cceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcHHHHH
Q 003780 511 GYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL 589 (796)
Q Consensus 511 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 589 (796)
+||.||+|... +|+.+|+|++........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999876 589999999987654432 468899999999999999999999999999999999999999999998
Q ss_pred hhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccccccC
Q 003780 590 RNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669 (796)
Q Consensus 590 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~ 669 (796)
..... +++..+..++.++++++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 79 KKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred HhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 76533 78899999999999999999999 99999999999999999999999999998765432 2334558889
Q ss_pred ccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHH
Q 003780 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVAL 749 (796)
Q Consensus 670 y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 749 (796)
|++||...+..++.++||||+|+++++|++|..||.... ......+............ .......+.+++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~ 222 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--------QLLELFKKIGKPKPPFPPP-EWKISPEAKDLIR 222 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHhccCCCCccc-cccCCHHHHHHHH
Confidence 999999988888999999999999999999999986321 1112222222222111110 0002235788999
Q ss_pred HcCCCCCCCCCCHHHHHHH
Q 003780 750 ACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 750 ~cl~~dP~~RPs~~evl~~ 768 (796)
+|+..+|++||++.+++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHccCCchhccCHHHHhhC
Confidence 9999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=294.63 Aligned_cols=262 Identities=20% Similarity=0.233 Sum_probs=170.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc-C----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeE-----
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-N----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF----- 566 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~----- 566 (796)
..++|++.+.||+|+||.||+|... + +..||+|++......+ ....| .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4678999999999999999999765 4 6899999886543221 11111 1111122222222111
Q ss_pred -EEecceeeEEEeeccCCcHHHHHhhcCcc-----------------cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEe
Q 003780 567 -CLHKKCMFLIYKYMKRGSLFCFLRNDYEA-----------------VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHR 628 (796)
Q Consensus 567 -~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 628 (796)
+..+...++|+||+++++|.++++..... .......+..++.|+++||+|||++ +|+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 24566899999999999999998753210 0112334567999999999999999 99999
Q ss_pred cCCCCCeEecC-CCcEEEeeeccccccCCC-CCCccccccccCccCccccccC----------------------CcCcc
Q 003780 629 DISSNNILLNS-KLEAFVADFGTARLLDSD-SSNRTIVAGTYGYIAPELAYTM----------------------VVTEK 684 (796)
Q Consensus 629 dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 684 (796)
||||+|||++. ++.+||+|||+|+.+... ........+++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 578999999999865432 2223445789999999965322 23446
Q ss_pred hhHHHHHHHHHHHHhCCCCCccccc-----CCCCCchhhhHHHHhhcCCCCCccch---hhHHHHHHHHHHHHHcCCCCC
Q 003780 685 CDVYSFGVVALEVLMGRHPGELLSS-----LSSPSSDQKIMLIDVLDSRLSPPVDR---MVMQDIVLVTTVALACLHSKP 756 (796)
Q Consensus 685 ~DVwSlGv~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP 756 (796)
+||||+||++|||+++..|++.... +..... ..............++... ..........+++.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDY-DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCC-cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 7999999999999998877542100 000000 0000011111111111000 000011124579999999999
Q ss_pred CCCCCHHHHHHHH
Q 003780 757 KFRPTMQRVCQEF 769 (796)
Q Consensus 757 ~~RPs~~evl~~L 769 (796)
++|||++|+++|-
T Consensus 439 ~kR~ta~e~L~Hp 451 (566)
T PLN03225 439 RQRISAKAALAHP 451 (566)
T ss_pred ccCCCHHHHhCCc
Confidence 9999999999984
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-33 Score=293.27 Aligned_cols=293 Identities=29% Similarity=0.433 Sum_probs=181.0
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCC-CCCCCCCCCCCCCCEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLT-GSIPPELGSLRNLEVL 150 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L 150 (796)
.+++-|.|...+|...+. .++.+.+|+.|.+++|++. .+-+.+..|+.|+.+++.+|++. .-+|..+-.|..|..|
T Consensus 32 t~~~WLkLnrt~L~~vPe--EL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~l 108 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLEQVPE--ELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTIL 108 (1255)
T ss_pred hheeEEEechhhhhhChH--HHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceee
Confidence 456666666666654332 3677778888888888876 34556777888888888888775 3467777788888888
Q ss_pred EecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc
Q 003780 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 151 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 230 (796)
|||+|+++ ..|..+..-+++..|+||+|+|..+....|-+|..|-.||||+|++... |..+..+.+|++|+|++|.+.
T Consensus 109 DLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L-PPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 109 DLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML-PPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred ecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhc-CHHHHHHhhhhhhhcCCChhh
Confidence 88888888 6788888888888888888888865556677888888888888888744 445777788888888888764
Q ss_pred ccCCCcccccCccceEEecccccc-ccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccc
Q 003780 231 GPIPSTLFRLTNLTYLYLHSNHLN-GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITI 309 (796)
Q Consensus 231 ~~~~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~ 309 (796)
...-..+.++++|+.|.+++.+-+ ..+|..+..+.+|..+|||.|++. ..|+.+.++++|+.|+||+|+|+ .+....
T Consensus 187 hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~ 264 (1255)
T KOG0444|consen 187 HFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTE 264 (1255)
T ss_pred HHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccH
Confidence 322222333344444444443221 234555555555555555555555 45555555555555555555555 233333
Q ss_pred ccccccceecccccccccCCCcccCCCCCCcEEEeeccccc-CCCCcccc-ccccceEEeccccc
Q 003780 310 AGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS-GSIPPEIG-LMKLEYLDLSHNKL 372 (796)
Q Consensus 310 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~-~~~L~~L~l~~N~l 372 (796)
..-.+|++|+||.|+|+ .+|.++.++++|+.|++.+|+|+ .-+|+.+| +.+|+.+..++|++
T Consensus 265 ~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L 328 (1255)
T KOG0444|consen 265 GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL 328 (1255)
T ss_pred HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc
Confidence 33344555555555555 45555555555555555555554 12344443 34444444444444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=284.86 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=187.9
Q ss_pred Cccceeeeccccee-EEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEEe
Q 003780 501 FDIKYCIGTGGYGS-VYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 501 ~~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 578 (796)
|...+++|.|+.|+ ||+|.. +|+.||||++.... .+-..+|+..++.-+ |||||++++.-.++...|+..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 34446789999884 699988 48999999986543 345788999999884 9999999999999999999999
Q ss_pred eccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---C--CcEEEeeecccc
Q 003780 579 YMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---K--LEAFVADFGTAR 652 (796)
Q Consensus 579 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~Dfg~a~ 652 (796)
.|.- +|.+++... .+.........+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9965 999999874 1111112144577899999999999997 9999999999999976 3 468999999999
Q ss_pred ccCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhC-CCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 653 LLDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMG-RHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 653 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
.+..+... .....||-+|+|||++....-+.++||||+||++|+.++| .+||.+.- .++. .++...
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~-------~R~~---NIl~~~ 729 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-------ERQA---NILTGN 729 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH-------Hhhh---hhhcCc
Confidence 88765433 2346699999999999988888899999999999999997 89998421 1111 111111
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..-. ........+..++|.+|+++||..||++.+|+.|-
T Consensus 730 ~~L~--~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 730 YTLV--HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred ccee--eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 1100 00000001467899999999999999999999873
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=235.67 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=165.7
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhh-cCCCceeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lV 576 (796)
++......||+|++|.|-+.++ .+|...|+|++........ .++..+|+.+..+ ..+|.+|.++|.+..++..++.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~--q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE--QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH--HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3444456799999999988864 4799999999987665432 4577788876554 5799999999999999999999
Q ss_pred EeeccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||.|.- ||+.+-.+. .....+++...-+|+..|.+||.|||++. .++|||+||+|||++.+|++|+||||.+..+.
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999975 776665432 23345888899999999999999999984 89999999999999999999999999998765
Q ss_pred CCCCCccccccccCccCcccccc----CCcCcchhHHHHHHHHHHHHhCCCCCc
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYT----MVVTEKCDVYSFGVVALEVLMGRHPGE 705 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVwSlGv~l~elltg~~p~~ 705 (796)
+ .-..+...|...|+|||.+.. ..|+-|+||||+|+.+.||.+++.||+
T Consensus 201 d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 201 D-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred h-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 3 333444568889999998753 368899999999999999999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=264.89 Aligned_cols=205 Identities=24% Similarity=0.381 Sum_probs=174.0
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.-|-.++.||-|+||.|+.++ ..+...||.|.+.+...-......-++.|..||...+.+=||+++-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 346677889999999999995 4456789999998766554444556789999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC--
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD-- 655 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-- 655 (796)
||++||++.++|-+.+ .+++..+..++..++.|+++.|.. |+|||||||+|||||.+|++||.|||++.-+.
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999987643 478888888889999999999999 99999999999999999999999999986431
Q ss_pred -------CCCCC--c-------------------------------cccccccCccCccccccCCcCcchhHHHHHHHHH
Q 003780 656 -------SDSSN--R-------------------------------TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVAL 695 (796)
Q Consensus 656 -------~~~~~--~-------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ 695 (796)
..+.. . ...+||+.|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 0 0134999999999999999999999999999999
Q ss_pred HHHhCCCCCccccc
Q 003780 696 EVLMGRHPGELLSS 709 (796)
Q Consensus 696 elltg~~p~~~~~~ 709 (796)
||+.|+.||.....
T Consensus 863 em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTP 876 (1034)
T ss_pred HHhhCCCCccCCCC
Confidence 99999999985443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=238.87 Aligned_cols=252 Identities=19% Similarity=0.279 Sum_probs=193.7
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecc--e
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKK--C 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~ 572 (796)
..++|++.+.+|+|.++.||.|. ..+.+.++||++++.+ .+.+.+|++++..++ ||||+++++...++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 35789999999999999999995 5678999999998765 357899999999998 999999999998764 5
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEeeeccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTA 651 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a 651 (796)
..+++||+.+.+...+.. .++...+..++.+++.||.|+|++ ||.|||+||.|+|+|.. -..+++|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 679999999988766553 267778888999999999999999 99999999999999975 46899999999
Q ss_pred cccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhH----------
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM---------- 720 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~---------- 720 (796)
.++.+..... ....+.-|..||.+... .|+..-|+|||||++..|+..+.||-.-..- ..+-..
T Consensus 181 EFYHp~~eYn-VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN----~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 181 EFYHPGKEYN-VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVKIAKVLGTDEL 255 (338)
T ss_pred hhcCCCceee-eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC----HHHHHHHHHHhChHHH
Confidence 9887643333 33456678999988765 4777889999999999999999998532210 011000
Q ss_pred --------------HHHhhcCCCCCccchhh-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 721 --------------LIDVLDSRLSPPVDRMV-----MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 721 --------------~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..+++....+....... .-...+..+++.+.+..|-.+|||++|.+.|
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11111111111111000 0112457899999999999999999999887
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-31 Score=281.70 Aligned_cols=312 Identities=30% Similarity=0.398 Sum_probs=261.9
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccc-cCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFG-SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+..|.+++|+|...-. .++.||.|+.+.++.|++.. -+|..+..+..|+.||||+|+++ ..|..+.+-+++-.|+
T Consensus 56 kLEHLs~~HN~L~~vhG--ELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLN 132 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLISVHG--ELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLN 132 (1255)
T ss_pred hhhhhhhhhhhhHhhhh--hhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEE
Confidence 45667788887653222 36678999999999999863 47788889999999999999999 8899999999999999
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc-
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM- 230 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~- 230 (796)
||+|+|..+....|-+|+.|-.||||+|++. .+|..+..|..|++|+|++|.+.-..-..+..+++|++|.+++.+-+
T Consensus 133 LS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl 211 (1255)
T KOG0444|consen 133 LSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTL 211 (1255)
T ss_pred cccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchh
Confidence 9999999554456679999999999999998 56778899999999999999987665566777888889999987654
Q ss_pred ccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccc
Q 003780 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIA 310 (796)
Q Consensus 231 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 310 (796)
..+|.++..+.+|..+|||.|++. .+|+++.++.+|+.|+||+|+|+ .+....+...+|+.|+||.|+++ .+|.++.
T Consensus 212 ~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avc 288 (1255)
T KOG0444|consen 212 DNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVC 288 (1255)
T ss_pred hcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHh
Confidence 467888999999999999999998 88999999999999999999998 44455667789999999999998 7899999
Q ss_pred cccccceeccccccccc-CCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCccc---ccccc
Q 003780 311 GLISLKGLDLSNNKLSG-PIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFL---YHRFP 385 (796)
Q Consensus 311 ~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~---~~~~~ 385 (796)
.+++|+.|.+.+|+|+- -+|..++++.+|+.+..++|+|. .+|..+ .+.+|+.|.|++|++. ++|..+ ..+..
T Consensus 289 KL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~v 366 (1255)
T KOG0444|consen 289 KLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKV 366 (1255)
T ss_pred hhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcce
Confidence 99999999999998863 47888999999999999999988 666665 4788999999999987 777654 44557
Q ss_pred ccccCCCC
Q 003780 386 LDLSYNDL 393 (796)
Q Consensus 386 l~l~~N~l 393 (796)
|||..|.-
T Consensus 367 LDlreNpn 374 (1255)
T KOG0444|consen 367 LDLRENPN 374 (1255)
T ss_pred eeccCCcC
Confidence 88887743
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=248.71 Aligned_cols=263 Identities=25% Similarity=0.311 Sum_probs=194.9
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----cee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-----KCM 573 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 573 (796)
+.+-.+.||-|+||.||.+.. ++|+.||.|++......- ...+.+.+|.+++..++|.|++..++...-+ .+.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L-~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNL-ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHH-HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 345568899999999999965 489999999987655432 2356888999999999999999998877643 356
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
|+++|.|.. +|...+-.. +.++...+.-+.+||++||.|||+. +|.||||||.|.+++.+...||||||+|+.
T Consensus 133 YV~TELmQS-DLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHh-hhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 788888865 676666543 3478888888999999999999999 999999999999999999999999999987
Q ss_pred cCCC-CCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCchhhh--
Q 003780 654 LDSD-SSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSDQKI-- 719 (796)
Q Consensus 654 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~~~~-- 719 (796)
-+.+ ..+.+...-|..|+|||.+.|. .|+.+.||||.||++.|++..+.-|+..+++ ..+..+...
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 5543 2334555678889999999875 5889999999999999999988888743331 111111110
Q ss_pred ---HHHHhhcCCCCCc-cch---h--hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 720 ---MLIDVLDSRLSPP-VDR---M--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 720 ---~~~~~~~~~~~~~-~~~---~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
....++.....++ ... . ......+...+...++..||++|.+..+.+.+.-
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1112222222211 110 0 1112223556778899999999999999988763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=262.01 Aligned_cols=201 Identities=25% Similarity=0.368 Sum_probs=175.1
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHH-----HHHHHHHHHhhcC---CCceeeEEeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFN-----SFQNEAHVLSKIA---HRNIVKLYGFC 567 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---hpniv~l~~~~ 567 (796)
...+|+..+.+|.|+||.|+.|.++ +...|+||.+.+.+.-...+.+ .+..|+++|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999765 5778999999887655444433 4678999999997 99999999999
Q ss_pred EecceeeEEEeec-cCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEe
Q 003780 568 LHKKCMFLIYKYM-KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA 646 (796)
Q Consensus 568 ~~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 646 (796)
++++.+|++||-. ++.+|++++..... +++.++..|++||+.|+++||+. +|||||||-+||.++.+|-+||+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 9999999999975 56699999986543 89999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCccCccccccCCcCc-chhHHHHHHHHHHHHhCCCCCc
Q 003780 647 DFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE-KCDVYSFGVVALEVLMGRHPGE 705 (796)
Q Consensus 647 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DVwSlGv~l~elltg~~p~~ 705 (796)
|||.|...... ......||.+|.|||++.|..|-- .-|||++|++||.++....||+
T Consensus 713 dfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999876543 334567999999999999988765 5699999999999999999986
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=247.97 Aligned_cols=133 Identities=23% Similarity=0.435 Sum_probs=112.3
Q ss_pred hcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-----C---CceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-----H---RNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~ 568 (796)
.++|-+.+.||.|.|++||.+. ..+.+.||+|+.+... .+.+....|++++++++ | ..||+++++|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 3689999999999999999995 4568899999987654 33456789999999985 2 48999999997
Q ss_pred e----cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec
Q 003780 569 H----KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN 638 (796)
Q Consensus 569 ~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~ 638 (796)
. +.++++|+|++ |.+|..++..... +.++...+.+|++||+.||.|||.+| +|||.||||+|||+.
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 5 45899999998 5588888876543 34899999999999999999999998 999999999999993
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=244.03 Aligned_cols=258 Identities=24% Similarity=0.296 Sum_probs=194.6
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------c
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------K 571 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 571 (796)
.+|.-...+|.|.- .|..+. .-.++.||+|+....... ....+...+|...+..+.|+||++++.++.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 45666777888887 566663 235899999998877444 33457888999999999999999999998643 3
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..|+|||+|.. +|...++.. ++-....+|..|++.|+.|||+. +|+||||||+||++..++..||.|||+|
T Consensus 95 e~y~v~e~m~~-nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILME-----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 67999999975 888887732 77788899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCch-----
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSSD----- 716 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~~----- 716 (796)
+.-..+ ...+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|...+..+ .+...
T Consensus 166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 865443 34556678889999999999889999999999999999999998876432210 00000
Q ss_pred --------------hhhHHHHhhcC-CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 717 --------------QKIMLIDVLDS-RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 717 --------------~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+.+.. ......+. ...+.....+++.+||-.||++|-+++++++|-
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~-~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG-SKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccC-CccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 00000111111 11111111 112223477899999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=235.85 Aligned_cols=212 Identities=33% Similarity=0.579 Sum_probs=184.7
Q ss_pred eecccceeEEEEEccC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcH
Q 003780 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSL 585 (796)
Q Consensus 507 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 585 (796)
||+|++|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999998754 8999999998765532 245789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-CCcEEEeeeccccccCCCCCCcccc
Q 003780 586 FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-KLEAFVADFGTARLLDSDSSNRTIV 664 (796)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 664 (796)
.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+.............
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 99987642 2478999999999999999999999 9999999999999999 8999999999998765443223335
Q ss_pred ccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHH
Q 003780 665 AGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL 743 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
.+...|++||..... .++.++|+|++|+++++| ..
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~ 189 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PE 189 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HH
Confidence 578899999998877 788899999999999999 23
Q ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 744 VTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 744 l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
+.+++.+|++.+|++||+++++++++
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 67899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=263.49 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=205.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|+...++|.|+||.|||++.+ .++..|+|+++....++ ++.+.+|+-+++..+||||+.++|.+...+..++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 468999999999999999999754 79999999998877654 45788899999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+.+|+|.+.-+-. ..+++.++..+++...+|++|||+. +-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 91 MEycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 9999999999887754 3488999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 657 DSSNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
.-.......||+.|||||+.. .+.|..++|||+.|+...|+-.-+.|--+..+ .....-.-.+...++.
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MRALFLMTKSGFQPPT 236 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------HHHHHHhhccCCCCCc
Confidence 444445578999999999764 55688999999999999999888877432221 1111111122222221
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
-.....-...+-++++.|+..+|++||++..+++|
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 11122223447899999999999999999887764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=228.96 Aligned_cols=253 Identities=20% Similarity=0.307 Sum_probs=187.5
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeE-EEecceee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGF-CLHKKCMF 574 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~~~~ 574 (796)
.+.|++.+.+|+|.||.+-.++++ ..+.+++|.++..... .++|.+|...--.+ .|.||+.-++. |+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 467999999999999999999765 5788999999877654 46788888776666 48999987664 56677888
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec--CCCcEEEeeecccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN--SKLEAFVADFGTAR 652 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~ 652 (796)
.++||++.|+|.+-+... .+.+....+++.|+++|+.|+|++ .+||||||.+|||+- +..++|+||||..+
T Consensus 99 F~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 999999999998877543 377888899999999999999999 999999999999993 34589999999998
Q ss_pred ccCCCCCCccccccccCccCccccccC-----CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTM-----VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
..+..-. ....+..|.|||..... ...+.+|||.||+++|..+||+.||+. .........+..........
T Consensus 172 k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 172 KVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred ccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhcccCc
Confidence 6543211 22345579999976532 355678999999999999999999983 22222222222222223333
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHH
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFR---PTMQRVCQEF 769 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L 769 (796)
..+..+.. .....+++.++-+.++|++| -+++.....+
T Consensus 248 ~~P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 248 ALPKKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred cCchhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 33333333 23346778889999999999 4555444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-28 Score=248.42 Aligned_cols=210 Identities=21% Similarity=0.253 Sum_probs=177.6
Q ss_pred CcccHHHHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC------Cc
Q 003780 487 GRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH------RN 559 (796)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pn 559 (796)
+.+.+.=-+....+|.+....|+|-|++|.+|.. .-|..||||++...... .+.=..|+++|++|+. -|
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhH
Confidence 3444433344567899999999999999999964 35889999999988765 3556789999999962 38
Q ss_pred eeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 560 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
+++++..|....++|||+|-+.- +|.+++++.+....+....+..+++|+.-||..|-.. +|+|.||||+|||+++
T Consensus 496 clrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 99999999999999999998754 8999999988888899999999999999999999987 9999999999999998
Q ss_pred CC-cEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcc
Q 003780 640 KL-EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEL 706 (796)
Q Consensus 640 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~ 706 (796)
.- ..||||||.|.....+. .+.+.-+..|.|||.+.|..|+...|+||.||.||||.||+.-|..
T Consensus 572 ~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred CcceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 65 56999999998765432 2333455679999999999999999999999999999999987753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=227.72 Aligned_cols=198 Identities=35% Similarity=0.537 Sum_probs=172.1
Q ss_pred CccceeeecccceeEEEEEccC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 5677899999999999997764 899999999876543 1356889999999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC-
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS- 658 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 658 (796)
+++++|.+++...... +++..+..++.++++++.+||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred cCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999999865321 78899999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccccccCccCcccc-ccCCcCcchhHHHHHHHHHHHHhCCCCCc
Q 003780 659 SNRTIVAGTYGYIAPELA-YTMVVTEKCDVYSFGVVALEVLMGRHPGE 705 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwSlGv~l~elltg~~p~~ 705 (796)
.......++..|++||.. ....++.++|||+||+++++|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 122334578889999998 66677889999999999999999999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-29 Score=248.93 Aligned_cols=293 Identities=30% Similarity=0.425 Sum_probs=158.2
Q ss_pred cCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccc
Q 003780 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLI 172 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 172 (796)
+.++.+|..|++.+|++....|..+. ++.|++||...|-++ .+|+.+++|.+|+-|+|..|+|. .+| .|.+++.|+
T Consensus 156 ~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~ 231 (565)
T KOG0472|consen 156 MVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLK 231 (565)
T ss_pred HHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHH
Confidence 44455555555666655544444443 556666666666555 55666666666666666666666 444 566666666
Q ss_pred eeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccc
Q 003780 173 TMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252 (796)
Q Consensus 173 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 252 (796)
+|+++.|+|+-...+...++++|..|||.+|+++ ..|+.+..+++|++||+++|.|+ ..|.+++++ .|+.|.+.+|.
T Consensus 232 Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNP 308 (565)
T KOG0472|consen 232 ELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNP 308 (565)
T ss_pred HHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCc
Confidence 6666666666333333446666666666666665 34555666666666666666666 345556666 66666666665
Q ss_pred ccc----------------------------------------------------------------cCCccccCCcc--
Q 003780 253 LNG----------------------------------------------------------------SIPPEIGNMTG-- 266 (796)
Q Consensus 253 l~~----------------------------------------------------------------~~p~~~~~l~~-- 266 (796)
+.. .+|+..+....
T Consensus 309 lrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~ 388 (565)
T KOG0472|consen 309 LRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSE 388 (565)
T ss_pred hHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhc
Confidence 420 00100000001
Q ss_pred -cceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEee
Q 003780 267 -ILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLR 345 (796)
Q Consensus 267 -L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 345 (796)
.+..+++.|++. .+|..+..+..+...-+.+|+..+.+|..+..+++|..|+|++|-+. .+|..++.+..|+.|+++
T Consensus 389 ~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS 466 (565)
T KOG0472|consen 389 IVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLS 466 (565)
T ss_pred ceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccc
Confidence 233344444444 33333333333333222222223356666677778888888888777 677888888888888888
Q ss_pred cccccCCCCcccc-ccccceEEecccccCCCCCccc---cccccccccCCCCcc
Q 003780 346 NNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFL---YHRFPLDLSYNDLEG 395 (796)
Q Consensus 346 ~N~l~~~~~~~~~-~~~L~~L~l~~N~l~~~~p~~~---~~~~~l~l~~N~l~~ 395 (796)
+|++. .+|.... +..|+.+-.++|++...-|..+ .++..|||.+|+++.
T Consensus 467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~ 519 (565)
T KOG0472|consen 467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQ 519 (565)
T ss_pred ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhh
Confidence 88776 3444332 2233333334444432222212 233345555555543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=231.77 Aligned_cols=263 Identities=26% Similarity=0.352 Sum_probs=195.9
Q ss_pred HHHHhcCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEE
Q 003780 494 IIKATEDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCL 568 (796)
Q Consensus 494 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 568 (796)
+....+.|..++.||+|.|++||++... ..+.||+|.+...... ..+.+|++++..+. +.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 3345678899999999999999999532 4788999999877654 46889999999996 899999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEee
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVAD 647 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~D 647 (796)
.++...+|+||++.....++... ++...+..+++.+..||+++|.. |||||||||+|++.+.. +.-.|.|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 99999999999999988888764 67888999999999999999999 99999999999999865 5678999
Q ss_pred eccccccCCCC--------------C------------------------------CccccccccCccCcccccc-CCcC
Q 003780 648 FGTARLLDSDS--------------S------------------------------NRTIVAGTYGYIAPELAYT-MVVT 682 (796)
Q Consensus 648 fg~a~~~~~~~--------------~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~ 682 (796)
||+|...+... . .....+||+||.|||++.. ..-+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99997221000 0 0011459999999998765 4467
Q ss_pred cchhHHHHHHHHHHHHhCCCCCcccccC-C---------------------CC---Cc-hh------hhHHHHhhc-CCC
Q 003780 683 EKCDVYSFGVVALEVLMGRHPGELLSSL-S---------------------SP---SS-DQ------KIMLIDVLD-SRL 729 (796)
Q Consensus 683 ~~~DVwSlGv~l~elltg~~p~~~~~~~-~---------------------~~---~~-~~------~~~~~~~~~-~~~ 729 (796)
+++||||.||+++.+++++.||-...+. . .. .. .+ ...-.+.++ ..+
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 8999999999999999999997532210 0 00 00 00 000000010 000
Q ss_pred CC-c---cchhhH--HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 730 SP-P---VDRMVM--QDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 730 ~~-~---~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. . ...... -....+.+++.+|++.||.+|.|++|.++|-.
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 00 0 000011 11236889999999999999999999998853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=268.95 Aligned_cols=197 Identities=19% Similarity=0.247 Sum_probs=140.3
Q ss_pred hcCC-CceeeEEeEE-------EecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003780 554 KIAH-RNIVKLYGFC-------LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625 (796)
Q Consensus 554 ~l~h-pniv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 625 (796)
.++| +||+++++++ .+.+..+.++||+ +++|.+++... ...+++..++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3445 5888888877 2334667788887 55999999753 23489999999999999999999999 99
Q ss_pred EEecCCCCCeEecC-------------------CCcEEEeeeccccccCCCC----------------CCccccccccCc
Q 003780 626 VHRDISSNNILLNS-------------------KLEAFVADFGTARLLDSDS----------------SNRTIVAGTYGY 670 (796)
Q Consensus 626 vH~dlkp~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~----------------~~~~~~~gt~~y 670 (796)
+||||||+|||++. ++.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 3455666666665321100 001113578889
Q ss_pred cCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHH
Q 003780 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALA 750 (796)
Q Consensus 671 ~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 750 (796)
+|||++.+..++.++|||||||++|||++|..|+.... ...........++.. .........++.+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 247 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRHRVLPPQI----LLNWPKEASFCLW 247 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHHhhcChhh----hhcCHHHHHHHHH
Confidence 99999999999999999999999999999988865211 011111111111111 1112234578889
Q ss_pred cCCCCCCCCCCHHHHHHHHh
Q 003780 751 CLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 751 cl~~dP~~RPs~~evl~~L~ 770 (796)
||+++|.+||+|.|++++-.
T Consensus 248 ~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred hCCCChhhCcChHHHhhchh
Confidence 99999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=209.73 Aligned_cols=168 Identities=20% Similarity=0.106 Sum_probs=126.3
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 662 (796)
|+|.++++... ..+++..+..++.|+++||+|||++ + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997542 3489999999999999999999998 5 999999999999999 99998764422
Q ss_pred ccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHH-
Q 003780 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDI- 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 741 (796)
..|++.|+|||++.+..++.++|||||||++|||+||+.||...... ................... .......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 137 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL----SAILEILLNGMPADDPRDR-SNLESVSA 137 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh----cHHHHHHHHHhccCCcccc-ccHHHHHh
Confidence 25889999999999999999999999999999999999998643211 0111111111111111000 0011111
Q ss_pred -HHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 742 -VLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 742 -~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
..+.+++.+|++.||++||++.|+++++....
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 25889999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-27 Score=238.25 Aligned_cols=263 Identities=31% Similarity=0.477 Sum_probs=156.2
Q ss_pred CcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccc
Q 003780 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178 (796)
Q Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 178 (796)
|+.|.+++|.+... .+.+.++..|.+|++++|+++ ..|++++.+..++.|+.++|+++ .+|..+..+.+|..|+.++
T Consensus 47 l~~lils~N~l~~l-~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLEVL-REDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchhhc-cHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 44455555555532 234555666666666666665 45555666666666666666666 5566666666666666666
Q ss_pred cccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCC
Q 003780 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 258 (796)
|.+. ..|+.++.+..|+.|+..+|+++. .|..++.+.+|..|++.+|++....|..+. ++.|++|+...|-+. .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~s-lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQISS-LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhcccccccc-CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 6665 345555566666666666666653 344455566666666666666644333333 666666666666665 566
Q ss_pred ccccCCcccceeecccccccccCccccccccccccccccCccccCccccc-cccccccceecccccccccCCCcccCCCC
Q 003780 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPIT-IAGLISLKGLDLSNNKLSGPIPPEIGKCS 337 (796)
Q Consensus 259 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 337 (796)
..++++.+|..|+|..|+|. ..| .|.+++.|.+|+++.|+|+ .+|.. ...+++|..|||.+|++. ..|+.+..+.
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr 275 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR 275 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence 66666666666666666666 344 5666666666666666666 33333 336666666666666666 5666666666
Q ss_pred CCcEEEeecccccCCCCccccccccceEEecccccC
Q 003780 338 ELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLN 373 (796)
Q Consensus 338 ~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~ 373 (796)
+|.+||+++|.+++ .|...+...|+.|-+.||++.
T Consensus 276 sL~rLDlSNN~is~-Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 276 SLERLDLSNNDISS-LPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred hhhhhcccCCcccc-CCcccccceeeehhhcCCchH
Confidence 66666666666663 344444336666666666654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=206.97 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=191.4
Q ss_pred ccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeecc
Q 003780 502 DIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
.....|.+...|..|+|++. |..+++|++....... ...+.|..|+-.++-+.||||..+++.|..+....++..||+
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhccCCCccccccccc-Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34456888999999999996 6667778776554433 335689999999999999999999999999999999999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEe--eeccccccCCCCC
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA--DFGTARLLDSDSS 659 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~--Dfg~a~~~~~~~~ 659 (796)
.|+|+..+++.. ....+..++.+++.+||+|++|||+. .|-|..--|.+..|++|++.+++|+ |-.++.
T Consensus 271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-------
Confidence 999999999763 45578889999999999999999996 3334455689999999999998874 433222
Q ss_pred CccccccccCccCccccccCCcC---cchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 660 NRTIVAGTYGYIAPELAYTMVVT---EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~~---~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
+.......|.|++||.++..+.+ .++|+|||++++||+.|...||.+..+. .-......+-+...+++...
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm----ecgmkialeglrv~ippgis-- 415 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM----ECGMKIALEGLRVHIPPGIS-- 415 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch----hhhhhhhhccccccCCCCcc--
Confidence 11223457889999998866533 5789999999999999999999865432 11122223333444443332
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
..+.+++.-|+..||.+||.++.|+-.|+..
T Consensus 416 -----~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 416 -----RHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -----HHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2356788889999999999999999888764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-26 Score=227.18 Aligned_cols=295 Identities=21% Similarity=0.218 Sum_probs=197.6
Q ss_pred EEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecC
Q 003780 75 IEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154 (796)
Q Consensus 75 ~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 154 (796)
..+++++.+|+..+...+ +....+.|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.+|++|..|-+.+
T Consensus 49 ~~VdCr~~GL~eVP~~LP----~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg 124 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANLP----PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYG 124 (498)
T ss_pred ceEEccCCCcccCcccCC----CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhc
Confidence 345566666664433322 4678889999999999999999999999999999999999999999999988887766
Q ss_pred -CCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc---
Q 003780 155 -NNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM--- 230 (796)
Q Consensus 155 -N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--- 230 (796)
|+|+...-+.|.+|..|+.|.+.-|++.-+..+.|..|++|..|.|.+|.+..+-...|..+.+++.+.+..|.+.
T Consensus 125 ~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 125 NNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred CCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccc
Confidence 8999777788999999999999999999888899999999999999999998777778999999999999998842
Q ss_pred ---------ccCCCcccccCccceEEeccccccccCCccccC-Ccccce-eecccccccccCccccccccccccccccCc
Q 003780 231 ---------GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGN-MTGILK-VDMSMNNIEGTIPLELTRLSQLLYLSISSN 299 (796)
Q Consensus 231 ---------~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~-L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 299 (796)
...|-.++...-..-..+..+++..+-+..|.. +..+.. +....+.........|..+++|+.|+|++|
T Consensus 205 nL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN 284 (498)
T KOG4237|consen 205 NLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNN 284 (498)
T ss_pred ccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCC
Confidence 122333444333444444444444322222221 111111 111111222112224556666666666666
Q ss_pred cccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcccc-ccccceEEecccccC
Q 003780 300 MLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLN 373 (796)
Q Consensus 300 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~L~~L~l~~N~l~ 373 (796)
+++++-+.+|.++..++.|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|. +..|..|+|-.|++.
T Consensus 285 ~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 285 KITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred ccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 66666666666666666666666666554455556666666666666666655555553 455666666666554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=237.94 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=199.0
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
..-..|+|++|+++ .+|..+. .+|+.|+|++|+|+ .+|.. +++|++|+|++|+|+. +|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 34678999999998 5676665 47999999999998 46643 5789999999999994 4543 468899999
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
++|.|+. +|..+ .+|+.|+|++|+++.++ . .+++|+.|+|++|+|++ +|.. ..+|+.|++++|++++
T Consensus 270 s~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~LP-~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~- 336 (788)
T PRK15387 270 FSNPLTH-LPALP---SGLCKLWIFGNQLTSLP-V---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS- 336 (788)
T ss_pred cCCchhh-hhhch---hhcCEEECcCCcccccc-c---cccccceeECCCCcccc-CCCC---cccccccccccCcccc-
Confidence 9999884 44433 57888999999998653 2 34789999999999985 4432 2468888999999984
Q ss_pred CCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCC
Q 003780 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKC 336 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 336 (796)
+|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|+. +|.. ..+|+.|+|++|+|++ +|.. .
T Consensus 337 LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~ 401 (788)
T PRK15387 337 LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---P 401 (788)
T ss_pred cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---c
Confidence 5642 2578999999999995 4543 3578888999999984 5543 3578999999999985 5543 3
Q ss_pred CCCcEEEeecccccCCCCccccccccceEEecccccCCCCCcccc---ccccccccCCCCcccCCCCC
Q 003780 337 SELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLY---HRFPLDLSYNDLEGEIPDYF 401 (796)
Q Consensus 337 ~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~---~~~~l~l~~N~l~~~~p~~~ 401 (796)
++|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+. .+..++|++|.|+|.+|+.+
T Consensus 402 s~L~~LdLS~N~Lss-IP~l--~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 402 SELKELMVSGNRLTS-LPML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred cCCCEEEccCCcCCC-CCcc--hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 678999999999985 5643 347888999999998 7887554 45578999999998887755
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=250.17 Aligned_cols=318 Identities=24% Similarity=0.261 Sum_probs=236.2
Q ss_pred CCeEEEeCCCCCcc-ccccccccCCCCCCcEEeccCCc------ccccCCcCccCC-CCCcEeecccCcCCCCCCCCCCC
Q 003780 72 RSIIEINLPEKKLK-GELSQFNFSCFPGLESLSLRFNY------LFGSIPSQVGAL-SKLRYLDFSFNNLTGSIPPELGS 143 (796)
Q Consensus 72 ~~v~~l~l~~~~l~-~~~~~~~~~~l~~L~~L~L~~n~------l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~p~~~~~ 143 (796)
.+|..+.+.-..+. -.+....|..+++|+.|.+..+. +...+|..|..+ .+|+.|++.+|.++ .+|..| .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-C
Confidence 34555544433332 23455678999999999997653 334567777776 46999999999887 677777 5
Q ss_pred CCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccc
Q 003780 144 LRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALN 223 (796)
Q Consensus 144 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 223 (796)
..+|++|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..++++++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 689999999999988 5777888999999999998875556664 78899999999999887778888999999999999
Q ss_pred cCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCcccc-
Q 003780 224 VGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLS- 302 (796)
Q Consensus 224 l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~- 302 (796)
+++|...+.+|..+ ++++|+.|+|++|...+.+|.. .++|+.|+|++|.++ .+|..+ .+++|++|++.++...
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~ 761 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK 761 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh
Confidence 99976555677655 7889999999998766666643 457889999999987 456554 5677777777664321
Q ss_pred ------CccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCCC
Q 003780 303 ------GQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTI 376 (796)
Q Consensus 303 ------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~ 376 (796)
...+..+...++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|....+++|+.|++++|.....+
T Consensus 762 l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~ 841 (1153)
T PLN03210 762 LWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTF 841 (1153)
T ss_pred ccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCccccc
Confidence 11222233346788888888877777788888888888888888765556777667778888888887766677
Q ss_pred CccccccccccccCCCCcccCCCC
Q 003780 377 PPFLYHRFPLDLSYNDLEGEIPDY 400 (796)
Q Consensus 377 p~~~~~~~~l~l~~N~l~~~~p~~ 400 (796)
|....++..|+|++|.++. +|.+
T Consensus 842 p~~~~nL~~L~Ls~n~i~~-iP~s 864 (1153)
T PLN03210 842 PDISTNISDLNLSRTGIEE-VPWW 864 (1153)
T ss_pred cccccccCEeECCCCCCcc-ChHH
Confidence 7666677777888877763 4543
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=234.50 Aligned_cols=265 Identities=26% Similarity=0.307 Sum_probs=209.5
Q ss_pred eEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEec
Q 003780 74 IIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLK 153 (796)
Q Consensus 74 v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (796)
-..|+|+.++|+ .+|.. +. ++|+.|++++|+++. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|+
T Consensus 203 ~~~LdLs~~~Lt-sLP~~-l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcc-hh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 346899999998 45542 22 589999999999995 454 2589999999999999 45653 4789999999
Q ss_pred CCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccC
Q 003780 154 GNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPI 233 (796)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 233 (796)
+|+|+ .+|..+ ++|+.|+|++|+++. +|. .+++|+.|+|++|+|+++. .. ..+|+.|++++|+|++ +
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp-~l---p~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASLP-AL---PSELCKLWAYNNQLTS-L 337 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCccccCC-CC---cccccccccccCcccc-c
Confidence 99998 455533 678899999999995 454 2478999999999999753 32 3568899999999985 5
Q ss_pred CCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccccc
Q 003780 234 PSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLI 313 (796)
Q Consensus 234 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 313 (796)
|.. ..+|++|+|++|+|+ .+|.. ..+|+.|++++|+|++ +|.. .++|+.|+|++|+|++ +|.. .+
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s 402 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PS 402 (788)
T ss_pred ccc---ccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---cc
Confidence 542 257999999999999 46653 3578889999999995 5653 3579999999999995 5543 36
Q ss_pred ccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCcccccc
Q 003780 314 SLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLYHR 383 (796)
Q Consensus 314 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~~ 383 (796)
+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+ .+.+|+.|+|++|+|++.+|..+.++
T Consensus 403 ~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 403 ELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred CCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 89999999999985 6654 357889999999999 577766 48899999999999999888766443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-25 Score=222.44 Aligned_cols=279 Identities=19% Similarity=0.195 Sum_probs=238.2
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeeccc-CcCCCCCCCCCCCCCCCCEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSF-NNLTGSIPPELGSLRNLEVL 150 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L 150 (796)
...++|+|..|+++ .|++..|+.+++|++||||+|+|+.+-|++|.++.+|.+|-+-+ |+|+....+.|++|.+|+.|
T Consensus 67 ~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 67 PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL 145 (498)
T ss_pred CcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence 36889999999998 57777899999999999999999999999999999998887776 99998878899999999999
Q ss_pred EecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccc------------cCcchhhhcCCCC
Q 003780 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL------------SGMLHQELGKLKN 218 (796)
Q Consensus 151 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l------------~~~~~~~~~~l~~ 218 (796)
.+.-|++.-...+.|..+++|..|.+.+|.+..+-..+|..+.+++.+.+..|.+ ....|..+++..-
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc 225 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC 225 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence 9999999988899999999999999999999966666999999999999999983 3345566777777
Q ss_pred ccccccCCccccccCCCccccc-CccceEEeccccccccCC-ccccCCcccceeecccccccccCccccccccccccccc
Q 003780 219 LVALNVGGNKLMGPIPSTLFRL-TNLTYLYLHSNHLNGSIP-PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSI 296 (796)
Q Consensus 219 L~~L~l~~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 296 (796)
..-..+.++++..+.+..|..- .++..=..+.+...+..| ..|..+++|++|+|++|+|+++-+.+|..+..+++|.|
T Consensus 226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 7777777877775555544321 222222223333444445 57899999999999999999999999999999999999
Q ss_pred cCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccC
Q 003780 297 SSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG 351 (796)
Q Consensus 297 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 351 (796)
..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+.+|..|+|-.|.+.-
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 9999998888899999999999999999999999999999999999999998763
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=238.56 Aligned_cols=268 Identities=33% Similarity=0.433 Sum_probs=221.0
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
++|+.|+.++|.+....+ -..-.+|+++|+|+|+++ .+|+.++.+.+|+.|+..+|+|. .+|..+...++|+.|.+
T Consensus 219 ~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence 455556666665552221 122357888899998888 56688888889999999999886 77888888888999999
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCC-ccccccCCccccccCCCcccccCccceEEeccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKN-LVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG 255 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 255 (796)
..|.++ -+|....++++|++|+|..|+|...++..+.-+.. |+.|+.+.|++....-..=..++.|+.|++.+|.++.
T Consensus 295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 999888 56777778889999999999998777766666655 8888888888875443233456789999999999998
Q ss_pred cCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCC
Q 003780 256 SIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGK 335 (796)
Q Consensus 256 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 335 (796)
..-..+-+..+|+.|+|++|+|.......+.+++.|++|+||+|+++ .+|..+..+..|++|...+|++. ..| .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 87778999999999999999999766677899999999999999999 78899999999999999999998 667 8999
Q ss_pred CCCCcEEEeecccccC-CCCccccccccceEEeccccc
Q 003780 336 CSELRNITLRNNNLSG-SIPPEIGLMKLEYLDLSHNKL 372 (796)
Q Consensus 336 l~~L~~L~L~~N~l~~-~~~~~~~~~~L~~L~l~~N~l 372 (796)
++.|+.+||+.|+|+. .+|.....++|++||+++|.-
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999999999995 455555678999999999984
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=215.05 Aligned_cols=169 Identities=16% Similarity=0.117 Sum_probs=130.4
Q ss_pred HHHhcCCccceeeecccceeEEEEEcc--CCcEEEEEEeccccc--hhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 495 IKATEDFDIKYCIGTGGYGSVYKAQLP--NGKVVALKKLHRAET--EETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 495 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
....++|.+.+.||+|+||+||+|+.+ +++.||||++..... ......+.+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999754 578889998763321 112234579999999999999999853322 2
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecC-CCCCeEecCCCcEEEeeec
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDI-SSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfg 649 (796)
+..++||||+++++|... .. .. ...++.++++||+|||+. +|+|||| ||+||+++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 467999999999999632 11 01 145788999999999999 9999999 9999999999999999999
Q ss_pred cccccCCCCCCc--------cccccccCccCccccccC
Q 003780 650 TARLLDSDSSNR--------TIVAGTYGYIAPELAYTM 679 (796)
Q Consensus 650 ~a~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~ 679 (796)
+|+.+....... ....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999765432111 234578889999998644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=206.84 Aligned_cols=274 Identities=19% Similarity=0.216 Sum_probs=199.4
Q ss_pred CCccceeeecccceeEEEEEccCC--cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC----CceeeEEeEE-Eecce
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLPNG--KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH----RNIVKLYGFC-LHKKC 572 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~ 572 (796)
+|.+.+.||+|+||.||.+..... +.+|+|.-........ ..+..|..++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 799999999999999999976543 5788887766533321 157778888888862 6889999999 57788
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-----CcEEEee
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-----LEAFVAD 647 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~D 647 (796)
.++||+.. |.+|.++..... ...++.....+|+.|++.+|+++|+. |++||||||.|+++... ..+.+.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 99999977 669999886654 45699999999999999999999999 99999999999999865 3588999
Q ss_pred ecccc--ccCCCC-C------C-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchh
Q 003780 648 FGTAR--LLDSDS-S------N-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 648 fg~a~--~~~~~~-~------~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 717 (796)
||+++ .+.... . . .....||..|+++....+...+.+.|+||++.++.|+..|..||....... .
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~-----~ 245 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD-----L 245 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc-----h
Confidence 99998 322111 1 1 223459999999999999999999999999999999999999986433211 1
Q ss_pred hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccccHHHHh
Q 003780 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLR 789 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~ 789 (796)
...+.............. .....+.++...+-..+...+|....+...++...........+..+|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~ 314 (322)
T KOG1164|consen 246 KSKFEKDPRKLLTDRFGD---LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVK 314 (322)
T ss_pred HHHHHHHhhhhccccccC---CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccc
Confidence 111111111111111111 112235555555666899999999999998876655443444455556543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-20 Score=202.84 Aligned_cols=258 Identities=29% Similarity=0.408 Sum_probs=200.2
Q ss_pred CccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCC-ceeeEEeEEEecceeeEEEee
Q 003780 501 FDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR-NIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lV~e~ 579 (796)
|.+.+.||.|+||.||++... ..+++|.+.............+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999876 88999999877665543467899999999999988 799999999877788999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEeeeccccccCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTARLLDSDS 658 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 658 (796)
+.++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543212478889999999999999999999 999999999999999988 79999999998655433
Q ss_pred C------CccccccccCccCcccccc---CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 659 S------NRTIVAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 659 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
. ......|+..|+|||...+ ..+....|+||+|++++++++|..||...... .........+....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~ 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcC
Confidence 2 2345679999999999987 57888999999999999999999996632211 00111111111111
Q ss_pred CC----ccch-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 730 SP----PVDR-MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 730 ~~----~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.+ .... ........+.+++..|+..+|..|.++.+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 1110 001112357789999999999999999988775
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-24 Score=235.96 Aligned_cols=288 Identities=28% Similarity=0.300 Sum_probs=202.7
Q ss_pred cCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccc
Q 003780 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLI 172 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 172 (796)
+.++++|+.|....|+++.. .-..++|+.|+.++|.++...+ .+. -.+|+++++++|+++ .+|.+++.+.+|+
T Consensus 195 ls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~-~p~-p~nl~~~dis~n~l~-~lp~wi~~~~nle 267 (1081)
T KOG0618|consen 195 LSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV-HPV-PLNLQYLDISHNNLS-NLPEWIGACANLE 267 (1081)
T ss_pred hhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeecc-ccc-cccceeeecchhhhh-cchHHHHhcccce
Confidence 34444455555555444421 1123456666666666652222 111 246777777777777 4457777777777
Q ss_pred eeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCc-cceEEeccc
Q 003780 173 TMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTN-LTYLYLHSN 251 (796)
Q Consensus 173 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~-L~~L~L~~N 251 (796)
.++..+|+++ .+|..+..+++|+.|+...|.++.+ |....+++.|++|+|..|+|....+..+.-+.. |..|..+.|
T Consensus 268 ~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yi-p~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n 345 (1081)
T KOG0618|consen 268 ALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYI-PPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSN 345 (1081)
T ss_pred EecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhC-CCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhc
Confidence 7777777774 4566666667777777777777643 445566677777777777776333323333322 566666666
Q ss_pred cccccCCc-cccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCC
Q 003780 252 HLNGSIPP-EIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330 (796)
Q Consensus 252 ~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 330 (796)
++. ..|. .=..++.|+.|++.+|.|++..-+.|.+..+|+.|+|++|+|.......+.+++.|+.|+||+|+|+ .+|
T Consensus 346 ~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp 423 (1081)
T KOG0618|consen 346 KLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLP 423 (1081)
T ss_pred ccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhh
Confidence 665 3331 1123567899999999999988888999999999999999999777778899999999999999999 788
Q ss_pred cccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCC-CCCccc--cccccccccCCC
Q 003780 331 PEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNG-TIPPFL--YHRFPLDLSYND 392 (796)
Q Consensus 331 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~-~~p~~~--~~~~~l~l~~N~ 392 (796)
..+.+++.|+.|...+|++. ..|....++.|+.+|+|.|.|+. .+|... .++++|||++|.
T Consensus 424 ~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 424 DTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred HHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 99999999999999999999 66766679999999999999984 455443 578899999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=228.74 Aligned_cols=255 Identities=19% Similarity=0.259 Sum_probs=188.5
Q ss_pred cceeeecccceeEEEEE-ccCCcEEEEEEecc---ccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 503 IKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHR---AETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 503 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
..+.+|.|++|.|+.+. ....+..+.|.+.. ....+..+...+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45789999999887774 33444455554331 122222223337788888899999999888888877776666799
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++ +|+.++.+.. .+...++..++.|+..|++|+|+. ||.|||+|++|++++.++.+||+|||.+....-+.
T Consensus 402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9999998652 378888999999999999999999 99999999999999999999999999998654332
Q ss_pred ----CCccccccccCccCccccccCCcCc-chhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 659 ----SNRTIVAGTYGYIAPELAYTMVVTE-KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 659 ----~~~~~~~gt~~y~aPE~~~~~~~~~-~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
......+|+-.|+|||.+.+..|.+ ..||||.|+++..|++|+.||.......... ...............
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----KTNNYSDQRNIFEGP 550 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----hhhccccccccccCh
Confidence 2234567999999999999999886 5799999999999999999987433221100 000001111111222
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.............++.+|+++||.+|-|+++|++.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 22233334457789999999999999999999875
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-21 Score=235.20 Aligned_cols=289 Identities=23% Similarity=0.291 Sum_probs=191.9
Q ss_pred cCCCC-CCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcc
Q 003780 93 FSCFP-GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171 (796)
Q Consensus 93 ~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 171 (796)
|..++ +|+.|++.++.+. .+|..| ...+|++|+|++|.+. .+|..+..+++|+.|+|++|...+.+|. +..+++|
T Consensus 584 ~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~L 659 (1153)
T PLN03210 584 FDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNL 659 (1153)
T ss_pred hhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcc
Confidence 44553 5888888887775 456656 4678888888888877 5677777888888888887765446664 7778888
Q ss_pred ceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccc
Q 003780 172 ITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSN 251 (796)
Q Consensus 172 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N 251 (796)
+.|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++|+.|++++|...+.+|.. .++|++|+|++|
T Consensus 660 e~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n 735 (1153)
T PLN03210 660 ETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDET 735 (1153)
T ss_pred cEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCC
Confidence 888888877666778888888888888888865444555544 6788888888887655555543 356778888888
Q ss_pred cccccCCccccCCcccceeecccccc-------cccCccccccccccccccccCccccCccccccccccccceecccccc
Q 003780 252 HLNGSIPPEIGNMTGILKVDMSMNNI-------EGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNK 324 (796)
Q Consensus 252 ~l~~~~p~~~~~l~~L~~L~Ls~N~l-------~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 324 (796)
.+. .+|..+ .+++|+.|++.++.. ....+..+...++|+.|+|++|...+.+|..+.++++|+.|+|++|.
T Consensus 736 ~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 736 AIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred ccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 876 556544 466677676665322 11122222334567777777777666777777777777777777765
Q ss_pred cccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCCCCcc---ccccccccccC-CCCcc
Q 003780 325 LSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF---LYHRFPLDLSY-NDLEG 395 (796)
Q Consensus 325 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~---~~~~~~l~l~~-N~l~~ 395 (796)
..+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.++ .+|.. +.++..|++++ |.+.+
T Consensus 814 ~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~ 884 (1153)
T PLN03210 814 NLETLPTGI-NLESLESLDLSGCSRLRTFPDI--STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR 884 (1153)
T ss_pred CcCeeCCCC-CccccCEEECCCCCcccccccc--ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCc
Confidence 444566554 5677777777776555444432 246777777777776 45543 33455667766 34443
|
syringae 6; Provisional |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-22 Score=227.90 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=144.4
Q ss_pred CCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecc
Q 003780 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALS 177 (796)
Q Consensus 98 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 177 (796)
+...|+|++++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 45667777776663 344332 46777777777777 4454443 46777777777776 4455443 357777777
Q ss_pred ccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccC
Q 003780 178 RNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI 257 (796)
Q Consensus 178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 257 (796)
+|+++ .+|..+. .+|+.|+|++|+|+. +|..+. ++|+.|++++|+|++ +|..+. ++|+.|++++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence 77776 3454443 467777777777764 343332 467777777777763 343332 356677777777763 4
Q ss_pred CccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCC
Q 003780 258 PPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337 (796)
Q Consensus 258 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 337 (796)
|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~ 388 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--A 388 (754)
T ss_pred Ccccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--H
Confidence 44332 466667777777664 454442 56677777777666 3444332 46667777777666 3444433 2
Q ss_pred CCcEEEeecccccCCCCccc-----cccccceEEecccccC
Q 003780 338 ELRNITLRNNNLSGSIPPEI-----GLMKLEYLDLSHNKLN 373 (796)
Q Consensus 338 ~L~~L~L~~N~l~~~~~~~~-----~~~~L~~L~l~~N~l~ 373 (796)
.|+.|++++|+|+ .+|..+ .++++..|++.+|+++
T Consensus 389 sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 389 ALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 5666667777666 334332 1355666667776665
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=225.20 Aligned_cols=269 Identities=25% Similarity=0.354 Sum_probs=208.0
Q ss_pred eeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCC
Q 003780 67 TCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146 (796)
Q Consensus 67 ~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 146 (796)
.|-. .+.+.+++++.+++...... .++|+.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. ++
T Consensus 174 ~Cl~-~~~~~L~L~~~~LtsLP~~I----p~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~ 242 (754)
T PRK15370 174 DCLK-NNKTELRLKILGLTTIPACI----PEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DT 242 (754)
T ss_pred hhcc-cCceEEEeCCCCcCcCCccc----ccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--cc
Confidence 4533 34688999998887533221 2579999999999995 455443 58999999999999 5676554 58
Q ss_pred CCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCC
Q 003780 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGG 226 (796)
Q Consensus 147 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 226 (796)
|+.|+|++|++. .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|+|++|+|+++. ..+. ++|+.|++++
T Consensus 243 L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP-~~lp--~sL~~L~Ls~ 313 (754)
T PRK15370 243 IQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTLP-AHLP--SGITHLNVQS 313 (754)
T ss_pred ccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccCc-ccch--hhHHHHHhcC
Confidence 999999999999 6787765 589999999999994 676654 58999999999999753 3332 5799999999
Q ss_pred ccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccc
Q 003780 227 NKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIP 306 (796)
Q Consensus 227 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 306 (796)
|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|.|+. +|
T Consensus 314 N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP 383 (754)
T PRK15370 314 NSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LP 383 (754)
T ss_pred Ccccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CC
Confidence 99995 555443 689999999999995 776664 68999999999998 4676553 689999999999994 56
Q ss_pred cccccccccceecccccccccCCCcc----cCCCCCCcEEEeecccccCCCCccccccccceEEecccccCC
Q 003780 307 ITIAGLISLKGLDLSNNKLSGPIPPE----IGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNG 374 (796)
Q Consensus 307 ~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~ 374 (796)
..+. .+|+.|++++|+|+ .+|.. ++.++++..|+|.+|.++. ..+.+|+.| ++.+.+.|
T Consensus 384 ~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~-----~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 384 ENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE-----RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred HhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH-----HHHHHHHHh-hhcccccC
Confidence 5554 37999999999998 45554 4456889999999999983 234456665 45555544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=179.48 Aligned_cols=278 Identities=17% Similarity=0.241 Sum_probs=210.9
Q ss_pred HhcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC-CceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~ 574 (796)
..+.|.+++.||.|+||.+|.|. ..+|+.||||.=...... .++..|.++.+.+++ ..|..+..|..+...-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 34679999999999999999994 678999999976544432 367889999999974 67778888888889999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC---CcEEEeeeccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK---LEAFVADFGTA 651 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a 651 (796)
+|||.. |-+|.++..-... .++...++-.+-|+..-++|+|.+ +++||||||+|++..-+ ..+.++|||+|
T Consensus 88 lVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 999987 4588888764432 377888899999999999999999 99999999999999754 35679999999
Q ss_pred cccCCCCC-------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh
Q 003780 652 RLLDSDSS-------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 652 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
+.+.+... ......||..|.+=....+..-+.+.|+=|+|.++.++--|..||+.... .........+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka-----~tk~QKyEkI 236 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA-----ATKKQKYEKI 236 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch-----hhHHHHHHHH
Confidence 87654221 12335699999988877777778899999999999999999999986543 2333344445
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccccHHHHhh
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLRN 790 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~ 790 (796)
....+.-+.+..+...+.++.-.+.-|-..--++-|...-+-+.+......-.-.+..+.+|.+..
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 555555555555556666777888888888888888876666655444333333445566666543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=219.96 Aligned_cols=252 Identities=23% Similarity=0.277 Sum_probs=185.6
Q ss_pred CCccceeeecccceeEEEEEccCCcEEEEEEeccccch-hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETE-ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|...+.+|.+.|=.|.+|+.++|. |+||++.+.... .-..+++-..|++ ...++|||.+++.-+...+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777889999999999999998887 889998766532 2222334444444 556689999999888888888899999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc--cCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL--LDS 656 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~--~~~ 656 (796)
|... +|+|++.-+ .-+...+.+.|+.|++.||..+|.. ||+|||||.+|||++.-..+.|+||..-+- +..
T Consensus 102 yvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9877 899988754 3477788889999999999999999 999999999999999998999999976642 222
Q ss_pred CCCC-cc----ccccccCccCccccccC----------C-cCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCc--hh
Q 003780 657 DSSN-RT----IVAGTYGYIAPELAYTM----------V-VTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSS--DQ 717 (796)
Q Consensus 657 ~~~~-~~----~~~gt~~y~aPE~~~~~----------~-~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~--~~ 717 (796)
++.. .. +......|+|||.+... . .+++.||||+||+++|+++ |++||+...-+.+... ..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 2211 11 12244579999977542 1 5678999999999999987 5777874322211111 00
Q ss_pred hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.....+.+ +...+++++..|++.||++|-++++.++.-....+
T Consensus 255 ~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 255 PEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred HHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 01111110 11137789999999999999999999999777666
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=184.04 Aligned_cols=188 Identities=12% Similarity=0.153 Sum_probs=143.7
Q ss_pred eccCCcccHHHHHH--HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHH------HHHHHHHHhh
Q 003780 483 WNYDGRIAFEDIIK--ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNS------FQNEAHVLSK 554 (796)
Q Consensus 483 ~~~~~~~~~~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~ 554 (796)
+-.+....|.++.. ..++|...+++|.|+||.||.+.. +++.+|+|.++............ +.+|+..+.+
T Consensus 13 ~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~r 91 (232)
T PRK10359 13 FYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDR 91 (232)
T ss_pred EecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHH
Confidence 33444445555543 468999999999999999999866 57789999998766554443333 6899999999
Q ss_pred cCCCceeeEEeEEEec--------ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003780 555 IAHRNIVKLYGFCLHK--------KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIV 626 (796)
Q Consensus 555 l~hpniv~l~~~~~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 626 (796)
++||+|..+.+++... +..++||||++|.+|.++.. .+. ....+++.++..+|+. |++
T Consensus 92 L~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~ 157 (232)
T PRK10359 92 VRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMV 157 (232)
T ss_pred HHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCc
Confidence 9999999999886643 35789999999999987632 222 2456899999999999 999
Q ss_pred EecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHH
Q 003780 627 HRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 698 (796)
Q Consensus 627 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ell 698 (796)
|||++|+||+++.++ ++++|||.......+... ..+.....+..++|+||||+.+....
T Consensus 158 H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 158 SGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cCCCChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999999988 999999988754322111 11334445667999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=180.07 Aligned_cols=143 Identities=20% Similarity=0.216 Sum_probs=109.5
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhH-----------------------HHHHHHHHHHHHhhcCCCce
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETT-----------------------FFNSFQNEAHVLSKIAHRNI 560 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~hpni 560 (796)
...||+|++|.||+|..++|+.||||+++........ .......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998889999999999765321110 01123459999999987776
Q ss_pred eeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEecCCCCCeEecC
Q 003780 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL-HHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 561 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~dlkp~NIll~~ 639 (796)
.....+.. ...++||||++++++....... ..++......++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 44333222 2348999999998776543222 2478889999999999999999 687 999999999999998
Q ss_pred CCcEEEeeeccccccC
Q 003780 640 KLEAFVADFGTARLLD 655 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~ 655 (796)
++.++++|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-19 Score=175.29 Aligned_cols=254 Identities=18% Similarity=0.215 Sum_probs=189.0
Q ss_pred cCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV 576 (796)
-.|.+.+.||+|+||.++.|. .-+++.||||.=..... .-++..|.+..+.+. .+.|..++-|..++..-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 478999999999999999995 55799999996433322 237888999888885 79999999888888899999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-----cEEEeeeccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-----EAFVADFGTA 651 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~Dfg~a 651 (796)
+|.+ |-+|.++..-... .++.+.+..++.|+..-++|+|++ ..|.|||||+|+||...+ .+.++|||+|
T Consensus 103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9987 4477777654332 389999999999999999999999 999999999999997543 4679999999
Q ss_pred cccCCCCCC-------ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh
Q 003780 652 RLLDSDSSN-------RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 652 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
+.+.++... .....||..||+=....+.+-+.+.|.=|+|=++++.+-|..||+.... ...+..+..+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA-----~tnK~kYeKI 251 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-----DTNKEKYEKI 251 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC-----cchHHHHHHh
Confidence 987654322 1234599999999999999999999999999999999999999985432 2333344444
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
-+....-+........+.++..-+.-.-..+-.+-|..+-+..-
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~L 295 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKL 295 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 34333333333333344444444444444455555665544333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=184.30 Aligned_cols=236 Identities=19% Similarity=0.242 Sum_probs=152.7
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC----------CceeeEEeEEE
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH----------RNIVKLYGFCL 568 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pniv~l~~~~~ 568 (796)
.+...+.||.|+++.||.++.. +|+.+|+|++..........++++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3445678999999999999754 699999999987775555557788877766555322 22333333322
Q ss_pred e---------c---c-----eeeEEEeeccCCcHHHHHhh---cCc-ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEE
Q 003780 569 H---------K---K-----CMFLIYKYMKRGSLFCFLRN---DYE-AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVH 627 (796)
Q Consensus 569 ~---------~---~-----~~~lV~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 627 (796)
- . . ..+++|+-+ .++|.+.+.- ... ...+....+..+..|+.+.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 1 1 1 235667766 4578776542 211 23355666778889999999999999 9999
Q ss_pred ecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccccccCccCcccccc--------CCcCcchhHHHHHHHHHHHHh
Q 003780 628 RDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT--------MVVTEKCDVYSFGVVALEVLM 699 (796)
Q Consensus 628 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DVwSlGv~l~ellt 699 (796)
+||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... ..++.+.|.|++|+++|.|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999998765432111 1234577999997644 247889999999999999999
Q ss_pred CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCC
Q 003780 700 GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFR 759 (796)
Q Consensus 700 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 759 (796)
|+.||+.......... .+.... +.+..+..+|..+|+++|++|
T Consensus 246 ~~lPf~~~~~~~~~~~----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999985432111110 122222 344558899999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=172.07 Aligned_cols=187 Identities=12% Similarity=0.059 Sum_probs=141.2
Q ss_pred CccceeeecccceeEEEEEccCCcEEEEEEeccccchhhH-HHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEEe
Q 003780 501 FDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETT-FFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 578 (796)
+.+...|++|+||+||.+.. .+..++.+.+......... ....+.+|+++++++. |+++.+++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999998866 5788887777665543221 1225789999999995 5889999886 34689999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecC-CCCCeEecCCCcEEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDI-SSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|++|.+|...... ....++.|++++|+++|+. ||+|||| ||+||+++.++.++|+|||+|......
T Consensus 79 yI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 79 YLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred eecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999998654321 1134778999999999999 9999999 799999999999999999999865443
Q ss_pred CCC-------------ccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCc
Q 003780 658 SSN-------------RTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGE 705 (796)
Q Consensus 658 ~~~-------------~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~ 705 (796)
... ......++.|++|+...- ..--.+.+.++.|+-+|.++||+.|+-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 321 011235778888885432 222256799999999999999999854
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-22 Score=212.64 Aligned_cols=208 Identities=24% Similarity=0.275 Sum_probs=95.4
Q ss_pred hhccCccceeeccccccCCCCCccccCCCC---ccEEEcccccccC----cchhhhcCC-CCccccccCCcccccc----
Q 003780 165 LCQLTKLITMALSRNGLHGPIPSAIGDLNN---LLILSLDSNKLSG----MLHQELGKL-KNLVALNVGGNKLMGP---- 232 (796)
Q Consensus 165 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~---- 232 (796)
+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++.
T Consensus 77 l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 156 (319)
T cd00116 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA 156 (319)
T ss_pred HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence 333444444444444444333333333333 4444444444442 112223333 4445555555544421
Q ss_pred CCCcccccCccceEEecccccccc----CCccccCCcccceeeccccccccc----CccccccccccccccccCccccCc
Q 003780 233 IPSTLFRLTNLTYLYLHSNHLNGS----IPPEIGNMTGILKVDMSMNNIEGT----IPLELTRLSQLLYLSISSNMLSGQ 304 (796)
Q Consensus 233 ~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~ 304 (796)
++..+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|++++|.+++.
T Consensus 157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~ 236 (319)
T cd00116 157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA 236 (319)
T ss_pred HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence 122333344555555555555421 122233344555555555555422 222344455566666666665542
Q ss_pred cccccc-----cccccceeccccccccc----CCCcccCCCCCCcEEEeecccccCCC----Ccccc-c-cccceEEecc
Q 003780 305 IPITIA-----GLISLKGLDLSNNKLSG----PIPPEIGKCSELRNITLRNNNLSGSI----PPEIG-L-MKLEYLDLSH 369 (796)
Q Consensus 305 ~~~~~~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~-~-~~L~~L~l~~ 369 (796)
....+. ..++|+.|++++|.++. .+...+..+++|++|++++|.++... ...+. . ..|+.|++.+
T Consensus 237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (319)
T cd00116 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD 316 (319)
T ss_pred HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence 222221 12566666666666641 22233445566677777777666431 11121 2 3566666666
Q ss_pred ccc
Q 003780 370 NKL 372 (796)
Q Consensus 370 N~l 372 (796)
|++
T Consensus 317 ~~~ 319 (319)
T cd00116 317 DSF 319 (319)
T ss_pred CCC
Confidence 653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-19 Score=173.35 Aligned_cols=143 Identities=22% Similarity=0.292 Sum_probs=112.1
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhh-----------------------HHHHHHHHHHHHHhhcCCCce
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEET-----------------------TFFNSFQNEAHVLSKIAHRNI 560 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~hpni 560 (796)
...||+|++|.||+|...+|+.||||+++....... .....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999877899999999986532100 001234678999999999987
Q ss_pred eeEEeEEEecceeeEEEeeccCCcHHHH-HhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEec
Q 003780 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCF-LRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLN 638 (796)
Q Consensus 561 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~ 638 (796)
.....+.... .++||||++++++... +.. ..++.....+++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 5544443332 4899999998865433 332 236778889999999999999999 8 999999999999999
Q ss_pred CCCcEEEeeeccccccCC
Q 003780 639 SKLEAFVADFGTARLLDS 656 (796)
Q Consensus 639 ~~~~~kl~Dfg~a~~~~~ 656 (796)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.6e-22 Score=211.57 Aligned_cols=274 Identities=25% Similarity=0.288 Sum_probs=203.4
Q ss_pred EEeCCCCCccccccccccCCCCCCcEEeccCCcccc----cCCcCccCCCCCcEeecccCcCCC------CCCCCCCCCC
Q 003780 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFG----SIPSQVGALSKLRYLDFSFNNLTG------SIPPELGSLR 145 (796)
Q Consensus 76 ~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~------~~p~~~~~l~ 145 (796)
.|+|..+.+.+.--...|..+++|+.|+++++.++. .++..+...+.|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 356666666643333446677889999999998854 255566777889999999988762 2334567788
Q ss_pred CCCEEEecCCCCCCCCchhhhccCc---cceeeccccccCC----CCCccccCC-CCccEEEcccccccCc----chhhh
Q 003780 146 NLEVLNLKGNNLNGAIPSSLCQLTK---LITMALSRNGLHG----PIPSAIGDL-NNLLILSLDSNKLSGM----LHQEL 213 (796)
Q Consensus 146 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~~~~~ 213 (796)
+|++|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999998777777777666 9999999999873 233456667 8999999999999843 34567
Q ss_pred cCCCCccccccCCcccccc----CCCcccccCccceEEecccccccc----CCccccCCcccceeecccccccccCcccc
Q 003780 214 GKLKNLVALNVGGNKLMGP----IPSTLFRLTNLTYLYLHSNHLNGS----IPPEIGNMTGILKVDMSMNNIEGTIPLEL 285 (796)
Q Consensus 214 ~~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 285 (796)
..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 7788999999999999842 233455667999999999998743 33456678889999999999986444433
Q ss_pred cc-----ccccccccccCccccC----ccccccccccccceecccccccccC----CCcccCCC-CCCcEEEeecccc
Q 003780 286 TR-----LSQLLYLSISSNMLSG----QIPITIAGLISLKGLDLSNNKLSGP----IPPEIGKC-SELRNITLRNNNL 349 (796)
Q Consensus 286 ~~-----l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~L~~N~l 349 (796)
.. .++|++|++++|.++. .+...+..+++|+++++++|.++.. ....+... +.|+.|++.+|.+
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 32 3799999999999873 3345566678999999999999854 33334444 7899999988764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=192.13 Aligned_cols=214 Identities=26% Similarity=0.489 Sum_probs=164.3
Q ss_pred HhhcCCCceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCe-EEecC
Q 003780 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI-VHRDI 630 (796)
Q Consensus 552 l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~dl 630 (796)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...+++.....++++|+.||+|+|+. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 45688999999999999999999999999999999999873 34589999999999999999999987 55 89999
Q ss_pred CCCCeEecCCCcEEEeeeccccccCCC--CCCccccccccCccCccccccCC-------cCcchhHHHHHHHHHHHHhCC
Q 003780 631 SSNNILLNSKLEAFVADFGTARLLDSD--SSNRTIVAGTYGYIAPELAYTMV-------VTEKCDVYSFGVVALEVLMGR 701 (796)
Q Consensus 631 kp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DVwSlGv~l~elltg~ 701 (796)
+++|++++....+|++|||+....... ........-..-|.|||.+.+.. .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998876421 11111122445799999987641 456799999999999999999
Q ss_pred CCCcccccCCCCCchhhhHHHHhhc---CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 702 HPGELLSSLSSPSSDQKIMLIDVLD---SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 702 ~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
.||+........ .+.+..+.+ ....+...... +....+..++..||..+|++||++++|-..++.....
T Consensus 156 ~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCCh----HHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999854432221 122222211 12233322211 2233588899999999999999999999998877654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.4e-21 Score=171.41 Aligned_cols=163 Identities=33% Similarity=0.594 Sum_probs=111.2
Q ss_pred ccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCcc
Q 003780 117 VGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL 196 (796)
Q Consensus 117 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 196 (796)
+.++++.+.|.||+|+++ .+|+.+..|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 345667778888888888 67778888888888888888888 67788888888888888888776 5677777777777
Q ss_pred EEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccc
Q 003780 197 ILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNN 276 (796)
Q Consensus 197 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 276 (796)
.|||.+|++..- .+|+.|+.++.|+-|+|+.|.|. .+|..++++++|+.|.+..|.
T Consensus 106 vldltynnl~e~-----------------------~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 106 VLDLTYNNLNEN-----------------------SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hhhccccccccc-----------------------cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 777777766521 34445555555555555555555 555555666666666666665
Q ss_pred ccccCccccccccccccccccCccccCccccc
Q 003780 277 IEGTIPLELTRLSQLLYLSISSNMLSGQIPIT 308 (796)
Q Consensus 277 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 308 (796)
+- ..|..++.+++|++|++.+|+++ .+|..
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppe 191 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPE 191 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChh
Confidence 55 45666666666666666666666 34433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.5e-19 Score=179.05 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=168.1
Q ss_pred cCCccceeeecccceeEEEEEccC-Cc-----------------------------------EEEEEEeccccch--hhH
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN-GK-----------------------------------VVALKKLHRAETE--ETT 540 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~-----------------------------------~vavK~~~~~~~~--~~~ 540 (796)
++|++.+.||+|..+.||.++.++ |. +.|+|.+.....+ +..
T Consensus 157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~ 236 (598)
T KOG4158|consen 157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH 236 (598)
T ss_pred hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence 568999999999999999986542 10 1456655433222 222
Q ss_pred HHHHHHHHHH------H--------Hhh--------cCCCceeeEEeEEEe---------------------------cc
Q 003780 541 FFNSFQNEAH------V--------LSK--------IAHRNIVKLYGFCLH---------------------------KK 571 (796)
Q Consensus 541 ~~~~~~~E~~------~--------l~~--------l~hpniv~l~~~~~~---------------------------~~ 571 (796)
..+.+.+|.. + .+. -+|||||+++++|.+ +.
T Consensus 237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~ 316 (598)
T KOG4158|consen 237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK 316 (598)
T ss_pred HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence 2333333321 1 111 259999999987742 34
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec--CCC--cEEEee
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN--SKL--EAFVAD 647 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~D 647 (796)
..|+||.-++. +|..++.... .+.....-++.|+++|+.|||.+ ||.|||+|++||++. +|+ ...|+|
T Consensus 317 tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 317 TLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred eEEEehhcchh-hHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcc
Confidence 67899988765 8988887543 45666777899999999999999 999999999999984 443 357899
Q ss_pred eccccccCCC------CCCccccccccCccCccccccCC------cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc
Q 003780 648 FGTARLLDSD------SSNRTIVAGTYGYIAPELAYTMV------VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS 715 (796)
Q Consensus 648 fg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~ 715 (796)
||++---+.. ........|.-.-||||+....+ --.|+|.|+.|.+.||+++...||+..........
T Consensus 389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r 468 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR 468 (598)
T ss_pred cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh
Confidence 9987432211 11122344777899999987543 22589999999999999999999985332211111
Q ss_pred hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 716 DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
. .....+++ ++......+.+++...+++||.+||+..-....+
T Consensus 469 ~-------Yqe~qLPa----lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 469 T-------YQESQLPA----LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred h-------hhhhhCCC----CcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 1 11112221 1223334478899999999999999876555444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-20 Score=199.02 Aligned_cols=236 Identities=25% Similarity=0.299 Sum_probs=180.7
Q ss_pred eecccceeEEEEE----ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEEeecc
Q 003780 507 IGTGGYGSVYKAQ----LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 507 lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
+|+|+||.|+.++ ...|..+|.|..++......... ....|..++...+ ||.+|++.-.++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6899999999873 33577889988876544332211 3456778888887 9999999999999999999999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCc
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 661 (796)
+|.+...+.+.. ..++.....+...+|-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988877543 256666666777788899999999 9999999999999999999999999999865433222
Q ss_pred cccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHH
Q 003780 662 TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDI 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
+||..|||||++. .+..++|.||||++++||+||..||.. .....++...+.. +.+..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~-----p~~l~ 211 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEM-----PRELS 211 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCC-----chhhh
Confidence 8999999999988 457789999999999999999999872 2223333323221 22333
Q ss_pred HHHHHHHHHcCCCCCCCCCCHH-HHHHHHhhc
Q 003780 742 VLVTTVALACLHSKPKFRPTMQ-RVCQEFLTC 772 (796)
Q Consensus 742 ~~l~~li~~cl~~dP~~RPs~~-evl~~L~~~ 772 (796)
.....++..++..+|..|--.. +.+.+.++.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 4467888899999999997553 344444333
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-20 Score=165.70 Aligned_cols=164 Identities=31% Similarity=0.502 Sum_probs=131.2
Q ss_pred cCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEE
Q 003780 168 LTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLY 247 (796)
Q Consensus 168 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~ 247 (796)
+++.+.|.|++|+++ .+|..+..+.+|+.|++++|+++ ..|..++.+++|+.|+++.|++. ..|..|+++|.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344455555555555 34445555666666666666665 34556667777777777777776 7888999999999999
Q ss_pred eccccccc-cCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccc
Q 003780 248 LHSNHLNG-SIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLS 326 (796)
Q Consensus 248 L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 326 (796)
|..|++.. .+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|..++.+..|++|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 99999874 58999999999999999999999 88999999999999999999998 78999999999999999999999
Q ss_pred cCCCcccCCCC
Q 003780 327 GPIPPEIGKCS 337 (796)
Q Consensus 327 ~~~~~~~~~l~ 337 (796)
.+|+.++++.
T Consensus 187 -vlppel~~l~ 196 (264)
T KOG0617|consen 187 -VLPPELANLD 196 (264)
T ss_pred -ecChhhhhhh
Confidence 7777777543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.4e-18 Score=194.90 Aligned_cols=250 Identities=22% Similarity=0.243 Sum_probs=186.1
Q ss_pred HHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC---CCceeeEEeEEEec
Q 003780 494 IIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA---HRNIVKLYGFCLHK 570 (796)
Q Consensus 494 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 570 (796)
.+...+.|.+.+.||+|+||+||+|...+|+.||+|+=+....++- .--.+++.+|+ -+-|..+...+.-.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3345678999999999999999999888899999999888776642 22234445554 23455666666667
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-------CCcE
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-------KLEA 643 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-------~~~~ 643 (796)
+.-++|+||.+.|+|.+++.. ...++|.....++.|+++.+++||.. +|||+||||+|.||.. ...+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 888999999999999999983 34589999999999999999999999 9999999999999943 2457
Q ss_pred EEeeeccccccCC--CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHH
Q 003780 644 FVADFGTARLLDS--DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 644 kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (796)
+|+|||.+..+.- +...-...++|-.+-.+|+..|..+++.+|-|.++-+++.|+.|++--. .....
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-----~~g~~------ 909 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-----KNGSS------ 909 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-----cCCcc------
Confidence 8999999987643 2333455778999999999999999999999999999999999986520 00000
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
........++...++ .-+++..+|.+|-..=|...++...+++..
T Consensus 910 -----~~~~~~~~Ry~~~~~--W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 910 -----WMVKTNFPRYWKRDM--WNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred -----eeccccchhhhhHHH--HHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 000011122222222 446777788855555578888887777653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.5e-17 Score=160.68 Aligned_cols=136 Identities=18% Similarity=0.187 Sum_probs=104.6
Q ss_pred ccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-----CCCceeeEEeEEEecc---e-
Q 003780 502 DIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-----AHRNIVKLYGFCLHKK---C- 572 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~- 572 (796)
+-.+.||+|+||.||. +++....+||++...... ..+.+.+|+.+++++ .||||++++|+++.+. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3457899999999996 443333479988764332 245789999999999 5799999999998863 3
Q ss_pred eeEEEee--ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHH-HHHhhcCCCCeEEecCCCCCeEecC----CCcEEE
Q 003780 573 MFLIYKY--MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL-SYLHHDCMPSIVHRDISSNNILLNS----KLEAFV 645 (796)
Q Consensus 573 ~~lV~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl 645 (796)
+.+|+|| +++|+|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 3378999 56899999997531 4444 35577777777 999999 9999999999999974 347999
Q ss_pred eeeccc
Q 003780 646 ADFGTA 651 (796)
Q Consensus 646 ~Dfg~a 651 (796)
+||+-+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 994433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.9e-17 Score=162.47 Aligned_cols=152 Identities=20% Similarity=0.204 Sum_probs=115.4
Q ss_pred HHHHHhcCCccceeeecccceeEEEEE--ccCCcEEEEEEeccccchh---------------------hHHHHHHHHHH
Q 003780 493 DIIKATEDFDIKYCIGTGGYGSVYKAQ--LPNGKVVALKKLHRAETEE---------------------TTFFNSFQNEA 549 (796)
Q Consensus 493 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~E~ 549 (796)
.+.+....|.+.+.||+|++|.||+|. ..+|+.||+|+++...... ......+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 333444468889999999999999998 5689999999987543210 00112467899
Q ss_pred HHHhhcCCC--ceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC-eE
Q 003780 550 HVLSKIAHR--NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS-IV 626 (796)
Q Consensus 550 ~~l~~l~hp--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iv 626 (796)
+.+.++.+. .+.+++++ ...++||||++++++........ .........++.|++.++++||+. + |+
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~ii 171 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELV 171 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEE
Confidence 999999753 33444443 23589999999988876543221 245566788999999999999999 9 99
Q ss_pred EecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 627 HRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 627 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||||+||+++ ++.++++|||.+...+
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999999 8899999999987544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=176.30 Aligned_cols=177 Identities=24% Similarity=0.375 Sum_probs=135.7
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...|+.|+++..++|.+|+.+.......++.....++.|++.|++| + +.+|||+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999876666668889999999999999999 6 899999999999999999999999999
Q ss_pred ccccCCCC------CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHH
Q 003780 651 ARLLDSDS------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 651 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
........ ...+...||..||+||.+.+..|+.|+||||+|++++|++. =..+++ ......+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~~d 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------RIATLTD 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhhhh
Confidence 98776544 12334569999999999999999999999999999999997 222322 1112222
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+-+..+++.... +.+.-..++.+++.+.|.+||++.++..+
T Consensus 472 ~r~g~ip~~~~~----d~p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 472 IRDGIIPPEFLQ----DYPEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred hhcCCCChHHhh----cCcHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 333333322211 11122367889999999999966665544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=156.51 Aligned_cols=148 Identities=20% Similarity=0.211 Sum_probs=113.9
Q ss_pred HHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhh-------------------HHHHHHHHHHHHH
Q 003780 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEET-------------------TFFNSFQNEAHVL 552 (796)
Q Consensus 492 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l 552 (796)
.++.+....|.+.+.||+|+||.||++..++|+.||||++........ .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444545888899999999999999888899999998765431100 0112367888999
Q ss_pred hhcCCC--ceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecC
Q 003780 553 SKIAHR--NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDI 630 (796)
Q Consensus 553 ~~l~hp--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 630 (796)
..+.|+ .+.+.++. ...++||||+++++|.+.... .....++.++++++.++|+. +|+||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 998877 44444442 345899999999998765321 23457889999999999998 9999999
Q ss_pred CCCCeEecCCCcEEEeeeccccccC
Q 003780 631 SSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 631 kp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.1e-16 Score=156.64 Aligned_cols=137 Identities=15% Similarity=0.278 Sum_probs=115.1
Q ss_pred eeeecccceeEEEEEccCCcEEEEEEeccccchh-----hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 505 YCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEE-----TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
+.||+|++|.||+|.. +|..+++|+........ ......+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999987 67889999876543221 11124678899999999999998888887778888999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++|++|.+++.... . .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986431 2 7788999999999999999 999999999999999 78899999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-16 Score=180.57 Aligned_cols=207 Identities=25% Similarity=0.310 Sum_probs=142.6
Q ss_pred hcCCccceeeecccceeEEEEEccC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..+|+.++.|..|+||.||.++++. .+.+|. ++++.... .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li--------lRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI--------LRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh--------hhc--cccccCCccee---------------
Confidence 4689999999999999999998774 556777 34333211 110 23333344444
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|+=...++..+. ++... +.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||+++....
T Consensus 136 ------gDc~tllk~~g~---lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGP---LPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------chhhhhcccCCC---Ccchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 333344443221 33322 6799999999 999999999999999999999999999875311
Q ss_pred C---------------CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHH
Q 003780 657 D---------------SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 657 ~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (796)
. ......++||+.|+|||++....|...+|+|++|+++||.+-|..||... ..++.+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd--------tpeelf 267 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--------TPEELF 267 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC--------CHHHHH
Confidence 0 01123368999999999999999999999999999999999999998732 222233
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCC
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRP 760 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 760 (796)
..++...+..+.. ......+..+++.+.|+.+|..|-
T Consensus 268 g~visd~i~wpE~--dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 GQVISDDIEWPEE--DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhhcccccc--CcCCCHHHHHHHHHHHHhChHhhc
Confidence 3333333222111 112233477899999999999994
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=151.96 Aligned_cols=133 Identities=18% Similarity=0.320 Sum_probs=108.4
Q ss_pred eeecccceeEEEEEccCCcEEEEEEeccccch-----hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeec
Q 003780 506 CIGTGGYGSVYKAQLPNGKVVALKKLHRAETE-----ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
.||+|++|.||+|.. +|..+++|+....... .....+.+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 5788999986543221 1112356789999999999887666655666677789999999
Q ss_pred cCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 581 KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
+|++|.+++..... .++.+++++|.++|+. +++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988764310 7899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.4e-16 Score=175.36 Aligned_cols=142 Identities=17% Similarity=0.230 Sum_probs=113.6
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEecccc-c----hhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAE-T----EETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~----~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
....|...+.||+|+||+||++...+. .+++|+..... . ......+.+.+|++++++++|++++....++..+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556788999999999999987544 34444322211 1 11122356889999999999999998888888877
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++||||+++++|.+++. ....++.+++++|.|||+. +++|||+||+||++ .++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999998875 2467899999999999999 99999999999999 6789999999999
Q ss_pred ccc
Q 003780 652 RLL 654 (796)
Q Consensus 652 ~~~ 654 (796)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.4e-15 Score=144.45 Aligned_cols=140 Identities=21% Similarity=0.221 Sum_probs=100.3
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHH---------------------HHHHHHHHhhcCCC--ce
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNS---------------------FQNEAHVLSKIAHR--NI 560 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~hp--ni 560 (796)
.+.||+|+||+||+|...+|+.||||++............. ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988889999999987643322111111 13566666666443 24
Q ss_pred eeEEeEEEecceeeEEEeeccCCcHHH-HHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEec
Q 003780 561 VKLYGFCLHKKCMFLIYKYMKRGSLFC-FLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLN 638 (796)
Q Consensus 561 v~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~ 638 (796)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 23589999999964321 111110 11 5567899999999999999 7 999999999999999
Q ss_pred CCCcEEEeeeccccccCC
Q 003780 639 SKLEAFVADFGTARLLDS 656 (796)
Q Consensus 639 ~~~~~kl~Dfg~a~~~~~ 656 (796)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-14 Score=133.94 Aligned_cols=135 Identities=18% Similarity=0.146 Sum_probs=113.9
Q ss_pred cceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC--CceeeEEeEEEecceeeEEEeec
Q 003780 503 IKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH--RNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 503 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~ 580 (796)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| ..+.+++++...++..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 45789999999999998754 7899998865543 2468889999999976 58999999988888999999999
Q ss_pred cCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 581 KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
+++.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98777533 4456677899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.6e-15 Score=160.35 Aligned_cols=194 Identities=32% Similarity=0.513 Sum_probs=141.9
Q ss_pred CCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccc
Q 003780 144 LRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALN 223 (796)
Q Consensus 144 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 223 (796)
|.--...||+.|++. .+|..++.+..|+.+.|..|.+. .+|..++++..|++|||+.|++
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nql------------------ 133 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQL------------------ 133 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchh------------------
Confidence 444556677777777 66777777767777777777666 4555555555555555555544
Q ss_pred cCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccC
Q 003780 224 VGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG 303 (796)
Q Consensus 224 l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 303 (796)
+ ..|..+..++ |+.|.+++|+++ .+|..++.+..|..||.+.|++. .+|..++++.+|+.|++..|++.
T Consensus 134 ------S-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~- 202 (722)
T KOG0532|consen 134 ------S-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE- 202 (722)
T ss_pred ------h-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-
Confidence 4 4555666665 888888888887 77888888888888888888888 66778888888888888888888
Q ss_pred ccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcccccc----ccceEEecccc
Q 003780 304 QIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLM----KLEYLDLSHNK 371 (796)
Q Consensus 304 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~----~L~~L~l~~N~ 371 (796)
.+|..+..| .|..||+|.|+++ .+|..|.+|..|++|-|.+|.|. +.|..+..+ =.++|+..-++
T Consensus 203 ~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 203 DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 566666654 4889999999998 78999999999999999999998 445444322 26777777774
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=140.67 Aligned_cols=138 Identities=17% Similarity=0.263 Sum_probs=106.1
Q ss_pred ceeee-cccceeEEEEEccCCcEEEEEEeccccc----------hhhHHHHHHHHHHHHHhhcCCCce--eeEEeEEEec
Q 003780 504 KYCIG-TGGYGSVYKAQLPNGKVVALKKLHRAET----------EETTFFNSFQNEAHVLSKIAHRNI--VKLYGFCLHK 570 (796)
Q Consensus 504 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~ 570 (796)
...|| .|+.|+||.+... +..+++|++..... ........+.+|++++.+++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999875 77899998864221 001123467889999999998775 6777765443
Q ss_pred c----eeeEEEeeccC-CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEE
Q 003780 571 K----CMFLIYKYMKR-GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV 645 (796)
Q Consensus 571 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 645 (796)
. ..++|+|++++ .+|.+++.+. .++.. .+.++++++.+||+. ||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6898887643 13433 357899999999999 9999999999999999999999
Q ss_pred eeeccccc
Q 003780 646 ADFGTARL 653 (796)
Q Consensus 646 ~Dfg~a~~ 653 (796)
+|||.++.
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998875
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.1e-14 Score=164.48 Aligned_cols=108 Identities=38% Similarity=0.587 Sum_probs=82.0
Q ss_pred CcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccc
Q 003780 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178 (796)
Q Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 178 (796)
++.|+|++|.+.|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 45566777777777777777777888888888877777777777788888888888888777787788888888888888
Q ss_pred cccCCCCCccccCC-CCccEEEccccccc
Q 003780 179 NGLHGPIPSAIGDL-NNLLILSLDSNKLS 206 (796)
Q Consensus 179 N~l~~~~p~~~~~l-~~L~~L~L~~N~l~ 206 (796)
|+++|.+|..+..+ .++..+++.+|...
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccc
Confidence 88887777777653 46677888887643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2e-14 Score=142.56 Aligned_cols=208 Identities=23% Similarity=0.343 Sum_probs=144.3
Q ss_pred HHHhhcCCCceeeEEeEEEec-----ceeeEEEeeccCCcHHHHHhhcCc-ccccCHHHHHHHHHHHHHHHHHHhhcCCC
Q 003780 550 HVLSKIAHRNIVKLYGFCLHK-----KCMFLIYKYMKRGSLFCFLRNDYE-AVVLDWTMRVNIIKCVANALSYLHHDCMP 623 (796)
Q Consensus 550 ~~l~~l~hpniv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 623 (796)
.-+-++.|.|||+++.|+.+. .....+.|||+.|++..+|++... ...+......+++.||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 344556799999999998653 356789999999999999987532 3457778888999999999999999 688
Q ss_pred CeEEecCCCCCeEecCCCcEEEeeeccccccC----CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh
Q 003780 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLD----SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM 699 (796)
Q Consensus 624 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt 699 (796)
+|+|+++..+-|++..++-+|++--.-..... ........-.+-++|.|||+-.....+.++|||+||+...||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999988875321111000 00011112236689999999877778889999999999999988
Q ss_pred CCCC-CcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 700 GRHP-GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 700 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
|..- -.... ....+......+- .+....+ ..++.+|++..|..||+|.+++.|.-...+
T Consensus 278 lEiq~tnseS-----~~~~ee~ia~~i~-~len~lq----------r~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 278 LEIQSTNSES-----KVEVEENIANVII-GLENGLQ----------RGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred heeccCCCcc-----eeehhhhhhhhee-eccCccc----------cCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 7644 21111 1111111111111 1111111 146778999999999999999988654433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-15 Score=172.35 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=187.1
Q ss_pred cCCccceeeecccceeEEEEEcc--CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP--NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 575 (796)
..|...+.||+|+|+.|-..... ....+|+|.+.... ......+....|..+-..+. |+|++.+++...+++..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 46777888999999999888553 34456667665554 22233456667888888887 9999999999999999999
Q ss_pred EEeeccCCcHHHHH-hhcCcccccCHHHHHHHHHHHHHHHHHHh-hcCCCCeEEecCCCCCeEecCCC-cEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFL-RNDYEAVVLDWTMRVNIIKCVANALSYLH-HDCMPSIVHRDISSNNILLNSKL-EAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~ 652 (796)
+.+|..++++.+.+ +... ...+....-.++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999888 4332 12455566778999999999999 76 999999999999999999 99999999998
Q ss_pred ccCC-CC--CCcccccc-ccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 653 LLDS-DS--SNRTIVAG-TYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 653 ~~~~-~~--~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
.+.. .. ......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .........
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-------~~~~~~~~~ 246 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-------GRYSSWKSN 246 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-------ccceeeccc
Confidence 7655 22 22234567 9999999998884 44567899999999999999999987433221 111111111
Q ss_pred C---CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 728 R---LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 728 ~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. ......... ....++..+++..+|..|.+.+++..+
T Consensus 247 ~~~~~~~~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 247 KGRFTQLPWNSIS----DQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccccccCccccCC----hhhhhcccccccCCchhcccccccccc
Confidence 1 011111111 125577888999999999999887655
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.4e-13 Score=152.36 Aligned_cols=201 Identities=36% Similarity=0.539 Sum_probs=141.0
Q ss_pred EEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCC-CCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR-NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 101 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
.|+++.|.+... ...+..++.++.|++.+|.++ .+|+....++ +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 466666666422 223555577788888888877 5566666664 7888888888877 55667777888888888888
Q ss_pred ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPP 259 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 259 (796)
+++. +|...+.+++|+.|++++|+++.+ |.....+..|++|.+++|.+. ..+..+.++.++..|.+.+|++. .++.
T Consensus 174 ~l~~-l~~~~~~~~~L~~L~ls~N~i~~l-~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLSD-LPKLLSNLSNLNNLDLSGNKISDL-PPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhhh-hhhhhhhhhhhhheeccCCccccC-chhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 8773 444444677788888888888744 334455566888888888544 35556777788888888888877 3466
Q ss_pred cccCCcccceeecccccccccCccccccccccccccccCccccCccccccc
Q 003780 260 EIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIA 310 (796)
Q Consensus 260 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 310 (796)
.++.+++++.|++++|+++...+ ++.+.+|++|++++|.+....|....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 67778888888888888884433 77888888888888888766555443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.3e-15 Score=158.04 Aligned_cols=197 Identities=31% Similarity=0.502 Sum_probs=147.2
Q ss_pred cCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccE
Q 003780 118 GALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLI 197 (796)
Q Consensus 118 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 197 (796)
-.+..-...||+.|++. .+|..+..+..|+.|.|..|.+. .+|..++++..|.+|+|+.|+++ ..|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34555667788888887 77877887888888888888887 77888888888888888888887 5677777765 888
Q ss_pred EEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccc
Q 003780 198 LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNI 277 (796)
Q Consensus 198 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 277 (796)
|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..+..+ .|..||+|.|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 888888887 45666778888888888888887 56777888888888888888887 566666644 577788888888
Q ss_pred cccCccccccccccccccccCccccCcccccccc---ccccceecccccc
Q 003780 278 EGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG---LISLKGLDLSNNK 324 (796)
Q Consensus 278 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~---l~~L~~L~Ls~N~ 324 (796)
+ .+|-.|.+|+.|++|-|.+|.|. ..|..+.- ..=.++|+..-++
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 8 67888888888888888888887 34444322 2234566666654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-13 Score=152.69 Aligned_cols=202 Identities=33% Similarity=0.466 Sum_probs=156.3
Q ss_pred cEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccC-ccceeeccccccCCCCCccccCCCCccEEEccc
Q 003780 124 RYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLT-KLITMALSRNGLHGPIPSAIGDLNNLLILSLDS 202 (796)
Q Consensus 124 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 202 (796)
..|+++.|.+.. ....+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++
T Consensus 96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 368888888752 2334556688999999999988 6677777774 8999999999988 4556778889999999999
Q ss_pred ccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCc
Q 003780 203 NKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIP 282 (796)
Q Consensus 203 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 282 (796)
|+++.+ +...+.+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+.++.++..|.+++|++.. .+
T Consensus 173 N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~ 248 (394)
T COG4886 173 NDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LP 248 (394)
T ss_pred chhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-cc
Confidence 998854 444447888899999999998 55655555666899999999654 466678888888888888888873 46
Q ss_pred cccccccccccccccCccccCccccccccccccceecccccccccCCCcccC
Q 003780 283 LELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 283 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
..++.+++|++|++++|.++...+ ++.+.+|+.|++++|.+....|....
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 778888889999999999885444 88888999999999988866655444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.9e-12 Score=141.65 Aligned_cols=145 Identities=21% Similarity=0.209 Sum_probs=101.2
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhH-------------------------------HHH------HHH
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETT-------------------------------FFN------SFQ 546 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-------------------------------~~~------~~~ 546 (796)
.+.||.|++|.||+|+.++|+.||||+.+........ ..+ .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999998764211100 000 244
Q ss_pred HHHHHHhhcC----CCceeeEEeEE-EecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHH-HHHHHhhc
Q 003780 547 NEAHVLSKIA----HRNIVKLYGFC-LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN-ALSYLHHD 620 (796)
Q Consensus 547 ~E~~~l~~l~----hpniv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~ 620 (796)
+|++.+.+++ |.+-+.+-..+ ......++||||++|++|.+....... .. .+.+++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5555555552 32223332222 223457899999999999887653211 12 23456666665 46788988
Q ss_pred CCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 621 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|++|+|++|.||+++.++.++++|||++..+.+
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.3e-11 Score=134.80 Aligned_cols=169 Identities=15% Similarity=0.191 Sum_probs=128.0
Q ss_pred EccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCccccc
Q 003780 519 QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVL 598 (796)
Q Consensus 519 ~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l 598 (796)
+..++.+|.|........ .......+-++.++.+|||||+++++.++.++..|+|+|-+. .|..++++.
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------ 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------ 101 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------
Confidence 344688888887766544 224567788899999999999999999999999999999874 466666643
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccccccCccCcccccc
Q 003780 599 DWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT 678 (796)
Q Consensus 599 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 678 (796)
........+.||+.||.+||+.| +++|++|....|+++..|..||++|.++..............--..|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 34556678899999999999776 8999999999999999999999999988654332211111112224667775443
Q ss_pred CCcCcchhHHHHHHHHHHHHhCCC
Q 003780 679 MVVTEKCDVYSFGVVALEVLMGRH 702 (796)
Q Consensus 679 ~~~~~~~DVwSlGv~l~elltg~~ 702 (796)
.. -..|.|.|||+++|++.|..
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCccc
Confidence 32 34699999999999999943
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=8e-13 Score=152.85 Aligned_cols=93 Identities=35% Similarity=0.585 Sum_probs=83.3
Q ss_pred ccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcccc-ccccceEEec
Q 003780 290 QLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLS 368 (796)
Q Consensus 290 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~L~~L~l~ 368 (796)
.++.|+|++|.++|.+|..+..+++|+.|+|++|++.|.+|..++.+++|+.|+|++|+++|.+|..++ +++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 478889999999999999999999999999999999999999999999999999999999999998774 7889999999
Q ss_pred ccccCCCCCccccc
Q 003780 369 HNKLNGTIPPFLYH 382 (796)
Q Consensus 369 ~N~l~~~~p~~~~~ 382 (796)
+|+++|.+|..+..
T Consensus 499 ~N~l~g~iP~~l~~ 512 (623)
T PLN03150 499 GNSLSGRVPAALGG 512 (623)
T ss_pred CCcccccCChHHhh
Confidence 99999999977643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.7e-13 Score=139.77 Aligned_cols=227 Identities=24% Similarity=0.192 Sum_probs=154.2
Q ss_pred EEeccCCcccccCCcCc----cCCCCCcEeecccCcCCCCCC--CCCCCCCCCCEEEecCCCCCCCCc--hhhhccCccc
Q 003780 101 SLSLRFNYLFGSIPSQV----GALSKLRYLDFSFNNLTGSIP--PELGSLRNLEVLNLKGNNLNGAIP--SSLCQLTKLI 172 (796)
Q Consensus 101 ~L~L~~n~l~~~~~~~~----~~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~ 172 (796)
.+.+++-.+.++--+.+ .++.+|+...|.+..+. ..+ .....+++++.||||+|-+....| .-...|++|+
T Consensus 97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le 175 (505)
T KOG3207|consen 97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLE 175 (505)
T ss_pred HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccch
Confidence 45555555554333323 45677888888877766 222 355678888888888888775332 3446788888
Q ss_pred eeeccccccCCCCCcc-ccCCCCccEEEcccccccCc-chhhhcCCCCccccccCCccccccCCCcccccCccceEEecc
Q 003780 173 TMALSRNGLHGPIPSA-IGDLNNLLILSLDSNKLSGM-LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHS 250 (796)
Q Consensus 173 ~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~ 250 (796)
.|+|+.|++....... -..++.|+.|.|+.|.|+.. +...+..+|+|+.|+|..|....+.......+..|++|+|++
T Consensus 176 ~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~ 255 (505)
T KOG3207|consen 176 NLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSN 255 (505)
T ss_pred hcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccC
Confidence 8888888887332221 22467888888988888732 334566788899999998864434444555677889999999
Q ss_pred ccccccC-CccccCCcccceeeccccccccc-Cccc-----cccccccccccccCccccCc-cccccccccccceecccc
Q 003780 251 NHLNGSI-PPEIGNMTGILKVDMSMNNIEGT-IPLE-----LTRLSQLLYLSISSNMLSGQ-IPITIAGLISLKGLDLSN 322 (796)
Q Consensus 251 N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~-~p~~-----l~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~Ls~ 322 (796)
|++.... -...+.++.|..|+++.+.+... .|+. ...+++|++|+++.|++... --..+..+++|+.|.+..
T Consensus 256 N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~ 335 (505)
T KOG3207|consen 256 NNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITL 335 (505)
T ss_pred CcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccc
Confidence 8887322 13567788888888888888753 2332 35678899999999988531 223455677888888888
Q ss_pred cccccC
Q 003780 323 NKLSGP 328 (796)
Q Consensus 323 N~l~~~ 328 (796)
|.++.+
T Consensus 336 n~ln~e 341 (505)
T KOG3207|consen 336 NYLNKE 341 (505)
T ss_pred cccccc
Confidence 888743
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.1e-12 Score=135.15 Aligned_cols=210 Identities=21% Similarity=0.226 Sum_probs=145.0
Q ss_pred CCCCCCCEEEecCCCCCCCCc--hhhhccCccceeeccccccCCC--CCccccCCCCccEEEcccccccCcchh-hhcCC
Q 003780 142 GSLRNLEVLNLKGNNLNGAIP--SSLCQLTKLITMALSRNGLHGP--IPSAIGDLNNLLILSLDSNKLSGMLHQ-ELGKL 216 (796)
Q Consensus 142 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l 216 (796)
.++.+|+...|.+.... ..+ .....+++++.|||++|-+... +-.....|++|+.|+|+.|++.....+ .-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45778888888888776 333 4667788888888888888743 224456788888888888888743332 22356
Q ss_pred CCccccccCCcccccc-CCCcccccCccceEEeccccccccCCccccCCcccceeeccccccccc-Cccccccccccccc
Q 003780 217 KNLVALNVGGNKLMGP-IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGT-IPLELTRLSQLLYL 294 (796)
Q Consensus 217 ~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L 294 (796)
+.|+.|.|+.|.|+.- +-..+..+|+|+.|+|..|...+.-......+..|+.|||++|++-.. .-...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 7788888888888732 223445678888888888863333334445577888888888887632 12456778888888
Q ss_pred cccCccccCcc-ccc-----cccccccceecccccccccC-CCcccCCCCCCcEEEeecccccCC
Q 003780 295 SISSNMLSGQI-PIT-----IAGLISLKGLDLSNNKLSGP-IPPEIGKCSELRNITLRNNNLSGS 352 (796)
Q Consensus 295 ~l~~N~l~~~~-~~~-----~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~ 352 (796)
+++.+.+...- |.. ...+++|++|+++.|++..- --..+..+++|+.|.+..|.++..
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 88888887532 322 35678888888888888531 123455677888888888888754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.4e-12 Score=136.86 Aligned_cols=249 Identities=24% Similarity=0.248 Sum_probs=178.5
Q ss_pred CCccceeeec--ccceeEEEEEc---cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEeccee
Q 003780 500 DFDIKYCIGT--GGYGSVYKAQL---PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 500 ~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 573 (796)
.|.+...+|. |.+|.||.+.. .++..+|+|+-+........ ...=.+|+....+++ |+|.++.+..+...+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCcc
Confidence 5667788999 99999999965 46889999985443332111 112345677777775 99999988889999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHH----HHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEeee
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN----ALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADF 648 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Df 648 (796)
++-+|++. .++.++.+.... .++....+.+..+..+ |+.++|+. .++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 99999886 577777765432 2566667777778878 99999999 99999999999999999 78899999
Q ss_pred ccccccCCCCCCcccc-----ccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 649 GTARLLDSDSSNRTIV-----AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|+...+.......... .|...|++||...+ .++.++|+|++|.+..+-.+|..+........+....+.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~----- 341 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG----- 341 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-----
Confidence 9998887654332222 57788999998655 568899999999999999998766442100000000000
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.+..++-+ .....+...+..|++.+|..|++.+++..+
T Consensus 342 ----~ip~e~~~---~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 342 ----YIPLEFCE---GGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ----cCchhhhc---CcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 01111111 111224458889999999999999887655
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1e-12 Score=145.62 Aligned_cols=246 Identities=28% Similarity=0.336 Sum_probs=119.0
Q ss_pred CCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceee
Q 003780 96 FPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMA 175 (796)
Q Consensus 96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 175 (796)
+..++.++++.|.+.. +-..+..+.+|+.|+|.+|.|.. +...+..+++|++|+|++|+|+.. ..+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhhe
Confidence 3445555566665553 22335555666666666666652 222255566666666666666644 2344445566666
Q ss_pred ccccccCCCCCccccCCCCccEEEcccccccCcch-hhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 176 LSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 176 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
+++|.|+.. ..+..+++|+.+++++|++..+.+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|.++
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 666666532 233335556666666665554433 2 34455555555555555421 22333334444455555554
Q ss_pred ccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccC
Q 003780 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
..-+ +..+.. ..|+.+++++|++. ..+..+..+..+..|++.+|++... ..+.
T Consensus 222 ~~~~--l~~~~~----------------------~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~ 274 (414)
T KOG0531|consen 222 KLEG--LNELVM----------------------LHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLE 274 (414)
T ss_pred eccC--cccchh----------------------HHHHHHhcccCccc-cccccccccccccccchhhcccccc--cccc
Confidence 2211 111111 02445555555444 2223344445555555555555432 2233
Q ss_pred CCCCCcEEEeecccccCC---CCc--cccccccceEEecccccCCCCC
Q 003780 335 KCSELRNITLRNNNLSGS---IPP--EIGLMKLEYLDLSHNKLNGTIP 377 (796)
Q Consensus 335 ~l~~L~~L~L~~N~l~~~---~~~--~~~~~~L~~L~l~~N~l~~~~p 377 (796)
..+.+..+.+..|.+... ... ....++++.+.+.+|.+....+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 275 RLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 344555555555555421 111 1124566666777776665444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=6e-12 Score=140.39 Aligned_cols=149 Identities=19% Similarity=0.195 Sum_probs=96.1
Q ss_pred HhcCCccceeeecccceeEEEEEccC-CcEEEEEEeccccchh-------------------------------hHHHHH
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEE-------------------------------TTFFNS 544 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-------------------------------~~~~~~ 544 (796)
....|+. +.||+|++|.||+|+.++ |+.||||+.++..... .+..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999887 9999999998652110 011122
Q ss_pred ------HHHHHHHHhhcC----CCceeeEEeEEEe-cceeeEEEeeccCCcHHHHH--hhcC-cccccCHHHHHHHHHHH
Q 003780 545 ------FQNEAHVLSKIA----HRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFL--RNDY-EAVVLDWTMRVNIIKCV 610 (796)
Q Consensus 545 ------~~~E~~~l~~l~----hpniv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~~i 610 (796)
+.+|+.-+.+++ +...+.+-..+.+ ....++||||++|+.+.+.- ...+ ....+.......++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 333444344332 3333433333322 34678999999999997742 2211 11112222233333333
Q ss_pred HHHHHHHhhcCCCCeEEecCCCCCeEecCCC----cEEEeeeccccccCC
Q 003780 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKL----EAFVADFGTARLLDS 656 (796)
Q Consensus 611 a~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 656 (796)
... |++|+|++|.||+++.++ .++++|||++..++.
T Consensus 277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 899999999987754
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.4e-13 Score=146.64 Aligned_cols=246 Identities=26% Similarity=0.287 Sum_probs=139.7
Q ss_pred cCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccE
Q 003780 118 GALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLI 197 (796)
Q Consensus 118 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 197 (796)
..+..++.+++..|.|.. +-..+..+++|+.|+|.+|+|..+ ...+..+++|++|+|++|.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~--------------- 131 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKIT--------------- 131 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccc---------------
Confidence 344555555566666652 233355556666666666666532 222444445555555555544
Q ss_pred EEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCC-ccccCCcccceeeccccc
Q 003780 198 LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP-PEIGNMTGILKVDMSMNN 276 (796)
Q Consensus 198 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~ 276 (796)
.+ ..+..++.|+.|++++|.|+.. ..+..++.|+.+++++|+++..-+ . ...+.+++.++++.|.
T Consensus 132 ---------~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~ 197 (414)
T KOG0531|consen 132 ---------KL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNS 197 (414)
T ss_pred ---------cc--cchhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCc
Confidence 33 2233344455555555555522 234445666666666666653322 1 3556666667777776
Q ss_pred ccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcc
Q 003780 277 IEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPE 356 (796)
Q Consensus 277 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 356 (796)
+... ..+..+..+..+++..|.++..-+........|+.+++++|.+. ..+..+..+..+..|++.+|++... ...
T Consensus 198 i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~-~~~ 273 (414)
T KOG0531|consen 198 IREI--EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL-EGL 273 (414)
T ss_pred hhcc--cchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc-ccc
Confidence 6532 23444555666677788777433222111114899999999998 3446678889999999999999843 222
Q ss_pred ccccccceEEecccccCCC---CC----ccccccccccccCCCCcccCC
Q 003780 357 IGLMKLEYLDLSHNKLNGT---IP----PFLYHRFPLDLSYNDLEGEIP 398 (796)
Q Consensus 357 ~~~~~L~~L~l~~N~l~~~---~p----~~~~~~~~l~l~~N~l~~~~p 398 (796)
-..+.+..+.+..|++... .. ........+.+.+|......+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 274 ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 3456778888888887632 11 112233456777776665444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.3e-12 Score=118.42 Aligned_cols=80 Identities=33% Similarity=0.413 Sum_probs=15.3
Q ss_pred CCcEEeccCCcccccCCcCcc-CCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhh-hccCccceee
Q 003780 98 GLESLSLRFNYLFGSIPSQVG-ALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSL-CQLTKLITMA 175 (796)
Q Consensus 98 ~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ 175 (796)
.+++|+|++|.|+.+ +.++ .+.+|+.||||+|.|+.. +.+..+++|++|+|++|+|+.. +..+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEE
Confidence 445555555555432 1233 344555555555555522 1344455555555555555532 2222 2344455555
Q ss_pred ccccccC
Q 003780 176 LSRNGLH 182 (796)
Q Consensus 176 L~~N~l~ 182 (796)
|++|+|.
T Consensus 95 L~~N~I~ 101 (175)
T PF14580_consen 95 LSNNKIS 101 (175)
T ss_dssp -TTS---
T ss_pred CcCCcCC
Confidence 5555544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-12 Score=126.69 Aligned_cols=129 Identities=29% Similarity=0.292 Sum_probs=77.1
Q ss_pred CCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEc
Q 003780 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSL 200 (796)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 200 (796)
..|++||||+|.|+ .+.+...-+|.++.|++|+|.|... +.+..|++|+.|||++|.++. +..+-..|.|.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeeh
Confidence 45666666666666 4445555556666666666666532 235666666666666666652 2333445566666666
Q ss_pred ccccccCcchhhhcCCCCccccccCCccccccC-CCcccccCccceEEeccccccc
Q 003780 201 DSNKLSGMLHQELGKLKNLVALNVGGNKLMGPI-PSTLFRLTNLTYLYLHSNHLNG 255 (796)
Q Consensus 201 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~ 255 (796)
+.|.|... ..++++-+|..||+++|+|.... -..++++|.|+.|.|.+|.+.+
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 66666532 34556666667777777665321 2356677777777777777764
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-11 Score=115.74 Aligned_cols=128 Identities=31% Similarity=0.401 Sum_probs=53.8
Q ss_pred CccCCCCCcEeecccCcCCCCCCCCCC-CCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCC
Q 003780 116 QVGALSKLRYLDFSFNNLTGSIPPELG-SLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNN 194 (796)
Q Consensus 116 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 194 (796)
.+.+..++++|+|++|.|+. + +.++ .+.+|+.|||++|.|+.. ..+..+++|++|++++|+|+...+.....+++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~ 89 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPN 89 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT
T ss_pred cccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCc
Confidence 35566789999999999994 3 3566 589999999999999954 35888999999999999999653333356899
Q ss_pred ccEEEcccccccCcch-hhhcCCCCccccccCCccccccCCC----cccccCccceEEe
Q 003780 195 LLILSLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPIPS----TLFRLTNLTYLYL 248 (796)
Q Consensus 195 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----~l~~l~~L~~L~L 248 (796)
|++|+|++|+|..... ..+..+++|+.|+|.+|.+... +. .+..+|+|+.||-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 9999999999986533 5678899999999999999843 22 4567899998874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.1e-11 Score=114.49 Aligned_cols=131 Identities=20% Similarity=0.208 Sum_probs=96.2
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCcee-eEEeEEEecceeeEEEeeccC
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV-KLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lV~e~~~~ 582 (796)
.+.++.|.++.||+++.. ++.|++|........ ...+..|+++++.+.+.+++ +++.+. ....++||||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 457899999999999875 778999987654321 12467889999988655544 444443 3345799999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC--MPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
.++.+. . . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 76 ~~l~~~--~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 887543 0 0 11345678999999999972 12369999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-12 Score=130.39 Aligned_cols=185 Identities=18% Similarity=0.177 Sum_probs=91.8
Q ss_pred CCCCCCcEEeccCCcccc----cCCcCccCCCCCcEeecccC---cCCCCCCCC-------CCCCCCCCEEEecCCCCCC
Q 003780 94 SCFPGLESLSLRFNYLFG----SIPSQVGALSKLRYLDFSFN---NLTGSIPPE-------LGSLRNLEVLNLKGNNLNG 159 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n---~l~~~~p~~-------~~~l~~L~~L~L~~N~l~~ 159 (796)
..+..++.|+||+|.+.. .+...+.+.++|+..++|+= ++...+|+. +...++|++||||.|-+..
T Consensus 27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~ 106 (382)
T KOG1909|consen 27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP 106 (382)
T ss_pred cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence 334556666666666642 23344555566666666642 222233332 3344567777777777654
Q ss_pred CCchh----hhccCccceeeccccccCCCCCcc-------------ccCCCCccEEEcccccccCcc----hhhhcCCCC
Q 003780 160 AIPSS----LCQLTKLITMALSRNGLHGPIPSA-------------IGDLNNLLILSLDSNKLSGML----HQELGKLKN 218 (796)
Q Consensus 160 ~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~ 218 (796)
..+.. +..++.|++|.|.+|.+.-.--.. ...-+.|+.+...+|++..-. ...|...+.
T Consensus 107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~ 186 (382)
T KOG1909|consen 107 KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPT 186 (382)
T ss_pred cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccc
Confidence 43333 334566777777777665211111 122345666666666655322 233445555
Q ss_pred ccccccCCcccccc----CCCcccccCccceEEecccccccc----CCccccCCcccceeeccccccc
Q 003780 219 LVALNVGGNKLMGP----IPSTLFRLTNLTYLYLHSNHLNGS----IPPEIGNMTGILKVDMSMNNIE 278 (796)
Q Consensus 219 L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 278 (796)
|+.+.++.|.|... +...|..+++|+.|||..|-|+.. +...+..+++|+.|+++++.+.
T Consensus 187 leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 187 LEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred cceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence 55555555555411 122344455555555555555421 1223333444444444444444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.1e-12 Score=131.91 Aligned_cols=98 Identities=26% Similarity=0.268 Sum_probs=52.5
Q ss_pred CccCCCCCcEeecccCcCCC----CCCCCCCCCCCCCEEEecCC---CCCCCCchhhhccCccceeeccccccCCCCCcc
Q 003780 116 QVGALSKLRYLDFSFNNLTG----SIPPELGSLRNLEVLNLKGN---NLNGAIPSSLCQLTKLITMALSRNGLHGPIPSA 188 (796)
Q Consensus 116 ~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~N---~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 188 (796)
....+..++.|+||+|.+.. .+.+.+.+.++|+..++|+= ++...+|.++..+ -..
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l-----------------~~a 87 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKML-----------------SKA 87 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHH-----------------HHH
Confidence 45566778888888887763 23334566677777777653 2222344433221 112
Q ss_pred ccCCCCccEEEcccccccCcch----hhhcCCCCccccccCCcccc
Q 003780 189 IGDLNNLLILSLDSNKLSGMLH----QELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 189 ~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~ 230 (796)
+...+.|++|+||+|-|....+ ..+..+.+|+.|.|.+|.+.
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg 133 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG 133 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC
Confidence 2333455555555555543322 22344566666666666654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.7e-10 Score=107.65 Aligned_cols=139 Identities=19% Similarity=0.192 Sum_probs=98.9
Q ss_pred eeeecccceeEEEEEccC-------CcEEEEEEeccccch----------h---------hHHHHHH----HHHHHHHhh
Q 003780 505 YCIGTGGYGSVYKAQLPN-------GKVVALKKLHRAETE----------E---------TTFFNSF----QNEAHVLSK 554 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~----------~---------~~~~~~~----~~E~~~l~~ 554 (796)
..||.|.-+.||.|...+ +..+|||+.+-.... + ....+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 579999987532100 0 0112233 389999999
Q ss_pred cCC--CceeeEEeEEEecceeeEEEeeccCCcHHH-HHhhcCcccccCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEecC
Q 003780 555 IAH--RNIVKLYGFCLHKKCMFLIYKYMKRGSLFC-FLRNDYEAVVLDWTMRVNIIKCVANALSYL-HHDCMPSIVHRDI 630 (796)
Q Consensus 555 l~h--pniv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~dl 630 (796)
+.. -++.+++++ ...++||||+.++.+.. .+++. .++......+..+++.+|.++ |.. ++||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 455566654 46789999998754421 22221 244455677889999999999 777 9999999
Q ss_pred CCCCeEecCCCcEEEeeeccccccC
Q 003780 631 SSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 631 kp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
++.||++++ +.+.++|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-11 Score=121.12 Aligned_cols=132 Identities=26% Similarity=0.292 Sum_probs=69.4
Q ss_pred CCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceee
Q 003780 192 LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271 (796)
Q Consensus 192 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 271 (796)
.+.|++||||+|.|+. +.++..-+|.++.|++++|.|... +.+..+++|+.|||++|.++ .+..+-..+.+++.|.
T Consensus 283 Wq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 3455556666665552 233344455555555555555422 22455555555555555555 3333333444455555
Q ss_pred cccccccccCccccccccccccccccCccccCccccccccccccceecccccccccC-CCcccCCCCCCcEEEeeccccc
Q 003780 272 MSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGP-IPPEIGKCSELRNITLRNNNLS 350 (796)
Q Consensus 272 Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~ 350 (796)
|+.|.|... ..+..+-+|..||+++|++... --..++++|-|+.|.|.+|.+.
T Consensus 359 La~N~iE~L--------------------------SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 359 LAQNKIETL--------------------------SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhhHhhh--------------------------hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 555554421 1233334555556666655431 1245778888888888888887
Q ss_pred CCC
Q 003780 351 GSI 353 (796)
Q Consensus 351 ~~~ 353 (796)
+..
T Consensus 413 ~~v 415 (490)
T KOG1259|consen 413 GSV 415 (490)
T ss_pred ccc
Confidence 543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5e-11 Score=129.48 Aligned_cols=250 Identities=18% Similarity=0.167 Sum_probs=175.0
Q ss_pred HHhcCCccceeeecccceeEEEEEc--cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecce
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQL--PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 572 (796)
....+|..+..||.|.|+.|++... .++..|++|.+........... .-..|+-+...+ .|.+++++...+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 3456889999999999999999853 4688999998876654432211 123445444444 48888888877777777
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEeeeccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTA 651 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a 651 (796)
.++=-||+++++...... -...++...++++..|++.++.++|+. .++|+|+||+||++..+ +.-+++|||.+
T Consensus 341 ~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 789999999998776552 223477888899999999999999998 99999999999999986 77789999998
Q ss_pred cccCCCCCCccccccccCcc--CccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 652 RLLDSDSSNRTIVAGTYGYI--APELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
..+... .......-++. +|+......+..++|++|||.-+.+.++|..--.... +. ..+....
T Consensus 415 t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~----~~i~~~~ 479 (524)
T KOG0601|consen 415 TRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS----LTIRSGD 479 (524)
T ss_pred ccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc----eeeeccc
Confidence 743211 11112223344 5555566778889999999999999998875422111 00 1111121
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.+.... ....++.+.+.+..+++..||.+.+...+.+.
T Consensus 480 ~p~~~~----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 480 TPNLPG----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccCCCc----hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111111 11336677888999999999999888766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3e-11 Score=137.39 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=172.7
Q ss_pred HHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
...+.+.+.+.+-.|.++.++-+.-. .|...++|.......-....++....+-.+.-..++|-++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567777888889999999887532 34344444333222111111233333444444455677776665555566788
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+|++|..+++|...++.... .+.......+..+.++.+|||+. .+.|||++|.|.+...+++.+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999987652 44444455566678899999998 7999999999999999999999999843321
Q ss_pred CC---------------------CC----------CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCC
Q 003780 655 DS---------------------DS----------SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703 (796)
Q Consensus 655 ~~---------------------~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p 703 (796)
.- .. .......||+.|.+||...+......+|+|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 00 011224589999999999999999999999999999999999999
Q ss_pred CcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 003780 704 GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQ 763 (796)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 763 (796)
|.... .+..+..+.......... +.....+..+++...+..+|.+|-.|.
T Consensus 1035 ~na~t--------pq~~f~ni~~~~~~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAET--------PQQIFENILNRDIPWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcc--------hhhhhhccccCCCCCCCC--ccccChhhhhhhhhhhccCchhccCcc
Confidence 88432 233333444433333221 222334467888899999999997776
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.6e-09 Score=100.91 Aligned_cols=133 Identities=21% Similarity=0.338 Sum_probs=100.2
Q ss_pred eeecccceeEEEEEccCCcEEEEEEe-cc----ccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeec
Q 003780 506 CIGTGGYGSVYKAQLPNGKVVALKKL-HR----AETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 506 ~lg~G~~g~Vy~~~~~~g~~vavK~~-~~----~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
.+++|+-+.+|.+.+. |..+++|.= .+ +..+..-......+|+.++.+++--.|-...=+..+++...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775 444555532 22 22222222346788999999987555555555666788888999999
Q ss_pred cCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 581 KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
+|..|.+.+... ...++..+-+-+.-||.. +|+|+||.++||.+..+. +.++|||++.+
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888754 245677777888899999 999999999999998865 99999999974
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-10 Score=136.61 Aligned_cols=273 Identities=25% Similarity=0.255 Sum_probs=128.1
Q ss_pred CCCCcEEeccCCcccccCCcCccCCCCCcEeecccCc--CCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 96 FPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN--LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
....+...+-+|.+.. ++.... .++|++|-+..|. +....++.|..++.|+.|||++|.=.+.+|..++.|-+|++
T Consensus 522 ~~~~rr~s~~~~~~~~-~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIEH-IAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hhheeEEEEeccchhh-ccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 3445555555555542 222222 2256666666654 33233333555666666666665544556666666666666
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc--ccCCCcccccCccceEEeccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM--GPIPSTLFRLTNLTYLYLHSN 251 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~l~~l~~L~~L~L~~N 251 (796)
|+|++..++ .+|..+.+|..|.+|++..+.-...++.....+++|++|.+..-... ...-..+.++.+|+.|.....
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 666666665 45566666666666666655544444555555666666655544311 111222333444444443222
Q ss_pred cccccCCccccCCcccc----eeecccccccccCccccccccccccccccCccccCcccccccc------ccccceeccc
Q 003780 252 HLNGSIPPEIGNMTGIL----KVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG------LISLKGLDLS 321 (796)
Q Consensus 252 ~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~------l~~L~~L~Ls 321 (796)
.. .+-..+..++.|. .+.+.++... ..+.++..+.+|+.|.+.++.+.......... ++++..+...
T Consensus 679 s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~ 755 (889)
T KOG4658|consen 679 SV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSIL 755 (889)
T ss_pred hh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhh
Confidence 22 0111122222222 2222222222 33445566666666666666665322222111 2222222222
Q ss_pred ccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCC
Q 003780 322 NNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGT 375 (796)
Q Consensus 322 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~ 375 (796)
++... ..+.+.--.++|+.|++..+.....+.+.. .+..+..+-+..+.+.+.
T Consensus 756 ~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 756 NCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred ccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 22211 222333345777777777766554433332 344555555666665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-09 Score=109.10 Aligned_cols=143 Identities=20% Similarity=0.221 Sum_probs=108.9
Q ss_pred eeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC--CceeeEEeEEEec---ceeeEEEee
Q 003780 505 YCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH--RNIVKLYGFCLHK---KCMFLIYKY 579 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~---~~~~lV~e~ 579 (796)
+.++.|..+.||++...+|+.+++|........ .....+..|+++++.+++ ..+.+++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998877789999987655432 123468899999999975 3457777777654 367899999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC-------------------------------------- 621 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 621 (796)
++++++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888765431 12566677778888888888887521
Q ss_pred ---------------CCCeEEecCCCCCeEecC--CCcEEEeeeccccc
Q 003780 622 ---------------MPSIVHRDISSNNILLNS--KLEAFVADFGTARL 653 (796)
Q Consensus 622 ---------------~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~ 653 (796)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56688999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.9e-09 Score=96.43 Aligned_cols=146 Identities=18% Similarity=0.250 Sum_probs=105.9
Q ss_pred cceeeecccceeEEEEEccCCcEEEEEEec-----cccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 503 IKYCIGTGGYGSVYKAQLPNGKVVALKKLH-----RAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 503 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~-----~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
....+.+|+-+.|+++.+. |+.+.||.=. .+..+..-..+...+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999885 7777776332 222222223456789999999887545544444556666777999
Q ss_pred eeccC-CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc---EEEeeeccccc
Q 003780 578 KYMKR-GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE---AFVADFGTARL 653 (796)
Q Consensus 578 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~a~~ 653 (796)
||+++ .++.+++.........+ ......+..|-+.+.-||.. +|+|+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 47788876654332222 22367888899999999999 9999999999999976653 47999999864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.2e-10 Score=132.95 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=166.8
Q ss_pred CCCcEEeccCCc--ccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcccee
Q 003780 97 PGLESLSLRFNY--LFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 97 ~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 174 (796)
+.|++|-+..|. +..+.+..|..++.|++||||+|.=-+.+|..+++|-+|++|+|++..++ .+|..+.+|++|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 478899999886 55454556888999999999998766789999999999999999999999 889999999999999
Q ss_pred eccccccCCCCCccccCCCCccEEEccccc--ccCcchhhhcCCCCccccccCCccccccCCCcccccCccc----eEEe
Q 003780 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSNK--LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLT----YLYL 248 (796)
Q Consensus 175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~----~L~L 248 (796)
++..+.-...+|.....|++|++|.|..-. .....-..+.++.+|+.|........ +-..+..++.|. .+.+
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~--~~e~l~~~~~L~~~~~~l~~ 701 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVL--LLEDLLGMTRLRSLLQSLSI 701 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhH--hHhhhhhhHHHHHHhHhhhh
Confidence 999988776778888889999999987654 22333445566666666665443331 111222333333 3333
Q ss_pred ccccccccCCccccCCcccceeecccccccccCcccccc------ccccccccccCccccCccccccccccccceecccc
Q 003780 249 HSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTR------LSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSN 322 (796)
Q Consensus 249 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 322 (796)
.++... ..+..+..+.+|+.|.+.+..+.......+.. ++++..+...++..- ..+.+..-.++|+.|.+..
T Consensus 702 ~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~ 779 (889)
T KOG4658|consen 702 EGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVS 779 (889)
T ss_pred cccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEec
Confidence 333333 44556777888888888877776433322221 122222222222211 2233334457888888888
Q ss_pred cccccCCCcccCCCCCCcEEEeecccccCC
Q 003780 323 NKLSGPIPPEIGKCSELRNITLRNNNLSGS 352 (796)
Q Consensus 323 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 352 (796)
+.....+.+....+..+..+-+..+.+.+.
T Consensus 780 ~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 780 CRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred ccccccCCCHHHHhhhcccEEecccccccc
Confidence 887766666666677777667777777654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=9.8e-10 Score=85.74 Aligned_cols=61 Identities=44% Similarity=0.548 Sum_probs=38.8
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCC
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNL 157 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l 157 (796)
|+|++|++++|++..+.+..|.++++|++|++++|.|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666666556666666666666666666655556666666666666666654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.3e-09 Score=84.97 Aligned_cols=57 Identities=40% Similarity=0.538 Sum_probs=21.2
Q ss_pred CCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccc
Q 003780 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSN 203 (796)
Q Consensus 147 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 203 (796)
|++|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333333333333332333333333333333333333333333333333333333333
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=4e-08 Score=94.99 Aligned_cols=129 Identities=24% Similarity=0.318 Sum_probs=84.2
Q ss_pred eEEEEEccCCcEEEEEEeccccc-----------------------hhhHHHHHHHHHHHHHhhcCCC--ceeeEEeEEE
Q 003780 514 SVYKAQLPNGKVVALKKLHRAET-----------------------EETTFFNSFQNEAHVLSKIAHR--NIVKLYGFCL 568 (796)
Q Consensus 514 ~Vy~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~ 568 (796)
.||.|...+|..+|+|..+.... ..........+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999988999999998754210 0111234578999999999755 456666543
Q ss_pred ecceeeEEEeecc--CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHH-HhhcCCCCeEEecCCCCCeEecCCCcEEE
Q 003780 569 HKKCMFLIYKYMK--RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY-LHHDCMPSIVHRDISSNNILLNSKLEAFV 645 (796)
Q Consensus 569 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~dlkp~NIll~~~~~~kl 645 (796)
..++||||++ |..+..+.... ++......++.++++.+.. +|.. ||+|+|+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 4579999999 65565444322 1123345677777775555 4677 99999999999999988 9999
Q ss_pred eeeccccccC
Q 003780 646 ADFGTARLLD 655 (796)
Q Consensus 646 ~Dfg~a~~~~ 655 (796)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.5e-07 Score=96.70 Aligned_cols=144 Identities=19% Similarity=0.135 Sum_probs=101.4
Q ss_pred eeeecccceeEEEEEccCCcEEEEEEeccccchhh--------HHHHHHHHHHHHHhhcCCC--ceeeEEeEEEe-----
Q 003780 505 YCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEET--------TFFNSFQNEAHVLSKIAHR--NIVKLYGFCLH----- 569 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~----- 569 (796)
+.+-+.....|+++.. +|+.|.||+......... .....+.+|...+.++... .+.+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455455555777765 578999997754432110 0011477888888887432 23445555543
Q ss_pred cceeeEEEeeccCC-cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-------CC
Q 003780 570 KKCMFLIYKYMKRG-SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-------KL 641 (796)
Q Consensus 570 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-------~~ 641 (796)
....++|+|++++. +|.+++.... ....+...+..++.++++.+.-||.. ||+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999986 8988875422 12345667788999999999999999 9999999999999975 46
Q ss_pred cEEEeeeccccc
Q 003780 642 EAFVADFGTARL 653 (796)
Q Consensus 642 ~~kl~Dfg~a~~ 653 (796)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998864
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.75 E-value=7e-10 Score=109.16 Aligned_cols=84 Identities=29% Similarity=0.356 Sum_probs=42.9
Q ss_pred CCCCcEeecccCcCCC--CCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCC-CCCccccCCCCcc
Q 003780 120 LSKLRYLDFSFNNLTG--SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLL 196 (796)
Q Consensus 120 l~~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~ 196 (796)
.++++.|||.+|.|+. .+-..+.+||.|++|+|+.|+++..|...-..+.+|+.|.|.+..+.- .....+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3556666666666652 222234556666666666666653332111344556666665555541 1223344455555
Q ss_pred EEEcccc
Q 003780 197 ILSLDSN 203 (796)
Q Consensus 197 ~L~L~~N 203 (796)
.|++|.|
T Consensus 150 elHmS~N 156 (418)
T KOG2982|consen 150 ELHMSDN 156 (418)
T ss_pred hhhhccc
Confidence 5555555
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.1e-07 Score=97.84 Aligned_cols=169 Identities=20% Similarity=0.311 Sum_probs=128.6
Q ss_pred ceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEE----ecceeeEEEeeccC-CcH
Q 003780 512 YGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCL----HKKCMFLIYKYMKR-GSL 585 (796)
Q Consensus 512 ~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~lV~e~~~~-gsL 585 (796)
..+.|++. ..||..|+.|+++..+..... ....-+++.+++.|+|||++.+++. .+...++||+|+++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35778995 458999999999766544321 2334578899999999999998876 34578999999986 477
Q ss_pred HHHHhhcC------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 586 FCFLRNDY------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 586 ~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
.++.-... +....++...+.++.|++.||.++|+. |..-+-|.+++|+++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 76643211 223467889999999999999999999 999999999999999999999998888876
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCC
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p 703 (796)
+..+.. |-+.+ -.+-|.=.||.+++.|.||..-
T Consensus 443 l~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 443 LQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 654431 11111 1356888999999999999644
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.3e-07 Score=93.61 Aligned_cols=258 Identities=15% Similarity=0.192 Sum_probs=152.6
Q ss_pred ccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEE------Eec-cee
Q 003780 502 DIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFC------LHK-KCM 573 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~------~~~-~~~ 573 (796)
...+.+|+|+-+.+|-.-. -+..+.|+.+....... .+.++.|... .||-+-.=+.|= -.+ ...
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 3457799999999997622 12235577776554321 1123334433 466433211111 111 224
Q ss_pred eEEEeeccCC-cHHHHH---hhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 574 FLIYKYMKRG-SLFCFL---RNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 574 ~lV~e~~~~g-sL~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
-+.|..+++. ....+. ++...-...+|...++.+..+|.+.+.||.. |.+-+|+.++|+|+++++.+.+.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 5667766654 222222 1222234578999999999999999999999 99999999999999999999998855
Q ss_pred cccccCCCCCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhC-CCCCcccccCCCCCchhhhHHH-
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMG-RHPGELLSSLSSPSSDQKIMLI- 722 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~- 722 (796)
.-.... ......-..|...|.+||... +..-+...|-|.+|+++++++.| +.||.............+..+.
T Consensus 163 sfqi~~-ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQINA-NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceeecc-CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 433321 222223345888999999754 33455678999999999999987 8998754332211111110110
Q ss_pred -H-----hhcCCCCCccchhhHH-HHHHHHHHHHHcCCCC--CCCCCCHHHHHHHHhh
Q 003780 723 -D-----VLDSRLSPPVDRMVMQ-DIVLVTTVALACLHSK--PKFRPTMQRVCQEFLT 771 (796)
Q Consensus 723 -~-----~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~ 771 (796)
. .-.....+....-+.. -...+.-+..+|+... |.-|||++.-+..|.+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 0 0011111111110111 1223666777887653 5679999877766544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.3e-07 Score=90.80 Aligned_cols=138 Identities=23% Similarity=0.248 Sum_probs=98.0
Q ss_pred CccceeeecccceeEEEEEccCCcEEEEEEeccccch-----------------h--hHHHHHHHHHHHHHhhcCCC--c
Q 003780 501 FDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETE-----------------E--TTFFNSFQNEAHVLSKIAHR--N 559 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~--~~~~~~~~~E~~~l~~l~hp--n 559 (796)
..+...||.|.-+.||.|..++|.++|||.=+..... . ........+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4556789999999999999999999999943211000 0 01123567899999998754 6
Q ss_pred eeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 560 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
|.+.+++ +...+||||++|--|...- ++......++..|++-+..+-.. |+||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 6666654 3567999999996664321 12333344555555555555566 9999999999999999
Q ss_pred CCcEEEeeeccccc
Q 003780 640 KLEAFVADFGTARL 653 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~ 653 (796)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.9e-10 Score=121.16 Aligned_cols=125 Identities=26% Similarity=0.262 Sum_probs=62.0
Q ss_pred cceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccc
Q 003780 243 LTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSN 322 (796)
Q Consensus 243 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 322 (796)
|...+.+.|++. ....++.-++.|+.|+|++|+++... .+..++.|++|||++|.+.-..--...++ .|..|.|++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lrn 241 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLRN 241 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hheeeeecc
Confidence 444455555554 33334444455555555555555332 44555555555555555552211112222 255566666
Q ss_pred cccccCCCcccCCCCCCcEEEeecccccCCC--CccccccccceEEecccccC
Q 003780 323 NKLSGPIPPEIGKCSELRNITLRNNNLSGSI--PPEIGLMKLEYLDLSHNKLN 373 (796)
Q Consensus 323 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~~~L~~L~l~~N~l~ 373 (796)
|.++.. ..+.++.+|+.|||++|-|.+.- ...+.+..|+.|+|.+|++.
T Consensus 242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 655421 33455566666666666665421 22223556666666666664
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.4e-08 Score=111.97 Aligned_cols=152 Identities=20% Similarity=0.245 Sum_probs=100.8
Q ss_pred HHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCc----c-----ccccccCccCccccc
Q 003780 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR----T-----IVAGTYGYIAPELAY 677 (796)
Q Consensus 607 ~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~----~-----~~~gt~~y~aPE~~~ 677 (796)
+.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+.+....+..... + ...-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34556899999987 489999999999999999999999999876544321110 0 112345799999999
Q ss_pred cCCcCcchhHHHHHHHHHHHHhCCCC-CcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCC
Q 003780 678 TMVVTEKCDVYSFGVVALEVLMGRHP-GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKP 756 (796)
Q Consensus 678 ~~~~~~~~DVwSlGv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 756 (796)
....+.++|+||+||++|.+..|..+ ++......... ... ...+..... . ...-+.++.+=+.+++..++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~~~-~~~~~~~~~-~---s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----FSR-NLLNAGAFG-Y---SNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh----hhh-ccccccccc-c---cccCcHHHHHHHHHHhcCCc
Confidence 98888999999999999999955554 33221110000 000 000000000 0 11122346677788999999
Q ss_pred CCCCCHHHHHHHH
Q 003780 757 KFRPTMQRVCQEF 769 (796)
Q Consensus 757 ~~RPs~~evl~~L 769 (796)
..||++.++....
T Consensus 254 ~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 254 AVRPTLDLLLSIP 266 (700)
T ss_pred ccCcchhhhhccc
Confidence 9999888776653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-09 Score=119.16 Aligned_cols=127 Identities=28% Similarity=0.278 Sum_probs=68.0
Q ss_pred ccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEec
Q 003780 170 KLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLH 249 (796)
Q Consensus 170 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~ 249 (796)
+|...+.+.|.+. .+..++.-++.|+.|+|++|+++... .+..++.|+.|||+.|.+....--...++ +|+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence 4555555566655 34445555566666666666665442 55556666666666666652221122222 36666666
Q ss_pred cccccccCCccccCCcccceeecccccccccCc-cccccccccccccccCcccc
Q 003780 250 SNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIP-LELTRLSQLLYLSISSNMLS 302 (796)
Q Consensus 250 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~ 302 (796)
+|.++.. ..+.++.+|+.||+++|-|.+.-- ..+..+..|+.|+|.+|.+-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 6666522 234556666666666666654211 12344556666666666654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2e-08 Score=99.16 Aligned_cols=62 Identities=35% Similarity=0.425 Sum_probs=28.2
Q ss_pred CCCCCEEEecCCCCCC--CCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccc
Q 003780 144 LRNLEVLNLKGNNLNG--AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL 205 (796)
Q Consensus 144 l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 205 (796)
.+.+++|||.+|+|+. .+-.-+.+++.|+.|+|+.|++...+...-..+.+|+.|-|.+..+
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L 133 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGL 133 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCC
Confidence 3455666666666653 2222334555555555555555432221112334444444444433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.3e-06 Score=82.08 Aligned_cols=140 Identities=16% Similarity=0.119 Sum_probs=101.3
Q ss_pred ecccceeEEEEEccCCcEEEEEEeccccchh---hHHHHHHHHHHHHHhhcCC--CceeeEEeEEEe---c--ceeeEEE
Q 003780 508 GTGGYGSVYKAQLPNGKVVALKKLHRAETEE---TTFFNSFQNEAHVLSKIAH--RNIVKLYGFCLH---K--KCMFLIY 577 (796)
Q Consensus 508 g~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~---~--~~~~lV~ 577 (796)
|.||-+.|++.... |+.+-+|+-...-... ......|.+|+..+.++.. -.+.++. ++.. + -..+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 66888889998764 4578888765221111 1124579999999998852 2244444 3321 1 2467999
Q ss_pred eeccC-CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc--EEEeeeccccc
Q 003780 578 KYMKR-GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE--AFVADFGTARL 653 (796)
Q Consensus 578 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~ 653 (796)
|-+++ -+|.+++.+.. ....+...+..++.++++.+.-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 48988886532 22467777889999999999999999 9999999999999986667 89999976653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.9e-08 Score=88.06 Aligned_cols=84 Identities=24% Similarity=0.269 Sum_probs=44.1
Q ss_pred CCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeec
Q 003780 193 NNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDM 272 (796)
Q Consensus 193 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 272 (796)
..|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|..+..++.|+.|+++.|.+. ..|..+..+.++-.|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 34444455555555444444444445555555555555 34555555556666666665555 34444444555555555
Q ss_pred cccccc
Q 003780 273 SMNNIE 278 (796)
Q Consensus 273 s~N~l~ 278 (796)
.+|.+.
T Consensus 131 ~~na~~ 136 (177)
T KOG4579|consen 131 PENARA 136 (177)
T ss_pred CCCccc
Confidence 555544
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.4e-08 Score=87.42 Aligned_cols=105 Identities=22% Similarity=0.314 Sum_probs=61.2
Q ss_pred CCcEeecccCcCCCCCCCCC---CCCCCCCEEEecCCCCCCCCchhh-hccCccceeeccccccCCCCCccccCCCCccE
Q 003780 122 KLRYLDFSFNNLTGSIPPEL---GSLRNLEVLNLKGNNLNGAIPSSL-CQLTKLITMALSRNGLHGPIPSAIGDLNNLLI 197 (796)
Q Consensus 122 ~L~~L~Ls~n~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 197 (796)
.+..||||.+.|- -+++.. .....|+..+|++|.+.. .|..| ...+.++.|+|++|+|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4556677776654 344433 333455555777777763 34444 33446666777777766 34555666666666
Q ss_pred EEcccccccCcchhhhcCCCCccccccCCcccc
Q 003780 198 LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 198 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 230 (796)
|+++.|.+. ..|..+..+.+|..|+..+|.+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 666666665 33444555666666666666665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 796 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-42 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-42 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-32 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-32 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-26 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-26 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-26 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-26 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-26 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-26 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-26 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-26 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-26 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-26 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-26 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-25 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-25 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-25 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-25 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-24 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 7e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 796 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-102 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-100 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-100 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-94 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-92 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-86 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-90 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 8e-86 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-85 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-79 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-74 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-70 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-69 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-67 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-66 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-65 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-64 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-54 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-49 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-18 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-67 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-65 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-61 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-60 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-57 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-62 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-62 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-59 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-58 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-54 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-53 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-53 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-49 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-31 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-57 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-56 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-53 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-26 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-16 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-57 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-54 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-54 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-54 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-50 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-49 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-49 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-34 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-33 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-24 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-54 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-54 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-53 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-52 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-51 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-51 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-50 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-49 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-37 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-25 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 9e-50 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-48 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-48 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-48 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-44 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-44 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-43 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-38 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-37 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-23 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-39 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-32 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-20 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-07 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-47 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-44 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-40 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-46 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-41 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-44 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-42 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-41 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-29 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-05 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-41 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-40 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-39 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-40 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-37 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-40 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-34 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-30 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-29 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-40 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-35 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-27 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 7e-11 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 7e-39 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 8e-39 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-38 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-25 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-38 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-37 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-37 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-36 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-33 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-37 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-36 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-32 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-28 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-26 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-37 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-37 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-35 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-14 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-37 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 7e-36 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-35 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-35 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-34 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-34 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-34 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-33 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-31 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-04 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-34 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-34 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 7e-34 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-34 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 8e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-33 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-33 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-33 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-33 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-33 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-33 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-33 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-32 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-33 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-33 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-33 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-33 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-33 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-33 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-33 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-33 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-33 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-33 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-32 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-32 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-32 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-32 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-32 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-32 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-32 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-32 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-32 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-32 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-32 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-32 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-32 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-32 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-31 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-31 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-31 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-25 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-05 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-25 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-04 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-31 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-22 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-31 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-31 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-30 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-20 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-20 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-30 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-30 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-30 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-30 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-30 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 8e-07 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-30 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-30 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-30 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-30 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-30 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-19 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-07 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-30 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-30 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-30 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-30 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-30 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-30 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-30 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-30 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-30 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 9e-30 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-30 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 9e-30 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-29 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-26 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-10 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-29 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-29 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-29 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 6e-29 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-28 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-28 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-28 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-28 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 9e-28 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 9e-28 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-27 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-27 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-17 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-27 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-27 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-27 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 9e-27 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-26 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-26 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-26 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-26 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-26 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-15 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-26 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-26 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-26 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-26 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-26 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-26 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-26 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-19 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-19 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-05 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 6e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-26 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 9e-26 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-25 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-25 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-25 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-25 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-25 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-25 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-25 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-25 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-18 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-25 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-25 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-24 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-24 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-24 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-23 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 7e-23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-20 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-22 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-22 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-22 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-15 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-22 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 7e-22 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-22 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-21 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-10 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-20 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-20 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-20 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-20 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 7e-14 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-20 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 7e-20 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-19 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-19 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-19 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 6e-19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-18 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-18 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-15 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-18 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-18 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-18 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-18 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-18 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-18 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-17 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-17 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-14 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-17 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-17 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 9e-17 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-05 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-15 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-12 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-15 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 6e-15 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-05 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-14 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-14 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 8e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-08 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-14 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-14 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-14 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-12 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-08 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-13 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-13 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-10 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-13 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-08 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-13 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 8e-13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 8e-13 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-12 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-12 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-12 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-12 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-12 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-12 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-12 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-12 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 7e-12 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 8e-12 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-11 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-10 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-10 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 8e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-04 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 7e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 9e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 8e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 9e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 8e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 8e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-04 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-102
Identities = 137/378 (36%), Positives = 188/378 (49%), Gaps = 22/378 (5%)
Query: 69 NTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDF 128
N ++ E+ L G++ +C L SL L FNYL G+IPS +G+LSKLR L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 129 SFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSA 188
N L G IP EL ++ LE L L N+L G IPS L T L ++LS N L G IP
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 189 IGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYL 248
IG L NL IL L +N SG + ELG ++L+ L++ N G IP+ +F+ + +
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----I 565
Query: 249 HSNHLNGSIPPEIGNMTGILKVDMSMNNIE--GTIPLELTRLSQLLYLSISSNMLSGQIP 306
+N + G I N + + N +E G +L RLS +I+S + G
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
Query: 307 ITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYL 365
T S+ LD+S N LSG IP EIG L + L +N++SGSIP E+G L L L
Sbjct: 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685
Query: 366 DLSHNKLNGTIPP------FLYHRFPLDLSYNDLEGEIPDY--FRDSPFKVY-GNQGIC- 415
DLS NKL+G IP L +DLS N+L G IP+ F P + N G+C
Sbjct: 686 DLSSNKLDGRIPQAMSALTMLTE---IDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742
Query: 416 -YFSACSTLHTPTASKSK 432
C + + +
Sbjct: 743 YPLPRCDPSNADGYAHHQ 760
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-100
Identities = 103/348 (29%), Positives = 160/348 (45%), Gaps = 17/348 (4%)
Query: 69 NTARSIIEINLPEKKLKGEL-SQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLD 127
N + S++ ++L G + + L+ L L+ N G IP + S+L L
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 128 FSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPS 187
SFN L+G+IP LGSL L L L N L G IP L + L T+ L N L G IPS
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 188 AIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLY 247
+ + NL +SL +N+L+G + + +G+L+NL L + N G IP+ L +L +L
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544
Query: 248 LHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQL--LYLSISSNMLSGQI 305
L++N NG+IP + +G ++ N I G + + + + + G
Sbjct: 545 LNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600
Query: 306 PITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEY 364
+ L + ++++ G P + + + N LSG IP EIG + L
Sbjct: 601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFI 660
Query: 365 LDLSHNKLNGTIPP------FLYHRFPLDLSYNDLEGEIPDYFRDSPF 406
L+L HN ++G+IP L LDLS N L+G IP
Sbjct: 661 LNLGHNDISGSIPDEVGDLRGLNI---LDLSSNKLDGRIPQAMSALTM 705
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-100
Identities = 107/336 (31%), Positives = 154/336 (45%), Gaps = 15/336 (4%)
Query: 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132
+ + + K+ G++ LE L + N IP +G S L++LD S N
Sbjct: 179 ELKHLAISGNKISGDVDVSRCV---NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234
Query: 133 LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAI-GD 191
L+G + + L++LN+ N G IP L L ++L+ N G IP + G
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 192 LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIP-STLFRLTNLTYLYLHS 250
+ L L L N G + G L +L + N G +P TL ++ L L L
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 251 NHLNGSIPPEIGNMTGILKV-DMSMNNIEGTIPLEL--TRLSQLLYLSISSNMLSGQIPI 307
N +G +P + N++ L D+S NN G I L + L L + +N +G+IP
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
Query: 308 TIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLD 366
T++ L L LS N LSG IP +G S+LR++ L N L G IP E+ + LE L
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 367 LSHNKLNGTIPPFLYHRFPL---DLSYNDLEGEIPD 399
L N L G IP L + L LS N L GEIP
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 8e-94
Identities = 106/339 (31%), Positives = 166/339 (48%), Gaps = 12/339 (3%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
+S+ ++L E K GE+ F L L L N+ +G++P G+ S L L S N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 132 NLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPSSLCQLT-KLITMALSRNGLHGPIPSAI 189
N +G +P + L +R L+VL+L N +G +P SL L+ L+T+ LS N GPI +
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 190 GD--LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLY 247
N L L L +N +G + L LV+L++ N L G IPS+L L+ L L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 248 LHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI 307
L N L G IP E+ + + + + N++ G IP L+ + L ++S+S+N L+G+IP
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 308 TIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDL 367
I L +L L LSNN SG IP E+G C L + L N +G+IP + +
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS---GKI 565
Query: 368 SHNKLNGTIPPFL-----YHRFPLDLSYNDLEGEIPDYF 401
+ N + G ++ + + +G +
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 3e-92
Identities = 109/382 (28%), Positives = 172/382 (45%), Gaps = 50/382 (13%)
Query: 39 EREALVNSSWWSNLIDSN-------SSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQF 91
E L+ S+ L D N + + C DGVTC + I+L
Sbjct: 13 EIHQLI--SFKDVLPDKNLLPDWSSNKNPCTFDGVTCRD-DKVTSIDLS----------- 58
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
S N F ++ S + +L+ L L S +++ GS+ +L L+
Sbjct: 59 -----------SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLD 106
Query: 152 LKGNNLNGAIPS--SLCQLTKLITMALSRNGLHGPIP-SAIGDLNNLLILSLDSNKLSGM 208
L N+L+G + + SL + L + +S N L P S LN+L +L L +N +SG
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 209 LHQEL---GKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
L L + GNK+ G + + R NL +L + SN+ + I P +G+ +
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCS 223
Query: 266 GILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
+ +D+S N + G ++ ++L L+ISSN G IP L SL+ L L+ NK
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKF 281
Query: 326 SGPIPPEI-GKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFLYHR 383
+G IP + G C L + L N+ G++PP G LE L LS N +G +P +
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 384 FP----LDLSYNDLEGEIPDYF 401
LDLS+N+ GE+P+
Sbjct: 342 MRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 2e-86
Identities = 89/313 (28%), Positives = 140/313 (44%), Gaps = 9/313 (2%)
Query: 68 CNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLD 127
N ++ ++L L G + + L L L N L G IP ++ + L L
Sbjct: 415 SN-CSELVSLHLSFNYLSGTIPS-SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 128 FSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPS 187
FN+LTG IP L + NL ++L N L G IP + +L L + LS N G IP+
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 188 AIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLY 247
+GD +L+ L L++N +G + + K +A N + G + +
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA----ANFIAGKRYVYIKNDGMKKECH 588
Query: 248 LHSN--HLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI 305
N G ++ ++ +++ G +++L +S NMLSG I
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 306 PITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEY 364
P I + L L+L +N +SG IP E+G L + L +N L G IP + L L
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708
Query: 365 LDLSHNKLNGTIP 377
+DLS+N L+G IP
Sbjct: 709 IDLSNNNLSGPIP 721
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 1e-90
Identities = 102/295 (34%), Positives = 154/295 (52%), Gaps = 34/295 (11%)
Query: 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHR-----AETEETTFFNSF 545
++ A+++F K +G GG+G VYK +L +G +VA+K+L E + F
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-------F 74
Query: 546 QNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEA-VVLDWTMRV 604
Q E ++S HRN+++L GFC+ L+Y YM GS+ LR E+ LDW R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN-RTI 663
I A L+YLH C P I+HRD+ + NILL+ + EA V DFG A+L+D ++ T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723
V GT G+IAPE T +EK DV+ +GV+ LE++ G+ + L+ ++D +ML+D
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD----LARLANDDDVMLLD 250
Query: 724 -------------VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
++D L ++ ++ VAL C S P RP M V
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ---VALLCTQSSPMERPKMSEV 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 8e-86
Identities = 86/330 (26%), Positives = 135/330 (40%), Gaps = 56/330 (16%)
Query: 46 SSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLR 105
SSW + + GV C+T + +L L
Sbjct: 25 SSWLP----TTDCCNRTWLGVLCDTDTQTYR----------------------VNNLDLS 58
Query: 106 FNYLFGS--IPSQVGALSKLRYLDFS-FNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIP 162
L IPS + L L +L NNL G IPP + L L L + N++GAIP
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 163 SSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVAL 222
L Q+ L+T+ S N L G +P +I L NL+ ++ D N++S
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS---------------- 162
Query: 223 NVGGNKLMGPIPSTLFRLTNL-TYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTI 281
G IP + + L T + + N L G IPP N+ + VD+S N +EG
Sbjct: 163 --------GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDA 213
Query: 282 PLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRN 341
+ + ++ N L+ + + +L GLDL NN++ G +P + + L +
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 342 ITLRNNNLSGSIPPEIGLMKLEYLDLSHNK 371
+ + NNL G IP L + + ++NK
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 2e-85
Identities = 90/326 (27%), Positives = 136/326 (41%), Gaps = 41/326 (12%)
Query: 112 SIPSQVGALSKLR----YLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNG--AIPSSL 165
I +G + L D G + + L+L G NL IPSSL
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 166 CQLTKLITMALS-RNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNV 224
L L + + N L GPIP AI L L L + +SG + L ++K LV L+
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 225 GGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLE 284
N L G +P ++ L NL + N ++G+IP G+
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS--------------------- 171
Query: 285 LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITL 344
++L + +S N L+G+IP T A L +L +DLS N L G G + I L
Sbjct: 172 FSKLFTSMTIS--RNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 345 RNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPD- 399
N+L+ + L LDL +N++ GT+P L + L++S+N+L GEIP
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL-TQLKFLHSLNVSFNNLCGEIPQG 287
Query: 400 -YFRD-SPFKVYGNQGIC--YFSACS 421
+ N+ +C AC+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 1e-79
Identities = 98/299 (32%), Positives = 135/299 (45%), Gaps = 35/299 (11%)
Query: 488 RIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHR----AETEETTFFN 543
R+ D+ +AT +FD K+ IG G +G VYK L +G VALK+ E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE------ 81
Query: 544 SFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL-RNDYEAVVLDWTM 602
F+ E LS H ++V L GFC + M LIYKYM+ G+L L +D + + W
Sbjct: 82 -FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 603 RVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR- 661
R+ I A L YLH I+HRD+ S NILL+ + DFG ++
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 662 -TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKI- 719
T+V GT GYI PE +TEK DVYSFGVV EVL R S P +
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA----IVQSLPREMVNLA 253
Query: 720 ----------MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
L ++D L+ + + + A+ CL + RP+M V +
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIR---PESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-74
Identities = 94/290 (32%), Positives = 140/290 (48%), Gaps = 24/290 (8%)
Query: 491 FEDIIKATEDFDIKYC------IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNS 544
F ++ T +FD + +G GG+G VYK + N VA+KKL T
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 545 -FQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR 603
F E V++K H N+V+L GF + L+Y YM GSL L L W MR
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD--SSNR 661
I + AN +++LH + +HRDI S NILL+ A ++DFG AR + +
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 662 TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGR------HPGELLSSLSSPSS 715
+ + GT Y+APE A +T K D+YSFGVV LE++ G +LL +
Sbjct: 193 SRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 716 DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
D++ + D +D +++ V + +VA CLH K RP +++V
Sbjct: 252 DEEKTIEDYIDKKMNDADSTSVEA----MYSVASQCLHEKKNKRPDIKKV 297
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 5e-70
Identities = 56/341 (16%), Positives = 115/341 (33%), Gaps = 41/341 (12%)
Query: 96 FPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGN 155
E+ + + + + + L L ++ +P L +L ++++N+ N
Sbjct: 224 CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 156 NL--------NGAIPSSLCQLTKLITMALSRNGL-HGPIPSAIGDLNNLLILSLDSNKLS 206
+ + K+ + + N L P+ +++ + L +L N+L
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343
Query: 207 GMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPP--EIGNM 264
G G L +LN+ N++ + + L N L IP + ++
Sbjct: 344 G-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSV 401
Query: 265 TGILKVDMSMNNIEG-------TIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKG 317
+ + +D S N I + + + +++S+N +S + L
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 318 LDLSNNKLSG-------PIPPEIGKCSELRNITLRNNNLSGSIPPEIG---LMKLEYLDL 367
++L N L+ L +I LR N L+ + + L L +DL
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDL 520
Query: 368 SHNKLNGTIPP---------FLYHRFPLDLSYNDLEGEIPD 399
S+N + P R D N E P+
Sbjct: 521 SYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 4e-69
Identities = 58/338 (17%), Positives = 113/338 (33%), Gaps = 36/338 (10%)
Query: 97 PGLESLSLRFNYL--------FGSIPSQVGALSKLRYLDFSFNNL-TGSIPPELGSLRNL 147
P ++ +++ N + K++ + +NNL T + L ++ L
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 148 EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG 207
+L N L G + KL ++ L+ N + + G + LS NKL
Sbjct: 333 GMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391
Query: 208 M-LHQELGKLKNLVALNVGGNKLMG-------PIPSTLFRLTNLTYLYLHSNHLNGSIPP 259
+ + + + A++ N++ P+ T F+ N++ + L +N ++
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 260 EIGNMTGILKVDMSMNNIEG-------TIPLELTRLSQLLYLSISSNMLSGQIP--ITIA 310
+ + +++ N + L + + N L+ +
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRAT 510
Query: 311 GLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRN------NNLSGSIPPEIG-LMKLE 363
L L G+DLS N S P + S L+ +RN N P I L
Sbjct: 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT 569
Query: 364 YLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPDYF 401
L + N + + LD+ N Y
Sbjct: 570 QLQIGSNDIRKVNEKITPNISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 1e-67
Identities = 56/396 (14%), Positives = 121/396 (30%), Gaps = 40/396 (10%)
Query: 41 EALVNSSWWSNLIDSN-------SSDHC---KLDGVTCNTARSIIEINLPEKKLKGELSQ 90
+AL +W + + + GV+ N+ + ++L G +
Sbjct: 40 DALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPD 99
Query: 91 FNFSCFPGLESLSLRFNYLFG----SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR- 145
LE L+L + P + A + +
Sbjct: 100 -AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDF 158
Query: 146 -NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204
+L + + +I S K + N + + A+ L L + ++
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP 217
Query: 205 LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNM 264
E + +N L +LT + +++ +P + +
Sbjct: 218 FVAENICEAWENENSEYAQ-----QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272
Query: 265 TGILKVDMSMNNI--------EGTIPLELTRLSQLLYLSISSNML-SGQIPITIAGLISL 315
+ ++++ N + + ++ + I N L + + ++ + L
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 316 KGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG--LMKLEYLDLSHNKLN 373
L+ N+L G P G +L ++ L N ++ IP ++E L +HNKL
Sbjct: 333 GMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK 390
Query: 374 GTIPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
F +D SYN++ F
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 6e-66
Identities = 48/344 (13%), Positives = 107/344 (31%), Gaps = 30/344 (8%)
Query: 84 LKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGS 143
K + F L + + SI K + NN+T + +
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMR 204
Query: 144 LRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSN 203
L L + + + + +L +L + + +
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQYKTEDLKWDNLKDLTDVEVYNC 259
Query: 204 KLSGMLHQELGKLKNLVALNVGGNKLM--------GPIPSTLFRLTNLTYLYLHSNHL-N 254
L L L + +NV N+ + + + +Y+ N+L
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319
Query: 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314
+ + M + ++ N +EG +P +L L+++ N ++
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 315 LKGLDLSNNKLSG-PIPPEIGKCSELRNITLRNNNLSG-------SIPPEIG-LMKLEYL 365
++ L ++NKL P + S + I N + + P + + +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 366 DLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
+LS+N+++ P L+ ++L N L + +D
Sbjct: 439 NLSNNQISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 7e-65
Identities = 55/326 (16%), Positives = 112/326 (34%), Gaps = 30/326 (9%)
Query: 92 NFSCFPGLESLSLRFNYLF-GSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150
+ ++ + + +N L + + + + KL L+ +N L G P GS L L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASL 358
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNKLSGM- 208
NL N + + ++ ++ + N L P ++ + + N++ +
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVD 418
Query: 209 ------LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG------- 255
L K N+ ++N+ N++ + L+ + L N L
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 256 SIPPEIGNMTGILKVDMSMNNIEGTIP-LELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314
N + +D+ N + T L L+ + +S N S P +
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 315 LKGLDLSN------NKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLS 368
LKG + N N+ P I C L + + +N++ + +I + LD+
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI-TPNISVLDIK 595
Query: 369 HNKLNGTIPPFLYHRFPL---DLSYN 391
N ++ L Y+
Sbjct: 596 DNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-64
Identities = 66/400 (16%), Positives = 125/400 (31%), Gaps = 56/400 (14%)
Query: 50 SNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYL 109
+D +I+ + + + + + + N +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT-LKDTQIGQLSNNI 195
Query: 110 FGSIPSQVGALSKLRYLDFSFNNLTG-------------------SIPPELGSLRNLEVL 150
+ V L+KLR + + + +L++L +
Sbjct: 196 -TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV 254
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLH--------GPIPSAIGDLNNLLILSLDS 202
+ +P+ L L ++ + ++ N + + I+ +
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 203 NKL-SGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI 261
N L + + L K+K L L N+L G +P+ L L L N + IP
Sbjct: 315 NNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE-IPANF 372
Query: 262 -GNMTGILKVDMSMNNIEGTIP--LELTRLSQLLYLSISSNMLSG-------QIPITIAG 311
G + + + N ++ IP + +S + + S N + + T
Sbjct: 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG-------SIPPEIG-LMKLE 363
I++ ++LSNN++S S L +I L N L+ L
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 364 YLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPD 399
+DL NKL F P +DLSYN P
Sbjct: 492 SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-54
Identities = 56/300 (18%), Positives = 110/300 (36%), Gaps = 34/300 (11%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKGNNL 157
L L +N L G +P+ G+ KL L+ ++N +T IP G +E L+ N L
Sbjct: 332 LGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKL 389
Query: 158 NGAIPSSL--CQLTKLITMALSRNGLHG-------PIPSAIGDLNNLLILSLDSNKLSGM 208
IP+ ++ + + S N + P+ N+ ++L +N++S
Sbjct: 390 KY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448
Query: 209 LHQELGKLKNLVALNVGGNKL-------MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI 261
+ L ++N+ GN L + LT + L N L + +
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDF 507
Query: 262 --GNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSI------SSNMLSGQIPITIAGLI 313
+ ++ +D+S N+ P + S L I N + P I
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566
Query: 314 SLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKL 372
SL L + +N + + +I + + +++N + ++ L ++K
Sbjct: 567 SLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-49
Identities = 46/276 (16%), Positives = 92/276 (33%), Gaps = 30/276 (10%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPP--ELGSLRNLEVLNLKGNN 156
L SL+L +N + + G ++ L F+ N L IP + S+ + ++ N
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE 413
Query: 157 LNG-------AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM- 208
+ + + + + ++ LS N + + L ++L N L+ +
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 209 ------LHQELGKLKNLVALNVGGNKLMGPIPSTLF--RLTNLTYLYLHSNHLNGSIPPE 260
++ L ++++ NKL + L L + L N + P +
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531
Query: 261 IGNMTGILK------VDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314
N + + D N P +T L L I SN + + I +
Sbjct: 532 PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPN 588
Query: 315 LKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350
+ LD+ +N + E L +
Sbjct: 589 ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-18
Identities = 23/141 (16%), Positives = 43/141 (30%), Gaps = 10/141 (7%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYL----- 126
+ I+L KL F + P L + L +N P+Q S L+
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQ 546
Query: 127 -DFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI 185
D N P + +L L + N++ + + + + + N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISID 603
Query: 186 PSAIGDLNNLLILSLDSNKLS 206
S + + L +K
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-67
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 45/307 (14%)
Query: 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAH 550
E++ + + G +G V+KAQ + VA+K + S+QNE
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQD------KQSWQNEYE 68
Query: 551 V--LSKIAHRNIVKLYGFCLH----KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRV 604
V L + H NI++ G ++LI + ++GSL FL+ + V+ W
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELC 124
Query: 605 NIIKCVANALSYLHHDCM-------PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657
+I + +A L+YLH D P+I HRDI S N+LL + L A +ADFG A ++
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 658 SS--NRTIVAGTYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL 710
S + GT Y+APE+ + + D+Y+ G+V E+ +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 711 ----------SSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVL--VTTVALACLHSKPKF 758
PS + M V+ + P + + + + C +
Sbjct: 245 YMLPFEEEIGQHPSLED--MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 759 RPTMQRV 765
R + V
Sbjct: 303 RLSAGCV 309
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-65
Identities = 78/335 (23%), Positives = 127/335 (37%), Gaps = 20/335 (5%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNL 147
L+Q + L+L N L + S+L LD FN ++ P L L
Sbjct: 16 LTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 148 EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG 207
+VLNL+ N L+ + T L + L N + + NL+ L L N LS
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTL--FRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
+L+NL L + NK+ L F ++L L L SN + P +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 266 GILKVDMSMNNIEGTIPLELT---RLSQLLYLSISSNMLSGQIPITIAGL--ISLKGLDL 320
+ + ++ + ++ +L + + LS+S++ LS T GL +L LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 321 SNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNG----- 374
S N L+ +L L NN+ + GL + YL+L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 375 ---TIPPFLYHRFP----LDLSYNDLEGEIPDYFR 402
I F + L++ ND+ G + F
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-61
Identities = 73/339 (21%), Positives = 123/339 (36%), Gaps = 30/339 (8%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
+LS F+ L L L N + + L LD S N L+ + L N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 147 LEVLNLKGNNLNGAIPS--SLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204
L+ L L N + + + L + LS N + P + L L L++ +
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 205 LSGMLHQELG---KLKNLVALNVGGNKLMGPIPSTLF--RLTNLTYLYLHSNHLNGSIPP 259
L L ++L ++ L++ ++L +T + TNLT L L N+LN
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 260 EIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYL---------SISSNMLSGQIPITIA 310
+ + + NNI+ L L + YL SIS L +
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326
Query: 311 GLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPE-----IGLMKLEYL 365
L L+ L++ +N + G L+ ++L N+ S + L L
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386
Query: 366 DLSHNKLNGTIP------PFLYHRFPLDLSYNDLEGEIP 398
+L+ NK++ L LDL N++ E+
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEV---LDLGLNEIGQELT 422
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 1e-60
Identities = 68/328 (20%), Positives = 114/328 (34%), Gaps = 23/328 (7%)
Query: 95 CFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154
C E L +P + + L+ + N L L L++
Sbjct: 2 CTVSHEVADCSHLKLT-QVPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 155 NNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELG 214
N ++ P +L L + L N L NL L L SN + + +
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 215 KLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNM--TGILKVDM 272
K KNL+ L++ N L T +L NL L L +N + E+ + + K+++
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178
Query: 273 SMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIA---GLISLKGLDLSNNKLSGPI 329
S N I+ P + +L L +++ L + + S++ L LSN++LS
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 330 PPEIG--KCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFL------ 380
K + L + L NNL+ L +LEY L +N + L
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298
Query: 381 ------YHRFPLDLSYNDLEGEIPDYFR 402
+S L F+
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQ 326
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-57
Identities = 73/345 (21%), Positives = 118/345 (34%), Gaps = 27/345 (7%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVG---ALSKLRYLDFSFNNLTGSIPPELGSLR--NL 147
F L L L L S+ ++ A + +R L S + L+ + L+ NL
Sbjct: 191 FHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL 250
Query: 148 EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDL---------NNLLIL 198
+L+L NNLN S L +L L N + ++ L +
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
Query: 199 SLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258
S+ L + LK L LN+ N + G + L NL YL L ++ +
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 259 PEIG----NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI-TIAGLI 313
+ + ++++ N I + L L L + N + ++ GL
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 314 SLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG--SIPPEI-GLMKLEYLDLSHN 370
++ + LS NK L+ + LR L S P L L LDLS+N
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 371 KLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFRDSPFKVYGN 411
+ I + LDL +N+L P
Sbjct: 491 NIAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 5e-57
Identities = 70/356 (19%), Positives = 128/356 (35%), Gaps = 18/356 (5%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
RS + ++ L + F+F LE L++ N + G + L L+YL S +
Sbjct: 305 RSFTKQSISLASLPK-IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 132 NLTGSIPPELG----SLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIP- 186
+ + L +LNL N ++ + L L + L N + +
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 187 SAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL--MGPIPSTLFRLTNLT 244
L N+ + L NK + + +L L + L + PS L NLT
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 245 YLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE--------GTIPLELTRLSQLLYLSI 296
L L +N++ + + + +D+ NN+ G L LS L L++
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 297 SSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPP- 355
SN L LK +DL N L+ L+++ L+ N ++
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 356 -EIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPDYFRDSPFKVYG 410
L LD+ N + T + ++ ++ ++ Y ++P +G
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG 659
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-62
Identities = 71/291 (24%), Positives = 128/291 (43%), Gaps = 32/291 (10%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++ +++ +G G +G V KA+ K VA+K++ + +F E LS++ H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK-----AFIVELRQLSRVNHP 61
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
NIVKLYG CL+ C+ + +Y + GSL+ L ++ + ++YLH
Sbjct: 62 NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAF-VADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
+++HRD+ N+LL + + DFGTA + + +N G+ ++APE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFE 176
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS-----PP 732
+EKCDV+S+G++ EV+ R P + + + +IM +R P
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVHNGTRPPLIKNLPK 231
Query: 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783
+M C P RP+M+ + + E +
Sbjct: 232 PIESLMTR----------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 7e-62
Identities = 78/275 (28%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
D +IK IG G +G+V++A+ +G VA+K L + N F E ++ ++ H
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHP 94
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
NIV G + ++ +Y+ RGSL+ L LD R+++ VA ++YLH
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT 678
+ P IVHR++ S N+L++ K V DFG +RL S + AGT ++APE+
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 679 MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD---- 734
EK DVYSFGV+ E+ + P L+ Q + + RL P +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRLEIPRNLNPQ 267
Query: 735 -RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
+++ C ++P RP+ +
Sbjct: 268 VAAIIEG----------CWTNEPWKRPSFATIMDL 292
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-59
Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 29/282 (10%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHR----AETEETTFFNSFQNEAHVLS 553
+ + + IG GG+G V+K + + + VVA+K L ETE F FQ E ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
+ H NIVKLYG + M + +++ G L+ L + +A + W++++ ++ +A
Sbjct: 79 NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAF-----VADFGTARLLDSDSSNRTIVAGTY 668
+ Y+ + P IVHRD+ S NI L S E VADFG ++ S G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNF 190
Query: 669 GYIAPEL--AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD 726
++APE A TEK D YSF ++ +L G P + S + + + +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINMIRE 244
Query: 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
L P + + V C PK RP + +E
Sbjct: 245 EGLRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKE 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-58
Identities = 70/372 (18%), Positives = 129/372 (34%), Gaps = 24/372 (6%)
Query: 50 SNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKL-----KGELSQFNFSCFPGLESLSL 104
L+ + L+ + + + + E +L + F+C + S SL
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 105 RFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSS 164
+ ++L+ +L SL+ L + KG N S
Sbjct: 290 VSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-----AFS 342
Query: 165 LCQLTKLITMALSRNGLH--GPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVAL 222
L L + LSRNGL G + +L L L N + + L+ L L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHL 401
Query: 223 NVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTI 281
+ + L ++F L NL YL + H + ++ + + M+ N+ +
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 282 PLE-LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELR 340
+ T L L +L +S L P L SL+ L++S+N + L+
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 521
Query: 341 NITLRNNNLSGSIPPEIGLM--KLEYLDLSHNKLNGTIPP-----FLYHRFPLDLSYNDL 393
+ N++ S E+ L +L+L+ N T ++ + L + +
Sbjct: 522 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM 581
Query: 394 EGEIPDYFRDSP 405
E P + P
Sbjct: 582 ECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 6e-54
Identities = 56/318 (17%), Positives = 102/318 (32%), Gaps = 17/318 (5%)
Query: 96 FPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGN 155
++L L FN L + +L+ LD S + SL +L L L GN
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 156 NLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM-LHQELG 214
+ + L+ L + L IG L L L++ N + L +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 215 KLKNLVALNVGGNKLMGPIPSTLFRLTNLTY----LYLHSNHLNGSIPPEIGNMTGILKV 270
L NL L++ NK+ + L L + L L N +N I P + K+
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205
Query: 271 DMSMNNIEGTIP-LELTRLSQLLYLSISSNMLSGQIPIT---IAGLISLKGLDLSNNKLS 326
+ N + + L+ L + + + + L L L + +L+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 327 ------GPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFL 380
I + + + +L + + + ++L+L + K L
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 381 YHRFPLDLSYNDLEGEIP 398
L + N
Sbjct: 325 KSLKRLTFTSNKGGNAFS 342
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-53
Identities = 63/308 (20%), Positives = 109/308 (35%), Gaps = 20/308 (6%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
IP + + LD SFN L S L+VL+L + + L+ L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 172 ITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231
T+ L+ N + A L++L L L+ + + +G LK L LNV N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 232 -PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGI----LKVDMSMNNIEGTIPLELT 286
+P LTNL +L L SN + ++ + + L +D+S+N + I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197
Query: 287 RLSQLLYLSISSNMLSGQIP-ITIAGLISLKGLDLSNNKLSGPI---PPEIGKCSELRNI 342
+ +L L++ +N S + I GL L+ L + + L N+
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 343 TLRNNNLS------GSIPPEI-GLMKLEYLDLSHNKLNGTIP-PFLYHRFPLDLSYNDLE 394
T+ L+ I L + L + + + L+L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 395 GEIPDYFR 402
+
Sbjct: 318 QFPTLKLK 325
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-53
Identities = 69/359 (19%), Positives = 120/359 (33%), Gaps = 44/359 (12%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
L ++F FP L+ L L + +LS L L + N + L +
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNKL 205
L+ L NL + L L + ++ N + +P +L NL L L SNK+
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 206 SGMLHQELGKLKNL----VALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE- 260
+ +L L + ++L++ N + I F+ L L L +N + ++
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 261 IGNMTGILKVDMSMNNIEGTIPLE---LTRLSQLLYLSISSNMLS------GQIPITIAG 311
I + G+ + + LE + L L L+I L+ I
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG-------------------- 351
L ++ L + + +++ L N
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 352 SIPPEIGLMKLEYLDLSHNKLNGT-IPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
+ E+ L LE+LDLS N L+ LDLS+N + + F
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-49
Identities = 62/292 (21%), Positives = 104/292 (35%), Gaps = 11/292 (3%)
Query: 87 ELSQFNFSCFPGL---ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLT--GSIPPEL 141
EL F FP L L F G L L +LD S N L+ G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 142 GSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIP-SAIGDLNNLLILSL 200
+L+ L+L N + + S+ L +L + + L S L NL+ L +
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 201 DSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPP 259
+ L +L L + GN +F L NLT+L L L P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 260 EIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLI-SLKGL 318
+++ + ++MS NN L+ L L S N + + SL L
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548
Query: 319 DLSNNKLSGPIPPE--IGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLS 368
+L+ N + + + + R + + + + P + M + L+++
Sbjct: 549 NLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 44/185 (23%), Positives = 66/185 (35%), Gaps = 11/185 (5%)
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292
IP L + L L N L + + +D+S I+ LS L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 293 YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGS 352
L ++ N + +GL SL+ L L+ IG L+ + + +N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 353 IPPEI--GLMKLEYLDLSHNKLNGTIPPFL-------YHRFPLDLSYNDLEGEIPDYFRD 403
PE L LE+LDLS NK+ L LDLS N + P F++
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 404 SPFKV 408
Sbjct: 200 IRLHK 204
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-57
Identities = 60/385 (15%), Positives = 120/385 (31%), Gaps = 49/385 (12%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYL---------FGSIPSQVGALSK 122
+ + ++ L +L P L+SL++ N + + K
Sbjct: 491 KDLTDVELYNCPNMTQLPD-FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 123 LRYLDFSFNNLTGSIPPE--LGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180
++ +NNL P L + L +L+ N + + KL + L N
Sbjct: 550 IQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQ 606
Query: 181 LHGPIPSAIG-DLNNLLILSLDSNKLSGMLHQ-ELGKLKNLVALNVGGNKLMG-----PI 233
+ IP + + L NKL + + + + +++ NK+
Sbjct: 607 IEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISC 665
Query: 234 PSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE-------GTIPLELT 286
++ N + + L N + + I + +S N +
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 287 RLSQLLYLSISSNMLSGQIP--ITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITL 344
L + + N L+ + L L +D+S N S P + S+L+ +
Sbjct: 726 NTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783
Query: 345 R------NNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFLYHR-FPLDLSYNDL-EG 395
R N + P I L L + N + + L + + LD++ N
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNISI 842
Query: 396 EIPDYFRDSPFKVY-----GNQGIC 415
++ +Y Q I
Sbjct: 843 DVTSVCPYIEAGMYVLLYDKTQDIR 867
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-56
Identities = 64/364 (17%), Positives = 112/364 (30%), Gaps = 62/364 (17%)
Query: 92 NFSCFPGLESLSLRFNYL------FGSIPSQVGALSKLRYLDFSFNNLTG---------- 135
+SL+ + I + L+KL+ + F+ + T
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472
Query: 136 ---------SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGP-- 184
+ +L++L + L +P L L +L ++ ++ N
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 185 -------IPSAIGDLNNLLILSLDSNKLSGM-LHQELGKLKNLVALNVGGNKLMGPIPST 236
+ + I + N L L K+ L L+ NK+
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEA 590
Query: 237 LFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV-DMSMNNIEGTIP--LELTRLSQLLY 293
LT L L N + IP + T ++ S N ++ IP + +
Sbjct: 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648
Query: 294 LSISSNMLSGQIP-----ITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNN 348
+ S N + + + I+ + LS N++ S + I L NN
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 349 LSGSIPPEI---------GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEG 395
++ SIP L +DL NKL F P +D+SYN
Sbjct: 709 MT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS- 766
Query: 396 EIPD 399
P
Sbjct: 767 SFPT 770
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-53
Identities = 58/387 (14%), Positives = 120/387 (31%), Gaps = 34/387 (8%)
Query: 41 EALVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLE 100
++S W+ + + GV + + ++L KG + L+
Sbjct: 294 NNTIHSLNWNFNKELDMW--GDQPGVDLDNNGRVTGLSLAGFGAKGRVPD-AIGQLTELK 350
Query: 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLN- 158
LS + S + + + L + L + +L + +N
Sbjct: 351 VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410
Query: 159 ----GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELG 214
I K + N + I AI L L I+ ++ +
Sbjct: 411 NPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-----DN 464
Query: 215 KLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSM 274
+ N K + L +LT + L++ +P + ++ + ++++
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524
Query: 275 NNIEG---------TIPLELTRLSQLLYLSISSNMLSG-QIPITIAGLISLKGLDLSNNK 324
N + + ++ + N L ++ ++ L LD +NK
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK 584
Query: 325 LSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG--LMKLEYLDLSHNKLNGTIPPFLYH 382
+ G +L ++ L N + IP + ++E L SHNKL F
Sbjct: 585 VR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAK 641
Query: 383 RFP----LDLSYNDLEGEIPDYFRDSP 405
+D SYN + E +
Sbjct: 642 SVYVMGSVDFSYNKIGSEGRNISCSMD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 9e-26
Identities = 46/351 (13%), Positives = 99/351 (28%), Gaps = 33/351 (9%)
Query: 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132
+ + + K+ E + + ++ + +P+ + +
Sbjct: 172 ELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAV-WLPAGTYQVVAYTTYS---QS 227
Query: 133 LTGSIPPELGSLRNLEVLNLKGNNLNGA--IPSSLCQLTKLIT--MALS--RNGLHGPIP 186
E S+R E + N L +P L + + I AL L G
Sbjct: 228 GIKRSELETQSVRG-ESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNW 286
Query: 187 SAIGDLNNLLIL------SLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRL 240
N I + + + +L + L++ G G +P + +L
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 241 TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIP------LELTRLSQLLYL 294
T L L ++ S + + I + LS LL
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 295 SISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIP 354
+I+ N I + + N+++ I I + ++L+ I N+ +
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI 465
Query: 355 PEIGLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYF 401
+ + K ++L ++PD+
Sbjct: 466 AVDWED----ANSDYAKQYENEELSW-SNLKDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 5e-16
Identities = 30/164 (18%), Positives = 59/164 (35%), Gaps = 12/164 (7%)
Query: 50 SNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYL 109
+NL+ S + K + I+L KL F + P L ++ + +N
Sbjct: 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYN-C 764
Query: 110 FGSIPSQVGALSKLRYL------DFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPS 163
F S P+Q S+L+ D N + P + + +L L + N++ +
Sbjct: 765 FSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDE 823
Query: 164 SLCQLTKLITMALSRNGL-HGPIPSAIGDLNNLLI-LSLDSNKL 205
L +L + ++ N + S + + L D +
Sbjct: 824 KL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-57
Identities = 71/284 (25%), Positives = 125/284 (44%), Gaps = 37/284 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETT-FFNSFQNEAHVLSKIAH 557
+ ++ IG GG+G VY+A G VA+K E+ + + + EA + + + H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
NI+ L G CL + + L+ ++ + G L L + + VN +A ++YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAF--------VADFGTARLLDSDSSNRTIVAGTYG 669
H + + I+HRD+ S+NIL+ K+E + DFG AR + + AG Y
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYA 179
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729
++APE+ + ++ DV+S+GV+ E+L G P + L + + L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKLAL 233
Query: 730 S-----PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
P +M+D C + P RP+ + +
Sbjct: 234 PIPSTCPEPFAKLMED----------CWNPDPHSRPSFTNILDQ 267
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-54
Identities = 73/297 (24%), Positives = 110/297 (37%), Gaps = 41/297 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHV--LSKIA 556
+ + IG G YG V+ + G+ VA+K E S+ E + +
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE------EASWFRETEIYQTVLMR 89
Query: 557 HRNIVKLYGFCLHKKC----MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN 612
H NI+ + ++LI Y + GSL+ +L++ LD + + +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVS 145
Query: 613 ALSYLH-----HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV--- 664
L +LH P+I HRD+ S NIL+ +AD G A SD++ I
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 665 -AGTYGYIAPE-LAYTMVV-----TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQ 717
GT Y+ PE L ++ D+YSFG++ EV G ++ P D
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 718 K-------IMLIDVLDSRLSPPVDRMVMQDIVLVTTVAL--ACLHSKPKFRPTMQRV 765
M V +L P D L L C P R T RV
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-54
Identities = 66/316 (20%), Positives = 123/316 (38%), Gaps = 13/316 (4%)
Query: 91 FNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150
F C +ES++L+ +Y F + S L+ LD + +L+ +P L L L+ L
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPS-AIGDLNNLLILSLDSNKL--SG 207
L N S L +++ N + + + +L NL L L + + S
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366
Query: 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI-GNMTG 266
+ +L L +L +LN+ N+ + L L L L N+
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426
Query: 267 ILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI---TIAGLISLKGLDLSNN 323
+ +++S + ++ + L L +L++ N ++ L L+ L LS
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
Query: 324 KLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHR 383
LS + ++ L +N L+ S + +K YL+L+ N ++ I P L
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHIS-IILPSLLPI 545
Query: 384 FP----LDLSYNDLEG 395
++L N L+
Sbjct: 546 LSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-54
Identities = 62/324 (19%), Positives = 107/324 (33%), Gaps = 12/324 (3%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNL 147
L++ + E L FN L + L L +LD + + S L
Sbjct: 24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 148 EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG 207
+ L L N L ++L L + + G+ + + L L L SN +S
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN-GSIPPEIGNMTG 266
+ + + L L+ N + + L T L L+ N + I P +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 267 ILKVDMSMNNIEGTIPLEL--TRLSQLLYLSISSNMLSGQIPITIAGL--ISLKGLDLSN 322
++ I L + + L + P GL +S++ ++L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 323 NKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLY 381
+ S L+ + L +LS +P + GL L+ L LS NK +
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN-LCQISA 321
Query: 382 HRFP----LDLSYNDLEGEIPDYF 401
FP L + N E+
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGC 345
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-50
Identities = 65/329 (19%), Positives = 117/329 (35%), Gaps = 21/329 (6%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152
F L++L L N L + + L++L F ++ L + + LE L L
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLD--SNKLSGMLH 210
N+++ KL + N +H + L LSL+ N ++G +
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IE 195
Query: 211 QELGKLKNLVALNVGGNKLMGPIPSTLF--RLTNLTYLYLHSNHLNGSIPPEIGNMTG-- 266
+LN GG + + I L + +L P +
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255
Query: 267 ILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLS 326
+ +++ + S L L +++ LS ++P + GL +LK L LS NK
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314
Query: 327 GPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIP------- 377
L +++++ N + L L LDLSH+ + +
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
Query: 378 -PFLYHRFPLDLSYNDLEGEIPDYFRDSP 405
L L+LSYN+ + F++ P
Sbjct: 375 LSHLQS---LNLSYNEPLSLKTEAFKECP 400
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-49
Identities = 52/329 (15%), Positives = 121/329 (36%), Gaps = 17/329 (5%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
+++ S L+ L + + L L N+++ P+
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKL--ITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204
L+VL+ + N ++ + L + +++ L+ N + G I D L+ +
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQ 213
Query: 205 LSGMLHQELG--KLKNLVALNVGGNKLMGPIPSTL--FRLTNLTYLYLHSNHLNGSIPPE 260
++ + L +++L P+ ++ + L ++
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 261 IGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDL 320
+G+ ++D++ ++ +P L LS L L +S+N I+ + SL L +
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 321 SNNKLSGPIPPE-IGKCSELRNITLRNNNLSGSIPPEI---GLMKLEYLDLSHNKLNGTI 376
N + + LR + L ++++ S + L L+ L+LS+N+ ++
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SL 391
Query: 377 PPFLYHRFP----LDLSYNDLEGEIPDYF 401
+ P LDL++ L+ +
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-49
Identities = 66/328 (20%), Positives = 127/328 (38%), Gaps = 18/328 (5%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEV--L 150
LESL L N++ + KL+ LDF N + ++ SL+ L
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIG--DLNNLLILSLDSNKLSGM 208
NL GN++ G I ++ I + + +L + + + +
Sbjct: 185 NLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243
Query: 209 LHQELGKLK--NLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTG 266
L ++ ++N+ + +T + L L L + HL+ +P + ++
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLST 302
Query: 267 ILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI-PITIAGLISLKGLDLSNNKL 325
+ K+ +S N E + + L +LSI N ++ + L +L+ LDLS++ +
Sbjct: 303 LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362
Query: 326 --SGPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLY 381
S ++ S L+++ L N S+ E +LE LDL+ +L +
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 382 HRFP----LDLSYNDLEGEIPDYFRDSP 405
L+LS++ L+ F P
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLP 449
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-48
Identities = 65/335 (19%), Positives = 119/335 (35%), Gaps = 21/335 (6%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLF-GSIPSQVGALSKLRYLDFSFNNLTGSIPPELG--S 143
LS+ + S +LSL N I + + L+F I L +
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 144 LRNLEVLNLKGNNLNGAIPSSLCQLTK--LITMALSRNGLHGPIPSAIGDLNNLLILSLD 201
+++L + + + P+ L + + ++ L ++ + + L L L
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 202 SNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE- 260
+ LS L L L L L + NK + +LT+L + N +
Sbjct: 287 ATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 261 IGNMTGILKVDMSMNNIE--GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGL 318
+ N+ + ++D+S ++IE L+L LS L L++S N L+ L
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 319 DLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGT 375
DL+ +L L+ + L ++ L ++ GL L++L+L N
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD-ISSEQLFDGLPALQHLNLQGNHFPK- 463
Query: 376 IPPFLYHRFP-------LDLSYNDLEGEIPDYFRD 403
+ L LS+ DL F
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-41
Identities = 55/267 (20%), Positives = 95/267 (35%), Gaps = 8/267 (2%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLN 151
L+ L L N L +L N + L +L NL L+
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 152 LKGNNLN--GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGML 209
L +++ L L+ L ++ LS N A + L +L L +L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 210 HQE-LGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI---PPEIGNMT 265
Q L L LN+ + L L L +L L NH + +
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 266 GILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
+ + +S ++ T L + ++ +S N L+ ++ L + L+L++N +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHI 535
Query: 326 SGPIPPEIGKCSELRNITLRNNNLSGS 352
S +P + S+ R I LR N L +
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-34
Identities = 59/301 (19%), Positives = 101/301 (33%), Gaps = 14/301 (4%)
Query: 59 DHCKLDGVTCNTAR---SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYL--FGSI 113
K + + +A S+ +++ + EL L L L + +
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 114 PSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIP-SSLCQLTKLI 172
Q+ LS L+ L+ S+N LE+L+L L S L L
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428
Query: 173 TMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE---LGKLKNLVALNVGGNKL 229
+ LS + L L L L+L N Q+ L L L L + L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 230 MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLS 289
L + ++ L N L S + ++ G + ++++ N+I +P L LS
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG-IYLNLASNHISIILPSLLPILS 547
Query: 290 QLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNL 349
Q +++ N L + + + KL LR + L + L
Sbjct: 548 QQRTINLRQNPLDC--TCSNIYFLEW--YKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
Query: 350 S 350
S
Sbjct: 604 S 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-33
Identities = 44/237 (18%), Positives = 72/237 (30%), Gaps = 10/237 (4%)
Query: 176 LSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPS 235
GL+ IP + N+ L N L + + +L NL L++ ++
Sbjct: 19 CENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 236 TLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLS 295
T L L L +N L + + + I + L L L
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 296 ISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLR-NNNLSGSIP 354
+ SN +S LK LD NN + ++ + N++L N N I
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195
Query: 355 PEIG-LMKLEYLDLSHNKLNGTIPPFLYHR-----FPLDLSYNDLEGEIPDYFRDSP 405
P + L+ + I L + + D E P F
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 36/182 (19%), Positives = 67/182 (36%), Gaps = 8/182 (4%)
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292
IP TL + L N L + + +D++ I +L
Sbjct: 27 IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 293 YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGS 352
L +++N L ++G +LK L +S + L ++ L +N++S
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 353 IPPEI-GLMKLEYLDLSHNKLNGTIPPFLYH-----RFPLDLSYNDLEGEIPDYFRDSPF 406
P+ KL+ LD +N ++ + L+L+ ND+ G P F + F
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 407 KV 408
+
Sbjct: 205 QS 206
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-54
Identities = 69/318 (21%), Positives = 118/318 (37%), Gaps = 52/318 (16%)
Query: 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNE 548
A + ++ + IG G YG+VYK L + + VA+K A +F NE
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINE 55
Query: 549 AHV--LSKIAHRNIVKLYGFCLHKKC-----MFLIYKYMKRGSLFCFLRNDYEAVVLDWT 601
++ + + H NI + L+ +Y GSL +L DW
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWV 111
Query: 602 MRVNIIKCVANALSYLHHD------CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655
+ V L+YLH + P+I HRD++S N+L+ + ++DFG + L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 656 SDSSNR--------TIVAGTYGYIAPELAYTMV-------VTEKCDVYSFGVVALEVLMG 700
+ R GT Y+APE+ V ++ D+Y+ G++ E+ M
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 701 ---RHPGELLSSLSSPSSDQK-------IMLIDVLDSRLSPPVDRMVMQDIVLVTTVA-- 748
PGE + + M + V + P ++ + V ++
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 749 -LACLHSKPKFRPTMQRV 765
C + R T Q
Sbjct: 292 IEDCWDQDAEARLTAQXA 309
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-54
Identities = 68/298 (22%), Positives = 117/298 (39%), Gaps = 41/298 (13%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHV--LSKI 555
D + C+G G YG V++ G+ VA+K + S+ E + +
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVML 59
Query: 556 AHRNIVKLYGFCLHKKC----MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
H NI+ + + ++LI Y + GSL+ +L+ LD + I+ +A
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIA 115
Query: 612 NALSYLHHD-----CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS----NRT 662
+ L++LH + P+I HRD+ S NIL+ + +AD G A + ++
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 663 IVAGTYGYIAPEL------AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD 716
GT Y+APE+ ++ D+++FG+V EV ++ P D
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 717 QK-------IMLIDVLDSRLSPPVDRMVMQDIVLVTTVAL--ACLHSKPKFRPTMQRV 765
M V + P + D L + L C + P R T R+
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-53
Identities = 49/280 (17%), Positives = 98/280 (35%), Gaps = 35/280 (12%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+ + + G ++K + G + +K L + F E L +H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKS-RDFNEECPRLRIFSHP 67
Query: 559 NIVKLYGFCLH--KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
N++ + G C LI +M GSL+ L V+D + V +A +++
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAF 126
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL- 675
LH P I ++S +++++ + A ++ S ++APE
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-----RMYAPAWVAPEAL 180
Query: 676 --AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733
D++SF V+ E++ P LS++ + M + + R + P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLRPTIPP 234
Query: 734 D-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
+M+ C++ P RP +
Sbjct: 235 GISPHVSKLMKI----------CMNEDPAKRPKFDMIVPI 264
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-51
Identities = 67/297 (22%), Positives = 115/297 (38%), Gaps = 41/297 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHV--LSKIA 556
++ IG G +G V++ + G+ VA+K E S+ EA + +
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLR 94
Query: 557 HRNIVKLYGFCLHKK----CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN 612
H NI+ ++L+ Y + GSLF +L + + + A+
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTAS 150
Query: 613 ALSYLHHDCM-----PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV--- 664
L++LH + + P+I HRD+ S NIL+ +AD G A DS + I
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 665 -AGTYGYIAPE-LAYTMVV-----TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQ 717
GT Y+APE L ++ + ++ D+Y+ G+V E+ G + P D
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 718 K-------IMLIDVLDSRLSPPVDRMVMQDIVLVTTVAL--ACLHSKPKFRPTMQRV 765
M V + +L P + L + C ++ R T R+
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-51
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
D +G G +G K G+V+ +K+L R + E +F E V+ + H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLEH 66
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N++K G K + I +Y+K G+L +++ W+ RV+ K +A+ ++YL
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYL 124
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--------------RTI 663
H +I+HRD++S+N L+ VADFG ARL+ + + R
Sbjct: 125 HS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723
V G ++APE+ EK DV+SFG+V E++ + + L
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT-----MDFGLNV 236
Query: 724 VLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P + + C P+ RP+ ++
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVR----------CCDLDPEKRPSFVKLEHWL 277
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-50
Identities = 66/281 (23%), Positives = 125/281 (44%), Gaps = 18/281 (6%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
S L +L + N + + S + L+ LR L + +N++ P L +L + LN
Sbjct: 83 PLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
L N+ S L +T L + ++ + + P I +L +L LSL+ N++ +
Sbjct: 139 LGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI--S 193
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271
L L +L N++ P + +T L L + +N + P + N++ + ++
Sbjct: 194 PLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 272 MSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPP 331
+ N I I + L++L L++ SN +S + L L L L+NN+L
Sbjct: 250 IGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 332 EIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKL 372
IG + L + L N+++ I P L K++ D ++ +
Sbjct: 306 VIGGLTNLTTLFLSQNHIT-DIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-49
Identities = 79/315 (25%), Positives = 132/315 (41%), Gaps = 23/315 (7%)
Query: 91 FNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150
F + L+ + + L + L + + SI + L NLE L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH 210
NL GN + P L L KL + + N + SA+ +L NL L L+ + +S +
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDI-- 125
Query: 211 QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV 270
L L + +LN+G N + S L +T L YL + + + P I N+T + +
Sbjct: 126 SPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
++ N IE PL L+ L Y + N ++ P+ A + L L + NNK++ P
Sbjct: 183 SLNYNQIEDISPLA--SLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITDLSP 238
Query: 331 PEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF--LYHRFPLDL 388
+ S+L + + N +S I L KL+ L++ N+++ I L L L
Sbjct: 239 --LANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFL 294
Query: 389 SYNDLEGEIPDYFRD 403
+ N L E +
Sbjct: 295 NNNQLGNEDMEVIGG 309
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-47
Identities = 72/331 (21%), Positives = 134/331 (40%), Gaps = 28/331 (8%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
I L + + + + L + + SI + L+ L YL+ + N
Sbjct: 22 AEGIRAVLQKASVTDVV---TQEELESITKLVVAGEKV-ASIQG-IEYLTNLEYLNLNGN 76
Query: 132 NLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD 191
+T P L +L L L + N + S+L LT L + L+ + + P + +
Sbjct: 77 QITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LAN 130
Query: 192 LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSN 251
L + L+L +N L L + L L V +K+ P + LT+L L L+ N
Sbjct: 131 LTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187
Query: 252 HLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311
+ P + ++T + +N I P+ +++L L I +N ++ P+ A
Sbjct: 188 QIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITDLSPL--AN 241
Query: 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNK 371
L L L++ N++S + ++L+ + + +N +S I L +L L L++N+
Sbjct: 242 LSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQ 298
Query: 372 LNGTIPPFLYHRFP----LDLSYNDLEGEIP 398
L + L LS N + P
Sbjct: 299 LGNEDMEVIGG-LTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 50/235 (21%), Positives = 99/235 (42%), Gaps = 15/235 (6%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
+ + SL+L N+ S S + ++ L YL + + + P + +L +L L+
Sbjct: 127 PLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
L N + P L LT L N + P + ++ L L + +NK++ +
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--S 237
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271
L L L L +G N++ + + LT L L + SN ++ + N++ + +
Sbjct: 238 PLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLF 293
Query: 272 MSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLS 326
++ N + + L+ L L +S N ++ P+ A L + D +N +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPL--ASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 58/275 (21%), Positives = 114/275 (41%), Gaps = 27/275 (9%)
Query: 126 LDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI 185
L + P L L+ ++ + +L + + ++ +
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-- 58
Query: 186 PSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTY 245
I L NL L+L+ N+++ + L L L L +G NK+ S L LTNL
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRE 114
Query: 246 LYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI 305
LYL+ ++++ P + N+T + +++ N+ + L+ ++ L YL+++ + +
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVT 171
Query: 306 PITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYL 365
P IA L L L L+ N++ P + + L T N ++ I P + +L L
Sbjct: 172 P--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT-DITPVANMTRLNSL 226
Query: 366 DLSHNKLNGTIPPF-----LYHRFPLDLSYNDLEG 395
+ +NK+ + P L L++ N +
Sbjct: 227 KIGNNKITD-LSPLANLSQLTW---LEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 39/203 (19%), Positives = 84/203 (41%), Gaps = 15/203 (7%)
Query: 198 LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI 257
L+ ++ + L + + + + L ++T L + + SI
Sbjct: 5 LATLPAPINQI--FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SI 59
Query: 258 PPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKG 317
I +T + ++++ N I PL L +L L I +N ++ + L +L+
Sbjct: 60 QG-IEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQNLTNLRE 114
Query: 318 LDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIP 377
L L+ + +S P + +++ ++ L N+ + P + L YL ++ +K+ +
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD-VT 171
Query: 378 PF--LYHRFPLDLSYNDLEGEIP 398
P L + L L+YN +E P
Sbjct: 172 PIANLTDLYSLSLNYNQIEDISP 194
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 9e-50
Identities = 54/284 (19%), Positives = 111/284 (39%), Gaps = 34/284 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E +I IG G +G VY + +G+V A++ + E +F+ E + H
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQL-KAFKREVMAYRQTRHE 89
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
N+V G C+ + +I K +L+ +R+ +VLD I + + + YLH
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR-----TIVAGTYGYIAP 673
I+H+D+ S N+ ++ + + DFG + + R I G ++AP
Sbjct: 148 A---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 674 EL---------AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724
E+ + ++ DV++ G + E+ P + + + M ++
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263
Query: 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
+ + +++ C + + RPT ++
Sbjct: 264 SQIGMGKEISDILLF-----------CWAFEQEERPTFTKLMDM 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 27/275 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+ IG+G +G+VYK + +G V A+K L+ +F+NE VL K H
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQL-QAFKNEVGVLRKTRHV 80
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
NI+ G+ + ++ ++ + SL+ L + ++I + A + YLH
Sbjct: 81 NILLFMGYST-APQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH 137
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD--SDSSNRTIVAGTYGYIAPEL- 675
SI+HRD+ SNNI L+ + DFG A S S ++G+ ++APE+
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 676 --AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS--DQKIMLIDVLDSRLS- 730
+ + + DVY+FG+V E++ G+ P +++ + + D+ R +
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
P + +M + CL K RP+ R+
Sbjct: 255 PKRMKRLMAE----------CLKKKRDERPSFPRI 279
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 5e-48
Identities = 62/333 (18%), Positives = 121/333 (36%), Gaps = 22/333 (6%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
L ++FS F L+ L L + L L L + N + P L +
Sbjct: 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNKL 205
LE L L + QL L + ++ N +H +P+ +L NL+ + L N +
Sbjct: 106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI 165
Query: 206 SGMLHQELGKLKNL----VALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE- 260
+ +L L+ ++L++ N + I F+ L L L N + +I
Sbjct: 166 QTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTC 224
Query: 261 IGNMTGILKVDMSMNNIEGTIPLELTRLS--------QLLYLSISSNMLSGQIPITIAGL 312
+ N+ G+ + + + LE+ S + ++ + L
Sbjct: 225 LQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL 284
Query: 313 ISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKL 372
++ + L+ + ++ K + +++++ L P + L L+ L L+ NK
Sbjct: 285 ANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF--PTLDLPFLKSLTLTMNKG 340
Query: 373 NGTIPPFLYHR--FPLDLSYNDLEGEIPDYFRD 403
+ + LDLS N L + D
Sbjct: 341 S-ISFKKVALPSLSYLDLSRNALSFSGCCSYSD 372
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-44
Identities = 59/317 (18%), Positives = 105/317 (33%), Gaps = 20/317 (6%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
E S C ++ L + F + L+ + + + ++ ++
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFK 308
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
+ L++ L L L L L+ N G I L +L L L N LS
Sbjct: 309 WQSLSIIRCQLKQFPTLDLPFLKSLT---LTMN--KGSISFKKVALPSLSYLDLSRNALS 363
Query: 207 GMLHQ--ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE-IGN 263
+L L++ N + + + L L +L + L +
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
Query: 264 MTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIP-ITIAGLISLKGLDLSN 322
+ +L +D+S N + L+ L L ++ N A +L LDLS
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 323 NKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFL 380
+L L+ + + +NNL + L L LD S N++ T L
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLL-FLDSSHYNQLYSLSTLDCSFNRIE-TSKGIL 540
Query: 381 YHRFP----LDLSYNDL 393
H +L+ N +
Sbjct: 541 QHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-44
Identities = 64/348 (18%), Positives = 116/348 (33%), Gaps = 28/348 (8%)
Query: 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALS--------KLR 124
+ E+ L + + GL L ++ S +
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
Query: 125 YLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGP 184
++ N + L N+ ++L G ++ + + K ++++ R L
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ- 321
Query: 185 IPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL--MGPIPSTLFRLTN 242
P+ DL L L+L NK S L +L L++ N L G + +
Sbjct: 322 FPTL--DLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377
Query: 243 LTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLE-LTRLSQLLYLSISSNML 301
L +L L N + + + +D + ++ L +LLYL IS
Sbjct: 378 LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
Query: 302 SGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--G 358
GL SL L ++ N + + L + L L I +
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE-QISWGVFDT 495
Query: 359 LMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFR 402
L +L+ L++SHN L + Y++ LD S+N +E
Sbjct: 496 LHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-43
Identities = 60/318 (18%), Positives = 110/318 (34%), Gaps = 20/318 (6%)
Query: 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLK 153
+ L +P + S + +D SFN L + L+ L+L
Sbjct: 8 IEVVPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLS 64
Query: 154 GNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL 213
+ + L L + L+ N + P + L +L L KL+ + +
Sbjct: 65 RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
Query: 214 GKLKNLVALNVGGNKLMG-PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTG----IL 268
G+L L LNV N + +P+ LTNL ++ L N++ ++ + L
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184
Query: 269 KVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIP-ITIAGLISLKGLDLSNNKLSG 327
+DMS+N I+ I + + +L L++ N S I + L L L +
Sbjct: 185 SLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
Query: 328 PIPPEIGKCSELRNIT--------LRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIP- 377
EI + S + + L N + L + + L+ +
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDV 303
Query: 378 PFLYHRFPLDLSYNDLEG 395
P + L + L+
Sbjct: 304 PKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-40
Identities = 65/339 (19%), Positives = 119/339 (35%), Gaps = 28/339 (8%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFG-SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR 145
L F L+ L++ N++ +P+ L+ L ++D S+N + +L LR
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 146 NL----EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPS-AIGDLNNLLILSL 200
L++ N ++ I Q KL + L N I + +L L + L
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 201 DSNKLSGMLHQE------LGKLKNLVA--LNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252
+ + E + L ++ + L N++ + L
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGL 312
+ ++ + + ++ L+L L L+++ N S I L
Sbjct: 297 IKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK---SLTLTMNKGS--ISFKKVAL 349
Query: 313 ISLKGLDLSNNKLS--GPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHN 370
SL LDLS N LS G + LR++ L N +GL +L++LD H+
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHS 409
Query: 371 KLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
L + LD+SY + + + F
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-40
Identities = 61/338 (18%), Positives = 105/338 (31%), Gaps = 29/338 (8%)
Query: 88 LSQFNFSCFPG--LESLSLRFNYLFGSIPSQV-GALSKLRYLD------FSFNNLTGSIP 138
+ F G L L+LR N+ +I L+ L NL P
Sbjct: 193 IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252
Query: 139 PELGSLRNL--EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL 196
+ L ++ + L N L + M+L+ +
Sbjct: 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--KHFKWQ 310
Query: 197 ILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN-- 254
LS+ +L L L +L + NK I L +L+YL L N L+
Sbjct: 311 SLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFS 365
Query: 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI-TIAGLI 313
G + +D+S N + L +L +L + L L
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424
Query: 314 SLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNK 371
L LD+S + L + + N+ + + L +LDLS +
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 372 LNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
L I ++ L++S+N+L ++
Sbjct: 485 LEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-40
Identities = 62/322 (19%), Positives = 103/322 (31%), Gaps = 28/322 (8%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNL 157
SL + N + I Q KL L N + +I L +L L V L
Sbjct: 183 NLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241
Query: 158 NG---------AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM 208
+I LC +T L+ L N+ +SL + +
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTID-EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL 300
Query: 209 LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGIL 268
+++ K +L++ +L P+ L L L L N SI + + +
Sbjct: 301 --EDVPKHFKWQSLSIIRCQL-KQFPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLS 353
Query: 269 KVDMSMNNIEGTIP--LELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLS 326
+D+S N + + + L +L +S N + GL L+ LD ++ L
Sbjct: 354 YLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLK 412
Query: 327 GPIPPE-IGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLYHRF 384
+L + + N GL L L ++ N ++
Sbjct: 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT 472
Query: 385 P----LDLSYNDLEGEIPDYFR 402
LDLS LE F
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFD 494
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-38
Identities = 63/243 (25%), Positives = 91/243 (37%), Gaps = 7/243 (2%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLT--GSIPPELGSLR 145
L QF P L+SL+L N SI + AL L YLD S N L+ G
Sbjct: 319 LKQFPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIP-SAIGDLNNLLILSLDSNK 204
+L L+L N + ++ L +L + + L SA L LL L +
Sbjct: 377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435
Query: 205 LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEIGN 263
L +L L + GN S +F TNLT+L L L
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495
Query: 264 MTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
+ + ++MS NN+ +L L L S N + I SL +L+NN
Sbjct: 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
Query: 324 KLS 326
++
Sbjct: 556 SVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-37
Identities = 54/289 (18%), Positives = 102/289 (35%), Gaps = 23/289 (7%)
Query: 135 GSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNN 194
GS+ P + + N+ L+ +P + + + LS N L + + +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 195 LLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254
L L L ++ + + L +L L + GN + P + LT+L L L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 255 GSIPPEIGNMTGILKVDMSMNNIEG-TIPLELTRLSQLLYLSISSNMLSGQIPITIAGL- 312
IG + + K++++ N I +P + L+ L+++ +S N + + L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 313 ---ISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDL 367
LD+S N + I + + +L +TLR N S +I L L L
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 368 SHNKLNG-----TIPPFLYHRFP------LDLSYNDLEGEIPDYFRDSP 405
+ P + L+Y + + F
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 28/159 (17%), Positives = 48/159 (30%), Gaps = 1/159 (0%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
+ ++ LK F L L + + L+ L L + N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 132 NLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIG 190
+ + + NL L+L L L +L + +S N L S
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 191 DLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL 229
L +L L N++ K+L N+ N +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-48
Identities = 52/288 (18%), Positives = 94/288 (32%), Gaps = 21/288 (7%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR--NLEVLNLKGNN 156
+ + S Q + + + L + L L L+
Sbjct: 35 WQRHYNADRNRWHSAWRQ-ANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVP 92
Query: 157 LNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKL 216
L P +L+ L M + GL +P + L L+L N L L + L
Sbjct: 93 LP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASL 149
Query: 217 KNLVALNVGGNKLMGPIPSTL---------FRLTNLTYLYLHSNHLNGSIPPEIGNMTGI 267
L L++ + +P L L NL L L + S+P I N+ +
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208
Query: 268 LKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSN-NKLS 326
+ + + + + + L +L L + P G LK L L + + L
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 327 GPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLN 373
+P +I + ++L + LR +P I L + + +
Sbjct: 268 T-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-47
Identities = 54/293 (18%), Positives = 104/293 (35%), Gaps = 22/293 (7%)
Query: 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNL 157
G E+L + + + + D + + + N ++ G L
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRAL 68
Query: 158 NGAIPSSL--CQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGK 215
A L + + L L P L++L +++D+ L L + +
Sbjct: 69 K-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQ 125
Query: 216 LKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV----- 270
L L + N L +P+++ L L L + + +P + + +
Sbjct: 126 FAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184
Query: 271 ----DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLS 326
+ I ++P + L L L I ++ LS + I L L+ LDL
Sbjct: 185 LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 327 GPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPP 378
PP G + L+ + L++ + ++P +I L +LE LDL +P
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 60/302 (19%), Positives = 110/302 (36%), Gaps = 26/302 (8%)
Query: 55 SNSSDHCKLDGVTCNTARSIIEINLPE------KKLKGELSQFNFSCFPGLESLSLRFNY 108
S H D ++A N P+ + LK + PG +L LR
Sbjct: 33 SQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVP 92
Query: 109 LFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQL 168
L P Q LS L+++ L +P + LE L L N L A+P+S+ L
Sbjct: 93 L-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
Query: 169 TKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNK 228
+L +++ +P + + E L NL +L +
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDAS---------------GEHQGLVNLQSLRLEWTG 194
Query: 229 LMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRL 288
+ +P+++ L NL L + ++ L+ ++ P I ++ + ++D+ P
Sbjct: 195 IRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 289 SQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNN 348
+ L L + +P+ I L L+ LDL +P I + I + +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
Query: 349 LS 350
+
Sbjct: 313 QA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 56/256 (21%), Positives = 94/256 (36%), Gaps = 22/256 (8%)
Query: 135 GSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNN 194
GS E L +G+ L Q + +R + NN
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 195 LLILSLDSNKLSGMLHQELGKLK--NLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252
I + L L VAL + L P FRL++L ++ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115
Query: 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSN---------MLSG 303
L +P + G+ + ++ N + +P + L++L LSI + + S
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 304 QIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKL 362
GL++L+ L L + +P I L+++ +RN+ LS ++ P I L KL
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 363 EYLDLSHNKLNGTIPP 378
E LDL PP
Sbjct: 232 EELDLRGCTALRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 44/202 (21%), Positives = 78/202 (38%), Gaps = 13/202 (6%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGS--------- 143
F GLE+L+L N L ++P+ + +L++LR L +P L S
Sbjct: 123 MQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
Query: 144 LRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSN 203
L NL+ L L+ + ++P+S+ L L ++ + + L + AI L L L L
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239
Query: 204 KLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGN 263
G L L + + +P + RLT L L L +P I
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
Query: 264 MTGILKVDMSMNNIEGTIPLEL 285
+ + + +++ +
Sbjct: 300 LPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 27/115 (23%), Positives = 47/115 (40%), Gaps = 1/115 (0%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
L+SL +R + L ++ + L KL LD + PP G L+ L LK +
Sbjct: 208 LKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL 213
+P + +LT+L + L +PS I L I+ + + + +
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRP 321
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 12/70 (17%), Positives = 27/70 (38%), Gaps = 3/70 (4%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGN--- 155
L+ L L+ ++P + L++L LD +P + L ++ + +
Sbjct: 255 LKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
Query: 156 NLNGAIPSSL 165
L+ P +
Sbjct: 315 QLDQHRPVAR 324
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-47
Identities = 82/314 (26%), Positives = 136/314 (43%), Gaps = 25/314 (7%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
+ L L+L N + P + L+ L L+ S N ++ L L +L+ L+
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
GN + P L LT L + +S N + S + L NL L +N++S +
Sbjct: 163 F-GNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDI--T 215
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271
LG L NL L++ GN+L TL LTNLT L L +N ++ P + +T + ++
Sbjct: 216 PLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 272 MSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPP 331
+ N I PL L+ L L ++ N L PI + L +L L L N +S P
Sbjct: 272 LGANQISNISPLA--GLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP- 326
Query: 332 EIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF--LYHRFPLDLS 389
+ ++L+ + NN +S + L + +L HN+++ + P L L L+
Sbjct: 327 -VSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLN 383
Query: 390 YNDLEGEIPDYFRD 403
+Y +
Sbjct: 384 DQAWTNAPVNYKAN 397
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-44
Identities = 75/310 (24%), Positives = 131/310 (42%), Gaps = 25/310 (8%)
Query: 91 FNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150
F + L + ++ L ++ L + + L NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH 210
N N L P L LTKL+ + ++ N + P + +L NL L+L +N+++ +
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-- 127
Query: 211 QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV 270
L L NL L + N + L LT+L L + + + N+T + ++
Sbjct: 128 DPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTD---LKPLANLTTLERL 182
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
D+S N + + L +L+ L L ++N +S P + L +L L L+ N+L
Sbjct: 183 DISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I 236
Query: 331 PEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF--LYHRFPLDL 388
+ + L ++ L NN +S ++ P GL KL L L N+++ I P L L+L
Sbjct: 237 GTLASLTNLTDLDLANNQIS-NLAPLSGLTKLTELKLGANQISN-ISPLAGLTALTNLEL 294
Query: 389 SYNDLEGEIP 398
+ N LE P
Sbjct: 295 NENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-40
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 21/285 (7%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
+ LE L + N + S S + L+ L L + N ++ P LG L NL+ L+
Sbjct: 172 PLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELS 227
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
L GN L +L LT L + L+ N + P + L L L L +N++S +
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--S 281
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271
L L L L + N+L P + L NLTYL L+ N+++ P + ++T + ++
Sbjct: 282 PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337
Query: 272 MSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPP 331
N + L L+ + +LS N +S P+ L + L L++ + P
Sbjct: 338 FYNNKVSDVSSLA--NLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTN-APV 392
Query: 332 EIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGT 375
+ N T++N + P I D++ N + T
Sbjct: 393 NYKANVSIPN-TVKNVTGALIAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 22/126 (17%), Positives = 43/126 (34%), Gaps = 10/126 (7%)
Query: 275 NNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334
I L++ + + ++ ++ L + L + +
Sbjct: 12 TPINQIFTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK--SIDGVE 65
Query: 335 KCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF--LYHRFPLDLSYND 392
+ L I NN L+ I P L KL + +++N++ I P L + L L N
Sbjct: 66 YLNNLTQINFSNNQLT-DITPLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQ 123
Query: 393 LEGEIP 398
+ P
Sbjct: 124 ITDIDP 129
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-46
Identities = 61/310 (19%), Positives = 119/310 (38%), Gaps = 20/310 (6%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
+I ++ + + ++L ++ S N++ L+L GN L+ + L TKL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 172 ITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231
+ LS N L+ + L+ L L L++N + EL ++ L+ N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEG-TIPLELTRLSQ 290
+ + + +YL +N + + G + + +D+ +N I+
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 291 LLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350
L +L++ N + + + LK LDLS+NKL+ + PE + + I+LRNN L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
Query: 351 GSIPPEIG-LMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
I + LE+ DL N + + + + + P
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 406 FKVYGNQGIC 415
+ C
Sbjct: 287 TLGHYGAYCC 296
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 47/309 (15%), Positives = 101/309 (32%), Gaps = 17/309 (5%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
+ ++ L L N L + + +KL L+ S N L +L SL
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
L L+L N + L + T+ + N + + + + L +NK++
Sbjct: 82 LRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSCSR--GQGKKNIYLANNKIT 133
Query: 207 GMLHQELGKLKNLVALNVGGNKLMG-PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
+ + G + L++ N++ L +L L N + + ++
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 266 GILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
+ +D+S N + + E + + ++S+ +N L I + +L+ DL N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 326 SGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFP 385
R T+ + + L + P +
Sbjct: 250 HC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL-GHYGAYCCEDLPAPFADRL 307
Query: 386 LDLSYNDLE 394
+ L ++
Sbjct: 308 IALGHHHHH 316
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-44
Identities = 59/299 (19%), Positives = 119/299 (39%), Gaps = 18/299 (6%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
+I ++ + + ++L ++ S N++ L+L GN L+ + L TKL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 172 ITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231
+ LS N L+ + L+ L L L++N + EL ++ L+ N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEG-TIPLELTRLSQ 290
+ + + +YL +N + + G + + +D+ +N I+
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 291 LLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350
L +L++ N + + + LK LDLS+NKL+ + PE + + I+LRNN L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
Query: 351 GSIPPEIG-LMKLEYLDLSHNKLNGTIPPFLYHRFP--LDLSYNDLEGEIPDYFRDSPF 406
I + LE+ DL N + + + ++ ++ +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-42
Identities = 52/300 (17%), Positives = 105/300 (35%), Gaps = 18/300 (6%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
+ + + L ++ S + ++ LD S N L+ +L LE+LNL N L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKN 218
L L+ L T+ L+ N + + ++ L +N +S + + +
Sbjct: 72 E--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV---SCSRGQG 121
Query: 219 LVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG-SIPPEIGNMTGILKVDMSMNNI 277
+ + NK+ + + YL L N ++ + + + +++ N I
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 278 EGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337
+ ++ ++L L +SSN L+ + + + L NNKL I +
Sbjct: 182 Y-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ 237
Query: 338 ELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNK-LNGTIPPFLYHRFPLDLSYNDLE 394
L + LR N + +++ + K L G E
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-41
Identities = 48/309 (15%), Positives = 100/309 (32%), Gaps = 17/309 (5%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
+ ++ L L N L + + +KL L+ S N L +L SL
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
L L+L N + L + T+ + N + + + + L +NK++
Sbjct: 82 LRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSCSR--GQGKKNIYLANNKIT 133
Query: 207 GMLHQELGKLKNLVALNVGGNKLMG-PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
+ + G + L++ N++ L +L L N + + ++
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 266 GILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
+ +D+S N + + E + + ++S+ +N L I + +L+ DL N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 326 SGPIPPE-IGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRF 384
+ K ++ + + E PF
Sbjct: 250 HCGTLRDFFSKNQRVQTVAK-QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
Query: 385 PLDLSYNDL 393
L + L
Sbjct: 309 ALKRKEHAL 317
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 45/269 (16%), Positives = 85/269 (31%), Gaps = 12/269 (4%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG-SIPPELGSLRN 146
+S+ + S G +++ L N + G S+++YLD N + + S
Sbjct: 111 ISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
LE LNL+ N + + + KL T+ LS N L + + +SL +NKL
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
Query: 207 GMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTG 266
++ + L +NL ++ GN F N + + T
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 267 ILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG----QIPITIAGLISLKGLDLSN 322
E RL L + G ++ + +D
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 323 NKLSGPIPPEIGK-CSELRNITLRNNNLS 350
+ + ++ + + L
Sbjct: 346 EQYRT-VIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 37/292 (12%), Positives = 82/292 (28%), Gaps = 10/292 (3%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFG-SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR 145
L + C ++ L L+ N + + + L +L+ +N + + ++
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL 205
L+ L+L N L + + ++L N L I A+ NL L N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249
Query: 206 SGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
++ KN V + T T + + P +
Sbjct: 250 HCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
Query: 266 GILKVDMSMNNIEG----TIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLS 321
+ + + ++ + +G + E ++ + I + L+
Sbjct: 309 ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368
Query: 322 NNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLN 373
L + +EL + L+ L +
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 18/169 (10%), Positives = 48/169 (28%), Gaps = 12/169 (7%)
Query: 88 LSQFNFSCFPGLESLSLRFNYL-------FGSIPSQVGALSKLRYLDFSFNNLTGSIPPE 140
L +L + + L + + ++ R +D ++ +
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQ 354
Query: 141 LGS-LRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILS 199
+ + L K L+ + + +L G + A + + L +L
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLR 413
Query: 200 LDSNKLSGMLHQ-ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLY 247
+ M + + + + ++ +K + RL L
Sbjct: 414 AIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE-TQLAEENARLKKLNGEA 461
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 81/350 (23%), Positives = 141/350 (40%), Gaps = 34/350 (9%)
Query: 43 LVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESL 102
+ ++ ID + D G T + + ++ +L F +E L
Sbjct: 18 QYDCVFYDVHIDMQTQDV--YFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 74
Query: 103 SLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLNGA 160
+L + I + ++ L FN + +PP ++ L VL L+ N+L+
Sbjct: 75 NLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 161 IPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLV 220
KL T+++S N L +L L L SN+L+ + +L + +L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLF 189
Query: 221 ALNVGGNKLMG-PIPSTLFRL---------------TNLTYLYLHSNHLNGSIPPEIGNM 264
NV N L IP + L LT L L N+L + + N
Sbjct: 190 HANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL--TDTAWLLNY 247
Query: 265 TGILKVDMSMNNIEGTIPLE-LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
G+++VD+S N +E I ++ +L L IS+N L + + + +LK LDLS+N
Sbjct: 248 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305
Query: 324 KLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLN 373
L + + L N+ L +N++ ++ L+ L LSHN +
Sbjct: 306 HLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST-HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-38
Identities = 60/317 (18%), Positives = 112/317 (35%), Gaps = 25/317 (7%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVL 150
N + + + L+ + + F + + +P L S R +E+L
Sbjct: 16 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 74
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH 210
NL + + + + + N + P ++ L +L L+ N LS +
Sbjct: 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 134
Query: 211 QELGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEIGNMTGILK 269
L L++ N L I F+ T+L L L SN L + + +
Sbjct: 135 GIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFH 190
Query: 270 VDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPI 329
++S N + L + L S N ++ + + + L L L +N L+
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT- 241
Query: 330 PPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPF---LYHRF 384
+ L + L N L I + +LE L +S+N+L + + +
Sbjct: 242 -AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 298
Query: 385 PLDLSYNDLEGEIPDYF 401
LDLS+N L +
Sbjct: 299 VLDLSHNHLL-HVERNQ 314
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-37
Identities = 57/300 (19%), Positives = 119/300 (39%), Gaps = 22/300 (7%)
Query: 110 FGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLT 169
+ I S + + E +L N +++ K + + + L
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69
Query: 170 KLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL 229
++ + L+ + A + + L + N + + + L L + N L
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 230 MGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLELTR 287
+P +F LT L + +N+L I + T + + +S N + ++L+
Sbjct: 130 SS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSL 184
Query: 288 LSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNN 347
+ L + ++S N+LS T+A I+++ LD S+N ++ + + EL + L++N
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHN 236
Query: 348 NLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFRD 403
NL+ + L +DLS+N+L I + + L +S N L + Y +
Sbjct: 237 NLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 293
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 36/177 (20%), Positives = 62/177 (35%), Gaps = 11/177 (6%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRN 146
++ L L L+ N L + + + L +D S+N L I ++
Sbjct: 217 INVVRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQR 273
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
LE L + N L A+ + L + LS N L + + L L LD N +
Sbjct: 274 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV 331
Query: 207 GMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGN 263
+ +L L L + N LFR N+ + + I ++ +
Sbjct: 332 TL---KLSTHHTLKNLTLSHNDWDCNSLRALFR--NVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 25/120 (20%), Positives = 42/120 (35%), Gaps = 7/120 (5%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
++ F LE L + N L ++ + L+ LD S N+L +
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
LE L L N++ + S L + LS N A+ N+ ++D
Sbjct: 320 LENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 374
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-40
Identities = 67/310 (21%), Positives = 112/310 (36%), Gaps = 44/310 (14%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR------------- 145
L+ + L +P + + +++ + PP G R
Sbjct: 13 LQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR 71
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL 205
L L L+ ++P L L+ S N L +P L +LL+ + + L
Sbjct: 72 QAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 206 SGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
S + L L V N+L +P L + L + + +N L +P ++
Sbjct: 127 SDLPP-------LLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLE 176
Query: 266 GILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
+ N +E +P EL L L + +N L ++P +SL+ + NN L
Sbjct: 177 ---FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAGNNIL 227
Query: 326 SGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFP 385
PE+ L I NN L ++P LE L++ N L +P
Sbjct: 228 E--ELPELQNLPFLTTIYADNNLLK-TLPDLPP--SLEALNVRDNYLT-DLPELPQSLTF 281
Query: 386 LDLSYNDLEG 395
LD+S N G
Sbjct: 282 LDVSENIFSG 291
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 68/333 (20%), Positives = 113/333 (33%), Gaps = 71/333 (21%)
Query: 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIP------------------ 138
P LE L + N L +P + S L+ +D N+L +P
Sbjct: 131 PLLEYLGVSNNQL-EKLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLEE 187
Query: 139 -PELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLI 197
PEL +L L + N+L +P L ++ N L + +L L
Sbjct: 188 LPELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTT 241
Query: 198 LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI 257
+ D+N L L L+ LNV N L +P +LT+L + N + +
Sbjct: 242 IYADNNLLK-TLPDLPPSLEA---LNVRDNYLTD-LPEL---PQSLTFLDVSENIFS-GL 292
Query: 258 PPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKG 317
N+ ++ S N I ++ L L++S+N L ++P A L+
Sbjct: 293 SELPPNLY---YLNASSNEIR-SLCDLPPSLE---ELNVSNNKLI-ELP---ALPPRLER 341
Query: 318 LDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-----------------LM 360
L S N L+ +P L+ + + N L P
Sbjct: 342 LIASFNHLAE-VPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQ 396
Query: 361 KLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDL 393
L+ L + N L P L ++ +
Sbjct: 397 NLKQLHVETNPLR-EFPDIPESVEDLRMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 54/295 (18%), Positives = 94/295 (31%), Gaps = 43/295 (14%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
P L ++ N L +P L + N L PEL +L L +
Sbjct: 190 ELQNLPFLTAIYADNNSL-KKLPDL---PLSLESIVAGNNILE--ELPELQNLPFLTTIY 243
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
N L +P L L + N L +P L L + + LS +
Sbjct: 244 ADNNLLK-TLPDLPPSLEALN---VRDNYLTD-LPELPQSLTFLDVSENIFSGLSELP-- 296
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271
NL LN N++ + +L L + +N L +P + ++
Sbjct: 297 -----PNLYYLNASSNEIRS-LCDLP---PSLEELNVSNNKLI-ELPALPPRLE---RLI 343
Query: 272 MSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPP 331
S N++ +P L L + N L + P + L+ N+ L+ +P
Sbjct: 344 ASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLR----MNSHLA-EVPE 393
Query: 332 EIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPL 386
+L + N L P +E L ++ ++ F +
Sbjct: 394 LPQNLKQL---HVETNPLR-EFPDIPE--SVEDLRMNSERVV-DPYEFAHETTDK 441
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-30
Identities = 50/263 (19%), Positives = 86/263 (32%), Gaps = 33/263 (12%)
Query: 137 IPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL 196
I P S L+ +NL +P + + + P G+ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 197 ILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256
+ L + L + L +P +L L N L
Sbjct: 62 VSRLRDC-----------LDRQAHELELNNLGL-SSLPEL---PPHLESLVASCNSLT-E 105
Query: 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLK 316
+P ++ +L + ++ + P L YL +S+N L ++P + LK
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLK 156
Query: 317 GLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTI 376
+D+ NN L +P L I NN L +P L L + +N L +
Sbjct: 157 IIDVDNNSLKK-LPDLPPS---LEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLK-KL 210
Query: 377 PPFLYHRFPLDLSYNDLEGEIPD 399
P + N LE E+P+
Sbjct: 211 PDLPLSLESIVAGNNILE-ELPE 232
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 53/265 (20%), Positives = 91/265 (34%), Gaps = 41/265 (15%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
LES+ N L ++ L L + N L ++P SL L V + +L
Sbjct: 217 LESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL- 272
Query: 159 GAIPSSLCQLTKLITMALSRNGL-------------HGPIPSAIGDLNNLLILSLDSNKL 205
P LT L +GL I S +L L++ +NKL
Sbjct: 273 ---PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL 329
Query: 206 SGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
L +L+ L N L +P NL L++ N L P ++
Sbjct: 330 I-ELPALPPRLERL---IASFNHLAE-VPELP---QNLKQLHVEYNPLR-EFPDIPESVE 380
Query: 266 GILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
D+ MN+ +P L L + +N L + P S++ L +++ ++
Sbjct: 381 -----DLRMNSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPE---SVEDLRMNSERV 428
Query: 326 SGPIPPEIGKCSELRNITLRNNNLS 350
P +L + +++
Sbjct: 429 VDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 40/281 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKK--LHRAETEETTFFNSFQNEAHVLSKI 555
E + IG G +G + +G+ +K+ + R ++E + E VL+ +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER---EESRREVAVLANM 80
Query: 556 AHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-----EAVVLDWTMRVNIIKCV 610
H NIV+ ++++ Y + G LF + E +LDW +++
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------ 134
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
AL ++H I+HRDI S NI L + DFG AR+L+S GT Y
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIM--LIDVLD 726
++PE+ K D+++ G V E+ +H + +L KI+ +
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-----LKIISGSFPPVS 246
Query: 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
S + +V Q P+ RP++ + +
Sbjct: 247 LHYSYDLRSLVSQ-----------LFKRNPRDRPSVNSILE 276
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-39
Identities = 68/297 (22%), Positives = 117/297 (39%), Gaps = 43/297 (14%)
Query: 96 FPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGN 155
+ +L + N L S+P+ +LR L+ S N LT S+P L L + +
Sbjct: 60 PAHITTLVIPDNNL-TSLPA---LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT 114
Query: 156 NLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGK 215
+L A+PS LC+L + N L +P L LS+ N+L+ L +
Sbjct: 115 HLP-ALPSGLCKLW------IFGNQLTS-LPVLPP---GLQELSVSDNQLA-SLPALPSE 162
Query: 216 LKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMN 275
L L N+L +P + L L + N L S+P + K+ N
Sbjct: 163 LCK---LWAYNNQLTS-LPML---PSGLQELSVSDNQLA-SLPTLPSELY---KLWAYNN 211
Query: 276 NIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGK 335
+ ++P + L + L +S N L+ +P+ + LK L +S N+L+ +P
Sbjct: 212 RLT-SLPALPSGLKE---LIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPMLPSG 262
Query: 336 CSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYN 391
L ++ N L+ +P + L ++L N L+ Y+
Sbjct: 263 LLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYS 314
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 4e-39
Identities = 64/280 (22%), Positives = 114/280 (40%), Gaps = 40/280 (14%)
Query: 120 LSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179
+ L+ + LT ++P L + ++ L + NNL ++P+ +L L +S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91
Query: 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR 239
L +P L L I S L + L L + GN+L +P
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLTS-LPVL--- 139
Query: 240 LTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSN 299
L L + N L S+P + K+ N + ++P+ + L + LS+S N
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQE---LSVSDN 191
Query: 300 MLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGL 359
L+ +P + L L NN+L+ +P L+ + + N L+ S+P
Sbjct: 192 QLA-SLPTLPS---ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPVLPS- 241
Query: 360 MKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPD 399
+L+ L +S N+L ++P L + N L +P+
Sbjct: 242 -ELKELMVSGNRLT-SLPMLPSGLLSLSVYRNQLT-RLPE 278
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-35
Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 39/280 (13%)
Query: 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLK 153
+ P L +L + N L S+P L +L +L L L +
Sbjct: 78 ALPPELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIF 129
Query: 154 GNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL 213
GN L ++P L +L +S N L +P+ +L L +N+L+ L
Sbjct: 130 GNQLT-SLPVLPPGLQELS---VSDNQLAS-LPALPSELCK---LWAYNNQLT-SLPMLP 180
Query: 214 GKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMS 273
L+ L+V N+L +P+ + L L+ ++N L S+P + ++ +S
Sbjct: 181 SGLQE---LSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALPSGLK---ELIVS 229
Query: 274 MNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI 333
N + ++P+ + +L L +S N L+ +P+ +GL+S L + N+L+ +P +
Sbjct: 230 GNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLTR-LPESL 280
Query: 334 GKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLN 373
S + L N L S L ++ +
Sbjct: 281 IHLSSETTVNLEGNPL--SERTLQALREITSAPGYSGPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 53/250 (21%), Positives = 98/250 (39%), Gaps = 44/250 (17%)
Query: 166 CQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVG 225
C + + +GL +P + ++ L + N L+ L +L+ L V
Sbjct: 37 CLNNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPALPPELRT---LEVS 89
Query: 226 GNKLMGPIPSTLFRLTNLTYLYLHSNHLNG----------------SIPPEIGNMTGILK 269
GN+L +P L L+ HL S+P + +
Sbjct: 90 GNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQ---E 145
Query: 270 VDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPI 329
+ +S N + ++P S+L L +N L+ +P+ + L+ L +S+N+L+ +
Sbjct: 146 LSVSDNQLA-SLPAL---PSELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-L 196
Query: 330 PPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLS 389
P + L + NN L+ S+P L+ L +S N+L ++P L +S
Sbjct: 197 PTLPSE---LYKLWAYNNRLT-SLPALPS--GLKELIVSGNRLT-SLPVLPSELKELMVS 249
Query: 390 YNDLEGEIPD 399
N L +P
Sbjct: 250 GNRLT-SLPM 258
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 28/124 (22%), Positives = 43/124 (34%), Gaps = 7/124 (5%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
L+ L + N L S+P S L L N LT +P L L + +NL+GN L+
Sbjct: 243 LKELMVSGNRL-TSLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKN 218
+L ++T + SA + L + + D L E
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW--LVPAREGEPAPADR 355
Query: 219 LVAL 222
Sbjct: 356 WHMF 359
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-39
Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 49/288 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
ED + IG G +G V+ +L VA+K + F EA +L + +H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQYSH 171
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
NIV+L G C K+ ++++ + ++ G FLR + + + + ++ A + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYL 229
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----A 672
+HRD+++ N L+ K ++DFG +R +G + A
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTA 283
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS---- 727
PE + + DV+SFG++ E G P + +
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPY------------PNLSNQQTREFVEKG 331
Query: 728 -RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P +M+ C +P RP+ + QE
Sbjct: 332 GRLPCPELCPDAVFRLMEQ----------CWAYEPGQRPSFSTIYQEL 369
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-39
Identities = 66/293 (22%), Positives = 117/293 (39%), Gaps = 11/293 (3%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSL 144
L+Q F+ FP LE L L N + ++ L LR L N L IP L
Sbjct: 46 TLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGL 103
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204
NL L++ N + + L L ++ + N L A LN+L L+L+
Sbjct: 104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN 163
Query: 205 LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNM 264
L+ + + L L L+ L + + + RL L L + ++ P
Sbjct: 164 LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 265 TGILKVDMSMNNIEGTIPLE-LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
+ + ++ N+ +P + L L +L++S N +S + L+ L+ + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 324 KLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLN 373
+L+ + P + LR + + N L+ ++ + + LE L L N L
Sbjct: 283 QLAV-VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-37
Identities = 74/311 (23%), Positives = 127/311 (40%), Gaps = 19/311 (6%)
Query: 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNL 152
C ++ ++P G ++ R LD N + ++ + S +LE L L
Sbjct: 8 ECSAQDRAVLCHRKRFV-AVPE--GIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELEL 63
Query: 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE 212
N ++ P + L L T+ L N L L+NL L + NK+ +L
Sbjct: 64 NENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYM 123
Query: 213 LGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEI-GNMTGILKV 270
L NL +L VG N L+ I F L +L L L +L SIP E ++ G++ +
Sbjct: 124 FQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVL 181
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
+ NI RL +L L IS + ++L L +++ L+ +P
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VP 240
Query: 331 PE-IGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP-- 385
+ LR + L N +S +I + L++L+ + L +L + P+ +
Sbjct: 241 YLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYL 298
Query: 386 --LDLSYNDLE 394
L++S N L
Sbjct: 299 RVLNVSGNQLT 309
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-38
Identities = 71/322 (22%), Positives = 131/322 (40%), Gaps = 24/322 (7%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGA-LSKLRYLDFSFNNLTGSIPPEL-GSL 144
E+ + F+ ++ L + FN + +P V + L L N+L+ S+P + +
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204
L L++ NNL + T L + LS N L + + + +L ++ N
Sbjct: 147 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNL 203
Query: 205 LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNM 264
LS L + L+ N + + + LT L L N+L + + N
Sbjct: 204 LS-----TLAIPIAVEELDASHNSINV-VRGPVN--VELTILKLQHNNL--TDTAWLLNY 253
Query: 265 TGILKVDMSMNNIEGTIPLE-LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
G+++VD+S N +E I ++ +L L IS+N L + + + +LK LDLS+N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
Query: 324 KLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGT-IPPFLYH 382
L + + L N+ L +N++ ++ L+ L LSHN + + +
Sbjct: 312 HLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST-HHTLKNLTLSHNDWDCNSLRALFRN 368
Query: 383 RFPLDLSYNDLEGEIPDYFRDS 404
+ D +I
Sbjct: 369 VARPAVDDADQHCKIDYQLEHG 390
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-35
Identities = 57/300 (19%), Positives = 119/300 (39%), Gaps = 22/300 (7%)
Query: 110 FGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLT 169
+ I S + + E +L N +++ K + + + L
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 170 KLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL 229
++ + L+ + A + + L + N + + + L L + N L
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135
Query: 230 MGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLELTR 287
+P +F LT L + +N+L I + T + + +S N + ++L+
Sbjct: 136 SS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSL 190
Query: 288 LSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNN 347
+ L + ++S N+LS T+A I+++ LD S+N ++ + + EL + L++N
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHN 242
Query: 348 NLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFRD 403
NL+ + L +DLS+N+L I + + L +S N L + Y +
Sbjct: 243 NLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 55/321 (17%), Positives = 113/321 (35%), Gaps = 28/321 (8%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNL 147
L+ + S P L ++ +N L S + + LD S N++ + L
Sbjct: 183 LTHVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVEL 234
Query: 148 EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG 207
+L L+ NNL + L L+ + LS N L + + L L + +N+L
Sbjct: 235 TILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 291
Query: 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGI 267
L+ + L L++ N L+ + + L LYL N + ++ +
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKL--STHHTL 347
Query: 268 LKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLD-------- 319
+ +S N+ + L + ++ +I + + K D
Sbjct: 348 KNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLL 405
Query: 320 --LSNNKLSGPIPPEIGKCSELRNI-TLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTI 376
++ + + G+CS I ++++ + + + L E L+ N+L +
Sbjct: 406 QYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV 465
Query: 377 PPFLYHRFPLDLSYNDLEGEI 397
+ + L EI
Sbjct: 466 QQLTNEQIQQEQLLQGLHAEI 486
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAE-TEETTFFNSFQNEAHVLSKIA 556
ED+++ Y IGTG YG K + +GK++ K+L TE +E ++L ++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELK 63
Query: 557 HRNIVKLYG-FCLHKKCMFLIY-KYMKRGSLFCFLRNDY-------EAVVLDWTMRVNII 607
H NIV+ Y I +Y + G L + E VL ++
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL--- 120
Query: 608 KCVANALSYLH--HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
AL H D +++HRD+ N+ L+ K + DFG AR+L+ D+S
Sbjct: 121 ---TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIM--L 721
GT Y++PE M EK D++S G + E+ P L+ KI
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-----GKIREGK 232
Query: 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+ R S ++ ++ + L+ K RP+++ + +
Sbjct: 233 FRRIPYRYSDELNEIITR-----------MLNLKDYHRPSVEEILE 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 59/280 (21%), Positives = 115/280 (41%), Gaps = 32/280 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+F I+ IG G + VY+A L +G VALKK+ + + E +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-------EAVVLDWTMRVNIIKCV 610
N++K Y + + ++ + G L +++ E V + +++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------ 145
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
+AL ++H ++HRDI N+ + + + D G R S ++ + GT Y
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID---VLDS 727
++PE + K D++S G + E+ + P ++ S +KI D +
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-GDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
S + ++V C++ P+ RP + V
Sbjct: 262 HYSEELRQLVNM-----------CINPDPEKRPDVTYVYD 290
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-37
Identities = 70/334 (20%), Positives = 124/334 (37%), Gaps = 36/334 (10%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLN 151
E L L FNY+ S L +L+ L+ +I E +L NL +L+
Sbjct: 20 PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI--PSAIGDLNNLLILSLDSNKLSGM- 208
L + + P + L L + L GL + +L L L L N++ +
Sbjct: 80 LGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139
Query: 209 LHQELGKLKNLVALNVGGNKLMGPIPSTL--FRLTNLTYLYLHSNHLNGSIPPEIGNMTG 266
LH GKL +L +++ N++ L + L++ L +N L + + G
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 267 ILK------------------VDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPIT 308
+ N I + L ++ + + T
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 309 IAGL--ISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--GLMKLE 363
AGL S++ LDLS+ + + + +L+ + L N ++ I E GL L+
Sbjct: 260 FAGLARSSVRHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQ 317
Query: 364 YLDLSHNKLNGTIPPFLYHRFP----LDLSYNDL 393
L+LS+N L + ++ P +DL N +
Sbjct: 318 VLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-36
Identities = 80/440 (18%), Positives = 158/440 (35%), Gaps = 32/440 (7%)
Query: 43 LVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKG-ELSQFNFSCFPGLES 101
+ + W ++ + S+ K + A I+ +K + + F +
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 102 LSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAI 161
L L ++F L L+ L+ ++N + L NL+VLNL N L
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330
Query: 162 PSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVA 221
S+ L K+ + L +N + L L L L N L+ + + ++
Sbjct: 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPD 385
Query: 222 LNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG-SIPPEIGNMTGILKVDMSMNNIEGT 280
+ + GNKL+ +P ++L N L I + + + + ++ N
Sbjct: 386 IFLSGNKLVT-LPKINL---TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441
Query: 281 IPLEL-TRLSQLLYLSISSNMLSGQIPITI-----AGLISLKGLDLSNNKLSGPIPPEI- 333
+ + L L + NML + GL L+ L L++N L+ +PP +
Sbjct: 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS-LPPGVF 500
Query: 334 GKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDL 393
+ LR ++L +N L+ + LE LD+S N+L P LD+++N
Sbjct: 501 SHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKF 559
Query: 394 EGEIP-----DYFRDSPFKVYGNQGICYFSACSTLH-------TPTASKSKSLVLRVLNI 441
E ++ + + G Y + + + ++ +
Sbjct: 560 ICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFS 619
Query: 442 ILPITACVIFLTLAFIVFLL 461
+ + + L L I+ +
Sbjct: 620 LFIVCTVTLTLFLMTILTVT 639
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-33
Identities = 66/346 (19%), Positives = 120/346 (34%), Gaps = 42/346 (12%)
Query: 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNL 152
SC RF L +P L+ L SFN + ++ L L++L L
Sbjct: 1 SCSFDGRIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLEL 55
Query: 153 KGNNLNGAIPSSLCQ-LTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
I + L L + L + ++ P A L +L L L LS + +
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 212 E--LGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEIGN---MT 265
+ LK L L++ N++ F L +L + SN + +
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGK 174
Query: 266 GILKVDMSMNNIEGTIPLELTRLSQLL------YLSISSNMLSGQIPITIAGLIS----- 314
+ ++ N++ + ++ + L +S N + I + IS
Sbjct: 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234
Query: 315 -------LKGLDLSNNKLSGPIPP--EIGKCSELRNITLRNNNLSGSIPPEI--GLMKLE 363
+ G + + P S +R++ L + + S+ + L L+
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLK 293
Query: 364 YLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
L+L++NK+N I ++ L+LSYN L F P
Sbjct: 294 VLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP 338
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-30
Identities = 68/366 (18%), Positives = 123/366 (33%), Gaps = 41/366 (11%)
Query: 70 TARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLR-----------------FNYLFGS 112
+++ +L L +S C ++ L N + S
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 113 IPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR--NLEVLNLKGNNLNGAIPSSLCQLTK 170
+ + F F+N+ L ++ L+L + L
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 171 LITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230
L + L+ N ++ A L+NL +L+L N L + L + +++ N +
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQ 290
T L L L L N L I + I + +S N + + L
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----T 402
Query: 291 LLYLSISSNMLSG-QIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNN 348
+ +S N L I + + L+ L L+ N+ S + + L + L N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 349 LSGSIPPEI------GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIP 398
L + E+ GL L+ L L+HN LN ++PP ++ L L+ N L
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSH 521
Query: 399 DYFRDS 404
+ +
Sbjct: 522 NDLPAN 527
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-37
Identities = 71/360 (19%), Positives = 123/360 (34%), Gaps = 46/360 (12%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPELGSLR 145
L ++F FP L+ L L + +I +LS L L + N + L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS 100
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGL-HGPIPSAIGDLNNLLILSLDSNK 204
+L+ L NL + L L + ++ N + +P +L NL L L SNK
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 205 LSGMLHQELGKLKNL----VALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE 260
+ + +L L + ++L++ N + I F+ L L L +N + ++
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
Query: 261 -IGNMTG------ILKVDMSMNNIEGTIPLELTRLSQL--LYLSISSNMLSG-QIPITIA 310
I + G +L + N+E L L L ++ I
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 311 GLISLKGLDLSNNKLSGPIPPEIG--------------------KCSELRNITLRNNNLS 350
L ++ L + + + K L+ +T +N
Sbjct: 280 CLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 351 GSIPPEIGLMKLEYLDLSHNKLNG-TIPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
+ E+ L LE+LDLS N L+ LDLS+N + + F
Sbjct: 339 -NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 396
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 57/313 (18%), Positives = 102/313 (32%), Gaps = 17/313 (5%)
Query: 96 FPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGN 155
++L L FN L + +L+ LD S + SL +L L L GN
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 156 NLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL-SGMLHQELG 214
+ + L+ L + L IG L L L++ N + S L +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 215 KLKNLVALNVGGNKLMGPIPSTLFRLTNLTY----LYLHSNHLNGSIPPEIGNMTGILKV 270
L NL L++ NK+ + L L + L L N +N I P + K+
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205
Query: 271 DMSMNNIEGTIPLE-LTRLSQLLYLSISSNMLSGQIPIT------IAGLISLKGLDLSNN 323
+ N + + L+ L + + + + GL +L +
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 324 KLSG---PIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFL 380
L I + + + +L + + + ++L+L + K L
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 381 YHRFPLDLSYNDL 393
L + N
Sbjct: 325 KSLKRLTFTSNKG 337
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 64/291 (21%), Positives = 100/291 (34%), Gaps = 59/291 (20%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
+FS G + L L P+ L L+ L F+ N + E+ L +LE L+
Sbjct: 299 DFSYNFGWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLD 353
Query: 152 LKGNNLN--GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGML 209
L N L+ G S T L + LS NG+ + S L L L + L M
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 210 HQE-LGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGIL 268
L+NL+ L++ L++L L + N + P+I
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI------- 465
Query: 269 KVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGP 328
T L L +L +S L P L SL+ L++++N+L
Sbjct: 466 ----------------FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-- 507
Query: 329 IPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIP 377
S+P I L L+ + L N + + P
Sbjct: 508 -----------------------SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 66/325 (20%), Positives = 106/325 (32%), Gaps = 31/325 (9%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKG--- 154
SL L N + I +L L N + ++ + L LEV L
Sbjct: 179 NLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 155 ---NNLNGAIPSSLCQLTKLITMALSRNGLHG---PIPSAIGDLNNLLILSLDSNKLSGM 208
NL S+L L L L I L N+ SL S + +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 209 LH-QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGI 267
++L +N + +L +L L SN + E+ ++ +
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQF------PTLKLKSLKRLTFTSNKGG-NAFSEV-DLPSL 349
Query: 268 LKVDMSMNNIE--GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
+D+S N + G + L YL +S N + + GL L+ LD ++ L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408
Query: 326 SGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYH 382
+ L + + + + I GL LE L ++ N P ++
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 383 RFP----LDLSYNDLEGEIPDYFRD 403
LDLS LE P F
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNS 492
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 69/339 (20%), Positives = 120/339 (35%), Gaps = 39/339 (11%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLT-GSIPPELGSLR 145
L+ FS L+ L L +G L L+ L+ + N + +P +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKL----ITMALSRNGLHGPIPSAIGDLNNLLILSLD 201
NLE L+L N + + L L ++ +++ LS N ++ I L L+L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 202 SNKLSG-MLHQELGKLKNLVALN------VGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254
+N S ++ + L L L S L L NLT +L+
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 255 GSIPPEIG---NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311
+ I +T + + I + + +L + +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ---FPTLK 323
Query: 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG-SIPPEI--GLMKLEYLDLS 368
L SLK L ++NK E+ L + L N LS + G L+YLDLS
Sbjct: 324 LKSLKRLTFTSNKGGN-AFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 369 HNKLNGTIPPFLYHRFP-------LDLSYNDLEGEIPDY 400
N + + F LD +++L+ ++ ++
Sbjct: 382 FNGVI-----TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 10/229 (4%)
Query: 60 HCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYL--FGSIPSQV 117
+CK +S+ + K + F+ P LE L L N L G
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGG---NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 118 GALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSS-LCQLTKLITMAL 176
+ L+YLD SFN + ++ L LE L+ + +NL S L LI + +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE-LGKLKNLVALNVGGNKLMGPIPS 235
S L++L +L + N + +L+NL L++ +L P+
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 236 TLFRLTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPL 283
L++L L + SN L S+P I +T + K+ + N + + P
Sbjct: 489 AFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 32/266 (12%)
Query: 506 CIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLY 564
IG G + +VYK VA +L + ++ F+ EA +L + H NIV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQHPNIVRFY 91
Query: 565 GFCL----HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
KKC+ L+ + M G+L +L+ V+ + + + + L +LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 621 CMPSIVHRDISSNNILLNSKL-EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM 679
P I+HRD+ +NI + + D G A L S + ++ GT ++APE+ Y
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVI-GTPEFMAPEM-YEE 204
Query: 680 VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV----LDSRLSPPVDR 735
E DVY+FG+ LE+ +P S + + + + V D P
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVAIP---- 257
Query: 736 MVMQDIVLVTTVALACLHSKPKFRPT 761
+++I+ C+ R +
Sbjct: 258 -EVKEII------EGCIRQNKDERYS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 68/316 (21%), Positives = 121/316 (38%), Gaps = 30/316 (9%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLN 151
F C L + L +P LD N +T I +L+NL L
Sbjct: 27 FRCQCHLRVVQCSDLGL-EKVPK--DLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLI 82
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
L N ++ P + L KL + LS+N L +P + L L + N+++ +
Sbjct: 83 LINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKS 139
Query: 212 ELGKLKNLVALNVGGNKL-MGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEIGNMTGILK 269
L ++ + +G N L I + F+ + L+Y+ + ++ +IP G + +
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTE 196
Query: 270 VDMSMNNIEGTIPLE-LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGP 328
+ + N I + L L+ L L +S N +S ++A L+ L L+NNKL
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK- 254
Query: 329 IPPEIGKCSELRNITLRNNNLSGSIPPEI--------GLMKLEYLDLSHNKLNGT-IPPF 379
+P + ++ + L NNN+S +I + L N + I P
Sbjct: 255 VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 380 LYHRFP----LDLSYN 391
+ + L
Sbjct: 314 TFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 60/290 (20%), Positives = 106/290 (36%), Gaps = 24/290 (8%)
Query: 96 FPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLK 153
P L L+ N + I L L L N ++ I P L LE L L
Sbjct: 51 PPDTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLS 108
Query: 154 GNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE- 212
N L +P + L + + N + S LN ++++ L +N L +
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 213 -LGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI-GNMTGILKV 270
+K L + + + IP L +LT L+L N + + + + K+
Sbjct: 166 AFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSG--- 327
+S N+I L L L +++N L ++P +A ++ + L NN +S
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 328 ---PIPPEIGKCSELRNITLRNNNLS-GSIPPEI--GLMKLEYLDLSHNK 371
P K + ++L +N + I P + + L + K
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 33/165 (20%), Positives = 68/165 (41%), Gaps = 15/165 (9%)
Query: 242 NLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNML 301
+L + L +P ++ T +L D+ N I + L L L + +N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALL--DLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 302 SGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GL 359
S P A L+ L+ L LS N+L +P ++ L+ + + N ++ + + GL
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 360 MKLEYLDLSHNKL-NGTIPPFLYHRFP----LDLSYNDLEGEIPD 399
++ ++L N L + I + + ++ ++ IP
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 56/291 (19%), Positives = 111/291 (38%), Gaps = 56/291 (19%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
DF IG+GG+G V+KA+ +GK +K++ + E+ + E L+K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-KYNNEKA------EREVKALAKLDH 63
Query: 558 RNIVKLYGF----------------CLHKKCMFLIYKYMKRGSLFCFLRNDY-----EAV 596
NIV G KC+F+ ++ +G+L ++ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 597 VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656
L+ + + + Y+H +++RD+ +NI L + + DFG L +
Sbjct: 124 ALEL------FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD 716
D GT Y++PE + ++ D+Y+ G++ E+L S
Sbjct: 175 DGKRTRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF----- 228
Query: 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+ ++ ++ + L KP+ RP + +
Sbjct: 229 TDLRDG-IISDIFDKKEKTLLQK-----------LLSKKPEDRPNTSEILR 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 7e-36
Identities = 57/244 (23%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G GG G VY+A+ ++VALK + + + F Q EA ++ ++V ++
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
F +++ + + L LR L V I++ + +AL H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT-IVAGTYGYIAPELAYTMVVTEK 684
HRD+ NIL+++ A++ DFG A + + GT Y+APE T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 685 CDVYSFGVVALEVLMGRHP--GELLSSLS--------SPSSDQKIMLIDVLDSRLSPPVD 734
D+Y+ V E L G P G+ LS + PS+ + + D
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPST---------VRPGIPVAFD 266
Query: 735 RMVM 738
++
Sbjct: 267 AVIA 270
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 27/245 (11%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G GG +VY A+ VA+K + E+ F+ E H S+++H+NIV +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
C +L+ +Y++ +L ++ + L +N + + + + H I
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT-IVAGTYGYIAPELAYTMVVTEK 684
VHRDI NIL++S + DFG A+ L S +T V GT Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 685 CDVYSFGVVALEVLMGRHP--GE---------LLSSLSSPSSDQKIMLIDVLDSRLSPPV 733
D+YS G+V E+L+G P GE + S+ + ++D + + +
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD--------VRKDIPQSL 244
Query: 734 DRMVM 738
+++
Sbjct: 245 SNVIL 249
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 55/302 (18%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
DF+ +G G +G V KA+ + + A+KK+ E + ++ +E +L+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLN 60
Query: 557 HRNIVKLYGF-------------CLHKKCMFLIYKYMKRGSLFCFL--RNDYEAVVLDWT 601
H+ +V+ Y K +F+ +Y + G+L+ + N + W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW- 119
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD---- 657
+ + + ALSY+H I+HRD+ NI ++ + DFG A+ +
Sbjct: 120 ---RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 658 ----------SSNRTIVAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVLMGRHPGEL 706
S N T GT Y+A E L T EK D+YS G++ E++ G
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 707 LSSLSSPSSDQKIMLIDV-LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
++ +K+ + + + V + I+ + P RP + +
Sbjct: 234 RVNIL-----KKLRSVSIEFPPDFDDNKMK-VEKKII------RLLIDHDPNKRPGARTL 281
Query: 766 CQ 767
Sbjct: 282 LN 283
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 81/274 (29%), Positives = 115/274 (41%), Gaps = 40/274 (14%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
E F IG G +G V+K KVVA+K + E E+ Q E VLS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCD 78
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
+ K YG L +++I +Y+ GS L LD T I++ + L Y
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDY 134
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
LH + +HRDI + N+LL+ E +ADFG A L R GT ++APE+
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM----LID-----VLDS 727
K D++S G+ A+E+ G P P S+ M LI L+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARG-EP---------PHSELHPMKVLFLIPKNNPPTLEG 241
Query: 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
S P+ V CL+ +P FRPT
Sbjct: 242 NYSKPLKEFVEA-----------CLNKEPSFRPT 264
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 67/290 (23%), Positives = 122/290 (42%), Gaps = 50/290 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL--PNGKV---VALKKLHRAETEETTFFNSFQNEAHVLS 553
+F +G+G +G+VYK KV VA+K+L A + + +EA+V++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMA 72
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
+ + ++ +L G CL + LI + M G L ++R + + +N +A
Sbjct: 73 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKG 129
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG------T 667
++YL + VHRD+++ N+L+ + + DFG A+LL ++ G
Sbjct: 130 MNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 668 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLD 726
A E + T + DV+S+GV E++ G P + + + +I +L+
Sbjct: 187 ----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEI--SSILE 233
Query: 727 S--RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P M+M+ C RP + + EF
Sbjct: 234 KGERLPQPPICTIDVYMIMRK----------CWMIDADSRPKFRELIIEF 273
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 43/284 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
D +K+ +G G YG VY+ + VA+K L E F EA V+ +I H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 275
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+V+L G C + ++I ++M G+L +LR + + + + +++A+ YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL 334
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS-SNRTIVAGTYGYIAPELA 676
+ +HR++++ N L+ VADFG +RL+ D+ + + APE
Sbjct: 335 EKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 677 YTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS-----RLS 730
+ K DV++FGV+ E+ G P + L V + R+
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVYELLEKDYRME 439
Query: 731 PPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P +M AC P RP+ + Q F
Sbjct: 440 RPEGCPEKVYELM----------RACWQWNPSDRPSFAEIHQAF 473
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 50/290 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKA-QLPNGKVVALK--KLHRAETEETTFFNSFQNEAHVLSKI 555
+D++++ IG+G V A P + VA+K L + +T + E +S+
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQC 70
Query: 556 AHRNIVKLYGFCLHKKCMFLIYKYMKRGSL-----FCFLRNDYEAVVLDWTMRVNIIKCV 610
H NIV Y + K ++L+ K + GS+ + ++++ VLD + I++ V
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG-----TARLLDSDSSNRTIVA 665
L YLH + +HRD+ + NILL +ADFG + + R
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 666 GTYGYIAPELAYTMVVTE------KCDVYSFGVVALEVLMGR------HPGE--LLSSLS 711
GT ++APE V+ + K D++SFG+ A+E+ G P + +L+ +
Sbjct: 188 GTPCWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
P S + + + + +M+ CL P+ RPT
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISL-----------CLQKDPEKRPT 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 51/287 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+ IG+G +G V+ N VA+K + E F EA V+ K++H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 63
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL- 617
+V+LYG CL + + L+ ++M+ G L +LR + + V ++YL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLE 121
Query: 618 -HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI---AP 673
++HRD+++ N L+ V+DFG R + D T GT + +P
Sbjct: 122 EAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASP 174
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS----- 727
E+ + K DV+SFGV+ EV G+ P E S +V++
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------------NSEVVEDISTGF 222
Query: 728 RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P +M C +P+ RP R+ ++
Sbjct: 223 RLYKPRLASTHVYQIMNH----------CWRERPEDRPAFSRLLRQL 259
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-34
Identities = 64/352 (18%), Positives = 121/352 (34%), Gaps = 58/352 (16%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLN 151
SC R SIPS + + ++ LD SFN +T I L + NL+VL
Sbjct: 2 LSC-DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLI 56
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM-LH 210
LK + +N + L L + LS N L S G L++L L+L N + +
Sbjct: 57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 211 QELGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPE-IGNMTGIL 268
L NL L +G + I F LT+L L + + L + + + ++ I
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIH 175
Query: 269 KVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNK---- 324
+ + ++ + + LS + YL + L+ + + +
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 325 ---------------------------------LSGPIPPEIGKCSELRNITLRNNNLSG 351
+ + + ++ +T+R ++
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 352 ----SIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDL 393
+ L K++ + + ++K+ +P LDLS N +
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-33
Identities = 60/339 (17%), Positives = 117/339 (34%), Gaps = 35/339 (10%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSL 144
+ + L+ L L+ + + +I +L L +LD S N+L+ S+ G L
Sbjct: 40 YIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPL 97
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQ-LTKLITMALSRNGLHGPIP-SAIGDLNNLLILSLDS 202
+L+ LNL GN +SL LT L T+ + I L +L L + +
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 203 NKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIG 262
L Q L ++++ L + ++ + L+++ YL L +L
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPL 216
Query: 263 NMTGILKVDMSMNNIEGTIP-------------------LELTRLSQLLYLSISSNMLSG 303
+ + + + +E + + +
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276
Query: 304 QIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMK 361
+ ++++ L + L + +++ IT+ N+ + +P L
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKS 335
Query: 362 LEYLDLSHNKL--NGTIPPFLYHRFP----LDLSYNDLE 394
LE+LDLS N + +P L LS N L
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 61/335 (18%), Positives = 123/335 (36%), Gaps = 41/335 (12%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYL-----------DFSFNNLTGS 136
L + + L LR L S + + D SFN L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL-K 245
Query: 137 IPPELGSLRNLEVLNLKGNNL---NGAIPSSLCQLTKLITMAL-----SRNGLHGPIPSA 188
+ + L +E + N L N + + +L K+ T+ + + L + +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 189 IGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM--GPIPSTLFR-LTNLTY 245
L + ++++++K+ + LK+L L++ N ++ S +L
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 246 LYLHSNHLNGSIPPEIG---NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLS 302
L L NHL S+ + + +D+S N +P ++ +L++SS +
Sbjct: 366 LVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
Query: 303 GQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKL 362
+ +L+ LD+SNN L + L+ + + N L ++P L
Sbjct: 424 V---VKTCIPQTLEVLDVSNNNLDS-FSLFL---PRLQELYISRNKLK-TLPDASLFPVL 475
Query: 363 EYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDL 393
+ +S N+L ++P ++ R + L N
Sbjct: 476 LVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-32
Identities = 63/316 (19%), Positives = 108/316 (34%), Gaps = 27/316 (8%)
Query: 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132
++ + S F G FN L + + LS++ + D + N
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNG 265
Query: 133 LTG------SIPPELGSLR--NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGP 184
L + ELG + + L++ L + + L K+ + + + +
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 185 IPSAIGDLNNLLILSLDSNKLSGML---HQELGKLKNLVALNVGGNKL--MGPIPSTLFR 239
S L +L L L N + G +L L + N L M L
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 240 LTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSN 299
L NLT L + N + +P + +++S I + + L L +S+N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN 441
Query: 300 MLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-- 357
L L L+ L +S NKL P+ L + + N L S+P I
Sbjct: 442 NLD-SFS---LFLPRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQLK-SVPDGIFD 494
Query: 358 GLMKLEYLDLSHNKLN 373
L L+ + L N +
Sbjct: 495 RLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-31
Identities = 58/343 (16%), Positives = 116/343 (33%), Gaps = 29/343 (8%)
Query: 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG 135
+ + + E+ + +F+ L L ++ L + ++ + +L +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNL 195
+ L ++ L L+ NL S L M + +L L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 196 L--ILSLDSNKLSGMLHQELGKLK----------------NLVALNVGGNKLMGPIPSTL 237
L IL L + LG + L++ L + +
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 238 FRLTNLTYLYLHSNHLNGSIPPEIG-NMTGILKVDMSMNNIEGTI---PLELTRLSQLLY 293
L + + + ++ + +P ++ + +D+S N + L
Sbjct: 307 SLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 294 LSISSNMLS--GQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG 351
L +S N L + + L +L LD+S N P+P ++R + L + +
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR- 423
Query: 352 SIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLE 394
+ I LE LD+S+N L+ + FL L +S N L+
Sbjct: 424 VVKTCI-PQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 19/94 (20%), Positives = 36/94 (38%), Gaps = 11/94 (11%)
Query: 318 LDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGT 375
D + + IP + + ++++ L N ++ I L+ L L +++N T
Sbjct: 10 CDGRSRSFTS-IPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRIN-T 64
Query: 376 IPPFLYHRFP----LDLSYNDLEGEIPDYFRDSP 405
I ++ LDLS N L +F
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLS 98
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 59/275 (21%), Positives = 105/275 (38%), Gaps = 50/275 (18%)
Query: 506 CIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLY 564
+G G YG VY L N +A+K++ ++ E + + H+NIV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQYL 85
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS 624
G + + + + GSL LR+ + + + K + L YLH +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 625 IVHRDISSNNILLNS-----KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM 679
IVHRDI +N+L+N+ K+ +DFGT++ L + GT Y+APE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKI----SDFGTSKRLAGINPCTETFTGTLQYMAPE----- 193
Query: 680 VV-------TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR---- 728
++ + D++S G +E+ G+ P L P + + +
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPP---FYELGEPQ--AAMFKVGMFKVHPEIP 248
Query: 729 --LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
+S +++ C P R
Sbjct: 249 ESMSAEAKAFILK-----------CFEPDPDKRAC 272
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 55/280 (19%)
Query: 503 IKYCIGTGGYGSVYKAQL--PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
+G G +GSV + ++ VA+K L + + T EA ++ ++ +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPY 71
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL-- 617
IV+L G C + + L+ + G L FL E + + ++ V+ + YL
Sbjct: 72 IVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE 128
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----A 672
+ VHRD+++ N+LL ++ A ++DFG ++ L +D S A + G A
Sbjct: 129 KN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYA 181
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS---- 727
PE + + DV+S+GV E L G+ P + + +V+
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------EVMAFIEQG 229
Query: 728 -RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
R+ P + +M D C K + RP
Sbjct: 230 KRMECPPECPPELYALMSD----------CWIYKWEDRPD 259
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 63/284 (22%), Positives = 114/284 (40%), Gaps = 55/284 (19%)
Query: 507 IGTGGYGSVYKAQLPNGKV---VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
+G+G +G+V K KV VA+K L + E + + EA+V+ ++ + IV++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL--HHDC 621
G C + L+ + + G L +L+ + + + ++ V+ + YL +
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----APELA 676
VHRD+++ N+LL ++ A ++DFG ++ L +D + A T+G APE
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECI 192
Query: 677 YTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS-----RLS 730
+ K DV+SFGV+ E G+ P + +V R+
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------------EVTAMLEKGERMG 240
Query: 731 PPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P +M C + RP V
Sbjct: 241 CPAGCPREMYDLMNL----------CWTYDVENRPGFAAVELRL 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 61/300 (20%), Positives = 115/300 (38%), Gaps = 47/300 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
DF+ C+G GG+G V++A+ + A+K++ E E L+K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEH 62
Query: 558 RNIVKLYGFCLHKKCM------------FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
IV+ + L K ++ + ++ +L ++ + ++ ++
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS------- 658
I +A A+ +LH ++HRD+ +NI V DFG +D D
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 659 -----SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP 713
+ T GT Y++PE + + K D++S G++ E+L +P S
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP-------FST 229
Query: 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIV-LVTTVALACLHSKPKFRPTMQRVCQ-EFLT 771
++ L DV + + PP+ +V L P RP + +
Sbjct: 230 QMERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQ----DMLSPSPMERPEAINIIENAVFE 284
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 49/324 (15%), Positives = 98/324 (30%), Gaps = 41/324 (12%)
Query: 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQ------LPNGKVVALKKLHRAETEETTFFNSF 545
+ ++ + + +G G + VY+A N + LK A E F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIG 114
Query: 546 QNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDYEAVVLDWTMR 603
L +K Y L + L+ + G+L + + V+ +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF-----------VADFGTAR 652
++ + + +H I+H DI +N +L + + D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 653 LLDSDSSNRTIVA--GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL 710
+ A T G+ E+ + D + +L G +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM------- 284
Query: 711 SSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLH--SKPKFRPTMQRVCQE 768
++ + + + V C H S R +++V Q+
Sbjct: 285 --KVKNEGGECK--PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
Query: 769 FLTCKI-ALVNPFEEISIWQLRNQ 791
T KI AL N + + R++
Sbjct: 341 HYTNKIRALRNRLIVLLLECKRSR 364
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 51/279 (18%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+D +GTG +G V + VA+K + E + F EA V+ ++H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 79
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL- 617
+V+LYG C ++ +F+I +YM G L +LR + + K V A+ YL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLE 137
Query: 618 -HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI---AP 673
+HRD+++ N L+N + V+DFG +R + D + G+ + P
Sbjct: 138 SKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSPP 190
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS----- 727
E+ + K D+++FGV+ E+ G+ P E + + +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------------NSETAEHIAQGL 238
Query: 728 RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
RL P +M C H K RPT
Sbjct: 239 RLYRPHLASEKVYTIMYS----------CWHEKADERPT 267
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 79/291 (27%), Positives = 118/291 (40%), Gaps = 51/291 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL---PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSK 554
I+ IG+G G V +L V VA+K L TE F +EA ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQ 106
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
H NI++L G + ++ +YM+ GSL FLR V +++ V +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGM 164
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI--- 671
YL VHRD+++ N+L++S L V+DFG +R+L+ D T G I
Sbjct: 165 RYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIPIR 219
Query: 672 --APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS- 727
APE + DV+SFGVV EVL G P +++ DV+ S
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------------DVISSV 267
Query: 728 ----RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P+ +M D C H RP ++
Sbjct: 268 EEGYRLPAPMGCPHALHQLMLD----------CWHKDRAQRPRFSQIVSVL 308
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 60/288 (20%), Positives = 105/288 (36%), Gaps = 44/288 (15%)
Query: 507 IGTGGYGSVYKAQLP-----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +G V + G+ VA+K L + E +L + H NIV
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIV 86
Query: 562 KLYGFCLHKKC--MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
K G C + LI +++ GSL +L + ++ ++ + + YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGS 144
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----APE 674
VHRD+++ N+L+ S+ + + DFG + +++D APE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKDDRDSPVFWYAPE 199
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSD-QKIM----LIDVLDS- 727
DV+SFGV E+L ++ M L++ L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259
Query: 728 -RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P + +M+ C +P R + Q + + F
Sbjct: 260 KRLPCPPNCPDEVYQLMRK----------CWEFQPSNRTSFQNLIEGF 297
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 54/271 (19%)
Query: 503 IKYCIGTGGYGSVYKA---QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
+K CI GG G +Y A + NG+ V LK L + E E L+++ H +
Sbjct: 84 VKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAE--AQAMAMAERQFLAEVVHPS 140
Query: 560 IVKLYGFCLH-----KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
IV+++ F H +++ +Y+ SL + L + + + AL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILPAL 195
Query: 615 SYLHHDCMPSIVHRDISSNNILLNS---KLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
SYLH +V+ D+ NI+L K + D G ++S + GT G+
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEEQLK----LIDLGAVSRINSFGY----LYGTPGFQ 244
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIMLIDVLDSRL 729
APE+ T T D+Y+ G + + G + L +
Sbjct: 245 APEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP----------VLKT 293
Query: 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRP 760
R++ + + P+ R
Sbjct: 294 YDSYGRLLRR-----------AIDPDPRQRF 313
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 60/281 (21%), Positives = 97/281 (34%), Gaps = 45/281 (16%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA- 556
+ F +G G YG V+K + +G++ A+K+ E K+
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQ 115
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY----EAVVLDWTMRVNIIKCVAN 612
H V+L ++L + SL EA V +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT------LL 168
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
AL++LH +VH D+ NI L + + DFG L + + G Y+A
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMA 224
Query: 673 PEL---AYTMVVTEKCDVYSFGVVALEVLMGRHP---GELLSSLSSPSSDQKIMLIDVLD 726
PEL +Y DV+S G+ LEV GE L ++ L
Sbjct: 225 PELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGWQQL------RQGYLPPEFT 274
Query: 727 SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+ LS ++ ++ + L PK R T + +
Sbjct: 275 AGLSSE-----LRSVL------VMMLEPDPKLRATAEALLA 304
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 66/285 (23%), Positives = 122/285 (42%), Gaps = 47/285 (16%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E+ + +G+G +G V + VA+K + E + F EA + K++H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHP 63
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+VK YG C + ++++ +Y+ G L +LR+ + L+ + + + V +++L
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLE 121
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI---APEL 675
+HRD+++ N L++ L V+DFG R + D + GT + APE+
Sbjct: 122 SH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSAPEV 176
Query: 676 AYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS-----RL 729
+ + K DV++FG++ EV G+ P +L + +V+ RL
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT------------NSEVVLKVSQGHRL 224
Query: 730 SPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P +M C H P+ RPT Q++
Sbjct: 225 YRPHLASDTIYQIMYS----------CWHELPEKRPTFQQLLSSI 259
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 65/315 (20%), Positives = 123/315 (39%), Gaps = 29/315 (9%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLN 151
F C L + L ++P ++ LD N+++ + + L++L L
Sbjct: 29 FGCHCHLRVVQCSDLGL-KAVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALV 84
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
L N ++ + L KL + +S+N L IP + ++L+ L + N++ +
Sbjct: 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKG 141
Query: 212 ELGKLKNLVALNVGGNKL-MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV 270
L+N+ + +GGN L F L YL + L IP + ++
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNEL 198
Query: 271 DMSMNNIEGTIPLE-LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPI 329
+ N I+ I LE L R S+L L + N + +++ L +L+ L L NNKLS +
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-V 256
Query: 330 PPEIGKCSELRNITLRNNNLSGSIPPE--------IGLMKLEYLDLSHNKL-NGTIPPFL 380
P + L+ + L NN++ + + + L +N + + P
Sbjct: 257 PAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPAT 315
Query: 381 YHRFP----LDLSYN 391
+ +
Sbjct: 316 FRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 59/291 (20%), Positives = 105/291 (36%), Gaps = 25/291 (8%)
Query: 95 CFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNL 152
P L L+ N + + L L L N ++ I + LR L+ L +
Sbjct: 52 ISPDTTLLDLQNNDI-SELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYI 109
Query: 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL-SGMLHQ 211
N+L IP +L + L+ + + N + L N+ + + N L +
Sbjct: 110 SKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI-GNMTGILKV 270
L L + KL G IP L L L+L N + +I E + + ++
Sbjct: 167 GAFDGLKLNYLRISEAKLTG-IPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
+ N I L+ L L L + +N LS ++P + L L+ + L N ++ +
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VG 280
Query: 331 PEI-------GKCSELRNITLRNNNLS-GSIPPEI--GLMKLEYLDLSHNK 371
K + I+L NN + + P + + + K
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 51/280 (18%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
D +K+ +G G YG VY+ + VA+K L E+T F EA V+ +I H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKH 68
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+V+L G C + ++I ++M G+L +LR + + + + +++A+ YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL 127
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----A 672
+ +HRD+++ N L+ VADFG +RL+ D T A A
Sbjct: 128 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 180
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS---- 727
PE + K DV++FGV+ E+ G P I L V +
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------------PGIDLSQVYELLEKD 228
Query: 728 -RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
R+ P +M+ C P RP+
Sbjct: 229 YRMERPEGCPEKVYELMRA----------CWQWNPSDRPS 258
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DF+ +G G G V+K P+G V+A K +H N E VL +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNS 90
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANAL 614
IV YG + + ++M GSL L+ E ++ + V L
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGL 144
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
+YL I+HRD+ +NIL+NS+ E + DFG + L DS + V GT Y++PE
Sbjct: 145 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMSPE 200
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + D++S G+ +E+ +GR+P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 35/284 (12%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL--PNGKV--VALKKLHRAETEETTFFNSFQNEAHVLSK 554
+D + +G G +G V + + P+GK VA+K L + + F E + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
+ HRN+++LYG L M ++ + GSL LR +L VA +
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGM 134
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT---YGYI 671
YL +HRD+++ N+LL ++ + DFG R L + + + + +
Sbjct: 135 GYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730
APE T + D + FGV E+ G+ P L+ Q + ID RL
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP 245
Query: 731 PPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P D VM C KP+ RPT +
Sbjct: 246 RPEDCPQDIYNVMVQ----------CWAHKPEDRPTFVALRDFL 279
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-33
Identities = 55/273 (20%), Positives = 99/273 (36%), Gaps = 33/273 (12%)
Query: 126 LDFSFNNLTGSIPPELGS-LRNLEVLNLKGNNLNGAIPS-SLCQLTKLITMALSRNGLHG 183
+ +N ++ + S E L G N N A+ C + + + L+R L
Sbjct: 15 QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS 73
Query: 184 PIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNL 243
+P + + +L + N L L + L+ L+ N+L +P +L
Sbjct: 74 -LPDNLP--PQITVLEITQNALI-SLPELPASLEY---LDACDNRLST-LPEL---PASL 122
Query: 244 TYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG 303
+L + +N L +P + ++ N + +P T L LS+ +N L+
Sbjct: 123 KHLDVDNNQLT-MLPELPALLE---YINADNNQLT-MLPELPTSLE---VLSVRNNQLT- 173
Query: 304 QIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNIT----LRNNNLSGSIPPEIG- 358
+P SL+ LD+S N L +P + R N ++ IP I
Sbjct: 174 FLP---ELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILS 228
Query: 359 LMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYN 391
L + L N L+ I L + +
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG 261
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-31
Identities = 56/295 (18%), Positives = 97/295 (32%), Gaps = 50/295 (16%)
Query: 93 FSCFPGLESLSL---RFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEV 149
FS + E +L N + +++ L + NL+ S+P L + V
Sbjct: 30 FSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPDNLPP--QITV 84
Query: 150 LNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGML 209
L + N L ++P L L N L +P L +L +D+N+L+ ML
Sbjct: 85 LEITQNAL-ISLPELPASLEYLD---ACDNRLST-LPELPASLKHL---DVDNNQLT-ML 135
Query: 210 HQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILK 269
+ L+ + N N+L +P T+L L + +N L +P ++
Sbjct: 136 PELPALLEYI---NADNNQL-TMLPELP---TSLEVLSVRNNQLT-FLPELPESLE---A 184
Query: 270 VDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPI 329
+D+S N +E ++P R I N+++ I
Sbjct: 185 LDVSTNLLE-SLPAVPVRNHHSEETEIF--------------------FRCRENRITH-I 222
Query: 330 PPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRF 384
P I I L +N LS I + +
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 27/119 (22%), Positives = 41/119 (34%), Gaps = 9/119 (7%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLR----YLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154
LE+L + N L S+P+ + N +T IP + SL + L+
Sbjct: 182 LEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED 239
Query: 155 NNLNGAIPSSLCQLTKLITMALSRNGLH---GPIPSAIGDLNNLLILSLDSNKLSGMLH 210
N L+ I SL Q T R G + L + + NK S +
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQ 298
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 51/283 (18%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGK----VVALKKLHRAETEETTFFNSFQNEAHVLSK 554
+ I +G G +G V +L VA+K L TE+ F EA ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQ 102
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
H NI++L G K + ++ +YM+ GSL FLR V +++ +A+ +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGM 160
Query: 615 SYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI- 671
YL VHRD+++ NIL+NS L V+DFG R+L+ D G I
Sbjct: 161 KYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 672 --APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS- 727
+PE T DV+S+G+V EV+ G P +S+ DV+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------------DVIKAV 263
Query: 728 ----RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
RL PP+D +M D C RP
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLD----------CWQKDRNNRPK 296
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-33
Identities = 61/289 (21%), Positives = 119/289 (41%), Gaps = 51/289 (17%)
Query: 500 DFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHR 558
F K +G G G++ + + + VA+K++ F+ E +L + H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE------CFSFADREVQLLRESDEHP 78
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLF------CFLRNDYEAVVLDWTMRVNIIKCVAN 612
N+++ + ++ ++ + +L F E + +++ +
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEP--------ITLLQQTTS 129
Query: 613 ALSYLHHDCMPSIVHRDISSNNILL-----NSKLEAFVADFGTARLLDSDSS---NRTIV 664
L++LH +IVHRD+ +NIL+ + K++A ++DFG + L R+ V
Sbjct: 130 GLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 665 AGTYGYIAPEL---AYTMVVTEKCDVYSFGVVALEVL-MGRHP-GELLSSLSSPSSDQKI 719
GT G+IAPE+ T D++S G V V+ G HP G+ L I
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------QRQANI 240
Query: 720 MLIDVLDSRLSPPVDR-MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+L L P ++ ++++ + P+ RP+ + V +
Sbjct: 241 LLGACSLDCLHPEKHEDVIARELI------EKMIAMDPQKRPSAKHVLK 283
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 82/290 (28%), Positives = 124/290 (42%), Gaps = 48/290 (16%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL--PNGKV---VALKKLHRAETEETTFFNSFQNEAHVLS 553
+ IG G +G VYK L +GK VA+K L TE+ F EA ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
+ +H NI++L G K M +I +YM+ G+L FLR V +++ +A
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAG 159
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-- 671
+ YL + + VHRD+++ NIL+NS L V+DFG +R+L+ D +G I
Sbjct: 160 MKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 672 -APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS-- 727
APE T DV+SFG+V EV+ G P LS+ +V+ +
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------------HEVMKAIN 264
Query: 728 ---RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P+D +M C + RP +
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQ----------CWQQERARRPKFADIVSIL 304
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 66/257 (25%), Positives = 111/257 (43%), Gaps = 46/257 (17%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLY- 564
+G GG V+ A+ L + + VA+K L + +F+ F+ EA + + H IV +Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 565 -------GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
L +++ +Y+ +L + + + + +I AL++
Sbjct: 80 TGEAETPAGPLP----YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFS 132
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT---IVAGTYGYIAPE 674
H + I+HRD+ NI++++ V DFG AR + ++ T V GT Y++PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLS-----------SPSSDQKIML 721
A V + DVYS G V EVL G P G+ S +S PS+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVREDPIPPSA------ 241
Query: 722 IDVLDSRLSPPVDRMVM 738
LS +D +V+
Sbjct: 242 ---RHEGLSADLDAVVL 255
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 43/283 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E ++ +G G +G V+ VA+K L F EA V+ K+ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V+LY ++ ++++ +YM +GSL FL+ + L V++ +A+ ++Y+
Sbjct: 240 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS-SNRTIVAGTYGYIAPELAY 677
+ VHRD+ + NIL+ L VADFG ARL++ + + R + APE A
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 678 TMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS-----RLSP 731
T K DV+SFG++ E+ GR P + +VLD R+
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYRMPC 402
Query: 732 PVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P + +M C +P+ RPT + +
Sbjct: 403 PPECPESLHDLMCQ----------CWRKEPEERPTFEYLQAFL 435
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 51/285 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++ + IG G +G V G VA+K + T + F EA V++++ H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA-----FLAEASVMTQLRHS 246
Query: 559 NIVKLYGFCLHKK-CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+V+L G + +K ++++ +YM +GSL +LR+ VL + V A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 618 -HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI-VAGTYGYIAPEL 675
++ VHRD+++ N+L++ A V+DFG + S + V T APE
Sbjct: 306 EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 357
Query: 676 AYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS-----RL 729
+ K DV+SFG++ E+ GR P +I L DV+ ++
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVP------------YPRIPLKDVVPRVEKGYKM 405
Query: 730 SPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P VM++ C H RPT ++ ++
Sbjct: 406 DAPDGCPPAVYDVMKN----------CWHLDAATRPTFLQLREQL 440
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 68/289 (23%), Positives = 108/289 (37%), Gaps = 47/289 (16%)
Query: 507 IGTGGYGSVYKAQLP-----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +GSV + G +VA+K+L + ++ FQ E +L + IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 87
Query: 562 KLYGFCLHKKC--MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH- 618
K G + L+ +Y+ G L FL+ LD + + + + YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQICKGMEYLGS 145
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----AP 673
C VHRD+++ NIL+ S+ +ADFG A+LL D V G AP
Sbjct: 146 RRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--YYVVREPGQSPIFWYAP 199
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLM-GRHP--GELLSSLSSPSSDQKIMLIDVLDS--- 727
E + + + DV+SFGVV E+ L +L+
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 728 --RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P +M+ C P+ RP+ + +
Sbjct: 260 GQRLPAPPACPAEVHELMKL----------CWAPSPQDRPSFSALGPQL 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 69/211 (32%), Positives = 112/211 (53%), Gaps = 19/211 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
EDF+I +G G +G+VY A+ + ++ALK L +A+ E+ + + E + S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVAN 612
NI++LYG+ ++LI +Y G+++ L+ ++ I +AN
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITELAN 120
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
ALSY H ++HRDI N+LL S E +ADFG + + SS RT + GT Y+
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLP 175
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
PE+ + EK D++S GV+ E L+G+ P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 51/277 (18%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++ + IG G +G V G VA+K + T + +F EA V++++ H
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 74
Query: 559 NIVKLYGFCLHKK-CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+V+L G + +K ++++ +YM +GSL +LR+ VL + V A+ YL
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 618 -HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI-VAGTYGYIAPEL 675
++ VHRD+++ N+L++ A V+DFG + S + V T APE
Sbjct: 134 EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 185
Query: 676 AYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS-----RL 729
+ K DV+SFG++ E+ GR P +I L DV+ ++
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPY------------PRIPLKDVVPRVEKGYKM 233
Query: 730 SPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
P VM++ C H RP+
Sbjct: 234 DAPDGCPPAVYEVMKN----------CWHLDAAMRPS 260
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 50/290 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL--PNGKV---VALKKLHRAETEETTFFNSFQNEAHVLS 553
+F +G+G +G+VYK KV VA+K+L A + + +EA+V++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMA 72
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
+ + ++ +L G CL + LI + M G L ++R + + +N +A
Sbjct: 73 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKG 129
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG------T 667
++YL + VHRD+++ N+L+ + + DFG A+LL ++ G
Sbjct: 130 MNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 668 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLD 726
A E + T + DV+S+GV E++ G P + + P+S+ + +L+
Sbjct: 187 ----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASE----ISSILE 233
Query: 727 S--RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P M+M C RP + + EF
Sbjct: 234 KGERLPQPPICTIDVYMIMVK----------CWMIDADSRPKFRELIIEF 273
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 51/236 (21%), Positives = 101/236 (42%), Gaps = 30/236 (12%)
Query: 486 DGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSF 545
+ F+ + + I IG+GG V++ ++ A+K ++ E + T +S+
Sbjct: 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSY 73
Query: 546 QNEAHVLSKIAHRN--IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR 603
+NE L+K+ + I++LY + + + ++++ + L +L+ +D R
Sbjct: 74 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---IDPWER 129
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVADFGTARLLDSDSSN 660
+ K + A+ +H IVH D+ N L+ KL DFG A + D+++
Sbjct: 130 KSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTS 182
Query: 661 --RTIVAGTYGYIAPEL-----------AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ GT Y+ PE ++ K DV+S G + + G+ P
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 72/299 (24%), Positives = 132/299 (44%), Gaps = 47/299 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E ++ +G G +G V+ A VA+K + F EA+V+ + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHD 243
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+VKL+ K+ +++I ++M +GSL FL++D E ++ +A ++++
Sbjct: 244 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI---APEL 675
+ +HRD+ + NIL+++ L +ADFG AR+++ + T G I APE
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEA 356
Query: 676 AYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS-----RL 729
T K DV+SFG++ +E++ GR P +S +V+ + R+
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------------NPEVIRALERGYRM 404
Query: 730 SPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783
P + +M C ++P+ RPT + + A + +EEI
Sbjct: 405 PRPENCPEELYNIMMR----------CWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 51/287 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E ++ +G G +G V+ VA+K L F EA V+ K+ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 322
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V+LY ++ ++++ +YM +GSL FL+ + L V++ +A+ ++Y+
Sbjct: 323 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----AP 673
+ VHRD+ + NIL+ L VADFG ARL++ + AP
Sbjct: 381 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR----QGAKFPIKWTAP 433
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS----- 727
E A T K DV+SFG++ E+ GR P + +VLD
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGY 481
Query: 728 RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
R+ P + +M C +P+ RPT + +
Sbjct: 482 RMPCPPECPESLHDLM----------CQCWRKEPEERPTFEYLQAFL 518
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 60/296 (20%), Positives = 110/296 (37%), Gaps = 50/296 (16%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ + +G GG+ V + L +G ALK++ E ++ Q EA + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNH 85
Query: 558 RNIVKLYGFCL----HKKCMFLIYKYMKRGSLFCFLRNDY-------EAVVLDWTMRVNI 606
NI++L +CL K +L+ + KRG+L+ + E +L +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL------WL 139
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA- 665
+ + L +H HRD+ NILL + + + D G+
Sbjct: 140 LLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 666 --------GTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP 713
T Y APEL ++ V+ E+ DV+S G V ++ G P +
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYD-------M 248
Query: 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIV-LVTTVALACLHSKPKFRPTMQRVCQE 768
+ + + ++LS P + L+ + + P RP + + +
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN----SMMTVDPHQRPHIPLLLSQ 300
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 45/218 (20%), Positives = 90/218 (41%), Gaps = 17/218 (7%)
Query: 498 TEDFDIKYCIGTG--GYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK 554
+++ IG G +V A+ P G+ V ++++ E Q E HV
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKL 82
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
H NIV + ++++ +M GS + + ++ I++ V AL
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKAL 141
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV-------AGT 667
Y+HH VHR + +++IL++ + +++ + + S + +V
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 668 YGYIAPELAYTMVV--TEKCDVYSFGVVALEVLMGRHP 703
+++PE+ + K D+YS G+ A E+ G P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 57/299 (19%), Positives = 118/299 (39%), Gaps = 64/299 (21%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL--------PNGKVVALKKLHRAETEETTFFNSFQNEAH 550
ED +G G + ++K + V LK L +A + SF A
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64
Query: 551 VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCV 610
++SK++H+++V YG C+ L+ +++K GSL +L+ + + + W ++ + K +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122
Query: 611 ANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAF--------VADFGTARLLDSDSSN 660
A A+ +L + ++H ++ + NILL + + ++D G + +
Sbjct: 123 AAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-- 175
Query: 661 RTIVAGTYGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSP 713
PE + + D +SFG E+ G P LS+
Sbjct: 176 -------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP------LSAL 222
Query: 714 SSDQKIMLIDVLDSRLSPPVD---RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
S +K+ + +L P ++ + C+ +P RP+ + + ++
Sbjct: 223 DSQRKLQFYED-RHQLPAPKAAELANLINN----------CMDYEPDHRPSFRAIIRDL 270
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 59/318 (18%), Positives = 124/318 (38%), Gaps = 49/318 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH- 557
+ I IG+GG V++ ++ A+K ++ E + T +S++NE L+K+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 67
Query: 558 -RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
I++LY + + + ++++ + L +L+ +D R + K + A+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHT 123
Query: 617 LHHDCMPSIVHRDISSNNILLNS---KLEAFVADFGTARLLDSDSSN--RTIVAGTYGYI 671
+H IVH D+ N L+ KL DFG A + D+++ + GT Y+
Sbjct: 124 IHQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 672 APEL-----------AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD-QKI 719
PE ++ K DV+S G + + G+ P + + S I
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAI 233
Query: 720 MLIDV---LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFLTCKIA 775
+ + + ++ CL PK R ++ + ++ +
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKC-----------CLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 776 LVNPFEEISIWQLRNQIN 793
VN + + +++ +
Sbjct: 283 PVNQMAKGTTEEMKYVLG 300
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 64/279 (22%), Positives = 122/279 (43%), Gaps = 51/279 (18%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E + +G G +G V+ VA+K L + ++F EA+++ ++ H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V+LY ++ +++I +YM+ GSL FL+ + L +++ +A ++++
Sbjct: 69 RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----AP 673
+ +HRD+ + NIL++ L +ADFG ARL++ + A AP
Sbjct: 127 ER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAP 179
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS----- 727
E T K DV+SFG++ E++ GR P ++ +V+ +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------------NPEVIQNLERGY 227
Query: 728 RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
R+ P + +M C +P+ RPT
Sbjct: 228 RMVRPDNCPEELYQLM----------RLCWKERPEDRPT 256
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 56/289 (19%), Positives = 106/289 (36%), Gaps = 48/289 (16%)
Query: 507 IGTGGYGSVYKAQLPN-----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +G V G++VA+K L + + ++ E +L + H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEHII 96
Query: 562 KLYGFCLHKKC--MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH- 618
K G C + L+ +Y+ GSL +L + + + + ++YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA 152
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----AP 673
+HRD+++ N+LL++ + DFG A+ + G AP
Sbjct: 153 QHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--YYRVREDGDSPVFWYAP 206
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSD--QKIMLIDVLDS--- 727
E DV+SFGV E+L + ++ ++ + +
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266
Query: 728 --RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P +M++ C ++ FRPT + +
Sbjct: 267 GERLPRPDKCPAEVYHLMKN----------CWETEASFRPTFENLIPIL 305
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-32
Identities = 69/316 (21%), Positives = 125/316 (39%), Gaps = 55/316 (17%)
Query: 494 IIKATEDFDIKYCIGTGGYGSVYKAQL--PNGKV-VALKKLHRAETEETTFFNSFQNEAH 550
+K +G G +GSV + ++ VA+K L + + T EA
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQ 388
Query: 551 VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCV 610
++ ++ + IV+L G C + + L+ + G L FL E + + ++ V
Sbjct: 389 IMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQV 445
Query: 611 ANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTY 668
+ + YL + VHR++++ N+LL ++ A ++DFG ++ L +D S A +
Sbjct: 446 SMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSA 498
Query: 669 GYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLI 722
G APE + + DV+S+GV E L G+ P + +
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------ 546
Query: 723 DVLDS-----RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772
+V+ R+ P + +M D C K + RP V Q C
Sbjct: 547 EVMAFIEQGKRMECPPECPPELYALMSD----------CWIYKWEDRPDFLTVEQRMRAC 596
Query: 773 KIALVNPFEEISIWQL 788
+L + E S ++
Sbjct: 597 YYSLASKVEGGSALEV 612
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-32
Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 24/237 (10%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ + +G G +V++ + G + A+K + + E VL K+ H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNH 66
Query: 558 RNIVKLYGF--CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALS 615
+NIVKL+ + LI ++ GSL+ L A L + + +++ V ++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSDSSNRTIVAGTYGYI 671
+L + IVHR+I NI+ + + DFG AR L+ D ++ GT Y+
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182
Query: 672 APELAYTMVV--------TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM 720
P++ V+ D++S GV G P P ++++M
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---FRPFEGPRRNKEVM 236
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 48/290 (16%)
Query: 507 IGTGGYGSVYKAQLP-----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIV 561
+G G +GSV + G+VVA+KKL + TEE F+ E +L + H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHDNIV 74
Query: 562 KLYGFCLH--KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH- 618
K G C ++ + LI +Y+ GSL +L+ E +D + + + YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGT 132
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----AP 673
+HRD+++ NIL+ ++ + DFG ++L D G AP
Sbjct: 133 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--FFKVKEPGESPIFWYAP 186
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVL----MGRHPGELLSSLSSPSSDQKIMLIDVLDS-- 727
E + DV+SFGVV E+ + P + ++++ +++
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 728 ---RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P M+M + C ++ RP+ + +
Sbjct: 247 NNGRLPRPDGCPDEIYMIMTE----------CWNNNVNQRPSFRDLALRV 286
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 64/279 (22%), Positives = 116/279 (41%), Gaps = 41/279 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHV-LSKIA 556
+D + +G G YG V K + +P+G+++A+K++ T + + + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVD 64
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN------IIKCV 610
V YG + +++ + M SL F + V+D + I +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ-----VIDKGQTIPEDILGKIAVSI 118
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
AL +LH S++HRD+ +N+L+N+ + + DFG + L D + I AG Y
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPY 175
Query: 671 IAPE--------LAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722
+APE Y++ K D++S G+ +E+ + R P S +P Q ++
Sbjct: 176 MAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP---YDSWGTP-FQQLKQVV 227
Query: 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPT 761
+ +L D CL K RPT
Sbjct: 228 EEPSPQLPADKFSAEFVDFT------SQCLKKNSKERPT 260
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 48/298 (16%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP-----NGKVVALKKLHRAETEETTFFNSFQNEAHVLS 553
+G G +GSV + G+VVA+KKL + TEE F+ E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILK 97
Query: 554 KIAHRNIVKLYGFCLHKKC--MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
+ H NIVK G C + LI +Y+ GSL +L+ E +D + +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQIC 155
Query: 612 NALSYLH-HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
+ YL +HRD+++ NIL+ ++ + DFG ++L D G
Sbjct: 156 KGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--YYKVKEPGE 209
Query: 671 I-----APELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQK----IML 721
APE + DV+SFGVV E+ + + +++
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 722 IDVLDS-----RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+++ RL P M+M + C ++ RP+ + +
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTE----------CWNNNVNQRPSFRDLALRV 317
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 58/318 (18%), Positives = 123/318 (38%), Gaps = 49/318 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH- 557
+ I IG+GG V++ ++ A+K ++ E + T +S++NE L+K+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 114
Query: 558 -RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
I++LY + + + ++++ + L +L+ +D R + K + A+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---IDPWERKSYWKNMLEAVHT 170
Query: 617 LHHDCMPSIVHRDISSNNILLNS---KLEAFVADFGTARLLDSDSSN--RTIVAGTYGYI 671
+H IVH D+ N L+ KL DFG A + D+++ + G Y+
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 672 APEL-----------AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD-QKI 719
PE ++ K DV+S G + + G+ P + + S I
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAI 280
Query: 720 MLIDV---LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFLTCKIA 775
+ + + ++ CL PK R ++ + ++ +
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKC-----------CLKRDPKQRISIPELLAHPYVQIQTH 329
Query: 776 LVNPFEEISIWQLRNQIN 793
VN + + +++ +
Sbjct: 330 PVNQMAKGTTEEMKYVLG 347
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 51/221 (23%), Positives = 87/221 (39%), Gaps = 37/221 (16%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ +G G +G V++ + G A+K + E + ++
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLS 108
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND---YEAVVLDWTMRVNIIKCVANA 613
IV LYG + + + ++ GSL ++ E L +
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL------YYLGQALEG 162
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTARLLDSDSSNRTI-----VAGT 667
L YLH I+H D+ ++N+LL+S A + DFG A L D +++ + GT
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 668 YGYIAPELAYTMVVTE-----KCDVYSFGVVALEVLMGRHP 703
++APE VV K D++S + L +L G HP
Sbjct: 220 ETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 62/278 (22%), Positives = 104/278 (37%), Gaps = 20/278 (7%)
Query: 110 FGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPSSLCQL 168
SIPS G ++ LD S N +T I L NL+ L L N +N S L
Sbjct: 43 LNSIPS--GLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL 99
Query: 169 TKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL-GKLKNLVALNVGGN 227
L + LS N L S L++L L+L N + L L L L VG
Sbjct: 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159
Query: 228 KLMGPIPSTLF-RLTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLEL 285
I F LT L L + ++ L S P+ ++ + + + M + + +
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218
Query: 286 TRLSQLLYLSISSNMLSG----QIPI----TIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337
S + L + L ++ ++ + + + +++ L + + + S
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 338 ELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLN 373
L + N L S+P I L L+ + L N +
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 53/252 (21%), Positives = 94/252 (37%), Gaps = 17/252 (6%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPEL-GSL 144
+S + L++L L N + +I +L L +LD S+N L+ ++ L
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPL 123
Query: 145 RNLEVLNLKGNNLNGAIPSSL-CQLTKLITMALSRNGLHGPIPS-AIGDLNNLLILSLDS 202
+L LNL GN +SL LTKL + + I L L L +D+
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 203 NKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNGSIPPEI 261
+ L + L ++N+ L + + + + +++ L L L+ E+
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 262 --------GNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLI 313
V ++ ++ + L ++S LL L S N L L
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT 301
Query: 314 SLKGLDLSNNKL 325
SL+ + L N
Sbjct: 302 SLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 35/173 (20%), Positives = 67/173 (38%), Gaps = 14/173 (8%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVL 150
FS L+ L + F I + L+ L L+ ++L S P+ L S++N+ L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHL 203
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAI--------GDLNNLLILSLDS 202
L + + + + + L L S + + +
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 203 NKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLN 254
L + + L ++ L+ L N+L +P +F RLT+L ++LH+N +
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 20/104 (19%), Positives = 32/104 (30%), Gaps = 11/104 (10%)
Query: 88 LSQFNFSCFPGLESLSLRFNYL----FGSIPSQVGA----LSKLRYLDFSFNNLTGSIPP 139
L + +E L LR L F + + R + + +L +
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMK 271
Query: 140 ELGSLRNLEVLNLKGNNLNGAIPSSLCQ-LTKLITMALSRNGLH 182
L + L L N L +P + LT L + L N
Sbjct: 272 LLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-31
Identities = 76/351 (21%), Positives = 128/351 (36%), Gaps = 44/351 (12%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGA-LSKLRYLDFSFNNLTGSIPPE-LGSL 144
EL++ +FS L+ L + I + LS L L +N + L
Sbjct: 44 ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGL 102
Query: 145 RNLEVLNLKGNNLNGAI--PSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLD 201
NLEVL L NL+GA+ + LT L + L N + P++ + +L L
Sbjct: 103 ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT 162
Query: 202 SNKLSGMLHQELGKL--KNLVALNVGGNKL--------MGPIPSTLFRLTNLTYLYLHSN 251
NK+ + ++L K+ L + L F+ T++T L L N
Sbjct: 163 FNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGN 222
Query: 252 HLNGSIPPEIGNMTGILKV-------------DMSMNNIEGTIPLELTRL--SQLLYLSI 296
S+ + K+ N + L S + +
Sbjct: 223 GFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDL 282
Query: 297 SSNMLSGQIPITI-AGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIP 354
S + + + ++ + L+ L L+ N+++ I + L + L N L SI
Sbjct: 283 SKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SID 339
Query: 355 PEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPD 399
+ L KLE LDLS+N + + + P L L N L+ +PD
Sbjct: 340 SRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPD 388
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 60/314 (19%), Positives = 109/314 (34%), Gaps = 42/314 (13%)
Query: 123 LRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPSSLCQ-LTKLITMALSRNG 180
+ Y+D S N++ + L++L+ L ++ I ++ + L+ LI + L N
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 181 LHGPIPSAIGDLNNLLILSLDSNKL-SGMLHQEL-GKLKNLVALNVGGNKLMGPIPSTLF 238
A L NL +L+L L +L L +L L + N + P++ F
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 239 -RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV-----------DMSMNNIEGTIPLELT 286
+ L L N + SI E DM+ +
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 287 RLSQLLYLSISSNMLSGQIPITIAGLIS---LKGLDLSNNKLSGPIPPEIG--------- 334
+ + + L +S N + I+ ++ L LSN+ G
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 335 ---KCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP---- 385
+ S ++ L + + ++ + LE L L+ N++N I +
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 386 LDLSYNDLEGEIPD 399
L+LS N L G I
Sbjct: 328 LNLSQNFL-GSIDS 340
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 59/312 (18%), Positives = 101/312 (32%), Gaps = 39/312 (12%)
Query: 93 FSCFPGLESLSLRFNYLFGS-IPSQV-GALSKLRYLDFSFNNLTGSIPPE--LGSLRNLE 148
F+ LE L+L L G+ + L+ L L NN+ I P ++R
Sbjct: 99 FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFH 157
Query: 149 VLNLKGNNLNGAIPSSLCQLTKLITMAL----------SRNGLHGPIPSAIGDLNNLLIL 198
VL+L N + L L + L ++ L
Sbjct: 158 VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217
Query: 199 SLDSNKLSGMLHQELGKLKNLVAL-------------NVGGNKLMGPIPSTLFRL--TNL 243
L N + + + + G P T L + +
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV 277
Query: 244 TYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLE-LTRLSQLLYLSISSNML 301
L + + ++ + + T + ++ ++ N I I L+ LL L++S N L
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335
Query: 302 SGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--G 358
L L+ LDLS N + + + L+ + L N L S+P I
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR 393
Query: 359 LMKLEYLDLSHN 370
L L+ + L N
Sbjct: 394 LTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 19/75 (25%), Positives = 31/75 (41%), Gaps = 4/75 (5%)
Query: 86 GELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGS 143
G + F LE L L +N++ ++ Q L L+ L N L S+P
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR 393
Query: 144 LRNLEVLNLKGNNLN 158
L +L+ + L N +
Sbjct: 394 LTSLQKIWLHTNPWD 408
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHV-LSKIA 556
ED IG G YGSV K P+G+++A+K++ E+ + V +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSD 79
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNII----KCVAN 612
IV+ YG + ++ + M S F + Y VLD + I+
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS--VLDDVIPEEILGKITLATVK 136
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
AL++L + I+HRDI +NILL+ + DFG + L DS +T AG Y+A
Sbjct: 137 ALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMA 193
Query: 673 PE--------LAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
PE Y + DV+S G+ E+ GR P
Sbjct: 194 PERIDPSASRQGY----DVRSDVWSLGITLYELATGRFP 228
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 69/285 (24%), Positives = 104/285 (36%), Gaps = 53/285 (18%)
Query: 507 IGTGGYGSVYKAQLPNGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
IG G +G VY L + A+K L+R + F E ++ +H N++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLS 154
Query: 563 LYGFCLHKKC-MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC 621
L G CL + ++ YMK G L F+RN E + VA + +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK- 211
Query: 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----APELA 676
VHRD+++ N +L+ K VADFG AR + + T + A E
Sbjct: 212 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV-HNKTGAKLPVKWMALESL 268
Query: 677 YTMVVTEKCDVYSFGVVALEVLM-------GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729
T T K DV+SFGV+ E++ + ++ L RL
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------------GRRL 315
Query: 730 SPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P VM C H K + RP+ +
Sbjct: 316 LQPEYCPDPLYEVMLK----------CWHPKAEMRPSFSELVSRI 350
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 53/326 (16%), Positives = 112/326 (34%), Gaps = 37/326 (11%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
+L+ + + L L+ N L + V L YL+ + N LT I +
Sbjct: 96 KLTNLDVTPLTKLTYLNCDTNKL-TKLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQ 149
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
L L+ N + + T+L T+ S N + + + L L+ D+N ++
Sbjct: 150 LTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNIT 204
Query: 207 GMLHQELGKLKNLVALNVGGNKLMGPIPSTL--FRLTNLTYLYLHSNHLNGSIPPEIGNM 264
+ +L + L L+ NKL + + LT LTY N L + + +
Sbjct: 205 KL---DLNQNIQLTFLDCSSNKL-----TEIDVTPLTQLTYFDCSVNPLT-ELD--VSTL 253
Query: 265 TGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNK 324
+ + + ++ ++LT +QL+Y + + L LD
Sbjct: 254 SKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGC--RKIKELDVTHNTQLYLLDCQAAG 308
Query: 325 LSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF--LYH 382
++ ++ + +L + L N L+ + KL+ L + + +
Sbjct: 309 IT---ELDLSQNPKLVYLYLNNTELT-ELDVS-HNTKLKSLSCVNAHIQ-DFSSVGKIPA 362
Query: 383 RFPLDLSYNDLEGEIPDYFRDSPFKV 408
+ + ++ +
Sbjct: 363 LNNNFEAEGQTITMPKETLTNNSLTI 388
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-31
Identities = 54/305 (17%), Positives = 110/305 (36%), Gaps = 30/305 (9%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
+L++ + S P L L+ N L I V ++L LD N ++
Sbjct: 117 KLTKLDVSQNPLLTYLNCARNTL-TEID--VSHNTQLTELDCHLNKKITK--LDVTPQTQ 171
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
L L+ N + + Q L + N + + + L L SNKL+
Sbjct: 172 LTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSNKLT 225
Query: 207 GMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTG 266
+ ++ L L + N L ST L+ LT L+ L I + + T
Sbjct: 226 EI---DVTPLTQLTYFDCSVNPLTELDVST---LSKLTTLHCIQTDLL-EID--LTHNTQ 276
Query: 267 ILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLS 326
++ L++T +QL L + ++ + ++ L L L+N +L+
Sbjct: 277 LIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT 331
Query: 327 GPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPL 386
+ + ++L++++ N ++ + L + + T+P L
Sbjct: 332 E-LD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI-TMPKETLTNNSL 386
Query: 387 DLSYN 391
++ +
Sbjct: 387 TIAVS 391
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 62/275 (22%), Positives = 104/275 (37%), Gaps = 27/275 (9%)
Query: 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
S + + L+ L LD +++T + + L L L NN+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKN 218
+ L Q T L +A N L + + L L L+ D+NKL+ + ++ +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKL---DVSQNPL 128
Query: 219 LVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278
L LN N L + T LT L H N ++ T + +D S N I
Sbjct: 129 LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT 183
Query: 279 GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSE 338
L++++ L L+ +N ++ + + I L LD S+NKL+ I + ++
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQ 234
Query: 339 LRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLN 373
L N L+ + L KL L L
Sbjct: 235 LTYFDCSVNPLT-ELDVS-TLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 56/275 (20%), Positives = 105/275 (38%), Gaps = 26/275 (9%)
Query: 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180
+ + + L L L+ +++ + + +LT L + + N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 181 LHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRL 240
+ + + NL L+ DSNKL+ + ++ L L LN NKL + +
Sbjct: 76 ITT-LD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKL---TKLDVSQN 126
Query: 241 TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNM 300
LTYL N L I + + T + ++D +N L++T +QL L S N
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNK 181
Query: 301 LSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLM 360
++ + ++ L L+ N ++ ++ + +L + +N L+ I L
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EIDVT-PLT 233
Query: 361 KLEYLDLSHNKLNGTIPPFLYHRFP-LDLSYNDLE 394
+L Y D S N L + + L DL
Sbjct: 234 QLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 54/320 (16%), Positives = 107/320 (33%), Gaps = 49/320 (15%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
L++ + S L L N + V ++L LD SFN +T + + +
Sbjct: 138 TLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKL 192
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
L LN NN+ + L Q +L + S N L I + L L N L+
Sbjct: 193 LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT 246
Query: 207 GMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTG 266
++ L L L+ L + N +Y + ++ + T
Sbjct: 247 ---ELDVSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298
Query: 267 ILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPIT------------------ 308
+ +D I L+L++ +L+YL +++ L+ ++ ++
Sbjct: 299 LYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELDVSHNTKLKSLSCVNAHIQDF 354
Query: 309 --IAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNN-----NLSGSIPPEIGLMK 361
+ + +L + + +P E + L + N P + G+
Sbjct: 355 SSVGKIPALNNNFEAEGQTIT-MPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYD 413
Query: 362 LEYLDLSHNKLNGTIPPFLY 381
++ L+ P Y
Sbjct: 414 QATNTITWENLSTDNPAVTY 433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 24/237 (10%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ + +G G +V++ + G + A+K + + E VL K+ H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNH 66
Query: 558 RNIVKLYGF--CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALS 615
+NIVKL+ + LI ++ GSL+ L A L + + +++ V ++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSDSSNRTIVAGTYGYI 671
+L + IVHR+I NI+ + + DFG AR L+ D ++ GT Y+
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182
Query: 672 APELAYTMVV--------TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM 720
P++ V+ D++S GV G P P ++++M
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---FRPFEGPRRNKEVM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 59/271 (21%), Positives = 98/271 (36%), Gaps = 39/271 (14%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPP-ELGSLRNLEVLNLKGNNLN--GAIPSSLCQL 168
S+P+ G S L+ N L S+P L L L+L N L+ G S
Sbjct: 21 SVPT--GIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 169 TKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL-GKLKNLVALNVGGN 227
T L + LS NG+ + S L L L + L M + L+NL+ L++
Sbjct: 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 228 KLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELT 286
+ +F L++L L + N + P+I T
Sbjct: 137 HTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDI-----------------------FT 172
Query: 287 RLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLR 345
L L +L +S L P L SL+ L++S+N + + L+ +
Sbjct: 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYS 231
Query: 346 NNNLSGSIPPEI---GLMKLEYLDLSHNKLN 373
N++ + + L +L+L+ N
Sbjct: 232 LNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 57/262 (21%), Positives = 87/262 (33%), Gaps = 34/262 (12%)
Query: 96 FPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLT-GSIPPE-LGSLRNLEVLNL 152
L L N L S+P V L++L L S N L+ + +L+ L+L
Sbjct: 27 PSSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
N + + S+ L +L + + L S L NL+ L + +
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 144
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEIGNMTGILKV 270
L +L L + GN +F L NLT+L L L + P
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA--------- 194
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
LS L L++S N L SL+ LD S N +
Sbjct: 195 --------------FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SK 239
Query: 331 PEI--GKCSELRNITLRNNNLS 350
+ S L + L N+ +
Sbjct: 240 KQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 16/177 (9%)
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIE--GTIPLELTRLS 289
+P+ + ++ T L L SN L S+P + +T + K+ +S N + G +
Sbjct: 22 VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 290 QLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNN 348
L YL +S N + + GL L+ LD ++ L + L + + + +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 349 LSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPD 399
I GL LE L ++ N P ++ LDLS LE ++
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 192
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 39/170 (22%), Positives = 63/170 (37%), Gaps = 11/170 (6%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGA---LSKLRYLDFSFNNLTGSIPPE-LGSLRNL 147
NF LE L + + L + L L YLD S + L +L
Sbjct: 96 NFLGLEQLEHLDFQHSNL-KQMSEF-SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSL 152
Query: 148 EVLNLKGNNLNGAIPS-SLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206
EVL + GN+ +L L + LS+ L P+A L++L +L++ N
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 212
Query: 207 GMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR--LTNLTYLYLHSNHLN 254
+ L +L L+ N +M + ++L +L L N
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 67/281 (23%), Positives = 114/281 (40%), Gaps = 48/281 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL----PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLS 553
+ +G+G +G+V+K + K+ V +K + ++ F + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--FQAVTDHMLAIG 70
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
+ H +IV+L G C + L+ +Y+ GSL +R A+ + +N +A
Sbjct: 71 SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKG 127
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-- 671
+ YL M VHR++++ N+LL S + VADFG A LL D +
Sbjct: 128 MYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYSEAKTPI 181
Query: 672 ---APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS 727
A E + T + DV+S+GV E++ G P L ++ + D+L+
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-----RLAE----VPDLLEK 232
Query: 728 --RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
RL+ P MVM C RPT
Sbjct: 233 GERLAQPQICTIDVYMVMVK----------CWMIDENIRPT 263
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 69/287 (24%), Positives = 103/287 (35%), Gaps = 57/287 (19%)
Query: 507 IGTGGYGSVYKAQLPNGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
IG G +G VY L + A+K L+R + F E ++ +H N++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLS 90
Query: 563 LYGFCLHKKC-MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL--HH 619
L G CL + ++ YMK G L F+RN+ + VA + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYLASKK 148
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----APE 674
VHRD+++ N +L+ K VADFG AR + T + A E
Sbjct: 149 -----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH-NKTGAKLPVKWMALE 202
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLM-------GRHPGELLSSLSSPSSDQKIMLIDVLDS 727
T T K DV+SFGV+ E++ + ++ L
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------------GR 249
Query: 728 RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P VM C H K + RP+ +
Sbjct: 250 RLLQPEYCPDPLYEVMLK----------CWHPKAEMRPSFSELVSRI 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ + IG G G+VY A + G+ VA+++++ + + NE V+ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENK 75
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSL-----FCFLRNDYEAVVLDWTMRVNIIKCVA 611
+ NIV L ++++ +Y+ GSL + A V ++
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------- 127
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
AL +LH + ++HRDI S+NILL + DFG + + S R+ + GT ++
Sbjct: 128 -ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 672 APELAYTMVVTE-----KCDVYSFGVVALEVLMGRHP 703
APE VVT K D++S G++A+E++ G P
Sbjct: 184 APE-----VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 56/284 (19%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL--PNGKV--VALKKLHRAETEETTFFNSFQNEAHVLSK 554
E ++ CIG G +G V++ P VA+K ++ F EA + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 72
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
H +IVKL G + +++I + G L FL+ ++ L + ++ AL
Sbjct: 73 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 129
Query: 615 SYL-HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-- 671
+YL VHRDI++ N+L++S + DFG +R ++ T + G +
Sbjct: 130 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPI 181
Query: 672 ---APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS 727
APE T DV+ FGV E+LM G P + + + DV+
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------------DVIGR 229
Query: 728 -----RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
RL P + +M C P RP
Sbjct: 230 IENGERLPMPPNCPPTLYSLMTK----------CWAYDPSRRPR 263
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 68/256 (26%), Positives = 110/256 (42%), Gaps = 15/256 (5%)
Query: 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180
++ + NL +P + N +LNL N + +S L L + LSRN
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 181 LHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR- 239
+ A L NL L L N+L+ + + L L L + N + IPS F
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNR 158
Query: 240 LTNLTYLYL-HSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSIS 297
+ +L L L L+ I ++ + ++++M N+ IP LT L +L L +S
Sbjct: 159 IPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215
Query: 298 SNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPE-IGKCSELRNITLRNNNLSGSIPPE 356
N LS P + GL+ L+ L + +++ I L I L +NNL+ +P +
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNNLT-LLPHD 273
Query: 357 I--GLMKLEYLDLSHN 370
+ L LE + L HN
Sbjct: 274 LFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 11/220 (5%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSL 144
+ +F LE L L N++ +I L+ L L+ N LT +IP L
Sbjct: 78 IIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYL 135
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR-NGLHGPIPSAIGDLNNLLILSLDSN 203
L+ L L+ N + + ++ L + L L A L+NL L+L
Sbjct: 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195
Query: 204 KLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE-IG 262
L + L L L L++ GN L P + L +L L++ + + I
Sbjct: 196 NLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFD 252
Query: 263 NMTGILKVDMSMNNIEGTIPLE-LTRLSQLLYLSISSNML 301
N+ +++++++ NN+ +P + T L L + + N
Sbjct: 253 NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 4/93 (4%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEV 149
N + L+ L L N+L +I L L+ L + + I +L++L
Sbjct: 202 NLTPLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVE 259
Query: 150 LNLKGNNLNGAIPSSLCQLTKLITMALSRNGLH 182
+NL NNL L L + L N +
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 60/311 (19%), Positives = 122/311 (39%), Gaps = 54/311 (17%)
Query: 492 EDIIKATEDFDIKYC----IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQN 547
+I + +G G G+V G+ VA+K++ F +
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALM 57
Query: 548 EAHVLSKI-AHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDYEAVVLDWTMR- 603
E +L++ H N+++ Y + +++ + +L + +N + +
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116
Query: 604 -VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF-------------VADFG 649
+++++ +A+ +++LH I+HRD+ NIL+++ ++DFG
Sbjct: 117 PISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 650 TARLLDSD----SSNRTIVAGTYGYIAPEL-------AYTMVVTEKCDVYSFGVVALEVL 698
+ LDS +N +GT G+ APEL +T D++S G V +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 699 -MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQD-IVLVTTVALACLHSKP 756
G+HP S + I+ + DR ++ + L++ + P
Sbjct: 234 SKGKHPFG-----DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS----QMIDHDP 284
Query: 757 KFRPTMQRVCQ 767
RPT +V +
Sbjct: 285 LKRPTAMKVLR 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 27/296 (9%), Positives = 65/296 (21%), Gaps = 48/296 (16%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+ G V+ + + ALK + +++ + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 566 FCLHKKCM--------------------------FLIYKYMKRGSLFCFLRNDYEAVV-- 597
L+ L V
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 598 --LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655
+ + + L +VH + +N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 656 SDSSNRTIVAGTYGYIAPEL--AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP 713
+ + Y E A T T + + G+ V P L++
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 714 SSDQKIMLIDVLDSRLSPPVDRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
S + + + DS + ++ ++ L+ + R +
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLI------GRFLNFDRRRRLLPLEAME 352
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
D IG G G V A+ +G+ VA+K + + + NE ++
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQ 100
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSL-----FCFLRNDYEAVVLDWTMRVNIIKCVA 611
H N+V++Y L + ++++ ++++ G+L L + A V + ++
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQ-------- 152
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
AL+YLH ++HRDI S++ILL ++DFG + D R + GT ++
Sbjct: 153 -ALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 208
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
APE+ + + D++S G++ +E++ G P
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 64/285 (22%), Positives = 107/285 (37%), Gaps = 58/285 (20%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL--PNGKV--VALKKLHRAETEETTFFNSFQNEAHVLSK 554
ED + +G G +G VY+ G+ VA+K + T + F +EA ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKN 69
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
+ H +IVKL G ++ ++I + G L +L + ++ + V + A+
Sbjct: 70 LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAM 126
Query: 615 SYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI- 671
+YL + VHRDI+ NIL+ S + DFG +R ++ + + +
Sbjct: 127 AYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLP 177
Query: 672 ----APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLD 726
+PE T DV+ F V E+L G+ P L + DV+
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK------------DVIG 225
Query: 727 S-----RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
RL P +M C P RP
Sbjct: 226 VLEKGDRLPKPDLCPPVLYTLMTR----------CWDYDPSDRPR 260
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 68/256 (26%), Positives = 105/256 (41%), Gaps = 15/256 (5%)
Query: 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180
++ + + L+ +P + N LNL NN+ + L L + L RN
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 181 LHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR- 239
+ A L +L L L N L+ + L L L + N + IPS F
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNR 169
Query: 240 LTNLTYLYL-HSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSIS 297
+ +L L L L I + + +++ M NI+ +P LT L L L +S
Sbjct: 170 VPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 298 SNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPE-IGKCSELRNITLRNNNLSGSIPPE 356
N P + GL SLK L + N+++S I + L + L +NNLS S+P +
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNLS-SLPHD 284
Query: 357 I--GLMKLEYLDLSHN 370
+ L L L L HN
Sbjct: 285 LFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 52/240 (21%), Positives = 81/240 (33%), Gaps = 31/240 (12%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSL 144
+ F LE L L N + I L+ L L+ N LT IP L
Sbjct: 89 MIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYL 146
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR-NGLHGPIPSAIGDLNNLLILSLDSN 203
L L L+ N + + ++ L+ + L L A L NL L+L
Sbjct: 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 204 KLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGN 263
+ M L L L L + GN P + L++L L++ ++ ++ I
Sbjct: 207 NIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNA-- 261
Query: 264 MTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
L+ L+ L+++ N LS L L L L +N
Sbjct: 262 ---------------------FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 53/233 (22%), Positives = 81/233 (34%), Gaps = 40/233 (17%)
Query: 170 KLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL 229
+ + +R GL +P I +N L+L N + + L +L L +G N +
Sbjct: 55 QFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 230 MGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRL 288
I F L +L L L N L IP L
Sbjct: 112 -RQIEVGAFNGLASLNTLELFDNWLT-VIPSGA-----------------------FEYL 146
Query: 289 SQLLYLSISSNMLSGQIPITI-AGLISLKGLDLSN-NKLSGPIPPEI-GKCSELRNITLR 345
S+L L + +N + IP + SL LDL KL I L+ + L
Sbjct: 147 SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEY-ISEGAFEGLFNLKYLNLG 204
Query: 346 NNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLE 394
N+ +P L+ LE L++S N I P +H L + + +
Sbjct: 205 MCNIK-DMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 4/93 (4%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEV 149
N + GLE L + N+ I LS L+ L + ++ I L +L
Sbjct: 213 NLTPLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 150 LNLKGNNLNGAIPSSLCQLTKLITMALSRNGLH 182
LNL NNL+ L L+ + L N +
Sbjct: 271 LNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 57/276 (20%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ +G GG+ ++ +V A K + ++ + E + +AH
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVAN 612
+++V +GF +F++ + +R SL + + EA R ++ +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 126
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
YLH + ++HRD+ N+ LN LE + DFG A ++ D + ++ GT YIA
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID-VLDSRLSP 731
PE+ + + DV+S G + +L+G+ P E + + +I + + ++P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLRIKKNEYSIPKHINP 240
Query: 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
++ + L + P RPT+ +
Sbjct: 241 VAASLIQK-----------MLQTDPTARPTINELLN 265
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 52/301 (17%), Positives = 101/301 (33%), Gaps = 62/301 (20%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
T +F IG+G +GSV+K +G + A+K+ + N+ E + + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA-LREVYAHAVLG 68
Query: 557 -HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-------EAVVLDWTMRVNIIK 608
H ++V+ + M + +Y GSL + +Y EA + D ++
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ----- 123
Query: 609 CVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV-------------------ADFG 649
V L Y+H S+VH DI +NI ++ D G
Sbjct: 124 -VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 650 TARLLDSDSSNRTIVAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLS 708
+ S+ + G ++A E L K D+++ + +
Sbjct: 180 HVTRI----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
Query: 709 SLSSPSSDQKIMLIDV--LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVC 766
+I + + LS ++ +H P+ RP+ +
Sbjct: 236 QW------HEIRQGRLPRIPQVLSQEFTELLKV-----------MIHPDPERRPSAMALV 278
Query: 767 Q 767
+
Sbjct: 279 K 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
E ++I +G G +G VYKA+ G + A K + EE + E +L+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCD 74
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA----N 612
H IVKL G H ++++ ++ G++ + LD + I+ V
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML------ELDRGLTEPQIQVVCRQMLE 128
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
AL++LH I+HRD+ + N+L+ + + +ADFG + R GT ++A
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 673 PELAYTMVVTE-----KCDVYSFGVVALEVLMGRHP 703
PE+ + + K D++S G+ +E+ P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 65/311 (20%), Positives = 111/311 (35%), Gaps = 68/311 (21%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G VY+ VA+K ++ A + F NEA V+ + ++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVMKEFNCHHV 90
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-------NDYEAVVLDWTMRVNIIKCVANA 613
V+L G + +I + M RG L +LR N+ + + + +A+
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 614 LSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
++YL + VHRD+++ N ++ + DFG R + R G G +
Sbjct: 151 MAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLL 202
Query: 672 -----APELAYTMVVTEKCDVYSFGVVALEVLM-GRHP------GELLSSLSSPSSDQKI 719
+PE V T DV+SFGVV E+ P ++L +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------- 255
Query: 720 MLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774
L P + +M+ C PK RP+ +
Sbjct: 256 ------GGLLDKPDNCPDMLFELMRM----------CWQYNPKMRPSFLEIISSIKEE-- 297
Query: 775 ALVNPFEEISI 785
+ F E+S
Sbjct: 298 -MEPGFREVSF 307
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 59/276 (21%), Positives = 109/276 (39%), Gaps = 36/276 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IA 556
D + +G+G G V+K + G V+A+K++ R+ +E + V+ K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHD 82
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANA 613
IV+ +G + +F+ + M + R E ++ + + A
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL------GKMTVAIVKA 136
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAP 673
L YL ++HRD+ +NILL+ + + + DFG + L D + AG Y+AP
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAP 193
Query: 674 ELAYTMVVTE-----KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728
E T+ + DV+S G+ +E+ G+ P + +D +++ + +
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP------YKNCKTDFEVLTKVLQEEP 247
Query: 729 LSPPVDRM---VMQDIVLVTTVALACLHSKPKFRPT 761
P Q V CL + RP
Sbjct: 248 PLLPGHMGFSGDFQSFV------KDCLTKDHRKRPK 277
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-30
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 494 IIKATEDFDIKYCI----GTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNE 548
+ +T F +Y G G +G V G+ A+K + + + ++ T S E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 549 AHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY-EAVVLDWTMRVN 605
+L ++ H NI+KLY F K +L+ + G LF + R + E
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------AR 130
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRT 662
II+ V + ++Y+H + IVHRD+ N+LL SK + + DFG + ++ +
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ GT YIAPE+ EKCDV+S GV+ +L G P
Sbjct: 188 KI-GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 74/299 (24%), Positives = 115/299 (38%), Gaps = 67/299 (22%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G VY+ Q+ VA+K L +E+ F EA ++SK H+NI
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKFNHQNI 95
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN----DYEAVVLDWTMRVNIIKCVANALSY 616
V+ G L F++ + M G L FLR + L +++ + +A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 617 L--HHDCMPSIVHRDISSNNILLNSKLEAFV---ADFGTARLLDSDSSNRTIVAGTYGYI 671
L +H +HRDI++ N LL V DFG AR + S R G +
Sbjct: 156 LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCAML 207
Query: 672 -----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGRHP------GELLSSLSSPSSDQK 718
PE + T K D +SFGV+ E+ +G P E+L ++S
Sbjct: 208 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS------ 260
Query: 719 IMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772
R+ PP + +M C +P+ RP + + C
Sbjct: 261 -------GGRMDPPKNCPGPVYRIMTQ----------CWQHQPEDRPNFAIILERIEYC 302
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 61/211 (28%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DFDI +G G +G+VY A+ N ++ALK L +++ E+ + + E + S + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVAN 612
NI+++Y + +K ++L+ ++ RG L+ L+ ++ + ++ +A+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS--------ATFMEELAD 125
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
AL Y H ++HRDI N+L+ K E +ADFG + + S R + GT Y+
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLDYLP 180
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
PE+ EK D++ GV+ E L+G P
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
E FD+ +G G YGSVYKA G++VA+K++ + E ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKEISIMQQCD 82
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLF-------CFLRNDYEAVVLDWTMRVNIIKC 609
++VK YG ++++ +Y GS+ L D A +L T++
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK------ 136
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
L YLH +HRDI + NILLN++ A +ADFG A L + R V GT
Sbjct: 137 ---GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
++APE+ + D++S G+ A+E+ G+ P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 57/276 (20%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ +G GG+ ++ +V A K + ++ + E + +AH
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVAN 612
+++V +GF +F++ + +R SL + + EA R ++ +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 152
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
YLH + ++HRD+ N+ LN LE + DFG A ++ D + ++ GT YIA
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID-VLDSRLSP 731
PE+ + + DV+S G + +L+G+ P E + + +I + + ++P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLRIKKNEYSIPKHINP 266
Query: 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
++ + L + P RPT+ +
Sbjct: 267 VAASLIQK-----------MLQTDPTARPTINELLN 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-30
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 16/218 (7%)
Query: 496 KATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK 554
+ +++K +GTGG+G V + G+ VA+K+ + + + + E ++ K
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKK 68
Query: 555 IAHRNIVKLY------GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIK 608
+ H N+V L +Y + G L +L L ++
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 609 CVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTIVA 665
+++AL YLH + I+HRD+ NI+L + + D G A+ LD V
Sbjct: 129 DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV- 184
Query: 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
GT Y+APEL T D +SFG +A E + G P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 67/279 (24%), Positives = 102/279 (36%), Gaps = 57/279 (20%)
Query: 507 IGTGGYGSVYKAQL---PNGKV-VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
IG G +G VY + ++ A+K L R + +F E ++ + H N++
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV--EAFLREGLLMRGLNHPNVLA 86
Query: 563 LYGFCLHKKCM-FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL--HH 619
L G L + + ++ YM G L F+R+ ++ VA + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYLAEQK 144
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-----APE 674
VHRD+++ N +L+ VADFG AR + + + A E
Sbjct: 145 -----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV-QQHRHARLPVKWTALE 198
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLM-------GRHPGELLSSLSSPSSDQKIMLIDVLDS 727
T T K DV+SFGV+ E+L P +L L+
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-------------GR 245
Query: 728 RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
RL P VMQ C + P RPT
Sbjct: 246 RLPQPEYCPDSLYQVMQQ----------CWEADPAVRPT 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 73/299 (24%), Positives = 114/299 (38%), Gaps = 67/299 (22%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G VY+ Q+ VA+K L +E+ F EA ++SK H+NI
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKFNHQNI 136
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN----DYEAVVLDWTMRVNIIKCVANALSY 616
V+ G L F++ + M G L FLR + L +++ + +A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 617 L--HHDCMPSIVHRDISSNNILLNSKLEAFV---ADFGTARLLDSDSSNRTIVAGTYGYI 671
L +H +HRDI++ N LL V DFG AR + R G +
Sbjct: 197 LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCAML 248
Query: 672 -----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGRHP------GELLSSLSSPSSDQK 718
PE + T K D +SFGV+ E+ +G P E+L ++S
Sbjct: 249 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS------ 301
Query: 719 IMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772
R+ PP + +M C +P+ RP + + C
Sbjct: 302 -------GGRMDPPKNCPGPVYRIMTQ----------CWQHQPEDRPNFAIILERIEYC 343
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 73/303 (24%), Positives = 119/303 (39%), Gaps = 71/303 (23%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G V+ A+ N +VA+K L A FQ EA +L+ + H++I
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA---RQDFQREAELLTMLQHQHI 105
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR------------NDYEAVVLDWTMRVNIIK 608
V+ +G C + + ++++YM+ G L FLR D L + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 609 CVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG 666
VA + YL H VHRD+++ N L+ L + DFG +R + S R G
Sbjct: 166 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VG 217
Query: 667 TYGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKI 719
+ PE + Y T + DV+SFGVV E+ G+ P LS+
Sbjct: 218 GRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--------- 267
Query: 720 MLIDVLDS-----RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ +D L P +M+ C +P+ R +++ V
Sbjct: 268 ---EAIDCITQGRELERPRACPPEVYAIMRG----------CWQREPQQRHSIKDVHARL 314
Query: 770 LTC 772
Sbjct: 315 QAL 317
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 57/257 (22%), Positives = 103/257 (40%), Gaps = 18/257 (7%)
Query: 141 LGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSL 200
+L N + +N+ + L + T++ G+ + LNNL+ L L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 201 DSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE 260
N+++ + L L + L + GN L S + L ++ L L S + + P
Sbjct: 71 KDNQITDL--APLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQIT-DVTP- 124
Query: 261 IGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDL 320
+ ++ + + + +N I PL L+ L YLSI + +S P+ A L L L
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTPL--ANLSKLTTLKA 180
Query: 321 SNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFL 380
+NK+S I P + L + L+NN +S + P L + L++ + P F
Sbjct: 181 DDNKISD-ISP-LASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTNQTIT-NQPVFY 236
Query: 381 YHRFPLDLSYNDLEGEI 397
+ + G
Sbjct: 237 NNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/267 (22%), Positives = 115/267 (43%), Gaps = 23/267 (8%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
+ G+ +LS + +I V L+ L L+ N +T + P L +L + L
Sbjct: 36 TQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELE 91
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
L GN L S++ L + T+ L+ + P + L+NL +L LD N+++ +
Sbjct: 92 LSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNI--S 145
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271
L L NL L++G ++ P L L+ LT L N ++ I P + ++ +++V
Sbjct: 146 PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVH 201
Query: 272 MSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPP 331
+ N I PL S L +++++ ++ + +L ++ PI P
Sbjct: 202 LKNNQISDVSPLA--NTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSGAPIAP 256
Query: 332 EIGKCSELRNITLRNNNLSGSIPPEIG 358
+ N T + NL+ ++ I
Sbjct: 257 A----TISDNGTYASPNLTWNLTSFIN 279
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 43/189 (22%), Positives = 74/189 (39%), Gaps = 15/189 (7%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
+ L+ L L N + +I + L+ L+YL ++ + P L +L L L
Sbjct: 124 PLAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLK 179
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
N ++ S L L LI + L N + S + + +NL I++L + ++ Q
Sbjct: 180 ADDNKISDI--SPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITN---Q 232
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271
+ NLV NV PI N TY S +L ++ I N++
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAPIAPATI-SDNGTYA---SPNLTWNLTSFINNVSYTFNQS 288
Query: 272 MSMNNIEGT 280
++ N
Sbjct: 289 VTFKNTTVP 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-29
Identities = 65/226 (28%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 494 IIKATEDFDIKYCI----GTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFFN 543
I Y G+G YG V A+K + + +
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK----- 82
Query: 544 SFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY-EAVVLDW 600
E VL + H NI+KLY F K+ +L+ + K G LF + R + E
Sbjct: 83 -LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--- 138
Query: 601 TMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSD 657
IIK V + ++YLH +IVHRD+ N+LL SK + + DFG + + ++
Sbjct: 139 ---AVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + GT YIAPE+ EKCDV+S GV+ +L G P
Sbjct: 193 KKMKERL-GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
EDF + +G G + VY+A+ + G VA+K + + + QNE + ++ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR------NDYEAVVLDWTMRVNIIKCVA 611
+I++LY + ++L+ + G + +L+ ++ EA + + +
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--------HFMHQII 122
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
+ YLH I+HRD++ +N+LL + +ADFG A L + GT YI
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+PE+A + DV+S G + +L+GR P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 63/302 (20%), Positives = 106/302 (35%), Gaps = 63/302 (20%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGK----VVALKKLHRAETEETTFFNSFQNEAHVLSK 554
+ +G G +GSV + L VA+K + + + F +EA +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI-EEFLSEAACMKD 92
Query: 555 IAHRNIVKLYGFCL-----HKKCMFLIYKYMKRGSLFCFLRN---DYEAVVLDWTMRVNI 606
+H N+++L G C+ +I +MK G L +L + + +
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 607 IKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664
+ +A + YL + +HRD+++ N +L + VADFG ++ + S R
Sbjct: 153 MVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--- 204
Query: 665 AGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-------GRHPGELLSSLSS 712
G + A E V T K DV++FGV E+ G E+ L
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
Query: 713 PSSDQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
RL P D +M C + P RPT +
Sbjct: 265 -------------GHRLKQPEDCLDELYEIMYS----------CWRTDPLDRPTFSVLRL 301
Query: 768 EF 769
+
Sbjct: 302 QL 303
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 69/303 (22%), Positives = 108/303 (35%), Gaps = 64/303 (21%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGK----VVALKKLHRAETEETTFFNSFQNEAHVLSK 554
+ F + +G G +GSV +AQL VA+K L + F EA + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-EEFLREAACMKE 81
Query: 555 IAHRNIVKLYGFCL------HKKCMFLIYKYMKRGSLFCFLRN---DYEAVVLDWTMRVN 605
H ++ KL G L +I +MK G L FL L V
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 606 IIKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663
+ +A + YL + +HRD+++ N +L + VADFG +R + S R
Sbjct: 142 FMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-- 194
Query: 664 VAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-------GRHPGELLSSLS 711
G + A E + T DV++FGV E++ G E+ + L
Sbjct: 195 -QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253
Query: 712 SPSSDQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVC 766
+RL P + +M C + PK RP+ +
Sbjct: 254 G-------------GNRLKQPPECMEEVYDLMYQ----------CWSADPKQRPSFTCLR 290
Query: 767 QEF 769
E
Sbjct: 291 MEL 293
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
F++ +G G YG VYK + + G++ A+K + EE + E ++L K +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYS 78
Query: 557 -HRNIVKLYGFCLHKKCMFLIYK------YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC 609
HRNI YG + K + + + GS+ ++N + L I +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICRE 137
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
+ LS+LH ++HRDI N+LL E + DFG + LD R GT
Sbjct: 138 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 670 YIAPELAYTMVVTE-----KCDVYSFGVVALEVLMGRHP 703
++APE+ + K D++S G+ A+E+ G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 75/300 (25%), Positives = 119/300 (39%), Gaps = 74/300 (24%)
Query: 507 IGTGGYGSVYKAQLPNGKV---VALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVK 562
IG G +G V KA++ + A+K++ +++ F E VL K+ H NI+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNIIN 90
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRN-------------DYEAVVLDWTMRVNIIKC 609
L G C H+ ++L +Y G+L FLR + A L ++
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 610 VANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGT 667
VA + YL +HRD+++ NIL+ A +ADFG +R + V T
Sbjct: 151 VARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQE----VYVKKT 199
Query: 668 YGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGRHP------GELLSSLSSPS 714
G + A E L Y+ V T DV+S+GV+ E++ +G P EL L
Sbjct: 200 MGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 256
Query: 715 SDQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
RL P++ +M+ C KP RP+ ++
Sbjct: 257 -----------GYRLEKPLNCDDEVYDLMRQ----------CWREKPYERPSFAQILVSL 295
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ F IG G +G+VY A+ + N +VVA+KK+ + + + E L K+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
H N ++ G L + +L+ +Y GS L L + L+Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAY 169
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
LH +++HRD+ + NILL+ + DFG+A ++ + GT ++APE+
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVI 222
Query: 677 YTMVVTE---KCDVYSFGVVALEVLMGRHP 703
M + K DV+S G+ +E+ + P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-28
Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 50/281 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL--PNGKV--VALKKLHRAETEETTFFNSFQNEAHVLSK 554
E ++ CIG G +G V++ P VA+K ++ F EA + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 447
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
H +IVKL G + +++I + G L FL+ + LD + ++ AL
Sbjct: 448 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTAL 504
Query: 615 SYLH-HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI-- 671
+YL VHRDI++ N+L++S + DFG +R ++ + + G +
Sbjct: 505 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLPI 556
Query: 672 ---APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDS 727
APE T DV+ FGV E+LM G P + + + +I +++
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------VIGRIEN 607
Query: 728 --RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPT 761
RL P + +M C P RP
Sbjct: 608 GERLPMPPNCPPTLYSLMTK----------CWAYDPSRRPR 638
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 65/231 (28%), Positives = 96/231 (41%), Gaps = 32/231 (13%)
Query: 494 IIKATEDFDIKYCI----GTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFFN 543
+ K Y G+G YG V + A+K + + +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 544 S-----FQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY-EA 595
NE +L + H NI+KL+ KK +L+ ++ + G LF + R+ + E
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 596 VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTAR 652
NI+K + + + YLH +IVHRDI NILL +K + DFG +
Sbjct: 147 DA------ANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
D R + GT YIAPE EKCDV+S GV+ +L G P
Sbjct: 198 FFSKDYKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 73/301 (24%), Positives = 120/301 (39%), Gaps = 72/301 (23%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G V+ A+ N +VA+K L FQ EA +L+ + H +I
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNLQHEHI 79
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-------------NDYEAVVLDWTMRVNII 607
VK YG C + ++++YMK G L FLR L + ++I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 608 KCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
+A+ + YL H VHRD+++ N L+ + L + DFG +R + S R
Sbjct: 140 SQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---V 191
Query: 666 GTYGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQK 718
G + + PE + Y T + DV+SFGV+ E+ G+ P LS+
Sbjct: 192 GGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------- 242
Query: 719 IMLIDVLDS-----RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
+V++ L P VM C +P+ R ++ + +
Sbjct: 243 ----EVIECITQGRVLERPRVCPKEVYDVMLG----------CWQREPQQRLNIKEIYKI 288
Query: 769 F 769
Sbjct: 289 L 289
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
E ++I +G G +G V K + A+K +++A + ++ E +L K+
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLD 79
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLF-------CFLRNDYEAVVLDWTMRVNIIKC 609
H NI+KL+ +++ + G LF F ++++A IIK
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDA--------ARIIKQ 129
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTIVAG 666
V + ++Y+H +IVHRD+ NILL SK + + DFG + ++ + + G
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-G 185
Query: 667 TYGYIAPEL---AYTMVVTEKCDVYSFGVV 693
T YIAPE+ Y EKCDV+S GV+
Sbjct: 186 TAYYIAPEVLRGTY----DEKCDVWSAGVI 211
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 34/251 (13%)
Query: 460 LLNKNEIAKLMTGPTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKA- 518
L N +EIA ++ VF D + + ++ +++ + +G+G G V A
Sbjct: 100 LNNNSEIA--LSLSRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAF 155
Query: 519 QLPNGKVVALK-----KLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573
+ K VA++ K E + + E +L K+ H I+K+ F +
Sbjct: 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDY 214
Query: 574 FLIYKYMKRGSLFCFL--RNDY---EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHR 628
+++ + M+ G LF + + A+ YLH + I+HR
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATC--------KLYFYQMLLAVQYLHEN---GIIHR 263
Query: 629 DISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAYTMVV--T 682
D+ N+LL+S+ E + DFG +++L S RT+ GT Y+APE L
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVGTAGYN 322
Query: 683 EKCDVYSFGVV 693
D +S GV+
Sbjct: 323 RAVDCWSLGVI 333
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFFNSFQNEAHV 551
E ++I +G G +G V K + A+K +T E +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST------ILREVEL 74
Query: 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY-EAVVLDWTMRVNIIK 608
L K+ H NI+KL+ +++ + G LF + R + E IIK
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA------ARIIK 128
Query: 609 CVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTIVA 665
V + ++Y+H +IVHRD+ NILL SK + + DFG + ++ + +
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI- 184
Query: 666 GTYGYIAPEL---AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
GT YIAPE+ Y EKCDV+S GV+ +L G P
Sbjct: 185 GTAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 13/223 (5%)
Query: 154 GNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL 213
L A+P + + L N + ++ NL IL L SN L+ +
Sbjct: 20 QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 214 GKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVD 271
L L L++ N + + F L L L+L L + P + + + +
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY 135
Query: 272 MSMNNIEGTIPLE-LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
+ N ++ +P + L L +L + N +S GL SL L L N+++ +
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VH 193
Query: 331 PEI-GKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHN 370
P L + L NNLS ++P E L L+YL L+ N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 11/210 (5%)
Query: 96 FPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLK 153
+ + L N + +P+ A L L N L I L LE L+L
Sbjct: 31 PAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLS 88
Query: 154 GNNLNGAIPSS-LCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE 212
N ++ + L +L T+ L R GL P L L L L N L +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 213 LGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEI-GNMTGILKV 270
L NL L + GN++ +P FR L +L L LH N + + P ++ ++ +
Sbjct: 149 FRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTL 206
Query: 271 DMSMNNIEGTIPLE-LTRLSQLLYLSISSN 299
+ NN+ +P E L L L YL ++ N
Sbjct: 207 YLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 42/166 (25%), Positives = 63/166 (37%), Gaps = 7/166 (4%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVL 150
F+ LE L L N S+ L +L L L + P L L+ L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 151 NLKGNNLNGAIPSSLCQ-LTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGML 209
L+ N L A+P + L L + L N + A L++L L L N+++ +
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 210 HQELGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLN 254
L L+ L + N L +P+ L L YL L+ N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 34/170 (20%), Positives = 66/170 (38%), Gaps = 15/170 (8%)
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLELTRLSQL 291
+P + ++LH N ++ +P + + + N + T L+ L
Sbjct: 26 VPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 292 LYLSISSNMLSGQIPI-TIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNL 349
L +S N + T GL L L L L + P + + L+ + L++N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNAL 141
Query: 350 SGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDL 393
++P + L L +L L N+++ ++P + L L N +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRV 189
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 50/230 (21%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNS-------------- 544
D+ I + G + + + + K ALKK ++ E+ F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 545 FQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLD 599
F+NE +++ I + + G + +++IY+YM+ S+ F + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 600 WTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659
+ IIK V N+ SY+H++ +I HRD+ +NIL++ ++DFG +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDK 205
Query: 660 NRTIVAGTYGYIAPELAYTMVVTE------KCDVYSFGVVALEVLMGRHP 703
GTY ++ PE E K D++S G+ + P
Sbjct: 206 KIKGSRGTYEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 492 EDIIKATEDFDIKY----CIGTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTF 541
E ++ A+ F Y +G G + V + G A K KL + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---- 73
Query: 542 FNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY---EAV 596
+ EA + K+ H NIV+L+ + +L++ + G LF + R Y +A
Sbjct: 74 --KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA- 130
Query: 597 VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARL 653
+ I+ + +++Y H + IVHR++ N+LL SK + +ADFG A
Sbjct: 131 -------SHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 654 LDSDSSNRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVV 693
++ + GT GY++PE+ Y ++ D+++ GV+
Sbjct: 181 VNDSEAWHGFA-GTPGYLSPEVLKKDPY----SKPVDIWACGVI 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 61/300 (20%), Positives = 109/300 (36%), Gaps = 71/300 (23%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G +G VYK L VA+K L F++EA + +++ H N+
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEFRHEAMLRARLQHPNV 74
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-------------NDYEAVVLDWTMRVNII 607
V L G + + +I+ Y G L FL + L+ V+++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 608 KCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
+A + YL HH +VH+D+++ N+L+ KL ++D G R + + +
Sbjct: 135 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK---L 186
Query: 666 GTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GRHP------GELLSSLSSP 713
+ APE + D++S+GVV EV G P +++ + +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN- 245
Query: 714 SSDQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
L P D +M + C + P RP + +
Sbjct: 246 ------------RQVLPCPDDCPAWVYALMIE----------CWNEFPSRRPRFKDIHSR 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 35/214 (16%)
Query: 496 KATEDFDIKYCI----GTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAH 550
D + Y + G G +G V A Q A KK+ + E+ + F+ E
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIE 58
Query: 551 VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY---EAVVLDWTMRVN 605
++ + H NI++LY ++L+ + G LF + + + +A
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------AR 110
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRT 662
I+K V +A++Y H ++ HRD+ N L + + DFG A RT
Sbjct: 111 IMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 663 IVAGTYGYIAPEL---AYTMVVTEKCDVYSFGVV 693
V GT Y++P++ Y +CD +S GV+
Sbjct: 168 KV-GTPYYVSPQVLEGLY----GPECDEWSAGVM 196
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 45/209 (21%), Positives = 85/209 (40%), Gaps = 22/209 (10%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRA--ETEETTFFNSFQNEAHVLSK 554
+ +++ IG G + V + G+ A+K + A + + EA +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLF------CFLRNDY-EAVVLDWTMRVNII 607
+ H +IV+L +++++++M L Y EAV + +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA------SHYM 136
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTIV 664
+ + AL Y H + +I+HRD+ + +LL SK + + FG A L
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 665 AGTYGYIAPELAYTMVVTEKCDVYSFGVV 693
GT ++APE+ + DV+ GV+
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 61/296 (20%)
Query: 507 IGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRN 559
+G G +G V +A VA+K L + + +E ++S + H N
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE--KEALMSELKIMSHLGQHEN 111
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR-----------VNIIK 608
IV L G C H + +I +Y G L FLR + D ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 609 CVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG 666
VA +++L + +HRD+++ N+LL + A + DFG AR + +DS+
Sbjct: 172 QVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VK 223
Query: 667 TYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIM 720
+ APE + V T + DV+S+G++ E+ +G +P P
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--------YPGILVNSK 275
Query: 721 LIDVLDS--RLSPPV---DRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
++ +++ P + +MQ C +P RPT Q++C
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQA----------CWALEPTHRPTFQQICSFL 321
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 487 GRIAFEDIIKATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSF 545
GR + F K +G+G +G V+ + +G +K +++ ++
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQI 67
Query: 546 QNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR-- 603
+ E VL + H NI+K++ M+++ + + G L E +V
Sbjct: 68 EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL-------ERIVSAQARGKA 120
Query: 604 ------VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLL 654
++K + NAL+Y H +VH+D+ NIL + DFG A L
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 655 DSDSSNRTIVAGTYGYIAPEL---AYTMVVTEKCDVYSFGVV 693
SD + GT Y+APE+ T KCD++S GVV
Sbjct: 178 KSDEHSTNAA-GTALYMAPEVFKRDV----TFKCDIWSAGVV 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 498 TEDFDIKYCI----GTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFFNSFQN 547
+ F Y + G G + V + G A K KL + + +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLER 54
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY---EAVVLDWTM 602
EA + K+ H NIV+L+ + +L++ + G LF + R Y +A
Sbjct: 55 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA------- 107
Query: 603 RVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSS 659
+ I+ + +++Y H + IVHR++ N+LL SK + +ADFG A ++ +
Sbjct: 108 -SHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 660 NRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVV 693
GT GY++PE+ Y ++ D+++ GV+
Sbjct: 164 WHGFA-GTPGYLSPEVLKKDPY----SKPVDIWACGVI 196
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFFNSFQNEAHV 551
TE++ + +G G + V + ++ G+ A KL + + + EA +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ------KLEREARI 63
Query: 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY---EAVVLDWTMRVNI 606
+ H NIV+L+ + +LI+ + G LF + R Y +A +
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS--------HC 115
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTI 663
I+ + A+ + H +VHR++ N+LL SKL+ +ADFG A ++ +
Sbjct: 116 IQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 664 VAGTYGYIAPEL----AYTMVVTEKCDVYSFGVV 693
AGT GY++PE+ Y + D+++ GV+
Sbjct: 173 FAGTPGYLSPEVLRKDPY----GKPVDLWACGVI 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 496 KATEDFDIKYCI----GTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAH 550
+ + + G G VY+ Q K ALK L + ++ + E
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIG 100
Query: 551 VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY---EAVVLDWTMRVN 605
VL +++H NI+KL + L+ + + G LF + + Y +A +
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA--------AD 152
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRT 662
+K + A++YLH + IVHRD+ N+L + +ADFG +++++ +T
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209
Query: 663 IVAGTYGYIAPELAYTMVVTEKCDVYSFGVV 693
+ GT GY APE+ + D++S G++
Sbjct: 210 VC-GTPGYCAPEILRGCAYGPEVDMWSVGII 239
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 54/289 (18%), Positives = 91/289 (31%), Gaps = 60/289 (20%)
Query: 99 LESLSLRFNYLFG-SIPS-------QVGALSKLRYLDFSFNNLTGSIPPELGSL--RNLE 148
++SLSL+ + IPS +V +S L+ L +TG+ PP L +L
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 149 VLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM 208
+LNL+ + + L +L + + L LS+
Sbjct: 125 ILNLRNVSWAT-RDAWLAELQQWLKPGLKV-------------------LSIAQAHSLNF 164
Query: 209 LHQELGKLKNLVALNVGGNKLMGPIPST----LFRLTNLTYLYLHSNHLNGSIPPEIGNM 264
+++ L L++ N +G + L L L + +
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM----------- 213
Query: 265 TGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIP-ITIAGLISLKGLDLSNN 323
G QL L +S N L + L L+LS
Sbjct: 214 ----------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263
Query: 324 KLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKL 372
L +P + ++L + L N L P L ++ L L N
Sbjct: 264 GLKQ-VPKGLP--AKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 57/285 (20%), Positives = 95/285 (33%), Gaps = 35/285 (12%)
Query: 123 LRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLH 182
L+ +D + + + SL+ L V + + + ++ L + L +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 183 GPIPSAIGDL--NNLLILSLDSNKLSGMLHQELGKL-----KNLVALNVGGNKLMGPIPS 235
G P + + +L IL+L + + L +L L L++ +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 236 TLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLS 295
+ L+ L L N G I PL+ L L +
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGL-----------------ISALCPLKFPTLQVLALRN 210
Query: 296 ISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIP 354
SG A + L+GLDLS+N L S+L ++ L L +P
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP 269
Query: 355 PEIGLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEG 395
+ KL LDLS+N+L+ P P L L N
Sbjct: 270 KGL-PAKLSVLDLSYNRLD-RNPSPD--ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 40/184 (21%), Positives = 63/184 (34%), Gaps = 13/184 (7%)
Query: 78 NLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSI 137
N+ L++ PGL+ LS+ + QV L LD S N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 138 -------PPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAI 189
P + +L+ L + N +G + +L + LS N L +
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 190 GDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLH 249
+ L L+L L + + L L L++ N+L PS L + L L
Sbjct: 250 DWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLK 304
Query: 250 SNHL 253
N
Sbjct: 305 GNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 34/228 (14%), Positives = 66/228 (28%), Gaps = 40/228 (17%)
Query: 190 GDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRL---TNLTYL 246
G + +L + ++ K +L L V ++ I R+ + L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 247 YLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIP 306
L + + G+ PP + T L L++ + + +
Sbjct: 101 TLENLEVTGTAPPPLLEAT----------------------GPDLNILNLRNVSWATRDA 138
Query: 307 ----ITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIP-----PEI 357
+ LK L ++ ++ L + L +N G +
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 358 GLMKLEYLDLSHNKLN--GTIPPFLYHRFP----LDLSYNDLEGEIPD 399
L+ L L + + + L LDLS+N L
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 507 IGTGGYGSVYKAQLPNGK--------VVALKKLHRAETEETTFFNSFQNEAHVLSKIA-H 557
+G G +G V A+ VA+K L TE+ + +E ++ I H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-------------NDYEAVVLDWTMRV 604
+NI+ L G C +++I +Y +G+L +LR N + + V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 605 NIIKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662
+ +A + YL +HRD+++ N+L+ +ADFG AR +++ +
Sbjct: 161 SCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 214
Query: 663 IVAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
T G + APE + V T + DV+SFGV+ E+ +G P
Sbjct: 215 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 71/299 (23%), Positives = 108/299 (36%), Gaps = 64/299 (21%)
Query: 507 IGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRN 559
+G G +G V +A + VA+K L T + +E +L I H N
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 92
Query: 560 IVKLYGFCLHKKC-MFLIYKYMKRGSLFCFLRN-------------DYEAVVLDWTMRVN 605
+V L G C + +I ++ K G+L +LR+ D L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 606 IIKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663
VA + +L +HRD+++ NILL+ K + DFG AR + D
Sbjct: 153 YSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV-- 205
Query: 664 VAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQ 717
+ APE + V T + DV+SFGV+ E+ +G P P
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------YPGVKI 256
Query: 718 KIMLIDVLDS--RLSPPV---DRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
L R+ P M M D C H +P RPT + +
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----------CWHGEPSQRPTFSELVEHL 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 47/233 (20%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
IG G +G V++A+ P +VA+K L + + FQ EA ++++ + NI
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPNI 112
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLR---------------------NDYEAVVLD 599
VKL G C K M L+++YM G L FLR + L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 600 WTMRVNIIKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657
++ I + VA ++YL VHRD+++ N L+ + +ADFG +R + S
Sbjct: 173 CAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 658 SSNRTIVAGTYGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
+ A I PE + Y T + DV+++GVV E+ G P
Sbjct: 228 DYYK---ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 40/218 (18%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFFNSFQNEAHV 551
+++ + +G+G G V A + K VA+K K E + + E +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY----------EAVVLDWT 601
L K+ H I+K+ F + +++ + M+ G LF D
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF-----DKVVGNKRLKEATC------ 116
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDS 658
+ A+ YLH + I+HRD+ N+LL+S+ E + DFG +++L S
Sbjct: 117 --KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 659 SNRTIVAGTYGYIAPE-LAYTMVV--TEKCDVYSFGVV 693
RT+ GT Y+APE L D +S GV+
Sbjct: 172 LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 507 IGTGGYGSVYKAQLPNGK--------VVALKKLHRAETEETTFFNSFQNEAHVLSKIA-H 557
+G G +G V A+ VA+K L TE+ + +E ++ I H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 146
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-------------NDYEAVVLDWTMRV 604
+NI+ L G C +++I +Y +G+L +LR N + + V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 605 NIIKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662
+ +A + YL +HRD+++ N+L+ +ADFG AR +++ +
Sbjct: 207 SCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 260
Query: 663 IVAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
T G + APE + V T + DV+SFGV+ E+ +G P
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALK---KLHRAETEETTFFNSFQNEAHVLS 553
+ +DI +G+G + V K + G A K K + + E +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLF--CFLRNDY-EAVVLDWTMRVNIIKCV 610
++ H NI+ L+ ++ + LI + + G LF + E + IK +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA------TSFIKQI 124
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSDSSNRTIVAG 666
+ ++YLH I H D+ NI+L K + DFG A ++ + I G
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 667 TYGYIAPE-LAYTMVVTEKCDVYSFGVVA 694
T ++APE + Y + + D++S GV+
Sbjct: 181 TPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 57/294 (19%), Positives = 106/294 (36%), Gaps = 18/294 (6%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNL 147
L N C S + L + + L ++ ++N+ +L +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTV 249
Query: 148 EVLNLKGNNLNGAIPSSL-----CQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDS 202
++ L G + L L + + P +N+ I +
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 203 NKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIG 262
+ + K+ + L+ N L + LT L L L N L +
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAE 368
Query: 263 ---NMTGILKVDMSMNNIEGTIPLEL-TRLSQLLYLSISSNMLSGQIPITIAGLISLKGL 318
M + ++D+S N++ + LL L++SSN+L+ I + +K L
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVL 426
Query: 319 DLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHN 370
DL +NK+ IP ++ K L+ + + +N L S+P I L L+ + L N
Sbjct: 427 DLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 55/360 (15%), Positives = 121/360 (33%), Gaps = 28/360 (7%)
Query: 60 HCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGA 119
H KL ++C+ ++ ++L F L+ L L +L S +
Sbjct: 78 HNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 120 LSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179
L+ + L P L++ +L + ++ L +
Sbjct: 138 LNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 180 GLHG-----------PIPSAIGDLNNLLILSLDSNKLSGMLHQELGKL---KNLVALNVG 225
+ I + + L L+L++ + + + +L + ++
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 226 GNKLMGPIPSTLFR-----LTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGT 280
KL G + F L L+ + S+ + + + +++
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELR 340
L +++S L+L S+N+L+ + L L+ L L N+L + ++++
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMK 374
Query: 341 NIT---LRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPP-FLYHRFPLDLSYNDLE 394
++ + N++S L L++S N L TI LDL N ++
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 60/334 (17%), Positives = 109/334 (32%), Gaps = 33/334 (9%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPELGSLR 145
EL + L L + N + + V +L YLD S N L I
Sbjct: 35 ELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTV 90
Query: 146 NLEVLNLKGNNLNG-AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204
NL+ L+L N + I +++L + LS L I LN +L +
Sbjct: 91 NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 205 LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG--------- 255
++ L++ ++ + ++ T L +++
Sbjct: 151 Y--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 256 --SIPPEIGNMTGILKVDMSMNNIEGTI---PLELTRLSQLLYLSISSNMLSGQIPITIA 310
SI ++ + + ++ L+L + + Y SIS+ L GQ+
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 311 GLI--SLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGS----IPPEIGLMKLEY 364
SLK L + P+ N+ ++N +SG+ + + +
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328
Query: 365 LDLSHNKLNGTIPPFLYHRFP----LDLSYNDLE 394
LD S+N L L L N L+
Sbjct: 329 LDFSNNLL-TDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 7e-21
Identities = 56/328 (17%), Positives = 108/328 (32%), Gaps = 34/328 (10%)
Query: 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNL 147
+ + + SL + + +S + +N+ + S
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211
Query: 148 EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG 207
+ L+ N +L+ L + + + S+ + KL G
Sbjct: 212 ILAKLQTN----------PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQG 261
Query: 208 MLHQELG-----KLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIG 262
L LK L V + P +N+ +
Sbjct: 262 QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS 321
Query: 263 NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLS--GQIPITIAGLISLKGLDL 320
++ L +D S N + T+ L++L L + N L +I + SL+ LD+
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDI 381
Query: 321 SNNKLSGPIPPEIGKCSELRNIT---LRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIP 377
S N +S G CS +++ + +N L+ +++ LDL NK+ +IP
Sbjct: 382 SQNSVSYDEKK--GDCSWTKSLLSLNMSSNILT-DTIFRCLPPRIKVLDLHSNKIK-SIP 437
Query: 378 ------PFLYHRFPLDLSYNDLEGEIPD 399
L L+++ N L+ +PD
Sbjct: 438 KQVVKLEALQE---LNVASNQLK-SVPD 461
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 55/298 (18%), Positives = 104/298 (34%), Gaps = 20/298 (6%)
Query: 126 LDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI 185
+D S N L +P +L +LN+ N ++ S + L+KL + +S N +
Sbjct: 5 VDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 186 PSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL-MGPIPSTLFRLTNLT 244
S L L L NKL + NL L++ N PI ++ L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLK 118
Query: 245 YLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSI---SSNML 301
+L L + HL S I ++ + + E + L I ++
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 302 SGQIPITIAGLISLKGLDLSNNKLSG------PIPPEIGKCSELRNITLRNNNLSG---- 351
+ +++ + +L+ ++ I ++ +L N+TL N +
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 352 SIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPDYFRDSPFKVY 409
I + + Y +S+ KL G + + L + + D F +Y
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 55/280 (19%), Positives = 104/280 (37%), Gaps = 34/280 (12%)
Query: 51 NLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSC-FPGLESLSLR--FN 107
L + ++ + + + ++ ++ KL+G+L +F L++LS+ +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 108 YLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLC 166
+FG S + S + +F+ + + L+ N L + +
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 167 QLTKLITMALSRNGLH--GPIPSAIGDLNNLLILSLDSNKLSGMLHQEL-GKLKNLVALN 223
LT+L T+ L N L I + +L L + N +S + K+L++LN
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405
Query: 224 VGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPL 283
+ N L I L + L LHSN + +IP
Sbjct: 406 MSSNILTDTIFRCL--PPRIKVLDLHSNKIK-------------------------SIPK 438
Query: 284 ELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
++ +L L L+++SN L L SL+ + L N
Sbjct: 439 QVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-18
Identities = 55/308 (17%), Positives = 95/308 (30%), Gaps = 33/308 (10%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
+P K L+ S N ++ ++ SL L +L + N + S +L
Sbjct: 14 HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 172 ITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM-LHQELGKLKNLVALNVGGNKLM 230
+ LS N L I NL L L N + + +E G + L L + L
Sbjct: 72 EYLDLSHNKLVK-ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI--GNMTGILKVDMSMNNIEGTIP------ 282
+ L L + PE T L + N I
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 283 ---LELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKC--- 336
LEL+ + +L + S LS I + L L L+N + + I +
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLS--ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 337 SELRNITLRNNNLSGSIPPEI------GLMKLEYLDLSHNKLNGTIPPFLYHRFP----L 386
+ + ++ N L G + L L + + ++Y F
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNIK 305
Query: 387 DLSYNDLE 394
+ + +
Sbjct: 306 NFTVSGTR 313
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 23/73 (31%), Positives = 35/73 (47%), Gaps = 4/73 (5%)
Query: 88 LSQFNFSCFPG-LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLR 145
L+ F C P ++ L L N + SIP QV L L+ L+ + N L S+P L
Sbjct: 411 LTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLT 468
Query: 146 NLEVLNLKGNNLN 158
+L+ + L N +
Sbjct: 469 SLQKIWLHTNPWD 481
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALK---KLHRAETEETTFFNSFQNEAHVLS 553
+ +DI +G+G + V K + G A K K + + E +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLF--CFLRNDY-EAVVLDWTMRVNIIKCV 610
++ H N++ L+ ++ + LI + + G LF + E + IK +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA------TSFIKQI 124
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSDSSNRTIVAG 666
+ ++YLH I H D+ NI+L K + DFG A ++ + I G
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 667 TYGYIAPE-LAYTMVVTEKCDVYSFGVVA 694
T ++APE + Y + + D++S GV+
Sbjct: 181 TPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 7e-26
Identities = 34/298 (11%), Positives = 85/298 (28%), Gaps = 61/298 (20%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK----------- 554
+G + +A G+ + + E + + E L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 555 -----------IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV------ 597
+ K+ L ++ M+++ ++ + L+ E ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 598 --LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655
L R+ + V L+ LHH +VH + +I+L+ + F+ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 656 SDSSNRTIVAGTYG---YIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELL 707
+ + + + + A + ++T D ++ G+ + P
Sbjct: 263 ASA--VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 708 SSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
+ ++ I + PV ++ L + R +
Sbjct: 317 --NTDDAALGGSEWIFRSCKNIPQPVRALLEG-----------FLRYPKEDRLLPLQA 361
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALK---KLHRAETEETTFFNSFQNEAHVLS 553
+ +++ +G+G + V K Q GK A K K + + + E ++L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLF--CFLRNDY-EAVVLDWTMRVNIIKCV 610
+I H NI+ L+ +K + LI + + G LF + E +K +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA------TQFLKQI 117
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSDSSNRTIVAG 666
+ + YLH I H D+ NI+L K + DFG A +++ + + I G
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-G 173
Query: 667 TYGYIAPE-LAYTMVVTEKCDVYSFGVVA 694
T ++APE + Y + + D++S GV+
Sbjct: 174 TPEFVAPEIVNYEP-LGLEADMWSIGVIT 201
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 68/298 (22%), Positives = 112/298 (37%), Gaps = 61/298 (20%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRN 559
+G G +G V +A VA+K L + + +E VLS + H N
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMN 88
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR---------------V 604
IV L G C +I +Y G L FLR ++ + T +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664
+ VA +++L + +HRD+++ NILL + DFG AR + +DS+
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--- 202
Query: 665 AGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQK 718
+ APE + V T + DV+S+G+ E+ +G P P
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--------YPGMPVD 254
Query: 719 IMLIDVLDS--RLSPPV---DRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
++ R+ P M +M+ C + P RPT +++ Q
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKT----------CWDADPLKRPTFKQIVQLI 302
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 72/328 (21%), Positives = 127/328 (38%), Gaps = 76/328 (23%)
Query: 507 IGTGGYGSVYKAQLPNGK--------VVALKKLHRAETEETTFFNSFQNEAHVLSKIA-H 557
+G G +G V A+ VA+K L TE+ + +E ++ I H
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 134
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN-------------DYEAVVLDWTMRV 604
+NI+ L G C +++I +Y +G+L +L+ L V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 605 NIIKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662
+ VA + YL +HRD+++ N+L+ +ADFG AR + +
Sbjct: 195 SCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK- 248
Query: 663 IVAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHP------GELLSSL 710
T G + APE + + T + DV+SFGV+ E+ +G P EL L
Sbjct: 249 --KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 711 SSPSSDQKIMLIDVLDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765
R+ P + M+M+D C H+ P RPT +++
Sbjct: 307 KE-------------GHRMDKPSNCTNELYMMMRD----------CWHAVPSQRPTFKQL 343
Query: 766 CQEFLTCKIALVNPFEEISIWQLRNQIN 793
++ +I + +E+ + + +
Sbjct: 344 VEDLD--RIVALTSNQEMGYYHHHHHHD 369
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ +DI +G+G +G V++ + G+V K ++ + + +NE +++++
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLH 106
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLF--CFLRND--YEAVVLDWTMRVNIIKCVAN 612
H ++ L+ K M LI +++ G LF + EA V +N ++
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV------INYMRQACE 160
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV--ADFGTARLLDSDSSNRTIVAGTYGY 670
L ++H SIVH DI NI+ +K + V DFG A L+ D + T +
Sbjct: 161 GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEF 216
Query: 671 IAPE-LAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
APE + V D+++ GV+ +L G P
Sbjct: 217 AAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 47/221 (21%), Positives = 94/221 (42%), Gaps = 28/221 (12%)
Query: 492 EDIIKATEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLH-RAETEETTFFNSFQNEA 549
+++ E + I +G G +G V++ + + K K + + + + E
Sbjct: 1 KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-----LVKKEI 52
Query: 550 HVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLF--CFLRNDY--EAVVLDWTMRVN 605
+L+ HRNI+ L+ + + +I++++ +F E + V+
Sbjct: 53 SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI------VS 106
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV--ADFGTARLLDSDSSNRTI 663
+ V AL +LH +I H DI NI+ ++ + + +FG AR L + R +
Sbjct: 107 YVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 664 VAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
Y APE + + V+ D++S G + +L G +P
Sbjct: 164 F-TAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINP 202
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 45/232 (19%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI 560
+G G +G V KA + K VA+K L + +E +VL ++ H ++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE--LRDLLSEFNVLKQVNHPHV 88
Query: 561 VKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN---------------------DYEAVVLD 599
+KLYG C + LI +Y K GSL FLR + L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 600 WTMRVNIIKCVANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657
++ ++ + YL +VHRD+++ NIL+ + ++DFG +R + +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 658 SSNRTIVAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHP 703
S + G I A E + + T + DV+SFGV+ E++ +G +P
Sbjct: 204 DSYV---KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 44/225 (19%)
Query: 496 KATEDFDIKY----CIGTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFFNSF 545
A ++F KY IG G V + G A+K + + +
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 546 QNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY----------E 594
+ E H+L ++A H +I+ L MFL++ M++G LF DY E
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF-----DYLTEKVALSEKE 201
Query: 595 AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654
+I++ + A+S+LH + +IVHRD+ NILL+ ++ ++DFG + L
Sbjct: 202 TR--------SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 655 DSDSSNRTIVAGTYGYIAPE-LAYTMVVTEK-----CDVYSFGVV 693
+ R + GT GY+APE L +M T D+++ GV+
Sbjct: 251 EPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 500 DFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+G G +G V+K + G +A K + ++ +NE V++++ H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLF------CFLRNDYEAVVLDWTMRVNIIKCVAN 612
N+++LY K + L+ +Y+ G LF + + + + +K +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT--------ILFMKQICE 198
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV--ADFGTARLLDSDSSNRTIVAGTYGY 670
+ ++H I+H D+ NIL ++ + DFG AR + GT +
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEF 254
Query: 671 IAPE-LAYTMVVTEKCDVYSFGVVA 694
+APE + Y V+ D++S GV+A
Sbjct: 255 LAPEVVNYD-FVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ +DI +GTG +G V++ + G A K + + + + E +S +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLR 212
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL---RNDY-EAVVLDWTMRVNIIKCVAN 612
H +V L+ M +IY++M G LF + N E V ++ V
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA------VEYMRQVCK 266
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV--ADFGTARLLDSDSSNRTIVAGTYGY 670
L ++H + + VH D+ NI+ +K + DFG LD S + GT +
Sbjct: 267 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEF 322
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
APE+A V D++S GV++ +L G P
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 63/305 (20%), Positives = 112/305 (36%), Gaps = 70/305 (22%)
Query: 507 IGTGGYGSVYKAQLPNGK------VVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRN 559
+G+G +G V A VA+K L + +E +++++ H N
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQLGSHEN 110
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC---------- 609
IV L G C ++LI++Y G L +LR+ E D N +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 610 ----------VANALSYL--HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657
VA + +L VHRD+++ N+L+ + DFG AR + SD
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 658 SSNRTIVAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLS 711
S+ + APE + + T K DV+S+G++ E+ +G +P
Sbjct: 226 SNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-------- 274
Query: 712 SPSSDQKIMLIDVLDS--RLSPPV---DRM--VMQDIVLVTTVALACLHSKPKFRPTMQR 764
P ++ + ++ P + + +MQ C + RP+
Sbjct: 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS----------CWAFDSRKRPSFPN 324
Query: 765 VCQEF 769
+
Sbjct: 325 LTSFL 329
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 45/226 (19%)
Query: 496 KATEDFDIKY----CIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFN------S 544
+T F Y +G G V + P K A+K + + +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 545 FQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY---------- 593
E +L K++ H NI++L FL++ MK+G LF DY
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEK 124
Query: 594 EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653
E I++ + + LH +IVHRD+ NILL+ + + DFG +
Sbjct: 125 ETR--------KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 654 LDSDSSNRTIVAGTYGYIAPE-LAYTMVV-----TEKCDVYSFGVV 693
LD R + GT Y+APE + +M ++ D++S GV+
Sbjct: 174 LDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 33/209 (15%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ F +G+G + V+ Q GK+ ALK + ++ +S +NE VL KI
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIK 64
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR---------VNII 607
H NIV L +L+ + + G LF D + +I
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELF------------DRILERGVYTEKDASLVI 112
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTIV 664
+ V +A+ YLH + IVHRD+ N+L + E + DFG +++ + +
Sbjct: 113 QQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTA 167
Query: 665 AGTYGYIAPELAYTMVVTEKCDVYSFGVV 693
GT GY+APE+ ++ D +S GV+
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 66/265 (24%), Positives = 96/265 (36%), Gaps = 57/265 (21%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPSSLC-QLT 169
IP + LD SFN L + S L+VL+L + I L+
Sbjct: 21 KIPD--NLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 170 KLITMALSRNGLHGPIPSAI-GDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNK 228
L T+ L+ N + + L++L L L+ + + +G LK L LNV N
Sbjct: 77 HLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 229 L-MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTR 287
+ +P LTNL +L L SN + SI L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD-----------------------LRV 171
Query: 288 LSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNN 347
L Q+ L++S LDLS N ++ I P K L+ + L N
Sbjct: 172 LHQMPLLNLS--------------------LDLSLNPMNF-IQPGAFKEIRLKELALDTN 210
Query: 348 NLSGSIPPEI--GLMKLEYLDLSHN 370
L S+P I L L+ + L N
Sbjct: 211 QLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 45/221 (20%), Positives = 91/221 (41%), Gaps = 22/221 (9%)
Query: 185 IPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNL 243
IP + + L L N L + L L++ ++ I + L++L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHL 78
Query: 244 TYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLEL-TRLSQLLYLSISSNML 301
+ L L N + S+ ++ + K+ N+ ++ L L L+++ N++
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 302 -SGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLR----NNNLSGSIPP 355
S ++P + L +L+ LDLS+NK+ I ++ + L N ++ I P
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 356 EI-GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYN 391
++L+ L L N+L ++P ++ R + L N
Sbjct: 195 GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 51/301 (16%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLY 564
+ GG+ VY+AQ + +G+ ALK+L E E+ + E + K++ H NIV+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92
Query: 565 GFCL-------HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+ FL+ + +G L FL+ L + I A+ ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA------------ 665
H P I+HRD+ N+LL+++ + DFG+A +
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 666 GTYGYIAPELAYTM---VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722
T Y PE+ + EK D+++ G + + +HP E + L
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----------- 260
Query: 723 DVLDSRLS-PPVDRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNP 779
+++ + S PP D V ++ A L P+ R ++ V + +IA
Sbjct: 261 -IVNGKYSIPPHDTQYTVFHSLI------RAMLQVNPEERLSIAEVVHQL--QEIAAARN 311
Query: 780 F 780
Sbjct: 312 V 312
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 27/213 (12%)
Query: 498 TEDFDIKYCI----GTGGYGSVYKA-QLPNGKVVALK---KLHRAETEETTFFNSFQNEA 549
E+ D Y G+G + V K + G A K K + + E
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 550 HVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLF--CFLRNDY-EAVVLDWTMRVNI 606
+L +I H N++ L+ +K + LI + + G LF + E
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA------TEF 119
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSDSSNRT 662
+K + N + YLH I H D+ NI+L + + DFG A +D + +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 663 IVAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVA 694
I GT ++APE + Y + + D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEP-LGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 494 IIKATEDFDIKYCI-----GTGGYGSVYKA-QLPNGKVVALK-----KLHRAETEETTFF 542
++ E+F+ Y + G G + V + G+ A K + + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE---- 74
Query: 543 NSFQNEAHVLSKIAHR-NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWT 601
+E VL ++ L+ + + LI +Y G +F + +
Sbjct: 75 --ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF-------SLCLPELA 125
Query: 602 MR------VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTAR 652
+ +IK + + YLH + +IVH D+ NILL+S + DFG +R
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 653 LLDSDSSNRTIVAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVA 694
+ R I+ GT Y+APE L Y +T D+++ G++A
Sbjct: 183 KIGHACELREIM-GTPEYLAPEILNYDP-ITTATDMWNIGIIA 223
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-24
Identities = 65/351 (18%), Positives = 118/351 (33%), Gaps = 44/351 (12%)
Query: 91 FNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150
F F +L+ + +Q L+ + + + +++ S+ + L N+ L
Sbjct: 15 FPDDAFAETIKDNLKKKSV-TDAVTQ-NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH 210
L GN L L L L + L N + + S++ DL L LSL+ N +S +
Sbjct: 71 FLNGNKLTDI--KPLTNLKNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISDI-- 124
Query: 211 QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV 270
L L L +L +G NK+ + L RLT L L L N ++ I P
Sbjct: 125 NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP----------- 170
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
L L++L L +S N +S + +AGL +L L+L + +
Sbjct: 171 --------------LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPI 214
Query: 331 PEIGKCSELRNITLRNNNLSG----SIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPL 386
+ + +L S + +++ I
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKA 274
Query: 387 DLSYNDLEGEIPDYFRDSPFKVYGNQGICYFSACSTLHTPTASKSKSLVLR 437
++ + + V G A + + P + V +
Sbjct: 275 KARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFK 325
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 66/234 (28%), Positives = 104/234 (44%), Gaps = 27/234 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ F+I IG G +G V Q K+ A+K +++ + E + E ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 558 RNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANA 613
+V L Y F + MF++ + G L L+ + E V + I + A
Sbjct: 75 PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLF------ICELVMA 127
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAP 673
L YL + I+HRD+ +NILL+ + DF A +L ++ T +AGT Y+AP
Sbjct: 128 LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMAP 183
Query: 674 EL-------AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM 720
E+ Y+ V D +S GV A E+L GR P + SS SS
Sbjct: 184 EMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE 233
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 58/254 (22%), Positives = 98/254 (38%), Gaps = 51/254 (20%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTF--FNSFQNEAHVLSK 554
+ + +K IG G YG V A + + A+K +++ + + + E ++ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRV---------- 604
+ H NI +LY ++ + L+ + G L L + M V
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 605 ---------------------------NIIKCVANALSYLHHDCMPSIVHRDISSNNILL 637
NI++ + +AL YLH+ I HRDI N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 638 NSKLEAFV--ADFGTARLLDSDSSNR----TIVAGTYGYIAPELAYTMV--VTEKCDVYS 689
++ + DFG ++ ++ T AGT ++APE+ T KCD +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 690 FGVVALEVLMGRHP 703
GV+ +LMG P
Sbjct: 262 AGVLLHLLLMGAVP 275
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 39/203 (19%)
Query: 507 IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLY 564
+G G + K + + A+K + + T Q E L H NIVKL+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT------QKEITALKLCEGHPNIVKLH 72
Query: 565 GFCLHKKCMFLIYKYMKRGSLF-------CFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+ FL+ + + G LF F ++ EA I++ + +A+S++
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHF--SETEAS--------YIMRKLVSAVSHM 122
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
H +VHRD+ N+L + + + DFG ARL D+ T Y APE
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 675 L----AYTMVVTEKCDVYSFGVV 693
L Y E CD++S GV+
Sbjct: 180 LLNQNGY----DESCDLWSLGVI 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 46/211 (21%), Positives = 87/211 (41%), Gaps = 37/211 (17%)
Query: 498 TEDFDIKYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
T+ +++K IG G Y + A+K + +++ + E +L +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-------TEEIEILLRYG 73
Query: 557 -HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFL--RNDY---EAVVLDWTMRVNIIKCV 610
H NI+ L K ++++ + MK G L + + + EA ++ +
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS--------AVLFTI 125
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSDSSNRTIVAG 666
+ YLH +VHRD+ +NIL + + DFG A+ L +++
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 667 TYGYIAPEL----AYTMVVTEKCDVYSFGVV 693
T ++APE+ Y CD++S GV+
Sbjct: 183 TANFVAPEVLERQGY----DAACDIWSLGVL 209
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 48/231 (20%), Positives = 99/231 (42%), Gaps = 19/231 (8%)
Query: 163 SSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVAL 222
S + I L + + + +LN++ + +++ + + Q + L N+ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKL 73
Query: 223 NVGGNKL--MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGT 280
+ GNKL + P+ + L NL +L+L N + + + ++ + + + N I
Sbjct: 74 FLNGNKLTDIKPLAN----LKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDI 127
Query: 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELR 340
L L QL L + +N ++ I ++ L L L L +N++S I P + ++L+
Sbjct: 128 NGLV--HLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQ 181
Query: 341 NITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYN 391
N+ L N++S + GL L+ L+L + + + N
Sbjct: 182 NLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 40/259 (15%)
Query: 91 FNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150
F+ F +L+ + + L+ + + + +++ S+ + L N+ L
Sbjct: 18 FSDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH 210
L GN L L L L + L N + S++ DL L LSL+ N +S +
Sbjct: 74 FLNGNKLTDI--KPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISDI-- 127
Query: 211 QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKV 270
L L L +L +G NK+ + L RLT L L L N ++ I P + +T + +
Sbjct: 128 NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
+S N+I + + +AGL +L L+L + +
Sbjct: 184 YLSKNHIS----------------DLRA----------LAGLKNLDVLELFSQECLNKPI 217
Query: 331 PEIGKCSELRNITLRNNNL 349
+ + +L
Sbjct: 218 NHQSNLVVPNTVKNTDGSL 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 1e-22
Identities = 38/306 (12%), Positives = 84/306 (27%), Gaps = 76/306 (24%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH--------------- 550
+G + +A G+ + + E + + E
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 551 ----------VLSKIAHRNIVKLYGFCLHKKCM--FLIYKYMKR------GSLFCFLRND 592
++ + ++++ + F +Y M+ L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 593 YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652
L R+ + V L+ LHH +VH + +I+L+ + F+ F
Sbjct: 201 KS---LVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 653 LLDSDSSNRTIVAGTYGYIAPEL-----------AYTMVVTEKCDVYSFGVVALEVLMGR 701
+ R + + + G+ PEL ++T D ++ G+V +
Sbjct: 255 RDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 702 HP--GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFR 759
P + S + I + PV ++ L + R
Sbjct: 311 LPITKDAALGGS-----EWIF---RSCKNIPQPVRALLEG-----------FLRYPKEDR 351
Query: 760 PTMQRV 765
+
Sbjct: 352 LLPLQA 357
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 43/225 (19%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRA------ETEETTFFNSFQNEAHV 551
EDF +G G + +V A+ + A+K L + + E V
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDV 83
Query: 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEAVVLDWT 601
+S++ H VKLY + ++ Y K G L ++R Y A ++
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-- 141
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
AL YLH I+HRD+ NILLN + + DFGTA++L +S
Sbjct: 142 -----------ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 662 ---TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ V GT Y++PEL + D+++ G + +++ G P
Sbjct: 188 RANSFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 53/232 (22%), Positives = 73/232 (31%), Gaps = 33/232 (14%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152
S ++ L ++P L S N L L L LNL
Sbjct: 6 VSKVASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE 212
L + L L T+ LS N L +P L L +L + N+L+ +
Sbjct: 63 DRAELT-KLQVDG-TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 213 LGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVD 271
L L L L + GN+L +P L L L L +N+L +P +
Sbjct: 120 LRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGL---------- 167
Query: 272 MSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
L L L L + N L IP G L L N
Sbjct: 168 -------------LNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 218 NLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNI 277
+ L++ N L +TL T LT L L L + G + + +D+S N +
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQL 89
Query: 278 EGTIPLELTRLSQLLYLSISSNMLSGQIPITI-AGLISLKGLDLSNNKLSGPIPPEI-GK 335
+ ++PL L L L +S N L+ +P+ GL L+ L L N+L +PP +
Sbjct: 90 Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTP 146
Query: 336 CSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPP 378
+L ++L NNNL+ +P + GL L+ L L N L TIP
Sbjct: 147 TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPK 189
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 33/182 (18%), Positives = 66/182 (36%), Gaps = 7/182 (3%)
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL 205
+ + + Q+ L + L+ + + I +N+ L++++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHA 78
Query: 206 SGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
+ + L NL L + G + L LT+LT L + + + SI +I +
Sbjct: 79 TNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 266 GILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
+ +D+S N I L L +L L+I + + I L L + +
Sbjct: 137 KVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
Query: 326 SG 327
G
Sbjct: 194 GG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 32/158 (20%), Positives = 66/158 (41%), Gaps = 7/158 (4%)
Query: 216 LKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMN 275
K + +G + T ++ +LTY+ L + ++ + I I + ++
Sbjct: 22 FKAYLNGLLGQSST---ANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNI 76
Query: 276 NIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGK 335
+ P+ LS L L I ++ ++GL SL LD+S++ I +I
Sbjct: 77 HATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 336 CSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLN 373
++ +I L N I P L +L+ L++ + ++
Sbjct: 135 LPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 24/138 (17%), Positives = 54/138 (39%), Gaps = 5/138 (3%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
++ L++ + + + + LS L L ++T P L L +L +L+
Sbjct: 61 GIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
+ + + +I + + L K+ ++ LS NG I + L L L++ + + +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--R 175
Query: 212 ELGKLKNLVALNVGGNKL 229
+ L L +
Sbjct: 176 GIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 26/160 (16%), Positives = 60/160 (37%), Gaps = 13/160 (8%)
Query: 238 FRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSIS 297
+ + + M + + ++ N+ +E + L+I+
Sbjct: 17 IPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIEY--AHNIKDLTIN 74
Query: 298 SNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI 357
+ + P I+GL +L+ L + ++ P + + L + + ++ SI +I
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 358 -GLMKLEYLDLSHNKLNGTIPPF-----LYHRFPLDLSYN 391
L K+ +DLS+N I P L L++ ++
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMPLKTLPELKS---LNIQFD 169
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 498 TEDFDI-KYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI 555
+ + + + +G G + V L + A+K + + + E +L +
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQC 67
Query: 556 A-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLF-------CFLRNDYEAVVLDWTMRVNII 607
HRN+++L F + +L+++ M+ GS+ F N+ EA ++
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF--NELEA--------SVVV 117
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTI- 663
+ VA+AL +LH+ I HRD+ NIL + + DF + + I
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 664 ------VAGTYGYIAPELAYTMVVT-----EKCDVYSFGVV 693
G+ Y+APE+ ++CD++S GV+
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-22
Identities = 66/219 (30%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAE---TEETTFFNSFQNEAHVLSK 554
EDF+I IG G +G V +L KV A+K L++ E ET F E VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR---EERDVLVN 130
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
+ I L+ ++L+ Y G L L + + + R + + V A+
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVI-AI 188
Query: 615 SYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTARLLDSDSSNRTIVA-GTYG 669
+H VHRDI +NIL++ +L ADFG+ L D + ++ VA GT
Sbjct: 189 DSVHQL---HYVHRDIKPDNILMDMNGHIRL----ADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 670 YIAPELAYTMVVTEK-----CDVYSFGVVALEVLMGRHP 703
YI+PE+ M + CD +S GV E+L G P
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-22
Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 52/225 (23%)
Query: 495 IKATEDFDIKYC----IGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEA 549
IK D +G G G V + + ALK L + E
Sbjct: 54 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREV 105
Query: 550 HVLSKIA-HRNIVKLYGFC----LHKKCMFLIYKYMKRGSLF---------CFLRNDYEA 595
+ + + +IV++ +KC+ ++ + + G LF F + EA
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREA 163
Query: 596 VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTAR 652
I+K + A+ YLH +I HRD+ N+L SK + DFG A+
Sbjct: 164 S--------EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 653 LLDSDSSNRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVV 693
S +S T T Y+APE+ Y + CD++S GV+
Sbjct: 213 ETTSHNSLTTPC-YTPYYVAPEVLGPEKY----DKSCDMWSLGVI 252
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-22
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAET---EETTFFNSFQNEAHVLSK 554
ED+++ IG G +G V + KV A+K L + E ++ FF E +++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW---EERDIMAF 125
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND---------YEA-VVLDWTMRV 604
+V+L+ + ++++ +YM G L + N Y A VVL
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL------ 179
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIV 664
AL +H +HRD+ +N+LL+ +ADFGT ++ + R
Sbjct: 180 --------ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 665 A-GTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
A GT YI+PE+ +CD +S GV E+L+G P
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 44/282 (15%), Positives = 97/282 (34%), Gaps = 30/282 (10%)
Query: 503 IKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
I K Q ++ + + ++ + + + +N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCM 622
K +++ + ++ +L ++ + + ++I +A A+ +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 623 PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS------------NRTIVAGTYGY 670
++HRD+ +NI V DFG +D D T GT Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730
++PE + + K D++S G++ E+L + S ++ ++ DV + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL---YSF-------STQMERVRIITDVRNLKFP 292
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFLT 771
+ Q+ ++V L P RP + +
Sbjct: 293 LLFTQKYPQEHMMVQ----DMLSPSPTERPEATDIIENAIFE 330
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 43/239 (17%), Positives = 91/239 (38%), Gaps = 15/239 (6%)
Query: 120 LSKLRYLDFSFNNLTGSIPPELG-----SLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174
+ YL+ +T I E +L++L + ++K + + ++
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIP 234
LS + ++ L+ N + + Q LK L L + N L
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FF 393
Query: 235 STLFRLTNLTYLYLHSNHLN----GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQ 290
N++ L LN + IL +++S N + G++ L +
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PK 451
Query: 291 LLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNN 348
+ L + +N + IP + L +L+ L++++N+L +P + + + L+ I L +N
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 49/336 (14%), Positives = 113/336 (33%), Gaps = 36/336 (10%)
Query: 87 ELSQFNFSCFPGLE----SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELG 142
+ Q + L L L ++ ++ + L F+ +
Sbjct: 157 KFRQLDLLPVAHLHLSCILLDLVSYHI-KGGETESLQIPNTTVLHLVFHPNSLFSVQVNM 215
Query: 143 SLRNLEVLNLKGNNLNGA----IPSSLCQLTKLITM-ALSRNGLHGPIPSAIGDLNNLLI 197
S+ L L L LN + + L +LT+ T+ ++ + ++
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275
Query: 198 -----LSLDSNKLSGMLHQELG-----KLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLY 247
L++ + ++ + +E LK+L+ +V + + +
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 248 LHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI 307
L + + + ++ + N ++ + L +L L + N L
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 308 TIAGLISLKGLDLSNNKLSG-PIPPEIGKCSELRNIT---LRNNNLSGSIPPEIGLMKLE 363
++ L+ + L+ C+ +I L +N L+GS+ + K++
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL-PPKVK 453
Query: 364 YLDLSHNKLNGTIP------PFLYHRFPLDLSYNDL 393
LDL +N++ +IP L L+++ N L
Sbjct: 454 VLDLHNNRIM-SIPKDVTHLQALQE---LNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 52/312 (16%), Positives = 103/312 (33%), Gaps = 45/312 (14%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPP-ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTK 170
+P + + L S N+++ + ++ L L VL L N + ++ +
Sbjct: 45 HVPK--DLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFL--- 97
Query: 171 LITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230
+L L + N+L + + +L L++ N
Sbjct: 98 --------------------FNQDLEYLDVSHNRLQNI---SCCPMASLRHLDLSFNDFD 134
Query: 231 G-PIPSTLFRLTNLTYLYLHSNHL-NGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRL 288
P+ LT LT+L L + + P + +D+ +I+G L
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194
Query: 289 SQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSG-------PIPPEIGKCSELRN 341
L + + S + +L L LSN KL+ E+ + L N
Sbjct: 195 -NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLN 253
Query: 342 ITLRNNNLSGSIPPEIG----LMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEI 397
+TL++ + ++ +EYL++ + + I + L +E
Sbjct: 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313
Query: 398 PDYFRDSPFKVY 409
F S +Y
Sbjct: 314 NQVFLFSKEALY 325
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 8e-16
Identities = 47/244 (19%), Positives = 85/244 (34%), Gaps = 28/244 (11%)
Query: 82 KKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPEL 141
+++ E ++ + L ++ S + +++ S ++
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 142 GSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLD 201
S + LN N ++ L +L T+ L RNGL N+ L
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETL 408
Query: 202 SNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI 261
L+ + T ++ L L SN L GS+ +
Sbjct: 409 DVSLNSLNS--------------------HAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 262 GNMTGILKV-DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI-TIAGLISLKGLD 319
+KV D+ N I +IP ++T L L L+++SN L +P L SL+ +
Sbjct: 449 ---PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIW 503
Query: 320 LSNN 323
L +N
Sbjct: 504 LHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 55/343 (16%), Positives = 108/343 (31%), Gaps = 53/343 (15%)
Query: 99 LESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKGNN 156
++LSL N + + LS+LR L S N + S+ + ++LE L++ N
Sbjct: 54 TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 157 LNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNKLSGMLHQELGK 215
L I + L + LS N P+ G+L L L L + K + +
Sbjct: 112 L-QNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 216 LK-NLVALNVGGNKLMGPIPSTLFRLT----------------------------NLTYL 246
L + + L++ + G +L L+ +
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 247 YLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIP-----LELTRLSQLLYLSISSNML 301
L+ + + G +++++ +IE T + + YL+I + +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 302 SGQIPITIAG-----LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNL-SGSIPP 355
+ +I L SL + N +E+ L ++ +
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 356 EIGLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLE 394
+L+ + N L L N L+
Sbjct: 349 PPSPSSFTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 51/282 (18%), Positives = 92/282 (32%), Gaps = 38/282 (13%)
Query: 95 CFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLK 153
C + + + IPS L F L I +LE + +
Sbjct: 7 CHCSNRVFLCQESKV-TEIPS--DLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEIS 62
Query: 154 GNNLNGAIPSS-LCQLTKLITMALSR-NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
N++ I + L KL + + + N L P A +L NL L + + + +
Sbjct: 63 QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 122
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFR--LTNLTYLYLHSNHLNGSIPPEIGNMTGILK 269
V L++ N + I F L+L+ N + I N T + +
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE 181
Query: 270 VDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPI 329
+++S NN L + +++ G LD+S ++ +
Sbjct: 182 LNLSDNN----------NLE-----ELPNDVFH--------GASGPVILDISRTRIH-SL 217
Query: 330 PPEI-GKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHN 370
P +LR NL +P L+ L L++
Sbjct: 218 PSYGLENLKKLR--ARSTYNLK-KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 44/225 (19%), Positives = 87/225 (38%), Gaps = 16/225 (7%)
Query: 162 PSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVA 221
+C + + + IPS + N + L KL + +L
Sbjct: 3 HHRICHCSNR-VFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 222 LNVGGNKLMGPIPSTLFR-LTNLTYLYL-HSNHLNGSIPPEI-GNMTGILKVDMSMNNIE 278
+ + N ++ I + +F L L + + +N+L I PE N+ + + +S I+
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK 117
Query: 279 GTIP-LELTRLSQLLYLSISSNMLSGQIPI-TIAGL-ISLKGLDLSNNKLSGPIPPEIGK 335
+P + Q + L I N+ I + GL L L+ N + I
Sbjct: 118 -HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFN 175
Query: 336 CSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPP 378
++L + L +NN +P ++ G LD+S +++ ++P
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS 219
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 56/279 (20%), Positives = 104/279 (37%), Gaps = 45/279 (16%)
Query: 60 HCKLDGVTCNTAR----------SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYL 109
HC C ++ + IE+ KL+ + + FS F LE + + N +
Sbjct: 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDV 66
Query: 110 FGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPS-SLC 166
I + V L KL + N I PE +L NL+ L + + +P
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
Query: 167 QLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGG 226
+ + + + +N+ I +++ N G+ V L +
Sbjct: 126 HSLQKVLLDIQ---------------DNINIHTIERNSFVGLSF-------ESVILWLNK 163
Query: 227 NKLMGPIPSTLFRLTNLTYLYL-HSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLE 284
N + I ++ F T L L L +N+L +P ++ +G + +D+S I
Sbjct: 164 NGIQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYG 221
Query: 285 LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
L L +L S + ++P T+ L++L L+
Sbjct: 222 LENLKKLRARSTYNL---KKLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 34/177 (19%), Positives = 53/177 (29%), Gaps = 39/177 (22%)
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292
IPS L N L L I + L
Sbjct: 24 IPSDLP--RNAIELRFVLTKLR-VIQKG-----------------------AFSGFGDLE 57
Query: 293 YLSISSNMLSGQIPI-TIAGLISLKGLDLSN-NKLSGPIPPEI-GKCSELRNITLRNNNL 349
+ IS N + I + L L + + N L I PE L+ + + N +
Sbjct: 58 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGI 116
Query: 350 SGSIPPE--IGLMKLEYLDLSHNKLNGTIPPFLYHRFP-----LDLSYNDLEGEIPD 399
+P I ++ LD+ N TI + L L+ N ++ EI +
Sbjct: 117 K-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHN 171
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DF+I IG G + V ++ G+V A+K +++ + + + F+ E VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 558 RNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
R I +L+ F + ++L+ +Y G L L E + + R + + V A+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVM-AIDS 177
Query: 617 LHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTARLLDSDSSNRTIVA-GTYGYI 671
+H VHRDI +NILL+ +L ADFG+ L +D + R++VA GT Y+
Sbjct: 178 VHRL---GYVHRDIKPDNILLDRCGHIRL----ADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 672 APELAYTMVVTEK-------CDVYSFGVVALEVLMGRHP 703
+PE+ + CD ++ GV A E+ G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 30/260 (11%), Positives = 66/260 (25%), Gaps = 50/260 (19%)
Query: 506 CIGTGGYGSVYKA---QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK 562
G ++A L + VAL + + LS+I + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCM 622
+ + ++ ++++ GSL + ++ +A A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 623 PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVT 682
+ + + V+ G L +
Sbjct: 149 -GVALSIDHPSRVR--------VSIDGDVVL------------AYPATMPD-------AN 180
Query: 683 EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKI-MLIDVLDSRLSPPVDRMVMQDI 741
+ D+ G +L+ R P L + + P + +DI
Sbjct: 181 PQDDIRGIGASLYALLVNRWP------LPEAGVRSGLAPAERDTAGQPIEP--ADIDRDI 232
Query: 742 -VLVTTVALACLHSKPKFRP 760
++ VA + R
Sbjct: 233 PFQISAVAARSVQGDGGIRS 252
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 52/223 (23%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 495 IKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLS 553
+ ++ F +G G Y +VYK G VALK++ + ++EE T + + E ++
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIR-EISLMK 58
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYM----KRGSLFCFLRNDYEAVVLDWTMRVNIIKC 609
++ H NIV+LY + + L++++M K+ + + +N++K
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKK------YMDSRTVGNTPRGLELNLVKY 112
Query: 610 VA----NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT--I 663
L++ H + I+HRD+ N+L+N + + + DFG AR + + +
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 664 VAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
V T Y AP++ Y+ + D++S G + E++ G+
Sbjct: 170 V--TLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 498 TEDFDI-KYCIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI 555
T+D+ + K +G G G V + G+ ALK L+ + + E +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQA 78
Query: 556 A-HRNIVKLYGFC----LHKKCMFLIYKYMKRGSLF---------CFLRNDYEAVVLDWT 601
+ +IV + K+C+ +I + M+ G LF F + EA
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF--TEREAA----- 131
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDS 658
I++ + A+ +LH +I HRD+ N+L SK + + DFG A+ ++
Sbjct: 132 ---EIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 659 SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVV 693
+T T Y+APE+ + CD++S GV+
Sbjct: 186 L-QTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E + +G G YG VYKA+ G++VALK++ R + E+ ++ E +L ++ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHHP 79
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA----NAL 614
NIV L ++C+ L++++M++ L L ++ + IK +
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE------NKTGLQDSQIKIYLYQLLRGV 132
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT--IVAGTYGYIA 672
++ H I+HRD+ N+L+NS +ADFG AR + T +V T Y A
Sbjct: 133 AHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRA 187
Query: 673 PEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
P++ Y+ V D++S G + E++ G+
Sbjct: 188 PDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-20
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E + IG G YG VYKAQ G+ ALKK+ R E E+ ++ E +L ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA----NAL 614
NIVKLY KK + L+++++ + L L + + K N +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV------CEGGLESVTAKSFLLQLLNGI 113
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
+Y H ++HRD+ N+L+N + E +ADFG AR T T Y AP+
Sbjct: 114 AYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 675 L-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
+ Y+ + D++S G + E++ G
Sbjct: 171 VLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 50/217 (23%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ ++ IG G YG+V+KA+ ++VALK++ R + ++ +S E +L ++ H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA----NA 613
+NIV+L+ K + L++++ + L + + + + I+K
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS------CNGDLDPEIVKSFLFQLLKG 113
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT--IVAGTYGYI 671
L + H ++HRD+ N+L+N E +A+FG AR + +V T Y
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYR 168
Query: 672 APEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
P++ Y+ + D++S G + E+ P
Sbjct: 169 PPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 35/235 (14%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLN 151
SC S+ L +IPS + + LD N L+ S+P + L L +L
Sbjct: 12 CSCNNNKNSVDCSSKKL-TAIPS--NIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLY 67
Query: 152 LKGNNLNGAIPSSLC-QLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLDSNKLSGML 209
L N L +P+ + +L L T+ ++ N L +P + D L NL L LD N+L +
Sbjct: 68 LNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLP 125
Query: 210 HQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNGSIPPEIGNMTGIL 268
+ L L L++G N+L +P +F +LT+L L L++N L +P
Sbjct: 126 PRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGA------- 176
Query: 269 KVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
+L++L L + +N L L LK L L N
Sbjct: 177 ----------------FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 218 NLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMN 275
+ L++ NKL +PS F RLT L LYL+ N L ++P I + + + ++ N
Sbjct: 38 DTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 276 NIEGTIPLEL-TRLSQLLYLSISSNMLSGQIPITI-AGLISLKGLDLSNNKLSGPIPPEI 333
++ +P+ + +L L L + N L +P + L L L L N+L +P +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGV 152
Query: 334 -GKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKL 372
K + L+ + L NN L +P L +L+ L L +N+L
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQL 193
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-20
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
F +G GG+G V Q+ GK+ A KKL + ++ NE +L K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 558 RNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
R +V L + K + L+ M G L + + +A + + L
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY-AAEICCGLED 301
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL- 675
LH + IV+RD+ NILL+ ++D G A + + + V GT GY+APE+
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVV 357
Query: 676 ---AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
YT D ++ G + E++ G+ P
Sbjct: 358 KNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G YG V K + G++VA+KK ++ ++ + + E +L ++ H N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625
C KK +L+++++ ++ L + LD+ + + + N + + H +I
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH---NI 145
Query: 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-----AYTMV 680
+HRDI NIL++ + DFG AR L + T Y APEL Y
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 681 VTEKCDVYSFGVVALEVLMGR 701
V DV++ G + E+ MG
Sbjct: 206 V----DVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
E + +G G Y +VYK + +VALK++ R E EE + + E +L + H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKH 59
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC----VANA 613
NIV L+ +K + L+++Y+ + L +L + + ++ +K +
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD------CGNIINMHNVKLFLFQLLRG 112
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT--IVAGTYGYI 671
L+Y H ++HRD+ N+L+N + E +ADFG AR + +V T Y
Sbjct: 113 LAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYR 167
Query: 672 APEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
P++ Y+ + D++ G + E+ GR
Sbjct: 168 PPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
E ++ IG G YG V+K + G++VA+KK +E + + + E +L ++ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKH 61
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+V L K+ + L+++Y ++ L D + + +I A+++
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-- 675
H + +HRD+ NIL+ + DFG ARLL S T Y +PEL
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 676 ---AYTMVVTEKCDVYSFGVVALEVLMGR 701
Y V DV++ G V E+L G
Sbjct: 176 GDTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 503 IKYCIGTGGYGSVYKAQ---LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
+G G YG VYKA+ + K ALK++ + E +L ++ H N
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CREIALLRELKHPN 79
Query: 560 IVKLYGFCLHK--KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN--IIKCVA---- 611
++ L L + ++L++ Y + L+ ++ + +++ ++K +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAF----VADFGTARLLDSDSSNRTIVAG- 666
+ + YLH + ++HRD+ NIL+ + +AD G ARL +S +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 667 --TYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRH--PG--ELLSSLSSPSS 715
T+ Y APEL YT + D+++ G + E+L E + + +
Sbjct: 196 VVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 716 DQ--KIM 720
DQ +I
Sbjct: 252 DQLDRIF 258
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
++ IG G +G V+KA+ G+ VALKK+ E E+ F + E +L + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKH 75
Query: 558 RNIVKLYG--------FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC 609
N+V L + K ++L++ + + L L N + ++ IK
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN------VLVKFTLSEIKR 128
Query: 610 VA----NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT--- 662
V N L Y+H + I+HRD+ + N+L+ +ADFG AR +++
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 663 ---IVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
+V T Y PEL Y + D++ G + E+
Sbjct: 186 TNRVV--TLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 40/221 (18%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ FD +GTG +G V + +G A+K L + + + NE +L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEAVVLDWTMRVNII 607
+VKL ++++ +Y+ G +F LR Y A
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA------------ 148
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT-IVAG 666
+ YLH +++RD+ N+L++ + V DFG A+ + RT + G
Sbjct: 149 -QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCG 200
Query: 667 TYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T +APE+ Y V D ++ GV+ E+ G P
Sbjct: 201 TPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 36/205 (17%), Positives = 83/205 (40%), Gaps = 14/205 (6%)
Query: 187 SAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYL 246
L N + +L ++ + +L + N + + + + TNL L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKEL 68
Query: 247 YLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIP 306
+L N ++ + P + ++T + ++ ++ N ++ + L L + +N L
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSA---CLSRLFLDNNELRD--T 121
Query: 307 ITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLD 366
++ L +L+ L + NNKL I +G S+L + L N ++ + L K+ ++D
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWID 178
Query: 367 LSHNKLNGTIPPFLYHRFPLDLSYN 391
L+ K + + + +
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 42/236 (17%), Positives = 83/236 (35%), Gaps = 17/236 (7%)
Query: 115 SQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174
L+ + ++T + L ++ N +N+ + + T L +
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKEL 68
Query: 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIP 234
LS N + S + DL L LS++ N+L + L L + N+L
Sbjct: 69 HLSHNQISD--LSPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNEL--RDT 121
Query: 235 STLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYL 294
+L L NL L + +N L SI +G ++ + +D+ N I T L RL ++ ++
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWI 177
Query: 295 SISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350
++ + L + + + P I + +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY--YISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 38/162 (23%), Positives = 68/162 (41%), Gaps = 13/162 (8%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
+ G+++ + + + + + + L+ L S N ++ + P L L LE L+
Sbjct: 36 SQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELS 91
Query: 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ 211
+ N L L++L L N L ++ L NL ILS+ +NKL +
Sbjct: 92 VNRNRLKNLNGIPSACLSRLF---LDNNELRD--TDSLIHLKNLEILSIRNNKLKSI--V 144
Query: 212 ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253
LG L L L++ GN++ L RL + ++ L
Sbjct: 145 MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKC 184
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 27/218 (12%)
Query: 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALK-----KLHRAETEETTFFNSFQNEAHVLS 553
+ +G+G +G V+ A K V +K K+ E E +LS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGS-LFCFLRNDY--EAVVLDWTMRVNIIKCV 610
++ H NI+K+ ++ L+ + G LF + LD + I + +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLF-----AFIDRHPRLDEPLASYIFRQL 139
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
+A+ YL I+HRDI NI++ + DFG+A L+ T GT Y
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-GTIEY 195
Query: 671 IAPEL----AYTMVVTEKCDVYSFGVVALEVLM-GRHP 703
APE+ Y + +++S GV L L+ +P
Sbjct: 196 CAPEVLMGNPYR---GPELEMWSLGVT-LYTLVFEENP 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ + +G G YG VYKA + VA+K++ R E EE + E +L ++ H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC----VANA 613
RNI++L H + LI++Y + L ++ + + + + +IK + N
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD-------VSMRVIKSFLYQLING 144
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAF-----VADFGTARLLDSDSSNRT--IVAG 666
+++ H +HRD+ N+LL+ + + DFG AR T I+
Sbjct: 145 VNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-- 199
Query: 667 TYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
T Y PE+ Y+ V D++S + E+LM
Sbjct: 200 TLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 493 DIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKL---HRAETEETTFFNSFQNE 548
D+ + ++ +G G + +VYKA+ ++VA+KK+ HR+E ++ + + E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-E 62
Query: 549 AHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIK 608
+L +++H NI+ L HK + L++ +M+ L +++ + + IK
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD------NSLVLTPSHIK 115
Query: 609 C----VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT-- 662
L YLH I+HRD+ NN+LL+ +ADFG A+ S + T
Sbjct: 116 AYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172
Query: 663 IVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
+V T Y APEL Y + V D+++ G + E+L+
Sbjct: 173 VV--TRWYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 72/248 (29%), Positives = 118/248 (47%), Gaps = 51/248 (20%)
Query: 502 DIKYC----IGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQN-EAHVLSKI 555
++ Y IG G +G VY+A+L +G++VA+KK+ + F+N E ++ K+
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKL 104
Query: 556 AHRNIVKLYGF------CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC 609
H NIV+L F + + L+ Y+ +++ R+ A T+ V +K
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA---KQTLPVIYVKL 160
Query: 610 ----VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF-VADFGTARLLDSDSSNRTIV 664
+ +L+Y+H I HRDI N+LL+ + DFG+A+ L N + +
Sbjct: 161 YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 665 AGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRH--PGELLSSLSSPSSDQ 717
Y Y APEL YT + DV+S G V E+L+G+ PG+ S + DQ
Sbjct: 218 CSRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGD--SGV-----DQ 265
Query: 718 KIMLIDVL 725
+ +I VL
Sbjct: 266 LVEIIKVL 273
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKL------HRAETEETTFFNSFQNEAHV 551
+ F +G GG+G V+ Q+ GK+ A KKL R + E +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA------MVEKKI 238
Query: 552 LSKIAHRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRNDYE-AVVLDWTMRVNIIKC 609
L+K+ R IV L + K + L+ M G + + N E +
Sbjct: 239 LAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYG 669
+ + L +LH +I++RD+ N+LL+ ++D G A L + + AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 670 YIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
++APEL Y V D ++ GV E++ R P
Sbjct: 355 FMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-18
Identities = 57/230 (24%), Positives = 88/230 (38%), Gaps = 53/230 (23%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRA-----ETEETTFFNSFQNEAHVL 552
DF + IG GG+G VY + GK+ A+K L + + E NE +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-----LNERIML 243
Query: 553 SKIA---HRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRND----------YEAVVL 598
S ++ IV + + H + I M G L L Y A
Sbjct: 244 SLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA--- 299
Query: 599 DWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658
+ L ++H+ +V+RD+ NILL+ ++D G A
Sbjct: 300 ----------EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346
Query: 659 SNRTIVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ V GT+GY+APE+ AY D +S G + ++L G P
Sbjct: 347 PH-ASV-GTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G +G V + G VA+K L+R + + E L H +I+KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
F++ +Y+ G LF ++ + EA L I+ +A+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ----QIL----SAVDYCHRH 130
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL----A 676
+VHRD+ N+LL++ + A +ADFG + ++ RT G+ Y APE+
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRL 186
Query: 677 YTMVVTEKCDVYSFGVVALEVLM-GRHP 703
Y + D++S GV+ L L+ G P
Sbjct: 187 YA---GPEVDIWSCGVI-LYALLCGTLP 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG G + V A+ + G+ VA+K + + + T+ F+ E ++ + H NIVKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
+K ++LI +Y G +F +L + EA I+ +A+ Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR----QIV----SAVQYCHQK 133
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL----A 676
IVHRD+ + N+LL++ + +ADFG + G Y APEL
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-GAPPYAAPELFQGKK 189
Query: 677 YTMVVTEKCDVYSFGVVALEVLM-GRHP 703
Y + DV+S GV+ L L+ G P
Sbjct: 190 YD---GPEVDVWSLGVI-LYTLVSGSLP 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 53/227 (23%), Positives = 85/227 (37%), Gaps = 48/227 (21%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKL------HRAETEETTFFNSFQNEAHV 551
+F+ +G G +G V + G+ A+K L + E T E V
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT------LTENRV 201
Query: 552 LSKIAHRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRND----------YEAVVLDW 600
L H + L + + + +Y G LF L + Y A
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA----- 255
Query: 601 TMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN 660
+ +AL YLH + ++V+RD+ N++L+ + DFG + D +
Sbjct: 256 --------EIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305
Query: 661 RTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
GT Y+APE+ Y V D + GVV E++ GR P
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLH-RAETEETTFFNS--------FQNEAHVLSKIA 556
IG G YG+VYKA+ +G VALK + + L
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR----LEAFE 72
Query: 557 HRNIVKLYGFCLHKKC-----MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
H N+V+L C + + L+++++ + L +L + IK +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-----GLPAETIKDLM 126
Query: 612 ----NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS--SNRTIVA 665
L +LH +C IVHRD+ NIL+ S +ADFG AR+ + +
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-- 181
Query: 666 GTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGR 701
T Y APE+ Y V D++S G + E+ +
Sbjct: 182 -TLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 56/250 (22%)
Query: 502 DIKYC----IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+I Y IG G +G V++A+L VA+KK+ + E ++ + H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKN------RELQIMRIVKH 91
Query: 558 RNIVKLYGF------CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC-- 609
N+V L F + + L+ +Y+ +++ R+ + TM + +IK
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL---KQTMPMLLIKLYM 147
Query: 610 --VANALSYLHHDCMPSIVHRDISSNNILLNS-----KLEAFVADFGTARLLDSDSSNRT 662
+ +L+Y+H I HRDI N+LL+ KL DFG+A++L + N +
Sbjct: 148 YQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL----IDFGSAKILIAGEPNVS 200
Query: 663 IVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR--HPGELLSSLSSPSS 715
+ Y Y APEL YT + D++S G V E++ G+ PGE S +
Sbjct: 201 YICSRY-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQPLFPGE--SGI----- 248
Query: 716 DQKIMLIDVL 725
DQ + +I VL
Sbjct: 249 DQLVEIIKVL 258
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 46/275 (16%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN---EAHVLSKIAHR--NI 560
+G+GG+GSVY + + VA+K + + + + E +L K++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 561 VKLYGFCLHKKCMFLIYKYMK-RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
++L + LI + + LF F+ E L + + V A+ + H+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHN 167
Query: 620 DCMPSIVHRDISSNNILLNS-KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL--- 675
++HRDI NIL++ + E + DFG+ LL D+ GT Y PE
Sbjct: 168 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD-GTRVYSPPEWIRY 222
Query: 676 -AYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDV-LDSRLSPP 732
Y V+S G++ L ++ G P E D++I+ V R+S
Sbjct: 223 HRYH---GRSAAVWSLGIL-LYDMVCGDIPFE---------HDEEIIRGQVFFRQRVSSE 269
Query: 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
++ CL +P RPT + +
Sbjct: 270 CQHLIRW-----------CLALRPSDRPTFEEIQN 293
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 38/226 (16%), Positives = 78/226 (34%), Gaps = 16/226 (7%)
Query: 162 PSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVA 221
S C+ + ++ + IPS + L L L + L N+
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQR-IPSL---PPSTQTLKLIETHLRTIPSHAFSNLPNISR 59
Query: 222 LNVGGNKLMGPIPSTLFR-LTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEG 279
+ V + + + S F L+ +T++ + + I P+ + + + + ++
Sbjct: 60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK- 118
Query: 280 TIP--LELTRLSQLLYLSISSNMLSGQIPI-TIAGLIS-LKGLDLSNNKLSGPIPPEIGK 335
P ++ L I+ N IP+ GL + L L NN + +
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFN 177
Query: 336 CSELRNITLRNNNLSGSIPPEI--GLM-KLEYLDLSHNKLNGTIPP 378
++L + L N I + G+ LD+S + +P
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 37/208 (17%), Positives = 74/208 (35%), Gaps = 12/208 (5%)
Query: 97 PGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKG 154
P ++L L +L +IPS L + + S + + +L + + ++
Sbjct: 31 PSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 155 NNLNGAIPSSLCQ-LTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNKLSGMLHQE 212
I + L L + + GL P + + + IL + N +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 213 L--GKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI--GNMTGIL 268
G + L + N + F T L +YL+ N I + G +G
Sbjct: 150 AFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 269 KVDMSMNNIEGTIPLE-LTRLSQLLYLS 295
+D+S ++ +P + L L +L+ +
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 36/198 (18%), Positives = 70/198 (35%), Gaps = 12/198 (6%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSF 130
S + L E L+ + FS P + + + + + S LSK+ +++
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 131 NNLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIP--SSLCQLTKLITMALSRNGLHGPIPS 187
I P+ L L L+ L + L P + + + ++ N IP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 188 -AIGDLNNLLI-LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR--LTNL 243
A L N + L L +N + + L A+ + NK + I F +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 244 TYLYLHSNHLNGSIPPEI 261
+ L + + ++P +
Sbjct: 208 SLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 29/167 (17%), Positives = 54/167 (32%), Gaps = 12/167 (7%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPE--LGSLRNLEV 149
F + + +R I L L++L L P + S +
Sbjct: 76 FYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFI 134
Query: 150 LNLKGNNLNGAIPS-SLCQLTK-LITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG 207
L + N +IP + L +T+ L NG + + L + L+ NK
Sbjct: 135 LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLT 193
Query: 208 MLHQEL--GKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252
++ ++ G L+V + +PS +L L +
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLE--HLKELIARNTW 237
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 54/228 (23%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRA------ETEETTFFNSFQNEAHV 551
+DF I +GTG +G V+ + NG+ A+K L + + E T +E +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT------NDERLM 59
Query: 552 LSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEA-VVLDW 600
LS + H I++++G + +F+I Y++ G LF LR Y A V L
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-- 117
Query: 601 TMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN 660
AL YLH I++RD+ NILL+ + DFG A+ + +
Sbjct: 118 ------------ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----D 158
Query: 661 RTI-VAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T + GT YIAPE+ Y + D +SFG++ E+L G P
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 58/289 (20%)
Query: 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN---EAHVLSKI 555
++ + +G GG+G+V+ L + VA+K + R + + E +L K+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 556 ----AHRNIVKLYGFCLHKKCMFLIYKYMKRGS-LFCFLR-----NDYEAVVLDWTMRVN 605
H +++L + ++ L+ + LF ++ + + R
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-------R-C 143
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTARLLDSDSSNRTIV 664
V A+ + H +VHRDI NIL++ + A + DFG+ LL D
Sbjct: 144 FFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFD 199
Query: 665 AGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKI 719
GT Y PE Y V+S G++ L ++ G P E DQ+I
Sbjct: 200 -GTRVYSPPEWISRHQYH---ALPATVWSLGIL-LYDMVCGDIPFE---------RDQEI 245
Query: 720 MLIDV-LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+ ++ + +SP ++ + CL KP RP+++ +
Sbjct: 246 LEAELHFPAHVSPDCCALIRR-----------CLAPKPSSRPSLEEILL 283
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 37/226 (16%)
Query: 496 KATEDFDIKYCIGTGGYGSVYKAQ--LPNGKVVALKKLHRAETEETTFFNSFQNEAHVL- 552
+A + ++ IG G YG V+KA+ G+ VALK++ R +T E S E VL
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLR 66
Query: 553 --SKIAHRNIVKLY-----GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
H N+V+L+ + + L+++++ + L +L +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK-VPEPGVP----TE 120
Query: 606 IIKCVA----NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS--S 659
IK + L +LH +VHRD+ NIL+ S + +ADFG AR+ +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 660 NRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGR 701
+ + T Y APE+ +Y V D++S G + E+ +
Sbjct: 178 SVVV---TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 49/260 (18%)
Query: 490 AFEDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNE 548
A E K + F ++ G G +G+V + G VA+KK+ ++ F N
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI----QDPRFRNRELQI 69
Query: 549 AHVLSKIAHRNIVKLYGFCLHKK-------CMFLIYKYMKRGSLFCFLRNDYEAVVLDWT 601
L+ + H NIV+L + + ++ +Y+ +L RN Y
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR---QVA 125
Query: 602 MRVNIIKC----VANALSYLHHDCMPSIVHRDISSNNILLNS-----KLEAFVADFGTAR 652
+IK + ++ LH + ++ HRDI +N+L+N KL DFG+A+
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKL----CDFGSAK 180
Query: 653 LLDSDSSNRTIVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRH--PGE 705
L N + Y Y APEL YT V D++S G + E+++G G+
Sbjct: 181 KLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGEPIFRGD 235
Query: 706 LLSSLSSPSSDQKIMLIDVL 725
+S Q ++ VL
Sbjct: 236 --NSA-----GQLHEIVRVL 248
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G +G V + G VA+K L+R + + E L H +I+KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDY----------EAVVLDWTMRVNIIKCVANALS 615
+F++ +Y+ G LF DY E+ L I+ + +
Sbjct: 84 VISTPSDIFMVMEYVSGGELF-----DYICKNGRLDEKESRRLFQ----QIL----SGVD 130
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
Y H +VHRD+ N+LL++ + A +ADFG + ++ RT G+ Y APE+
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAPEV 186
Query: 676 ----AYTMVVTEKCDVYSFGVVALEVLM-GRHP 703
Y + D++S GV+ L L+ G P
Sbjct: 187 ISGRLYA---GPEVDIWSSGVI-LYALLCGTLP 215
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.0 bits (199), Expect = 5e-16
Identities = 47/260 (18%), Positives = 85/260 (32%), Gaps = 19/260 (7%)
Query: 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLC----QLTKLITMAL 176
S + D +L +P + + K L P C +L L
Sbjct: 297 SHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL 356
Query: 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPST 236
S + S + L L ++ + + L L+ ST
Sbjct: 357 SVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF-----ST 410
Query: 237 LFRLTNL--TYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYL 294
L + + YL + + + ++ ++ + L +L + +L
Sbjct: 411 LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHL 468
Query: 295 SISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG--S 352
+S N L +P +A L L+ L S+N L + L+ + L NN L +
Sbjct: 469 DLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAA 525
Query: 353 IPPEIGLMKLEYLDLSHNKL 372
I P + +L L+L N L
Sbjct: 526 IQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 4e-14
Identities = 51/319 (15%), Positives = 102/319 (31%), Gaps = 21/319 (6%)
Query: 29 DDICVAAFELEREALVNSSW-WSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGE 87
++ C++ + + ++D N + +LP L +
Sbjct: 253 EEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQ 312
Query: 88 LSQFNFSC---FPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSL 144
L Q F + + +L + S T + EL S
Sbjct: 313 LPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESC 371
Query: 145 RNLEVLNLKGNNL---NGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLD 201
+ L+ L + + +L L + L P L++L L
Sbjct: 372 KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 202 SNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI 261
N + M + ++ L ++ L + L +L +T+L L N L ++PP +
Sbjct: 432 ENSVLKMEYADVRVL------HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPAL 482
Query: 262 GNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG-QIPITIAGLISLKGLDL 320
+ + + S N +E + + L +L L + +N L + L L+L
Sbjct: 483 AALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540
Query: 321 SNNKLSGPIPPEIGKCSEL 339
N L + +E+
Sbjct: 541 QGNSLCQ-EEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 38/179 (21%), Positives = 66/179 (36%), Gaps = 10/179 (5%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
R++ + ++ L+ S L + + +R L +
Sbjct: 393 RALDPLLYEKETLQ-YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451
Query: 132 NLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD 191
+LT + L L + L+L N L A+P +L L L + S N L + + +
Sbjct: 452 DLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VAN 506
Query: 192 LNNLLILSLDSNKLSGMLH-QELGKLKNLVALNVGGN---KLMGPIPSTLFRLTNLTYL 246
L L L L +N+L Q L LV LN+ GN + G L +++ +
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 57/328 (17%), Positives = 105/328 (32%), Gaps = 21/328 (6%)
Query: 79 LPEKKLKGELS--QFNFSCFPGLESLSLRFNYLFGSIPSQ-------VGALSKLRYLDFS 129
LPE L EL Q F P +S +L G V + FS
Sbjct: 203 LPENVLLKELELVQNAFFTDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFS 262
Query: 130 FNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAI 189
GS L + + L+++ +G S L L +L+
Sbjct: 263 RPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIW 322
Query: 190 GDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLH 249
++ L ++ ++ + L + K + S L L L
Sbjct: 323 TGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPE 380
Query: 250 SNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITI 309
+ +I I M + + ++ L+ + YL + + +
Sbjct: 381 NKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLK 437
Query: 310 AGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLS 368
++ L L++ L+ + + + + ++ L +N L ++PP + L LE L S
Sbjct: 438 MEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS 494
Query: 369 HNKLNGTIPPF--LYHRFPLDLSYNDLE 394
N L + L L L N L+
Sbjct: 495 DNALE-NVDGVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 25/105 (23%), Positives = 43/105 (40%), Gaps = 11/105 (10%)
Query: 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG 135
++L +L+ L + LE L N L ++ V L +L+ L N L
Sbjct: 467 HLDLSHNRLR-ALPP-ALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ 522
Query: 136 -SIPPELGSLRNLEVLNLKGNNL------NGAIPSSLCQLTKLIT 173
+ L S L +LNL+GN+L + L ++ ++T
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 38/214 (17%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G YG V A + VA+K + + + + E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYG 72
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN--------IIKCVANALSYL 617
+L +Y G LF D + D M ++ + YL
Sbjct: 73 HRREGNIQYLFLEYCSGGELF-----DR--IEPDIGMPEPDAQRFFHQLM----AGVVYL 121
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR---TIVAGTYGYIAPE 674
H I HRDI N+LL+ + ++DFG A + ++ R + GT Y+APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 675 L----AYTMVVTEKCDVYSFGVVALEVLM-GRHP 703
L + E DV+S G+V L ++ G P
Sbjct: 178 LLKRREFH---AEPVDVWSCGIV-LTAMLAGELP 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G +G V A + VALK + R +++ + E L + H +I+KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLR-----NDYEAVVLDWTMRVNIIKCVANALSYLHHD 620
+ ++ +Y G LF ++ + E II A+ Y H
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQ----QII----CAIEYCHRH 127
Query: 621 CMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL----A 676
IVHRD+ N+LL+ L +ADFG + ++ + +T G+ Y APE+
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKL 183
Query: 677 YTMVVTEKCDVYSFGVVALEVLM-GRHP 703
Y + DV+S G+V L V++ GR P
Sbjct: 184 YA---GPEVDVWSCGIV-LYVMLVGRLP 207
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 14/173 (8%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPE--LGSLRNLEVLNLKGNNLNGAIPS-SLCQL 168
++P S LD S NNL+ + E L NL L L N+LN I S + +
Sbjct: 32 NVPQ--SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 169 TKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNK 228
L + LS N LH DL L +L L +N + + + L L + N+
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 229 LMGPIPSTLF----RLTNLTYLYLHSNHLNGSIPPE-IGNMTGILKVDMSMNN 276
+ P L +L L L L SN L +P + + +K + ++N
Sbjct: 148 ISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 20/163 (12%)
Query: 256 SIPPEIGNMTGILKVDMSMNNIEGTIPLE--LTRLSQLLYLSISSNMLSGQIPI-TIAGL 312
++P + + T +L D+S NN+ + E TRL+ L L +S N L+ I +
Sbjct: 32 NVPQSLPSYTALL--DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 313 ISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSH 369
+L+ LDLS+N L + + L + L NN++ + + +L+ L LS
Sbjct: 88 PNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 370 NKLNGTIPPFLYHRFP-------LDLSYNDLEGEIPDYFRDSP 405
N+++ P L LDLS N L+ + P
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP 187
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 53/228 (23%), Positives = 79/228 (34%), Gaps = 62/228 (27%)
Query: 129 SFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPS--SLCQLTKLITMALSRNGLHGPIP 186
S L ++P L S +L+L NNL + + + +LT L ++ LS N L+
Sbjct: 26 SKQQLP-NVPQSLPS--YTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISS 81
Query: 187 SAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR-LTNLTY 245
A + NL L L SN L + LF L L
Sbjct: 82 EAFVPVPNLRYLDLSSNHLHT-------------------------LDEFLFSDLQALEV 116
Query: 246 LYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI 305
L L++NH+ + ++QL L +S N +S +
Sbjct: 117 LLLYNNHIV-VVDRNA-----------------------FEDMAQLQKLYLSQNQIS-RF 151
Query: 306 P----ITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLR-NNN 348
P L L LDLS+NKL ++ K L +NN
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 51/228 (22%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVA---LKK---LHRAETEETTFFNSFQNEAHV 551
DFD +G G +G V + G+ A L+K + + E T E+ V
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT------VTESRV 58
Query: 552 LSKIAHRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRND----------YEAVVLDW 600
L H + L + + + +Y G LF L + Y A
Sbjct: 59 LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----- 112
Query: 601 TMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL-LDSDSS 659
+ +AL YLH +V+RDI N++L+ + DFG + + ++
Sbjct: 113 --------EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161
Query: 660 NRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+T GT Y+APE+ Y V D + GVV E++ GR P
Sbjct: 162 MKTFC-GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 61/234 (26%)
Query: 499 EDFDIKYCIGTGGYGSVY----KAQLPNGKVVALKKLHRA-----ETEETTFFNSFQNEA 549
F++ +G G +G V+ + ++ A+K L +A + T E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK------MER 77
Query: 550 HVLSKIAHRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEAVVL 598
+L ++ H IVKL Y F K ++LI +++ G LF L + Y A
Sbjct: 78 DILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA--- 133
Query: 599 DWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTARL- 653
+A AL +LH I++RD+ NILL+ KL DFG ++
Sbjct: 134 ----------ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKL----TDFGLSKES 176
Query: 654 LDSDSSNRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+D + + GT Y+APE+ +T D +SFGV+ E+L G P
Sbjct: 177 IDHEKKAYSFC-GTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 38/214 (17%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
+G G YG V A + VA+K + + + + E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYG 72
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN--------IIKCVANALSYL 617
+L +Y G LF D + D M ++ + YL
Sbjct: 73 HRREGNIQYLFLEYCSGGELF-----DR--IEPDIGMPEPDAQRFFHQLM----AGVVYL 121
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR---TIVAGTYGYIAPE 674
H I HRDI N+LL+ + ++DFG A + ++ R + GT Y+APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 675 L----AYTMVVTEKCDVYSFGVVALEVLM-GRHP 703
L + E DV+S G+V L ++ G P
Sbjct: 178 LLKRREFH---AEPVDVWSCGIV-LTAMLAGELP 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 47/224 (20%), Positives = 75/224 (33%), Gaps = 71/224 (31%)
Query: 495 IKATEDFDIKY----CIGTGGYGSVYKA-QLPNGKVVALKKLHRAETEETTFFNSFQNEA 549
IK D +G G G V + + ALK L + E
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREV 61
Query: 550 HVLSKIA-HRNIVKLYGFC----LHKKCMFLIYKYMKRGSLF---------CFLRNDYEA 595
+ + + +IV++ +KC+ ++ + + G LF F + EA
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREA 119
Query: 596 VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTAR 652
I+K + A+ YLH +I HRD+ N+L SK + DFG
Sbjct: 120 S--------EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG--- 165
Query: 653 LLDSDSSNRTIVAGTYGYIAPEL---AYTMVVTEKCDVYSFGVV 693
A E Y + CD++S GV+
Sbjct: 166 ------------------FAKETTGEKY----DKSCDMWSLGVI 187
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 50/236 (21%), Positives = 84/236 (35%), Gaps = 57/236 (24%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQN---------E 548
+ ++ I +G YG+V G VA+K++ + N + E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNT-VSDGRTVNILSDSFLCKRVLRE 79
Query: 549 AHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIK 608
+L+ H NI+ L +H + + Y+ + +R D +I
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL----VTELMRTDLA----------QVIH 125
Query: 609 CVANALS----------------YLHHDCMPS--IVHRDISSNNILLNSKLEAFVADFGT 650
+S LH +VHRD+ NILL + + DF
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLH-----EAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 651 ARLLDSDSSNRTIVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
AR +D++ V Y APEL +T +V D++S G V E+ +
Sbjct: 181 AREDTADANKTHYVT-HRWYRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 47/231 (20%), Positives = 86/231 (37%), Gaps = 46/231 (19%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN------------------ 547
IG G YG V A + A+K L + + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 548 -----EAHVLSKIAHRNIVKLYG--FCLHKKCMFLIYKYMKRGSLFCFLRND----YEAV 596
E +L K+ H N+VKL ++ ++++++ + +G + +A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 597 VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656
+ + + YLH+ I+HRDI +N+L+ +ADFG +
Sbjct: 141 --------FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 657 DSSNRTIVAGTYGYIAPEL---AYTMVVTEKCDVYSFGVVALEVLM-GRHP 703
+ + GT ++APE + + DV++ GV L + G+ P
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT-LYCFVFGQCP 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 78.0 bits (191), Expect = 7e-15
Identities = 80/572 (13%), Positives = 161/572 (28%), Gaps = 167/572 (29%)
Query: 245 YLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQ 304
Y +L S P + I + D N+ + ++RL L L L
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QALLEL 147
Query: 305 IP---ITIAGLI-----SLKGLDLSNNKLSGPIPPEI-----GKCSELRNITLRNNNLSG 351
P + I G++ + + K+ + +I C+ + L
Sbjct: 148 RPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 352 SIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPDYFRDSPFK---- 407
I P + S H + L + ++ E+ + P++
Sbjct: 208 QIDPN-------WTSRSD------------HSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 408 ----VYGNQGICYFS-ACSTLHTP--------------------------TASKSKSLVL 436
V + F+ +C L T T + KSL+L
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 437 RVLNII---LPITACVIF-LTLAFIVFLLNKNEIAKLMTGPTKSGDVFSIWNYDGRIAFE 492
+ L+ LP L+ I + ++ +A + W +
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESI-RDGLAT-----------WDNWKHVNCDKLT 356
Query: 493 DIIKAT----EDFDIKYCIGTGGYGSVYK--AQLPNGKVVALKKLHR-----AETEETTF 541
II+++ E + + + + P + L +++
Sbjct: 357 TIIESSLNVLEPAEYRKM---------FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV 407
Query: 542 FNSFQNEAHVLSKIAHRNIVKLYG------------FCLHKKCMFLIYKYMKRGSLFCFL 589
N + ++ K + + + + LH+ ++ Y F
Sbjct: 408 VNKLHKYS-LVEKQPKESTISIPSIYLELKVKLENEYALHRS---IVDHYNIPK---TFD 460
Query: 590 RNDYEAVVLD--WTMRVNIIKCVANALSYL-HHDCMPSIVHRDISS--NNILLNSK-LEA 643
+D LD + S++ HH + +I H + + + L+ + LE
Sbjct: 461 SDDLIPPYLDQYF-------------YSHIGHH--LKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 644 FVADFGTARLLDSDSSNRTIVAGTY-GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRH 702
+ TA N Y YI + Y V A+ + +
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYI----------CDNDPKYERLVNAILDFLPKI 555
Query: 703 PGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734
E L + S + D+L L +
Sbjct: 556 -EENL--ICSKYT-------DLLRIALMAEDE 577
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 1e-05
Identities = 91/578 (15%), Positives = 166/578 (28%), Gaps = 195/578 (33%)
Query: 10 VFVIGATLLVGASYFGATTDDICVAAFELEREALVNSSWWSNLIDSNSSDHC-------- 61
V + G ++G G T + V + + +W NL + NS +
Sbjct: 153 VLIDG---VLG---SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL 206
Query: 62 -KLDGVTCNTARSIIEINLPEKKLKGELSQ-------------------------FNFSC 95
++D + + I L ++ EL + FN SC
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266
Query: 96 FPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGN 155
L L+ RF + + A + LD LT P E+ SL L+ L+ +
Sbjct: 267 -KIL--LTTRFKQVTDFL---SAATTTHISLDHHSMTLT---PDEVKSLL-LKYLDCRPQ 316
Query: 156 NLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGK 215
+L P + N LS+ ++ + L
Sbjct: 317 DL----PREVLTT-------------------------NPRRLSI----IAESIRDGLAT 343
Query: 216 LKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMN 275
N + +++ + L I + S+N
Sbjct: 344 WDN--------------------------WKHVNCDKLTTII-------------ESSLN 364
Query: 276 NIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGK 335
+E P E + ++ +S + I L + + +
Sbjct: 365 VLE---PAEY----RKMFDRLS--VFPPSAHIPTILLSLIWF------DVIKSDVMVV-- 407
Query: 336 CSELRNITL---RNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYND 392
++L +L + + SIP + YL+L N L HR +D YN
Sbjct: 408 VNKLHKYSLVEKQPKESTISIP---SI----YLELKVKLEN---EYAL-HRSIVD-HYNI 455
Query: 393 LEGEIPDYFRDSPFKVYGNQGICYFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFL 452
+ D Y I + H + + L + +FL
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGH-------HLKNIEHPERMTL------FRM----VFL 498
Query: 453 TLAFIVFLLNKNEIAKLMTGPTKSGDVFS----IWNYDGRI-----AFEDIIKATEDFDI 503
F+ + +I T SG + + + Y I +E ++ A DF
Sbjct: 499 DFRFL-----EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP 553
Query: 504 KYCIGTGGYGSVYK--AQL----PNGKVV--ALKKLHR 533
K S Y ++ + + A K++ R
Sbjct: 554 KI--EENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 63/236 (26%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGK----VVALKKL-------HRAETEETTFFNSFQN 547
E F++ +G GGYG V++ + G + A+K L + +T T +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT------KA 70
Query: 548 EAHVLSKIAHRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEAV 596
E ++L ++ H IV L Y F K ++LI +Y+ G LF L + Y A
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLA- 128
Query: 597 VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTAR 652
++ AL +LH I++RD+ NI+LN KL DFG +
Sbjct: 129 ------------EISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKL----TDFGLCK 169
Query: 653 L-LDSDSSNRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + T GT Y+APE+ + V D +S G + ++L G P
Sbjct: 170 ESIHDGTVTHTFC-GTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 49/279 (17%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH------ 550
+ + IG+G G V A + VA+KKL R FQN+ H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP----------FQNQTHAKRAYR 73
Query: 551 ---VLSKIAHRNIVKLYG-FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV---LDWTMR 603
++ + H+NI+ L F K Y+ + + + V+ LD
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI----VMELMDANLCQVIQMELDHERM 129
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663
++ + + +LH I+HRD+ +NI++ S + DFG AR +
Sbjct: 130 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRH--PGELLSSLSSPSSDQKIML 721
V T Y APE+ M E D++S G + E++ G PG + DQ +
Sbjct: 187 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-------TDHIDQWNKV 238
Query: 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRP 760
I+ L +P + + + + ++PK+
Sbjct: 239 IEQLG---TPCPE-----FMKKLQPTVRTYVENRPKYAG 269
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 69/239 (28%), Positives = 99/239 (41%), Gaps = 65/239 (27%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKL------HRAETEETTFFNSFQNE 548
E+F++ +GTG YG V+ + GK+ A+K L +A+T E T + E
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-----RTE 108
Query: 549 AHVLSKIAHRN-IVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEA- 595
VL I +V L Y F K + LI Y+ G LF L Y
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 596 VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTA 651
+VL AL +LH I++RDI NILL+S L DFG +
Sbjct: 168 IVL--------------ALEHLHKL---GIIYRDIKLENILLDSNGHVVL----TDFGLS 206
Query: 652 RLLDSDSSNRTI-VAGTYGYIAPEL------AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ +D + R GT Y+AP++ + V D +S GV+ E+L G P
Sbjct: 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG+G +G + ++VA+K + R + + Q E + H NIV+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRN-----DYEAVVLDWTMRVNIIKCVANALSYLHHD 620
L + +I +Y G L+ + N + EA R + + + +SY H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA-------R-FFFQQLLSGVSYCHSM 135
Query: 621 CMPSIVHRDISSNNILLNSKLEAF--VADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT 678
I HRD+ N LL+ + DFG ++ S ++ V GT YIAPE
Sbjct: 136 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE---- 187
Query: 679 MVVTEK------CDVYSFGVVALEVLM-GRHP 703
V+ + DV+S GV L V++ G +P
Sbjct: 188 -VLLRQEYDGKIADVWSCGVT-LYVMLVGAYP 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 32/218 (14%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH------ 550
+ + IG+G G V A + VA+KKL R FQN+ H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP----------FQNQTHAKRAYR 110
Query: 551 ---VLSKIAHRNIVKLYG-FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV---LDWTMR 603
++ + H+NI+ L F K Y+ + + + V+ LD
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL----VMELMDANLCQVIQMELDHERM 166
Query: 604 VNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663
++ + + +LH I+HRD+ +NI++ S + DFG AR +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGR 701
V T Y APE+ M E D++S G + E++ +
Sbjct: 224 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 52/321 (16%), Positives = 99/321 (30%), Gaps = 47/321 (14%)
Query: 99 LESLSLRFNYL-FGSIPSQVGALSKLRYLDFSFNNLT----GSIPPELGSLRNLEVLNLK 153
++SL ++ L + L + + + LT I L L LNL+
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 154 GNNLNGAIPSSLCQL-----TKLITMALSRNGLH----GPIPSAIGDLNNLLILSLDSNK 204
N L + Q K+ ++L L G + S + L L L L N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 205 LSG-----MLHQELGKLKNLVALNVGGNKL----MGPIPSTLFRLTNLTYLYLHSNHLNG 255
L + L L L + L P+ S L + L + +N +N
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 256 SIPPEIG-----NMTGILKVDMSMNNI--EGTIPL--ELTRLSQLLYLSISSNMLSGQ-- 304
+ + + + + + + + L + + L L++ SN L
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 305 ---IPITIAGLISLKGLDLSNNKLSGP----IPPEIGKCSELRNITLRNNNLSGSIPPEI 357
P + L+ L + ++ + + L+ ++L N L +
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 358 GLM------KLEYLDLSHNKL 372
+LE L +
Sbjct: 305 CETLLEPGCQLESLWVKSCSF 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 62/330 (18%), Positives = 111/330 (33%), Gaps = 57/330 (17%)
Query: 97 PGLESLSLRFNYLFGSIPSQVGALS--------KLRYLDFSFNNLT----GSIPPELGSL 144
P L L+LR N L V + K++ L LT G + L +L
Sbjct: 56 PALAELNLRSNEL---GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 112
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQL-----TKLITMALSRNGLH----GPIPSAIGDLNNL 195
L+ L+L N L A LC+ +L + L L P+ S + +
Sbjct: 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF 172
Query: 196 LILSLDSNKLSGMLHQELGK-LK----NLVALNVGGNKL----MGPIPSTLFRLTNLTYL 246
L++ +N ++ + L + LK L AL + + + + +L L
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232
Query: 247 YLHSNHLNGSIPPEIGNM-----TGILKVDMSMNNI--EGTIPL--ELTRLSQLLYLSIS 297
L SN L E+ + + + + I +G L L L LS++
Sbjct: 233 ALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292
Query: 298 SNMLSGQIPITIAGLI-----SLKGLDLSNNKLSG----PIPPEIGKCSELRNITLRNNN 348
N L + + + L+ L + + + + + L + + NN
Sbjct: 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 352
Query: 349 LSGSIPPEIGLM------KLEYLDLSHNKL 372
L + E+ L L L+ +
Sbjct: 353 LEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 54/304 (17%), Positives = 106/304 (34%), Gaps = 59/304 (19%)
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQ-LTKLITMALSRNGLH----GPIPSAIGDLNNLLILS 199
+++ L+++ L+ A + L L + + L GL I SA+ L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 200 LDSNKLSGMLHQELGK-LKN----LVALNVGGNKL----MGPIPSTLFRLTNLTYLYLHS 250
L SN+L + + + L+ + L++ L G + STL L L L+L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 251 NHLNGSIPPEIGNM-----TGILKVDMSMNNI--EGTIPL--ELTRLSQLLYLSISSNML 301
N L + + + K+ + ++ PL L L++S+N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 302 SGQIPITIAGLI-----SLKGLDLSNNKLS----GPIPPEIGKCSELRNITLRNNNLSGS 352
+ + + L+ L L + ++ + + + LR + L +N L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 353 IPPEIGLM------KLEYLDLSHNKL--------------NGTIPPFLYHRFPLDLSYND 392
E+ +L L + + + L L L+ N+
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES----LKE---LSLAGNE 295
Query: 393 LEGE 396
L E
Sbjct: 296 LGDE 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 58/308 (18%), Positives = 103/308 (33%), Gaps = 45/308 (14%)
Query: 88 LSQFNFSCFPGLESLSLRFNYL----FGSIPSQVGALSKLRYLDFSFNNLTGSIPPELG- 142
L + LE L L + L + S + A + L S N++ + L
Sbjct: 133 LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQ 192
Query: 143 ----SLRNLEVLNLKGNNLN----GAIPSSLCQLTKLITMALSRNGLHGP----IPSAIG 190
S LE L L+ + + + L +AL N L + +
Sbjct: 193 GLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLL 252
Query: 191 DLN-NLLILSLDSNKLS----GMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRL----- 240
+ L L + ++ G L + L ++L L++ GN+L L
Sbjct: 253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 241 TNLTYLYLHSNHLNG----SIPPEIGNMTGILKVDMSMNNI--EGTIPLE---LTRLSQL 291
L L++ S + +L++ +S N + G L S L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 292 LYLSISSNMLSGQIPITIAGLI----SLKGLDLSNNKLSGPIPPEIGK-----CSELRNI 342
L ++ +S ++A + SL+ LDLSNN L ++ + L +
Sbjct: 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQL 432
Query: 343 TLRNNNLS 350
L + S
Sbjct: 433 VLYDIYWS 440
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 59/280 (21%), Positives = 99/280 (35%), Gaps = 83/280 (29%)
Query: 502 DIKYC----IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN-EAHVLSKI 555
KY +GTG +G V + + +GK ALKK+ + ++N E ++ +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVL 57
Query: 556 AHRNIVKLYGF--CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN-------- 605
H NI+KL + + L
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 606 ---------IIKCVAN-------------------ALSYLHHDCMPSIVHRDISSNNILL 637
++K A+ ++H I HRDI N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 638 NS-----KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL-----AYTMVVTEKCDV 687
NS KL DFG+A+ L + + + Y APEL YT + D+
Sbjct: 175 NSKDNTLKL----CDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DL 225
Query: 688 YSFGVVALEVLMGRH--PGELLSSLSSPSSDQKIMLIDVL 725
+S G V E+++G+ GE +S+ DQ + +I ++
Sbjct: 226 WSIGCVFGELILGKPLFSGE--TSI-----DQLVRIIQIM 258
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 6e-14
Identities = 27/234 (11%), Positives = 60/234 (25%), Gaps = 42/234 (17%)
Query: 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNG----KVVALKKLHRAETEETTFFNS 544
+ F + TE IG G +G V++ + K++A++ F
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 545 FQNEAHVLSKIA---------HRNIVKLYGFCLHK----KCMFLIYKYM--KRGSLFCFL 589
E + +++ + L + + + + +GS
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 590 R--------------------NDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRD 629
+ +I+ + +L+ HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRD 187
Query: 630 ISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTE 683
+ N+LL + + S + Y E +V +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD 241
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 48/146 (32%), Positives = 69/146 (47%), Gaps = 15/146 (10%)
Query: 119 ALSKLRYLDFSFNNLTGSIPPELG---SLRNLEVLNLKGNNLNGAIPSSLCQ-LTKLITM 174
L +RYL N L ++ L NL L L GN L ++P+ + LT L +
Sbjct: 61 YLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKEL 114
Query: 175 ALSRNGLHGPIPSAIGD-LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPI 233
L N L +P + D L NL L+L N+L + KL NL L++ N+L +
Sbjct: 115 VLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-L 172
Query: 234 PSTLF-RLTNLTYLYLHSNHLNGSIP 258
P +F +LT L L L+ N L S+P
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLK-SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 17/170 (10%)
Query: 95 CFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154
F +L+ + +Q L+ + + + +++ S+ + L N+ L L G
Sbjct: 17 AFAETIKANLKKKSV-TDAVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGG 72
Query: 155 NNLNGAIPSSLC---QLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLDSNKLSGMLH 210
N L + +LT L + L+ N L +P+ + D L NL L L N+L +
Sbjct: 73 NKL-----HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPD 126
Query: 211 QELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNGSIPP 259
KL NL LN+ N+L +P +F +LTNLT L L N L S+P
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPE 174
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 99 LESLSLRFNYLFGSIPSQVGA---LSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKG 154
+ L+L N L + A L+ L YL + N L S+P + L NL+ L L
Sbjct: 65 VRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVE 118
Query: 155 NNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLDSNKLSGMLHQEL 213
N L +LT L + L+ N L +P + D L NL L L N+L +
Sbjct: 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGVF 177
Query: 214 GKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSN 251
KL L L + N+L +P +F RLT+L Y++LH N
Sbjct: 178 DKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 47/212 (22%)
Query: 198 LSLDSNKLSGMLHQELGKLKNLVALNVGGNKL--MGPIPSTLFRLTNLTYLYLHSNHLNG 255
+L ++ + Q +L ++ + + + + I L N+ YL L N L+
Sbjct: 24 ANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH- 76
Query: 256 SIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITI-AGLIS 314
I L L+ L YL ++ N L +P + L +
Sbjct: 77 DISA-------------------------LKELTNLTYLILTGNQLQ-SLPNGVFDKLTN 110
Query: 315 LKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNK 371
LK L L N+L +P + K + L + L +N L S+P + L L LDLS+N+
Sbjct: 111 LKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQ 168
Query: 372 LNGTIPPFLYHRFP----LDLSYNDLEGEIPD 399
L ++P ++ + L L N L+ +PD
Sbjct: 169 LQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPD 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAE-TEETTFFNSFQNEAHVLSKIAHRNIVKLY 564
+G G YG V + A+K L + + + + E +L ++ H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 565 GFCLH--KKCMFLIYKYMKRGS--LFCFLRN----DYEAVVLDWTMRVNIIKCVANALSY 616
+ K+ M+++ +Y G + + +A +I + L Y
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC----QLI----DGLEY 124
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI--VAGTYGYIAPE 674
LH IVH+DI N+LL + ++ G A L +++ T G+ + PE
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 675 LAYTMVVTE--KCDVYSFGVVALEVLM-GRHP 703
+A + K D++S GV L + G +P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVT-LYNITTGLYP 212
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 8/156 (5%)
Query: 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKGNNLN 158
E L L+ L + L+KL +L+ +N L ++ + L L L L N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 159 GAIPSSL-CQLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLDSNKLSGMLHQELGKL 216
++P + LT+L + L N L +PS + D L L L L++N+L + KL
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154
Query: 217 KNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSN 251
NL L++ N+L +P F RL L + L N
Sbjct: 155 TNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 53/189 (28%), Positives = 76/189 (40%), Gaps = 28/189 (14%)
Query: 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNL 195
S+P G + E L+L+ L ++ LTKL + L N L DL L
Sbjct: 28 SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 196 LILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLN 254
L L +N+L+ + L L L +GGN+L +PS +F RLT L L L++N L
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ 144
Query: 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314
SIP +L+ L LS+S+N L L
Sbjct: 145 -SIPAGA-----------------------FDKLTNLQTLSLSTNQLQSVPHGAFDRLGK 180
Query: 315 LKGLDLSNN 323
L+ + L N
Sbjct: 181 LQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 47/174 (27%), Positives = 68/174 (39%), Gaps = 28/174 (16%)
Query: 176 LSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPS 235
L GL + L L L+LD N+L + L L L + N+L +P
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-LPL 100
Query: 236 TLF-RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYL 294
+F LT L LYL N L S+P + RL++L L
Sbjct: 101 GVFDHLTQLDKLYLGGNQLK-SLPSGV-----------------------FDRLTKLKEL 136
Query: 295 SISSNMLSGQIPITI-AGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNN 347
+++N L IP L +L+ L LS N+L + +L+ ITL N
Sbjct: 137 RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 11/113 (9%)
Query: 294 LSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGS 352
L + S L+ T GL L L+L N+L + + +EL + L NN L+ S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA-S 97
Query: 353 IPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPD 399
+P + L +L+ L L N+L ++P ++ R L L+ N L+ IP
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 31/142 (21%), Positives = 56/142 (39%), Gaps = 6/142 (4%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPSSLC-QLT 169
IP+ + + N + IPP + L ++L N ++ + L
Sbjct: 25 EIPT--NLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 170 KLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL 229
L ++ L N + S L +L +L L++NK++ + L NL L++ NKL
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 230 MGPIPSTLFRLTNLTYLYLHSN 251
T L + ++L N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 28/165 (16%)
Query: 160 AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNL 219
IP++L + + L +N + P A L + L +N++S + L++L
Sbjct: 25 EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 220 VALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278
+L + GNK+ +P +LF L +L L L++N +N + +
Sbjct: 83 NSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDA----------------- 123
Query: 279 GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323
L L LS+ N L T + L +++ + L+ N
Sbjct: 124 ------FQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 26/153 (16%), Positives = 53/153 (34%), Gaps = 30/153 (19%)
Query: 198 LSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNGS 256
+ L+ N + + K L +++ N++ + F L +L L L+ N +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI-TIAGLISL 315
+P + L L L +++N ++ + + L +L
Sbjct: 95 LPKSL-----------------------FEGLFSLQLLLLNANKIN-CLRVDAFQDLHNL 130
Query: 316 KGLDLSNNKLSGPIPPEI-GKCSELRNITLRNN 347
L L +NKL I ++ + L N
Sbjct: 131 NLLSLYDNKLQT-IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 26/119 (21%), Positives = 42/119 (35%), Gaps = 4/119 (3%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPEL-GSL 144
+ FS + L + L N + + L L L N +T +P L L
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGL 103
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSN 203
+L++L L N +N + L L ++L N L L + + L N
Sbjct: 104 FSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 28/120 (23%), Positives = 51/120 (42%), Gaps = 16/120 (13%)
Query: 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSEL 339
+P +T + + N + P + L+ +DLSNN++S + P+ L
Sbjct: 30 LPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSL 82
Query: 340 RNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDL 393
++ L N ++ +P + GL L+ L L+ NK+N + + L L N L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 41/253 (16%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA- 556
+DFD+ IG G Y V +L ++ A+K + + + + Q E HV + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 557 HRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRND----------YEAVVLDWTMRVN 605
H +V L+ C + +F + +Y+ G L ++ Y A
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA---------- 117
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL-LDSDSSNRTIV 664
++ AL+YLH I++RD+ +N+LL+S+ + D+G + L + T
Sbjct: 118 ---EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 171
Query: 665 AGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP-GELLSSLSSPSSDQKI 719
GT YIAPE+ Y V D ++ GV+ E++ GR P + SS + + +
Sbjct: 172 -GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226
Query: 720 MLIDVLDSRLSPP 732
+ +L+ ++ P
Sbjct: 227 LFQVILEKQIRIP 239
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 48/248 (19%), Positives = 100/248 (40%), Gaps = 46/248 (18%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA--------- 556
+G G + +V+ A+ + N VA+K + + + + ++E +L ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 557 --HRNIVKLYGFCLHKKC----MFLIYKYMKRGSLFCFL-RNDYEAVVLDWTMRVNIIKC 609
+I+KL HK + ++++ + +L + + ++ + L + + I K
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQ 139
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF------VADFGTARLLDSDSSNRTI 663
+ L Y+H C I+H DI N+L+ +AD G A D +N +I
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN-SI 196
Query: 664 VAGTYGYIAPE----LAYTMVVTEKCDVYSFGVVALEVLMGRH--PGELLSSLSSPSSDQ 717
T Y +PE + D++S + E++ G + S + D
Sbjct: 197 Q--TREYRSPEVLLGAPWGC----GADIWSTACLIFELITGDFLFEPDEGHSYTK-DDDH 249
Query: 718 KIMLIDVL 725
+I++L
Sbjct: 250 IAQIIELL 257
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 48/243 (19%), Positives = 95/243 (39%), Gaps = 69/243 (28%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN--------- 547
+ +G GG G V+ A K VA+KK+ +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------------VLTDPQSVKHALR 57
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAV--VLDWTMRV- 604
E ++ ++ H NIVK++ ++ + + + +V V ++ M
Sbjct: 58 EIKIIRRLDHDNIVKVFE---------ILGPSGSQLTDDVGSLTELNSVYIVQEY-METD 107
Query: 605 --NIIKC--------------VANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVAD 647
N+++ + L Y+H +++HRD+ N+ +N++ L + D
Sbjct: 108 LANVLEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164
Query: 648 FGTARLLDSDSSNRTI----VAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVL 698
FG AR++D S++ + T Y +P L YT + D+++ G + E+L
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEML 219
Query: 699 MGR 701
G+
Sbjct: 220 TGK 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH------ 550
+ + +G+G YGSV A +G+ VA+KKL R FQ+E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP----------FQSEIFAKRAYR 72
Query: 551 ---VLSKIAHRNIVKLYGFCLHKKCM------FLIYKYMKRGSLFCFLRNDYEAVVLDWT 601
+L + H N++ L + +L+ +M+ L+ +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEK 127
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
++ ++ + L Y+H +VHRD+ N+ +N E + DFG AR D++ +
Sbjct: 128 IQY-LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183
Query: 662 TIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGR 701
V T Y APE+ + M + D++S G + E+L G+
Sbjct: 184 --VV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 62/257 (24%), Positives = 111/257 (43%), Gaps = 49/257 (19%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA- 556
+DFD+ IG G Y V +L ++ A++ + + + + Q E HV + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 557 HRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRND----------YEAVVLDWTMRVN 605
H +V L+ C + +F + +Y+ G L ++ Y A
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA---------- 160
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTARL-LDSDSSN 660
++ AL+YLH I++RD+ +N+LL+S KL D+G + L +
Sbjct: 161 ---EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL----TDYGMCKEGLRPGDTT 210
Query: 661 RTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP-GELLSSLSSPSS 715
T GT YIAPE+ Y V D ++ GV+ E++ GR P + SS + +
Sbjct: 211 STFC-GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
Query: 716 DQKIMLIDVLDSRLSPP 732
+ + +L+ ++ P
Sbjct: 266 TEDYLFQVILEKQIRIP 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 65/233 (27%), Positives = 96/233 (41%), Gaps = 60/233 (25%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVA---LKK---LHRAETEETTFFNSFQNEAHV 551
DF IG G +G V A+ A L+K L + E + +E +V
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI------MSERNV 91
Query: 552 LSK-IAHRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEAVVLD 599
L K + H +V L + F K ++ + Y+ G LF L+ + Y A
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPRARFYAA---- 146
Query: 600 WTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTARL-L 654
+A+AL YLH +IV+RD+ NILL+S L DFG + +
Sbjct: 147 ---------EIASALGYLHSL---NIVYRDLKPENILLDSQGHIVL----TDFGLCKENI 190
Query: 655 DSDSSNRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ +S+ T GT Y+APE+ Y V D + G V E+L G P
Sbjct: 191 EHNSTTSTFC-GTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLH------RAETEETTFFNSFQNEAHV 551
DF+ +G G +G V ++ ++ A+K L + E T E V
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT------MVEKRV 394
Query: 552 LSKIA-HRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC 609
L+ + +L+ C ++ + +Y+ G L + + V
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAE 450
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL-LDSDSSNRTIVAGTY 668
+A L +L I++RD+ +N++L+S+ +ADFG + + + +T GT
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-CGTP 506
Query: 669 GYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
YIAPE+ Y V D ++FGV+ E+L G+ P
Sbjct: 507 DYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVA---LKK---LHRAETEETTFFNSFQNEAHV 551
EDF + +G G +G V+ A+ + A LKK L + E T E V
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT------MVEKRV 70
Query: 552 LSKIA-HRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC 609
LS H + + F + +F + +Y+ G L ++ D +
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAE 126
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV--ADFGTARL-LDSDSSNRTIVAG 666
+ L +LH IV+RD+ +NILL+ + + ADFG + + D+ T G
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNTFC-G 180
Query: 667 TYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
T YIAPE+ Y V D +SFGV+ E+L+G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 26/132 (19%), Positives = 51/132 (38%), Gaps = 5/132 (3%)
Query: 126 LDFSFNNLTGSIPPE--LGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG 183
L + N T + L L +N N + + + + + L+ N L
Sbjct: 37 LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 184 PIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTN 242
L +L L L SN+++ + + L ++ L++ N++ + F L +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTLHS 154
Query: 243 LTYLYLHSNHLN 254
L+ L L +N N
Sbjct: 155 LSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 30/154 (19%), Positives = 57/154 (37%), Gaps = 31/154 (20%)
Query: 198 LSLDSNKLSGMLHQ-ELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNG 255
L L++N+ + + KL L +N NK+ I F + + + L SN L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLE- 94
Query: 256 SIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI-TIAGLIS 314
++ ++ L L L + SN ++ + + GL S
Sbjct: 95 NVQHKM-----------------------FKGLESLKTLMLRSNRIT-CVGNDSFIGLSS 130
Query: 315 LKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNN 347
++ L L +N+++ + P L + L N
Sbjct: 131 VRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 26/120 (21%), Positives = 45/120 (37%), Gaps = 15/120 (12%)
Query: 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSEL 339
IP L L + +G L L+ ++ SNNK++ I S +
Sbjct: 30 IPQYTAELR-LNNNEFTVLEATG----IFKKLPQLRKINFSNNKITD-IEEGAFEGASGV 83
Query: 340 RNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDL 393
I L +N L ++ ++ GL L+ L L N++ + + L L N +
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 20/89 (22%), Positives = 37/89 (41%), Gaps = 4/89 (4%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVL 150
F G+ + L N L ++ ++ L L+ L N +T + + L ++ +L
Sbjct: 77 FEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLL 134
Query: 151 NLKGNNLNGAIPSSLCQLTKLITMALSRN 179
+L N + P + L L T+ L N
Sbjct: 135 SLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 43/233 (18%), Positives = 96/233 (41%), Gaps = 37/233 (15%)
Query: 483 WNYD-GRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETT 540
W+Y+ + + + +D+ + +G G Y V++A + N + V +K L + ++
Sbjct: 23 WDYESHVVEWGN----QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI- 77
Query: 541 FFNSFQNEAHVLSKIA-HRNIVKLYGFCLH---KKCMFLIYKYMKRGSLFCFLRNDYEAV 596
+ E +L + NI+ L + + L+++++ +
Sbjct: 78 -----KREIKILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQT----- 126
Query: 597 VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTARLLD 655
+ D+ +R + + AL Y H I+HRD+ +N++++ + + + D+G A
Sbjct: 127 LTDYDIR-FYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 656 SDSSNRTIVAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
VA Y + PEL Y + D++S G + ++ + P
Sbjct: 183 PGQEYNVRVASRY-FKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 59/281 (20%), Positives = 100/281 (35%), Gaps = 93/281 (33%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH------ 550
+ DF +K +G G YG V A P G++VA+KK+ F
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-----------EPFDKPLFALRTLR 58
Query: 551 ---VLSKIAHRNIVKLYGFCL--HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
+L H NI+ ++ + +Y ++ D
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYII------QELMQTDLH----------R 102
Query: 606 IIKCVANALS----------------YLHHDCMPS--IVHRDISSNNILLNSKLEAFVAD 647
+I LS LH ++HRD+ +N+L+NS + V D
Sbjct: 103 VIS--TQMLSDDHIQYFIYQTLRAVKVLH-----GSNVIHRDLKPSNLLINSNCDLKVCD 155
Query: 648 FGTARLLDSDSSNRTIVAGTYG----------YIAPEL-----AYTMVVTEKCDVYSFGV 692
FG AR++D +++ + G Y APE+ Y+ + DV+S G
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGC 211
Query: 693 VALEVLMGRH--PGE--------LLSSLSSPSSDQKIMLID 723
+ E+ + R PG + + +P SD + I+
Sbjct: 212 ILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLH------RAETEETTFFNSFQNEAHV 551
++F+ +G G +G V A++ G + A+K L + E T E +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT------MTEKRI 76
Query: 552 LSKIA-HRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEAVVLD 599
LS H + +L F + +F + +++ G L ++ Y A
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA---- 131
Query: 600 WTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL-LDSDS 658
+ +AL +LH I++RD+ +N+LL+ + +ADFG + + +
Sbjct: 132 ---------EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
Query: 659 SNRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ T GT YIAPE+ Y V D ++ GV+ E+L G P
Sbjct: 180 TTATFC-GTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH------ 550
+ +G+G YG+V A G VA+KKL+R FQ+E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP----------FQSELFAKRAYR 73
Query: 551 ---VLSKIAHRNIVKLYGFCLHKKCM------FLIYKYMKRGSLFCFLRNDYEAVVLDWT 601
+L + H N++ L + + +L+ +M L ++++ L
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE----KLGED 128
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
++ + L Y+H I+HRD+ N+ +N E + DFG AR DS+ +
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 662 TIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGR 701
V T Y APE+ M T+ D++S G + E++ G+
Sbjct: 186 --VV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 50/229 (21%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN--------- 547
+ IG G YG V A N VA+KK+ + F++
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----------SPFEHQTYCQRTLR 74
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNII 607
E +L + H NI+ + + Y+ + + D ++ + + I
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYI----VQDLMETDLYKLLKTQHLSNDHI 130
Query: 608 KC----VANALSYLHHDCMPS--IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
+ L Y+H S ++HRD+ +N+LLN+ + + DFG AR+ D D +
Sbjct: 131 CYFLYQILRGLKYIH-----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 662 TI----VAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGR 701
VA T Y APE+ YT + D++S G + E+L R
Sbjct: 186 GFLTEYVA-TRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 60/233 (25%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVA---LKK---LHRAETEETTFFNSFQNEAHV 551
DF+ +G G +G V ++ ++ A LKK + + E T E V
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT------MVEKRV 73
Query: 552 LSKIA-HRNIVKL-YGFCLHKKCMFLIYKYMKRGSLFCFLRND----------YEAVVLD 599
L+ + +L F + ++ + +Y+ G L ++ Y A
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA---- 128
Query: 600 WTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTARL-L 654
+A L +L I++RD+ +N++L+S K+ ADFG + +
Sbjct: 129 ---------EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI----ADFGMCKENI 172
Query: 655 DSDSSNRTIVAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ +T GT YIAPE+ Y V D ++FGV+ E+L G+ P
Sbjct: 173 WDGVTTKTFC-GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 53/275 (19%), Positives = 92/275 (33%), Gaps = 97/275 (35%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN--------- 547
+++ IK+ IG G YG VY A K VA+KK++R F++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM----------FEDLIDCKRILR 74
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKC-----MFLIYKYMKRGSLFCFLRNDYEAVVLDWTM 602
E +L+++ I++LY + ++++ + D +
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA------------------DSDL 116
Query: 603 RVNIIKCVAN---------------ALSYLHHDCMPS--IVHRDISSNNILLNSKLEAFV 645
+ + K +++H I+HRD+ N LLN V
Sbjct: 117 K-KLFKTPIFLTEEHIKTILYNLLLGENFIH-----ESGIIHRDLKPANCLLNQDCSVKV 170
Query: 646 ADFGTARLLDSDSSNRTIVAGTYG----------------------YIAPEL-----AYT 678
DFG AR ++S+ + Y APEL YT
Sbjct: 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 230
Query: 679 MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP 713
+ D++S G + E+L + P
Sbjct: 231 KSI----DIWSTGCIFAELLNMLQSHINDPTNRFP 261
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 49/230 (21%), Positives = 90/230 (39%), Gaps = 51/230 (22%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQN--------- 547
+ ++I++ IGTG YG V +A +VVA+KK+ R F++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV----------FEDLIDCKRILR 101
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI- 606
E +L+++ H ++VK+ + K Y+ + +D++ + R +
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV----VLEIADSDFKKL-----FRTPVY 152
Query: 607 -----IKCVA----NALSYLHHDCMPS--IVHRDISSNNILLNSKLEAFVADFGTARLLD 655
IK + + Y+H S I+HRD+ N L+N V DFG AR +D
Sbjct: 153 LTELHIKTLLYNLLVGVKYVH-----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
Query: 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVV-----ALEVLMG 700
+ + + + L + VV A E+++
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 62/233 (26%), Positives = 92/233 (39%), Gaps = 62/233 (26%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH------ 550
E + +G+G YGSV A G VA+KKL R FQ+ H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP----------FQSIIHAKRTYR 77
Query: 551 ---VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRND-YEAVVLDWTMRV-- 604
+L + H N++ L ++ + F ND Y +V M
Sbjct: 78 ELRLLKHMKHENVIGLLD----------VFTPARSLEEF----NDVY--LVTHL-MGADL 120
Query: 605 -NIIKC--------------VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649
NI+KC + L Y+H I+HRD+ +N+ +N E + DFG
Sbjct: 121 NNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 650 TARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGR 701
AR + + VA T Y APE+ M + D++S G + E+L GR
Sbjct: 178 LARHTADEMTGY--VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 45/222 (20%), Positives = 84/222 (37%), Gaps = 27/222 (12%)
Query: 494 IIKATEDFDIKY----CIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNE 548
+ + +Y IG G +G V KA + VALK + E F E
Sbjct: 88 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEE 143
Query: 549 AHVLSKIAHR------NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWT 601
+L + + N++ + + + + ++ + +L+ ++ N ++ L
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLV 202
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF--VADFGTARLLDSDSS 659
+ + L LH I+H D+ NILL + + V DFG++
Sbjct: 203 RK--FAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257
Query: 660 NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGR 701
T + + Y APE+ D++S G + E+L G
Sbjct: 258 --TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 43/174 (24%), Positives = 63/174 (36%), Gaps = 37/174 (21%)
Query: 609 CVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTY 668
VA + +L +HRD+++ NILL+ K + DFG AR + D
Sbjct: 201 QVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGD 254
Query: 669 GYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLI 722
+ APE + V T + DV+SFGV+ E+ +G P P
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------YPGVKIDEEFC 306
Query: 723 DVLDS--RLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
L R+ P M D C H +P RPT + +
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLD----------CWHGEPSQRPTFSELVEHL 350
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 28/150 (18%), Positives = 51/150 (34%), Gaps = 20/150 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVL 552
+ + +G G +G V +A + VA+K L T + +E +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79
Query: 553 SKIA-HRNIVKLYGFCLHKKC-MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCV 610
I H N+V L G C + +I ++ K G+L +LR+ R +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----------KRNEFVPYK 129
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSK 640
+ + D+ + S
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSS 159
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 60/263 (22%), Positives = 103/263 (39%), Gaps = 83/263 (31%)
Query: 487 GRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSF 545
GR+ +++ +G G YG V+K+ G+VVA+KK+ A F
Sbjct: 1 GRVDRH----VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA----------F 46
Query: 546 QNEAH---VLSKI-------AHRNIVKLYGFCL--HKKCMFLIYKYMK-------RGSLF 586
QN +I H NIV L + + ++L++ YM+ R ++
Sbjct: 47 QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI- 105
Query: 587 CFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS--IVHRDISSNNILLNSKLEAF 644
L ++ V+ ++ + YLH S ++HRD+ +NILLN++
Sbjct: 106 --LEPVHKQYVVYQLIK---------VIKYLH-----SGGLLHRDMKPSNILLNAECHVK 149
Query: 645 VADFGTARLLDSDSSNRTIVAGTYG---------------------YIAPEL-----AYT 678
VADFG +R + + + Y APE+ YT
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 679 MVVTEKCDVYSFGVVALEVLMGR 701
+ D++S G + E+L G+
Sbjct: 210 KGI----DMWSLGCILGEILCGK 228
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 7/125 (5%)
Query: 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNN 194
S+P G L+L+ N+L +LT L + L N L +P+ + + L +
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTS 77
Query: 195 LLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHL 253
L L+L +N+L + + KL L L + N+L +P +F +LT L L L+ N L
Sbjct: 78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQL 136
Query: 254 NGSIP 258
S+P
Sbjct: 137 K-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 44/155 (28%), Positives = 62/155 (40%), Gaps = 30/155 (19%)
Query: 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKGNNLN 158
L L N L L+ L L N L S+P + L +L LNL N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN--- 86
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLDSNKLSGMLHQELGKLK 217
QL L P+ + D L L L+L++N+L + KL
Sbjct: 87 --------QLQSL--------------PNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT 124
Query: 218 NLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSN 251
L L + N+L +P +F RLT+L Y++LH N
Sbjct: 125 QLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 5/101 (4%)
Query: 160 AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNL 219
++P+ + T + L N L +L +L L L NKL + + KL +L
Sbjct: 21 SVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 220 VALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNGSIPP 259
LN+ N+L +P+ +F +LT L L L++N L S+P
Sbjct: 79 TYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQ-SLPD 117
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 11/114 (9%)
Query: 293 YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSG 351
YL + +N L L SL L L NKL +P + K + L + L N L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 352 SIPPEI--GLMKLEYLDLSHNKLNGTIPPFLYHRFP----LDLSYNDLEGEIPD 399
S+P + L +L+ L L+ N+L ++P ++ + L L N L+ +PD
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPD 141
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 57/298 (19%), Positives = 107/298 (35%), Gaps = 86/298 (28%)
Query: 499 EDFDIKYCI----GTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLS 553
+ F+ +Y + G G + +V+ + + K VA+K + ++ T + +E +L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYT---ETALDEIRLLK 88
Query: 554 KIA--------HRNIVKLYG-FCL------HKKCMFLIYKYMKRGSLFCFL-RNDYEAVV 597
+ +V+L F + H CM +++ + L ++ +++Y+ +
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHI-CM--VFEVL-GHHLLKWIIKSNYQGLP 144
Query: 598 LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN------------------- 638
L + II+ V L YLH C I+H DI NILL+
Sbjct: 145 LPCVKK--IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 639 ------------------------------SKLEAFVADFGTARLLDSDSSNRTIVAGTY 668
KL+ +AD G A + T T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTR 257
Query: 669 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKI-MLIDVL 725
Y + E+ D++S +A E+ G + E S + I ++I++L
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR- 558
++I IG G +G V KA + VA+K + + + F N Q E +L +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKK---AFLNQAQIEVRLLELMNKHD 111
Query: 559 -----NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWTMRVNIIKCVAN 612
IV L + + + L+++ + +L+ LR ++ V L+ T + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQMCT 168
Query: 613 ALSYLHHDCMPSIVHRDISSNNILL--NSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
AL +L + SI+H D+ NILL + + DFG++ L + + Y
Sbjct: 169 ALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRF-Y 224
Query: 671 IAPE----LAYTMVVTEKCDVYSFGVVALEVLMGR 701
+PE + Y + D++S G + +E+ G
Sbjct: 225 RSPEVLLGMPYDL----AIDMWSLGCILVEMHTGE 255
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 46/296 (15%), Positives = 93/296 (31%), Gaps = 59/296 (19%)
Query: 123 LRYLDFSFNNLTG----SIPPELGSLRNLEVLNLKGNNLNG----AIPSSLCQLTKLITM 174
+ + +T S+ L +++ + L GN + + ++ L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL----M 230
S G + + + +L L Q L K L + + N
Sbjct: 66 EFSDIF--------TGRVKDEIPEALRL------LLQALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 231 GPIPSTLFRLTNLTYLYLHSNHL-------------NGSIPPEIGNMTGILKVDMSMNNI 277
P+ L + T L +LYLH+N L ++ + N + + N +
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 278 --EGTIPL--ELTRLSQLLYLSISSNMLSGQ-IPITIAGLI----SLKGLDLSNNKLSGP 328
L + + N + + I + + LK LDL +N +
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
Query: 329 ----IPPEIGKCSELRNITLRNNNLS-------GSIPPEIGLMKLEYLDLSHNKLN 373
+ + LR + L + LS ++ + L+ L L +N++
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 5/92 (5%)
Query: 298 SNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPE-IGKCSELRNITLRNNNLSGSIPPE 356
+ + + G +L L + N + + + ELRN+T+ + L + P+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 357 I--GLMKLEYLDLSHNKLNGTIPPFLYHRFPL 386
+L L+LS N L ++ L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSL 105
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 19/129 (14%), Positives = 34/129 (26%), Gaps = 25/129 (19%)
Query: 126 LDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI 185
L + + L NL L ++ +
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLE----------------------- 48
Query: 186 PSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTY 245
+ L L L++ + L + L LN+ N L + + +L
Sbjct: 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQE 107
Query: 246 LYLHSNHLN 254
L L N L+
Sbjct: 108 LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 21/101 (20%), Positives = 38/101 (37%), Gaps = 4/101 (3%)
Query: 227 NKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE-IGNMTGILKVDMSMNNIEGTIPLE- 284
L NLT LY+ + + + + + + + + + + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 285 LTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKL 325
+L L++S N L T+ GL SL+ L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 19/95 (20%), Positives = 28/95 (29%), Gaps = 2/95 (2%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPE-LGSLRNLEVLNLKGNNLNGAIPSSLCQLTK 170
+ L L + L L L L + + L P + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 171 LITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL 205
L + LS N L + L +L L L N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 5e-07
Identities = 16/78 (20%), Positives = 26/78 (33%), Gaps = 2/78 (2%)
Query: 185 IPSAIGDLNNLLILSLDSNKLSGMLHQE-LGKLKNLVALNVGGNKLMGPIPSTLFRLTNL 243
+ NL L +++ + L L L L L + + L P L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 244 TYLYLHSNHLNGSIPPEI 261
+ L L N L S+ +
Sbjct: 83 SRLNLSFNALE-SLSWKT 99
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 47/155 (30%), Positives = 68/155 (43%), Gaps = 31/155 (20%)
Query: 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKGNNLN 158
+ L L N + P +L L+ L N L ++P + SL L VL+L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN--- 98
Query: 159 GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLDSNKLSGMLHQELGKLK 217
QLT L PSA+ D L +L L + NKL+ L + + +L
Sbjct: 99 --------QLTVL--------------PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLT 135
Query: 218 NLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSN 251
+L L + N+L IP F RL++LT+ YL N
Sbjct: 136 HLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 35/125 (28%), Positives = 55/125 (44%), Gaps = 3/125 (2%)
Query: 176 LSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPS 235
L N + P L NL L L SN+L + L L L++G N+L +PS
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV-LPS 105
Query: 236 TLF-RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYL 294
+F RL +L L++ N L +P I +T + + + N ++ RLS L +
Sbjct: 106 AVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164
Query: 295 SISSN 299
+ N
Sbjct: 165 YLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 9/107 (8%)
Query: 293 YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSG 351
L + N ++ P LI+LK L L +N+L +P + ++L + L N L+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 352 SIPPEI--GLMKLEYLDLSHNKLNGTIPP---FLYHRFPLDLSYNDL 393
+P + L+ L+ L + NKL +P L H L L N L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 37/157 (23%), Positives = 60/157 (38%), Gaps = 17/157 (10%)
Query: 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGA 160
L + + + + L ++L S NN+ I L + NL +L+L N +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-K 84
Query: 161 IPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH-QELGKLKNL 219
I + L + +S N + S I L NL +L + +NK++ +L L L
Sbjct: 85 IENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 220 VALNVGGNKLMGPIPST----------LFRLTNLTYL 246
L + GN L + RL NL L
Sbjct: 143 EDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 23/109 (21%), Positives = 47/109 (43%), Gaps = 11/109 (10%)
Query: 268 LKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGL---ISLKGLDLSNNK 324
+++ + IE + L+ L +L++S+N + I+ L +L+ L L N
Sbjct: 28 VELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNL 81
Query: 325 LSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLN 373
+ I L + + N ++ S+ L+ L L +S+NK+
Sbjct: 82 IKK-IENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 40/183 (21%), Positives = 71/183 (38%), Gaps = 35/183 (19%)
Query: 204 KLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGN 263
+ + + L+ + + +TL L +L L +N++ +I +
Sbjct: 13 IFEERKSVVATEAEKV-ELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISS 65
Query: 264 MTGI--LKV-DMSMNNIEGTIPLELTRLSQLLYLSISSNM---LSGQIPITIAGLISLKG 317
++G+ L++ + N I+ L+ L L IS N LSG I L++L+
Sbjct: 66 LSGMENLRILSLGRNLIKKIENLD-AVADTLEELWISYNQIASLSG-----IEKLVNLRV 119
Query: 318 LDLSNNKLSGPIPPEIGK---CSELRNITLRNNNLSGSIPPEIG-----------LMKLE 363
L +SNNK++ EI K +L ++ L N L L L+
Sbjct: 120 LYMSNNKITN--WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177
Query: 364 YLD 366
LD
Sbjct: 178 KLD 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 56/352 (15%), Positives = 108/352 (30%), Gaps = 72/352 (20%)
Query: 97 PGLESLSLRFNYLFGSIPSQVGAL----------SKLRYLDFSFNNLTGSIPPELGSL-- 144
G+ SL L N L + + + + L+ S N+L EL +
Sbjct: 22 HGVTSLDLSLNNL-----YSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 145 ---RNLEVLNLKGNNLN--------GAIPSSLCQLTKLITMALSRNGL----HGPIPSAI 189
N+ LNL GN L+ + + +T L L N A
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLD---LGWNDFSSKSSSEFKQAF 133
Query: 190 GDLN-NLLILSLDSNKLSGMLHQELGKL-----KNLVALNVGGNKL----MGPIPSTLFR 239
+L ++ L+L N L EL ++ N+ +LN+ GN L + L
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193
Query: 240 L-TNLTYLYLHSNHLNGSIPPEIG-----NMTGILKVDMSMNNIEGT----IPLELTRLS 289
+ ++T L L +N L E+ ++ +++ +N + G + L L
Sbjct: 194 IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253
Query: 290 QLLYLSISSNMLSGQIPITIAGLIS-------LKGLDLSNNKLSGPIPPEIGKCSELRNI 342
L + + +++ L + + +D + ++ I +
Sbjct: 254 HLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSG 313
Query: 343 TLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLE 394
+L + DL+ + L
Sbjct: 314 KADVPSLLNQCLIFAQKHQTNIEDLNIPD----------ELRESIQTCKPLL 355
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 28/105 (26%), Positives = 47/105 (44%), Gaps = 3/105 (2%)
Query: 148 EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG 207
L L GN +P L L + LS N + + ++ LL L L N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSN 251
+ + LK+L L++ GN + +P F L+ L++L + +N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 20/75 (26%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 185 IPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNL 243
+P + + +L ++ L +N++S + +Q + L+ L + N+L IP F L +L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSL 104
Query: 244 TYLYLHSNHLNGSIP 258
L LH N ++ +P
Sbjct: 105 RLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 31/133 (23%), Positives = 50/133 (37%), Gaps = 30/133 (22%)
Query: 241 TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNM 300
++T LYL N +P EL+ L + +S+N
Sbjct: 31 RDVTELYLDGNQFT-------------------------LVPKELSNYKHLTLIDLSNNR 65
Query: 301 LSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI-- 357
+S + + + L L LS N+L IPP LR ++L N++S +P
Sbjct: 66 ISTLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN 123
Query: 358 GLMKLEYLDLSHN 370
L L +L + N
Sbjct: 124 DLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 12/95 (12%)
Query: 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSEL 339
IP ++T L YL N + +P ++ L +DLSNN++S + + ++L
Sbjct: 29 IPRDVTEL----YLD--GNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 340 RNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKL 372
+ L N L IPP GL L L L N +
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 268 LKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSG 327
L +D +N L L +LS+ + L + + L LK L+LS N++ G
Sbjct: 29 LVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFG 85
Query: 328 PIPPEIGKCSELRNITLRNNNLS--GSIPPEIGLMKLEYLDLSHN 370
+ K L ++ L N L ++ P L L+ LDL +
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 35/174 (20%), Positives = 57/174 (32%), Gaps = 40/174 (22%)
Query: 81 EKKLKGELSQFNFSCFPGLESLSLRFNYL-FGSIPSQVGALSKLRYLDFSFNNLTGSIPP 139
++++ EL + + L L G I L +L L S+
Sbjct: 11 KRRIHLELRNRTPA---AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN 66
Query: 140 ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILS 199
L L L+ L L N + G + +L L + LS N + D++ L
Sbjct: 67 -LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTL---- 113
Query: 200 LDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPI-------PSTLFRLTNLTYL 246
+ L KL+ L +L++ + S L LTYL
Sbjct: 114 -----------EPLKKLECLKSLDLFNC----EVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 32/105 (30%), Positives = 45/105 (42%), Gaps = 3/105 (2%)
Query: 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG 135
E+ L K + + F LE LSL L S+ S + L KL+ L+ S N + G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISV-SNLPKLPKLKKLELSENRIFG 85
Query: 136 SIPPELGSLRNLEVLNLKGNNLNG-AIPSSLCQLTKLITMALSRN 179
+ L NL LNL GN L + L +L L ++ L
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 6/92 (6%)
Query: 164 SLCQLTKLITMALSRNGLH-GPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVAL 222
+ + +L+ L + G I + NL LSL + L + L KL L L
Sbjct: 22 TPAAVRELV---LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKL 76
Query: 223 NVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254
+ N++ G + +L NLT+L L N L
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 148 EVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLDSNKLS 206
L L+ N L +LT+L ++LS+N + +P + D L L IL L NKL
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ 89
Query: 207 GMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSN 251
+ + KL L L + N+L +P +F RLT+L ++LH+N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 38/128 (29%), Positives = 56/128 (43%), Gaps = 26/128 (20%)
Query: 197 ILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLNG 255
L L+SNKL + H KL L L++ N++ +P +F +LT LT LYLH N L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ- 89
Query: 256 SIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISL 315
S+P G+ +L+QL L++ +N L L SL
Sbjct: 90 SLPN------GVFD-----------------KLTQLKELALDTNQLKSVPDGIFDRLTSL 126
Query: 316 KGLDLSNN 323
+ + L N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 27/84 (32%), Positives = 37/84 (44%), Gaps = 3/84 (3%)
Query: 176 LSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPS 235
L N L L L LSL N++ + KL L L + NKL +P+
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-LPN 93
Query: 236 TLF-RLTNLTYLYLHSNHLNGSIP 258
+F +LT L L L +N L S+P
Sbjct: 94 GVFDKLTQLKELALDTNQLK-SVP 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-08
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 268 LKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSG 327
L +D S +N G + +L +LS + L+ I + L LK L+LS+N++SG
Sbjct: 22 LVLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSG 78
Query: 328 PIPPEIGKCSELRNITLRNNNLS--GSIPPEIGLMKLEYLDLSHN 370
+ KC L ++ L N + +I P L L+ LDL +
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 37/174 (21%), Positives = 61/174 (35%), Gaps = 40/174 (22%)
Query: 81 EKKLKGELSQFNFSCFPGLESLSLRFN-YLFGSIPSQVGALSKLRYLDFSFNNLTGSIPP 139
+++ EL S ++ L L + G + +L +L LT SI
Sbjct: 4 GRRIHLELRNRTPS---DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN 59
Query: 140 ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILS 199
L L L+ L L N ++G + + L + LS N I DL+ +
Sbjct: 60 -LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTI---- 106
Query: 200 LDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPI-------PSTLFRLTNLTYL 246
+ L KL+NL +L++ + + L LTYL
Sbjct: 107 -----------EPLKKLENLKSLDLFNC----EVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 18/72 (25%), Positives = 30/72 (41%), Gaps = 2/72 (2%)
Query: 183 GPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTN 242
G + + L LS + L+ + L KL L L + N++ G + + N
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 243 LTYLYLHSNHLN 254
LT+L L N +
Sbjct: 90 LTHLNLSGNKIK 101
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 8e-08
Identities = 33/224 (14%), Positives = 69/224 (30%), Gaps = 36/224 (16%)
Query: 193 NNLLILSLDSNKLSGMLHQELGK-LKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSN 251
+ + ++S + +L L + LN K + NL L + S
Sbjct: 144 LFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISG 203
Query: 252 HLNGSIPPEIG-----NMTGILKVDMSMNNIEGTIP-------LELTRLSQLLYLSISSN 299
L S+ +I N+ L + + + + R L +L I
Sbjct: 204 GLPDSVVEDILGSDLPNLE-KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262
Query: 300 MLSGQIPITIAG---LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPE 356
+ L L+ +D+S L+ L +
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL----------------LLDHVDK- 305
Query: 357 IGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPDY 400
+ L+++++ +N L+ + L P+ + +D + DY
Sbjct: 306 --IKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDDDY 347
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 1e-05
Identities = 17/84 (20%), Positives = 34/84 (40%), Gaps = 7/84 (8%)
Query: 91 FNFSCFPGLESLSLRFNYLFGSIPSQVGA---LSKLRYLDFSFNNLTGS----IPPELGS 143
F+ FP L+ L + + L +L +D S LT + +
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305
Query: 144 LRNLEVLNLKGNNLNGAIPSSLCQ 167
+++L+ +N+K N L+ + L +
Sbjct: 306 IKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 3e-05
Identities = 26/146 (17%), Positives = 50/146 (34%), Gaps = 19/146 (13%)
Query: 97 PGLESLSLRFNYLFGSIPSQVGA--LSKLRYLDFSF--NNLTGSIPPEL-------GSLR 145
P L+SL + L S+ + L L L + +
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252
Query: 146 NLEVLNLKGNNLNGAIPSSLCQ---LTKLITMALSRNGLHG----PIPSAIGDLNNLLIL 198
NL+ L + + + L +L TM +S L + + + +L +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312
Query: 199 SLDSNKLSGMLHQELGK-LKNLVALN 223
++ N LS + +EL K L + ++
Sbjct: 313 NMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 8e-05
Identities = 19/123 (15%), Positives = 37/123 (30%), Gaps = 17/123 (13%)
Query: 94 SCFPGLESLSLRF---NYLFGSIPSQV------GALSKLRYLDFSFNNLTGSIPPELGS- 143
S P LE L L +Y F + L++L +
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275
Query: 144 --LRNLEVLNLKGNNLNG----AIPSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNNLL 196
L LE +++ L + + ++ L + + N L + + L +
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI 335
Query: 197 ILS 199
+S
Sbjct: 336 DVS 338
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 4/86 (4%)
Query: 176 LSRNGLHGPIPSAIGD-LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIP 234
L+ N L + L +L+ L L N+L+G+ ++ L +G NK+ I
Sbjct: 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI-KEIS 94
Query: 235 STLF-RLTNLTYLYLHSNHLNGSIPP 259
+ +F L L L L+ N ++ + P
Sbjct: 95 NKMFLGLHQLKTLNLYDNQIS-CVMP 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 5/110 (4%)
Query: 148 EVLNLKGNNLNGAIPSSL-CQLTKLITMALSRNGLHGPIPSAIGD-LNNLLILSLDSNKL 205
L L N L L +L L+ + L RN L G I + +++ L L NK+
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI 90
Query: 206 SGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLN 254
+ ++ L L LN+ N++ + F L +LT L L SN N
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 31/133 (23%), Positives = 50/133 (37%), Gaps = 28/133 (21%)
Query: 241 TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNM 300
+ T L L+ N L I G+ RL L+ L + N
Sbjct: 29 LHTTELLLNDNELG-RISS-----DGLFG-----------------RLPHLVKLELKRNQ 65
Query: 301 LSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI-GKCSELRNITLRNNNLSGSIPPEI-- 357
L+G P G ++ L L NK+ I ++ +L+ + L +N +S + P
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFE 123
Query: 358 GLMKLEYLDLSHN 370
L L L+L+ N
Sbjct: 124 HLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 32/129 (24%), Positives = 53/129 (41%), Gaps = 27/129 (20%)
Query: 197 ILSLDSNKLSGMLHQEL-GKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNHLN 254
L L+ N+L + L G+L +LV L + N+L G I F +++ L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK 91
Query: 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314
I ++ L QL L++ N +S +P + L S
Sbjct: 92 -EISNKM-----------------------FLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 315 LKGLDLSNN 323
L L+L++N
Sbjct: 128 LTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 5/107 (4%)
Query: 100 ESLSLRFNYLFGSIPSQV-GALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKGNNL 157
L L N L + G L L L+ N LT I P +++ L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 158 NGAIPSSLC-QLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSN 203
I + + L +L T+ L N + +P + LN+L L+L SN
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 12/90 (13%)
Query: 318 LDLSNNKLSGPIPPE--IGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLN 373
L L++N+L I + G+ L + L+ N L+ I P G ++ L L NK+
Sbjct: 34 LLLNDNELGR-ISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 374 GTIPPFLYHRFP----LDLSYNDLEGEIPD 399
I ++ L+L N + +
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISC-VMP 119
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 185 IPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNL 243
+P+ I +L L N+++ + +L L L++ N+L +P+ +F +LT L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQL 80
Query: 244 TYLYLHSNHLNGSIP 258
T L L+ N L SIP
Sbjct: 81 TQLSLNDNQLK-SIP 94
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 33/118 (27%), Positives = 49/118 (41%), Gaps = 30/118 (25%)
Query: 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNN 194
S+P G +VL L N Q+TKL + D L
Sbjct: 23 SVPT--GIPTTTQVLYLYDN-----------QITKL--------------EPGVFDRLTQ 55
Query: 195 LLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSN 251
L L LD+N+L+ + KL L L++ N+L IP F L +LT+++L +N
Sbjct: 56 LTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 27/75 (36%), Positives = 40/75 (53%), Gaps = 5/75 (6%)
Query: 185 IPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNL 243
+P+ I + L L++N+++ + L NL L NKL IP+ +F +LT L
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQL 83
Query: 244 TYLYLHSNHLNGSIP 258
T L L+ NHL SIP
Sbjct: 84 TQLDLNDNHLK-SIP 97
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 34/118 (28%), Positives = 49/118 (41%), Gaps = 30/118 (25%)
Query: 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGD-LNN 194
S+P G + + L L N Q+TKL + D L N
Sbjct: 26 SVPA--GIPTDKQRLWLNNN-----------QITKL--------------EPGVFDHLVN 58
Query: 195 LLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSN 251
L L +SNKL+ + KL L L++ N L IP F L +LT++YL++N
Sbjct: 59 LQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 51/244 (20%), Positives = 85/244 (34%), Gaps = 51/244 (20%)
Query: 494 IIKATEDFDIKY----CIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNE 548
K + + +G G +G V Q + N K A+K + + + S + E
Sbjct: 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK----YTRSAKIE 81
Query: 549 AHVLSKIAHR-----NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWTM 602
A +L KI + NIVK +G ++ M LI++ + SL+ + N+Y ++
Sbjct: 82 ADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIK 140
Query: 603 RVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT 662
+ AL+YL S+ H D+ NILL+
Sbjct: 141 L--YCIEILKALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 663 IVAGT----------------YGYI------APE----LAYTMVVTEKCDVYSFGVVALE 696
+ I APE L + + D++SFG V E
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDV----SSDMWSFGCVLAE 251
Query: 697 VLMG 700
+ G
Sbjct: 252 LYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 47/236 (19%), Positives = 93/236 (39%), Gaps = 57/236 (24%)
Query: 501 FDIKYCIGTGGYGSVYKAQ--LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++I +G G +G V + G+ VA+K + + + + ++E VL +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVD---RYCEAARSEIQVLEHLNTT 71
Query: 559 ------NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWTMRVNIIKCVA 611
V++ + H + ++++ + S + F++ N + L + I+ +A
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRL------DHIRKMA 124
Query: 612 ----NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA-------------------DF 648
++++LH + H D+ NIL DF
Sbjct: 125 YQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 649 GTARLLDSDSSNRTIVAGTYGYIAPE----LAYTMVVTEKCDVYSFGVVALEVLMG 700
G+A D S T+V+ + Y APE L ++ CDV+S G + +E +G
Sbjct: 182 GSATYDDEHHS--TLVSTRH-YRAPEVILALGWSQ----PCDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 44/229 (19%), Positives = 83/229 (36%), Gaps = 43/229 (18%)
Query: 501 FDIKYCIGTGGYGSVYKA--QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++I +G G +G V + VALK + R + + + E +VL KI +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNVG---KYREAARLEINVLKKIKEK 76
Query: 559 ------NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-NDYEAVVLDWTMRVNIIKCVA 611
V + + M + ++ + + + F FL+ N+++ L + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRH--MAYQLC 133
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGT-- 667
+AL +LH + H D+ NIL + + + + S + R G+
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 668 ------YGYI------APE----LAYTMVVTEKCDVYSFGVVALEVLMG 700
+ PE L + CDV+S G + E G
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILELGWAQ----PCDVWSIGCILFEYYRG 235
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 28/136 (20%), Positives = 42/136 (30%), Gaps = 35/136 (25%)
Query: 240 LTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSN 299
L L + P I N+ L Q + S N
Sbjct: 18 AVRDRELDLRGYKI-----PVIENLG--------------------ATLDQFDAIDFSDN 52
Query: 300 MLSGQIPITIAG---LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS--GSIP 354
+ + G L LK L ++NN++ +L + L NN+L G +
Sbjct: 53 EIR-----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLD 107
Query: 355 PEIGLMKLEYLDLSHN 370
P L L YL + N
Sbjct: 108 PLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 16/87 (18%), Positives = 31/87 (35%), Gaps = 3/87 (3%)
Query: 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLK 153
+ +++ N + + L +L+ L + N + +L +L L L
Sbjct: 39 ATLDQFDAIDFSDNEI-RKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96
Query: 154 GNNLNG-AIPSSLCQLTKLITMALSRN 179
N+L L L L + + RN
Sbjct: 97 NNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 22/129 (17%), Positives = 40/129 (31%), Gaps = 29/129 (22%)
Query: 126 LDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI 185
+ + + + + + L+L+G + I + L + + S N +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---- 54
Query: 186 PSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTY 245
KL G L+ L L V N++ L +LT
Sbjct: 55 -----------------RKLDG-----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92
Query: 246 LYLHSNHLN 254
L L +N L
Sbjct: 93 LILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLT--GSIPPELGSLRNLEV 149
F L++L + N + AL L L + N+L G + P L SL++L
Sbjct: 59 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTY 117
Query: 150 LNLKGN 155
L + N
Sbjct: 118 LCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 18/87 (20%), Positives = 33/87 (37%), Gaps = 7/87 (8%)
Query: 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNK 371
+ + LDL K+ I + I +N + + L +L+ L +++N+
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75
Query: 372 LNGTIPPFLYHRFP----LDLSYNDLE 394
+ I L P L L+ N L
Sbjct: 76 IC-RIGEGLDQALPDLTELILTNNSLV 101
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 36/180 (20%), Positives = 62/180 (34%), Gaps = 54/180 (30%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALK-----KLHRAET----EETTFFNSFQNEAHV-----L 552
IG GG+G +Y A + + + V K+ ++ E F+ +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 553 SKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLD-----------WT 601
K+ + + K +G LH K Y +++D
Sbjct: 103 RKLKYLGVPKYWGSGLHDKN-----------------GKSYRFMIMDRFGSDLQKIYEAN 145
Query: 602 MRVNIIKCVA-------NALSYLHHDCMPSIVHRDISSNNILLNSKLE--AFVADFGTAR 652
+ K V + L Y+H VH DI ++N+LLN K ++ D+G A
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 41/304 (13%), Positives = 94/304 (30%), Gaps = 45/304 (14%)
Query: 93 FSCFPGLESLSLR---------------FNYLFGSIPSQVGALSKLRYLDFSFNNLTGSI 137
FP + S+ L+ Y++ I + + + L + +T
Sbjct: 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDC 121
Query: 138 PPELG-SLRNLEVLNLKGNNL--NGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNN 194
+ S +N +VL L + + L + L + + + +
Sbjct: 122 LELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181
Query: 195 L------LILSLDSNKLSGM-LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLY 247
L +S ++++S L + + + NL +L + + + + L R L L
Sbjct: 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG 241
Query: 248 LHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI 307
G + + L+ +L LS + + +P
Sbjct: 242 TGGYTAEVRPDVYSG------------------LSVALSGCKELRCLSGFWDAVPAYLPA 283
Query: 308 TIAGLISLKGLDLSNNKLSGP-IPPEIGKCSELRNITLRNNNLSGSIPPEIGLMK-LEYL 365
+ L L+LS + + + +C +L+ + + + + K L L
Sbjct: 284 VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLREL 343
Query: 366 DLSH 369
+
Sbjct: 344 RVFP 347
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 30/156 (19%), Positives = 62/156 (39%), Gaps = 26/156 (16%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIVKLY 564
IG+G +G +Y + G+ VA+K E +T E+ + + I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKH-PQLHIESKIYKMMQGGVGIPTIR 71
Query: 565 GFCLHKKCMFLIYKYMKRGSL-----FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
++ + + SL FC + + V+L + + + + Y+H
Sbjct: 72 WCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLL-------LADQMISRIEYIHS 123
Query: 620 DCMPSIVHRDISSNNILLNSKLEA---FVADFGTAR 652
+ +HRD+ +N L+ + ++ DFG A+
Sbjct: 124 K---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 35/167 (20%), Positives = 67/167 (40%), Gaps = 26/167 (15%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLY 564
IG+G +G +Y + + VA+K E +T E+ + + I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKH-PQLLYESKIYRILQGGTGIPNVR 69
Query: 565 GFCLHKKCMFLIYKYMKRGSL-----FCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
F + L+ + SL FC + + V++ + + N + ++H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLM-------LADQMINRVEFVHS 121
Query: 620 DCMPSIVHRDISSNNILLNSKLEA---FVADFGTARLLDSDSSNRTI 663
S +HRDI +N L+ A ++ DFG A+ S+++ I
Sbjct: 122 K---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 32/166 (19%), Positives = 58/166 (34%), Gaps = 29/166 (17%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565
IG+GG+G +Y A + A E +E ++A ++ +K +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH----VVKVEYQENGPLFSELKFYQRVAKKDCIKKW- 99
Query: 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLD------WTMRVNI----IKCVA---- 611
+ I + G F Y +V++ + V
Sbjct: 100 IERKQLDYLGIPLFYGSGL-TEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 612 ---NALSYLHHDCMPSIVHRDISSNNILLNSKLE--AFVADFGTAR 652
+ L Y+H + VH DI + N+LL K ++AD+G +
Sbjct: 159 RMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 37/161 (22%), Positives = 62/161 (38%), Gaps = 34/161 (21%)
Query: 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIVKLY 564
IG G +G +++ L N + VA+K E + ++E +A I +Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDA-PQLRDEYRTYKLLAGCTGIPNVY 72
Query: 565 GFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA-------NALSYL 617
F L+ + SL +LD R +K VA + +
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SL---------EDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 618 HHDCMPSIVHRDISSNNILL------NSKLEAFVADFGTAR 652
H S+V+RDI +N L+ N+ + +V DFG +
Sbjct: 123 HEK---SLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 29/166 (17%), Positives = 59/166 (35%), Gaps = 32/166 (19%)
Query: 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-R 558
F + IG G +G + + L + VA+K + E ++
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-----KSRAPQLHLEYRFYKQLGSGD 65
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA------- 611
I ++Y F K ++ + + SL + D R +K V
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGP-SL---------EDLFDLCDRTFSLKTVLMIAIQLI 115
Query: 612 NALSYLHHDCMPSIVHRDISSNNILL-----NSKLEAFVADFGTAR 652
+ + Y+H ++++RD+ N L+ ++ + DF A+
Sbjct: 116 SRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 796 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 100.0 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.93 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.93 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.91 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.8 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.63 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.42 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.4 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.29 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.03 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.89 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.81 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.58 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.53 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.51 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.23 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.95 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.89 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.68 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.45 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.4 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.75 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.73 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.69 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.64 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.08 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.96 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.3 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.4 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.85 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=431.23 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=205.7
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.+++.+.+.||+|+||+||+|+++ ..||||+++...... ...+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 467888999999999999999875 369999997654433 335789999999999999999999999864 5689999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|||++|+|.++++... ..+++..+..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999997643 3489999999999999999999999 9999999999999999999999999999876533
Q ss_pred C--CCccccccccCccCcccccc---CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC-CC
Q 003780 658 S--SNRTIVAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL-SP 731 (796)
Q Consensus 658 ~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 731 (796)
. ......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ...+...+.... .+
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~~~~~~~~~~~p 257 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQIIFMVGRGYASP 257 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHTTCCCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCCCC
Confidence 2 22344679999999999863 4689999999999999999999999974221 112222222222 22
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
............+.+++.+||+.||++||||+||+++|+..+-
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 2222222233458899999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=439.89 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=207.9
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++........ ..+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 36899999999999999999975 4799999999987655433 356899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 102 mEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999997643 23478999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||... .....+..+......+....
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~~~~~~~~- 248 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------SMKNLVLKIISGSFPPVSLH- 248 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTCCCCCCTT-
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCCCCCCCcc-
Confidence 322334567999999999999999999999999999999999999999732 12233334444433322211
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
....+.+++.+||+.||++|||++|+++|
T Consensus 249 ---~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 249 ---YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12347899999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=433.06 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=210.4
Q ss_pred cCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
+++++.+.||+|+||+||+|++. +++.||||+++..... ...++|.+|+.++++++|||||+++|+|.+++.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 45677899999999999999752 5789999999765433 224689999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
.++|||||++|+|.++++.... ...++|..+.+|+.|||+||+|||++ +||||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 9999999999999999975421 24589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCch
Q 003780 640 KLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSD 716 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~ 716 (796)
++.+||+|||+|+....... ......||+.|||||++.++.|+.++|||||||++|||+| |+.||....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-------- 252 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------- 252 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------
Confidence 99999999999987643322 2344679999999999999999999999999999999998 899987422
Q ss_pred hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
...... .+......+... .....+.+++.+||+.||++||||+||+++|+..
T Consensus 253 ~~~~~~-~i~~~~~~~~p~---~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 253 NQDVVE-MIRNRQVLPCPD---DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHH-HHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHH-HHHcCCCCCCcc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122222 222222222221 2234578999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=432.35 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=210.8
Q ss_pred cCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
++|.+.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|++++++++|||||+++|+|.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 56888999999999999999753 478899999976533 235689999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcC----------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDY----------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE 642 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 642 (796)
.++|||||++|+|.+++++.. ....++|..+.+|+.|||+||+|||++ +||||||||+|||++.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999998643 234689999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhh
Q 003780 643 AFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKI 719 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (796)
+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ...
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~ 238 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNE 238 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 999999999876543222 223468999999999999999999999999999999999 899987422 122
Q ss_pred HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 720 MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
....+...... +.+. .....+.+++.+||+.||++||||+||.+.|+....
T Consensus 239 ~~~~i~~~~~~-~~p~---~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 239 VIECITQGRVL-QRPR---TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHHHTCCC-CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC-CCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22233322221 1111 122347899999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=434.04 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=205.5
Q ss_pred cCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
++|.+.+.||+|+||+||+|+++ +++.||||+++.... ...++|.+|++++++++|||||+++|+|.+++.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46778899999999999999754 478999999976532 235689999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCc------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYE------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK 640 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 640 (796)
.++|||||++|+|.+++++... ...++|.++++|+.|||+||+|||++ +||||||||+|||++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999986532 24589999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchh
Q 003780 641 LEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~ 717 (796)
+.+||+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.... .
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~ 266 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------N 266 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------H
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------H
Confidence 9999999999987654322 2234579999999999999999999999999999999999 899987422 1
Q ss_pred hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
......+... ...+... .....+.+++.+||+.||++||||+||+++|+.+..
T Consensus 267 ~~~~~~i~~g-~~~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 267 TEAIDCITQG-RELERPR---ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHHT-CCCCCCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcC-CCCCCcc---cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 2222222222 2222211 122347899999999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=434.19 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=211.1
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|++.+.||+|+||+||+|+.+ +|+.||||++....... .+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999754 79999999997654433 346889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+. .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999999753 389999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+.. ...+.... .
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~-~~~~~~~~-~ 293 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRD-NLPPRLKN-L 293 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHH-SSCCCCSC-G
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHc-CCCCCCCc-c
Confidence 555566789999999999999999999999999999999999999997321 1112222222 22211111 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+.+++.+||+.||++|||++|+++|-
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 12234578999999999999999999999873
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=428.05 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=218.2
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+. .+|+.||||++.+.........+.+.+|++++++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999975 579999999998765444444578999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998654 489999999999999999999999 9999999999999999999999999999987543
Q ss_pred CC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||... ........+.......+ .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~~~~~p--~ 255 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEGLIFAKIIKLEYDFP--E 255 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCCC--T
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCCCCCC--c
Confidence 32 234568999999999999999999999999999999999999999732 12233333443333221 1
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhhcCccccCccc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE--FLTCKIALVNPFE 781 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~ 781 (796)
.....+.+++.+||+.||++|||++|++.+ +.++.++..-.|.
T Consensus 256 ---~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 256 ---KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp ---TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ---ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 112347789999999999999999997543 5555544433333
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=413.74 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=193.9
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999975 479999999998766555444568999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+ +|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999997653 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. .....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... .......+.......+ ..
T Consensus 166 ~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i~~~~~~~p--~~ 234 (275)
T 3hyh_A 166 N-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNISNGVYTLP--KF 234 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCC--TT
T ss_pred C-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCC--CC
Confidence 2 2344679999999999998876 579999999999999999999997321 1222333333322211 11
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
....+.+++.+||+.||++|||++|+++|-
T Consensus 235 ---~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 235 ---LSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 123477899999999999999999999873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=415.49 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=200.6
Q ss_pred ccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe----cceeeEE
Q 003780 502 DIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH----KKCMFLI 576 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV 576 (796)
.+.+.||+|+||+||+|.. .+++.||+|++........ ..+.|.+|++++++++|||||++++++.. ++..++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 5677899999999999975 4689999999986654433 35689999999999999999999999875 3568999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-CCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-KLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 655 (796)
||||++|+|.+++++.. .+++..+..++.||++||+|||++ .++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999998653 489999999999999999999998 113999999999999985 7899999999998643
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC-ccc
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP-PVD 734 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 734 (796)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ....+...+.....+ ...
T Consensus 184 ~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--------~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 184 A--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--------NAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp T--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--------SHHHHHHHHTTTCCCGGGG
T ss_pred C--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------cHHHHHHHHHcCCCCCCCC
Confidence 2 23445689999999998865 69999999999999999999999996321 112222333332222 121
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. .....+.+++.+||+.||++|||++|+++|
T Consensus 253 ~---~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 K---VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G---CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c---cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 122347899999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=435.09 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=210.8
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|++.+.||+|+||.||+|+. .+|+.||||++....... .+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5699999999999999999975 479999999997654433 346889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|||++|+|.++++.. .+++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999999999999754 389999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ...+..+.. ...+.... .
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~-~~~~~~~~-~ 370 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRD-NLPPRLKN-L 370 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH-SCCCCCSC-T
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHc-CCCCCCcc-c
Confidence 5555667899999999999999999999999999999999999999973221 112222222 21111111 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+.+++.+||+.||++|||++|+++|-
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 11223478999999999999999999999973
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=424.01 Aligned_cols=250 Identities=21% Similarity=0.264 Sum_probs=203.4
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.+.|++.+.||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35688889999999999999975 4699999999975432 24699999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 655 (796)
|||+++|+|.+++++.. .+++..+..++.||+.||+|||++ +||||||||+|||++.++ ++||+|||+|+.+.
T Consensus 129 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999998653 489999999999999999999999 999999999999999987 69999999999775
Q ss_pred CCCCC-----ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 656 SDSSN-----RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 656 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
.+... ....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... .....+......
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~~ 274 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--------PLCLKIASEPPP 274 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--------CCHHHHHHSCCG
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHHcCCCC
Confidence 43221 22357999999999999999999999999999999999999999743221 111122221111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
....+......+.+++.+||+.||++|||++|+++++..
T Consensus 275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111111223357789999999999999999999998864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=419.56 Aligned_cols=244 Identities=24% Similarity=0.326 Sum_probs=197.2
Q ss_pred cCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||+||+|+.. .++.||||++......... ...+.+|++++++++|||||++++++.+++..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999999642 4789999999865543222 246888999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999998654 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
..........+||+.|||||++.+..|+.++||||+||++|||+||+.||...+ .......+.......+
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~~~p-- 246 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILKAKLGMP-- 246 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC--
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHcCCCCCC--
Confidence 554444556789999999999999999999999999999999999999997321 2223333333333221
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTM 762 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 762 (796)
. .....+.+++.+||+.||++|||+
T Consensus 247 ~---~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 247 Q---FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred C---cCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 112347799999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=416.42 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=205.1
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----eee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----CMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 574 (796)
++|.+.+.||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++++|.+++ ..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4678889999999999999987 5899999999754321 123345666677899999999999998764 579
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD-----CMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
+||||+++|+|.+++++. .++|..+.+++.|+|+||+|||++ +.++|+||||||+|||++.++++||+|||
T Consensus 78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 999999999999999864 389999999999999999999976 24589999999999999999999999999
Q ss_pred cccccCCCCCC----ccccccccCccCccccccC------CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCC------
Q 003780 650 TARLLDSDSSN----RTIVAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP------ 713 (796)
Q Consensus 650 ~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~------ 713 (796)
+|+........ ....+||+.|+|||++.+. .++.++|||||||++|||+||+.||........+
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99876543322 2235799999999998754 4678999999999999999998887543221111
Q ss_pred -CchhhhHHHHhhcCCCCCccchh--hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 714 -SSDQKIMLIDVLDSRLSPPVDRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 714 -~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
..........+.....++..... ..+....+.+++.+||+.||++||||+||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11112223334444444433221 2234456889999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=426.94 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=214.5
Q ss_pred HHHHHHhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC-CceeeEE
Q 003780 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIVKLY 564 (796)
Q Consensus 492 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~ 564 (796)
.+++...++|++.+.||+|+||+||+|.+. .++.||||++....... ..+.|.+|++++.+++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~--~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH--HHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 445556789999999999999999999753 24689999998665433 24689999999999965 8999999
Q ss_pred eEEEec-ceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecC
Q 003780 565 GFCLHK-KCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDI 630 (796)
Q Consensus 565 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 630 (796)
|+|.++ +..++|||||++|+|.+++++... ...+++..+..++.|||+||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999765 568999999999999999986432 24589999999999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCccc
Q 003780 631 SSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELL 707 (796)
Q Consensus 631 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~ 707 (796)
||+|||+++++.+||+|||+|+.+..+... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999976544332 234578999999999999999999999999999999998 89998743
Q ss_pred ccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 708 SSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.. ...+...+............ ..++.+++.+||+.||++||||+||+++|+..
T Consensus 292 ~~--------~~~~~~~i~~g~~~~~p~~~---~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KI--------DEEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CC--------SHHHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CH--------HHHHHHHHHcCCCCCCCccC---CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 21 11222222222222222212 23478899999999999999999999999765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=407.24 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=194.7
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc------
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK------ 571 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 571 (796)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 4699999999999999999975 47999999999765432 23467899999999999999999999987654
Q ss_pred ------eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEE
Q 003780 572 ------CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV 645 (796)
Q Consensus 572 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 645 (796)
..|+||||+++|+|.+++.........++..+..++.||++||+|||++ +|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 3689999999999999998765555567788899999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCCC------------ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCC
Q 003780 646 ADFGTARLLDSDSSN------------RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP 713 (796)
Q Consensus 646 ~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~ 713 (796)
+|||+|+.+...... .+..+||+.|||||++.+..|+.++||||+||++|||++ ||...
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~------ 230 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------ 230 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH------
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc------
Confidence 999999876543221 123579999999999999999999999999999999996 76521
Q ss_pred CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...............++ ..........+++.+||+.||++|||+.|+++|
T Consensus 231 -~~~~~~~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 231 -MERVRTLTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -HHHHHHHHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cHHHHHHHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11112222222222221 122233346789999999999999999999986
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=449.86 Aligned_cols=353 Identities=38% Similarity=0.575 Sum_probs=296.0
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCC-CCcEeecccCcCCCCCCCCCCC--CCCCCE
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALS-KLRYLDFSFNNLTGSIPPELGS--LRNLEV 149 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~--l~~L~~ 149 (796)
+++.|+++++.+.|.++...|..+++|++|+|++|.+.+.+|..+.+++ +|++|+|++|.+++.+|..+.. +++|++
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~ 398 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence 3455555555555555544456666666666666666666666666655 6666666666666666666655 677888
Q ss_pred EEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccc
Q 003780 150 LNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL 229 (796)
Q Consensus 150 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 229 (796)
|+|++|++++.+|..++++++|+.|+|++|++++.+|..|+++++|++|+|++|++++.+|..+..+++|++|++++|++
T Consensus 399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 88888888888899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccc
Q 003780 230 MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITI 309 (796)
Q Consensus 230 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~ 309 (796)
++.+|..+.++++|++|+|++|++++.+|.+++++++|+.|+|++|++++.+|..+.++++|++|++++|+++|.+|..+
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~ 558 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988777543
Q ss_pred ----------------------------------------------------------------------ccccccceec
Q 003780 310 ----------------------------------------------------------------------AGLISLKGLD 319 (796)
Q Consensus 310 ----------------------------------------------------------------------~~l~~L~~L~ 319 (796)
..+++|++||
T Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld 638 (768)
T 3rgz_A 559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638 (768)
T ss_dssp GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence 3357799999
Q ss_pred ccccccccCCCcccCCCCCCcEEEeecccccCCCCcccc-ccccceEEecccccCCCCCccccc---cccccccCCCCcc
Q 003780 320 LSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIPPFLYH---RFPLDLSYNDLEG 395 (796)
Q Consensus 320 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~L~~L~l~~N~l~~~~p~~~~~---~~~l~l~~N~l~~ 395 (796)
|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++ +++|+.|||++|+++|.+|..+.. +..||+++|+++|
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence 999999999999999999999999999999999999885 899999999999999999987655 5589999999999
Q ss_pred cCCCCCC--CC-CccccCCccccccC--CCCCCCC
Q 003780 396 EIPDYFR--DS-PFKVYGNQGICYFS--ACSTLHT 425 (796)
Q Consensus 396 ~~p~~~~--~~-~~~~~~n~~~c~~~--~~~~~~~ 425 (796)
.+|+... .. +..+.||+++||.+ .|....+
T Consensus 719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~~~ 753 (768)
T 3rgz_A 719 PIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNA 753 (768)
T ss_dssp ECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSCC-
T ss_pred cCCCchhhccCCHHHhcCCchhcCCCCcCCCCCcc
Confidence 9998532 22 23457999999986 6765433
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=436.12 Aligned_cols=340 Identities=22% Similarity=0.257 Sum_probs=302.4
Q ss_pred CCCCCCccC---CceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCc-----------------------
Q 003780 55 SNSSDHCKL---DGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNY----------------------- 108 (796)
Q Consensus 55 ~~~~~~C~w---~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~----------------------- 108 (796)
..+++||.| .||+|+..++|+.|+|+++++.|.+++ .|+.|++|++|+|++|.
T Consensus 61 ~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~ 139 (636)
T 4eco_A 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139 (636)
T ss_dssp CCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECG-GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHH
T ss_pred CCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCCh-HHhcCccceEEECcCCccccCCccccccccccCchHHHHH
Confidence 346899999 999999889999999999999999996 69999999999999984
Q ss_pred -------------------------------------------------------ccccCCcCccCCCCCcEeecccCcC
Q 003780 109 -------------------------------------------------------LFGSIPSQVGALSKLRYLDFSFNNL 133 (796)
Q Consensus 109 -------------------------------------------------------l~~~~~~~~~~l~~L~~L~Ls~n~l 133 (796)
++| +|..|+++++|++|+|++|.+
T Consensus 140 ~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l 218 (636)
T 4eco_A 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218 (636)
T ss_dssp HHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCC
T ss_pred HHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcc
Confidence 445 788999999999999999999
Q ss_pred CCC-----------------CCCCCC--CCCCCCEEEecCCCCCCCCchhhhccCccceeeccccc-cCC-CCCccccCC
Q 003780 134 TGS-----------------IPPELG--SLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG-LHG-PIPSAIGDL 192 (796)
Q Consensus 134 ~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l 192 (796)
++. +|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L 298 (636)
T 4eco_A 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298 (636)
T ss_dssp CGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred ccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhh
Confidence 985 999999 99999999999999999999999999999999999998 998 889988887
Q ss_pred ------CCccEEEcccccccCcchh--hhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCC
Q 003780 193 ------NNLLILSLDSNKLSGMLHQ--ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNM 264 (796)
Q Consensus 193 ------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 264 (796)
++|++|+|++|+++ .+|. .++++++|+.|++++|+++|.+| .+..+++|++|+|++|+++ .+|..+.++
T Consensus 299 ~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 375 (636)
T 4eco_A 299 ADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGF 375 (636)
T ss_dssp HHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEE
T ss_pred hccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhh
Confidence 99999999999999 6676 89999999999999999998899 8999999999999999999 889899999
Q ss_pred cc-cceeecccccccccCcccccccc--ccccccccCccccCccccccc-------cccccceecccccccccCCCcccC
Q 003780 265 TG-ILKVDMSMNNIEGTIPLELTRLS--QLLYLSISSNMLSGQIPITIA-------GLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 265 ~~-L~~L~Ls~N~l~~~~p~~l~~l~--~L~~L~l~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
++ |+.|++++|+++ .+|..+..++ +|++|++++|.+++.+|..+. .+++|++|+|++|++++..+..+.
T Consensus 376 ~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~ 454 (636)
T 4eco_A 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454 (636)
T ss_dssp CTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHH
T ss_pred cccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHc
Confidence 99 999999999999 7888887755 899999999999999998888 788999999999999954444566
Q ss_pred CCCCCcEEEeecccccCCCCccc-ccc--------ccceEEecccccCCCCCcccc-----ccccccccCCCCcccCCCC
Q 003780 335 KCSELRNITLRNNNLSGSIPPEI-GLM--------KLEYLDLSHNKLNGTIPPFLY-----HRFPLDLSYNDLEGEIPDY 400 (796)
Q Consensus 335 ~l~~L~~L~L~~N~l~~~~~~~~-~~~--------~L~~L~l~~N~l~~~~p~~~~-----~~~~l~l~~N~l~~~~p~~ 400 (796)
.+++|+.|+|++|+++ .+|... ... +|++|+|++|+++ .+|..+. ++..|+|++|.+++ +|..
T Consensus 455 ~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~ 531 (636)
T 4eco_A 455 TGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531 (636)
T ss_dssp TTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCG
T ss_pred cCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChh
Confidence 7899999999999999 556543 322 8999999999999 7886554 56689999999998 7765
Q ss_pred CCC
Q 003780 401 FRD 403 (796)
Q Consensus 401 ~~~ 403 (796)
+..
T Consensus 532 ~~~ 534 (636)
T 4eco_A 532 PLN 534 (636)
T ss_dssp GGG
T ss_pred hhc
Confidence 543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=450.76 Aligned_cols=366 Identities=33% Similarity=0.490 Sum_probs=233.4
Q ss_pred CCchHHHhhcHHHHH-HhhcCCccccCCCCCCCCCccCCceeeCCCCCeEEEeCCCCCcccc---ccc------------
Q 003780 27 TTDDICVAAFELERE-ALVNSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGE---LSQ------------ 90 (796)
Q Consensus 27 ~~~~~~~~~~~~~~~-~l~~~~w~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~---~~~------------ 90 (796)
..|..++.+||+... ...-++| ..++|||+|+||+|+ .++|+.|+|+++++.|. +++
T Consensus 11 ~~~~~all~~k~~~~~~~~l~~W------~~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~ 83 (768)
T 3rgz_A 11 YREIHQLISFKDVLPDKNLLPDW------SSNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF 83 (768)
T ss_dssp HHHHHHHHHHHTTCSCTTSSTTC------CTTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEE
T ss_pred HHHHHHHHHHHhhCCCcccccCC------CCCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccC
Confidence 335566666664321 0011345 246799999999999 78999999999999987 443
Q ss_pred ----------cccCCCCCCcEEeccCCcccccCCc--CccCCCCCcEeecccCcCCCCCCCCC-CCCCCCCEEEecCCCC
Q 003780 91 ----------FNFSCFPGLESLSLRFNYLFGSIPS--QVGALSKLRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKGNNL 157 (796)
Q Consensus 91 ----------~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~L~~N~l 157 (796)
..|+.+++|++|+|++|.+.|.+|. .++++++|++|||++|.+++.+|..+ .++++|++|+|++|++
T Consensus 84 ~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 163 (768)
T 3rgz_A 84 LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163 (768)
T ss_dssp CTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCC
T ss_pred CcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCcc
Confidence 3688999999999999999998888 89999999999999999998888776 7899999999999999
Q ss_pred CCCCchh---hhccCccceeeccccccC----------------------CCCCccccCCCCccEEEcccccccCcchhh
Q 003780 158 NGAIPSS---LCQLTKLITMALSRNGLH----------------------GPIPSAIGDLNNLLILSLDSNKLSGMLHQE 212 (796)
Q Consensus 158 ~~~~p~~---~~~l~~L~~L~L~~N~l~----------------------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 212 (796)
++..|.. +.++++|++|++++|.++ +.+|. ++++++|++|+|++|++++.+|..
T Consensus 164 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~ 242 (768)
T 3rgz_A 164 SGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRA 242 (768)
T ss_dssp EEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHH
T ss_pred CCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHH
Confidence 8877766 555555555555555554 44443 445555555555555555555555
Q ss_pred hcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCC-cccceeecccccccccCcccccccccc
Q 003780 213 LGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNM-TGILKVDMSMNNIEGTIPLELTRLSQL 291 (796)
Q Consensus 213 ~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L 291 (796)
++++++|++|++++|++++.+|.. .+++|++|+|++|++++.+|..+... ++|+.|+|++|++++.+|..|+++++|
T Consensus 243 l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L 320 (768)
T 3rgz_A 243 ISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320 (768)
T ss_dssp TTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTC
T ss_pred HhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCc
Confidence 555555555555555555444433 44555555555555555555555443 555555555555555555555555555
Q ss_pred ccccccCccccCccccc-cccccccceecccccccccCCCcccCCCC-CCcEEEeecccccCCCCcccc---ccccceEE
Q 003780 292 LYLSISSNMLSGQIPIT-IAGLISLKGLDLSNNKLSGPIPPEIGKCS-ELRNITLRNNNLSGSIPPEIG---LMKLEYLD 366 (796)
Q Consensus 292 ~~L~l~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~---~~~L~~L~ 366 (796)
++|++++|.++|.+|.. +..+++|++|+|++|++++.+|..+..++ +|+.|+|++|++++.+|..+. +++|++|+
T Consensus 321 ~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~ 400 (768)
T 3rgz_A 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400 (768)
T ss_dssp CEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEE
T ss_pred cEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEE
Confidence 55555555555555543 55555555555555555555555555554 555555555555555554442 34566666
Q ss_pred ecccccCCCCCcccc---ccccccccCCCCcccCCCCCC
Q 003780 367 LSHNKLNGTIPPFLY---HRFPLDLSYNDLEGEIPDYFR 402 (796)
Q Consensus 367 l~~N~l~~~~p~~~~---~~~~l~l~~N~l~~~~p~~~~ 402 (796)
+++|++++.+|..+. ++..|++++|.++|.+|..+.
T Consensus 401 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 439 (768)
T 3rgz_A 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439 (768)
T ss_dssp CCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG
T ss_pred CCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHh
Confidence 666666665655443 334566666666666665543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=402.80 Aligned_cols=259 Identities=24% Similarity=0.294 Sum_probs=202.5
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe------c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH------K 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~ 570 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++........ ..+.+.+|+++|++++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT-NAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH-HHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchH-HHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 35799999999999999999975 5799999999976554332 34678899999999999999999999864 3
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
+..|+||||++ |+|.+++.+.. .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 57899999996 68999997643 499999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC----CCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH--
Q 003780 651 ARLLDSD----SSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID-- 723 (796)
Q Consensus 651 a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 723 (796)
|+.+... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.. .....+..
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-----~~l~~I~~~~ 279 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-----HQLQLIMMVL 279 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhc
Confidence 9876432 2223456899999999998775 5689999999999999999999999743210 00000000
Q ss_pred ---------------------hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 724 ---------------------VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 724 ---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
....................+.+|+.+||+.||++|||++|+++|-
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 0111111111111111123577999999999999999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=390.74 Aligned_cols=198 Identities=26% Similarity=0.344 Sum_probs=170.7
Q ss_pred HHHHhcCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 494 IIKATEDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 494 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
+....++|++.+.||+|+||+||+|+.+ .++.||+|++..... ..++.+|+++++.+ +|||||++++++.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 3345688999999999999999999643 478999999876543 24678899999998 6999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEee
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVAD 647 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~D 647 (796)
+++..++||||+++|+|.+++.. +++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ECCEEEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 99999999999999999999842 78999999999999999999999 99999999999999877 7999999
Q ss_pred eccccccCCCCC----------------------------CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHH
Q 003780 648 FGTARLLDSDSS----------------------------NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVL 698 (796)
Q Consensus 648 fg~a~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~ell 698 (796)
||+|+....... .....+||+.|+|||++.+. .|+.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999986543211 11235799999999998875 4889999999999999999
Q ss_pred hCCCCCc
Q 003780 699 MGRHPGE 705 (796)
Q Consensus 699 tg~~p~~ 705 (796)
+|+.||.
T Consensus 242 ~G~~Pf~ 248 (361)
T 4f9c_A 242 SGRYPFY 248 (361)
T ss_dssp HTCSSSS
T ss_pred HCCCCCC
Confidence 9999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=404.95 Aligned_cols=254 Identities=22% Similarity=0.240 Sum_probs=203.9
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHH---HHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFN---SFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.......... ....++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999754 7999999999765433222222 334446677788999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
|+||||++||+|.+++.+.. .+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998653 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
+.... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||...... ................+
T Consensus 342 ~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 342 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMAVELP 414 (689)
T ss_dssp CSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHCCCCCC
T ss_pred cCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCCCCCCC
Confidence 65432 334679999999999964 57999999999999999999999999743221 11122222223222211
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPT-----MQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 769 (796)
. .....+.+++.+||+.||.+|++ ++||++|-
T Consensus 415 --~---~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 415 --D---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp --T---TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred --c---cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 1 11234779999999999999998 78888773
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=406.35 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=210.0
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|+. .+|+.||+|++......+ .+.+.+|+++|+.++|||||++++++.+++..++|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999975 479999999997655332 35788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC--CcEEEeeecccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK--LEAFVADFGTARLL 654 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfg~a~~~ 654 (796)
||||++|+|.+++.+.. ..+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999996532 2489999999999999999999999 99999999999999864 89999999999987
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ....+..+..........
T Consensus 308 ~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 378 (573)
T 3uto_A 308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMDDS 378 (573)
T ss_dssp CTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCCCCCSG
T ss_pred cCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCCCCCCcc
Confidence 643 23345679999999999999999999999999999999999999997322 222233333322221111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
........+.+|+.+||+.||++|||++|+++|-
T Consensus 379 -~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 379 -AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp -GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred -cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 1111223477999999999999999999999974
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=421.05 Aligned_cols=329 Identities=22% Similarity=0.274 Sum_probs=279.8
Q ss_pred CceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEec-cCCccccc------------------------------
Q 003780 64 DGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSL-RFNYLFGS------------------------------ 112 (796)
Q Consensus 64 ~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L-~~n~l~~~------------------------------ 112 (796)
.||+|+..++|+.|+|+++++.|.+++ .|++|++|++|+| ++|.+.|.
T Consensus 315 ~GV~C~~~~~V~~L~Ls~~~L~G~ip~-~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~ 393 (876)
T 4ecn_A 315 PGVDLDNNGRVTGLSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393 (876)
T ss_dssp TTEEECTTSCEEEEECTTTCCEEEECG-GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTC
T ss_pred CceEecCCCCEEEEECccCCCCCcCch-HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhc
Confidence 999999889999999999999999996 5999999999999 77766544
Q ss_pred ----------------------------------------------CCcCccCCCCCcEeecccCcCCC-----------
Q 003780 113 ----------------------------------------------IPSQVGALSKLRYLDFSFNNLTG----------- 135 (796)
Q Consensus 113 ----------------------------------------------~~~~~~~l~~L~~L~Ls~n~l~~----------- 135 (796)
+|..|+++++|++|+|++|.|++
T Consensus 394 ~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s 473 (876)
T 4ecn_A 394 YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN 473 (876)
T ss_dssp CCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTT
T ss_pred cCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccc
Confidence 78889999999999999999998
Q ss_pred ------CCCCCCC--CCCCCCEEEecCCCCCCCCchhhhccCccceeeccccc-cCC-CCCccccCCC-------CccEE
Q 003780 136 ------SIPPELG--SLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG-LHG-PIPSAIGDLN-------NLLIL 198 (796)
Q Consensus 136 ------~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L 198 (796)
.+|..++ ++++|++|+|++|++.+.+|..|+++++|+.|+|++|+ +++ .+|..++.++ +|++|
T Consensus 474 ~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L 553 (876)
T 4ecn_A 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553 (876)
T ss_dssp SHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEE
T ss_pred cccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEE
Confidence 3899988 99999999999999999999999999999999999998 988 7888777665 99999
Q ss_pred EcccccccCcchh--hhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcc-cceeecccc
Q 003780 199 SLDSNKLSGMLHQ--ELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTG-ILKVDMSMN 275 (796)
Q Consensus 199 ~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N 275 (796)
+|++|+++ .+|. .++++++|+.|+|++|+++ .+| .+.++++|+.|+|++|+++ .+|..+.++++ |+.|+|++|
T Consensus 554 ~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N 629 (876)
T 4ecn_A 554 YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHN 629 (876)
T ss_dssp ECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSS
T ss_pred EeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCC
Confidence 99999999 6677 8999999999999999999 777 8999999999999999999 89989999999 999999999
Q ss_pred cccccCccccccccc--cccccccCccccCcccccc---c--cccccceecccccccccCCCcc-cCCCCCCcEEEeecc
Q 003780 276 NIEGTIPLELTRLSQ--LLYLSISSNMLSGQIPITI---A--GLISLKGLDLSNNKLSGPIPPE-IGKCSELRNITLRNN 347 (796)
Q Consensus 276 ~l~~~~p~~l~~l~~--L~~L~l~~N~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N 347 (796)
+++ .+|..+..++. |+.|+|++|.+++.+|... . .+++|+.|+|++|+++ .+|.. +..+++|+.|+|++|
T Consensus 630 ~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N 707 (876)
T 4ecn_A 630 KLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNN 707 (876)
T ss_dssp CCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSC
T ss_pred CCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCC
Confidence 999 77888877654 9999999999988766332 2 3347888888888888 45544 447888888888888
Q ss_pred cccCCCCccc-cc--------cccceEEecccccCCCCCcccc-----ccccccccCCCCcccCCCCCC
Q 003780 348 NLSGSIPPEI-GL--------MKLEYLDLSHNKLNGTIPPFLY-----HRFPLDLSYNDLEGEIPDYFR 402 (796)
Q Consensus 348 ~l~~~~~~~~-~~--------~~L~~L~l~~N~l~~~~p~~~~-----~~~~l~l~~N~l~~~~p~~~~ 402 (796)
+++ .+|... .. ++|+.|+|++|+++ .+|..+. ++..|+|++|.+++ +|..+.
T Consensus 708 ~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~ 773 (876)
T 4ecn_A 708 LMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773 (876)
T ss_dssp CCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGG
T ss_pred cCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhh
Confidence 888 555443 22 27888888888888 6775543 45678888888887 565443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=377.97 Aligned_cols=290 Identities=35% Similarity=0.575 Sum_probs=231.9
Q ss_pred CCcccHHHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEe
Q 003780 486 DGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYG 565 (796)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~ 565 (796)
...+++.++....++|++.+.||+|+||.||+|+.++|+.||||++........ ...+.+|++++++++||||+++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEE
Confidence 446788999999999999999999999999999988899999999986654322 236899999999999999999999
Q ss_pred EEEecceeeEEEeeccCCcHHHHHhhcCc-ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEE
Q 003780 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYE-AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 566 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 644 (796)
++..++..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999986542 34589999999999999999999998778999999999999999999999
Q ss_pred EeeeccccccCCCCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 645 VADFGTARLLDSDSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|+|||+++........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||+..................
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999999876543322 334559999999999988889999999999999999999999996332211111111111111
Q ss_pred ---------hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCcccc
Q 003780 724 ---------VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEE 782 (796)
Q Consensus 724 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~ 782 (796)
..+..... .........+.+++.+||+.||++|||++||+++|+.... ..+|++
T Consensus 255 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~--~~~~~~ 317 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQG---NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL--AERWEE 317 (326)
T ss_dssp TTSSCCSTTSSCTTCTT---SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC--SSSCC-
T ss_pred HhhchhhhhhcChhhcc---ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch--hhhhhh
Confidence 11111111 1234455679999999999999999999999999998655 334544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=370.31 Aligned_cols=268 Identities=29% Similarity=0.408 Sum_probs=207.5
Q ss_pred HHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
...++|++.+.||+|+||+||+|+. +|+.||||++....... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3457899999999999999999977 58899999998765443 235688999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS--IVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
||||+++|+|.+++........+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999998765445589999999999999999999998 8 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .................
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFKCKRLEI 260 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHHSCCCCCC
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCC
Confidence 5544333445679999999999999999999999999999999999999987322 11122222111111111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCc
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNP 779 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 779 (796)
.. .....+.+++.+||+.||++|||++|+++.|+.......++
T Consensus 261 ~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 261 PR---NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp CT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred Cc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 11 12234789999999999999999999999998876554443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=363.03 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=209.8
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|.. .+|+.||+|++....... .+.+.+|+.++++++||||+++++++..++..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 46899999999999999999975 579999999997655433 35788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999999764 388999999999999999999999 999999999999999999999999999987766
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC-CCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL-SPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 735 (796)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............ ....
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~-- 238 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTPELQN-- 238 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSCCCSC--
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC--
Confidence 55555566799999999999999999999999999999999999999873221 111111111111 1111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.......+.+++.+||+.||++|||++|++++-
T Consensus 239 -~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 239 -PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 112233478999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=362.40 Aligned_cols=265 Identities=24% Similarity=0.349 Sum_probs=216.0
Q ss_pred CCcccHHHHHHHhcC----------CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhh
Q 003780 486 DGRIAFEDIIKATED----------FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSK 554 (796)
Q Consensus 486 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~ 554 (796)
.+.++++++..+++. |+..+.||+|+||.||+|+.+ +|+.||||++....... .+.+.+|+.++++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~ 98 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRD 98 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTT
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHh
Confidence 346778888877764 777889999999999999865 79999999997654332 4578899999999
Q ss_pred cCCCceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCC
Q 003780 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNN 634 (796)
Q Consensus 555 l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 634 (796)
++||||+++++++...+..++||||+++|+|.+++.+. .+++..+..++.|+++||+|||+. +|+||||||+|
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N 171 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence 99999999999999999999999999999999998753 389999999999999999999999 99999999999
Q ss_pred eEecCCCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCC
Q 003780 635 ILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS 714 (796)
Q Consensus 635 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~ 714 (796)
|+++.++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----- 246 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----- 246 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 999999999999999998776544444556799999999999999999999999999999999999999873211
Q ss_pred chhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 715 SDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......... ..+.... .......+.+++.+||+.||++|||++|++++-.
T Consensus 247 ---~~~~~~~~~~-~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 247 ---VQAMKRLRDS-PPPKLKN-SHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp ---HHHHHHHHHS-SCCCCTT-GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ---HHHHHHHhcC-CCCCcCc-cccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 1111122221 1111111 1122335789999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.00 Aligned_cols=264 Identities=25% Similarity=0.356 Sum_probs=212.4
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999975 47899999999776555555567899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999998653 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ........+..........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQDSVPNVTTD 235 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSSCCCCHHHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhccCCCcchh
Confidence 322 2334569999999999999999999999999999999999999997321 1112222223222221111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhhcCcc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRP-TMQRVCQEFLTCKIA 775 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~ 775 (796)
........+.+++.+|++.||++|| +++++.+.|+.....
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1122234588999999999999998 899999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.70 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=209.8
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+. .+|+.||||++....... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 46899999999999999999975 589999999997765433 2356788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997653 389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCcC-cchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
. ......+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.... .......+.......+.
T Consensus 167 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~p~-- 235 (328)
T 3fe3_A 167 G-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGKYRIPF-- 235 (328)
T ss_dssp S-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCT--
T ss_pred C-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCC--
Confidence 3 233456799999999999887765 78999999999999999999997321 12222233333222211
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+||+.||.+|||++|+++|-
T Consensus 236 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 236 ---YMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ---TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ---CCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 1123477899999999999999999999984
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=359.22 Aligned_cols=261 Identities=26% Similarity=0.429 Sum_probs=211.2
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 36799999999999999999975 4699999999865432 2356899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.++++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999998643 3489999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCCc--------------cccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 657 DSSNR--------------TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 657 ~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
..... ....||+.|+|||++.+..++.++||||||+++|||++|..|+........... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---~~~~ 237 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---LNVR 237 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---BCHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---hhhh
Confidence 32211 145699999999999999999999999999999999999999874332211111 1111
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
........+... ..+.+++.+||+.||++|||++|+++.|+......
T Consensus 238 ~~~~~~~~~~~~-------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 238 GFLDRYCPPNCP-------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHHHHTCCTTCC-------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccccccCCCCCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 222222222111 13678999999999999999999999998876443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=363.57 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=211.2
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++...........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999765 6999999999765433333356788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999997643 489999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+.
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p~--- 226 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRFPR--- 226 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCT---
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCC---
Confidence 4444455679999999999999999999999999999999999999987321 12222333333222111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
.....+.+++.+||+.||++|| +++|+++|-
T Consensus 227 --~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 227 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp --TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred --CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 1123477899999999999999 899998873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.57 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=208.8
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||.||+|+.+ +++.||+|+++..........+.+..|..++.++ +||||+++++++..++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999755 6889999999876554444456788999999887 89999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998653 389999999999999999999999 99999999999999999999999999998644
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc-hhhhHHHHhhcCCCCCccc
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS-DQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 734 (796)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||+.......... ........+.......+.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~- 283 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR- 283 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT-
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC-
Confidence 444445567899999999999999999999999999999999999999974332111111 112222333333332211
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTM------QRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 768 (796)
.....+.+++.+||+.||++||++ +|+++|
T Consensus 284 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 284 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 112347789999999999999985 677766
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.00 Aligned_cols=274 Identities=34% Similarity=0.512 Sum_probs=220.5
Q ss_pred cHHHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 003780 490 AFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH 569 (796)
Q Consensus 490 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 569 (796)
++.++..++++|++.+.||+|+||.||+|+.++|+.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 344455577899999999999999999999888999999998765433 24678999999999999999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
++..++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999987543 223589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC--CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhH------
Q 003780 649 GTARLLDSDS--SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM------ 720 (796)
Q Consensus 649 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~------ 720 (796)
|+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998654322 22234568999999999988899999999999999999999999987433321111110000
Q ss_pred -HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 721 -LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 721 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
....+++.... .........+.+++.+||+.||++|||++|++++|+..
T Consensus 264 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 264 QLEQIVDPNLAD---KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCCSSSSSSCTT---CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHhcChhhcc---ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00111111111 12344566788999999999999999999999999865
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=363.17 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=210.0
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 576 (796)
++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|..+++++ +||||+++++++..++..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999765 6899999999876655444566788999999988 899999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999998653 389999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc-hhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS-DQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 735 (796)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||........... ........+.......+.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-- 240 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-- 240 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--
Confidence 44444556799999999999999999999999999999999999999974322111111 111222223333222111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTM------QRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 768 (796)
.....+.+++.+||+.||++||++ +|+++|
T Consensus 241 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 241 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 112347789999999999999996 677766
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=374.44 Aligned_cols=257 Identities=21% Similarity=0.243 Sum_probs=210.8
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||+||+|.. .+|+.||+|++........ ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH-HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 457899999999999999999964 5799999999987665433 25678999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec---CCCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN---SKLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~ 652 (796)
||||+++|+|.+.+.... .+++..+..++.||++||+|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999998653 389999999999999999999999 999999999999998 45789999999998
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
.............||+.|+|||++.+..++.++||||+||++|+|++|+.||... ........+.......+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~~~~ 233 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--------DQHRLYQQIKAGAYDFP 233 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTCCCCC
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhCCCCCC
Confidence 7765544445567999999999999989999999999999999999999998632 12222223332222211
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
... .......+.+++.+||+.||++|||++|+++|-
T Consensus 234 ~~~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 234 SPE-WDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp TTT-TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred ccc-cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 110 111223478999999999999999999999974
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.69 Aligned_cols=278 Identities=32% Similarity=0.505 Sum_probs=224.9
Q ss_pred CcccHHHHHHHhcCCccc------eeeecccceeEEEEEccCCcEEEEEEeccccc-hhhHHHHHHHHHHHHHhhcCCCc
Q 003780 487 GRIAFEDIIKATEDFDIK------YCIGTGGYGSVYKAQLPNGKVVALKKLHRAET-EETTFFNSFQNEAHVLSKIAHRN 559 (796)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpn 559 (796)
..++++++..+++.|... +.||+|+||.||+|.. +++.||||++..... ......+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 467889999999999887 8999999999999987 588999999976432 22233568999999999999999
Q ss_pred eeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 560 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
|+++++++..++..++||||+++|+|.+++........+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999998655555689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchh
Q 003780 640 KLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 717 (796)
++.+||+|||+++........ .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.............
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543222 233468999999998765 57899999999999999999999997543321111100
Q ss_pred h------hHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 718 K------IMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 718 ~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
. ..+...++..+. .........+.+++.+||+.||++|||++|++++|++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHhhhhhhhhhhhcccccc----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 0 011222233222 123344556889999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=355.82 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=204.0
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||+||+|+.++|+.||+|++....... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE-GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc-hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 357899999999999999999998889999999997654332 2346788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++ +|.+.+.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 8888877543 3489999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc--
Q 003780 657 DSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV-- 733 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 733 (796)
.........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... .....+............
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-----DQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-----THHHHHHHHHCCCCTTTSGG
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHCCCChHHhhh
Confidence 4444455678999999999876 56899999999999999999999999743221 111111111111111000
Q ss_pred --------------------chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 734 --------------------DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 734 --------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.........++.+++.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00011112357899999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=366.64 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=211.0
Q ss_pred hcCCccceeeecccceeEEEEEc--------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL--------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
.++|++.+.||+|+||.||+|+. .++..||||+++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH--HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 46899999999999999999974 24568999999766432 2356899999999999 8999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
.++..++||||+++|+|.+++..... ...+++..+..++.||++||+|||++ +|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 99999999999999999999986532 23478999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~ 712 (796)
+++.++.+||+|||+++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--- 311 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 9999999999999999876543322 223457789999999999999999999999999999999 9999874221
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
. .....+.......... .....+.+++.+||+.||++||++.|++++|+.+.
T Consensus 312 -----~-~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 -----E-ELFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -----G-GHHHHHHTTCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----H-HHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1122222222222111 12234789999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=366.64 Aligned_cols=254 Identities=21% Similarity=0.342 Sum_probs=206.3
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++...........+.+.+|..+++.+ +||||+++++++..++..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999754 6899999999876544444456788999999988 6999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999998653 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~~~~p~- 245 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--------NEDDLFEAILNDEVVYPT- 245 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCT-
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCCCCCCC-
Confidence 44444455567999999999999989999999999999999999999999732 222333344443332221
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTM------QRVCQEF 769 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~L 769 (796)
.....+.+++.+||+.||++||++ +|+++|-
T Consensus 246 ----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 246 ----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred ----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 112347789999999999999998 7787763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=362.78 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=210.7
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhh---HHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEET---TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++........ ...+.+.+|+.++++++||||+++++++..++.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999755 699999999987654321 124578999999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC----cEEEeee
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL----EAFVADF 648 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df 648 (796)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999997543 489999999999999999999999 999999999999998877 7999999
Q ss_pred ccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
|++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||... ........+....
T Consensus 164 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--------~~~~~~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANITAVS 234 (361)
T ss_dssp SSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHTTC
T ss_pred CCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcC
Confidence 9998765432 233456999999999999989999999999999999999999999732 1222233333322
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..... .........+.+++.+||+.||++|||+.|+++|-.
T Consensus 235 ~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 235 YDFDE-EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp CCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCCc-hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 22111 111122345789999999999999999999998743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.93 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=211.1
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|+||.||+|+.++++.||+|++...... .+++.+|++++++++||||+++++++..++..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 4689999999999999999999888889999999866543 256899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999997643 3489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
... .....+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... .......... ........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~~ 228 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQ-GHRLYRPH 228 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHT-TCCCCCCT
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHc-CCCCCCCC
Confidence 221 122346678999999998889999999999999999999 999987322 1111222211 11111111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
. ....+.+++.+|++.||++|||++|++++|+....
T Consensus 229 ~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 229 L---ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp T---SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred c---ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1 12347899999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=363.87 Aligned_cols=259 Identities=19% Similarity=0.259 Sum_probs=209.5
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhh--HHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEET--TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
.++|++.+.||+|+||+||+|.. .+|+.||||++........ ...+.+.+|+.++++++||||+++++++..++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999975 4799999999875432211 12457899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc---EEEeeecc
Q 003780 575 LIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE---AFVADFGT 650 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~ 650 (796)
+||||+++|+|.+.+.+.. ....+++..+..++.||++||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988876542 223489999999999999999999999 9999999999999987655 99999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
++.............||+.|+|||++.+..++.++||||+||++|+|++|+.||... .......+......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---------KERLFEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---------HHHHHHHHHHTCCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---------HHHHHHHHHcCCCC
Confidence 988765444444567999999999999999999999999999999999999998732 12222233333222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.... ........+.+++.+||+.||++|||+.|+++|-
T Consensus 251 ~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 251 MNPR-QWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp CCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCcc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 2111 0111234578999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=359.86 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=209.1
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----ee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----CM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 573 (796)
.++|++.+.||+|+||+||+|+.. ++.||||++...... ......|+.++++++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 468999999999999999999875 899999999654322 235667999999999999999999998754 46
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhc-------CCCCeEEecCCCCCeEecCCCcEEEe
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD-------CMPSIVHRDISSNNILLNSKLEAFVA 646 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------~~~~ivH~dlkp~NIll~~~~~~kl~ 646 (796)
++||||+++|+|.++++.. .+++..+..++.|+++||+|||+. +.++|+||||||+||+++.++.+||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999999764 389999999999999999999986 23489999999999999999999999
Q ss_pred eeccccccCCCCCC--ccccccccCccCcccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc----
Q 003780 647 DFGTARLLDSDSSN--RTIVAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS---- 715 (796)
Q Consensus 647 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~---- 715 (796)
|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999876543322 233569999999999886 3566789999999999999999999875332111110
Q ss_pred ----hhhhHHHHhhcCCCCCccchh--hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 716 ----DQKIMLIDVLDSRLSPPVDRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 716 ----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
...............+..... .......+.+++.+||+.||++|||++|+++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111112222233333322221 1233456889999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=349.97 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=210.5
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|+||.||+|...+++.||+|++...... .+++.+|++++++++||||+++++++.+++..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 3579999999999999999999888999999999876543 246899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999997643 3489999999999999999999999 9999999999999999999999999999866432
Q ss_pred CC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. ......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... ........ ..........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~-~~~~~~~~~~ 230 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDI-STGFRLYKPR 230 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHH-HTTCCCCCCT
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHH-hcCccCCCCC
Confidence 11 1223346778999999998899999999999999999999 999987321 11122222 2222222111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
. ....+.+++.+|++.||++||+++|++++|++..
T Consensus 231 ~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 231 L---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c---CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 1 1234789999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=357.03 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=210.3
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|..+ +++.||+|.+...... ...+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 468999999999999999999754 6899999998754322 35688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC--CCcEEEeeecccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS--KLEAFVADFGTARLL 654 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~ 654 (796)
|||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999997542 3489999999999999999999999 9999999999999997 789999999999877
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||... ........+..........
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~ 225 (321)
T 1tki_A 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCCCCHH
T ss_pred CCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC--------CHHHHHHHHHcCCCCCChh
Confidence 543 2334466999999999999988999999999999999999999999732 1222333333333322211
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
........+.+++.+||+.||++|||+.|+++|-.
T Consensus 226 -~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 226 -AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 11122345789999999999999999999999853
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.49 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=207.6
Q ss_pred hcCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||.||+|+.. .+..||||++....... ..+.+.+|++++++++||||+++++++..++..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 357899999999999999999764 45569999997654332 246799999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.++++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999997543 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc---cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 654 LDSDSSNR---TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 654 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
........ ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..... ..+....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~-~~~~~~~ 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVI-SSVEEGY 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHH-HHHHTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHH-HHHHcCC
Confidence 65432221 22335778999999998899999999999999999999 999986321 11122 2222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
..+... .....+.+++.+||+.||++|||++|+++.|+....
T Consensus 272 ~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 272 RLPAPM---GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC---CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 222111 122347899999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.49 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=209.9
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|..+ +|+.||+|++........ ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4568999999999999999999754 689999999987654332 35678999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC---cEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL---EAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~ 652 (796)
||||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++ .+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999987543 489999999999999999999999 999999999999998654 59999999998
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .......+.......+
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~~i~~~~~~~~ 250 (362)
T 2bdw_A 180 EVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAGAYDYP 250 (362)
T ss_dssp CCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCC
T ss_pred EecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCCC
Confidence 765432 2334579999999999999899999999999999999999999987321 1222222222222211
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
... .......+.+++.+||+.||++||+++|++++-.
T Consensus 251 ~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 251 SPE-WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp TTG-GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred ccc-ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 110 1122345789999999999999999999998843
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.02 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=213.8
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc--eee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK--CMF 574 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~ 574 (796)
.++|.+.+.||+|+||+||+|+.. +|+.||||++........ .+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 357999999999999999999765 599999999976543322 457889999999999999999999998765 779
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe----cCCCcEEEeeecc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL----NSKLEAFVADFGT 650 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~ 650 (796)
+||||+++|+|.+++........+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999998765555589999999999999999999999 99999999999999 7888899999999
Q ss_pred ccccCCCCCCccccccccCccCccccc--------cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAY--------TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||...... ........
T Consensus 163 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~ 237 (319)
T 4euu_A 163 ARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMY 237 (319)
T ss_dssp CEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----GGCHHHHH
T ss_pred ceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----chhHHHHH
Confidence 987654432 23456999999999876 567889999999999999999999998743221 11122222
Q ss_pred HhhcCCCC--------------------CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 723 DVLDSRLS--------------------PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 723 ~~~~~~~~--------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
..+..... +............+.+++.+||+.||++|||++|++++......
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 22221110 11112233445568899999999999999999999999976543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=364.20 Aligned_cols=257 Identities=23% Similarity=0.276 Sum_probs=202.1
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHH-HhhcCCCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHV-LSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+..|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999765 688999999987665443334566777776 577899999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999998643 388899999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......++........
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~-- 260 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKPLQLKP-- 260 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHSCCCCCS--
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcccCCCC--
Confidence 44444556779999999999999999999999999999999999999997321 22333334443332111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.....+.+++.+||+.||++||++.+.+++++.+.
T Consensus 261 ---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 261 ---NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp ---SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred ---CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 11234778999999999999999865555555443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=360.16 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=205.8
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999975 57999999999765444333345789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+ +|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999887643 389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+........ ..+...... ..
T Consensus 161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------~~i~~~~~~-~p- 228 (336)
T 3h4j_B 161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------KKVNSCVYV-MP- 228 (336)
T ss_dssp SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------CCCCSSCCC-CC-
T ss_pred Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------HHHHcCCCC-Cc-
Confidence 32 2334579999999999988776 68999999999999999999999743221100 000111100 11
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
......+.+++.+||+.||.+|||++|++++-.
T Consensus 229 --~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 229 --DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred --ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 111234778999999999999999999998843
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=361.88 Aligned_cols=254 Identities=23% Similarity=0.330 Sum_probs=208.4
Q ss_pred HHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEeccee
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 573 (796)
...++|++.+.||+|+||.||+|+.+ +|+.||+|+++..........+.+..|..++..+ +||||+++++++..++..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999765 6899999999875433333345778899999887 899999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999998643 389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
...........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDNPFYP- 238 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC-
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCCCCCC-
Confidence 5443344455679999999999999999999999999999999999999997321 1222222222222111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQ-RVCQE 768 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 768 (796)
. .....+.+++.+||+.||++||++. |+++|
T Consensus 239 -~---~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 239 -R---WLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -T---TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -c---ccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1 1123477899999999999999998 77655
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.35 Aligned_cols=256 Identities=25% Similarity=0.317 Sum_probs=208.6
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhh---HHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEET---TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||.||+|..+ +|+.||+|++........ ...+.+.+|+.++++++||||+++++++..++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457999999999999999999764 699999999976543321 1245789999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC----cEEEeeec
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL----EAFVADFG 649 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 649 (796)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997543 489999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .............
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVNY 234 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHTCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHhcCC
Confidence 998765432 2334569999999999998899999999999999999999999986321 1222222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
... ..........+.+++.+||+.||++|||++|+++|-
T Consensus 235 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 235 EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp CCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 111 111112234578999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=359.04 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=204.4
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK---- 571 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 571 (796)
..++|++.+.||+|+||.||+|+.+ +|+.||||++...... ...+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 3467999999999999999999765 7999999999765432 23468999999999999999999999986543
Q ss_pred -----------------------------------------------------eeeEEEeeccCCcHHHHHhhcCccccc
Q 003780 572 -----------------------------------------------------CMFLIYKYMKRGSLFCFLRNDYEAVVL 598 (796)
Q Consensus 572 -----------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l 598 (796)
..++||||+++|+|.+++.+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 379999999999999999987666667
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC------------Ccccccc
Q 003780 599 DWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS------------NRTIVAG 666 (796)
Q Consensus 599 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~g 666 (796)
++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 8888999999999999999999 999999999999999999999999999987765421 1233569
Q ss_pred ccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHH
Q 003780 667 TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTT 746 (796)
Q Consensus 667 t~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 746 (796)
|+.|+|||++.+..++.++||||+||++|||++|..|+.. ............. + .........+.+
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~~~~~-~---~~~~~~~~~~~~ 304 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVRNLKF-P---LLFTQKYPQEHM 304 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHHTTCC-C---HHHHHHCHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhhccCC-C---cccccCChhHHH
Confidence 9999999999999999999999999999999999877431 1111222222211 1 112223345688
Q ss_pred HHHHcCCCCCCCCCCHHHHHHH
Q 003780 747 VALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 747 li~~cl~~dP~~RPs~~evl~~ 768 (796)
++.+||+.||++|||++|++++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.84 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=209.6
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999764 7999999999865443333456788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998653 388999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+.
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~p~--- 224 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAELRFPP--- 224 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCCCCCCT---
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCC---
Confidence 2 234579999999999999999999999999999999999999997321 22233334333332211
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
.....+.+++.+|++.||++|| +++|+++|-
T Consensus 225 --~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 225 --FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp --TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 1123477899999999999999 899998773
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.12 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=200.5
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhh--cCCCceeeEEeEEEec----c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK--IAHRNIVKLYGFCLHK----K 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~----~ 571 (796)
.++|++.+.||+|+||+||+|+. +|+.||||++.... .+.+..|.+++.. ++||||+++++++... .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 46899999999999999999987 68999999986543 2345566666666 7899999999997653 4
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEEecCCCCCeEecCCCcE
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH--------HDCMPSIVHRDISSNNILLNSKLEA 643 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~dlkp~NIll~~~~~~ 643 (796)
..++||||+++|+|.++++.. .+++..+.+++.|+++||+||| +. +|+||||||+||+++.++.+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 689999999999999999643 4899999999999999999999 76 99999999999999999999
Q ss_pred EEeeeccccccCCCCCC----ccccccccCccCccccccC------CcCcchhHHHHHHHHHHHHhC----------CCC
Q 003780 644 FVADFGTARLLDSDSSN----RTIVAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMG----------RHP 703 (796)
Q Consensus 644 kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DVwSlGv~l~elltg----------~~p 703 (796)
||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 99999999876543322 2234699999999998876 556799999999999999999 777
Q ss_pred CcccccCCCCCchhhhHHHHhhcCCCCCcc--chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 704 GELLSSLSSPSSDQKIMLIDVLDSRLSPPV--DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
|....... ................+.. ..........+.+++.+||+.||++|||++|+++.|+++
T Consensus 233 f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPND---PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSS---CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCC---cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 65322211 1111111111111111111 112233456789999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.49 Aligned_cols=258 Identities=26% Similarity=0.337 Sum_probs=200.7
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
++|++.+.||+|+||+||+|+..+|+.||+|++....... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999988889999999997655332 223578899999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 9986 8998887543 3488999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC---------
Q 003780 659 SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR--------- 728 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 728 (796)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHHCCCChhhchhhh
Confidence 334445689999999998764 589999999999999999999999874221 01111111111100
Q ss_pred --------CC----CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 729 --------LS----PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 729 --------~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.. .............+.+++.+||+.||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00000011123457799999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.40 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=209.7
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++...........+.+..|..++..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999765 5889999999876543333356788999999988 7999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999998643 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~~~~p~- 242 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHNVAYPK- 242 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCT-
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhCCCCCCC-
Confidence 44444445567999999999999999999999999999999999999999732 122333334333332211
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPT-----MQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 768 (796)
.....+.+++.+||+.||++||+ ++|+++|
T Consensus 243 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 243 ----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11234779999999999999995 5777766
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=365.67 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=209.6
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|.+.+.||+|+||.||+|+.+ +++.||||+++..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH--HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 3468999999999999999999875 7999999999765332 224578899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.++++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 190 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999998643 3488999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 656 SDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 656 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... .......+......+
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---------~~~~~~~~~~~~~~~ 335 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---------NQQTREFVEKGGRLP 335 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---------HHHHHHHHHTTCCCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---------HHHHHHHHHcCCCCC
Confidence 32111 112235778999999998899999999999999999998 999987322 111222222222222
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.... ....+.+++.+||+.||++|||++++++.|++..
T Consensus 336 ~~~~---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 336 CPEL---CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 2111 2234778999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=373.79 Aligned_cols=263 Identities=24% Similarity=0.293 Sum_probs=212.0
Q ss_pred HHHHHHHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 003780 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH 569 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 569 (796)
+.++....++|++.+.||+|+||+||+|+.+ +++.||+|++...........+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455556789999999999999999999865 588999999976543333333458899999999999999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
++..++||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999998632 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-ccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 650 TARLLDSDSSN-RTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 650 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
+++........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~~~ 292 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGK 292 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHHHh
Confidence 99876544332 23457999999999987 5678999999999999999999999997322 1122222
Q ss_pred hhc----CCCCCccchhhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHh
Q 003780 724 VLD----SRLSPPVDRMVMQDIVLVTTVALACLHSKPKF--RPTMQRVCQEFL 770 (796)
Q Consensus 724 ~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 770 (796)
++. ...+..... ....+.+++.+|+..+|++ ||+++|+++|-.
T Consensus 293 i~~~~~~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 293 IMNHKERFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp HHTHHHHCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred hhhccccccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 221 111111111 1234778999999999988 999999999843
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=365.48 Aligned_cols=268 Identities=24% Similarity=0.354 Sum_probs=213.0
Q ss_pred cHHHHHHHhcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceee
Q 003780 490 AFEDIIKATEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVK 562 (796)
Q Consensus 490 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~ 562 (796)
...++....++|++.+.||+|+||.||+|++ .+++.||||++....... ..+.+.+|++++.++ +||||++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH--HHHHHHHHHHHHHhhcCCcceee
Confidence 3445555678999999999999999999962 356899999997654332 246799999999999 7999999
Q ss_pred EEeEEEecce-eeEEEeeccCCcHHHHHhhcCc-----------------------------------------------
Q 003780 563 LYGFCLHKKC-MFLIYKYMKRGSLFCFLRNDYE----------------------------------------------- 594 (796)
Q Consensus 563 l~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------- 594 (796)
+++++.+++. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999986532
Q ss_pred ----------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 595 ----------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 595 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12288999999999999999999999 99999999999999999999999999998764432
Q ss_pred C--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 659 S--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 659 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
. ......||+.|+|||++.+..++.++|||||||++|||++ |+.||..... .......+..........
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~ 319 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--------DEEFCRRLKEGTRMRAPD 319 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--------SHHHHHHHHHTCCCCCCT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch--------hHHHHHHHHcCCCCCCCC
Confidence 2 2234568899999999999999999999999999999998 9999874221 111112222221111111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.....+.+++.+||+.||++|||++|++++|++..
T Consensus 320 ---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 320 ---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11234789999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.46 Aligned_cols=254 Identities=20% Similarity=0.271 Sum_probs=199.2
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchh-----------------------hHHHHHHHHHHHHHh
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEE-----------------------TTFFNSFQNEAHVLS 553 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 553 (796)
.++|++.+.||+|+||.||+|+. .+++.||||++....... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999975 478999999997654221 112357899999999
Q ss_pred hcCCCceeeEEeEEEe--cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCC
Q 003780 554 KIAHRNIVKLYGFCLH--KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDIS 631 (796)
Q Consensus 554 ~l~hpniv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk 631 (796)
+++||||+++++++.. .+..++||||+++++|.+++.. ..+++..+..++.|+++||+|||+. +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999987 5688999999999999876532 3489999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeeeccccccCCCCCCccccccccCccCccccccCC---cCcchhHHHHHHHHHHHHhCCCCCcccc
Q 003780 632 SNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMV---VTEKCDVYSFGVVALEVLMGRHPGELLS 708 (796)
Q Consensus 632 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DVwSlGv~l~elltg~~p~~~~~ 708 (796)
|+||+++.++.+||+|||+++.............||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987765444344567999999999987655 4778999999999999999999987321
Q ss_pred cCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 709 SLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
...............+... .....+.+++.+||+.||++|||++|+++|-
T Consensus 245 --------~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 245 --------IMCLHSKIKSQALEFPDQP---DIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp --------HHHHHHHHHHCCCCCCSSS---CCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred --------HHHHHHHHhcccCCCCCcc---ccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 1111222222222211111 1123478999999999999999999998763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=348.01 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=203.0
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+.+ +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 57999999999999999999764 68999999998665433 23467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++ ++.+.+.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99986 5555554432 3489999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCCccccccccCccCccccccCC-cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC-----
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP----- 731 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 731 (796)
........||+.|+|||++.+.. ++.++||||+||++|||++|+.|+..... .......+..........
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHHhCCCChhhhhhh
Confidence 44455567899999999987765 79999999999999999999988542111 001111111111100000
Q ss_pred ----------------ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 732 ----------------PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 732 ----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
............+.+++.+||+.||++|||++|+++|-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 00000111234577999999999999999999999873
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=356.49 Aligned_cols=267 Identities=28% Similarity=0.466 Sum_probs=189.4
Q ss_pred CCCCcc--CCceeeCCC---CCeEEEeCCCCCccc--cccccccCCCCCCcEEeccC-CcccccCCcCccCCCCCcEeec
Q 003780 57 SSDHCK--LDGVTCNTA---RSIIEINLPEKKLKG--ELSQFNFSCFPGLESLSLRF-NYLFGSIPSQVGALSKLRYLDF 128 (796)
Q Consensus 57 ~~~~C~--w~gv~C~~~---~~v~~l~l~~~~l~~--~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L 128 (796)
+++||. |.||+|+.. ++|+.|+|+++++.| .++. .|..+++|++|+|++ |.+.+.+|..|+++++|++|+|
T Consensus 30 ~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~L 108 (313)
T 1ogq_A 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108 (313)
T ss_dssp TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEE
T ss_pred CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEEC
Confidence 568998 999999864 678888888777777 5554 467777777777774 7777777777777777777777
Q ss_pred ccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCC-CccEEEcccccccC
Q 003780 129 SFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLN-NLLILSLDSNKLSG 207 (796)
Q Consensus 129 s~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~ 207 (796)
++|.+++.+|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|..+..++ +|++|+|++|++++
T Consensus 109 s~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~ 188 (313)
T 1ogq_A 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188 (313)
T ss_dssp EEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE
T ss_pred cCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeec
Confidence 77777767777777777777777777777777777777777777777777777766777777766 67777777777776
Q ss_pred cchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCcccccc
Q 003780 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTR 287 (796)
Q Consensus 208 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 287 (796)
.+|..+..++ |++|++++|++++..|..+..+++|+.|+|++|++++.+|. +..+++|+.|+|++|++++.+|..+..
T Consensus 189 ~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 266 (313)
T 1ogq_A 189 KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQ 266 (313)
T ss_dssp ECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGG
T ss_pred cCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhc
Confidence 6676666665 77777777777666666666677777777777777655544 566666677777777766666666666
Q ss_pred ccccccccccCccccCccccccccccccceecccccc-ccc
Q 003780 288 LSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNK-LSG 327 (796)
Q Consensus 288 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~ 327 (796)
+++|++|+|++|+++|.+|.. ..+++|+.|++++|. +.|
T Consensus 267 l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 267 LKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred CcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 666666666666666666654 566666666666665 443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.63 Aligned_cols=256 Identities=27% Similarity=0.476 Sum_probs=196.1
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchh-hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEE-TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|... |+.||||++....... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357999999999999999999875 8999999987654332 22346789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC--------CCcEEEeee
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS--------KLEAFVADF 648 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--------~~~~kl~Df 648 (796)
|||+++++|.+++... .+++..+..++.|+++||+|||++...+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998643 4899999999999999999999992222999999999999986 678999999
Q ss_pred ccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
|+++...... .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ............
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------GLAVAYGVAMNK 230 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHTSC
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHhhhcCC
Confidence 9998665432 223568999999999999899999999999999999999999987321 122222222222
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
....... .....+.+++.+|++.||++|||+.|++++|++
T Consensus 231 ~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LALPIPS---TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCc---ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 2222211 122347899999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.31 Aligned_cols=266 Identities=25% Similarity=0.431 Sum_probs=216.1
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||.||+|..++++.||||+++..... .+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 45689999999999999999999888999999999865432 468999999999999999999999986 6678999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.++++... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999997542 23478899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... .....+++.|+|||++....++.++|||||||++|||+| |+.||.... ...... .+......+..
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~-~i~~~~~~~~~ 407 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIR-ALERGYRMPRP 407 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHH-HHHHTCCCCCC
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHH-HHHcCCCCCCC
Confidence 2111 122346778999999998899999999999999999999 999987321 111121 22222221111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 783 (796)
. .....+.+++.+||+.||++|||+++|++.|+.........|.+.
T Consensus 408 ~---~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~~~~ 453 (454)
T 1qcf_A 408 E---NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453 (454)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSSBCC
T ss_pred C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccccccC
Confidence 1 122347899999999999999999999999999887776666654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=359.08 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=206.7
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|+++++.++||||+++++++..++..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999754 68999999998765444444578899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999998643 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccCccCcccccc---CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 658 SSNRTIVAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .................+ .
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~p-~ 241 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-----TSSKEIVHTFETTVVTYP-S 241 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-----SCHHHHHHHHHHCCCCCC-T
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhhcccCCC-C
Confidence 33345679999999999874 4588999999999999999999999974321 111122222222222111 1
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPT-MQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 768 (796)
.....+.+++.+||+.||++||+ ++++.++
T Consensus 242 ----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 242 ----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ----cCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 11234789999999999999998 7777654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=370.14 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=210.0
Q ss_pred HHHHHHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 492 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
.++....++|++.+.||+|+||+||+|+.+ +++.||+|++...........+.+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455689999999999999999999765 6899999999764433322234688999999999999999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
+..++||||+++|+|.+++++. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999999754 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-CccccccccCccCccccccCC----cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 651 ARLLDSDSS-NRTIVAGTYGYIAPELAYTMV----VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 651 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......++
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~ 286 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIM 286 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHHHH
Confidence 987654332 223567999999999987655 7889999999999999999999997321 122222222
Q ss_pred cCC--CCCccchhhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHh
Q 003780 726 DSR--LSPPVDRMVMQDIVLVTTVALACLHSKPKF--RPTMQRVCQEFL 770 (796)
Q Consensus 726 ~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 770 (796)
... ...+... .....+.+++.+||+.+|++ ||+++||++|-.
T Consensus 287 ~~~~~~~~p~~~---~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 287 NHKNSLTFPDDN---DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp THHHHCCCCTTC---CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred hccccccCCCcc---cccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 211 1111100 11234778999999999999 999999999854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.89 Aligned_cols=256 Identities=28% Similarity=0.437 Sum_probs=197.5
Q ss_pred hcCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||.||+|+.+ ++..||||+++..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 357999999999999999999764 5778999999765432 2346899999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++++.. ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999998643 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc---cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 654 LDSDSSNR---TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 654 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
........ ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .. .....+....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~-~~~~~i~~~~ 267 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQ-DVIKAVDEGY 267 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HH-HHHHHHHTTE
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HH-HHHHHHHcCC
Confidence 65432211 12235678999999999999999999999999999998 999986321 11 1222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
..+.. ......+.+++.+||+.||++||+++|+++.|+..
T Consensus 268 ~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 268 RLPPP---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ECCCC---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11111 12233478999999999999999999999999765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=355.98 Aligned_cols=250 Identities=19% Similarity=0.254 Sum_probs=209.7
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999764 7999999999766544434456789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998653 389999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+.
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p~--- 259 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGKVRFPS--- 259 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCT---
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCCCCCCC---
Confidence 2 234579999999999999999999999999999999999999987321 22233333333322111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPT-----MQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 769 (796)
.....+.+++.+||+.||++||+ ++|+++|-
T Consensus 260 --~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 260 --HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp --TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 11234789999999999999998 88888764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.88 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=207.8
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||.||+|+.++++.||+|++...... .+++.+|++++++++||||+++++++..++..++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 35689999999999999999999888999999999876544 25688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp ECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999997632 3489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... ..... ..+.........
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~-~~~~~~~~~~~~ 243 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETA-EHIAQGLRLYRP 243 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHH-HHHHTTCCCCCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHH-HHHhcccCCCCC
Confidence 211 1122346778999999998899999999999999999998 999987322 11112 222222222111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
... ...+.+++.+||+.||++|||++|++++|++..
T Consensus 244 ~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 244 HLA---SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp TTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 111 234779999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.89 Aligned_cols=274 Identities=18% Similarity=0.192 Sum_probs=215.7
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... +.+.+|+.+++++ +|+|++++++++......++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 46799999999999999999974 57999999998654432 3578899999999 79999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc-----EEEeeecc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE-----AFVADFGT 650 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfg~ 650 (796)
||||+ +++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 84 v~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999 999999998643 2489999999999999999999999 9999999999999987776 99999999
Q ss_pred ccccCCCCC-------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 651 ARLLDSDSS-------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 651 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~ 232 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYER 232 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc-----ccHHHHHH
Confidence 987654322 123456999999999999999999999999999999999999999753221 11111111
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccccHHH
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQ 787 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 787 (796)
....................+.+++.+|++.||++||++++|++.|++..........+..+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 1111111111111112234588999999999999999999999999887654444444444443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=355.10 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=203.8
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ +++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999755 79999999997554332 235688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999987543 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CC--CCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 657 DS--SNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 657 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
.. .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... ................
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~ 230 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDWKEKKTYLNP 230 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-------SHHHHHHHTTCTTSTT
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHHhcccccCCc
Confidence 22 22234579999999999987765 67899999999999999999999743211 1111111122111111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......+.+++.+||+.||++|||++|++++-.
T Consensus 231 ---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 1112234778999999999999999999998853
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=361.54 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=212.2
Q ss_pred hcCCccceeeecccceeEEEEEcc--------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP--------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
.++|.+.+.||+|+||.||+|+.. .++.||||++...... ...+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH--HHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 468999999999999999999742 3468999999766433 2356889999999999 8999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
.++..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999986532 23589999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~ 712 (796)
+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---- 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 999999999999999987654322 2233457889999999999999999999999999999999 999986321
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.......+.......... .....+.+++.+||+.||++|||++|++++|++...
T Consensus 299 -----~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 299 -----VEELFKLLKEGHRMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp -----HHHHHHHHHTTCCCCCCS---SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHcCCCCCCCc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112222222222222211 122347899999999999999999999999987653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=368.37 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=210.0
Q ss_pred HHHHHHHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 003780 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH 569 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 569 (796)
+++.....++|++.+.||+|+||.||+|+.+ +|+.||+|++.+.........+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4444556789999999999999999999764 799999999976543333334568899999999999999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
++..++||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 999999999999999999998643 2489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-ccccccccCccCccccc-------cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHH
Q 003780 650 TARLLDSDSSN-RTIVAGTYGYIAPELAY-------TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 650 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (796)
+++........ ....+||+.|+|||++. +..++.++|||||||++|||++|+.||.... .....
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~ 279 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TAETY 279 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 99876544332 23457999999999987 3568999999999999999999999997321 12222
Q ss_pred HHhhcC--CCC-CccchhhHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHH
Q 003780 722 IDVLDS--RLS-PPVDRMVMQDIVLVTTVALACLHSKPKFR---PTMQRVCQEF 769 (796)
Q Consensus 722 ~~~~~~--~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L 769 (796)
..++.. ... +... ......+.+++.+||+ +|++| |+++|+++|-
T Consensus 280 ~~i~~~~~~~~~p~~~---~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 280 GKIVHYKEHLSLPLVD---EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHHHTHHHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred HHHHhcccCcCCCccc---cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 222211 111 1110 1112347789999999 99998 6999998874
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=374.47 Aligned_cols=340 Identities=22% Similarity=0.259 Sum_probs=285.3
Q ss_pred CCccCCc--eeeCCC---------CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccC-CcCccCCCCCcEe
Q 003780 59 DHCKLDG--VTCNTA---------RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSI-PSQVGALSKLRYL 126 (796)
Q Consensus 59 ~~C~w~g--v~C~~~---------~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L 126 (796)
..|.|.+ |.|+.. .+++.|+|+++.+++..+ ..|+.+++|++|+|++|.+.+.+ +..|.++++|++|
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECT-TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCCh-hHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 4466655 778643 468999999999987544 46899999999999999998554 6689999999999
Q ss_pred ecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchh--hhccCccceeeccccccCCCCCcc-ccCCCCccEEEcccc
Q 003780 127 DFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSS--LCQLTKLITMALSRNGLHGPIPSA-IGDLNNLLILSLDSN 203 (796)
Q Consensus 127 ~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N 203 (796)
+|++|.+++..|..|+++++|++|+|++|++++.+|.. |.++++|++|+|++|++++..|.. |.++++|++|+|++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99999999888999999999999999999999866655 999999999999999999988876 899999999999999
Q ss_pred cccCcchhhhcCC--CCccccccCCccccccCCCc--------ccccCccceEEeccccccccCCccccC----------
Q 003780 204 KLSGMLHQELGKL--KNLVALNVGGNKLMGPIPST--------LFRLTNLTYLYLHSNHLNGSIPPEIGN---------- 263 (796)
Q Consensus 204 ~l~~~~~~~~~~l--~~L~~L~l~~N~l~~~~~~~--------l~~l~~L~~L~L~~N~l~~~~p~~~~~---------- 263 (796)
++++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|++|+|++|++++.+|..+..
T Consensus 165 ~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp CBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred cccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence 9999999888776 67888888888887655433 235577888888888776554433321
Q ss_pred -----------------------------CcccceeecccccccccCccccccccccccccccCccccCccccccccccc
Q 003780 264 -----------------------------MTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314 (796)
Q Consensus 264 -----------------------------l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 314 (796)
.++|+.|++++|++++..|..+..+++|++|+|++|.+++..|..|.++++
T Consensus 245 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 324 (455)
T 3v47_A 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324 (455)
T ss_dssp ECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred eeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence 257899999999999888999999999999999999999888889999999
Q ss_pred cceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCcc---ccccccccccC
Q 003780 315 LKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPF---LYHRFPLDLSY 390 (796)
Q Consensus 315 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~---~~~~~~l~l~~ 390 (796)
|++|+|++|++++..|..|..+++|+.|+|++|++++..|..+ .+++|++|+|++|++++..+.. +.++..|++++
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 404 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccC
Confidence 9999999999988888899999999999999999998878776 4789999999999998655433 34566899999
Q ss_pred CCCcccCCC
Q 003780 391 NDLEGEIPD 399 (796)
Q Consensus 391 N~l~~~~p~ 399 (796)
|.+++..|.
T Consensus 405 N~l~~~~~~ 413 (455)
T 3v47_A 405 NPWDCSCPR 413 (455)
T ss_dssp SCBCCCTTT
T ss_pred CCcccCCCc
Confidence 999998884
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.08 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=206.1
Q ss_pred hcCCccceeeecccceeEEEEEc-----cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-- 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 570 (796)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46899999999999999999973 3689999999976543 2346889999999999999999999999654
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 45899999999999999998653 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC---CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCccccc-------CCCCCchhhhH
Q 003780 651 ARLLDSDSS---NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSS-------LSSPSSDQKIM 720 (796)
Q Consensus 651 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~-------~~~~~~~~~~~ 720 (796)
++....... ......++..|+|||.+.+..++.++||||||+++|||+||..|+..... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987654322 12233477789999999999999999999999999999999999763211 00001111112
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
....+......+... .....+.+++.+||+.||++|||++|+++.|++...
T Consensus 241 ~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNGRLPRPD---GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTCCCCCCT---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCc---CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 222222222222211 222358899999999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=352.61 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=197.8
Q ss_pred hcCCccceeeecccceeEEEEEc----cCCcEEEEEEeccccchh-hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETEE-TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
.++|++.+.||+|+||.||+|+. .+|+.||+|++....... ......+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999975 479999999998654321 1224567899999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997643 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~p 241 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKCKLNLP 241 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCCC
Confidence 65444333445679999999999999899999999999999999999999997321 1222333333322211
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
. .....+.+++.+||+.||++|| ++.|+++|-
T Consensus 242 ~-----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 242 P-----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp T-----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred C-----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 1 1123477899999999999999 788998874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=356.38 Aligned_cols=264 Identities=26% Similarity=0.387 Sum_probs=212.8
Q ss_pred HHhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH 569 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 569 (796)
...++|++.+.||+|+||.||+|+.. +++.||+|+++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34678999999999999999999764 3589999999865432 235689999999999999999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCc---------------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEe
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYE---------------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHR 628 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 628 (796)
++..++||||+++|+|.+++..... ...+++..++.++.||++||+|||++ +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9999999999999999999986421 14589999999999999999999999 99999
Q ss_pred cCCCCCeEecCCCcEEEeeeccccccCCCC--CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCc
Q 003780 629 DISSNNILLNSKLEAFVADFGTARLLDSDS--SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGE 705 (796)
Q Consensus 629 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~ 705 (796)
||||+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999998654322 12233457889999999998899999999999999999999 999987
Q ss_pred ccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 706 LLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
... .......+.......... .....+.+++.+||+.||++||++.|++++|++.....
T Consensus 279 ~~~--------~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 279 GMA--------HEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TSC--------HHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCC--------hHHHHHHHhCCCcCCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 321 122222222222211111 12234789999999999999999999999999876533
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.82 Aligned_cols=259 Identities=15% Similarity=0.174 Sum_probs=207.5
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +.+.+|+++++++ +||||+++++++..++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 46799999999999999999974 57999999998755432 3578999999999 89999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc-----EEEeeecc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE-----AFVADFGT 650 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfg~ 650 (796)
||||+ +++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99999 999999998642 3589999999999999999999999 9999999999999999887 99999999
Q ss_pred ccccCCCCCC-------ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 651 ARLLDSDSSN-------RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 651 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-----~~~~~~~~~ 231 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-----DTLKERYQK 231 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----SSHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-----ccHHHHHHH
Confidence 9876543221 2346799999999999999999999999999999999999999974321 111111111
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
+................. .+.+++..|++.||.+||+++++.+.|++..
T Consensus 232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 111111111111011112 6889999999999999999999999987543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.53 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=200.8
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC---- 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 572 (796)
.++|++.+.||+|+||.||+|+. .+++.||||++...........+.+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999975 5799999999987765555556789999999999999999999999977654
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+++|+|.++++... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 499999999999999998653 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 653 LLDSDSS---NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 653 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~ 236 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDP 236 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCCC
Confidence 7654322 1233568999999999999999999999999999999999999987321 1122222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.+.. .........+.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~-~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 237 IPPS-ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CCHH-HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCcc-cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 2211 1011123457899999999999999977776655
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=359.48 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=208.2
Q ss_pred hcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
.++|++.+.||+|+||.||+|+.. +++.||||++....... ....+.+|+.++++++||||+++++++...+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 367999999999999999999742 47789999997544332 2457889999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcC----cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC---cEE
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDY----EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL---EAF 644 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~k 644 (796)
..++||||+++|+|.+++.... ....+++..++.++.||++||+|||++ +|+||||||+||+++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999998653 224589999999999999999999999 999999999999999555 599
Q ss_pred EeeeccccccCCCC--CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHH
Q 003780 645 VADFGTARLLDSDS--SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 645 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 721 (796)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.... .. ..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~-~~ 295 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQ-EV 295 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HH-HH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HH-HH
Confidence 99999998653221 22334568899999999999999999999999999999998 999987321 11 22
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
...+.......... .....+.+++.+||+.||++|||++|++++|+...
T Consensus 296 ~~~i~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 296 LEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCc---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 22222222211111 12234789999999999999999999999997654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=357.42 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=210.5
Q ss_pred HHhcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
...++|++.+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3457899999999999999999975 24678999999754322 2246889999999999 8999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCcc--------------------cccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYEA--------------------VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHR 628 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 628 (796)
.++..++||||+++|+|.+++...... ..+++..+..++.|+++||+|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999865321 3478999999999999999999999 99999
Q ss_pred cCCCCCeEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCc
Q 003780 629 DISSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGE 705 (796)
Q Consensus 629 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~ 705 (796)
||||+||+++.++.+||+|||++......... .....||+.|+|||.+.+..++.++|||||||++|+|+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543322 233457889999999998899999999999999999998 999987
Q ss_pred ccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 706 LLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
.... .......+.......... .....+.+++.+||+.||.+|||+.|++++|+......
T Consensus 277 ~~~~--------~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 277 GIPV--------DANFYKLIQNGFKMDQPF---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TCCC--------SHHHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCc--------HHHHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 4321 112222233322222211 12234788999999999999999999999998876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=354.28 Aligned_cols=251 Identities=23% Similarity=0.281 Sum_probs=183.0
Q ss_pred eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEEeeccC
Q 003780 505 YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
+.||+|+||.||+|..+ +++.||||++.... ...+.+|+.+++.+. ||||+++++++.++...++||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 78999999999999764 68999999996432 346788999999997 99999999999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC---cEEEeeeccccccCCCCC
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL---EAFVADFGTARLLDSDSS 659 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~ 659 (796)
|+|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 91 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 91 GELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999998653 489999999999999999999999 999999999999998765 899999999987665544
Q ss_pred CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHH
Q 003780 660 NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQ 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||......... .........+........ ......
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~~~~~-~~~~~~ 242 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGDFSFE-GEAWKN 242 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTCCCCC-SHHHHT
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCCCCCC-cccccC
Confidence 455567899999999999999999999999999999999999999753321111 111122222222222211 111122
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 740 DIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 740 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
....+.+++.+||+.||++|||++|++++-
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 334588999999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=349.70 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=210.7
Q ss_pred hcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|++++++++||||+++++++..++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 56899999999999999999964 34588999999765432 23568899999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCc---------------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecC
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYE---------------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDI 630 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 630 (796)
..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||++ +|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999986532 23488999999999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCccc
Q 003780 631 SSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELL 707 (796)
Q Consensus 631 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~ 707 (796)
||+||+++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++||||+||++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543222 223347788999999998889999999999999999999 99998732
Q ss_pred ccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 708 SSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.. ......+.......... .....+.+++.+||+.||++||+++|++++|++..
T Consensus 257 ~~---------~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 257 PP---------ERLFNLLKTGHRMERPD---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CG---------GGHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CH---------HHHHHHhhcCCcCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 21 11222222222222111 12234789999999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=357.35 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=207.1
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|..+ +|+.||+|++......+ ...+.+|++++++++||||+++++++.+++..++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999754 78999999997654332 34788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC--CCcEEEeeecccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS--KLEAFVADFGTARLL 654 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~ 654 (796)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999987542 3489999999999999999999999 9999999999999974 477999999999876
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+..........
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 272 (387)
T 1kob_A 202 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDWEFDED 272 (387)
T ss_dssp CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCCCCCSS
T ss_pred CCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCcc
Confidence 5432 2334569999999999999999999999999999999999999987321 112222222222111110
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
........+.+++.+||+.||++|||++|++++-
T Consensus 273 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 273 -AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 0111223478999999999999999999999984
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=350.26 Aligned_cols=261 Identities=20% Similarity=0.309 Sum_probs=191.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|..+ +|+.||+|++....... ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999765 68999999997654322 235788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcC---cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 577 YKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
|||++ |+|.+++.... ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 59999887542 123488999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC-----
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS----- 727 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 727 (796)
............||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.+....
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTT
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhH
Confidence 7544444445578999999999876 4689999999999999999999999974221 0001111111100
Q ss_pred ------------CCC----Cccch-----hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 728 ------------RLS----PPVDR-----MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 728 ------------~~~----~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
... ..... ........+.+++.+||+.||++|||++|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 000 00000 0001123588999999999999999999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=366.45 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=209.3
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999765 7999999999866544333456889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997543 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+... .......+.......+.
T Consensus 169 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~p~-- 237 (476)
T 2y94_A 169 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFKKICDGIFYTPQ-- 237 (476)
T ss_dssp TC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHHHHHTTCCCCCT--
T ss_pred cc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCcCCCc--
Confidence 32 2344579999999999988765 689999999999999999999997422 11222223322222111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+||+.||++|||++|+++|-
T Consensus 238 ---~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 238 ---YLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp ---TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred ---cCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 1123477899999999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=354.67 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=203.1
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC--CceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH--RNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||.||++...+++.||||++....... ...+.+.+|++++++++| |||+++++++..++..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45799999999999999999998889999999997665433 335688999999999986 999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||| +.+|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 56889999998653 488999999999999999999999 999999999999997 5789999999998765
Q ss_pred CCCC--CccccccccCccCcccccc-----------CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 656 SDSS--NRTIVAGTYGYIAPELAYT-----------MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 656 ~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~ 231 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 231 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------hHHHHHH
Confidence 4322 2234569999999999865 678899999999999999999999997321 1222333
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..++............ ..+.+++.+||+.||++|||+.|++++..
T Consensus 232 ~~~~~~~~~~~~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 232 AIIDPNHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHHCTTSCCCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhcCCcccCCcccCC---HHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 4444433333222221 24778999999999999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=370.75 Aligned_cols=253 Identities=22% Similarity=0.275 Sum_probs=199.9
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+. .+|+.||||++.............+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999975 47999999999865433333346788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|||+++|+|.+++.+.. .+++..+..++.||++||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997653 48999999999999999999998 7 99999999999999999999999999998655
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+.
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p~-- 370 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFPR-- 370 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCT--
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCCCCc--
Confidence 44444455779999999999999999999999999999999999999986321 12222233333322111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
.....+.+++.+||+.||++|| +++|+++|-
T Consensus 371 ---~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 371 ---TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 1123477999999999999999 999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.58 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=187.4
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999975 57999999999765544433456889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999998642 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........||+.|+|||.+.+..++.++||||+|+++|+|++|+.||...... ............ ..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~--~~-- 232 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--------NTLNKVVLADYE--MP-- 232 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCC--CC--
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--------HHHHHHhhcccC--Cc--
Confidence 433334456899999999999888999999999999999999999998743211 011111111111 11
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+.+++.+||+.||++|||++|++++-
T Consensus 233 -~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 233 -SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred -cccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 11123477999999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.05 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=208.0
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|..+ +|+.||+|++........ ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 578999999999999999999754 689999999977654432 356789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc---EEEeeeccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE---AFVADFGTARL 653 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~a~~ 653 (796)
|||+++++|.+.+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||.+..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999887653 389999999999999999999999 9999999999999987655 99999999987
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
..... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .................
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 158 VNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp CCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCCT
T ss_pred cccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhHHHHHHHhccccCCc
Confidence 65432 2334569999999999999999999999999999999999999986321 11222222222221111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. .......+.+++.+|++.||++|||++|++++-
T Consensus 229 ~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 229 PE-WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp TT-TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred hh-hcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 10 111223478999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.04 Aligned_cols=252 Identities=30% Similarity=0.448 Sum_probs=205.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|..+ +++.||+|++...........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999654 6789999999766544444456789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999997653 389999999999999999999999 999999999999999999999999999865433
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ...............+ .
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~--~- 228 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVEFTFP--D- 228 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCC--T-
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhCCCCCC--C-
Confidence 2 2234568999999999999999999999999999999999999987321 1112222222211111 1
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.....+.+++.+||+.||++|||++|+++|-.
T Consensus 229 --~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 229 --FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp --TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred --cCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 11234778999999999999999999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=355.21 Aligned_cols=255 Identities=23% Similarity=0.284 Sum_probs=197.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+++.+ +++.||+|++...... .+.+.+|+.++++++||||+++++++..++..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 468999999999999999999765 7999999999765433 24688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc--EEEeeecccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE--AFVADFGTARLL 654 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~~ 654 (796)
|||+++|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 95 MEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999997643 389999999999999999999999 9999999999999987765 999999999754
Q ss_pred CCCCCCccccccccCccCccccccCCcCcc-hhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEK-CDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
.... ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...... .................+.
T Consensus 169 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 169 VLHS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTIQRILSVKYSIPD 243 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHHHHHHTTCCCCCT
T ss_pred cccC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhcCCCCCCC
Confidence 3322 2234569999999999988877655 89999999999999999999743321 1112222333333222211
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. .....+.+++.+||+.||++|||+.|+++|-.
T Consensus 244 ~~---~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 244 DI---RISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp TS---CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred cC---CCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 11 11234779999999999999999999999843
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.52 Aligned_cols=249 Identities=22% Similarity=0.226 Sum_probs=196.3
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||+||+|+.+ +|+.||||++......... ...+..|+..+.++ +||||+++++++.+++..++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 357999999999999999999765 7999999998765544333 23445566555555 89999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+ +++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 668988887643 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...........+..
T Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~~~~~~~~~-- 273 (311)
T 3p1a_A 209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLRQGYLPPEF-- 273 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHTTTCCCHHH--
T ss_pred cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHhccCCCccc--
Confidence 432 2334569999999999876 68999999999999999999977654211 11112222221111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.......+.+++.+||+.||++|||++|++++-
T Consensus 274 -~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 274 -TAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp -HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 112234588999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.07 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=198.5
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||+||+|+.. ..||+|++....... ...+.+.+|++++++++||||+++++++ .....++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 3568999999999999999999864 359999997665443 3356899999999999999999999965 45668999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999997543 3489999999999999999999999 999999999999999999999999999986543
Q ss_pred C--CCCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 657 D--SSNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 657 ~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
. ........||+.|+|||.+. +..++.++||||+|+++|+|++|+.||..... ..............+
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLSP 245 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHHHHHHHHHTSCCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcccccCc
Confidence 2 12223456899999999986 56788899999999999999999999974221 111111122222222
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
............+.+++.+||+.||++|||++|+++.|++..
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 222212223345889999999999999999999999998864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.03 Aligned_cols=254 Identities=19% Similarity=0.269 Sum_probs=207.5
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--ceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 575 (796)
.++|++.+.||+|+||.||+|+.+ ++.||||++........ ..+.+.+|+.++++++||||+++++++..+ +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHH-HHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 357999999999999999999885 89999999987654332 346799999999999999999999999887 78899
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS--IVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
||||+++|+|.+++++.. ...+++..+..++.|+++||+|||+. + |+||||||+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999998653 23589999999999999999999998 7 99999999999999999999999988764
Q ss_pred cCCCCCCccccccccCccCccccccCCcCc---chhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTE---KCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
... ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||.... ..............
T Consensus 163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~~ 229 (271)
T 3kmu_A 163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEGLR 229 (271)
T ss_dssp TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSCCC
T ss_pred ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcCCC
Confidence 322 2245899999999988765554 7999999999999999999987321 12222233333333
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
+.... .....+.+++.+||+.||++|||++|+++.|++..
T Consensus 230 ~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 PTIPP---GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 22222 12234789999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=355.06 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=192.1
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|+.+ +++.||||++..... .+.+.+|++++++++||||+++++++..++..++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 4568999999999999999999765 688999999976532 2468899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~ 652 (796)
||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999997643 389999999999999999999999 9999999999999975 8899999999998
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........+........
T Consensus 200 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~i~~~~~~~~ 271 (349)
T 2w4o_A 200 IVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER-------GDQFMFRRILNCEYYFI 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-------CHHHHHHHHHTTCCCCC
T ss_pred ccCccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc-------ccHHHHHHHHhCCCccC
Confidence 765432 2334569999999999999999999999999999999999999986321 11112223333222111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
. .........+.+++.+||+.||++|||+.|++++-
T Consensus 272 ~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 272 S-PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp T-TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred C-chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1 00112233578999999999999999999999974
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=349.38 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=212.6
Q ss_pred HhcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLH 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 569 (796)
..++|++.+.||+|+||.||+|+. .+++.||+|++....... ..+.+.+|+++++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH--HHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 346899999999999999999974 357899999998654332 246789999999999 89999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCc---------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCC
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYE---------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNN 634 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 634 (796)
++..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999986532 12489999999999999999999999 99999999999
Q ss_pred eEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCC
Q 003780 635 ILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLS 711 (796)
Q Consensus 635 Ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~ 711 (796)
|+++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 253 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-- 253 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc--
Confidence 99999999999999999876544322 223457788999999998899999999999999999999 9999874321
Q ss_pred CCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
. ......+.......... .....+.+++.+|++.||++|||++|++++|++....
T Consensus 254 --~----~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 --D----SKFYKMIKEGFRMLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp --S----HHHHHHHHHTCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --h----hHHHHHhccCCCCCCcc---cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 11122222222211111 1123478999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=353.94 Aligned_cols=265 Identities=25% Similarity=0.327 Sum_probs=207.6
Q ss_pred HHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccch--hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 494 IIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETE--ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 494 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
+....++|++.+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|++++++++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345678899999999999999999975 57889999999765321 122356899999999999999999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcC-------------------------------------cccccCHHHHHHHHHHHHHH
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDY-------------------------------------EAVVLDWTMRVNIIKCVANA 613 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~ 613 (796)
+..++||||+++|+|.+++.... ....+++..+..++.|+++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985211 01224677788999999999
Q ss_pred HHHHhhcCCCCeEEecCCCCCeEecCCC--cEEEeeeccccccCCCCC----CccccccccCccCcccccc--CCcCcch
Q 003780 614 LSYLHHDCMPSIVHRDISSNNILLNSKL--EAFVADFGTARLLDSDSS----NRTIVAGTYGYIAPELAYT--MVVTEKC 685 (796)
Q Consensus 614 L~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~ 685 (796)
|+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999986543221 2234569999999999875 6788999
Q ss_pred hHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 003780 686 DVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRV 765 (796)
Q Consensus 686 DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 765 (796)
|||||||++|||++|+.||... .................... .......+.+++.+||+.||++||++.|+
T Consensus 258 DiwslG~il~el~~g~~pf~~~--------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGV--------NDADTISQVLNKKLCFENPN-YNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCTTSGG-GGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCC--------ChHHHHHHHHhcccccCCcc-cccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999999998732 12233334444443322211 11223458899999999999999999999
Q ss_pred HHHHh
Q 003780 766 CQEFL 770 (796)
Q Consensus 766 l~~L~ 770 (796)
+++-.
T Consensus 329 l~hp~ 333 (345)
T 3hko_A 329 LQHPW 333 (345)
T ss_dssp HHSHH
T ss_pred hcChh
Confidence 99743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.78 Aligned_cols=271 Identities=19% Similarity=0.277 Sum_probs=204.4
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...........+.+.+|+.++++++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999975 57999999999865444444467889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999987532 234588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
..........|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...............+....
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~ 261 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCDYPPLPSD 261 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHHHTTCSCCCCTT
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHhhcccCCCCccc
Confidence 544334445689999999999999999999999999999999999999863211 11111111111111111111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCcc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPF 780 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 780 (796)
.....+.+++.+||+.||++|||++|+++.|++.....+.+-
T Consensus 262 ---~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 262 ---HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ---ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 112347899999999999999999999999999877665443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=350.14 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=194.0
Q ss_pred HHhcCCccceeeecccceeEEEEEccCC----cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLPNG----KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
...++|++.+.||+|+||.||+|+.... ..||||++........ ..+.+.+|++++++++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH-HHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH-HHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456899999999999999999986543 2799999976543332 2578999999999999999999999998776
Q ss_pred ee------eEEEeeccCCcHHHHHhhcCc---ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc
Q 003780 572 CM------FLIYKYMKRGSLFCFLRNDYE---AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE 642 (796)
Q Consensus 572 ~~------~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 642 (796)
.. ++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 55 999999999999999875421 22589999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhh
Q 003780 643 AFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKI 719 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (796)
+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~ 247 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------AE 247 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GG
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--------HH
Confidence 999999999876443221 223446788999999999999999999999999999999 9999874221 11
Q ss_pred HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 720 MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
............... .....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 248 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 248 IYNYLIGGNRLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222222222111111 12234789999999999999999999999998653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=367.05 Aligned_cols=266 Identities=26% Similarity=0.416 Sum_probs=211.0
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||.||+|..+++..||||+++..... .+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 34678999999999999999999888888999999865432 3578999999999999999999999876 678999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 257 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999997532 23488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... ..... ..+......+..
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~-~~i~~~~~~~~~ 403 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVL-DQVERGYRMPCP 403 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHH-HHHHTTCCCCCC
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHcCCCCCCC
Confidence 3221 223346788999999998899999999999999999999 999986321 11122 222222222211
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 783 (796)
. .....+.+++.+||+.||++|||++++++.|+.......++|.+.
T Consensus 404 ~---~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~ 449 (452)
T 1fmk_A 404 P---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449 (452)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred C---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence 1 122347899999999999999999999999999877766666543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.40 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=211.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|+.++++++||||+++++++..++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999765 6889999999876544444457889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999987643 489999999999999999999999 999999999999999999999999999987764
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ...............+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~--- 236 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNEYSIPK--- 236 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCCCCCT---
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhhccCCCcc---
Confidence 4444455679999999999999889999999999999999999999987321 11122222222221111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+|++.||++|||++|++++-
T Consensus 237 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 237 --HINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred --ccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1123477899999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.51 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=198.7
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
++|++.+.||+|+||.||+|+.. ++.||+|++.... ..+.+.+|++++++++||||+++++++. +..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence 57899999999999999999875 7899999986432 2457899999999999999999999886 34789999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc-EEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE-AFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~ 657 (796)
|+++|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999987655455789999999999999999999933239999999999999998886 799999999765432
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... . ........ .....+....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~-~~~~~~~~~~-- 227 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-----P-AFRIMWAV-HNGTRPPLIK-- 227 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-----S-HHHHHHHH-HTTCCCCCBT--
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-----c-HHHHHHHH-hcCCCCCccc--
Confidence 2234589999999999999999999999999999999999999874221 1 11111111 1111221111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.....+.+++.+||+.||++|||++|+++.|+...
T Consensus 228 -~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 228 -NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred -ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 12234789999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.90 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=204.9
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|... +++.||+|++......+....+.+.+|+.++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999754 789999999987765555556789999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999998653 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC-CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 656 SDS-SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 656 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+....... .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~~~~~~~~~~-~ 255 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---------LSVMGAHINQAIPRP-S 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---------HHHHHHHHHSCCCCG-G
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---------HHHHHHHhccCCCCc-c
Confidence 432 12234568999999999999999999999999999999999999987321 112222222222211 1
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhhcCccc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRP-TMQRVCQEFLTCKIAL 776 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 776 (796)
.........+.+++.+||+.||++|| +++++++.|+......
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11112223477899999999999999 9999999998875543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=340.03 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=209.8
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++..++..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 3578999999999999999999888999999999876543 257899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999997643 3478999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 S-SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
. .......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... .......+ ..........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i-~~~~~~~~~~ 228 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDI-STGFRLYKPR 228 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHH-HTTCCCCCCT
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHH-hcCCcCCCCc
Confidence 1 11122346788999999998889999999999999999999 899987321 11122222 2222111111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.....+.+++.+|++.||++||+++|++++|++..
T Consensus 229 ---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 229 ---LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11234789999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.43 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=208.8
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhh---HHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEET---TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++........ ...+.+.+|+.++++++||||+++++++..++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999765 699999999976543321 1246789999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC----cEEEeeec
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL----EAFVADFG 649 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 649 (796)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 488999999999999999999999 999999999999999888 79999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... .............
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITSVSY 235 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCC
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhccc
Confidence 998765432 2234569999999999999999999999999999999999999986321 1222222222221
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
... ..........+.+++.+||+.||++|||++|++++-
T Consensus 236 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 236 DFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp CCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred ccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 111 111112234578999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=357.08 Aligned_cols=253 Identities=22% Similarity=0.363 Sum_probs=203.3
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC--CCceeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA--HRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lV 576 (796)
.+|++.+.||+|+||.||+|...+++.||||++....... ...+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH-HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4699999999999999999998889999999997655432 33578999999999996 59999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|| +.+++|.+++.+.. .+++..+..++.||++||+|||+. +|+||||||+||+++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 67889999998654 478889999999999999999999 999999999999996 58999999999987654
Q ss_pred CCC--CccccccccCccCcccccc-----------CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 657 DSS--NRTIVAGTYGYIAPELAYT-----------MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 657 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~~ 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLHA 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHHH
Confidence 322 1234569999999999865 368889999999999999999999997321 12223344
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.++........... ...+.+++.+||+.||++|||+.|++++-.
T Consensus 280 ~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 280 IIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhCccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 44444333222212 234779999999999999999999998854
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.84 Aligned_cols=259 Identities=25% Similarity=0.335 Sum_probs=200.0
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+.. +|+.||+|++...... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 67999999999999999999765 5999999998766543 233567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999999887543 389999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC---------
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS--------- 727 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 727 (796)
........||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||..... .............
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhccccccccccc
Confidence 444445679999999999876 6689999999999999999999999874321 1111111111100
Q ss_pred ---------CCCCcc-----chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 728 ---------RLSPPV-----DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 728 ---------~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
...... ..........+.+++.+||+.||++|||++|+++|-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 000000 000011223478999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=353.27 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=205.0
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
..++|++.+.||+|+||.||+|..+ +|+.||+|++..... ...+|++++.++ +||||+++++++.+++..+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 4568999999999999999999754 689999999976543 234688888888 7999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC----CcEEEeeecc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK----LEAFVADFGT 650 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~ 650 (796)
+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||++..+ +.+||+|||+
T Consensus 93 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999997653 489999999999999999999999 99999999999998543 3599999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
++............+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .........+......
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIGSGKFS 241 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHHHCCCC
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHccCCcc
Confidence 98776554444556799999999999888899999999999999999999999973211 1122222222222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
... .........+.+++.+||+.||++||+++|+++|-.
T Consensus 242 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 242 LSG-GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CCS-TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred cCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 111 001112234779999999999999999999999854
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.12 Aligned_cols=262 Identities=19% Similarity=0.291 Sum_probs=205.1
Q ss_pred hcCCccceeeecc--cceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 498 TEDFDIKYCIGTG--GYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 498 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
.++|++.+.||+| +||.||+|+.+ +|+.||||++....... ...+.+.+|+.++++++||||+++++++..++..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4689999999999 99999999765 79999999998765433 33567889999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++..... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999986532 3489999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCC-------CCccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 655 DSDS-------SNRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 655 ~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ..........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~ 254 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKLNGTV 254 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT----HHHHC-----
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCC
Confidence 2211 11223468999999999987 578999999999999999999999997432210 0000000000
Q ss_pred ----cCC-----------------------C----------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 ----DSR-----------------------L----------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 ----~~~-----------------------~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+.. . ..............+.+++.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 0 000000111123458899999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.42 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=206.3
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|+..+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999974 579999999998765444444678999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++ |++.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 68888876432 3489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 658 SSNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..................
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~ 275 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPALQS 275 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCCCCCC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCCCCCC
Confidence 2356999999999884 5678999999999999999999999986321 111222222222211111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
. .....+.+++.+||+.||++|||++|++++..-..
T Consensus 276 ~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 276 G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred C---CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 1 11234778999999999999999999999865443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=368.44 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=212.3
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||.||+|+.+ +|+.||+|++...........+.+.+|++++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999765 6999999999876544444456789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCc-ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRNDYE-AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|||+++|+|.+++..... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976532 34589999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..........+.......+ .
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~----~~~~~~~~~~i~~~~~~~p-~- 414 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRVLEQAVTYP-D- 414 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC----CCCHHHHHHHHHHCCCCCC-T-
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc----chhHHHHHHHHhhcccCCC-c-
Confidence 544444456799999999999999999999999999999999999999974321 1111222233333322211 1
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTM-----QRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 768 (796)
.....+.+++.+||+.||++||++ +|+++|
T Consensus 415 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 415 ---KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ---TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ---ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 112347789999999999999965 677665
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=350.82 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=199.1
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcE----EEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKV----VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
.++|++.+.||+|+||+||+|+.. +++. ||+|.+...... ...+.+.+|+.++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 357999999999999999999753 4444 588887654322 22468999999999999999999999998754
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 779999999999999998643 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 653 LLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 653 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------~~~~~~~~~~~ 236 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------SEISSILEKGE 236 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---------GGHHHHHHTTC
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---------HHHHHHHHcCC
Confidence 76544322 223346789999999999999999999999999999999 9999874221 11222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
...... .....+.+++.+||+.||++||++.|++++|+..
T Consensus 237 ~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 RLPQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp CCCCCT---TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred CCCCCc---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 222111 1223478899999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.59 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=198.7
Q ss_pred cceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeecc
Q 003780 503 IKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 503 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
..+.||+|+||.||+|.. .+|+.||+|++....... .+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 357899999999999975 579999999998654332 4578999999999999999999999999999999999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe--cCCCcEEEeeeccccccCCCCC
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL--NSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
+|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||++ +.++.+||+|||+++......
T Consensus 170 ~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 170 GGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 999999887542 3489999999999999999999999 99999999999999 567899999999998765432
Q ss_pred CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHH
Q 003780 660 NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQ 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+........... ...
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~~~~~~-~~~ 314 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACRWDLEDEE-FQD 314 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCSCSGG-GTT
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCCCChhh-hcc
Confidence 2334569999999999998899999999999999999999999987321 1223333333322211111 112
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 740 DIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 740 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
....+.+++.+||+.||++|||++|++++-
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 234578999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.83 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=204.6
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHH----HHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTF----FNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
.++|++.+.||+|+||.||+|+. .+++.||+|++.......... .+.+.+|++++++++||||+++++++..+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999999975 579999999997654432221 267899999999999999999999997655
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEecCCCCCeEecCCCc-----EEE
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS--IVHRDISSNNILLNSKLE-----AFV 645 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~-----~kl 645 (796)
++||||+++|+|.+++.+.. ..+++..+..++.|+++||+|||+. + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 69999999999999887543 3589999999999999999999998 8 999999999999988776 999
Q ss_pred eeeccccccCCCCCCccccccccCccCcccc--ccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 646 ADFGTARLLDSDSSNRTIVAGTYGYIAPELA--YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 646 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
+|||+++.... ......||+.|+|||.+ ....++.++||||+||++|||++|+.||..... ........
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~ 241 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY------GKIKFINM 241 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------CHHHHHHH
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------cHHHHHHH
Confidence 99999975432 23345699999999998 455678899999999999999999999974321 11111222
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.......+.... .....+.+++.+||+.||++|||++|+++.|++.
T Consensus 242 ~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREEGLRPTIPE---DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSCCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HhccCCCCCCCc---ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 222333222222 1223478999999999999999999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=338.33 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=207.0
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|..+ ++..||+|++....... .+.+.+|++++++++||||+++++++..++..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 3567999999999999999999754 57899999997654433 4578999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe---cCCCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL---NSKLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~ 652 (796)
||||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999999987643 389999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
...... ......||+.|+|||.+.+. ++.++||||+|+++|+|++|+.||.... ...............+
T Consensus 158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~ 227 (277)
T 3f3z_A 158 RFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLKIREGTFTFP 227 (277)
T ss_dssp ECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC
T ss_pred eccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCCC
Confidence 765433 23345699999999998664 8999999999999999999999987321 1222223333322222
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. ........+.+++.+|++.||++|||+.|++++-
T Consensus 228 ~~-~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 228 EK-DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp HH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ch-hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11 0112234578999999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.53 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=196.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
..++|++.+.||+|+||.||+|... .+..||+|++...... ...+.+.+|+.++++++||||+++++++. ++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3468999999999999999999764 2567999998765432 23567899999999999999999999984 567
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 889999999999999997643 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 653 LLDSDSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 653 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~~~~~i~~~~~~ 236 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGERL 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HHHHHHHHcCCCC
Confidence 76543221 223446788999999998899999999999999999997 9999874221 1112222221111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
... ......+.+++.+|++.||++|||+.|++++|++..
T Consensus 237 -~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 237 -PMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 112234789999999999999999999999998763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.91 Aligned_cols=274 Identities=15% Similarity=0.227 Sum_probs=214.1
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEE-EecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFC-LHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~l 575 (796)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +.+.+|+.+++.++|++++..+.++ ...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 56899999999999999999975 67999999998765432 3688999999999988776666655 56678899
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe---cCCCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL---NSKLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~ 652 (796)
||||+ +++|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 99999 899999997533 2489999999999999999999999 99999999999999 488899999999998
Q ss_pred ccCCCCCC-------ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 653 LLDSDSSN-------RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 653 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||............ ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~ 235 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH-HHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh-hhhccccc
Confidence 76544321 23456999999999999999999999999999999999999999854322111111 11111111
Q ss_pred cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccccHHH
Q 003780 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQ 787 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 787 (796)
.. ............+.+++.+||+.||++|||++++++.|++.......++.+.-+|+
T Consensus 236 ~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 236 ST----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HS----CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred CC----chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 11 11111111223478999999999999999999999999987766666666666665
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=351.68 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=213.2
Q ss_pred HHHHHhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeE
Q 003780 493 DIIKATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566 (796)
Q Consensus 493 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 566 (796)
++....++|++.+.||+|+||.||+|..+ +++.||+|++....... ....+.+|++++++++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH--HHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 44456688999999999999999999654 47889999997654332 24578999999999999999999999
Q ss_pred EEecceeeEEEeeccCCcHHHHHhhcCc-------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYE-------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 567 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
+..++..++||||+++|+|.+++..... ...+++..+.+++.|+++||+|||++ +|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 9999999999999999999999976421 13468999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCch
Q 003780 640 KLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSD 716 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~ 716 (796)
++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------- 245 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------- 245 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--------
Confidence 999999999999865433221 122346889999999998899999999999999999999 889986321
Q ss_pred hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.................. .....+.+++.+|++.||++|||+.|++++|++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 NEQVLRFVMEGGLLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 122222222222221111 122347899999999999999999999999988643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=369.82 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=211.7
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|..+ +++.||||+++..... .+.|.+|+.++++++||||+++++++..++..++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 457899999999999999999866 4889999999765432 46799999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999998643 23488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.+.........
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~~~~ 441 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQVYELLEKDYRMERP 441 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---------GGHHHHHHTTCCCCCC
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCCCCCC
Confidence 3221 122346778999999998899999999999999999999 9999874321 1122223333222221
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
. .....+.+++.+||+.||++|||++|+++.|+....
T Consensus 442 ~---~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 E---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C---CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1 122347899999999999999999999999988753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=345.63 Aligned_cols=275 Identities=15% Similarity=0.236 Sum_probs=210.2
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEE-Eecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFC-LHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~ 574 (796)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +.+.+|+++++.++|++++..++++ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 457899999999999999999975 57999999987655432 3578899999999988777666665 5677889
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe---cCCCcEEEeeeccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL---NSKLEAFVADFGTA 651 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a 651 (796)
+||||+ +++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999999 999999997543 2489999999999999999999999 99999999999999 78899999999999
Q ss_pred cccCCCCC-------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh
Q 003780 652 RLLDSDSS-------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 652 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
+....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||............ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~ 230 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-----ERI 230 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH-----HHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh-----hhh
Confidence 87654322 123456999999999999999999999999999999999999999854332211111 111
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccccHHH
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQ 787 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 787 (796)
.......+...........+.+++.+|++.||++|||++++++.|+........++.+.-+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 111111111110111123588999999999999999999999999887766655565555554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=342.53 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=208.1
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cceee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKCMF 574 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 574 (796)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++....... ...+.+.+|++++++++||||+++++++.. +...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 468999999999999999999764 78999999998665433 235679999999999999999999998854 56889
Q ss_pred EEEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEEecCCCCCeEecCCCcEEEeee
Q 003780 575 LIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPS-----IVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
+||||+++|+|.+++.... ....+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999997643 234489999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
|.++.............|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~~ 232 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGK 232 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHHHhhcc
Confidence 999876544333334568999999999998889999999999999999999999987321 111222222222
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
... ... .....+.+++.+||+.||++||+++|+++++....+
T Consensus 233 ~~~-~~~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 233 FRR-IPY---RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CCC-CCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ccc-CCc---ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 211 111 122347899999999999999999999998765443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=387.62 Aligned_cols=354 Identities=23% Similarity=0.251 Sum_probs=201.7
Q ss_pred ccCCceeeCCCCCeEEEeCCCCCccc------------------------cccccccCCCCCCcEEeccCCcccccCCcC
Q 003780 61 CKLDGVTCNTARSIIEINLPEKKLKG------------------------ELSQFNFSCFPGLESLSLRFNYLFGSIPSQ 116 (796)
Q Consensus 61 C~w~gv~C~~~~~v~~l~l~~~~l~~------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 116 (796)
|+|+.|.+ ...+++.|+|++|.+++ .+++..|.++++|++|+|++|.+.+..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45666666 44556666666665544 333444566666666666666666666666
Q ss_pred ccCCCCCcEeecccCcCCCCCCCC--CCCCCCCCEEEecCCCCCCCCc-hhhhccCccceeeccccccCCCCCccccCC-
Q 003780 117 VGALSKLRYLDFSFNNLTGSIPPE--LGSLRNLEVLNLKGNNLNGAIP-SSLCQLTKLITMALSRNGLHGPIPSAIGDL- 192 (796)
Q Consensus 117 ~~~l~~L~~L~Ls~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l- 192 (796)
|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 666666666666666666544443 6666666666666666655443 455666666666666665554433332211
Q ss_pred --------------------------------------------------------------------------------
Q 003780 193 -------------------------------------------------------------------------------- 192 (796)
Q Consensus 193 -------------------------------------------------------------------------------- 192 (796)
T Consensus 173 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l 252 (844)
T 3j0a_A 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252 (844)
T ss_dssp HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence
Q ss_pred -------------CCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCc
Q 003780 193 -------------NNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPP 259 (796)
Q Consensus 193 -------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 259 (796)
++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|.
T Consensus 253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 332 (844)
T 3j0a_A 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332 (844)
T ss_dssp TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSC
T ss_pred CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHH
Confidence 1233333333333333334444455555555555555555555555555555555555555555555
Q ss_pred cccCCcccceeecccccccccCccccccccccccccccCccccCcc------------------c---------------
Q 003780 260 EIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI------------------P--------------- 306 (796)
Q Consensus 260 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~------------------~--------------- 306 (796)
.|.++++|+.|+|++|++++..+..|.++++|++|+|++|.+++.. |
T Consensus 333 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~ 412 (844)
T 3j0a_A 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENR 412 (844)
T ss_dssp SCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCC
T ss_pred HhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCc
Confidence 5555555555555555555555555555555555555555544210 0
Q ss_pred -------cccccccccceeccccccccc------------------------------CCCcccCCCCCCcEEEeecccc
Q 003780 307 -------ITIAGLISLKGLDLSNNKLSG------------------------------PIPPEIGKCSELRNITLRNNNL 349 (796)
Q Consensus 307 -------~~~~~l~~L~~L~Ls~N~l~~------------------------------~~~~~~~~l~~L~~L~L~~N~l 349 (796)
..+..+++|++|+|++|++++ ..+..|..+++|+.|+|++|++
T Consensus 413 l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 492 (844)
T 3j0a_A 413 LENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492 (844)
T ss_dssp CCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHH
T ss_pred cccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcc
Confidence 001123334444444443332 2223466778888888888888
Q ss_pred cCCCCccc-cccccceEEecccccCCCCCccc-cccccccccCCCCcccCCCCCCCCC-ccccCCcccc
Q 003780 350 SGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFL-YHRFPLDLSYNDLEGEIPDYFRDSP-FKVYGNQGIC 415 (796)
Q Consensus 350 ~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~-~~~~~l~l~~N~l~~~~p~~~~~~~-~~~~~n~~~c 415 (796)
++..|..+ ++++|+.|+|++|++++..|..+ .++..|||++|++++.+|+.|.... ....+|+..|
T Consensus 493 ~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFIC 561 (844)
T ss_dssp TTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCC
T ss_pred cccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccc
Confidence 88777766 57888888888888886555444 4566788888888888887765322 2235666665
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.33 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=211.0
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||.||+++.. +++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999765 5889999999876544444457889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999987643 489999999999999999999999 999999999999999999999999999987764
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ...............+.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~--- 262 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNEYSIPK--- 262 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCCT---
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcCCCCCCc---
Confidence 4444455679999999999999889999999999999999999999987321 11122222222221111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+||+.||++||+++|++++-
T Consensus 263 --~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 263 --HINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred --cCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 1123477899999999999999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=359.44 Aligned_cols=275 Identities=16% Similarity=0.192 Sum_probs=206.9
Q ss_pred HhcCCccceeeecccceeEEEEEccC------CcEEEEEEeccccchhhH---H-----HHHHHHHHHHHhhcCCCceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETT---F-----FNSFQNEAHVLSKIAHRNIVK 562 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~---~-----~~~~~~E~~~l~~l~hpniv~ 562 (796)
..++|++.+.||+|+||.||+|..+. ++.||||++......... . ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999997654 478999998765422111 0 113445666778889999999
Q ss_pred EEeEEEec----ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec
Q 003780 563 LYGFCLHK----KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN 638 (796)
Q Consensus 563 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~ 638 (796)
+++++... ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99999775 4589999999 999999998642 3489999999999999999999999 999999999999999
Q ss_pred --CCCcEEEeeeccccccCCCCCC-------ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCccccc
Q 003780 639 --SKLEAFVADFGTARLLDSDSSN-------RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSS 709 (796)
Q Consensus 639 --~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~ 709 (796)
.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876432211 1334599999999999999999999999999999999999999984221
Q ss_pred CCCCCchhhh--------HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccc
Q 003780 710 LSSPSSDQKI--------MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFE 781 (796)
Q Consensus 710 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 781 (796)
. ..... .....++..+.. ......+.+++..|++.||++||+++++++.|+........++.
T Consensus 267 ~----~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 267 D----PKYVRDSKIRYRENIASLMDKCFPA------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp C----HHHHHHHHHHHHHCHHHHHHHHSCT------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred C----HHHHHHHHHHhhhhHHHHHHHhccc------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 1 11000 011111111110 01123478999999999999999999999998776544444444
Q ss_pred cccHHH
Q 003780 782 EISIWQ 787 (796)
Q Consensus 782 ~~~~~~ 787 (796)
...+|.
T Consensus 337 ~~~dw~ 342 (364)
T 3op5_A 337 GKLDLS 342 (364)
T ss_dssp CCCCC-
T ss_pred CccceE
Confidence 333343
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=345.07 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=212.4
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|..+ +++.||+|++...... .+.+.+|++++++++||||+++++++..++..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 4678999999999999999999765 5889999999765432 4678999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 87 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999998643 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 656 SDSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 656 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
..... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||..... ......+........
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---------~~~~~~~~~~~~~~~ 233 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQVYELLEKDYRMER 233 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---------GGHHHHHHTTCCCCC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHhccCCCCC
Confidence 43322 223456788999999998899999999999999999999 9999874221 112222222222221
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.. .....+.+++.+|++.||++|||++|+++.|+....
T Consensus 234 ~~---~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 234 PE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 11 122347899999999999999999999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=367.95 Aligned_cols=258 Identities=22% Similarity=0.248 Sum_probs=210.2
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.............+.+|++++++++||||+++++++..++..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999764 7999999999766544333356788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999997653 23489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .........+...... ...
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~~~i~~~i~~~~~~--~p~- 410 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKEVPEE--YSE- 410 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCHHHHHHHHHHCCCC--CCT-
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhHHHHHHHhhccccc--CCc-
Confidence 32 233457999999999999989999999999999999999999999743221 1111111112111111 111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQEF 769 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 769 (796)
.....+.+++.+||+.||++|| +++|+++|-
T Consensus 411 --~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 411 --RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred --cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 1123477899999999999999 789998873
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=361.44 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=205.5
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-eeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK-CMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~l 575 (796)
..++|++.+.||+|+||.||+|..+ |+.||||+++.... .+.+.+|++++++++||||+++++++...+ ..++
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3467899999999999999999875 78999999976542 357899999999999999999999987765 7899
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.++++... ...+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999998653 23478999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.. .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .... ..+.........
T Consensus 341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~-~~i~~~~~~~~p 408 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVV-PRVEKGYKMDAP 408 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--------TTHH-HHHHTTCCCCCC
T ss_pred cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH-HHHHcCCCCCCC
Confidence 22 122357889999999999999999999999999999998 9999874321 1111 112222222211
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
. .....+.+++.+||+.||++|||+.|+++.|+...
T Consensus 409 ~---~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 409 D---GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 12234789999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.83 Aligned_cols=259 Identities=22% Similarity=0.384 Sum_probs=202.0
Q ss_pred hcCCccceeeecccceeEEEEEcc-CC-------cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NG-------KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH 569 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 569 (796)
.++|.+.+.||+|+||+||+|..+ ++ +.||+|++...... ..+.+.+|++++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN---YSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG---GHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 357999999999999999999654 23 57999998655432 24678999999999999999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc-------
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE------- 642 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~------- 642 (796)
++..++||||+++|+|.+++.+.. ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999998653 3488999999999999999999999 9999999999999998887
Q ss_pred -EEEeeeccccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhH
Q 003780 643 -AFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM 720 (796)
Q Consensus 643 -~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 720 (796)
+||+|||.+..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+.... .......
T Consensus 159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~ 229 (289)
T 4fvq_A 159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DSQRKLQ 229 (289)
T ss_dssp EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHH
T ss_pred eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----chHHHHH
Confidence 99999999875432 233458899999999887 678999999999999999999655533111 1111111
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccc
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFE 781 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 781 (796)
.. .......... ...+.+++.+||+.||++|||++|++++|++...+...+..
T Consensus 230 ~~-~~~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~ 282 (289)
T 4fvq_A 230 FY-EDRHQLPAPK-------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282 (289)
T ss_dssp HH-HTTCCCCCCS-------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred Hh-hccCCCCCCC-------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence 11 1111111111 12367899999999999999999999999998766655443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.44 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=207.1
Q ss_pred cCCccceeeecccceeEEEEE-----ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--c
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQ-----LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--K 571 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~ 571 (796)
+.|++.+.||+|+||.||+|+ ..+++.||+|++....... ..+.+.+|++++++++||||+++++++..+ .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 468899999999999999998 3468999999998654322 246789999999999999999999999876 6
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 6899999999999999996543 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCccccc------CCCCCchhhhHHH
Q 003780 652 RLLDSDSS---NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSS------LSSPSSDQKIMLI 722 (796)
Q Consensus 652 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~------~~~~~~~~~~~~~ 722 (796)
........ ......||..|+|||.+.+..++.++||||+|+++|+|++|+.|+..... .............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87765432 12334578889999999998999999999999999999999998652210 0111111222222
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
..+.......... .....+.+++.+||+.||++|||++|+++.|++.
T Consensus 254 ~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 254 NTLKEGKRLPCPP---NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHTTCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccCCCCCCC---CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 3333322222211 1223478999999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.73 Aligned_cols=206 Identities=26% Similarity=0.321 Sum_probs=178.7
Q ss_pred ccHHHHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-----CCceee
Q 003780 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-----HRNIVK 562 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~ 562 (796)
+++++.....++|.+.+.||+|+||+||+|+. .+++.||||++..... ..+.+..|+.+++.++ ||||++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK----YTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH----HHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh----hhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34444445678999999999999999999975 5789999999975332 2456788999999986 999999
Q ss_pred EEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---
Q 003780 563 LYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS--- 639 (796)
Q Consensus 563 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--- 639 (796)
+++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 999999999999999999 8999999986532 3488999999999999999999999 9999999999999975
Q ss_pred ----------------------CCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHH
Q 003780 640 ----------------------KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEV 697 (796)
Q Consensus 640 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~el 697 (796)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|+|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999865432 2345689999999999999999999999999999999
Q ss_pred HhCCCCCcc
Q 003780 698 LMGRHPGEL 706 (796)
Q Consensus 698 ltg~~p~~~ 706 (796)
++|+.||..
T Consensus 253 l~g~~pf~~ 261 (360)
T 3llt_A 253 YTGSLLFRT 261 (360)
T ss_dssp HHSSCSCCC
T ss_pred HHCCCCCCC
Confidence 999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=337.76 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=212.0
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999764 6889999999765444333356789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999998653 389999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .......+.......+ .
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~--~- 233 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIVNVDLKFP--P- 233 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCCCCC--T-
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHhccccCCC--C-
Confidence 2 2334568999999999999999999999999999999999999987321 1112222222222111 1
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhhcCccccCcc
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE--FLTCKIALVNPF 780 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~ 780 (796)
.....+.+++.+|++.||++||+++|++++ ++.......+++
T Consensus 234 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~ 277 (284)
T 2vgo_A 234 --FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277 (284)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCC
T ss_pred --cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCc
Confidence 112347789999999999999999999986 343333333333
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.94 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=208.8
Q ss_pred hcCCccceeeecccceeEEEEEc--------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL--------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ...+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH--HHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 47899999999999999999975 35778999999765432 2356789999999999 8999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
.++..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 99999999999999999999986532 23488999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~ 712 (796)
+++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---- 264 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 264 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----
Confidence 9999999999999999876543221 222346788999999988889999999999999999999 999986321
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
... ....+.......... .....+.+++.+||+.||.+|||++|++++|++...
T Consensus 265 ----~~~-~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 265 ----VEE-LFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ----HHH-HHHHHHHTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHH-HHHHHhcCCCCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 111222111111111 122347899999999999999999999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.77 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=210.7
Q ss_pred HHHHHHHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccch-----hhHHHHHHHHHHHHHhhc-CCCceeeE
Q 003780 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETE-----ETTFFNSFQNEAHVLSKI-AHRNIVKL 563 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~hpniv~l 563 (796)
........++|++.+.||+|+||.||+|..+ +|+.||||++...... .....+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999865 7999999998765421 122345788999999999 79999999
Q ss_pred EeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcE
Q 003780 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEA 643 (796)
Q Consensus 564 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 643 (796)
++++......++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999997543 489999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCCCccccccccCccCcccccc------CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchh
Q 003780 644 FVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT------MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 644 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 717 (796)
||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .
T Consensus 240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~ 310 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------Q 310 (365)
T ss_dssp EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------H
T ss_pred EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------H
Confidence 999999998775433 2334679999999998863 357889999999999999999999986321 1
Q ss_pred hhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 718 KIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+.......... ........+.+++.+||+.||++|||++|++++-
T Consensus 311 ~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 311 ILMLRMIMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHHHHHHHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHHHhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 22222222222221111 0111233478999999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=356.32 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=211.7
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc--eee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK--CMF 574 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~ 574 (796)
.++|.+.+.||+|+||.||+|+.+ +|+.||||++........ .+.+.+|++++++++||||+++++++...+ ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 357999999999999999999765 599999999976543322 457789999999999999999999998765 779
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe----cCCCcEEEeeecc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL----NSKLEAFVADFGT 650 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~ 650 (796)
+||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999998765545589999999999999999999999 99999999999999 7788899999999
Q ss_pred ccccCCCCCCccccccccCccCcccccc--------CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYT--------MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~----~~~~~~~~ 237 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMY 237 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT----TTCHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc----cchHHHHH
Confidence 98765432 2233569999999998865 56788999999999999999999999743221 11122222
Q ss_pred HhhcCCCC--------------------CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 723 DVLDSRLS--------------------PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 723 ~~~~~~~~--------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
..+..... +............+.+++.+||+.||++||+++|++++++..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 22222111 111112234556688999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=338.59 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=205.2
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhh---HHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEET---TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||.||+|+.+ +|+.||+|.+........ ...+.+.+|++++++++||||+++++++..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999765 699999999976543321 1246789999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC----cEEEeeec
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL----EAFVADFG 649 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 649 (796)
++||||+++++|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997643 489999999999999999999999 999999999999998877 89999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
.+....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .............
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTNISAVNY 228 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCC
T ss_pred cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHHhHhccc
Confidence 998765432 2234568999999999998899999999999999999999999987321 1122222222211
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
... ..........+.+++.+|++.||++||+++|++++-
T Consensus 229 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 229 DFD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CCC-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred CCc-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 111 111112234578999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=351.51 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=210.5
Q ss_pred HHHhcCCccceeeecccceeEEEEEcc-C-----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 003780 495 IKATEDFDIKYCIGTGGYGSVYKAQLP-N-----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFC 567 (796)
Q Consensus 495 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 567 (796)
....++|++.+.||+|+||.||+|... . ++.||+|.+....... ..+.+.+|+++++++ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH--HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 334678999999999999999999753 2 3479999997665332 246789999999999 899999999999
Q ss_pred EecceeeEEEeeccCCcHHHHHhhcCc-----------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeE
Q 003780 568 LHKKCMFLIYKYMKRGSLFCFLRNDYE-----------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNIL 636 (796)
Q Consensus 568 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 636 (796)
..++..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999975421 23478999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCC
Q 003780 637 LNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSP 713 (796)
Q Consensus 637 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~ 713 (796)
++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||.....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---- 272 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---- 272 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----
Confidence 999999999999999866443221 223457889999999998899999999999999999998 9999874221
Q ss_pred CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.......+.......... .....+.+++.+||+.||.+|||++|++++|++..
T Consensus 273 ----~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 273 ----NSKFYKLVKDGYQMAQPA---FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ----SHHHHHHHHHTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hHHHHHHHhcCCCCCCCC---CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111222222222211111 11234788999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.44 Aligned_cols=282 Identities=26% Similarity=0.368 Sum_probs=207.9
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.. +|+.||+|++....... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 468999999999999999999765 59999999987654432 3346788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988876443 389999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh----------
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL---------- 725 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 725 (796)
.........||+.|+|||++.+. .++.++||||+||++|+|++|+.||...... ..........
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-----DQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCChhhhhH
Confidence 44444456799999999998775 6889999999999999999999998743210 0000000000
Q ss_pred -------cC-CCCC-----ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccccHHHHhhhh
Q 003780 726 -------DS-RLSP-----PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLRNQI 792 (796)
Q Consensus 726 -------~~-~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~ 792 (796)
.. .... ............+.+++.+||+.||++|||++|++++-.-. ...+.+....+.+-++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~----~~~~~~~~~~~~~~~~ 327 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ----MDGFAERFSQELQLKV 327 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH----GGGHHHHHHHHHHC--
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc----cCChhhhhhHHHhhcc
Confidence 00 0000 00000111234588999999999999999999999874322 2234444445556666
Q ss_pred ccC
Q 003780 793 NTT 795 (796)
Q Consensus 793 ~~~ 795 (796)
|++
T Consensus 328 ~~~ 330 (331)
T 4aaa_A 328 QKD 330 (331)
T ss_dssp ---
T ss_pred ccC
Confidence 554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=339.81 Aligned_cols=253 Identities=30% Similarity=0.461 Sum_probs=209.6
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.+.|++.+.||+|+||.||+|.. .+++.||+|++....... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 45799999999999999999975 579999999997665332 246899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999998753 489999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ...... +.....+....
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~~~~~~- 241 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFL-IPKNNPPTLEG- 241 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH-HHHSCCCCCCS-
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHH-hhcCCCCCCcc-
Confidence 44444456799999999999999999999999999999999999999873211 111111 11111111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.....+.+++.+||+.||++|||+.|++++..-
T Consensus 242 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 242 --NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp --SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred --ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 112347899999999999999999999998543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=338.66 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=209.4
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||.||+|..++++.||+|++...... .+.+.+|++++++++||||+++++++. .+..++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 35689999999999999999999888889999999765433 357899999999999999999999986 4568899
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999999997542 12489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..... ..+.........
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~-~~~~~~~~~~~~ 232 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVI-QNLERGYRMVRP 232 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHH-HHHHTTCCCCCC
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHH-HHHhcccCCCCc
Confidence 3221 223346788999999988889999999999999999999 899986321 11111 222222221111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
. .....+.+++.+|++.||++|||++++++.|+......
T Consensus 233 ~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 233 D---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred c---cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1 12234789999999999999999999999998765443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=338.51 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=208.8
Q ss_pred cCCccce-eeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKY-CIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|.+.+ .||+|+||.||+|... +++.||+|++...... ...+.+.+|++++++++||||+++++++ ..+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 4566666 8999999999999743 6788999999875432 2356899999999999999999999999 556789
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999997532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~-~~~~i~~~~~ 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PE-VMAFIEQGKR 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HH-HHHHHHTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HH-HHHHHhcCCc
Confidence 543221 122346889999999988889999999999999999998 9999873221 11 1122222221
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNP 779 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 779 (796)
..... .....+.+++.+||+.||++||++.|++++|+........+
T Consensus 232 ~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 232 MECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp CCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCC---CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 11111 22335889999999999999999999999998876544433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.30 Aligned_cols=258 Identities=20% Similarity=0.254 Sum_probs=194.8
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|.+.+.||+|+||+||+|+.+ +++.||+|++........ ...+.+|++++++++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc--chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 57999999999999999999765 789999999975543221 224567999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp ECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9998 58988887643 2488999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc---
Q 003780 658 SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV--- 733 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 733 (796)
........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ......+............
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHhchhh
Confidence 444445578999999999876 5689999999999999999999999974221 1111111111111110000
Q ss_pred -------------------chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 734 -------------------DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 734 -------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..........+.+++.+||+.||++|||++|+++|-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 000011223578999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.50 Aligned_cols=262 Identities=27% Similarity=0.328 Sum_probs=200.3
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchh--hHHHHHHHHHHHHHhhcC---CCceeeEEeEEEec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEE--TTFFNSFQNEAHVLSKIA---HRNIVKLYGFCLHK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 570 (796)
..++|++.+.||+|+||+||+|+. .+|+.||+|++....... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999985 578999999997543211 111235667777777664 99999999999875
Q ss_pred c-----eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEE
Q 003780 571 K-----CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV 645 (796)
Q Consensus 571 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 645 (796)
. ..++||||+. |+|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 599999986543 3489999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 646 ADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 646 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
+|||+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+....
T Consensus 162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----ADQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHh
Confidence 999999876543 233456799999999999999999999999999999999999999974221 11111111111
Q ss_pred cCCC-------------------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 726 DSRL-------------------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 726 ~~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.... ..............+.+++.+||+.||++|||++|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 1000 0000011112234578999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.90 Aligned_cols=262 Identities=22% Similarity=0.270 Sum_probs=195.1
Q ss_pred HHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
...++|++.+.||+|+||+||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3457899999999999999999974 579999999997654332 23456789999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec-----CCCcEEEeeec
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN-----SKLEAFVADFG 649 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-----~~~~~kl~Dfg 649 (796)
+||||+++ +|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999984 9999998654 389999999999999999999999 999999999999994 55569999999
Q ss_pred cccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
+++.............||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ..............
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-----IDQLFKIFEVLGLP 257 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCC
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-----HHHHHHHHHHhCCC
Confidence 998776544444556789999999998874 489999999999999999999999874221 01111111111000
Q ss_pred CCC----------------c-----cch-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 729 LSP----------------P-----VDR-MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 729 ~~~----------------~-----~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
... . ... ........+.+++.+||+.||++|||++|+++|-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 000 0 000 00002245789999999999999999999998744
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.18 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=202.3
Q ss_pred HHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc--CCCceeeEEeEEEec---
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI--AHRNIVKLYGFCLHK--- 570 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~--- 570 (796)
...++|++.+.||+|+||.||+|+.. ++.||||++..... ..+..|.+++... +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 35578999999999999999999875 89999999864432 2344555555554 899999999999887
Q ss_pred -ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEEecCCCCCeEecCCCcEE
Q 003780 571 -KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC-----MPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 571 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~k 644 (796)
...++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7899999999999999999754 3899999999999999999999752 34899999999999999999999
Q ss_pred EeeeccccccCCCCCC----ccccccccCccCccccccCCcCcc------hhHHHHHHHHHHHHhC----------CCCC
Q 003780 645 VADFGTARLLDSDSSN----RTIVAGTYGYIAPELAYTMVVTEK------CDVYSFGVVALEVLMG----------RHPG 704 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DVwSlGv~l~elltg----------~~p~ 704 (796)
|+|||+++........ .....||+.|+|||++.+..++.+ +|||||||++|||+|| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999999876543222 124569999999999987766655 9999999999999999 5555
Q ss_pred cccccCCCCCchhhhHHHHhhcCCCCCccch--hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 705 ELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR--MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
...... .................+.... ........+.+++.+||+.||++|||++|++++|+....
T Consensus 263 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 263 HDLVPS---DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTTSCS---SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhcCC---CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 422111 1111111122222222222221 122445568899999999999999999999999988654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=336.19 Aligned_cols=251 Identities=22% Similarity=0.382 Sum_probs=199.1
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||.||+|..+ +|+.||+|++...........+.+.+|+.++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999765 7999999999765544334456889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997653 388999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. ......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.... ...............+ .
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~-~- 232 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIRGGVFYIP-E- 232 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC-T-
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhcCcccCc-h-
Confidence 32 2234568999999999987765 589999999999999999999987321 1112222222211111 1
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+|++.||++|||++|++++
T Consensus 233 ---~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 233 ---YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112347789999999999999999999997
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.39 Aligned_cols=259 Identities=25% Similarity=0.338 Sum_probs=192.0
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecc--e
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKK--C 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~ 572 (796)
..++|++.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+.+++++. ||||+++++++..++ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 467899999999999999999974 579999999997654332 23467889999999997 999999999997654 6
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||++ |+|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 5899988753 488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC---------------------CCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccC
Q 003780 653 LLDSD---------------------SSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSL 710 (796)
Q Consensus 653 ~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~ 710 (796)
.+... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~- 236 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST- 236 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 65321 111233579999999999876 6789999999999999999999999974321
Q ss_pred CCCCchhhhHHHHhhcCCC--------------------------CCccchhhH-------------HHHHHHHHHHHHc
Q 003780 711 SSPSSDQKIMLIDVLDSRL--------------------------SPPVDRMVM-------------QDIVLVTTVALAC 751 (796)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~-------------~~~~~l~~li~~c 751 (796)
......+...+.... ......... .....+.+++.+|
T Consensus 237 ----~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 237 ----MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp ----HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred ----HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 001111111110000 000000000 1123578999999
Q ss_pred CCCCCCCCCCHHHHHHHH
Q 003780 752 LHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 752 l~~dP~~RPs~~evl~~L 769 (796)
|+.||++|||++|+++|-
T Consensus 313 L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 313 LQFNPNKRISANDALKHP 330 (388)
T ss_dssp CCSSGGGSCCHHHHTTST
T ss_pred hccCcccCCCHHHHhCCH
Confidence 999999999999999983
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.62 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=200.3
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcE----EEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKV----VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
++|++.+.||+|+||.||+|... +++. ||+|.+...... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 57899999999999999999754 4444 788877544322 12346788999999999999999999986 5678
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 89999999999999997642 3488899999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||..... ......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~~~~ 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---------AEVPDLLEKGER 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT---------THHHHHHHTTCB
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH---------HHHHHHHHcCCC
Confidence 754432 2234567889999999998999999999999999999999 9999874321 111122222111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
...... ....+.+++.+||+.||++||+++|++++|++..
T Consensus 236 ~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 LAQPQI---CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCCCTT---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCCc---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 1123668999999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=362.20 Aligned_cols=256 Identities=22% Similarity=0.238 Sum_probs=196.5
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------ 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 570 (796)
.++|++.+.||+|+||+||+|.. .+|+.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh-HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 56899999999999999999964 479999999998654332 3356788999999999999999999999654
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...++||||++++ +.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3579999999864 6666643 288999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHH---------
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIML--------- 721 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~--------- 721 (796)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .....+
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-----~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 211 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-----DQWNKVIEQLGTPCP 284 (464)
T ss_dssp C-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCSCCH
T ss_pred eeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCCH
Confidence 9876543 2334467999999999999999999999999999999999999999743210 000000
Q ss_pred ----------HHhhcCCCC---------------CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 722 ----------IDVLDSRLS---------------PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 722 ----------~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
...+..... +............+.+++.+||+.||++|||++|+++|-
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 011111000 000111111245688999999999999999999999984
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.41 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=205.7
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhh-----HHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEET-----TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
..++|++.+.||+|+||.||+|+. .+++.||||++........ ...+.+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999974 5799999999987643221 1234677899999999999999999999999
Q ss_pred ceeeEEEeeccCC-cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 571 KCMFLIYKYMKRG-SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 571 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999998653 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .....
T Consensus 176 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~~~~ 240 (335)
T 3dls_A 176 SAAYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TVEAA 240 (335)
T ss_dssp TCEECCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GTTTC
T ss_pred cceECCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HHhhc
Confidence 9987654332 334569999999999988776 7899999999999999999999874221 11111
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
...+.. ....+.+++.+||+.||++|||++|++++-.
T Consensus 241 ~~~~~~-----~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 241 IHPPYL-----VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp CCCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred cCCCcc-----cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 111110 1234779999999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.55 Aligned_cols=267 Identities=24% Similarity=0.357 Sum_probs=212.1
Q ss_pred HHHHHHHhcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeE
Q 003780 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKL 563 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l 563 (796)
...+....++|++.+.||+|+||.||+|+. .+++.||||++....... ..+.+.+|++++.++ +||||+++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH--HHHHHHHHHHHHHhcccCCCeeeE
Confidence 334444568999999999999999999963 357899999998654332 246789999999999 69999999
Q ss_pred EeEEEecc-eeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEec
Q 003780 564 YGFCLHKK-CMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRD 629 (796)
Q Consensus 564 ~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d 629 (796)
++++..++ ..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99998755 58999999999999999986543 12278999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcc
Q 003780 630 ISSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGEL 706 (796)
Q Consensus 630 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~ 706 (796)
|||+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543322 233457889999999999999999999999999999998 9999874
Q ss_pred cccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 707 LSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
... . . .....+.......... .....+.+++.+||+.||++|||++|++++|+...
T Consensus 254 ~~~----~---~-~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKI----D---E-EFCRRLKEGTRMRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCC----S---H-HHHHHHHHTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cch----h---H-HHHHHhccCccCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 221 1 1 1111111111111111 11234789999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=344.42 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=210.2
Q ss_pred hcCCccceeeecccceeEEEEEc-----cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEE--ec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCL--HK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~ 570 (796)
.++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++++++||||+++++++. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH---HHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 36899999999999999999973 46899999999765432 2467899999999999999999999987 45
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...++||||+++++|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 678999999999999999986432 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC------CCCCchhhhHH
Q 003780 651 ARLLDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL------SSPSSDQKIML 721 (796)
Q Consensus 651 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~------~~~~~~~~~~~ 721 (796)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 9876543321 22345788899999999988999999999999999999999998632210 00001111122
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
...+.......... .....+.+++.+||+.||++|||++|++++|+.....
T Consensus 254 ~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 254 LELLEEGQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHHhhcccCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 22333333222221 2223478999999999999999999999999887543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.05 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=204.4
Q ss_pred hcCCccce-eeecccceeEEEEEc---cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKY-CIGTGGYGSVYKAQL---PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|.+.+ .||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 46788888 999999999999953 34789999999766433 23356899999999999999999999999 56778
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999998653 388999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 654 LDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 654 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~~~ 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEKGE 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHcCC
Confidence 6543322 122346788999999988889999999999999999999 9999873221 11222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
...... .....+.+++.+||+.||++||++.|+++.|+....
T Consensus 238 ~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 RMGCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222111 223348899999999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=336.56 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=198.6
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|.+.+.||+|+||.||+|+. .+++.||+|++....... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 46799999999999999999975 468999999997765332 246789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe---cCCCcEEEeeecccc
Q 003780 577 YKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL---NSKLEAFVADFGTAR 652 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~ 652 (796)
|||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999886532 224589999999999999999999999 99999999999999 456789999999998
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
...... ......||+.|+|||.+. ..++.++||||+|+++|||++|+.||.... ..................
T Consensus 176 ~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~ 247 (285)
T 3is5_A 176 LFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS------LEEVQQKATYKEPNYAVE 247 (285)
T ss_dssp C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCCCC-
T ss_pred ecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC------HHHHHhhhccCCcccccc
Confidence 765432 233456899999999876 467899999999999999999999987321 111111111111111111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
... ....+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 12347789999999999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=359.21 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=195.1
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchh-----hHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEE-----TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
..++|.+.+.||+|+||.||+|.. .+++.||||++....... ......+.+|++++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 567899999999999999999965 468999999997654221 112235889999999999999999999985 4
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC---cEEEee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL---EAFVAD 647 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~D 647 (796)
+..++||||+++|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 55789999999999998887543 489999999999999999999999 999999999999997544 599999
Q ss_pred eccccccCCCCCCccccccccCccCcccccc---CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ......
T Consensus 286 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--------~~~~~~ 356 (419)
T 3i6u_A 286 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--------VSLKDQ 356 (419)
T ss_dssp SSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--------CCHHHH
T ss_pred cccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--------HHHHHH
Confidence 9999876543 22344679999999999863 56788999999999999999999999742211 111111
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
+..................+.+++.+||+.||++|||++|+++|-.
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 1222111111111122345789999999999999999999998743
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=365.77 Aligned_cols=256 Identities=24% Similarity=0.358 Sum_probs=210.2
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ +|+.||||++...........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999765 7999999999766543333356899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe---cCCCcEEEeeeccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL---NSKLEAFVADFGTARL 653 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~ 653 (796)
|||+.+|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999987653 389999999999999999999999 99999999999999 5678999999999987
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .......+.........
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 179 FEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVEKGKYTFEL 248 (484)
T ss_dssp BCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCS
T ss_pred ccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCCC
Confidence 65433 3344569999999999876 68999999999999999999999997321 12223333333322221
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. .......+.+++.+||+.||++|||++|+++|-.
T Consensus 249 ~~-~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 249 PQ-WKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp GG-GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred cc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 11 1122345789999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=342.06 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=199.4
Q ss_pred HHhcCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
...++|.+.+.||+|+||.||+|... .++.||+|++....... ...+.+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 35678999999999999999999653 35589999997664433 23567899999999999999999999998765
Q ss_pred -----eeeEEEeeccCCcHHHHHhhcC---cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcE
Q 003780 572 -----CMFLIYKYMKRGSLFCFLRNDY---EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEA 643 (796)
Q Consensus 572 -----~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 643 (796)
..++||||+++|+|.+++.... ....+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 3499999999999999985432 234589999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhH
Q 003780 644 FVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIM 720 (796)
Q Consensus 644 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (796)
||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~ 258 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--------HEM 258 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHH
Confidence 9999999987644321 2233457889999999999999999999999999999999 8889863221 111
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
......... ..... .....+.+++.+||+.||++|||+++++++|+....
T Consensus 259 ~~~~~~~~~-~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 259 YDYLLHGHR-LKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHHTTCC-CCCBT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCC-CCCCc---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222222211 11111 122347899999999999999999999999987643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.40 Aligned_cols=267 Identities=17% Similarity=0.182 Sum_probs=202.1
Q ss_pred hcCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhH--------HHHHHHHHHHHHhhcCCCceeeEEe
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETT--------FFNSFQNEAHVLSKIAHRNIVKLYG 565 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~ 565 (796)
.++|.+.+.||+|+||.||+|... ++..+|+|++......... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999765 5788999998765432111 1134678889999999999999999
Q ss_pred EEEe----cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC
Q 003780 566 FCLH----KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL 641 (796)
Q Consensus 566 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 641 (796)
++.. ....++||||+ +++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9988 77899999999 999999997653 589999999999999999999999 999999999999999887
Q ss_pred --cEEEeeeccccccCCCCC-------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC
Q 003780 642 --EAFVADFGTARLLDSDSS-------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS 712 (796)
Q Consensus 642 --~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~ 712 (796)
.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--- 265 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK--- 265 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT---
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence 999999999987643211 11345699999999999999999999999999999999999999963211
Q ss_pred CCchhhhHHHHhhcCCCCCccchhh--HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMV--MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
........................ ......+.+++.+||+.||++||++++|++.|+.....
T Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 266 -DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp -CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred -ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 111111111111222211110000 01223588999999999999999999999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=342.21 Aligned_cols=262 Identities=19% Similarity=0.302 Sum_probs=199.9
Q ss_pred hcCCccc-eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 498 TEDFDIK-YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 498 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
.+.|++. +.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.++ +||||+++++++..++..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3568774 7899999999999975 47999999999765432 245788999999985 7999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc---EEEeeeccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE---AFVADFGTA 651 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~a 651 (796)
+||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999998653 388999999999999999999999 9999999999999998776 999999999
Q ss_pred cccCCCCC-------CccccccccCccCcccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc----
Q 003780 652 RLLDSDSS-------NRTIVAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS---- 715 (796)
Q Consensus 652 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~---- 715 (796)
........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 76542211 1123459999999999875 5688999999999999999999999975432110000
Q ss_pred ---hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 716 ---DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 716 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
........+.......+.. ........+.+++.+||+.||++|||++|+++|-
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred chhHHHHHHHHHhccCcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 0111222222222221111 0111234588999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.48 Aligned_cols=200 Identities=27% Similarity=0.374 Sum_probs=169.1
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-----K 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~ 571 (796)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 56899999999999999999975 46899999999765433 23356889999999999999999999999776 5
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++||||++ |+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999987 59999997543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----------------------CccccccccCccCcccc-ccCCcCcchhHHHHHHHHHHHHhCCCCCc
Q 003780 652 RLLDSDSS----------------------NRTIVAGTYGYIAPELA-YTMVVTEKCDVYSFGVVALEVLMGRHPGE 705 (796)
Q Consensus 652 ~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwSlGv~l~elltg~~p~~ 705 (796)
+....... ......||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87654321 12456799999999985 56679999999999999999999766654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=369.58 Aligned_cols=266 Identities=26% Similarity=0.414 Sum_probs=215.1
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
..++|++.+.||+|+||.||+|..+++..||||+++..... .+.|.+|++++++++||||+++++++.+ +..++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 35678999999999999999999888889999999865432 3578999999999999999999999876 678999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.++++... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999997532 23488999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 657 DSS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 657 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ... +...+.........
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~-~~~~i~~~~~~~~~ 486 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NRE-VLDQVERGYRMPCP 486 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHH-HHHHHHTTCCCCCC
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHH-HHHHHHcCCCCCCC
Confidence 211 1122346788999999998899999999999999999999 999987321 111 22222222221111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 783 (796)
. .....+.+++.+||+.||++|||+++|++.|+.......+.|.+.
T Consensus 487 ~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~ 532 (535)
T 2h8h_A 487 P---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532 (535)
T ss_dssp T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC-
T ss_pred C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCcc
Confidence 1 122347899999999999999999999999999887776666543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.06 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=208.2
Q ss_pred CccceeeecccceeEEEEEc-----cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec--cee
Q 003780 501 FDIKYCIGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--KCM 573 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 573 (796)
|++.+.||+|+||+||++.+ .+++.||||++...... ...+.+.+|++++++++||||+++++++... ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP--QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh--HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 48999999999999998854 26899999999866432 2356799999999999999999999999874 678
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++.+.. +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999997642 89999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC-----C-CCCchhhhHHHHh
Q 003780 654 LDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL-----S-SPSSDQKIMLIDV 724 (796)
Q Consensus 654 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~-----~-~~~~~~~~~~~~~ 724 (796)
....... .....+|+.|+|||.+.+..++.++||||+|+++|+|++|+.||...... . .............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 7543321 22345788899999999988999999999999999999999998732110 0 0011111223333
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
+.......... .....+.+++.+||+.||++|||++|+++.|+....
T Consensus 264 ~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 264 LERGERLPRPD---KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcccCCCCCc---cccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 33333322222 222358899999999999999999999999987643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.42 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=205.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|..+ +++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 3468999999999999999999765 79999999997654332 24678999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999999988654 2489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC--CCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 656 SDS--SNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 656 ~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
... .......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||...... ...............
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~ 229 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDWKEKKTYLN 229 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-------SHHHHHHHTTCTTST
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHhhhcccccC
Confidence 322 12234568999999999987665 67899999999999999999999743210 011111111111111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
. .......+.+++.+||+.||++|||++|++++-
T Consensus 230 ~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 230 P---WKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp T---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred c---hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 1 111233477899999999999999999998863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.43 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=201.0
Q ss_pred CCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
+|.....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 455566999999999999975 57899999999765432 24678999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-CCcEEEeeeccccccCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-KLEAFVADFGTARLLDSD 657 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~ 657 (796)
|+++++|.+++.........++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||.+......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999998765545577899999999999999999999 9999999999999987 899999999999876544
Q ss_pred CCCccccccccCccCccccccCC--cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ........... ...+....
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-~~~~~~~~ 249 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMF-KVHPEIPE 249 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHH-CCCCCCCT
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccc-cccccccc
Confidence 33344456899999999987653 78899999999999999999999874221 11111111111 11111111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+.+++.+||+.||++||+++|++++-
T Consensus 250 ---~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 250 ---SMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp ---TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred ---cCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1123477899999999999999999999763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.94 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=193.4
Q ss_pred hcCCccc-eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhh-cCCCceeeEEeEEEe----c
Q 003780 498 TEDFDIK-YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IAHRNIVKLYGFCLH----K 570 (796)
Q Consensus 498 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~----~ 570 (796)
.++|.+. +.||+|+||+||+|..+ +|+.||||++... ..+.+|++++.+ .+||||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 3567776 68999999999999754 6899999998632 246678888754 489999999999876 5
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVAD 647 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~D 647 (796)
...++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 67899999999999999998643 23589999999999999999999999 9999999999999998 78999999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...+...
T Consensus 208 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~i~~~ 282 (400)
T 1nxk_A 208 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMG 282 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----HHHHHHT
T ss_pred cccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----HHHHHcC
Confidence 99998765322 234467899999999999999999999999999999999999999754332111111 1111111
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
........ .......+.+++.+||+.||++|||++|+++|-.
T Consensus 283 ~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 283 QYEFPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CCCCCTTT-TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cccCCCcc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 11111000 0112234789999999999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=362.03 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=206.3
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||+||+|..+ +++.||||++........ ..+.+.+|++++++++||||+++++++..+...++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3568999999999999999999754 799999999975443222 24678999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec---CCCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN---SKLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~ 652 (796)
||||+++|+|.+.+.... .+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999999887653 389999999999999999999999 999999999999995 45679999999998
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .......+........
T Consensus 173 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~ 242 (486)
T 3mwu_A 173 CFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYAFD 242 (486)
T ss_dssp TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCSC
T ss_pred ECCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCC
Confidence 765432 2334569999999999876 58999999999999999999999987321 1222333333332222
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
... .......+.+++.+||+.||++|||+.|+++|-.
T Consensus 243 ~~~-~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 243 LPQ-WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp SGG-GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred Ccc-cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 111 1122345789999999999999999999999843
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.70 Aligned_cols=267 Identities=23% Similarity=0.338 Sum_probs=210.3
Q ss_pred HHHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhh--cCCCceeeEEeEEE
Q 003780 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK--IAHRNIVKLYGFCL 568 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~ 568 (796)
+.--....++|++.+.||+|+||.||+|+. +|+.||||++.... .+.+.+|++++.. ++||||+++++++.
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 333345667899999999999999999987 48999999986432 2467788888887 78999999999998
Q ss_pred ecc----eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEEecCCCCCeE
Q 003780 569 HKK----CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH--------HDCMPSIVHRDISSNNIL 636 (796)
Q Consensus 569 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~dlkp~NIl 636 (796)
... ..++||||+++|+|.+++.+. .+++..++.++.|+++||+||| +. +|+||||||+||+
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 876 789999999999999999754 3899999999999999999999 66 9999999999999
Q ss_pred ecCCCcEEEeeeccccccCCCCCC----ccccccccCccCccccccC------CcCcchhHHHHHHHHHHHHhC------
Q 003780 637 LNSKLEAFVADFGTARLLDSDSSN----RTIVAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMG------ 700 (796)
Q Consensus 637 l~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DVwSlGv~l~elltg------ 700 (796)
++.++.+||+|||++......... .....||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876544321 2334699999999998765 344689999999999999999
Q ss_pred ----CCCCcccccCCCCCchhhhHHHHhhcCCCCCccch--hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 701 ----RHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR--MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 701 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
+.||...... .................+.... ........+.+++.+||+.||++|||+.|++++|++...
T Consensus 260 ~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 260 HEDYQLPYYDLVPS---DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCCCCCTTTTTSCS---SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccccCccccCcC---cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 6777533221 1111222222333333333221 122445568899999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.94 Aligned_cols=256 Identities=29% Similarity=0.416 Sum_probs=200.6
Q ss_pred cCCccceeeecccceeEEEEEccC-----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPN-----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.+|++.+.||+|+||.||+|..+. +..||+|++...... .....+.+|++++++++||||+++++++...+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 567888999999999999997542 346999999765432 2245789999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999997642 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 654 LDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 654 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
....... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ..... ..+....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~-~~~~~~~ 267 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVM-KAINDGF 267 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH-HHHHTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHH-HHHHCCC
Confidence 6543221 122345778999999998899999999999999999999 999986321 11122 2222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
..+... .....+.+++.+||+.||++||+++|++++|++..
T Consensus 268 ~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 RLPTPM---DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCCT---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCCcc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 12234789999999999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.44 Aligned_cols=250 Identities=20% Similarity=0.297 Sum_probs=201.0
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
..++|++.+.||+|+||.||+|... +++.||+|++......... ...+.+|+..+.++ +||||+++++++.+++..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 3568999999999999999999765 7999999999865443322 46788999999999 8999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCc-ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-------------
Q 003780 575 LIYKYMKRGSLFCFLRNDYE-AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK------------- 640 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~------------- 640 (796)
+||||+++|+|.+++..... ...+++..+..++.||++||+|||++ +|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999976432 14589999999999999999999999 99999999999999844
Q ss_pred ------CcEEEeeeccccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCC
Q 003780 641 ------LEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSP 713 (796)
Q Consensus 641 ------~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~ 713 (796)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|+|++|..|+...
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred cccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 478999999998765432 23489999999998766 5668999999999999999999875421
Q ss_pred CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 714 SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.. .......... .... .....+.+++.+||+.||++|||++|++++-
T Consensus 235 --~~---~~~~~~~~~~-~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 235 --DQ---WHEIRQGRLP-RIPQ---VLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp --HH---HHHHHTTCCC-CCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred --hH---HHHHHcCCCC-CCCc---ccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 11 1111122221 1111 1123478999999999999999999999874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=358.78 Aligned_cols=342 Identities=20% Similarity=0.228 Sum_probs=280.7
Q ss_pred CCceeeCCC----------CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCc
Q 003780 63 LDGVTCNTA----------RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132 (796)
Q Consensus 63 w~gv~C~~~----------~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 132 (796)
|..|.|... .+++.|+|+++++++..+ ..|..+++|++|+|++|.+.+..|..|+++++|++|+|++|.
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 667777532 367888999988886543 458889999999999999998888889999999999999999
Q ss_pred CCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhh
Q 003780 133 LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE 212 (796)
Q Consensus 133 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 212 (796)
+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|+++++.+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 98776677888999999999999998888888899999999999999998888888999999999999999999888888
Q ss_pred hcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccc
Q 003780 213 LGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292 (796)
Q Consensus 213 ~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 292 (796)
+.++++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+.+|.......+|+.|+|++|++++..+..|..+++|+
T Consensus 172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 251 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251 (477)
T ss_dssp HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCC
T ss_pred hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccC
Confidence 99999999999999999888888888899999999999888878887777777899999999999876667788899999
Q ss_pred cccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccc
Q 003780 293 YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNK 371 (796)
Q Consensus 293 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~ 371 (796)
+|+|++|.+++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+ .+++|+.|+|++|+
T Consensus 252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 331 (477)
T 2id5_A 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP 331 (477)
T ss_dssp EEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSC
T ss_pred eeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCC
Confidence 99999999988888888889999999999999998888889999999999999999987666555 47889999999999
Q ss_pred cCCCCCccc--cccccccccCCCCcccCCCCCCCCC
Q 003780 372 LNGTIPPFL--YHRFPLDLSYNDLEGEIPDYFRDSP 405 (796)
Q Consensus 372 l~~~~p~~~--~~~~~l~l~~N~l~~~~p~~~~~~~ 405 (796)
+++..+... .....+++.++.....-|..+...+
T Consensus 332 l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~~~g~~ 367 (477)
T 2id5_A 332 LACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQGKE 367 (477)
T ss_dssp EECSGGGHHHHTTTTSSCCTTCCCBEEESGGGTTCB
T ss_pred ccCccchHhHHhhhhccccCccCceeCCchHHcCCc
Confidence 886654211 1122344555555544555444433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.53 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=200.9
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe----ccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH----KKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~ 573 (796)
..|.+.+.||+|+||.||+|.. .++..||+|.+........ ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3578888999999999999965 4688999999986654432 35688999999999999999999999875 3568
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEecCCCCCeEec-CCCcEEEeeecc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS--IVHRDISSNNILLN-SKLEAFVADFGT 650 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~ 650 (796)
++||||+++|+|.+++.+.. .+++..+..++.|+++||+|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999998643 388999999999999999999998 7 99999999999998 789999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
+...... ......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||.... ........+.....
T Consensus 179 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 179 ATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--------NAAQIYRRVTSGVK 247 (290)
T ss_dssp GGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--------SHHHHHHHHTTTCC
T ss_pred ccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC--------cHHHHHHHHhccCC
Confidence 9764432 3334569999999998764 58999999999999999999999986321 11122222222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+.. ........+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 PAS--FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGG--GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccc--cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111 111122358899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=360.57 Aligned_cols=264 Identities=24% Similarity=0.296 Sum_probs=186.9
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-----K 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~ 571 (796)
.++|++.+.||+|+||+||+|+.+ +|+.||||++....... ...+.+.+|++++++++||||+++++++... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL-IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH-HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 468999999999999999999754 78999999997654332 3356889999999999999999999999543 5
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++||||+. |+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 7899999985 69999987543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---------------------------CccccccccCccCcccc-ccCCcCcchhHHHHHHHHHHHHh----
Q 003780 652 RLLDSDSS---------------------------NRTIVAGTYGYIAPELA-YTMVVTEKCDVYSFGVVALEVLM---- 699 (796)
Q Consensus 652 ~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwSlGv~l~ellt---- 699 (796)
+....... .....+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87643211 12335689999999976 56679999999999999999999
Q ss_pred -------CCCCCcccccCCCCC---------------chhhhHHHHhh-----------------------cCCCCCccc
Q 003780 700 -------GRHPGELLSSLSSPS---------------SDQKIMLIDVL-----------------------DSRLSPPVD 734 (796)
Q Consensus 700 -------g~~p~~~~~~~~~~~---------------~~~~~~~~~~~-----------------------~~~~~~~~~ 734 (796)
|+.+|.......... ..+...+.+.+ .........
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 445543222110000 00000000110 011111111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.........+.+++.+||+.||++|||++|+++|-
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 11112234578999999999999999999999984
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.45 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=202.5
Q ss_pred HhcCCccceeeecccceeEEEEEccC----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPN----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
..++|.+.+.||+|+||.||+|...+ +..||+|.+...... ...+.+.+|+.++++++||||+++++++.+ +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--HHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--hHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 34689999999999999999997532 346999999866432 224689999999999999999999999865 45
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+++++|.+++.+.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 689999999999999997643 3488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 653 LLDSDSS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 653 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... .... ..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--------~~~~-~~~~~~~~ 232 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--------KDVI-GVLEKGDR 232 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--------GGHH-HHHHHTCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--------HHHH-HHHhcCCC
Confidence 7654322 2233457889999999988889999999999999999998 9999863221 1111 11111111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
..... .....+.+++.+|++.||++||++.|++++|+...
T Consensus 233 ~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 233 LPKPD---LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC---CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11111 11234789999999999999999999999998763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=339.62 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=204.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|.+.+.||+|+||.||+|+.+ +|+.||+|++....... .+.+.+|++++++++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 3567999999999999999999764 79999999998654322 3468899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe---cCCCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL---NSKLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~ 652 (796)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999987643 388999999999999999999999 99999999999999 788999999999997
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
..... ......|++.|+|||.+.+..++.++||||+||++|+|++|+.||.... .......+........
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~~~ 227 (304)
T 2jam_A 158 MEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEKIKEGYYEFE 227 (304)
T ss_dssp CCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHCCCCCC
T ss_pred ecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCC
Confidence 54322 2334569999999999999999999999999999999999999987321 1112222222221111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
. .........+.+++.+|++.||++|||++|++++-
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 228 S-PFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp T-TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred c-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 0 00112234578999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.05 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=206.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe------
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH------ 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------ 569 (796)
...+|++.+.||+|+||.||+|... +|+.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4567999999999999999999765 79999999997553 246789999999999999999998864
Q ss_pred ----------cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC
Q 003780 570 ----------KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS 639 (796)
Q Consensus 570 ----------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 639 (796)
....++||||+++|+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 456899999999999999997643 23589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhh
Q 003780 640 KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKI 719 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~ 719 (796)
++.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..|+... ..
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~ 226 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK 226 (284)
T ss_dssp TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH
T ss_pred CCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH
Confidence 9999999999998765433 233456999999999999989999999999999999999999986521 11
Q ss_pred HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 720 MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
.............. ...+.+++.+||+.||++|||+.|++++|+.....
T Consensus 227 ~~~~~~~~~~~~~~-------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 227 FFTDLRDGIISDIF-------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHTTCCCTTS-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHhhcccccccC-------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11222222222111 12367899999999999999999999999887643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=372.81 Aligned_cols=253 Identities=20% Similarity=0.291 Sum_probs=211.5
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
..++|++.+.||+|+||.||+|+.+ +++.||||++...........+.+..|..++..+ +||+|+++++++...+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999754 6889999999865443333456788899999988 6999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998653 389999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........++......+.
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~~~~p~- 563 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHNVAYPK- 563 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHSSCCCCCT-
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhCCCCCCc-
Confidence 54444455678999999999999999999999999999999999999999732 223334444444333221
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTM-----QRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 768 (796)
.....+.+++.+||+.||++||++ +||++|
T Consensus 564 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 564 ----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 122347899999999999999997 777665
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=347.05 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=199.4
Q ss_pred HHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchh--hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEE--TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
...++|++.+.||+|+||.||+|..+ +|+.||||++....... ....+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999865 68999999997644322 1123468899999999999999999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 8888887543 3478888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
.............||+.|+|||++.+. .++.++||||+||++|||++|..||..... ......+..........
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-----~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCTT
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHcCCCChh
Confidence 776554444556799999999998754 588999999999999999999999863221 01111111111100000
Q ss_pred c--------------------cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 732 P--------------------VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 732 ~--------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
. ...........+.+++.+||+.||++|||++|++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 0 00000112245889999999999999999999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.74 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=203.3
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|..+ +|+.||+|++..... .+.+.+|+.++++++||||+++++++...+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4568999999999999999999765 699999999976532 3578899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999987432 3489999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 656 SDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
..........|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ...+....
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~~~ 247 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFMIPT-NPPPTFRK 247 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH-SCCCCCSS
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhc-CCCcccCC
Confidence 544444456789999999999998999999999999999999999999873221 111111111 11111110
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.......+.+++.+||+.||++|||+.|++++-.-
T Consensus 248 -~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp -GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred -cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 11123357899999999999999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=344.18 Aligned_cols=269 Identities=20% Similarity=0.286 Sum_probs=210.2
Q ss_pred ccHHHHHHHhcCCccc-eeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEe
Q 003780 489 IAFEDIIKATEDFDIK-YCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYG 565 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~ 565 (796)
+.++......++|.+. +.||+|+||.||+|..+ +|+.||+|++........ ....+.+|+.++++++ ||||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 4445555667788887 89999999999999755 699999999987654332 2467899999999995 699999999
Q ss_pred EEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCc
Q 003780 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLE 642 (796)
Q Consensus 566 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~ 642 (796)
++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999986532 24589999999999999999999999 9999999999999998 789
Q ss_pred EEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 643 AFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ......
T Consensus 173 ~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~ 243 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------NQETYL 243 (327)
T ss_dssp EEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred EEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------chHHHH
Confidence 9999999998765432 2234569999999999999999999999999999999999999986321 111222
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+.......... ........+.+++.+||+.||++|||++|++++-.-.
T Consensus 244 ~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 244 NISQVNVDYSEE-TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp HHHHTCCCCCTT-TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred HHHhcccccCch-hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 222211111111 0112233478999999999999999999999885443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=360.92 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=205.3
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhh----------HHHHHHHHHHHHHhhcCCCceeeEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEET----------TFFNSFQNEAHVLSKIAHRNIVKLYG 565 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~ 565 (796)
..++|.+.+.||+|+||+||+|..+ +++.||+|++........ ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999754 689999999986543321 22467899999999999999999999
Q ss_pred EEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC---c
Q 003780 566 FCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL---E 642 (796)
Q Consensus 566 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~ 642 (796)
++..+...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999987653 389999999999999999999999 999999999999999876 6
Q ss_pred EEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 643 AFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ......
T Consensus 188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDIIK 257 (504)
T ss_dssp EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 9999999998765432 3344569999999999874 68999999999999999999999997321 222333
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.+........... .......+.+++.+||+.||.+|||++|+++|-.
T Consensus 258 ~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 258 KVEKGKYYFDFND-WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHHCCCCCCHHH-HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHcCCCCCCccc-cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 3333333222111 1122345789999999999999999999998843
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=337.33 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=198.8
Q ss_pred hcCCccceeeecccceeEEEEEcc--CCc--EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP--NGK--VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||+||+|++. +++ .||+|+++..........+.+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999743 333 68999998765444445678999999999999999999999998765 8
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++|+||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997643 3488999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 654 LDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 654 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~ 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEGE 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccCC
Confidence 6543322 223457788999999988889999999999999999999 999987321 1222222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
...... .....+.+++.+|++.||++|||+++++++|++...
T Consensus 243 ~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 RLPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCc---CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 222111 123348899999999999999999999999988765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=341.68 Aligned_cols=265 Identities=21% Similarity=0.318 Sum_probs=206.0
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe----cce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH----KKC 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~ 572 (796)
.++|++.+.||+|+||.||+++. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 46899999999999999999975 5799999999865432 234678999999999999999999999973 457
Q ss_pred eeEEEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
.++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 899999999999999987632 234589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCC---------ccccccccCccCccccccCC---cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhh
Q 003780 652 RLLDSDSSN---------RTIVAGTYGYIAPELAYTMV---VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKI 719 (796)
Q Consensus 652 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~ 719 (796)
......... .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||....... .
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~---- 254 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---D---- 254 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---S----
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---c----
Confidence 764321111 11234799999999987543 6889999999999999999999987422110 0
Q ss_pred HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccC
Q 003780 720 MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVN 778 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 778 (796)
............+.. ......+.+++.+||+.||.+|||++|++++|+........
T Consensus 255 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 255 SVALAVQNQLSIPQS---PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp CHHHHHHCC--CCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hhhHHhhccCCCCcc---ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 011111111111111 11123488999999999999999999999999998765543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.04 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=197.1
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----- 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 571 (796)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|++++++++||||+++++++..++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 46899999999999999999975 57999999999765433 233567899999999999999999999998653
Q ss_pred -eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 572 -CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 572 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 78999998763 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CCCc----
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SPSS---- 715 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~~~---- 715 (796)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .+..
T Consensus 175 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 175 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9875432 334568999999999877 678999999999999999999999997432100 0000
Q ss_pred ----hhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 716 ----DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 716 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.........+..................+.+++.+||+.||++|||++|+++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 000000001111111111111122234578999999999999999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.34 Aligned_cols=246 Identities=16% Similarity=0.154 Sum_probs=192.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHH---HHHhhcCCCceeeEE-------eE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEA---HVLSKIAHRNIVKLY-------GF 566 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~l~-------~~ 566 (796)
.++|++.+.||+|+||.||+|+. .+|+.||||++...........+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999986 46999999999865444444467899999 455566899999998 66
Q ss_pred EEecc-----------------eeeEEEeeccCCcHHHHHhhcCc----ccccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003780 567 CLHKK-----------------CMFLIYKYMKRGSLFCFLRNDYE----AVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625 (796)
Q Consensus 567 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 625 (796)
+..++ ..++||||+ +|+|.+++..... ...+++..+..++.||++||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 278999999 6899999986421 12344688889999999999999999 99
Q ss_pred EEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccccccCccCccccccC-----------CcCcchhHHHHHHHH
Q 003780 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-----------VVTEKCDVYSFGVVA 694 (796)
Q Consensus 626 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DVwSlGv~l 694 (796)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999986432 2334557 999999999887 899999999999999
Q ss_pred HHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 695 LEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 695 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
|||++|+.||......... .... ... .. ....+.+++.+||+.||++|||+.|++++
T Consensus 304 ~elltg~~Pf~~~~~~~~~--------~~~~-~~~-~~-------~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGS--------EWIF-RSC-KN-------IPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHSSCCC------CCS--------GGGG-SSC-CC-------CCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHCCCCCcccccccch--------hhhh-hhc-cC-------CCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999743321110 0111 111 11 12247789999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.93 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=203.6
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEE--EEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVV--ALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||.||+|+.+ +++.+ |+|++...... ...+.+.+|+++++++ +||||+++++++..++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 67999999999999999999754 56644 99988754322 2246789999999999 8999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcC-------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC
Q 003780 575 LIYKYMKRGSLFCFLRNDY-------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL 641 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 641 (796)
+||||+++|+|.+++.... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997653 224589999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhH
Q 003780 642 EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIM 720 (796)
Q Consensus 642 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (796)
.+||+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... .. .
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~-~ 249 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CA-E 249 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH-H
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HH-H
Confidence 9999999999753321 12233457889999999988889999999999999999998 999987321 11 1
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
....+.......... .....+.+++.+||+.||++|||++|++++|++..
T Consensus 250 ~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 250 LYEKLPQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHHHGGGTCCCCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222222222211111 12234789999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=360.44 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=200.5
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|+.+ +++.||+|++......... .+.+.+|+.++++++||||+++++++..+...++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 457999999999999999999764 7899999999866533222 45789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC---CcEEEeeeccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK---LEAFVADFGTARL 653 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~ 653 (796)
|||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999887653 389999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
..... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.... .......+.........
T Consensus 189 ~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 189 FENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVEKGKYTFDS 258 (494)
T ss_dssp CBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCCS
T ss_pred CCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCc
Confidence 65432 233456999999999876 468999999999999999999999997321 12222333332222111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.. .......+.+++.+||+.||.+|||+.|+++|
T Consensus 259 ~~-~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 PE-WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GG-GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hh-cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11 11223347899999999999999999999987
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=371.63 Aligned_cols=329 Identities=22% Similarity=0.225 Sum_probs=233.8
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+++++.+++..+ ..|..+++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 578999999999986554 4589999999999999999998899999999999999999999988899999999999999
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCC-CCCccccCCCCccEEEcccccccCcchhhhcCCC-------------
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLK------------- 217 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~------------- 217 (796)
|++|++++..|..++++++|++|+|++|.+++ .+|..|+++++|++|+|++|++++..+..++.++
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 99999998877889999999999999999986 5688999999999999999988876554333222
Q ss_pred --------------------------------------------------------------------------------
Q 003780 218 -------------------------------------------------------------------------------- 217 (796)
Q Consensus 218 -------------------------------------------------------------------------------- 217 (796)
T Consensus 191 n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred CCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 003780 218 -------------------------------------------------------------------------------- 217 (796)
Q Consensus 218 -------------------------------------------------------------------------------- 217 (796)
T Consensus 271 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~ 350 (606)
T 3vq2_A 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP 350 (606)
T ss_dssp CTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCT
T ss_pred cccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCC
Confidence
Q ss_pred CccccccCCcccccc--CCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCc-cccccccccccc
Q 003780 218 NLVALNVGGNKLMGP--IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIP-LELTRLSQLLYL 294 (796)
Q Consensus 218 ~L~~L~l~~N~l~~~--~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L 294 (796)
+|++|++++|++++. .|..+..+++|++|+|++|.+++ +|..+..+++|+.|++++|++++..| ..+.++++|++|
T Consensus 351 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 429 (606)
T 3vq2_A 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429 (606)
T ss_dssp TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence 222222222222222 12333334444444444444442 34455566666666666666666555 456666677777
Q ss_pred cccCccccCccccccccccccceeccccccccc-CCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEeccccc
Q 003780 295 SISSNMLSGQIPITIAGLISLKGLDLSNNKLSG-PIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKL 372 (796)
Q Consensus 295 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l 372 (796)
++++|.+++..|..+.++++|++|++++|++++ .+|..++.+++|+.|+|++|++++..|..+ .+++|++|++++|++
T Consensus 430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 509 (606)
T 3vq2_A 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509 (606)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcC
Confidence 777777766666667777777777777777766 356667777777777777777776666655 366777777777777
Q ss_pred CCCCCcccc---ccccccccCCCCcccCCCCCCC
Q 003780 373 NGTIPPFLY---HRFPLDLSYNDLEGEIPDYFRD 403 (796)
Q Consensus 373 ~~~~p~~~~---~~~~l~l~~N~l~~~~p~~~~~ 403 (796)
++.+|..+. ++..|++++|+++ .+|..+..
T Consensus 510 ~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~ 542 (606)
T 3vq2_A 510 LFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQH 542 (606)
T ss_dssp SCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGG
T ss_pred CCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhh
Confidence 766665543 3456777777776 34444433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.22 Aligned_cols=259 Identities=26% Similarity=0.381 Sum_probs=204.1
Q ss_pred hcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 571 (796)
.++|++.+.||+|+||.||+|+. .+++.||||++...... .....+.+|+.++++++||||+++++++..++
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch--hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 46899999999999999999974 35778999999754432 22457899999999999999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCc----ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEE
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYE----AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAF 644 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k 644 (796)
..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+. +|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999986532 14588999999999999999999999 9999999999999994 44699
Q ss_pred EeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHH
Q 003780 645 VADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 721 (796)
|+|||+++....... ......|++.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .. ..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~-~~ 254 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQ-EV 254 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HH-HH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HH-HH
Confidence 999999986543322 2233457889999999998899999999999999999998 999986321 11 12
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
...+.......... .....+.+++.+||+.||++||+++|++++++...
T Consensus 255 ~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 255 LEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 22222221111111 12234789999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=342.81 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=198.4
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcE----EEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKV----VALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
.++|++.+.||+|+||.||+|+.. +++. ||+|.+...... ...+.+.+|+.++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 367999999999999999999753 4544 577777544322 22468899999999999999999999998765
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++|+||+++|+|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 7899999999999999986532 488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 653 LLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 653 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
........ .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---------~~~~~~~~~~~ 236 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------SEISSILEKGE 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---------GGHHHHHHTTC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH---------HHHHHHHHcCC
Confidence 76543222 223346778999999999999999999999999999999 9999874321 11222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
...... .....+.+++.+||+.||++||++.|+++.|+...
T Consensus 237 ~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 RLPQPP---ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222211 12234788999999999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=334.93 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=199.1
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-ceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-KCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ |+.||+|++..... .+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 468999999999999999999874 88999999975532 35789999999999999999999997654 478999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999997642 23378899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
. .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... . .....+..........
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~~ 237 (278)
T 1byg_A 170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------K-DVVPRVEKGYKMDAPD 237 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------G-GHHHHHTTTCCCCCCT
T ss_pred c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------H-HHHHHHhcCCCCCCcc
Confidence 2 223357889999999998889999999999999999998 9999873221 1 1112222222221111
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.....+.+++.+||+.||++|||+.|+++.|+....
T Consensus 238 ---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 238 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 122347899999999999999999999999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=349.36 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=192.4
Q ss_pred CCccceeeecccceeEEEEEcc--C--CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-cceee
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP--N--GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-KKCMF 574 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~ 574 (796)
.|++.+.||+|+||.||+|... + +..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4677889999999999999753 2 246899998754332 335689999999999999999999999754 56789
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 168 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999997543 3478899999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC----CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 655 DSDSS----NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 655 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
..... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||...... . ..........
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~---~~~~~~~~~~ 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----D---ITVYLLQGRR 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----C---HHHHHHTTCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----H---HHHHHHcCCC
Confidence 43321 1223457788999999999999999999999999999999 66777633211 1 1111111111
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
..... .....+.+++.+||+.||++|||++|++++|++..
T Consensus 315 -~~~p~---~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 315 -LLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 11234789999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=335.71 Aligned_cols=258 Identities=25% Similarity=0.322 Sum_probs=202.8
Q ss_pred CCccceeeecccceeEEEEEcc-C---CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee-e
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-N---GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM-F 574 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~ 574 (796)
.|...+.||+|+||+||+|... + +..||+|++...... ...+.+.+|+.++++++||||+++++++..++.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM--QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4566789999999999999743 2 337999999764432 2356889999999999999999999999876655 9
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+|+||+.+|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999997632 3478999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC----CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSDS----SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
.... .......+++.|+|||.+.+..++.++||||+|+++|+|++|..|+.... ........+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--------DPFDLTHFLAQGRR 246 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CGGGHHHHHHTTCC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--------CHHHHHHHhhcCCC
Confidence 4321 22233457889999999999999999999999999999999666643111 11112222222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
..... .....+.+++.+|++.||++|||++|+++.|++....
T Consensus 247 ~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 247 LPQPE---YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCc---cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111 1123478999999999999999999999999886543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=352.23 Aligned_cols=258 Identities=10% Similarity=0.037 Sum_probs=185.5
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc--CCCceeeEE-------eEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI--AHRNIVKLY-------GFC 567 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~-------~~~ 567 (796)
..+|.+.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999754 7999999999987654445566788886555444 699988755 455
Q ss_pred Eec-----------------ceeeEEEeeccCCcHHHHHhhcCcccccCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 003780 568 LHK-----------------KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMR------VNIIKCVANALSYLHHDCMPS 624 (796)
Q Consensus 568 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 624 (796)
..+ ...++||||++ |+|.+++..... .+++..+ ..++.||++||+|||++ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 433 33799999999 899999986422 2344555 77889999999999999 9
Q ss_pred eEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCC
Q 003780 625 IVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRH 702 (796)
Q Consensus 625 ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~ 702 (796)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999865432 213457799999999987 679999999999999999999999
Q ss_pred CCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 703 PGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 703 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
||............ ..............+. .......+.+++.+||+.||++|||++|+++|
T Consensus 292 Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWK-RPSLRVPGTDSLAFGS---CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCC-BCCTTSCCCCSCCCTT---SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchh-hhhhhhccccccchhh---ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99854321110000 0000000011111110 01123357899999999999999999999876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=355.82 Aligned_cols=278 Identities=17% Similarity=0.242 Sum_probs=218.9
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC-CceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||.||+|.. .+++.||||++...... +++.+|+++++.++| +++..+..++...+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 46899999999999999999975 57999999987755432 357889999999986 566677777778889999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe---cCCCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL---NSKLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~ 652 (796)
||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 81 vme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 99999 999999997543 2489999999999999999999999 99999999999999 688999999999998
Q ss_pred ccCCCCCC-------ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 653 LLDSDSSN-------RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 653 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~ 229 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKIS 229 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHh
Confidence 76543321 12456999999999999999999999999999999999999999753321 1111122221
Q ss_pred cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccccHHHHhhh
Q 003780 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLRNQ 791 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~ 791 (796)
.................++.+++..||+.||++||++++|++.|+........++...-+|+....
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (483)
T ss_dssp HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence 111111111111122345889999999999999999999999998877666667777777776543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=335.77 Aligned_cols=259 Identities=27% Similarity=0.376 Sum_probs=201.5
Q ss_pred hcCCccceeeecccceeEEEEEccC----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEE-ecce
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCL-HKKC 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 572 (796)
..+|++.+.||+|+||.||+|...+ +..+|+|.+...... ...+.+.+|+.++++++||||+++++++. .++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH--HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 3568889999999999999997542 336899998764432 23568899999999999999999999865 4567
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence 899999999999999997543 3478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC----CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhC-CCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 653 LLDSDS----SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMG-RHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 653 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
...... .......+|+.|+|||.+.+..++.++||||+|+++|+|++| ..||..... ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------~~~~~~~~~~ 248 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITVYLLQG 248 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--------TTHHHHHHTT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhcC
Confidence 664322 112334577889999999998999999999999999999995 555543211 1111111111
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCcc
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIA 775 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 775 (796)
........ ....+.+++.+|++.||++|||++|+++.|++....
T Consensus 249 ~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 RRLLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 123478999999999999999999999999886543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.31 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=204.9
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH--HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 367999999999999999999765 7899999999866432 2356889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ +|+||||||+||+++.++.+||+|||++.....
T Consensus 110 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999998653 3889999999999999999999832 899999999999999999999999999976532
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCC-------------------------
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS------------------------- 711 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~------------------------- 711 (796)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2 1223568999999999999999999999999999999999999987422100
Q ss_pred ---------CCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 712 ---------SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 712 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
....................... ......+.+++.+||+.||++|||++|+++|-.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCT---TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCc---ccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00000000111111111111110 011234889999999999999999999999853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=333.13 Aligned_cols=257 Identities=25% Similarity=0.323 Sum_probs=207.1
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccc------hhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAET------EETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCL 568 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 568 (796)
..++|++.+.||+|+||.||+|..+ +|+.||||++..... ......+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999764 689999999976531 11223467889999999996 999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
.++..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999998643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCccCccccc------cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAY------TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
|.+....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||.... ......
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLR 239 (298)
T ss_dssp TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHHH
Confidence 9998765432 233456899999999875 4567889999999999999999999986321 112222
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
............ ........+.+++.+||+.||++|||++|++++-
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 240 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHhcCCcccCcc-cccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 222222221111 0112234588999999999999999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.40 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=199.4
Q ss_pred HHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEe-
Q 003780 493 DIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLH- 569 (796)
Q Consensus 493 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~- 569 (796)
++....++|++.+.||+|+||.||+|+. .+|+.||+|++...... .+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344578899999999999999999975 57999999999765432 35788999999999 79999999999987
Q ss_pred -----cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEE
Q 003780 570 -----KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 570 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 644 (796)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 468899999999999999998653 24588999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhh
Q 003780 645 VADFGTARLLDSDSSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKI 719 (796)
Q Consensus 645 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~ 719 (796)
|+|||++..............|++.|+|||++. +..++.++|||||||++|+|++|+.||..... ..
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~ 241 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------MR 241 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HH
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HH
Confidence 999999987654433334456999999999987 56688999999999999999999999863221 11
Q ss_pred HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 720 MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
................ .....+.+++.+||+.||++||+++|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 242 ALFLIPRNPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHHHHHHSCCCCCSCS---CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred HHHHhhcCccccCCcc---ccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 1111211111111111 1123478999999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.03 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=197.6
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccch-----hhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETE-----ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... .......+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 456899999999999999999975 46899999999765321 112234588999999999999999999998765
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc---EEEee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE---AFVAD 647 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~D 647 (796)
. .++||||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 899999999999999987543 489999999999999999999999 9999999999999987664 99999
Q ss_pred eccccccCCCCCCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... . .....
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~----~~~~~ 231 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----V----SLKDQ 231 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----S----CHHHH
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----H----HHHHH
Confidence 9999876432 1223456899999999864 566889999999999999999999998743211 0 11111
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
+..................+.+++.+||+.||++||+++|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 111111111111112234578999999999999999999999763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=346.70 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=203.9
Q ss_pred hcCCccceeeecccceeEEEEEc----cCCcEEEEEEeccccch-hhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecc
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETE-ETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKK 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 571 (796)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... .....+.+.+|+++++++ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999976 37899999999764321 111234577899999999 6999999999999999
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++||||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999998653 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC-CCccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 652 RLLDSDS-SNRTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 652 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSE 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----chHHHHHHHHhccC
Confidence 8654322 22234569999999999885 34788999999999999999999999743221 11111222222222
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhh
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRP-----TMQRVCQEFLT 771 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 771 (796)
.... . .....+.+++.+||+.||++|| +++|++++..-
T Consensus 283 ~~~~-~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 283 PPYP-Q----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp CCCC-T----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CCCC-c----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 1111 1 1123477899999999999999 99999988643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.53 Aligned_cols=252 Identities=14% Similarity=0.153 Sum_probs=202.8
Q ss_pred HhcCCccceeeecccceeEEEEE------ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC---CCceeeEEeEE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQ------LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA---HRNIVKLYGFC 567 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~ 567 (796)
..++|.+.+.||+|+||+||+|. ..+++.||+|++.... ..++..|++++++++ |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 35689999999999999999993 4568999999997653 236777888888886 99999999999
Q ss_pred EecceeeEEEeeccCCcHHHHHhhcC--cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC------
Q 003780 568 LHKKCMFLIYKYMKRGSLFCFLRNDY--EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS------ 639 (796)
Q Consensus 568 ~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~------ 639 (796)
..++..++||||+++|+|.++++... ....+++..+..++.||++||+|||+. +|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 99999999999999999999997532 234599999999999999999999999 9999999999999998
Q ss_pred -----CCcEEEeeeccccccCCC--CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC
Q 003780 640 -----KLEAFVADFGTARLLDSD--SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS 712 (796)
Q Consensus 640 -----~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~ 712 (796)
++.+||+|||+|+.+... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-- 291 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-- 291 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC--
Confidence 899999999999765422 22334467999999999999999999999999999999999999998643221
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhhcCc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFR-PTMQRVCQEFLTCKI 774 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~ 774 (796)
.. ......... .....+.+++..|++.+|.+| |+++++.+.|+....
T Consensus 292 --~~-------~~~~~~~~~------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 292 --EC-------KPEGLFRRL------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp --EE-------EECSCCTTC------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred --ce-------eechhcccc------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 00 011111111 112346689999999999998 678888877776544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=343.19 Aligned_cols=261 Identities=21% Similarity=0.239 Sum_probs=193.7
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----- 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 571 (796)
.++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh-HHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 46899999999999999999965 478999999997654332 33567889999999999999999999997665
Q ss_pred -eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 572 -CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 572 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 78888753 278999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCchh---
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSDQ--- 717 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~~--- 717 (796)
++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ..+....
T Consensus 174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9866432 2233456999999999999999999999999999999999999999743210 0000000
Q ss_pred -hhHHHHhhcCCC---------------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 718 -KIMLIDVLDSRL---------------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 718 -~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
............ .+............+.+++.+||+.||++|||++|+++|-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000000000 0001111122245688999999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=342.64 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=200.6
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH------- 569 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------- 569 (796)
.++|++.+.||+|+||.||+|+. .+|+.||+|++........ ....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-chHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 36899999999999999999976 5799999999976654332 23567899999999999999999999987
Q ss_pred -cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 570 -KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 570 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
.+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999985 7777776543 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC----CCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 649 GTARLLDSDS----SNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 649 g~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|+++.+.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~ 243 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQ 243 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHH
Confidence 9998765321 22234568999999998876 4579999999999999999999999874221 111111111
Q ss_pred hhcCCCCCccc------------------hhhHH------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 724 VLDSRLSPPVD------------------RMVMQ------DIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 724 ~~~~~~~~~~~------------------~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
........... ..... ....+.+++.+||+.||++|||++|+++|-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 11110000000 00000 1234789999999999999999999999843
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=364.60 Aligned_cols=326 Identities=18% Similarity=0.189 Sum_probs=247.8
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
..++.|+++++.+++.. +..|+.+++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 33 ~~l~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQ-NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp TTCCEEECTTCCCSEEC-TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CcCcEEEccCCccCcCC-hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 47899999999998654 44699999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCcc--ccccCCccc
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLV--ALNVGGNKL 229 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~l~~N~l 229 (796)
|++|++++..|..+.++++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..++.+++|+ .|++++|++
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 999999988788999999999999999999986555555699999999999999999999999999998 888999988
Q ss_pred cccCCCccccc---------------------------------------------------CccceEEeccccccccCC
Q 003780 230 MGPIPSTLFRL---------------------------------------------------TNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 230 ~~~~~~~l~~l---------------------------------------------------~~L~~L~L~~N~l~~~~p 258 (796)
++..|..+... .+|+.|++++|.+++..+
T Consensus 192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 87666544321 046666666666666556
Q ss_pred ccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCc-ccCCCC
Q 003780 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPP-EIGKCS 337 (796)
Q Consensus 259 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~ 337 (796)
..|.++++|+.|++++|+++ .+|..+.++++|++|++++|.+++..|..+..+++|++|++++|.+.+.+|. .+..++
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 66666777777777777766 5566666667777777777776666666666666666666666666654443 366666
Q ss_pred CCcEEEeecccccCCC--Cccc-cccccceEEecccccCCCCCccc---cccccccccCCCCcccCCC
Q 003780 338 ELRNITLRNNNLSGSI--PPEI-GLMKLEYLDLSHNKLNGTIPPFL---YHRFPLDLSYNDLEGEIPD 399 (796)
Q Consensus 338 ~L~~L~L~~N~l~~~~--~~~~-~~~~L~~L~l~~N~l~~~~p~~~---~~~~~l~l~~N~l~~~~p~ 399 (796)
+|+.|++++|++++.. +..+ .+++|++|++++|++++..|..+ .++..|++++|.+++..|.
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 418 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTC
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccc
Confidence 6666666666666543 3333 35566666666666665555433 3344566666666655443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=368.53 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=203.3
Q ss_pred cCCccce-eeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKY-CIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
+++.+.+ .||+|+||.||+|..+ ++..||||+++..... ...+.+.+|++++++++||||+++++++.. +..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 3444445 7999999999999653 5678999999865332 224689999999999999999999999976 5689
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 412 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999999997542 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... . .+...+.....
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~-~~~~~i~~~~~ 557 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------P-EVMAFIEQGKR 557 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------H-HHHHHHHTTCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------H-HHHHHHHcCCC
Confidence 543221 112335688999999998999999999999999999998 9999874221 1 12222222222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccC
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVN 778 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 778 (796)
..... .....+.+++.+||+.||++||+++++++.|+........
T Consensus 558 ~~~p~---~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 558 MECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCCCT---TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCC---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 22111 1233588999999999999999999999999886554433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.01 Aligned_cols=268 Identities=24% Similarity=0.359 Sum_probs=198.2
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHH--HhhcCCCceeeEEeEEEe-----c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHV--LSKIAHRNIVKLYGFCLH-----K 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~-----~ 570 (796)
.++|++.+.||+|+||.||+|+. +++.||||++..... +.+..|.++ +..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46899999999999999999976 689999999975432 233444444 556899999999986643 2
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC------CCCeEEecCCCCCeEecCCCcEE
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC------MPSIVHRDISSNNILLNSKLEAF 644 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~dlkp~NIll~~~~~~k 644 (796)
...++||||+++|+|.+++.... .++..+..++.|+++||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 36789999999999999997643 588899999999999999999863 33899999999999999999999
Q ss_pred EeeeccccccCCCC--------CCccccccccCccCcccccc-------CCcCcchhHHHHHHHHHHHHhCCCCCccccc
Q 003780 645 VADFGTARLLDSDS--------SNRTIVAGTYGYIAPELAYT-------MVVTEKCDVYSFGVVALEVLMGRHPGELLSS 709 (796)
Q Consensus 645 l~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~ 709 (796)
|+|||+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998765321 11223469999999999886 4567799999999999999999877643222
Q ss_pred CCCCCch----------hhhHHHHhhcCCCCCccch---hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 710 LSSPSSD----------QKIMLIDVLDSRLSPPVDR---MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 710 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
....... ..............+.... ........+.+++.+||+.||++|||++|+++.|++....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1111000 0000111111111111111 11223446889999999999999999999999998865433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=368.07 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=199.1
Q ss_pred eeeecccceeEEEEEc---cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeecc
Q 003780 505 YCIGTGGYGSVYKAQL---PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
+.||+|+||.||+|.+ +.++.||||+++...... ...+++.+|++++++++|||||++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999954 346889999997654332 335689999999999999999999999964 56889999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC--
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS-- 659 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 659 (796)
+|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999997643 489999999999999999999999 999999999999999999999999999987654322
Q ss_pred -CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 660 -NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+..........
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---------~~~~~~i~~~~~~~~p~-- 595 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEKGERMGCPA-- 595 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHTTCCCCCCT--
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCCCCCCC--
Confidence 1223346788999999999999999999999999999998 9999873221 12222232222222211
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.....+.+++.+||+.||++||++++|++.|+....
T Consensus 596 -~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 596 -GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122347899999999999999999999999987543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=368.00 Aligned_cols=337 Identities=22% Similarity=0.240 Sum_probs=240.2
Q ss_pred CccCCceeeCCC------------CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEee
Q 003780 60 HCKLDGVTCNTA------------RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLD 127 (796)
Q Consensus 60 ~C~w~gv~C~~~------------~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 127 (796)
.|.|.|| |+.. .+++.|+++++++++..+ ..|..+++|++|+|++|.+.+..|..|+++++|++||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 4999998 8642 368999999999886554 3589999999999999999999889999999999999
Q ss_pred cccCcCCCCCCCCCCCCCCCCEEEecCCCCCC-CCchhhhccCccceeeccccccC-CCCCccccCCCCccEEEcccccc
Q 003780 128 FSFNNLTGSIPPELGSLRNLEVLNLKGNNLNG-AIPSSLCQLTKLITMALSRNGLH-GPIPSAIGDLNNLLILSLDSNKL 205 (796)
Q Consensus 128 Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l 205 (796)
|++|.+++..|..|+++++|++|+|++|++++ ..|..+.++++|++|++++|.+. ...+..|.++++|++|++++|.+
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999998777779999999999999999986 35778899999999999999844 44446888999999999999999
Q ss_pred cCcchhhhcC------------------------CCCccccccCCccccccC--CCcc----------------------
Q 003780 206 SGMLHQELGK------------------------LKNLVALNVGGNKLMGPI--PSTL---------------------- 237 (796)
Q Consensus 206 ~~~~~~~~~~------------------------l~~L~~L~l~~N~l~~~~--~~~l---------------------- 237 (796)
++..|..++. +++|++|++++|++++.. |..+
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 240 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred cccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence 8877777665 455666666666665421 0000
Q ss_pred -------c-----------------------------------------------------------ccCccceEEeccc
Q 003780 238 -------F-----------------------------------------------------------RLTNLTYLYLHSN 251 (796)
Q Consensus 238 -------~-----------------------------------------------------------~l~~L~~L~L~~N 251 (796)
. ..++|+.|++++|
T Consensus 241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n 320 (549)
T 2z81_A 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320 (549)
T ss_dssp HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence 0 0122333444444
Q ss_pred cccccCCccc-cCCcccceeecccccccccCcc---ccccccccccccccCccccCccc--cccccccccceeccccccc
Q 003780 252 HLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPL---ELTRLSQLLYLSISSNMLSGQIP--ITIAGLISLKGLDLSNNKL 325 (796)
Q Consensus 252 ~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~---~l~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l 325 (796)
+++ .+|..+ ..+++|+.|+|++|++++.+|. .++.+++|++|++++|++++..+ ..+..+++|++|+|++|++
T Consensus 321 ~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 399 (549)
T 2z81_A 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399 (549)
T ss_dssp CCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred ccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCC
Confidence 443 344333 3577777888888887776543 36677778888888887775432 4577778888888888888
Q ss_pred ccCCCcccCCCCCCcEEEeecccccCCCCccc-------------------cccccceEEecccccCCCCCcc--ccccc
Q 003780 326 SGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-------------------GLMKLEYLDLSHNKLNGTIPPF--LYHRF 384 (796)
Q Consensus 326 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------~~~~L~~L~l~~N~l~~~~p~~--~~~~~ 384 (796)
+ .+|..+..+++|+.|+|++|++++. |..+ .+++|++|+|++|+++ .+|.. +.++.
T Consensus 400 ~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~ 476 (549)
T 2z81_A 400 H-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLL 476 (549)
T ss_dssp C-CCCSCCCCCTTCCEEECTTSCCSCC-CTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCGGGCTTCC
T ss_pred c-cCChhhcccccccEEECCCCCcccc-cchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCCcccCccCC
Confidence 7 5677777777777777777777632 2211 3456666666666665 45532 33455
Q ss_pred cccccCCCCcccCCCCCC
Q 003780 385 PLDLSYNDLEGEIPDYFR 402 (796)
Q Consensus 385 ~l~l~~N~l~~~~p~~~~ 402 (796)
.|||++|++++.+|..|.
T Consensus 477 ~L~Ls~N~l~~~~~~~~~ 494 (549)
T 2z81_A 477 VMKISRNQLKSVPDGIFD 494 (549)
T ss_dssp EEECCSSCCCCCCTTGGG
T ss_pred EEecCCCccCCcCHHHHh
Confidence 667777777766665443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.52 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=200.1
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|..+ +++.||+|++....... .+.+.+|++++++++||||+++++++..++..++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 3568999999999999999999765 68999999987654322 4678999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999987532 2489999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCCCccccccccCccCcccc-----ccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 656 SDSSNRTIVAGTYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
..........||+.|+|||++ .+..++.++||||||+++|+|++|+.||..... .............
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSDPP 240 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCC
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhccCCc
Confidence 221122334689999999988 466788999999999999999999999874221 1112222222211
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.... .......+.+++.+||+.||++|||++|++++-.
T Consensus 241 ~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 241 TLLT--PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp CCSS--GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred ccCC--ccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 1110 1122335789999999999999999999998743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=337.25 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=208.0
Q ss_pred hcCCccceeeecccceeEEEEEc-----cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-----PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK- 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~- 571 (796)
.++|++.+.||+|+||.||+|+. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---HHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 35789999999999999999973 4689999999976533 23568999999999999999999999987654
Q ss_pred -eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 572 -CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 572 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 7899999999999999998653 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCccccc-------CCCCCchhhhH
Q 003780 651 ARLLDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSS-------LSSPSSDQKIM 720 (796)
Q Consensus 651 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~-------~~~~~~~~~~~ 720 (796)
++........ .....++..|+|||.+.+..++.++||||||+++|||+||..|+..... ...........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9876543321 1223467789999999988899999999999999999999999763210 00000111111
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
..+.+......+... .....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 272 ~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 272 LIELLKNNGRLPRPD---GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHTTCCCCCCT---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222333222222111 12235889999999999999999999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.02 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=188.1
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEE-------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCL------- 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~------- 568 (796)
..+|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|+.++.++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH---HHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 45799999999999999999975 47999999998655332 2467899999999996 999999999994
Q ss_pred -ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEecCCCCCeEecCCCcEEE
Q 003780 569 -HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS--IVHRDISSNNILLNSKLEAFV 645 (796)
Q Consensus 569 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl 645 (796)
.....++||||+. |+|.+++........+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3445899999996 79999887644445699999999999999999999998 7 999999999999999999999
Q ss_pred eeeccccccCCCCCC------------ccccccccCccCcccc---ccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC
Q 003780 646 ADFGTARLLDSDSSN------------RTIVAGTYGYIAPELA---YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL 710 (796)
Q Consensus 646 ~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~ 710 (796)
+|||+++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876543221 1134589999999998 5667889999999999999999999998742211
Q ss_pred CCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 711 SSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
............... ...+.+++.+||+.||++|||++|++++|+....
T Consensus 260 ------------~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 ------------RIVNGKYSIPPHDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------------CCCCTTCCS---SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HhhcCcccCCccccc---chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111111101 1126689999999999999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.33 Aligned_cols=262 Identities=18% Similarity=0.214 Sum_probs=204.2
Q ss_pred hcCCccceeeecccceeEEEEEccC---------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceee------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN---------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVK------ 562 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~------ 562 (796)
.++|++.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3689999999999999999997653 789999998754 25788999999999999987
Q ss_pred ---------EEeEEEe-cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCC
Q 003780 563 ---------LYGFCLH-KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISS 632 (796)
Q Consensus 563 ---------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp 632 (796)
+++++.. ++..++||||+ +++|.+++.... ...+++..+..++.||++||+|||+. +|+||||||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 6777776 67889999999 999999998652 24589999999999999999999999 999999999
Q ss_pred CCeEecCCC--cEEEeeeccccccCCCCC-------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCC
Q 003780 633 NNILLNSKL--EAFVADFGTARLLDSDSS-------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703 (796)
Q Consensus 633 ~NIll~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p 703 (796)
+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 899999999987643221 12334699999999999998999999999999999999999999
Q ss_pred CcccccCCCCCchhhhHHHHhhcCCCCCccchh--hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 704 GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
|..... ....................... .......+.+++.+||+.||++||+++|+++.|++.....
T Consensus 268 f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 268 WTNCLP----NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TGGGTT----CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccCCc----CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 984321 11111111111111111111000 0011234889999999999999999999999998765443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.09 Aligned_cols=269 Identities=22% Similarity=0.280 Sum_probs=202.6
Q ss_pred ccHHHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchh--------hHHHHHHHHHHHHHhhcCCCce
Q 003780 489 IAFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEE--------TTFFNSFQNEAHVLSKIAHRNI 560 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpni 560 (796)
...+++....++|++.+.||+|+||.||+|...+|+.||||++....... ....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34567788899999999999999999999998889999999997643321 2224689999999999999999
Q ss_pred eeEEeEEEe-----cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 561 VKLYGFCLH-----KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 561 v~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
+++++++.. ....++||||++ |+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999999854 336899999998 58888887542 3589999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS 714 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~ 714 (796)
+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---- 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---- 240 (362)
T ss_dssp EECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred EEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH----
Confidence 9999999999999999754433 22334568999999999876 67899999999999999999999999742210
Q ss_pred chhhhHH--------------------HHhhcCCCCC----ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 715 SDQKIML--------------------IDVLDSRLSP----PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 715 ~~~~~~~--------------------~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.....+ .+........ ............+.+++.+||+.||++|||++|+++|-
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 000000 0111111110 11111112234588999999999999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=332.00 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=190.4
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+. .+|+.||+|++........ ..+.+.++...++.++||||+++++++..++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH-HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 46899999999999999999975 5799999999976644332 234455566668888999999999999999999999
Q ss_pred EeeccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|||++ |+|.+++... .....+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99998 4888777642 12345899999999999999999999853 89999999999999999999999999998765
Q ss_pred CCCCCccccccccCccCcccc----ccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 656 SDSSNRTIVAGTYGYIAPELA----YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
... ......||+.|+|||.+ .+..++.++||||+||++|+|++|+.||.... ................
T Consensus 162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-------TPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-------CHHHHHHHHHHSCCCC
T ss_pred ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-------chHHHHHHHhccCCCC
Confidence 432 22334699999999996 56678899999999999999999999987321 1122222233332222
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.... .....+.+++.+|++.||++|||++|+++|-
T Consensus 234 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 234 LPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp CCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred cccc---cCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 1111 1123478999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.36 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=184.4
Q ss_pred hcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------ 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 570 (796)
.++|++.+.||+|+||.||+|. ..+|+.||||++....... ...+.+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4789999999999999999996 4579999999997654332 2356788999999999999999999999754
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
...++|+|++ +++|.+++... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 68999888652 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh-----
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV----- 724 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 724 (796)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+...
T Consensus 179 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 179 ARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTPG 250 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCC
T ss_pred ccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCC
Confidence 9865432 334568999999999877 67899999999999999999999999743210 000011110
Q ss_pred ------------------hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 725 ------------------LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 725 ------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
+..................+.+++.+||+.||++|||++|+++|-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 011011111111111234578999999999999999999999984
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=358.23 Aligned_cols=327 Identities=21% Similarity=0.175 Sum_probs=295.0
Q ss_pred eeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCC
Q 003780 66 VTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR 145 (796)
Q Consensus 66 v~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 145 (796)
-.|... ...+++++++++..... -.++++.|+|++|++.+..+..|.++++|++|+|++|.|++..|..|.+++
T Consensus 7 C~C~~~--~~~v~c~~~~l~~ip~~----~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 80 (477)
T 2id5_A 7 CECSAQ--DRAVLCHRKRFVAVPEG----IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF 80 (477)
T ss_dssp CEEETT--TTEEECCSCCCSSCCSC----CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred CeECCC--CCEEEeCCCCcCcCCCC----CCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCc
Confidence 346543 34688888888754332 236899999999999999999999999999999999999998899999999
Q ss_pred CCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccC
Q 003780 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVG 225 (796)
Q Consensus 146 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 225 (796)
+|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.++++.+..|.++++|+.|+|+
T Consensus 81 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 160 (477)
T 2id5_A 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE 160 (477)
T ss_dssp TCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEE
T ss_pred cCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECC
Confidence 99999999999998777889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcc
Q 003780 226 GNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI 305 (796)
Q Consensus 226 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 305 (796)
+|++++..+..+.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.+|.......+|++|+|++|.+++..
T Consensus 161 ~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 240 (477)
T 2id5_A 161 KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP 240 (477)
T ss_dssp SCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCC
T ss_pred CCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccC
Confidence 99999877778999999999999999999988889999999999999999988888888777789999999999999766
Q ss_pred ccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCccc---c
Q 003780 306 PITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFL---Y 381 (796)
Q Consensus 306 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~---~ 381 (796)
+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+ .+++|+.|+|++|++++..+..+ .
T Consensus 241 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 320 (477)
T 2id5_A 241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG 320 (477)
T ss_dssp HHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGG
T ss_pred HHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCc
Confidence 6789999999999999999999889999999999999999999999888877 58999999999999996555443 4
Q ss_pred ccccccccCCCCcccCC
Q 003780 382 HRFPLDLSYNDLEGEIP 398 (796)
Q Consensus 382 ~~~~l~l~~N~l~~~~p 398 (796)
++..|++++|.+.+.-+
T Consensus 321 ~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 321 NLETLILDSNPLACDCR 337 (477)
T ss_dssp GCCEEECCSSCEECSGG
T ss_pred ccCEEEccCCCccCccc
Confidence 56789999999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.04 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=199.5
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchh-hHHHHHHHHHHHHHhhcCCCceeeEEeEEE--ecce
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEE-TTFFNSFQNEAHVLSKIAHRNIVKLYGFCL--HKKC 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~ 572 (796)
..++|.+.+.||+|+||.||+|... +++.||+|++....... ....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999764 68999999997654322 223467899999999999999999999984 4568
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||++++ +.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999986 777776543 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC--CCccccccccCccCccccccCC--cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 653 LLDSDS--SNRTIVAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 653 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
...... .......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||.... .......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~~ 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGKGS 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhcCC
Confidence 765322 2223456899999999987643 4779999999999999999999987321 111222222222
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.... . .....+.+++.+|++.||++|||++|++++-
T Consensus 230 ~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 230 YAIP-G----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp CCCC-S----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CCCC-C----ccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 1111 1 1123477899999999999999999999874
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=370.33 Aligned_cols=322 Identities=19% Similarity=0.278 Sum_probs=285.4
Q ss_pred CCeEEEeCCCCCcccc-----------------ccccccC--CCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCc
Q 003780 72 RSIIEINLPEKKLKGE-----------------LSQFNFS--CFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN 132 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~-----------------~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 132 (796)
.++..|+|+++.++|. ++. .++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 5788999999999995 554 366 99999999999999999999999999999999999998
Q ss_pred -CCC-CCCCCCCCC------CCCCEEEecCCCCCCCCch--hhhccCccceeeccccccCCCCCccccCCCCccEEEccc
Q 003780 133 -LTG-SIPPELGSL------RNLEVLNLKGNNLNGAIPS--SLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDS 202 (796)
Q Consensus 133 -l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 202 (796)
+++ .+|..++++ ++|++|+|++|+++ .+|. .++++++|++|+|++|+++|.+| .|+.+++|++|+|++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 998 889888877 99999999999999 7888 99999999999999999998899 999999999999999
Q ss_pred ccccCcchhhhcCCCC-ccccccCCccccccCCCcccccC--ccceEEeccccccccCCcccc-------CCcccceeec
Q 003780 203 NKLSGMLHQELGKLKN-LVALNVGGNKLMGPIPSTLFRLT--NLTYLYLHSNHLNGSIPPEIG-------NMTGILKVDM 272 (796)
Q Consensus 203 N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L 272 (796)
|+++ .+|..+.++++ |++|++++|+++ .+|..+..++ +|++|++++|++++.+|..+. .+++|+.|+|
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~L 440 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEEC
T ss_pred Cccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEEC
Confidence 9999 77788999999 999999999999 7788887755 899999999999999999888 8889999999
Q ss_pred ccccccccCccccccccccccccccCccccCcccc-ccccc-------cccceecccccccccCCCcccC--CCCCCcEE
Q 003780 273 SMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPI-TIAGL-------ISLKGLDLSNNKLSGPIPPEIG--KCSELRNI 342 (796)
Q Consensus 273 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~-~~~~l-------~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L 342 (796)
++|++++..+..+..+++|++|+|++|.++ .+|. .+... ++|++|+|++|+++ .+|..+. .+++|+.|
T Consensus 441 s~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L 518 (636)
T 4eco_A 441 SNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGI 518 (636)
T ss_dssp CSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEE
T ss_pred cCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEE
Confidence 999999655555667999999999999999 4554 44433 39999999999999 6888887 99999999
Q ss_pred EeecccccCCCCccc-cccccceEEe------cccccCCCCCccccc---cccccccCCCCcccCCCCCC
Q 003780 343 TLRNNNLSGSIPPEI-GLMKLEYLDL------SHNKLNGTIPPFLYH---RFPLDLSYNDLEGEIPDYFR 402 (796)
Q Consensus 343 ~L~~N~l~~~~~~~~-~~~~L~~L~l------~~N~l~~~~p~~~~~---~~~l~l~~N~l~~~~p~~~~ 402 (796)
+|++|++++ +|..+ .+++|+.|+| ++|++.+.+|..+.. +..|+|++|.+ +.+|..+.
T Consensus 519 ~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~ 586 (636)
T 4eco_A 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT 586 (636)
T ss_dssp ECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC
T ss_pred ECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh
Confidence 999999998 77666 5899999999 568889999977644 56899999999 78888655
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=333.21 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=201.9
Q ss_pred HhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC--CCceeeEEeEEEecceee
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA--HRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~ 574 (796)
..++|++.+.||+|+||.||++..++++.||||++....... ...+.+.+|++++++++ ||||+++++++..++..+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc-cchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 456899999999999999999998889999999997654432 23568899999999997 599999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||| +.+++|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||++++ +.+||+|||+++..
T Consensus 105 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999 67889999998653 488999999999999999999999 9999999999999965 89999999999876
Q ss_pred CCCCCC--ccccccccCccCcccccc-----------CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHH
Q 003780 655 DSDSSN--RTIVAGTYGYIAPELAYT-----------MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 655 ~~~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (796)
...... .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~ 249 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKL 249 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------HHHHHH
Confidence 543221 233568999999999875 468889999999999999999999987321 112223
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
....+........... ...+.+++.+||+.||++||+++|++++-.
T Consensus 250 ~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHhcccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 3344433332222211 234778999999999999999999998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=329.01 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=205.9
Q ss_pred HHhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
...++|++.+.||+|+||.||+|+.+ +++.||+|++........ ..+.+.+|++++++++||||+++++++...+..+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 35678999999999999999999765 799999999976544322 2467899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC---CcEEEeeeccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK---LEAFVADFGTA 651 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a 651 (796)
+|+||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999887543 389999999999999999999999 99999999999999764 46999999999
Q ss_pred cccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
........ .....|++.|+|||.+.+. ++.++||||||+++|+|++|+.||.... .......+.......
T Consensus 172 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYAF 241 (287)
T ss_dssp GTBCCCSS-CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCC
T ss_pred eeecCCCc-cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCC
Confidence 87654322 2334589999999988764 8899999999999999999999987321 112222222222221
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
.... .......+.+++.+|++.||++|||++|++++-
T Consensus 242 ~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 242 DLPQ-WRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp CSGG-GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred Cchh-hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 1111 111233578999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=346.02 Aligned_cols=256 Identities=22% Similarity=0.285 Sum_probs=195.0
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC----- 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 572 (796)
..+|++.+.||+|+||+||+|+...+..||+|++...... ..+|+++++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3579999999999999999999877777999988654322 2369999999999999999999965443
Q ss_pred -eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec-CCCcEEEeeecc
Q 003780 573 -MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN-SKLEAFVADFGT 650 (796)
Q Consensus 573 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~ 650 (796)
.++||||++++.+....+.......+++..+..++.||++||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 789999998865544443222334589999999999999999999999 999999999999999 789999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh-----
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV----- 724 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 724 (796)
++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+...
T Consensus 189 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 189 AKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-----IDQLVEIIKVLGTPS 262 (394)
T ss_dssp CEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCC
T ss_pred cccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCC
Confidence 987654332 3345689999999998764 589999999999999999999999974321 0011111110
Q ss_pred -----------hcCCCCC----ccch-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 725 -----------LDSRLSP----PVDR-MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 725 -----------~~~~~~~----~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
....... .... ........+.+++.+||+.||++|||+.|+++|-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 0000000 0000 0011234588999999999999999999999983
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.46 Aligned_cols=251 Identities=23% Similarity=0.405 Sum_probs=193.7
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe------
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH------ 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------ 569 (796)
..++|++.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 356899999999999999999975 479999999996432 224678999999999999999999998865
Q ss_pred -------cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc
Q 003780 570 -------KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE 642 (796)
Q Consensus 570 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 642 (796)
.+..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 457899999999999999998643 3478889999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCC--------------CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCccc
Q 003780 643 AFVADFGTARLLDSDS--------------SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELL 707 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~ 707 (796)
+||+|||++....... .......|++.|+|||.+.+. .++.++||||+||++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999998654321 112335689999999998764 68899999999999999998 44311
Q ss_pred ccCCCCCchhhhHHHHhhc--CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 708 SSLSSPSSDQKIMLIDVLD--SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
............ ...++.. .......+.+++.+||+.||++|||++|++++-
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 232 -------MERVNILKKLRSVSIEFPPDF---DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp -------HHHHHHHHHHHSTTCCCCTTC---CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred -------hhHHHHHHhccccccccCccc---cccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 111111111111 1122222 122234478999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=336.68 Aligned_cols=252 Identities=17% Similarity=0.235 Sum_probs=198.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEe--ccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLH--KKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~ 573 (796)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .+.+.+|++++++++ ||||+++++++.. ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 36799999999999999999964 579999999987543 357889999999997 9999999999988 5678
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEeeecccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTAR 652 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~ 652 (796)
++||||+++++|.+++.. +++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 109 ~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999999988853 78889999999999999999999 999999999999999777 89999999998
Q ss_pred ccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhH---------HH
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM---------LI 722 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~---------~~ 722 (796)
....... .....|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||..... ....... ..
T Consensus 180 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~----~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD----NYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS----HHHHHHHHHHHHCHHHHH
T ss_pred EcCCCCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc----hHHHHHHHHHhcCCchhh
Confidence 7654332 334568999999999877 6789999999999999999999999852211 0000000 00
Q ss_pred Hhhc---------------CCCCCccc-----hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 723 DVLD---------------SRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 723 ~~~~---------------~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
+.+. ........ .........+.+++.+||+.||++|||++|+++|-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 0000 00000000 00011234588999999999999999999999873
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=341.78 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=206.0
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHH--------------HHHHHHHHHHHhhcCCCceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTF--------------FNSFQNEAHVLSKIAHRNIVKL 563 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~l 563 (796)
.++|++.+.||+|+||.||+|.. +|+.||+|++.......... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 89999999997654332211 1689999999999999999999
Q ss_pred EeEEEecceeeEEEeeccCCcHHHH------HhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeE
Q 003780 564 YGFCLHKKCMFLIYKYMKRGSLFCF------LRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNIL 636 (796)
Q Consensus 564 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIl 636 (796)
++++.+++..++||||+++|+|.++ +... ....+++..+..++.|+++||+|||+ . +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 5432 13458999999999999999999999 8 9999999999999
Q ss_pred ecCCCcEEEeeeccccccCCCCCCccccccccCccCccccccC-CcCc-chhHHHHHHHHHHHHhCCCCCcccccCCCCC
Q 003780 637 LNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTE-KCDVYSFGVVALEVLMGRHPGELLSSLSSPS 714 (796)
Q Consensus 637 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DVwSlGv~l~elltg~~p~~~~~~~~~~~ 714 (796)
++.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++|||||||++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 999999999999999876443 33345689999999999877 6666 999999999999999999998742210
Q ss_pred chhhhHHHHhhcCCCCCccc--------------hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 715 SDQKIMLIDVLDSRLSPPVD--------------RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..............+.. .........+.+++.+||+.||++|||++|++++-
T Consensus 259 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 259 ---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp ---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred ---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 11122222221111100 00012234578999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=347.37 Aligned_cols=197 Identities=20% Similarity=0.305 Sum_probs=171.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc------CCCceeeEEeEEEec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI------AHRNIVKLYGFCLHK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~ 570 (796)
..+|++.+.||+|+||.||+|.. .+++.||||++..... ..+++.+|+++++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 45799999999999999999965 4689999999976432 235677888888877 577999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc--EEEeee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE--AFVADF 648 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Df 648 (796)
+..++||||+. ++|.+++..... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999996 589998876532 3489999999999999999999999 9999999999999999987 999999
Q ss_pred ccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcc
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEL 706 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~ 706 (796)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 999765432 2335689999999999999999999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.41 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=186.8
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 4578999999999999999999754 6899999998755432 224578899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhc-----CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 576 IYKYMKRGSLFCFLRND-----YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
||||+++++|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998742 1234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-----CccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh
Q 003780 651 ARLLDSDSS-----NRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 651 a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
+........ ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~ 239 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--------KVLMLT 239 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--------hHHHHH
Confidence 986643211 1233568999999999875 56889999999999999999999998743211 111111
Q ss_pred hcCCCCCccc-----hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 725 LDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 725 ~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.......... .........+.+++.+||+.||.+||+++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111110000 0001112347899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.86 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=201.4
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-----K 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~ 571 (796)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|++++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 46899999999999999999975 47899999999754432 2346789999999999999999999999765 3
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++|+||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 6899999998 5999988753 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC---ccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc-
Q 003780 652 RLLDSDSSN---RTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD- 726 (796)
Q Consensus 652 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 726 (796)
+........ .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... .....+...+.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~ 250 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGS 250 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-----GHHHHHHHHHCS
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHHHhCC
Confidence 876533221 234579999999998654 45899999999999999999999999743221 00011110000
Q ss_pred ----------------------CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 727 ----------------------SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 727 ----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.................+.+++.+||+.||++|||++|+++|-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00001111111122345789999999999999999999999853
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.21 Aligned_cols=257 Identities=23% Similarity=0.300 Sum_probs=194.3
Q ss_pred HHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec---
Q 003780 495 IKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK--- 570 (796)
Q Consensus 495 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--- 570 (796)
....++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 34567899999999999999999964 57999999998755322 34699999999999999999998543
Q ss_pred -----------------------------------ceeeEEEeeccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHH
Q 003780 571 -----------------------------------KCMFLIYKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANAL 614 (796)
Q Consensus 571 -----------------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L 614 (796)
...++||||++ |+|.+.+... .....+++..+..++.|+++||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 34889999998 5887777642 1234589999999999999999
Q ss_pred HHHhhcCCCCeEEecCCCCCeEec-CCCcEEEeeeccccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHH
Q 003780 615 SYLHHDCMPSIVHRDISSNNILLN-SKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGV 692 (796)
Q Consensus 615 ~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv 692 (796)
+|||+. +|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999 999999999999998 68899999999998765433 23345689999999998765 4899999999999
Q ss_pred HHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc-----------CC-----CC----Cccc-hhhHHHHHHHHHHHHHc
Q 003780 693 VALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD-----------SR-----LS----PPVD-RMVMQDIVLVTTVALAC 751 (796)
Q Consensus 693 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~-----~~----~~~~-~~~~~~~~~l~~li~~c 751 (796)
++|||++|+.||..... ......+..... +. .+ .... .........+.+++.+|
T Consensus 231 il~ell~g~~pf~~~~~-----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 231 VFGELILGKPLFSGETS-----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 99999999999974321 111111111100 00 00 0000 00111233478999999
Q ss_pred CCCCCCCCCCHHHHHHH
Q 003780 752 LHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 752 l~~dP~~RPs~~evl~~ 768 (796)
|+.||++|||+.|+++|
T Consensus 306 L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCSSGGGSCCHHHHHTS
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999976
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=352.92 Aligned_cols=308 Identities=19% Similarity=0.252 Sum_probs=268.5
Q ss_pred CCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCC--CCCCCCCC
Q 003780 71 ARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPE--LGSLRNLE 148 (796)
Q Consensus 71 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~--~~~l~~L~ 148 (796)
-.+++.|+++++.+.+.+++..|..+++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..|.. |.++++|+
T Consensus 53 l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~ 132 (455)
T 3v47_A 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132 (455)
T ss_dssp CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCC
T ss_pred CccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCC
Confidence 3579999999999999998888999999999999999999999999999999999999999999755544 99999999
Q ss_pred EEEecCCCCCCCCchh-hhccCccceeeccccccCCCCCccccCC--CCccEEEcccccccCcchhhh--------cCCC
Q 003780 149 VLNLKGNNLNGAIPSS-LCQLTKLITMALSRNGLHGPIPSAIGDL--NNLLILSLDSNKLSGMLHQEL--------GKLK 217 (796)
Q Consensus 149 ~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~--------~~l~ 217 (796)
+|+|++|++++..|.. +.++++|++|+|++|++++..|..+..+ .+|+.|++++|.+.+..+..+ ..++
T Consensus 133 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~ 212 (455)
T 3v47_A 133 MLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212 (455)
T ss_dssp EEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC
T ss_pred EEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccc
Confidence 9999999999888876 8999999999999999999999888776 566666666666665544332 2445
Q ss_pred CccccccCCccccccCCCccc-------------------------------------c--cCccceEEeccccccccCC
Q 003780 218 NLVALNVGGNKLMGPIPSTLF-------------------------------------R--LTNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 218 ~L~~L~l~~N~l~~~~~~~l~-------------------------------------~--l~~L~~L~L~~N~l~~~~p 258 (796)
+|++|++++|++++..|..+. . .++|++|++++|++++.+|
T Consensus 213 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 292 (455)
T 3v47_A 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLK 292 (455)
T ss_dssp EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECT
T ss_pred eeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccch
Confidence 666666666666543333221 1 2689999999999999999
Q ss_pred ccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCC
Q 003780 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSE 338 (796)
Q Consensus 259 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 338 (796)
..+..+++|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..+.++++|++|+|++|++++..|..|..+++
T Consensus 293 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 372 (455)
T 3v47_A 293 SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN 372 (455)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred hhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccccc
Confidence 99999999999999999999999999999999999999999999888999999999999999999999999999999999
Q ss_pred CcEEEeecccccCCCCccc-cccccceEEecccccCCCCCc
Q 003780 339 LRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPP 378 (796)
Q Consensus 339 L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~ 378 (796)
|+.|+|++|++++..+..+ .+++|++|++++|++++.+|.
T Consensus 373 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 373 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 9999999999998666665 589999999999999999884
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.13 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=200.7
Q ss_pred HhcCCccceeeecccceeEEEEEc--cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc---CCCceeeEEeEEE---
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL--PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI---AHRNIVKLYGFCL--- 568 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~--- 568 (796)
+.++|++.+.||+|+||.||+|+. .+|+.||+|++........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 457899999999999999999976 4689999999976543321 123566777777766 8999999999997
Q ss_pred --ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEe
Q 003780 569 --HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA 646 (796)
Q Consensus 569 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 646 (796)
.....++||||++ |+|.+++..... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5667899999998 599999976532 3488999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc
Q 003780 647 DFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD 726 (796)
Q Consensus 647 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (796)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.....
T Consensus 163 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHC
T ss_pred cCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHcC
Confidence 999998654321 23345689999999999998999999999999999999999999874221 000001111000
Q ss_pred -------------------CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 -------------------SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 -------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.................+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000111111223457899999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.63 Aligned_cols=264 Identities=22% Similarity=0.248 Sum_probs=189.5
Q ss_pred HHHHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec
Q 003780 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK 570 (796)
Q Consensus 492 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 570 (796)
++.....++|++.+.||+|+||.||+|+. .+|+.||||++...... ...+.+|++.++.++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 44556778999999999999999999976 46899999998655432 23567788888999999999999999764
Q ss_pred ce-------eeEEEeeccCCcHHHHHh-hcCcccccCHHHHHHHHHHHHHHHHHHh--hcCCCCeEEecCCCCCeEecC-
Q 003780 571 KC-------MFLIYKYMKRGSLFCFLR-NDYEAVVLDWTMRVNIIKCVANALSYLH--HDCMPSIVHRDISSNNILLNS- 639 (796)
Q Consensus 571 ~~-------~~lV~e~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~dlkp~NIll~~- 639 (796)
+. .++||||++++ |.+.+. .......+++..+..++.|++.||.||| +. +|+||||||+||+++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred ccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 43 78999999975 444333 2223345889999999999999999999 77 9999999999999997
Q ss_pred CCcEEEeeeccccccCCCCCCccccccccCccCccccccCC-cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhh
Q 003780 640 KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQK 718 (796)
Q Consensus 640 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~ 718 (796)
++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ....
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~ 241 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-----AGQL 241 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred CCcEEEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-----HHHH
Confidence 89999999999987654332 33456899999999986554 89999999999999999999999974221 0000
Q ss_pred hHHHHh-----------hcCCCC---------Ccc----chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 719 IMLIDV-----------LDSRLS---------PPV----DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 719 ~~~~~~-----------~~~~~~---------~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..+... +.+... ... ..........+.+++.+||+.||++|||+.|+++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 011100 000000 000 000011244688999999999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.43 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=198.1
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee---
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM--- 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~--- 573 (796)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE-IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch-hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 46899999999999999999975 479999999998654332 3356889999999999999999999999877654
Q ss_pred ---eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 574 ---FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 574 ---~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 588877743 288999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CC------
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SP------ 713 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~------ 713 (796)
++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ..
T Consensus 191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9865432 234568999999999887 678999999999999999999999997432100 00
Q ss_pred --CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 714 --SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 714 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
...........+..................+.+++.+||+.||++|||++|++++-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00000000011111111111111112234588999999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.22 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=198.8
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC--------CCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA--------HRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~ 568 (796)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 46899999999999999999964 578999999997543 22457889999999985 788999999998
Q ss_pred ----ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC---
Q 003780 569 ----HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL--- 641 (796)
Q Consensus 569 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~--- 641 (796)
.....++||||+ ++++.+.+.... ...+++..+..++.||++||+|||+++ +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 556899999999 456666555432 234899999999999999999999864 899999999999999775
Q ss_pred ----------------------------------------------cEEEeeeccccccCCCCCCccccccccCccCccc
Q 003780 642 ----------------------------------------------EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675 (796)
Q Consensus 642 ----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~ 675 (796)
.+||+|||.++..... .....||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999999876532 233468999999999
Q ss_pred cccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhh-hHHHHhhcCCC-----------------------CC
Q 003780 676 AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQK-IMLIDVLDSRL-----------------------SP 731 (796)
Q Consensus 676 ~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~-----------------------~~ 731 (796)
+.+..++.++|||||||++|||++|+.||.............. ........... ..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999974332211111111 01111111000 00
Q ss_pred --c---------cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 732 --P---------VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 732 --~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. ...........+.+++.+||+.||++|||++|+++|
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 000123344568899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=350.10 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=184.7
Q ss_pred cCCcc-ceeeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cce
Q 003780 499 EDFDI-KYCIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKC 572 (796)
Q Consensus 499 ~~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~ 572 (796)
+.|++ .+.||+|+||+||+|+.+ +++.||+|++...... +.+.+|++++++++||||+++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 45666 457999999999999865 5789999999765432 367899999999999999999999954 678
Q ss_pred eeEEEeeccCCcHHHHHhhcC------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe----cCCCc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDY------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL----NSKLE 642 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~ 642 (796)
.++||||+++ +|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 9999999975 7887775332 123489999999999999999999999 99999999999999 67789
Q ss_pred EEEeeeccccccCCCC---CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCC----CCC
Q 003780 643 AFVADFGTARLLDSDS---SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----SPS 714 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----~~~ 714 (796)
+||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999999998765432 222345789999999998874 58999999999999999999999996432210 000
Q ss_pred chhhhHHHHhhcCCCCCccchh---------------------h---------HHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 003780 715 SDQKIMLIDVLDSRLSPPVDRM---------------------V---------MQDIVLVTTVALACLHSKPKFRPTMQR 764 (796)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~---------------------~---------~~~~~~l~~li~~cl~~dP~~RPs~~e 764 (796)
......+...+........... . ......+.+++.+||+.||++|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 0111111111111100000000 0 000234778999999999999999999
Q ss_pred HHHHHh
Q 003780 765 VCQEFL 770 (796)
Q Consensus 765 vl~~L~ 770 (796)
+++|-.
T Consensus 331 ~L~hp~ 336 (405)
T 3rgf_A 331 AMQDPY 336 (405)
T ss_dssp HHTSGG
T ss_pred HhcChh
Confidence 999854
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.27 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=199.0
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-----K 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~ 571 (796)
.++|++.+.||+|+||.||+|... +|+.||||++...... .....+.+|++++++++||||+++++++..+ .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP--LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc--hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 468999999999999999999754 7999999999654322 2345788999999999999999999998764 6
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..++||||++ |+|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 7899999997 5899988753 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC----------ccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC---------
Q 003780 652 RLLDSDSSN----------RTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS--------- 711 (796)
Q Consensus 652 ~~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~--------- 711 (796)
+........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 876532211 122468999999998754 678999999999999999999999997432100
Q ss_pred -------CCCchhhhHHHHhhcCC---CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 712 -------SPSSDQKIMLIDVLDSR---LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 712 -------~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
...........+..... ...............+.+++.+||+.||++|||++|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00000000000111100 00011111112234578999999999999999999999974
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=372.01 Aligned_cols=311 Identities=24% Similarity=0.268 Sum_probs=189.6
Q ss_pred ccCCCCCCcEEeccCCcccccC-CcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchh--hhcc
Q 003780 92 NFSCFPGLESLSLRFNYLFGSI-PSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSS--LCQL 168 (796)
Q Consensus 92 ~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l 168 (796)
.|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.+++.+|.. |.++
T Consensus 43 ~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L 122 (844)
T 3j0a_A 43 SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122 (844)
T ss_dssp SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSC
T ss_pred HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCcccccc
Confidence 3666777777777777544443 667777777777777777777777777777777777777777777655554 7777
Q ss_pred CccceeeccccccCCCCC-ccccCCCCccEEEcccccccCcchhhhcCC--CC---------------------------
Q 003780 169 TKLITMALSRNGLHGPIP-SAIGDLNNLLILSLDSNKLSGMLHQELGKL--KN--------------------------- 218 (796)
Q Consensus 169 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~--------------------------- 218 (796)
++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..+ ++
T Consensus 123 ~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~ 202 (844)
T 3j0a_A 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202 (844)
T ss_dssp SSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTT
T ss_pred CCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccc
Confidence 778888888877776654 467778888888888777766555444332 22
Q ss_pred ---ccccccCCc--------------------------------------------------------------cccccC
Q 003780 219 ---LVALNVGGN--------------------------------------------------------------KLMGPI 233 (796)
Q Consensus 219 ---L~~L~l~~N--------------------------------------------------------------~l~~~~ 233 (796)
|+.|++++| .+.+..
T Consensus 203 ~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~ 282 (844)
T 3j0a_A 203 NMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282 (844)
T ss_dssp TCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEEC
T ss_pred cCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccC
Confidence 233333333 222223
Q ss_pred CCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccccc
Q 003780 234 PSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLI 313 (796)
Q Consensus 234 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 313 (796)
|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|++|++++|.+++..+..|.+++
T Consensus 283 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 362 (844)
T 3j0a_A 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362 (844)
T ss_dssp SCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCC
T ss_pred hhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCC
Confidence 33344444455555555555544444555555555555555555544455555555555555555555544444555555
Q ss_pred ccceecccccccccCC------------------Cc----------------------ccCCCCCCcEEEeecccccCCC
Q 003780 314 SLKGLDLSNNKLSGPI------------------PP----------------------EIGKCSELRNITLRNNNLSGSI 353 (796)
Q Consensus 314 ~L~~L~Ls~N~l~~~~------------------~~----------------------~~~~l~~L~~L~L~~N~l~~~~ 353 (796)
+|++|+|++|.+++.. |. .+..+++|+.|+|++|++++..
T Consensus 363 ~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~ 442 (844)
T 3j0a_A 363 KLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS 442 (844)
T ss_dssp CCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCC
T ss_pred CCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccc
Confidence 5555555555544210 00 0123445555555555554321
Q ss_pred C------------------------------ccc-cccccceEEecccccCCCCCccc---cccccccccCCCCcccCCC
Q 003780 354 P------------------------------PEI-GLMKLEYLDLSHNKLNGTIPPFL---YHRFPLDLSYNDLEGEIPD 399 (796)
Q Consensus 354 ~------------------------------~~~-~~~~L~~L~l~~N~l~~~~p~~~---~~~~~l~l~~N~l~~~~p~ 399 (796)
+ ..+ ++++|+.|+|++|++++..|..+ .++..|+|++|++++..|.
T Consensus 443 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 522 (844)
T 3j0a_A 443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN 522 (844)
T ss_dssp SSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCC
T ss_pred cccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChh
Confidence 1 112 35789999999999998877654 5567899999999998777
Q ss_pred CCC
Q 003780 400 YFR 402 (796)
Q Consensus 400 ~~~ 402 (796)
.+.
T Consensus 523 ~~~ 525 (844)
T 3j0a_A 523 DLP 525 (844)
T ss_dssp CCC
T ss_pred hhh
Confidence 665
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.76 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=191.9
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEE--------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCL-------- 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-------- 568 (796)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh---HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 468999999999999999999765 589999999875532 23568899999999999999999999874
Q ss_pred ------ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec-CCC
Q 003780 569 ------HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN-SKL 641 (796)
Q Consensus 569 ------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~ 641 (796)
+....++||||++ |+|.+++.+. .+++..+..++.|+++||+|||+. +|+||||||+||+++ .++
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 3467899999998 6999998653 388999999999999999999999 999999999999997 567
Q ss_pred cEEEeeeccccccCCCC---CCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchh
Q 003780 642 EAFVADFGTARLLDSDS---SNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 642 ~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 717 (796)
.+||+|||+++...... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------- 230 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-------- 230 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--------
Confidence 99999999998764321 12233457899999998765 6788999999999999999999999974321
Q ss_pred hhHHHHhhcCC-------------------------CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 718 KIMLIDVLDSR-------------------------LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 718 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
......+.... ...............+.+++.+||+.||++|||++|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 01111111000 00000111111234588999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.63 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=192.3
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------c
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------K 571 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 571 (796)
.+|++.+.||+|+||.||+|+.+ +|+.||||++..... ...+|++++++++||||+++++++... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 46889999999999999999765 699999999875432 234699999999999999999998642 2
Q ss_pred eeeEEEeeccCCcHHHHHhhc-CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEeeec
Q 003780 572 CMFLIYKYMKRGSLFCFLRND-YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFG 649 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg 649 (796)
..++||||+++ ++.+.+... .....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 36799999986 566555431 2234589999999999999999999999 99999999999999965 568999999
Q ss_pred cccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh----
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV---- 724 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 724 (796)
+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+...
T Consensus 203 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-----~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 203 SAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-----VDQLVEIIKVLGTP 276 (420)
T ss_dssp TCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCSC
T ss_pred hhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCC
Confidence 9987654332 2345689999999998764 789999999999999999999999974221 0111111111
Q ss_pred -------hcCCCC----Cccch------hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 725 -------LDSRLS----PPVDR------MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 725 -------~~~~~~----~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..+... +.... ........+.+++.+||+.||++||++.|+++|-
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 011100 00000 0011124588999999999999999999999874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=359.09 Aligned_cols=330 Identities=21% Similarity=0.185 Sum_probs=277.2
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEe
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (796)
.+..++++++.+.. +++..|..+++|++|+|++|.+.+..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|
T Consensus 52 ~l~~l~l~~~~l~~-lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 52 NQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCSEEEESSCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCCCCC-cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 34566677766654 55555788999999999999999988889999999999999999999888888999999999999
Q ss_pred cCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccccc
Q 003780 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP 232 (796)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 232 (796)
++|.|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.. ++.+++|+.|++++|.+++
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~- 206 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST- 206 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE-
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc-
Confidence 999999777777899999999999999999988889999999999999999998763 5667889999999998875
Q ss_pred CCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccc
Q 003780 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGL 312 (796)
Q Consensus 233 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 312 (796)
+...++|+.|++++|.++...+. + .++|+.|+|++|.+++ +..+..+++|++|+|++|.+++..|..|..+
T Consensus 207 ----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 277 (597)
T 3oja_B 207 ----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 277 (597)
T ss_dssp ----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred ----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCc
Confidence 34456899999999999854332 2 3689999999999997 4679999999999999999999999999999
Q ss_pred cccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCccccccccccccCC
Q 003780 313 ISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYN 391 (796)
Q Consensus 313 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~l~~N 391 (796)
++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+++ +|..+ .+++|++|+|++|++++..+..+..+..|++++|
T Consensus 278 ~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N 355 (597)
T 3oja_B 278 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHN 355 (597)
T ss_dssp SSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSS
T ss_pred cCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCC
Confidence 999999999999996 57778889999999999999994 55555 5899999999999999776667788889999999
Q ss_pred CCcccCCC-CCCCCC-ccccCCccccccC
Q 003780 392 DLEGEIPD-YFRDSP-FKVYGNQGICYFS 418 (796)
Q Consensus 392 ~l~~~~p~-~~~~~~-~~~~~n~~~c~~~ 418 (796)
.+++.... ++...+ ..+.++...|+.+
T Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 356 DWDCNSLRALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CEEHHHHHHHTTTCCTTTBCCCCCCCCTT
T ss_pred CCCChhHHHHHHHHhhhccccccccCCcc
Confidence 99875432 333322 2235777788754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=331.82 Aligned_cols=253 Identities=19% Similarity=0.340 Sum_probs=200.5
Q ss_pred hcCCccceeeecccceeEEEEEc--cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCC------ceeeEEeEEEe
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL--PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR------NIVKLYGFCLH 569 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~l~~~~~~ 569 (796)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+++++.++|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46899999999999999999975 368999999997543 2245788999999988755 49999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC----------
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---------- 639 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---------- 639 (796)
.+..++||||+ +++|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999 8899999976532 3488999999999999999999999 9999999999999987
Q ss_pred ---------CCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC
Q 003780 640 ---------KLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL 710 (796)
Q Consensus 640 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~ 710 (796)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 239 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS- 239 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-
Confidence 668999999999865432 2345689999999999999999999999999999999999999874221
Q ss_pred CCCCchhhhHHHHhhcCCCCC-------------------------------------ccchhhHHHHHHHHHHHHHcCC
Q 003780 711 SSPSSDQKIMLIDVLDSRLSP-------------------------------------PVDRMVMQDIVLVTTVALACLH 753 (796)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~l~~li~~cl~ 753 (796)
............. .+. ............+.+++.+||+
T Consensus 240 ----~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 240 ----KEHLAMMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp ----HHHHHHHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred ----HHHHHHHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 0111111111100 000 0000011234568899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003780 754 SKPKFRPTMQRVCQE 768 (796)
Q Consensus 754 ~dP~~RPs~~evl~~ 768 (796)
.||++|||++|++++
T Consensus 315 ~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 315 YDPAKRITLREALKH 329 (339)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=335.53 Aligned_cols=261 Identities=20% Similarity=0.365 Sum_probs=200.3
Q ss_pred HHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
...++|++.+.||+|+||.||+|+.++ .+|+|++........ ..+.+.+|+.++++++||||+++++++..++..++
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED-QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC-CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH-HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 345789999999999999999998753 499999876543322 23467889999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999997643 3488999999999999999999999 999999999999998 6799999999987653
Q ss_pred CC-----CCCccccccccCccCcccccc---------CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHH
Q 003780 656 SD-----SSNRTIVAGTYGYIAPELAYT---------MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIML 721 (796)
Q Consensus 656 ~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (796)
.. ........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~ 252 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------AEAII 252 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------HHHHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 21 122233458999999999874 347889999999999999999999987321 11112
Q ss_pred HHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
..... ...+.... ......+.+++.+||+.||++|||++|+++.|+......
T Consensus 253 ~~~~~-~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 253 WQMGT-GMKPNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHT-TCCCCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHhcc-CCCCCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 12211 11111110 011123778999999999999999999999999876543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=352.38 Aligned_cols=342 Identities=20% Similarity=0.205 Sum_probs=238.5
Q ss_pred cCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCC
Q 003780 62 KLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPEL 141 (796)
Q Consensus 62 ~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~ 141 (796)
.+++|..+-..+++.|++++|.+.+.. +..|..+++|++|+|++|.+++..|..|+++++|++|||++|.|+ .+|..
T Consensus 42 ~L~~ip~~~~~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~- 118 (562)
T 3a79_B 42 NLTHVPKDLPPRTKALSLSQNSISELR-MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC- 118 (562)
T ss_dssp CCCSCCTTSCTTCCEEECCSSCCCCCC-GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC-
T ss_pred CCccCCCCCCCCcCEEECCCCCccccC-hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc-
Confidence 444555444456778888888777544 335778888888888888888777777888888888888888887 45555
Q ss_pred CCCCCCCEEEecCCCCCCC-CchhhhccCccceeeccccccCCCCCccccCCCCc--cEEEcccccc--cCcchhhhcCC
Q 003780 142 GSLRNLEVLNLKGNNLNGA-IPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNL--LILSLDSNKL--SGMLHQELGKL 216 (796)
Q Consensus 142 ~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l 216 (796)
.+++|++|+|++|++++. +|..|+++++|++|+|++|++++. .+..+++| ++|+|++|.+ ++..|..+..+
T Consensus 119 -~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l 194 (562)
T 3a79_B 119 -PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194 (562)
T ss_dssp -CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEEC
T ss_pred -ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCccccccc
Confidence 678888888888888763 457788888888888888887753 34444444 8888888877 55555555443
Q ss_pred C-------------------------------------------------------------------------------
Q 003780 217 K------------------------------------------------------------------------------- 217 (796)
Q Consensus 217 ~------------------------------------------------------------------------------- 217 (796)
.
T Consensus 195 ~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~ 274 (562)
T 3a79_B 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274 (562)
T ss_dssp CEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHT
T ss_pred CcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhh
Confidence 2
Q ss_pred --CccccccCCccccccCCCcc-----cccC--------------------------ccceEEeccccccccCCccccCC
Q 003780 218 --NLVALNVGGNKLMGPIPSTL-----FRLT--------------------------NLTYLYLHSNHLNGSIPPEIGNM 264 (796)
Q Consensus 218 --~L~~L~l~~N~l~~~~~~~l-----~~l~--------------------------~L~~L~L~~N~l~~~~p~~~~~l 264 (796)
+|++|++++|.++|.+|..+ .+++ +|++|++++|.+.... ....+
T Consensus 275 ~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l 352 (562)
T 3a79_B 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSP 352 (562)
T ss_dssp TSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSC
T ss_pred cccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCC
Confidence 44455555555554444443 2221 2333333333332111 01677
Q ss_pred cccceeecccccccccCccccccccccccccccCccccC--ccccccccccccceecccccccccCCCc-ccCCCCCCcE
Q 003780 265 TGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG--QIPITIAGLISLKGLDLSNNKLSGPIPP-EIGKCSELRN 341 (796)
Q Consensus 265 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~ 341 (796)
++|+.|++++|++++.+|..+.++++|++|++++|++++ .+|..+.++++|++|++++|++++.+|. .+..+++|+.
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 889999999999998888889999999999999999987 3456788899999999999999884554 5888899999
Q ss_pred EEeecccccCCCCccccccccceEEecccccCCCCCcccc---ccccccccCCCCcccCCCC-CCCCC----ccccCCcc
Q 003780 342 ITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLY---HRFPLDLSYNDLEGEIPDY-FRDSP----FKVYGNQG 413 (796)
Q Consensus 342 L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~---~~~~l~l~~N~l~~~~p~~-~~~~~----~~~~~n~~ 413 (796)
|+|++|++++.+|..+. ++|++|+|++|+++ .+|..++ ++..|+|++|++++ +|.. |...+ ....+|+.
T Consensus 433 L~l~~n~l~~~~~~~l~-~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~ 509 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509 (562)
T ss_dssp EECCSSCCCGGGGSSCC-TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCB
T ss_pred EECCCCCCCcchhhhhc-CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCc
Confidence 99999999887776554 68999999999988 6776544 45678999999985 4543 54332 12355655
Q ss_pred cc
Q 003780 414 IC 415 (796)
Q Consensus 414 ~c 415 (796)
.|
T Consensus 510 ~c 511 (562)
T 3a79_B 510 DC 511 (562)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=334.36 Aligned_cols=259 Identities=23% Similarity=0.300 Sum_probs=197.2
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC---- 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 572 (796)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 46799999999999999999975 47999999999765433 2335678999999999999999999999987654
Q ss_pred --eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 573 --MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 573 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
.++||||++ |+|.+++.. .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 588877643 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CC------
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SP------ 713 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~------ 713 (796)
++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ..
T Consensus 173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865432 233568999999999876 678899999999999999999999997432100 00
Q ss_pred --CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 714 --SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 714 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
...........+..................+.+++.+||+.||++|||++|+++|-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000000001111111111111122234588999999999999999999999884
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=354.93 Aligned_cols=324 Identities=20% Similarity=0.172 Sum_probs=270.0
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+++++.+++..+ ..|..+++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..+..|+++++|++|+
T Consensus 56 ~~L~~L~Ls~n~l~~i~~-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIED-KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp TTCCEEECTTCCCCEECT-TTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred ccCcEEeCCCCcccccCH-HHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 467788888887775433 3577888888888888888877788888888888888888888766667778888888888
Q ss_pred ecCCCCCC-CCchhhhccCccceeeccccccCCCCCccc-----------------------------------------
Q 003780 152 LKGNNLNG-AIPSSLCQLTKLITMALSRNGLHGPIPSAI----------------------------------------- 189 (796)
Q Consensus 152 L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----------------------------------------- 189 (796)
|++|++++ .+|..|+++++|++|+|++|++++..|..|
T Consensus 135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n 214 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214 (606)
T ss_dssp CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCC
Confidence 88888775 457777777777777777777665433211
Q ss_pred --------------------------------------------------------------------------------
Q 003780 190 -------------------------------------------------------------------------------- 189 (796)
Q Consensus 190 -------------------------------------------------------------------------------- 189 (796)
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~ 294 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence
Q ss_pred ----------------------------------------------------cCCCCccEEEcccccccCcc--hhhhcC
Q 003780 190 ----------------------------------------------------GDLNNLLILSLDSNKLSGML--HQELGK 215 (796)
Q Consensus 190 ----------------------------------------------------~~l~~L~~L~L~~N~l~~~~--~~~~~~ 215 (796)
..+++|++|+|++|++++.. +..+..
T Consensus 295 ~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 374 (606)
T 3vq2_A 295 VSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374 (606)
T ss_dssp CCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHC
T ss_pred ccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhcc
Confidence 12345666666666766553 778899
Q ss_pred CCCccccccCCccccccCCCcccccCccceEEeccccccccCC-ccccCCcccceeecccccccccCccccccccccccc
Q 003780 216 LKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP-PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYL 294 (796)
Q Consensus 216 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 294 (796)
+++|++|++++|.+++ +|..+..+++|+.|++++|++++..| ..+.++++|+.|++++|++++..|..+.++++|++|
T Consensus 375 ~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 453 (606)
T 3vq2_A 375 TNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453 (606)
T ss_dssp CSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEE
Confidence 9999999999999985 56889999999999999999998887 689999999999999999999999999999999999
Q ss_pred cccCccccC-ccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcccc-ccccceEEeccccc
Q 003780 295 SISSNMLSG-QIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKL 372 (796)
Q Consensus 295 ~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~L~~L~l~~N~l 372 (796)
++++|.+++ .+|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+. +++|+.|+|++|++
T Consensus 454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 533 (606)
T 3vq2_A 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533 (606)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCC
T ss_pred ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcC
Confidence 999999998 4799999999999999999999999999999999999999999999998888875 88999999999999
Q ss_pred CCCCCcccc----ccccccccCCCCcccCC
Q 003780 373 NGTIPPFLY----HRFPLDLSYNDLEGEIP 398 (796)
Q Consensus 373 ~~~~p~~~~----~~~~l~l~~N~l~~~~p 398 (796)
+ .+|..+. .+..+++++|.+.+..+
T Consensus 534 ~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 534 E-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp C-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred c-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 8 6776543 36689999999988665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=352.11 Aligned_cols=315 Identities=22% Similarity=0.268 Sum_probs=261.7
Q ss_pred CCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCC-CCCCCCCCCCCCCE
Q 003780 71 ARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG-SIPPELGSLRNLEV 149 (796)
Q Consensus 71 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~p~~~~~l~~L~~ 149 (796)
-.+++.|++++|.+++..+ ..|..+++|++|+|++|.++. +|.. .+++|++|+|++|.+++ .+|..|+++++|++
T Consensus 75 l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~ 150 (562)
T 3a79_B 75 LSELRVLRLSHNRIRSLDF-HVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTF 150 (562)
T ss_dssp CTTCCEEECCSCCCCEECT-TTTTTCTTCCEEECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCE
T ss_pred CCCccEEECCCCCCCcCCH-HHhCCCCCCCEEECCCCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccE
Confidence 3579999999999987544 469999999999999999994 5555 89999999999999997 34689999999999
Q ss_pred EEecCCCCCCCCchhhhccCcc--ceeecccccc--CCCCCccccCCC--------------------------------
Q 003780 150 LNLKGNNLNGAIPSSLCQLTKL--ITMALSRNGL--HGPIPSAIGDLN-------------------------------- 193 (796)
Q Consensus 150 L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~-------------------------------- 193 (796)
|+|++|++++. .+..+++| +.|+|++|.+ ++..|..|..+.
T Consensus 151 L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~ 227 (562)
T 3a79_B 151 LGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227 (562)
T ss_dssp EEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEE
T ss_pred EecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEec
Confidence 99999999864 45555555 9999999999 778787776654
Q ss_pred -------------------------------------------------CccEEEcccccccCcchhhh-----cCCC--
Q 003780 194 -------------------------------------------------NLLILSLDSNKLSGMLHQEL-----GKLK-- 217 (796)
Q Consensus 194 -------------------------------------------------~L~~L~L~~N~l~~~~~~~~-----~~l~-- 217 (796)
+|++|++++|.+++.+|..+ ..++
T Consensus 228 l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L 307 (562)
T 3a79_B 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307 (562)
T ss_dssp EECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEE
T ss_pred ccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchhe
Confidence 78888888898887777665 3333
Q ss_pred ------------------------CccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecc
Q 003780 218 ------------------------NLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMS 273 (796)
Q Consensus 218 ------------------------~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 273 (796)
+|+.|++++|.+.... ....+++|++|++++|++++.+|..+.++++|+.|+|+
T Consensus 308 ~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 385 (562)
T 3a79_B 308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385 (562)
T ss_dssp EEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECC
T ss_pred ehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECC
Confidence 4666667777665321 12678999999999999999899999999999999999
Q ss_pred ccccccc--CccccccccccccccccCccccCccc-cccccccccceecccccccccCCCcccCCCCCCcEEEeeccccc
Q 003780 274 MNNIEGT--IPLELTRLSQLLYLSISSNMLSGQIP-ITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350 (796)
Q Consensus 274 ~N~l~~~--~p~~l~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 350 (796)
+|++++. +|..+.++++|++|++++|.+++.+| ..+..+++|++|++++|++++.+|..+. ++|+.|+|++|+++
T Consensus 386 ~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463 (562)
T ss_dssp SSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC
T ss_pred CCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc
Confidence 9999973 45779999999999999999998555 4588999999999999999987777665 79999999999999
Q ss_pred CCCCc-cccccccceEEecccccCCCCCcc-c---cccccccccCCCCcccCC
Q 003780 351 GSIPP-EIGLMKLEYLDLSHNKLNGTIPPF-L---YHRFPLDLSYNDLEGEIP 398 (796)
Q Consensus 351 ~~~~~-~~~~~~L~~L~l~~N~l~~~~p~~-~---~~~~~l~l~~N~l~~~~p 398 (796)
.+|. .+.+++|++|+|++|+++ .+|.. + .++..|++++|.+.+..|
T Consensus 464 -~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 464 -SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp -CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 4554 446899999999999999 56654 3 456689999999998665
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=331.17 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=174.6
Q ss_pred HhcCCccce-eeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe----c
Q 003780 497 ATEDFDIKY-CIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH----K 570 (796)
Q Consensus 497 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~ 570 (796)
..++|.+.+ .||+|+||+||+|..+ +|+.||||++..... ...+....++.++||||+++++++.. +
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 356898855 6999999999999765 799999999865321 11222334566789999999999976 4
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVAD 647 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~D 647 (796)
...++||||+++|+|.+++.+... ..+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 568999999999999999986532 3589999999999999999999999 9999999999999986 45599999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
||+++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. .. .....
T Consensus 175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-~~~~~ 250 (336)
T 3fhr_A 175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-RI-RLGQY 250 (336)
T ss_dssp CTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-hh-hcccc
Confidence 9999865432 22345689999999999888899999999999999999999999974332111000000 00 00000
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
...... .......+.+++.+||+.||++|||++|++++-.
T Consensus 251 ~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 251 GFPNPE---WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp CCCTTT---STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred ccCchh---hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 111110 1112334789999999999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=342.04 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=187.0
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++..++..++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 3455578899999999987766789999999986542 24578899999886 8999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCccc----ccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-------------
Q 003780 578 KYMKRGSLFCFLRNDYEAV----VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK------------- 640 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~------------- 640 (796)
||+. |+|.+++....... ...+..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 69999998653211 112334578999999999999999 99999999999999754
Q ss_pred CcEEEeeeccccccCCCCCC----ccccccccCccCcccccc-------CCcCcchhHHHHHHHHHHHHh-CCCCCcccc
Q 003780 641 LEAFVADFGTARLLDSDSSN----RTIVAGTYGYIAPELAYT-------MVVTEKCDVYSFGVVALEVLM-GRHPGELLS 708 (796)
Q Consensus 641 ~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~ 708 (796)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999877543221 223569999999999875 568899999999999999999 999986321
Q ss_pred cCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 709 SLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
............. ..............+.+++.+||+.||++|||+.|+++|-
T Consensus 245 ------~~~~~i~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 245 ------SRESNIIRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp ------THHHHHHHTCCCC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ------hhHHHHhcCCCCc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 1111111111111 1000001123345688999999999999999999999763
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=350.63 Aligned_cols=326 Identities=21% Similarity=0.236 Sum_probs=253.8
Q ss_pred cCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCC
Q 003780 62 KLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPEL 141 (796)
Q Consensus 62 ~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~ 141 (796)
..++|.-.-..+++.|+++++.+++..+ ..|..+++|++|+|++|++.+..|..|+++++|++|||++|+|+ .+|..
T Consensus 11 ~l~~ip~~~~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~- 87 (520)
T 2z7x_B 11 GLIHVPKDLSQKTTILNISQNYISELWT-SDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH- 87 (520)
T ss_dssp CCSSCCCSCCTTCSEEECCSSCCCCCCH-HHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC-
T ss_pred CcccccccccccccEEECCCCcccccCh-hhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc-
Confidence 3444443333679999999999987554 35899999999999999999998999999999999999999999 56665
Q ss_pred CCCCCCCEEEecCCCCCC-CCchhhhccCccceeeccccccCCCCCccccCCCCc--cEEEcccccc--cCcchhhhcCC
Q 003780 142 GSLRNLEVLNLKGNNLNG-AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNL--LILSLDSNKL--SGMLHQELGKL 216 (796)
Q Consensus 142 ~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l 216 (796)
.+++|++|+|++|++++ .+|..|+++++|++|+|++|.+++ ..|..+++| ++|+|++|.+ .+..|..+..+
T Consensus 88 -~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l 163 (520)
T 2z7x_B 88 -PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDF 163 (520)
T ss_dssp -CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTC
T ss_pred -ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccccccccccccc
Confidence 89999999999999997 478999999999999999999986 467778888 9999999999 66666666553
Q ss_pred C-------------------------------------------------------------------------------
Q 003780 217 K------------------------------------------------------------------------------- 217 (796)
Q Consensus 217 ~------------------------------------------------------------------------------- 217 (796)
.
T Consensus 164 ~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~ 243 (520)
T 2z7x_B 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243 (520)
T ss_dssp CEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHH
T ss_pred ccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHH
Confidence 2
Q ss_pred ----CccccccCCccccccCCCcc-----cccCccceEEeccccccccCCc-c-------------------------cc
Q 003780 218 ----NLVALNVGGNKLMGPIPSTL-----FRLTNLTYLYLHSNHLNGSIPP-E-------------------------IG 262 (796)
Q Consensus 218 ----~L~~L~l~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~p~-~-------------------------~~ 262 (796)
+|++|++++|+++|.+|..+ .++++|+.+++++|.+ .+|. . +.
T Consensus 244 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 321 (520)
T 2z7x_B 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS 321 (520)
T ss_dssp HHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCS
T ss_pred hhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchh
Confidence 56666666666666666666 5555555555555554 2220 0 15
Q ss_pred CCcccceeecccccccccCccccccccccccccccCccccC--ccccccccccccceecccccccccCCCc-ccCCCCCC
Q 003780 263 NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG--QIPITIAGLISLKGLDLSNNKLSGPIPP-EIGKCSEL 339 (796)
Q Consensus 263 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L 339 (796)
.+++|+.|++++|++++.+|..+.++++|++|++++|++++ .+|..+..+++|++|+|++|++++.+|. .+..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 67788888888888888888888888888888888888886 5567788888888888888888875554 47788888
Q ss_pred cEEEeecccccCCCCccccccccceEEecccccCCCCCccc---cccccccccCCCCcccCCC
Q 003780 340 RNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFL---YHRFPLDLSYNDLEGEIPD 399 (796)
Q Consensus 340 ~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~~---~~~~~l~l~~N~l~~~~p~ 399 (796)
+.|+|++|++++.+|..+. ++|+.|++++|+++ .+|..+ .++..|++++|++++ +|.
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~ 461 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP-PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPD 461 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC-TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCT
T ss_pred CEEECcCCCCCcchhhhhc-ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCH
Confidence 8888888888877666554 68888888888888 777654 345578888888884 444
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.08 Aligned_cols=200 Identities=25% Similarity=0.347 Sum_probs=170.5
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CC-----ceeeEEeEEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HR-----NIVKLYGFCLH 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~ 569 (796)
..++|++.+.||+|+||+||+|..+ +++.||||++.... ...+++..|+.+++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 4578999999999999999999754 68999999997543 22456788888888885 54 49999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec--CCCcEEEee
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN--SKLEAFVAD 647 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~D 647 (796)
.+..++||||+++ +|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+|
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999964 99999986532 3489999999999999999999952 22899999999999995 477899999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcc
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEL 706 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~ 706 (796)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 205 FGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999876532 2345689999999999999999999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=356.37 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=203.2
Q ss_pred HhcCCccceeeecccceeEEEEEcc----CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC 572 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 572 (796)
..++|++.+.||+|+||.||+|... .+..||+|++...... ...+.+.+|+.++++++||||+++++++. ++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 4568999999999999999999754 2567999998765432 23468999999999999999999999985 466
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 899999999999999998643 3488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 653 LLDSDSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 653 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.... .......+.....
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~~~~- 610 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENGER- 610 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHHTCC-
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcCCC-
Confidence 76543222 223446789999999998899999999999999999997 999987321 1112222222111
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
..... .....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 611 ~~~~~---~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 LPMPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc---cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111 1223478999999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=340.65 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=187.5
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 576 (796)
..+|+..+.||+|+||+||.....+|+.||||++...... .+.+|+++++++ +||||+++++++.+....++|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3568899999999999976655667999999999754432 356799999999 799999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-----CCcEEEeeeccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-----KLEAFVADFGTA 651 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~a 651 (796)
|||+. |+|.+++..... ...+..+..++.||++||+|||+. +|+||||||+||+++. ...+||+|||++
T Consensus 97 ~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99997 599999976532 234445678999999999999999 9999999999999953 346889999999
Q ss_pred cccCCCC---CCccccccccCccCccccc---cCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHh
Q 003780 652 RLLDSDS---SNRTIVAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDV 724 (796)
Q Consensus 652 ~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 724 (796)
+...... .......||+.|+|||++. ...++.++||||+||++|||++ |..||.... .. .....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~------~~---~~~~~ 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------QR---QANIL 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT------TH---HHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh------HH---HHHHH
Confidence 8765432 1233456999999999987 4567789999999999999999 999986311 11 11111
Q ss_pred hcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...... ............+.+++.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 242 LGACSL-DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTCCCC-TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccCCc-cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111111 1111112233447789999999999999999999976
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=335.60 Aligned_cols=329 Identities=21% Similarity=0.175 Sum_probs=265.8
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEe
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (796)
++..++++++.++. ++...|..+++|++|+|++|.+.+..+..|+.+++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 46 ~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 46 NQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCSEEEEESCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEecCCchhh-CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 45667777766654 45545788889999999999988888888899999999999999998887888888999999999
Q ss_pred cCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccccc
Q 003780 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP 232 (796)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 232 (796)
++|+++...+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++. .+..+++|+.|++++|.+++.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc
Confidence 99998866556678889999999999999888888888899999999999988876 356678888899999888742
Q ss_pred CCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccc
Q 003780 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGL 312 (796)
Q Consensus 233 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 312 (796)
...++|++|++++|.++.. |.. ..++|+.|++++|++++. ..+..+++|++|++++|.+++..|..+..+
T Consensus 202 -----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l 271 (390)
T 3o6n_A 202 -----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKM 271 (390)
T ss_dssp -----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred -----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcccc
Confidence 3446899999999999854 432 347899999999999974 578999999999999999999999999999
Q ss_pred cccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCccccccccccccCC
Q 003780 313 ISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYN 391 (796)
Q Consensus 313 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~l~~N 391 (796)
++|++|+|++|++++ +|..+..+++|+.|+|++|++++ +|..+ .+++|++|++++|+++..-...+.++..|++++|
T Consensus 272 ~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N 349 (390)
T 3o6n_A 272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHN 349 (390)
T ss_dssp SSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSS
T ss_pred ccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCC
Confidence 999999999999985 56677889999999999999995 44444 5899999999999998765566778889999999
Q ss_pred CCcccCCC-CCCCCC-ccccCCcccccc
Q 003780 392 DLEGEIPD-YFRDSP-FKVYGNQGICYF 417 (796)
Q Consensus 392 ~l~~~~p~-~~~~~~-~~~~~n~~~c~~ 417 (796)
.+++.-.. ++...+ ..+.+++..|..
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 350 DWDCNSLRALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp CEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred CccchhHHHHHHHHHhhcccccCceecc
Confidence 99874332 222211 122455555653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=347.39 Aligned_cols=325 Identities=23% Similarity=0.284 Sum_probs=273.6
Q ss_pred ccCCceee---CCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCC-C
Q 003780 61 CKLDGVTC---NTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG-S 136 (796)
Q Consensus 61 C~w~gv~C---~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~ 136 (796)
|...++.. ..-.+++.|++++|.+++..+. .|..+++|++|+|++|.+++ +|.. .+++|++|+|++|.+++ .
T Consensus 31 n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~ 106 (520)
T 2z7x_B 31 NYISELWTSDILSLSKLRILIISHNRIQYLDIS-VFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALP 106 (520)
T ss_dssp SCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGG-GGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEECCSSCCSSCC
T ss_pred CcccccChhhccccccccEEecCCCccCCcChH-HhhcccCCCEEecCCCceee-cCcc--ccCCccEEeccCCcccccc
Confidence 55555542 2346799999999999876544 59999999999999999995 4554 89999999999999997 4
Q ss_pred CCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcc--ceeecccccc--CCCCCccccCCC-------------------
Q 003780 137 IPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL--ITMALSRNGL--HGPIPSAIGDLN------------------- 193 (796)
Q Consensus 137 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~------------------- 193 (796)
+|..|+++++|++|+|++|++++ ..+..+++| +.|+|++|.+ .+..|..+..+.
T Consensus 107 ~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~ 183 (520)
T 2z7x_B 107 ICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD 183 (520)
T ss_dssp CCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCC
T ss_pred chhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhh
Confidence 78999999999999999999986 567788888 9999999999 777777776643
Q ss_pred ----------------------------------------------------------------CccEEEcccccccCcc
Q 003780 194 ----------------------------------------------------------------NLLILSLDSNKLSGML 209 (796)
Q Consensus 194 ----------------------------------------------------------------~L~~L~L~~N~l~~~~ 209 (796)
+|++|++++|++++.+
T Consensus 184 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 263 (520)
T 2z7x_B 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263 (520)
T ss_dssp CCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCC
T ss_pred hhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCcc
Confidence 7888888999998888
Q ss_pred hhhh-----cCCCCccccccCCccccccCC-Cc-------------------------ccccCccceEEeccccccccCC
Q 003780 210 HQEL-----GKLKNLVALNVGGNKLMGPIP-ST-------------------------LFRLTNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 210 ~~~~-----~~l~~L~~L~l~~N~l~~~~~-~~-------------------------l~~l~~L~~L~L~~N~l~~~~p 258 (796)
|..+ +++++|+.+++++|.+ .+| .. +..+++|++|++++|++++.+|
T Consensus 264 p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 341 (520)
T 2z7x_B 264 DFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341 (520)
T ss_dssp CCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTT
T ss_pred ccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhh
Confidence 8877 7777777777777766 223 11 2678999999999999999899
Q ss_pred ccccCCcccceeecccccccc--cCccccccccccccccccCccccCcccc-ccccccccceecccccccccCCCcccCC
Q 003780 259 PEIGNMTGILKVDMSMNNIEG--TIPLELTRLSQLLYLSISSNMLSGQIPI-TIAGLISLKGLDLSNNKLSGPIPPEIGK 335 (796)
Q Consensus 259 ~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 335 (796)
..++++++|+.|+|++|++++ .+|..+..+++|++|++++|.+++.+|. .+..+++|++|++++|++++..|..+.
T Consensus 342 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~- 420 (520)
T 2z7x_B 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP- 420 (520)
T ss_dssp TTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-
T ss_pred hhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-
Confidence 999999999999999999997 5678899999999999999999985665 588999999999999999988877765
Q ss_pred CCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCcc-c---cccccccccCCCCcccCC
Q 003780 336 CSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPF-L---YHRFPLDLSYNDLEGEIP 398 (796)
Q Consensus 336 l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~-~---~~~~~l~l~~N~l~~~~p 398 (796)
++|+.|+|++|+++ .+|..+ .+++|++|++++|+++ .+|.. + .++..|++++|.+++..+
T Consensus 421 -~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp -TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred -ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 79999999999999 666644 6899999999999999 57764 3 456689999999987554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=355.86 Aligned_cols=331 Identities=23% Similarity=0.302 Sum_probs=270.5
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+++++++++.. +..|..+++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..+..|+++++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLP-AANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCC-GGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCcC-HHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 57999999999998744 44689999999999999999999999999999999999999999976666899999999999
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhc--CCCCccccccCCccc
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELG--KLKNLVALNVGGNKL 229 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l 229 (796)
|++|++++..|..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..+. .+++|+.|++++|++
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999999988889999999999999999999999999999999999999999999999888765 458999999999999
Q ss_pred cccCCCccccc---------------------------CccceEEeccccccccCCccccCCcc--cceeeccccccccc
Q 003780 230 MGPIPSTLFRL---------------------------TNLTYLYLHSNHLNGSIPPEIGNMTG--ILKVDMSMNNIEGT 280 (796)
Q Consensus 230 ~~~~~~~l~~l---------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~ 280 (796)
++..|..+..+ ++|+.|++++|.+++..|..+.+++. |+.|+|++|++++.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 98888776654 45677888888888888888887765 89999999998888
Q ss_pred CccccccccccccccccCccccCccccccccccccceeccccccccc-----CCCc----ccCCCCCCcEEEeecccccC
Q 003780 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSG-----PIPP----EIGKCSELRNITLRNNNLSG 351 (796)
Q Consensus 281 ~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----~~~~----~~~~l~~L~~L~L~~N~l~~ 351 (796)
.|..|..+++|++|++++|.+++..|..+.++++|++|++++|...+ .+|. .|..+++|+.|++++|++++
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 88888888999999999998888888888888888888887765543 2232 56777778888888888877
Q ss_pred CCCccc-cccccceEEecccccCCC-CCcc-c-----cccccccccCCCCcccCCCCCCC
Q 003780 352 SIPPEI-GLMKLEYLDLSHNKLNGT-IPPF-L-----YHRFPLDLSYNDLEGEIPDYFRD 403 (796)
Q Consensus 352 ~~~~~~-~~~~L~~L~l~~N~l~~~-~p~~-~-----~~~~~l~l~~N~l~~~~p~~~~~ 403 (796)
..+..+ ++++|++|++++|.+.+. +|.. + ..+..|++++|.+++..|..|..
T Consensus 344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 666655 366777777777765433 2211 1 23456667777776666655543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=329.67 Aligned_cols=259 Identities=24% Similarity=0.288 Sum_probs=179.5
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHH-HHhhcCCCceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAH-VLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||.||+|..+ +|+.||||++....... ...++..|+. +++.++||||+++++++..++..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH--HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch--HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 468999999999999999999764 79999999997654332 2345555665 7778899999999999999999999
Q ss_pred EEeeccCCcHHHHHhhc--CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 576 IYKYMKRGSLFCFLRND--YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
||||+++ +|.+++... .....+++..+..++.|+++||.|||+.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999985 887777532 12345899999999999999999999852 899999999999999999999999999987
Q ss_pred cCCCCCCccccccccCccCcccc----ccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELA----YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... ............
T Consensus 176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~ 247 (327)
T 3aln_A 176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVVKGDP 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHhcCCC
Confidence 65432 22334699999999998 4566889999999999999999999998742211 001111111111
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..............+.+++.+||+.||++|||++|++++-
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 1000000111233578999999999999999999998864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=333.78 Aligned_cols=261 Identities=20% Similarity=0.301 Sum_probs=198.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-----------CCceeeEEe
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-----------HRNIVKLYG 565 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~ 565 (796)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ..+.+.+|++++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35899999999999999999975 5799999999975432 2356788999998886 899999999
Q ss_pred EEEecc----eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec---
Q 003780 566 FCLHKK----CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN--- 638 (796)
Q Consensus 566 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--- 638 (796)
++...+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ +|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 998654 789999999 8899999986432 34889999999999999999999953 899999999999994
Q ss_pred ---CCCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCc
Q 003780 639 ---SKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS 715 (796)
Q Consensus 639 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~ 715 (796)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4447999999999876532 2234689999999999999999999999999999999999999984332111111
Q ss_pred hhh-hHHHHhhcCC-----------------------CCC-c----------cchhhHHHHHHHHHHHHHcCCCCCCCCC
Q 003780 716 DQK-IMLIDVLDSR-----------------------LSP-P----------VDRMVMQDIVLVTTVALACLHSKPKFRP 760 (796)
Q Consensus 716 ~~~-~~~~~~~~~~-----------------------~~~-~----------~~~~~~~~~~~l~~li~~cl~~dP~~RP 760 (796)
... ..+...+... ... . ...........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111 0111111000 000 0 0001223455688999999999999999
Q ss_pred CHHHHHHHH
Q 003780 761 TMQRVCQEF 769 (796)
Q Consensus 761 s~~evl~~L 769 (796)
|++|+++|-
T Consensus 327 t~~ell~hp 335 (373)
T 1q8y_A 327 DAGGLVNHP 335 (373)
T ss_dssp CHHHHHTCG
T ss_pred CHHHHhhCh
Confidence 999999974
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=350.51 Aligned_cols=330 Identities=22% Similarity=0.225 Sum_probs=213.4
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+++++++++..+ ..|..+++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEECT-TTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCccCh-hHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 468888888888876443 4588888888888888888888888888888888888888888877778888888888888
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCC-CCCccccCCCCccEEEcccccccCcchhhhcCCCCc----cccccCC
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNL----VALNVGG 226 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~l~~ 226 (796)
|++|++++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+..++.+++| +.|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 88888887666678888888888888888886 368888888888888888888877666666555555 4555555
Q ss_pred ccccccCC------------------------------------------------------------------------
Q 003780 227 NKLMGPIP------------------------------------------------------------------------ 234 (796)
Q Consensus 227 N~l~~~~~------------------------------------------------------------------------ 234 (796)
|.+++..|
T Consensus 187 n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 54433222
Q ss_pred ---------CcccccCccceEEeccccccccCCccc------------------------------------------cC
Q 003780 235 ---------STLFRLTNLTYLYLHSNHLNGSIPPEI------------------------------------------GN 263 (796)
Q Consensus 235 ---------~~l~~l~~L~~L~L~~N~l~~~~p~~~------------------------------------------~~ 263 (796)
..+..+++|++|++++|.++ .+|..+ ..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCB
T ss_pred chhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccccc
Confidence 12222333444444443333 122111 23
Q ss_pred CcccceeecccccccccC--ccc-----------------------cccccccccccccCccccCccc-cccccccccce
Q 003780 264 MTGILKVDMSMNNIEGTI--PLE-----------------------LTRLSQLLYLSISSNMLSGQIP-ITIAGLISLKG 317 (796)
Q Consensus 264 l~~L~~L~Ls~N~l~~~~--p~~-----------------------l~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~ 317 (796)
+++|+.|++++|++++.. |.. +..+++|++|++++|.+.+..+ ..+..+++|++
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 344555555555554332 333 5555555555555555555443 34556666666
Q ss_pred ecccccccccCCCcccCCCCCCcEEEeeccccc-CCCCccc-cccccceEEecccccCCCCCcccc---ccccccccCCC
Q 003780 318 LDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS-GSIPPEI-GLMKLEYLDLSHNKLNGTIPPFLY---HRFPLDLSYND 392 (796)
Q Consensus 318 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~---~~~~l~l~~N~ 392 (796)
|++++|.+++..|..+..+++|+.|+|++|+++ +.+|..+ .+++|++|++++|++++..|..+. ++..|++++|.
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 666666666666666666666666666666665 3455444 356666666666666655554433 34466666776
Q ss_pred CcccCCCCCCC
Q 003780 393 LEGEIPDYFRD 403 (796)
Q Consensus 393 l~~~~p~~~~~ 403 (796)
+++.+|..|..
T Consensus 506 l~~~~~~~~~~ 516 (570)
T 2z63_A 506 LKSVPDGIFDR 516 (570)
T ss_dssp CSCCCTTTTTT
T ss_pred CCCCCHHHhhc
Confidence 66666555543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.35 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=182.9
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|..+ +|+.||||++........ ..+.+.++..+++.++||||+++++++..++..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 467999999999999999999764 799999999987654332 234455556678888999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
|||+ ++.+..+..... ..+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 556655554322 348899999999999999999998 5 89999999999999999999999999997664
Q ss_pred CCCCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 656 SDSSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
... ......|++.|+|||++. ...++.++|||||||++|+|++|+.||.... ...............
T Consensus 177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~ 248 (318)
T 2dyl_A 177 DDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------TDFEVLTKVLQEEPP 248 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHHHHSCCC
T ss_pred CCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------ccHHHHHHHhccCCC
Confidence 432 223456899999999984 5568889999999999999999999987321 111222222222211
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
. ... .......+.+++.+||+.||.+||+++|++++-
T Consensus 249 ~-~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 249 L-LPG-HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp C-CCS-SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred C-CCc-cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 1 100 011223478999999999999999999999874
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=349.96 Aligned_cols=322 Identities=19% Similarity=0.190 Sum_probs=195.8
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+++++.+.+.. +..|..+++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 57 ~~L~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~ 135 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIH-EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135 (606)
T ss_dssp TTCSEEECTTCCCCEEC-TTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEE
T ss_pred ccceEEECCCCccceeC-hhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEE
Confidence 34556666666655432 23456666666666666666655555566666666666666655554445555555555555
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCcc-----------------------------------
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL----------------------------------- 196 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----------------------------------- 196 (796)
|++|++++..+..+..+++|++|+|++|.+++..|..|+.+++|+
T Consensus 136 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~ 215 (606)
T 3t6q_A 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL 215 (606)
T ss_dssp CCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCH
T ss_pred CCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhH
Confidence 555555543322333345555555555544444444444444333
Q ss_pred ------------------------------------------EEEcccccccCcchhhhcCCCCccccccCCccccccCC
Q 003780 197 ------------------------------------------ILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIP 234 (796)
Q Consensus 197 ------------------------------------------~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 234 (796)
.|++++|.++++.+..|..+++|++|++++|+++ .+|
T Consensus 216 ~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp 294 (606)
T 3t6q_A 216 LVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP 294 (606)
T ss_dssp HHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCC
T ss_pred HHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCC
Confidence 3444444444444455667777888888888777 566
Q ss_pred CcccccCccceEEeccccccccCCccccCCcccceeecccccccccCcc-ccccccccccccccCccccCcc--cccccc
Q 003780 235 STLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPL-ELTRLSQLLYLSISSNMLSGQI--PITIAG 311 (796)
Q Consensus 235 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~l~~N~l~~~~--~~~~~~ 311 (796)
..+.++++|++|++++|++++..|..+.++++|+.|++++|.+.+.+|. .+..+++|++|++++|.+++.. +..+..
T Consensus 295 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 374 (606)
T 3t6q_A 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374 (606)
T ss_dssp SSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTT
T ss_pred hhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhccc
Confidence 6777777788888887777766666777777777777777777655544 3666777777777777776554 556666
Q ss_pred ccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcc-c-cccccceEEecccccCCCCCccc---cccccc
Q 003780 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPE-I-GLMKLEYLDLSHNKLNGTIPPFL---YHRFPL 386 (796)
Q Consensus 312 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~-~~~~L~~L~l~~N~l~~~~p~~~---~~~~~l 386 (796)
+++|++|++++|++++..|..|..+++|+.|++++|++++..|.. + .+++|+.|++++|++++..|..+ .++..|
T Consensus 375 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 454 (606)
T 3t6q_A 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454 (606)
T ss_dssp CTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence 777777777777776666666666777777777777766655443 2 35666666666666666555443 334456
Q ss_pred cccCCCCcc
Q 003780 387 DLSYNDLEG 395 (796)
Q Consensus 387 ~l~~N~l~~ 395 (796)
++++|.+++
T Consensus 455 ~L~~n~l~~ 463 (606)
T 3t6q_A 455 NLQGNHFPK 463 (606)
T ss_dssp ECTTCBCGG
T ss_pred ECCCCCCCc
Confidence 666666655
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.79 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=193.2
Q ss_pred HHHHhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhh---HHHHHHHHHHHHHhhc----CCCceeeEEe
Q 003780 494 IIKATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEET---TFFNSFQNEAHVLSKI----AHRNIVKLYG 565 (796)
Q Consensus 494 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~hpniv~l~~ 565 (796)
.....++|++.+.||+|+||.||+|+. .+++.||||++........ .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999975 4789999999976543221 1123456789999988 8999999999
Q ss_pred EEEecceeeEEEee-ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec-CCCcE
Q 003780 566 FCLHKKCMFLIYKY-MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN-SKLEA 643 (796)
Q Consensus 566 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~ 643 (796)
++...+..++|+|+ +.+++|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 99999999999999 78999999998643 389999999999999999999999 999999999999999 88999
Q ss_pred EEeeeccccccCCCCCCccccccccCccCccccccCCcC-cchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH
Q 003780 644 FVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI 722 (796)
Q Consensus 644 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (796)
||+|||+++..... ......|++.|+|||++.+..+. .++||||+|+++|+|++|+.||....
T Consensus 180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------- 243 (312)
T 2iwi_A 180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------- 243 (312)
T ss_dssp EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------
T ss_pred EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------------
Confidence 99999999876543 23345689999999998876664 58999999999999999999987321
Q ss_pred HhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.......... . .....+.+++.+||+.||++|||++|++++-.
T Consensus 244 ~~~~~~~~~~--~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 244 EILEAELHFP--A---HVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp HHHHTCCCCC--T---TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred HHhhhccCCc--c---cCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 1111111111 0 11234778999999999999999999998743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.56 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=200.7
Q ss_pred HhcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhh---HHHHHHHHHHHHHhhcC--CCceeeEEeEEEec
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEET---TFFNSFQNEAHVLSKIA--HRNIVKLYGFCLHK 570 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~ 570 (796)
..++|++.+.||+|+||.||+|.. .+++.||||++........ ...+.+.+|+.++++++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 457899999999999999999964 5789999999976543321 11235678999999996 59999999999999
Q ss_pred ceeeEEEeeccC-CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec-CCCcEEEeee
Q 003780 571 KCMFLIYKYMKR-GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN-SKLEAFVADF 648 (796)
Q Consensus 571 ~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Df 648 (796)
+..++|+|++.+ ++|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999986 89999998643 489999999999999999999999 999999999999999 7889999999
Q ss_pred ccccccCCCCCCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 649 GTARLLDSDSSNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 649 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
|+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .....
T Consensus 195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------------~~~~~ 258 (320)
T 3a99_A 195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRG 258 (320)
T ss_dssp TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHC
T ss_pred ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------------hhhcc
Confidence 999876532 2233569999999999887665 678999999999999999999987321 11111
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
..... . .....+.+++.+||+.||++|||++|++++-.
T Consensus 259 ~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 259 QVFFR-Q----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp CCCCS-S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ccccc-c----cCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 11110 1 11234778999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.81 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=196.9
Q ss_pred hcCCccceeeecccceeEEEEEcc-CC-cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCc------eeeEEeEEEe
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NG-KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN------IVKLYGFCLH 569 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~ 569 (796)
.++|++.+.||+|+||.||+|... ++ +.||+|++..... ..+.+.+|+.++++++|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK----YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 468999999999999999999754 44 7899999975432 2457888999999987655 9999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEe------------
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILL------------ 637 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll------------ 637 (796)
.+..++||||+ ++++.+++.... ...+++..+..++.||++||+|||+. +|+||||||+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 556767666542 23489999999999999999999999 99999999999999
Q ss_pred -------cCCCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC
Q 003780 638 -------NSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL 710 (796)
Q Consensus 638 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~ 710 (796)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN- 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-
Confidence 56789999999999865432 2345699999999999999999999999999999999999999974221
Q ss_pred CCCCchhhhHHHHhhcCC----------------------------------CCC--ccchhhHHHHHHHHHHHHHcCCC
Q 003780 711 SSPSSDQKIMLIDVLDSR----------------------------------LSP--PVDRMVMQDIVLVTTVALACLHS 754 (796)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~----------------------------------~~~--~~~~~~~~~~~~l~~li~~cl~~ 754 (796)
.............. ..+ ............+.+++.+||+.
T Consensus 245 ----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 245 ----REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp ----HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ----HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 00001111111000 000 00000112234688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003780 755 KPKFRPTMQRVCQE 768 (796)
Q Consensus 755 dP~~RPs~~evl~~ 768 (796)
||++|||++|+++|
T Consensus 321 dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 321 DPAQRITLAEALLH 334 (355)
T ss_dssp STTTSCCHHHHTTS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=360.13 Aligned_cols=322 Identities=19% Similarity=0.252 Sum_probs=275.5
Q ss_pred CCeEEEeCCCCCccc-----------------ccccc-ccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCc-
Q 003780 72 RSIIEINLPEKKLKG-----------------ELSQF-NFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN- 132 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~-----------------~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~- 132 (796)
.++..|+|++|.++| .++.. .|.++++|++|+|++|.+.+.+|..|+++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 578899999999999 25543 24499999999999999999999999999999999999998
Q ss_pred CCC-CCCCCCCCC-------CCCCEEEecCCCCCCCCch--hhhccCccceeeccccccCCCCCccccCCCCccEEEccc
Q 003780 133 LTG-SIPPELGSL-------RNLEVLNLKGNNLNGAIPS--SLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDS 202 (796)
Q Consensus 133 l~~-~~p~~~~~l-------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 202 (796)
+++ .+|..++++ ++|++|+|++|+++ .+|. .|+++++|+.|+|++|+++ .+| .|+.+++|+.|+|++
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDY 604 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCS
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcC
Confidence 998 788766555 49999999999999 8888 9999999999999999999 777 899999999999999
Q ss_pred ccccCcchhhhcCCCC-ccccccCCccccccCCCcccccCc--cceEEeccccccccCCcc---cc--CCcccceeeccc
Q 003780 203 NKLSGMLHQELGKLKN-LVALNVGGNKLMGPIPSTLFRLTN--LTYLYLHSNHLNGSIPPE---IG--NMTGILKVDMSM 274 (796)
Q Consensus 203 N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~l~~l~~--L~~L~L~~N~l~~~~p~~---~~--~l~~L~~L~Ls~ 274 (796)
|+++ .+|..+.++++ |+.|+|++|+++ .+|..+..++. |+.|+|++|++++.+|.. +. .+++|+.|+|++
T Consensus 605 N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~ 682 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682 (876)
T ss_dssp SCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCS
T ss_pred Cccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccC
Confidence 9999 77888999999 999999999999 77888877654 999999999999877642 22 345899999999
Q ss_pred ccccccCccccccccccccccccCccccCcccccccc--------ccccceecccccccccCCCcccC--CCCCCcEEEe
Q 003780 275 NNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG--------LISLKGLDLSNNKLSGPIPPEIG--KCSELRNITL 344 (796)
Q Consensus 275 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L 344 (796)
|+++...+..+..+++|+.|+|++|.++ .+|..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|
T Consensus 683 N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~L 760 (876)
T 4ecn_A 683 NEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDV 760 (876)
T ss_dssp SCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEEC
T ss_pred CcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEe
Confidence 9999544444558999999999999999 55554332 349999999999999 7888887 9999999999
Q ss_pred ecccccCCCCccc-cccccceEEecc------cccCCCCCcccc---ccccccccCCCCcccCCCCCC
Q 003780 345 RNNNLSGSIPPEI-GLMKLEYLDLSH------NKLNGTIPPFLY---HRFPLDLSYNDLEGEIPDYFR 402 (796)
Q Consensus 345 ~~N~l~~~~~~~~-~~~~L~~L~l~~------N~l~~~~p~~~~---~~~~l~l~~N~l~~~~p~~~~ 402 (796)
++|++++ +|..+ .+++|+.|+|++ |++.+.+|..+. ++..|+|++|.+ +.+|..+.
T Consensus 761 s~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~ 826 (876)
T 4ecn_A 761 SYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT 826 (876)
T ss_dssp CSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC
T ss_pred CCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc
Confidence 9999998 66555 589999999976 888899997664 456899999999 88888654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=349.90 Aligned_cols=326 Identities=21% Similarity=0.226 Sum_probs=253.8
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+++++++++. ++..|..+++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..+..|+++++|++|+
T Consensus 52 ~~L~~L~Ls~n~i~~i-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 130 (570)
T 2z63_A 52 PELQVLDLSRCEIQTI-EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (570)
T ss_dssp SSCCEEECTTCCCCEE-CTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEE
T ss_pred CCceEEECCCCcCCcc-CcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEe
Confidence 4688888888888763 444588888888888888888888888888888888888888888866665788888888888
Q ss_pred ecCCCCCC-CCchhhhccCccceeeccccccCCCCCccccCCCCc----cEEEcccccccCcch----------------
Q 003780 152 LKGNNLNG-AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNL----LILSLDSNKLSGMLH---------------- 210 (796)
Q Consensus 152 L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~~N~l~~~~~---------------- 210 (796)
|++|++++ .+|..|+++++|++|++++|++++..|..|+.+++| +.|++++|.++++.+
T Consensus 131 L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n 210 (570)
T 2z63_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210 (570)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccc
Confidence 88888886 468888888888888888888776655555544444 444444444332221
Q ss_pred -----------------------------------------------------------------hhh------------
Q 003780 211 -----------------------------------------------------------------QEL------------ 213 (796)
Q Consensus 211 -----------------------------------------------------------------~~~------------ 213 (796)
..+
T Consensus 211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~ 290 (570)
T 2z63_A 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290 (570)
T ss_dssp CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence 111
Q ss_pred -----------------------------------------------------cCCCCccccccCCccccccC--CCccc
Q 003780 214 -----------------------------------------------------GKLKNLVALNVGGNKLMGPI--PSTLF 238 (796)
Q Consensus 214 -----------------------------------------------------~~l~~L~~L~l~~N~l~~~~--~~~l~ 238 (796)
..+++|++|++++|++++.. |..+.
T Consensus 291 ~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 370 (570)
T 2z63_A 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370 (570)
T ss_dssp SCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHH
T ss_pred CccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccccccc
Confidence 22344444455555544332 34455
Q ss_pred ccCccceEEeccccccccCCccccCCcccceeecccccccccCc-cccccccccccccccCccccCccccccccccccce
Q 003780 239 RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIP-LELTRLSQLLYLSISSNMLSGQIPITIAGLISLKG 317 (796)
Q Consensus 239 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 317 (796)
++++|++|++++|.+++..+ .+..+++|+.|++++|.+++..| ..+.++++|++|++++|.+.+..|..+.++++|++
T Consensus 371 ~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 449 (570)
T 2z63_A 371 GTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449 (570)
T ss_dssp TCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred ccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcE
Confidence 66677777777777765433 38888999999999999988766 57899999999999999999999999999999999
Q ss_pred ecccccccc-cCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCccc---cccccccccCCC
Q 003780 318 LDLSNNKLS-GPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPPFL---YHRFPLDLSYND 392 (796)
Q Consensus 318 L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~---~~~~~l~l~~N~ 392 (796)
|+|++|+++ +.+|..+..+++|+.|+|++|++++..|..+ .+++|++|++++|++++..|..+ .++..|++++|.
T Consensus 450 L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 529 (570)
T 2z63_A 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529 (570)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCc
Confidence 999999998 6789999999999999999999999888777 48899999999999998777554 456689999999
Q ss_pred CcccCCC
Q 003780 393 LEGEIPD 399 (796)
Q Consensus 393 l~~~~p~ 399 (796)
++|..|.
T Consensus 530 ~~~~~~~ 536 (570)
T 2z63_A 530 WDCSCPR 536 (570)
T ss_dssp BCCCTTT
T ss_pred ccCCCcc
Confidence 9998885
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=349.41 Aligned_cols=263 Identities=24% Similarity=0.297 Sum_probs=198.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe------c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH------K 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~ 570 (796)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ...+.+.+|++++++++||||+++++++.. +
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH--HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 46899999999999999999975 46899999998765332 234678999999999999999999998765 6
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc---EEEee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE---AFVAD 647 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~D 647 (796)
+..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 77899999999999999998765545688899999999999999999999 9999999999999997765 89999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCccccc---CCCCC---chhhhHH
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSS---LSSPS---SDQKIML 721 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~---~~~~~---~~~~~~~ 721 (796)
||.+....... ......||+.|+|||.+.+..++.++||||+||++|+|++|+.||..... +.... .......
T Consensus 168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 99998765433 23345799999999999999999999999999999999999999863210 00000 0000000
Q ss_pred HHhhcCC-----CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 003780 722 IDVLDSR-----LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVC 766 (796)
Q Consensus 722 ~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 766 (796)
....... ..+............+.+++.+||+.||++|||++|++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000000 00111112223455688999999999999999998743
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.10 Aligned_cols=250 Identities=31% Similarity=0.494 Sum_probs=154.7
Q ss_pred CCCcEEeccCCcccc--cCCcCccCCCCCcEeeccc-CcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 97 PGLESLSLRFNYLFG--SIPSQVGALSKLRYLDFSF-NNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
.+++.|+|++|.+.+ .+|..|+++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356666666666666 6666666666666666663 6666666666666666666666666666666666666666666
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 253 (796)
|+|++|.+++.+|..|..+++|++|+|++|++++.+|..+..++ ++|++|+|++|++
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-----------------------~~L~~L~L~~N~l 186 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS-----------------------KLFTSMTISRNRL 186 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCC-----------------------TTCCEEECCSSEE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhh-----------------------hcCcEEECcCCee
Confidence 66666666655555555555555555555555544444444444 0455555555555
Q ss_pred cccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCccc
Q 003780 254 NGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI 333 (796)
Q Consensus 254 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 333 (796)
++.+|..+..++ |+.|+|++|++++..|..|..+++|++|+|++|.+++.+|. +..+++|++|+|++|++++.+|..+
T Consensus 187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 555555555544 55555555555555555555556666666666666554444 5556677777777777777777777
Q ss_pred CCCCCCcEEEeecccccCCCCccccccccceEEecccc
Q 003780 334 GKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNK 371 (796)
Q Consensus 334 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~ 371 (796)
..+++|+.|+|++|+++|.+|....+++|+.|++++|+
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCCccccccChHHhcCCC
Confidence 77777777777777777777766556667777777776
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=312.45 Aligned_cols=235 Identities=10% Similarity=0.064 Sum_probs=186.8
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999765 5999999999877655445567899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.+. ....++.+++.|+++||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999643 35557888999999999999999 99999999999999999999997433
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
|++| ++.++|||||||++|||+||+.||............ ......... .....
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~-~~~~~ 228 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----ERDTAGQPI-EPADI 228 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----CBCTTSCBC-CHHHH
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----HHHhccCCC-Chhhc
Confidence 3333 688999999999999999999999854332100000 000001000 00011
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
.......+.+++.+||+.||++| |+.|+++.|++...
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 11122347899999999999999 99999999988654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=343.52 Aligned_cols=342 Identities=22% Similarity=0.253 Sum_probs=254.6
Q ss_pred eEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCC-----CCCC----CCCCC
Q 003780 74 IIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG-----SIPP----ELGSL 144 (796)
Q Consensus 74 v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-----~~p~----~~~~l 144 (796)
++.|+++++.+.+..+. .|+.+++|++|+|++|.+.+..|..|.++++|++|+|++|...+ .+|. .|..+
T Consensus 250 L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l 328 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGND-SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328 (680)
T ss_dssp CCEEECTTSCCCEECTT-TTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTC
T ss_pred CCEEECCCCCcCccCcc-cccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccC
Confidence 66666666666554332 46666666666666666666666666666666666666654432 1222 56667
Q ss_pred CCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCC--CCccccCC--CCccEEEcccccccCcchhhhcCCCCcc
Q 003780 145 RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGP--IPSAIGDL--NNLLILSLDSNKLSGMLHQELGKLKNLV 220 (796)
Q Consensus 145 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 220 (796)
++|++|+|++|++++..|..|.++++|++|++++|.++.. .+..|..+ ++|+.|++++|+++++.+..|..+++|+
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 408 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCC
Confidence 7777777777777777677777777777777777764422 22333333 4677778888888888888999999999
Q ss_pred ccccCCccccccCC-CcccccCccceEEeccccccccCCccccCCcccceeeccccccc--ccCcccccccccccccccc
Q 003780 221 ALNVGGNKLMGPIP-STLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE--GTIPLELTRLSQLLYLSIS 297 (796)
Q Consensus 221 ~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~l~ 297 (796)
.|++++|++++.+| ..+.++++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..|.++++|++|+++
T Consensus 409 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls 488 (680)
T 1ziw_A 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488 (680)
T ss_dssp EEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECC
T ss_pred EEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECC
Confidence 99999999987665 67888999999999999999888888999999999999999987 5788889999999999999
Q ss_pred CccccCccccccccccccceecccccccccCC--------CcccCCCCCCcEEEeecccccCCCCccc-cccccceEEec
Q 003780 298 SNMLSGQIPITIAGLISLKGLDLSNNKLSGPI--------PPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLS 368 (796)
Q Consensus 298 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--------~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~ 368 (796)
+|.+++..+..|.++++|++|+|++|++++.. +..|..+++|+.|+|++|+++...+..+ ++++|+.|+|+
T Consensus 489 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 568 (680)
T 1ziw_A 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECC
Confidence 99999888888999999999999999988642 2347888999999999999995444444 58899999999
Q ss_pred ccccCCCCCccc---cccccccccCCCCcccCCCCCC----C-CCccccCCccccc
Q 003780 369 HNKLNGTIPPFL---YHRFPLDLSYNDLEGEIPDYFR----D-SPFKVYGNQGICY 416 (796)
Q Consensus 369 ~N~l~~~~p~~~---~~~~~l~l~~N~l~~~~p~~~~----~-~~~~~~~n~~~c~ 416 (796)
+|++++..+..+ ..+..|+|++|.+++..|..|. . ......+|+..|.
T Consensus 569 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred CCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 999985444333 4566899999999987776443 1 1223367777774
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=338.40 Aligned_cols=343 Identities=21% Similarity=0.217 Sum_probs=260.0
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
..++.|+|++|++++ +++..|.++++|++|+|++|+|+++.|++|+++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 368999999999985 5556799999999999999999999899999999999999999999977778899999999999
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCC-CCccccCCCCccEEEcccccccCcchhhhcCCCCcc----ccccCC
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGP-IPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLV----ALNVGG 226 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~l~~ 226 (796)
|++|+|++..+..|+++++|++|+|++|.+++. .|..++.+++|++|+|++|+++++.+..+..+.+++ .++++.
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 999999988888899999999999999999864 678899999999999999999888776665444332 233333
Q ss_pred ccccccCCC-----------------------------------------------------------------------
Q 003780 227 NKLMGPIPS----------------------------------------------------------------------- 235 (796)
Q Consensus 227 N~l~~~~~~----------------------------------------------------------------------- 235 (796)
|.++...+.
T Consensus 211 n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 211 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred CcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 333211100
Q ss_pred --------------------------------cccccCccceEEeccccccccCCc-------------------cccCC
Q 003780 236 --------------------------------TLFRLTNLTYLYLHSNHLNGSIPP-------------------EIGNM 264 (796)
Q Consensus 236 --------------------------------~l~~l~~L~~L~L~~N~l~~~~p~-------------------~~~~l 264 (796)
.+....+|+.|++.+|.+.+..+. ...++
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l 370 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 370 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBC
T ss_pred hcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccc
Confidence 001112233344444333221111 11123
Q ss_pred cccceeecccccc-------------------------------------------------cccC-ccccccccccccc
Q 003780 265 TGILKVDMSMNNI-------------------------------------------------EGTI-PLELTRLSQLLYL 294 (796)
Q Consensus 265 ~~L~~L~Ls~N~l-------------------------------------------------~~~~-p~~l~~l~~L~~L 294 (796)
++|+.|+++.|.+ .... +..|..+++++.+
T Consensus 371 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l 450 (635)
T 4g8a_A 371 PSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 450 (635)
T ss_dssp TTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEE
T ss_pred cccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccc
Confidence 3444444444433 3222 2346677889999
Q ss_pred cccCccccCccccccccccccceeccccccc-ccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEeccccc
Q 003780 295 SISSNMLSGQIPITIAGLISLKGLDLSNNKL-SGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKL 372 (796)
Q Consensus 295 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l 372 (796)
+++.|.+.+..+..+..+++|+.|+|++|.+ .+..|..|..+++|+.|+|++|+|++..|..+ ++++|++|+|++|+|
T Consensus 451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l 530 (635)
T 4g8a_A 451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 530 (635)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcC
Confidence 9999999999999999999999999999975 45678899999999999999999999888877 588999999999999
Q ss_pred CCCCCccc---cccccccccCCCCcccCCCCCCCCC--c---cccCCcccc
Q 003780 373 NGTIPPFL---YHRFPLDLSYNDLEGEIPDYFRDSP--F---KVYGNQGIC 415 (796)
Q Consensus 373 ~~~~p~~~---~~~~~l~l~~N~l~~~~p~~~~~~~--~---~~~~n~~~c 415 (796)
++..|..+ .++..|||++|+|++.+|+.|...+ . ...+|+..|
T Consensus 531 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 531 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 97777554 4567899999999999998886543 2 236787776
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=338.15 Aligned_cols=180 Identities=21% Similarity=0.235 Sum_probs=154.1
Q ss_pred eeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCC
Q 003780 67 TCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146 (796)
Q Consensus 67 ~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 146 (796)
+|...+ + .++++++++..... + .++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++
T Consensus 3 ~C~~~~-~--c~~~~~~l~~ip~~--~--~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 3 SCDASG-V--CDGRSRSFTSIPSG--L--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp EECTTS-E--EECTTSCCSSCCSC--C--CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCc-e--EECCCCcccccccc--C--CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 576544 3 78888888754332 2 379999999999999999999999999999999999999988899999999
Q ss_pred CCEEEecCCCCCCCCchhhhccCccceeeccccccCCC-CCccccCCCCccEEEccccc-ccCcchhhhcCCCCcccccc
Q 003780 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGP-IPSAIGDLNNLLILSLDSNK-LSGMLHQELGKLKNLVALNV 224 (796)
Q Consensus 147 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l 224 (796)
|++|+|++|++++..|..|+++++|++|+|++|.+++. .|..|+++++|++|++++|. +..+.+..|.++++|++|++
T Consensus 76 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L 155 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155 (549)
T ss_dssp CCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEE
T ss_pred CCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeec
Confidence 99999999999998888899999999999999999974 67889999999999999999 55555678999999999999
Q ss_pred CCccccccCCCcccccCccceEEeccccc
Q 003780 225 GGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 225 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 253 (796)
++|++++..|..+..+++|++|+++.|.+
T Consensus 156 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 156 KALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp EETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred cCCcccccChhhhhccccCceEecccCcc
Confidence 99999998888877655555444444443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.41 Aligned_cols=234 Identities=21% Similarity=0.298 Sum_probs=179.9
Q ss_pred hcCCccc-eeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHH-hhcCCCceeeEEeEEEe----c
Q 003780 498 TEDFDIK-YCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVL-SKIAHRNIVKLYGFCLH----K 570 (796)
Q Consensus 498 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----~ 570 (796)
.++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4567777 7899999999999975 57899999998642 2567788887 55689999999999987 6
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVAD 647 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~D 647 (796)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 788999999999999999987532 3589999999999999999999999 9999999999999998 78899999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
||++.... +..++.++||||+||++|||++|+.||........... ....+..
T Consensus 164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-----~~~~~~~ 216 (299)
T 3m2w_A 164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTRIRM 216 (299)
T ss_dssp CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----SCCSSCT
T ss_pred cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----HHHHHhh
Confidence 99987533 23467899999999999999999999974322110000 0000000
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
................+.+++.+||+.||++|||++|+++|-.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 0000000000122345889999999999999999999999753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=344.88 Aligned_cols=238 Identities=23% Similarity=0.322 Sum_probs=191.1
Q ss_pred hcCCccceeeecccceeEEEEEcc--CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecce---
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP--NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKC--- 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 572 (796)
.++|++.+.||+|+||.||+|... +|+.||||++...... ...+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH--HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 368999999999999999999764 6899999998764332 234678999999999999999999999988765
Q ss_pred --eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 573 --MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 573 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
.++||||+++++|.+++.. .+++..+..++.||++||+|||++ +|+||||||+||+++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999887754 389999999999999999999999 99999999999999986 899999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||...... .+.
T Consensus 228 a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~~ 285 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GLP 285 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SCC
T ss_pred chhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------ccc
Confidence 9876543 3456999999999987654 88999999999999999999887632110 000
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHh
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPT-MQRVCQEFL 770 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~ 770 (796)
.. .........+.+++.+||+.||++||+ ++++.+.+.
T Consensus 286 ~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 ED--DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp TT--CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cc--ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00 001122245789999999999999996 455555454
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=324.07 Aligned_cols=246 Identities=16% Similarity=0.130 Sum_probs=181.3
Q ss_pred hcCCccceeeecccceeEEEEE-ccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC-Ccee---------eEE--
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIV---------KLY-- 564 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv---------~l~-- 564 (796)
...|...+.||+|+||+||+|. ..+|+.||||++...........+.+.+|+.+++.++| +|.. ...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457788999999999999997 55799999999985554444445789999999999987 2211 111
Q ss_pred ----------eEEEe-----cceeeEEEeeccCCcHHHHHhhc----CcccccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003780 565 ----------GFCLH-----KKCMFLIYKYMKRGSLFCFLRND----YEAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625 (796)
Q Consensus 565 ----------~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 625 (796)
.++.. ....+++|+++ +++|.+++... .....+++..+..++.|+++||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11111 12356666654 67999888521 1234578889999999999999999999 99
Q ss_pred EEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccccccccCccCcccc----------ccCCcCcchhHHHHHHHHH
Q 003780 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA----------YTMVVTEKCDVYSFGVVAL 695 (796)
Q Consensus 626 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DVwSlGv~l~ 695 (796)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999865432 334457 999999998 5666888999999999999
Q ss_pred HHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 696 EVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 696 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
||++|+.||....... .....+.... . ....+.+++.+||+.||++||++.|++++
T Consensus 309 elltg~~Pf~~~~~~~--------~~~~~~~~~~--~-------~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALG--------GSEWIFRSCK--N-------IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGS--------CSGGGGSSCC--C-------CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhh--------hHHHHHhhcc--c-------CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999997433211 0111111111 1 11347899999999999999998888654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=333.25 Aligned_cols=323 Identities=21% Similarity=0.224 Sum_probs=251.2
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+|++|++++ +++..|.++++|++|+|++|+|++..+..|+++++|++|+|++|+|++..+..|+++++|++|+
T Consensus 76 ~~L~~L~Ls~N~i~~-i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~ 154 (635)
T 4g8a_A 76 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 154 (635)
T ss_dssp TTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCC-cChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence 478899999999986 5555799999999999999999998888999999999999999999988888899999999999
Q ss_pred ecCCCCCC-CCchhhhccCccceeeccccccCCCCCccccCCCCcc----EEEcccccccCcchh---------------
Q 003780 152 LKGNNLNG-AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL----ILSLDSNKLSGMLHQ--------------- 211 (796)
Q Consensus 152 L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~~~--------------- 211 (796)
|++|++++ .+|..+..+++|++|+|++|+|++..|..|..+.+++ .++++.|.++.+.+.
T Consensus 155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n 234 (635)
T 4g8a_A 155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 234 (635)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence 99999986 4688999999999999999999877776655443322 233333332211100
Q ss_pred --------------------------------------------------------------------------------
Q 003780 212 -------------------------------------------------------------------------------- 211 (796)
Q Consensus 212 -------------------------------------------------------------------------------- 211 (796)
T Consensus 235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence
Q ss_pred --------hhc-------------------------------------------CCCCccccccCCcccccc--C-----
Q 003780 212 --------ELG-------------------------------------------KLKNLVALNVGGNKLMGP--I----- 233 (796)
Q Consensus 212 --------~~~-------------------------------------------~l~~L~~L~l~~N~l~~~--~----- 233 (796)
.+. .+++|+.|++++|.+... .
T Consensus 315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 394 (635)
T 4g8a_A 315 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 394 (635)
T ss_dssp SCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred ccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchh
Confidence 011 123333344444333210 0
Q ss_pred ------------------CCcccccCccceEEeccccccccCC-ccccCCcccceeecccccccccCccccccccccccc
Q 003780 234 ------------------PSTLFRLTNLTYLYLHSNHLNGSIP-PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYL 294 (796)
Q Consensus 234 ------------------~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 294 (796)
+..+..+++|+.++++.|+.....+ ..+.++.+++.++++.|.+.+..+..+..+++|+.|
T Consensus 395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L 474 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 474 (635)
T ss_dssp SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 1122233344444444444333332 356778899999999999999999999999999999
Q ss_pred cccCcccc-CccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEeccccc
Q 003780 295 SISSNMLS-GQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKL 372 (796)
Q Consensus 295 ~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l 372 (796)
++++|.+. +..|..|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..|..+ ++++|++|+|++|+|
T Consensus 475 ~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l 554 (635)
T 4g8a_A 475 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 554 (635)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred hhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence 99999854 5678899999999999999999999999999999999999999999999888777 489999999999999
Q ss_pred CCCCCcccc----ccccccccCCCCcc
Q 003780 373 NGTIPPFLY----HRFPLDLSYNDLEG 395 (796)
Q Consensus 373 ~~~~p~~~~----~~~~l~l~~N~l~~ 395 (796)
++..|..+. ++..|+|++|.+.+
T Consensus 555 ~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 555 MTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 988887664 45679999999976
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.84 Aligned_cols=301 Identities=27% Similarity=0.378 Sum_probs=261.4
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.++++++++... + .+..+++|++|+|++|.+.+..+ +..+++|++|+|++|.+++. +.|.++++|++|+
T Consensus 44 ~~L~~L~l~~~~i~~~-~--~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~ 116 (347)
T 4fmz_A 44 ESITKLVVAGEKVASI-Q--GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELY 116 (347)
T ss_dssp TTCSEEECCSSCCCCC-T--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred ccccEEEEeCCccccc-h--hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEE
Confidence 5688999999988753 3 37889999999999999997644 99999999999999999953 3699999999999
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccc
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 231 (796)
|++|++++..+ +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+
T Consensus 117 l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp CTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC
T ss_pred CcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc
Confidence 99999996543 8999999999999997665544 48999999999999999997765 8899999999999999986
Q ss_pred cCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccc
Q 003780 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311 (796)
Q Consensus 232 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 311 (796)
..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|.+++. ..+..
T Consensus 192 ~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~ 263 (347)
T 4fmz_A 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKD 263 (347)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTT
T ss_pred ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhc
Confidence 544 8899999999999999996544 8899999999999999997655 89999999999999999864 46889
Q ss_pred ccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCC-cccccccccccc
Q 003780 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIP-PFLYHRFPLDLS 389 (796)
Q Consensus 312 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p-~~~~~~~~l~l~ 389 (796)
+++|++|++++|++++. ..+..+++|+.|++++|++++..|..+ .+++|++|++++|++++..| ..+.++..|+++
T Consensus 264 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~ 341 (347)
T 4fmz_A 264 LTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFA 341 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSS
T ss_pred CCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehh
Confidence 99999999999999865 568899999999999999998877766 48999999999999998777 445677799999
Q ss_pred CCCCc
Q 003780 390 YNDLE 394 (796)
Q Consensus 390 ~N~l~ 394 (796)
+|.++
T Consensus 342 ~N~i~ 346 (347)
T 4fmz_A 342 NQVIK 346 (347)
T ss_dssp CC---
T ss_pred hhccc
Confidence 99875
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.54 Aligned_cols=268 Identities=21% Similarity=0.267 Sum_probs=191.0
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
+.|++|+|++|.+.+..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 67888888888888777778888888888888888888777888888888888888888887 4555443 67888888
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccC--cchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSG--MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
++|++++..+..|.++++|++|++++|.++. ..+..+.++++|++|++++|+++. +|..+. ++|++|+|++|+++
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCC
Confidence 8888877777777778888888888887753 566677777777777777777774 444433 67777777777777
Q ss_pred ccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccC
Q 003780 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
+..|..+.++++|+.|+|++|++++..+..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+..|.
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~ 284 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence 766777777777777777777777766667777777777777777777 5666677777777777777777766555554
Q ss_pred C------CCCCcEEEeecccccC--CCCccc-cccccceEEecccc
Q 003780 335 K------CSELRNITLRNNNLSG--SIPPEI-GLMKLEYLDLSHNK 371 (796)
Q Consensus 335 ~------l~~L~~L~L~~N~l~~--~~~~~~-~~~~L~~L~l~~N~ 371 (796)
. .+.|+.|++++|.+.. ..|..+ .+.+|+.++|++|+
T Consensus 285 ~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 3 2566667777776653 233333 25566666666664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.66 Aligned_cols=301 Identities=29% Similarity=0.388 Sum_probs=185.1
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+++++.+++..+ +..+++|++|+|++|.+.+..+ ++++++|++|+|++|.+++..+ +.++++|++|+
T Consensus 68 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 140 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140 (466)
T ss_dssp TTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCEEECCCCccCCchh---hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEE
Confidence 457777777777766443 6777777777777777776544 7777777777777777775433 77777777777
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccc
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 231 (796)
|++|++++. + .+..+++|+.|+++ |.+.+.. .+.++++|++|++++|.+++. ..+..+++|++|++++|++++
T Consensus 141 l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 213 (466)
T 1o6v_A 141 LSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD 213 (466)
T ss_dssp EEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccc
Confidence 777777753 2 35555555555553 3333222 256666667777777766654 236666666666666666665
Q ss_pred cCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccc
Q 003780 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311 (796)
Q Consensus 232 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 311 (796)
..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|++|++++|.+++..+ +..
T Consensus 214 ~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~ 285 (466)
T 1o6v_A 214 ITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 285 (466)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTT
T ss_pred ccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccC
Confidence 444 55566666666666666642 245566666666666666665443 5666666666666666665433 556
Q ss_pred ccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCCCCc--ccccccccccc
Q 003780 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPP--FLYHRFPLDLS 389 (796)
Q Consensus 312 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~--~~~~~~~l~l~ 389 (796)
+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| ...+++|+.|++++|++++. +. .+.++..|+++
T Consensus 286 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~ 361 (466)
T 1o6v_A 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAG 361 (466)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECC
T ss_pred CCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCC
Confidence 6666666666666665333 5566666666666666665443 33455666666666666543 21 22344456666
Q ss_pred CCCCcccCC
Q 003780 390 YNDLEGEIP 398 (796)
Q Consensus 390 ~N~l~~~~p 398 (796)
+|++++.+|
T Consensus 362 ~n~l~~~~~ 370 (466)
T 1o6v_A 362 HNQISDLTP 370 (466)
T ss_dssp SSCCCBCGG
T ss_pred CCccCccch
Confidence 666665554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.27 Aligned_cols=267 Identities=21% Similarity=0.257 Sum_probs=210.2
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
++|++|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 67888999999988888888889999999999999988877888888999999999999888 5555554 78888889
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccC--cchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSG--MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
++|++++..+..|.++++|++|++++|.++. ..+..+..+ +|+.|++++|++++ +|..+. ++|++|+|++|+++
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~ 206 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ 206 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCC
Confidence 9888887777788888888888888888863 667777777 88888888888885 454443 67888888888888
Q ss_pred ccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccC
Q 003780 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
+..+..+.++++|+.|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|.
T Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp CCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 777778888888888888888888777777888888888888888887 6777788888888888888888877666665
Q ss_pred CC------CCCcEEEeeccccc--CCCCccc-cccccceEEecccc
Q 003780 335 KC------SELRNITLRNNNLS--GSIPPEI-GLMKLEYLDLSHNK 371 (796)
Q Consensus 335 ~l------~~L~~L~L~~N~l~--~~~~~~~-~~~~L~~L~l~~N~ 371 (796)
.. ++|+.|++++|.+. +..|..+ .+++|+.|++++|+
T Consensus 286 ~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 43 56777888888776 4444444 36677777777764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=315.68 Aligned_cols=245 Identities=16% Similarity=0.148 Sum_probs=187.9
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccch-----hhHHHHHHHHHHHHHhhcC---------CCceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETE-----ETTFFNSFQNEAHVLSKIA---------HRNIVKL 563 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hpniv~l 563 (796)
.++|++.+.||+|+||+||+|+. +|+.||||++...... .....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999987 6899999999876432 1222467889999988886 7777777
Q ss_pred EeEEE------------------------------ecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHH
Q 003780 564 YGFCL------------------------------HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613 (796)
Q Consensus 564 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 613 (796)
.+.+. .++..++||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77643 26789999999999977666643 247999999999999999
Q ss_pred HHHHh-hcCCCCeEEecCCCCCeEecCCC--------------------cEEEeeeccccccCCCCCCccccccccCccC
Q 003780 614 LSYLH-HDCMPSIVHRDISSNNILLNSKL--------------------EAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672 (796)
Q Consensus 614 L~~LH-~~~~~~ivH~dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~a 672 (796)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999887 8999999999876532 3479999999
Q ss_pred ccccccCCcCcchhHHHHHHH-HHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC--CCccchhhHHHHHHHHHHHH
Q 003780 673 PELAYTMVVTEKCDVYSFGVV-ALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL--SPPVDRMVMQDIVLVTTVAL 749 (796)
Q Consensus 673 PE~~~~~~~~~~~DVwSlGv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~ 749 (796)
||++.+.. +.++||||+|++ .+++++|..||.... .............. ..............+.+++.
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence 99998766 889999998777 788999999975211 00111112221111 11112223344567899999
Q ss_pred HcCCCCCCCCCCHHHHH-HH
Q 003780 750 ACLHSKPKFRPTMQRVC-QE 768 (796)
Q Consensus 750 ~cl~~dP~~RPs~~evl-~~ 768 (796)
+||+.| |++|++ +|
T Consensus 318 ~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 318 TMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HGGGSS-----SHHHHHHHC
T ss_pred HHhccC-----CHHHHHhcC
Confidence 999976 999998 65
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.02 Aligned_cols=289 Identities=18% Similarity=0.151 Sum_probs=257.0
Q ss_pred CCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcccee
Q 003780 95 CFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 174 (796)
.+++++.|++++|.+....+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46899999999999998777778999999999999999998888899999999999999999999989999999999999
Q ss_pred eccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
+|++|+++...+..|.++++|++|+|++|.+++..+..+.++++|++|++++|++++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 9999999977777789999999999999999999999999999999999999999865 3677899999999999998
Q ss_pred ccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccC
Q 003780 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
+ +...++|+.|++++|.++.. |.. ..++|+.|++++|.+++. ..+..+++|++|+|++|.+++..|..|.
T Consensus 200 ~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (390)
T 3o6n_A 200 T-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 269 (390)
T ss_dssp E-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred c-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence 5 23456899999999999965 332 247999999999999964 5789999999999999999999999999
Q ss_pred CCCCCcEEEeecccccCCCCccccccccceEEecccccCCCCCcc---ccccccccccCCCCcccC
Q 003780 335 KCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF---LYHRFPLDLSYNDLEGEI 397 (796)
Q Consensus 335 ~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~---~~~~~~l~l~~N~l~~~~ 397 (796)
.+++|+.|+|++|++++..+....+++|++|++++|+++ .+|.. +.++..|++++|.++...
T Consensus 270 ~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~ 334 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 334 (390)
T ss_dssp TCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC
T ss_pred ccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC
Confidence 999999999999999975443446899999999999998 45654 356778999999998654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=297.52 Aligned_cols=284 Identities=22% Similarity=0.305 Sum_probs=242.7
Q ss_pred CcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccc
Q 003780 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178 (796)
Q Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 178 (796)
++.++++++.+.. +|..+. ++|++|+|++|.|++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 33 l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 33 LRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp TTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 4555666666653 454443 6899999999999988888999999999999999999988899999999999999999
Q ss_pred cccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccc--cCCCcccccCccceEEecccccccc
Q 003780 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG--PIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
|+++. +|..+. ++|++|++++|++++..+..+.++++|+.|++++|.++. ..+..+.++++|++|++++|+++ .
T Consensus 110 n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~ 185 (330)
T 1xku_A 110 NQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 185 (330)
T ss_dssp SCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred CcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-c
Confidence 99995 454443 799999999999999999999999999999999999964 77889999999999999999999 4
Q ss_pred CCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCC
Q 003780 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKC 336 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 336 (796)
+|..+. ++|+.|++++|++++..|..|..+++|++|++++|.+++..+..+..+++|++|+|++|+++ .+|..+..+
T Consensus 186 l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 262 (330)
T 1xku_A 186 IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262 (330)
T ss_dssp CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccC
Confidence 666554 79999999999999998999999999999999999999888889999999999999999999 788899999
Q ss_pred CCCcEEEeecccccCCCCcccc-------ccccceEEecccccCC-CCC-ccc---cccccccccCCC
Q 003780 337 SELRNITLRNNNLSGSIPPEIG-------LMKLEYLDLSHNKLNG-TIP-PFL---YHRFPLDLSYND 392 (796)
Q Consensus 337 ~~L~~L~L~~N~l~~~~~~~~~-------~~~L~~L~l~~N~l~~-~~p-~~~---~~~~~l~l~~N~ 392 (796)
++|+.|+|++|++++..+..+. ...|+.|++++|++.. .++ ..+ ..+..++|++|+
T Consensus 263 ~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 9999999999999987666552 3678999999999863 233 333 335578888774
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=327.62 Aligned_cols=307 Identities=18% Similarity=0.145 Sum_probs=266.3
Q ss_pred CCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcccee
Q 003780 95 CFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 174 (796)
.+++++.|++++|.+....+..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 36789999999999998888889999999999999999998888899999999999999999999999999999999999
Q ss_pred eccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
+|++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|+.|+|++|.+++. .+..+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccc
Confidence 9999999988888889999999999999999999999999999999999999999975 3667899999999999998
Q ss_pred ccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccC
Q 003780 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
+ +...++|+.|++++|.++...+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|+
T Consensus 206 ~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 275 (597)
T 3oja_B 206 T-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFV 275 (597)
T ss_dssp E-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred c-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhc
Confidence 5 344568999999999998654433 2689999999999997 47889999999999999999999999999
Q ss_pred CCCCCcEEEeecccccCCCCccccccccceEEecccccCCCCCcc---ccccccccccCCCCcccCCCCCCCC-CccccC
Q 003780 335 KCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF---LYHRFPLDLSYNDLEGEIPDYFRDS-PFKVYG 410 (796)
Q Consensus 335 ~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~---~~~~~~l~l~~N~l~~~~p~~~~~~-~~~~~~ 410 (796)
.+++|+.|+|++|++++..+....+++|+.|+|++|+++ .+|.. +.++..|+|++|.+.+..+..+... .....+
T Consensus 276 ~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~ 354 (597)
T 3oja_B 276 KMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSH 354 (597)
T ss_dssp TCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCS
T ss_pred CccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeC
Confidence 999999999999999985433345899999999999999 56654 3567789999999987654433221 122356
Q ss_pred Ccccc
Q 003780 411 NQGIC 415 (796)
Q Consensus 411 n~~~c 415 (796)
|+..|
T Consensus 355 N~~~~ 359 (597)
T 3oja_B 355 NDWDC 359 (597)
T ss_dssp SCEEH
T ss_pred CCCCC
Confidence 65544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.36 Aligned_cols=284 Identities=23% Similarity=0.327 Sum_probs=243.5
Q ss_pred CCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecc
Q 003780 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALS 177 (796)
Q Consensus 98 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 177 (796)
+++.++++++.+. .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4566777777776 4455553 689999999999998888899999999999999999998889999999999999999
Q ss_pred ccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc--ccCCCcccccCccceEEeccccccc
Q 003780 178 RNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM--GPIPSTLFRLTNLTYLYLHSNHLNG 255 (796)
Q Consensus 178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~ 255 (796)
+|+++. +|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++ +..+..+..+ +|++|++++|++++
T Consensus 111 ~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 999995 454444 89999999999999998889999999999999999996 4778888888 99999999999995
Q ss_pred cCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCC
Q 003780 256 SIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGK 335 (796)
Q Consensus 256 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 335 (796)
+|..+. ++|+.|+|++|++++..+..|.++++|++|++++|.+++..+..+..+++|++|+|++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 666554 79999999999999988899999999999999999999988889999999999999999999 78888999
Q ss_pred CCCCcEEEeecccccCCCCcccc-------ccccceEEecccccC--CCCCccc---cccccccccCCC
Q 003780 336 CSELRNITLRNNNLSGSIPPEIG-------LMKLEYLDLSHNKLN--GTIPPFL---YHRFPLDLSYND 392 (796)
Q Consensus 336 l~~L~~L~L~~N~l~~~~~~~~~-------~~~L~~L~l~~N~l~--~~~p~~~---~~~~~l~l~~N~ 392 (796)
+++|+.|+|++|++++..+..+. ..+|+.|++++|++. +..|..+ .++..+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 99999999999999977665552 357999999999987 3344433 335567887764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=313.70 Aligned_cols=300 Identities=27% Similarity=0.379 Sum_probs=262.3
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.+++.++++.. ++ .+..+++|++|+|++|.+.+..+ ++++++|++|+|++|.+++..+ ++++++|++|+
T Consensus 46 ~~l~~L~l~~~~i~~-l~--~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred ccccEEecCCCCCcc-Cc--chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 468899999998875 43 37889999999999999997755 9999999999999999997655 99999999999
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccc
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 231 (796)
|++|++++..+ +.++++|++|++++|.+++. + .+..+++|++|+++ |.+.+..+ +.++++|+.|++++|.+++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC
Confidence 99999997643 99999999999999999964 3 58999999999997 56665543 9999999999999999986
Q ss_pred cCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccc
Q 003780 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311 (796)
Q Consensus 232 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 311 (796)
. ..+..+++|++|++++|.+++..| ++.+++|+.|++++|++++. ..+..+++|++|++++|.+++..+ +..
T Consensus 192 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 263 (466)
T 1o6v_A 192 I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 263 (466)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence 4 358899999999999999997655 78899999999999999964 468899999999999999997765 889
Q ss_pred ccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCCCC-ccccccccccccC
Q 003780 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIP-PFLYHRFPLDLSY 390 (796)
Q Consensus 312 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p-~~~~~~~~l~l~~ 390 (796)
+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ ...+++|+.|++++|++++..| ..+.++..|++++
T Consensus 264 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~ 340 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYN 340 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCS
T ss_pred CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCC
Confidence 9999999999999997544 8899999999999999997544 4568999999999999998766 3456677899999
Q ss_pred CCCccc
Q 003780 391 NDLEGE 396 (796)
Q Consensus 391 N~l~~~ 396 (796)
|.+++.
T Consensus 341 n~l~~~ 346 (466)
T 1o6v_A 341 NKVSDV 346 (466)
T ss_dssp SCCCCC
T ss_pred CccCCc
Confidence 999885
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=309.26 Aligned_cols=303 Identities=21% Similarity=0.191 Sum_probs=256.8
Q ss_pred CCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEE
Q 003780 71 ARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150 (796)
Q Consensus 71 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (796)
..+++.|+++++++++. +++.+++|++|+|++|.+++. + ++++++|++|+|++|.+++. | ++.+++|++|
T Consensus 63 l~~L~~L~Ls~n~l~~~----~~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L 132 (457)
T 3bz5_A 63 LTGLTKLICTSNNITTL----DLSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYL 132 (457)
T ss_dssp CTTCSEEECCSSCCSCC----CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEE
T ss_pred cCCCCEEEccCCcCCeE----ccccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEE
Confidence 35789999999999884 389999999999999999985 3 99999999999999999974 4 8999999999
Q ss_pred EecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc
Q 003780 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 151 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 230 (796)
+|++|++++. + ++++++|++|++++|+..+.+ .+..+++|++|++++|+++++. ++.+++|+.|++++|+++
T Consensus 133 ~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 133 NCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNIT 204 (457)
T ss_dssp ECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCS
T ss_pred ECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec---cccCCCCCEEECcCCcCC
Confidence 9999999974 3 889999999999999766555 4888999999999999999863 889999999999999999
Q ss_pred ccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCcccccccc-------ccccccccCccccC
Q 003780 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLS-------QLLYLSISSNMLSG 303 (796)
Q Consensus 231 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-------~L~~L~l~~N~l~~ 303 (796)
+. .+..+++|++|++++|++++ +| ++.+++|+.|++++|++++..+..+.+++ +|+.|++++|.+.+
T Consensus 205 ~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~ 278 (457)
T 3bz5_A 205 KL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278 (457)
T ss_dssp CC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCC
T ss_pred ee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCC
Confidence 75 38889999999999999997 66 88999999999999999988776676665 67888888888887
Q ss_pred ccccccccccccceecccccccccCCCc--------ccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCC
Q 003780 304 QIPITIAGLISLKGLDLSNNKLSGPIPP--------EIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGT 375 (796)
Q Consensus 304 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~ 375 (796)
.+| +..+++|+.|++++|.+.+.+|. .+..+++|+.|++++|++++. + ...+++|+.|++++|++++
T Consensus 279 ~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~-l~~l~~L~~L~l~~N~l~~- 353 (457)
T 3bz5_A 279 YFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D-VSHNTKLKSLSCVNAHIQD- 353 (457)
T ss_dssp EEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C-CTTCTTCSEEECCSSCCCB-
T ss_pred ccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c-cccCCcCcEEECCCCCCCC-
Confidence 777 56789999999999987766554 356678999999999999984 3 4468899999999999986
Q ss_pred CCc--cc-------------cccccccccCCCCcccCCCCCC
Q 003780 376 IPP--FL-------------YHRFPLDLSYNDLEGEIPDYFR 402 (796)
Q Consensus 376 ~p~--~~-------------~~~~~l~l~~N~l~~~~p~~~~ 402 (796)
+|. .+ ..+..+++++|+|+|.+|..+.
T Consensus 354 l~~L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 354 FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp CTTGGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCTTCB
T ss_pred ccccccccccCCcEEecceeeecCccccccCcEEEEcChhHh
Confidence 331 11 1234578888888888887543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=304.34 Aligned_cols=277 Identities=22% Similarity=0.254 Sum_probs=169.5
Q ss_pred CCchHHHhhcHHHHHHhh---cCCccccCCCCCCCCCccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEe
Q 003780 27 TTDDICVAAFELEREALV---NSSWWSNLIDSNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLS 103 (796)
Q Consensus 27 ~~~~~~~~~~~~~~~~l~---~~~w~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~ 103 (796)
.++..++.+++....+-- .++|-.. ...+.++|.|.|++|+.... .+. ....++++.|+
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~~~w~~~--~~~~~~~~~~~g~~~~~~~~-------------~l~---~~~~~~l~~L~ 87 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWHSAWRQA--NSNNPQIETRTGRALKATAD-------------LLE---DATQPGRVALE 87 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHHHHHHHH--TTTCTTSCCSHHHHHHHHHH-------------HHH---HHTSTTCCEEE
T ss_pred chHHHHHHHHHHhccCCchhhhhhhccc--ccccccccccCCcchhhhHH-------------HHh---cccccceeEEE
Confidence 345566667665432110 0233211 12357899999999963210 000 12246778888
Q ss_pred ccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCC
Q 003780 104 LRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG 183 (796)
Q Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 183 (796)
|++|.+. .+|..++++++|++|+|++|.++ .+|..|+++++|++|+|++|+++ .+|..+.++++|++|+|++|++.+
T Consensus 88 L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~ 164 (328)
T 4fcg_A 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164 (328)
T ss_dssp EESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCC
T ss_pred ccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCcc
Confidence 8888887 66777888999999999999988 78888888999999999999988 778888889999999999988888
Q ss_pred CCCccccC---------CCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 184 PIPSAIGD---------LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 184 ~~p~~~~~---------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
.+|..+.. +++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..+..+++|++|+|++|++
T Consensus 165 ~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~- 241 (328)
T 4fcg_A 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA- 241 (328)
T ss_dssp CCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTT-
T ss_pred ccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcc-
Confidence 88876654 555555555555554 333444444445555555544442 333344444444444444444
Q ss_pred ccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccC
Q 003780 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
.+.+|..+.++++|++|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..++
T Consensus 242 -----------------------~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 242 -----------------------LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp -----------------------CCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred -----------------------hhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 444444444445555555555544445555555555555555555555555555555
Q ss_pred CCCCCcEEEeeccccc
Q 003780 335 KCSELRNITLRNNNLS 350 (796)
Q Consensus 335 ~l~~L~~L~L~~N~l~ 350 (796)
.+++|+.+++..|.+.
T Consensus 299 ~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 299 QLPANCIILVPPHLQA 314 (328)
T ss_dssp GSCTTCEEECCGGGSC
T ss_pred hccCceEEeCCHHHHH
Confidence 5555555555544443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=308.36 Aligned_cols=296 Identities=20% Similarity=0.207 Sum_probs=257.3
Q ss_pred CCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEE
Q 003780 71 ARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150 (796)
Q Consensus 71 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (796)
-.+++.|+++++++++. + .|..+++|++|+|++|++++. | ++.+++|++|+|++|.|++. | ++++++|++|
T Consensus 41 l~~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L 111 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYL 111 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEE
T ss_pred cCCCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEE
Confidence 35799999999999975 3 589999999999999999985 4 99999999999999999975 3 8999999999
Q ss_pred EecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc
Q 003780 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 151 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 230 (796)
+|++|++++. | ++.+++|++|++++|++++. + ++++++|++|++++|+..+.+ .++.+++|+.|++++|+++
T Consensus 112 ~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~ 183 (457)
T 3bz5_A 112 NCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183 (457)
T ss_dssp ECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccc
Confidence 9999999974 4 89999999999999999985 3 889999999999999655554 5889999999999999999
Q ss_pred ccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccc
Q 003780 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIA 310 (796)
Q Consensus 231 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 310 (796)
+. | +..+++|+.|++++|++++. .++.+++|+.|++++|++++ +| +..+++|++|++++|++++..+..+.
T Consensus 184 ~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~ 254 (457)
T 3bz5_A 184 EL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLS 254 (457)
T ss_dssp CC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCT
T ss_pred ee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCC
Confidence 74 4 88899999999999999975 38899999999999999998 56 88999999999999999987766666
Q ss_pred ccc-------ccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc---------cccccceEEecccccCC
Q 003780 311 GLI-------SLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI---------GLMKLEYLDLSHNKLNG 374 (796)
Q Consensus 311 ~l~-------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---------~~~~L~~L~l~~N~l~~ 374 (796)
.+. +|+.|++++|.+.+.+| ++.+++|+.|+|++|.+.+.+|... ++++|++|++++|++++
T Consensus 255 ~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~ 332 (457)
T 3bz5_A 255 KLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTE 332 (457)
T ss_dssp TCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSC
T ss_pred CCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccc
Confidence 665 66788888888877776 5788999999999999887766421 35689999999999998
Q ss_pred CCC-ccccccccccccCCCCcc
Q 003780 375 TIP-PFLYHRFPLDLSYNDLEG 395 (796)
Q Consensus 375 ~~p-~~~~~~~~l~l~~N~l~~ 395 (796)
. | ..+.++..|++++|++++
T Consensus 333 l-~l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 333 L-DVSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp C-CCTTCTTCSEEECCSSCCCB
T ss_pred c-ccccCCcCcEEECCCCCCCC
Confidence 4 4 334567789999999997
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-32 Score=294.94 Aligned_cols=282 Identities=23% Similarity=0.331 Sum_probs=248.9
Q ss_pred CCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEE
Q 003780 71 ARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVL 150 (796)
Q Consensus 71 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (796)
..+++.|+++++.+++..+ |..+++|++|+|++|.+.+. +.|..+++|++|+|++|.+++..+ +..+++|++|
T Consensus 65 ~~~L~~L~l~~n~i~~~~~---~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L 137 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSL 137 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEE
T ss_pred cCCccEEEccCCccccchh---hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCchh--hccCCceeEE
Confidence 3579999999999886433 89999999999999999874 469999999999999999996533 8999999999
Q ss_pred EecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc
Q 003780 151 NLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 151 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 230 (796)
++++|.....++ .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.++
T Consensus 138 ~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 212 (347)
T 4fmz_A 138 NLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212 (347)
T ss_dssp ECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred ECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCC
Confidence 999997765544 49999999999999999986654 8899999999999999997755 899999999999999999
Q ss_pred ccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccc
Q 003780 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIA 310 (796)
Q Consensus 231 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 310 (796)
+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+++. ..+..+++|++|++++|.+++. ..+.
T Consensus 213 ~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~ 284 (347)
T 4fmz_A 213 DITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLN 284 (347)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGG
T ss_pred CCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhc
Confidence 7654 8899999999999999996444 89999999999999999974 4689999999999999999975 4688
Q ss_pred cccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccC
Q 003780 311 GLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLN 373 (796)
Q Consensus 311 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~ 373 (796)
.+++|+.|++++|++++..|..+..+++|+.|+|++|++++..| ...+++|++|++++|+++
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC---
T ss_pred CCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhccc
Confidence 99999999999999999999999999999999999999998666 556899999999999986
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=301.58 Aligned_cols=286 Identities=20% Similarity=0.229 Sum_probs=198.5
Q ss_pred CCCCccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCC
Q 003780 57 SSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGS 136 (796)
Q Consensus 57 ~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 136 (796)
....|.|.|+ |+. ++++++. ++. .-.++|++|+|++|++.+..+..|.++++|++|+|++|.+++.
T Consensus 26 ~~~~C~~~~~-c~~---------~~~~l~~-iP~---~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (353)
T 2z80_A 26 ASLSCDRNGI-CKG---------SSGSLNS-IPS---GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91 (353)
T ss_dssp -CCEECTTSE-EEC---------CSTTCSS-CCT---TCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred cCCCCCCCeE-eeC---------CCCCccc-ccc---cccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc
Confidence 3467999998 754 3444443 222 2236899999999999988777899999999999999999988
Q ss_pred CCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCC-ccccCCCCccEEEcccc-cccCcchhhhc
Q 003780 137 IPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIP-SAIGDLNNLLILSLDSN-KLSGMLHQELG 214 (796)
Q Consensus 137 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~ 214 (796)
.|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++| .++...+..+.
T Consensus 92 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 171 (353)
T 2z80_A 92 EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT
T ss_pred CHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHcc
Confidence 88889999999999999999997666678899999999999999986555 57888899999999988 47767677788
Q ss_pred CCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCcccccc---cccc
Q 003780 215 KLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTR---LSQL 291 (796)
Q Consensus 215 ~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~---l~~L 291 (796)
++++|++|++++|++++..|..+.++++|++|++++|+++...+..+..+++|+.|++++|++++..+..+.. .+.+
T Consensus 172 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l 251 (353)
T 2z80_A 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251 (353)
T ss_dssp TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCC
T ss_pred CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchh
Confidence 8888888888888888777777888888888888888876433333445677777777777777654443321 2333
Q ss_pred ccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcc-c-cccccceEEecc
Q 003780 292 LYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPE-I-GLMKLEYLDLSH 369 (796)
Q Consensus 292 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~-~~~~L~~L~l~~ 369 (796)
+.+++++|.+++ |.+. .+|..+..+++|+.|+|++|+++ .+|.. + .+++|++|++++
T Consensus 252 ~~l~L~~~~l~~-------------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~ 310 (353)
T 2z80_A 252 KKFTFRNVKITD-------------------ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHT 310 (353)
T ss_dssp CEEEEESCBCCH-------------------HHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred hccccccccccC-------------------cchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeC
Confidence 444444433332 1111 23445555556666666666665 33332 2 355666666666
Q ss_pred cccCCCCC
Q 003780 370 NKLNGTIP 377 (796)
Q Consensus 370 N~l~~~~p 377 (796)
|++++..|
T Consensus 311 N~~~~~~~ 318 (353)
T 2z80_A 311 NPWDCSCP 318 (353)
T ss_dssp SCBCCCHH
T ss_pred CCccCcCC
Confidence 66665544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=287.18 Aligned_cols=231 Identities=23% Similarity=0.242 Sum_probs=163.1
Q ss_pred CCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCC--CchhhhccCccceeeccccccCCCCCccccCCCCccEE
Q 003780 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGA--IPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLIL 198 (796)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 198 (796)
++|++|+|++|.++...+..|.++++|++|+|++|+++.. .|..+..+++|++|+|++|.+++ +|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEE
Confidence 4667777777777644444567777777777777777632 25666667777777777777763 45567777777777
Q ss_pred EcccccccCcch-hhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccc-cCCccccCCcccceeeccccc
Q 003780 199 SLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG-SIPPEIGNMTGILKVDMSMNN 276 (796)
Q Consensus 199 ~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~ 276 (796)
++++|++++..+ ..+..+++|++|++++|.+++..+..+.++++|++|+|++|.+++ .+|..+..+++|+.|+|++|+
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 777777776655 567777777777777777776667777777777777777777765 466677777777777777777
Q ss_pred ccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCC-CCcEEEeecccccCC
Q 003780 277 IEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS-ELRNITLRNNNLSGS 352 (796)
Q Consensus 277 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~ 352 (796)
+++..|..|..+++|++|+|++|.+++..+..+..+++|++|+|++|++++..|..+..++ +|+.|+|++|.+++.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 7776677777777777777777777766666677777777777777777777777777764 677777777777654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=300.36 Aligned_cols=295 Identities=24% Similarity=0.326 Sum_probs=165.0
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCC-------------cEeecccCcCCCC--
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKL-------------RYLDFSFNNLTGS-- 136 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-------------~~L~Ls~n~l~~~-- 136 (796)
.++..++++++++ |.+|. .++++++|++|++++|.+.|.+|..++++.+| ++|++++|.+++.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence 4567777888887 67765 37788888888888888777777777766542 5555555554431
Q ss_pred -----------------CCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEE
Q 003780 137 -----------------IPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILS 199 (796)
Q Consensus 137 -----------------~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 199 (796)
+|.. +++|++|+|++|++++. |.. .++|++|++++|++++ +| .|+++++|++|+
T Consensus 89 ~~~~L~~L~l~~n~l~~lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 89 LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CcCCCCEEEccCCcCCccccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 3322 13455555555554431 111 1577788888888776 55 477888888888
Q ss_pred cccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccc
Q 003780 200 LDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEG 279 (796)
Q Consensus 200 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 279 (796)
+++|+++++ |.. ..+|++|++++|++++ +| .+.++++|++|++++|++++ +|... ++|+.|++++|+++
T Consensus 160 l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~- 228 (454)
T 1jl5_A 160 VDNNSLKKL-PDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE- 228 (454)
T ss_dssp CCSSCCSCC-CCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-
T ss_pred CCCCcCccc-CCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-
Confidence 888887763 332 2477777777777775 44 47777777777777777774 44322 46677777777776
Q ss_pred cCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccC--CCCccc
Q 003780 280 TIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG--SIPPEI 357 (796)
Q Consensus 280 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~ 357 (796)
.+| .+..+++|++|++++|++++ +|.. +++|++|++++|++++ +|.. +++|+.|++++|++++ .+|...
T Consensus 229 ~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L 299 (454)
T 1jl5_A 229 ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNL 299 (454)
T ss_dssp SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTC
T ss_pred ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcC
Confidence 455 36667777777777777664 3322 2456666666666554 3322 2445555555555554 222111
Q ss_pred --------------cc-cccceEEecccccCCCCCccccccccccccCCCCcccCCC
Q 003780 358 --------------GL-MKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPD 399 (796)
Q Consensus 358 --------------~~-~~L~~L~l~~N~l~~~~p~~~~~~~~l~l~~N~l~~~~p~ 399 (796)
.+ .+|++|++++|++++ +|..+.++..|++++|.+++ +|.
T Consensus 300 ~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~~~~L~~L~L~~N~l~~-lp~ 354 (454)
T 1jl5_A 300 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLIASFNHLAE-VPE 354 (454)
T ss_dssp CEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC-CCC
T ss_pred CEEECcCCcCCcccCCcCcCCEEECCCCcccc-ccccCCcCCEEECCCCcccc-ccc
Confidence 11 367777777777775 66666667777777777774 444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-33 Score=293.63 Aligned_cols=252 Identities=22% Similarity=0.255 Sum_probs=223.2
Q ss_pred ccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCC--CC
Q 003780 61 CKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGS--IP 138 (796)
Q Consensus 61 C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~--~p 138 (796)
|.|++|.|+..+ ++. ++. .-.++|++|+|++|.+....+..|+++++|++|+|++|.++.. .|
T Consensus 7 C~~~~l~c~~~~-----------l~~-ip~---~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 71 (306)
T 2z66_A 7 CSGTEIRCNSKG-----------LTS-VPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71 (306)
T ss_dssp EETTEEECCSSC-----------CSS-CCS---CCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred eCCCEEEcCCCC-----------ccc-CCC---CCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc
Confidence 789999997532 221 111 2236899999999999977777789999999999999999833 36
Q ss_pred CCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCC-ccccCCCCccEEEcccccccCcchhhhcCCC
Q 003780 139 PELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIP-SAIGDLNNLLILSLDSNKLSGMLHQELGKLK 217 (796)
Q Consensus 139 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 217 (796)
..+.++++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+.+++
T Consensus 72 ~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 150 (306)
T 2z66_A 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150 (306)
T ss_dssp HHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT
T ss_pred cccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCc
Confidence 67778999999999999998 567789999999999999999997765 6899999999999999999999999999999
Q ss_pred CccccccCCccccc-cCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccc
Q 003780 218 NLVALNVGGNKLMG-PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSI 296 (796)
Q Consensus 218 ~L~~L~l~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 296 (796)
+|++|++++|.+++ ..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|++|+|
T Consensus 151 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 230 (306)
T 2z66_A 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 230 (306)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEEC
T ss_pred CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeEC
Confidence 99999999999987 67889999999999999999999888999999999999999999999888888999999999999
Q ss_pred cCccccCcccccccccc-ccceecccccccccC
Q 003780 297 SSNMLSGQIPITIAGLI-SLKGLDLSNNKLSGP 328 (796)
Q Consensus 297 ~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~ 328 (796)
++|.+++..|..+..++ +|++|+|++|.+++.
T Consensus 231 ~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 231 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp TTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 99999999999999985 999999999999864
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=290.48 Aligned_cols=280 Identities=25% Similarity=0.322 Sum_probs=152.6
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.++++++.+++ ++. .+++|++|++++|.+.+. |.. .++|++|+|++|.+++ +| .|+++++|++|+
T Consensus 91 ~~L~~L~l~~n~l~~-lp~----~~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPE----LPQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp TTCSEEECCSSCCSS-CCC----CCTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCc-ccc----ccCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 456777777777766 332 135666666666666642 211 1567777777777764 55 467777777777
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccc
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 231 (796)
+++|++++ +|..+ ++|++|++++|++++ +| .|+++++|++|++++|+++++ |.. .++|++|++++|+++
T Consensus 160 l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~n~l~- 228 (454)
T 1jl5_A 160 VDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILE- 228 (454)
T ss_dssp CCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCS-
T ss_pred CCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECcCCcCC-
Confidence 77777664 44332 466777777777665 34 466677777777777766653 221 246666666666666
Q ss_pred cCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccc
Q 003780 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311 (796)
Q Consensus 232 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 311 (796)
.+| .+..+++|++|++++|++++ +|.. +++|+.|++++|++++ +|.. +++|++|++++|.+++. |..
T Consensus 229 ~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~--- 295 (454)
T 1jl5_A 229 ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL--- 295 (454)
T ss_dssp SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---
T ss_pred ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---
Confidence 444 36666667777777766664 4432 2566666666666664 3332 25566666666666541 110
Q ss_pred ccccceecccccccccCCCcccCCC-CCCcEEEeecccccCCCCccccccccceEEecccccCCCCCccccccccccccC
Q 003780 312 LISLKGLDLSNNKLSGPIPPEIGKC-SELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSY 390 (796)
Q Consensus 312 l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~l~~ 390 (796)
.++|++|++++|++++. + .+ ++|+.|++++|++++ +|.. +++|++|++++|+++ .+|..+.++..|++++
T Consensus 296 ~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~--~~~L~~L~L~~N~l~-~lp~~l~~L~~L~L~~ 366 (454)
T 1jl5_A 296 PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL--PPRLERLIASFNHLA-EVPELPQNLKQLHVEY 366 (454)
T ss_dssp CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCS-CCCCCCTTCCEEECCS
T ss_pred CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc--CCcCCEEECCCCccc-cccchhhhccEEECCC
Confidence 12344444444444321 1 11 244445555444443 2322 234444444444444 2333333344444444
Q ss_pred CCCcc
Q 003780 391 NDLEG 395 (796)
Q Consensus 391 N~l~~ 395 (796)
|.+++
T Consensus 367 N~l~~ 371 (454)
T 1jl5_A 367 NPLRE 371 (454)
T ss_dssp SCCSS
T ss_pred CCCCc
Confidence 44444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=290.91 Aligned_cols=270 Identities=22% Similarity=0.209 Sum_probs=165.8
Q ss_pred EEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccc
Q 003780 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180 (796)
Q Consensus 101 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 180 (796)
..++++++++. +|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 35 ~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (353)
T 2z80_A 35 ICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111 (353)
T ss_dssp EEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCc
Confidence 35666777763 344343 467777777777776555567777777777777777776666666666666666666666
Q ss_pred cCCCCCccccCCCCccEEEcccccccCcch-hhhcCCCCccccccCCc-cccccCCCcccccCccceEEeccccccccCC
Q 003780 181 LHGPIPSAIGDLNNLLILSLDSNKLSGMLH-QELGKLKNLVALNVGGN-KLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 181 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 258 (796)
+++..+..|.++++|++|+|++|+++++.+ ..+.++++|++|++++| .+++..+..+.++++|++|++++|++++..|
T Consensus 112 l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (353)
T 2z80_A 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191 (353)
T ss_dssp CSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred CCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCH
Confidence 665544456666666666666666654433 34555555555555555 2443444445555555555555555554444
Q ss_pred ccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCccc---CC
Q 003780 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEI---GK 335 (796)
Q Consensus 259 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~ 335 (796)
..+.+ +++|++|++++|.++...+..+..+++|+.|++++|++++..+..+ ..
T Consensus 192 ~~l~~------------------------l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~ 247 (353)
T 2z80_A 192 KSLKS------------------------IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247 (353)
T ss_dssp TTTTT------------------------CSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------C
T ss_pred HHHhc------------------------cccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccc
Confidence 44444 4455555555554443222233345555555566665555443333 23
Q ss_pred CCCCcEEEeecccccC----CCCccc-cccccceEEecccccCCCCCccc----cccccccccCCCCcccCC
Q 003780 336 CSELRNITLRNNNLSG----SIPPEI-GLMKLEYLDLSHNKLNGTIPPFL----YHRFPLDLSYNDLEGEIP 398 (796)
Q Consensus 336 l~~L~~L~L~~N~l~~----~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~----~~~~~l~l~~N~l~~~~p 398 (796)
.+.++.++|++|.+++ .+|..+ .+++|+.|++++|+++ .+|..+ .++..|++++|.+.+..|
T Consensus 248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 5678889999998886 345544 4789999999999999 677543 456689999999998776
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=278.98 Aligned_cols=268 Identities=23% Similarity=0.190 Sum_probs=155.9
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
+.++.+++.+..+ |..+ .++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~i-p~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQAV-PVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSSC-CTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcccC-CcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 4567777766633 4322 356777777777777666666777777777777777777666666666666666666666
Q ss_pred c-cCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCC
Q 003780 180 G-LHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 180 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 258 (796)
. ++...|..|..+++|++|+|++|.+++..+..+.++++|++|++++|++++..+..+..+++|++|+|++|++++
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--- 167 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS--- 167 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE---
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc---
Confidence 5 555556666666666666666666665555555555555555555555554444445555555555555555543
Q ss_pred ccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCC
Q 003780 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSE 338 (796)
Q Consensus 259 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 338 (796)
..+..|..+++|++|++++|.+++..|..+..+++|+.|++++|++++..+..+..+++
T Consensus 168 ---------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 226 (285)
T 1ozn_A 168 ---------------------VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (285)
T ss_dssp ---------------------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred ---------------------cCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence 33334444455555555555555444555555555666666666666544455666666
Q ss_pred CcEEEeecccccCCCCccccccccceEEecccccCCCCCccccccccccccCCCCc
Q 003780 339 LRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLE 394 (796)
Q Consensus 339 L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~l~~N~l~ 394 (796)
|+.|+|++|.+....+...-...++.+..+.|.+.+..|+.+......++..++|+
T Consensus 227 L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~ 282 (285)
T 1ozn_A 227 LQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQ 282 (285)
T ss_dssp CCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSC
T ss_pred cCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhc
Confidence 66677766666654332222233555556667776666665544433344444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-31 Score=275.11 Aligned_cols=255 Identities=22% Similarity=0.247 Sum_probs=223.1
Q ss_pred EEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecC
Q 003780 75 IEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154 (796)
Q Consensus 75 ~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 154 (796)
+.+++++++++.... +..++|++|+|++|.+.+..+..|+.+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~~ip~----~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPV----GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCSSCCT----TCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcccCCc----CCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 567777777765322 3357999999999999998888999999999999999999988899999999999999999
Q ss_pred CC-CCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccC
Q 003780 155 NN-LNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPI 233 (796)
Q Consensus 155 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 233 (796)
|+ ++...|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 97 88777899999999999999999999998999999999999999999999998889999999999999999999887
Q ss_pred CCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccccc
Q 003780 234 PSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLI 313 (796)
Q Consensus 234 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 313 (796)
+..+..+++|++|+|++|++++..|..+.++++|+.|+|++|++++..+..+..+++|++|++++|.+....+.. .-..
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~ 248 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA 248 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence 778999999999999999999988999999999999999999999888788999999999999999998644322 2224
Q ss_pred ccceecccccccccCCCcccC
Q 003780 314 SLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 314 ~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
.++.+..+.+.+....|..+.
T Consensus 249 ~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp HHHHCCSEECCCBEEESGGGT
T ss_pred HHHhcccccCccccCCchHhC
Confidence 456666666666666665544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=290.88 Aligned_cols=230 Identities=23% Similarity=0.206 Sum_probs=147.1
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
++|++|+|++|+|.+..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 45666666666666666666666666666666666666666666666666666666666666555555666666666666
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
++|++++..+..|.++++|++|+|++| |.+....+..|.++++|++|+|++|++++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~-----------------------~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 210 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGEL-----------------------KKLEYISEGAFEGLFNLKYLNLGMCNIKD- 210 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCC-----------------------TTCCEECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCC-----------------------CCccccChhhccCCCCCCEEECCCCcccc-
Confidence 666665555555555555555555552 22222223345555555555555555553
Q ss_pred CCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCC
Q 003780 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKC 336 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 336 (796)
+| .+..+++|+.|+|++|++++..|..|.++++|++|+|++|.+++..+..|.++++|+.|+|++|++++..+..|..+
T Consensus 211 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 211 MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 23 35556666666666666666666666667777777777777776667777777777777777777776666777778
Q ss_pred CCCcEEEeecccccC
Q 003780 337 SELRNITLRNNNLSG 351 (796)
Q Consensus 337 ~~L~~L~L~~N~l~~ 351 (796)
++|+.|+|++|.+..
T Consensus 290 ~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 290 RYLVELHLHHNPWNC 304 (452)
T ss_dssp TTCCEEECCSSCEEC
T ss_pred cCCCEEEccCCCcCC
Confidence 888888888887764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=277.06 Aligned_cols=235 Identities=21% Similarity=0.259 Sum_probs=212.6
Q ss_pred CCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEE
Q 003780 119 ALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLIL 198 (796)
Q Consensus 119 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 198 (796)
...++++|+|++|.++ .+|..+.++++|++|+|++|+++ .+|..++++++|++|+|++|.++ .+|..|.++++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3578999999999999 78888999999999999999999 88999999999999999999999 778889999999999
Q ss_pred EcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccccc
Q 003780 199 SLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278 (796)
Q Consensus 199 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 278 (796)
+|++|++.+.+|..+... ..+..+.++++|++|+|++|+++ .+|..++++++|+.|+|++|+++
T Consensus 156 ~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 156 SIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred ECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 999988887777655431 12345778999999999999999 78888999999999999999999
Q ss_pred ccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcccc
Q 003780 279 GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG 358 (796)
Q Consensus 279 ~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 358 (796)
+ +|..+..+++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..++
T Consensus 220 ~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 220 A-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp C-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred c-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 5 566799999999999999999999999999999999999999999999999999999999999999999999999885
Q ss_pred -ccccceEEecccccC
Q 003780 359 -LMKLEYLDLSHNKLN 373 (796)
Q Consensus 359 -~~~L~~L~l~~N~l~ 373 (796)
+++|+.+++..|.+.
T Consensus 299 ~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 299 QLPANCIILVPPHLQA 314 (328)
T ss_dssp GSCTTCEEECCGGGSC
T ss_pred hccCceEEeCCHHHHH
Confidence 899999999988775
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=286.89 Aligned_cols=227 Identities=23% Similarity=0.248 Sum_probs=127.3
Q ss_pred CCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcc
Q 003780 122 KLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLD 201 (796)
Q Consensus 122 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 201 (796)
++++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 144 (440)
T 3zyj_A 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144 (440)
T ss_dssp TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence 34444444444444444444444444444444444444444444444444444444444444444444445555555555
Q ss_pred cccccCcchhhhcCCCCccccccCC-ccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccccccc
Q 003780 202 SNKLSGMLHQELGKLKNLVALNVGG-NKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGT 280 (796)
Q Consensus 202 ~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 280 (796)
+|+++.+.+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|+++ .+| .+..+++|+.|+|++|++++.
T Consensus 145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEE
T ss_pred CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCcc
Confidence 5555544444455555555555554 2333333335555666666666666665 333 255566666666666666666
Q ss_pred CccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeeccccc
Q 003780 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350 (796)
Q Consensus 281 ~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 350 (796)
.|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 6666666666666666666666666666666777777777777777666666677777777777777665
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=288.43 Aligned_cols=231 Identities=26% Similarity=0.235 Sum_probs=183.4
Q ss_pred CCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEc
Q 003780 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSL 200 (796)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 200 (796)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..+.
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------------- 141 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSG------------- 141 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTT-------------
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChh-------------
Confidence 5677777777777777777777777777777777777766556666665555555555555544444
Q ss_pred ccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecc-ccccccCCccccCCcccceeecccccccc
Q 003780 201 DSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHS-NHLNGSIPPEIGNMTGILKVDMSMNNIEG 279 (796)
Q Consensus 201 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 279 (796)
.|.++++|++|+|++|++++..+..|.++++|++|+|++ |.+....+..|.++++|+.|+|++|++++
T Consensus 142 -----------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 142 -----------AFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp -----------TSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred -----------hhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 444555555555555555555566788899999999999 45554445578999999999999999996
Q ss_pred cCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-c
Q 003780 280 TIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-G 358 (796)
Q Consensus 280 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~ 358 (796)
. | .+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+ .
T Consensus 211 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 211 M-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp C-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred c-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 4 4 58899999999999999999999999999999999999999999999999999999999999999997777666 4
Q ss_pred ccccceEEecccccCCCCC
Q 003780 359 LMKLEYLDLSHNKLNGTIP 377 (796)
Q Consensus 359 ~~~L~~L~l~~N~l~~~~p 377 (796)
+++|+.|+|++|++.....
T Consensus 289 l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CTTCCEEECCSSCEECSTT
T ss_pred ccCCCEEEccCCCcCCCCC
Confidence 8899999999999986543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=287.75 Aligned_cols=245 Identities=23% Similarity=0.203 Sum_probs=222.0
Q ss_pred EEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCC
Q 003780 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGN 155 (796)
Q Consensus 76 ~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N 155 (796)
.+++.+.+++..... -.++++.|+|++|++.+..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus 47 ~v~c~~~~l~~iP~~----~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 47 KVICVRKNLREVPDG----ISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp EEECCSCCCSSCCSC----CCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred EEEeCCCCcCcCCCC----CCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 455555555533322 2378999999999999999999999999999999999999888889999999999999999
Q ss_pred CCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEccc-ccccCcchhhhcCCCCccccccCCccccccCC
Q 003780 156 NLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDS-NKLSGMLHQELGKLKNLVALNVGGNKLMGPIP 234 (796)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 234 (796)
+|++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++ |.+..+.+..|.++++|++|+|++|+++. +|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc
Confidence 99988788899999999999999999988888999999999999999 55666666789999999999999999994 45
Q ss_pred CcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccc
Q 003780 235 STLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314 (796)
Q Consensus 235 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 314 (796)
.+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 4889999999999999999999999999999999999999999999999999999999999999999888888999999
Q ss_pred cceecccccccc
Q 003780 315 LKGLDLSNNKLS 326 (796)
Q Consensus 315 L~~L~Ls~N~l~ 326 (796)
|+.|+|++|.+.
T Consensus 281 L~~L~L~~Np~~ 292 (440)
T 3zyj_A 281 LERIHLHHNPWN 292 (440)
T ss_dssp CCEEECCSSCEE
T ss_pred CCEEEcCCCCcc
Confidence 999999999986
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-32 Score=288.07 Aligned_cols=203 Identities=19% Similarity=0.193 Sum_probs=95.8
Q ss_pred ccCccceeeccccccCCCCCccc--cCCCCccEEEcccccccCcchhhhcCC-----CCccccccCCccccccCCCcccc
Q 003780 167 QLTKLITMALSRNGLHGPIPSAI--GDLNNLLILSLDSNKLSGMLHQELGKL-----KNLVALNVGGNKLMGPIPSTLFR 239 (796)
Q Consensus 167 ~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~l~~ 239 (796)
++++|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..+.+
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 34444444444444444444433 4444444444444444444 3333333 44444444444444444444444
Q ss_pred cCccceEEecccccccc--CCccc--cCCcccceeecccccccc---cCccccccccccccccccCccccCccc-ccccc
Q 003780 240 LTNLTYLYLHSNHLNGS--IPPEI--GNMTGILKVDMSMNNIEG---TIPLELTRLSQLLYLSISSNMLSGQIP-ITIAG 311 (796)
Q Consensus 240 l~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~---~~p~~l~~l~~L~~L~l~~N~l~~~~~-~~~~~ 311 (796)
+++|++|+|++|++.+. .|..+ ..+++|+.|+|++|++++ .....+.++++|++|+|++|.+++..| ..+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 44444444444444332 11122 444555555555555542 111222344555555555555555443 33444
Q ss_pred ccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCC
Q 003780 312 LISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNG 374 (796)
Q Consensus 312 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~ 374 (796)
+++|++|+|++|+++ .+|..+. ++|+.|+|++|++++. |....+++|++|++++|++++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence 555555555555555 4444444 5555566666655544 433345556666666666553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-31 Score=285.32 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=161.7
Q ss_pred CCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCC-CCCCCCCC-------CCCCCCEEEecCCCCCCCCchhh
Q 003780 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLT-GSIPPELG-------SLRNLEVLNLKGNNLNGAIPSSL 165 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~ 165 (796)
...++|+.|++++|.+ .+|..+... |++|+|++|.++ ..+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 4445667777777777 555555443 677777777763 34454444 56777777777777776666665
Q ss_pred --hccCccceeeccccccCCCCCccccCC-----CCccEEEcccccccCcchhhhcCCCCccccccCCcccccc--CCCc
Q 003780 166 --CQLTKLITMALSRNGLHGPIPSAIGDL-----NNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP--IPST 236 (796)
Q Consensus 166 --~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~ 236 (796)
..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|+++++|++|+|++|++.+. .+..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 6677777777777777765 6666666 6777777777777777667777777777777777776543 2222
Q ss_pred c--cccCccceEEecccccccc--CC-ccccCCcccceeecccccccccCc-cccccccccccccccCccccCccccccc
Q 003780 237 L--FRLTNLTYLYLHSNHLNGS--IP-PEIGNMTGILKVDMSMNNIEGTIP-LELTRLSQLLYLSISSNMLSGQIPITIA 310 (796)
Q Consensus 237 l--~~l~~L~~L~L~~N~l~~~--~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 310 (796)
+ ..+++|++|+|++|++++. ++ ..+.++++|+.|+|++|++++..| ..+..+++|++|+|++|.++ .+|..+.
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 3 5667777777777777621 12 233456677777777777776554 34555677777777777776 5555554
Q ss_pred cccccceecccccccccCCCcccCCCCCCcEEEeecccccC
Q 003780 311 GLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG 351 (796)
Q Consensus 311 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 351 (796)
++|++|+|++|++++. |. +..+++|+.|+|++|++++
T Consensus 274 --~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 --AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp --SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred --CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 6777777777777654 44 6677777777777777664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=257.91 Aligned_cols=218 Identities=26% Similarity=0.284 Sum_probs=168.5
Q ss_pred CCCccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCC
Q 003780 58 SDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSI 137 (796)
Q Consensus 58 ~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 137 (796)
.++|.|.|+.|....+.+.+++++++++...... .++|++|+|++|++.+..+..|+++++|++|+|++|.|+...
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~----~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLTAIPSNI----PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCSSCCSCC----CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCCccCCCC----CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 4789999999987777788999999888533221 257888888888888777778888888888888888888666
Q ss_pred CCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCC
Q 003780 138 PPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLK 217 (796)
Q Consensus 138 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 217 (796)
+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+++++.+..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 66678888888888888888877777778888888888888888877777778888888888888888777777777777
Q ss_pred CccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccc
Q 003780 218 NLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEG 279 (796)
Q Consensus 218 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 279 (796)
+|+.|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|.+..
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 77777777777776666667777777777777777775555556667777777777776654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=289.82 Aligned_cols=284 Identities=24% Similarity=0.274 Sum_probs=227.1
Q ss_pred CCCCCccCCceeeC------C-CCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeec
Q 003780 56 NSSDHCKLDGVTCN------T-ARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDF 128 (796)
Q Consensus 56 ~~~~~C~w~gv~C~------~-~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (796)
.+.++|.|+|..|. + ...++.|++++++++ .++.. +. ++|++|+|++|.|++ +|. .+++|++|+|
T Consensus 17 ~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~-l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L 88 (622)
T 3g06_A 17 RAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLTS-LPA---LPPELRTLEV 88 (622)
T ss_dssp HTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSC-CC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred hcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChh-hC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEc
Confidence 35678999875432 1 135889999999998 55542 22 899999999999985 454 5789999999
Q ss_pred ccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCc
Q 003780 129 SFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM 208 (796)
Q Consensus 129 s~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 208 (796)
++|+|+ .+|. .+++|++|+|++|++++. |. .+++|+.|+|++|+|++ +|.. +++|++|+|++|+++++
T Consensus 89 s~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l 156 (622)
T 3g06_A 89 SGNQLT-SLPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL 156 (622)
T ss_dssp CSCCCS-CCCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC
T ss_pred CCCcCC-cCCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc
Confidence 999998 4565 679999999999999964 44 67899999999999996 4543 48999999999999875
Q ss_pred chhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccc
Q 003780 209 LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRL 288 (796)
Q Consensus 209 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 288 (796)
.. .+++|+.|++++|+|++ +| ..+++|+.|+|++|++++ +|.. +++|+.|++++|.++. +|.. +
T Consensus 157 ~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~ 220 (622)
T 3g06_A 157 PA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---P 220 (622)
T ss_dssp CC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---C
T ss_pred CC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---C
Confidence 32 45789999999999996 45 456889999999999995 5543 4789999999999994 4543 4
Q ss_pred cccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEe
Q 003780 289 SQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDL 367 (796)
Q Consensus 289 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l 367 (796)
++|++|+|++|.+++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|..+ .+++|+.|+|
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 789999999999996 55 456889999999999984 555 6789999999999999 667666 5889999999
Q ss_pred cccccCCCCCccccccc
Q 003780 368 SHNKLNGTIPPFLYHRF 384 (796)
Q Consensus 368 ~~N~l~~~~p~~~~~~~ 384 (796)
++|++++.+|..+..+.
T Consensus 292 ~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 292 EGNPLSERTLQALREIT 308 (622)
T ss_dssp CSCCCCHHHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHhcc
Confidence 99999988877665543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-31 Score=281.63 Aligned_cols=262 Identities=20% Similarity=0.189 Sum_probs=168.8
Q ss_pred CcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccc
Q 003780 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178 (796)
Q Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 178 (796)
++.++++.+.+.......+..+++|++|+|++|.|++..|..|.++++|++|+|++|++++..| +..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3445555555554444455556666777777776666555666666777777777776665443 66666677777777
Q ss_pred cccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCC
Q 003780 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 258 (796)
|++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+..+..+++|++|+|++|++++..+
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 6666422 2366777777777776655443 4567777777777776666666667777777777777776555
Q ss_pred cccc-CCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCC
Q 003780 259 PEIG-NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337 (796)
Q Consensus 259 ~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 337 (796)
..+. .+++|+.|+|++|++++. | ....+++|++|+|++|.+++. |..+..+++|+.|+|++|+++ .+|..+..++
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred HHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCC
Confidence 5553 567777777777777654 2 223467777777777777743 334777777777777777777 3566677777
Q ss_pred CCcEEEeeccccc-CCCCccc-cccccceEEeccc-ccCC
Q 003780 338 ELRNITLRNNNLS-GSIPPEI-GLMKLEYLDLSHN-KLNG 374 (796)
Q Consensus 338 ~L~~L~L~~N~l~-~~~~~~~-~~~~L~~L~l~~N-~l~~ 374 (796)
+|+.|+|++|.++ +.+|..+ .+++|+.|++++| .++|
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHS
T ss_pred CCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccC
Confidence 7888888877777 4444444 3566777777633 3443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-31 Score=279.19 Aligned_cols=270 Identities=19% Similarity=0.168 Sum_probs=228.3
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEe
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (796)
+....+++.+.+...+.. .+..+++|++|+|++|.+.+..|..|..+++|++|+|++|.+++..+ |..+++|++|+|
T Consensus 11 ~l~i~~ls~~~l~~~~~~-~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALAS-LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp EEEEESCCTTTHHHHHHH-HHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred ceeEeeccccchhhhHHH-HhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 345556677776544433 35677899999999999999888899999999999999999987655 999999999999
Q ss_pred cCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccccc
Q 003780 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP 232 (796)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 232 (796)
++|++++.. ..++|++|++++|++++..+.. +++|++|+|++|++++..+..++.+++|++|++++|++++.
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence 999998543 3489999999999999766554 57899999999999999898999999999999999999987
Q ss_pred CCCccc-ccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccc
Q 003780 233 IPSTLF-RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAG 311 (796)
Q Consensus 233 ~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 311 (796)
.+..+. .+++|++|+|++|++++. |. ...+++|+.|+|++|++++. |..+..+++|++|+|++|.++ .+|..+..
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~ 235 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRF 235 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCC
T ss_pred cHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhc
Confidence 777764 789999999999999965 32 34589999999999999965 445999999999999999999 57888999
Q ss_pred ccccceecccccccc-cCCCcccCCCCCCcEEEee-cccccCCCCccc
Q 003780 312 LISLKGLDLSNNKLS-GPIPPEIGKCSELRNITLR-NNNLSGSIPPEI 357 (796)
Q Consensus 312 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~ 357 (796)
+++|+.|++++|.+. +.+|..+..+++|+.|+++ .+.++|..|...
T Consensus 236 l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~~ 283 (317)
T 3o53_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283 (317)
T ss_dssp CTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCCC
T ss_pred CCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhcc
Confidence 999999999999998 7788899999999999999 455666655443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=291.10 Aligned_cols=188 Identities=15% Similarity=0.080 Sum_probs=134.4
Q ss_pred eecccceeEEEEE-ccCCcEEEEEEeccccch-------hhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceeeEEE
Q 003780 507 IGTGGYGSVYKAQ-LPNGKVVALKKLHRAETE-------ETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 507 lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.+.|++|.+..++ .-.|+.||||++...... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666666653 335899999999765321 123356799999999999 6999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||++|++|.+++.+... ++.. +|+.||++||+|+|++ |||||||||+|||++.++.+||+|||+|+....+
T Consensus 322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999986543 5543 5899999999999999 9999999999999999999999999999987665
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCC
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPG 704 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~ 704 (796)
.......+||++|+|||++.+ .+..++|+||+|++++++.++..|+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 555566789999999999876 4577899999999998887765553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-32 Score=303.42 Aligned_cols=322 Identities=21% Similarity=0.169 Sum_probs=196.8
Q ss_pred CeEEEeCCCCCcccc----ccccccCCCCCCcEEeccCCcccccCCcCc-cCCC----CCcEeecccCcCCC----CCCC
Q 003780 73 SIIEINLPEKKLKGE----LSQFNFSCFPGLESLSLRFNYLFGSIPSQV-GALS----KLRYLDFSFNNLTG----SIPP 139 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~----~L~~L~Ls~n~l~~----~~p~ 139 (796)
+++.|+++++++... ++ ..+..+++|++|+|++|.+.+..+..+ ..+. +|++|+|++|.|+. .++.
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~-~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDIS-SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHH-HHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHH-HHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 456666666666532 11 135566777777777777665333222 2333 57777777777663 3466
Q ss_pred CCCCCCCCCEEEecCCCCCCCCchhhhc-----cCccceeeccccccCCCC----CccccCCCCccEEEcccccccCcch
Q 003780 140 ELGSLRNLEVLNLKGNNLNGAIPSSLCQ-----LTKLITMALSRNGLHGPI----PSAIGDLNNLLILSLDSNKLSGMLH 210 (796)
Q Consensus 140 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~ 210 (796)
.|..+++|++|+|++|++++..+..+.. .++|++|+|++|++++.. +..+..+++|++|+|++|.++...+
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 187 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHH
Confidence 6677777777777777766544443332 346777777777776532 4455566777777777777665544
Q ss_pred hhhc-----CCCCccccccCCcccccc----CCCcccccCccceEEeccccccccC-----CccccCCcccceeeccccc
Q 003780 211 QELG-----KLKNLVALNVGGNKLMGP----IPSTLFRLTNLTYLYLHSNHLNGSI-----PPEIGNMTGILKVDMSMNN 276 (796)
Q Consensus 211 ~~~~-----~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~ 276 (796)
..+. ..++|++|++++|.+++. ++..+..+++|++|+|++|++++.. +..+..+++|+.|+|++|+
T Consensus 188 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~ 267 (461)
T 1z7x_W 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267 (461)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCC
Confidence 4443 245777777777777653 3555666677777777777766432 2222346677777777777
Q ss_pred cccc----CccccccccccccccccCccccCccccccccc-----cccceecccccccccC----CCcccCCCCCCcEEE
Q 003780 277 IEGT----IPLELTRLSQLLYLSISSNMLSGQIPITIAGL-----ISLKGLDLSNNKLSGP----IPPEIGKCSELRNIT 343 (796)
Q Consensus 277 l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~ 343 (796)
+++. ++..+..+++|++|++++|.+++..+..+... ++|++|+|++|.+++. ++..+..+++|+.|+
T Consensus 268 l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~ 347 (461)
T 1z7x_W 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 347 (461)
T ss_dssp CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEE
T ss_pred CCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEE
Confidence 7653 45566667777777777777765444444332 5777777777777654 344555667777777
Q ss_pred eecccccCCCCcccc------ccccceEEecccccCC----CCCcc---ccccccccccCCCCcc
Q 003780 344 LRNNNLSGSIPPEIG------LMKLEYLDLSHNKLNG----TIPPF---LYHRFPLDLSYNDLEG 395 (796)
Q Consensus 344 L~~N~l~~~~~~~~~------~~~L~~L~l~~N~l~~----~~p~~---~~~~~~l~l~~N~l~~ 395 (796)
|++|++++..+..+. .++|++|++++|++++ .+|.. ..++..|++++|.+++
T Consensus 348 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 348 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 777777654433332 4467777777777764 45543 3445567777777654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=286.07 Aligned_cols=233 Identities=21% Similarity=0.214 Sum_probs=140.9
Q ss_pred CCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcc
Q 003780 122 KLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLD 201 (796)
Q Consensus 122 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 201 (796)
+|++|+|++|.|++..|..|+++++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|++|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 55666666666655555555566666666666666554443 5555566666666665553221 2566666666
Q ss_pred cccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCcccc-CCcccceeeccccccccc
Q 003780 202 SNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIG-NMTGILKVDMSMNNIEGT 280 (796)
Q Consensus 202 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~ 280 (796)
+|.+++..+.. +++|+.|+|++|.+++..|..+.++++|++|+|++|.+++.+|..+. .+++|+.|+|++|.|++.
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 66666554432 35566666666666666666666666666666666666665565554 566666666666666654
Q ss_pred CccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeeccccc-CCCCccc-c
Q 003780 281 IPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS-GSIPPEI-G 358 (796)
Q Consensus 281 ~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~-~ 358 (796)
.+ +..+++|++|+|++|.+++..| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+. +.+|..+ .
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred cc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 22 2346667777777777765333 36667777777777777774 5666777777777777777776 4444443 2
Q ss_pred ccccceEEec
Q 003780 359 LMKLEYLDLS 368 (796)
Q Consensus 359 ~~~L~~L~l~ 368 (796)
++.|+.++++
T Consensus 261 l~~L~~l~~~ 270 (487)
T 3oja_A 261 NQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHH
T ss_pred CCCCcEEecc
Confidence 4555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-31 Score=297.02 Aligned_cols=323 Identities=22% Similarity=0.180 Sum_probs=256.1
Q ss_pred CCeEEEeCCCCCccccccccccCCCC----CCcEEeccCCcccc----cCCcCccCCCCCcEeecccCcCCCCCCCCC--
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFP----GLESLSLRFNYLFG----SIPSQVGALSKLRYLDFSFNNLTGSIPPEL-- 141 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~----~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~-- 141 (796)
.+++.|+++++.+........+..++ +|++|+|++|.+.. .++..+..+++|++|+|++|.+++..+..+
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 135 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE 135 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH
Confidence 56999999999987643332334455 79999999999984 568889999999999999999875433332
Q ss_pred ---CCCCCCCEEEecCCCCCCCC----chhhhccCccceeeccccccCCCCCcccc-----CCCCccEEEcccccccCc-
Q 003780 142 ---GSLRNLEVLNLKGNNLNGAI----PSSLCQLTKLITMALSRNGLHGPIPSAIG-----DLNNLLILSLDSNKLSGM- 208 (796)
Q Consensus 142 ---~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~- 208 (796)
..+++|++|+|++|++++.. +..+..+++|++|+|++|.++...+..+. ..++|++|+|++|.+++.
T Consensus 136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 23678999999999999744 66777889999999999999865454443 366999999999999975
Q ss_pred ---chhhhcCCCCccccccCCccccccC-----CCcccccCccceEEecccccccc----CCccccCCcccceeeccccc
Q 003780 209 ---LHQELGKLKNLVALNVGGNKLMGPI-----PSTLFRLTNLTYLYLHSNHLNGS----IPPEIGNMTGILKVDMSMNN 276 (796)
Q Consensus 209 ---~~~~~~~l~~L~~L~l~~N~l~~~~-----~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~ 276 (796)
++..+..+++|++|++++|++++.. +..+..+++|++|+|++|++++. ++..+..+++|+.|+|++|.
T Consensus 216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 295 (461)
T 1z7x_W 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCC
T ss_pred HHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCC
Confidence 5778889999999999999997542 22233588999999999999864 57777889999999999999
Q ss_pred ccccCccccccc-----cccccccccCccccCc----cccccccccccceecccccccccCCCcccCC-----CCCCcEE
Q 003780 277 IEGTIPLELTRL-----SQLLYLSISSNMLSGQ----IPITIAGLISLKGLDLSNNKLSGPIPPEIGK-----CSELRNI 342 (796)
Q Consensus 277 l~~~~p~~l~~l-----~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L 342 (796)
+++..+..+... ++|++|++++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|+.|
T Consensus 296 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L 375 (461)
T 1z7x_W 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred CchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEE
Confidence 987666555543 6999999999999875 5667778899999999999998765555443 6899999
Q ss_pred EeecccccC----CCCccc-cccccceEEecccccCCC--------CCccccccccccccCCCCc
Q 003780 343 TLRNNNLSG----SIPPEI-GLMKLEYLDLSHNKLNGT--------IPPFLYHRFPLDLSYNDLE 394 (796)
Q Consensus 343 ~L~~N~l~~----~~~~~~-~~~~L~~L~l~~N~l~~~--------~p~~~~~~~~l~l~~N~l~ 394 (796)
+|++|++++ .+|..+ .+++|++|++++|++++. +|.....+..|++.++.+.
T Consensus 376 ~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp ECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred ECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 999999996 566655 478999999999999854 4443444555665555444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=283.75 Aligned_cols=238 Identities=19% Similarity=0.176 Sum_probs=206.8
Q ss_pred CCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
..+++|++|+|++|.+.+..|..|+.+++|++|+|++|.|++..| |+.+++|++|+|++|.|++..+ .++|+.
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 345589999999999999888899999999999999999987665 8999999999999999985433 389999
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCccc-ccCccceEEecccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF-RLTNLTYLYLHSNH 252 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~-~l~~L~~L~L~~N~ 252 (796)
|+|++|.+++..+.. +++|+.|+|++|.+++..|..++.+++|+.|+|++|.+++..|..+. .+++|++|+|++|.
T Consensus 104 L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 999999999776653 57899999999999999999999999999999999999988888876 78999999999999
Q ss_pred ccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccc-cCCCc
Q 003780 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLS-GPIPP 331 (796)
Q Consensus 253 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~ 331 (796)
+++..+ +..+++|+.|+|++|+|++..| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+. +.+|.
T Consensus 181 l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 181 IYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred cccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 997633 4468999999999999997555 58899999999999999995 7778899999999999999997 67788
Q ss_pred ccCCCCCCcEEEee
Q 003780 332 EIGKCSELRNITLR 345 (796)
Q Consensus 332 ~~~~l~~L~~L~L~ 345 (796)
.+..++.|+.|+++
T Consensus 257 ~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 257 FFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHTTCHHHHHHHHH
T ss_pred HHHhCCCCcEEecc
Confidence 88888888888876
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=270.02 Aligned_cols=263 Identities=26% Similarity=0.339 Sum_probs=220.1
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
.+++.|++++|.++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 35899999999999 6676665 89999999999999 5665 57999999999999995 555 7899999999
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
++|++++. |. .+++|+.|+|++|+++++.+ .+++|++|+|++|++++ +|. .+++|+.|++++|++++
T Consensus 109 s~N~l~~l-~~---~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~- 175 (622)
T 3g06_A 109 FSNPLTHL-PA---LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS- 175 (622)
T ss_dssp CSCCCCCC-CC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-
T ss_pred cCCcCCCC-CC---CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-
Confidence 99999975 44 56899999999999997543 35899999999999996 443 35789999999999995
Q ss_pred CCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCC
Q 003780 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKC 336 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 336 (796)
+| ..+++|+.|+|++|+|++ +|.. +++|+.|++++|.++. +|.. +++|+.|+|++|++++ +| ..+
T Consensus 176 l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l 240 (622)
T 3g06_A 176 LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLP 240 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCC
T ss_pred Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCC
Confidence 66 457899999999999996 4443 4789999999999994 4433 4789999999999996 55 566
Q ss_pred CCCcEEEeecccccCCCCccccccccceEEecccccCCCCCcccc---ccccccccCCCCcccCCCCCC
Q 003780 337 SELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLY---HRFPLDLSYNDLEGEIPDYFR 402 (796)
Q Consensus 337 ~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~---~~~~l~l~~N~l~~~~p~~~~ 402 (796)
++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|..+. ++..|+|++|.+++.+|+.+.
T Consensus 241 ~~L~~L~Ls~N~L~~-lp~--~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 241 SELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred CcCcEEECCCCCCCc-CCc--ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence 899999999999994 555 6789999999999999 7887654 455799999999998887543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=244.47 Aligned_cols=206 Identities=24% Similarity=0.231 Sum_probs=108.5
Q ss_pred CCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccC
Q 003780 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVG 225 (796)
Q Consensus 146 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 225 (796)
+|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 34444444444443333344444444444444444443334444444445555555555544444445555555555555
Q ss_pred CccccccCCCcccccCccceEEecccccccc-CCccccCCcccceeecccccccccCccccccccccc----cccccCcc
Q 003780 226 GNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS-IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL----YLSISSNM 300 (796)
Q Consensus 226 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~l~~N~ 300 (796)
+|++++..+..+..+++|++|+|++|++++. +|..+.++++|+.|+|++|++++..+..+..+++|+ +|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 5555544444555566666666666666542 455666666666666666666665555666666655 55566666
Q ss_pred ccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCC
Q 003780 301 LSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGS 352 (796)
Q Consensus 301 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 352 (796)
+++..+..+.. .+|++|+|++|++++..+..|..+++|+.|+|++|.+++.
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 65444333332 3566666666666655444555566555555555555543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=245.60 Aligned_cols=206 Identities=21% Similarity=0.213 Sum_probs=161.0
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
++|++|+|++|.+.+..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46889999999998887778888999999999999888777778888899999999999988877788888888888888
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCc-chhhhcCCCCccccccCCccccccCCCcccccCccc----eEEeccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM-LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLT----YLYLHSN 251 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~----~L~L~~N 251 (796)
++|.+++..+..+.++++|++|+|++|++++. +|..+.++++|++|++++|++++..+..+..+++|+ +|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 88888877777788888888888888888775 477888888888888888888877667777766666 6777777
Q ss_pred cccccCCccccCCcccceeecccccccccCccccccccccccccccCccccC
Q 003780 252 HLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG 303 (796)
Q Consensus 252 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 303 (796)
++++..+..+. ..+|+.|+|++|++++..+..|.++++|++|+|++|++.+
T Consensus 188 ~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 188 PMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred cccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 77754444333 3367777777777776555556666666666666666664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=246.24 Aligned_cols=227 Identities=24% Similarity=0.262 Sum_probs=152.3
Q ss_pred CCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecc
Q 003780 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALS 177 (796)
Q Consensus 98 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 177 (796)
.+..+++..+.+.+.. ....+++|++|++++|.++. + +.+..+++|++|+|++|++++. ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 3444555555554432 34556677777777777663 2 2466677777777777777653 356667777777777
Q ss_pred ccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccC
Q 003780 178 RNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI 257 (796)
Q Consensus 178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 257 (796)
+|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..+..+++|++|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 77777666666677777777777777777666666777777777777777777666666667777777777777777666
Q ss_pred CccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCC
Q 003780 258 PPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337 (796)
Q Consensus 258 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 337 (796)
+..+..+++|+.|+|++|++++..|..+..+++|++|++++|.+.+. +++|+.|+++.|.++|.+|.+++.++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccC
Confidence 66666777777777777777766666667777777777777766643 33567777777777777777666544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=239.26 Aligned_cols=212 Identities=24% Similarity=0.253 Sum_probs=173.2
Q ss_pred cCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccc
Q 003780 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLI 172 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 172 (796)
+..+++|+.|++++|.+... ..++.+++|++|+|++|.+++. +.+.++++|++|+|++|++++..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 45567788888888887643 3477888888888888888853 3678888888888888888877777788888888
Q ss_pred eeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccc
Q 003780 173 TMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252 (796)
Q Consensus 173 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 252 (796)
+|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++..+..+..+++|++|+|++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 88888888888777778888888888888888888888888888888888888888887777777888888888888888
Q ss_pred ccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCcccccccccccc
Q 003780 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISL 315 (796)
Q Consensus 253 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 315 (796)
+++..|..+..+++|+.|+|++|.+.+. +++|++|++..|.++|.+|..++.+...
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 8887777788888888888888888754 4578888888888888888887776543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=232.88 Aligned_cols=204 Identities=23% Similarity=0.261 Sum_probs=155.7
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
..++.+++++++++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++...+..|.++++|++|+|
T Consensus 16 ~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 456788888888874 455443 57888888888888776778888888888888888888666666778888888888
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 88888877777778888888888888888877777777888888888888888766666677777788888877777766
Q ss_pred CCccccCCcccceeecccccccccCccccccccccccccccCccccC
Q 003780 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG 303 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 303 (796)
.+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 66667777777777777777776655566667777777777776653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=243.46 Aligned_cols=223 Identities=20% Similarity=0.231 Sum_probs=140.6
Q ss_pred CCcEEeccCCcccccCCc---CccCCCCCcEeecccCcCCCCCCCCC--CCCCCCCEEEecCCCCCCCCc----hhhhcc
Q 003780 98 GLESLSLRFNYLFGSIPS---QVGALSKLRYLDFSFNNLTGSIPPEL--GSLRNLEVLNLKGNNLNGAIP----SSLCQL 168 (796)
Q Consensus 98 ~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l 168 (796)
.++.|.+.++.+....-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467777777766431100 12234568888888888888888777 778888888888888886554 344567
Q ss_pred CccceeeccccccCCCCCccccCCCCccEEEcccccccCc--c--hhhhcCCCCccccccCCccccccCCC----ccccc
Q 003780 169 TKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM--L--HQELGKLKNLVALNVGGNKLMGPIPS----TLFRL 240 (796)
Q Consensus 169 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~~~----~l~~l 240 (796)
++|++|+|++|++++..|..|+.+++|++|+|++|++.+. . +..++.+++|++|+|++|+++.. +. .+.++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHHhcC
Confidence 7888888888888777777788888888888888876642 1 12235677777777777777522 22 23556
Q ss_pred CccceEEeccccccccCCccccCC---cccceeecccccccccCccccccccccccccccCccccCccccccccccccce
Q 003780 241 TNLTYLYLHSNHLNGSIPPEIGNM---TGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKG 317 (796)
Q Consensus 241 ~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 317 (796)
++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--------------------------~~L~~ 276 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--------------------------AKLRV 276 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--------------------------SCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--------------------------CCCCE
Confidence 677777777777766656555544 35555555555555 3343332 34555
Q ss_pred ecccccccccCCCcccCCCCCCcEEEeeccccc
Q 003780 318 LDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350 (796)
Q Consensus 318 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 350 (796)
|+|++|++++. |. +..+++|+.|+|++|+++
T Consensus 277 L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 277 LDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp EECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred EECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 55555555532 22 445555666666666554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=229.33 Aligned_cols=191 Identities=25% Similarity=0.298 Sum_probs=117.6
Q ss_pred CCccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCC
Q 003780 59 DHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIP 138 (796)
Q Consensus 59 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p 138 (796)
+||.|.|++|... ...+++++++++...... .++|+.|+|++|.+.+..+..|+++++|++|+|++|.|++..+
T Consensus 3 ~Cp~~~gC~C~~~--~~~l~~~~~~l~~~p~~~----~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG--KKEVDCQGKSLDSVPSGI----PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG--GTEEECTTCCCSSCCSCC----CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC--CeEEecCCCCccccCCCC----CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 5789999999632 345777777776433221 1466666666666666666666666666666666666666666
Q ss_pred CCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCC
Q 003780 139 PELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKN 218 (796)
Q Consensus 139 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 218 (796)
..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+++.+..|..+++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 66666666666666666666555556666666666666666666555555566666666666666665555555555555
Q ss_pred ccccccCCccccccCCCcccccCccceEEeccccccc
Q 003780 219 LVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNG 255 (796)
Q Consensus 219 L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 255 (796)
|+.|+|++|++++..+..+..+++|++|+|++|.+++
T Consensus 157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 5555555555555444455555555555555555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-27 Score=259.06 Aligned_cols=254 Identities=19% Similarity=0.215 Sum_probs=165.8
Q ss_pred EEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCC----CCCCCCC-CCCEEEecCCCCCCCCchhhhcc-----Cc
Q 003780 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIP----PELGSLR-NLEVLNLKGNNLNGAIPSSLCQL-----TK 170 (796)
Q Consensus 101 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 170 (796)
.++|++|+++|.+|..+...++|++|||++|.|++..+ ..|.+++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35677777777777666666667777777777776555 5666677 77777777777777667666665 77
Q ss_pred cceeeccccccCCCCCccccC----C-CCccEEEcccccccCcchhhhcC-----CCCccccccCCccccccCC----Cc
Q 003780 171 LITMALSRNGLHGPIPSAIGD----L-NNLLILSLDSNKLSGMLHQELGK-----LKNLVALNVGGNKLMGPIP----ST 236 (796)
Q Consensus 171 L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~~----~~ 236 (796)
|++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+.. .++|++|+|++|++++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 777777777777666654433 3 67777777777777666654433 2577777777777774332 23
Q ss_pred ccccC-ccceEEeccccccccCCcccc----CC-cccceeeccccccccc----Ccccccc-ccccccccccCccccCcc
Q 003780 237 LFRLT-NLTYLYLHSNHLNGSIPPEIG----NM-TGILKVDMSMNNIEGT----IPLELTR-LSQLLYLSISSNMLSGQI 305 (796)
Q Consensus 237 l~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~l~~-l~~L~~L~l~~N~l~~~~ 305 (796)
+..++ +|++|+|++|++++..+..+. .. ++|+.|+|++|++++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 34444 777777777777765554333 33 4777777777777753 3444444 347777777777777644
Q ss_pred c----cccccccccceecccccccccCC-------CcccCCCCCCcEEEeecccccCCCC
Q 003780 306 P----ITIAGLISLKGLDLSNNKLSGPI-------PPEIGKCSELRNITLRNNNLSGSIP 354 (796)
Q Consensus 306 ~----~~~~~l~~L~~L~Ls~N~l~~~~-------~~~~~~l~~L~~L~L~~N~l~~~~~ 354 (796)
+ ..+..+++|+.|+|++|.+.+.. +..+..+++|+.|++++|++.+..+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 3 33455677777777777744332 2355667777777777777765533
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-27 Score=254.84 Aligned_cols=265 Identities=18% Similarity=0.200 Sum_probs=169.5
Q ss_pred CccCCceeeCCCCCeEEEeCCCCCccccccccccCCC--CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCC-
Q 003780 60 HCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCF--PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGS- 136 (796)
Q Consensus 60 ~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~- 136 (796)
|.+|.++.|+. ..++.++++++++.. ..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++.
T Consensus 36 c~~W~~~~~~~-~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 36 CKRWYRLASDE-SLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp CHHHHHHHTCS-TTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHhcCc-hhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 44699998873 347778888776652 234445 6777788887777766554 45677777777777777654
Q ss_pred CCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc-ccCCC-CCccccCCCCccEEEcccc-cccCc-chhh
Q 003780 137 IPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN-GLHGP-IPSAIGDLNNLLILSLDSN-KLSGM-LHQE 212 (796)
Q Consensus 137 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~ 212 (796)
+|..+..+++|++|+|++|++++..|..+..+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++..
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~ 189 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence 6666777777777777777777667777777777777777777 56542 4555667777777777777 77654 4566
Q ss_pred hcCCC-CccccccCCc--ccc-ccCCCcccccCccceEEecccc-ccccCCccccCCcccceeeccccc-ccccCccccc
Q 003780 213 LGKLK-NLVALNVGGN--KLM-GPIPSTLFRLTNLTYLYLHSNH-LNGSIPPEIGNMTGILKVDMSMNN-IEGTIPLELT 286 (796)
Q Consensus 213 ~~~l~-~L~~L~l~~N--~l~-~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~ 286 (796)
+..++ +|++|++++| .++ +.+|..+..+++|++|+|++|. +++..+..+..+++|+.|++++|. ++......+.
T Consensus 190 ~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~ 269 (336)
T 2ast_B 190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 269 (336)
T ss_dssp HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGG
T ss_pred HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHh
Confidence 66777 7777777777 343 3345555666777777777776 555555666666667777776664 2222222455
Q ss_pred cccccccccccCccccCccccccccc-cccceecccccccccCCCcccC
Q 003780 287 RLSQLLYLSISSNMLSGQIPITIAGL-ISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 287 ~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
++++|++|++++| ++ ...+..+ .+|..|++++|++++..|..++
T Consensus 270 ~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 270 EIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp GCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred cCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 6666666666666 22 1123333 2355555566666655555544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=231.41 Aligned_cols=203 Identities=23% Similarity=0.195 Sum_probs=96.3
Q ss_pred cCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccc
Q 003780 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLI 172 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 172 (796)
++++++++.+++++|+++. +|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 3344445555555555442 222221 3455555555555544444455555555555555555432211 4444555
Q ss_pred eeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccc
Q 003780 173 TMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNH 252 (796)
Q Consensus 173 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 252 (796)
+|+|++|+++ .+|..+..+++|++|+|++|+++++.+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 5555555554 334444445555555555555554444445555555555555555554444444445555555555555
Q ss_pred ccccCCccccCCcccceeecccccccccCccccccccccccccccCcccc
Q 003780 253 LNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLS 302 (796)
Q Consensus 253 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 302 (796)
+++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 55333333444455555555555554 33444444444455555554443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=230.60 Aligned_cols=203 Identities=26% Similarity=0.254 Sum_probs=100.9
Q ss_pred ccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCcc
Q 003780 117 VGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL 196 (796)
Q Consensus 117 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 196 (796)
++++++|+++++++|+++ .+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|.|++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 455666666666666666 3444443 4566666666666655555555555555555555555532221 3344444
Q ss_pred EEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccc
Q 003780 197 ILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNN 276 (796)
Q Consensus 197 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 276 (796)
+|+|++|+++ .+|..+..+++|++|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-------------------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 81 TLDLSHNQLQ-------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp EEECCSSCCS-------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-------------------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 4444444433 233334444444555555555444333444444444444444444
Q ss_pred ccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeeccccc
Q 003780 277 IEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350 (796)
Q Consensus 277 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 350 (796)
+++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+.
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 44444444444444444444444444333334444455555555555554 34444444445555555555444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=225.26 Aligned_cols=197 Identities=19% Similarity=0.206 Sum_probs=144.0
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCc-CCCCCCCCCCCCCCCCEEEecC-CCCCCCCchhhhccCcccee
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN-LTGSIPPELGSLRNLEVLNLKG-NNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 174 (796)
++|++|+|++|+++++.+..|+++++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 478888888888888877788888888888888886 8766666888888888888888 88887767788888888888
Q ss_pred eccccccCCCCCccccCCCCcc---EEEcccc-cccCcchhhhcCCCCcc-ccccCCccccccCCCcccccCccceEEec
Q 003780 175 ALSRNGLHGPIPSAIGDLNNLL---ILSLDSN-KLSGMLHQELGKLKNLV-ALNVGGNKLMGPIPSTLFRLTNLTYLYLH 249 (796)
Q Consensus 175 ~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~l~~l~~L~~L~L~ 249 (796)
++++|++++ +|. |..+++|+ +|++++| +++++.+..|.++++|+ .|++++|+++...+..+.. ++|++|+|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 888888886 454 77777777 8888888 77777777777777777 7777777777433333333 677777777
Q ss_pred ccc-ccccCCccccCC-cccceeecccccccccCccccccccccccccccCc
Q 003780 250 SNH-LNGSIPPEIGNM-TGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSN 299 (796)
Q Consensus 250 ~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 299 (796)
+|+ +++..+..|.++ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 774 765555666666 6677777777766643322 3445555555544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-25 Score=255.99 Aligned_cols=187 Identities=14% Similarity=0.179 Sum_probs=148.0
Q ss_pred ccceeeecccceeEEEEEccCCcEEEEEEeccccchh-----hHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 502 DIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEE-----TTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
...+.||+|+||.||+|.. .++.+++|+........ ....+.+.+|++++++++||||+++..++..++..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999955 47889999875533221 11245689999999999999999777777778888999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++++|.+++.+ +..++.|+++||+|||++ +|+||||||+||+++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999875 457999999999999999 9999999999999999 999999999998754
Q ss_pred CCCC-------ccccccccCccCcccccc--CCcCcchhHHHHHHHHHHHHhCCCCCc
Q 003780 657 DSSN-------RTIVAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGRHPGE 705 (796)
Q Consensus 657 ~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGv~l~elltg~~p~~ 705 (796)
.... .....||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3211 134579999999999987 567788999999999999888877753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=222.24 Aligned_cols=131 Identities=19% Similarity=0.168 Sum_probs=73.7
Q ss_pred CCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCC-CCCCCchhhhccCccceeeccc-cccCCCCCccccCCCCccEEE
Q 003780 122 KLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNN-LNGAIPSSLCQLTKLITMALSR-NGLHGPIPSAIGDLNNLLILS 199 (796)
Q Consensus 122 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 199 (796)
+|++|+|++|+|++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777776555567777777777777775 6655555666666666666666 666655555666666666666
Q ss_pred cccccccCcchhhhcCCCCcc---ccccCCc-cccccCCCcccccCccc-eEEecccccc
Q 003780 200 LDSNKLSGMLHQELGKLKNLV---ALNVGGN-KLMGPIPSTLFRLTNLT-YLYLHSNHLN 254 (796)
Q Consensus 200 L~~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~~~~l~~l~~L~-~L~L~~N~l~ 254 (796)
|++|+++++ |. +..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++
T Consensus 112 l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 112 IFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred CCCCCCccc-cc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 666665542 22 44444443 4444444 44433333344444444 4444444443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-26 Score=250.32 Aligned_cols=253 Identities=18% Similarity=0.207 Sum_probs=201.9
Q ss_pred EeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCc----hhhhccC-ccceeeccccccCCCCCccccCC-----CC
Q 003780 125 YLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIP----SSLCQLT-KLITMALSRNGLHGPIPSAIGDL-----NN 194 (796)
Q Consensus 125 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 194 (796)
+++|++|++++.+|..+...++|++|+|++|++++..+ ..|.+++ +|++|+|++|++++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999888877777789999999999998777 7788888 89999999999998888888776 99
Q ss_pred ccEEEcccccccCcchhhhcC----C-CCccccccCCccccccCCCcccc-----cCccceEEeccccccccCCc----c
Q 003780 195 LLILSLDSNKLSGMLHQELGK----L-KNLVALNVGGNKLMGPIPSTLFR-----LTNLTYLYLHSNHLNGSIPP----E 260 (796)
Q Consensus 195 L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~l~~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~~p~----~ 260 (796)
|++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+.. .++|++|+|++|++++..+. .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999887775544 3 89999999999998766655443 25899999999999864433 3
Q ss_pred ccCCc-ccceeecccccccccCccccccc-----cccccccccCccccCc----ccccccc-ccccceecccccccccCC
Q 003780 261 IGNMT-GILKVDMSMNNIEGTIPLELTRL-----SQLLYLSISSNMLSGQ----IPITIAG-LISLKGLDLSNNKLSGPI 329 (796)
Q Consensus 261 ~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~L~~L~l~~N~l~~~----~~~~~~~-l~~L~~L~Ls~N~l~~~~ 329 (796)
+..++ +|+.|+|++|++++..+..+... ++|++|+|++|.+++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 44555 89999999999998777655544 6999999999999863 4455555 358999999999998755
Q ss_pred C----cccCCCCCCcEEEeecccccCCCCc-------cc-cccccceEEecccccCCCCC
Q 003780 330 P----PEIGKCSELRNITLRNNNLSGSIPP-------EI-GLMKLEYLDLSHNKLNGTIP 377 (796)
Q Consensus 330 ~----~~~~~l~~L~~L~L~~N~l~~~~~~-------~~-~~~~L~~L~l~~N~l~~~~p 377 (796)
+ ..+..+++|+.|+|++|.+.+..+. .+ .+.+|+.||+++|++.+..|
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 4 3456788999999999986654332 12 35678888899998876544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-27 Score=257.22 Aligned_cols=190 Identities=19% Similarity=0.250 Sum_probs=98.5
Q ss_pred CCcCccCCCCCcEeecccCcCCCC----CCCCCCCCCCCCEEEecCCC---CCCCCchhh-------hccCccceeeccc
Q 003780 113 IPSQVGALSKLRYLDFSFNNLTGS----IPPELGSLRNLEVLNLKGNN---LNGAIPSSL-------CQLTKLITMALSR 178 (796)
Q Consensus 113 ~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~N~---l~~~~p~~~-------~~l~~L~~L~L~~ 178 (796)
++..+..+++|++|+|++|.|++. ++..|..+++|++|+|++|. +++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 445566666677777777766644 22335566777777777643 334445444 4556666666666
Q ss_pred cccCC----CCCccccCCCCccEEEcccccccCcchhhhcC----C---------CCccccccCCcccc-ccCC---Ccc
Q 003780 179 NGLHG----PIPSAIGDLNNLLILSLDSNKLSGMLHQELGK----L---------KNLVALNVGGNKLM-GPIP---STL 237 (796)
Q Consensus 179 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~~L~l~~N~l~-~~~~---~~l 237 (796)
|.+++ .+|..+..+++|++|+|++|.++...+..+.. + ++|++|+|++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 66664 24555566666666666666665433332222 2 55555555555554 2222 233
Q ss_pred cccCccceEEeccccccc-----cCCccccCCcccceeeccccccc----ccCccccccccccccccccCcccc
Q 003780 238 FRLTNLTYLYLHSNHLNG-----SIPPEIGNMTGILKVDMSMNNIE----GTIPLELTRLSQLLYLSISSNMLS 302 (796)
Q Consensus 238 ~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~l~~l~~L~~L~l~~N~l~ 302 (796)
..+++|++|+|++|+++. .+|..+..+++|+.|+|++|.++ +.+|..+..+++|++|+|++|.++
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~ 257 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCc
Confidence 444555555555555541 22224444445555555555543 334444444444444444444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=231.18 Aligned_cols=204 Identities=16% Similarity=0.147 Sum_probs=175.4
Q ss_pred CCCCCcEEeccCCcccccCCcCc--cCCCCCcEeecccCcCCCCCC----CCCCCCCCCCEEEecCCCCCCCCchhhhcc
Q 003780 95 CFPGLESLSLRFNYLFGSIPSQV--GALSKLRYLDFSFNNLTGSIP----PELGSLRNLEVLNLKGNNLNGAIPSSLCQL 168 (796)
Q Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 168 (796)
.+++|++|+|++|.+.+..|..+ +.+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|..+
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 34679999999999999999988 999999999999999997665 345679999999999999999989999999
Q ss_pred CccceeeccccccCCC---C-CccccCCCCccEEEcccccccCcchh---hhcCCCCccccccCCccccccCCCccccc-
Q 003780 169 TKLITMALSRNGLHGP---I-PSAIGDLNNLLILSLDSNKLSGMLHQ---ELGKLKNLVALNVGGNKLMGPIPSTLFRL- 240 (796)
Q Consensus 169 ~~L~~L~L~~N~l~~~---~-p~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~l~~l- 240 (796)
++|++|+|++|++.+. . +..+..+++|++|+|++|+++...+. .++++++|++|+|++|++++..|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 9999999999998752 2 23457899999999999999754332 46789999999999999998888888777
Q ss_pred --CccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccC
Q 003780 241 --TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG 303 (796)
Q Consensus 241 --~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 303 (796)
++|++|+|++|+++ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+++.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 6787775 7999999999999964 33 6777888888888888764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-26 Score=246.49 Aligned_cols=255 Identities=18% Similarity=0.213 Sum_probs=163.1
Q ss_pred CCcEEeccCCcccccCCcCccCC--CCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCC-CchhhhccCcccee
Q 003780 98 GLESLSLRFNYLFGSIPSQVGAL--SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGA-IPSSLCQLTKLITM 174 (796)
Q Consensus 98 ~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 174 (796)
.++.|++++|.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3678888888776 4556666 7888888888888866555 55678888888888887755 67777777888888
Q ss_pred eccccccCCCCCccccCCCCccEEEcccc-cccCc-chhhhcCCCCccccccCCc-ccccc-CCCcccccC-ccceEEec
Q 003780 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSN-KLSGM-LHQELGKLKNLVALNVGGN-KLMGP-IPSTLFRLT-NLTYLYLH 249 (796)
Q Consensus 175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~l~~l~-~L~~L~L~ 249 (796)
+|++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|+|+
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 88888777666777777777777777777 56542 4555666666666666666 66543 344455555 66666666
Q ss_pred cccccccCCccccCCcccceeeccccccc-ccCccccccccccccccccCcc-ccCccccccccccccceecccccc-cc
Q 003780 250 SNHLNGSIPPEIGNMTGILKVDMSMNNIE-GTIPLELTRLSQLLYLSISSNM-LSGQIPITIAGLISLKGLDLSNNK-LS 326 (796)
Q Consensus 250 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~ 326 (796)
+|.+ .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.
T Consensus 204 ~~~~----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~ 261 (336)
T 2ast_B 204 GYRK----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 261 (336)
T ss_dssp SCGG----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred CCcc----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCC
Confidence 5521 222 2334444455555555555555 444455555556666666666663 22
Q ss_pred cCCCcccCCCCCCcEEEeecccccCCCCccc-cc-cccceEEecccccCCCCCccccc
Q 003780 327 GPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GL-MKLEYLDLSHNKLNGTIPPFLYH 382 (796)
Q Consensus 327 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~-~~L~~L~l~~N~l~~~~p~~~~~ 382 (796)
......++++++|+.|+|++| ++. ..+ .+ ..|+.|++++|++++..|+.+.+
T Consensus 262 ~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 262 PETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp GGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred HHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 111224666777777777777 221 112 22 34777778888888888776654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-26 Score=251.81 Aligned_cols=235 Identities=17% Similarity=0.199 Sum_probs=182.3
Q ss_pred cCCCCCCcEEeccCCccccc----CCcCccCCCCCcEeecccCc---CCCCCCCCC-------CCCCCCCEEEecCCCCC
Q 003780 93 FSCFPGLESLSLRFNYLFGS----IPSQVGALSKLRYLDFSFNN---LTGSIPPEL-------GSLRNLEVLNLKGNNLN 158 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~---l~~~~p~~~-------~~l~~L~~L~L~~N~l~ 158 (796)
+..+++|++|+|++|.+.+. ++..+..+++|++|+|++|. +++.+|..+ ..+++|++|+|++|+++
T Consensus 28 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 107 (386)
T 2ca6_A 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107 (386)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCC
Confidence 56778999999999999876 34457789999999999964 445556554 68899999999999999
Q ss_pred C----CCchhhhccCccceeeccccccCCCCCcccc----CC---------CCccEEEccccccc-Ccch---hhhcCCC
Q 003780 159 G----AIPSSLCQLTKLITMALSRNGLHGPIPSAIG----DL---------NNLLILSLDSNKLS-GMLH---QELGKLK 217 (796)
Q Consensus 159 ~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~~---~~~~~l~ 217 (796)
+ .+|..+..+++|++|+|++|.++...+..+. .+ ++|++|+|++|+++ ...+ ..+..++
T Consensus 108 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~ 187 (386)
T 2ca6_A 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 187 (386)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCC
Confidence 7 4788899999999999999999754444443 34 89999999999998 3444 5778899
Q ss_pred CccccccCCcccc--c---cCCCcccccCccceEEecccccc----ccCCccccCCcccceeeccccccccc----Cccc
Q 003780 218 NLVALNVGGNKLM--G---PIPSTLFRLTNLTYLYLHSNHLN----GSIPPEIGNMTGILKVDMSMNNIEGT----IPLE 284 (796)
Q Consensus 218 ~L~~L~l~~N~l~--~---~~~~~l~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 284 (796)
+|++|+|++|+++ | ..|..+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|.+++. +|..
T Consensus 188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 267 (386)
T 2ca6_A 188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267 (386)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred CcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHH
Confidence 9999999999998 3 45557889999999999999996 56788899999999999999999875 4555
Q ss_pred ccc--ccccccccccCccccC----cccccc-ccccccceeccccccccc
Q 003780 285 LTR--LSQLLYLSISSNMLSG----QIPITI-AGLISLKGLDLSNNKLSG 327 (796)
Q Consensus 285 l~~--l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~ 327 (796)
+.. +++|++|+|++|.+++ .+|..+ .++++|++|+|++|.+++
T Consensus 268 l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 532 6777777777777665 244444 334455555555554443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=225.68 Aligned_cols=194 Identities=25% Similarity=0.394 Sum_probs=131.4
Q ss_pred CCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
..+++|++|++++|.+... | .+..+++|++|+|++|.+++..+ +.++++|++|+|++|++++. ..+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 3456677777777777643 3 46777777777777777775433 77777777777777777753 25677777777
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 253 (796)
|+|++|++++. + .+..+++|++|+|++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++
T Consensus 112 L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 112 LDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185 (308)
T ss_dssp EECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence 77777777753 2 26777777777777777776544 6677777777777777765433 66677777777777777
Q ss_pred cccCCccccCCcccceeecccccccccCccccccccccccccccCccccC
Q 003780 254 NGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG 303 (796)
Q Consensus 254 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 303 (796)
++..+ +..+++|+.|+|++|++++..+ +..+++|++|++++|++++
T Consensus 186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 64332 6667777777777777775443 6667777777777777764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=209.89 Aligned_cols=183 Identities=22% Similarity=0.213 Sum_probs=119.5
Q ss_pred CccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCC
Q 003780 60 HCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPP 139 (796)
Q Consensus 60 ~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~ 139 (796)
.|.|++|.|+..+ ++. ++ ....++|++|+|++|++.+..+..|+.+++|++|+|++|++++..+.
T Consensus 6 ~C~~~~v~c~~~~-----------l~~-~p---~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (208)
T 2o6s_A 6 SCSGTTVECYSQG-----------RTS-VP---TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG 70 (208)
T ss_dssp EEETTEEECCSSC-----------CSS-CC---SCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred EECCCEEEecCCC-----------ccC-CC---CCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence 4789999997533 111 11 22235677778877777776666677777777777777777766566
Q ss_pred CCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCc
Q 003780 140 ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNL 219 (796)
Q Consensus 140 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 219 (796)
.|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+++++.+..+..+++|
T Consensus 71 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 150 (208)
T 2o6s_A 71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 150 (208)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCc
Confidence 67777777777777777776656666777777777777777776666666666677777777666666655556666666
Q ss_pred cccccCCccccccCCCcccccCccceEEeccccccccCCccccCC
Q 003780 220 VALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNM 264 (796)
Q Consensus 220 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 264 (796)
+.|++++|.+.+ .+++|++|+++.|+++|.+|..++.+
T Consensus 151 ~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 151 QYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp CEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred cEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccc
Confidence 666666665543 23345555555555555555554443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=214.20 Aligned_cols=180 Identities=23% Similarity=0.252 Sum_probs=128.5
Q ss_pred CCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecc
Q 003780 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALS 177 (796)
Q Consensus 98 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 177 (796)
..+.++++++.+.. +|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 45677777777773 444443 577788888888877777777777888888888888777777777777777777777
Q ss_pred ccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccC
Q 003780 178 RNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI 257 (796)
Q Consensus 178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 257 (796)
+|++++..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 77777766677777777777777777777766666677777777777777777665556666777777777777776655
Q ss_pred CccccCCcccceeeccccccccc
Q 003780 258 PPEIGNMTGILKVDMSMNNIEGT 280 (796)
Q Consensus 258 p~~~~~l~~L~~L~Ls~N~l~~~ 280 (796)
+..+..+++|+.|+|++|.+++.
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCC
Confidence 55666666666666666666643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=6.3e-24 Score=225.04 Aligned_cols=207 Identities=27% Similarity=0.370 Sum_probs=131.6
Q ss_pred EeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccccc
Q 003780 102 LSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGL 181 (796)
Q Consensus 102 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 181 (796)
+.+..+.+.+.+ .+..+++|++|++++|.++. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|++
T Consensus 24 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (308)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcC
Confidence 344555555432 24567788888888888874 44 57888888888888888886544 78888888888888888
Q ss_pred CCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccc
Q 003780 182 HGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI 261 (796)
Q Consensus 182 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 261 (796)
++. ..+..+++|++|+|++|++++..+ +..+++|++|++++|++++..+ +..+++|++|+|++|++++. +. +
T Consensus 98 ~~~--~~~~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l 169 (308)
T 1h6u_A 98 KNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-L 169 (308)
T ss_dssp SCC--GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-G
T ss_pred CCc--hhhcCCCCCCEEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-h
Confidence 753 357777888888888887776532 6777777777777777765433 66666677777777766643 22 5
Q ss_pred cCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccc
Q 003780 262 GNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLS 326 (796)
Q Consensus 262 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 326 (796)
..+++|+.|+|++|++++..+ +..+++|++|++++|++++..+ +..+++|+.|+|++|.++
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 566666666666666654332 4444555555555554443321 334444444444444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=225.95 Aligned_cols=222 Identities=19% Similarity=0.171 Sum_probs=147.8
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCC-CCCCCCCCCCE-EEecCCCCCCCCchhhhccCcccee
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIP-PELGSLRNLEV-LNLKGNNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L 174 (796)
+++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.+.+| ..|.++++|++ +.+++|+|+...|..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 578888888888887777788888888888888888766554 46788887765 5666788887777888888888888
Q ss_pred eccccccCCCCCccccCCCCccEEEccc-ccccCcchhhhcCCC-CccccccCCccccccCCCcccccCccceEEecc-c
Q 003780 175 ALSRNGLHGPIPSAIGDLNNLLILSLDS-NKLSGMLHQELGKLK-NLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHS-N 251 (796)
Q Consensus 175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~-N 251 (796)
++++|++++..+..+....++..|++.+ |++..+.+..|..+. .|+.|+|++|+|+.+.+ .....++|++|++++ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~-~~f~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN-SAFNGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECT-TSSTTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCCh-hhccccchhHHhhccCC
Confidence 8888888877777777777777888755 566666666666654 46677777777764333 333455677777764 4
Q ss_pred cccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceeccccc
Q 003780 252 HLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNN 323 (796)
Q Consensus 252 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 323 (796)
.++...++.|.++++|+.|||++|+|+...+..|.++++|+.+++. .++ .+| .+..+++|+.++++++
T Consensus 189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp TCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TCC-CCC-CTTTCCSCCEEECSCH
T ss_pred cccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--CcC-cCC-CchhCcChhhCcCCCC
Confidence 4553333456667777777777777765544445555544444432 222 333 2455555555555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-23 Score=224.43 Aligned_cols=223 Identities=19% Similarity=0.179 Sum_probs=185.7
Q ss_pred CCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCc-hhhhccCccce-eeccccccCCCCCccccCCCCccEE
Q 003780 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIP-SSLCQLTKLIT-MALSRNGLHGPIPSAIGDLNNLLIL 198 (796)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L 198 (796)
+++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|++ +.++.|+++...|..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 589999999999996666789999999999999999977665 57889988775 6777899999999999999999999
Q ss_pred EcccccccCcchhhhcCCCCccccccCC-ccccccCCCcccccC-ccceEEeccccccccCCccccCCcccceeeccc-c
Q 003780 199 SLDSNKLSGMLHQELGKLKNLVALNVGG-NKLMGPIPSTLFRLT-NLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSM-N 275 (796)
Q Consensus 199 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N 275 (796)
++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+ .+|.......+|+.|++++ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCC
Confidence 9999999998888888888899999965 678776677777765 6899999999999 4565566678999999985 6
Q ss_pred cccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeeccc
Q 003780 276 NIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNN 348 (796)
Q Consensus 276 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 348 (796)
.++...+..|.++++|++|+|++|+|+...+..+.++++|+.+++. .+. .+| .+.++++|+.++++++.
T Consensus 189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp TCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred cccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--CcC-cCC-CchhCcChhhCcCCCCc
Confidence 7776656689999999999999999997666667776666666553 343 556 48899999999998764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-23 Score=235.09 Aligned_cols=203 Identities=24% Similarity=0.327 Sum_probs=136.3
Q ss_pred CCCCc-----cCCce-eeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeeccc
Q 003780 57 SSDHC-----KLDGV-TCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSF 130 (796)
Q Consensus 57 ~~~~C-----~w~gv-~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 130 (796)
+.++| .|.|+ .|.. ++++.|+|+++++++ ++.. + +++|++|+|++|+|+ .+| +.+++|++|+|++
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~ 109 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP---ELPASLEYLDACD 109 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCS
T ss_pred cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccC
Confidence 45667 79999 7864 468888888888876 4432 2 367888888888877 445 4467788888888
Q ss_pred CcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcch
Q 003780 131 NNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH 210 (796)
Q Consensus 131 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 210 (796)
|.|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|+++ |
T Consensus 110 N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~l-p 176 (571)
T 3cvr_A 110 NRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFL-P 176 (571)
T ss_dssp SCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-C
T ss_pred CCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCc-c
Confidence 88875 565 554 78888888888776 454 56777777777777775 444 456777777777777763 3
Q ss_pred hhhcCCCCccccccCCccccccCCCcccccCcc-------ceEEeccccccccCCccccCCcccceeecccccccccCcc
Q 003780 211 QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNL-------TYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPL 283 (796)
Q Consensus 211 ~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 283 (796)
. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|.
T Consensus 177 ~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 177 E-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp C-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred h-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 3 44 67777777777776 4444 433 55 66677777666 4566666666666666666666666666
Q ss_pred cccccc
Q 003780 284 ELTRLS 289 (796)
Q Consensus 284 ~l~~l~ 289 (796)
.|..++
T Consensus 249 ~l~~l~ 254 (571)
T 3cvr_A 249 SLSQQT 254 (571)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 655543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-22 Score=199.05 Aligned_cols=180 Identities=24% Similarity=0.303 Sum_probs=126.4
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
+.++++++.+... |..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 3466667776643 3333 357888888888888766667788888888888888888666666777888888888888
Q ss_pred ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPP 259 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 259 (796)
++++..+..|.++++|++|+|++|++++..+..|.++++|+.|++++|++++..+..+..+++|++|+|++|.+.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--- 163 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--- 163 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC---
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC---
Confidence 88776666777777777777777777777666677777777777777777766555566677777777777766532
Q ss_pred cccCCcccceeecccccccccCcccccccc
Q 003780 260 EIGNMTGILKVDMSMNNIEGTIPLELTRLS 289 (796)
Q Consensus 260 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 289 (796)
+++|+.|+++.|+++|.+|..++.++
T Consensus 164 ----~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 164 ----CPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp ----TTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ----CCCHHHHHHHHHhCCceeeccCcccc
Confidence 23556666666666666666555443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-24 Score=251.34 Aligned_cols=300 Identities=15% Similarity=0.071 Sum_probs=141.0
Q ss_pred CCeEEEeCCCCCcccc----ccccccCCCCCCcEEeccCCccc----ccCCcCccCCCCCcEeecccCcCCCCCCCCCCC
Q 003780 72 RSIIEINLPEKKLKGE----LSQFNFSCFPGLESLSLRFNYLF----GSIPSQVGALSKLRYLDFSFNNLTGSIPPELGS 143 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~----~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~ 143 (796)
.++..|+|+++.+.+. ++. .+..+++|++|+|++|.+. +.++..+.++++|++|+|++|.+.+ +|..+.+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~-~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHE-LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHH-HHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCEEECccccccCcchhHHHH-HHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 4577788888776543 221 2345677777777777776 2334445667777777777777664 4455555
Q ss_pred CCCCCEEEecCCCCC---CCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCc------------
Q 003780 144 LRNLEVLNLKGNNLN---GAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM------------ 208 (796)
Q Consensus 144 l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------------ 208 (796)
+++|++|+++++... +..+..+..+++|+.|+++++.. +.+|..+..+++|++|+|++|.+++.
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 666666666542221 12223334444444444444321 23344444444444444444444322
Q ss_pred -------------chhhhcCCCCccccccC-----------CccccccC-CCcccccCccceEEeccccccccCCccccC
Q 003780 209 -------------LHQELGKLKNLVALNVG-----------GNKLMGPI-PSTLFRLTNLTYLYLHSNHLNGSIPPEIGN 263 (796)
Q Consensus 209 -------------~~~~~~~l~~L~~L~l~-----------~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 263 (796)
++..+..+++|++|+++ .|.+++.. +.....+++|++|+++.|++++..+..++.
T Consensus 321 ~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~ 400 (592)
T 3ogk_B 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400 (592)
T ss_dssp CEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHH
T ss_pred CEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHh
Confidence 22223344445555554 23333211 111223445555555555554443333333
Q ss_pred -Ccccceeecc----ccccccc-----CccccccccccccccccCc--cccCcccccccc-ccccceeccccccccc-CC
Q 003780 264 -MTGILKVDMS----MNNIEGT-----IPLELTRLSQLLYLSISSN--MLSGQIPITIAG-LISLKGLDLSNNKLSG-PI 329 (796)
Q Consensus 264 -l~~L~~L~Ls----~N~l~~~-----~p~~l~~l~~L~~L~l~~N--~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~-~~ 329 (796)
+++|+.|+++ .|.+++. ++..+.++++|++|++++| .+++..+..+.. +++|++|+|++|++++ .+
T Consensus 401 ~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 480 (592)
T 3ogk_B 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGL 480 (592)
T ss_dssp HCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHH
T ss_pred hCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHH
Confidence 4445555553 3444432 2222344455555555422 233332222222 4455555555555543 12
Q ss_pred CcccCCCCCCcEEEeecccccCCCCccc--cccccceEEecccccCC
Q 003780 330 PPEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNG 374 (796)
Q Consensus 330 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~--~~~~L~~L~l~~N~l~~ 374 (796)
+..+..+++|+.|+|++|.+++.....+ .+++|++|+|++|++++
T Consensus 481 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 481 MEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred HHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 2233445555555555555443211111 24455555555555543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-22 Score=228.31 Aligned_cols=189 Identities=24% Similarity=0.305 Sum_probs=153.5
Q ss_pred CCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecc
Q 003780 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALS 177 (796)
Q Consensus 98 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 177 (796)
+|+.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 89999999999987 666553 78999999999999 567 457899999999999997 666 655 89999999
Q ss_pred ccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccC
Q 003780 178 RNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI 257 (796)
Q Consensus 178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 257 (796)
+|+|++ +|. .+++|+.|+|++|+|+++. . .+++|+.|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp-~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTMLP-E---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCcCC-C---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999997 555 6789999999999998744 3 57889999999999986 665 55 88999999999998 66
Q ss_pred CccccCCccc-------ceeecccccccccCccccccccccccccccCccccCccccccccccc
Q 003780 258 PPEIGNMTGI-------LKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314 (796)
Q Consensus 258 p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 314 (796)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 76 654 67 88899998888 56777777888888888888888888877766544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-25 Score=256.84 Aligned_cols=247 Identities=9% Similarity=-0.010 Sum_probs=167.3
Q ss_pred CeEEEeCCCCC-ccccccccccCCCCCCcEEeccCCccccc----CCcCccCCCCCcEeecccCcCCCC----CCCCCCC
Q 003780 73 SIIEINLPEKK-LKGELSQFNFSCFPGLESLSLRFNYLFGS----IPSQVGALSKLRYLDFSFNNLTGS----IPPELGS 143 (796)
Q Consensus 73 ~v~~l~l~~~~-l~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~ 143 (796)
++..|+++++. +...--......+++|++|+|++|.+.+. ++..+..+++|++|+|++|.+++. ++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 48889888765 21110011134789999999999998765 444567889999999999999843 3344567
Q ss_pred CCCCCEEEecCCCCCCCCchhhhccCccceeeccccccC---CCCCccccCCCCccEEEcccccccCcchhhhcCCCCcc
Q 003780 144 LRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLH---GPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLV 220 (796)
Q Consensus 144 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 220 (796)
+++|++|+|++|.+.+ +|..+.++++|++|+++.+... +..+..+..+++|+.|+++++.. ..+|..+..+++|+
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~ 296 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIR 296 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCC
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCc
Confidence 8999999999999985 7899999999999999875433 34556788899999999998643 45677888999999
Q ss_pred ccccCCccccccCC-CcccccCccceEEeccccccccCCccccCCcccceeecc-----------cccccccCc-ccccc
Q 003780 221 ALNVGGNKLMGPIP-STLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMS-----------MNNIEGTIP-LELTR 287 (796)
Q Consensus 221 ~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-----------~N~l~~~~p-~~l~~ 287 (796)
+|+|++|.+++... ..+..+++|++|+++++-..+.++..+..+++|++|+|+ .|.+++... .....
T Consensus 297 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~ 376 (592)
T 3ogk_B 297 KLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG 376 (592)
T ss_dssp EEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHH
T ss_pred EEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhh
Confidence 99999999865432 235667777777777332222223333445566666666 345543221 12334
Q ss_pred ccccccccccCccccCcccccccc-ccccceeccc
Q 003780 288 LSQLLYLSISSNMLSGQIPITIAG-LISLKGLDLS 321 (796)
Q Consensus 288 l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~Ls 321 (796)
+++|++|+++.|.+++..+..+.. +++|+.|+++
T Consensus 377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~ 411 (592)
T 3ogk_B 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411 (592)
T ss_dssp CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence 555666666555555544444433 5555555554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=210.40 Aligned_cols=157 Identities=15% Similarity=0.167 Sum_probs=123.5
Q ss_pred cHHHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhh---------------HHHHHHHHHHHHHhh
Q 003780 490 AFEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEET---------------TFFNSFQNEAHVLSK 554 (796)
Q Consensus 490 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~ 554 (796)
+...+......|++.+.||+|+||.||+|...+|+.||+|.++....... .....+.+|++++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455556677888899999999999999887899999999975432111 124578999999999
Q ss_pred cCCCceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCC
Q 003780 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNN 634 (796)
Q Consensus 555 l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 634 (796)
++ | +++.+++. .+..++||||+++|+|.+ +.. .....++.|+++||+|||+. +|+||||||+|
T Consensus 161 l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 161 LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 99 4 56666543 356799999999999987 421 12346999999999999999 99999999999
Q ss_pred eEecCCCcEEEeeeccccccCCCCCCccccccccCccCccccc
Q 003780 635 ILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677 (796)
Q Consensus 635 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 677 (796)
||++ ++.+||+|||+|+.. ..|.|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET-------------TSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeEC-------------CCCCHHHHHH
Confidence 9999 999999999999742 3478898864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.9e-21 Score=191.58 Aligned_cols=160 Identities=25% Similarity=0.278 Sum_probs=109.8
Q ss_pred CCCCCccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCC
Q 003780 56 NSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG 135 (796)
Q Consensus 56 ~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 135 (796)
.+...|.|++|.|+..+ +. .++. +-.++|++|+|++|.|.+..|..|..+++|++|+|++|.|+.
T Consensus 14 ~~~~~Cs~~~v~c~~~~-----------l~-~ip~---~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 78 (229)
T 3e6j_A 14 PSQCSCSGTTVDCRSKR-----------HA-SVPA---GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA 78 (229)
T ss_dssp CTTCEEETTEEECTTSC-----------CS-SCCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCEEeCCEeEccCCC-----------cC-ccCC---CCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC
Confidence 46788999999997432 11 1221 122677777777777777777777777777777777777776
Q ss_pred CCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcC
Q 003780 136 SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGK 215 (796)
Q Consensus 136 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 215 (796)
..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+++.+..|..
T Consensus 79 i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 157 (229)
T 3e6j_A 79 LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157 (229)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred cChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhC
Confidence 55566777777777777777777666666777777777777777777 45666666777777777777666665555666
Q ss_pred CCCccccccCCccccc
Q 003780 216 LKNLVALNVGGNKLMG 231 (796)
Q Consensus 216 l~~L~~L~l~~N~l~~ 231 (796)
+++|+.|+|++|.+..
T Consensus 158 l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 158 LSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CTTCCEEECTTSCBCT
T ss_pred CCCCCEEEeeCCCccC
Confidence 6666666666666553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.5e-21 Score=201.23 Aligned_cols=172 Identities=25% Similarity=0.365 Sum_probs=106.1
Q ss_pred CCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
..+++|+.|++++|.+.+. + .+..+++|++|+|++|.+++..+ +.++++|++|+|++|++++ + ..+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCE
Confidence 3456667777777766644 2 36666777777777777765433 6667777777777777664 2 23666666666
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 253 (796)
|+|++|++++. ..+..+++|++|+|++|++++. ..+..+++|+.|++++|++++..+ +..+++|++|+|++|++
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 66666666653 3466666666666666666654 456666666666666666665433 55666666666666666
Q ss_pred cccCCccccCCcccceeecccccccc
Q 003780 254 NGSIPPEIGNMTGILKVDMSMNNIEG 279 (796)
Q Consensus 254 ~~~~p~~~~~l~~L~~L~Ls~N~l~~ 279 (796)
++ +| .+..+++|+.|++++|+++.
T Consensus 191 ~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 191 SD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CC-Ch-hhccCCCCCEEECcCCcccC
Confidence 53 23 25555666666666666554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.9e-21 Score=202.69 Aligned_cols=189 Identities=26% Similarity=0.329 Sum_probs=133.6
Q ss_pred CcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccc
Q 003780 99 LESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178 (796)
Q Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 178 (796)
+..+.+..+.+.+..+ +..+++|++|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|++|+|++
T Consensus 26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 3444566666654433 45678888888888888844 3 47888888888888888886544 88888888888888
Q ss_pred cccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCC
Q 003780 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258 (796)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 258 (796)
|++++. ..+..+++|++|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|++|+|++|++++..|
T Consensus 100 n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 888752 3477888888888888888765 4577777777777777777754 456777777777777777775433
Q ss_pred ccccCCcccceeecccccccccCccccccccccccccccCccccC
Q 003780 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG 303 (796)
Q Consensus 259 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 303 (796)
+..+++|+.|+|++|++++. | .+..+++|+.|++++|+++.
T Consensus 174 --l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred --hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 66677777777777777643 2 35666666666666666654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.84 E-value=7e-21 Score=218.85 Aligned_cols=173 Identities=24% Similarity=0.341 Sum_probs=96.2
Q ss_pred CCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
..|++|+.|+|++|.+... + .+..+++|++|+|++|.|++..| +..+++|+.|+|++|+|++. | .+..+++|+.
T Consensus 40 ~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-S-SLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-T-TSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-h-hhccCCCCCE
Confidence 3445556666666665533 2 35556666666666666654433 55666666666666666532 2 4555566666
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 253 (796)
|+|++|+|++. ..+..+++|+.|+|++|+++++ ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|
T Consensus 114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence 66666665542 2355556666666666665554 445555556666666665554444 55555566666666655
Q ss_pred cccCCccccCCcccceeeccccccccc
Q 003780 254 NGSIPPEIGNMTGILKVDMSMNNIEGT 280 (796)
Q Consensus 254 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 280 (796)
++. ..+..+++|+.|+|++|++.+.
T Consensus 188 ~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 188 SDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred CCC--hHHccCCCCCEEEccCCcCcCC
Confidence 532 2355555555555555555543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.3e-21 Score=221.63 Aligned_cols=198 Identities=25% Similarity=0.305 Sum_probs=161.6
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
..+..+.|+.+.+.+..+ +..+.+|++|+|++|.|.. +| .|..+++|+.|+|++|+|++..| +..+++|+.|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 345666777777776544 6788999999999999984 34 58999999999999999997655 899999999999
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
++|.|++. ..+..+++|+.|+|++|+++++ ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.
T Consensus 95 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 95 DENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred cCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 99999863 3688999999999999999875 4588889999999999999865 5788888999999999998876
Q ss_pred CCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccc
Q 003780 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIA 310 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 310 (796)
.| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+.+.....+.
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~ 218 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 218 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence 55 88888888888888888864 3578888888888888888765443333
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-21 Score=230.99 Aligned_cols=249 Identities=20% Similarity=0.142 Sum_probs=81.7
Q ss_pred CCccccCCC-CCCCCCccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCc
Q 003780 46 SSWWSNLID-SNSSDHCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLR 124 (796)
Q Consensus 46 ~~w~~~~~~-~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 124 (796)
.+|..+..+ ..++..+.|.+++++. .+++.++|..+++..... ..|+.++|+.|.|.+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~~-------~~l~~l~Ls~~~i~~------------- 205 (727)
T 4b8c_D 147 SKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEANQ-------ALLQHKKLSQYSIDE------------- 205 (727)
T ss_dssp HHTTC---------------------------------------------------------------------------
T ss_pred ccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCcchh-------hHhhcCccCcccccC-------------
Confidence 445443222 2234567899998876 568889888887765322 335556666665543
Q ss_pred EeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEccccc
Q 003780 125 YLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204 (796)
Q Consensus 125 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 204 (796)
++++.|.+. ..|..|..+++|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|.
T Consensus 206 -~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 206 -DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNR 281 (727)
T ss_dssp ------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSC
T ss_pred -cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCc
Confidence 233344444 44555555555555555555555 44444555555666666666555 455555555666666666666
Q ss_pred ccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcc-cceeecccccccccCcc
Q 003780 205 LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTG-ILKVDMSMNNIEGTIPL 283 (796)
Q Consensus 205 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~ 283 (796)
|+ .+|..|+++++|++|+|++|.|+ .+|..|.++++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 282 l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 282 LT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 55 33555555666666666666555 44555566666666666666666555555443322 12355666666655554
Q ss_pred ccccccccccccccCc--------cccCccccccccccccceeccccccccc
Q 003780 284 ELTRLSQLLYLSISSN--------MLSGQIPITIAGLISLKGLDLSNNKLSG 327 (796)
Q Consensus 284 ~l~~l~~L~~L~l~~N--------~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 327 (796)
. |..|+++.| .+.+..+..+..+.++....+++|-+.+
T Consensus 360 ~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 360 E------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp C-----------------------------------------------CCCG
T ss_pred c------cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 3 334444444 3333444445556666677777777653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.7e-23 Score=240.49 Aligned_cols=320 Identities=14% Similarity=0.117 Sum_probs=192.1
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCC-ccccc-CCcCccCCCCCcEeecccCcCCCCCCCCCC----CCC
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFN-YLFGS-IPSQVGALSKLRYLDFSFNNLTGSIPPELG----SLR 145 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~----~l~ 145 (796)
.+++.|+++++.+.+.....-...+++|++|+|++| .+... ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 468888888887766443322225789999999988 55432 444455788999999999988765544443 567
Q ss_pred CCCEEEecCCCCCCCCchh----hhccCccceeecccc-ccCCCCCccccCCCCccEEEccccc----------------
Q 003780 146 NLEVLNLKGNNLNGAIPSS----LCQLTKLITMALSRN-GLHGPIPSAIGDLNNLLILSLDSNK---------------- 204 (796)
Q Consensus 146 ~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~---------------- 204 (796)
+|++|+|++|. ....+.. +.++++|+.|+|++| .+.+ +|..+..+++|++|+++.+.
T Consensus 185 ~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 185 SLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred cCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 89999999887 2122222 345688999999888 3333 55666666777777654431
Q ss_pred ----------ccC----cchhhhcCCCCccccccCCccccccC-CCcccccCccceEEecccccccc-CCccccCCcccc
Q 003780 205 ----------LSG----MLHQELGKLKNLVALNVGGNKLMGPI-PSTLFRLTNLTYLYLHSNHLNGS-IPPEIGNMTGIL 268 (796)
Q Consensus 205 ----------l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~ 268 (796)
+.. .++..+..+++|++|++++|.+++.. +..+..+++|++|++++| ++.. ++.....+++|+
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 111 12333345678888888888866432 222456778888888877 4322 222223466777
Q ss_pred eeec---------ccccccccCccccc-cccccccccccCccccCccccccc-cccccceeccc--c----cccccCC--
Q 003780 269 KVDM---------SMNNIEGTIPLELT-RLSQLLYLSISSNMLSGQIPITIA-GLISLKGLDLS--N----NKLSGPI-- 329 (796)
Q Consensus 269 ~L~L---------s~N~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~~-- 329 (796)
.|++ +.|.+++.....+. .+++|++|.++.|.+++.....+. .+++|+.|+|+ + |.+++..
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~ 421 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence 7777 33455543333333 367777777777777655544444 46677777777 3 3444211
Q ss_pred ---CcccCCCCCCcEEEeecccccCCCCcccc--ccccceEEecccccCCCCCc----cccccccccccCCCCcc
Q 003780 330 ---PPEIGKCSELRNITLRNNNLSGSIPPEIG--LMKLEYLDLSHNKLNGTIPP----FLYHRFPLDLSYNDLEG 395 (796)
Q Consensus 330 ---~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~~~L~~L~l~~N~l~~~~p~----~~~~~~~l~l~~N~l~~ 395 (796)
+..+..+++|+.|+|++ .+++..+..+. +++|++|+|++|.+++..+. .+.++..|++++|.+++
T Consensus 422 ~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 422 IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 11244566777777755 44443332221 55677777777776543332 23455667777776643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=204.92 Aligned_cols=152 Identities=27% Similarity=0.247 Sum_probs=93.9
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCC-CCCCCCEEEecCCCCCCCCchhhhccCccceeeccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELG-SLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 178 (796)
+.++++++++.. +|..+. ..+++|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 467777777764 444443 3467777777777766666666 777777777777777766666677777777777777
Q ss_pred cccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcc---cccCccceEEecccccc
Q 003780 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTL---FRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l---~~l~~L~~L~L~~N~l~ 254 (796)
|+|++..+..|.++++|++|+|++|+|+++.+..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 77666656666666666666666666666555556666666666666665554333222 23444444444444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-20 Score=185.76 Aligned_cols=151 Identities=19% Similarity=0.205 Sum_probs=78.1
Q ss_pred EEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCC-CCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIP-PELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 101 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
.+++++|.++. +|..+. ..+++|+|++|.|++..| ..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 56666666653 343332 234566666666664433 23555666666666666665554555555555555555555
Q ss_pred ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
++++..+..|.++++|++|+|++|+|+++.|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 555555555555555555555555555444444444444444444444444444444444444444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-20 Score=185.70 Aligned_cols=134 Identities=26% Similarity=0.334 Sum_probs=79.8
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
++|+.|+|++|.|.++.+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 45666666666666666666666666666666666666666666666666666666666666544445555666666666
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 230 (796)
++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666665555555555555555555555555554444444444444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.5e-20 Score=185.90 Aligned_cols=152 Identities=21% Similarity=0.254 Sum_probs=98.5
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
+.+++++++++. +|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 456777777764 344333 56777777777777666666777777777777777777666677777777777777777
Q ss_pred ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
+|++..+..|.++++|++|+|++|+|+++.+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 776655555666666666666666666666666666666666666666666555555555555555555555554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.6e-23 Score=235.68 Aligned_cols=203 Identities=18% Similarity=0.160 Sum_probs=132.9
Q ss_pred CCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccc-------------cCCCCCccccCCCCccEEE-cccccccC
Q 003780 142 GSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG-------------LHGPIPSAIGDLNNLLILS-LDSNKLSG 207 (796)
Q Consensus 142 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~ 207 (796)
..+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 34556666666666665 556666666666666665553 3445555666666666666 555433
Q ss_pred cchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCcccccc
Q 003780 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTR 287 (796)
Q Consensus 208 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 287 (796)
.+|+.+.+++|.++...+ ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..|++
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 234455555565553222 246777777777774 555 777777777777777777 56777777
Q ss_pred ccccccccccCccccCccccccccccccceecccccccccCC-CcccCCCCCCcEEEeecccccCCCCccc----ccccc
Q 003780 288 LSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPI-PPEIGKCSELRNITLRNNNLSGSIPPEI----GLMKL 362 (796)
Q Consensus 288 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~~~L 362 (796)
+++|+.|+|++|.|++ +| .+..+++|+.|+|++|++++.. |..++.+++|+.|+|++|++++..|... .+++|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 7777777777777775 45 6777777777778777777765 7777778888888888888776655332 25677
Q ss_pred ceEEe
Q 003780 363 EYLDL 367 (796)
Q Consensus 363 ~~L~l 367 (796)
+.|++
T Consensus 563 ~~L~l 567 (567)
T 1dce_A 563 SSILT 567 (567)
T ss_dssp SEEEC
T ss_pred CccCC
Confidence 77764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=202.49 Aligned_cols=175 Identities=25% Similarity=0.216 Sum_probs=152.2
Q ss_pred EEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCcc-CCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecC
Q 003780 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVG-ALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154 (796)
Q Consensus 76 ~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 154 (796)
.+++++++++..... -.+.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 22 ~l~c~~~~l~~iP~~----~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 22 ILSCSKQQLPNVPQS----LPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EEECCSSCCSSCCSS----CCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEEeCCCCcCccCcc----CCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 456666777653222 235689999999999999888888 999999999999999988888999999999999999
Q ss_pred CCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhh---cCCCCccccccCCccccc
Q 003780 155 NNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL---GKLKNLVALNVGGNKLMG 231 (796)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~ 231 (796)
|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|+++.+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998888899999999999999999999999999999999999999999999888777 679999999999999997
Q ss_pred cCCCcccccCc--cceEEecccccc
Q 003780 232 PIPSTLFRLTN--LTYLYLHSNHLN 254 (796)
Q Consensus 232 ~~~~~l~~l~~--L~~L~L~~N~l~ 254 (796)
..+..+..++. |+.|+|++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 76677777776 477888888776
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.1e-20 Score=185.38 Aligned_cols=153 Identities=20% Similarity=0.193 Sum_probs=120.4
Q ss_pred EEeCCCCCccccccccccCCCCCCcEEeccCCcccccCC-cCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecC
Q 003780 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIP-SQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154 (796)
Q Consensus 76 ~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 154 (796)
.+++++++++. ++.. -.+.+++|+|++|.|++..+ ..|..+++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 15 ~l~~s~n~l~~-iP~~---~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEH---IPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCSS-CCSC---CCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCccc-CccC---CCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 34455555554 2221 12456788888888887754 4578888888888888888877777888888888888888
Q ss_pred CCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccccc
Q 003780 155 NNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP 232 (796)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 232 (796)
|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+...
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 888887778888888888888888888888888888888888888888888888888888888888888888888754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-22 Score=231.59 Aligned_cols=204 Identities=20% Similarity=0.172 Sum_probs=163.4
Q ss_pred cCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCC-------------CCCCCchhhhccCccceee-ccccccCC
Q 003780 118 GALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNN-------------LNGAIPSSLCQLTKLITMA-LSRNGLHG 183 (796)
Q Consensus 118 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~ 183 (796)
..+++|+.|+|++|.|+ .+|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 56788888899988887 778888888888888887765 5667788888888888888 777654
Q ss_pred CCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccC
Q 003780 184 PIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGN 263 (796)
Q Consensus 184 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 263 (796)
.+|+.+.+++|.++.+.+. .|+.|+|++|+|++ +|. +..+++|+.|+|++|+|+ .+|..+++
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 3567777888887765432 47888888888886 565 888888999999999888 77888888
Q ss_pred CcccceeecccccccccCccccccccccccccccCccccCcc-ccccccccccceecccccccccCCCcc---cCCCCCC
Q 003780 264 MTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQI-PITIAGLISLKGLDLSNNKLSGPIPPE---IGKCSEL 339 (796)
Q Consensus 264 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~L 339 (796)
+++|+.|+|++|+|++ +| .++++++|++|+|++|.|++.. |..+..+++|+.|+|++|.+++.+|.. +..+++|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 8889999999998886 56 7888888999999999888876 888888888999999999888765432 2347888
Q ss_pred cEEEe
Q 003780 340 RNITL 344 (796)
Q Consensus 340 ~~L~L 344 (796)
+.|++
T Consensus 563 ~~L~l 567 (567)
T 1dce_A 563 SSILT 567 (567)
T ss_dssp SEEEC
T ss_pred CccCC
Confidence 88864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-20 Score=192.57 Aligned_cols=171 Identities=25% Similarity=0.270 Sum_probs=129.1
Q ss_pred CCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcccee
Q 003780 95 CFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 174 (796)
.+.++..+++++|.+.+.. .+..+++|++|++++|.|+. +| .+..+++|++|+|++|+|++..| +.++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 3455667778888877554 57778888888888888874 44 67888888888888888886544 8888888888
Q ss_pred eccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
+|++|++++..+ +.. ++|++|+|++|++++. ..+..+++|+.|++++|++++. + .+..+++|++|+|++|+++
T Consensus 91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 888888886432 222 7888888888888865 3577888888888888888764 3 5777888888888888887
Q ss_pred ccCCccccCCcccceeeccccccccc
Q 003780 255 GSIPPEIGNMTGILKVDMSMNNIEGT 280 (796)
Q Consensus 255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ 280 (796)
+. ..+..+++|+.|++++|.+++.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 65 5677778888888888887755
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-19 Score=180.81 Aligned_cols=151 Identities=26% Similarity=0.283 Sum_probs=75.9
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
+.++.+++.+. .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 44666666555 2333222 55666666666666555555666666666666666665444444555555555555555
Q ss_pred ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 555544444555555555555555544 22333344444444444444444333333444444444444444433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.8e-21 Score=196.65 Aligned_cols=171 Identities=22% Similarity=0.324 Sum_probs=125.6
Q ss_pred CCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEE
Q 003780 119 ALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLIL 198 (796)
Q Consensus 119 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 198 (796)
.+.++..+++++|.+++.. .+..+++|++|+|++|+++. +| .+..+++|++|+|++|++++..+ +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 4667888888888888543 57888899999999998884 44 67888888888888888886554 8888888888
Q ss_pred EcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccccc
Q 003780 199 SLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278 (796)
Q Consensus 199 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 278 (796)
+|++|++++..+ +.. ++|+.|++++|++++. ..+..+++|++|+|++|++++. + .+..+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 888888876533 222 7777777777777753 2477777777777777777753 3 5667777777777777777
Q ss_pred ccCccccccccccccccccCccccCc
Q 003780 279 GTIPLELTRLSQLLYLSISSNMLSGQ 304 (796)
Q Consensus 279 ~~~p~~l~~l~~L~~L~l~~N~l~~~ 304 (796)
+. ..+..+++|+.|++++|.+++.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 55 5566667777777777766644
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-20 Score=219.99 Aligned_cols=224 Identities=21% Similarity=0.190 Sum_probs=128.9
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
+.++.|+|.+|.+... + ...|+.++|+.|.|.+ ++++.|++. ..|..+..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~~-~-----~~~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-N-----QALLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCcc-h-----hhHhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 5567777777777642 2 2345666777766552 355667776 77899999999999999
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|.++++|++|+|++|.|+ .
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence 999999 66777779999999999999999 67888999999999999999999 67999999999999999999998 7
Q ss_pred CCccccCCcccceeecccccccccCccccccccc-cccccccCccccCccccccccccccceeccccc--------cccc
Q 003780 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQ-LLYLSISSNMLSGQIPITIAGLISLKGLDLSNN--------KLSG 327 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N--------~l~~ 327 (796)
+|..|+++++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.. |..|++++| .|.+
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~ 381 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQ 381 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccc
Confidence 8988999999999999999999999998876533 345899999999988864 566777777 4555
Q ss_pred CCCcccCCCCCCcEEEeecccccC
Q 003780 328 PIPPEIGKCSELRNITLRNNNLSG 351 (796)
Q Consensus 328 ~~~~~~~~l~~L~~L~L~~N~l~~ 351 (796)
..+..+..+..+....++.|-+.+
T Consensus 382 ~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 382 STEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp --------------------CCCG
T ss_pred cccchhhcccccceeeeecccccc
Confidence 555566677778888888888764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=9.9e-22 Score=228.43 Aligned_cols=319 Identities=13% Similarity=0.081 Sum_probs=225.3
Q ss_pred CCeEEEeCCCC-CccccccccccCCCCCCcEEeccCCcccccCCcCc----cCCCCCcEeecccCcCCCCCCCC----CC
Q 003780 72 RSIIEINLPEK-KLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQV----GALSKLRYLDFSFNNLTGSIPPE----LG 142 (796)
Q Consensus 72 ~~v~~l~l~~~-~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~l~~L~~L~Ls~n~l~~~~p~~----~~ 142 (796)
.++..|++.++ .+...--...+..+++|++|+|++|.+++..+..+ ..+++|++|+|++|. ....... +.
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence 46888998887 44432112224578999999999999887554433 467899999999997 2111122 34
Q ss_pred CCCCCCEEEecCC-CCCCCCchhhhccCccceeeccccc--------------------------cCCC----CCccccC
Q 003780 143 SLRNLEVLNLKGN-NLNGAIPSSLCQLTKLITMALSRNG--------------------------LHGP----IPSAIGD 191 (796)
Q Consensus 143 ~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~--------------------------l~~~----~p~~~~~ 191 (796)
++++|++|+|++| .+. .+|..+..+++|+.|+++.+. +... ++..+..
T Consensus 209 ~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~ 287 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287 (594)
T ss_dssp HCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHH
T ss_pred hCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHh
Confidence 5699999999998 444 377788888888888866542 2211 3333446
Q ss_pred CCCccEEEcccccccCcch-hhhcCCCCccccccCCcccccc-CCCcccccCccceEEecc---------ccccccCCcc
Q 003780 192 LNNLLILSLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGP-IPSTLFRLTNLTYLYLHS---------NHLNGSIPPE 260 (796)
Q Consensus 192 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~---------N~l~~~~p~~ 260 (796)
+++|++|+|++|.+++... ..+..+++|++|++++| ++.. ++.....+++|++|+|.+ |.+++.....
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 7899999999999775433 34678999999999998 4422 222233588999999943 4555433333
Q ss_pred cc-CCcccceeecccccccccCccccc-ccccccccccc--C----ccccCc-----cccccccccccceeccccccccc
Q 003780 261 IG-NMTGILKVDMSMNNIEGTIPLELT-RLSQLLYLSIS--S----NMLSGQ-----IPITIAGLISLKGLDLSNNKLSG 327 (796)
Q Consensus 261 ~~-~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~l~--~----N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~ 327 (796)
+. ++++|+.|+++.|++++..+..+. .+++|+.|+++ + |.+++. ++..+..+++|+.|+|++ .+++
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 33 478999999999999877666665 58999999999 4 556522 223366788999999987 6666
Q ss_pred CCCcccCC-CCCCcEEEeecccccCCCCccc--cccccceEEecccccCCCCC----ccccccccccccCCCCc
Q 003780 328 PIPPEIGK-CSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNGTIP----PFLYHRFPLDLSYNDLE 394 (796)
Q Consensus 328 ~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~--~~~~L~~L~l~~N~l~~~~p----~~~~~~~~l~l~~N~l~ 394 (796)
..+..++. +++|+.|+|++|.+++..+..+ ++++|+.|+|++|++++..+ ..+.++..|++++|.++
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 55555555 8899999999999876544433 47899999999999964333 23456778999999874
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=174.49 Aligned_cols=154 Identities=13% Similarity=0.220 Sum_probs=104.6
Q ss_pred ccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCcc
Q 003780 117 VGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL 196 (796)
Q Consensus 117 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 196 (796)
.+.+++|++|++++|.|+ .+| .+..+++|++|+|++|.++. +..+..+++|++|++++|++++..|..|+.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 355667777777777777 444 57777777777777776552 24667777777777777777766667777777777
Q ss_pred EEEcccccccCcchhhhcCCCCccccccCCcc-ccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccc
Q 003780 197 ILSLDSNKLSGMLHQELGKLKNLVALNVGGNK-LMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMN 275 (796)
Q Consensus 197 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 275 (796)
+|+|++|++++..+..+..+++|++|++++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 77777777777667777777777777777776 44 334 56677777777777777764 33 4666666666666666
Q ss_pred ccc
Q 003780 276 NIE 278 (796)
Q Consensus 276 ~l~ 278 (796)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 655
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.4e-19 Score=175.51 Aligned_cols=155 Identities=19% Similarity=0.245 Sum_probs=129.2
Q ss_pred cCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccc
Q 003780 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLI 172 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 172 (796)
...+++|++|++++|.+. .+| .+..+++|++|++++|.++. ++.+..+++|++|+|++|++++..|..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 355678899999999988 445 68889999999999997763 34788899999999999999887888899999999
Q ss_pred eeeccccccCCCCCccccCCCCccEEEccccc-ccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccc
Q 003780 173 TMALSRNGLHGPIPSAIGDLNNLLILSLDSNK-LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSN 251 (796)
Q Consensus 173 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N 251 (796)
+|+|++|++++..|..+..+++|++|+|++|. ++.. + .+..+++|+.|++++|++++. + .+..+++|++|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence 99999999998788889999999999999998 6654 4 688999999999999999864 3 6888999999999999
Q ss_pred cccc
Q 003780 252 HLNG 255 (796)
Q Consensus 252 ~l~~ 255 (796)
++.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 9864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=8.4e-19 Score=171.86 Aligned_cols=171 Identities=20% Similarity=0.241 Sum_probs=102.6
Q ss_pred ccccCCccccccCCCcccccCccceEEeccccccccCCc-cccCCcccceeecccccccccCccccccccccccccccCc
Q 003780 221 ALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPP-EIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSN 299 (796)
Q Consensus 221 ~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 299 (796)
.+++++|+++ .+|..+.. +|++|+|++|++++..+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4455555554 33433322 566666666666654443 3566666666666666666666666666666666666666
Q ss_pred cccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCCCCcc
Q 003780 300 MLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF 379 (796)
Q Consensus 300 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~ 379 (796)
+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+++..+...-...++...+..+......|..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~ 168 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChH
Confidence 66666666667777777777777777777777777777777777777777765442221112333334445555555655
Q ss_pred ccccccccccCCCCc
Q 003780 380 LYHRFPLDLSYNDLE 394 (796)
Q Consensus 380 ~~~~~~l~l~~N~l~ 394 (796)
+......++..+.+.
T Consensus 169 l~~~~l~~l~~~~~~ 183 (192)
T 1w8a_A 169 VRDVQIKDLPHSEFK 183 (192)
T ss_dssp TTTSBGGGSCTTTCC
T ss_pred HcCCChhhCcHhhcC
Confidence 555555555555554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5e-18 Score=174.59 Aligned_cols=141 Identities=22% Similarity=0.241 Sum_probs=107.7
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcE--EEEEEeccccchh---------------------hHHHHHHHHHHHHHhh
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKV--VALKKLHRAETEE---------------------TTFFNSFQNEAHVLSK 554 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~ 554 (796)
.-|++.+.||+|+||.||+|.. .+|+. ||||+++...... ......+.+|+..+.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999987 68999 9999876542110 0112367899999999
Q ss_pred cCCCce--eeEEeEEEecceeeEEEeeccC-C----cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHh-hcCCCCeE
Q 003780 555 IAHRNI--VKLYGFCLHKKCMFLIYKYMKR-G----SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH-HDCMPSIV 626 (796)
Q Consensus 555 l~hpni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iv 626 (796)
++|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|+++||.||| +. +|+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 988754 344432 356899999942 4 66665432 123456789999999999999 88 999
Q ss_pred EecCCCCCeEecCCCcEEEeeecccccc
Q 003780 627 HRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 627 H~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=5.5e-18 Score=166.01 Aligned_cols=128 Identities=23% Similarity=0.265 Sum_probs=60.4
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCC-CCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPP-ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 178 (796)
+.|++++|++. .+|..+.. +|++|+|++|.|++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 34555555553 23333322 555555555555543332 245555555555555555544455555555555555555
Q ss_pred cccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccc
Q 003780 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 230 (796)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 5554444444444444444444444444444444444444444444444443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=159.53 Aligned_cols=133 Identities=20% Similarity=0.184 Sum_probs=101.0
Q ss_pred CCCCcEEeccCCccc-ccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcccee
Q 003780 96 FPGLESLSLRFNYLF-GSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 96 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 174 (796)
.++|+.|+|++|.+. +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 467888888888887 67777778888888888888888865 678888888888888888887777777778888888
Q ss_pred eccccccCCCC-CccccCCCCccEEEcccccccCcch---hhhcCCCCccccccCCcccc
Q 003780 175 ALSRNGLHGPI-PSAIGDLNNLLILSLDSNKLSGMLH---QELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 175 ~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~ 230 (796)
+|++|.+++.. +..+..+++|++|+|++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 88888887642 2667777777777777777776655 46666777777777776665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=4e-18 Score=182.35 Aligned_cols=236 Identities=13% Similarity=0.139 Sum_probs=128.4
Q ss_pred CCCCcEEeccCCccc--ccCCcCccCCCCCcEeecccCcCCCCCCCCCCC--------CCCCCEEEecCCCCCCCCchhh
Q 003780 96 FPGLESLSLRFNYLF--GSIPSQVGALSKLRYLDFSFNNLTGSIPPELGS--------LRNLEVLNLKGNNLNGAIPSSL 165 (796)
Q Consensus 96 l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~p~~~ 165 (796)
+++|+.|||++|+|. ...+..+ +.++.+++..|.|. +..|.+ +++|+.|+|.+ +++.+.+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 788999999999987 3333222 22455555555432 355666 78888888877 7776666777
Q ss_pred hccCccceeeccccccCCCCCccccCCCCccEEEccccc----ccCcchhhhcCCCCcc-ccccCCccccccCCCcc---
Q 003780 166 CQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK----LSGMLHQELGKLKNLV-ALNVGGNKLMGPIPSTL--- 237 (796)
Q Consensus 166 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~l--- 237 (796)
.++++|+.|++++|.++.+.+.+|.++.++..+.+..+. ...+....|.++.+|+ .+.+.... .++..+
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~ 197 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKA 197 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHT
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhhc
Confidence 788888888888887777777777777777777666532 2223334455555555 33332211 011100
Q ss_pred -c------------------------ccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccc
Q 003780 238 -F------------------------RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292 (796)
Q Consensus 238 -~------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 292 (796)
. .+++|+.|+|++|+++.+.+.+|.++++|+.|+|++| ++.+.+.+|.++++|+
T Consensus 198 ~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~ 276 (329)
T 3sb4_A 198 GLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA 276 (329)
T ss_dssp TCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred ccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence 0 1344555555555554333344445555555555444 4444444455555554
Q ss_pred -cccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEE
Q 003780 293 -YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNIT 343 (796)
Q Consensus 293 -~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 343 (796)
.|++.+ .++.+.+.+|.++++|+.|++++|+++...+.+|.++++|+.|+
T Consensus 277 ~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 277 GTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 555544 34434444455555555555555554444444455555444443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-18 Score=184.98 Aligned_cols=258 Identities=14% Similarity=0.121 Sum_probs=171.8
Q ss_pred CCCCcEEeccCCcccccCCcCccC-CCCCcEeecccCcCC--CCCCCCCCCCCCCCEEEecCCCCCCCCchhhhc-----
Q 003780 96 FPGLESLSLRFNYLFGSIPSQVGA-LSKLRYLDFSFNNLT--GSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQ----- 167 (796)
Q Consensus 96 l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~----- 167 (796)
+++|+.|.++++ +....-..+.. +++|++|||++|+|. ...+..+ +.++.+.+..|.|. +..|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhccccccc
Confidence 567888988864 22111122333 789999999999998 3333333 33677777777443 467778
Q ss_pred ---cCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccc----cccCCCccccc
Q 003780 168 ---LTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL----MGPIPSTLFRL 240 (796)
Q Consensus 168 ---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l----~~~~~~~l~~l 240 (796)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+..+.+..|.++.++..+.+..+.. .......|.++
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 99999999999 88888888999999999999999999999999999998888888777432 33445567777
Q ss_pred Cccc-eEEeccccccccCCccc----------------------------cCCcccceeecccccccccCcccccccccc
Q 003780 241 TNLT-YLYLHSNHLNGSIPPEI----------------------------GNMTGILKVDMSMNNIEGTIPLELTRLSQL 291 (796)
Q Consensus 241 ~~L~-~L~L~~N~l~~~~p~~~----------------------------~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 291 (796)
..|+ .+.+.... .++..+ ..+++|+.|+|++|+++...+.+|.++++|
T Consensus 176 ~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L 252 (329)
T 3sb4_A 176 EPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYL 252 (329)
T ss_dssp CCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTC
T ss_pred cccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCC
Confidence 7777 44443221 111100 024566666666666666555666666666
Q ss_pred ccccccCccccCccccccccccccc-eecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEE
Q 003780 292 LYLSISSNMLSGQIPITIAGLISLK-GLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLD 366 (796)
Q Consensus 292 ~~L~l~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~ 366 (796)
+.|+|.+| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.|++++|+++...+..| ++++|+.++
T Consensus 253 ~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 253 LKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 66666666 5555566666666666 666666 5555556666666666666666666665544444 355666554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-17 Score=159.65 Aligned_cols=133 Identities=29% Similarity=0.273 Sum_probs=104.4
Q ss_pred CCCCcEeecccCcCC-CCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEE
Q 003780 120 LSKLRYLDFSFNNLT-GSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLIL 198 (796)
Q Consensus 120 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 198 (796)
.++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367888999998887 67788888888888888888888865 777888888888888888887777777778888888
Q ss_pred EcccccccCcch-hhhcCCCCccccccCCccccccCC---CcccccCccceEEecccccc
Q 003780 199 SLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPIP---STLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 199 ~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~---~~l~~l~~L~~L~L~~N~l~ 254 (796)
+|++|++++... ..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 888888877533 667777777777777777775544 36667777777777777776
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=154.69 Aligned_cols=128 Identities=20% Similarity=0.220 Sum_probs=101.7
Q ss_pred CCCCcEEeccCCccc-ccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcccee
Q 003780 96 FPGLESLSLRFNYLF-GSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 96 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 174 (796)
.++|+.|++++|.+. +.+|..+..+++|++|+|++|.+++. ..++++++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467888888888888 77788888888888888888888865 678888888888888888887788888888888888
Q ss_pred eccccccCCC-CCccccCCCCccEEEcccccccCcch---hhhcCCCCccccccC
Q 003780 175 ALSRNGLHGP-IPSAIGDLNNLLILSLDSNKLSGMLH---QELGKLKNLVALNVG 225 (796)
Q Consensus 175 ~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~ 225 (796)
++++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 8888888763 34677777888888888887776655 567777777777765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-16 Score=154.69 Aligned_cols=135 Identities=22% Similarity=0.239 Sum_probs=95.8
Q ss_pred CccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCC
Q 003780 60 HCKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPP 139 (796)
Q Consensus 60 ~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~ 139 (796)
.|.|++|.|+..+ ++. ++ ....++|++|+|++|++.+..+..|+.+++|++|+|++|.|++..+.
T Consensus 6 ~C~~~~l~~~~~~-----------l~~-~p---~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 6 SCSGTEIRCNSKG-----------LTS-VP---TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp EEETTEEECCSSC-----------CSS-CC---TTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred EeCCCEEEecCCC-----------Ccc-CC---CCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence 3789888886432 221 11 12236778888888888777666777788888888888888766666
Q ss_pred CCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcc
Q 003780 140 ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGML 209 (796)
Q Consensus 140 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 209 (796)
.|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+.+..
T Consensus 71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 6777888888888888887666666777777777777777777666666677777777777777776543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-16 Score=170.88 Aligned_cols=267 Identities=10% Similarity=0.053 Sum_probs=215.8
Q ss_pred CCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
.....++.+.+.+ .+..+...+|.+. +|+.++|..| ++.+...+|.+ .+|+.++|.. .++.+.+.+|.++++|+.
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCe
Confidence 3446778888865 4666777888875 7999999776 77666778888 4799999986 677677788999999999
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 253 (796)
++|.+|+++.+...+|. ..+|+.+.|..+ ++.+....|.++++|+.+++..| ++.+...+|.+ .+|+.+.| .|.+
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i 259 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGV 259 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTC
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCc
Confidence 99999999877777777 589999999854 88888889999999999999875 66566677777 78999999 5567
Q ss_pred cccCCccccCCcccceeeccccccc-----ccCccccccccccccccccCccccCccccccccccccceecccccccccC
Q 003780 254 NGSIPPEIGNMTGILKVDMSMNNIE-----GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGP 328 (796)
Q Consensus 254 ~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 328 (796)
+...+.+|.++++|+.+++.+|.+. ...+.+|.++++|+.+.|. |.++.+...+|.++.+|+.++|..| ++.+
T Consensus 260 ~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I 337 (401)
T 4fdw_A 260 TNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQI 337 (401)
T ss_dssp CEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEE
T ss_pred cEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEE
Confidence 7666788999999999999888775 4667789999999999998 4577777889999999999999665 7767
Q ss_pred CCcccCCCCCCcEEEeecccccCCCCccc-cc-cccceEEecccccC
Q 003780 329 IPPEIGKCSELRNITLRNNNLSGSIPPEI-GL-MKLEYLDLSHNKLN 373 (796)
Q Consensus 329 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~-~~L~~L~l~~N~l~ 373 (796)
...+|.++ +|+.|++++|.+....+..+ ++ .+++.|++..+.+.
T Consensus 338 ~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 338 NFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 78899999 99999999998886555555 34 36888988887654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.9e-17 Score=153.82 Aligned_cols=128 Identities=25% Similarity=0.269 Sum_probs=96.5
Q ss_pred CCCCcEeecccCcCC-CCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEE
Q 003780 120 LSKLRYLDFSFNNLT-GSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLIL 198 (796)
Q Consensus 120 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 198 (796)
.++|++|++++|.++ +.+|..+..+++|++|+|++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 367888888888887 67888888888888888888888865 677778888888888888887777777777888888
Q ss_pred EcccccccCc-chhhhcCCCCccccccCCccccccCC---CcccccCccceEEec
Q 003780 199 SLDSNKLSGM-LHQELGKLKNLVALNVGGNKLMGPIP---STLFRLTNLTYLYLH 249 (796)
Q Consensus 199 ~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~---~~l~~l~~L~~L~L~ 249 (796)
++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 8888877764 34666777777777777777765544 356666666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-16 Score=155.74 Aligned_cols=126 Identities=25% Similarity=0.353 Sum_probs=60.9
Q ss_pred EeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEccccc
Q 003780 125 YLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204 (796)
Q Consensus 125 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 204 (796)
++++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 3444444444 3333322 34555555555554 334445555555555555555554444445555555555555555
Q ss_pred ccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 205 LSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 205 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
|+++.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 55444444444455555555555554444444444555555555555544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.7e-16 Score=169.93 Aligned_cols=243 Identities=9% Similarity=0.074 Sum_probs=167.0
Q ss_pred CCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEE
Q 003780 119 ALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLIL 198 (796)
Q Consensus 119 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 198 (796)
.+..++.+.+.. .++.+...+|.+. +|+.++|..| ++.+...+|.+ .+|+.+.+.. .++.+.+.+|.++++|+.+
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCee
Confidence 346667777754 4554556667764 6888887666 66555666766 4677777775 6666666777788888888
Q ss_pred EcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccccc
Q 003780 199 SLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278 (796)
Q Consensus 199 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 278 (796)
+|++|.++.+....|. ..+|+.+.|.++ ++.+...+|.++++|+.++|..| ++.....+|.+ .+|+.+.| .|.++
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~ 260 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT 260 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc
Confidence 8887777777666776 477888877744 66666677777778888887764 55445556666 67777777 45566
Q ss_pred ccCccccccccccccccccCcccc-----CccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCC
Q 003780 279 GTIPLELTRLSQLLYLSISSNMLS-----GQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSI 353 (796)
Q Consensus 279 ~~~p~~l~~l~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 353 (796)
.....+|.++++|+.+.+.+|.+. .+.+..|.++++|+.++|. +.++.+...+|.++++|+.|.|..| ++..-
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 566677777888888887777664 3556677777788888887 3466666677777788888888544 55444
Q ss_pred CccccccccceEEecccccC
Q 003780 354 PPEIGLMKLEYLDLSHNKLN 373 (796)
Q Consensus 354 ~~~~~~~~L~~L~l~~N~l~ 373 (796)
+..|...+|+.+++++|.+.
T Consensus 339 ~~aF~~~~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 339 FSAFNNTGIKEVKVEGTTPP 358 (401)
T ss_dssp TTSSSSSCCCEEEECCSSCC
T ss_pred HHhCCCCCCCEEEEcCCCCc
Confidence 44553227888888877665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-16 Score=155.00 Aligned_cols=109 Identities=23% Similarity=0.269 Sum_probs=64.5
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
++|++|+|++|.|+ .+|..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 45666666666665 34455666666666666666666555555666666666666666666555555555666666666
Q ss_pred cccccCCCCCccccCCCCccEEEccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLS 206 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 206 (796)
++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 666655554455555555555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-16 Score=151.39 Aligned_cols=126 Identities=22% Similarity=0.245 Sum_probs=54.2
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
+.+++++|++... |..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 3455555554432 2211 134555555555555444444444555555555555554443334444444444444444
Q ss_pred ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNK 228 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 228 (796)
++++..+..|..+++|++|+|++|+++++.+..+..+++|++|++++|.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 135 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCC
Confidence 4444333334444444444444444443333333333333333333333
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.2e-18 Score=168.69 Aligned_cols=154 Identities=25% Similarity=0.308 Sum_probs=105.3
Q ss_pred CCCCCCcEEeccCCcccccCCc------CccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhc
Q 003780 94 SCFPGLESLSLRFNYLFGSIPS------QVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQ 167 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 167 (796)
...+.++.++++.+.+.|.+|. .|..+++|++|+|++|.|++ +| .+.++++|++|+|++|+++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3445666667777777766665 67777788888888887775 55 7777778888888888777 56667777
Q ss_pred cCccceeeccccccCCCCCccccCCCCccEEEcccccccCcch-hhhcCCCCccccccCCccccccCCCc----------
Q 003780 168 LTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPIPST---------- 236 (796)
Q Consensus 168 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~---------- 236 (796)
+++|+.|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++..|..
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 169 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence 7777777777777775 33 56777777777777777776543 46667777777777777776554432
Q ss_pred ccccCccceEEecccccc
Q 003780 237 LFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 237 l~~l~~L~~L~L~~N~l~ 254 (796)
+..+++|+.|+ +|.++
T Consensus 170 ~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 170 VKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHCSSCSEEC--CGGGT
T ss_pred HHhCCCcEEEC--CcccC
Confidence 55556666554 44443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.60 E-value=7.4e-18 Score=166.05 Aligned_cols=135 Identities=27% Similarity=0.307 Sum_probs=85.4
Q ss_pred ccCCCCCcEeecccCcCCCCCCC------CCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCcccc
Q 003780 117 VGALSKLRYLDFSFNNLTGSIPP------ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIG 190 (796)
Q Consensus 117 ~~~l~~L~~L~Ls~n~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 190 (796)
+.....++.++++.|.+++..|. .|..+++|++|+|++|++++ +| .+.++++|+.|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45566788888888888877776 66777777777777777775 45 6677777777777777776 4556666
Q ss_pred CCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCC-CcccccCccceEEecccccccc
Q 003780 191 DLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIP-STLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 191 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
.+++|++|+|++|+++++ | .+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+++.
T Consensus 91 ~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 91 VADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred cCCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 666677777777766653 2 35555555555555555553221 2344455555555555555443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=9.4e-16 Score=147.82 Aligned_cols=109 Identities=21% Similarity=0.212 Sum_probs=55.7
Q ss_pred cCCCCCCcEEeccCCcccccCCcCccCCC-CCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcc
Q 003780 93 FSCFPGLESLSLRFNYLFGSIPSQVGALS-KLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 171 (796)
+...++|+.|+|++|++... |. +..+. +|++|+|++|.|++. +.|.++++|++|+|++|+|++..|..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 34445556666666655533 32 33333 566666666655543 445555555555555555554433444555555
Q ss_pred ceeeccccccCCCCCc--cccCCCCccEEEccccccc
Q 003780 172 ITMALSRNGLHGPIPS--AIGDLNNLLILSLDSNKLS 206 (796)
Q Consensus 172 ~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~ 206 (796)
++|+|++|+|+. +|. .+..+++|+.|+|++|.++
T Consensus 91 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 91 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC
Confidence 555555555542 232 4444455555555555444
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.2e-15 Score=160.60 Aligned_cols=149 Identities=11% Similarity=0.111 Sum_probs=106.5
Q ss_pred HHHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchh---------------hHHH----HHHHHHHHH
Q 003780 491 FEDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEE---------------TTFF----NSFQNEAHV 551 (796)
Q Consensus 491 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---------------~~~~----~~~~~E~~~ 551 (796)
+..+.....=|++.+.||+|++|.||+|..++|+.||||+++.....- ..+. -...+|...
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 344444444589999999999999999999999999999876432110 0000 112456777
Q ss_pred HhhcCCCcee--eEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEec
Q 003780 552 LSKIAHRNIV--KLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRD 629 (796)
Q Consensus 552 l~~l~hpniv--~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d 629 (796)
+.++.+.++. ..+++ ...++||||+++++|.++... .....++.|++.+|.|||.. ||||||
T Consensus 167 L~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrD 230 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGD 230 (397)
T ss_dssp HHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred HHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence 7777554432 22222 234799999999888654321 12356789999999999998 999999
Q ss_pred CCCCCeEecCCC----------cEEEeeeccccccC
Q 003780 630 ISSNNILLNSKL----------EAFVADFGTARLLD 655 (796)
Q Consensus 630 lkp~NIll~~~~----------~~kl~Dfg~a~~~~ 655 (796)
|||.|||+++++ .+.|+||+-+....
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999999998876 37899999876543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=6.7e-16 Score=148.86 Aligned_cols=133 Identities=20% Similarity=0.223 Sum_probs=79.5
Q ss_pred CccCCCCCcEeecccCcCCCCCCCCCCCCC-CCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCC
Q 003780 116 QVGALSKLRYLDFSFNNLTGSIPPELGSLR-NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNN 194 (796)
Q Consensus 116 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 194 (796)
.+.++.+|++|+|++|.++. +|. +..+. +|++|+|++|+|++. ..|..+++|++|+|++|+|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 46667777888888887773 343 44443 777777777777754 45666666777777777766554455566666
Q ss_pred ccEEEcccccccCcch-hhhcCCCCccccccCCccccccCCCc----ccccCccceEEeccccc
Q 003780 195 LLILSLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPIPST----LFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 195 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~----l~~l~~L~~L~L~~N~l 253 (796)
|++|+|++|+++...+ ..+..+++|+.|++++|.++. +|.. +..+++|+.|++++|.+
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence 6666666666654322 245555555555555555542 2332 44455555555555444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=4.4e-14 Score=135.09 Aligned_cols=104 Identities=22% Similarity=0.241 Sum_probs=57.3
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
+.|++++|.+.. +|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 456666666553 333332 55566666666666555555555666666666666655554455555555555555555
Q ss_pred ccCCCCCccccCCCCccEEEccccccc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLS 206 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 206 (796)
+|++..+..|..+++|++|+|++|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 555544445555555555555555544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=7.7e-14 Score=133.37 Aligned_cols=87 Identities=24% Similarity=0.200 Sum_probs=59.9
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
++|++|+|++|.|++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 56677777777777666666777777777777777777665556667777777777777777655566667777777777
Q ss_pred cccccCC
Q 003780 177 SRNGLHG 183 (796)
Q Consensus 177 ~~N~l~~ 183 (796)
++|.++.
T Consensus 110 ~~N~~~c 116 (170)
T 3g39_A 110 LNNPWDC 116 (170)
T ss_dssp CSSCBCT
T ss_pred CCCCCCC
Confidence 7776664
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.1e-14 Score=134.13 Aligned_cols=104 Identities=23% Similarity=0.248 Sum_probs=63.5
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
+.+++++|.+. .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666664 3444443 56666666666666666666666666666666666666554555566666666666666
Q ss_pred ccCCCCCccccCCCCccEEEccccccc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLS 206 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 206 (796)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666555445555666666666665554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.4e-13 Score=132.03 Aligned_cols=105 Identities=22% Similarity=0.193 Sum_probs=70.3
Q ss_pred EEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecC
Q 003780 75 IEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKG 154 (796)
Q Consensus 75 ~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 154 (796)
+.++++++++.. ++.. + .++|++|+|++|.|.+..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 15 ~~l~~~~n~l~~-iP~~-~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLAS-VPAG-I--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCSS-CCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCCc-cCCC-c--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 356666666643 3321 1 26677777777777777777777777777777777777765555567777777777777
Q ss_pred CCCCCCCchhhhccCccceeeccccccCC
Q 003780 155 NNLNGAIPSSLCQLTKLITMALSRNGLHG 183 (796)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 183 (796)
|+|++..+..|..+++|+.|+|++|.+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 77776555567777777777777777663
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.8e-12 Score=142.04 Aligned_cols=270 Identities=11% Similarity=0.033 Sum_probs=124.7
Q ss_pred ccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCC------------
Q 003780 88 LSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGN------------ 155 (796)
Q Consensus 88 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N------------ 155 (796)
|....|.+..+|+.+.|.. .++.+...+|.++++|+.++|..+ ++.+....|.++++|+.+.+..+
T Consensus 62 Ig~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~ 139 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGC 139 (394)
T ss_dssp ECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTC
T ss_pred hHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecc
Confidence 3344455555566655543 244444555555566666655433 33333444555555555444332
Q ss_pred ---------CCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCC
Q 003780 156 ---------NLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGG 226 (796)
Q Consensus 156 ---------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 226 (796)
.+......+|.++++|+.+.+.++. ..+....|.++.+|+.+.+..| ++.+....|.++..|+.+.+..
T Consensus 140 ~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 140 DFKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp CCSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred cccccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 1111223445555666666665432 2244455666666666666554 4444455566666666655554
Q ss_pred ccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccc------------------
Q 003780 227 NKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRL------------------ 288 (796)
Q Consensus 227 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l------------------ 288 (796)
+... +.+......+|+.+.+..+ ++......+.+...|+.+.+..+... .....|..+
T Consensus 218 ~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F 293 (394)
T 4fs7_A 218 SLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTF 293 (394)
T ss_dssp TCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTT
T ss_pred CceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccc
Confidence 4322 1122222344444444322 22123334555555666655544332 333344444
Q ss_pred ---cccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccce
Q 003780 289 ---SQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEY 364 (796)
Q Consensus 289 ---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~ 364 (796)
.+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..| ++..-...| ++.+|+.
T Consensus 294 ~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~ 370 (394)
T 4fs7_A 294 YGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKK 370 (394)
T ss_dssp TTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCE
T ss_pred cccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCE
Confidence 44444444332 33333444445555555555432 33333444555555555555443 332222222 2344555
Q ss_pred EEec
Q 003780 365 LDLS 368 (796)
Q Consensus 365 L~l~ 368 (796)
+++.
T Consensus 371 i~lp 374 (394)
T 4fs7_A 371 VELP 374 (394)
T ss_dssp EEEE
T ss_pred EEEC
Confidence 5443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=5e-15 Score=160.18 Aligned_cols=110 Identities=19% Similarity=0.189 Sum_probs=46.4
Q ss_pred CCccEEEcccccccCcchhhh-----cCCCCccccccCCcccccc----CCCcccccCccceEEecccccccc----CCc
Q 003780 193 NNLLILSLDSNKLSGMLHQEL-----GKLKNLVALNVGGNKLMGP----IPSTLFRLTNLTYLYLHSNHLNGS----IPP 259 (796)
Q Consensus 193 ~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~p~ 259 (796)
++|++|+|++|.|+......+ ...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++. ++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 345555555555543332222 1234455555555544321 122233444555555555554421 122
Q ss_pred cccCCcccceeeccccccccc----CccccccccccccccccCcccc
Q 003780 260 EIGNMTGILKVDMSMNNIEGT----IPLELTRLSQLLYLSISSNMLS 302 (796)
Q Consensus 260 ~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~ 302 (796)
.+...++|+.|+|++|.|++. ++..+...++|++|+|++|.|+
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 333344445555555544432 1222233344444444444444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.9e-12 Score=137.85 Aligned_cols=264 Identities=14% Similarity=0.133 Sum_probs=190.8
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCc-------------------
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN------------------- 132 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~------------------- 132 (796)
..+++++++.+ ++ .|....|.++++|+.++|..+ +..+...+|.++.+|+.+.+..+-
T Consensus 71 ~~L~~i~lp~~-i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 71 RKVTEIKIPST-VR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TTEEEEECCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEECC
T ss_pred CCceEEEeCCC-cc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccccccC
Confidence 46889999754 43 577788999999999999765 665667788888888887765431
Q ss_pred --CCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccc-----
Q 003780 133 --LTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL----- 205 (796)
Q Consensus 133 --l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----- 205 (796)
+......+|.++++|+.+.+.++. ..+....|.++++|+.+++..| ++.+...+|.++..|+.+.+..+..
T Consensus 148 ~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~ 225 (394)
T 4fs7_A 148 EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDF 225 (394)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTT
T ss_pred ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehh
Confidence 111223568888999999997664 4366678889999999999876 5545566777777777776655432
Q ss_pred ----------------cCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccce
Q 003780 206 ----------------SGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILK 269 (796)
Q Consensus 206 ----------------~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 269 (796)
+.+....|.++.+|+.+.+..+... +....|.....++.+.+..+.+ ....|....+|+.
T Consensus 226 ~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~ 301 (394)
T 4fs7_A 226 ALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTE 301 (394)
T ss_dssp TTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCE
T ss_pred hcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccc
Confidence 1222334555566666666555333 4445566666666666655432 2346778888999
Q ss_pred eecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecc
Q 003780 270 VDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNN 347 (796)
Q Consensus 270 L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 347 (796)
+.+..+ ++.....+|.++++|+.++|..+ ++.+...+|.++.+|+.+++..| ++.+...+|.++++|+.+++..+
T Consensus 302 i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 302 VKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp EEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 988765 66666778999999999999755 77677889999999999999887 77677889999999999999865
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=4.2e-15 Score=160.75 Aligned_cols=166 Identities=18% Similarity=0.153 Sum_probs=103.5
Q ss_pred CCCcEeecccCcCCCCCCCCCCC-----CCCCCEEEecCCCCCCCCchhh-hccCccceeeccccccCCCCCccc-----
Q 003780 121 SKLRYLDFSFNNLTGSIPPELGS-----LRNLEVLNLKGNNLNGAIPSSL-CQLTKLITMALSRNGLHGPIPSAI----- 189 (796)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~----- 189 (796)
++|++|+|++|.|+......|.. .++|++|+|++|.++......+ ..+++|+.|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45666777776665332222222 2567777777777654333332 245667777777777764333333
Q ss_pred cCCCCccEEEcccccccCc----chhhhcCCCCccccccCCcccccc----CCCcccccCccceEEecccccccc----C
Q 003780 190 GDLNNLLILSLDSNKLSGM----LHQELGKLKNLVALNVGGNKLMGP----IPSTLFRLTNLTYLYLHSNHLNGS----I 257 (796)
Q Consensus 190 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~ 257 (796)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++. ++..+...++|++|+|++|.|++. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2346788888888877643 334456677788888888887642 244566677888888888888753 2
Q ss_pred CccccCCcccceeecccccccccCccccc
Q 003780 258 PPEIGNMTGILKVDMSMNNIEGTIPLELT 286 (796)
Q Consensus 258 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 286 (796)
+..+...++|+.|+|++|.|++.....+.
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 33445567888888888888765444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=9.7e-13 Score=141.53 Aligned_cols=102 Identities=22% Similarity=0.174 Sum_probs=62.3
Q ss_pred EeccCC-cccccCCcCccCCCCCcEeeccc-CcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 102 LSLRFN-YLFGSIPSQVGALSKLRYLDFSF-NNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 102 L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
++++++ ++++ +|. +..+++|++|+|++ |.|++..+..|++|++|++|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 456665 5653 444 66666666666664 6666555556666666666666666666666666666666666666666
Q ss_pred ccCCCCCccccCCCCccEEEccccccc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLS 206 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 206 (796)
+|++..+..|..++ |+.|+|++|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 66655555555444 666666666554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-12 Score=139.06 Aligned_cols=109 Identities=24% Similarity=0.222 Sum_probs=90.7
Q ss_pred ccCCceeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccC-CcccccCCcCccCCCCCcEeecccCcCCCCCCC
Q 003780 61 CKLDGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRF-NYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPP 139 (796)
Q Consensus 61 C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~ 139 (796)
|.|.+|.|+... +|++ ++. |..+++|+.|+|++ |.|.++.+..|+++++|++|+|++|+|++..|.
T Consensus 8 C~~~~v~~~~~n----------~l~~-ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCTRDG----------ALDS-LHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECCSSC----------CCTT-TTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcCCCC----------CCCc-cCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 778777775421 3443 444 78888999999996 999988888999999999999999999988888
Q ss_pred CCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCC
Q 003780 140 ELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG 183 (796)
Q Consensus 140 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 183 (796)
.|.+|++|++|+|++|+|++..+..|..++ |+.|+|.+|.+..
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 899999999999999999977777777666 9999999999874
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.8e-11 Score=131.42 Aligned_cols=111 Identities=14% Similarity=0.212 Sum_probs=70.9
Q ss_pred CccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCC
Q 003780 258 PPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCS 337 (796)
Q Consensus 258 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 337 (796)
..+|.+...|+.+.+..+..+ .....|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 345666677777777655433 455667777777777775 3455455667777777777777654 5545566777777
Q ss_pred CCcEEEeecccccCCCCccc-cccccceEEeccccc
Q 003780 338 ELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKL 372 (796)
Q Consensus 338 ~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l 372 (796)
+|+.+.|..+ ++..-...| ++.+|+.+++.+|..
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 7777777544 543333344 466777777777654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.24 E-value=1e-10 Score=127.98 Aligned_cols=271 Identities=9% Similarity=0.099 Sum_probs=127.3
Q ss_pred ccccccCCCC-CCcEEeccCCcccccCCcCccCCCCCcEeecccCc---CCCCCCCCCCCCCCCCEEEecCCCCCCCCch
Q 003780 88 LSQFNFSCFP-GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNN---LTGSIPPELGSLRNLEVLNLKGNNLNGAIPS 163 (796)
Q Consensus 88 ~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 163 (796)
|....|.+.. .|+.+.+..+ ++.+-..+|.++++|+.+.++.|. ++.+-..+|.++.+|+.+.+..+ ++.+...
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence 4444555553 4666666543 555556666666666666666553 44344455666666666665543 3334445
Q ss_pred hhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCcc
Q 003780 164 SLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNL 243 (796)
Q Consensus 164 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L 243 (796)
+|.++.+|+.+.+..+ +..+....|.++.+|+.+.+..+ ++.+....|.+ .+|+.+.+..+-.. ....+|.+..+|
T Consensus 132 aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l 207 (394)
T 4gt6_A 132 AFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFAL 207 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTC
T ss_pred hhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccc
Confidence 5666666666666533 33344455666666666666543 33343444433 34555555443221 333344444444
Q ss_pred ceEEeccccccccCCcccc--------------CCcccceeecccccccccCccccccccccccccccCccccCcccccc
Q 003780 244 TYLYLHSNHLNGSIPPEIG--------------NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITI 309 (796)
Q Consensus 244 ~~L~L~~N~l~~~~p~~~~--------------~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~ 309 (796)
+......+... .+...+. ....+..+.+. +.++.....+|.++.+|+.+.+..+..+ +....|
T Consensus 208 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF 284 (394)
T 4gt6_A 208 STITSDSESYP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAF 284 (394)
T ss_dssp CEEEECCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTT
T ss_pred ceecccccccc-cccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCccc
Confidence 44444433322 1111100 01111122221 1222233344555555555555443322 334445
Q ss_pred ccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecc
Q 003780 310 AGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSH 369 (796)
Q Consensus 310 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~ 369 (796)
.++.+|+.+.+. +.++......|.++.+|+.+.|..+ ++..-...| ++.+|+.+.+..
T Consensus 285 ~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~ 343 (394)
T 4gt6_A 285 MNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPS 343 (394)
T ss_dssp TTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECT
T ss_pred ccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECc
Confidence 555555555553 2343344445555555555555433 332222233 345555555543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=8.3e-11 Score=120.96 Aligned_cols=147 Identities=15% Similarity=0.070 Sum_probs=114.3
Q ss_pred HHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecce
Q 003780 494 IIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKC 572 (796)
Q Consensus 494 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 572 (796)
+....+.|++....+.|+.+.||++... ++.+++|+........ ...+.+|+++++.+. +..+.++++++...+.
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 3445567888888999999999999864 6889999987532111 135888999999885 6778899999999899
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhc--------------------------------
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD-------------------------------- 620 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------- 620 (796)
.++||||++|.++.+.+.. ......++.+++++++.||+.
T Consensus 85 ~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred eEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 9999999999999766321 112346788999999999981
Q ss_pred ------------------------CCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 621 ------------------------CMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 621 ------------------------~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++.++|+|++|.||+++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999876556799998775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.08 E-value=4.4e-11 Score=128.12 Aligned_cols=140 Identities=16% Similarity=0.147 Sum_probs=68.4
Q ss_pred CchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhc--CCCCccccccCC--cccccc----
Q 003780 161 IPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELG--KLKNLVALNVGG--NKLMGP---- 232 (796)
Q Consensus 161 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~--N~l~~~---- 232 (796)
++..+..+++|+.|+|++|.-.. ++. +. +++|+.|+|..|.+.......+. .+++|+.|+|+. |...+.
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~ 240 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN 240 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG
T ss_pred HHHHHhcCCCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH
Confidence 33445555666666666552111 122 22 56677777766666543333333 566666666642 111111
Q ss_pred -CCCcc--cccCccceEEeccccccccCCcccc---CCcccceeeccccccccc----CccccccccccccccccCcccc
Q 003780 233 -IPSTL--FRLTNLTYLYLHSNHLNGSIPPEIG---NMTGILKVDMSMNNIEGT----IPLELTRLSQLLYLSISSNMLS 302 (796)
Q Consensus 233 -~~~~l--~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~ 302 (796)
+...+ ..+++|++|+|.+|.+++..+..+. .+++|+.|+|+.|.+++. ++..+..+++|+.|+|++|.++
T Consensus 241 ~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 00011 2356677777776666543222221 355666666666666542 2223344555555555555554
Q ss_pred C
Q 003780 303 G 303 (796)
Q Consensus 303 ~ 303 (796)
.
T Consensus 321 d 321 (362)
T 2ra8_A 321 D 321 (362)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=3.4e-10 Score=116.14 Aligned_cols=138 Identities=17% Similarity=0.145 Sum_probs=101.3
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCc--eeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN--IVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lV 576 (796)
.++.+....+.|..+.||++...+|+.+++|...... ...+.+|+++++.+++.+ +.+++++...++..++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 3455443334566799999988778889999976541 235778999999886444 45688888888889999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC----------------------------------- 621 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------- 621 (796)
|||++|.++. ... .+ ...++.++++.|..||+..
T Consensus 94 ~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998884 211 11 2356777888888888641
Q ss_pred --------------------CCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 622 --------------------MPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 622 --------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++.++|+|++|.||+++++..+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999998753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.03 E-value=6.3e-11 Score=126.91 Aligned_cols=102 Identities=20% Similarity=0.179 Sum_probs=57.9
Q ss_pred CCeEEEeCCCCCccc-cc----c--ccccCCCCCCcEEeccCCccc---------ccCCcCccCCCCCcEeecccCc-CC
Q 003780 72 RSIIEINLPEKKLKG-EL----S--QFNFSCFPGLESLSLRFNYLF---------GSIPSQVGALSKLRYLDFSFNN-LT 134 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~-~~----~--~~~~~~l~~L~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~Ls~n~-l~ 134 (796)
.+|+.|.+...+..| .. . ......+++|+.|.+..+... +.+...+..+++|+.|+|++|. +.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 457777777555442 11 0 112445778888887654321 1233445566778888887763 22
Q ss_pred CCCCCCCCCCCCCCEEEecCCCCCCCCchhhh--ccCccceeecc
Q 003780 135 GSIPPELGSLRNLEVLNLKGNNLNGAIPSSLC--QLTKLITMALS 177 (796)
Q Consensus 135 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~ 177 (796)
++. +. +++|++|+|..|.++......+. .+++|+.|+|+
T Consensus 187 --l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 187 --IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp --CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred --ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 222 33 67777777777776543333343 56777777764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.01 E-value=1.6e-12 Score=131.97 Aligned_cols=23 Identities=9% Similarity=-0.125 Sum_probs=15.4
Q ss_pred CCccCCceeeCCCC-CeEEEeCCC
Q 003780 59 DHCKLDGVTCNTAR-SIIEINLPE 81 (796)
Q Consensus 59 ~~C~w~gv~C~~~~-~v~~l~l~~ 81 (796)
..|+|.|+.|+..+ +|+.+..++
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~ 99 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSS 99 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEEC
T ss_pred HHHhcCcEEECCCCCEEEEEEecC
Confidence 35899999998653 555554433
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.3e-08 Score=108.62 Aligned_cols=284 Identities=11% Similarity=0.074 Sum_probs=182.7
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEe
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (796)
+++++.++.. ++ .|....|.++.+|+.++|..+ +..+...+|.++ +|+.+.+..+ ++.+...+|.+ .+|+.+++
T Consensus 47 ~i~~v~ip~~-vt-~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~l 120 (379)
T 4h09_A 47 RISEVRVNSG-IT-SIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEF 120 (379)
T ss_dssp GCSEEEECTT-EE-EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEEC
T ss_pred CCEEEEeCCC-cc-ChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccC
Confidence 4566666542 22 466667888888888888654 666667788876 6777777643 55444556665 47888888
Q ss_pred cCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCc------------chhhhcCCCCcc
Q 003780 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM------------LHQELGKLKNLV 220 (796)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------------~~~~~~~l~~L~ 220 (796)
..+ +.......|.+. +|+.+.+..+ ++......|..+.+|+.+.+..+..... ....+.....+.
T Consensus 121 p~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (379)
T 4h09_A 121 PGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGT 197 (379)
T ss_dssp CTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCS
T ss_pred CCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccccccc
Confidence 765 332334455443 5666655543 4445566777788888887766543321 112233344444
Q ss_pred ccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCcc
Q 003780 221 ALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNM 300 (796)
Q Consensus 221 ~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~ 300 (796)
.+.+..+. .......+....+|+.+.+..+ ++......|.+...|+.+.+..+ ++.....+|.++.+|+.+.+..+
T Consensus 198 ~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~- 273 (379)
T 4h09_A 198 EFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK- 273 (379)
T ss_dssp EEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-
T ss_pred ccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-
Confidence 44444322 2234456666777888877655 34355567777888888888765 55566677888888888888654
Q ss_pred ccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEeccc
Q 003780 301 LSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHN 370 (796)
Q Consensus 301 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N 370 (796)
+.......|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++..-...| ++.+|+.+.+..+
T Consensus 274 i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 274 VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 55455667888888888888888887777788888888888888654 553333444 4677887777554
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=4e-09 Score=113.70 Aligned_cols=143 Identities=17% Similarity=0.246 Sum_probs=106.3
Q ss_pred cceeeecccceeEEEEEccCCcEEEEEEec--cccchhhHHHHHHHHHHHHHhhcC--CCceeeEEeEEEec---ceeeE
Q 003780 503 IKYCIGTGGYGSVYKAQLPNGKVVALKKLH--RAETEETTFFNSFQNEAHVLSKIA--HRNIVKLYGFCLHK---KCMFL 575 (796)
Q Consensus 503 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~---~~~~l 575 (796)
..+.++.|.++.||++...+ ..+++|+.. ...... ....+.+|+++++.+. +..+.+++.++.+. +..++
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 35678999999999998764 678888776 332111 1246788999999987 45678899988776 45899
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC---------------------------------- 621 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------- 621 (796)
||||++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 119 vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99999998774311 112677888899999999999999731
Q ss_pred ---------------------CCCeEEecCCCCCeEecCCCc--EEEeeeccccc
Q 003780 622 ---------------------MPSIVHRDISSNNILLNSKLE--AFVADFGTARL 653 (796)
Q Consensus 622 ---------------------~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~ 653 (796)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247899999999999997753 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=2.9e-09 Score=111.91 Aligned_cols=185 Identities=22% Similarity=0.207 Sum_probs=121.8
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCc--eeeEEeEEEecc---eeeEEE
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRN--IVKLYGFCLHKK---CMFLIY 577 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lV~ 577 (796)
.+.++.|....||++. +.+++|+.... .....+.+|+++++.+. +.. +.+++.+....+ ..++||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568999999999873 56888886433 12357889999998884 322 345555443333 458899
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD------------------------------------- 620 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------- 620 (796)
++++|.++.+.... .++..++..++.++++.++.||+.
T Consensus 96 ~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp ECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 99999988653321 256677778888888888888861
Q ss_pred ------------------CCCCeEEecCCCCCeEecC--CCcEEEeeeccccccCCCCCCccc---------------cc
Q 003780 621 ------------------CMPSIVHRDISSNNILLNS--KLEAFVADFGTARLLDSDSSNRTI---------------VA 665 (796)
Q Consensus 621 ------------------~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~---------------~~ 665 (796)
..+.++|+|++|.||++++ ...+.|+||+.+..-.+. ..... ..
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHH
Confidence 1235899999999999998 455789999998753221 00000 00
Q ss_pred cccCccC-ccccccCCcCcchhHHHHHHHHHHHHhCCCCCc
Q 003780 666 GTYGYIA-PELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE 705 (796)
Q Consensus 666 gt~~y~a-PE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~ 705 (796)
..+++.. |+.... .....+.|++|.++|.+.+|+.+|.
T Consensus 250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1111122 222111 1223689999999999999998854
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.81 E-value=5.4e-08 Score=105.64 Aligned_cols=272 Identities=11% Similarity=0.034 Sum_probs=194.1
Q ss_pred cCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccc
Q 003780 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLI 172 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 172 (796)
+..-.+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+-..+|.+. +|+.+.+..+ ++.+...+|.. .+|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence 44556788888864 577777889999999999999754 776667788886 7888888754 55455566655 5899
Q ss_pred eeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccccc------------CCCccccc
Q 003780 173 TMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP------------IPSTLFRL 240 (796)
Q Consensus 173 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~------------~~~~l~~l 240 (796)
.+.+..+ ++......|.+. +|+.+.+..+ ++.+....|..+.+++.+.+..+..... ....+...
T Consensus 117 ~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (379)
T 4h09_A 117 DFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAA 193 (379)
T ss_dssp EEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTT
T ss_pred cccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccc
Confidence 9999765 343445566654 6777766543 5556677888888888887776544311 11123334
Q ss_pred CccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecc
Q 003780 241 TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDL 320 (796)
Q Consensus 241 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 320 (796)
..+..+.+..+.-. .....+....+|+.+.+..+ +.......|.++.+|+.+.+..+ ++.+....|.+..+|+.+.+
T Consensus 194 ~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l 270 (379)
T 4h09_A 194 KTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNF 270 (379)
T ss_dssp CCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccc
Confidence 45555555443322 45566777888999888655 45466678889999999999776 66567788999999999999
Q ss_pred cccccccCCCcccCCCCCCcEEEeecccccCCCCccc-cccccceEEecccccCCCCCc
Q 003780 321 SNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI-GLMKLEYLDLSHNKLNGTIPP 378 (796)
Q Consensus 321 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~p~ 378 (796)
..+ +.......|..+++|+.+.+.++.++..-...| ++.+|+.++|..+ ++ .|+.
T Consensus 271 ~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~ 326 (379)
T 4h09_A 271 YAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQV 326 (379)
T ss_dssp CCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECT
T ss_pred ccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHH
Confidence 764 655667789999999999999998886555556 5789999999765 43 4443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.58 E-value=3e-09 Score=107.93 Aligned_cols=79 Identities=25% Similarity=0.332 Sum_probs=45.3
Q ss_pred CCCCCCEEEecCCCCCC--CCchhhhccCccceeeccccccCCCCCccccCCC--CccEEEcccccccCcch-------h
Q 003780 143 SLRNLEVLNLKGNNLNG--AIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLN--NLLILSLDSNKLSGMLH-------Q 211 (796)
Q Consensus 143 ~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~-------~ 211 (796)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+..| .
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 45566666666666655 2345555666666666666666543 2233333 67777777777665333 3
Q ss_pred hhcCCCCccccc
Q 003780 212 ELGKLKNLVALN 223 (796)
Q Consensus 212 ~~~~l~~L~~L~ 223 (796)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 456677777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.53 E-value=1e-08 Score=98.97 Aligned_cols=91 Identities=15% Similarity=0.190 Sum_probs=40.7
Q ss_pred CccCCCCCcEeecccC-cCCCC----CCCCCCCCCCCCEEEecCCCCCCCC----chhhhccCccceeeccccccCCC--
Q 003780 116 QVGALSKLRYLDFSFN-NLTGS----IPPELGSLRNLEVLNLKGNNLNGAI----PSSLCQLTKLITMALSRNGLHGP-- 184 (796)
Q Consensus 116 ~~~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~-- 184 (796)
.+...+.|++|+|++| .|... +...+...++|++|+|++|+|.... ...+...++|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3444455555555555 44421 1223334455666666666554321 22233334455555555544421
Q ss_pred --CCccccCCCCccEEEc--cccccc
Q 003780 185 --IPSAIGDLNNLLILSL--DSNKLS 206 (796)
Q Consensus 185 --~p~~~~~l~~L~~L~L--~~N~l~ 206 (796)
+...+...++|++|+| ++|.|+
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2233333444555555 445444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=1.3e-08 Score=98.14 Aligned_cols=119 Identities=21% Similarity=0.192 Sum_probs=60.0
Q ss_pred CCCCCCCCCEEEecCC-CCCCC----CchhhhccCccceeeccccccCCC----CCccccCCCCccEEEcccccccCcch
Q 003780 140 ELGSLRNLEVLNLKGN-NLNGA----IPSSLCQLTKLITMALSRNGLHGP----IPSAIGDLNNLLILSLDSNKLSGMLH 210 (796)
Q Consensus 140 ~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~ 210 (796)
.+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+....
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3455677888888877 77642 223334445566666666665421 12233333455555555555543211
Q ss_pred hhhcCCCCccccccCCccccccCCCcccccCccceEEe--cccccccc----CCccccCCcccceeeccccccc
Q 003780 211 QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYL--HSNHLNGS----IPPEIGNMTGILKVDMSMNNIE 278 (796)
Q Consensus 211 ~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 278 (796)
. .+...+...++|++|+| ++|.++.. +...+...++|+.|+|++|.+.
T Consensus 111 ~--------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 L--------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp H--------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred H--------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 0 01233444455555555 55555432 1223334456666666666664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.4e-06 Score=85.73 Aligned_cols=135 Identities=19% Similarity=0.175 Sum_probs=96.6
Q ss_pred eeecccce-eEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeEEEeeccC
Q 003780 506 CIGTGGYG-SVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 506 ~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
.+..|..+ .||+...+ +++.+++|+-.... ...+.+|...++.+. +--+.++++++..++..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 45556555 68998765 56788999765332 346788999998885 33367888999999999999999999
Q ss_pred CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 003780 583 GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD------------------------------------------ 620 (796)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 620 (796)
.++.+...... .....++.++++.|..||+.
T Consensus 105 ~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 105 KTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred ccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 98877654321 12334556666666666642
Q ss_pred -------------CCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 621 -------------CMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 621 -------------~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
..+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 011379999999999999876667999988753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=1e-05 Score=84.64 Aligned_cols=136 Identities=17% Similarity=0.115 Sum_probs=91.9
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCC---ceeeEEeEEE-ecceeeEEEee
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR---NIVKLYGFCL-HKKCMFLIYKY 579 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lV~e~ 579 (796)
.+.++.|....||+. |+.+++|+-... .....+.+|+++++.+.+. .+.+++.++. ..+..++||||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456888999999998 567888874321 1245789999999999742 3556677764 45567899999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhc---------------------------------------
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHD--------------------------------------- 620 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------- 620 (796)
++|.++.+..-. .++...+..++.++++.|+.||+.
T Consensus 95 i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 95 VQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred cCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 999888653211 123333444444444444444432
Q ss_pred ------------------CCCCeEEecCCCCCeEecC---CCcE-EEeeeccccc
Q 003780 621 ------------------CMPSIVHRDISSNNILLNS---KLEA-FVADFGTARL 653 (796)
Q Consensus 621 ------------------~~~~ivH~dlkp~NIll~~---~~~~-kl~Dfg~a~~ 653 (796)
..+.++|+|+.|.||+++. ++.+ .|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999997 4554 7999998864
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.95 E-value=2.1e-06 Score=80.59 Aligned_cols=83 Identities=18% Similarity=0.183 Sum_probs=47.1
Q ss_pred CCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCC-CCCCCchhhhcc----Cccceeeccccc-cCCCCCccccCCCCc
Q 003780 122 KLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNN-LNGAIPSSLCQL----TKLITMALSRNG-LHGPIPSAIGDLNNL 195 (796)
Q Consensus 122 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 195 (796)
+|++|||+++.|+..--..+.++++|++|+|++|. |+...-..+..+ ++|++|+|++|. |+...-..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 56677777666665444456667777777777774 553333334433 246666666653 553322344556666
Q ss_pred cEEEccccc
Q 003780 196 LILSLDSNK 204 (796)
Q Consensus 196 ~~L~L~~N~ 204 (796)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=1.3e-05 Score=85.85 Aligned_cols=83 Identities=8% Similarity=-0.010 Sum_probs=55.2
Q ss_pred ceee-ecccceeEEEEEcc-------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-C--CceeeEEeEEEec--
Q 003780 504 KYCI-GTGGYGSVYKAQLP-------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-H--RNIVKLYGFCLHK-- 570 (796)
Q Consensus 504 ~~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~-- 570 (796)
.+.| +.|....+|+.... +++.+++|+..............+.+|+.+++.+. + -.+.+++.++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998754 26788898765432000000125677888888774 2 3467788887655
Q ss_pred -ceeeEEEeeccCCcHH
Q 003780 571 -KCMFLIYKYMKRGSLF 586 (796)
Q Consensus 571 -~~~~lV~e~~~~gsL~ 586 (796)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 4568999999987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.87 E-value=3.9e-06 Score=78.77 Aligned_cols=83 Identities=11% Similarity=0.094 Sum_probs=53.4
Q ss_pred CCCCEEEecCCCCCCCCchhhhccCccceeeccccc-cCCCCCccccCC----CCccEEEccccc-ccCcchhhhcCCCC
Q 003780 145 RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG-LHGPIPSAIGDL----NNLLILSLDSNK-LSGMLHQELGKLKN 218 (796)
Q Consensus 145 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~ 218 (796)
.+|++|||+++.|+..--..+.++++|+.|+|++|. |+...-..++.+ ++|++|+|++|. ++...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 579999999999886655667777888888888874 553333334443 357777777764 65444444555555
Q ss_pred ccccccCCc
Q 003780 219 LVALNVGGN 227 (796)
Q Consensus 219 L~~L~l~~N 227 (796)
|+.|+++++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 555555554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00012 Score=77.62 Aligned_cols=140 Identities=20% Similarity=0.301 Sum_probs=79.4
Q ss_pred eeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-----CCceeeEE-e--EEEecceeeEE
Q 003780 505 YCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-----HRNIVKLY-G--FCLHKKCMFLI 576 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~-~--~~~~~~~~~lV 576 (796)
+.|+.|..+.||++...+| .+++|+..... ..+..|..+++.+. .|.++... | +....+..++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 4466677889999987655 58999887521 12334455544442 34444311 1 12346678999
Q ss_pred EeeccCCcHH--------------HHHhhcCc----c-------cccCHHHH----------------------------
Q 003780 577 YKYMKRGSLF--------------CFLRNDYE----A-------VVLDWTMR---------------------------- 603 (796)
Q Consensus 577 ~e~~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~---------------------------- 603 (796)
++|++|..+. ..+|.... . ....|...
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986442 11222110 0 01122211
Q ss_pred ---HHHHHHHHHHHHHHhh----------cCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 604 ---VNIIKCVANALSYLHH----------DCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 604 ---~~i~~~ia~~L~~LH~----------~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
..+...+.+++++|+. ..++.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224446667763 124589999999999999888889999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00014 Score=79.05 Aligned_cols=78 Identities=10% Similarity=0.123 Sum_probs=49.8
Q ss_pred ceeeecccceeEEEEEcc-CCcEEEEEEeccccc--hh--hHHHHHHHHHHHHHhhcCC--Cc-eeeEEeEEEecceeeE
Q 003780 504 KYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAET--EE--TTFFNSFQNEAHVLSKIAH--RN-IVKLYGFCLHKKCMFL 575 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~--~~~~~~~~~E~~~l~~l~h--pn-iv~l~~~~~~~~~~~l 575 (796)
.+.+|.|..+.||++... +++.++||....... .. ....+.+..|.++++.+.. |. +.+++.+ +++..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 468899998654321 00 0112456778888887742 33 3355544 3455689
Q ss_pred EEeeccCC
Q 003780 576 IYKYMKRG 583 (796)
Q Consensus 576 V~e~~~~g 583 (796)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00046 Score=71.82 Aligned_cols=138 Identities=19% Similarity=0.181 Sum_probs=91.8
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC---CCceeeEEeEEEecceeeEEEeec
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA---HRNIVKLYGFCLHKKCMFLIYKYM 580 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~e~~ 580 (796)
.+.|+.|....+|+... +++.+++|+..... ...+..|++.++.+. ...+.++++++..++..++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 46789999999999986 46788899875431 346788999888884 356888899888888999999999
Q ss_pred cCCcHH--------H---HHhhcCc--c-----------------cccCHHHHH---HHHH----------------HHH
Q 003780 581 KRGSLF--------C---FLRNDYE--A-----------------VVLDWTMRV---NIIK----------------CVA 611 (796)
Q Consensus 581 ~~gsL~--------~---~l~~~~~--~-----------------~~l~~~~~~---~i~~----------------~ia 611 (796)
++..+. . .+|.... . -.-+|.... ++.. .+.
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987541 1 2333211 0 012454332 1111 111
Q ss_pred -HHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 612 -NALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 612 -~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
.....|.. ...+.++|+|+.+.|++++.++ +.|.|++
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11223432 2246899999999999999887 8888873
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.45 E-value=3.2e-05 Score=74.04 Aligned_cols=12 Identities=8% Similarity=0.127 Sum_probs=6.0
Q ss_pred CCCCCcEeeccc
Q 003780 119 ALSKLRYLDFSF 130 (796)
Q Consensus 119 ~l~~L~~L~Ls~ 130 (796)
+-+.|++|+|++
T Consensus 39 ~n~~L~~L~L~~ 50 (197)
T 1pgv_A 39 DDTDLKEVNINN 50 (197)
T ss_dssp TCSSCCEEECTT
T ss_pred cCCCccEEECCC
Confidence 334455555554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.40 E-value=2.3e-05 Score=75.00 Aligned_cols=65 Identities=14% Similarity=0.132 Sum_probs=31.7
Q ss_pred CCCCCCcEEeccCC-cccc----cCCcCccCCCCCcEeecccCcCCCCCCCC----CCCCCCCCEEEecCCCCC
Q 003780 94 SCFPGLESLSLRFN-YLFG----SIPSQVGALSKLRYLDFSFNNLTGSIPPE----LGSLRNLEVLNLKGNNLN 158 (796)
Q Consensus 94 ~~l~~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 158 (796)
.+-+.|+.|+|++| .|.. .+-..+..-+.|+.|+|++|.|.+..... +..-+.|++|+|++|+|+
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 34456666777664 5542 12233444455666666666555322222 223345555555555554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00083 Score=69.28 Aligned_cols=79 Identities=15% Similarity=0.172 Sum_probs=56.4
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC---CceeeEEeEEEecceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH---RNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~~~~~l 575 (796)
......+.+|.|..+.||+.+..||+.|++|+-....... ...|..|++.|+.+.- --+.+++++. ..++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 3455567899999999999999999999999876543222 2357889998888742 1244555542 3478
Q ss_pred EEeeccCCc
Q 003780 576 IYKYMKRGS 584 (796)
Q Consensus 576 V~e~~~~gs 584 (796)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999988764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0016 Score=71.08 Aligned_cols=78 Identities=12% Similarity=0.046 Sum_probs=47.6
Q ss_pred CCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCcccccc--ccCccCccccccC---CcCcchhHHHHHHHHHH
Q 003780 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG--TYGYIAPELAYTM---VVTEKCDVYSFGVVALE 696 (796)
Q Consensus 622 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DVwSlGv~l~e 696 (796)
.+.++|+|++|.||+++.++ +.++||+.+..-.+. .......+ ...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999999876 999999988753211 11111111 1235666554311 11223455677888888
Q ss_pred HHhCC
Q 003780 697 VLMGR 701 (796)
Q Consensus 697 lltg~ 701 (796)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0024 Score=66.89 Aligned_cols=158 Identities=13% Similarity=0.115 Sum_probs=88.1
Q ss_pred ccHHHHHHHhcCCcc-----ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-----CC
Q 003780 489 IAFEDIIKATEDFDI-----KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-----HR 558 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp 558 (796)
++.+++.....+|.+ .+.|+.|....+|+....+| .+++|....... ...+..|+.+++.+. -|
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCC
Confidence 455666666666765 23466788889999987655 688898875311 124556777776663 23
Q ss_pred ceeeEE-e--EEEecceeeEEEeeccCCcHHH--------------HHhhcC---ccc------ccCHHHHHH-------
Q 003780 559 NIVKLY-G--FCLHKKCMFLIYKYMKRGSLFC--------------FLRNDY---EAV------VLDWTMRVN------- 605 (796)
Q Consensus 559 niv~l~-~--~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~---~~~------~l~~~~~~~------- 605 (796)
.++... | +....+..+++++|++|..+.. .+|... ... ...|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 333210 1 1123466789999999864311 122210 000 011222110
Q ss_pred -----HHHHHHHHHHHHhhc----CCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 606 -----IIKCVANALSYLHHD----CMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 606 -----i~~~ia~~L~~LH~~----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
+...+.+.+++++.. .+.+++|+|+.+.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455566532 23478999999999999987556799998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0081 Score=62.93 Aligned_cols=158 Identities=13% Similarity=0.133 Sum_probs=88.4
Q ss_pred ccHHHHHHHhcCCcc-----ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCC--cee
Q 003780 489 IAFEDIIKATEDFDI-----KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR--NIV 561 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv 561 (796)
++.+++....+.|.+ ...++ |....||++...+|+.+++|........ ...+..|..+++.+... .+.
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeec
Confidence 444455444444432 34566 8888999998777888999998644221 23566677777776421 133
Q ss_pred eEEeE-----EEecceeeEEEeeccCCcHH-----H---------HHhhcC------cccccCHHHH----HHH------
Q 003780 562 KLYGF-----CLHKKCMFLIYKYMKRGSLF-----C---------FLRNDY------EAVVLDWTMR----VNI------ 606 (796)
Q Consensus 562 ~l~~~-----~~~~~~~~lV~e~~~~gsL~-----~---------~l~~~~------~~~~l~~~~~----~~i------ 606 (796)
+++.. ....+..++|++|++|..+. . .+|... .....++... ..+
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 34332 22355668899999885432 1 122110 0111222111 001
Q ss_pred ---------HHHHHHHHHHHhhc----CCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 607 ---------IKCVANALSYLHHD----CMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 607 ---------~~~ia~~L~~LH~~----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
...+.+.++.+... .+..++|+|+++.||+++ + .+.++||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 234678999999999999 4 889999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0029 Score=66.69 Aligned_cols=141 Identities=16% Similarity=0.132 Sum_probs=72.8
Q ss_pred eeeeccccee-EEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-C-CceeeEEeEEEecceeeEEEeecc
Q 003780 505 YCIGTGGYGS-VYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-H-RNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 505 ~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-pniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
+.++.|.... +|+....+|+.+++|....... ..+..|+.+++.+. + -.+.+++.+....+ ++|||++.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 3455554443 6777665467787776544321 12345666666663 2 23456666643333 68999997
Q ss_pred CCcHHHHHhhcC---------------------c--ccccCHHHHH-------H-------------HHHHHHHHHHHHh
Q 003780 582 RGSLFCFLRNDY---------------------E--AVVLDWTMRV-------N-------------IIKCVANALSYLH 618 (796)
Q Consensus 582 ~gsL~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~~ia~~L~~LH 618 (796)
+..+.+++.... . ....+..... . ....+.+.++.+.
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 766654433210 0 0011111000 0 0011112222221
Q ss_pred ---hcCCCCeEEecCCCCCeEecCC----CcEEEeeeccccc
Q 003780 619 ---HDCMPSIVHRDISSNNILLNSK----LEAFVADFGTARL 653 (796)
Q Consensus 619 ---~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~ 653 (796)
...++.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123478999999999999875 6789999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0021 Score=57.32 Aligned_cols=34 Identities=32% Similarity=0.266 Sum_probs=14.2
Q ss_pred CcEeecccCcCCCCCCCCCCCCCCCCEEEecCCC
Q 003780 123 LRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNN 156 (796)
Q Consensus 123 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~ 156 (796)
|++|+|++|+|+.+.+..|..+++|++|+|++|.
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 4444444444443333334444444444444443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0023 Score=69.98 Aligned_cols=73 Identities=21% Similarity=0.274 Sum_probs=48.4
Q ss_pred ceeeecccceeEEEEEccC--------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCce-eeEEeEEEecceee
Q 003780 504 KYCIGTGGYGSVYKAQLPN--------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI-VKLYGFCLHKKCMF 574 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~ 574 (796)
.+.|+.|....+|++...+ ++.+++|+...... ...+..|..+++.+...++ .++++.+.. .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4568888889999998653 57899998844211 1244578888888753333 566665532 2
Q ss_pred EEEeeccCCcH
Q 003780 575 LIYKYMKRGSL 585 (796)
Q Consensus 575 lV~e~~~~gsL 585 (796)
+|+||++|.++
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0032 Score=65.25 Aligned_cols=138 Identities=15% Similarity=0.153 Sum_probs=74.7
Q ss_pred ceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCce-eeEEeEEEecceeeEEEeec-c
Q 003780 504 KYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI-VKLYGFCLHKKCMFLIYKYM-K 581 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~-~ 581 (796)
.+.|+.|....+|++ +.+++|+....... .-...+|+.+++.+....+ .+++++ .++.-++|+||+ +
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 678999999999999 45888877643211 1123457777776642222 355544 344457899999 6
Q ss_pred CCcHHH------------------HHhhcCcc--cccC-HHHHHHHHH--------------HHHHHH----HHHhh-cC
Q 003780 582 RGSLFC------------------FLRNDYEA--VVLD-WTMRVNIIK--------------CVANAL----SYLHH-DC 621 (796)
Q Consensus 582 ~gsL~~------------------~l~~~~~~--~~l~-~~~~~~i~~--------------~ia~~L----~~LH~-~~ 621 (796)
+.++.. .+|..... ...+ +.....+.. .+.+.+ +.+.. ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 554421 11111100 0011 111111110 011111 11111 12
Q ss_pred CCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 622 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5566789999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.003 Score=56.24 Aligned_cols=37 Identities=35% Similarity=0.352 Sum_probs=22.4
Q ss_pred CCCEEEecCCCCCCCCchhhhccCccceeeccccccC
Q 003780 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLH 182 (796)
Q Consensus 146 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 182 (796)
+|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4666666666666555555666666666666666554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0042 Score=66.39 Aligned_cols=141 Identities=18% Similarity=0.201 Sum_probs=80.3
Q ss_pred eeeecccceeEEEEEcc--------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceeeE
Q 003780 505 YCIGTGGYGSVYKAQLP--------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 575 (796)
+.+..|-...+|++... +++.+++|+...... ....+.+|.++++.+. +.-..++++++.. .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~----~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ----GVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C----CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc----hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 46777888899999865 357899998633211 1235668999888874 3223566666543 28
Q ss_pred EEeeccCCcHHH--------------H---HhhcCc--ccccC--HHHHHHHHHHHHH-------------------HHH
Q 003780 576 IYKYMKRGSLFC--------------F---LRNDYE--AVVLD--WTMRVNIIKCVAN-------------------ALS 615 (796)
Q Consensus 576 V~e~~~~gsL~~--------------~---l~~~~~--~~~l~--~~~~~~i~~~ia~-------------------~L~ 615 (796)
|+||++|.++.. . +|.... ..... +..+.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999765421 0 122110 01112 3444444433321 223
Q ss_pred HHh----hc-CCCCeEEecCCCCCeEecCC----CcEEEeeeccccc
Q 003780 616 YLH----HD-CMPSIVHRDISSNNILLNSK----LEAFVADFGTARL 653 (796)
Q Consensus 616 ~LH----~~-~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~ 653 (796)
.|. .. .+..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 21 23368999999999999876 6889999988753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.21 E-value=0.034 Score=53.34 Aligned_cols=102 Identities=19% Similarity=0.069 Sum_probs=66.5
Q ss_pred cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCCccc
Q 003780 584 SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI 663 (796)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 663 (796)
+|.++|.... .++++.+++.++.|.+.+|.-.-.+.. . ..+=+.|..|++..+|.+...+ +.+.
T Consensus 34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 8999998654 359999999999999998877622101 1 1233456889999999987753 1110
Q ss_pred cccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCC
Q 003780 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p 703 (796)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122467888763 3456788999999999999865555
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.014 Score=63.99 Aligned_cols=74 Identities=18% Similarity=0.128 Sum_probs=47.1
Q ss_pred ceeeecccceeEEEEEccC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCce-eeEEeEEEecceeeEEEeecc
Q 003780 504 KYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI-VKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~ 581 (796)
.+.|+.|-...+|++...+ ++.+++|+.......- . ...+|..+++.+...++ .++++++. + ..|+||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---I-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---S-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---c-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 4568888889999998765 5788888774432110 1 12578888888864444 46666662 2 25999998
Q ss_pred CCcH
Q 003780 582 RGSL 585 (796)
Q Consensus 582 ~gsL 585 (796)
|.++
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0061 Score=65.20 Aligned_cols=74 Identities=14% Similarity=0.089 Sum_probs=43.0
Q ss_pred ceeeecccceeEEEEEccC---------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCc-eeeEEeEEEeccee
Q 003780 504 KYCIGTGGYGSVYKAQLPN---------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN-IVKLYGFCLHKKCM 573 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~ 573 (796)
.+.++.|....+|++...+ ++.+++|+....... ......|.++++.+...+ +.++++.. + -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 3467778888999997653 267888876543211 112356788877775223 34566543 2 3
Q ss_pred eEEEeeccCCcH
Q 003780 574 FLIYKYMKRGSL 585 (796)
Q Consensus 574 ~lV~e~~~~gsL 585 (796)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.01 Score=62.54 Aligned_cols=31 Identities=23% Similarity=0.480 Sum_probs=27.5
Q ss_pred CCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 623 PSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 623 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.96 E-value=0.38 Score=51.93 Aligned_cols=74 Identities=11% Similarity=0.051 Sum_probs=46.5
Q ss_pred ceeeecccceeEEEEEccC--------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEecceee
Q 003780 504 KYCIGTGGYGSVYKAQLPN--------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 574 (796)
.+.+..|-...+|+....+ ++.|++|+....... .-...+|..+++.+. +.-..++++.+ . -+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF--P--EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CC
Confidence 3567778888999997653 578999886443211 112356788877774 22234555433 2 26
Q ss_pred EEEeeccCCcH
Q 003780 575 LIYKYMKRGSL 585 (796)
Q Consensus 575 lV~e~~~~gsL 585 (796)
.|+||++|..+
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.30 E-value=0.54 Score=50.45 Aligned_cols=30 Identities=30% Similarity=0.464 Sum_probs=24.7
Q ss_pred CeEEecCCCCCeEe------cCCCcEEEeeeccccc
Q 003780 624 SIVHRDISSNNILL------NSKLEAFVADFGTARL 653 (796)
Q Consensus 624 ~ivH~dlkp~NIll------~~~~~~kl~Dfg~a~~ 653 (796)
.++|+|+.+.||++ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4456789999988863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.40 E-value=1.1 Score=42.78 Aligned_cols=116 Identities=6% Similarity=0.056 Sum_probs=82.2
Q ss_pred CCCceeeEEeEEEecceeeEEEeeccCC-cHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCC
Q 003780 556 AHRNIVKLYGFCLHKKCMFLIYKYMKRG-SLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNN 634 (796)
Q Consensus 556 ~hpniv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 634 (796)
.||+.++. ..-..++.+.+.|+.-+.+ ++.. + ...+...+++++.+|+....+++++ +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 58888876 5666677777777765432 3332 2 2378889999999999888766655 899999999
Q ss_pred eEecCCCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcc
Q 003780 635 ILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGEL 706 (796)
Q Consensus 635 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~ 706 (796)
++++.++.+++.--|+...+. |.- .++..=.-.+=+++..+++++..|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~-----------------P~~-----~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVD-----------------PLP-----VSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTTBS-----------------CCC-----CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccCCC-----------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999998777654332 221 11222233667888899999999873
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.85 E-value=2.4 Score=40.68 Aligned_cols=115 Identities=13% Similarity=0.118 Sum_probs=80.1
Q ss_pred CCCceeeEEeEEEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHH-HHhhcCCCCeEEecCCCCC
Q 003780 556 AHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALS-YLHHDCMPSIVHRDISSNN 634 (796)
Q Consensus 556 ~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~dlkp~N 634 (796)
.||++ -...-..++.+.+.++.-+++.=+..++ ..+...+++++.+|+.... +++++ +|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence 58888 4455577788888888765543333333 2678899999999987766 56654 888999999
Q ss_pred eEecCCCcEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCc
Q 003780 635 ILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGE 705 (796)
Q Consensus 635 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~ 705 (796)
++++.++.+++.-.|.-..+ +|.-. ++.-=.-++=+++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~l-----------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL-----------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTTB-----------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcccC-----------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999877765433 23221 111112366778888999988877
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 796 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-23 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-07 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 7e-61
Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 21/276 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+ IG+G +G+VYK + VA+K L+ +F+NE VL K H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHV 64
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
NI+ G+ + ++ ++ + SL+ L + ++I + A + YLH
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR--TIVAGTYGYIAPELA 676
SI+HRD+ SNNI L+ L + DFG A + S + ++G+ ++APE+
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 677 YTM---VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733
+ + DVY+FG+V E++ G+ P S+ ++ +I+ + V LSP +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFM-VGRGYLSPDL 231
Query: 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
++ + + CL K RP ++
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-59
Identities = 62/278 (22%), Positives = 119/278 (42%), Gaps = 26/278 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E + +G G +G V+ VA+K L + ++F EA+++ ++ H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V+LY + +++I +YM+ GSL FL+ + L +++ +A ++++
Sbjct: 69 RLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN-RTIVAGTYGYIAPELAY 677
+HRD+ + NIL++ L +ADFG ARL++ + R + APE
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-LIDVLDSRLSPPVDRM 736
T K DV+SFG++ E++ P +I L+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI---------PYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQ---EFLT 771
+++ + C +P+ RPT + +F T
Sbjct: 235 CPEELY---QLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-59
Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 23/277 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
ED+++ Y IGTG YG K + +GK++ K+L E +E ++L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 62
Query: 558 RNIVKLYGFCLHK--KCMFLIYKYMKRGSLFCFL-RNDYEAVVLDWTMRVNIIKCVANAL 614
NIV+ Y + + ++++ +Y + G L + + E LD + ++ + AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 615 SYLH--HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
H D +++HRD+ N+ L+ K + DFG AR+L+ D+S GT Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV--LDSRLS 730
PE M EK D++S G + E+ P ++ S KI + R S
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP---FTAFSQKELAGKIREGKFRRIPYRYS 239
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
++ ++ + L+ K RP+++ + +
Sbjct: 240 DELNEIITR-----------MLNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-58
Identities = 74/276 (26%), Positives = 131/276 (47%), Gaps = 25/276 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
EDF+I +G G +G+VY A+ + ++ALK L +A+ E+ + + E + S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
NI++LYG+ ++LI +Y G+++ L+ D I +ANALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H ++HRDI N+LL S E +ADFG + S + GT Y+ PE+
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEMIE 177
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV-LDSRLSPPVDRM 736
+ EK D++S GV+ E L+G+ P + + + ++I ++ ++ +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGARDL 234
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFLT 771
+ + L P RP ++ V + ++T
Sbjct: 235 ISR-----------LLKHNPSQRPMLREVLEHPWIT 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-58
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 10/208 (4%)
Query: 497 ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI 555
+DF+ +G G G V+K P+G V+A K +H N E VL +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHEC 61
Query: 556 AHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALS 615
IV YG + + ++M GSL L+ + + + V L+
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 118
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
YL I+HRD+ +NIL+NS+ E + DFG + L +N + GT Y++PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPER 174
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + D++S G+ +E+ +GR+P
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-57
Identities = 57/272 (20%), Positives = 110/272 (40%), Gaps = 21/272 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+ IG+G +G V+ N VA+K + E F EA V+ K++H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V+LYG CL + + L++++M+ G L +LR + + + V +
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEG---MA 115
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI-VAGTYGYIAPELAY 677
+ ++HRD+++ N L+ V+DFG R + D + + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737
+ K DV+SFGV+ EV + +++ + + R+
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI--------PYENRSNSEVVEDISTGFRLYKPRLA 227
Query: 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ + C +P+ RP R+ ++
Sbjct: 228 STHVY---QIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 65/274 (23%), Positives = 119/274 (43%), Gaps = 23/274 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+D +GTG +G V + VA+K + E + F EA V+ ++H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 59
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V+LYG C ++ +F+I +YM G L +LR + + K V A+ YL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL-DSDSSNRTIVAGTYGYIAPELAY 677
+HRD+++ N L+N + V+DFG +R + D + ++ + PE+
Sbjct: 118 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 678 TMVVTEKCDVYSFGVVALEVL-MGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736
+ K D+++FGV+ E+ +G+ P E ++ + + L +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIAQGLRLYRPHL 225
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770
+ + T+ +C H K RPT + + L
Sbjct: 226 ASEKVY---TIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 27/273 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++ + IG G +G V G VA+K + T + +F EA V++++ H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 60
Query: 559 NIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+V+L G + K ++++ +YM +GSL +LR+ +V L + V A+ YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 119
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
+ VHRD+++ N+L++ A V+DFG + SS + + APE
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-LIDVLDSRLSPPVDRM 736
+ K DV+SFG++ E+ P + ++ ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV---------PYPRIPLKDVVPRVEKGYKMDAPDG 224
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ V C H RP+ ++ ++
Sbjct: 225 CPPAVY---EVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-55
Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 23/273 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E ++ +G G +G V+ VA+K L +F EA V+ K+ H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
+V+LY + ++++ +YM +GSL FL+ + + V++ +A+ ++Y+
Sbjct: 73 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE 130
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL-DSDSSNRTIVAGTYGYIAPELAY 677
VHRD+ + NIL+ L VADFG ARL+ D++ + R + APE A
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-LIDVLDSRLSPPVDRM 736
T K DV+SFG++ E+ P ++D ++ P
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV---------PYPGMVNREVLDQVERGYRMPCPPE 238
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ + + C +P+ RPT + +
Sbjct: 239 CPESLH---DLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 5e-54
Identities = 63/279 (22%), Positives = 116/279 (41%), Gaps = 26/279 (9%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ F IG G +G+VY A+ + N +VVA+KK+ + + + E L K+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
H N ++ G L + +L+ +Y + + L + L+Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
LH +++HRD+ + NILL+ + DFG+A ++ +S GT ++APE+
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVI 183
Query: 677 YTM---VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733
M K DV+S G+ +E+ + P ++++S+ + + S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFLT 771
V CL P+ RPT + + + F+
Sbjct: 244 RNFVDS-----------CLQKIPQDRPTSEVLLKHRFVL 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 8e-54
Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 38/298 (12%)
Query: 491 FEDIIKATEDFD---------IKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETE 537
FED +A +F I+ IG G +G V L VA+K L TE
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 538 ETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV 597
+ F +EA ++ + H N++ L G + +I ++M+ GSL FLR +
Sbjct: 69 K--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 598 LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657
V +++ +A + YL VHRD+++ NIL+NS L V+DFG +R L+ D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 658 SSNRTIVA-----GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLS 711
+S+ T + + APE T DV+S+G+V EV+ G P
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW------ 235
Query: 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
++Q ++ D RL PP+D + + L C RP ++
Sbjct: 236 -DMTNQDVINAIEQDYRLPPPMD--CPSALH---QLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 1e-53
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 23/274 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
D +K+ +G G YG VY+ VA+K L E F EA V+ +I H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKH 72
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+V+L G C + ++I ++M G+L +L + + + + + +++A+ YL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR-TIVAGTYGYIAPELA 676
+ +HRD+++ N L+ VADFG +RL+ D+ + APE
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-LIDVLDSRLSPPVDR 735
+ K DV++FGV+ E+ P + + ++L+
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMS---------PYPGIDLSQVYELLEKDYRMERPE 239
Query: 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ + + AC P RP+ + Q F
Sbjct: 240 GCPEKVY---ELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-53
Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 29/301 (9%)
Query: 496 KATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK 554
K EDF +G G + +V A+ L + A+K L + + E V+S+
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
+ H VKLY + ++ Y K G L ++R D T + +AL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSAL 121
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIA 672
YLH I+HRD+ NILLN + + DFGTA++L +S GT Y++
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 673 PELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV-LDSRLSP 731
PEL + D+++ G + +++ G P + + QKI+ ++ + P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP---FRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNP-FEEISIWQLRN 790
+V + L R C+E +P FE ++ L
Sbjct: 236 KARDLVEK-----------LLVLDATKRLG----CEEMEGYGPLKAHPFFESVTWENLHQ 280
Query: 791 Q 791
Q
Sbjct: 281 Q 281
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-53
Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 47/306 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVL 552
E+ + +G+G +G V A VA+K L + +E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 94
Query: 553 SKIA-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN-------------------- 591
+++ H NIV L G C ++LI++Y G L +LR+
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 592 DYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651
+ + VL + + VA + +L S VHRD+++ N+L+ + DFG A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 652 RLLDSDSSNRTI--VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGRHPGELLS 708
R + SDS+ ++APE + + T K DV+S+G++ E+ +G +P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----- 266
Query: 709 SLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
P ++ + ++I + +C + RP+ +
Sbjct: 267 ---YPGIPVDANFYKLIQNGFKMDQPFYATEEIY---IIMQSCWAFDSRKRPSFPNLTS- 319
Query: 769 FLTCKI 774
FL C++
Sbjct: 320 FLGCQL 325
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-53
Identities = 64/273 (23%), Positives = 106/273 (38%), Gaps = 22/273 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
ED+D+ +G G YG V A + VA+K + + + + E + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNH 62
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
N+VK YG +L +Y G LF + D + + + YL
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYL 119
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI--VAGTYGYIAPEL 675
H I HRDI N+LL+ + ++DFG A + ++ R + + GT Y+APEL
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 676 AYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734
E DV+S G+V +L G P + SD D + +
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD-------QPSDSCQEYSDWKEKKTYLNPW 229
Query: 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+ + + + L P R T+ + +
Sbjct: 230 KKIDSAPL---ALLHKILVENPSARITIPDIKK 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-53
Identities = 62/298 (20%), Positives = 116/298 (38%), Gaps = 28/298 (9%)
Query: 492 EDIIKATEDFDI-KYCIGTGGYGSVYKAQL---PNGKVVALKKLHRAETEETTFFNSFQN 547
+ + ++ I +G G +GSV + VA+K L + +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 58
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNII 607
EA ++ ++ + IV+L G C + + L+ + G L FL E + + ++
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELL 115
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN---RTIV 664
V+ + YL + VHRD+++ N+LL ++ A ++DFG ++ L +D S R+
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 665 AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-LID 723
+ APE + + DV+S+GV E L P K ++
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------PYKKMKGPEVMA 223
Query: 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFE 781
++ ++ + C K + RP V Q C +L + E
Sbjct: 224 FIEQGKRMECPPECPPELY---ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-53
Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 39/295 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVL 552
+G G +G V +A VA+K L + + +E VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 553 SKIA-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN---------------DYEAV 596
S + H NIV L G C +I +Y G L FLR + + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 597 VLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656
LD ++ VA +++L + +HRD+++ NILL + DFG AR + +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 657 DSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS 714
DS+ + ++APE + V T + DV+S+G+ E+ P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------PG 250
Query: 715 SDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
++ ++ + C + P RPT +++ Q
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMY---DIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 63/299 (21%), Positives = 115/299 (38%), Gaps = 37/299 (12%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
++ IG G +G V++ + G+ VA+K E + E + + H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR----EAEIYQTVMLRHE 57
Query: 559 NIVKLYGFC----LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
NI+ ++L+ Y + GSLF +L + + + A+ L
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGL 113
Query: 615 SYLHHDCM-----PSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN----RTIVA 665
++LH + + P+I HRD+ S NIL+ +AD G A DS +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 666 GTYGYIAPELAYTMV------VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSD--- 716
GT Y+APE+ + ++ D+Y+ G+V E+ G + P D
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 717 ----QKIMLIDVLDSRLSP--PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ M V + +L P P + + ++ + C ++ R T R+ +
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 59/271 (21%), Positives = 116/271 (42%), Gaps = 21/271 (7%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ + IG G G+VY A + G+ VA+++++ + + NE V+ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENK 75
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
+ NIV L ++++ +Y+ GSL + D + + AL +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEF 131
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
LH + ++HRDI S+NILL + DFG + + S R+ + GT ++APE+
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736
K D++S G++A+E++ G P + + + I + + + +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+D + CL + R + + + Q
Sbjct: 246 -FRDFL------NRCLDMDVEKRGSAKELLQ 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 3e-52
Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 26/273 (9%)
Query: 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
FDI+ IG G + +VYK VA +L + + + F+ EA +L + H N
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 560 IVKLYGFCL----HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALS 615
IV+ Y KKC+ L+ + M G+L +L+ V+ + + + + L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQ 126
Query: 616 YLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
+LH P I+HRD+ +NI + + D G A L + + V GT ++APE
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--VIGTPEFMAPE 183
Query: 675 LAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734
+ Y E DVY+FG+ LE+ +P S + + V D
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASFD 235
Query: 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
++ + ++ + C+ R +++ +
Sbjct: 236 KVAIPEVK---EIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-52
Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 36/295 (12%)
Query: 491 FEDIIK---ATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQ 546
+E + + + ++I +G G +G VYKAQ + A K + EE +
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYM 57
Query: 547 NEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNI 606
E +L+ H NIVKL ++ ++++ ++ G++ + L + +
Sbjct: 58 VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVV 115
Query: 607 IKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAG 666
K +AL+YLH I+HRD+ + NIL + +ADFG + R G
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172
Query: 667 TYGYIAPELAYTMV-----VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM- 720
T ++APE+ K DV+S G+ +E+ P L+ KI
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP---HHELNPMRVLLKIAK 229
Query: 721 ---LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFLT 771
SR S + + CL R T ++ Q F+T
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLKK-----------CLEKNVDARWTTSQLLQHPFVT 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (460), Expect = 2e-51
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 29/301 (9%)
Query: 479 VFSIWNYD----GRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHR 533
VF IW I + ++ + +DI +GTG +G V++ G A K +
Sbjct: 5 VFDIWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61
Query: 534 AETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY 593
+ + + E +S + H +V L+ M +IY++M G LF + +++
Sbjct: 62 PHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH 118
Query: 594 EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFV--ADFGTA 651
+ V ++ V L ++H + VH D+ NI+ +K + DFG
Sbjct: 119 NK--MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173
Query: 652 RLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLS 711
LD S + GT + APE+A V D++S GV++ +L G P
Sbjct: 174 AHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP------FG 226
Query: 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFL 770
+ D+ + + D + + +D L + P R T+ + + +L
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAFSGISEDGK---DFIRKLLLADPNTRMTIHQALEHPWL 283
Query: 771 T 771
T
Sbjct: 284 T 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 60/284 (21%), Positives = 116/284 (40%), Gaps = 34/284 (11%)
Query: 507 IGTGGYGSVYKAQLPN---GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKL 563
+G+G +G+V K K VA+K L E + + EA+V+ ++ + IV++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
G C + M L+ + + G L +L+ + + + ++ V+ + YL
Sbjct: 74 IGICEAESWM-LVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---S 126
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN---RTIVAGTYGYIAPELAYTMV 680
+ VHRD+++ N+LL ++ A ++DFG ++ L +D + +T + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 681 VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-LIDVLDSRLSPPVDRMVMQ 739
+ K DV+SFGV+ E P K + +L+ +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK---------PYRGMKGSEVTAMLEKGERMGCPAGCPR 237
Query: 740 DIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783
++ + C + RP V L N + ++
Sbjct: 238 EMY---DLMNLCWTYDVENRPGFAAVEL-------RLRNYYYDV 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 3e-51
Identities = 66/300 (22%), Positives = 119/300 (39%), Gaps = 45/300 (15%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVL 552
+ + IG G +G V++A+ P +VA+K L + + FQ EA ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 70
Query: 553 SKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRN--------------------- 591
++ + NIVKL G C K M L+++YM G L FLR+
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 592 DYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651
L ++ I + VA ++YL VHRD+++ N L+ + +ADFG +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 652 RLLDSDSSNR--TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSS 709
R + S + A ++ PE + T + DV+++GVV E+
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------ 241
Query: 710 LSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ ++ V D + + ++ + + C P RP+ + +
Sbjct: 242 -PYYGMAHEEVIYYVRDGNILACPENCPLE----LYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 5e-50
Identities = 65/289 (22%), Positives = 107/289 (37%), Gaps = 36/289 (12%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNG---KVVALKKLHRAETEETTFFNSFQNEAHVLSKI 555
D + IG G +G V KA++ A+K++ +++ F E VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67
Query: 556 A-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-------------EAVVLDWT 601
H NI+ L G C H+ ++L +Y G+L FLR A L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 602 MRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
++ VA + YL +HRD+++ NIL+ A +ADFG +R +
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 662 TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM- 720
++A E V T DV+S+GV+ E++ P
Sbjct: 185 MGR-LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------PYCGMTCAE 234
Query: 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
L + L ++ + C KP RP+ ++
Sbjct: 235 LYEKLPQGYRLEKPLNCDDEVY---DLMRQCWREKPYERPSFAQILVSL 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (447), Expect = 1e-49
Identities = 57/272 (20%), Positives = 109/272 (40%), Gaps = 21/272 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ +DI +G+G +G V++ G+V K ++ + + +NE +++++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
++ L+ K M LI +++ G LF + E + +N ++ L ++
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHM 143
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFV--ADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
H SIVH DI NI+ +K + V DFG A L+ D + T + APE+
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEI 199
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735
V D+++ GV+ +L G P + + + + D
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP------FAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
V + L +P+ R T+ +
Sbjct: 254 SVSPEAK---DFIKNLLQKEPRKRLTVHDALE 282
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 68/279 (24%), Positives = 110/279 (39%), Gaps = 26/279 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNG-----KVVALKKLHRAETEETTFFNSFQNEAHVLS 553
+ IG G +G VYK L VA+K L TE+ F EA ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 64
Query: 554 KIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
+ +H NI++L G K M +I +YM+ G+L FLR V +++ +A
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAG 122
Query: 614 LSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN---RTIVAGTYGY 670
+ + + VHRD+++ NIL+NS L V+DFG +R+L+ D + +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 671 IAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730
APE T DV+SFG+V EV+ ++ ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER--------PYWELSNHEVMKAINDGFR 231
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
P I + + C + RP +
Sbjct: 232 LPTPMDCPSAIY---QLMMQCWQQERARRPKFADIVSIL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 25/283 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP----NGKVVALKKLHRAETEETTFFNSFQNEAHVLSK 554
+D + +G G +G V + + VA+K L + + F E + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
+ HRN+++LYG M ++ + GSL LR +L R VA +
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN---RTIVAGTYGYI 671
YL +HRD+++ N+LL ++ + DFG R L + + + + +
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730
APE T + D + FGV E+ G+ P + +L +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGER 233
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773
P QDI V + C KP+ RPT + L +
Sbjct: 234 LPRPEDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-49
Identities = 69/301 (22%), Positives = 112/301 (37%), Gaps = 31/301 (10%)
Query: 481 SIWNYDGRIAFEDIIKATEDFDIKY--CIGTGGYGSVYKAQLPNGK----VVALKKLHRA 534
S N + A + ++ + + IG G +G VY L + A+K L+R
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66
Query: 535 ETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-KKCMFLIYKYMKRGSLFCFLRNDY 593
+ F E ++ +H N++ L G CL + ++ YMK G L F+RN+
Sbjct: 67 TDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 594 EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653
+ + + + VHRD+++ N +L+ K VADFG AR
Sbjct: 125 HNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179
Query: 654 LDSDS----SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSS 709
+ N+T ++A E T T K DV+SFGV+ E++ P
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP------ 233
Query: 710 LSSPSSDQKIM-LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
P D + L + V L C H K + RP+ +
Sbjct: 234 ---PYPDVNTFDITVYLLQGRRLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSR 287
Query: 769 F 769
Sbjct: 288 I 288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 4e-49
Identities = 77/311 (24%), Positives = 124/311 (39%), Gaps = 30/311 (9%)
Query: 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH 550
EDI + +D + +GTG + V A+ K+VA+K + + E S +NE
Sbjct: 5 EDI---RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIA 59
Query: 551 VLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCV 610
VL KI H NIV L ++LI + + G LF + +I V
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQV 116
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAF---VADFGTARLLDSDSSNRTIVAGT 667
+A+ YLH IVHRD+ N+L S E ++DFG +++ D S T GT
Sbjct: 117 LDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-GT 172
Query: 668 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIMLIDVL 725
GY+APE+ ++ D +S GV+A +L G P E + L +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232
Query: 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFLTCKIALVNPFEEIS 784
+S + + P+ R T ++ Q ++ AL +
Sbjct: 233 WDDISDSAKDFIRH-----------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSV 281
Query: 785 IWQLRNQINTT 795
Q++ +
Sbjct: 282 SEQIKKNFAKS 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 65/288 (22%), Positives = 124/288 (43%), Gaps = 29/288 (10%)
Query: 490 AFEDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKV----VALKKLHRAETEETTFFNS 544
A I+K T +F +G+G +G+VYK +P G+ VA+K+L A + +
Sbjct: 1 ALLRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKE 57
Query: 545 FQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRV 604
+EA+V++ + + ++ +L G CL + LI + M G L ++R + + +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI--GSQYLL 114
Query: 605 NIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTI- 663
N +A ++YL +VHRD+++ N+L+ + + DFG A+LL ++
Sbjct: 115 NWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 664 -VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-L 721
++A E + T + DV+S+GV E++ P +
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------PYDGIPASEI 222
Query: 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+L+ P + D+ + + C RP + + EF
Sbjct: 223 SSILEKGERLPQPPICTIDVY---MIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-48
Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 26/277 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN----GKVVALKKLHRAETEETTFFNSFQNEAHVLSK 554
E ++ CIG G +G V++ + VA+K ++ F EA + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 64
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
H +IVKL G + +++I + G L FL+ + LD + ++ AL
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTAL 121
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR-TIVAGTYGYIAP 673
+YL VHRDI++ N+L++S + DFG +R ++ + + + ++AP
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 674 ELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIM-LIDVLDSRLSPP 732
E T DV+ FGV E+LM P K +I +++ P
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVK---------PFQGVKNNDVIGRIENGERLP 229
Query: 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ + ++ C P RP + +
Sbjct: 230 MPPNCPPTLY---SLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 65/302 (21%), Positives = 120/302 (39%), Gaps = 28/302 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
E + I +G G +G V++ + K K + T++ + E +L+ H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILNIARH 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
RNI+ L+ + + +I++++ +F + A L+ V+ + V AL +L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFL 118
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFV--ADFGTARLLDSDSSNRTIVAGTYGYIAPEL 675
H +I H DI NI+ ++ + + +FG AR L + R + Y APE+
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEV 174
Query: 676 AYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733
VV+ D++S G + +L G +P E + + + + +S
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ-EFLTCKIALVNPFEEISIWQLRNQI 792
V + L + K R T Q +L KI V+ + I + R
Sbjct: 235 MDFVDR-----------LLVKERKSRMTASEALQHPWLKQKIERVST-KVIRTLKHRRYY 282
Query: 793 NT 794
+T
Sbjct: 283 HT 284
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 58/267 (21%), Positives = 109/267 (40%), Gaps = 21/267 (7%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSK-IA 556
EDF + +G G +G V+ A+ + A+K L + E VLS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSY 616
H + ++ K+ +F + +Y+ G L +++ ++ D + + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 617 LHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELA 676
LH IV+RD+ +NILL+ +ADFG + + GT YIAPE+
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736
D +SFGV+ E+L+G+ P ++++ +D+ P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH-------GQDEEELFHSIRMDNPFYPRWLEK 228
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQ 763
+D++ + +P+ R ++
Sbjct: 229 EAKDLL------VKLFVREPEKRLGVR 249
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (413), Expect = 7e-46
Identities = 66/284 (23%), Positives = 122/284 (42%), Gaps = 28/284 (9%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
++ +++ +G GG V+ A+ L + VA+K L + +F+ F+ EA + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 557 HRNIVKLYGFCLHK----KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN 612
H IV +Y + +++ +Y+ +L + + + + +I
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT---IVAGTYG 669
AL++ H I+HRD+ NI++++ V DFG AR + ++ T V GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP--GELLSSLSSPSSDQKIMLIDVLDS 727
Y++PE A V + DVYS G V EVL G P G+ S++ + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRP-TMQRVCQEFL 770
LS +D +V++ L P+ R T + + +
Sbjct: 240 GLSADLDAVVLK-----------ALAKNPENRYQTAAEMRADLV 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-45
Identities = 61/296 (20%), Positives = 113/296 (38%), Gaps = 42/296 (14%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP--------NGKVVALKKLHRAETEETTFFNSFQNEAH 550
+ + +G G +G V A+ VA+K L TE+ + +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 551 VLSKIA-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVV------------ 597
++ I H+NI+ L G C +++I +Y +G+L +L+ +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 598 -LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656
L V+ VA + YL +HRD+++ N+L+ +ADFG AR +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 657 DSSNRT--IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPS 714
+ ++APE + + T + DV+SFGV+ E+ P
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---------PY 238
Query: 715 SDQKIM-LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
+ L +L ++ + C H+ P RPT +++ ++
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELY---MMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 34/303 (11%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVL 552
E + +G G +G VY+ VA+K ++ A + F NEA V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 553 SKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLR-------NDYEAVVLDWTMRVN 605
+ ++V+L G + +I + M RG L +LR N+ + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR--TI 663
+ +A+ ++YL+ + VHRD+++ N ++ + DFG R + R
Sbjct: 138 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723
+++PE V T DV+SFGVV E+ + +L
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQGLSNEQVLRF 247
Query: 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEI 783
V++ L D + + C PK RP+ + K + F E+
Sbjct: 248 VMEGGLLDKPDNCPDM----LFELMRMCWQYNPKMRPSFLEIISSI---KEEMEPGFREV 300
Query: 784 SIW 786
S +
Sbjct: 301 SFY 303
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 2e-44
Identities = 61/284 (21%), Positives = 112/284 (39%), Gaps = 30/284 (10%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+DF I +GTG +G V+ + NG+ A+K L + +E +LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
I++++G + +F+I Y++ G LF LR A L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLAL 117
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
+ I++RD+ NILL+ + DFG A+ + + GT YIAPE+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV-LDSRLSPPVDRM 736
T + D +SFG++ E+L G P ++ + +KI+ ++ + V +
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP---FYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPF 780
+ + + R + + +P+
Sbjct: 232 LSR-----------LITRDLSQRLGNLQ-----NGTEDVKNHPW 259
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 2e-44
Identities = 63/283 (22%), Positives = 109/283 (38%), Gaps = 30/283 (10%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETT------FFNSFQNEAHV 551
E+++ K +G G V + P K A+K + + + E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 552 LSKIA-HRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCV 610
L K++ H NI++L FL++ MK+G LF +L V L I++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 119
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGY 670
+ LH IVHRD+ NILL+ + + DFG + LD R + GT Y
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-GTPSY 175
Query: 671 IAPELAYTMVV------TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV 724
+APE+ + ++ D++S GV+ +L G P + +I
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------FWHRKQMLMLRMIMS 229
Query: 725 LDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+ + P + + L +P+ R T +
Sbjct: 230 GNYQFGSPEWDDYSDTVK---DLVSRFLVVQPQKRYTAEEALA 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 27/284 (9%)
Query: 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRA---ETEETTFFNSFQN 547
E++ + +D +G+G + V K + G A K + + + +
Sbjct: 6 ENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 548 EAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNII 607
E +L +I H N++ L+ +K + LI + + G LF E L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFL 119
Query: 608 KCVANALSYLHHDCMPSIVHRDISSNNILLNS----KLEAFVADFGTARLLDSDSSNRTI 663
K + N +++ I H D+ NI+L K + DFG A +D + + I
Sbjct: 120 KQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 664 VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723
GT ++APE+ + + D++S GV+ +L G P + + + +
Sbjct: 177 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------FLGDTKQETLANVS 229
Query: 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
++ L PK R T+Q Q
Sbjct: 230 AVNYEFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (400), Expect = 4e-43
Identities = 59/279 (21%), Positives = 100/279 (35%), Gaps = 26/279 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRA---ETEETTFFNSFQNEAHVLSK 554
DF + IG GG+G VY + GK+ A+K L + + T + + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 555 IAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANAL 614
IV + + I M G L L + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 615 SYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE 674
++H+ +V+RD+ NILL+ ++D G A + ++ GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 675 -LAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV-LDSRLSPP 732
L + D +S G + ++L G P + D+ + + V L SP
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 733 VDRMVMQDIVLVTTVALACLHSKPKFRPT-MQRVCQEFL 770
+ ++ L R + R QE
Sbjct: 236 LRSLLEG-----------LLQRDVNRRLGCLGRGAQEVK 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (389), Expect = 2e-42
Identities = 68/286 (23%), Positives = 118/286 (41%), Gaps = 24/286 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
E + IG G YG VYKAQ G+ ALKK+ R E E+ ++ E +L ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60
Query: 559 NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLH 618
NIVKLY KK + L+++++ + + L+ + + + N ++Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH 117
Query: 619 HDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LAY 677
++HRD+ N+L+N + E +ADFG AR T T Y AP+ L
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHP----------GELLSSLSSPSSDQKIMLIDVLDS 727
+ + D++S G + E++ G + L +P+S + ++
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 728 RLSPPVDRMVMQDIVLVTTVALA------CLHSKPKFRPTMQRVCQ 767
+ V + + L L P R T ++ +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 57/268 (21%), Positives = 93/268 (34%), Gaps = 22/268 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
DFD +G G +G V + G+ A+K L + E+ VL H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+ L + + +Y G LF L + V + +AL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSAL--- 118
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
+ +V+RDI N++L+ + DFG + SD + GT Y+APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV-LDSRLSPPVDRM 736
D + GVV E++ GR P + + I++ ++ LSP +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 737 VMQDIVLVTTVALACLHSKPKFRPTMQR 764
+ L PK R
Sbjct: 236 LAG-----------LLKKDPKQRLGGGP 252
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 65/293 (22%), Positives = 107/293 (36%), Gaps = 38/293 (12%)
Query: 499 EDFDIKYCIGTGGYGSVYKA------QLPNGKVVALKKLHRAETEETTFFNSFQNEAHVL 552
+ + +G G +G V +A + + VA+K L T + +E +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKIL 70
Query: 553 SKIAHR-NIVKLYGFCLHK-KCMFLIYKYMKRGSLFCFLRN-------------DYEAVV 597
I H N+V L G C + +I ++ K G+L +LR+ D
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 598 LDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657
L + VA + +L +HRD+++ NILL+ K + DFG AR + D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 658 SSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSS 715
+ ++APE + V T + DV+SFGV+ E+ P
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------PYPGV 240
Query: 716 DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768
L ++ L C H +P RPT + +
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 63/280 (22%), Positives = 110/280 (39%), Gaps = 25/280 (8%)
Query: 507 IGTGGYGSVYKAQLPN-GKVVALKKLHRAETEET--TFFNSFQNEAHVLSKIAHRNIVKL 563
+G G + +VYKA+ N ++VA+KK+ E + E +L +++H NI+ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 564 YGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMP 623
HK + L++ +M+ N VL + + L YLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 624 SIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVT 682
I+HRD+ NN+LL+ +ADFG A+ S + T T Y APEL + +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 683 EKCDVYSFGVVALEVLMGRHP----------GELLSSLSSPSSDQKIMLIDVLDSRLSPP 732
D+++ G + E+L+ + +L +P+ +Q + + D
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 733 VDRMVMQDIVLVTTVAL-----ACLHSKPKFRPTMQRVCQ 767
+ + I L P R T + +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-41
Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 24/287 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
E+F IG G YG VYKA+ G+VVALKK+ R +TE ++ E +L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
NIVKL + ++L+++++ + + + + + + + L++
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFC 118
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPE-LA 676
H ++HRD+ N+L+N++ +ADFG AR T T Y APE L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 677 YTMVVTEKCDVYSFGVVALEVLMGRHP----------GELLSSLSSPSSDQKIMLIDVLD 726
+ D++S G + E++ R + +L +P + + D
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 727 SRLSPPVDRMVMQDIVLVTTVALA------CLHSKPKFRPTMQRVCQ 767
+ S P V+ LH P R + +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-41
Identities = 61/296 (20%), Positives = 118/296 (39%), Gaps = 31/296 (10%)
Query: 496 KATEDFDIKYCIGTGGYGSVYKAQ--LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLS 553
+A + ++ IG G YG V+KA+ G+ VALK++ R +T E S E VL
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLR 62
Query: 554 KIA---HRNIVKLYGFCL-----HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
+ H N+V+L+ C + + L+++++ + + + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKD 120
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
++ + L +LH +VHRD+ NIL+ S + +ADFG AR+ + ++V
Sbjct: 121 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV- 176
Query: 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP----------GELLSSLSSPSS 715
T Y APE+ D++S G + E+ + G++L + P
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 716 DQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVAL----ACLHSKPKFRPTMQRVCQ 767
+ + + + + + + + + CL P R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 58/277 (20%), Positives = 109/277 (39%), Gaps = 36/277 (12%)
Query: 500 DFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHR---AETEETTFFNSFQNEAHVLSKI 555
+ + +G+GG+GSVY + + VA+K + + ++ E E +L K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 556 --AHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANA 613
+++L + LI + + + A L + + V A
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 122
Query: 614 LSYLHHDCMPSIVHRDISSNNILLN-SKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIA 672
+ + H+ ++HRDI NIL++ ++ E + DFG+ LL + T GT Y
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSP 177
Query: 673 PE-LAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV-LDSRLS 730
PE + Y V+S G++ +++ G P D++I+ V R+S
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------FEHDEEIIRGQVFFRQRVS 228
Query: 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
++ CL +P RPT + +
Sbjct: 229 SECQHLIRW-----------CLALRPSDRPTFEEIQN 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 1e-40
Identities = 40/280 (14%), Positives = 96/280 (34%), Gaps = 26/280 (9%)
Query: 501 FDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN 559
+ + IG+G +G +Y + G+ VA+K E+ + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGV 63
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
+ +C + ++ + SL + + + + + Y+H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 121
Query: 620 DCMPSIVHRDISSNNILLNSK---LEAFVADFGTARLLDSDSSN-------RTIVAGTYG 669
+ +HRD+ +N L+ ++ DFG A+ ++ + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 670 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729
Y + + + + D+ S G V + +G P + ++ ++ + + ++
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ-----GLKAATKRQKYERISEKKM 233
Query: 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
S P++ + T C + +P + Q F
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-40
Identities = 59/285 (20%), Positives = 107/285 (37%), Gaps = 40/285 (14%)
Query: 499 EDFDI-KYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+D+ + +G G G V + + ALK L + E + + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRAS 62
Query: 557 -HRNIVKLYGFC----LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
+IV++ +KC+ ++ + + G LF ++ D I+K +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIG 121
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLE---AFVADFGTARLLDSDSSNRTIVAGTY 668
A+ YLH +I HRD+ N+L SK + DFG A+ S +S T T
Sbjct: 122 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTP 177
Query: 669 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP------GELLSSLSSPSSDQKIMLI 722
Y+APE+ + CD++S GV+ +L G P + + + +
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 723 DVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQ 767
+ S +S V ++ L ++P R T+
Sbjct: 238 NPEWSEVSEEVKMLIRN-----------LLKTEPTQRMTITEFMN 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 3e-39
Identities = 57/288 (19%), Positives = 113/288 (39%), Gaps = 26/288 (9%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ ++ IG G YG+V+KA+ ++VALK++ + +E +S E +L ++ H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+NIV+L+ K + L++++ + F + + + L L
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
+++HRD+ N+L+N E +A+FG AR + T Y P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 678 -TMVVTEKCDVYSFGVVALEVLMGRHP-----------GELLSSLSSPSSDQKIMLIDVL 725
+ + D++S G + E+ P + L +P+ +Q + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 726 DSRLSPPVDRMVMQDIVLVTTVALA------CLHSKPKFRPTMQRVCQ 767
D + P V+ A L P R + + Q
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-39
Identities = 63/292 (21%), Positives = 107/292 (36%), Gaps = 34/292 (11%)
Query: 500 DFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHR 558
+ IG G +G VY+A+L +G++VA+KK+ + + E ++ K+ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHC 73
Query: 559 NIVKLYGFCLH------KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN 612
NIV+L F + + L+ Y+ L + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAF-VADFGTARLLDSDSSNRTIVAGTYGYI 671
+L+Y+H I HRDI N+LL+ + DFG+A+ L N + + Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHP----------GELLSSLSSPSSDQKIML 721
+ T DV+S G V E+L+G+ E++ L +P+ +Q +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 722 IDVLDSRLSPPVDRMVMQDIVLVTTVALA------CLHSKPKFRPTMQRVCQ 767
P + + T A L P R T C
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 66/297 (22%), Positives = 111/297 (37%), Gaps = 36/297 (12%)
Query: 498 TEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA 556
+ IG G YG V A N VA+KK+ E + + E +L +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLRFR 64
Query: 557 HRNIVKLYGFCLHKKCMFLIYKYM----KRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN 612
H NI+ + + Y+ L+ L+ + L + +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILR 120
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN---RTIVAGTYG 669
L Y+H +++HRD+ +N+LLN+ + + DFG AR+ D D + T T
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 670 YIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHP----------GELLSSLSSPSSD-- 716
Y APE+ T+ D++S G + E+L R +L L SPS +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 717 QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALA------CLHSKPKFRPTMQRVCQ 767
I+ + + LS P V + + + A L P R +++
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 2e-38
Identities = 47/291 (16%), Positives = 94/291 (32%), Gaps = 32/291 (10%)
Query: 493 DIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHV 551
+++ + + IG G +G +++ L N + VA+K R ++E
Sbjct: 1 NVVG--VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRT 53
Query: 552 LSKIAHRN-IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCV 610
+A I +Y F L+ + + K +
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQM 110
Query: 611 ANALSYLHHDCMPSIVHRDISSNNILLNSKLE-----AFVADFGTARLLDSDSSNRTI-- 663
+ +H S+V+RDI +N L+ +V DFG + + + I
Sbjct: 111 LARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167
Query: 664 -----VAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQK 718
++GT Y++ + + D+ + G V + L G P L + ++ QK
Sbjct: 168 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQK 224
Query: 719 IMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769
I + + S P+ + + P + F
Sbjct: 225 YERI--GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 3e-38
Identities = 49/267 (18%), Positives = 91/267 (34%), Gaps = 23/267 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ FD +GTG +G V + +G A+K L + + + NE +L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 558 RNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYL 617
+VKL ++++ +Y+ G +F L + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 618 HHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAY 677
H +++RD+ N+L++ + V DFG A+ + GT +APE+
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211
Query: 678 TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737
+ + D ++ GV+ E+ G P + Q I R +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP------FFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 738 MQDIVLVTTVALACLHSKPKFRPTMQR 764
+ L R +
Sbjct: 266 KDLL-------RNLLQVDLTKRFGNLK 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 65/275 (23%), Positives = 107/275 (38%), Gaps = 24/275 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKLHRAE-TEETTFFNSFQNEAHVLS 553
E+F++ +GTG YG V+ + GK+ A+K L +A ++ + E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 554 KIAHR-NIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVAN 612
I +V L+ + + LI Y+ G LF L + V
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGE 137
Query: 613 ALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRT-IVAGTYGYI 671
+ L H I++RDI NILL+S + DFG ++ +D + R GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 672 APELAYTMV--VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729
AP++ + D +S GV+ E+L G P + +S +I +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRRILKSEPP 254
Query: 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQR 764
P + +D++ L PK R
Sbjct: 255 YPQEMSALAKDLI------QRLLMKDPKKRLGCGP 283
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 57/302 (18%), Positives = 99/302 (32%), Gaps = 40/302 (13%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
++ IG G +G V+KA+ G+ VALKK+ E E+ F + E +L + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLLKH 68
Query: 558 RNIVKLYGFCL--------HKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKC 609
N+V L C K ++L++ + + + + +++
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQM 125
Query: 610 VANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS----NRTIVA 665
+ L+ L++ I+HRD+ + N+L+ +ADFG AR + T
Sbjct: 126 L---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 666 GTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVLMGRHP-------------GELLSSLS 711
T Y PE L D++ G + E+ +L S++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 712 SPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALA------CLHSKPKFRPTMQRV 765
L R V + A L P R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 766 CQ 767
Sbjct: 303 LN 304
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 1e-34
Identities = 39/229 (17%), Positives = 87/229 (37%), Gaps = 25/229 (10%)
Query: 481 SIWNYDG-RIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEE 538
W+Y+ + + + +D+ + +G G Y V++A + N + V +K L + ++
Sbjct: 20 EYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK 75
Query: 539 TTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLH--KKCMFLIYKYMKRGSLFCFLRNDYEA 595
+ E +L + NI+ L + L+++++ +
Sbjct: 76 ------IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---- 125
Query: 596 VVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGTARLL 654
L + + AL Y H I+HRD+ +N++++ + + + D+G A
Sbjct: 126 --LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
Query: 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
VA Y L + D++S G + ++ + P
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 12/218 (5%)
Query: 492 EDIIKATEDFDIKY----CIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQ 546
+++ K + Y +G+G YG+V A G VA+KKL+R E F
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAY 65
Query: 547 NEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDY-EAVVLDWTMRVN 605
E +L + H N++ L + + + + L
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
++ + L Y+H + HRD+ N+ +N E + DFG AR DS+ + V
Sbjct: 126 LVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVV 180
Query: 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + M T+ D++S G + E++ G+
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 1e-31
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 18/212 (8%)
Query: 499 EDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH 557
+ + IG+G G V A + VA+KKL R +T E ++ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNH 75
Query: 558 RNIVKLYGFCLHKKCM------FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVA 611
+NI+ L +K + +L+ + M D ++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQML 129
Query: 612 NALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVAGTYGYI 671
+ +LH + +HRD+ +NI++ S + DFG AR S T T Y
Sbjct: 130 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185
Query: 672 APELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
APE+ M E D++S G + E++ +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 16/218 (7%)
Query: 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKLHRAETEETTFFNSFQNEAH 550
+ I + E + +G+G YGSV A G VA+KKL R + E
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 551 VLSKIAHRNIVKLYGFC-----LHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVN 605
+L + H N++ L L + + ++ L ++ L
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQF 125
Query: 606 IIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNRTIVA 665
+I + L Y+H + HRD+ +N+ +N E + DFG AR +D VA
Sbjct: 126 LIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA 180
Query: 666 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP 703
+ + M + D++S G + E+L GR
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 2e-28
Identities = 55/314 (17%), Positives = 103/314 (32%), Gaps = 39/314 (12%)
Query: 473 PTKSGDVFSIWNYDGRIAFEDIIKATEDFDIKYCIGTGGYGSVYKAQ-LPNGKVVALKKL 531
P G+ + D R + + +G G + +V+ A+ + N VA+K +
Sbjct: 3 PAFKGEPYK----DAR------------YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV 46
Query: 532 HRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCL-------------HKKCMFLIYK 578
+ + + ++E +L ++ + K + ++
Sbjct: 47 RG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMV 102
Query: 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN 638
+ G L YE + I K + L Y+H C I+H DI N+L+
Sbjct: 103 FEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME 160
Query: 639 SK-LEAFVADFGTARLLDSDSSNRT--IVAGTYGYIAPELAYTMVVTEKCDVYSFGVVAL 695
+ A L ++ + T Y +PE+ D++S +
Sbjct: 161 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220
Query: 696 EVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSK 755
E++ G E S D I I L L + R + L SK
Sbjct: 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 280
Query: 756 PKFRPTMQRVCQEF 769
KF P + +++
Sbjct: 281 LKFWPLEDVLTEKY 294
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (260), Expect = 3e-25
Identities = 54/280 (19%), Positives = 98/280 (35%), Gaps = 14/280 (5%)
Query: 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNN 156
P L L+ N + L L L N ++ P L LE L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 157 LNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKL 216
L L +L + + + + ++ L + K SG+ + +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGM 149
Query: 217 KNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNN 276
K L + + + IP L +LT L+L N + + + + K+ +S N+
Sbjct: 150 KKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 277 IEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSG------PIP 330
I L L L +++N L ++P +A ++ + L NN +S P
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 331 PEIGKCSELRNITLRNNNLS-GSIPPEI--GLMKLEYLDL 367
K + ++L +N + I P + + L
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (255), Expect = 1e-24
Identities = 60/276 (21%), Positives = 103/276 (37%), Gaps = 17/276 (6%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
+P + LD N +T + +L+NL L L N ++ P + L KL
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 172 ITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231
+ LS+N L L L + + K+ + L +V L K G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSG 140
Query: 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQL 291
+ L+Y+ + ++ +IP G + ++ + N I L L+ L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 292 LYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG 351
L +S N +S ++A L+ L L+NNKL +P + ++ + L NNN+S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS- 255
Query: 352 SIPPEI--------GLMKLEYLDLSHNKLN-GTIPP 378
+I + L N + I P
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.0 bits (175), Expect = 3e-14
Identities = 33/237 (13%), Positives = 67/237 (28%), Gaps = 4/237 (1%)
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292
+P L + L L +N + + N+ + + + N I P L +L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 293 YLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGS 352
L +S N L L L+ + K+ + + + + T +
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 353 IPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPDYFRDSPFKVYGNQ 412
G+ KL Y+ ++ + L L N + +
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202
Query: 413 GICYFSACSTLHTPTASKSKSLVLRVLNIILPITACVIFLTLAFIVFLLNKNEIAKL 469
SA + L L ++ + + L+ N I+ +
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVY--LHNNNISAI 257
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 7e-24
Identities = 58/264 (21%), Positives = 101/264 (38%), Gaps = 6/264 (2%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
++P + A + + N ++ + RNL +L L N L ++ L L
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 172 ITMALSRNGLHGPI-PSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLM 230
+ LS N + P+ L L L LD L + L L L + N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 231 GPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQ 290
T L NLT+L+LH N ++ + + ++ + N + P L +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 291 LLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350
L+ L + +N LS +A L +L+ L L++N + L+ ++ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 351 GSIPPEIGLMKLEYLDLSHNKLNG 374
S+P + L L+ N L G
Sbjct: 262 CSLPQRLAGRDL--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (244), Expect = 2e-23
Identities = 56/271 (20%), Positives = 90/271 (33%), Gaps = 4/271 (1%)
Query: 126 LDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI 185
L ++P + + + + L GN ++ +S L + L N L
Sbjct: 16 TSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 186 PSAIGDLNNLLILSLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLT 244
+A L L L L N + L L L++ L P L L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 245 YLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQ 304
YLYL N L ++ + + + N I L L L + N ++
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 305 IPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEY 364
P L L L L N LS + L+ + L +N L+
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252
Query: 365 LDLSHNKLNGTIPPFLYHRFPLDLSYNDLEG 395
S +++ ++P L R L+ NDL+G
Sbjct: 253 FRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 6e-14
Identities = 45/194 (23%), Positives = 72/194 (37%), Gaps = 4/194 (2%)
Query: 86 GELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR 145
+ F L +L L L P L+ L+YL N L L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKL 205
NL L L GN ++ + L L + L +N + P A DL L+ L L +N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 206 SGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMT 265
S + + L L+ L L + N + + L S+ + S+P +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQ---RLA 269
Query: 266 GILKVDMSMNNIEG 279
G ++ N+++G
Sbjct: 270 GRDLKRLAANDLQG 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.2 bits (228), Expect = 6e-22
Identities = 25/162 (15%), Positives = 54/162 (33%), Gaps = 17/162 (10%)
Query: 507 IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFN-------SFQNEAHVLSKIAHRN 559
+G G +V+ +K T F A ++ R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 560 IVKLYGFCLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH 619
+ KL G + K + + ++ L + E + ++ + ++ +H
Sbjct: 68 LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 620 DCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSNR 661
IVH D+S N+L+ S+ ++ DF + + +
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWRE 159
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.2 bits (238), Expect = 8e-22
Identities = 71/382 (18%), Positives = 134/382 (35%), Gaps = 82/382 (21%)
Query: 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFN 131
++ L + + +SQ + + +L + SI V L+ L ++FS N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQTDLD---QVTTLQADRLGI-KSIDG-VEYLNNLTQINFSNN 76
Query: 132 NLTGSIPPELGSLRNLEVLNLKGNNLNGAIP----------------------------- 162
LT P L +L L + + N + P
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 163 -------SSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL-G 214
+++ ++ L + + G + + L NL L + + +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 215 KLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSM 274
KL NL +L N++ P + TNL L L+ N L + ++T + +D++
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 275 NNIEGTIPLELTRLSQLLYLSISSNMLSGQIPIT--------------------IAGLIS 314
N I PL L++L L + +N +S P+ I+ L +
Sbjct: 251 NQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 315 LKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLN 373
L L L N +S P + ++L+ + NN +S + L + +L HN+++
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364
Query: 374 GTIP----PFLYHRFPLDLSYN 391
P + L L+
Sbjct: 365 DLTPLANLTRITQ---LGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.9 bits (180), Expect = 1e-14
Identities = 63/292 (21%), Positives = 103/292 (35%), Gaps = 23/292 (7%)
Query: 120 LSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179
L ++ L + SI + L NL +N N L P L LTKL+ + ++ N
Sbjct: 43 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98
Query: 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQ------------ELGKLKNLVALNVGGN 227
+ P A L L + L + + L L
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 228 KLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI-GNMTGILKVDMSMNNIEGTIPLELT 286
G + L L NLT L N + +T + + + N I PL +
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL 218
Query: 287 RLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRN 346
+ L LS++ N L T+A L +L LDL+NN++S P + ++L + L
Sbjct: 219 --TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 347 NNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIP 398
N +S P + + + L + L L +N++ P
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.4 bits (158), Expect = 7e-12
Identities = 39/190 (20%), Positives = 73/190 (38%), Gaps = 32/190 (16%)
Query: 59 DHCKLDGVT-CNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQV 117
+ ++ +T ++ E++L +LK + + L L L N + P +
Sbjct: 205 TNNQISDITPLGILTNLDELSLNGNQLKDIGT---LASLTNLTDLDLANNQISNLAP--L 259
Query: 118 GALSKLRYLDFSFNNLTGSIP--------------------PELGSLRNLEVLNLKGNNL 157
L+KL L N ++ P + +L+NL L L NN+
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 158 NGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLK 217
+ P + LTKL + + N + S++ +L N+ LS N++S + L L
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLT--PLANLT 373
Query: 218 NLVALNVGGN 227
+ L +
Sbjct: 374 RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 5e-04
Identities = 22/96 (22%), Positives = 40/96 (41%), Gaps = 10/96 (10%)
Query: 184 PIPSAIGD--LNNLLILSLDSNKLSGMLHQ-ELGKLKNLVALNVGGNKLMGPIPSTLFRL 240
PI D L + L ++ + Q +L ++ L A +G + G + L
Sbjct: 11 PINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYL 65
Query: 241 TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNN 276
NLT + +N L P + N+T ++ + M+ N
Sbjct: 66 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 0.001
Identities = 14/85 (16%), Positives = 36/85 (42%), Gaps = 6/85 (7%)
Query: 216 LKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMN 275
L + +G + + + L +T L + SI + + + +++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76
Query: 276 NIEGTIPLELTRLSQLLYLSISSNM 300
+ PL+ L++L+ + +++N
Sbjct: 77 QLTDITPLK--NLTKLVDILMNNNQ 99
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 94.0 bits (232), Expect = 1e-21
Identities = 69/266 (25%), Positives = 110/266 (41%), Gaps = 4/266 (1%)
Query: 115 SQVGALSKLRYLDFSFNNLTG--SIPPELGSLRNLEVLNLKGN-NLNGAIPSSLCQLTKL 171
++ LD S NL IP L +L L L + G NL G IP ++ +LT+L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 172 ITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231
+ ++ + G IP + + L+ L N LSG L + L NLV + GN++ G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQL 291
IP + + L S + P + VD+S N +EG L +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS-VLFGSDKN 222
Query: 292 LYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG 351
+ + +L GLDL NN++ G +P + + L ++ + NNL G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 352 SIPPEIGLMKLEYLDLSHNKLNGTIP 377
IP L + + ++NK P
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 93.7 bits (231), Expect = 2e-21
Identities = 78/315 (24%), Positives = 117/315 (37%), Gaps = 37/315 (11%)
Query: 46 SSWWSNLIDSNSSDHCKL--DGVTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLS 103
SSW ++D C GV C+T +N +L
Sbjct: 25 SSWL------PTTDCCNRTWLGVLCDTDTQTYRVN----------------------NLD 56
Query: 104 LRFNYLFG--SIPSQVGALSKLRYLDFSFN-NLTGSIPPELGSLRNLEVLNLKGNNLNGA 160
L L IPS + L L +L NL G IPP + L L L + N++GA
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 161 IPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLV 220
IP L Q+ L+T+ S N L G +P +I L NL+ ++ D N++SG + G L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 221 A-LNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEG 279
+ + N+L G IP T L + + + +
Sbjct: 177 TSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236
Query: 280 TIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSEL 339
+ L++ L L +N + G +P + L L L++S N L G I P+ G
Sbjct: 237 LGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRF 293
Query: 340 RNITLRNNNLSGSIP 354
NN P
Sbjct: 294 DVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.6 bits (205), Expect = 5e-18
Identities = 67/263 (25%), Positives = 101/263 (38%), Gaps = 7/263 (2%)
Query: 142 GSLRNLEVLNLKGNNLNGA--IPSSLCQLTKLITMALSRN-GLHGPIPSAIGDLNNLLIL 198
+ L+L G NL IPSSL L L + + L GPIP AI L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 199 SLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIP 258
+ +SG + L ++K LV L+ N L G +P ++ L NL + N ++G+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 259 PEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGL 318
G+ + + N T + T + L S + + G
Sbjct: 167 DSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 319 DLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG-LMKLEYLDLSHNKLNGTIP 377
++G L + LRNN + G++P + L L L++S N L G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 378 PF--LYHRFPLDLSYNDLEGEIP 398
L + N P
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 5e-13
Identities = 24/77 (31%), Positives = 34/77 (44%), Gaps = 1/77 (1%)
Query: 90 QFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEV 149
L L LR N ++G++P + L L L+ SFNNL G I P+ G+L+ +V
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDV 295
Query: 150 LNLKGNNLNGAIPSSLC 166
N P C
Sbjct: 296 SAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 214 GKLKNLVALNVGGNKLMG--PIPSTLFRLTNLTYLYLHSNH-LNGSIPPEIGNMTGILKV 270
+ + L++ G L PIPS+L L L +LY+ + L G IPP I +T + +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
++ N+ G IP L+++ L+ L S N LSG +P +I+ L +L G+ N++SG IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 331 PEIGKCSELR-NITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPL--- 386
G S+L ++T+ N L+G IPP + L ++DLS N L G
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 387 -----------------------DLSYNDLEGEIPDYFRDSPF 406
DL N + G +P F
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (159), Expect = 3e-12
Identities = 35/264 (13%), Positives = 96/264 (36%), Gaps = 23/264 (8%)
Query: 98 GLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG-SIPPELGSLRNLEVLNLKGNN 156
G+ + +++ + + +++++D S + + ++ L L+ L+L+G
Sbjct: 24 GVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 157 LNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKL 216
L+ I ++L + + L+ + +L+ S + + L +L
Sbjct: 83 LSDPIVNTLAKNSNLVRL----------------NLSGCSGFSEFALQTLLSSCSRLDEL 126
Query: 217 KNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMN- 275
+ + + +T L N + + ++ +D+S +
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186
Query: 276 NIEGTIPLELTRLSQLLYLSISS-NMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334
++ E +L+ L +LS+S + + + + + +LK L + G +
Sbjct: 187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE 246
Query: 335 KCSELRNITLRNNNLSGSIPPEIG 358
L+ + ++ + P IG
Sbjct: 247 ALPHLQ---INCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 3e-08
Identities = 41/272 (15%), Positives = 89/272 (32%), Gaps = 39/272 (14%)
Query: 150 LNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG-M 208
L+L G NL+ + L +I R+ + P+ + + L ++ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 209 LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGIL 268
LH L + L L++ G +L PI +TL + +NL L L + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 269 KVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSG------------------------- 303
+++++ + + +I+ LSG
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 304 --------QIPITIAGLISLKGLDLSN-NKLSGPIPPEIGKCSELRNITLRNNNLSGSIP 354
L L+ L LS + E+G+ L+ + + G++
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL- 241
Query: 355 PEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPL 386
++ L +L ++ + P + ++
Sbjct: 242 -QLLKEALPHLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 14/108 (12%), Positives = 35/108 (32%), Gaps = 5/108 (4%)
Query: 318 LDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIP 377
LDL+ L + + + + + + +++++DLS++ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 378 PFLYHRFP----LDLSYNDLEGEIPDYFRDSPFKVYGNQGICYFSACS 421
+ + L L L I + + V N C +
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 111
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 62.0 bits (149), Expect = 3e-11
Identities = 38/217 (17%), Positives = 70/217 (32%), Gaps = 21/217 (9%)
Query: 167 QLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGG 226
L I +A ++ + + A DL+ + LS ++ + + + L NL+ L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 227 NKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELT 286
N++ P L + +I T L + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 287 RLSQLLYLSISSNML--------------SGQIPITIAGLISLKGLDLSNNKLSGPIPPE 332
L L + + L +A L L L +NK+S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 333 IGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSH 369
+ L + L+NN +S + P L + L++
Sbjct: 191 LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 41/228 (17%), Positives = 71/228 (31%), Gaps = 18/228 (7%)
Query: 119 ALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSR 178
AL+ + +N+T ++ L + L+ G + + L LI + L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 179 NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLF 238
N + P +L + L + + L + T
Sbjct: 73 NQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 239 RLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISS 298
I +S+ N + + L LS+L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 299 NMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRN 346
N +S P+ A L +L + L NN++S P + S L +TL N
Sbjct: 183 NKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 20/66 (30%), Positives = 31/66 (46%), Gaps = 4/66 (6%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
S + + LSKL L N ++ P L SL NL ++LK N ++ P L + L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 172 ITMALS 177
+ L+
Sbjct: 220 FIVTLT 225
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (148), Expect = 5e-11
Identities = 43/211 (20%), Positives = 74/211 (35%), Gaps = 8/211 (3%)
Query: 164 SLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALN 223
+ ++ + + + L +P + + IL L N L L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 224 VGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPL 283
+ +L L L S++ S+P + + +D+S N +
Sbjct: 62 LDRAELTKLQVD--GTLPVL-GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 284 ELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNIT 343
L L +L L + N L P + L+ L L+NN L+ + L +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 344 LRNNNLSGSIPPEI-GLMKLEYLDLSHNKLN 373
L+ N+L +IP G L + L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 1e-09
Identities = 43/207 (20%), Positives = 68/207 (32%), Gaps = 7/207 (3%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152
S ++ L ++P + L S N L L L LNL
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE 212
+ L L T+ LS N L L +L + N+L+ +
Sbjct: 63 --DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLGA 119
Query: 213 LGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDM 272
L L L L + GN+L P L L L L +N+L + + + + +
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 273 SMNNIEGTIPLELTRLSQLLYLSISSN 299
N++ TIP L + + N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 13/53 (24%), Positives = 16/53 (30%), Gaps = 1/53 (1%)
Query: 106 FNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLN 158
N L + L L L N+L +IP L L GN
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 6e-04
Identities = 27/96 (28%), Positives = 34/96 (35%), Gaps = 1/96 (1%)
Query: 87 ELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146
L L+ L L+ N L P + KL L + NNLT L L N
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLH 182
L+ L L+ N+L IP L L N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.002
Identities = 12/49 (24%), Positives = 20/49 (40%), Gaps = 2/49 (4%)
Query: 332 EIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFL 380
E+ K + + NL+ ++PP++ L LS N L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATL 51
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.5 bits (133), Expect = 5e-10
Identities = 32/127 (25%), Positives = 48/127 (37%), Gaps = 9/127 (7%)
Query: 124 RYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG 183
R L + +LT + L L + L+L N L P +L L L + S N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55
Query: 184 PIPSAIGDLNNLLILSLDSNKLSGM-LHQELGKLKNLVALNVGGNKLMGP---IPSTLFR 239
+ +L L L L +N+L Q L LV LN+ GN L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 240 LTNLTYL 246
L +++ +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 7e-08
Identities = 23/118 (19%), Positives = 44/118 (37%), Gaps = 5/118 (4%)
Query: 222 LNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTI 281
L++ L + L +L +T+L L N L +PP + + + + S N +E
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVD 59
Query: 282 PLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSEL 339
+ Q L L ++ + + L L+L N L + +E+
Sbjct: 60 GVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 2e-07
Identities = 28/119 (23%), Positives = 46/119 (38%), Gaps = 9/119 (7%)
Query: 271 DMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIP 330
++ ++ T+ L +L + +L +S N L P +A L L+ L S+N
Sbjct: 4 HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENV 58
Query: 331 PEIGKCSELRNITLRNNNLSGSIPPEI--GLMKLEYLDLSHNKLNG--TIPPFLYHRFP 385
+ L+ + L NN L S + +L L+L N L I L P
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 30/107 (28%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 102 LSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAI 161
L L L ++ + L + +LD S N L +PP L +LR LEVL N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE--N 57
Query: 162 PSSLCQLTKLITMALSRNGL-HGPIPSAIGDLNNLLILSLDSNKLSG 207
+ L +L + L N L + L++L+L N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 25/108 (23%), Positives = 41/108 (37%), Gaps = 6/108 (5%)
Query: 245 YLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQ 304
L+L L ++ + + + +D+S N + P L L L L S N L
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 305 IPITIAGLISLKGLDLSNNKL-SGPIPPEIGKCSELRNITLRNNNLSG 351
+ L+ L L NN+L + C L + L+ N+L
Sbjct: 59 DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 4e-04
Identities = 22/111 (19%), Positives = 36/111 (32%), Gaps = 30/111 (27%)
Query: 92 NFSCFPGLESLSLRFNYLFGSIPSQVGALSKL----------------------RYLDFS 129
+ + L L N L P+ + AL L + L
Sbjct: 15 HLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73
Query: 130 FNNLTG-SIPPELGSLRNLEVLNLKGNNLNG------AIPSSLCQLTKLIT 173
N L + L S L +LNL+GN+L + L ++ ++T
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 124
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 56.0 bits (133), Expect = 2e-09
Identities = 28/162 (17%), Positives = 51/162 (31%), Gaps = 3/162 (1%)
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292
IP + + T L L+ N L + L N I + +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 293 YLSISSNMLSGQI-PITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSG 351
+I GL LK L+L +N++S +P + L ++ L +N +
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 352 SIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDL 393
+ L L+ P + DL +++
Sbjct: 141 NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEF 182
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 1e-08
Identities = 21/82 (25%), Positives = 34/82 (41%), Gaps = 8/82 (9%)
Query: 299 NMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIG 358
N S +I SL+ L++SNNKL +P + L + N+L+ +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPELPQ 324
Query: 359 LMKLEYLDLSHNKLNGTIPPFL 380
L+ L + +N L P
Sbjct: 325 --NLKQLHVEYNPLR-EFPDIP 343
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 4e-08
Identities = 21/82 (25%), Positives = 34/82 (41%), Gaps = 9/82 (10%)
Query: 90 QFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEV 149
+ P LE L++ N L +P+ +L L SFN+L +P NL+
Sbjct: 277 RSLCDLPPSLEELNVSNNKL-IELPA---LPPRLERLIASFNHLA-EVPELPQ---NLKQ 328
Query: 150 LNLKGNNLNGAIPSSLCQLTKL 171
L+++ N L P + L
Sbjct: 329 LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 21/94 (22%), Positives = 30/94 (31%), Gaps = 9/94 (9%)
Query: 104 LRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPS 163
N I S L L+ S N L +P LE L N+L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321
Query: 164 SLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLI 197
L +L + N L P + +L +
Sbjct: 322 LPQNLKQLH---VEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 9e-06
Identities = 46/294 (15%), Positives = 86/294 (29%), Gaps = 19/294 (6%)
Query: 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180
+ L+ + L+ S+P +LE L N+L +P L L+ +
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 181 LHGPIPSAIGDLNNL-----------LILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL 229
L P + + + L + +L + G N+L
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 230 MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLS 289
Y +S +P + ++ + + ++ L
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 290 QLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNL 349
L ++ S + ++ + SEL N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 350 SGSIPPEIGLMK-LEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPDYFR 402
S I L LE L++S+NKL +P L S+N L E+P+ +
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIASFNHLA-EVPELPQ 324
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 3e-05
Identities = 15/58 (25%), Positives = 24/58 (41%), Gaps = 5/58 (8%)
Query: 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151
+ P LE L FN+L +P L+ L +N L P S+ +L + +
Sbjct: 301 ALPPRLERLIASFNHL-AEVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 8e-05
Identities = 23/103 (22%), Positives = 36/103 (34%), Gaps = 14/103 (13%)
Query: 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPI 233
N I S +L L++ +NKL L +L+ L N L +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLAE-V 319
Query: 234 PSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNN 276
P NL L++ N L P ++ D+ MN+
Sbjct: 320 PELP---QNLKQLHVEYNPLR-EFPDIPESVE-----DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 16/60 (26%), Positives = 23/60 (38%), Gaps = 4/60 (6%)
Query: 336 CSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEG 395
+ + L N LS S+P LE L S N L +P L + N+L+
Sbjct: 37 DRQAHELELNNLGLS-SLPELPP--HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 2e-08
Identities = 39/202 (19%), Positives = 83/202 (41%), Gaps = 15/202 (7%)
Query: 167 QLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGG 226
+ I L + + + +LN++ + +++ + + Q + L N+ L + G
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 227 NKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELT 286
NKL P + +L + S+ +S+ + + L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK------SLSLEHNGISDINGLV 131
Query: 287 RLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRN 346
L QL L + +N ++ ++ L L L L +N++S +P + ++L+N+ L
Sbjct: 132 HLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 347 NNLSGSIPPEIGLMKLEYLDLS 368
N++S + GL L+ L+L
Sbjct: 188 NHIS-DLRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 1e-07
Identities = 40/204 (19%), Positives = 74/204 (36%), Gaps = 16/204 (7%)
Query: 143 SLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDS 202
+ NLK ++ A+ + +L + + + + + I L N+ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 203 NKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIG 262
NKL+ + L L G + + + I G
Sbjct: 78 NKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 263 NMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSN 322
+ + + N + T L+RL++L LS+ N +S +P+ AGL L+ L LS
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSK 187
Query: 323 NKLSGPIPPEIGKCSELRNITLRN 346
N +S + L + L +
Sbjct: 188 NHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 32/202 (15%), Positives = 67/202 (33%), Gaps = 20/202 (9%)
Query: 184 PIPSAIGD------LNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTL 237
+P+ I + +L ++ + Q +L ++ + + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 238 FRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSIS 297
L N+T L+L+ N L + N+ + + + N ++ +
Sbjct: 65 QYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSS-------LKDLKKLK 115
Query: 298 SNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI 357
S L I GL+ L L+ + + + +N I P
Sbjct: 116 SLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA 175
Query: 358 GLMKLEYLDLSHNKLNGTIPPF 379
GL KL+ L LS N ++ +
Sbjct: 176 GLTKLQNLYLSKNHIS-DLRAL 196
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 36/179 (20%), Positives = 61/179 (34%), Gaps = 14/179 (7%)
Query: 120 LSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179
L+ + + + +++ + L N+ L L GN L P L L L + L N
Sbjct: 45 LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100
Query: 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFR 239
+ L L + L + N + L R
Sbjct: 101 KVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN------KITDITVLSR 154
Query: 240 LTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISS 298
LT L L L N ++ +P + +T + + +S N+I + L L L L + S
Sbjct: 155 LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 3e-08
Identities = 17/91 (18%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 123 LRYLDFSFNNLTGSIPPEL-GSLRNLEVLNLKGNNLNG----AIPSSLCQLTKLITMALS 177
++ LD L+ + EL L+ +V+ L L I S+L L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 178 RNGLHGPIPSAIGDLNNLLILSLDSNKLSGM 208
N L + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 4e-07
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 99 LESLSLRFNYL-FGSIPSQVGALSKLRYLDFSFNNLTG----SIPPELGSLRNLEVLNLK 153
++SL ++ L + L + + + LT I L L LNL+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 154 GNNLNGAIPSSLCQLTKLITMALSRNGLHG 183
N L + Q + + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 4e-07
Identities = 18/92 (19%), Positives = 33/92 (35%), Gaps = 13/92 (14%)
Query: 121 SKLRYLDFSFNNLTG----SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQ-----LTKL 171
S LR L + +++ S+ L + +L L+L N L A L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 172 ITMALSRNGLHGPIPSAIGDL----NNLLILS 199
+ L + + L +L ++S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 13/74 (17%), Positives = 29/74 (39%), Gaps = 6/74 (8%)
Query: 313 ISLKGLDLSNNKLSGPIPPEIGKC-SELRNITLRNNNLSGSIPPEIG-----LMKLEYLD 366
+ ++ LD+ +LS E+ + + + L + L+ + +I L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 367 LSHNKLNGTIPPFL 380
L N+L +
Sbjct: 62 LRSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 14/90 (15%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 267 ILKVDMSMNNIEGTIPLEL-TRLSQLLYLSISSNMLSGQIPITIAGLI----SLKGLDLS 321
I +D+ + EL L Q + + L+ I+ + +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 322 NNKLSGPIPPEIGKCSELRNITLRNNNLSG 351
+N+L + + + + ++ +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 21/90 (23%), Positives = 29/90 (32%), Gaps = 9/90 (10%)
Query: 90 QFNFSCFPGLESLSLRFNYL----FGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGS-- 143
Q L L L + S+ + + A LR LD S N L + +L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 144 ---LRNLEVLNLKGNNLNGAIPSSLCQLTK 170
LE L L + + L L K
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 11/91 (12%)
Query: 291 LLYLSISSNMLS-GQIPITIAGLISLKGLDLSNNKLSG----PIPPEIGKCSELRNITLR 345
+ L I LS + + L + + L + L+ I + L + LR
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 346 NNNLSGSIPPEIG------LMKLEYLDLSHN 370
+N L + K++ L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 15/76 (19%), Positives = 24/76 (31%), Gaps = 5/76 (6%)
Query: 194 NLLILSLDSNKLS-GMLHQELGKLKNLVALNVGGNKL----MGPIPSTLFRLTNLTYLYL 248
++ L + +LS + L L+ + + L I S L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 249 HSNHLNGSIPPEIGNM 264
SN L +
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 4e-05
Identities = 17/76 (22%), Positives = 33/76 (43%), Gaps = 5/76 (6%)
Query: 146 NLEVLNLKGNNLNGAIPSSLC-QLTKLITMALSRNGLHG----PIPSAIGDLNNLLILSL 200
+++ L+++ L+ A + L L + + L GL I SA+ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 201 DSNKLSGMLHQELGKL 216
SN+L + + +
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 8e-05
Identities = 18/89 (20%), Positives = 35/89 (39%), Gaps = 9/89 (10%)
Query: 289 SQLLYLSISSNMLSGQIPITIAGLI----SLKGLDLSNNKLSGPIPPEIGK-----CSEL 339
S L L ++ +S ++A + SL+ LDLSNN L ++ + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 340 RNITLRNNNLSGSIPPEIGLMKLEYLDLS 368
+ L + S + + ++ + L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 10/88 (11%), Positives = 23/88 (26%), Gaps = 4/88 (4%)
Query: 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYL----FGSIPSQVGALSKLRYLDFSFN 131
+++ ++L + + L L I S + L L+ N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 132 NLTGSIPPELGSLRNLEVLNLKGNNLNG 159
L + ++ +L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 10/88 (11%), Positives = 30/88 (34%), Gaps = 9/88 (10%)
Query: 263 NMTGILKVDMSMNNIEGT----IPLELTRLSQLLYLSISSNMLSGQIPITIAGLI----- 313
+ + + ++ ++ + + L L L +S+N L + + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 314 SLKGLDLSNNKLSGPIPPEIGKCSELRN 341
L+ L L + S + + + +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKP 454
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 13/92 (14%), Positives = 29/92 (31%), Gaps = 10/92 (10%)
Query: 217 KNLVALNVGGNKL----MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIG-----NMTGI 267
L L + + + +TL +L L L +N L + ++ +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 268 LKVDMSMNNIEGTIPLELTRLSQLL-YLSISS 298
++ + + L L + L + S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.6 bits (124), Expect = 8e-08
Identities = 40/310 (12%), Positives = 95/310 (30%), Gaps = 36/310 (11%)
Query: 99 LESLSLRFNYL----FGSIPSQVGALSKLRYLDFSFNNLTG----SIPPELGSLRNLEVL 150
+E SL+ + + S+ + + ++ + S N + + + S ++LE+
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 151 NLKGN---NLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSG 207
+ IP +L L + + + + + LI L +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGI 267
L+ L + + L + N L E
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 268 LKVDMSMNNIEGTIPLELTRLSQLLYL-------------SISSNMLSGQIPITIAGLIS 314
++ ++ ++ I E L L + +++ S + I + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 315 LKGLDLSNNKLSGPIPPEIGKC------SELRNITLRNNNLSGSIPPEIG------LMKL 362
L+ L L++ LS + L+ + L+ N + + + L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 363 EYLDLSHNKL 372
+L+L+ N+
Sbjct: 305 LFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.4 bits (108), Expect = 7e-06
Identities = 42/310 (13%), Positives = 90/310 (29%), Gaps = 36/310 (11%)
Query: 122 KLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNG----AIPSSLCQLTKLITMALS 177
L+ + + S+ L +++ + L GN + + ++ L S
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 178 RNGLHGPIPSAIGDLNNLLILSLDSNKLS---GMLHQELGKLKNLVALNVGGNKLMGPIP 234
L LL L KL + + + + + + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 235 STLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYL 294
L + ++ + N + + N +E E + Q L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 295 SISSNMLSGQIPITIAGLISLKGL-------------DLSNNKLSGPIPPEIGKCSELRN 341
+ M+ I + L+GL + + S + + LR
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 342 ITLRNNNLSGSIPPEIG-------LMKLEYLDLSHNKLNG----TIPPFLYHRFP----L 386
+ L + LS + + L+ L L +N++ T+ + + P L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 387 DLSYNDLEGE 396
+L+ N E
Sbjct: 308 ELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 9/59 (15%), Positives = 21/59 (35%), Gaps = 6/59 (10%)
Query: 120 LSKLRYLDFSFNNLTGSIPPELGS-----LRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173
L+ L +N + L + + +L L L GN + ++ ++ +
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFS 329
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (113), Expect = 4e-07
Identities = 21/131 (16%), Positives = 42/131 (32%), Gaps = 7/131 (5%)
Query: 120 LSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179
+ R LD + I +L + ++ N + L +L T+ ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73
Query: 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQE----LGKLKNLVALNVGGNKLMGPIPS 235
+ L +L L L +N L + + L L L L
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 236 TLFRLTNLTYL 246
++++ + L
Sbjct: 134 VIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 25/135 (18%), Positives = 44/135 (32%), Gaps = 7/135 (5%)
Query: 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152
++ L LR + I + L + +DFS N + LR L+ L +
Sbjct: 14 YTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLV 70
Query: 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHG-PIPSAIGDLNNLLILSLDSNK---LSGM 208
N + L L + L+ N L + L +L L + N
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 209 LHQELGKLKNLVALN 223
+ K+ + L+
Sbjct: 131 RLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 15/129 (11%), Positives = 33/129 (25%), Gaps = 3/129 (2%)
Query: 283 LELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNI 342
+ T + L + + I A L +D S+N++ L+ +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 343 TLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGEIPDYFR 402
+ NN + + + N + L+Y + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 403 DSPFKVYGN 411
V
Sbjct: 129 HYRLYVIYK 137
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 5e-07
Identities = 31/189 (16%), Positives = 59/189 (31%), Gaps = 20/189 (10%)
Query: 168 LTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGN 227
L + + L + + + DL+ + L D + + + L NL +N N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 228 KLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTR 287
+L P + + + L + + L R
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 288 LSQLLYLSISSNMLSGQI--------------PITIAGLISLKGLDLSNNKLSGPIPPEI 333
L + LSG +A L +L+ LD+S+NK+S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 334 GKCSELRNI 342
K + L ++
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 27/180 (15%), Positives = 57/180 (31%), Gaps = 22/180 (12%)
Query: 216 LKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMN 275
L + +G + + + L +T L + SI + + + +++ S N
Sbjct: 17 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 72
Query: 276 NIEGTIPLELTRL----------------SQLLYLSISSNMLSGQIPITIAGLISLKGLD 319
+ PL+ L + + QI
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 320 LSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF 379
L + + + + L+ + +N ++ + P L LE LD+S NK++ I
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSNKVSD-ISVL 190
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (110), Expect = 3e-06
Identities = 36/236 (15%), Positives = 68/236 (28%), Gaps = 10/236 (4%)
Query: 124 RYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHG 183
R + +T IP +L RN L L + L + +S+N +
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 184 PIPSAIGDLNNLLILSLD---SNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRL 240
I + + L +N L L P + L
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 241 TNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNM 300
+ + +++ ++ + N I +QL L++S N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 301 LSGQIPITI-AGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPP 355
++P + G LD+S ++ + +LR NL +P
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR--ARSTYNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 7e-05
Identities = 33/217 (15%), Positives = 58/217 (26%), Gaps = 6/217 (2%)
Query: 112 SIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKL 171
IPS + L F L +LE + + N++ I + +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 172 ITMAL----SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGN 227
+ + P L++S K +H+ K L+ + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 228 KLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTR 287
S + L+L+ N + NN+E
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 288 LSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNK 324
S + L IS + + L L+ N K
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 10/44 (22%), Positives = 16/44 (36%), Gaps = 3/44 (6%)
Query: 120 LSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPS 163
S LD S + L +L+ L + NL +P+
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL-KKLPT 240
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 28/153 (18%), Positives = 58/153 (37%), Gaps = 6/153 (3%)
Query: 161 IPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLV 220
+ + + AL GL + N ++L+ + ++ L + L+
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELL 68
Query: 221 ALNVGGNKL--MGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278
+LN+ N+L + + S + + NL L L N L + + ++ + N++
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 279 GTIPLELTRLSQLLYLSISSNMLSGQ-IPITIA 310
T + T +S + L G +P IA
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 2e-05
Identities = 29/144 (20%), Positives = 57/144 (39%), Gaps = 13/144 (9%)
Query: 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLL 292
+ + + + + L L P++ I V +++ T+ + + +LL
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQ-NIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 293 YLSISSNMLSGQ--IPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLS 350
L++S+N L + + +LK L+LS N+L + K +L + L N+LS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 351 GSIPPEIG--------LMKLEYLD 366
+ + KL LD
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.004
Identities = 25/127 (19%), Positives = 47/127 (37%), Gaps = 12/127 (9%)
Query: 92 NFSCFPGLESLSL-----RFNYLFGSIPSQVGALSKLRYLDFSFNNLTG--SIPPELGSL 144
P L + ++ R + + ++ + +L L+ S N L + +
Sbjct: 31 GLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKA 90
Query: 145 RNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLL-----ILS 199
NL++LNL GN L + KL + L N L ++ + +L
Sbjct: 91 PNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR 150
Query: 200 LDSNKLS 206
LD ++L
Sbjct: 151 LDGHELP 157
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 26/146 (17%), Positives = 45/146 (30%), Gaps = 4/146 (2%)
Query: 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQ-LTKLITMALSRN 179
L + + L NL L ++ + + L +L + + ++
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPST-LF 238
GL P A L L+L N L L + + +L L + GN L L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 239 RLTNLTYLYLHSNHLNGSIPPEIGNM 264
R + L + +M
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 24/151 (15%), Positives = 47/151 (31%), Gaps = 4/151 (2%)
Query: 164 SLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQEL-GKLKNLVAL 222
C + +R+G + NL L +++ + L L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 223 NVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIP 282
+ + L P L+ L L N S+ + + ++ +S N + +
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 283 LE-LTRLSQLLYLSISSNMLSGQIPITIAGL 312
L L R + + L +A +
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 796 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.66 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.65 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.55 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.44 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.69 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.59 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.82 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.22 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.72 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=408.96 Aligned_cols=249 Identities=31% Similarity=0.465 Sum_probs=210.7
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+.+ +|+.||+|++......+....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999764 68999999998765554445678999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998654 389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+ .
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~p--~-- 225 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVEFTFP--D-- 225 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCCCCC--T--
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCC--c--
Confidence 2344679999999999999999999999999999999999999997321 1222233333222211 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+||+.||++|||++|+++|
T Consensus 226 -~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 226 -FVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -cCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 112347789999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=412.12 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=197.8
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe--cceeeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH--KKCMFL 575 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 575 (796)
++|++.+.||+|+||+||+|+. .+|+.||||++......+. ..+.+.+|++++++++|||||++++++.+ ++..++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH-HHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH-HHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 6799999999999999999975 4799999999987655433 35678999999999999999999999865 456899
Q ss_pred EEeeccCCcHHHHHhhcC-cccccCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDY-EAVVLDWTMRVNIIKCVANALSYLHHDC--MPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
||||+++|+|.+++.+.. ....+++..++.++.|+++||+|||++. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999987542 2345899999999999999999999872 1149999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
.+..+........||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+........
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~i~~~~~~~~ 234 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKFRRI 234 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCCCC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCCCC
Confidence 87655444556779999999999999999999999999999999999999997321 1222223333322221
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
... ...++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 PYR----YSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Ccc----cCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111 12347899999999999999999999876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=410.24 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=209.8
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|++++++++|||||++++++.+++..++||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4799999999999999999975 579999999997654332 357899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999999988653 389999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCC-CCCccchh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSR-LSPPVDRM 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 736 (796)
.......+||+.|+|||++.+..++.++||||+||++|||+||+.||..... ........... ......
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~-- 239 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTPELQNP-- 239 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSCCCSSG--
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCCCCCCCc--
Confidence 5555667899999999999999999999999999999999999999973221 11222222211 111111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
......+.+++.+||+.||++|||++|+++|
T Consensus 240 -~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 -EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1222357899999999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=415.17 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=205.6
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|+||+||+|+.+ ..||||+++....... ..+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTT-HHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 468999999999999999999875 3699999976654433 35789999999999999999999998854 5689999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.++++... ..+++..+..++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999997643 3489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC--CccccccccCccCcccccc---CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc-CCCCC
Q 003780 658 SS--NRTIVAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD-SRLSP 731 (796)
Q Consensus 658 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 731 (796)
.. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... .......+. ....+
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~p 229 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRGYLSP 229 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHHTSCCC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCCCC
Confidence 22 2344679999999999864 3578999999999999999999999974221 111222222 22222
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
............+.+++.+||+.||++||||+||+++|+....
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2222222333458899999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=408.90 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=200.2
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
++|++.+.||+|+||+||+|++++++.||||++...... .++|.+|++++++++|||||+++|+|..++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 578899999999999999999988999999999765443 3578999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++.... ..+++..+..++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999987643 3488999999999999999999999 99999999999999999999999999998765443
Q ss_pred CC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCC-CcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 659 SN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP-GELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 659 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.. .....||+.|+|||++.+..++.++|||||||++|||+|+..| |... ........ +...........
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--------~~~~~~~~-i~~~~~~~~p~~ 226 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--------SNSEVVED-ISTGFRLYKPRL 226 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--------CHHHHHHH-HHHTCCCCCCTT
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--------CHHHHHHH-HHhcCCCCCccc
Confidence 22 2335689999999999999999999999999999999996544 4321 11112222 222222222111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
....+.+++.+||+.||++||||+||+++|+++.
T Consensus 227 ---~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 227 ---ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1234789999999999999999999999998763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=408.92 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=203.7
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++......+ ..+.+.+|++++++++|||||++++++.+++..++|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 35799999999999999999976 479999999997654332 235789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999987543 489999999999999999999999 999999999999999999999999999987653
Q ss_pred CC--CCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 657 DS--SNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 657 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... .................
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-------SCQEYSDWKEKKTYLNP 228 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST-------TSHHHHHHHTTCTTSTT
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCc
Confidence 32 22345679999999999988776 5789999999999999999999974221 11111122222211111
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. ......+.+++.+||+.||++|||++|+++|
T Consensus 229 ~---~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 W---KKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp G---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c---ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1112347789999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-49 Score=410.38 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=197.3
Q ss_pred cCCccceeeecccceeEEEEEcc-CC---cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NG---KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||+||+|+.+ ++ ..||||++....... ..+.|.+|++++++++|||||+++|++..++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH--HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 45667789999999999999764 23 368999887654432 3468999999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.... ..+++.++.+++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999887643 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCc-----cccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCC
Q 003780 655 DSDSSNR-----TIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSR 728 (796)
Q Consensus 655 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (796)
....... ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ... +...+...
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------~~~-~~~~i~~~ 249 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------NQD-VINAIEQD 249 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHH-HHHHHHTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--------HHH-HHHHHHcC
Confidence 5432221 12357899999999999999999999999999999998 899987321 111 22222222
Q ss_pred CCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 729 LSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
...+... .....+.+++.+||+.||++||||+||++.|++.
T Consensus 250 ~~~~~~~---~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 YRLPPPM---DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CCCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2222211 2233478999999999999999999999999765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=408.43 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=207.5
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|+||+||+|++++++.||||+++..... .+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 4689999999999999999999988899999999765433 3579999999999999999999998854 5678999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... ...+++..+.+|+.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999876543 23489999999999999999999999 9999999999999999999999999999987543
Q ss_pred CC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 658 SS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 658 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.. ......||+.|+|||++.+..++.++|||||||++|||+||..|+.... ... .....+.....+....
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------~~~-~~~~~i~~~~~~~~p~- 233 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNP-EVIQNLERGYRMVRPD- 233 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHH-HHHHHHHTTCCCCCCT-
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-------CHH-HHHHHHHhcCCCCCcc-
Confidence 22 2334568999999999999999999999999999999999766644211 111 1222222222222222
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.....+.+++.+||+.||++||||+||++.|+..
T Consensus 234 --~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1223478999999999999999999999988753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-49 Score=412.04 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=215.0
Q ss_pred HhcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeE
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 575 (796)
..++|++.+.||+|+||+||+|+.+ +|+.||||+++..... .++|.+|++++++++|||||++++++.+++..++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 4568999999999999999999765 6899999999765433 4579999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccC
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLD 655 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 655 (796)
||||+++|+|.+++.+.. ...+++..+..++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999997643 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 656 SDSSN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 656 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
..... .....|++.|+|||++.+..++.++|||||||++|||++|+.|+.... ....+.+.+.....++..
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--------~~~~~~~~i~~~~~~~~~ 238 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYELLEKDYRMERP 238 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHHHHTTCCCCCC
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--------hHHHHHHHHhcCCCCCCC
Confidence 44332 233458899999999999999999999999999999999887764211 122233344444433332
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
... ...+.+++.+||+.||++||||+||++.|+....
T Consensus 239 ~~~---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 EGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 222 2347899999999999999999999999987644
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=398.65 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=211.8
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
++|++.+.||+|+||+||+|+.++++.||||+++..... .++|.+|++++++++||||++++|+|.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 579999999999999999999988999999999876544 3578999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.+++.... ..+++..+.+++.|+|+||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred ccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999977543 3488999999999999999999999 99999999999999999999999999998765443
Q ss_pred CC-ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 659 SN-RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 659 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.. .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||+... ..... ..+........+.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~-~~i~~~~~~~~p~- 224 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETA-EHIAQGLRLYRPH- 224 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHH-HHHHTTCCCCCCT-
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHH-HHHHhCCCCCCcc-
Confidence 32 334568999999999999999999999999999999998 899987432 12222 2222222222222
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLT 771 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 771 (796)
.....+.+++.+||+.||++|||++|++++|..
T Consensus 225 --~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 --LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122358899999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=407.17 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=207.6
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999975 479999999998655444444568999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999988654 489999999999999999999999 9999999999999999999999999999877543
Q ss_pred CC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 658 SS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 658 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+.......+ .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p--~ 231 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKLEYDFP--E 231 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTCCCCC--T
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcCCCCCC--c
Confidence 22 2334679999999999999999999999999999999999999997321 1222333333322211 1
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+.+++.+||+.||++|||++|++++
T Consensus 232 ---~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 232 ---KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---cCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 112347799999999999999999998655
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=407.89 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=206.2
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|++.+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|++++++++|||||++++++.+++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 5689999999999999999975 479999999997654332 467899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.+.. ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999999987542 2489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccccccCccCccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCc
Q 003780 658 SSNRTIVAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPP 732 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (796)
........||+.|+|||++. +..|+.++||||+||++|||+||+.||..... ......+........
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEPPTL 235 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHHHHHSCCCCC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 22233467999999999874 45688999999999999999999999974321 122223333222111
Q ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 733 VDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 733 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.. +......+.+++.+||+.||++|||++|+++|
T Consensus 236 ~~--~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 AQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SS--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Cc--cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 11223457899999999999999999999886
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=396.01 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=200.0
Q ss_pred CccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe----cceeeE
Q 003780 501 FDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH----KKCMFL 575 (796)
Q Consensus 501 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~l 575 (796)
|++.+.||+|+||+||+|..+ +++.||+|++........ ..+.+.+|++++++++|||||++++++.. +...++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 356678999999999999754 688999999987654432 25679999999999999999999999875 356899
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEecCCCCCeEec-CCCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPS--IVHRDISSNNILLN-SKLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~a~ 652 (796)
||||+++|+|.+++.+.. .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999998653 489999999999999999999998 6 99999999999997 47899999999998
Q ss_pred ccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCC-
Q 003780 653 LLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP- 731 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 731 (796)
.... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||.... ....+...+.....+
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--------~~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--------NAAQIYRRVTSGVKPA 232 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--------SHHHHHHHHTTTCCCG
T ss_pred eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--------cHHHHHHHHHcCCCCc
Confidence 6433 23345679999999999865 58999999999999999999999986321 112222223322222
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... ....++.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~---~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGGG---CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCc---cCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 2211 123347899999999999999999999886
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-48 Score=406.64 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=207.1
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
+.|+..+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3599999999999999999975 578999999998776555555678999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|++..++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999987765443 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCccccccccCccCcccccc---CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 658 SSNRTIVAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... .......+..........
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 236 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPALQS 236 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCCCCSC
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCCCCC
Confidence 33569999999999864 458899999999999999999999986321 122233333333222221
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.. ....+.+++.+||+.||++|||++|+++|
T Consensus 237 ~~---~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 237 GH---WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC---CCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11 12347899999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-48 Score=406.00 Aligned_cols=253 Identities=26% Similarity=0.341 Sum_probs=192.8
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.+.|++.+.||+|+||+||+|+.+ +|+.||||++........ .+.+.+|++++++++|||||++++++.+++..++|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999754 689999999986654332 35688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec---CCCcEEEeeeccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN---SKLEAFVADFGTARL 653 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~ 653 (796)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999997643 489999999999999999999999 999999999999995 578999999999987
Q ss_pred cCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
..... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... .......+.........
T Consensus 160 ~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 160 EDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAEYEFDS 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTCCCCCT
T ss_pred ccCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhccCCCCCC
Confidence 65432 2334679999999999999999999999999999999999999997321 12222333333222211
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. ........+.+++.+||+.||++|||++|+++|
T Consensus 231 ~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 P-YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred c-cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 111222357899999999999999999999997
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=410.24 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=205.2
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|+. .+|+.||+|+++..... ...+++.+|+.++++++|||||++++++.+++..++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46899999999999999999975 57999999999765432 2346889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.|+++||+|||+++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999998654 3899999999999999999999731 899999999999999999999999999987643
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCC----------CC------------
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS----------PS------------ 714 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~----------~~------------ 714 (796)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||........ ..
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2 22345799999999999999999999999999999999999999964221000 00
Q ss_pred -----------chhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 715 -----------SDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 715 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
................+.... .....++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000000011111111100 0112347889999999999999999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=397.85 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=206.8
Q ss_pred cCCcccee-eecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYC-IGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~-lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|.+.+. ||+|+||+||+|..+ ++..||||+++..... ...++|.+|++++++++|||||+++|++.. +..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH--HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 45667774 999999999999653 4567999999765433 235689999999999999999999999865 4678
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.... ..+++..+.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999986543 3489999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... . .+...+.....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~-~~~~~i~~~~~ 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------P-EVMAFIEQGKR 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------H-HHHHHHHTTCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------H-HHHHHHHcCCC
Confidence 543322 233468999999999999999999999999999999998 8999874221 1 12222223222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
++... ....++.+++.+||+.||++||||.+|.+.|+....
T Consensus 231 ~~~p~---~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 MECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22222 122357899999999999999999999999876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=407.36 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=207.4
Q ss_pred hcCCccceeeecccceeEEEEEccC------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 570 (796)
.++|++.+.||+|+||+||+|+... ...||+|++....... ..+.+.+|+.++.++ +|||||++++++.++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH--HHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 4689999999999999999997542 2369999987654332 245789999999998 899999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCc--------------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecC
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYE--------------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDI 630 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 630 (796)
+..++||||+++|+|.++++.... ...+++..++.++.||++||+|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999976432 23589999999999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCccc
Q 003780 631 SSNNILLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELL 707 (796)
Q Consensus 631 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~ 707 (796)
||+||+++.++.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 234568999999999999999999999999999999998 89998743
Q ss_pred ccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 003780 708 SSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFL 770 (796)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 770 (796)
.. ...+...+......+..... ...+.+++.+||+.||++|||++||+++|.
T Consensus 271 ~~--------~~~~~~~~~~~~~~~~p~~~---~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PV--------DANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CC--------SHHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CH--------HHHHHHHHhcCCCCCCCCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 12233334443333322212 234789999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=394.91 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=198.7
Q ss_pred eeeecccceeEEEEEcc---CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEeecc
Q 003780 505 YCIGTGGYGSVYKAQLP---NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKYMK 581 (796)
Q Consensus 505 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 581 (796)
+.||+|+||+||+|.++ .++.||||+++..... ....++|.+|++++++++|||||+++++|.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 57999999999999754 3578999999765433 3335689999999999999999999999965 45789999999
Q ss_pred CCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCCC-
Q 003780 582 RGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSSN- 660 (796)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 660 (796)
+|+|.+++++.. .+++..+.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999998654 389999999999999999999999 9999999999999999999999999999876543322
Q ss_pred --ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 661 --RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 661 --~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ...+...+.....++.+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---------~~~~~~~i~~~~~~~~p~-- 233 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------GSEVTAMLEKGERMGCPA-- 233 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---------HHHHHHHHHTTCCCCCCT--
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---------HHHHHHHHHcCCCCCCCc--
Confidence 223468999999999999999999999999999999998 899987321 112223333333322222
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 738 MQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.....+.+++.+||+.||++|||++||.+.|+..
T Consensus 234 -~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 234 -GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1223478999999999999999999999888654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=396.57 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=202.5
Q ss_pred cCCccceeeecccceeEEEEEccCC-----cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNG-----KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
++|+..+.||+|+||+||+|.+++. ..||||++....... ...+|.+|++++++++|||||+++|++.+++..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH--HHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 5688899999999999999976532 479999997655432 245789999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+.+|++.+++.... ..+++..+.+++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999887643 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|..|+... .... .+...+.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-------~~~~-~~~~~i~~~~~ 231 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-------LSNH-EVMKAINDGFR 231 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHH-HHHHHHHTTCC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc-------CCHH-HHHHHHhccCC
Confidence 6543222 22345899999999999999999999999999999999977665421 1111 22233333333
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
++... .....+.+++.+||+.||++||||.||++.|+.+.
T Consensus 232 ~~~~~---~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 232 LPTPM---DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp CCCCT---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCch---hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 33322 12234789999999999999999999999997653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=397.28 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=208.0
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
.++|++.+.||+|+||.||+|+.++++.||||+++..... .+.|.+|+.++++++|||||++++++.+ +..++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 3679999999999999999999988889999999765543 3579999999999999999999999854 5678999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|.+++.... ...+++.+++.++.|||+||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 91 Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 91 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 9999999999887642 23489999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 658 S-SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 658 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. .......||+.|+|||++.++.++.++|||||||++|||++|..|+... .... .....+......+....
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-------~~~~-~~~~~i~~~~~~~~~~~ 238 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNR-EVLDQVERGYRMPCPPE 238 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHH-HHHHHHHTTCCCCCCTT
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-------CCHH-HHHHHHHhcCCCCCCcc
Confidence 2 2233456899999999999999999999999999999999987775421 1112 22222333333222221
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCcc
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPF 780 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 780 (796)
. ...+.+++.+||+.||++||+|++|++.|+.......++|
T Consensus 239 ~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~ 279 (285)
T d1fmka3 239 C---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279 (285)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred c---CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence 2 2347899999999999999999999999988665555444
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=402.81 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=213.2
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999975 57999999999876544444457889999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999998654 388999999999999999999999 999999999999999999999999999997665
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
........+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+ ...............+.
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~~~~~~p~--- 226 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRFPR--- 226 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCT---
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhcCCCCCCc---
Confidence 5555556789999999999999999999999999999999999999987422 12223333333322211
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPT-----MQRVCQE 768 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 768 (796)
....++.+++.+||+.||++||+ ++|+++|
T Consensus 227 --~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 227 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --cCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11234778999999999999995 8888876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=397.16 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=209.9
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhh---HHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEET---TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++........ ...+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999976 5799999999976543321 2246799999999999999999999999999999
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC----cEEEeeec
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL----EAFVADFG 649 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 649 (796)
++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999998653 489999999999999999999999 999999999999998876 49999999
Q ss_pred cccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.....
T Consensus 163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVNY 233 (293)
T ss_dssp TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTCC
T ss_pred hhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCC
Confidence 998775432 2334569999999999999999999999999999999999999997321 1222223333222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..+. .........+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCH-HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCc-hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2111 1112223457899999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.3e-47 Score=404.12 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=209.7
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+. .+|+.||||++......+ .+.+.+|++++++++|||||++++++.+++..++|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46899999999999999999975 579999999997655432 45789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC--CCcEEEeeecccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS--KLEAFVADFGTARLL 654 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~ 654 (796)
|||+++|+|.+++.+.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.+
T Consensus 102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999999986543 2489999999999999999999999 9999999999999964 578999999999877
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+..........
T Consensus 177 ~~~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 247 (350)
T d1koaa2 177 DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMDDS 247 (350)
T ss_dssp CTTS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCSCCG
T ss_pred cccc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCcc
Confidence 6433 3345679999999999999999999999999999999999999997321 222233333332222111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
........+.+++.+||+.||++|||++|+++|
T Consensus 248 -~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 -AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223357899999999999999999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.9e-47 Score=404.66 Aligned_cols=253 Identities=22% Similarity=0.288 Sum_probs=209.2
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++......+ .+.+.+|++++++++|||||++++++.+++..++|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35799999999999999999975 579999999997665432 35788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEec--CCCcEEEeeecccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLN--SKLEAFVADFGTARLL 654 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~ 654 (796)
|||+++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+
T Consensus 105 mE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999998876542 3489999999999999999999999 999999999999998 5789999999999987
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.... .......+.......+..
T Consensus 180 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 180 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDWEFDED 250 (352)
T ss_dssp CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCCCCCSS
T ss_pred CCCC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCcc
Confidence 6533 3345679999999999999999999999999999999999999997321 122222333222221111
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
........+.+++.+||+.||++|||++|+++|
T Consensus 251 -~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 -AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011222347899999999999999999999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-46 Score=395.37 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=209.4
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+. .+|+.||||+++..........+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999976 479999999998765444444678999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+++|+|..++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999886543 78888899999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
....+||+.|+|||++.+..|+.++||||+||++|||+||+.||...+ .......+.......+.
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~~~~p~---- 222 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAELRFPP---- 222 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCCCCCCT----
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcCCCCCCC----
Confidence 234679999999999999999999999999999999999999997321 22233333333322111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
.....+.+++.+||+.||.+|| |++|+++|
T Consensus 223 -~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 223 -FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1123477899999999999996 89999886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-46 Score=388.70 Aligned_cols=260 Identities=24% Similarity=0.355 Sum_probs=207.0
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----e
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----C 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 572 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.....+....+.+.+|++++++++||||+++++++..++ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999975 579999999998776655555678999999999999999999999998654 4
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.|+||||+++|+|.+++.... .+++.++..++.||++||+|||++ +|+||||||+||+++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999887654 389999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCC---CCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 653 LLDSDS---SNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 653 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ........+....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDP 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcCC
Confidence 654332 22344579999999999999999999999999999999999999997321 1222333333322
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhhc
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRP-TMQRVCQEFLTC 772 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 772 (796)
.+... ........+.+++.+||++||++|| |++++++.|.+.
T Consensus 232 ~~~~~-~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 IPPSA-RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCGGG-TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCch-hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 22111 1112234578999999999999999 899999988764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=387.22 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=198.8
Q ss_pred hcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-cceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-KKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV 576 (796)
.++|++.+.||+|+||.||+|+.+ |+.||||+++.... .+.+.+|++++++++||||++++|++.+ ++..++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 357889999999999999999985 78999999976542 3578999999999999999999999865 4668999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.+++.... ...+++..+++|+.|||.||+|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999997642 23589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCCccch
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDR 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
. .....+++.|+|||++.+..++.++|||||||++|||+| |+.||..... . .+...+.....++...
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~-~~~~~i~~~~~~~~~~ 223 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------K-DVVPRVEKGYKMDAPD 223 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------G-GHHHHHTTTCCCCCCT
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--------H-HHHHHHHcCCCCCCCc
Confidence 2 233458899999999999999999999999999999998 6777763211 1 1222222223333222
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 736 MVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 736 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
.....+.+++.+||+.||++||||+|++++|++++
T Consensus 224 ---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 12235789999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=389.05 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=199.7
Q ss_pred cCCccceeeecccceeEEEEEcc--C--CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP--N--GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||.||+|+.. + ...||||++...........++|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999753 2 24789999987766555666789999999999999999999999965 4678
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|++.+++.... ..+++..+.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999999887643 3489999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC---ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 655 DSDSSN---RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 655 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
...... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||... ........+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEGER 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhCCCC
Confidence 554332 223457889999999999999999999999999999998 89998732 222333344444333
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
++... .....+.+++.+||+.||++||||+||.+.|++.
T Consensus 234 ~~~~~---~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 LPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcc---cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 33222 1123478999999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=395.73 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=212.9
Q ss_pred HHHHHhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeE
Q 003780 493 DIIKATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566 (796)
Q Consensus 493 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 566 (796)
+++...++|++.+.||+|+||+||+|+.+ +++.||||+++..... ...++|.+|++++++++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCcccceee
Confidence 34445678999999999999999999754 4678999999765433 235689999999999999999999999
Q ss_pred EEecceeeEEEeeccCCcHHHHHhhcC---------------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003780 567 CLHKKCMFLIYKYMKRGSLFCFLRNDY---------------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSI 625 (796)
Q Consensus 567 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 625 (796)
+...+..++||||+++|+|.++++... ....+++..+..|+.|+|.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999997532 123488999999999999999999999 99
Q ss_pred EEecCCCCCeEecCCCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCC-C
Q 003780 626 VHRDISSNNILLNSKLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGR-H 702 (796)
Q Consensus 626 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~-~ 702 (796)
|||||||+||+++.++.+||+|||+|+.+..... ......|++.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999987644322 223456889999999999999999999999999999999996 5
Q ss_pred CCcccccCCCCCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 703 PGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 703 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
||... ........+..... ++... ..+..+.+++.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~--------~~~e~~~~v~~~~~-~~~p~---~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGM--------AHEEVIYYVRDGNI-LACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTS--------CHHHHHHHHHTTCC-CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCC--------CHHHHHHHHHcCCC-CCCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 66532 12222333333332 22221 12234789999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.7e-46 Score=383.92 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=209.0
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchh------hHHHHHHHHHHHHHhhcC-CCceeeEEeEEEe
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEE------TTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLH 569 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 569 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++....... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999975 579999999997654332 223456889999999997 9999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
++..++||||+++|+|.++++... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999997653 489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCccCcccccc------CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 650 TARLLDSDSSNRTIVAGTYGYIAPELAYT------MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 650 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~~ 226 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRM 226 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHHHHH
Confidence 999876543 3344679999999998763 346789999999999999999999997321 2222333
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
+........... ......++.+++.+||++||++|||++|+++|
T Consensus 227 i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNYQFGSPE-WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCCCCCTTT-GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCCCCCCcc-cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 333332211111 11223458899999999999999999999886
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-46 Score=395.78 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=209.7
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||.||+|+. .+|+.||||++...........+.+.+|++++++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999975 479999999997665444444568899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+.+|+|.+++.+.. .+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997654 389999999999999999999999 9999999999999999999999999999977543
Q ss_pred CCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchhh
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRMV 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||... ........+.......+. .
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~~~~p~-~-- 260 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSGKVRFPS-H-- 260 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCT-T--
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--------CHHHHHHHHhcCCCCCCc-c--
Confidence 23457999999999999999999999999999999999999999732 122223333333322211 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 003780 738 MQDIVLVTTVALACLHSKPKFRP-----TMQRVCQE 768 (796)
Q Consensus 738 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 768 (796)
....+.+++.+||+.||.+|+ |++|+++|
T Consensus 261 --~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 123477999999999999994 89999876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=386.73 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=196.2
Q ss_pred hcCCccceeeecccceeEEEEEccC----CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN----GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.++|++.+.||+|+||.||+|.... +..||||+++..... ...+.+.+|++++++++|||||++++++. ++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 4689999999999999999997542 457899988655433 23568999999999999999999999995 5678
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++||||+++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999999876543 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCCC
Q 003780 654 LDSDSS-NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLSP 731 (796)
Q Consensus 654 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (796)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |..||..... ......+.. ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~~~i~~-~~~~ 228 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIEN-GERL 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHT-TCCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CCCC
Confidence 654332 2334568999999999999999999999999999999998 8899874321 112222222 2222
Q ss_pred ccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 732 PVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 732 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
+... .....+.+++.+||+.||++|||++||+++|+..
T Consensus 229 ~~~~---~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 PMPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2211 1223488999999999999999999999999765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=393.22 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=207.0
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHh-hcCCCceeeEEeEEEecceeeEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLS-KIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lV 576 (796)
++|++.+.||+|+||+||+|+.+ +|+.||||+++..........+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999754 79999999997654333333456667777665 68999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCC
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDS 656 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 656 (796)
|||+++|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999998654 388999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccchh
Q 003780 657 DSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVDRM 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+...... ....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~~--~p~~ 225 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDNPF--YPRW 225 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC--CCTT
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCC--CCcc
Confidence 5555566789999999999999999999999999999999999999997321 11222222222221 1111
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 003780 737 VMQDIVLVTTVALACLHSKPKFRPTMQ-RVCQE 768 (796)
Q Consensus 737 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 768 (796)
....+.+++.+||+.||++||++. |+++|
T Consensus 226 ---~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 226 ---LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---CCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 123477999999999999999995 78654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=390.30 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=200.0
Q ss_pred cCCccceeeecccceeEEEEEcc-CCc----EEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEeccee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGK----VVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCM 573 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 573 (796)
.+|++.+.||+|+||+||+|... +|+ .||+|+++..... ...++|.+|++++++++|||||+++|+|.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 46999999999999999999754 444 5889988754332 2356899999999999999999999999865 56
Q ss_pred eEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 574 FLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 574 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
++++||+.+|+|.+++.... ..+++..+.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 78899999999999887643 3489999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCCCCchhhhHHHHhhcCCCC
Q 003780 654 LDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSSPSSDQKIMLIDVLDSRLS 730 (796)
Q Consensus 654 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (796)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||+.... ..+...+.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---------~~~~~~i~~~~~ 231 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------SEISSILEKGER 231 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---------GGHHHHHHHTCC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---------HHHHHHHHcCCC
Confidence 7544332 233458999999999999999999999999999999998 7888863221 112222322222
Q ss_pred CccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 731 PPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 731 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
.+... .....+.+++.+||+.||++|||+.|++++|+..
T Consensus 232 ~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 LPQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc---ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 22221 1223478999999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=388.66 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=209.2
Q ss_pred hcCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLI 576 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 576 (796)
.++|++.+.||+|+||+||+|..+ +|+.||||+++..... ...+.+|++++++++|||||++++++.+++..|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999764 7899999999765433 24678999999999999999999999999999999
Q ss_pred EeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC--CcEEEeeecccccc
Q 003780 577 YKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK--LEAFVADFGTARLL 654 (796)
Q Consensus 577 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfg~a~~~ 654 (796)
|||+++|+|.+++.... ..+++.++..++.||++||+|||+. +|+||||||+|||++.+ ..+||+|||+++..
T Consensus 80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999997643 2489999999999999999999999 99999999999999854 58999999999876
Q ss_pred CCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... .......+|+.|+|||...+..++.++||||+||++|+|++|+.||... ........+.......+..
T Consensus 155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--------~~~~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCCCCHH
T ss_pred ccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCCChh
Confidence 543 2334466899999999999999999999999999999999999999732 2223334444443332211
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. .......+.+++.+||+.||++|||++|+++|
T Consensus 226 ~-~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 A-FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H-HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h-ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 11123347899999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-45 Score=393.79 Aligned_cols=252 Identities=21% Similarity=0.239 Sum_probs=200.8
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHH---HHHHHHhhcCCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQ---NEAHVLSKIAHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||.||+|+.+ +|+.||||++.............+. .|+++++.++|||||++++++..++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999754 7999999999765433222222333 4467777888999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLL 654 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 654 (796)
+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999998653 378999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCcc
Q 003780 655 DSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPV 733 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (796)
... ......||+.|+|||++.. ..|+.++||||+||++|||+||+.||..... ............... ..
T Consensus 158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~~--~~ 228 (364)
T d1omwa3 158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMAV--EL 228 (364)
T ss_dssp SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSSSCCC--CC
T ss_pred CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcccCCC--CC
Confidence 543 2334579999999999864 5689999999999999999999999974321 111111111111111 11
Q ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 003780 734 DRMVMQDIVLVTTVALACLHSKPKFRPT-----MQRVCQE 768 (796)
Q Consensus 734 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 768 (796)
.. .....+.+++.+||+.||++||| ++|+++|
T Consensus 229 ~~---~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 229 PD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CS---SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CC---CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11 11234789999999999999999 6888876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-46 Score=388.92 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=198.1
Q ss_pred HhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEe
Q 003780 497 ATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLH 569 (796)
Q Consensus 497 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 569 (796)
..++|++.+.||+|+||.||+|+.. +++.||||+++...... ..+.+.+|...+.++ +|+||+.+++++.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 3478999999999999999999743 35789999997654432 245778888888877 68999999999876
Q ss_pred c-ceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 570 K-KCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 570 ~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
+ ...++||||+++|+|.++++.... ...+++..+..++.||++||+|||++ +|+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 5 468999999999999999975432 23488999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCC-CCCcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGR-HPGELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~-~p~~~~~~~~~ 712 (796)
|++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||.....
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--- 242 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--- 242 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999987654332 233467999999999999999999999999999999999975 56653211
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
...+...+.....+..... ....+.+++.+||+.||++|||++|++++|+.+
T Consensus 243 -----~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 243 -----DEEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp -----SHHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHHhcCCCCCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1122222222222222221 123478999999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=385.41 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=203.7
Q ss_pred cCCccceeeecccceeEEEEEcc-CCc--EEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEecceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGK--VVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHKKCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 574 (796)
++|++.+.||+|+||+||+|.++ +|. .||||++......+ ..+.+.+|+++++++ +|||||++++++.+++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH--HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 57899999999999999999765 444 47788876544332 246799999999998 7999999999999999999
Q ss_pred EEEeeccCCcHHHHHhhcC-------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC
Q 003780 575 LIYKYMKRGSLFCFLRNDY-------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL 641 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 641 (796)
+||||+++|+|.+++++.. ....+++..+.+++.|||+||.|+|+. +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 9999999999999997542 235689999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCC-CCcccccCCCCCchhhhH
Q 003780 642 EAFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRH-PGELLSSLSSPSSDQKIM 720 (796)
Q Consensus 642 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~-p~~~~~~~~~~~~~~~~~ 720 (796)
.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|.. ||... .....
T Consensus 165 ~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~ 235 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAEL 235 (309)
T ss_dssp CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHH
T ss_pred ceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------CHHHH
Confidence 99999999998654322 2234568999999999999999999999999999999999765 56522 11222
Q ss_pred HHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 721 LIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
. ..+.....++... .....+.+++.+||+.||++||||+||+++|+++.
T Consensus 236 ~-~~i~~~~~~~~~~---~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 236 Y-EKLPQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp H-HHGGGTCCCCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HHHHhcCCCCCCc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2 2222222222222 12235889999999999999999999999987754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=383.92 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=202.1
Q ss_pred ceeeecccceeEEEEEccCC----cEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-cceeeEEEe
Q 003780 504 KYCIGTGGYGSVYKAQLPNG----KVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH-KKCMFLIYK 578 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~e 578 (796)
.++||+|+||+||+|++.++ ..||||+++..... ...++|.+|++++++++||||++++|++.. ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 57899999999999976432 35899999754332 335789999999999999999999999876 468999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
|+++|+|.++++... ...++..+++++.|+|+||.|+|+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999987643 3477888999999999999999999 99999999999999999999999999998765432
Q ss_pred CC----ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCCCCccc
Q 003780 659 SN----RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRLSPPVD 734 (796)
Q Consensus 659 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.. .....||+.|+|||.+.+..++.++||||||+++|||+||+.||..... .......+. ....+...
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~~~~i~-~g~~~~~p 256 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLL-QGRRLLQP 256 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHH-TTCCCCCC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-------HHHHHHHHH-cCCCCCCc
Confidence 22 2335689999999999999999999999999999999998888763211 111111111 11122211
Q ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccc
Q 003780 735 RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIAL 776 (796)
Q Consensus 735 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 776 (796)
.. ....+.+++.+||+.||++||+|.||+++|+++....
T Consensus 257 ~~---~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 EY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cc---CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 11 1234789999999999999999999999998876443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=386.27 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=199.3
Q ss_pred hcCCccce-eeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEe----c
Q 003780 498 TEDFDIKY-CIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLH----K 570 (796)
Q Consensus 498 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~ 570 (796)
.++|.+.. .||+|+||+||+|+. .+|+.||||++... +.+.+|++++.++ +|||||++++++.+ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 46798875 699999999999975 57999999998643 3567899887655 89999999999875 4
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEee
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVAD 647 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~D 647 (796)
...|+||||+++|+|.+++.+.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 67899999999999999998643 23589999999999999999999999 9999999999999985 46799999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcC
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDS 727 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (796)
||+|+....... .....||+.|+|||++.+..|+.++||||+||++|+|+||+.||........ .......+...
T Consensus 158 FG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~----~~~~~~~i~~~ 232 (335)
T d2ozaa1 158 FGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKTRIRMG 232 (335)
T ss_dssp CTTCEECCCCCC-CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSC
T ss_pred cceeeeccCCCc-cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH----HHHHHHHHhcC
Confidence 999987664433 3446799999999999999999999999999999999999999975332110 00011111111
Q ss_pred CCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 728 RLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
....+. ........++.+++.+||+.||++|||+.|+++|
T Consensus 233 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 QYEFPN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSSCCT-THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCC-cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 1112223458899999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=385.48 Aligned_cols=260 Identities=24% Similarity=0.341 Sum_probs=211.7
Q ss_pred hcCCccceeeecccceeEEEEEc------cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEEec
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL------PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCLHK 570 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 570 (796)
.++|++.+.||+|+||.||+|++ .+++.||||+++...... ....+.+|+.+++++ +|||||++++++.++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH--HHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 46899999999999999999964 346789999998765433 245789999999999 699999999999999
Q ss_pred ceeeEEEeeccCCcHHHHHhhcC---------------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDY---------------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
+..++||||+++|+|.+++++.. ....+++..+.+++.|||+||+|||++ +|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999998643 123588999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCC-CcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHP-GELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p-~~~~~~~~~ 712 (796)
+++.++.+|++|||.++........ .....||+.|+|||++.+..++.++|||||||++|||+|++.| |....
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~---- 252 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 252 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC----
Confidence 9999999999999999977644322 2345789999999999999999999999999999999995544 44211
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcC
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCK 773 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 773 (796)
....+...+.....+..... ....+.+++.+||+.||++||||+||++.|++.-
T Consensus 253 ----~~~~~~~~i~~~~~~~~~~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 253 ----VDSKFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ----SSHHHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHhcCCCCCCccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11223333333333333221 2234789999999999999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=383.85 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=199.9
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+. .+|+.||||+++.....+ ...+++.+|++++++++|||||++++++.+++..++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 5899999999999999999975 579999999997654332 23468899999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
||+.++.+ +++... ....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||.|+.....
T Consensus 81 e~~~~~~~-~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQDLK-KFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSEEHH-HHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eecCCchh-hhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99976544 444332 223489999999999999999999999 9999999999999999999999999999887665
Q ss_pred CCCccccccccCccCccccccCC-cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh-----------
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL----------- 725 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 725 (796)
........||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+.. ..........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-----DQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTG
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-----HHHHHHHHhcCCCchhhcccc
Confidence 55555667999999999877655 578999999999999999999999742210 0000000000
Q ss_pred ------c----CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 ------D----SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 ------~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
. .................+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000000000011112357889999999999999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=380.21 Aligned_cols=267 Identities=22% Similarity=0.327 Sum_probs=203.4
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----eee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----CMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 574 (796)
++|.+.+.||+|+||+||+|+. +|+.||||++...... ......|+..+.+++|||||++++++..++ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4678889999999999999986 5899999999654321 112334555566789999999999998654 578
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEEecCCCCCeEecCCCcEEEeeec
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC-----MPSIVHRDISSNNILLNSKLEAFVADFG 649 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~Dfg 649 (796)
+||||+++|+|.+++++. .++|..+.+++.|+|.||+|+|+.. .++|+||||||+|||++.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999999864 3899999999999999999999731 3499999999999999999999999999
Q ss_pred cccccCCCCC----CccccccccCccCccccccC------CcCcchhHHHHHHHHHHHHhCCCCCcccccCCC-------
Q 003780 650 TARLLDSDSS----NRTIVAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSS------- 712 (796)
Q Consensus 650 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~------- 712 (796)
+++....... ......||+.|+|||++.+. .++.++|||||||++|||+||..|+........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9987654322 22346799999999998754 367799999999999999999988753222111
Q ss_pred CCchhhhHHHHhhcCCCCCccchh--hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
..................+..... ..+....+.+++.+||+.||++||||.||+++|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111122223333444444332221 22344568899999999999999999999999987643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=382.79 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=196.2
Q ss_pred cceeeecccceeEEEEEcc-CCcEEEEEEeccccchhh--HHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEee
Q 003780 503 IKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEET--TFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYKY 579 (796)
Q Consensus 503 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 579 (796)
..+.||+|+||+||+|+.+ +|+.||||++........ ...+.+.+|+.++++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999864 699999999976543321 2235789999999999999999999999999999999999
Q ss_pred ccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCCC
Q 003780 580 MKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDSS 659 (796)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 659 (796)
++++++..+.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998877666533 3488889999999999999999999 999999999999999999999999999987766555
Q ss_pred CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC---------
Q 003780 660 NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL--------- 729 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 729 (796)
.....+||+.|+|||++.+. .++.++||||+||++|||+||+.||..... ......+.+......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-----HHHHHHHHHhcCCCChhhccchhc
Confidence 55556799999999988654 579999999999999999999999863221 000011111110000
Q ss_pred -----------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 730 -----------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 730 -----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..+...........+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000011122358899999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=381.08 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=206.9
Q ss_pred hcCCccceeeecccceeEEEEEccC--------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQLPN--------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKI-AHRNIVKLYGFCL 568 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 568 (796)
.++|++.+.||+|+||.||+|+... +..||||+++...... ...++.+|...+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH--HHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 4689999999999999999997432 3579999998765432 246788999999888 7999999999999
Q ss_pred ecceeeEEEeeccCCcHHHHHhhcCc-------------ccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCe
Q 003780 569 HKKCMFLIYKYMKRGSLFCFLRNDYE-------------AVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNI 635 (796)
Q Consensus 569 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 635 (796)
+++..++||||+++|+|.+++..... ...+++..+++++.|||+||+|||+. +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999975532 24589999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeeeccccccCCCCC--CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHh-CCCCCcccccCCC
Q 003780 636 LLNSKLEAFVADFGTARLLDSDSS--NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GRHPGELLSSLSS 712 (796)
Q Consensus 636 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~ellt-g~~p~~~~~~~~~ 712 (796)
|++.++.+||+|||+++....... ......|++.|+|||.+.++.|+.++|||||||++|||++ |+.||....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---- 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC----
Confidence 999999999999999987654322 2334568999999999999999999999999999999998 688876321
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
. ..+...+.....++.... ....+.+++.+||+.||++|||+.||++.|+++
T Consensus 243 ----~-~~~~~~i~~~~~~~~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 243 ----V-EELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ----H-HHHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----H-HHHHHHHHcCCCCCCCcc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 122233333333333222 223488999999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-45 Score=380.19 Aligned_cols=258 Identities=25% Similarity=0.311 Sum_probs=201.5
Q ss_pred cCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEEe
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIYK 578 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 578 (796)
++|++.+.||+|+||+||+|+.++|+.||||++......+ ...+.+.+|+.++++++||||+++++++..++..++|+|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 5899999999999999999998899999999997765433 235689999999999999999999999999999999999
Q ss_pred eccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCCC
Q 003780 579 YMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSDS 658 (796)
Q Consensus 579 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 658 (796)
++.++.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99988777776543 3499999999999999999999999 99999999999999999999999999998876555
Q ss_pred CCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhc-----------
Q 003780 659 SNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLD----------- 726 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 726 (796)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... .....+.....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-----DQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhCCCChhhccchh
Confidence 545556789999999998754 5689999999999999999999999743210 00000000000
Q ss_pred ----------CCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 727 ----------SRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 727 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.....+...........+.+++.+||+.||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000011111112357899999999999999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=382.24 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=212.7
Q ss_pred HHhcCCccceeeecccceeEEEEEcc------CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 003780 496 KATEDFDIKYCIGTGGYGSVYKAQLP------NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH 569 (796)
Q Consensus 496 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 569 (796)
...++|++.+.||+|+||+||+|.++ +++.||||+++...... ....|.+|++++++++||||+++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH--HHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 34578999999999999999999753 36789999997654332 24578999999999999999999999999
Q ss_pred cceeeEEEeeccCCcHHHHHhhcC-------cccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCc
Q 003780 570 KKCMFLIYKYMKRGSLFCFLRNDY-------EAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLE 642 (796)
Q Consensus 570 ~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 642 (796)
++..++||||+++|+|.+++.... ....+++..+.+++.|+|+||.|||++ +|+||||||+|||++.+++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 999999999999999999987532 223478999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCC--ccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCC-CCCcccccCCCCCchhhh
Q 003780 643 AFVADFGTARLLDSDSSN--RTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGR-HPGELLSSLSSPSSDQKI 719 (796)
Q Consensus 643 ~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~-~p~~~~~~~~~~~~~~~~ 719 (796)
+||+|||+|+.+...... .....||+.|+|||.+.+..++.++|||||||++|||+||. .||.. .....
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~~~ 243 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQ 243 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CCHHH
Confidence 999999999876543222 22345899999999999999999999999999999999985 66652 12223
Q ss_pred HHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCc
Q 003780 720 MLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKI 774 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 774 (796)
....+.+....+.... ....+.+++.+||+.||++||||+||+++|++...
T Consensus 244 ~~~~i~~~~~~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHhCCCCCCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3333333333222221 22348899999999999999999999999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=373.07 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=197.6
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhh---HHHHHHHHHHHHHhhcC--CCceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEET---TFFNSFQNEAHVLSKIA--HRNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 572 (796)
++|++.+.||+|+||+||+|+. .+|+.||||++......+. ...+++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999975 5799999999976543321 11234678999999997 8999999999999999
Q ss_pred eeEEEeeccC-CcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCC-CcEEEeeecc
Q 003780 573 MFLIYKYMKR-GSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSK-LEAFVADFGT 650 (796)
Q Consensus 573 ~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~ 650 (796)
.++||||+.+ +++.+++.+.. .+++..+..++.||++||+|||++ +|+||||||+||+++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999986 57888877543 489999999999999999999999 99999999999999854 7999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccCCc-CcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ++.....
T Consensus 158 a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~~~ 221 (273)
T d1xwsa_ 158 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRGQV 221 (273)
T ss_dssp CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHCCC
T ss_pred ceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhccc
Confidence 9875432 2344679999999999887665 567899999999999999999987321 1111111
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.... . ....+.+++.+||+.||++|||++|+++|
T Consensus 222 ~~~~-~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 FFRQ-R----VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCSS-C----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC-C----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 1 12347789999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=372.58 Aligned_cols=259 Identities=26% Similarity=0.365 Sum_probs=197.1
Q ss_pred hcCCccceeeecccceeEEEEEc-cC-CcEEEEEEeccccchhhHHHHHHHHHHHHHhhc---CCCceeeEEeEEEe---
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PN-GKVVALKKLHRAETEETTFFNSFQNEAHVLSKI---AHRNIVKLYGFCLH--- 569 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~--- 569 (796)
.++|++.+.||+|+||+||+|+. ++ ++.||||+++.....+.. ...+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999975 44 677999999765433221 23466777777665 79999999999853
Q ss_pred --cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEee
Q 003780 570 --KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVAD 647 (796)
Q Consensus 570 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 647 (796)
....+++|||++++.+....... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34789999999998776554432 23488999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh--
Q 003780 648 FGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL-- 725 (796)
Q Consensus 648 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 725 (796)
||.++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...... .....+....
T Consensus 160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~ 233 (305)
T d1blxa_ 160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGL 233 (305)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCC
T ss_pred hhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhCC
Confidence 9999765432 2334567999999999999999999999999999999999999999743210 0000011100
Q ss_pred -----------------cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 726 -----------------DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 726 -----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..................+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000111111111122347789999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=368.17 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=196.5
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc----e
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----C 572 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 572 (796)
+++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+++|++++||||+++++++..+. .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 46799999999999999999964 5899999999976543 233568899999999999999999999997653 2
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.+++++|+.+|+|.+++... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 35556677899999999754 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---CccccccccCccCccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCch--
Q 003780 653 LLDSDSS---NRTIVAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSD-- 716 (796)
Q Consensus 653 ~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~-- 716 (796)
....... ......||+.|+|||++. +..++.++||||+||++|||++|+.||...... ......
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 6543221 234456999999999985 456788999999999999999999999743210 000000
Q ss_pred ------hhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 717 ------QKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 717 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...............+...........+.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000011111111111111112357899999999999999999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-42 Score=358.21 Aligned_cols=259 Identities=21% Similarity=0.284 Sum_probs=206.1
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecceeeEEE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKKCMFLIY 577 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 577 (796)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....+++.+|+.+++.++||||+++++++..+...++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 5799999999999999999975 57899999999766543 334678999999999999999999999999999999999
Q ss_pred eeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccccccCCC
Q 003780 578 KYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTARLLDSD 657 (796)
Q Consensus 578 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 657 (796)
|++.++++..+++... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999988877543 478999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCccccccccCccCccccccCC-cCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC-------
Q 003780 658 SSNRTIVAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL------- 729 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 729 (796)
........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||..... .......+........
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC----HHHHHHHHHhhcCCCChhhhhhh
Confidence 55555566888999999887655 68999999999999999999999742111 0000001111000000
Q ss_pred --------------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 730 --------------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 730 --------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..............+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000111122347789999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=368.19 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=195.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEecc-----
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHKK----- 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 571 (796)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.....+ ...+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 46899999999999999999975 579999999998654433 33568899999999999999999999998655
Q ss_pred -eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecc
Q 003780 572 -CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGT 650 (796)
Q Consensus 572 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 650 (796)
..++||||+ +++|..+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 56787777543 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------CC------
Q 003780 651 ARLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------SP------ 713 (796)
Q Consensus 651 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~~------ 713 (796)
|+..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... ..
T Consensus 168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 9876432 3345699999999998764 56899999999999999999999987432100 00
Q ss_pred --CchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 714 --SSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 714 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
..............................+.+++.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000111111111111111111222357789999999999999999999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=361.92 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=195.5
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEe-------
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLH------- 569 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------- 569 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++......+ ...+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 36899999999999999999975 579999999987665433 234678899999999999999999999855
Q ss_pred -cceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeee
Q 003780 570 -KKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADF 648 (796)
Q Consensus 570 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 648 (796)
++..++||||++++.+....... ..++...+..++.|+++||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 34689999999987776554432 3478899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC----CccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 649 GTARLLDSDSS----NRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 649 g~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|+++....... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-----~~~~~~i~~ 236 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQ 236 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-----HHHHHHHHH
Confidence 99987654321 22335699999999998754 688999999999999999999999973221 011111111
Q ss_pred hhcCC--------------------CCCcc--chh--hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 724 VLDSR--------------------LSPPV--DRM--VMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 724 ~~~~~--------------------~~~~~--~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
..... ..... ... .......+.+++.+||+.||++|||++|+++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 11000 00000 000 001123467899999999999999999999884
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-42 Score=360.03 Aligned_cols=276 Identities=15% Similarity=0.210 Sum_probs=202.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCce-eeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI-VKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... +++..|++++++++|+|+ +.+.++..+++..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 35799999999999999999975 57899999988765432 357889999999987665 555566677888999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC---CCcEEEeeecccc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS---KLEAFVADFGTAR 652 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~ 652 (796)
||||+.+ ++.+.+.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++. +..+|++|||+|+
T Consensus 81 vme~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLGP-SLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCCC-BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEcCC-chhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 9999954 5655554432 3489999999999999999999999 9999999999999864 5579999999999
Q ss_pred ccCCCCC-------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhh
Q 003780 653 LLDSDSS-------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVL 725 (796)
Q Consensus 653 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (796)
.+..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-----~~~~~ 229 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-----YERIS 229 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------------HHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-----HHHhh
Confidence 8754322 12345799999999999999999999999999999999999999975432211111 11111
Q ss_pred cCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhcCccccCccccccHHHHh
Q 003780 726 DSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTCKIALVNPFEEISIWQLR 789 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~ 789 (796)
......+........+.++.+++..|++.||++||+++++.+.|+.......-.+.+..+|+..
T Consensus 230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (299)
T d1ckia_ 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293 (299)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHG
T ss_pred cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhh
Confidence 1111111111111122347889999999999999999988777765433222334445567644
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=366.52 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=192.7
Q ss_pred CCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------ce
Q 003780 500 DFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------KC 572 (796)
Q Consensus 500 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 572 (796)
+|+..++||+|+||+||+|+.+ +|+.||||++...... ..+|++++++++||||+++++++... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 5888999999999999999764 7999999999765432 34699999999999999999998643 24
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEeeeccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTA 651 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a 651 (796)
.++||||++++.+..+.+.......+++..+..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 789999998765555444333445689999999999999999999999 999999999999999775 8999999999
Q ss_pred cccCCCCCCccccccccCccCcccccc-CCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHH--------
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLI-------- 722 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 722 (796)
+....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+.
T Consensus 171 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-----~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 171 KQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-----DQLVEIIKVLGTPTR 244 (350)
T ss_dssp EECCTTSC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHHCCCCH
T ss_pred hhccCCcc-cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-----HHHHHHHHHhCCChH
Confidence 87754433 334569999999998765 56899999999999999999999999732210 0000000
Q ss_pred ----Hh----hcCCCCC----cc-chhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 723 ----DV----LDSRLSP----PV-DRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 723 ----~~----~~~~~~~----~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.. ....... .. ..........+.+++.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000 00 00001122347899999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-41 Score=354.62 Aligned_cols=259 Identities=18% Similarity=0.197 Sum_probs=202.3
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC-CceeeEEeEEEecceeeE
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH-RNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~l 575 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... +.+.+|++.++.++| +|++.+++++..+...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 46899999999999999999975 47999999988654322 357788999999975 899999999999999999
Q ss_pred EEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecC-----CCcEEEeeecc
Q 003780 576 IYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNS-----KLEAFVADFGT 650 (796)
Q Consensus 576 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~ 650 (796)
||||+ +++|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 79 vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 99998 679999887643 2489999999999999999999999 9999999999999974 57899999999
Q ss_pred ccccCCCCC-------CccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHH
Q 003780 651 ARLLDSDSS-------NRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLID 723 (796)
Q Consensus 651 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (796)
|+.+..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-----~~~~~~~~ 227 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYER 227 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-----hHHHHHHH
Confidence 987653321 123456999999999999999999999999999999999999999743221 11111111
Q ss_pred hhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhc
Q 003780 724 VLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEFLTC 772 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 772 (796)
+................+.++.+++..|+..+|++||+++.+.+.|++.
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111111111111111223578899999999999999998887776653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-42 Score=360.61 Aligned_cols=255 Identities=26% Similarity=0.347 Sum_probs=201.8
Q ss_pred cCCccceeeecccceeEEEEEc----cCCcEEEEEEeccccch-hhHHHHHHHHHHHHHhhcCC-CceeeEEeEEEecce
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL----PNGKVVALKKLHRAETE-ETTFFNSFQNEAHVLSKIAH-RNIVKLYGFCLHKKC 572 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~ 572 (796)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... +....+.+.+|++++++++| |||+++++++.++..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999964 25899999999765432 11224568899999999976 899999999999999
Q ss_pred eeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 573 MFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 573 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.++||||+.+|+|.+++..... +.+..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999986643 67888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CCccccccccCccCccccccC--CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHhhcCCC
Q 003780 653 LLDSDS-SNRTIVAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDVLDSRL 729 (796)
Q Consensus 653 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (796)
.+.... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... ...............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSEP 253 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcccCCC
Confidence 764332 223446799999999998754 4678999999999999999999999754321 111112222222222
Q ss_pred CCccchhhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 003780 730 SPPVDRMVMQDIVLVTTVALACLHSKPKFRPT-----MQRVCQE 768 (796)
Q Consensus 730 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 768 (796)
..+ . ....++.+++.+||++||++||| ++|+++|
T Consensus 254 ~~~--~---~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 254 PYP--Q---EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCC--T---TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCc--c---cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111 1 12234788999999999999994 7888875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.8e-41 Score=355.48 Aligned_cols=250 Identities=17% Similarity=0.231 Sum_probs=194.4
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEec--ceee
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHK--KCMF 574 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~ 574 (796)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .+++.+|++++++++ ||||+++++++..+ ...+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 5799999999999999999975 579999999997543 346889999999996 99999999999754 5689
Q ss_pred EEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCC-cEEEeeeccccc
Q 003780 575 LIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKL-EAFVADFGTARL 653 (796)
Q Consensus 575 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~ 653 (796)
+||||+++|+|..+.+ .+++..+..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 9999999999976532 388999999999999999999999 999999999999998765 689999999987
Q ss_pred cCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchhhhHHHHh--------
Q 003780 654 LDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQKIMLIDV-------- 724 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 724 (796)
..... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ......+...
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~----~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH----HHHHHHHHHHHCHHHHHH
T ss_pred ccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh----HHHHHHHHHHHCCchhhh
Confidence 65433 23445689999999998765 4789999999999999999999998632210 0000000000
Q ss_pred ----------------hcCCCCCccc-----hhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 725 ----------------LDSRLSPPVD-----RMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 725 ----------------~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
.......... ........++.+++.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000 0011122357899999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-41 Score=359.47 Aligned_cols=260 Identities=21% Similarity=0.239 Sum_probs=191.3
Q ss_pred cCCccceeeecccceeEEEEEcc-CCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec------c
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQLP-NGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK------K 571 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 571 (796)
++|++.+.||+|+||+||+|+.+ +|+.||||++....... ...+.+.+|+.++++++||||+++++++... .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH-HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 57999999999999999999754 79999999998765433 3356789999999999999999999999643 6
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..|+||||+.++.+ +.+.. .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 78999999976554 44432 378999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccC----------CCCCch----h
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSL----------SSPSSD----Q 717 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~----------~~~~~~----~ 717 (796)
+..... .......||+.|+|||++.+..+++++||||+||++|||++|+.||...+.. ...... .
T Consensus 167 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 167 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred hccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 865543 2334457999999999999999999999999999999999999999632210 000000 0
Q ss_pred hhHHHHhhcCCC---------------CCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 003780 718 KIMLIDVLDSRL---------------SPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQEF 769 (796)
Q Consensus 718 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 769 (796)
............ ..............+.+++.+||+.||++|||++|+++|-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 000011111111 1111111223345688999999999999999999999883
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=358.70 Aligned_cols=260 Identities=23% Similarity=0.254 Sum_probs=195.9
Q ss_pred hcCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCceeeEEeEEEec-----c
Q 003780 498 TEDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNIVKLYGFCLHK-----K 571 (796)
Q Consensus 498 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~ 571 (796)
.++|++.+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|++++++++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 56899999999999999999974 579999999998665433 2346788999999999999999999999643 3
Q ss_pred eeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEeeeccc
Q 003780 572 CMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVADFGTA 651 (796)
Q Consensus 572 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 651 (796)
..+++++|+.+|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 457778888999999998653 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCccCccccccC-CcCcchhHHHHHHHHHHHHhCCCCCcccccCC----------C--------
Q 003780 652 RLLDSDSSNRTIVAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGRHPGELLSSLS----------S-------- 712 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~----------~-------- 712 (796)
..... ......|++.|+|||...+. .++.++||||+||++|+|++|+.||...+... .
T Consensus 169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 76432 23345689999999987665 46889999999999999999999996322100 0
Q ss_pred CCchhhhHHHHhhcCCCCCccchhhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 003780 713 PSSDQKIMLIDVLDSRLSPPVDRMVMQDIVLVTTVALACLHSKPKFRPTMQRVCQE 768 (796)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 768 (796)
...............................+.+++.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000001111111111111123347789999999999999999999997
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.5e-39 Score=344.38 Aligned_cols=266 Identities=27% Similarity=0.439 Sum_probs=175.2
Q ss_pred CCCCCc--cCCceeeCCC---CCeEEEeCCCCCcccccc-ccccCCCCCCcEEeccC-CcccccCCcCccCCCCCcEeec
Q 003780 56 NSSDHC--KLDGVTCNTA---RSIIEINLPEKKLKGELS-QFNFSCFPGLESLSLRF-NYLFGSIPSQVGALSKLRYLDF 128 (796)
Q Consensus 56 ~~~~~C--~w~gv~C~~~---~~v~~l~l~~~~l~~~~~-~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L 128 (796)
.++||| .|+||+|+.. .||++|+|+++++.|..+ +..+++|++|++|+|++ |++.|.+|..|+++++|++|+|
T Consensus 29 ~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~L 108 (313)
T d1ogqa_ 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108 (313)
T ss_dssp TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEE
T ss_pred CCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhh
Confidence 367999 4999999864 378888888888877432 22466677777777765 5666666666777777777777
Q ss_pred ccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCc-cEEEcccccccC
Q 003780 129 SFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNL-LILSLDSNKLSG 207 (796)
Q Consensus 129 s~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~ 207 (796)
++|++.+..+..+..+++|++|++++|++.+.+|..+.++++|+.+++++|.+++.+|..+..+.++ +.+++++|++++
T Consensus 109 s~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~ 188 (313)
T d1ogqa_ 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188 (313)
T ss_dssp EEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE
T ss_pred ccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccc
Confidence 7777666666666666667777777776666666666666666666666666666666666666554 666666666666
Q ss_pred cchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCcccccc
Q 003780 208 MLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTR 287 (796)
Q Consensus 208 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 287 (796)
..+..+..+..+ .+++++|.+.+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|+|++|+++|.+|..|++
T Consensus 189 ~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~ 266 (313)
T d1ogqa_ 189 KIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266 (313)
T ss_dssp ECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGG
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhC
Confidence 666666555443 46666666666666666666666666666666665443 4555666666666666666666666666
Q ss_pred ccccccccccCccccCccccccccccccceecccccc
Q 003780 288 LSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNK 324 (796)
Q Consensus 288 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 324 (796)
+++|++|+|++|+|+|.+|. ++.+++|+.+++++|+
T Consensus 267 L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 267 LKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred CCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 66666666666666665553 4555666666666665
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-36 Score=325.10 Aligned_cols=260 Identities=21% Similarity=0.270 Sum_probs=189.6
Q ss_pred cCCccceeeecccceeEEEEEc-cCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-----------CCceeeEEeE
Q 003780 499 EDFDIKYCIGTGGYGSVYKAQL-PNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-----------HRNIVKLYGF 566 (796)
Q Consensus 499 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~ 566 (796)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|++++++++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3599999999999999999975 57999999999765432 356788888888775 5789999998
Q ss_pred EEec--ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCc-
Q 003780 567 CLHK--KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLE- 642 (796)
Q Consensus 567 ~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~- 642 (796)
+... ...+++++++..+..............+++..+..++.||++||+|||+ . +|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence 8653 4566777776655444443333344568899999999999999999998 5 9999999999999987653
Q ss_pred -----EEEeeeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHHHHHHhCCCCCcccccCCCCCchh
Q 003780 643 -----AFVADFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGRHPGELLSSLSSPSSDQ 717 (796)
Q Consensus 643 -----~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 717 (796)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.............
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 899999999865432 234569999999999999999999999999999999999999987433211111100
Q ss_pred hhH-HHHhh------------------c-----CCCCCc-----------cchhhHHHHHHHHHHHHHcCCCCCCCCCCH
Q 003780 718 KIM-LIDVL------------------D-----SRLSPP-----------VDRMVMQDIVLVTTVALACLHSKPKFRPTM 762 (796)
Q Consensus 718 ~~~-~~~~~------------------~-----~~~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 762 (796)
... ....+ + ...... ...........+.+++.+||+.||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 000 00000 0 000000 000122344568899999999999999999
Q ss_pred HHHHHH
Q 003780 763 QRVCQE 768 (796)
Q Consensus 763 ~evl~~ 768 (796)
+|+++|
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999998
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.8e-33 Score=297.24 Aligned_cols=249 Identities=31% Similarity=0.504 Sum_probs=146.8
Q ss_pred CCcEEeccCCcccc--cCCcCccCCCCCcEeeccc-CcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCcccee
Q 003780 98 GLESLSLRFNYLFG--SIPSQVGALSKLRYLDFSF-NNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 98 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 174 (796)
+++.|+|++|++.| .+|+.++++++|++|||++ |+++|.+|..|++|++|++|+|++|++.+..|..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 46667777777766 3566666666666666665 56666666666666666666666666666666666666666666
Q ss_pred eccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc
Q 003780 175 ALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (796)
++++|.+.+.+|..+.++++|+.+++++|.+++.+|..+..+.++ ++.++++.|+++
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l-----------------------~~~l~~~~n~l~ 187 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-----------------------FTSMTISRNRLT 187 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----------------------CCEEECCSSEEE
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccc-----------------------cccccccccccc
Confidence 666666666666666666666666665555555555544444443 144444444444
Q ss_pred ccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccC
Q 003780 255 GSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 334 (796)
+..|..+.++..+ .++++.|.+.+.+|..+..+++|+.|++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..|+
T Consensus 188 ~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~ 265 (313)
T d1ogqa_ 188 GKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT 265 (313)
T ss_dssp EECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHh
Confidence 4444444443322 35555555555555555555555555555555554433 345555666666666666666666666
Q ss_pred CCCCCcEEEeecccccCCCCccccccccceEEecccc
Q 003780 335 KCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNK 371 (796)
Q Consensus 335 ~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~ 371 (796)
++++|++|+|++|+|+|.+|....+.+|+.+++++|+
T Consensus 266 ~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred CCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCc
Confidence 6666666666666666666654445566666666665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-28 Score=254.67 Aligned_cols=269 Identities=22% Similarity=0.193 Sum_probs=165.7
Q ss_pred EEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecc-cc
Q 003780 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALS-RN 179 (796)
Q Consensus 101 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N 179 (796)
.++.++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++....+..+.+++.++.+... .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3566666666 4454443 457778888887776656677777777777777777777666667777777666543 45
Q ss_pred ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPP 259 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 259 (796)
.++...+..|.++++|++|++++|.+....+..+..+.+|+.+++++|+|+++.+..|..+++|++|+|++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 55555566666666666666666666655555555555666666666665554445555555555555555555544444
Q ss_pred cccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCC
Q 003780 260 EIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSEL 339 (796)
Q Consensus 260 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 339 (796)
.|.++++|+ +|++++|++++..|..|.++++|++|++++|++.+..+..|+.+++|
T Consensus 172 ~f~~l~~L~------------------------~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L 227 (284)
T d1ozna_ 172 AFRGLHSLD------------------------RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227 (284)
T ss_dssp TTTTCTTCC------------------------EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred hhccccccc------------------------hhhhhhccccccChhHhhhhhhccccccccccccccccccccccccc
Confidence 444444444 44444444444445555555555555555555555555566666666
Q ss_pred cEEEeecccccCCCCccccccccceEEecccccCCCCCccccccccccccCCCCccc
Q 003780 340 RNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRFPLDLSYNDLEGE 396 (796)
Q Consensus 340 ~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~l~~N~l~~~ 396 (796)
+.|+|++|.+...-+...-...++.+....+.+....|..+......+++.++|+|.
T Consensus 228 ~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l~g~~l~~l~~~~l~gc 284 (284)
T d1ozna_ 228 QYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284 (284)
T ss_dssp CEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred CEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchHHcCCccccCCHHHCCCc
Confidence 666666666665433222223456666677777777787777777777888777763
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=5e-27 Score=246.49 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=146.6
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
+++++|+|++|+|+.+.+..|.++++|++|++++|.+....|..|.++++|++|+|++|+++. +|..+ ...|..|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhc
Confidence 456666666666665555566666666666666666665556666666666666666666663 33322 234555555
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
.+|.+.+..+..+.....+..++...|.... ....+..+..+++|+.+++++|+++ .
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~----------------------~~~~~~~~~~l~~L~~l~l~~n~l~-~ 164 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIENGAFQGMKKLSYIRIADTNIT-T 164 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred cccchhhhhhhhhhccccccccccccccccc----------------------cCCCccccccccccCccccccCCcc-c
Confidence 5555554444444444455555554443221 1122334455555555555555555 2
Q ss_pred CCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCC
Q 003780 257 IPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKC 336 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 336 (796)
+|..+ .++|+.|++++|..++..+..|.+++.+++|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|..+
T Consensus 165 l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l 241 (305)
T d1xkua_ 165 IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241 (305)
T ss_dssp CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccc
Confidence 33322 345556666666666555556666666666666666666655666666666666666666665 345666666
Q ss_pred CCCcEEEeecccccCCCCccc-------cccccceEEecccccC-CCCCccc
Q 003780 337 SELRNITLRNNNLSGSIPPEI-------GLMKLEYLDLSHNKLN-GTIPPFL 380 (796)
Q Consensus 337 ~~L~~L~L~~N~l~~~~~~~~-------~~~~L~~L~l~~N~l~-~~~p~~~ 380 (796)
++|++|+|++|+|+......+ .+.+|+.|+|++|++. ..+++..
T Consensus 242 ~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~ 293 (305)
T d1xkua_ 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293 (305)
T ss_dssp SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGG
T ss_pred cCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhH
Confidence 677777777776664322222 2456788888888775 3455443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=4.6e-27 Score=255.13 Aligned_cols=304 Identities=26% Similarity=0.336 Sum_probs=232.6
Q ss_pred eeeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCC
Q 003780 66 VTCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLR 145 (796)
Q Consensus 66 v~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 145 (796)
|+...-.++++|++++++++. +. .++.|++|++|+|++|+|++..| ++++++|++|+|++|.|++.. .+++++
T Consensus 38 ~~~~~l~~l~~L~l~~~~I~~-l~--gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~ 110 (384)
T d2omza2 38 VSQTDLDQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLT 110 (384)
T ss_dssp ECHHHHTTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCT
T ss_pred cCHHHhCCCCEEECCCCCCCC-cc--ccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc--cccccc
Confidence 333334579999999998874 33 47889999999999999997643 999999999999999999653 389999
Q ss_pred CCCEEEecCCCCCCCCchhhhccCccceeeccccccC-----------------------------------------CC
Q 003780 146 NLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLH-----------------------------------------GP 184 (796)
Q Consensus 146 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----------------------------------------~~ 184 (796)
+|+.|++++|.+++..+. .....+..+....|.+. ..
T Consensus 111 ~L~~L~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (384)
T d2omza2 111 NLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188 (384)
T ss_dssp TCCEEECCSSCCCCCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc
Confidence 999999999999865332 22333334333333321 12
Q ss_pred CCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCC
Q 003780 185 IPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNM 264 (796)
Q Consensus 185 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 264 (796)
.+..+..+++++.|++++|.+++..+ +..+++|++|++++|+++.. +.+..+++|+.|++++|.+++..+ +..+
T Consensus 189 ~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~ 262 (384)
T d2omza2 189 DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 262 (384)
T ss_dssp CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--cccc
Confidence 23456777889999999999887755 46678899999999988753 367888899999999999886443 7788
Q ss_pred cccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEe
Q 003780 265 TGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITL 344 (796)
Q Consensus 265 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 344 (796)
++|+.|++++|++++.. .+..++.++.+.++.|.+++. ..+..+++++.|++++|++++.. .+..+++|+.|+|
T Consensus 263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEEC
Confidence 89999999999988654 377788889999999988853 35778888999999999998653 3788899999999
Q ss_pred ecccccCCCCccccccccceEEecccccCCCCC-ccccccccccccCC
Q 003780 345 RNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIP-PFLYHRFPLDLSYN 391 (796)
Q Consensus 345 ~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p-~~~~~~~~l~l~~N 391 (796)
++|++++ ++....+++|++|++++|++++..| ..+.++..|+|++|
T Consensus 337 ~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 337 ANNKVSD-VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCCCC-ChhHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 9999885 4444468889999999999986654 33456677888876
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.3e-26 Score=243.39 Aligned_cols=242 Identities=23% Similarity=0.294 Sum_probs=190.3
Q ss_pred CCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEc
Q 003780 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSL 200 (796)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 200 (796)
+++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|++++|+++.. |..+ ...|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l-~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL-PEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBC-CSSC--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcC-ccch--hhhhhhhhc
Confidence 5789999999999866666789999999999999999877788888888888888888888754 3322 245666666
Q ss_pred ccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccc--ccCCccccCCcccceeeccccccc
Q 003780 201 DSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLN--GSIPPEIGNMTGILKVDMSMNNIE 278 (796)
Q Consensus 201 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~ 278 (796)
++|.+.++.+..+ .....+..++...|... ...+..+..+++|+.+++++|+++
T Consensus 108 ~~n~l~~l~~~~~------------------------~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 108 HENEITKVRKSVF------------------------NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp CSSCCCBBCHHHH------------------------TTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred cccchhhhhhhhh------------------------hccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 6666655444333 33444555566555432 344567888999999999999998
Q ss_pred ccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccc-
Q 003780 279 GTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEI- 357 (796)
Q Consensus 279 ~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~- 357 (796)
. +|..+ +++|+.|++++|.+++..+..+.+++.++.|++++|.+++..+..+..+++|++|+|++|+|+. +|..+
T Consensus 164 ~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~ 239 (305)
T d1xkua_ 164 T-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLA 239 (305)
T ss_dssp S-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTT
T ss_pred c-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccc
Confidence 4 45443 5799999999999999999999999999999999999999999999999999999999999984 56665
Q ss_pred cccccceEEecccccCCCCCcc----------ccccccccccCCCCc
Q 003780 358 GLMKLEYLDLSHNKLNGTIPPF----------LYHRFPLDLSYNDLE 394 (796)
Q Consensus 358 ~~~~L~~L~l~~N~l~~~~p~~----------~~~~~~l~l~~N~l~ 394 (796)
.+++|++|+|++|+|+ .++.. ..++..|+|++|.++
T Consensus 240 ~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 240 DHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 5899999999999998 44432 133457899999885
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.2e-27 Score=246.39 Aligned_cols=254 Identities=21% Similarity=0.241 Sum_probs=218.0
Q ss_pred EEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEec-C
Q 003780 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLK-G 154 (796)
Q Consensus 76 ~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~-~ 154 (796)
.+++++.+++. +|.. + .+.+++|+|++|+|+++.+..|.++++|++||+++|.|....+..+.+++.++.|+.. .
T Consensus 15 ~v~c~~~~L~~-iP~~-i--p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQA-VPVG-I--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCSS-CCTT-C--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCCc-cCCC-C--CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 34566666663 3321 1 2578999999999998888899999999999999999998888899999999999875 6
Q ss_pred CCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCC
Q 003780 155 NNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIP 234 (796)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 234 (796)
|.++...|..|.++++|++|++++|.+....+..+....+|+.+++++|+++++.+..|..+++|+.|++++|++++..+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 67887778999999999999999999998888899999999999999999999999999999999999999999999889
Q ss_pred CcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccc
Q 003780 235 STLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLIS 314 (796)
Q Consensus 235 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 314 (796)
..|.++++|+.|++++|++++..|..|.++++|+.|++++|++.+..+..|.++++|++|+|++|++...-+. ..-...
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~ 249 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHH
T ss_pred hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999864321 112234
Q ss_pred cceecccccccccCCCcccC
Q 003780 315 LKGLDLSNNKLSGPIPPEIG 334 (796)
Q Consensus 315 L~~L~Ls~N~l~~~~~~~~~ 334 (796)
++.+....+++....|..+.
T Consensus 250 l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 250 LQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp HHHCCSEECCCBEEESGGGT
T ss_pred HHhCcCCCCceEeCCchHHc
Confidence 66666666666655555544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=1.5e-25 Score=243.10 Aligned_cols=298 Identities=29% Similarity=0.354 Sum_probs=237.2
Q ss_pred eCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCC
Q 003780 78 NLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNL 157 (796)
Q Consensus 78 ~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l 157 (796)
.++..++.+.+.. ..+.+|++|++++++|... +.++.+++|++|||++|+|++.. .|+++++|++|+|++|++
T Consensus 28 ~l~~~~~~~~~~~---~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 28 VLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HTTCSSTTSEECH---HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HhCCCCCCCccCH---HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccc
Confidence 3444455554443 4567899999999999864 46889999999999999999653 399999999999999999
Q ss_pred CCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCc-----------------------------
Q 003780 158 NGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGM----------------------------- 208 (796)
Q Consensus 158 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----------------------------- 208 (796)
++.. .+.++++|+.|++++|.+++..+ ......+..+....|.+...
T Consensus 101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (384)
T d2omza2 101 ADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTT 176 (384)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTT
T ss_pred cccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 9653 38899999999999999986543 33445566666655554321
Q ss_pred ------------chhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccc
Q 003780 209 ------------LHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNN 276 (796)
Q Consensus 209 ------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 276 (796)
....+..+++++.+++++|.+++..| +...++|++|++++|+++. + ..+..+++|+.|++++|.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~ 252 (384)
T d2omza2 177 LERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQ 252 (384)
T ss_dssp CCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSC
T ss_pred cccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCc
Confidence 22456678899999999999997654 4667899999999999984 3 368889999999999999
Q ss_pred ccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCcc
Q 003780 277 IEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPE 356 (796)
Q Consensus 277 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 356 (796)
+++..+ +..+++|++|++++|++++.. .+..++.++.+++++|.+++. ..+..+++++.|++++|++++. +..
T Consensus 253 l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~~l 325 (384)
T d2omza2 253 ISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI-SPV 325 (384)
T ss_dssp CCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC-GGG
T ss_pred cCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCC-ccc
Confidence 997554 788999999999999998654 377888999999999999863 4588899999999999999975 334
Q ss_pred ccccccceEEecccccCCCCCc--cccccccccccCCCCcccCC
Q 003780 357 IGLMKLEYLDLSHNKLNGTIPP--FLYHRFPLDLSYNDLEGEIP 398 (796)
Q Consensus 357 ~~~~~L~~L~l~~N~l~~~~p~--~~~~~~~l~l~~N~l~~~~p 398 (796)
..+++|+.|++++|++++ +|. .+.++..|++++|++++.+|
T Consensus 326 ~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 326 SSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp GGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG
T ss_pred ccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh
Confidence 468899999999999985 442 34567789999999997654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.2e-24 Score=221.03 Aligned_cols=204 Identities=24% Similarity=0.219 Sum_probs=158.4
Q ss_pred eeCCCCCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCC
Q 003780 67 TCNTARSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRN 146 (796)
Q Consensus 67 ~C~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 146 (796)
.|+...+..++++++++|+. +|+. +. ++|++|+|++|.|+++.+..|.++++|++|+|++|+|+. +| .++.+++
T Consensus 5 ~~~~~~~~~~v~C~~~~L~~-iP~~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~ 78 (266)
T d1p9ag_ 5 EVSKVASHLEVNCDKRNLTA-LPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPV 78 (266)
T ss_dssp EEECSTTCCEEECTTSCCSS-CCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTT
T ss_pred EEcccCCCeEEEccCCCCCe-eCcC-cC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccc
Confidence 35555566778888888885 4321 21 578899999999988777888889999999999998884 33 3577888
Q ss_pred CCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCC
Q 003780 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGG 226 (796)
Q Consensus 147 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 226 (796)
|++|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+|++|++++|.++.+.+..+..+++|+.|++++
T Consensus 79 L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~ 157 (266)
T d1p9ag_ 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (266)
T ss_dssp CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccc
Confidence 999999988888 4466778888888888888888877777888888888888888888877777777788888888888
Q ss_pred ccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccccc
Q 003780 227 NKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIE 278 (796)
Q Consensus 227 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 278 (796)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 158 N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 8887777777777788888888888877 67777777777777777777665
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.5e-24 Score=218.73 Aligned_cols=202 Identities=23% Similarity=0.199 Sum_probs=142.9
Q ss_pred CCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
.....+.+++.++++++. +|..+. ++|++|||++|.|++..+..|.++++|++|+|++|+|+. +| .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence 344556667777777774 455443 467788888888876655677778888888888887773 33 3466777777
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 253 (796)
|+|++|++++ .+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|++
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 7777777774 355677777777777777777777777777777777777777777766666666777777777777777
Q ss_pred cccCCccccCCcccceeecccccccccCccccccccccccccccCcccc
Q 003780 254 NGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLS 302 (796)
Q Consensus 254 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 302 (796)
++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 7666666777777777777777777 56666666677777777776654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=4.3e-22 Score=192.83 Aligned_cols=172 Identities=16% Similarity=0.203 Sum_probs=122.0
Q ss_pred ccceeeecccceeEEEEEccCCcEEEEEEeccccch---------------hhHHHHHHHHHHHHHhhcCCCceeeEEeE
Q 003780 502 DIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETE---------------ETTFFNSFQNEAHVLSKIAHRNIVKLYGF 566 (796)
Q Consensus 502 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 566 (796)
.+.+.||+|+||+||+|...+|+.||||+++..... ..........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999889999999987643211 01112345678899999999999988765
Q ss_pred EEecceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecCCCCCeEecCCCcEEEe
Q 003780 567 CLHKKCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDCMPSIVHRDISSNNILLNSKLEAFVA 646 (796)
Q Consensus 567 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 646 (796)
. ..++||||++++.+.+ ++......++.|++++++|||++ +|+||||||+|||++++ .++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 4 2379999999865532 33344567899999999999999 99999999999999965 58999
Q ss_pred eeccccccCCCCCCccccccccCccCccccccCCcCcchhHHHHHHHH
Q 003780 647 DFGTARLLDSDSSNRTIVAGTYGYIAPELAYTMVVTEKCDVYSFGVVA 694 (796)
Q Consensus 647 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv~l 694 (796)
|||.|.....+.. .......... -.|. ....|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~-~~~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW-REILERDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH-HHHHHHHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc-HHHHHHHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 9999986543211 1100000000 0111 235678899999975443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=5.7e-20 Score=183.12 Aligned_cols=203 Identities=27% Similarity=0.339 Sum_probs=106.0
Q ss_pred EEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccc
Q 003780 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNG 180 (796)
Q Consensus 101 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 180 (796)
.++++.+.+.+.. .+..+.+|++|++++|+|+. ++ .+.++++|++|+|++|++++..| +.++++|+.+++++|.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 3445555555433 34556666777777776663 32 46666777777777776664432 5666666666666666
Q ss_pred cCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCcc
Q 003780 181 LHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPE 260 (796)
Q Consensus 181 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 260 (796)
++.. ..+.++++|+.+++++|...+. ..+...+.++.+.++++.+... ..+.+.++|++|++++|.+++.. .
T Consensus 97 ~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~ 168 (227)
T d1h6ua2 97 LKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--P 168 (227)
T ss_dssp CSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--G
T ss_pred cccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--h
Confidence 6532 2355666666666666655433 2234445555555555555422 12444455555555555554211 1
Q ss_pred ccCCcccceeecccccccccCccccccccccccccccCccccCccccccccccccceecccccccccCCCcccCCCCCCc
Q 003780 261 IGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELR 340 (796)
Q Consensus 261 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 340 (796)
++++++|+.|+|++|++++. + .+.++++|++|+|++|++++.. .++++++|+
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l-~-------------------------~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~ 220 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDI-S-------------------------PLASLPNLIEVHLKNNQISDVS--PLANTSNLF 220 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCC-G-------------------------GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCC
T ss_pred hcccccceecccCCCccCCC-h-------------------------hhcCCCCCCEEECcCCcCCCCc--ccccCCCCC
Confidence 44444444444444444431 1 1444455555555555554322 255555555
Q ss_pred EEEee
Q 003780 341 NITLR 345 (796)
Q Consensus 341 ~L~L~ 345 (796)
.|+|+
T Consensus 221 ~L~ls 225 (227)
T d1h6ua2 221 IVTLT 225 (227)
T ss_dssp EEEEE
T ss_pred EEEee
Confidence 55554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=7.1e-20 Score=184.41 Aligned_cols=217 Identities=17% Similarity=0.157 Sum_probs=123.5
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCC-chhhhccCccceeeccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAI-PSSLCQLTKLITMALSR 178 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~ 178 (796)
+.++.++++++ .+|..+- +++++|||++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45667776666 4444332 46777777777777555556777777777777777776543 34566677777776653
Q ss_pred -cccCCCCCccccCCCCccEEEcccccccCcch-hhhcCCCCccccccCCccccccCCCcccccC-ccceEEeccccccc
Q 003780 179 -NGLHGPIPSAIGDLNNLLILSLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPIPSTLFRLT-NLTYLYLHSNHLNG 255 (796)
Q Consensus 179 -N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~ 255 (796)
|.+....+..|.++++|++|++++|.+....+ ..+..++.|..+...++.+....+..+.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 56666666667777777777777776654432 2234445555555555555554444554443 45556666666653
Q ss_pred cCCccccCCcccce-eecccccccccCccccccccccccccccCccccCccccccccccccceecc
Q 003780 256 SIPPEIGNMTGILK-VDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIAGLISLKGLDL 320 (796)
Q Consensus 256 ~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 320 (796)
..+ .....++++. +++++|+++...+..|.++++|++|+|++|+++...+..|.++++|+.|++
T Consensus 168 i~~-~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 168 IHN-CAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ECT-TTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccc-ccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 322 2233333333 234555555443444555555555555555555443444555555555444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=2e-18 Score=183.59 Aligned_cols=286 Identities=26% Similarity=0.296 Sum_probs=193.1
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEe
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNL 152 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (796)
+++.|+|++++++. +|. ..++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+|
T Consensus 39 ~l~~LdLs~~~L~~-lp~----~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPE----LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCSC-CCS----CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred CCCEEEeCCCCCCC-CCC----CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 57789999999874 553 3578999999999998 456554 57899999999988 34432 146999999
Q ss_pred cCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCcccccc
Q 003780 153 KGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGP 232 (796)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 232 (796)
++|.+. .+|. +..+++|+.|++++|.++...+ ....+..+.+..+.... ...+..++.++.|++++|.+...
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSC
T ss_pred cccccc-cccc-hhhhccceeecccccccccccc----ccccccchhhccccccc--cccccccccceeccccccccccc
Confidence 999998 4554 5789999999999999875432 23667788887776543 45677889999999999988743
Q ss_pred CCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCccccccccccccccccCccccCccccccc--
Q 003780 233 IPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSNMLSGQIPITIA-- 310 (796)
Q Consensus 233 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~-- 310 (796)
. .. ....+.+...++.+. .++ .+..++.|+.+++++|.... +|.. ..++..+.+.+|.+... +....
T Consensus 178 ~-~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~~---~~~l~~~~~~~~~~~~~-~~~~~~l 246 (353)
T d1jl5a_ 178 P-DL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDL-PELPQSL 246 (353)
T ss_dssp C-CC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCC-CCCCTTC
T ss_pred c-cc---ccccccccccccccc-ccc-cccccccccccccccccccc-cccc---ccccccccccccccccc-ccccccc
Confidence 2 21 123445555555554 333 34567777777777776653 3322 23455555555555421 11111
Q ss_pred -----------ccc----ccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCC
Q 003780 311 -----------GLI----SLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGT 375 (796)
Q Consensus 311 -----------~l~----~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~ 375 (796)
++. .....++..|.+. .....+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .
T Consensus 247 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~-~lp~~--~~~L~~L~L~~N~L~-~ 318 (353)
T d1jl5a_ 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHLA-E 318 (353)
T ss_dssp CEEECCSSCCSEESCCCTTCCEEECCSSCCS----EECCCCTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSCCS-C
T ss_pred cccccccccccccccccchhcccccccCccc----cccccCCCCCEEECCCCccC-ccccc--cCCCCEEECCCCcCC-c
Confidence 111 1223333333333 22334678999999999988 45643 568999999999988 6
Q ss_pred CCccccccccccccCCCCcccCCC
Q 003780 376 IPPFLYHRFPLDLSYNDLEGEIPD 399 (796)
Q Consensus 376 ~p~~~~~~~~l~l~~N~l~~~~p~ 399 (796)
+|..+.++..|++++|.++ .+|+
T Consensus 319 l~~~~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 319 VPELPQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CCCCCTTCCEEECCSSCCS-SCCC
T ss_pred cccccCCCCEEECcCCcCC-CCCc
Confidence 8877778888999999987 4554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=5.4e-20 Score=183.30 Aligned_cols=202 Identities=24% Similarity=0.370 Sum_probs=157.5
Q ss_pred EeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCC
Q 003780 77 INLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNN 156 (796)
Q Consensus 77 l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~ 156 (796)
++++.+++++.+. +..+.+|+.|++.+|+|... + .+..+++|++|+|++|.+++..| +..+++|++|++++|.
T Consensus 24 ~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 24 IAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHhCCCCcCCcCC---HHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 3444445544332 45567889999999998864 3 58889999999999999986544 8889999999999998
Q ss_pred CCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCc
Q 003780 157 LNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPST 236 (796)
Q Consensus 157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 236 (796)
++.. ..+.++++|+.+++++|...+. ..+...+.++.+.++.+.+.... .+.++++|+.|++++|.+.+.. .
T Consensus 97 ~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~ 168 (227)
T d1h6ua2 97 LKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--P 168 (227)
T ss_dssp CSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--G
T ss_pred cccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--h
Confidence 8843 3578889999999999888754 34667788999999998887553 4778889999999999987543 4
Q ss_pred ccccCccceEEeccccccccCCccccCCcccceeecccccccccCcccccccccccccccc
Q 003780 237 LFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSIS 297 (796)
Q Consensus 237 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 297 (796)
+.++++|+.|+|++|++++ ++ .+.++++|+.|+|++|++++..| ++++++|++|+++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred hcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 7889999999999999985 43 37888899999999998886433 7777888888775
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=3.4e-18 Score=181.88 Aligned_cols=275 Identities=25% Similarity=0.292 Sum_probs=186.9
Q ss_pred CCeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEE
Q 003780 72 RSIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLN 151 (796)
Q Consensus 72 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (796)
.+++.|+|++|+++ .++. .+.+|+.|++++|+++.. +. + .+.|++|||++|.++ .+|. ++.+++|++|+
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp TTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSCC-CS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCEEECCCCCCc-cccc----chhhhhhhhhhhcccchh-hh-h--ccccccccccccccc-cccc-hhhhccceeec
Confidence 46899999999998 4543 257899999999998743 32 1 146999999999998 5564 68899999999
Q ss_pred ecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccc
Q 003780 152 LKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMG 231 (796)
Q Consensus 152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 231 (796)
+++|.+... |.. ...+..+.+..+... .+..+..++.++.|++++|.+..... .....+.+...++.+.
T Consensus 127 l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~----~~~~~~~l~~~~~~~~- 195 (353)
T d1jl5a_ 127 VDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILE- 195 (353)
T ss_dssp CCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCS-
T ss_pred ccccccccc-ccc---cccccchhhcccccc--ccccccccccceeccccccccccccc----cccccccccccccccc-
Confidence 999999844 332 456677777776655 34567788999999999998875432 1223345556655554
Q ss_pred cCCCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCcccccccc-----------------ccccc
Q 003780 232 PIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLS-----------------QLLYL 294 (796)
Q Consensus 232 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-----------------~L~~L 294 (796)
.++ .+..++.|+.+++++|... .+|.. ..++..+.+..|.+... +.....+. .....
T Consensus 196 ~~~-~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~ 269 (353)
T d1jl5a_ 196 ELP-ELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELPPNLYYL 269 (353)
T ss_dssp SCC-CCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSCC-CCCCTTCCEEECCSSCCSEESCCCTTCCEE
T ss_pred ccc-ccccccccccccccccccc-ccccc---ccccccccccccccccc-ccccccccccccccccccccccccchhccc
Confidence 333 3566788888888888776 34432 34556666666666532 21111111 11222
Q ss_pred cccCccccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCC
Q 003780 295 SISSNMLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNG 374 (796)
Q Consensus 295 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~ 374 (796)
++..|.+. .....+++|++|+|++|+++ .+|.. +++|+.|+|++|+|+ .+|.. +.+|++|++++|+++
T Consensus 270 ~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~--~~~L~~L~L~~N~L~- 337 (353)
T d1jl5a_ 270 NASSNEIR----SLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNPLR- 337 (353)
T ss_dssp ECCSSCCS----EECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSCCS-
T ss_pred ccccCccc----cccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc--cCCCCEEECcCCcCC-
Confidence 22333222 22344679999999999998 56643 678999999999998 56643 458999999999987
Q ss_pred CCCccccccccc
Q 003780 375 TIPPFLYHRFPL 386 (796)
Q Consensus 375 ~~p~~~~~~~~l 386 (796)
.+|.....+..|
T Consensus 338 ~lp~~~~~L~~L 349 (353)
T d1jl5a_ 338 EFPDIPESVEDL 349 (353)
T ss_dssp SCCCCCTTCCEE
T ss_pred CCCccccccCee
Confidence 677544444433
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2.8e-19 Score=179.93 Aligned_cols=201 Identities=18% Similarity=0.171 Sum_probs=168.2
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCC-CCCCCCCCCCCEEEecC-CCCCCCCchhhhccCcccee
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSI-PPELGSLRNLEVLNLKG-NNLNGAIPSSLCQLTKLITM 174 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 174 (796)
+++++|+|++|.|+.+.+..|.++++|++|+|++|.+...+ +..|.+++++++|++.. |++....+..|.++++|+.|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 57999999999999887888999999999999999988654 55789999999999875 78887888899999999999
Q ss_pred eccccccCCCCC-ccccCCCCccEEEcccccccCcchhhhcCCC-CccccccCCccccccCCCcccccCccceE-Eeccc
Q 003780 175 ALSRNGLHGPIP-SAIGDLNNLLILSLDSNKLSGMLHQELGKLK-NLVALNVGGNKLMGPIPSTLFRLTNLTYL-YLHSN 251 (796)
Q Consensus 175 ~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~l~~l~~L~~L-~L~~N 251 (796)
++++|++....+ ..+..+..|..+..+++.+..+.+..|.+++ .++.|++++|+++...+..+ +.++++++ ++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhcccccccc
Confidence 999999986543 3455677888888889999988888888765 79999999999996555544 45565555 57888
Q ss_pred cccccCCccccCCcccceeecccccccccCccccccccccccccccC
Q 003780 252 HLNGSIPPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISS 298 (796)
Q Consensus 252 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 298 (796)
+++...+..|.++++|+.|+|++|+|+...+..|.++++|+.|++.+
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 99855556789999999999999999977777899999999988754
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=1.3e-19 Score=175.31 Aligned_cols=126 Identities=24% Similarity=0.278 Sum_probs=55.1
Q ss_pred EEeccCCcccccCCcCccCCCCCcEeecccCcCCC-CCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 101 SLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTG-SIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 101 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
.++.++++++ .+|..+. +++++|+|++|.|++ ..+..|.++++|++|+|++|++.+..+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3445555544 2233221 344445555554443 22333444444444444444444444444444444444444444
Q ss_pred ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccc
Q 003780 180 GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKL 229 (796)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 229 (796)
+|++..|.+|.++++|++|+|++|+|+++.++.|..+++|++|+|++|.+
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence 44444444444444444444444444444444444444444444444433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=8.2e-20 Score=176.69 Aligned_cols=175 Identities=19% Similarity=0.225 Sum_probs=129.1
Q ss_pred ccccCCccccccCCCcccccCccceEEeccccccccC-CccccCCcccceeecccccccccCccccccccccccccccCc
Q 003780 221 ALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSI-PPEIGNMTGILKVDMSMNNIEGTIPLELTRLSQLLYLSISSN 299 (796)
Q Consensus 221 ~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 299 (796)
.++.++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4555666665 3444442 46777777777776533 445667777777777777777777777777777888888888
Q ss_pred cccCccccccccccccceecccccccccCCCcccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCCCCcc
Q 003780 300 MLSGQIPITIAGLISLKGLDLSNNKLSGPIPPEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPF 379 (796)
Q Consensus 300 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~ 379 (796)
+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+....+..+....++.+.+..|.++...|..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~ 168 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh
Confidence 88777777788888888888888888887888888888899999999888765443333345777788889988888888
Q ss_pred ccccccccccCCCCcccCC
Q 003780 380 LYHRFPLDLSYNDLEGEIP 398 (796)
Q Consensus 380 ~~~~~~l~l~~N~l~~~~p 398 (796)
+..+..+||+.|+|....+
T Consensus 169 l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 169 VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp TTTSBGGGSCTTTCCCCCC
T ss_pred hcCCEeeecCHhhCcCCCC
Confidence 8888888999998875433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2e-18 Score=167.78 Aligned_cols=176 Identities=26% Similarity=0.348 Sum_probs=100.8
Q ss_pred EeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccccc
Q 003780 102 LSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGL 181 (796)
Q Consensus 102 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 181 (796)
+.++.+.+++.++ ...+.+|++|++++|.|+.. +.+..+++|++|+|++|++++..| +.++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 3455555554432 23456666677777666632 236666677777777776664432 66666666666666666
Q ss_pred CCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccc
Q 003780 182 HGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEI 261 (796)
Q Consensus 182 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 261 (796)
... + .+.++++|+.|++++|.+.... .+..+++|+.|++++|++.. + +.+..+++|++|++++|++++. + .+
T Consensus 97 ~~~-~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l 168 (199)
T d2omxa2 97 ADI-T-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PL 168 (199)
T ss_dssp CCC-G-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GG
T ss_pred ccc-c-cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-cc
Confidence 532 2 3566666666666666665432 35556666666666666653 2 2455666666666666666532 2 25
Q ss_pred cCCcccceeecccccccccCcccccccccccc
Q 003780 262 GNMTGILKVDMSMNNIEGTIPLELTRLSQLLY 293 (796)
Q Consensus 262 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 293 (796)
+++++|+.|++++|++++. + .++++++|+.
T Consensus 169 ~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~ 198 (199)
T d2omxa2 169 ANLTTLERLDISSNKVSDI-S-VLAKLTNLES 198 (199)
T ss_dssp TTCTTCCEEECCSSCCCCC-G-GGGGCTTCSE
T ss_pred cCCCCCCEEECCCCCCCCC-c-cccCCCCCCc
Confidence 5566666666666665532 2 3445555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.7e-18 Score=169.81 Aligned_cols=163 Identities=27% Similarity=0.367 Sum_probs=79.5
Q ss_pred CCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEc
Q 003780 121 SKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSL 200 (796)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 200 (796)
.+|++|++++|.+++. + .+..+++|++|+|++|+|++.. .++.+++|+.|++++|+|++ +| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 3444444444444422 1 2444445555555555444321 23444455555555554443 12 2444555555555
Q ss_pred ccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccccccCCccccCCcccceeeccccccccc
Q 003780 201 DSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGT 280 (796)
Q Consensus 201 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 280 (796)
++|.+... ..+..+++|+.+++++|.+++. ..+..+++|+.+++++|++++ ++ .+.++++|+.|+|++|++++
T Consensus 120 ~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-
T ss_pred cccccccc--cccccccccccccccccccccc--ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-
Confidence 55544432 2344555555555555555422 234455556666666665553 22 25555666666666666653
Q ss_pred Ccccccccccccccccc
Q 003780 281 IPLELTRLSQLLYLSIS 297 (796)
Q Consensus 281 ~p~~l~~l~~L~~L~l~ 297 (796)
+| .+.++++|++|+|+
T Consensus 193 l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CG-GGTTCTTCSEEEEE
T ss_pred Ch-hhcCCCCCCEEEcc
Confidence 23 35566666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.2e-18 Score=170.88 Aligned_cols=163 Identities=25% Similarity=0.353 Sum_probs=75.6
Q ss_pred CCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeec
Q 003780 97 PGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMAL 176 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 176 (796)
.+|++|++++|.+.+.. .+..+++|++|+|++|.|++.. .++++++|++|++++|+|++ +| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 34455555555544321 2444555555555555554322 23445555555555555542 22 3444555555555
Q ss_pred cccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEecccccccc
Q 003780 177 SRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHLNGS 256 (796)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (796)
++|.+.. ...+..+++|+.+++++|.+++. ..+..+++|+.+++++|++++.. .+.++++|++|+|++|+++.
T Consensus 120 ~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 120 EHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp TTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-
T ss_pred ccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-
Confidence 5554442 12344445555555555554432 23444455555555555554321 24445555555555555542
Q ss_pred CCccccCCcccceeecc
Q 003780 257 IPPEIGNMTGILKVDMS 273 (796)
Q Consensus 257 ~p~~~~~l~~L~~L~Ls 273 (796)
+| .+.++++|+.|+|+
T Consensus 193 l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CG-GGTTCTTCSEEEEE
T ss_pred Ch-hhcCCCCCCEEEcc
Confidence 22 34455555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.8e-18 Score=166.74 Aligned_cols=163 Identities=26% Similarity=0.334 Sum_probs=126.9
Q ss_pred CCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccce
Q 003780 94 SCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLIT 173 (796)
Q Consensus 94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 173 (796)
..++++++|++++|.+... +.+..+++|++|+|++|+|++..| ++++++|++|++++|.+... + .+.++++|+.
T Consensus 37 ~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~ 110 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTG 110 (199)
T ss_dssp HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSE
T ss_pred HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-cccccccccc
Confidence 3457788888888888753 347788888888888888886433 88888888888888888743 3 4788888888
Q ss_pred eeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccCCccccccCCCcccccCccceEEeccccc
Q 003780 174 MALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPSTLFRLTNLTYLYLHSNHL 253 (796)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 253 (796)
|++++|.+... ..+..+++|+.|++++|++... ..+..+++|+.|++++|++++.. .+.++++|++|++++|++
T Consensus 111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKV 184 (199)
T ss_dssp EECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCC
Confidence 88888888753 3477888899999998888754 35788888999999999888643 478888999999999988
Q ss_pred cccCCccccCCccccee
Q 003780 254 NGSIPPEIGNMTGILKV 270 (796)
Q Consensus 254 ~~~~p~~~~~l~~L~~L 270 (796)
++ ++ .++++++|+.|
T Consensus 185 ~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 185 SD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CC-CG-GGGGCTTCSEE
T ss_pred CC-Cc-cccCCCCCCcC
Confidence 84 43 47778877765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.6e-19 Score=199.50 Aligned_cols=325 Identities=21% Similarity=0.157 Sum_probs=211.8
Q ss_pred CeEEEeCCCCCccccccccccCCCCCCcEEeccCCcccc----cCCcCccCCCCCcEeecccCcCCCC----CCCCCC-C
Q 003780 73 SIIEINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFG----SIPSQVGALSKLRYLDFSFNNLTGS----IPPELG-S 143 (796)
Q Consensus 73 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~-~ 143 (796)
++.+||++.+++++.--..-+..+++++.|+|++|+|+. .+...+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 477888888887653222235567888888888888763 3445567788888888888887521 122222 2
Q ss_pred CCCCCEEEecCCCCCCC----CchhhhccCccceeeccccccCCCCC---------------------------------
Q 003780 144 LRNLEVLNLKGNNLNGA----IPSSLCQLTKLITMALSRNGLHGPIP--------------------------------- 186 (796)
Q Consensus 144 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p--------------------------------- 186 (796)
.++|++|+|++|++++. ++..+..+++|++|+|++|.++....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35788888888888753 34566778888888888887642100
Q ss_pred ccccCCCCccEEEccccccc-----------------------------Cc----chhhhcCCCCccccccCCcccccc-
Q 003780 187 SAIGDLNNLLILSLDSNKLS-----------------------------GM----LHQELGKLKNLVALNVGGNKLMGP- 232 (796)
Q Consensus 187 ~~~~~l~~L~~L~L~~N~l~-----------------------------~~----~~~~~~~l~~L~~L~l~~N~l~~~- 232 (796)
..+.....++.++++++... .. ....+...+.++.+++++|++...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 00112234555555544332 11 112234567788888888876421
Q ss_pred ----CCCcccccCccceEEeccccccccC----CccccCCcccceeecccccccccCcccc-----ccccccccccccCc
Q 003780 233 ----IPSTLFRLTNLTYLYLHSNHLNGSI----PPEIGNMTGILKVDMSMNNIEGTIPLEL-----TRLSQLLYLSISSN 299 (796)
Q Consensus 233 ----~~~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~l~~N 299 (796)
.+........|+.|++++|.+.... ...+...+.++.+++++|.+++.....+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 2233345678999999999887432 2334567889999999999875433332 23467999999999
Q ss_pred cccCccccc----cccccccceecccccccccC----CCcccC-CCCCCcEEEeecccccCC----CCccc-cccccceE
Q 003780 300 MLSGQIPIT----IAGLISLKGLDLSNNKLSGP----IPPEIG-KCSELRNITLRNNNLSGS----IPPEI-GLMKLEYL 365 (796)
Q Consensus 300 ~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~L~~N~l~~~----~~~~~-~~~~L~~L 365 (796)
.++...... +...++|++|+|++|++++. ++..+. ..+.|+.|+|++|+++.. ++..+ ..++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 988654333 34556899999999998753 233333 467799999999999853 22222 35789999
Q ss_pred EecccccCCCCCc--------cccccccccccCCCCcccC
Q 003780 366 DLSHNKLNGTIPP--------FLYHRFPLDLSYNDLEGEI 397 (796)
Q Consensus 366 ~l~~N~l~~~~p~--------~~~~~~~l~l~~N~l~~~~ 397 (796)
+|++|+++..... ....+..|++.+|.+....
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHH
Confidence 9999999753221 1224667889888886543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.1e-19 Score=200.68 Aligned_cols=299 Identities=20% Similarity=0.170 Sum_probs=206.9
Q ss_pred CCCcEEeccCCccccc-CCcCccCCCCCcEeecccCcCCC----CCCCCCCCCCCCCEEEecCCCCCCCCchhhh-----
Q 003780 97 PGLESLSLRFNYLFGS-IPSQVGALSKLRYLDFSFNNLTG----SIPPELGSLRNLEVLNLKGNNLNGAIPSSLC----- 166 (796)
Q Consensus 97 ~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----- 166 (796)
++|++||+++|++++. +...+..+++|++|+|++|.|+. .++..+..+++|++|||++|+|+......+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3689999999999863 23456778999999999999873 3344567899999999999998632212222
Q ss_pred ccCccceeeccccccCCC----CCccccCCCCccEEEcccccccCcchhh------------------------------
Q 003780 167 QLTKLITMALSRNGLHGP----IPSAIGDLNNLLILSLDSNKLSGMLHQE------------------------------ 212 (796)
Q Consensus 167 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------------ 212 (796)
...+|++|+|++|+++.. ++..+..+++|++|+|++|.++......
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235799999999999854 4566788999999999999886421111
Q ss_pred ---hcCCCCccccccCCcccccc--------------------------CC-------CcccccCccceEEeccccccc-
Q 003780 213 ---LGKLKNLVALNVGGNKLMGP--------------------------IP-------STLFRLTNLTYLYLHSNHLNG- 255 (796)
Q Consensus 213 ---~~~l~~L~~L~l~~N~l~~~--------------------------~~-------~~l~~l~~L~~L~L~~N~l~~- 255 (796)
+.....++.++++++.+... .. ..+...+.++.++++.|++..
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 12234455555555433200 00 112235678888998887643
Q ss_pred ----cCCccccCCcccceeeccccccccc----CccccccccccccccccCccccCcccccc-----ccccccceecccc
Q 003780 256 ----SIPPEIGNMTGILKVDMSMNNIEGT----IPLELTRLSQLLYLSISSNMLSGQIPITI-----AGLISLKGLDLSN 322 (796)
Q Consensus 256 ----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~Ls~ 322 (796)
..+........++.|++++|.+... ....+...+.++.+++++|.++......+ .....|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 1223344567899999999998743 33345677899999999999875333222 2345799999999
Q ss_pred cccccCCCcc----cCCCCCCcEEEeecccccCC----CCccc--cccccceEEecccccCCC----CCccc---ccccc
Q 003780 323 NKLSGPIPPE----IGKCSELRNITLRNNNLSGS----IPPEI--GLMKLEYLDLSHNKLNGT----IPPFL---YHRFP 385 (796)
Q Consensus 323 N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~----~~~~~--~~~~L~~L~l~~N~l~~~----~p~~~---~~~~~ 385 (796)
|.++...... +...++|++|+|++|++++. ++..+ ....|++|+|++|+++.. ++..+ ..+..
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~ 401 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence 9987654333 34567899999999999753 22222 245699999999999742 22222 45778
Q ss_pred ccccCCCCcc
Q 003780 386 LDLSYNDLEG 395 (796)
Q Consensus 386 l~l~~N~l~~ 395 (796)
|||++|.++.
T Consensus 402 L~Ls~N~i~~ 411 (460)
T d1z7xw1 402 LDLSNNCLGD 411 (460)
T ss_dssp EECCSSSCCH
T ss_pred EECCCCcCCH
Confidence 9999999975
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=6.5e-17 Score=166.24 Aligned_cols=221 Identities=19% Similarity=0.230 Sum_probs=109.7
Q ss_pred EEeCCCCCccccccccccCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCC-CCCCCCCCCCCCEEEecC
Q 003780 76 EINLPEKKLKGELSQFNFSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGS-IPPELGSLRNLEVLNLKG 154 (796)
Q Consensus 76 ~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~L~~ 154 (796)
.+|++++.+.+......+. ..+..+.++...+...... .....+|++|||++|.+++. ++..+.++++|++|+|++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred EEECCCCCCCchHHHHHHh--ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 4566665554322211111 1234455555544433222 33445677777776666532 233355666777777777
Q ss_pred CCCCCCCchhhhccCccceeecccc-ccCCC-CCccccCCCCccEEEcccc-cccCc-chhhhcC-CCCccccccCCc--
Q 003780 155 NNLNGAIPSSLCQLTKLITMALSRN-GLHGP-IPSAIGDLNNLLILSLDSN-KLSGM-LHQELGK-LKNLVALNVGGN-- 227 (796)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~-l~~L~~L~l~~N-- 227 (796)
|.+++..+..+.++++|++|+|++| .++.. +...+.++++|++|+++++ .++.. ....+.. .++|+.|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 7666656666666667777777664 34321 1122345666666666664 23321 1122222 345666666543
Q ss_pred ccccc-CCCcccccCccceEEeccc-cccccCCccccCCcccceeeccc-ccccccCccccccccccccccccCc
Q 003780 228 KLMGP-IPSTLFRLTNLTYLYLHSN-HLNGSIPPEIGNMTGILKVDMSM-NNIEGTIPLELTRLSQLLYLSISSN 299 (796)
Q Consensus 228 ~l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~l~~N 299 (796)
.++.. +.....++++|++|+|++| .+++.....+.++++|++|+|++ +.+++.....++++++|++|+++++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 22211 1112234555666666554 34444444555555555555555 3454444444555555555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=5.5e-16 Score=144.31 Aligned_cols=109 Identities=20% Similarity=0.194 Sum_probs=44.4
Q ss_pred CCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEE
Q 003780 119 ALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLIL 198 (796)
Q Consensus 119 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 198 (796)
+..+|++|||++|+|+ .++..+..+++|+.|+|++|+|+.. + .|..+++|++|++++|+++...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 3344444444444444 2233333444444444444444421 1 23344444444444444443333333344444444
Q ss_pred EcccccccCcch-hhhcCCCCccccccCCcccc
Q 003780 199 SLDSNKLSGMLH-QELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 199 ~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~ 230 (796)
+|++|+++.... ..+..+++|++|++++|.++
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred eeccccccccccccccccccccchhhcCCCccc
Confidence 444444443211 23334444444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=8.7e-16 Score=142.95 Aligned_cols=128 Identities=19% Similarity=0.157 Sum_probs=108.9
Q ss_pred cCCCCCCcEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccc
Q 003780 93 FSCFPGLESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLI 172 (796)
Q Consensus 93 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 172 (796)
|.+...+++|+|++|+|+.+ +..+..+++|++|||++|.|+. + +.|..+++|++|+|++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 67788999999999999865 6677889999999999999994 4 3589999999999999999977777788999999
Q ss_pred eeeccccccCCCCC-ccccCCCCccEEEcccccccCcc---hhhhcCCCCccccc
Q 003780 173 TMALSRNGLHGPIP-SAIGDLNNLLILSLDSNKLSGML---HQELGKLKNLVALN 223 (796)
Q Consensus 173 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ 223 (796)
.|+|++|+|+.... ..+..+++|++|++++|.++... +..+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 99999999985432 57889999999999999997553 23567777777776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=8.9e-17 Score=165.19 Aligned_cols=259 Identities=17% Similarity=0.194 Sum_probs=146.0
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCC-CchhhhccCccceeeccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGA-IPSSLCQLTKLITMALSR 178 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~ 178 (796)
++|||+++.+.......+.. ..+..+.+++..+...... .....+|++|||++|.++.. ++..+.++++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 46888888775322221111 2355677777666543333 34456889999988887643 344567778888888888
Q ss_pred cccCCCCCccccCCCCccEEEcccc-cccCc-chhhhcCCCCccccccCCc-ccccc-CCCcccc-cCccceEEeccccc
Q 003780 179 NGLHGPIPSAIGDLNNLLILSLDSN-KLSGM-LHQELGKLKNLVALNVGGN-KLMGP-IPSTLFR-LTNLTYLYLHSNHL 253 (796)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~l~~-l~~L~~L~L~~N~l 253 (796)
|.+++..+..+..+++|++|+|++| .++.. ....+.++++|++|+++++ .++.. +...+.. .++|+.|+++++.
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~- 159 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR- 159 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG-
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc-
Confidence 8877666677777788888888774 45432 1222345666777766664 23211 1111222 2445555555431
Q ss_pred cccCCccccCCcccceeeccccccccc-CccccccccccccccccCc-cccCccccccccccccceeccccc-ccccCCC
Q 003780 254 NGSIPPEIGNMTGILKVDMSMNNIEGT-IPLELTRLSQLLYLSISSN-MLSGQIPITIAGLISLKGLDLSNN-KLSGPIP 330 (796)
Q Consensus 254 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~ 330 (796)
+.++.. +...+.++++|++|++++| .+++.....+..+++|++|+|++| .+++...
T Consensus 160 ---------------------~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l 218 (284)
T d2astb2 160 ---------------------KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218 (284)
T ss_dssp ---------------------GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGG
T ss_pred ---------------------cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHH
Confidence 112211 1122334566666666654 355555556666667777777763 4555555
Q ss_pred cccCCCCCCcEEEeecccccCCCCccccccccceEEecccccCCCCCccccccc
Q 003780 331 PEIGKCSELRNITLRNNNLSGSIPPEIGLMKLEYLDLSHNKLNGTIPPFLYHRF 384 (796)
Q Consensus 331 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~ 384 (796)
..++++++|+.|+++++ ++...-..+ ...+..|.+..++++...++.++...
T Consensus 219 ~~L~~~~~L~~L~l~~~-~~d~~l~~l-~~~lp~L~i~~~~ls~~~~~~~~~~~ 270 (284)
T d2astb2 219 LELGEIPTLKTLQVFGI-VPDGTLQLL-KEALPHLQINCSHFTTIARPTIGNKK 270 (284)
T ss_dssp GGGGGCTTCCEEECTTS-SCTTCHHHH-HHHSTTSEESCCCSCCTTCSSCSSTT
T ss_pred HHHhcCCCCCEEeeeCC-CCHHHHHHH-HHhCccccccCccCCCCCCCccCccc
Confidence 56677777888877766 221110000 12355556677788776666665543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=3.6e-15 Score=131.89 Aligned_cols=101 Identities=32% Similarity=0.377 Sum_probs=45.5
Q ss_pred EeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEccccc
Q 003780 125 YLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204 (796)
Q Consensus 125 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 204 (796)
+|||++|+|+ .++ .+.++++|++|+|++|+|+ .+|..++.+++|+.|++++|+|++. | .+.++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 4444444444 222 2444444555555555444 2334444444444444444444432 2 24444455555555554
Q ss_pred ccCcch-hhhcCCCCccccccCCcccc
Q 003780 205 LSGMLH-QELGKLKNLVALNVGGNKLM 230 (796)
Q Consensus 205 l~~~~~-~~~~~l~~L~~L~l~~N~l~ 230 (796)
|+.... ..+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 443321 33444444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=4.4e-15 Score=131.27 Aligned_cols=118 Identities=26% Similarity=0.342 Sum_probs=95.4
Q ss_pred cEEeccCCcccccCCcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeecccc
Q 003780 100 ESLSLRFNYLFGSIPSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN 179 (796)
Q Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 179 (796)
+.|+|++|+|+.. + .++++++|++|||++|.|+ .+|+.|+.+++|++|++++|+|++. | .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 5789999999844 4 4899999999999999998 5677899999999999999999954 4 5899999999999999
Q ss_pred ccCCCC-CccccCCCCccEEEcccccccCcc---hhhhcCCCCcccc
Q 003780 180 GLHGPI-PSAIGDLNNLLILSLDSNKLSGML---HQELGKLKNLVAL 222 (796)
Q Consensus 180 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L 222 (796)
+|+... ...+..+++|++|++++|.++... ......+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 998654 367889999999999999987432 2333445555443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.56 E-value=5.9e-17 Score=171.85 Aligned_cols=37 Identities=22% Similarity=0.354 Sum_probs=19.2
Q ss_pred CCCcEEEeecccccCCCC----ccc--cccccceEEecccccC
Q 003780 337 SELRNITLRNNNLSGSIP----PEI--GLMKLEYLDLSHNKLN 373 (796)
Q Consensus 337 ~~L~~L~L~~N~l~~~~~----~~~--~~~~L~~L~l~~N~l~ 373 (796)
+.|+.|+|++|+++.... ..+ ..++|++|+|++|++.
T Consensus 273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 446666666666553211 111 1345666666666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.55 E-value=1.4e-16 Score=168.81 Aligned_cols=136 Identities=18% Similarity=0.207 Sum_probs=73.3
Q ss_pred CCCccccccCCcccccc----CCCcccccCccceEEecccccccc-----CCccccCCcccceeeccccccccc----Cc
Q 003780 216 LKNLVALNVGGNKLMGP----IPSTLFRLTNLTYLYLHSNHLNGS-----IPPEIGNMTGILKVDMSMNNIEGT----IP 282 (796)
Q Consensus 216 l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 282 (796)
.+.|+.|++++|+++.. +...+...+.|++|+|++|+++.. +...+...++|+.|+|++|.++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 34455555555554421 112233445566666666655421 223344556666666666665432 33
Q ss_pred cccccccccccccccCccccCcccccc----c--cccccceecccccccccCC----CcccC-CCCCCcEEEeecccccC
Q 003780 283 LELTRLSQLLYLSISSNMLSGQIPITI----A--GLISLKGLDLSNNKLSGPI----PPEIG-KCSELRNITLRNNNLSG 351 (796)
Q Consensus 283 ~~l~~l~~L~~L~l~~N~l~~~~~~~~----~--~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~L~~N~l~~ 351 (796)
..+..+++|++|+|++|.|++.....+ . ..++|++|++++|+++... ...+. ++++|+.|+|++|++..
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 445566667777777776654322222 1 1346777788877775422 22232 46778888888888864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.44 E-value=1.6e-15 Score=146.25 Aligned_cols=115 Identities=27% Similarity=0.341 Sum_probs=78.4
Q ss_pred CcCccCCCCCcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCC
Q 003780 114 PSQVGALSKLRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLN 193 (796)
Q Consensus 114 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 193 (796)
|..+..+++|++|+|++|+|+. ++ .|.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+.. ..+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence 3456677777777777777774 33 4777777777777777776 4455555566777777777777743 3466677
Q ss_pred CccEEEcccccccCcch-hhhcCCCCccccccCCccccccC
Q 003780 194 NLLILSLDSNKLSGMLH-QELGKLKNLVALNVGGNKLMGPI 233 (796)
Q Consensus 194 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~ 233 (796)
+|+.|+|++|+++.... ..+..+++|+.|+|++|++....
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 156 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCc
Confidence 77777777777765533 45677777777777777765433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=3.3e-15 Score=144.08 Aligned_cols=112 Identities=27% Similarity=0.299 Sum_probs=61.3
Q ss_pred CCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEcccccccCcchhhhcCCC
Q 003780 138 PPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLK 217 (796)
Q Consensus 138 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 217 (796)
+..+..|++|++|+|++|+|+.. + .+.++++|+.|+|++|+|+. +|..+..+++|++|++++|+++.+ ..+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccc
Confidence 34456666666666666666632 3 36666666666666666653 344444445566666666666543 2345555
Q ss_pred CccccccCCccccccCC-CcccccCccceEEecccccc
Q 003780 218 NLVALNVGGNKLMGPIP-STLFRLTNLTYLYLHSNHLN 254 (796)
Q Consensus 218 ~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~ 254 (796)
+|+.|++++|+|+.... ..+..+++|+.|+|++|.+.
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccc
Confidence 55555555555543211 23445555555555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=6.5e-13 Score=122.30 Aligned_cols=81 Identities=22% Similarity=0.198 Sum_probs=34.4
Q ss_pred eecccCcCCCCCCCCCCCCCCCCEEEecCCC-CCCCCchhhhccCccceeeccccccCCCCCccccCCCCccEEEccccc
Q 003780 126 LDFSFNNLTGSIPPELGSLRNLEVLNLKGNN-LNGAIPSSLCQLTKLITMALSRNGLHGPIPSAIGDLNNLLILSLDSNK 204 (796)
Q Consensus 126 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 204 (796)
++.+++++. ..|..+..+++|++|+|++|+ |+.+.+..|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 444444443 233344444444444444332 443333344444444444444444444444444444444444444444
Q ss_pred ccC
Q 003780 205 LSG 207 (796)
Q Consensus 205 l~~ 207 (796)
|+.
T Consensus 92 l~~ 94 (156)
T d2ifga3 92 LES 94 (156)
T ss_dssp CSC
T ss_pred Ccc
Confidence 443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.1e-12 Score=120.72 Aligned_cols=83 Identities=16% Similarity=0.046 Sum_probs=38.1
Q ss_pred CCEEEecCCCCCCCCchhhhccCccceeecccc-ccCCCCCccccCCCCccEEEcccccccCcchhhhcCCCCccccccC
Q 003780 147 LEVLNLKGNNLNGAIPSSLCQLTKLITMALSRN-GLHGPIPSAIGDLNNLLILSLDSNKLSGMLHQELGKLKNLVALNVG 225 (796)
Q Consensus 147 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 225 (796)
.+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+..|.++++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555555555 33444444444455544433 2444334444444444444444444444444444444444444444
Q ss_pred Ccccc
Q 003780 226 GNKLM 230 (796)
Q Consensus 226 ~N~l~ 230 (796)
+|+|+
T Consensus 89 ~N~l~ 93 (156)
T d2ifga3 89 FNALE 93 (156)
T ss_dssp SSCCS
T ss_pred CCCCc
Confidence 44444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=1e-09 Score=101.25 Aligned_cols=120 Identities=24% Similarity=0.180 Sum_probs=63.3
Q ss_pred CcEeecccCcCCCCCCCCCCCCCCCCEEEecCCCCCCCCchhhhccCccceeeccccccCCCC--CccccCCCCccEEEc
Q 003780 123 LRYLDFSFNNLTGSIPPELGSLRNLEVLNLKGNNLNGAIPSSLCQLTKLITMALSRNGLHGPI--PSAIGDLNNLLILSL 200 (796)
Q Consensus 123 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L 200 (796)
.+.||++++... +.+..+..+..|++..|... .++..+.++++|++|+|++|+|+... +..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 444555544322 12333444444444444332 33444456666777777777766432 344556666777777
Q ss_pred ccccccCcchhhhcCCCCccccccCCccccccCCCc-------ccccCccceEE
Q 003780 201 DSNKLSGMLHQELGKLKNLVALNVGGNKLMGPIPST-------LFRLTNLTYLY 247 (796)
Q Consensus 201 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-------l~~l~~L~~L~ 247 (796)
++|.|+.+.+-.+....+|+.|++++|.+....... +..+|+|+.||
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 777666554433334445667777777666443321 33455666543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=2.2e-09 Score=98.91 Aligned_cols=82 Identities=22% Similarity=0.222 Sum_probs=38.0
Q ss_pred cCCCCccccccCCccccccC--CCcccccCccceEEeccccccccCCccccCCcccceeecccccccccCcc-------c
Q 003780 214 GKLKNLVALNVGGNKLMGPI--PSTLFRLTNLTYLYLHSNHLNGSIPPEIGNMTGILKVDMSMNNIEGTIPL-------E 284 (796)
Q Consensus 214 ~~l~~L~~L~l~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~ 284 (796)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|+++...+-.+....+|+.|++++|.+.+.... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 34445555555555554321 22334445555555555555532221222333455555555555533221 2
Q ss_pred ccccccccccc
Q 003780 285 LTRLSQLLYLS 295 (796)
Q Consensus 285 l~~l~~L~~L~ 295 (796)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 44566777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=2.5e-06 Score=84.61 Aligned_cols=149 Identities=15% Similarity=0.088 Sum_probs=101.1
Q ss_pred HHHHHHhcCCccceeeecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-CCceeeEEeEEEec
Q 003780 492 EDIIKATEDFDIKYCIGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-HRNIVKLYGFCLHK 570 (796)
Q Consensus 492 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 570 (796)
+++.+..+.|+..+..+.++.+.||+... +++.+++|+........ ...+.+|..+++.+. +--+.+++.+...+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 35666667787666655555678999875 46667888876554332 224677888877764 32356778888888
Q ss_pred ceeeEEEeeccCCcHHHHHhhcCcccccCHHHHHHHHHHHHHHHHHHhhcC-----------------------------
Q 003780 571 KCMFLIYKYMKRGSLFCFLRNDYEAVVLDWTMRVNIIKCVANALSYLHHDC----------------------------- 621 (796)
Q Consensus 571 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------- 621 (796)
+..++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 99999999999988865443211 12234555555566666420
Q ss_pred ---------------------------CCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 622 ---------------------------MPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 622 ---------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.+.++|+|+.|.||++++++..-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999987666799998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=1.1e-05 Score=79.39 Aligned_cols=74 Identities=18% Similarity=0.132 Sum_probs=54.0
Q ss_pred eeecccc-eeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCC--CceeeEEeEEEecceeeEEEeeccC
Q 003780 506 CIGTGGY-GSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAH--RNIVKLYGFCLHKKCMFLIYKYMKR 582 (796)
Q Consensus 506 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~ 582 (796)
.+..|.. +.||+....++..+++|....... ..+..|...++.+.. -.+.+++++..+++..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 4455553 678999988888899997654432 246677887777642 3356778888888899999999988
Q ss_pred CcH
Q 003780 583 GSL 585 (796)
Q Consensus 583 gsL 585 (796)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.83 E-value=3.1e-06 Score=77.55 Aligned_cols=16 Identities=31% Similarity=0.426 Sum_probs=8.1
Q ss_pred CCCCccEEEccccccc
Q 003780 191 DLNNLLILSLDSNKLS 206 (796)
Q Consensus 191 ~l~~L~~L~L~~N~l~ 206 (796)
..+.|++|+|++|.++
T Consensus 70 ~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLT 85 (167)
T ss_dssp HCSSCCEEECCSSBCC
T ss_pred hcccccceeeehhhcc
Confidence 3344555555555554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.82 E-value=2.2e-06 Score=78.62 Aligned_cols=40 Identities=13% Similarity=0.089 Sum_probs=18.2
Q ss_pred ccCccceeeccccccCCC----CCccccCCCCccEEEccccccc
Q 003780 167 QLTKLITMALSRNGLHGP----IPSAIGDLNNLLILSLDSNKLS 206 (796)
Q Consensus 167 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 206 (796)
..+.|++|+|++|.|+.. +...+...++|++|+|++|.+.
T Consensus 70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 334455555555544421 1122334455666666555443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00046 Score=72.00 Aligned_cols=79 Identities=10% Similarity=0.095 Sum_probs=49.3
Q ss_pred ceeeecccceeEEEEEccC-CcEEEEEEeccccch----hhHHHHHHHHHHHHHhhcC-C--CceeeEEeEEEecceeeE
Q 003780 504 KYCIGTGGYGSVYKAQLPN-GKVVALKKLHRAETE----ETTFFNSFQNEAHVLSKIA-H--RNIVKLYGFCLHKKCMFL 575 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~~~~l 575 (796)
.+.||.|....||++...+ ++.++||.-...... ......+...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998654 678999975432111 0111234566888887663 2 345555554 4556789
Q ss_pred EEeeccCCc
Q 003780 576 IYKYMKRGS 584 (796)
Q Consensus 576 V~e~~~~gs 584 (796)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.22 E-value=3.3e-05 Score=70.40 Aligned_cols=16 Identities=13% Similarity=0.237 Sum_probs=7.4
Q ss_pred CCCCCCEEEecCCCCC
Q 003780 143 SLRNLEVLNLKGNNLN 158 (796)
Q Consensus 143 ~l~~L~~L~L~~N~l~ 158 (796)
..++|++|+|++|.++
T Consensus 44 ~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCCSCCEEECTTSCCC
T ss_pred cCCccCeeeccCCccc
Confidence 3444444444444443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.20 E-value=2.1e-05 Score=71.80 Aligned_cols=17 Identities=0% Similarity=-0.099 Sum_probs=8.5
Q ss_pred cCCCCCcEeecccCcCC
Q 003780 118 GALSKLRYLDFSFNNLT 134 (796)
Q Consensus 118 ~~l~~L~~L~Ls~n~l~ 134 (796)
...++|++|+|++|.++
T Consensus 43 ~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TTCCSCCEEECTTSCCC
T ss_pred hcCCccCeeeccCCccc
Confidence 34445555555555444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.67 E-value=0.0036 Score=63.16 Aligned_cols=136 Identities=13% Similarity=0.174 Sum_probs=78.1
Q ss_pred ceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCc-----eeeE--EeEEEecceeeEEEeeccCCc
Q 003780 512 YGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRN-----IVKL--YGFCLHKKCMFLIYKYMKRGS 584 (796)
Q Consensus 512 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-----iv~l--~~~~~~~~~~~lV~e~~~~gs 584 (796)
--.||+++.++|+.|++|..+..... .+++..|.+.+..+.... .+.. -......+..+.|+++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 35899999999999999998765433 246777888887764211 1111 112345667888999988653
Q ss_pred HH-----H---------HHhhc------CcccccCHH-------------------HHHHHHHHHHHHHHHHhh----cC
Q 003780 585 LF-----C---------FLRND------YEAVVLDWT-------------------MRVNIIKCVANALSYLHH----DC 621 (796)
Q Consensus 585 L~-----~---------~l~~~------~~~~~l~~~-------------------~~~~i~~~ia~~L~~LH~----~~ 621 (796)
+. . .+|.. ..+...++. .+..+...+.+.++.+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 21 1 11110 000111111 111122222333333322 22
Q ss_pred CCCeEEecCCCCCeEecCCCcEEEeeeccccc
Q 003780 622 MPSIVHRDISSNNILLNSKLEAFVADFGTARL 653 (796)
Q Consensus 622 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 653 (796)
+.++||+|+.+.|||++++ ..++||+.+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4578999999999999754 45899998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.44 E-value=0.0079 Score=60.17 Aligned_cols=158 Identities=11% Similarity=0.018 Sum_probs=83.4
Q ss_pred ccHHHHHHHhcCCcccee-----eecccceeEEEEEccCCcEEEEEEeccccchhhHHHHHHHHHHHHHhhcC-----CC
Q 003780 489 IAFEDIIKATEDFDIKYC-----IGTGGYGSVYKAQLPNGKVVALKKLHRAETEETTFFNSFQNEAHVLSKIA-----HR 558 (796)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp 558 (796)
++.+++.....+|.+.+. |..|---+.|+.+..+|+ +++|+....... +++..|++++..+. .|
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH-----HHHHHHHHHHHhhhhcccccc
Confidence 466788888888987544 345666788999876665 899988653221 24555676766663 22
Q ss_pred ceeeEEe---EEEecceeeEEEeeccCCcHHH--------------HHhhcC------ccc------------------c
Q 003780 559 NIVKLYG---FCLHKKCMFLIYKYMKRGSLFC--------------FLRNDY------EAV------------------V 597 (796)
Q Consensus 559 niv~l~~---~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~------~~~------------------~ 597 (796)
..+...+ +....+....++.+..+..... .++... ... .
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 2221100 1122445556666665542210 111000 000 0
Q ss_pred cCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecCCCCCeEecCCCcEEEeeecccc
Q 003780 598 LDWTMRVNIIKCVANALSYLHH-DCMPSIVHRDISSNNILLNSKLEAFVADFGTAR 652 (796)
Q Consensus 598 l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 652 (796)
.........+......+...+. ..+.++||+|+.++||+++.+...-|.||+.+.
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011111122222222222222 234479999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.72 E-value=0.011 Score=61.29 Aligned_cols=73 Identities=21% Similarity=0.274 Sum_probs=47.1
Q ss_pred ceeeecccceeEEEEEccC--------CcEEEEEEeccccchhhHHHHHHHHHHHHHhhcCCCce-eeEEeEEEecceee
Q 003780 504 KYCIGTGGYGSVYKAQLPN--------GKVVALKKLHRAETEETTFFNSFQNEAHVLSKIAHRNI-VKLYGFCLHKKCMF 574 (796)
Q Consensus 504 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~ 574 (796)
.+.|+.|-.-.+|++..++ .+.|.+++...... .-...+|..+++.+.-.++ .++++++.. .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 3568888889999997653 34566666543221 1234578888888753333 467776642 5
Q ss_pred EEEeeccCCcH
Q 003780 575 LIYKYMKRGSL 585 (796)
Q Consensus 575 lV~e~~~~gsL 585 (796)
.|+||+++..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987544
|